PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, Y; Cheng, Y; Ren, X; Zhang, L; Yap, KL; Wu, H; Patel, R; Liu, D; Qin, ZH; Shih, IM; Yang, JM				Zhang, Y.; Cheng, Y.; Ren, X.; Zhang, L.; Yap, K. L.; Wu, H.; Patel, R.; Liu, D.; Qin, Z-H; Shih, I-M; Yang, J-M			NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response	ONCOGENE			English	Article						NAC1; autophagy; apoptosis; HMGB1; cisplatin; ovarian cancer	EMBRYONIC STEM-CELLS; HMGB1 RELEASE; REGULATES AUTOPHAGY; MEDIATED AUTOPHAGY; PROTEIN NAC-1; TUMOR-CELLS; RESISTANCE; CARCINOMA; APOPTOSIS; PLURIPOTENCY	Nucleus accumbens-1 (NAC1), a nuclear factor belonging to the BTB/POZ gene family, is known to have important roles in proliferation and growth of tumor cells and in chemotherapy resistance. Yet, the mechanisms underlying how NAC1 contributes to drug resistance remain largely unclear. We report here that autophagy was involved in NAC1-mediated resistance to cisplatin, a commonly used chemotherapeutic drug in the treatment of ovarian cancer. We found that treatment with cisplatin caused an activation of autophagy in ovarian cancer cell lines, A2780, OVCAR3 and SKOV3. We further demonstrated that knockdown of NAC1 by RNA interference or inactivation of NAC1 by inducing the expression of a NAC1 deletion mutant that contains only the BTB/POZ domain significantly inhibited the cisplatin-induced autophagy, resulting in increased cisplatin cytotoxicity. Moreover, inhibition of autophagy and sensitization to cisplatin by NAC1 knockdown or inactivation were accompanied by induction of apoptosis. To confirm that the sensitizing effect of NAC1 inhibition on the cytotoxicity of cisplatin was attributed to suppression of autophagy, we assessed the effects of the autophagy inhibitors 3-methyladenosine and chloroquine, and small interfering RNAs (siRNAs) targeting beclin 1 or Atg5 on the cytotoxicity of cisplatin. Treatment with 3-methyladenosine, chloroquine or beclin 1 and Atg5-targeted siRNA also enhanced the sensitivity of SKOV3, A2780 and OVCAR3 cells to cisplatin, indicating that suppression of autophagy indeed renders tumor cells more sensitive to cisplatin. Regulation of autophagy by NAC1 was mediated by the high-mobility group box 1 (HMGB1), as the functional status of NAC1 was associated with the expression, translocation and release of HMGB1. The results of our study not only revealed a new mechanism determining cisplatin sensitivity but also identified NAC1 as a novel regulator of autophagy. Thus, the NAC1-mediated autophagy may be exploited as a new target for enhancing the efficacy of cisplatin against ovarian cancer and other types of malignancies. Oncogene (2012) 31, 1055-1064; doi:10.1038/onc.2011.290; published online 11 July 2011	[Zhang, Y.; Cheng, Y.; Ren, X.; Liu, D.; Yang, J-M] Penn State Univ, Dept Pharmacol, Penn State Hershey Canc Inst, Coll Med, Hershey, PA 17033 USA; [Zhang, Y.; Cheng, Y.; Ren, X.; Liu, D.; Yang, J-M] Penn State Univ Hosp, Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Zhang, Y.; Zhang, L.; Qin, Z-H; Yang, J-M] Soochow Univ, Sch Pharm, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Yap, K. L.; Shih, I-M] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD USA; [Yap, K. L.; Shih, I-M] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD USA; [Yap, K. L.; Shih, I-M] Johns Hopkins Univ, Sch Med, Dept Obstet Gynecol, Baltimore, MD USA; [Wu, H.; Patel, R.] Univ Med & Dent New Jersey, Dept Pathol, Robert Wood Johnson Med Sch, Newark, NJ 07103 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Soochow University - China; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yang, JM (corresponding author), Penn State Univ, Dept Pharmacol, Penn State Hershey Canc Inst, Coll Med, CH74,500 Univ Dr,POB 850, Hershey, PA 17033 USA.	shihie@yahoo.com; juy16@psu.edu	sdsd, shihieih/ABE-6190-2020	Yap, Kai Lee/0000-0003-4496-5464	US Public Health Service [R01CA135038, RO1CA103937]; Penn State College of Medicine; NATIONAL CANCER INSTITUTE [R01CA135038, R01CA103937] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Penn State College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the US Public Health Service (R01CA135038 and RO1CA103937) and the Penn State College of Medicine	Borst P, 2008, CELL CYCLE, V7, P1353, DOI 10.4161/cc.7.10.5930; Cheng Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009715; Davidson B, 2007, HUM PATHOL, V38, P1030, DOI 10.1016/j.humpath.2006.12.009; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Fanzani A, 2011, TOXICOL APPL PHARM, V250, P312, DOI 10.1016/j.taap.2010.11.003; Harhaji-Trajkovic L, 2009, J CELL MOL MED, V13, P3644, DOI 10.1111/j.1582-4934.2009.00663.x; He Q, 2000, P NATL ACAD SCI USA, V97, P5768, DOI 10.1073/pnas.100108697; Jinawath N, 2009, ONCOGENE, V28, P1941, DOI 10.1038/onc.2009.37; Kaushal GP, 2008, AUTOPHAGY, V4, P710, DOI 10.4161/auto.6309; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Liu D., 2009, MED ONCOL, V28, P105; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nagatani G, 2001, CANCER RES, V61, P1592; Nakayama K, 2007, CANCER RES, V67, P8058, DOI 10.1158/0008-5472.CAN-07-1357; Nakayama K, 2006, P NATL ACAD SCI USA, V103, P18739, DOI 10.1073/pnas.0604083103; Nakayama K, 2006, CANCER BIOL THER, V5, P630, DOI 10.4161/cbt.5.6.2675; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; Ren JH, 2010, CANCER BIOTHER RADIO, V25, P75, DOI 10.1089/cbr.2009.0701; Sharma A, 2009, DNA CELL BIOL, V28, P311, DOI 10.1089/dna.2009.0851; Sun Y, 2010, CANCER LETT, V294, P204, DOI 10.1016/j.canlet.2010.02.001; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Thorburn J, 2009, AUTOPHAGY, V5, P247, DOI 10.4161/auto.5.2.7552; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang J, 2007, CANCER RES, V67, P11933, DOI 10.1158/0008-5472.CAN-07-5185; Wei M, 2003, J BIOL CHEM, V278, P1769, DOI 10.1074/jbc.M210562200; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wu H, 2009, CANCER RES, V69, P2453, DOI 10.1158/0008-5472.CAN-08-2872; Yeasmin S, 2008, CLIN CANCER RES, V14, P1686, DOI 10.1158/1078-0432.CCR-07-4085	32	88	93	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	8					1055	1064		10.1038/onc.2011.290	http://dx.doi.org/10.1038/onc.2011.290			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21743489	Green Accepted			2022-12-25	WOS:000300709700011
J	Sorrentino, V; Scheer, L; Santos, A; Reits, E; Bleijlevens, B; Zelcer, N				Sorrentino, Vincenzo; Scheer, Lilith; Santos, Ana; Reits, Eric; Bleijlevens, Boris; Zelcer, Noam			Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING DOMAIN; FAMILIAL HYPERCHOLESTEROLEMIA; DEPENDENT UBIQUITINATION; POLYUBIQUITIN CHAIN; ADAPTER PROTEIN; ERM PROTEINS; COMPLEX; MUTATIONS; BINDING; INTEGRATORS	We recently identified the liver X receptor-regulated E3 ubiquitin ligase inducible degrader of the LDL receptor (IDOL) as a modulator of lipoprotein metabolism. Acting as an E3 ubiquitin ligase, IDOL triggers ubiquitination and subsequent degradation of the low density lipoprotein receptor (LDLR). We demonstrate here that this outcome requires the conserved FERM and RING domains present in IDOL. The RING domain promotes ubiquitination in vitro and Lys-63-specific ubiquitination of the LDLR in vivo in response to IDOL or liver X receptor activation. We further identify RING residues that differentially influence ubiquitination of the LDLR or stability of IDOL. The FERM domain interacts with the LDLR and in living cells co-localizes with the receptor at the plasma membrane. Homology modeling revealed a phosphotyrosine-binding element embedded in the FERM domain. Mutating residues within this region or residues in the LDLR preceding the NPVY endocytosis motif abrogate LDLR degradation by IDOL. Collectively, our results indicate that both the FERM and RING domains are required for promoting lysosomal degradation of the LDLR by IDOL. Our findings may facilitate development of structure-based IDOL inhibitors aimed at increasing LDLR abundance in therapeutic strategies to treat cardiovascular disease.	[Sorrentino, Vincenzo; Scheer, Lilith; Santos, Ana; Bleijlevens, Boris; Zelcer, Noam] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Reits, Eric] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Zelcer, N (corresponding author), Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	n.zelcer@amc.uva.nl	; Sorrentino, Vincenzo/R-4403-2018	Zelcer, Noam/0000-0001-6935-7532; Sorrentino, Vincenzo/0000-0002-7212-370X	Human Frontier Science Program Organization; Netherlands Organization for Scientific Research	Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by a career development award from the Human Frontier Science Program Organization and by a VIDI grant from the Netherlands Organization for Scientific Research. To whom correspondence should be addressed: Meibergdreef 15, 1105 AZ Amsterdam, The Netherlands. Tel.: 31-20-5665131; Fax: 31-20-6915519; E-mail: n.zelcer@amc.uva.nl.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Beffert U, 2006, J NEUROSCI, V26, P2041, DOI 10.1523/JNEUROSCI.4566-05.2006; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dodd RB, 2004, J BIOL CHEM, V279, P53840, DOI 10.1074/jbc.M409662200; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Han BG, 2000, NAT STRUCT BIOL, V7, P871; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Michaely P, 2004, J BIOL CHEM, V279, P34023, DOI 10.1074/jbc.M405242200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	37	37	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30190	30199		10.1074/jbc.M111.249557	http://dx.doi.org/10.1074/jbc.M111.249557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21734303	hybrid, Green Published			2022-12-25	WOS:000294046600076
J	Christopher, S; Verghis, RM; Antonisamy, B; Sowmyanarayanan, TV; Brahmadathan, KN; Kang, G; Cooper, B				Christopher, Solomon; Verghis, Rejina Mariam; Antonisamy, Belavendra; Sowmyanarayanan, Thuppal Varadachari; Brahmadathan, Kootallur Narayanan; Kang, Gagandeep; Cooper, Ben Symons			Transmission Dynamics of Methicillin-Resistant Staphylococcus aureus in a Medical Intensive Care Unit in India	PLOS ONE			English	Article							INFECTION-CONTROL; COLONIZATION; PATHOGENS; HOSPITALS; ROUTES	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a global pathogen and an important but seldom investigated cause of morbidity and mortality in lower and middle-income countries where it can place a major burden on limited resources. Quantifying nosocomial transmission in resource-poor settings is difficult because molecular typing methods are prohibitively expensive. Mechanistic statistical models can overcome this problem with minimal cost. We analyse the transmission dynamics of MRSA in a hospital in south India using one such approach and provide conservative estimates of the organism's economic burden. Methods and Findings: Fifty months of MRSA infection data were collected retrospectively from a Medical Intensive Care Unit (MICU) in a tertiary hospital in Vellore, south India. Data were analysed using a previously described structured hidden Markov model. Seventy-two patients developed MRSA infections and, of these, 49 (68%) died in the MICU. We estimated that 4.2% (95% CI 1.0, 19.0) of patients were MRSA-positive when admitted, that there were 0.39 MRSA infections per colonized patient month (0.06, 0.73), and that the ward-level reproduction number for MRSA was 0.42 (0.08, 2.04). Anti-MRSA antibiotic treatment costs alone averaged $124/patient, over three times the monthly income of more than 40% of the Indian population. Conclusions: Our analysis of routine data provides the first estimate of the nosocomial transmission potential of MRSA in India. The high levels of transmission estimated underline the need for cost-effective interventions to reduce MRSA transmission in hospital settings in low and middle income countries.	[Christopher, Solomon; Antonisamy, Belavendra] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Verghis, Rejina Mariam] Royal Hosp, NI Clin Res Support Ctr, Belfast, Antrim, North Ireland; [Cooper, Ben Symons] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Cooper, Ben Symons] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Sowmyanarayanan, Thuppal Varadachari; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Brahmadathan, Kootallur Narayanan] Christian Med Coll & Hosp, Dept Microbiol, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Christopher, S (corresponding author), Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India.	solomon.christopher@gmail.com	Cooper, Ben/HGC-7082-2022; Verghis, Rejina/I-3887-2016	Kang, Gagandeep/0000-0002-3656-564X; Cooper, Ben/0000-0002-9445-7217; Verghis, Rejina/0000-0002-8322-213X				Allegranzi B, 2008, SUMMARY EVIDENCE PAT; Allegranzi B, 2008, LANCET, V372, P1719, DOI 10.1016/S0140-6736(08)61715-8; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Bootsma MCJ, 2007, AM J EPIDEMIOL, V166, P841, DOI 10.1093/aje/kwm149; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Chen S.H., 2008, WIDER WORKING PAPER; Cooper B, 2004, BIOSTATISTICS, V5, P223, DOI 10.1093/biostatistics/5.2.223; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Forrester M, 2005, INFECT CONT HOSP EP, V26, P598, DOI 10.1086/502588; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Lynch P, 2007, J HOSP INFECT, V65, P148, DOI 10.1016/S0195-6701(07)60033-4; McBryde ES, 2007, J R SOC INTERFACE, V4, P745, DOI 10.1098/rsif.2007.0224; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; Mehta A, 1996, J Postgrad Med, V42, P1; Nickerson EK, 2006, LANCET INFECT DIS, V6, P70, DOI 10.1016/S1473-3099(06)70363-2; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; Pittet D, 2008, J HOSP INFECT, V68, P285, DOI 10.1016/j.jhin.2007.12.013; R Development Core Team, 2007, R LANG ENV STAT COMP; Rajaduraipandi K, 2006, Indian J Med Microbiol, V24, P34	24	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20604	10.1371/journal.pone.0020604	http://dx.doi.org/10.1371/journal.pone.0020604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750700	Green Submitted, gold, Green Published			2022-12-25	WOS:000292512000006
J	Mironczuk, AM; Manu, A; Kuipers, OP; Kovacs, AT				Mironczuk, Aleksandra M.; Manu, Amagoia; Kuipers, Oscar P.; Kovacs, Akos T.			Distinct Roles of ComK1 and ComK2 in Gene Regulation in Bacillus cereus	PLOS ONE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; SUBTILIS K-STATE; STREPTOCOCCUS-LACTIS; EXPRESSION DATA; TRANSFORMATION; DNA; PROTEIN; ANTHRACIS; BINDING; OPERON	The B. subtilis transcriptional factor ComK regulates a set of genes coding for DNA uptake from the environment and for its integration into the genome. In previous work we showed that Bacillus cereus expressing the B. subtilis ComK protein is able to take up DNA and integrate it into its own genome. To extend our knowledge on the effect of B. subtilis ComK overexpression in B. cereus we first determined which genes are significantly altered. Transcriptome analysis showed that only part of the competence gene cluster is significantly upregulated. Two ComK homologues can be identified in B. cereus that differ in their respective homologies to other ComK proteins. ComK1 is most similar, while ComK2 lacks the C-terminal region previously shown to be important for transcription activation by B. subtilis ComK. comK1 and comK2 overexpression and deletion studies using transcriptomics techniques showed that ComK1 enhances and ComK2 decreases expression of the comG operon, when B. subtilis ComK was overexpressed simultaneously.	[Mironczuk, Aleksandra M.; Manu, Amagoia; Kuipers, Oscar P.; Kovacs, Akos T.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, Groningen, Netherlands; [Kuipers, Oscar P.] Kluyver Ctr Genom Ind Fermentat, Groningen, Netherlands	University of Groningen	Mironczuk, AM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Genet Grp, Groningen, Netherlands.	o.p.kuipers@rug.nl	Kuipers, Oscar/B-6752-2009; Mironczuk, Aleksandra/A-1823-2017; Kovács, Ákos T/A-9433-2015	Kuipers, Oscar/0000-0001-5596-7735; Mironczuk, Aleksandra/0000-0003-1604-1635; Kovács, Ákos T/0000-0002-4465-1636	ALW-NWO [818.02.004]	ALW-NWO(Netherlands Organization for Scientific Research (NWO))	ATK was financially supported by Grant 818.02.004 from ALW-NWO Open programma. This project was carried out within the research programme of the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikaga S, 2000, J BACTERIOL, V182, P2411, DOI 10.1128/JB.182.9.2411-2415.2000; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; den Hengst CD, 2005, J BIOL CHEM, V280, P34332, DOI 10.1074/jbc.M502349200; DSOUZA C, 1994, P NATL ACAD SCI USA, V91, P9397, DOI 10.1073/pnas.91.20.9397; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; GASSON MJ, 1983, J BACTERIOL, V154, P1; Burgos MJG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-227; Granum PE, 1997, FEMS MICROBIOL LETT, V157, P223, DOI 10.1016/S0378-1097(97)00438-2; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; HAHN J, 1993, MOL MICROBIOL, V10, P99, DOI 10.1111/j.1365-2958.1993.tb00907.x; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 1998, GENE DEV, V12, P1539, DOI 10.1101/gad.12.10.1539; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; Hamoen LW, 2002, NUCLEIC ACIDS RES, V30, P5517, DOI 10.1093/nar/gkf698; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoffmann K, 2010, APPL ENVIRON MICROB, V76, P8211, DOI 10.1128/AEM.01404-10; Holo H, 1995, Methods Mol Biol, V47, P195; INAMINE GS, 1995, J BACTERIOL, V177, P3045, DOI 10.1128/jb.177.11.3045-3051.1995; KONG LY, 1993, MOL MICROBIOL, V9, P365, DOI 10.1111/j.1365-2958.1993.tb01697.x; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Kovacs AT, 2009, ENVIRON MICROBIOL, V11, P1911, DOI 10.1111/j.1462-2920.2009.01937.x; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONDONOVALLEJO JA, 1993, MOL MICROBIOL, V9, P119, DOI 10.1111/j.1365-2958.1993.tb01674.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mironczuk AM, 2008, MICROB BIOTECHNOL, V1, P226, DOI 10.1111/j.1751-7915.2008.00023.x; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009724; Provvedi R, 2001, MOL MICROBIOL, V40, P634, DOI 10.1046/j.1365-2958.2001.02406.x; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Serror P, 1996, J BACTERIOL, V178, P5910, DOI 10.1128/jb.178.20.5910-5915.1996; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Susanna KA, 2006, MICROBIOL-SGM, V152, P473, DOI 10.1099/mic.0.28357-0; Susanna KA, 2004, J BACTERIOL, V186, P1120, DOI 10.1128/JB.186.4.1120-1128.2004; THORNE CB, 1966, J BACTERIOL, V91, P1012, DOI 10.1128/JB.91.3.1012-1020.1966; TRIEUCUOT P, 1991, GENE, V106, P21, DOI 10.1016/0378-1119(91)90561-O; TRIEUCUOT P, 1988, J BACTERIOL, V170, P4388, DOI 10.1128/jb.170.9.4388-4391.1988; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Turgay K, 1998, EMBO J, V17, P6730; van Hijum SAFT, 2003, BIOINFORMATICS, V19, P1580, DOI 10.1093/bioinformatics/btg203; VANSINDEREN D, 1994, J BACTERIOL, V176, P5762, DOI 10.1128/JB.176.18.5762-5770.1994	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21859	10.1371/journal.pone.0021859	http://dx.doi.org/10.1371/journal.pone.0021859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747963	gold, Green Published, Green Submitted			2022-12-25	WOS:000292293400039
J	Belda, E; Pedrola, L; Pereto, J; Martinez-Blanch, JF; Montagud, A; Navarro, E; Urchueguia, J; Ramon, D; Moya, A; Porcar, M				Belda, Eugeni; Pedrola, Laia; Pereto, Juli; Martinez-Blanch, Juan F.; Montagud, Arnau; Navarro, Emilio; Urchueguia, Javier; Ramon, Daniel; Moya, Andres; Porcar, Manuel			Microbial Diversity in the Midguts of Field and Lab-Reared Populations of the European Corn Borer Ostrinia nubilalis	PLOS ONE			English	Article							CELLULOLYTIC BACTERIUM; GLYCOSIDE HYDROLASES; FUNCTIONAL-ANALYSIS; MULTIPLE ALIGNMENT; COMMUNITY; GUT; METAGENOMICS; RECONSTRUCTION; LEPIDOPTERA; ENVIRONMENT	Background: Insects are associated with microorganisms that contribute to the digestion and processing of nutrients. The European Corn Borer (ECB) is a moth present world-wide, causing severe economical damage as a pest on corn and other crops. In the present work, we give a detailed view of the complexity of the microorganisms forming the ECB midgut microbiota with the objective of comparing the biodiversity of the midgut-associated microbiota and explore their potential as a source of genes and enzymes with biotechnological applications. Methodological/Principal Findings: A high-throughput sequencing approach has been used to identify bacterial species, genes and metabolic pathways, particularly those involved in plant-matter degradation, in two different ECB populations (field-collected vs. lab-reared population with artificial diet). Analysis of the resulting sequences revealed the massive presence of Staphylococcus warneri and Weissella paramesenteroides in the lab-reared sample. This enabled us to reconstruct both genomes almost completely. Despite the apparently low diversity, 208 different genera were detected in the sample, although most of them at very low frequency. By contrast, the natural population exhibited an even higher taxonomic diversity along with a wider array of cellulolytic enzyme families. However, in spite of the differences in relative abundance of major taxonomic groups, not only did both metagenomes share a similar functional profile but also a similar distribution of non-redundant genes in different functional categories. Conclusions/Significance: Our results reveal a highly diverse pool of bacterial species in both O. nubilalis populations, with major differences: The lab-reared sample is rich in gram-positive species (two of which have almost fully sequenced genomes) while the field sample harbors mainly gram-negative species and has a larger set of cellulolytic enzymes. We have found a clear relationship between the diet and the midgut microbiota, which reveals the selection pressure of food on the community of intestinal bacteria.	[Belda, Eugeni; Pereto, Juli; Moya, Andres; Porcar, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain; [Belda, Eugeni; Montagud, Arnau; Urchueguia, Javier] Univ Politecn Valencia, Inst Univ Matemat Pura & Aplicada, E-46071 Valencia, Spain; [Pedrola, Laia; Martinez-Blanch, Juan F.; Ramon, Daniel] Lifesequencing, Valencia, Spain; [Navarro, Emilio] Univ Malaga, Dept Lenguajes & Ciencias Computac, E-29071 Malaga, Spain	University of Valencia; Universitat Politecnica de Valencia; Universidad de Malaga	Belda, E (corresponding author), CEA GENOSCOPE, Lab Anal Bioinformat Genom & Metab, Evry, France.	manuel.porcar@uv.es	Navarro, Emilio/A-1420-2013; M, Juan/ABB-8388-2021; Montagud, Arnau/B-8001-2008; Urchueguia, Javier F./AAD-7469-2021; Peretó, Juli/G-5969-2015; Porcar, Manuel/D-2503-2010; Moya, Andrés/A-8190-2008; Belda, Eugeni/ABI-1349-2020	Navarro, Emilio/0000-0002-0608-2129; M, Juan/0000-0002-9340-6207; Montagud, Arnau/0000-0002-7696-1241; Peretó, Juli/0000-0002-5756-1517; Porcar, Manuel/0000-0002-7916-9479; Moya, Andrés/0000-0002-2867-1119; Belda, Eugeni/0000-0003-4307-5072; Pedrola, Laia/0000-0002-3031-6124; Urchueguia, Javier F./0000-0002-3054-3431	Spanish Ministerio de Ciencia e Innovacion [CIT-010000-2008-5]; MICINN (Ministerio de Ciencia e Innovacion) [TIN2009-12359]; Generalitat Valenciana grant [BFPI/2007/283]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MICINN (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana grant(Center for Forestry Research & Experimentation (CIEF))	The research was funded by the Spanish Ministerio de Ciencia e Innovacion, under grant agreement CIT-010000-2008-5 and by a MICINN (Ministerio de Ciencia e Innovacion) TIN2009-12359 ArtBioCom project. Arnau Montagud acknowledges Generalitat Valenciana grant BFPI/2007/283. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, DNA CELL BIOL, V28, P109, DOI 10.1089/dna.2008.0812; Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand AAP, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.10701; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Burnum KE, 2011, ISME J, V5, P161, DOI 10.1038/ismej.2010.97; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chaves Sandra, 2009, Biotechnology Journal, V4, P1753, DOI 10.1002/biot.200800237; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Diaz-Mendoza M, 2005, INSECT BIOCHEM MOLEC, V35, P1005, DOI 10.1016/j.ibmb.2005.04.003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Enright AJ, 2003, NUCLEIC ACIDS RES, V31, P4632, DOI 10.1093/nar/gkg495; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GRINGORTEN JL, 1993, J EXP BIOL, V183, P353; Guan CH, 2007, APPL ENVIRON MICROB, V73, P3669, DOI 10.1128/AEM.02617-06; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Kato S, 2005, APPL ENVIRON MICROB, V71, P7099, DOI 10.1128/AEM.71.11.7099-7106.2005; Kelley ST, 2011, GENETICA, V139, P541, DOI 10.1007/s10709-010-9498-0; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morrison M, 2009, CURR OPIN BIOTECH, V20, P358, DOI 10.1016/j.copbio.2009.05.004; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; POITOUT S, 1974, ANN NUTR ALIMENT, V28, P173; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pytelkova J, 2009, FEBS J, V276, P3531, DOI 10.1111/j.1742-4658.2009.07074.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robert C, 2007, INT J SYST EVOL MICR, V57, P1516, DOI 10.1099/ijs.0.64998-0; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van der Hoeven R, 2008, FEMS MICROBIOL LETT, V286, P249, DOI 10.1111/j.1574-6968.2008.01277.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wilm A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn174; Wilson DB, 2008, ANN NY ACAD SCI, V1125, P289, DOI 10.1196/annals.1419.026; Zhu YT, 2010, BIORESOURCE TECHNOL, V101, P6432, DOI 10.1016/j.biortech.2010.03.041	44	53	55	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21751	10.1371/journal.pone.0021751	http://dx.doi.org/10.1371/journal.pone.0021751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738787	Green Published, gold			2022-12-25	WOS:000292291800039
J	Bejon, P; Turner, L; Lavstsen, T; Cham, G; Olotu, A; Drakeley, CJ; Lievens, M; Vekemans, J; Savarese, B; Lusingu, J; von Seidlein, L; Bull, PC; Marsh, K; Theander, TG				Bejon, Philip; Turner, Louise; Lavstsen, Thomas; Cham, Gerald; Olotu, Ally; Drakeley, Chris J.; Lievens, Marc; Vekemans, Johan; Savarese, Barbara; Lusingu, John; von Seidlein, Lorenz; Bull, Peter C.; Marsh, Kevin; Theander, Thor G.			Serological Evidence of Discrete Spatial Clusters of Plasmodium falciparum Parasites	PLOS ONE			English	Article							MALARIA TRANSMISSION; CLINICAL MALARIA; TREATED NETS; VAR GENES; DIVERSITY; AREA; EPIDEMIOLOGY; PREVALENCE; MORBIDITY; CHILDREN	Background: Malaria transmission may be considered to be homogenous with well-mixed parasite populations (as in the classic Ross/Macdonald models). Marked fine-scale heterogeneity of transmission has been observed in the field (i.e., over a few kilometres), but there are relatively few data on the degree of mixing. Since the Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) is highly polymorphic, the host's serological responses may be used to infer exposure to parasite sub-populations. Methods and Findings: We measured the antibody responses to 46 individual PfEMP1 domains at four time points among 450 children in Kenya, and identified distinct spatial clusters of antibody responses to individual domains. 35 domains showed strongly significant sero-clusters at p = 0.001. Individuals within the high transmission hotspot showed the greatest diversity of anti-PfEMP1 responses. Individuals outside the hotspot had a less diverse range of responses, even if as individuals they were at relatively intense exposure. Conclusions: We infer that antigenically distinct sub-populations of parasites exist on a fine spatial scale in a study area of rural Kenya. Further studies should examine antigenic variation over longer periods of time and in different study areas.	[Bejon, Philip; Olotu, Ally; Bull, Peter C.; Marsh, Kevin] Wellcome Trust Programme, Kenya Med Res Inst, Ctr Geog Med Res, Coast, Kilifi, Kenya; [Bejon, Philip; Marsh, Kevin] Univ Oxford, Nuffield Dept Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Turner, Louise; Lavstsen, Thomas; Cham, Gerald; Lusingu, John; Theander, Thor G.] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark; [Turner, Louise; Lavstsen, Thomas; Cham, Gerald; Lusingu, John; Theander, Thor G.] Rigshosp, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Drakeley, Chris J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immun & Infect, London WC1, England; [Lievens, Marc; Vekemans, Johan] GlaxoSmithKline Biol, Rixensart, Belgium; [Savarese, Barbara] Program Appropriate Technol Hlth PATH Malaria Vac, Bethesda, MD USA; [Lusingu, John] Natl Inst Med Res, Tanga Ctr, Tanga, Tanzania; [von Seidlein, Lorenz] Menzies Sch Hlth Res, Casuarina, Australia	Kenya Medical Research Institute; University of Oxford; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine; GlaxoSmithKline; National Institute of Medical Research; Charles Darwin University; Menzies School of Health Research	Bejon, P (corresponding author), Wellcome Trust Programme, Kenya Med Res Inst, Ctr Geog Med Res, Coast, Kilifi, Kenya.	pbejon@well.ox.ac.uk	Theander, Thor/F-6714-2015; Lusingu, John P. A./GSJ-3228-2022	Theander, Thor/0000-0002-3509-7514; Lusingu, John P. A./0000-0002-9407-0602; Lavstsen, Thomas/0000-0002-3044-4249; Turner, Louise/0000-0003-4494-2289; Bull, Peter/0000-0002-7674-6752	PATH Malaria Vaccine Initiative (MVI); GlaxoSmithKline Biologicals; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; University of Copenhagen; NIHR Biomedical Research Centre in Oxford	PATH Malaria Vaccine Initiative (MVI); GlaxoSmithKline Biologicals(GlaxoSmithKline); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Copenhagen; NIHR Biomedical Research Centre in Oxford	The study received financial support from PATH Malaria Vaccine Initiative (MVI), from GlaxoSmithKline Biologicals, from a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative, and from University of Copenhagen Program of Excellence. PB is funded by the NIHR Biomedical Research Centre in Oxford. GSK Biologicals and PATH MVI employees are co-authors and had a role in study design, preparing the analysis plan and manuscript preparation. The other funders had no role in study design, data collection and analysis, the decision to publish or the preparation of the manuscript.	Abdulla S, 2005, TROP MED INT HEALTH, V10, P11, DOI 10.1111/j.1365-3156.2004.01354.x; Armitage P, 2001, STAT METHODS MED RES, V4th; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bogreau H, 2006, AM J TROP MED HYG, V74, P953; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Clarke SE, 2002, T ROY SOC TROP MED H, V96, P499, DOI 10.1016/S0035-9203(02)90419-0; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; FORSYTH KP, 1989, AM J TROP MED HYG, V40, P344, DOI 10.4269/ajtmh.1989.40.344; Fowler EV, 2006, J INFECT DIS, V194, P939, DOI 10.1086/506619; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2006, INFECT IMMUN, V74, P6778, DOI 10.1128/IAI.01187-06; Jolliffe, 2002, PRINCIPAL COMPONENT; Kleinschmidt I, 2002, AM J EPIDEMIOL, V155, P257, DOI 10.1093/aje/155.3.257; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; NAUS JI, 1965, J AM STAT ASSOC, V60, P532, DOI 10.2307/2282688; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; OSIER FH, 2010, INFECT IMMUN; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Saul A, 1997, ACTA TROP, V63, P267, DOI 10.1016/S0001-706X(96)00626-2; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Thompson J. N., 2005, INTERSPEC INTERACT; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	47	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21711	10.1371/journal.pone.0021711	http://dx.doi.org/10.1371/journal.pone.0021711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747921	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292290100059
J	Savard, C; Guerin, A; Drouin, K; Bolduc, M; Laliberte-Gagne, ME; Dumas, MC; Majeau, N; Leclerc, D				Savard, Christian; Guerin, Annie; Drouin, Karine; Bolduc, Marilene; Laliberte-Gagne, Marie-Eve; Dumas, Marie-Christine; Majeau, Nathalie; Leclerc, Denis			Improvement of the Trivalent Inactivated Flu Vaccine Using PapMV Nanoparticles	PLOS ONE			English	Article							INFLUENZA-A VIRUS; CYTOTOXIC T-LYMPHOCYTE; HETEROSUBTYPIC IMMUNITY; NONNEUTRALIZING ANTIBODIES; PROTECTIVE IMMUNITY; MICE; INFECTION; RESPONSES; CELLS; H5N1	Commercial seasonal flu vaccines induce production of antibodies directed mostly towards hemaglutinin (HA). Because HA changes rapidly in the circulating virus, the protection remains partial. Several conserved viral proteins, e. g., nucleocapsid (NP) and matrix proteins (M1), are present in the vaccine, but are not immunogenic. To improve the protection provided by these vaccines, we used nanoparticles made of the coat protein of a plant virus (papaya mosaic virus; PapMV) as an adjuvant. Immunization of mice and ferrets with the adjuvanted formulation increased the magnitude and breadth of the humoral response to NP and to highly conserved regions of HA. They also triggered a cellular mediated immune response to NP and M1, and long-lasting protection in animals challenged with a heterosubtypic influenza strain (WSN/33). Thus, seasonal flu vaccine adjuvanted with PapMV nanoparticles can induce universal protection to influenza, which is a major advancement when facing a pandemic.	[Savard, Christian; Guerin, Annie; Drouin, Karine; Bolduc, Marilene; Laliberte-Gagne, Marie-Eve; Dumas, Marie-Christine; Majeau, Nathalie; Leclerc, Denis] Univ Laval, Infect Dis Res Ctr, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada	Laval University	Savard, C (corresponding author), Univ Laval, Infect Dis Res Ctr, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada.	Denis.Leclerc@crchul.ulaval.ca	Majeau, Nathalie/AAU-1964-2021; Leclerc, Denis/AAG-6112-2019; Leclerc, Denis/P-1604-2019		Canadian Institute of Health Research Canada (CIHR) [185160]	Canadian Institute of Health Research Canada (CIHR)(Canadian Institutes of Health Research (CIHR))	This research project was funded by the Canadian Institute of Health Research Canada (CIHR)(grant number: 185160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1986, CURR TOP MICROBIOL, V128, P1; Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; Atmar RL, 2009, CURR TOP MICROBIOL, V333, P323, DOI 10.1007/978-3-540-92165-3_16; BEEBE DP, 1983, J IMMUNOL, V130, P1317; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chen GL, 2009, NAT MED, V15, P1251, DOI 10.1038/nm1109-1251; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; DONNELLY JJ, 1995, NAT MED, V1, P583, DOI 10.1038/nm0695-583; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Feng JQ, 2002, J VIROL, V76, P1369, DOI 10.1128/JVI.76.3.1369-1378.2002; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; GORMAN OT, 1992, CURR TOP MICROBIOL, V176, P75; GORMAN OT, 1990, J VIROL, V64, P1487, DOI 10.1128/JVI.64.4.1487-1497.1990; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Guillon C, 2007, VACCINE, V25, P7491, DOI 10.1016/j.vaccine.2007.08.060; HOCART MJ, 1989, J GEN VIROL, V70, P2439, DOI 10.1099/0022-1317-70-9-2439; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kodihalli S, 2000, VACCINE, V18, P2592, DOI 10.1016/S0264-410X(99)00485-5; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Leclerc D, 2007, J VIROL, V81, P1319, DOI 10.1128/JVI.01720-06; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; LIANG SH, 1994, J IMMUNOL, V152, P1653; Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534; Nguyen HH, 2001, J INFECT DIS, V183, P368, DOI 10.1086/318084; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; O'Hagan DT, 2009, DRUG DISCOV TODAY, V14, P541, DOI 10.1016/j.drudis.2009.02.009; Rangel-Moreno J, 2008, J IMMUNOL, V180, P454, DOI 10.4049/jimmunol.180.1.454; RIMMELZWAAN GF, 1995, VACCINE, V13, P703; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tao P, 2009, ANTIVIR RES, V81, P253, DOI 10.1016/j.antiviral.2008.12.009; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Tremblay MH, 2006, FEBS J, V273, P14, DOI 10.1111/j.1742-4658.2005.05033.x; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Wieseler-Frank J, 2004, NEUROCHEM INT, V45, P389, DOI 10.1016/j.neuint.2003.09.009; Xie H, 2007, VACCINE, V25, P7649, DOI 10.1016/j.vaccine.2007.08.052; Xu JT, 2006, PAIN, V123, P306, DOI 10.1016/j.pain.2006.03.011; YAP KL, 1978, SCAND J IMMUNOL, V7, P389, DOI 10.1111/j.1365-3083.1978.tb00469.x; Zhou ZG, 2010, PAIN, V151, P296, DOI 10.1016/j.pain.2010.06.017; Zuccotti GV, 2011, EXPERT OPIN BIOL TH, V11, P1, DOI 10.1517/14712598.2010.539047	50	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21522	10.1371/journal.pone.0021522	http://dx.doi.org/10.1371/journal.pone.0021522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747909	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100031
J	Chhabra, SR; Joachimiak, MP; Petzold, CJ; Zane, GM; Price, MN; Reveco, SA; Fok, V; Johanson, AR; Batth, TS; Singer, M; Chandonia, JM; Joyner, D; Hazen, TC; Arkin, AP; Wall, JD; Singh, AK; Keasling, JD				Chhabra, Swapnil R.; Joachimiak, Marcin P.; Petzold, Christopher J.; Zane, Grant M.; Price, Morgan N.; Reveco, Sonia A.; Fok, Veronica; Johanson, Alyssa R.; Batth, Tanveer S.; Singer, Mary; Chandonia, John-Marc; Joyner, Dominique; Hazen, Terry C.; Arkin, Adam P.; Wall, Judy D.; Singh, Anup K.; Keasling, Jay D.			Towards a Rigorous Network of Protein-Protein Interactions of the Model Sulfate Reducer Desulfovibrio vulgaris Hildenborough	PLOS ONE			English	Article							ESCHERICHIA-COLI; MASS-SPECTROMETRY; GLOBAL ANALYSIS; VULGATIS HILDENBOROUGH; PURIFICATION; METHYLATION; COMPLEXES; ACETYLATION; PEPTIDES; AFFINITY	Protein-protein interactions offer an insight into cellular processes beyond what may be obtained by the quantitative functional genomics tools of proteomics and transcriptomics. The aforementioned tools have been extensively applied to study Escherichia coli and other aerobes and more recently to study the stress response behavior of Desulfovibrio vulgaris Hildenborough, a model obligate anaerobe and sulfate reducer and the subject of this study. Here we carried out affinity purification followed by mass spectrometry to reconstruct an interaction network among 12 chromosomally encoded bait and 90 prey proteins based on 134 bait-prey interactions identified to be of high confidence. Protein-protein interaction data are often plagued by the lack of adequate controls and replication analyses necessary to assess confidence in the results, including identification of potential false positives. We addressed these issues through the use of biological replication, exponentially modified protein abundance indices, results from an experimental negative control, and a statistical test to assign confidence to each putative interacting pair applicable to small interaction data studies. We discuss the biological significance of metabolic features of D. vulgaris revealed by these protein-protein interaction data and the observed protein modifications. These include the distinct role of the putative carbon monoxide-induced hydrogenase, unique electron transfer routes associated with different oxidoreductases, and the possible role of methylation in regulating sulfate reduction.	[Chhabra, Swapnil R.; Joachimiak, Marcin P.; Zane, Grant M.; Price, Morgan N.; Singer, Mary; Chandonia, John-Marc; Joyner, Dominique; Hazen, Terry C.; Arkin, Adam P.; Wall, Judy D.; Singh, Anup K.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA; [Chhabra, Swapnil R.; Joachimiak, Marcin P.; Petzold, Christopher J.; Price, Morgan N.; Reveco, Sonia A.; Fok, Veronica; Johanson, Alyssa R.; Batth, Tanveer S.; Chandonia, John-Marc; Arkin, Adam P.; Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Singer, Mary; Joyner, Dominique; Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Chandonia, John-Marc] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Zane, Grant M.; Wall, Judy D.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Zane, Grant M.; Wall, Judy D.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Singh, Anup K.] Sandia Natl Labs, Biosyst Res Dept, Livermore, CA USA; [Arkin, Adam P.; Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Arkin, Adam P.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Chhabra, Swapnil R.; Petzold, Christopher J.; Reveco, Sonia A.; Fok, Veronica; Johanson, Alyssa R.; Batth, Tanveer S.; Hazen, Terry C.; Arkin, Adam P.; Singh, Anup K.; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Chhabra, SR (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Virtual Inst Microbial Stress & Survival, Berkeley, CA 94720 USA.	srchhabra@lbl.gov; mpjoachimiak@lbl.gov	Arkin, Adam P/A-6751-2008; Arkin, Adam/M-9941-2019; Keasling, Jay D/J-9162-2012; Hazen, Terry C/C-1076-2012	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Keasling, Jay D/0000-0003-4170-6088; Hazen, Terry C/0000-0002-2536-9993; Zane, Grant/0000-0002-3357-3097; joachimiak, marcin/0000-0001-8175-045X; Price, Morgan/0000-0002-4251-0362; Petzold, Christopher/0000-0002-8270-5228; Chandonia, John-Marc/0000-0002-5153-9079; Batth, Tanveer Singh/0000-0001-5346-4544	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics [DE-AC02-05CH11231]; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics(United States Department of Energy (DOE)); Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was part of the U.S. Department of Energy Genomics Sciences program: ENIGMA is a Scientific Focus Area Program supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, Genomics: GTL Foundational Science through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. This work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Arnold Randy J, 2002, Methods Mol Biol, V194, P205; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; BROWN T, 1993, CURRENT PROTOCOLS MO; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHEN L, 1994, BIOCHEM BIOPH RES CO, V203, P839, DOI 10.1006/bbrc.1994.2259; Chhabra SR, 2006, J BACTERIOL, V188, P1817, DOI 10.1128/JB.188.5.1817-1828.2006; Chiang T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r186; Clark ME, 2006, APPL ENVIRON MICROB, V72, P5578, DOI 10.1128/AEM.00284-06; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; CONG Y, P NATL ACAD SCI US, V107, P4967; Davydova MN, 2003, ANAEROBE, V9, P39, DOI 10.1016/S1075-9964(03)00045-3; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ELIAS DA, 2009, NUCL ACIDS RES; Fritz G, 2002, P NATL ACAD SCI USA, V99, P1836, DOI 10.1073/pnas.042664399; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; Gaucher SP, 2008, J PROTEOME RES, V7, P2320, DOI 10.1021/pr700772s; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2003, CURR OPIN CHEM BIOL, V7, P21, DOI 10.1016/S1367-5931(02)00007-8; Gentleman R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-112; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; KERBY RL, 1992, J BACTERIOL, V174, P5284, DOI 10.1128/JB.174.16.5284-5294.1992; Kessel M, 1996, FEBS LETT, V398, P274, DOI 10.1016/S0014-5793(96)01261-6; Kim JY, 2002, ANAL CHEM, V74, P5443, DOI 10.1021/ac0256080; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Mizutani T, 2009, GENES CELLS, V14, P1405, DOI 10.1111/j.1365-2443.2009.01357.x; Mukhopadhyay A, 2007, J BACTERIOL, V189, P5996, DOI 10.1128/JB.00368-07; Mukhopadhyay A, 2006, J BACTERIOL, V188, P4068, DOI 10.1128/JB.01921-05; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; PIERIK AJ, 1992, EUR J BIOCHEM, V205, P111, DOI 10.1111/j.1432-1033.1992.tb16757.x; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Rodionov DA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r90; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rousset M, 1998, PLASMID, V39, P114, DOI 10.1006/plas.1997.1321; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Seol JH, 1997, EUR J BIOCHEM, V247, P1143, DOI 10.1111/j.1432-1033.1997.01143.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Soboh B, 2002, EUR J BIOCHEM, V269, P5712, DOI 10.1046/j.1432-1033.2002.03282.x; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; Vasilescu J, 2006, CURR OPIN BIOTECH, V17, P394, DOI 10.1016/j.copbio.2006.06.008; WALL J, 2007, GENETICS GENOMICS SU, P1; Wildschut JD, 2006, J BACTERIOL, V188, P6253, DOI 10.1128/JB.00425-06; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503; ZHOU JZ, 2010, NATURE REV MIC UNPUB; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	63	10	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21470	10.1371/journal.pone.0021470	http://dx.doi.org/10.1371/journal.pone.0021470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738675	Green Submitted, gold, Green Published			2022-12-25	WOS:000292142800026
J	Reed, TE; Schindler, DE; Hague, MJ; Patterson, DA; Meir, E; Waples, RS; Hinch, SG				Reed, Thomas E.; Schindler, Daniel E.; Hague, Merran J.; Patterson, David A.; Meir, Eli; Waples, Robin S.; Hinch, Scott G.			Time to Evolve? Potential Evolutionary Responses of Fraser River Sockeye Salmon to Climate Change and Effects on Persistence	PLOS ONE			English	Article							FRESH-WATER; LIFE-HISTORY; CONTEMPORARY EVOLUTION; MIGRATION MORTALITY; ONCORHYNCHUS-NERKA; EXTINCTION RISK; TEMPERATURE; ADAPTATION; PHYSIOLOGY; MODELS	Evolutionary adaptation affects demographic resilience to climate change but few studies have attempted to project changes in selective pressures or quantify impacts of trait responses on population dynamics and extinction risk. We used a novel individual-based model to explore potential evolutionary changes in migration timing and the consequences for population persistence in sockeye salmon Oncorhynchus nerka in the Fraser River, Canada, under scenarios of future climate warming. Adult sockeye salmon are highly sensitive to increases in water temperature during their arduous upriver migration, raising concerns about the fate of these ecologically, culturally, and commercially important fish in a warmer future. Our results suggest that evolution of upriver migration timing could allow these salmon to avoid increasingly frequent stressful temperatures, with the odds of population persistence increasing in proportion to the trait heritability and phenotypic variance. With a simulated 2 degrees C increase in average summer river temperatures by 2100, adult migration timing from the ocean to the river advanced by similar to 10 days when the heritability was 0.5, while the risk of quasi-extinction was only 17% of that faced by populations with zero evolutionary potential (i.e., heritability fixed at zero). The rates of evolution required to maintain persistence under simulated scenarios of moderate to rapid warming are plausible based on estimated heritabilities and rates of microevolution of timing traits in salmon and related species, although further empirical work is required to assess potential genetic and ecophysiological constraints on phenological adaptation. These results highlight the benefits to salmon management of maintaining evolutionary potential within populations, in addition to conserving key habitats and minimizing additional stressors where possible, as a means to build resilience to ongoing climate change. More generally, they demonstrate the importance and feasibility of considering evolutionary processes, in addition to ecology and demography, when projecting population responses to environmental change.	[Reed, Thomas E.; Schindler, Daniel E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Reed, Thomas E.; Waples, Robin S.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Hague, Merran J.; Patterson, David A.] Simon Fraser Univ, Sch Resource & Environm Management, Fisheries & Oceans Canada, Sci Branch, Burnaby, BC V5A 1S6, Canada; [Meir, Eli] SimBiot Software, Ithaca, NY USA; [Hinch, Scott G.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Hinch, Scott G.] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia; University of British Columbia	Reed, TE (corresponding author), Netherlands Inst Ecol, Wageningen, Netherlands.	t.reed@nioo.knaw.nl	Waples, Robin S/K-1126-2016; Reed, Thomas E/A-5788-2012	Reed, Thomas E/0000-0002-2993-0477; Meir, Eli/0000-0002-1874-1750	Gordon and Betty Moore Foundation; Fisheries and Oceans Canada	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Fisheries and Oceans Canada	This work was supported by grants from the Gordon and Betty Moore Foundation (Synthesis of climate effects on salmon; http://www.moore.org/grants-awarded.aspx) and from the Fisheries and Oceans Canada, Environmental Watch Program (http://www.pac.dfo-mpo.gc.ca/science/habitat/frw-rfo/intro-eng.htm). The funders had no direct role in study design, data analysis, decision to publish, or preparation of the manuscript. Temperature data were provided by Fisheries and Oceans Canada's Environmental Watch Program.	[Anonymous], 2005, MILLENNIUM ECOSYSTEM; BARTON NH, 1986, GENET RES, V47, P209, DOI 10.1017/S0016672300023156; Betts RA, 2011, PHILOS T R SOC A, V369, P67, DOI 10.1098/rsta.2010.0292; Blackbourn D.J., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P296; BRETT JR, 1971, AM ZOOL, V11, P99; Bryant MD, 2009, CLIMATIC CHANGE, V95, P169, DOI 10.1007/s10584-008-9530-x; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Burgner R. L., 1991, PACIFIC SALMON LIFE; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Cooke SJ, 2008, BEHAV ECOL, V19, P747, DOI 10.1093/beheco/arn006; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Falconer D. S, 1996, INTRO QUANTITATIVE G; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Fleming I.A., 2002, ENCY GLOBAL ENV CHAN, P309; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; GABLE JG, 1993, 5 PAC SALM COMM, P36; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; GILHOUSEN P, 1990, INT PACIFIC SALMON C, V26; HAGUE M, 2007, CANADIAN TECHNICAL R, V2776, P55; Hague MJ, 2011, GLOBAL CHANGE BIOL, V17, P87, DOI 10.1111/j.1365-2486.2010.02225.x; Hard JJ, 2008, EVOL APPL, V1, P388, DOI 10.1111/j.1752-4571.2008.00020.x; Healey M, 2011, CAN J FISH AQUAT SCI, V68, P718, DOI [10.1139/F11-010, 10.1139/f2011-010]; Hellmann JJ, 2007, BIOL CONSERV, V137, P599, DOI 10.1016/j.biocon.2007.03.018; Hendry AP, 2008, MOL ECOL, V17, P20, DOI 10.1111/j.1365-294X.2007.03428.x; HINCH S, 2009, P C EARL MIGR PREM M, P8; Hinch Scott G., 2006, Fish Physiology, V24, P239; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; Hodgson S, 2006, FISH OCEANOGR, V15, P1, DOI 10.1111/j.1365-2419.2005.00354.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Isaac Joanne L., 2009, Endangered Species Research, V7, P115, DOI 10.3354/esr00093; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Keefer ML, 2008, ECOL FRESHW FISH, V17, P136, DOI 10.1111/j.1600-0633.2007.00267.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kinnison MT, 2008, MOL ECOL, V17, P405, DOI 10.1111/j.1365-294X.2007.03495.x; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Kinnison MT, 2001, GENETICA, V112, P145, DOI 10.1023/A:1013375419520; Lovejoy Thomas E., 2005, pi; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Macdonald J.S., 2000, Canadian Technical Report of Fisheries and Aquatic Sciences, V2315, pi; Macdonald JS, 2010, T AM FISH SOC, V139, P768, DOI 10.1577/T08-223.1; Martins EG, 2011, GLOBAL CHANGE BIOL, V17, P99, DOI 10.1111/j.1365-2486.2010.02241.x; MCDANIELS T, 2010, J ENVIRON MANAGE, P2771; Morrison J, 2002, J HYDROL, V263, P230, DOI 10.1016/S0022-1694(02)00065-3; Mote PW, 2003, CLIMATIC CHANGE, V61, P45, DOI 10.1023/A:1026302914358; MOUSSALLI E, 1986, CAN J FISH AQUAT SCI, V43, P135, DOI 10.1139/f86-014; Naughton GP, 2005, CAN J FISH AQUAT SCI, V62, P30, DOI 10.1139/F04-147; Patterson DA, 2007, CANADIAN TECHNICAL R, V2724; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinn TP, 2009, AM FISH S S, V69, P23; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; Quinn TP, 2000, EVOLUTION, V54, P1372, DOI 10.1111/j.0014-3820.2000.tb00569.x; Rand PS, 2006, T AM FISH SOC, V135, P655, DOI 10.1577/T05-023.1; Reed TE, 2011, CONSERV BIOL, V25, P56, DOI 10.1111/j.1523-1739.2010.01552.x; Reed TE, 2010, P ROY SOC B-BIOL SCI, V277, P3391, DOI 10.1098/rspb.2010.0771; Schindler DE, 2008, FISHERIES, V33, P502, DOI 10.1577/1548-8446-33.10.502; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997	67	81	81	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20380	10.1371/journal.pone.0020380	http://dx.doi.org/10.1371/journal.pone.0020380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738573	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800002
J	Jiang, Y; Shen, H; Liu, XA; Dai, JC; Jin, GF; Qin, ZZ; Chen, JP; Wang, S; Wang, XR; Hu, ZB; Shen, HB				Jiang, Yue; Shen, Hao; Liu, Xiao'an; Dai, Juncheng; Jin, Guangfu; Qin, Zhenzhen; Chen, Jiaping; Wang, Shui; Wang, Xinru; Hu, Zhibin; Shen, Hongbing			Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; LOCI; ALLELES; NOTCH2	Background: Genome-wide association studies (GWAS) have identified several breast cancer susceptibility loci, and one genetic variant, rs11249433, at 1p11.2 was reported to be associated with breast cancer in European populations. To explore the genetic variants in this region associated with breast cancer in Chinese women, we conducted a two-stage fine-mapping study with a total of 1792 breast cancer cases and 1867 controls. Methodology/Principal Findings: Seven single nucleotide polymorphisms (SNPs) including rs11249433 in a 277 kb region at 1p11.2 were selected and genotyping was performed by using TaqMan (R) OpenArray (TM) Genotyping System for stage 1 samples (878 cases and 900 controls). In stage 2 (914 cases and 967 controls), three SNPs (rs2580520, rs4844616 and rs11249433) were further selected and genotyped for validation. The results showed that one SNP (rs2580520) located at a predicted enhancer region of SRGAP2 was consistently associated with a significantly increased risk of breast cancer in a recessive genetic model [Odds Ratio (OR) = 1.66, 95% confidence interval (CI) = 1.16-2.36 for stage 2 samples; OR = 1.51, 95% CI = 1.16-1.97 for combined samples, respectively]. However, no significant association was observed between rs11249433 and breast cancer risk in this Chinese population (dominant genetic model in combined samples: OR = 1.20, 95% CI = 0.92-1.57). Conclusions/Significance: Genotypes of rs2580520 at 1p11.2 suggest that Chinese women may have different breast cancer susceptibility loci, which may contribute to the development of breast cancer in this population.	[Jiang, Yue; Jin, Guangfu; Wang, Xinru; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, State Key Lab Reprod Med, Inst Toxicol, Nanjing, Peoples R China; [Jiang, Yue; Shen, Hao; Dai, Juncheng; Jin, Guangfu; Qin, Zhenzhen; Chen, Jiaping; Wang, Xinru; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, MOE Key Lab Modern Toxicol, Nanjing, Peoples R China; [Jiang, Yue; Jin, Guangfu; Chen, Jiaping; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Clin Epidemiol Sect, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Peoples R China; [Liu, Xiao'an; Wang, Shui] Nanjing Med Univ, Dept Gen Surg, Affiliated Hosp 1, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Jiang, Y (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Inst Toxicol, Nanjing, Peoples R China.	hongbingshen@gmail.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	National Natural Science Foundation of China [81071715]; Natural Science Foundation of Jiangsu Higher Education Institutions [09KJA330001]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0631]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (grant number 81071715), Key Grant of Natural Science Foundation of Jiangsu Higher Education Institutions (09KJA330001), and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Chai L, 2010, J DENT RES, V89, P705, DOI 10.1177/0022034510365444; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hirose H, 2010, ONCOL REP, V23, P35, DOI 10.3892/or_00000603; Iwasaki M, 2011, BREAST CANCER RES TR, V126, P497, DOI 10.1007/s10549-010-1109-3; Kuwano Y, 2007, ARCH DERMATOL RES, V298, P493, DOI 10.1007/s00403-006-0717-6; Lee SH, 2007, APMIS, V115, P1357, DOI 10.1111/j.1600-0463.2007.00751.x; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Li YN, 2008, J NEUROSCI RES, V86, P3556, DOI 10.1002/jnr.21810; McKinney C, 2010, ANN RHEUM DIS, V69, P1711, DOI 10.1136/ard.2009.123588; Parr C, 2004, INT J MOL MED, V14, P779; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003019; Szamalek JM, 2006, HUM GENET, V120, P126, DOI 10.1007/s00439-006-0209-y; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Wu C, 2009, CANCER RES, V69, P5065, DOI 10.1158/0008-5472.CAN-09-0081; Wu FT, 2007, FRONT BIOSCI-LANDMRK, V12, P4370, DOI 10.2741/2394; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	22	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21563	10.1371/journal.pone.0021563	http://dx.doi.org/10.1371/journal.pone.0021563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738711	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600052
J	Kaminitz, A; Yolcu, ES; Askenasy, EM; Stein, J; Yaniv, I; Shirwan, H; Askenasy, N				Kaminitz, Ayelet; Yolcu, Esma S.; Askenasy, Enosh M.; Stein, Jerry; Yaniv, Isaac; Shirwan, Haval; Askenasy, Nadir			Effector and Naturally Occurring Regulatory T Cells Display No Abnormalities in Activation Induced Cell Death in NOD Mice	PLOS ONE			English	Article							NONOBESE DIABETIC MOUSE; FAS-LIGAND; CUTTING EDGE; IN-VIVO; APOPTOSIS; CD4(+)CD25(+); HOMEOSTASIS; MECHANISMS; INTERLEUKIN-2; SUPPRESSION	Background: Disturbed peripheral negative regulation might contribute to evolution of autoimmune insulitis in type 1 diabetes. This study evaluates the sensitivity of naive/effector (Teff) and regulatory T cells (Treg) to activation-induced cell death mediated by Fas cross-linking in NOD and wild-type mice. Principal Findings: Both effector (CD25(-), FoxP3(-)) and suppressor (CD25(+), FoxP3(+)) CD4(+) T cells are negatively regulated by Fas cross-linking in mixed splenocyte populations of NOD, wild type mice and FoxP3-GFP tranegenes. Proliferation rates and sensitivity to Fas cross-linking are dissociated in Treg cells: fast cycling induced by IL-2 and CD3/CD28 stimulation improve Treg resistance to Fas-ligand (FasL) in both strains. The effector and suppressor CD4(+) subsets display balanced sensitivity to negative regulation under baseline conditions, IL-2 and CD3/CD28 stimulation, indicating that stimulation does not perturb immune homeostasis in NOD mice. Effective autocrine apoptosis of diabetogenic cells was evident from delayed onset and reduced incidence of adoptive disease transfer into NOD. SCID by CD4(+) CD25(-) T cells decorated with FasL protein. Treg resistant to Fas-mediated apoptosis retain suppressive activity in vitro. The only detectable differential response was reduced Teff proliferation and upregulation of CD25 following CD3-activation in NOD mice. Conclusion: These data document negative regulation of effector and suppressor cells by Fas cross-linking and dissociation between sensitivity to apoptosis and proliferation in stimulated Treg. There is no evidence that perturbed AICD in NOD mice initiates or promotes autoimmune insulitis.	[Kaminitz, Ayelet; Askenasy, Enosh M.; Askenasy, Nadir] Schneider Childrens Med Ctr Israel, Frankel Lab, Ctr Stem Cell Res, Petah Tiqwa, Israel; [Kaminitz, Ayelet; Yaniv, Isaac] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Yolcu, Esma S.; Shirwan, Haval] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40292 USA; [Yolcu, Esma S.; Shirwan, Haval] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Stein, Jerry] Schneider Childrens Med Ctr Israel, Bone Marrow Transplant Unit, Petah Tiqwa, Israel; [Shirwan, Haval] Schneider Childrens Med Ctr Israel, Dept Pediat Hematol Oncol, Petah Tiqwa, Israel	Tel Aviv University; Sackler Faculty of Medicine; University of Louisville; University of Louisville	Kaminitz, A (corresponding author), Schneider Childrens Med Ctr Israel, Frankel Lab, Ctr Stem Cell Res, Petah Tiqwa, Israel.	anadir@012.net.il			Frankel Trust for Experimental Bone Marrow Transplantation	Frankel Trust for Experimental Bone Marrow Transplantation	This work was supported by grants from the Frankel Trust for Experimental Bone Marrow Transplantation and a generous donation in memory of Papi and Mordechai Steigman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arreaza G, 2003, CLIN IMMUNOL, V107, P103, DOI 10.1016/S1521-6616(03)00049-4; Arreaza GA, 1997, J CLIN INVEST, V100, P2243, DOI 10.1172/JCI119762; Askenasy EM, 2010, AUTOIMMUN REV, V9, P687, DOI 10.1016/j.autrev.2010.05.019; Askenasy N, 2005, BLOOD, V105, P1396, DOI 10.1182/blood-2004-06-2364; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Banz A, 2002, J IMMUNOL, V169, P750, DOI 10.4049/jimmunol.169.2.750; Beilhack GF, 2003, DIABETES, V52, P59, DOI 10.2337/diabetes.52.1.59; Belghith M, 2003, NAT MED, V9, P1202, DOI 10.1038/nm924; Berzins SP, 2003, DIABETES, V52, P327, DOI 10.2337/diabetes.52.2.327; Christen U, 2004, DIABETES, V53, P591, DOI 10.2337/diabetes.53.3.591; Colucci F, 1996, J AUTOIMMUN, V9, P271, DOI 10.1006/jaut.1996.0034; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Decallonne B, 2003, J AUTOIMMUN, V20, P219, DOI 10.1016/S0896-8411(03)00025-8; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Franke DDH, 2007, MOL IMMUNOL, V44, P2884, DOI 10.1016/j.molimm.2007.01.014; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; GIORDANO C, 1995, DIABETOLOGIA, V38, P1449, DOI 10.1007/BF00400606; Gregg RK, 2004, J IMMUNOL, V173, P7308, DOI 10.4049/jimmunol.173.12.7308; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; KAMINITZ A, 2011, J AUTOIMMUN IN PRESS; Kaminitz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015684; Kaminitz A, 2010, J AUTOIMMUN, V35, P145, DOI 10.1016/j.jaut.2010.06.002; Kaminitz A, 2009, J AUTOIMMUN, V33, P83, DOI 10.1016/j.jaut.2009.07.001; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Klein L, 2003, P NATL ACAD SCI USA, V100, P8886, DOI 10.1073/pnas.1533365100; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2672; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lan RY, 2008, J AUTOIMMUN, V31, P7, DOI 10.1016/j.jaut.2008.03.002; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li H, 1996, J IMMUNOL, V156, P380; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Mohamood AS, 2006, INT IMMUNOL, V18, P1265, DOI 10.1093/intimm/dxl057; Pandiyan P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-6; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Parijs LV, 1997, J IMMUNOL, V158, P3738; Pearl-Yafe M, 2006, BIOESSAYS, V28, P211, DOI 10.1002/bies.20356; Pearl-Yafe M, 2007, STEM CELLS, V25, P1448, DOI 10.1634/stemcells.2007-0013; Pearl-Yafe M, 2007, CURR PHARM DESIGN, V13, P749, DOI 10.2174/138161207780249155; Pop SM, 2005, J EXP MED, V201, P1333, DOI 10.1084/jem.20042398; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Radosevic K, 1999, J AUTOIMMUN, V13, P373, DOI 10.1006/jaut.1999.0338; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Waid DM, 2008, J LEUKOCYTE BIOL, V84, P431, DOI 10.1189/jlb.1207857; Wang RD, 1996, EUR J IMMUNOL, V26, P2263, DOI 10.1002/eji.1830260944; Weber SE, 2006, J IMMUNOL, V176, P4730, DOI 10.4049/jimmunol.176.8.4730; Yang W, 2004, J IMMUNOL, V173, P4407, DOI 10.4049/jimmunol.173.7.4407; Yaniv I, 2009, J AUTOIMMUN, V33, P255, DOI 10.1016/j.jaut.2009.09.002; Yarkoni S, 2010, DIABETOLOGIA, V53, P356, DOI 10.1007/s00125-009-1604-4; Yarkoni S, 2008, BIOESSAYS, V30, P875, DOI 10.1002/bies.20812; Yolcu ES, 2002, IMMUNITY, V17, P795, DOI 10.1016/S1074-7613(02)00482-X; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	66	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21630	10.1371/journal.pone.0021630	http://dx.doi.org/10.1371/journal.pone.0021630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738739	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600064
J	Redman, RS; Kim, YO; Woodward, CJDA; Greer, C; Espino, L; Doty, SL; Rodriguez, RJ				Redman, Regina S.; Kim, Yong Ok; Woodward, Claire J. D. A.; Greer, Chris; Espino, Luis; Doty, Sharon L.; Rodriguez, Rusty J.			Increased Fitness of Rice Plants to Abiotic Stress Via Habitat Adapted Symbiosis: A Strategy for Mitigating Impacts of Climate Change	PLOS ONE			English	Article							MONOCOT-DICOT DIVERGENCE; PHENOTYPIC PLASTICITY; PIRIFORMOSPORA-INDICA; TOLERANCE; GROWTH; CONSTRAINTS; RESISTANCE; DIVERSITY; EVOLUTION; PHENOLOGY	Climate change and catastrophic events have contributed to rice shortages in several regions due to decreased water availability and soil salinization. Although not adapted to salt or drought stress, two commercial rice varieties achieved tolerance to these stresses by colonizing them with Class 2 fungal endophytes isolated from plants growing across moisture and salinity gradients. Plant growth and development, water usage, ROS sensitivity and osmolytes were measured with and without stress under controlled conditions. The endophytes conferred salt, drought and cold tolerance to growth chamber and greenhouse grown plants. Endophytes reduced water consumption by 20-30% and increased growth rate, reproductive yield, and biomass of greenhouse grown plants. In the absence of stress, there was no apparent cost of the endophytes to plants, however, endophyte colonization decreased from 100% at planting to 65% compared to greenhouse plants grown under continual stress (maintained 100% colonization). These findings indicate that rice plants can exhibit enhanced stress tolerance via symbiosis with Class 2 endophytes, and suggest that symbiotic technology may be useful in mitigating impacts of climate change on other crops and expanding agricultural production onto marginal lands.	[Redman, Regina S.; Kim, Yong Ok; Woodward, Claire J. D. A.; Doty, Sharon L.; Rodriguez, Rusty J.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Redman, Regina S.] Univ Washington, Coll Forest Resources, Seattle, WA 98195 USA; [Redman, Regina S.; Kim, Yong Ok; Woodward, Claire J. D. A.; Rodriguez, Rusty J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Greer, Chris] Univ Calif Cooperat Extens, Yuba City, CA USA; [Espino, Luis] Univ Calif Cooperat Extens, Colusa, CA USA	United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California System	Redman, RS (corresponding author), US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA.	redmanr@u.washington.edu		Doty, Sharon/0000-0002-9546-315X	California Rice Research Board [RM-6]; United States Geological Survey; National Science Foundation [0414463]; United States-Israel Binational Agricultural Research and Development Fund [3260-01C]; Direct For Biological Sciences [0950447] Funding Source: National Science Foundation	California Rice Research Board; United States Geological Survey(United States Geological Survey); National Science Foundation(National Science Foundation (NSF)); United States-Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was made possible by the permission, assistance, and guidelines of Yellowstone National Park and the University of Washington Cedar Rocks Biological Preserve. This work was supported by the California Rice Research Board (RM-6; 2007, 2008, 2009), United States Geological Survey, and support funding from the National Science Foundation (0414463) and United States-Israel Binational Agricultural Research and Development Fund (3260-01C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MICROBIAL ROOT ENDOP; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Bacon C. W., 1996, P155; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; FAO, 2005, 20 THINGS KNOW IMP S; Givnish TJ, 2002, EVOL ECOL, V16, P213, DOI 10.1023/A:1019676410041; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Leone A, 2003, ABIOTIC STRESSES IN PLANTS, P1; Luo Q, 2009, AGR ECOSYST ENVIRON, V129, P261, DOI 10.1016/j.agee.2008.09.010; Marquez LM, 2007, SCIENCE, V315, P513, DOI 10.1126/science.1136237; Pan XY, 2006, ACTA OECOL, V30, P333, DOI 10.1016/j.actao.2006.03.003; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Perelman SB, 2007, J ECOL, V95, P662, DOI 10.1111/j.1365-2745.2007.01255.x; Petrini Orlando, 1996, P87; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Redman RS, 2002, SYMBIOSIS, V32, P55; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Robe WE, 2000, PLANT CELL ENVIRON, V23, P1041, DOI 10.1046/j.1365-3040.2000.00615.x; RODRIGUEZ RJ, 2009, NEW PHYTOLO IN PRESS; RODRIGUEZ RJ, 2009, COMMUNICATIVE INTEGR, V2, P1; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Sahay NS, 1999, FEMS MICROBIOL LETT, V181, P297, DOI 10.1111/j.1574-6968.1999.tb08858.x; *SAS I INC, 2000, SAS STAT GUID PERS C; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Schurr U, 2006, PLANT CELL ENVIRON, V29, P340, DOI 10.1111/j.1365-3040.2005.01490.x; Schwaegerle KE, 2005, EVOLUTION, V59, P1259, DOI 10.1111/j.0014-3820.2005.tb01776.x; Smallwood MF, 1999, PLANT RESPONSES ENV; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stout RG, 2002, ANN BOT-LONDON, V90, P259, DOI 10.1093/aob/mcf174; Sultan SE, 2003, EVOL DEV, V5, P25, DOI 10.1046/j.1525-142X.2003.03005.x; Tao FL, 2006, AGR FOREST METEOROL, V138, P82, DOI 10.1016/j.agrformet.2006.03.014; TU JC, 1985, MICROBIOS, V44, P87; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; VAUGHN KC, 1983, PLANT CELL ENVIRON, V6, P13; Waller F, 2005, P NATL ACAD SCI USA, V102, P13386, DOI 10.1073/pnas.0504423102; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yin XY, 2004, TRENDS PLANT SCI, V9, P426, DOI 10.1016/j.tplants.2004.07.007; Zhou L, 2007, FIELD CROP RES, V100, P294, DOI 10.1016/j.fcr.2006.08.003	46	250	273	5	202	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e14823	10.1371/journal.pone.0014823	http://dx.doi.org/10.1371/journal.pone.0014823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750695	Green Published, gold, Green Submitted			2022-12-25	WOS:000292512000002
J	Stewart, CR; Karpala, AJ; Lowther, S; Lowenthal, JW; Bean, AG				Stewart, Cameron R.; Karpala, Adam J.; Lowther, Sue; Lowenthal, John W.; Bean, Andrew G.			Immunostimulatory Motifs Enhance Antiviral siRNAs Targeting Highly Pathogenic Avian Influenza H5N1	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; RNA-INTERFERENCE; RIG-I; INDUCTION; VIRUS; ACTIVATION; TRANSCRIPTION; THERAPEUTICS; INHIBITION; VECTORS	Highly pathogenic avian influenza (HPAI) H5N1 virus is endemic in many regions around the world and remains a significant pandemic threat. To date H5N1 has claimed almost 300 human lives worldwide, with a mortality rate of 60% and has caused the death or culling of hundreds of millions of poultry since its initial outbreak in 1997. We have designed multi-functional RNA interference (RNAi)-based therapeutics targeting H5N1 that degrade viral mRNA via the RNAi pathway while at the same time augmenting the host antiviral response by inducing host type I interferon (IFN) production. Moreover, we have identified two factors critical for maximising the immunostimulatory properties of short interfering (si) RNAs in chicken cells (i) mode of synthesis and (ii) nucleoside sequence to augment the response to virus. The 5-bp nucleoside sequence 5'-UGUGU-3' is a key determinant in inducing high levels of expression of IFN -alpha, -beta, -lambda and interleukin 1- beta in chicken cells. Positioning of this 5'-UGUGU-3' motif at the 5'- end of the sense strand of siRNAs, but not the 3'- end, resulted in a rapid and enhanced induction of type I IFN. An anti-H5N1 avian influenza siRNA directed against the PB1 gene (PB1-2257) tagged with 5'-UGUGU-3' induced type I IFN earlier and to a greater extent compared to a non-tagged PB1-2257. Tested against H5N1 in vitro, the tagged PB1-2257 was more effective than non-tagged PB1-2257. These data demonstrate the ability of an immunostimulatory motif to improve the performance of an RNAi-based antiviral, a finding that may influence the design of future RNAi-based anti-influenza therapeutics.	[Stewart, Cameron R.; Karpala, Adam J.; Lowther, Sue; Lowenthal, John W.; Bean, Andrew G.] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Stewart, CR (corresponding author), CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia.	Cameron.stewart@csiro.au	lowenthal, john w/G-4459-2010; karpala, adam/H-9294-2013; Bean, Andrew G/H-8664-2013; Stewart, Cameron R/E-6823-2011	lowenthal, john w/0000-0002-0548-2497; Bean, Andrew G/0000-0002-4585-3811; Stewart, Cameron/0000-0002-3395-7859; Tripp, Ralph/0000-0002-2924-9956	CSIRO (Commonwealth Science and Industrial Research Organisation)	CSIRO (Commonwealth Science and Industrial Research Organisation)(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was funded by CSIRO (Commonwealth Science and Industrial Research Organisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V422, P247, DOI 10.1038/422247b; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cyranoski D, 2003, NATURE, V422, P6, DOI 10.1038/422006a; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Gantier MP, 2010, MOL THER, V18, P785, DOI 10.1038/mt.2010.4; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Hawkes RA, 1979, DIAGNOSTIC PROCEDURE, V5th, P3; Hefner E, 2008, J Biomol Tech, V19, P231; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Karpala AJ, 2008, J INTERF CYTOK RES, V28, P341, DOI 10.1089/jir.2007.0117; Karpala AJ, 2008, DEV COMP IMMUNOL, V32, P435, DOI 10.1016/j.dci.2007.08.004; KARPALA AJ, 2011, J IMMUNOL; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Layne SP, 2009, SCIENCE, V323, P1560, DOI 10.1126/science.323.5921.1560; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Reich S, 2003, MOL VIS, V9, P210; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Schlender J, 2005, J VIROL, V79, P5507, DOI 10.1128/JVI.79.9.5507-5515.2005; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stram Y, 2006, VIRUS GENES, V32, P299, DOI 10.1007/s11262-005-6914-0; Villanueva AI, 2011, DEV COMP IMMUNOL, V35, P28, DOI 10.1016/j.dci.2010.08.001; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; *WHO, 2010, SEAS INFL; WHO, 2009, H5N1 AV INFL TIM MAJ; *WHO, 2009, CUM NUMB CONF HUM CA	34	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21552	10.1371/journal.pone.0021552	http://dx.doi.org/10.1371/journal.pone.0021552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747939	Green Submitted, Green Published, gold			2022-12-25	WOS:000292293400015
J	Brufau, G; Kuipers, F; Lin, YG; Trautwein, EA; Groen, AK				Brufau, Gemma; Kuipers, Folkert; Lin, Yuguang; Trautwein, Elke A.; Groen, Albert K.			A Reappraisal of the Mechanism by Which Plant Sterols Promote Neutral Sterol Loss in Mice	PLOS ONE			English	Article							LIVER-X-RECEPTOR; BILIARY CHOLESTEROL SECRETION; BINDING CASSETTE TRANSPORTERS; ACTIVATION; EXCRETION; STANOLS; ABCA1; METABOLISM; ABSORPTION; ABCG8	Dietary plant sterols (PS) reduce serum total and LDL-cholesterol in hyperlipidemic animal models and in humans. This hypocholesterolemic effect is generally ascribed to inhibition of cholesterol absorption. However, whether this effect fully explains the reported strong induction of neutral sterol excretion upon plant sterol feeding is not known. Recent data demonstrate that the intestine directly mediates plasma cholesterol excretion into feces, i.e., without involvement of the hepato-biliary route. Objective: Aim of this study was to determine whether stimulation of fecal neutral sterol loss during PS feeding is (partly) explained by increased intestinal cholesterol excretion and to assess the role of the cholesterol transporter Abcg5/Abcg8 herein. Methods and Results: Wild-type mice were fed a control diet or diets enriched with increasing amounts of PS (1%, 2%, 4% or 8%, wt/wt) for two weeks. In addition, Abcg5(-/-) mice were fed either control or 8% PS diet. PS feeding resulted in a dose-dependent decrease of fractional cholesterol absorption (similar to 2-7-fold reduction) in wild-type mice and similar to 80% reduction in Abcg5(-/-) mice. Furthermore, PS feeding led to a strong, dose-independent induction of neutral sterol excretion (3.4-fold in wild-types and 2.7-fold in Abcg5(-/-) mice) without changes in biliary cholesterol secretion. It was calculated that PS feeding stimulated intestinal cholesterol excretion by similar to 500% in wild-type mice and by similar to 250% in Abcg5(-/-). Conclusions: Our data indicate that in mice the cholesterol-lowering effects of PS are to a large extent attributable to stimulation of intestinal, non-bile derived, cholesterol excretion. The Abcg5/Abcg8 heterodimer is involved in facilitating this PS-induced flux of cholesterol.	[Brufau, Gemma; Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Groningen, Netherlands; [Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Lab Med, Groningen, Netherlands; [Lin, Yuguang; Trautwein, Elke A.] Unilever R&D, Vlaardingen, Netherlands	University of Groningen; University of Groningen; Unilever	Brufau, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, Groningen, Netherlands.	g.brufau.dones@med.umcg.nl		Kuipers, Folkert/0000-0003-2518-737X	The Netherlands Heart Foundation [2008B100]; Unilever R&D (Vlaardingen, The Netherlands); Unilever RD	The Netherlands Heart Foundation(Netherlands Heart Foundation); Unilever R&D (Vlaardingen, The Netherlands)(Netherlands Government); Unilever RD(Unilever)	This study was supported by The Netherlands Heart Foundation (grant 2008B100) and Unilever R&D (Vlaardingen, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Unilever R&D funded part of this study; however, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown JM, 2008, J BIOL CHEM, V283, P10522, DOI 10.1074/jbc.M707659200; Calpe-Berdie L, 2007, PROTEOMICS, V7, P2659, DOI 10.1002/pmic.200600792; Calpe-Berdiel L, 2008, J LIPID RES, V49, P1904, DOI 10.1194/jlr.M700470-JLR200; Calpe-Berdiel L, 2009, ATHEROSCLEROSIS, V203, P18, DOI 10.1016/j.atherosclerosis.2008.06.026; Drobnik W, 2001, GASTROENTEROLOGY, V120, P1203, DOI 10.1053/gast.2001.23250; FEREZOU J, 1981, DIGESTION, V21, P232, DOI 10.1159/000198568; Field FJ, 1997, J LIPID RES, V38, P348; Groen AK, 2001, J CLIN INVEST, V108, P843, DOI 10.1172/JCI12473; Jones PJH, 2009, CURR OPIN CLIN NUTR, V12, P147, DOI 10.1097/MCO.0b013e328326770f; Kaneko E, 2003, J BIOL CHEM, V278, P36091, DOI 10.1074/jbc.M304153200; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Langheim S, 2005, J LIPID RES, V46, P1732, DOI 10.1194/jlr.M500115-JLR200; Mensink RP, 2010, AM J CLIN NUTR, V92, P24, DOI 10.3945/ajcn.2009.29143; MURPHY GM, 1970, J CLIN PATHOL, V23, P594, DOI 10.1136/jcp.23.7.594; Plat J, 2005, J LIPID RES, V46, P2468, DOI 10.1194/jlr.M500272-JLR200; Plat J, 2002, FASEB J, V16, DOI 10.1096/fj.01-0718hyp; Plosch T, 2004, GASTROENTEROLOGY, V126, P290, DOI 10.1053/j.gastro.2003.10.074; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Plosch T, 2006, J NUTR, V136, P2135, DOI 10.1093/jn/136.8.2135; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; Temel RE, 2003, J BIOL CHEM, V278, P47594, DOI 10.1074/jbc.M308235200; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Temel RE, 2010, CELL METAB, V12, P96, DOI 10.1016/j.cmet.2010.05.011; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; van der Velde AE, 2010, CURR OPIN LIPIDOL, V21, P167, DOI 10.1097/MOL.0b013e3283395e45; Vrins CLJ, 2009, J LIPID RES, V50, P2046, DOI 10.1194/jlr.M800579-JLR200; Wu T, 2009, ASIA PAC J CLIN NUTR, V18, P179; Xie CL, 2009, J LIPID RES, V50, P1316, DOI 10.1194/jlr.M900024-JLR200; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	34	57	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21576	10.1371/journal.pone.0021576	http://dx.doi.org/10.1371/journal.pone.0021576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738715	Green Published, gold			2022-12-25	WOS:000292291800024
J	Tokarz, R; Firth, C; Street, C; Cox-Foster, DL; Lipkin, WI				Tokarz, Rafal; Firth, Cadhla; Street, Craig; Cox-Foster, Diana L.; Lipkin, W. Ian			Lack of Evidence for an Association between Iridovirus and Colony Collapse Disorder	PLOS ONE			English	Article							HONEY-BEE; IRIDESCENT-VIRUS; GENE	Colony collapse disorder (CCD) is characterized by the unexplained losses of large numbers of adult worker bees (Apis mellifera) from apparently healthy colonies. Although infections, toxins, and other stressors have been associated with the onset of CCD, the pathogenesis of this disorder remains obscure. Recently, a proteomics study implicated a double-stranded DNA virus, invertebrate iridescent virus (Family Iridoviridae) along with a microsporidium (Nosema sp.) as the cause of CCD. We tested the validity of this relationship using two independent methods: (i) we surveyed healthy and CCD colonies from the United States and Israel for the presence of members of the Iridovirus genus and (ii) we reanalyzed metagenomics data previously generated from RNA pools of CCD colonies for the presence of Iridovirus-like sequences. Neither analysis revealed any evidence to suggest the presence of an Iridovirus in healthy or CCD colonies.	[Tokarz, Rafal; Firth, Cadhla; Street, Craig; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Cox-Foster, Diana L.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tokarz, R (corresponding author), Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY 10027 USA.	wil2001@columbia.edu	Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Firth, Cadhla/0000-0002-2040-8973	U. S. Department of Defense; Pennsylvania Department of Agriculture [ME 447514]	U. S. Department of Defense(United States Department of Defense); Pennsylvania Department of Agriculture	Funding was provided by the U. S. Department of Defense, Google.org, and the Pennsylvania Department of Agriculture (ME 447514, "Colony Collapse disorder in Honey Bees: Defining associated pathology and enabling reuse of equipment"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY L, 1976, J GEN VIROL, V31, P459, DOI 10.1099/0022-1317-31-3-459; BAILEY L, 1978, J INVERTEBR PATHOL, V31, P368, DOI 10.1016/0022-2011(78)90231-8; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Cox-Foster D, 2009, SCI AM, V300, P40, DOI 10.1038/scientificamerican0409-40; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Ince IA, 2010, VIROLOGY, V405, P253, DOI 10.1016/j.virol.2010.05.038; Kleespies RG, 1999, J INVERTEBR PATHOL, V73, P84, DOI 10.1006/jipa.1998.4821; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; *UN ENV PROGR, 2010, UNEP EM ISS; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Webby R, 1998, ARCH VIROL, V143, P1949, DOI 10.1007/s007050050432; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Williams T, 1996, ADV VIRUS RES, V46, P345, DOI 10.1016/S0065-3527(08)60076-7; Williams T, 2008, NEOTROP ENTOMOL, V37, P615, DOI 10.1590/S1519-566X2008000600001	19	17	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21844	10.1371/journal.pone.0021844	http://dx.doi.org/10.1371/journal.pone.0021844			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738798	gold, Green Published			2022-12-25	WOS:000292291800049
J	Tao, KP; Fong, SW; Lu, ZH; Ching, YP; Chan, KW; Chan, SY				Tao, Kin Pong; Fong, Sze Wan; Lu, Zhihong; Ching, Yick Pang; Chan, Kin Wang; Chan, Siu Yuen			TSPYL2 Is Important for G1 Checkpoint Maintenance upon DNA Damage	PLOS ONE			English	Article							NUCLEOSOME ASSEMBLY PROTEIN; Y-CHROMOSOME; TARGET DENTT; CYCLIN B; MOUSE; GENE; P53; TRANSCRIPTION; EXPRESSION; NAP1	Nucleosome assembly proteins play important roles in chromatin remodeling, which determines gene expression, cell proliferation and terminal differentiation. Testis specific protein, Y-encoded-like 2 (TSPYL2) is a nucleosome assembly protein expressed in neuronal precursors and mature neurons. Previous studies have shown that TSPYL2 binds cyclin B and inhibits cell proliferation in cultured cells suggesting a role in cell cycle regulation. To investigate the physiological significance of TSPYL2 in the control of cell cycle, we generated mice with targeted disruption of Tspyl2. These mutant mice appear grossly normal, have normal life span and do not exhibit increased tumor incidence. To define the role of TSPYL2 in DNA repair, checkpoint arrest and apoptosis, primary embryonic fibroblasts and thymocytes from Tspyl2 deficient mice were isolated and examined under unperturbed and stressed conditions. We show that mutant fibroblasts are impaired in G1 arrest under the situation of DNA damage induced by gamma irradiation. This is mainly attributed to the defective activation of p21 transcription despite proper p53 protein accumulation, suggesting that TSPYL2 is additionally required for p21 induction. TSPYL2 serves a biological role in maintaining the G1 checkpoint under stress condition.	[Tao, Kin Pong; Fong, Sze Wan; Lu, Zhihong; Chan, Kin Wang; Chan, Siu Yuen] Univ Hong Kong, Dept Paediat & Adolescent Med, Ctr Reprod Dev & Growth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Ching, Yick Pang] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Tao, KP (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Ctr Reprod Dev & Growth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	sychan@hkucc.hku.hk		CHING, Yick Pang/0000-0002-6461-8358; Chan, Siu Yuen/0000-0001-7262-1293	Research Grants Council of the Hong Kong Special Administrative Region, China [HKU7323/03M, HKU2/02C]; Committee for Research and Conference Grants, The University of Hong Kong	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Committee for Research and Conference Grants, The University of Hong Kong(University of Hong Kong)	The work described in this paper was substantially supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. HKU7323/03M and HKU2/02C) and partly by the Committee for Research and Conference Grants, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Chai ZL, 2001, J BIOL CHEM, V276, P33665, DOI 10.1074/jbc.M007681200; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Kandalaft LE, 2008, CARCINOGENESIS, V29, P1282, DOI 10.1093/carcin/bgn087; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Kristiansen LV, 2010, SYNAPSE, V64, P495, DOI 10.1002/syn.20754; Lankenau S, 2003, GENETICS, V163, P611; Lau YFC, 2003, CYTOGENET GENOME RES, V101, P250, DOI 10.1159/000074345; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Li Y, 2008, ONCOGENE, V27, P6141, DOI 10.1038/onc.2008.206; Lin CW, 2006, J COMP NEUROL, V494, P606, DOI 10.1002/cne.20825; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Luebben WR, 2010, P NATL ACAD SCI USA, V107, P19254, DOI 10.1073/pnas.1009650107; Mazeyrat S, 1998, HUM MOL GENET, V7, P557, DOI 10.1093/hmg/7.3.557; Niida H, 2010, EMBO J, V29, P3558, DOI 10.1038/emboj.2010.218; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Oram SW, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-154; Ozbun LL, 2001, GENOMICS, V73, P179, DOI 10.1006/geno.2001.6505; Pham Y, 2010, DIABETOLOGIA, V53, P170, DOI 10.1007/s00125-009-1555-9; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rogner UC, 2000, NAT GENET, V25, P431, DOI 10.1038/78124; Rogner UC, 2002, AM J MED GENET, V110, P208, DOI 10.1002/ajmg.10453; Schnieders F, 1996, HUM MOL GENET, V5, P1801, DOI 10.1093/hmg/5.11.1801; Shikama N, 2000, MOL CELL BIOL, V20, P8933, DOI 10.1128/MCB.20.23.8933-8943.2000; Sun GF, 2002, BBA-MOL BASIS DIS, V1588, P241, DOI 10.1016/S0925-4439(02)00171-0; Tsuchiya KD, 2004, GENOME RES, V14, P1275, DOI 10.1101/gr.2575904; Tu YG, 2007, J BIOL CHEM, V282, P11722, DOI 10.1074/jbc.M609623200; WALTER PP, 1995, MOL CELL BIOL, V15, P6178; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wang YA, 1997, P NATL ACAD SCI USA, V94, P14590, DOI 10.1073/pnas.94.26.14590	39	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21602	10.1371/journal.pone.0021602	http://dx.doi.org/10.1371/journal.pone.0021602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738728	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600061
J	Wang, WH; Liu, YF; Su, CC; Su, MC; Li, SY; Yang, JJ				Wang, Wen-Hung; Liu, Yu-Fan; Su, Ching-Chyuan; Su, Mao-Chang; Li, Shuan-Yow; Yang, Jiann-Jou			A Novel Missense Mutation in the Connexin30 Causes Nonsyndromic Hearing Loss	PLOS ONE			English	Article							GAP-JUNCTION CONNEXINS; ENCODING CONNEXIN-26; LARGE DELETION; GENE MUTATION; DEAFNESS; GJB2; EXPRESSION; MOUSE; PHOSPHORYLATION; IDENTIFICATION	Dysfunctional gap junctions caused by GJB2 (CX26) and GJB6 (CX30) mutations are implicated in nearly half of nonsyndromic hearing loss cases. A recent study identified a heterozygous mutation, c.119C>T (p.A40V), in the GJB6 gene of patients with nonsyndromic hearing loss. However, the functional role of the mutation in hearing loss remains unclear. In this study, analyses of cell biology indicated that a p.A40V missense mutation of CX30 causes CX30 protein accumulation in the Golgi body rather than in the cytoplasmic membrane. The tet-on protein expression system was used for further study of mutant proteins in CX30 and CX30A40V co-expressions and in CX26 and CX30A40V co-expressions. The p.A40V missense mutation exerted a dominant negative effect on both normal CX30 and CX26, which impaired gap junction formation. Moreover, computer-assisted modeling suggested that this p.A40V mutation affects the intra molecular interaction in the hydrophobic core of Trp44, which significantly alters the efficiency of gap junction formation. These findings suggest that the p.A40V mutation in CX30 causes autosomal-dominant nonsyndromic hearing loss. These data provide a novel molecular explanation for the role of GJB6 in hearing loss.	[Wang, Wen-Hung] Chang Gung Univ, Coll Med, Dept Otolaryngol, Chang Gung Mem Hosp Chiayi, Gueishan, Taoyuan County, Taiwan; [Liu, Yu-Fan; Li, Shuan-Yow; Yang, Jiann-Jou] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fan; Li, Shuan-Yow; Yang, Jiann-Jou] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Su, Ching-Chyuan] Tian Sheng Mem Hosp, Dept Cardiovasc Surg, Tong Kang, Pin Tong, Taiwan; [Su, Mao-Chang] Chung Shan Med Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taichung, Taiwan; [Su, Mao-Chang] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Su, Mao-Chang] Chung Shan Med Univ, Dept Speech Language Pathol & Audiol, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Wang, WH (corresponding author), Chang Gung Univ, Coll Med, Dept Otolaryngol, Chang Gung Mem Hosp Chiayi, Gueishan, Taoyuan County, Taiwan.	syl@csmu.edu.tw; jiannjou@csmu.edu.tw	Yang, Jiann-Jou/E-9502-2011	Yang, Jiann-Jou/0000-0002-9019-2178	National Science Council, Republic of China [NSC 98-2320-B-040-012-MY3, NSC 98-2320-B-040-016-MY3]; National Science Council; Ministry of Education; Chung Shan Medical University	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education; Chung Shan Medical University	This work is supported by National Science Council, Republic of China (NSC 98-2320-B-040-012-MY3; NSC 98-2320-B-040-016-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wei-Chi Chen for his technical assistance, and Ted Knoy is acknowledged for his editorial assistance. Fluorescence microscope was performed in the Instrument Center of Chung Shan Medical University, which is supported by National Science Council, Ministry of Education, and Chung Shan Medical University.	Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Apps SA, 2007, INT J AUDIOL, V46, P75, DOI 10.1080/14992020600582190; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Dinh EH, 2009, BRAIN RES, V1277, P52, DOI 10.1016/j.brainres.2009.02.008; EVANS WH, 1994, BIOCHEM SOC T, V22, P788, DOI 10.1042/bst0220788; Falk MM, 1997, EMBO J, V16, P2703, DOI 10.1093/emboj/16.10.2703; FALK MM, 1994, J CELL BIOL, V127, P343, DOI 10.1083/jcb.127.2.343; Feldmann D, 2004, AM J MED GENET A, V127A, P263, DOI 10.1002/ajmg.a.20588; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; GILULA NB, 1972, NATURE, V235, P262, DOI 10.1038/235262a0; Grifa A, 1999, NAT GENET, V23, P16, DOI 10.1038/12612; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hong HM, 2010, HUM GENET, V127, P191, DOI 10.1007/s00439-009-0758-y; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KIKUCHI T, 1994, ACTA OTO-LARYNGOL, V114, P520, DOI 10.3109/00016489409126097; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kleopa KA, 2002, J NEUROSCI RES, V68, P522, DOI 10.1002/jnr.10255; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Lamartine J, 2000, NAT GENET, V26, P142, DOI 10.1038/79851; Lautermann J, 1999, DEV GENET, V25, P306, DOI 10.1002/(SICI)1520-6408(1999)25:4<306::AID-DVG4>3.0.CO;2-R; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; LEUBE RE, 1995, J CELL SCI, V108, P883; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MAKOWSKI L, 1977, J CELL BIOL, V74, P629, DOI 10.1083/jcb.74.2.629; Martin PEM, 2000, CURR TOP MEMBR, V49, P461; Marziano NK, 2003, HUM MOL GENET, V12, P805, DOI 10.1093/hmg/ddg076; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Montgomery JR, 2004, J AM ACAD DERMATOL, V51, P377, DOI 10.1016/j.jaad.2003.12.042; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nickel Regina, 2009, P419, DOI 10.1007/978-1-59745-489-6_20; Pallares-Ruiz N, 2002, EUR J HUM GENET, V10, P72, DOI 10.1038/sj.ejhg.5200762; Peitsch MC, 2002, BIOINFORMATICS, V18, P934, DOI 10.1093/bioinformatics/18.7.934; Petit C, 1996, NAT GENET, V14, P385, DOI 10.1038/ng1296-385; Qu CY, 2009, EXP CELL RES, V315, P1683, DOI 10.1016/j.yexcr.2009.03.001; Richard G, 2002, AM J HUM GENET, V70, P1341, DOI 10.1086/339986; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Sasin JM, 2004, NUCLEIC ACIDS RES, V32, pW586, DOI 10.1093/nar/gkh440; SCHULTE BA, 1994, HEARING RES, V78, P65, DOI 10.1016/0378-5955(94)90045-0; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; Tang HY, 2006, AM J MED GENET A, V140A, P2401, DOI 10.1002/ajmg.a.31525; White TW, 1996, J BIOENERG BIOMEMBR, V28, P339, DOI 10.1007/BF02110110; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yang JJ, 2007, AUDIOL NEURO-OTOL, V12, P198, DOI 10.1159/000099024; Yang JJ, 2010, HUM GENET, V128, P303, DOI 10.1007/s00439-010-0856-x; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	56	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21473	10.1371/journal.pone.0021473	http://dx.doi.org/10.1371/journal.pone.0021473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731760	gold, Green Published, Green Submitted			2022-12-25	WOS:000292036900036
J	De Angelis, G; Moschioni, M; Muzzi, A; Pezzicoli, A; Censini, S; Delany, I; Lo Sapio, M; Sinisi, A; Donati, C; Masignani, V; Barocchi, MA				De Angelis, Gabriella; Moschioni, Monica; Muzzi, Alessandro; Pezzicoli, Alfredo; Censini, Stefano; Delany, Isabel; Lo Sapio, Morena; Sinisi, Antonia; Donati, Claudio; Masignani, Vega; Barocchi, Michele A.			The Streptococcus pneumoniae Pilus-1 Displays a Biphasic Expression Pattern	PLOS ONE			English	Article							RLRA PATHOGENICITY ISLET; PHASE VARIATION; PNEUMOCOCCAL PILUS; HAEMOPHILUS-INFLUENZAE; ANTIGENIC VARIATION; VIRULENCE FACTORS; SEQUENCE REPEATS; NASOPHARYNGEAL; CARRIAGE; PROTEIN	The Streptococcus pneumoniae pilus-1 is encoded by pilus islet 1 (PI-1), which has three clonal variants (clade I, II and III) and is present in about 30% of clinical pneumococcal isolates. In vitro and in vivo assays have demonstrated that pilus-1 is involved in attachment to epithelial cells and virulence, as well as protection in mouse models of infection. Several reports suggest that pilus-1 expression is tightly regulated and involves the interplay of numerous genetic regulators, including the PI-1 positive regulator RlrA. In this report we provide evidence that pilus expression, when analyzed at the single-cell level in PI-1 positive strains, is biphasic. In fact, the strains present two phenotypically different sub-populations of bacteria, one that expresses the pilus, while the other does not. The proportions of these two phenotypes are variable among the strains tested and are not influenced by genotype, serotype, growth conditions, colony morphology or by the presence of antibodies directed toward the pilus components. Two sub-populations, enriched in pilus expressing or not expressing bacteria were obtained by means of colony selection and immuno-detection methods for five strains. PI-1 sequencing in the two sub-populations revealed the absence of mutations, thus indicating that the biphasic expression observed is not due to a genetic modification within PI-1. Microarray expression profile and western blot analyses on whole bacterial lysates performed comparing the two enriched sub-populations, revealed that pilus expression is regulated at the transcriptional level (on/off regulation), and that there are no other genes, in addition to those encoded by PI-1, concurrently regulated across the strains tested. Finally, we provide evidence that the over-expression of the RrlA positive regulator is sufficient to induce pilus expression in pilus-1 negative bacteria. Overall, the data presented here suggest that the observed biphasic pilus expression phenotype could be an example of bistability in pneumococcus.	[De Angelis, Gabriella; Moschioni, Monica; Muzzi, Alessandro; Pezzicoli, Alfredo; Censini, Stefano; Delany, Isabel; Lo Sapio, Morena; Sinisi, Antonia; Donati, Claudio; Masignani, Vega; Barocchi, Michele A.] Novartis Vaccines & Diagnost, Siena, Italy	Novartis	De Angelis, G (corresponding author), Novartis Vaccines & Diagnost, Siena, Italy.	michele.barocchi@novartis.com	Donati, Claudio/J-5180-2012; Muzzi, Alessandro/J-6200-2012; Donati, Claudio/AAF-1246-2020	Donati, Claudio/0000-0001-8688-1651	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	The study was completely funded by Novartis Vaccines and Diagnostics. No other external funding was used for this study. The funder had a role in deciding the topic (S. pneumoniae) but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHEN MG, 1986, GENE, V45, P45, DOI 10.1016/0378-1119(86)90130-7; Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Arai J, 2011, J CLIN MICROBIOL, V49, P1646, DOI 10.1128/JCM.01990-10; Auranen K, 2010, AM J EPIDEMIOL, V171, P169, DOI 10.1093/aje/kwp351; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; El Mortaji L, 2010, J BIOL CHEM, V285, P12405, DOI 10.1074/jbc.M109.082776; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Fletcher MA, 2007, VACCINE, V25, P2507, DOI 10.1016/j.vaccine.2006.09.027; Garcia-Suarez MDM, 2006, ENFERM INFEC MICR CL, V24, P512, DOI 10.1157/13092469; Gianfaldoni C, 2007, INFECT IMMUN, V75, P1059, DOI 10.1128/IAI.01400-06; Givon-Lavi N, 1999, CLIN INFECT DIS, V29, P1274, DOI 10.1086/313465; Greenberg D, 2004, J CLIN MICROBIOL, V42, P4604, DOI 10.1128/JCM.42.10.4604-4609.2004; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; Hemsley C, 2003, J BACTERIOL, V185, P6640, DOI 10.1128/JB.185.22.6640-6647.2003; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Janulczyk R, 2010, J BACTERIOL, V192, P3990, DOI 10.1128/JB.01465-09; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Melchiorre S, 2009, CLIN MICROBIOL INFEC; Moschioni M, 2008, J INFECT DIS, V197, P888, DOI 10.1086/528375; Muzzi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003660; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Overweg K, 2000, INFECT IMMUN, V68, P4604, DOI 10.1128/IAI.68.8.4604-4610.2000; Pelton SI, 2009, PEDIATR INFECT DIS J, V28, pS133, DOI 10.1097/INF.0b013e3181b6d81a; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Puopolo KM, 2003, MOL MICROBIOL, V50, P977, DOI 10.1046/j.1365-2958.2003.03745.x; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08; Rosch JW, 2009, MOL MICROBIOL, V72, P12, DOI 10.1111/j.1365-2958.2009.06638.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryan MW, 2000, LARYNGOSCOPE, V110, P961, DOI 10.1097/00005537-200006000-00014; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Serrano I, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-67; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; Song XM, 2009, MICROB PATHOGENESIS, V46, P28, DOI 10.1016/j.micpath.2008.10.006; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Turner KH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000779; Vallon-Christersson J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-330; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x; Weiser JN, 1998, MICROB DRUG RESIST, V4, P129, DOI 10.1089/mdr.1998.4.129; Weiser JN, 1996, INFECT IMMUN, V64, P2240, DOI 10.1128/IAI.64.6.2240-2245.1996; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Wisniewski-Dye F, 2008, ANTON LEEUW INT J G, V94, P493, DOI 10.1007/s10482-008-9267-6; Zahner D, 2000, J BACTERIOL, V182, P5919, DOI 10.1128/JB.182.20.5919-5921.2000	64	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21269	10.1371/journal.pone.0021269	http://dx.doi.org/10.1371/journal.pone.0021269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731688	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700054
J	Lyons, L; ELBeltagy, M; Bennett, G; Wigmore, P				Lyons, Laura; ELBeltagy, Maha; Bennett, Geoffrey; Wigmore, Peter			The Effects of Cyclophosphamide on Hippocampal Cell Proliferation and Spatial Working Memory in Rat	PLOS ONE			English	Article							COGNITIVE FUNCTION; ADJUVANT CHEMOTHERAPY; CANCER-CHEMOTHERAPY; NEUROGENESIS; METHOTREXATE; DEFICITS; IMPAIRMENT; PLASTICITY; NEURONS; AGENT	Cyclophosphamide (CP) is a chemotherapy used in combinations that are associated with cognitive impairment. In the present study male Lister-hooded rats (n = 12) were used to investigate the effects of chronic administration of CP (30mg/kg, 7 i.v. doses, or an equivalent volume of saline) on performance in the novel location recognition (NLR) task and on the proliferation and survival of hippocampal cells. The survival of hippocampal cells dividing at the beginning of treatment was significantly reduced by CP. However, no difference was seen between CP treated and control groups for the number of cells proliferating 7 days after the final injection and both groups performed equally well in the NLR task. These results indicate that the given dose of CP acutely reduces the survival of newly born hippocampal cells. However, it does not have a longer term effect on spatial working memory or hippocampal proliferation, suggesting that CP is less neurotoxic than other chemotherapies with which it is used in combination.	[Lyons, Laura; Bennett, Geoffrey; Wigmore, Peter] Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2RD, England; [ELBeltagy, Maha] Menoufiya Univ, Dept Anat, Shibin Al Kawm, Egypt	University of Nottingham; Egyptian Knowledge Bank (EKB); Menofia University	Lyons, L (corresponding author), Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Nottingham NG7 2RD, England.	mbxll@nottingham.ac.uk	Elbeltagy, Maha/Y-1139-2019	Elbeltagy, Maha/0000-0002-4777-2388	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This project was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles Tim A, 2002, Clin Breast Cancer, V3 Suppl 3, pS84, DOI 10.3816/CBC.2002.s.018; Branda RF, 2002, J LAB CLIN MED, V140, P358, DOI 10.1067/mlc.2002.128648; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bunting KD, 1996, J BIOL CHEM, V271, P11891, DOI 10.1074/jbc.271.20.11891; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; ELBeltagy M, 2010, BEHAV BRAIN RES, V208, P112, DOI 10.1016/j.bbr.2009.11.017; FOLEY J, 2008, PSYCHOPHARMACOLOGY B, V208, P112; Gandal MJ, 2008, NEUROSCIENCE, V157, P95, DOI 10.1016/j.neuroscience.2008.08.060; Goldhirsch A, 1998, ANN ONCOL, V9, P489, DOI 10.1023/A:1008236502420; Huang GJ, 2006, BIOL PSYCHIAT, V59, P619, DOI 10.1016/j.biopsych.2005.09.016; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Janelsins MC, 2010, CANCER INVEST, V28, P544, DOI 10.3109/07357900903405942; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Ko HG, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-1; Konat GW, 2008, METAB BRAIN DIS, V23, P325, DOI 10.1007/s11011-008-9100-y; Kreukels BPC, 2008, CLIN BREAST CANCER, V8, P80, DOI 10.3816/CBC.2008.n.006; Lee GD, 2006, CLIN CANCER RES, V12, P198, DOI 10.1158/1078-0432.CCR-05-1286; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lyons L, 2011, PSYCHOPHARMACOLOGY, V215, P105, DOI 10.1007/s00213-010-2122-2; MacLeod JE, 2007, BEHAV BRAIN RES, V181, P168, DOI 10.1016/j.bbr.2007.04.003; Matalon ST, 2004, REPROD TOXICOL, V18, P219, DOI 10.1016/j.reprotox.2003.10.014; Matsuda Tomohiro, 2005, Breast Cancer, V12, P279, DOI 10.2325/jbcs.12.279; MAYHEW TM, 1988, PLACENTA, V9, P565, DOI 10.1016/0143-4004(88)90001-X; McGregor A, 2004, BEHAV NEUROSCI, V118, P1011, DOI 10.1037/0735-7044.118.5.1011; Mondie CM, 2010, BEHAV BRAIN RES, V209, P66, DOI 10.1016/j.bbr.2010.01.016; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; MUSTAFA S, 2008, EUROPEAN J NEUROSCIE, V10, P1460; PEREZLOPEZ F, 1984, REV ESPANOLA ONCOLOG; Reiriz AB, 2006, CLIN CANCER RES, V12, P5000, DOI 10.1158/1078-0432.CCR-06-0138; Schagen SB, 2002, ANN ONCOL, V13, P1387, DOI 10.1093/annonc/mdf241; Schagen SB, 1999, CANCER, V85, P640, DOI 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Seigers R, 2011, NEUROSCI BIOBEHAV R, V35, P729, DOI 10.1016/j.neubiorev.2010.09.006; Seigers R, 2010, BRAIN RES BULL, V81, P472, DOI 10.1016/j.brainresbull.2009.10.006; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Taillibert S, 2007, CURR OPIN ONCOL, V19, P623, DOI 10.1097/CCO.0b013e3282f0e224; Wantuch C, 2007, NEUROSCI LETT, V421, P250, DOI 10.1016/j.neulet.2007.05.043; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Yang M, 2010, NEUROBIOL LEARN MEM, V93, P487, DOI 10.1016/j.nlm.2010.01.006; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	44	46	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21445	10.1371/journal.pone.0021445	http://dx.doi.org/10.1371/journal.pone.0021445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731752	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700087
J	Oka, T; Tagawa, K; Ito, H; Okazawa, H				Oka, Tsutomu; Tagawa, Kazuhiko; Ito, Hikaru; Okazawa, Hitoshi			Dynamic Changes of the Phosphoproteome in Postmortem Mouse Brains	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; TYROSINE PHOSPHORYLATION; HUNTINGTONS-DISEASE; GAMMA-SECRETASE; TAU; MUTATIONS	Protein phosphorylation is deeply involved in the pathological mechanism of various neurodegenerative disorders. However, in human pathological samples, phosphorylation can be modified during preservation by postmortem factors such as time and temperature. Postmortem changes may also differ among proteins. Unfortunately, there is no comprehensive database that could support the analysis of protein phosphorylation in human brain samples from the standpoint of postmortem changes. As a first step toward addressing the issue, we performed phosphoproteome analysis with brain tissue dissected from mouse bodies preserved under different conditions. Quantitative whole proteome mass analysis showed surprisingly diverse postmortem changes in phosphoproteins that were dependent on temperature, time and protein species. Twelve hrs postmortem was a critical time point for preservation at room temperature. At 4 degrees C, after the body was cooled down, most phosphoproteins were stable for 72 hrs. At either temperature, increase greater than 2-fold was exceptional during this interval. We found several standard proteins by which we can calculate the postmortem time at room temperature. The information obtained in this study will be indispensable for evaluating experimental data with human as well as mouse brain samples.	[Oka, Tsutomu; Tagawa, Kazuhiko; Ito, Hikaru; Okazawa, Hitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Oka, T (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Neuropathol, Tokyo, Japan.	okazawa-tky@umin.ac.jp	Ito, Hikaru/GRR-6595-2022	Ito, Hikaru/0000-0002-4693-2482	Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Strategic Research Program for Brain Sciences (SRPBS) to H.O. from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had a role in the decision of study direction but no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson FI, 2011, J MOL BIOL, V407, P261, DOI 10.1016/j.jmb.2010.12.029; Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Chang KH, 2010, J NEUROCHEM, V113, P1221, DOI 10.1111/j.1471-4159.2010.06687.x; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Imam SZ, 2011, J NEUROSCI, V31, P157, DOI 10.1523/JNEUROSCI.1833-10.2011; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Katashima R, 1998, BBA-GENE STRUCT EXPR, V1396, P245, DOI 10.1016/S0167-4781(97)00217-0; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; Lautier C, 2008, AM J HUM GENET, V82, P822, DOI 10.1016/j.ajhg.2008.01.015; MASLIAH E, 1992, AM J PATHOL, V140, P263; Modregger J, 2000, J CELL SCI, V113, P4511; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; Mortiboys H, 2010, NEUROLOGY, V75, P2017, DOI 10.1212/WNL.0b013e3181ff9685; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; NUKINA N, 1985, J BIOCHEM-TOKYO, V98, P1715, DOI 10.1093/oxfordjournals.jbchem.a135443; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; PALAIOLOGOS G, 1988, J NEUROCHEM, V51, P317, DOI 10.1111/j.1471-4159.1988.tb04872.x; PETERS HI, 1995, EUR J BIOCHEM, V234, P550, DOI 10.1111/j.1432-1033.1995.550_b.x; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; SANG LJ, 2002, BIOCHEM BIOPH RES CO, V291, P158; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi K, 2008, BIOCHEM BIOPH RES CO, V377, P544, DOI 10.1016/j.bbrc.2008.10.013; Tarr PE, 2002, BIOCHEM BIOPH RES CO, V295, P324, DOI 10.1016/S0006-291X(02)00678-2; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; VANDAMME HTF, 1990, BIOCHIM BIOPHYS ACTA, V1050, P241, DOI 10.1016/0167-4781(90)90174-Z; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x	44	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21405	10.1371/journal.pone.0021405	http://dx.doi.org/10.1371/journal.pone.0021405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731734	Green Submitted, gold, Green Published			2022-12-25	WOS:000292033700078
J	Wu, L; Wang, JX; Tang, P; Chen, HJ; Gao, HC				Wu, Lin; Wang, Jixuan; Tang, Peng; Chen, Haijiang; Gao, Haichun			Genetic and Molecular Characterization of Flagellar Assembly in Shewanella oneidensis	PLOS ONE			English	Article							HELICOBACTER-PYLORI; POLAR FLAGELLUM; FUNCTIONAL-CHARACTERIZATION; CAULOBACTER-CRESCENTUS; EXPORT CHAPERONES; PSEUDAMINIC ACID; CELL MOTILITY; CAMPYLOBACTER; PROTEIN; FILAMENT	Shewanella oneidensis is a highly motile organism by virtue of a polar flagellum. Unlike most flagellated bacteria, it contains only one major chromosome segment encoding the components of the flagellum with the exception of the motor proteins. In this region, three genes encode flagellinsaccording to the original genome annotation. However, we find that only flaA and flaB encode functional filament subunits. Although these two genesare under the control of different promoters, they are actively transcribed and subsequently translated, producing a considerable number of flagellin proteins. Additionally, both flagellins are able to interact with their chaperon FliS and are subjected to feedback regulation. Furthermore, FlaA and FlaB are glycosylated by a pathwayinvolving a major glycosylating enzyme, PseB, in spite of the lack of the majority of theconsensus glycosylation sites. In conclusion, flagellar assembly in S. oneidensis has novel features despite the conservation of homologous genes across taxa.	[Wu, Lin] Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, L (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	haichung@zju.edu.cn	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022; Chen, Haijiang/D-1893-2009	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563; 	Major State Basic Research Development Program [2010CB833803]; Fundamental Research Funds for the Central Universities	Major State Basic Research Development Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by Major State Basic Research Development Program (973 Progam: 2010CB833803) and by the Fundamental Research Funds for the Central Universities to HG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 2002, CURR OPIN MICROBIOL, V5, P160, DOI 10.1016/S1369-5274(02)00302-8; Anderson PE, 2000, MOL MICROBIOL, V38, P41, DOI 10.1046/j.1365-2958.2000.02108.x; Bardy SL, 2003, MICROBIOL-SGM, V149, P295, DOI 10.1099/mic.0.25948-0; Bennett JCQ, 2001, MOL MICROBIOL, V39, P781, DOI 10.1046/j.1365-2958.2001.02268.x; BOUHENNI RA, ELECTROANALYSIS, V22, P856; Bresolin G, 2008, MICROBIOL-SGM, V154, P196, DOI 10.1099/mic.0.2007/008458-0; Brown JD, 2008, MOL MICROBIOL, V70, P924, DOI 10.1111/j.1365-2958.2008.06455.x; Caccavo F, 2002, GEOMICROBIOL J, V19, P161, DOI 10.1080/01490450252864262; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Childers SE, 2002, NATURE, V416, P767, DOI 10.1038/416767a; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; Ewing CP, 2009, J BACTERIOL, V191, P7086, DOI 10.1128/JB.00378-09; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015295; Gao HC, 2009, ISME J, V3, P966, DOI 10.1038/ismej.2009.40; Gao WM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-76; GUERRY P, 1991, J BACTERIOL, V173, P4757, DOI 10.1128/jb.173.15.4757-4764.1991; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Karpinets TV, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq012; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kim JS, 1999, J BACTERIOL, V181, P6969; Klose KE, 1998, J BACTERIOL, V180, P303, DOI 10.1128/JB.180.2.303-316.1998; Koerdt A, 2009, J BACTERIOL, V191, P5085, DOI 10.1128/JB.00206-09; KOSTRZYNSKA M, 1991, J BACTERIOL, V173, P937, DOI 10.1128/jb.173.3.937-946.1991; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; KUWAJIMA G, 1988, J BACTERIOL, V170, P3305, DOI 10.1128/jb.170.7.3305-3309.1988; Lambert C, 2006, MOL MICROBIOL, V60, P274, DOI 10.1111/j.1365-2958.2006.05081.x; Li J, 2007, FEMS MICROBIOL LETT, V273, P180, DOI 10.1111/j.1574-6968.2007.00810.x; Liang YL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-291; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Martinez RM, 2010, J BACTERIOL, V192, P2085, DOI 10.1128/JB.01562-09; Martinez RM, 2009, J BACTERIOL, V191, P5669, DOI 10.1128/JB.00632-09; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; McCarter LL, 2001, MICROBIOL MOL BIOL R, V65, P445, DOI 10.1128/MMBR.65.3.445-462.2001; Merino S, 2006, FEMS MICROBIOL LETT, V263, P127, DOI 10.1111/j.1574-6968.2006.00403.x; MINNICH SA, 1988, J BACTERIOL, V170, P3953, DOI 10.1128/jb.170.9.3953-3960.1988; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; Neal-McKinney JM, 2010, MOL MICROBIOL, V76, P918, DOI 10.1111/j.1365-2958.2010.07144.x; Nealson K. H., 2006, PROKARYOTES; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; NUIJTEN PJM, 1990, J BIOL CHEM, V265, P17798; Ozin AJ, 2003, FEMS MICROBIOL LETT, V219, P219, DOI 10.1016/S0378-1097(02)01208-9; Pallen MJ, 2006, NAT REV MICROBIOL, V4, P784, DOI 10.1038/nrmicro1493; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Prouty MG, 2001, MOL MICROBIOL, V39, P1595, DOI 10.1046/j.1365-2958.2001.02348.x; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Schoenhofen IC, 2006, GLYCOBIOLOGY, V16, p8C, DOI 10.1093/glycob/cwl010; Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039; Schoenhofen IC, 2006, J BIOL CHEM, V281, P8907, DOI 10.1074/jbc.M512987200; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; Song WJ, 2007, FEMS MICROBIOL LETT, V271, P222, DOI 10.1111/j.1574-6968.2007.00720.x; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Stewart BJ, 2003, J BACTERIOL, V185, P4508, DOI 10.1128/JB.185.15.4508-4518.2003; Syed MH, 2009, BIOINFORMATION, V4, P169, DOI 10.6026/97320630004169; Terashima H, 2010, J BACTERIOL, V192, P5609, DOI 10.1128/JB.00720-10; Thibault P, 2001, J BIOL CHEM, V276, P34862, DOI 10.1074/jbc.M104529200; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Vegh BM, 2006, BIOCHEM BIOPH RES CO, V345, P93, DOI 10.1016/j.bbrc.2006.04.055; Wang SY, 2006, J MOL BIOL, V355, P798, DOI 10.1016/j.jmb.2005.11.020; WASSENAAR TM, 1991, EMBO J, V10, P2055, DOI 10.1002/j.1460-2075.1991.tb07736.x; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006; Yamamoto S, 2006, J BACTERIOL, V188, P6703, DOI 10.1128/JB.00799-06; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; YOKOSEKI T, 1995, MICROBIOL-SGM, V141, P1715, DOI 10.1099/13500872-141-7-1715; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; YOSHIOKA K, 1995, J BACTERIOL, V177, P1090, DOI 10.1128/jb.177.4.1090-1093.1995; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	82	76	77	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21479	10.1371/journal.pone.0021479	http://dx.doi.org/10.1371/journal.pone.0021479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731763	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700089
J	Quintavalle, C; Garofalo, M; Zanca, C; Romano, G; Iaboni, M; De Caro, MD; Martinez-Montero, JC; Incoronato, M; Nuovo, G; Croce, CM; Condorelli, G				Quintavalle, C.; Garofalo, M.; Zanca, C.; Romano, G.; Iaboni, M.; De Caro, M. del Basso; Martinez-Montero, J. C.; Incoronato, M.; Nuovo, G.; Croce, C. M.; Condorelli, G.			miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTP mu	ONCOGENE			English	Article						Glioma; microRNA; tumorigenesis; apoptosis	GLIOMA-CELL MIGRATION; MICRORNA SIGNATURES; TRAIL RESISTANCE; INVASION; RECEPTOR; CANCER; GENE	Glioblastoma is the most frequent brain tumor in adults and is the most lethal form of human cancer. Despite the improvements in treatments, survival of patients remains poor. In order to identify microRNAs (miRs) involved in glioma tumorigenesis, we evaluated, by a miRarray, differential expression of miRs in the tumorigenic glioma LN-18, LN-229 and U87MG cells compared with the non-tumorigenic T98G cells. Among different miRs we focused our attention on miR-221 and -222. We demonstrated the presence of a binding site for these two miRs in the 30 untranslated region of the protein tyrosine phosphatase l (PTP mu). Previous studies indicated that PTPl suppresses cell migration and is downregulated in glioblastoma. Significantly, we found that miR-221 and -222 overexpression induced a downregulation of PTPl as analyzed by both western blot and real-time PCR. Furthermore, miR-222 and -221 induced an increase in cell migration and growth in soft agar in glioma cells. Interestingly, the re-expression of PTPl gene was able to revert the miR-222 and -221 effects on cell migration. Furthermore, we found an inverse correlation between miR-221 and -222 and PTPl in human glioma cancer samples. In conclusion, our results suggest that miR-221 and -222 regulate glioma tumorigenesis at least in part through the control of PTPl protein expression. Oncogene (2012) 31, 858-868; doi: 10.1038/onc.2011.280;published online 11 July 2011	[Condorelli, G.] Univ Naples Federico II, Fac Sci Biotecnol, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, NA, Italy; [Garofalo, M.; Nuovo, G.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; [Romano, G.; Incoronato, M.] Fdn IRCCS SDN, Naples, Italy; [De Caro, M. del Basso] Sez Anat Patol & Fitopatol, Dipartimento Sci Biomorfol & Funzionali, Bologna, Italy; [Martinez-Montero, J. C.] Hosp Univ Gregorio Maranon, Inst Oftalm, Madrid, Spain; [Condorelli, G.] CNR, IEOS, I-80125 Naples, Italy	University of Naples Federico II; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); General University Gregorio Maranon Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Condorelli, G (corresponding author), Univ Naples Federico II, Fac Sci Biotecnol, Dipartimento Biol & Patol Cellulare & Mol, Ed 19 A,2 Floor,Via Pansini 5, I-80131 Naples, NA, Italy.	gecondor@unina.it	Quintavalle, Cristina/AHH-9379-2022; Young, Richard A/F-6495-2012; Condorelli, Gerolama/AAC-3472-2022; Incoronato, Mariarosaria/AAA-7541-2021; Incoronato, Mariarosaria/K-8727-2016	Young, Richard A/0000-0001-8855-8647; Condorelli, Gerolama/0000-0003-0177-8829; Incoronato, Mariarosaria/0000-0001-7019-0581; Incoronato, Mariarosaria/0000-0001-7019-0581; Del Basso De Caro, Marialaura/0000-0002-5055-5050	Associazione Italiana Ricerca sul Cancro, AIRC [10620]; MERIT [RBNE08E8CZ_002]; Federazione Italiana Ricerca sul Cancro (FIRC); American-Italian Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA129242, P30CA016058] Funding Source: NIH RePORTER	Associazione Italiana Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro); MERIT; Federazione Italiana Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); American-Italian Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by funds from Associazione Italiana Ricerca sul Cancro, AIRC to GC ( Grant n. ro 10620) and MERIT (RBNE08E8CZ_002) to GC. CQ is supported by a Federazione Italiana Ricerca sul Cancro (FIRC) Post-Doctoral Research Fellowship. CZ is supported by an American-Italian Cancer Foundation Post-Doctoral Research Fellowship.	BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Burgoyne AM, 2009, NEURO-ONCOLOGY, V11, P767, DOI 10.1215/15228517-2009-019; Burgoyne AM, 2009, CANCER RES, V69, P6960, DOI 10.1158/0008-5472.CAN-09-0863; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cerchia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007971; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; DERIDDER LI, 1987, ACTA NEUROPATHOL, V72, P207, DOI 10.1007/BF00691091; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Liang YX, 2002, J BIOL CHEM, V277, P20087, DOI 10.1074/jbc.M201766200; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nuovo GJ, 2009, BIOTECHNIQUES, V46, P115, DOI 10.2144/000113068; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Sredni ST, 2010, CHILD NERV SYST, V26, P279, DOI 10.1007/s00381-009-1028-y; Tran B, 2010, J CLIN NEUROSCI, V17, P417, DOI 10.1016/j.jocn.2009.09.004; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037	29	145	151	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	7					858	868		10.1038/onc.2011.280	http://dx.doi.org/10.1038/onc.2011.280			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21743492	Green Accepted			2022-12-25	WOS:000300615800005
J	Xu, PZ; Chen, ML; Jeon, SM; Peng, XD; Hay, N				Xu, P-Z; Chen, M-L; Jeon, S-M; Peng, X-D; Hay, N.			The effect Akt2 deletion on tumor development in Pten(+/-) mice	ONCOGENE			English	Article						Akt2; Pten; tumor development; hyperinsulinemia	INSULIN-RESISTANCE; PROSTATE-CANCER; CELL-MIGRATION; IN-VIVO; PTEN; DEFICIENCY; BREAST; SUPPRESSION; NEOPLASIA; GROWTH	The serine/threonine kinase Akt is frequently activated in human cancers and is considered an attractive therapeutic target. However, the relative contributions of the different Akt isoforms to tumorigenesis, and the effect of their deficiencies on cancer development are not well understood. We had previously shown that Akt1 deficiency is sufficient to markedly reduce the incidence of tumors in Pten(+/-) mice. Particularly, Akt1 deficiency inhibits endometrial carcinoma and prostate neoplasia in Pten(+/-) mice. Here, we analyzed the effect of Akt2 deficiency on the incidence of tumors in Pten(+/-) mice. Relative to Akt1, Akt2 deficiency had little-to-no effect on the incidence of prostate neoplasia, endometrial carcinoma, intestinal polyps and adrenal lesions in Pten(+/-) mice. However, Akt2 deficiency significantly decreased the incidence of thyroid tumors in Pten(+/-), which correlates with the relatively high level of Akt2 expression in the thyroid. Thus, unlike Akt1 deletion, Akt2 deletion is not sufficient to markedly inhibit tumorigenesis in Pten(+/-) mice in most tested tissues. The relatively small effect of Akt2 deletion on the inhibition of tumorigenesis in Pten(+/-) mice could be explained, in part, by an insufficient decrease in total Akt activity, due to the relatively lower Akt2 versus Akt1 expression, and relatively high blood insulin levels in Pten(+/-) Akt2(-/-) mice. The relatively high blood insulin levels in Pten(+/-) Akt2(-/-) mice may elevate the activity of Akt1, and possibly Akt3, thus, limiting the reduction of total Akt activity and preventing this activity from dropping to a threshold level required to inhibit tumorigenesis. Oncogene (2012) 31, 518-526; doi: 10.1038/onc.2011.243; published online 11 July 2011	[Xu, P-Z; Chen, M-L; Jeon, S-M; Peng, X-D; Hay, N.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hay, N (corresponding author), Univ Illinois, Dept Biochem & Mol Genet MC 669, Coll Med, 900 S Ashland Ave, Chicago, IL 60607 USA.	nhay@uic.edu	Jeon, Sang-Min/I-7917-2018; Peng, Xiao-ding/B-2478-2012	Jeon, Sang-Min/0000-0002-0132-925X; Peng, Xiao-ding/0000-0002-9214-0136	NIH [CA090764, AG016927, AG025953]; NATIONAL CANCER INSTITUTE [R01CA090764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025953, R01AG016927] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000733] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by NIH grants, CA090764, AG016927 and AG025953 to NH.	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Cairns P, 1997, CANCER RES, V57, P4997; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006; Chen WS, 2009, MOL CELL BIOL, V29, P3151, DOI 10.1128/MCB.01792-08; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Chin YR, 2010, MOL CELL, V38, P333, DOI 10.1016/j.molcel.2010.02.031; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Gallagher EJ, 2010, CURR DIABETES REP, V10, P93, DOI 10.1007/s11892-010-0101-y; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Li YW, 2009, BIOORG MED CHEM LETT, V19, P834, DOI 10.1016/j.bmcl.2008.12.017; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Muller M, 2000, Prostate Cancer Prostatic Dis, V3, pS32, DOI 10.1038/sj.pcan.4500457; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Novosyadlyy R, 2010, CANCER RES, V70, P741, DOI 10.1158/0008-5472.CAN-09-2141; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Parsons Ramon, 2003, Methods Mol Biol, V222, P147; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Ringel MD, 2001, CANCER RES, V61, P6105; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Stambolic V, 2000, CANCER RES, V60, P3605; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tashiro H, 1997, CANCER RES, V57, P3935; Walker KS, 1998, BIOCHEM J, V331, P299, DOI 10.1042/bj3310299	31	26	27	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	4					518	526		10.1038/onc.2011.243	http://dx.doi.org/10.1038/onc.2011.243			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891LU	21743498	hybrid, Green Published			2022-12-25	WOS:000300219300010
J	McDowell, MA; Johnson, S; Deane, JE; Cheung, M; Roehrich, AD; Blocker, AJ; McDonnell, JM; Lea, SM				McDowell, Melanie A.; Johnson, Steven; Deane, Janet E.; Cheung, Martin; Roehrich, A. Dorothea; Blocker, Ariel J.; McDonnell, James M.; Lea, Susan M.			Structural and Functional Studies on the N-terminal Domain of the Shigella Type III Secretion Protein MxiG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEEDLE COMPLEX; FHA DOMAIN; SUPRAMOLECULAR STRUCTURE; LARGER PROTEINS; SYSTEM; PHOSPHORYLATION; SPECIFICITY; ASSIGNMENT; KINASE; IDENTIFICATION	MxiG is a single-pass membrane protein that oligomerizes within the inner membrane ring of the Shigella flexneri type III secretion system (T3SS). The MxiG N-terminal domain (MxiG-N) is the predominant cytoplasmic structure; however, its role in T3SS assembly and secretion is largely uncharacterized. We have determined the solution structure of MxiG-N residues 6-112 (MxiG-N(6-112)), representing the first published structure of this T3SS domain. The structure shows strong structural homology to forkhead-associated (FHA) domains. Canonically, these cell-signaling modules bind phosphothreonine (Thr(P)) via highly conserved residues. However, the putative phosphate-binding pocket of MxiG-N(6-112) does not align with other FHA domain structures or interact with Thr(P). Furthermore, mutagenesis of potential phosphate-binding residues has no effect on S. flexneri T3SS assembly and function. Therefore, MxiG-N has a novel function for an FHA domain. Positioning of MxiG-N(6-112) within the EM density of the S. flexneri needle complex gives insight into the ambiguous stoichiometry of the T3SS, supporting models with 24 MxiG subunits in the inner membrane ring.	[McDowell, Melanie A.; Johnson, Steven; Deane, Janet E.; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [McDonnell, James M.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Cheung, Martin; Roehrich, A. Dorothea; Blocker, Ariel J.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Cheung, Martin; Roehrich, A. Dorothea; Blocker, Ariel J.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Oxford; University of Oxford; University of Bristol; University of Bristol	Lea, SM (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	susan.lea@path.ox.ac.uk	Blocker, Ariel/Q-6617-2016; Johnson, Steven J/F-9182-2016; Lea, Susan M/B-7678-2009	Johnson, Steven J/0000-0002-7877-3543; Lea, Susan M/0000-0001-9287-8053; Deane, Janet/0000-0002-4863-0330; McDowell, Melanie/0000-0002-5231-8809; McDonnell, James/0000-0001-9037-2980	Wellcome Trust [086833, 059011]; MRC [G0401595] Funding Source: UKRI; Medical Research Council [G1000758B, G1000758, G0401595] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by Wellcome Trust-funded studentship 086833.; Supported by Wellcome Trust Programme Grant 059011 (to S. M. L.).	Alderwick LJ, 2006, P NATL ACAD SCI USA, V103, P2558, DOI 10.1073/pnas.0507766103; ALLAOUI A, 1995, MOL MICROBIOL, V17, P461, DOI 10.1111/j.1365-2958.1995.mmi_17030461.x; ALLAOUI A, 1992, J BACTERIOL, V174, P7661, DOI 10.1128/JB.174.23.7661-7669.1992; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Blocker AJ, 2008, P NATL ACAD SCI USA, V105, P6507, DOI 10.1073/pnas.0708344105; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Crepin VF, 2005, MOL MICROBIOL, V55, P1658, DOI 10.1111/j.1365-2958.2005.04508.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deane JE, 2006, ACTA CRYSTALLOGR F, V62, P302, DOI 10.1107/S1744309106006555; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARMER BT, 1995, J AM CHEM SOC, V117, P4187, DOI 10.1021/ja00119a042; Goddard T.D., SPARKY 3; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hammet A, 2003, IUBMB LIFE, V55, P23, DOI 10.1080/1521654031000070636; Hodgkinson JL, 2009, NAT STRUCT MOL BIOL, V16, P477, DOI 10.1038/nsmb.1599; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kim JF, 2001, TRENDS GENET, V17, P65, DOI 10.1016/S0168-9525(00)02175-2; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lario PI, 2005, EMBO J, V24, P1111, DOI 10.1038/sj.emboj.7600610; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Meitert T, 1991, Roum Arch Microbiol Immunol, V50, P45; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Morita-Ishihara T., 2007, Bioscience and Microflora, V26, P29; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Okon M, 2008, STRUCTURE, V16, P1544, DOI 10.1016/j.str.2008.08.006; Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9; Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001; PARSOT C, 1995, MOL MICROBIOL, V16, P291, DOI 10.1111/j.1365-2958.1995.tb02301.x; PLANO GV, 1995, J BACTERIOL, V177, P3843, DOI 10.1128/jb.177.13.3843-3854.1995; Ross JA, 2011, J BACTERIOL, V193, P2276, DOI 10.1128/JB.01137-10; Sani M, 2007, MICRON, V38, P291, DOI 10.1016/j.micron.2006.04.007; Sanowar S, 2010, MBIO, V1, DOI 10.1128/mBio.00158-10; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Schraidt O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000824; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Tsai MD, 2002, STRUCTURE, V10, P887, DOI 10.1016/S0969-2126(02)00795-5; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Zenk SF, 2007, MICROBIOL-SGM, V153, P2405, DOI 10.1099/mic.0.2007/007781-0	69	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30606	30614		10.1074/jbc.M111.243865	http://dx.doi.org/10.1074/jbc.M111.243865			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21733840	Green Published, hybrid			2022-12-25	WOS:000294283600040
J	Castonguay, R; Werner, ED; Matthews, RG; Presman, E; Mulivor, AW; Solban, N; Sako, D; Pearsall, RS; Underwood, KW; Seehra, J; Kumar, R; Grinberg, AV				Castonguay, Roselyne; Werner, Eric D.; Matthews, Robert G.; Presman, Eleonora; Mulivor, Aaron W.; Solban, Nicolas; Sako, Dianne; Pearsall, R. Scott; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra; Grinberg, Asya V.			Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; BETA-RECEPTOR COMPLEX; ENDOTHELIAL-CELLS; ANGIOGENESIS; IDENTIFICATION; EXPRESSION; MICE; PROLIFERATION; BETAGLYCAN; MUTATIONS	Endoglin (CD105), a transmembrane protein of the transforming growth factor beta superfamily, plays a crucial role in angiogenesis. Mutations in endoglin result in the vascular defect known as hereditary hemorrhagic telangiectasia (HHT1). The soluble form of endoglin was suggested to contribute to the pathogenesis of preeclampsia. To obtain further insight into its function, we cloned, expressed, purified, and characterized the extracellular domain (ECD) of mouse and human endoglin fused to an immunoglobulin Fc domain. We found that mouse and human endoglin ECD-Fc bound directly, specifically, and with high affinity to bone morphogenetic proteins 9 and 10 (BMP9 and BMP10) in surface plasmon resonance (Biacore) and cell-based assays. We performed a function mapping analysis of the different domains of endoglin by examining their contributions to the selectivity and biological activity of the protein. The BMP9/BMP10 binding site was localized to the orphan domain of human endoglin composed of the amino acid sequence 26-359. We established that endoglin and type II receptors bind to overlapping sites on BMP9. In the in vivo chick chorioallantoic membrane assay, the mouse and the truncated human endoglin ECD-Fc both significantly reduced VEGF-induced vessel formation. Finally, murine endoglin ECD-Fc acted as an anti-angiogenic factor that decreased blood vessel sprouting in VEGF/FGF-induced angiogenesis in in vivo angioreactors and reduced the tumor burden in the colon-26 mouse tumor model. Together our findings indicate an important role of soluble endoglin ECD in the regulation of angiogenesis and highlight efficacy of endoglin-Fc as a potential anti-angiogenesis therapeutic agent.	[Castonguay, Roselyne; Werner, Eric D.; Matthews, Robert G.; Presman, Eleonora; Mulivor, Aaron W.; Solban, Nicolas; Sako, Dianne; Pearsall, R. Scott; Underwood, Kathryn W.; Seehra, Jasbir; Kumar, Ravindra; Grinberg, Asya V.] Acceleron Pharma Inc, Cambridge, MA 02139 USA	Acceleron Pharma	Grinberg, AV (corresponding author), Acceleron Pharma Inc, 128 Sidney St, Cambridge, MA 02139 USA.	agrinberg@acceleronpharma.com			Acceleron Pharma	Acceleron Pharma	We thank Tim Ahern, a scientific/technical writer supported by Acceleron Pharma, who provided editorial assistance during preparation of this manuscript. We also thank Erin Ronayne and Tiffany Travis for preparation and purification of several endoglin constructs, Eileen Pobre, Dianne Mitchell, and June Liu for assay development work, Erik Vogan for secondary structure prediction, John Knopf and John Quisel for critical review of the manuscript, and all members of Acceleron Pharma Cell Biology, Protein Biochemistry, and Preclinical Pharmacology groups for contributions in support of this work.	Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bourdeau A, 1999, J CLIN INVEST, V104, P1343, DOI 10.1172/JCI8088; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Fernandez-L A, 2006, CLIN MED RES, V4, P66, DOI 10.3121/cmr.4.1.66; Guerrero-Esteo M, 2002, J BIOL CHEM, V277, P29197, DOI 10.1074/jbc.M111991200; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Jerkic M, 2006, CARDIOVASC RES, V69, P845, DOI 10.1016/j.cardiores.2005.11.020; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Letamendia A, 1998, J BIOL CHEM, V273, P33011, DOI 10.1074/jbc.273.49.33011; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lux A, 2000, HUM MOL GENET, V9, P745, DOI 10.1093/hmg/9.5.745; Mahmoud M, 2010, CIRC RES, V106, P1425, DOI 10.1161/CIRCRESAHA.109.211037; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Miller DW, 1999, INT J CANCER, V81, P568, DOI 10.1002/(SICI)1097-0215(19990517)81:4<568::AID-IJC11>3.3.CO;2-O; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Nockowski Piotr, 2004, Acta Dermatovenerol Croat, V12, P2; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Signore C, 2008, PRENATAL DIAG, V28, P852, DOI 10.1002/pd.2065; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Tsujie M, 2008, INT J CANCER, V122, P2266, DOI 10.1002/ijc.23314; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; VENTURA F, 1994, EMBO J, V13, P5581, DOI 10.1002/j.1460-2075.1994.tb06895.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wehner LE, 2006, CLIN GENET, V69, P239, DOI 10.1111/j.1399-0004.2006.00574.x	36	151	165	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30034	30046		10.1074/jbc.M111.260133	http://dx.doi.org/10.1074/jbc.M111.260133			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737454	hybrid, Green Published			2022-12-25	WOS:000294046600062
J	Papatsenko, D; Levine, M				Papatsenko, Dmitri; Levine, Michael			The Drosophila Gap Gene Network Is Composed of Two Parallel Toggle Switches	PLOS ONE			English	Article							COOPERATIVE DNA-BINDING; TRANSCRIPTIONAL REGULATION; BICOID PROTEIN; EXPRESSION; HUNCHBACK; ACTIVATION; KRUPPEL; GRADIENT; LAMBDA; STRIPE	Drosophila "gap'' genes provide the first response to maternal gradients in the early fly embryo. Gap genes are expressed in a series of broad bands across the embryo during first hours of development. The gene network controlling the gap gene expression patterns includes inputs from maternal gradients and mutual repression between the gap genes themselves. In this study we propose a modular design for the gap gene network, involving two relatively independent network domains. The core of each network domain includes a toggle switch corresponding to a pair of mutually repressive gap genes, operated in space by maternal inputs. The toggle switches present in the gap network are evocative of the phage lambda switch, but they are operated positionally (in space) by the maternal gradients, so the synthesis rates for the competing components change along the embryo anterior-posterior axis. Dynamic model, constructed based on the proposed principle, with elements of fractional site occupancy, required 5-7 parameters to fit quantitative spatial expression data for gap gradients. The identified model solutions (parameter combinations) reproduced major dynamic features of the gap gradient system and explained gap expression in a variety of segmentation mutants.	[Papatsenko, Dmitri] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Gene & Cell Med, New York, NY USA; [Levine, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Berkeley	Papatsenko, D (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Gene & Cell Med, New York, NY USA.	dimitri.papatsenko@mssm.edu	Papatsenko, Dmitri/G-7375-2016	Papatsenko, Dmitri/0000-0002-4390-5446; Levine, Michael/0000-0001-7629-0081	National Institutes of Health [GM46638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046638, R37GM046638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by a grant from the National Institutes of Health GM46638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Berezhkovskii AM, 2010, BIOPHYS J, V99, pL59, DOI 10.1016/j.bpj.2010.07.045; Bintu L, 2005, CURR OPIN GENET DEV, V15, P125, DOI 10.1016/j.gde.2005.02.006; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; Bolouri H, 2008, COMPUTATIONAL MODELI; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8406, DOI 10.1021/bi00194a004; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DILAO R, PLOS, V5; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Fujimoto K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002772; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Holloway DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001069; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; Ishihara S, 2008, J THEOR BIOL, V252, P131, DOI 10.1016/j.jtbi.2008.01.027; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; KAZEMIAN M, PLOS, V8; KRAUT R, 1991, DEVELOPMENT, V111, P601; KRAUT R, 1991, DEVELOPMENT, V111, P611; Ladame S, 2006, BIOCHEMISTRY-US, V45, P1393, DOI 10.1021/bi050229x; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; LANGELAND JA, 1994, DEVELOPMENT, V120, P2945; Lebrecht D, 2005, P NATL ACAD SCI USA, V102, P13176, DOI 10.1073/pnas.0506462102; Librizzi MD, 1996, J BIOL CHEM, V271, P32695, DOI 10.1074/jbc.271.51.32695; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Lopes FJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000184; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Owen AB, 2005, P NATL ACAD SCI USA, V102, P8844, DOI 10.1073/pnas.0409596102; Papatsenko D, 2008, P NATL ACAD SCI USA, V105, P2901, DOI 10.1073/pnas.0711941105; Papatsenko D, 2009, NUCLEIC ACIDS RES, V37, P5665, DOI 10.1093/nar/gkp619; Papatsenko D, 2009, BIOESSAYS, V31, P1172, DOI 10.1002/bies.200900096; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Poustelnikova E, 2004, BIOINFORMATICS, V20, P2212, DOI 10.1093/bioinformatics/bth222; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Sample C, 2010, P NATL ACAD SCI USA, V107, P10092, DOI 10.1073/pnas.1001139107; SCHULZ C, 1994, DEVELOPMENT, V120, P3043; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Zinzen RP, 2007, PLOS COMPUT BIOL, V3, P826, DOI 10.1371/journal.pcbi.0030084; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044; ZUO P, 1991, GENE DEV, V5, P254, DOI 10.1101/gad.5.2.254	56	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21145	10.1371/journal.pone.0021145	http://dx.doi.org/10.1371/journal.pone.0021145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747931	Green Published, Green Submitted, gold			2022-12-25	WOS:000292293400006
J	Caron, F; d'Errico, F; Del Moral, P; Santos, F; Zilhao, J				Caron, Francois; d'Errico, Francesco; Del Moral, Pierre; Santos, Frederic; Zilhao, Joao			The Reality of Neandertal Symbolic Behavior at the Grotte du Renne, Arcy-sur-Cure, France	PLOS ONE			English	Article							ORNAMENTS; MODERNITY; EMERGENCE; REMAINS; CONTEXT; MIDDLE	Background: The question of whether symbolically mediated behavior is exclusive to modern humans or shared with anatomically archaic populations such as the Neandertals is hotly debated. At the Grotte du Renne, Arcy-sur-Cure, France, the Chatelperronian levels contain Neandertal remains and large numbers of personal ornaments, decorated bone tools and colorants, but it has been suggested that this association reflects intrusion of the symbolic artifacts from the overlying Protoaurignacian and/or of the Neandertal remains from the underlying Mousterian. Methodology/Principal Findings: We tested these hypotheses against the horizontal and vertical distributions of the various categories of diagnostic finds and statistically assessed the probability that the Chatelperronian levels are of mixed composition. Our results reject that the associations result from large or small scale, localized or generalized post-depositional displacement, and they imply that incomplete sample decontamination is the parsimonious explanation for the stratigraphic anomalies seen in the radiocarbon dating of the sequence. Conclusions/Significance: The symbolic artifacts in the Chatelperronian of the Grotte du Renne are indeed Neandertal material culture.	[Caron, Francois; Del Moral, Pierre] Univ Bordeaux, Inst Math Bordeaux, Inst Natl Rech Informat & Automat Bordeaux Sud Ou, Talence, France; [d'Errico, Francesco; Santos, Frederic] Univ Bordeaux, Unite Mixte Rech Prehist Actuel Culture Environm, Talence, France; [d'Errico, Francesco] Univ Bergen, Inst Archaeol Hist Cultural & Religious Studies, Bergen, Norway; [Zilhao, Joao] Univ Barcelona, Inst Catalana Recerca & Estudis Avancats, Seminari Estudis & Recerques Preistor, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); Inria; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of Bergen; ICREA; University of Barcelona	Caron, F (corresponding author), Univ Bordeaux, Inst Math Bordeaux, Inst Natl Rech Informat & Automat Bordeaux Sud Ou, Talence, France.	f.derrico@pacea.u-bordeaux1.fr	Caron, Francois/G-1312-2010; Zilhão, João/L-5670-2014; Santos, Frédéric/I-3565-2019; Del Moral, Pierre/F-5433-2014	Zilhão, João/0000-0001-5937-3061; Santos, Frédéric/0000-0003-1445-3871; Del Moral, Pierre/0000-0003-1151-6662	European Research Council [249587]; ICREA Funding Source: Custom	European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This work was supported by the European Research Council (FP7/2007/2013/ERC Grant TRACSYMBOLS no249587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Bailey SE, 2006, J HUM EVOL, V50, P485, DOI 10.1016/j.jhevol.2005.11.008; Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; BARYOSEF O, 2006, NEANDERTHALS MODERN, P467; Bernardo J.M., 2004, BAYESIAN THEORY; Brantingham PJ, 2007, J ANTHROPOL ARCHAEOL, V26, P517, DOI 10.1016/j.jaa.2007.08.003; Conard NJ, 2008, S AFR ARCHAEOL SOC G, V10, P175; Couraud C., 1991, GALLIA PREHISTOIRE, V33, P17, DOI DOI 10.3406/galip.1991.2284; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; D'Errico F., 2003, CHRONOLOGY AURIGNACI, P247; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; David F., 2001, B SOC PREHIST FR, V98, P207; de Beaune S.A., 2002, AURIGNACIEN GROTTE R, P199; DeGiorgio M, 2009, P NATL ACAD SCI USA, V106, P16057, DOI 10.1073/pnas.0903341106; Granger JM, 1997, CR ACAD SCI II A, V325, P537, DOI 10.1016/S1251-8050(97)89874-6; Higham T, 2006, P NATL ACAD SCI USA, V103, P553, DOI 10.1073/pnas.0510005103; Higham T, 2011, ANTIQUITY, V85, P235, DOI 10.1017/S0003598X00067570; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Hovers E, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P455, DOI 10.1007/978-0-387-76487-0_30; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Julien M., 2002, AURIGNACIEN GROTTE S, P217; Langley MC, 2008, CAMB ARCHAEOL J, V18, P289, DOI 10.1017/S0959774308000371; LEROI-GOURHAN A., 1964, RELIG PREHISTOIRE; Leroi-Gourhan A., 1968, PREHISTOIRE PROBLEME, P275; LEROIGOURHANARL, 1964, GALLIA PREHISTOIRE, V7, P36; Mellars P, 2010, P NATL ACAD SCI USA, V107, P20147, DOI 10.1073/pnas.1014588107; Nowell A, 2010, ANNU REV ANTHROPOL, V39, P437, DOI 10.1146/annurev.anthro.012809.105113; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rightmire GP, 2009, P NATL ACAD SCI USA, V106, P16046, DOI 10.1073/pnas.0903930106; Roussel M, 2010, PREHISTOIRE ENTRE VI, P203; SALOMON H, 2009, THESIS U BORDEAUX; SALVATORE JR, 2009, SOURCEBOOK PALEOLITH, P377; Schmider B., 2002, AURIGNACIEN GROTTE R, P253; SCHMIDER B, 2002, AURIGNACIEN GROTTE R, P15; Wasserman L., 2003, ALL STAT CONCISE COU; White R., 2001, ATHENA REV, V2, P41, DOI DOI 10.1016/J.JHEVOL.2008.08.017; Zilhao J., 2003, PALEO, V15, P69; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103; Zilhao J, 2011, VERTEBR PALEOBIOL PA, P331, DOI 10.1007/978-94-007-0492-3_25; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	43	112	115	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21545	10.1371/journal.pone.0021545	http://dx.doi.org/10.1371/journal.pone.0021545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	786FZ	21738702	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100034
J	Dullinger, S; Hulber, K				Dullinger, Stefan; Huelber, Karl			Experimental Evaluation of Seed Limitation in Alpine Snowbed Plants	PLOS ONE			English	Article							SPECIES-RICHNESS; CLIMATE-CHANGE; COMMUNITIES; DISPERSAL; DISTRIBUTIONS; RECRUITMENT; DEMOGRAPHY; MICROSITE; HABITAT; ROLES	Background: The distribution and abundance of plants is controlled by the availability of seeds and of sites suitable for establishment. The relative importance of these two constraints is still contentious and possibly varies among species and ecosystems. In alpine landscapes, the role of seed limitation has traditionally been neglected, and the role of abiotic gradients emphasized. Methodology/Principal Findings: We evaluated the importance of seed limitation for the incidence of four alpine snowbed species (Achillea atrata L., Achillea clusiana Tausch, Arabis caerulea L., Gnaphalium hoppeanum W. D. J. Koch) in local plant communities by comparing seedling emergence, seedling, juvenile and adult survival, juvenile and adult growth, flowering frequency as well as population growth rates lambda of experimental plants transplanted into snowbed patches which were either occupied or unoccupied by the focal species. In addition, we accounted for possible effects of competition or facilitation on these rates by including a measure of neighbourhood biomass into the analysis. We found that only A. caerulea had significantly lower seedling and adult survival as well as a lower population growth rate in unoccupied sites whereas the vital rates of the other three species did not differ among occupied and unoccupied sites. By contrast, all species were sensitive to competitive effects of the surrounding vegetation in terms of at least one of the studied rates. Conclusions/Significance: We conclude that seed and site limitation jointly determine the species composition of these snowbed plant communities and that constraining site factors include both abiotic conditions and biotic interactions. The traditional focus on abiotic gradients for explaining alpine plant distribution hence appears lopsided. The influence of seed limitation on the current distribution of these plants casts doubt on their ability to readily track shifting habitats under climate change unless seed production is considerably enhanced under a warmer climate.	[Dullinger, Stefan; Huelber, Karl] Univ Vienna, Fac Ctr Biodivers, Dept Conservat Biol Vegetat & Landscape Ecol, Vienna, Austria; [Dullinger, Stefan; Huelber, Karl] Vienna Inst Nat Conservat & Anal, Vienna, Austria	University of Vienna	Dullinger, S (corresponding author), Univ Vienna, Fac Ctr Biodivers, Dept Conservat Biol Vegetat & Landscape Ecol, Vienna, Austria.	karl.huelber@vinca.at	Hülber, Karl/H-7822-2019	Hülber, Karl/0000-0001-9274-1647; Dullinger, Stefan/0000-0003-3919-0887	Austrian Science Fund FWF [P17632-B03]; European Science Commission [036866:ECOCHANGE]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); European Science Commission	The study was funded by the Austrian Science Fund FWF (P17632-B03). Additional financial support came from the European Science Commission (FP 6 project 036866:ECOCHANGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES D, 2004, DAI B LME4 LINEAR MI; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; CANTY A, 2008, BOOT BOOTSTRAP R S P, P2; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; DIRNBOCK T, 1997, LINZER BIOL BEITRAGE, V229, P623; Dirnbock T., 1999, MITTEILUNGEN NATURWI, V129, P111; Dirnboeck T., 1997, Linzer Biologische Beitrage, V29, P299; Dullinger S, 2007, J ECOL, V95, P1284, DOI 10.1111/j.1365-2745.2007.01288.x; Dullinger S, 2011, ECOGRAPHY, V34, P576, DOI 10.1111/j.1600-0587.2010.06601.x; Efron B., 1994, INTRO BOOTSTRAP; Ehrlen J, 2006, J ECOL, V94, P1224, DOI 10.1111/j.1365-2745.2006.01169.x; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Emery NC, 2009, NEW PHYTOL, V181, P734, DOI 10.1111/j.1469-8137.2008.02676.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Engler R, 2009, ECOGRAPHY, V32, P34, DOI 10.1111/j.1600-0587.2009.05789.x; Eskelinen A, 2005, OIKOS, V110, P360, DOI 10.1111/j.0030-1299.2005.13579.x; Forbis TA, 2004, AM J BOT, V91, P1147, DOI 10.3732/ajb.91.7.1147; Forbis TA, 2003, AM J BOT, V90, P1197, DOI 10.3732/ajb.90.8.1197; Foster BL, 2001, ECOL LETT, V4, P530, DOI 10.1046/j.1461-0248.2001.00266.x; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Grabherr G., 1993, PFLANZENGESELLSCHA 2, P276; Greene DF, 2002, DISPERSAL ECOLOGY, P3; Greimler J., 1996, Linzer Biologische Beitraege, V28, P437; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gustafsson C, 2002, J VEG SCI, V13, P719, DOI 10.1111/j.1654-1103.2002.tb02099.x; Heegaard E, 2004, OECOLOGIA, V139, P459, DOI 10.1007/s00442-004-1523-5; Heer C, 2002, BASIC APPL ECOL, V3, P39, DOI 10.1078/1439-1791-00075; HORVITZ CC, 1995, ECOL MONOGR, V65, P155, DOI 10.2307/2937136; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Hulber K, 2011, PERSPECT PLANT ECOL, V13, P15, DOI 10.1016/j.ppees.2011.01.001; Kikvidze Z, 2005, ECOLOGY, V86, P1395, DOI 10.1890/04-1926; Klanderud K, 2005, J ECOL, V93, P127, DOI 10.1111/j.1365-2745.2004.00944.x; Klanderud K, 2010, J ECOL, V98, P1128, DOI 10.1111/j.1365-2745.2010.01703.x; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Moore KA, 2006, ECOL LETT, V9, P797, DOI 10.1111/j.1461-0248.2006.00923.x; Moore KA, 2009, ECOLOGY, V90, P378, DOI 10.1890/07-1753.1; Munzbergova Z, 2005, OECOLOGIA, V145, P1, DOI 10.1007/s00442-005-0052-1; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Ouborg N. J., 2003, ECOLOGY GENETICS EVO, P447; Pearman PB, 2008, ECOL LETT, V11, P357, DOI 10.1111/j.1461-0248.2007.01150.x; R Development Core Team, 2008, LANG ENV STAT COMP; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Zobel M, 2000, ECOLOGY, V81, P3274, DOI 10.1890/0012-9658(2000)081[3274:ISSSRL]2.0.CO;2	52	19	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21537	10.1371/journal.pone.0021537	http://dx.doi.org/10.1371/journal.pone.0021537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738694	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100033
J	Bidard, F; Benkhali, JA; Coppin, E; Imbeaud, S; Grognet, P; Delacroix, H; Debuchy, R				Bidard, Frederique; Benkhali, Jinane Ait; Coppin, Evelyne; Imbeaud, Sandrine; Grognet, Pierre; Delacroix, Herve; Debuchy, Robert			Genome-Wide Gene Expression Profiling of Fertilization Competent Mycelium in Opposite Mating Types in the Heterothallic Fungus Podospora anserina	PLOS ONE			English	Article							REAL-TIME PCR; PHEROMONE PRECURSOR GENES; NEUROSPORA-CRASSA; MITOCHONDRIAL GENOME; SORDARIA-MACROSPORA; GIBBERELLA-ZEAE; DNA-SEQUENCE; CELL-TYPE; PROTEIN; FERTILITY	Background: Mating-type loci in yeasts and ascomycotan filamentous fungi (Pezizomycotina) encode master transcriptional factors that play a critical role in sexual development. Genome-wide analyses of mating-type-specification circuits and mating-type target genes are available in Saccharomyces cerevisiae and Schizosaccharomyces pombe; however, no such analyses have been performed in heterothallic (self-incompatible) Pezizomycotina. The heterothallic fungus Podospora anserina serves as a model for understanding the basic features of mating-type control. Its mat+ and mat- mating types are determined by dissimilar allelic sequences. The mat- sequence contains three genes, designated FMR1, SMR1 and SMR2, while the mat+ sequence contains one gene, FPR1. FMR1 and FPR1 are the major regulators of fertilization, and this study presents a genome-wide view of their target genes and analyzes their target gene regulation. Methodology/Principal Findings: The transcriptomic profiles of the mat+ and mat- strains revealed 157 differentially transcribed genes, and transcriptomic analysis of fmr1(-) and fpr1(-) mutant strains was used to determine the regulatory actions exerted by FMR1 and FPR1 on these differentially transcribed genes. All possible combinations of transcription repression and/or activation by FMR1 and/or FPR1 were observed. Furthermore, 10 additional mating-type target genes were identified that were up-or down-regulated to the same level in mat+ and mat- strains. Of the 167 genes identified, 32 genes were selected for deletion, which resulted in the identification of two genes essential for the sexual cycle. Interspecies comparisons of mating-type target genes revealed significant numbers of orthologous pairs, although transcriptional profiles were not conserved between species. Conclusions/Significance: This study represents the first comprehensive genome-wide analysis of mating-type direct and indirect target genes in a heterothallic filamentous fungus. Mating-type transcription factors have many more target genes than are found in yeasts and exert a much greater diversity of regulatory actions on target genes, most of which are not directly related to mating.	[Bidard, Frederique; Benkhali, Jinane Ait; Coppin, Evelyne; Grognet, Pierre; Debuchy, Robert] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Bidard, Frederique; Benkhali, Jinane Ait; Coppin, Evelyne; Debuchy, Robert] CNRS, UMR8621, Inst Genet & Microbiol, F-91405 Orsay, France; [Imbeaud, Sandrine; Delacroix, Herve] CNRS, Ctr Genet Mol, FRE3144, GODMAP, Gif Sur Yvette, France; [Grognet, Pierre] Univ Paris 07, UFR Sci Vivant, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Bidard, F (corresponding author), Ecole Normale Super, Inst Biol, IBENS, 24 Rue Lhomond, F-75231 Paris, France.	robert.debuchy@igmors.u-psud.fr	Grognet, Pierre/R-9615-2017; Debuchy, Robert/J-3040-2012; Imbeaud, Sandrine/P-8780-2017	Grognet, Pierre/0000-0002-2791-6233; Debuchy, Robert/0000-0003-1206-0361; Imbeaud, Sandrine/0000-0001-8439-6732	French National Research Agency [ANR-05-BLAN-0385];  [IFR115]	French National Research Agency(French National Research Agency (ANR)); 	This study and the salary of FB were funded by the French National Research Agency (http://www.agence-nationale-recherche.fr/) grant number ANR-05-BLAN-0385, project SexDevMycol, coordinator R. Debuchy. The microarray scanner was provided by the Programme Pluri-Formation (PPF) of Univ Paris-Sud 11 "Plate-forme Puces a ADN Gif-Orsay 2005-2008''. The http://podospora.igmors.u-psud.fr/methods.php address was hosted on a server funded by IFR115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaise S, 2001, GENETICS, V159, P545; ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidard Frederique, 2010, BMC Res Notes, V3, P171, DOI 10.1186/1756-0500-3-171; Bobrowicz P, 2002, MOL MICROBIOL, V45, P795, DOI 10.1046/j.1365-2958.2002.03052.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Coppin E, 2000, GENETICS, V155, P657; Coppin E, 2005, EUKARYOT CELL, V4, P407, DOI 10.1128/EC.4.2.407-420.2005; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; Davey J, 1998, SEMIN CELL DEV BIOL, V9, P19, DOI 10.1006/scdb.1997.0197; DEBUCHY R, 1993, MOL GEN GENET, V241, P667, DOI 10.1007/BF00279909; DEBUCHY R, 1992, MOL GEN GENET, V233, P113, DOI 10.1007/BF00587568; Debuchy R, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P501; DEQUARDCHABLAT M, 1994, J BIOL CHEM, V269, P14951; DYER P, 1992, CONTROL SEXUAL MORPH, P421; DYER PS, 1993, MYCOL RES, V97, P485, DOI 10.1016/S0953-7562(09)80137-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; El-Khoury R, 2008, CURR GENET, V53, P249, DOI 10.1007/s00294-008-0180-3; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Ferreira AVB, 1998, GENETICS, V148, P1069; Ferreira AVB, 1996, MOL GEN GENET, V250, P767, DOI 10.1007/BF02172989; Fleissner A, 2009, GENETICS, V181, P497, DOI 10.1534/genetics.108.096149; Galgoczy DJ, 2004, P NATL ACAD SCI USA, V101, P18069, DOI 10.1073/pnas.0407611102; GLASS NL, 1990, P NATL ACAD SCI USA, V87, P4912, DOI 10.1073/pnas.87.13.4912; GLASS NL, 1992, GENETICS, V132, P125; Goodrich-Tanrikulu M, 1998, MICROBIOL-UK, V144, P1713, DOI 10.1099/00221287-144-7-1713; Grossetete S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-81; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Jamet-Vierny C, 2007, FUNGAL GENET BIOL, V44, P1219, DOI 10.1016/j.fgb.2007.04.005; Kanematsu S, 2007, CURR GENET, V52, P11, DOI 10.1007/s00294-007-0132-3; Keszthelyi A, 2007, ANTON LEEUW INT J G, V91, P373, DOI 10.1007/s10482-006-9123-5; Kim H, 2004, MOL MICROBIOL, V52, P1781, DOI 10.1111/j.1365-2958.2004.04096.x; Kim H, 2002, EUKARYOT CELL, V1, P987, DOI 10.1128/EC.1.6.987-999.2002; Klix V, 2010, EUKARYOT CELL, V9, P894, DOI 10.1128/EC.00019-10; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; Lee SH, 2008, CURR GENET, V53, P175, DOI 10.1007/s00294-008-0176-z; Lorin S, 2001, MOL MICROBIOL, V42, P1259, DOI 10.1046/j.1365-2958.2001.02690.x; Malagnac Fabienne, 2008, Commun Integr Biol, V1, P180; Marisa L, 2007, BIOINFORMATICS, V23, P2339, DOI 10.1093/bioinformatics/btm321; Martin T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015199; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; ORBACH MJ, 1994, GENE, V150, P159, DOI 10.1016/0378-1119(94)90877-X; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poggeler S, 2006, MOL GENET GENOMICS, V275, P492, DOI 10.1007/s00438-006-0107-y; Poggeler S, 1997, GENETICS, V147, P567; Qi WH, 2006, MOL GENET GENOMICS, V276, P87, DOI 10.1007/s00438-006-0125-9; RIDDER R, 1992, CURR GENET, V21, P207, DOI 10.1007/BF00336843; RIZET GEORGES, 1949, REV CYTOL ET BIOL VEG, V11, P201; RIZET GEORGES, 1952, REV CYTOL ET BIOL VEG, V13, P51; Rubini A, 2011, NEW PHYTOL, V189, P710, DOI 10.1111/j.1469-8137.2010.03492.x; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; SAMILS N, 2011, FUNGAL GENETICS RE S, V58; Saupe S, 1996, MOL GEN GENET, V250, P115, DOI 10.1007/BF02191831; Schmoll M, 2010, MOL MICROBIOL, V77, P1483, DOI 10.1111/j.1365-2958.2010.07295.x; Shen WC, 1999, FUNGAL GENET BIOL, V27, P253, DOI 10.1006/fgbi.1999.1151; Silar P, 1995, FUNG GENET NEWSLETT, V42, P73, DOI DOI 10.4148/1941-4765.1353; STABEN C, 1990, P NATL ACAD SCI USA, V87, P4917, DOI 10.1073/pnas.87.13.4917; Turgeon B. Gillian, 2007, P93; Turgeon G, 2000, FUNGAL GENET BIOL, V31, P1, DOI 10.1006/fgbi.2000.1227; Vallim MA, 2004, MICROBIOL-SGM, V150, P1925, DOI 10.1099/mic.0.27030-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wik L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-109; Wirsel S, 1998, MOL GEN GENET, V259, P272, DOI 10.1007/s004380050813; Wirsel S, 1996, CURR GENET, V29, P241; WURMBACH E, 2010, PCR REVOLUTION BASIC, P262; Wurmbach Elisa, 2009, P137; Xiang QJ, 2002, GENETICS, V160, P169; Zhang L, 1998, MOL CELL BIOL, V18, P953, DOI 10.1128/MCB.18.2.953; ZICKLER D, 1995, GENETICS, V140, P493; ZICKLER D, 1973, MEIOSE MITOSES COURS	78	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21476	10.1371/journal.pone.0021476	http://dx.doi.org/10.1371/journal.pone.0021476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738678	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800028
J	de Vries, LE; Valles, Y; Agerso, Y; Vaishampayan, PA; Garcia-Montaner, A; Kuehl, JV; Christensen, H; Barlow, M; Francino, MP				de Vries, Lisbeth E.; Valles, Yvonne; Agerso, Yvonne; Vaishampayan, Parag A.; Garcia-Montaner, Andrea; Kuehl, Jennifer V.; Christensen, Henrik; Barlow, Miriam; Francino, M. Pilar			The Gut as Reservoir of Antibiotic Resistance: Microbial Diversity of Tetracycline Resistance in Mother and Infant	PLOS ONE			English	Article							STREPTOCOCCUS-GALLOLYTICUS; GENE; SEQUENCE; TET(W); BACTEROIDES; BACTERIA	The microbiota in the human gastrointestinal tract (GIT) is highly exposed to antibiotics, and may be an important reservoir of resistant strains and transferable resistance genes. Maternal GIT strains can be transmitted to the offspring, and resistances could be acquired from birth. This is a case study using a metagenomic approach to determine the diversity of microorganisms conferring tetracycline resistance (Tc-r) in the guts of a healthy mother-infant pair one month after childbirth, and to investigate the potential for horizontal transfer and maternal transmission of Tc-r genes. Fecal fosmid libraries were functionally screened for Tc-r, and further PCR-screened for specific Tc-r genes. Tc-r fosmid inserts were sequenced at both ends to establish bacterial diversity. Mother and infant libraries contained Tc-r, although encoded by different genes and organisms. Tc-r organisms in the mother consisted mainly of Firmicutes and Bacteroidetes, and the main gene detected was tet(O), although tet(W) and tet(X) were also found. Identical Tc-r gene sequences were present in different bacterial families and even phyla, which may indicate horizontal transfer within the maternal GIT. In the infant library, Tc-r was present exclusively in streptococci carrying tet(M), tet(L) and erm(T) within a novel composite transposon, Tn6079. This transposon belongs to a family of broad host range conjugative elements, implying a potential for the joint spread of tetracycline and erythromycin resistance within the infant's gut. In addition, although not found in the infant metagenomic library, tet(O) and tet(W) could be detected in the uncloned DNA purified from the infant fecal sample. This is the first study to reveal the diversity of Tc-r bacteria in the human gut, to detect a likely transmission of antibiotic resistance from mother to infant GITs and to indicate the possible occurrence of gene transfers among distantly related bacteria coinhabiting the GIT of the same individual.	[de Vries, Lisbeth E.; Christensen, Henrik] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [de Vries, Lisbeth E.; Agerso, Yvonne] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Valles, Yvonne; Garcia-Montaner, Andrea; Francino, M. Pilar] Univ Valencia, Inst Cavanilles, Ctr Super Invest Salut Publ, Unitat Mixta Invest Genom & Salut, Valencia, Spain; [Vaishampayan, Parag A.; Kuehl, Jennifer V.; Francino, M. Pilar] Joint Genome Inst, Dept Energy, Evolutionary Genom Program, Walnut Creek, CA USA; [Barlow, Miriam; Francino, M. Pilar] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of Copenhagen; Technical University of Denmark; University of Valencia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Merced	de Vries, LE (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark.	francino_pil@gva.es	Valles, Yvonne/AAC-9380-2019; Francino, M.Pilar/H-9090-2015	Francino, M.Pilar/0000-0002-4510-5653; , Andrea/0000-0002-1034-1672; Valles, Yvonne/0000-0002-5435-4504; Christensen, Henrik/0000-0003-4238-4658	Danish Research Council for Technology and Production Sciences [274-05-0117]; NIH (National Institutes of Health, USA) [R01 DK66288]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066288] Funding Source: NIH RePORTER	Danish Research Council for Technology and Production Sciences; NIH (National Institutes of Health, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was partly funded by a grant from The Danish Research Council for Technology and Production Sciences (274-05-0117) and by a grant R01 DK66288 from NIH (National Institutes of Health, USA) to MPF. Part of this work was performed at the U.S. Department of Energy Joint Genome Institute. The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2000, VET MICROBIOL, V74, P353, DOI 10.1016/S0378-1135(00)00197-8; Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Alazmi W, 2006, DIGEST DIS SCI, V51, P732, DOI 10.1007/s10620-006-3199-7; *AM AC PED, 2003, ANT AG REL THER TETR; Barbosa TM, 1999, ENVIRON MICROBIOL, V1, P53, DOI 10.1046/j.1462-2920.1999.00004.x; Beck M, 2008, J CLIN MICROBIOL, V46, P2966, DOI 10.1128/JCM.00078-08; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cochetti I, 2008, ANTIMICROB AGENTS CH, V52, P1285, DOI 10.1128/AAC.01457-07; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Gueimonde M, 2006, FEMS IMMUNOL MED MIC, V48, P21, DOI 10.1111/j.1574-695X.2006.00112.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kazimierczak KA, 2006, ANTIMICROB AGENTS CH, V50, P2632, DOI 10.1128/AAC.01587-05; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manichanh C, 2008, NUCLEIC ACIDS RES, V36, P5180, DOI 10.1093/nar/gkn496; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Rice LB, 1998, ANTIMICROB AGENTS CH, V42, P1871, DOI 10.1128/AAC.42.8.1871; Roberts AP, 2008, PLASMID, V60, P167, DOI 10.1016/j.plasmid.2008.08.001; Roberts AP, 2009, TRENDS MICROBIOL, V17, P251, DOI 10.1016/j.tim.2009.03.002; Roberts MC, 2003, ANAEROBE, V9, P63, DOI 10.1016/S1075-9964(03)00058-1; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Rusniok C, 2010, J BACTERIOL, V192, P2266, DOI 10.1128/JB.01659-09; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Scott KP, 2000, ANTIMICROB AGENTS CH, V44, P775, DOI 10.1128/AAC.44.3.775-777.2000; Seville LA, 2009, MICROB DRUG RESIST, V15, P159, DOI 10.1089/mdr.2009.0916; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; SPEER BS, 1990, J BACTERIOL, V172, P292, DOI 10.1128/JB.172.1.292-298.1990; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsai JC, 2005, ANTIMICROB AGENTS CH, V49, P4347, DOI 10.1128/AAC.49.10.4347-4350.2005; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turroni F, 2008, ANTON LEEUW INT J G, V94, P35, DOI 10.1007/s10482-008-9232-4; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Warburton PJ, 2007, J ANTIMICROB CHEMOTH, V60, P973, DOI 10.1093/jac/dkm331	42	87	87	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21644	10.1371/journal.pone.0021644	http://dx.doi.org/10.1371/journal.pone.0021644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738748	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800051
J	Schanzer, DL; Langley, JM; Dummer, T; Aziz, S				Schanzer, Dena L.; Langley, Joanne M.; Dummer, Trevor; Aziz, Samina			The Geographic Synchrony of Seasonal Influenza: A Waves across Canada and the United States	PLOS ONE			English	Article							SPREAD; MORTALITY; EPIDEMIC; PATTERNS	Background: As observed during the 2009 pandemic, a novel influenza virus can spread globally before the epidemic peaks locally. As consistencies in the relative timing and direction of spread could form the basis for an early alert system, the objectives of this study were to use the case-based reporting system for laboratory confirmed influenza from the Canadian FluWatch surveillance program to identify the geographic scale at which spatial synchrony exists and then to describe the geographic patterns of influenza A virus across Canada and in relationship to activity in the United States (US). Methodology/Principal Findings: Weekly laboratory confirmations for influenza A were obtained from the Canadian FluWatch and the US FluView surveillance programs from 1997/98 to 2006/07. For the six seasons where at least 80% of the specimens were antigenically similar, we identified the epidemic midpoint of the local/regional/provincial epidemics and analyzed trends in the direction of spread. In three out of the six seasons, the epidemic appeared first in Canada. Regional epidemics were more closely synchronized across the US (3-5 weeks) compared to Canada (5-13 weeks), with a slight gradient in timing from the southwest regions in the US to northeast regions of Canada and the US. Cities, as well as rural areas within provinces, usually peaked within a couple of weeks of each other. The anticipated delay in peak activity between large cities and rural areas was not observed. In some mixed influenza A seasons, lack of synchronization sub-provincially was evident. Conclusions/Significance: As mixing between regions appears to be too weak to force a consistency in the direction and timing of spread, local laboratory-based surveillance is needed to accurately assess the level of influenza activity in the community. In comparison, mixing between urban communities and adjacent rural areas, and between some communities, may be sufficient to force synchronization.	[Schanzer, Dena L.; Aziz, Samina] Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ottawa, ON, Canada; [Langley, Joanne M.] Dalhousie Univ, Canadian Ctr Vaccinol, IWK Hlth Ctr, Halifax, NS, Canada; [Langley, Joanne M.] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Dummer, Trevor] Dalhousie Univ, Dept Pediat, Populat Canc Res Program, Halifax, NS, Canada	Public Health Agency of Canada; Dalhousie University; Dalhousie University; Dalhousie University	Schanzer, DL (corresponding author), Publ Hlth Agcy Canada, Infect Dis Prevent & Control Branch, Ottawa, ON, Canada.	Dena_Schanzer@phac-aspc.gc.ca	Schanzer, Dena/G-1593-2011	Schanzer, Dena/0000-0001-7093-4309; Langley, Joanne/0000-0003-3270-7345	National FluWatch Network	National FluWatch Network	The authors gratefully acknowledge the support of the National FluWatch Network, and all those involved in the collection and compilation of this data, as well as the data provided to FluView. Special thanks to the reviewers for their thoughtful comments.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Arkema JM, 2008, EURO SURVEILL, V13; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; *CDC, 1999, MMWR-MORBID MORTAL W, V48, P374; CDC, 1998, UPDATE, V47, P280; *CDCP, 2009, FLUVIEW WEEKL INFL S; Chowell G, 2008, P ROY SOC B-BIOL SCI, V275, P501, DOI 10.1098/rspb.2007.1477; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; FLAHAULT A, 1988, STAT MED, V7, P1147, DOI 10.1002/sim.4780071107; FLAHAULT A, 1994, EUR J EPIDEMIOL, V10, P471, DOI 10.1007/BF01719679; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Khan K, 2009, NEW ENGL J MED, V361, P212, DOI 10.1056/NEJMc0904559; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; McNiven C., 2000, CENSUS METROPOLITAN; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Onozuka D, 2008, EPIDEMIOLOGY, V19, P824, DOI 10.1097/EDE.0b013e3181880eda; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; *PUBL HLTH AG CAN, 2008, FLUWATCH REP; Reyes F, 2007, Can Commun Dis Rep, V33, P21; *ROCH LAB INC, 2004, TAMIFLU COMPL PROD I; SAITO R, 2005, EUROSURVEILLANCE, V10; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Schanzer DL, 2008, VACCINE, V26, P4697, DOI 10.1016/j.vaccine.2008.06.087; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Schanzer DL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-90; Schanzer DL, 2010, INFLUENZA OTHER RESP, V4, P295, DOI 10.1111/j.1750-2659.2010.00154.x; *STAT CAN, 2008, PLAC WORK COMM WORK; *STAT CAN, 2002, POP DWELL COUNTS ON; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21471	10.1371/journal.pone.0021471	http://dx.doi.org/10.1371/journal.pone.0021471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738676	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800027
J	Caspers, BA; Schroeder, FC; Franke, S; Voigt, CC				Caspers, Barbara A.; Schroeder, Frank C.; Franke, Stephan; Voigt, Christian C.			Scents of Adolescence: The Maturation of the Olfactory Phenotype in a Free-Ranging Mammal	PLOS ONE			English	Article							SACCOPTERYX-BILINEATA CHIROPTERA; SEXUAL SELECTION; POTENTIAL USE; BAT; EMBALLONURIDAE; ODOR; RECOGNITION; PUBERTY	Olfaction is an important sensory modality for mate recognition in many mammal species. Odorants provide information about the health status, genotype, dominance status and/or reproductive status. How and when odor profiles change during sexual maturation is, however often unclear, particularly in free-ranging mammals. Here, we investigated whether the wing sac odorant of male greater sac-winged bats (Saccopteryx bilineata, Emballonuridae) differs between young and adults, and thus offers information about sexual maturity to potential mating partners. Using gas chromatography - mass spectrometry, we found differences in the odorants of young and adult males prior and during, but not after the mating period. The wing sac odorant of adult males consists of several substances, such as Pyrocoll, 2,6,10-trimethyl-3-oxo-6,10-dodecadienolide, and a so far unidentified substance; all being absent in the odor profiles of juveniles prior to the mating season. During the mating season, these substances are present in most of the juvenile odorants, but still at lower quantities compared to the wing sac odorants of adults. These results suggest that the wing sac odorant of males encodes information about age and/or sexual maturity. Although female S. bilineata start to reproduce at the age of half a year, most males of the same age postpone the sexual maturation of their olfactory phenotype until after the first mating season.	[Caspers, Barbara A.] Univ Bielefeld, Dept Anim Behaviour, Bielefeld, Germany; [Schroeder, Frank C.] Boyce Thompson Inst Plant Res, Ithaca, NY USA; [Schroeder, Frank C.] Cornell Univ, Ithaca, NY USA; [Franke, Stephan] Univ Hamburg, Inst Organ Chem, D-2000 Hamburg, Germany; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Evolutionary Ecol Res Grp, Berlin, Germany	University of Bielefeld; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; University of Hamburg; Leibniz Institut fur Zoo und Wildtierforschung	Caspers, BA (corresponding author), Univ Bielefeld, Dept Anim Behaviour, Bielefeld, Germany.	barbara.caspers@uni-bielefeld.de	Schroeder, Frank/H-5026-2012; Caspers, Barbara/C-5573-2011	Caspers, Barbara/0000-0002-4380-0476; Schroeder, Frank/0000-0002-4420-0237	German National Science Council [Vo 890/9]; National Institutes of Health [GM 53830]; Boyce-Thompson Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053830] Funding Source: NIH RePORTER	German National Science Council; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boyce-Thompson Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by a grant from the German National Science Council (to CCV: DFG; Vo 890/9), the National Institutes of Health (GM 53830), and the Boyce-Thompson Institute (to FCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication fee was supported by the Open Access Publication Fund of Bielefeld University.	Bloss J, 2002, J CHEM ECOL, V28, P819, DOI 10.1023/A:1015296928423; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Caspers B, 2008, CHEM SIGNAL, V11, P151, DOI 10.1007/978-0-387-73945-8_14; Caspers B, 2009, ZOOMORPHOLOGY, V128, P37, DOI 10.1007/s00435-008-0072-6; Caspers BA, 2009, ETHOLOGY, V115, P713, DOI 10.1111/j.1439-0310.2009.01651.x; Caspers BA, 2009, BEHAV ECOL SOCIOBIOL, V63, P741, DOI 10.1007/s00265-009-0708-7; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dechmann Dina K. N., 2005, COGNITION BRAIN BEHA, V9, P479; Ebling F.J., 1977, P17; EBLING FJ, 1972, GEN COMP ENDOCR S, V3, P223; Greene E, 2000, NATURE, V407, P1000, DOI 10.1038/35039500; Greiner S, 2011, J TROP ECOL, V27, P121, DOI 10.1017/S0266467410000696; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Muehter VR, 1997, BEHAV ECOL SOCIOBIOL, V41, P281, DOI 10.1007/s002650050389; MYER JS, 1964, J COMP PHYSIOL PSYCH, V58, P112, DOI 10.1037/h0045533; MYKYTOWYCZ R, 1972, NATURWISSENSCHAFTEN, V59, P133, DOI 10.1007/BF00637350; Nagy M, 2007, P ROY SOC B-BIOL SCI, V274, P3019, DOI 10.1098/rspb.2007.1008; Osada K, 2009, CHEM SENSES, V34, P713, DOI 10.1093/chemse/bjp058; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Quay W., 1970, BIOL BATS, P2; Rasmussen LEL, 2002, NATURE, V415, P975, DOI 10.1038/415975a; Schaffer J., 1940, HAUTDRUSENORGANE SAU; Setchell JM, 2010, CHEM SENSES, V35, P205, DOI 10.1093/chemse/bjp105; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Starck D., 1958, Gegenbaurs Jahrbuch, V99, P3; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stevenson IR, 1995, P ROY SOC B-BIOL SCI, V262, P267, DOI 10.1098/rspb.1995.0205; TANNENBAUM R, 1975, THESIS CORNELL U; Trillmich F, 2009, PHYSIOL BEHAV, V96, P476, DOI 10.1016/j.physbeh.2008.11.014; Voigt CC, 1999, BEHAV ECOL SOCIOBIOL, V47, P29, DOI 10.1007/s002650050646; Voigt CC, 2008, J MAMMAL, V89, P50, DOI 10.1644/06-MAMM-A-432.1; Voigt CC, 2007, ACTA CHIROPTEROL, V9, P463, DOI 10.3161/1733-5329(2007)9[463:AOFTMA]2.0.CO;2; Voigt CC, 2008, J MAMMAL, V89, P1401, DOI 10.1644/08-MAMM-S-060.1; Zhang JX, 2001, PHYSIOL BEHAV, V74, P415, DOI 10.1016/S0031-9384(01)00506-6	36	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21162	10.1371/journal.pone.0021162	http://dx.doi.org/10.1371/journal.pone.0021162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738615	gold, Green Submitted, Green Published			2022-12-25	WOS:000292092600015
J	Hu, ZZ; Kagan, BL; Ariazi, EA; Rosenthal, DS; Zhang, LH; Li, JV; Huang, HZ; Wu, C; Jordan, VC; Riegel, AT; Wellstein, A				Hu, Zhang-Zhi; Kagan, Benjamin L.; Ariazi, Eric A.; Rosenthal, Dean S.; Zhang, Lihua; Li, Jordan V.; Huang, Hongzhan; Wu, Cathy; Jordan, V. Craig; Riegel, Anna T.; Wellstein, Anton			Proteomic Analysis of Pathways Involved in Estrogen-Induced Growth and Apoptosis of Breast Cancer Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR COACTIVATOR; TYROSINE PHOSPHORYLATION; ANTIHORMONAL THERAPY; TAMOXIFEN RESISTANCE; ENDOCRINE THERAPY; AIB1; KINASE; SRC-3; PROLIFERATION; MODULATION	Background: Estrogen is a known growth promoter for estrogen receptor (ER)-positive breast cancer cells. Paradoxically, in breast cancer cells that have been chronically deprived of estrogen stimulation, re-introduction of the hormone can induce apoptosis. Methodology/Principal Findings: Here, we sought to identify signaling networks that are triggered by estradiol (E2) in isogenic MCF-7 breast cancer cells that undergo apoptosis (MCF-7: 5C) versus cells that proliferate upon exposure to E2 (MCF-7). The nuclear receptor co-activator AIB1 (Amplified in Breast Cancer-1) is known to be rate-limiting for E2-induced cell survival responses in MCF-7 cells and was found here to also be required for the induction of apoptosis by E2 in the MCF-7: 5C cells. Proteins that interact with AIB1 as well as complexes that contain tyrosine phosphorylated proteins were isolated by immunoprecipitation and identified by mass spectrometry (MS) at baseline and after a brief exposure to E2 for two hours. Bioinformatic network analyses of the identified protein interactions were then used to analyze E2 signaling pathways that trigger apoptosis versus survival. Comparison of MS data with a computationally-predicted AIB1 interaction network showed that 26 proteins identified in this study are within this network, and are involved in signal transduction, transcription, cell cycle regulation and protein degradation. Conclusions: G-protein-coupled receptors, PI3 kinase, Wnt and Notch signaling pathways were most strongly associated with E2-induced proliferation or apoptosis and are integrated here into a global AIB1 signaling network that controls qualitatively distinct responses to estrogen.	[Hu, Zhang-Zhi; Kagan, Benjamin L.; Rosenthal, Dean S.; Zhang, Lihua; Li, Jordan V.; Jordan, V. Craig; Riegel, Anna T.; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA; [Ariazi, Eric A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Georgetown University; Fox Chase Cancer Center	Hu, ZZ (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA.	wellstea@georgetown.edu	Rosenthal, Dean S/J-2360-2014; Jordan, V. Craig/H-4491-2011; JORDAN, V.Craig/AAX-3562-2020	Rosenthal, Dean/0000-0002-7624-0209; Wellstein, Anton/0000-0002-0570-4950; Wu, Cathy/0000-0001-6379-8601	Department of Defense, Center of Excellence [W81XWH-06-10590]; National Institutes of Health/National Cancer Institute [R01 CA113477, P30 CA051008]; NATIONAL CANCER INSTITUTE [P50CA058185, P30CA051008, R01CA113477] Funding Source: NIH RePORTER	Department of Defense, Center of Excellence(United States Department of Defense); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Breast Program W81XWH-06-10590 Center of Excellence Grant (V.C.J., A.W., A.T.R.), National Institutes of Health/National Cancer Institute R01 CA113477 (A.T.R.) and P30 CA051008. Views and opinions of, and endorsements by the author(s) do not reflect those of the U.S. Army or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aebersold R, 2009, NAT METHODS, V6, P411, DOI [10.1038/NMETH.F.255, 10.1038/nmeth.f.255]; Ahn J, 2009, J BIOL CHEM, V284, P13812, DOI 10.1074/jbc.M808821200; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Ariazi EA, 2006, J STEROID BIOCHEM, V102, P128, DOI 10.1016/j.jsbmb.2006.09.003; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Brauch H, 2009, EUR J CANCER, V45, P2274, DOI 10.1016/j.ejca.2009.05.032; Brinkmeier ML, 2003, MOL ENDOCRINOL, V17, P2152, DOI 10.1210/me.2003-0225; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; CARTER AC, 1977, JAMA-J AM MED ASSOC, V237, P2079, DOI 10.1001/jama.237.19.2079; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Coste A, 2006, EMBO J, V25, P2453, DOI 10.1038/sj.emboj.7601106; Cuevas IC, 2005, CANCER RES, V65, P5070, DOI 10.1158/0008-5472.CAN-05-0240; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Deng QD, 2004, ONCOGENE, V23, P4903, DOI 10.1038/sj.onc.1207615; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Engelmann A, 2008, ONCOGENE, V27, P1429, DOI 10.1038/sj.onc.1210772; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Fernando RI, 2004, MOL BIOL CELL, V15, P3266, DOI 10.1091/mbc.E03-11-0823; Fichtner I, 2004, EUR J CANCER, V40, P845, DOI 10.1016/j.ejca.2003.11.030; Haddow A, 1944, BMJ-BRIT MED J, V1944, P393; Han Sang Jun, 2006, Nucl Recept Signal, V4, pe014; Hiraike H, 2010, BRIT J CANCER, V102, P1061, DOI 10.1038/sj.bjc.6605577; Hoffman BG, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-81; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Hu ZZ, 2011, METHODS MOL BIOL, V719, P547, DOI 10.1007/978-1-61779-027-0_26; Hu Zhang-Zhi, 2008, J Proteomics Bioinform, V1, P47; JIANG SY, 1992, MOL CELL ENDOCRINOL, V90, P77, DOI 10.1016/0303-7207(92)90104-E; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Jordan VC, 2007, BREAST, V16, pS105, DOI 10.1016/j.breast.2007.07.020; Jordan VC, 2005, BREAST, V14, P624, DOI 10.1016/j.breast.2005.08.022; JORDAN VC, 2011, CANC PREVENTION RES; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lahusen T, 2007, CANCER RES, V67, P7256, DOI 10.1158/0008-5472.CAN-07-1013; Lahusen T, 2009, BREAST CANCER RES TR, V116, P225, DOI 10.1007/s10549-009-0405-2; Lanz RB, 2010, MOL ENDOCRINOL, V24, P859, DOI 10.1210/me.2009-0499; Lewis JS, 2005, J STEROID BIOCHEM, V94, P131, DOI 10.1016/j.jsbmb.2004.12.032; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; LIPPMAN ME, 1975, NATURE, V256, P592, DOI 10.1038/256592a0; List HJ, 2001, J BIOL CHEM, V276, P23763, DOI 10.1074/jbc.M102397200; Liu YL, 1996, GENOMICS, V31, P58, DOI 10.1006/geno.1996.0009; Liu ZJ, 2008, CANCER INVEST, V26, P878, DOI 10.1080/07357900801965042; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Lonning PE, 2001, BREAST CANCER RES TR, V67, P111, DOI 10.1023/A:1010619225209; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; Macedo LF, 2009, ANN NY ACAD SCI, V1155, P162, DOI 10.1111/j.1749-6632.2008.03689.x; Mathas S, 2005, BLOOD, V106, P4287, DOI 10.1182/blood-2004-09-3620; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nagahama Y, 2008, CANCER SCI, V99, P23, DOI 10.1111/j.1349-7006.2007.00650.x; Nicholson RI, 2005, BREAST CANCER RES TR, V93, pS3, DOI 10.1007/s10549-005-9036-4; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Song RXD, 2001, J NATL CANCER I, V93, P1714, DOI 10.1093/jnci/93.22.1714; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Tilli MT, 2005, MOL ENDOCRINOL, V19, P644, DOI 10.1210/me.2004-0106; Tong DD, 2009, PATHOBIOLOGY, V76, P163, DOI 10.1159/000218332; Torres-Arzayus MI, 2006, CANCER RES, V66, P11381, DOI 10.1158/0008-5472.CAN-06-2316; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; van Agthoven T, 2009, J CLIN ONCOL, V27, P542, DOI 10.1200/JCO.2008.17.1462; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Zhang JY, 2005, CANCER RES, V65, P8372, DOI 10.1158/0008-5472.CAN-05-0576; Zhao WH, 2009, BIOCHEM BIOPH RES CO, V380, P699, DOI 10.1016/j.bbrc.2009.01.155; Zhao Y, 2002, J BIOL CHEM, V277, P30031, DOI 10.1074/jbc.M203811200; Zhou G, 2003, MOL CELL BIOL, V23, P7742, DOI 10.1128/MCB.23.21.7742-7755.2003; ZIMMER A, 1994, BIOCHEM BIOPH RES CO, V201, P943, DOI 10.1006/bbrc.1994.1793	78	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20410	10.1371/journal.pone.0020410	http://dx.doi.org/10.1371/journal.pone.0020410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738574	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600002
J	Ma, KU; Liu, Y; Zhu, Q; Liu, CH; Duan, JL; Tan, BKH; Zhu, YZ				Ma, Kaium; Liu, Yan; Zhu, Qing; Liu, Chun-hua; Duan, Jun-Li; Tan, Benny K-H; Zhu, Yi Zhun			H2S Donor, S-Propargyl-Cysteine, Increases CSE in SGC-7901 and Cancer-Induced Mice: Evidence for a Novel Anti-Cancer Effect of Endogenous H2S?	PLOS ONE			English	Article							ACINAR-CELL APOPTOSIS; DIALLYL TRISULFIDE; HYDROGEN-SULFIDE; PROSTATE-CANCER; E-CADHERIN; CYCLE ARREST; IN-VITRO; CARCINOMA; GROWTH; RAT	Background: S-propargyl-cysteine (SPRC), an H2S donor, is a structural analogue of S-allycysteine (SAC). It was investigated for its potential anti-cancer effect on SGC-7901 gastric cancer cells and the possible mechanisms that may be involved. Methods and Findings: SPRC treatment significantly decreased cell viability, suppressed the proliferation and migration of SPRC-7901 gastric cancer cells, was pro-apoptotic as well as caused cell cycle arrest at the G(1)/S phase. In an in vivo study, intra-peritoneal injection of 50 mg/kg and 100 mg/kg of SPRC significantly reduced tumor weights and tumor volumes of gastric cancer implants in nude mice, with a tumor growth inhibition rate of 40-75%. SPRC also induced a pro-apoptotic effect in cancer tissues and elevated the expressions of p53 and Bax in tumors and cells. SPRC treatment also increased protein expression of cystathione-gamma-lyase (CSE) in cells and tumors, and elevated H2S levels in cell culture media, plasma and tumoral CSE activity of gastric cancer-induced nude mice by 2, 2.3 and 1.4 fold, respectively. Most of the anti-cancer functions of SPRC on cells and tumors were significantly suppressed by PAG, an inhibitor of CSE activity. Conclusions: Taken together, the results of our study provide insights into a novel anti-cancer effect of H2S as well as of SPRC on gastric cancer through inducing the activity of a new target, CSE.	[Ma, Kaium; Zhu, Qing; Liu, Chun-hua; Zhu, Yi Zhun] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China; [Ma, Kaium; Zhu, Qing; Liu, Chun-hua; Zhu, Yi Zhun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Liu, Yan] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Cardiovasc Med, Shanghai 200030, Peoples R China; [Duan, Jun-Li] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Gerontol, Shanghai 200030, Peoples R China; [Tan, Benny K-H; Zhu, Yi Zhun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	Fudan University; Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; National University of Singapore	Ma, KU (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 200433, Peoples R China.	zhuyz@fudan.edu.cn	Zhu, Yi Zhun/ABG-8449-2021; Zhu, Qing/G-4522-2018	Zhu, Yi Zhun/0000-0001-7700-8041; Zhu, Qing/0000-0002-9411-9517	National Distinguished Young Scientists Grant in China [385 (30888002)]; National 973 Project [2007CB512006, 2010CB912600]; Shanghai-Unilever Research & Development Fund [08540750400]	National Distinguished Young Scientists Grant in China; National 973 Project(National Basic Research Program of China); Shanghai-Unilever Research & Development Fund	We acknowledge the financial assistance provided by a grant from the National Distinguished Young Scientists Grant 385 (No. 30888002) in China, the National 973 Project (2007CB512006 and 2010CB912600) and Shanghai-Unilever Research & Development Fund (08540750400).	Adhikari S, 2008, J CELL MOL MED, V12, P1374, DOI 10.1111/j.1582-4934.2008.00318.x; Arunkumar A, 2006, MOL CELL BIOCHEM, V288, P107, DOI 10.1007/s11010-006-9126-6; Baskar R, 2007, FASEB J, V21, P247, DOI 10.1096/fj.06-6255com; BRESLOW N, 1977, INT J CANCER, V20, P680, DOI 10.1002/ijc.2910200506; Cao Y, 2006, AM J PHYSIOL-CELL PH, V291, pC503, DOI 10.1152/ajpcell.00547.2005; Chu QJ, 2006, CARCINOGENESIS, V27, P2180, DOI 10.1093/carcin/bgl054; Davis SR, 2005, MYCOSES, V48, P95, DOI 10.1111/j.1439-0507.2004.01076.x; Dong CN, 2009, BIOORGAN MED CHEM, V17, P3499, DOI 10.1016/j.bmc.2009.02.065; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; GIROLDI LA, 1993, CANCER METAST REV, V12, P29, DOI 10.1007/BF00689788; Harada K, 2005, CANCER LETT, V226, P161, DOI 10.1016/j.canlet.2004.12.048; Herman-Antosiewicz A, 2004, MUTAT RES-FUND MOL M, V555, P121, DOI 10.1016/j.mrfmmm.2004.04.016; Hong YS, 2000, EXP MOL MED, V32, P127, DOI 10.1038/emm.2000.22; Jacob C, 2008, PLANTA MED, V74, P1580, DOI 10.1055/s-0028-1088299; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Liu XH, 2009, CLIN EXP PHARMACOL P, V36, P696, DOI 10.1111/j.1440-1681.2008.05135.x; Loh KP, 2009, J ETHNOPHARMACOL, V125, P337, DOI 10.1016/j.jep.2009.05.025; MARCOTTE P, 1975, BIOCHEM BIOPH RES CO, V62, P677, DOI 10.1016/0006-291X(75)90452-0; Miyake H, 1999, BRIT J CANCER, V79, P1651, DOI 10.1038/sj.bjc.6690264; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Nakagawa H, 2001, CARCINOGENESIS, V22, P891, DOI 10.1093/carcin/22.6.891; Shen JK, 1996, PLANTA MED, V62, P415, DOI 10.1055/s-2006-957929; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Sundaram SG, 1996, J NUTR, V126, P1355, DOI 10.1093/jn/126.5.1355; Wang Q, 2009, J CARDIOVASC PHARM, V54, P139, DOI 10.1097/FJC.0b013e3181ac8e12; Wang XH, 2003, ONCOGENE, V22, P109, DOI 10.1038/sj.onc.1206069; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao DH, 2003, CANCER RES, V63, P6825; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yoshiji H, 1998, INT J CANCER, V75, P81, DOI 10.1002/(SICI)1097-0215(19980105)75:1<81::AID-IJC13>3.3.CO;2-J; Zhang ZM, 2007, CHINESE MED J-PEKING, V120, P1336, DOI 10.1097/00029330-200708010-00008	32	77	79	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20525	10.1371/journal.pone.0020525	http://dx.doi.org/10.1371/journal.pone.0020525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738579	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600004
J	Bengestrate, L; Virtue, S; Campbell, M; Vidal-Puig, A; Hadaschik, D; Hahn, P; Bielke, W				Bengestrate, Lena; Virtue, Sam; Campbell, Mark; Vidal-Puig, Antonio; Hadaschik, Dirk; Hahn, Peter; Bielke, Wolfgang			Genome-Wide Profiling of MicroRNAs in Adipose Mesenchymal Stem Cell Differentiation and Mouse Models of Obesity	PLOS ONE			English	Article							GENE-EXPRESSION; ADIPOGENESIS; MICROARRAY; ADIPOCYTES; PROTEIN; TISSUE	In recent years, there has been accumulating evidence that microRNAs are key regulator molecules of gene expression. The cellular processes that are regulated by microRNAs include e. g. cell proliferation, programmed cell death and cell differentiation. Adipocyte differentiation is a highly regulated cellular process for which several important regulating factors have been discovered, but still not all are known to fully understand the underlying mechanisms. In the present study, we analyzed the expression of 597 microRNAs during the differentiation of mouse mesenchymal stem cells into terminally differentiated adipocytes by real-time RT-PCR. In total, 66 miRNAs were differentially expressed in mesenchymal stem cell-derived adipocytes compared to the undifferentiated progenitor cells. To further study the regulation of these 66 miRNAs in white adipose tissue in vivo and their dependence on PPAR gamma activity, mouse models of genetically or diet induced obesity as well as a mouse line expressing a dominant negative PPAR gamma mutant were employed.	[Bengestrate, Lena; Hadaschik, Dirk; Hahn, Peter; Bielke, Wolfgang] QIAGEN GmbH, Dept Epigenet, Hilden, Germany; [Virtue, Sam; Campbell, Mark; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England	QIAGEN GmbH; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Bengestrate, L (corresponding author), Univ Cologne, Inst Biochem 2, Cologne, Germany.	wolfgang.bielke@qiagen.com	Virtue, SAm/B-7578-2013; Xie, Huangming/B-2260-2012	Virtue, SAm/0000-0002-9545-5432; Vidal-Puig, Antonio/0000-0003-4220-9577	MRC [14133]; BBSRC [20485]; R&D department of QIAGEN GmbH; MRC [G0802051] Funding Source: UKRI; Medical Research Council [G0802051] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); R&D department of QIAGEN GmbH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work for this project was funded in part by MRC Programme grant number 14133 (www.mrc.ac.uk/index.htm) and BBSRC grant number 20485 (www.bbsrc.ac.uk) to Antonio Vidal-Puig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors DH, PH, and WB are currently employees within the R&D department of QIAGEN GmbH and declare potential competing financial interests, including personal ownership of QIAGEN stocks and/or stock options. Several commercially available products, marketed by QIAGEN, were employed for this study. These products include kits and items for nucleic acid isolation and amplification, as well as the miScript system for microRNA detection. QIAGEN holds several issued and pending patents related to these products. The above said does not alter the authors' adherence to all the PloS ONE policies on sharing data and materials.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; BAXA CA, 1989, BIOCHEMISTRY-US, V28, P8683, DOI 10.1021/bi00448a003; Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Caballero B, 2007, EPIDEMIOL REV, V29, P1, DOI 10.1093/epirev/mxm012; Canales RD, 2006, NAT BIOTECHNOL, V24, P1115, DOI 10.1038/nbt1236; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Kumar P, 2011, RNA, V17, P365, DOI 10.1261/rna.2490111; Leski TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006569; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; McPherson R, 2007, CAN J CARDIOL, V23, p23A, DOI 10.1016/S0828-282X(07)71002-4; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Soukas A, 2000, GENE DEV, V14, P963; Vaananen HK, 2005, ANN MED, V37, P469, DOI 10.1080/07853890500371957; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	33	39	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21305	10.1371/journal.pone.0021305	http://dx.doi.org/10.1371/journal.pone.0021305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731698	gold, Green Submitted, Green Published			2022-12-25	WOS:000292035400020
J	Ivashuta, S; Banks, IR; Wiggins, BE; Zhang, YJ; Ziegler, TE; Roberts, JK; Heck, GR				Ivashuta, Sergey; Banks, Isaac R.; Wiggins, B. Elizabeth; Zhang, Yuanji; Ziegler, Todd E.; Roberts, James K.; Heck, Gregory R.			Regulation of Gene Expression in Plants through miRNA Inactivation	PLOS ONE			English	Article							MICRORNA TARGETS; SIRNA BIOGENESIS; SMALL RNAS; PREDICTION; SPONGES	Eukaryotic organisms possess a complex RNA-directed gene expression regulatory network allowing the production of unique gene expression patterns. A recent addition to the repertoire of RNA-based gene regulation is miRNA target decoys, endogenous RNA that can negatively regulate miRNA activity. miRNA decoys have been shown to be a valuable tool for understanding the function of several miRNA families in plants and invertebrates. Engineering and precise manipulation of an endogenous RNA regulatory network through modification of miRNA activity also affords a significant opportunity to achieve a desired outcome of enhanced plant development or response to environmental stresses. Here we report that expression of miRNA decoys as single or heteromeric non-cleavable microRNA (miRNA) sites embedded in either non-protein-coding or within the 3' untranslated region of protein-coding transcripts can regulate the expression of one or more miRNA targets. By altering the sequence of the miRNA decoy sites, we were able to attenuate miRNA inactivation, which allowed for fine regulation of native miRNA targets and the production of a desirable range of plant phenotypes. Thus, our results demonstrate miRNA decoys are a flexible and robust tool, not only for studying miRNA function, but also for targeted engineering of gene expression in plants. Computational analysis of the Arabidopsis transcriptome revealed a number of potential miRNA decoys, suggesting that endogenous decoys may have an important role in natural modulation of expression in plants.	[Ivashuta, Sergey; Banks, Isaac R.; Wiggins, B. Elizabeth; Zhang, Yuanji; Ziegler, Todd E.; Roberts, James K.; Heck, Gregory R.] Monsanto Co, Chesterfield, MO USA	Monsanto	Ivashuta, S (corresponding author), Monsanto Co, Chesterfield, MO USA.	sergey.i.ivashuta@monsanto.com		Ziegler, Todd/0000-0001-8947-5763				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alves L, 2009, NUCLEIC ACIDS RES, V37, P4010, DOI 10.1093/nar/gkp272; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conlon Helen E, 2007, Methods Mol Biol, V362, P379; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Hinkelmann K., 1994, DESIGN ANAL EXPT, V1; James C, 2003, CURR SCI INDIA, V84, P303; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mullen JL, 2006, PLANT CELL ENVIRON, V29, P1099, DOI 10.1111/j.1365-3040.2005.01484.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pearson W R, 2000, Methods Mol Biol, V132, P185; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sambrook J., 2001, MOL CLONING; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Todesco M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001031; Towbin H, 1992, Biotechnology, V24, P145; Vandenbussche F, 2003, PLANT PHYSIOL, V133, P517, DOI 10.1104/pp.103.022665	29	61	63	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21330	10.1371/journal.pone.0021330	http://dx.doi.org/10.1371/journal.pone.0021330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731706	gold, Green Published, Green Submitted			2022-12-25	WOS:000292035400023
J	Eilers, EJ; Kremen, C; Greenleaf, SS; Garber, AK; Klein, AM				Eilers, Elisabeth J.; Kremen, Claire; Greenleaf, Sarah Smith; Garber, Andrea K.; Klein, Alexandra-Maria			Contribution of Pollinator-Mediated Crops to Nutrients in the Human Food Supply	PLOS ONE			English	Article							WORLD AGRICULTURE; NORTH-AMERICAN; ECONOMIC VALUE; HUMAN HEALTH; PLANTS; CONSERVATION; DECLINES; LYCOPENE; TRENDS; YIELD	The contribution of nutrients from animal pollinated world crops has not previously been evaluated as a biophysical measure for the value of pollination services. This study evaluates the nutritional composition of animal-pollinated world crops. We calculated pollinator dependent and independent proportions of different nutrients of world crops, employing FAO data for crop production, USDA data for nutritional composition, and pollinator dependency data according to Klein et al. (2007). Crop plants that depend fully or partially on animal pollinators contain more than 90% of vitamin C, the whole quantity of Lycopene and almost the full quantity of the antioxidants beta-cryptoxanthin and beta-tocopherol, the majority of the lipid, vitamin A and related carotenoids, calcium and fluoride, and a large portion of folic acid. Ongoing pollinator decline may thus exacerbate current difficulties of providing a nutritionally adequate diet for the global human population.	[Eilers, Elisabeth J.] Free Univ Berlin, Dept Appl Zool Anim Ecol, D-1000 Berlin, Germany; [Eilers, Elisabeth J.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany; [Kremen, Claire] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Greenleaf, Sarah Smith] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Garber, Andrea K.] Univ Calif San Francisco, Div Adolescent Med, San Francisco, CA 94143 USA; [Klein, Alexandra-Maria] Leuphana Univ Luneburg, Inst Ecol, Sect Ecosyst Funct, Luneburg, Germany	Free University of Berlin; Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California San Francisco; Leuphana University Luneburg	Eilers, EJ (corresponding author), Free Univ Berlin, Dept Appl Zool Anim Ecol, D-1000 Berlin, Germany.	eeilers@ice.mpg.de	Klein, Alexandra-Maria/J-5871-2016	Klein, Alexandra-Maria/0000-0003-2139-8575	German Science Foundation [KL 1849/4-1]; NSF [BEB-00-72909]; European Commission [244090 - STEP - CP - FP]	German Science Foundation(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The German Science Foundation provided funding to AMK (KL 1849/4-1). This work is part of the National Center for Ecological Analysis and Synthesis Restoring Pollination Services Working Group (led by C. Kremen and N. M. Williams, and supported by the Center's NSF grant no. BEB-00-72909) and part of the STEP (Status and Trends of European Pollinators) project of the European Commission under the 7th Framework Program for Research and Technological Development (grant no. 244090 - STEP - CP - FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; [Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; DellaPenna D, 1999, SCIENCE, V285, P375, DOI 10.1126/science.285.5426.375; Food and Nutrition Board IOM, 1997, DIET REF INT CALC MA; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gilland B, 2002, FOOD POLICY, V27, P47, DOI 10.1016/S0306-9192(02)00002-7; GROSS BJ, 2010, THESIS U CALIFORNIA; Heaney RP, 2000, J AM COLL NUTR, V19, p83S, DOI 10.1080/07315724.2000.10718088; Kearns CA, 2001, CONSERV ECOL, V5; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Maberly G, 2008, TRENDS WHEAT FLOUR F; Pinstrup-Andersen P., 1999, WORLD FOOD PROSPECTS; Poletti S, 2004, CURR OPIN BIOTECH, V15, P162, DOI 10.1016/j.copbio.2004.03.002; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PRESCOTTALLEN R, 1990, CONSERV BIOL, V4, P365, DOI 10.1111/j.1523-1739.1990.tb00310.x; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Richards AJ, 2001, ANN BOT-LONDON, V88, P165, DOI 10.1006/anbo.2001.1463; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Stahl W, 1998, FEBS LETT, V427, P305, DOI 10.1016/S0014-5793(98)00434-7; Stahl W, 1996, ARCH BIOCHEM BIOPHYS, V336, P1, DOI 10.1006/abbi.1996.0525; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; *US FAO, 2011, INT FOOD COMP TABL; *US FAO, 2008, PROD DAT; *USDA, 2002, US ALM IND SIT; WEAVER CM, 1994, AM J CLIN NUTR, V59, p1238S, DOI 10.1093/ajcn/59.5.1238S; Welch RM, 1999, FIELD CROP RES, V60, P1, DOI 10.1016/S0378-4290(98)00129-4	35	177	184	4	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21363	10.1371/journal.pone.0021363	http://dx.doi.org/10.1371/journal.pone.0021363			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731717	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700067
J	Tyagi, AM; Srivastava, K; Sharan, K; Yadav, D; Maurya, R; Singh, D				Tyagi, Abdul Malik; Srivastava, Kamini; Sharan, Kunal; Yadav, Dinesh; Maurya, Rakesh; Singh, Divya			Daidzein Prevents the Increase in CD4(+)CD28null T Cells and B Lymphopoesis in Ovariectomized Mice: A Key Mechanism for Anti-Osteoclastogenic Effect	PLOS ONE			English	Article							BONE-MINERAL DENSITY; CD28 EXPRESSION; PHYTOESTROGEN GENISTEIN; SOYBEAN ISOFLAVONE; PANCREATIC-ISLETS; OXIDATIVE STRESS; LYMPHOPOIESIS; POSTMENOPAUSAL; SENESCENCE; MARROW	Estrogen deficiency leads to an upregulation of TNF-alpha producing T cells and B-lymphopoesis which augments osteoclastogenesis. Estrogen deficiency also increases the population of premature senescent CD4(+)CD28null T cells which secrete a higher amount of TNF-alpha thus leading to enhanced osteoclastogenesis. Isoflavonoids like daidzein and genistein are found mostly in soybeans, legumes, and peas. These share structural similarity with 17 beta-stradiol (E2) and have osteoprotective role. This study explores the effect of daidzein (Daid) on the proliferation of TNF-alpha producing T cells, premature senescent T cells and B cell lymphopoesis under estrogen deficient conditions. For this study adult Balb/c mice were treated with Daid at 10 mg/kg body weight dose by oral gavage daily post ovariectomy (Ovx). After six weeks animals were autopsied and bone marrow and spleen cells were collected for FACS analysis. Blood serum was collected for ELISA. It was observed that Ovx mice treated with Daid for six weeks show reduction in Ovx induced expansion of CD4(+) T cells in bone marrow and spleen when analysed by flow cytometry. Estrogen deficiency led to increased prevalence of TNF-alpha secreting CD4(+)CD28null T cells, however, treatment with Daid increased the percentage of CD4(+)CD28(+) T cells. Co-culture of CD4(+)CD28null T cells and bone marrow resulted in enhanced osteoclastogenesis as evident by increased tartarate resistant acid phosphatase (TRAP) expression, an osteoclast marker. However, treatment with Daid resulted in reduced osteoclastogenesis in CD4(+)CD28null T cells and bone marrow cell co-culture. Daid also regulated B lymphopoesis and decreased mRNA levels of RANKL in B220(+) cells. Taken together, we propose that one of the mechanisms by which Daid prevents bone loss is by reversing the detrimental immune changes as a result of estrogen deficiency.	[Tyagi, Abdul Malik; Srivastava, Kamini; Sharan, Kunal; Singh, Divya] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Yadav, Dinesh; Maurya, Rakesh] CSIR, Cent Drug Res Inst, Div Med & Proc Chem, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Tyagi, AM (corresponding author), CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	divya_singh@cdri.res.in	Malik, Abdul/AAX-5715-2020	Malik, Abdul/0000-0001-9012-5779; SRIVASTAVA, KAMINI/0000-0002-3928-0885; Sharan, Kunal/0000-0003-2139-2544	Ministry of Health and Family Welfare, Department of Science and Technology, Department of Biotechnology and Council of Scientific and Industrial Research, Government of India	Ministry of Health and Family Welfare, Department of Science and Technology, Department of Biotechnology and Council of Scientific and Industrial Research, Government of India	Generous funding was provided by the Ministry of Health and Family Welfare, Department of Science and Technology, Department of Biotechnology and Council of Scientific and Industrial Research, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin JE, 2000, OSTEOPOROSIS INT, V11, P905, DOI 10.1007/s001980070028; Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Banfi G, 2008, CLIN CHEM LAB MED, V46, P1550, DOI 10.1515/CCLM.2008.302; BIANCHI F, 1993, TISSUE CELL, V25, P817, DOI 10.1016/0040-8166(93)90030-O; Bitto A, 2009, J ENDOCRINOL, V201, P321, DOI 10.1677/JOE-08-0552; Bryl E, 2005, ARTHRITIS RHEUM-US, V52, P2996, DOI 10.1002/art.21353; Bryl E, 2001, J IMMUNOL, V167, P3231, DOI 10.4049/jimmunol.167.6.3231; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; Effros RB, 1998, AGING-CLIN EXP RES, V10, P152; Erlandsson MC, 2000, CELL IMMUNOL, V205, P103, DOI 10.1006/cimm.2000.1719; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Hertrampf T, 2007, BONE, V40, P1529, DOI 10.1016/j.bone.2007.02.006; Horowitz MC, 2005, IMMUNOL REV, V208, P141, DOI 10.1111/j.0105-2896.2005.00328.x; Imanishi T, 2005, HYPERTENS RES, V28, P263, DOI 10.1291/hypres.28.263; Ishimi Y, 2002, BONE, V31, P180, DOI 10.1016/S8756-3282(02)00780-9; Ishimi Y, 1999, ENDOCRINOLOGY, V140, P1893, DOI 10.1210/en.140.4.1893; KALU DN, 1993, BONE MINER, V23, P145, DOI 10.1016/S0169-6009(08)80050-5; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kozlowska E, 2007, IMMUNOLOGY, V122, P445, DOI 10.1111/j.1365-2567.2007.02667.x; Kritz-Silverstein D, 2002, J WOMEN HEALTH GEN-B, V11, P69, DOI 10.1089/152460902753473480; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Li R, 2002, CANCER-AM CANCER SOC, V95, P960, DOI 10.1002/cncr.10791; Li Y, 2007, J CELL BIOCHEM, V100, P1370, DOI 10.1002/jcb.21121; MARCHETTI P, 1994, TRANSPLANTATION, V57, P1532; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Mei J, 2001, J CLIN ENDOCR METAB, V86, P5217, DOI 10.1210/jc.86.11.5217; Miyamoto M, 1998, PLANTA MED, V64, P516, DOI 10.1055/s-2006-957505; Miyaura C, 1997, P NATL ACAD SCI USA, V94, P9360, DOI 10.1073/pnas.94.17.9360; Morito K, 2002, BIOL PHARM BULL, V25, P48, DOI 10.1248/bpb.25.48; Pacifici R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2126; Pandey R, 2010, MENOPAUSE, V17, P602, DOI 10.1097/gme.0b013e3181d0f7f0; Picherit C, 2000, J NUTR, V130, P1675, DOI 10.1093/jn/130.7.1675; Puel C, 2006, CLIN NUTR, V25, P859, DOI 10.1016/j.clnu.2006.03.009; Rapaport FT, 1997, TRANSPL P, V29, P1261, DOI 10.1016/S0041-1345(96)00489-7; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; ROSEN CJ, 1990, J BONE MINER RES, V5, P851; Sakai T, 2010, J NUTR SCI VITAMINOL, V56, P72, DOI 10.3177/jnsv.56.72; Sakai T, 2008, J MED INVESTIG, V55, P167, DOI 10.2152/jmi.55.167; Setchell KDR, 2003, AM J CLIN NUTR, V78, p593S, DOI 10.1093/ajcn/78.3.593S; Somekawa Y, 2001, OBSTET GYNECOL, V97, P109, DOI 10.1016/S0029-7844(00)01080-2; Sun DX, 2003, J BONE MINER RES, V18, P1206, DOI 10.1359/jbmr.2003.18.7.1206; Tarjanyi Oktavia, 2009, Immun Ageing, V6, P8, DOI 10.1186/1742-4933-6-8; TYAGI AM, 2011, OSTEOPOROS IN PRESS; Vallejo AN, 1999, J IMMUNOL, V162, P6572; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; Vallejo AN, 2002, J BIOL CHEM, V277, P46940, DOI 10.1074/jbc.M207352200; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Yellayi S, 2002, P NATL ACAD SCI USA, V99, P7616, DOI 10.1073/pnas.102650199	51	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21216	10.1371/journal.pone.0021216	http://dx.doi.org/10.1371/journal.pone.0021216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731677	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700048
J	Wang, DC; Wang, HY; Zhou, YY; Zhang, QX; Zhang, FF; Du, PC; Wang, SJ; Chen, C; Kan, BA				Wang, Duochun; Wang, Haiyin; Zhou, Yanyan; Zhang, Qiuxiang; Zhang, Fanfei; Du, Pengcheng; Wang, Shujing; Chen, Chen; Kan, Biao			Genome Sequencing Reveals Unique Mutations in Characteristic Metabolic Pathways and the Transfer of Virulence Genes between V. mimicus and V. cholerae	PLOS ONE			English	Article							VIBRIO PATHOGENICITY ISLAND; LYSOGENIC CONVERSION; CTX-PHI; TOXIN; STRAINS; IDENTIFICATION; HEMOLYSIN; PROPHAGE; EXPRESSION; EPIDEMIC	Vibrio mimicus, the species most similar to V. cholerae, is a microbe present in the natural environmental and sometimes causes diarrhea and internal infections in humans. It shows similar phenotypes to V. cholerae but differs in some biochemical characteristics. The molecular mechanisms underlying the differences in biochemical metabolism between V. mimicus and V. cholerae are currently unclear. Several V. mimicus isolates have been found that carry cholera toxin genes (ctxAB) and cause cholera-like diarrhea in humans. Here, the genome of the V. mimicus isolate SX-4, which carries an intact CTX element, was sequenced and annotated. Analysis of its genome, together with those of other Vibrio species, revealed extensive differences within the Vibrionaceae. Common mutations in gene clusters involved in three biochemical metabolism pathways that are used for discrimination between V. mimicus and V. cholerae were found in V. mimicus strains. We also constructed detailed genomic structures and evolution maps for the general types of genomic drift associated with pathogenic characters in polysaccharides, CTX elements and toxin co-regulated pilus (TCP) gene clusters. Overall, the whole-genome sequencing of the V. mimicus strain carrying the cholera toxin gene provides detailed information for understanding genomic differences among Vibrio spp. V. mimicus has a large number of diverse gene and nucleotide differences from its nearest neighbor, V. cholerae. The observed mutations in the characteristic metabolism pathways may indicate different adaptations to different niches for these species and may be caused by ancient events in evolution before the divergence of V. cholerae and V. mimicus. Horizontal transfers of virulence-related genes from an uncommon clone of V. cholerae, rather than the seventh pandemic strains, have generated the pathogenic V. mimicus strain carrying cholera toxin genes.	[Wang, Duochun; Wang, Haiyin; Zhou, Yanyan; Du, Pengcheng; Wang, Shujing; Chen, Chen; Kan, Biao] Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Qiuxiang; Zhang, Fanfei] Ctr Dis Control & Prevent Shanxi Prov, Taiyuan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, DC (corresponding author), Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	chenchen@icdc.cn; kanbiao@icdc.cn	CHEN, CHEN/HDM-6657-2022; chen, chen/AAQ-1805-2021	chen, chen/0000-0003-1765-8899	National Basic Research Priorities Program [2009CB522604]; National High Technology Research and Development Program of China (863 Program) [2006AA02Z425]; National Natural Science Foundation of China [30872260]; special grant for Prevention and Treatment of Infectious Diseases [2008ZX10004-012]	National Basic Research Priorities Program(National Basic Research Program of China); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special grant for Prevention and Treatment of Infectious Diseases	This work was supported by grants from the National Basic Research Priorities Program (2009CB522604), the National High Technology Research and Development Program of China (863 Program) (2006AA02Z425), the National Natural Science Foundation of China (No. 30872260) and a special grant for Prevention and Treatment of Infectious Diseases (2008ZX10004-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna MT, 1999, APPL ENVIRON MICROB, V65, P336; ALBERT MJ, 1993, LANCET, V341, P704; Boyd EF, 2000, INFECT IMMUN, V68, P1507, DOI 10.1128/IAI.68.3.1507-1513.2000; DAVIS BR, 1981, J CLIN MICROBIOL, V14, P631, DOI 10.1128/JCM.14.6.631-639.1981; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Faruque SM, 2003, INFECT IMMUN, V71, P1020, DOI 10.1128/IAI.71.2.1020-1025.2003; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Faruque SM, 1999, INFECT IMMUN, V67, P5723, DOI 10.1128/IAI.67.11.5723-5729.1999; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hasan NA, 2010, P NATL ACAD SCI USA, V107, P21134, DOI 10.1073/pnas.1013825107; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kim GT, 1997, BBA-MOL BASIS DIS, V1360, P102, DOI 10.1016/S0925-4439(97)00008-2; Kumar P, 2009, J MED MICROBIOL, V58, P234, DOI 10.1099/jmm.0.002089-0; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Liu Guang-wen, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P379; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maiti D, 2006, MICROBIOL-SGM, V152, P3633, DOI 10.1099/mic.0.2006/000117-0; Mukhopadhyay AK, 2001, J BACTERIOL, V183, P4737, DOI 10.1128/JB.183.16.4737-4746.2001; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Rubin EJ, 1998, MOL MICROBIOL, V28, P1247, DOI 10.1046/j.1365-2958.1998.00889.x; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Saunders J, 2004, NAT REV MICROBIOL, V2, P86, DOI 10.1038/nrmicro830; SHANDERA WX, 1983, ANN INTERN MED, V99, P169, DOI 10.7326/0003-4819-99-2-169; Shi L, 1998, MICROBIOL IMMUNOL, V42, P823, DOI 10.1111/j.1348-0421.1998.tb02357.x; Shi L, 2000, J HEALTH SCI, V46, P63; Shinoda S, 2004, MICROBIOL IMMUNOL, V48, P547, DOI 10.1111/j.1348-0421.2004.tb03551.x; SPIRA WM, 1983, APPL ENVIRON MICROB, V46, P704, DOI 10.1128/AEM.46.3.704-709.1983; Srividhya KV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001193; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; UCHIMURA M, 1993, EPIDEMIOL INFECT, V111, P49, DOI 10.1017/S0950268800056661; Vicente ACP, 1997, J MED MICROBIOL, V46, P398, DOI 10.1099/00222615-46-5-398; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	40	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21299	10.1371/journal.pone.0021299	http://dx.doi.org/10.1371/journal.pone.0021299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731695	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700057
J	Jiang, J; Zhang, Y; Chuai, S; Wang, Z; Zheng, D; Xu, F; Zhang, Y; Li, C; Liang, Y; Chen, Z				Jiang, J.; Zhang, Y.; Chuai, S.; Wang, Z.; Zheng, D.; Xu, F.; Zhang, Y.; Li, C.; Liang, Y.; Chen, Z.			Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype	ONCOGENE			English	Article						gastric cancer; cancer stem cells; CD90; ERBB2; trastuzumab (herceptin)	MAMMARY STEM/PROGENITOR CELLS; BREAST-CANCER; INITIATING CELLS; PROSPECTIVE IDENTIFICATION; GASTROINTESTINAL-TRACT; EXPRESSION PATTERNS; GENE AMPLIFICATION; PROGENITOR CELLS; LIVER-CANCER; POPULATION	Identification and characterization of cancer stem cells (CSCs) in gastric cancer are difficult owing to the lack of specific markers and consensus methods. In this study, we show that cells with the CD90 surface marker in gastric tumors could be enriched under non-adherent, serum-free and sphere-forming conditions. These CD90(+) cells possess a higher ability to initiate tumor in vivo and could re-establish the cellular hierarchy of tumors from single-cell implantation, demonstrating their self-renewal properties. Interestingly, higher proportion of CD90(+) cells correlates with higher in vivo tumorigenicity of gastric primary tumor models. In addition, it was found that ERBB2 was overexpressed in about 25% of the gastric primary tumor models, which correlates with the higher level of CD90 expression in these tumors. Trastuzumab (humanized anti-ERBB2 antibody) treatment of high-tumorigenic gastric primary tumor models could reduce the CD90(+) population in tumor mass and suppress tumor growth when combined with traditional chemotherapy. Moreover, tumorigenicity of tumor cells could also be suppressed when trastuzumab treatment starts at the same time as cell implantation. Therefore, we have identified a CSC population in gastric primary tumors characterized by their CD90 phenotype. The finding that trastuzumab targets the CSC population in gastric tumors suggests that ERBB2 signaling has a role in maintaining CSC populations, thus contributing to carcinogenesis and tumor invasion. In conclusion, the results from this study provide new insights into the gastric tumorigenic process and offer potential implications for the development of anticancer drugs as well as therapeutic treatment of gastric cancers. Oncogene (2012) 31, 671-682; doi:10.1038/onc.2011.282; published online 11 July 2011	[Jiang, J.; Zhang, Y.; Chuai, S.; Wang, Z.; Zheng, D.; Xu, F.; Zhang, Y.; Li, C.; Liang, Y.; Chen, Z.] China Novartis Inst Biomed Res, Shanghai, Peoples R China	Novartis	Chen, Z (corresponding author), Novartis Inst Biomed Res, Lab Anim Sci, Bldg 8,Lane 898,Halei Rd,Zhangjiang Hitech Pk,Pud, Shanghai 201203, Peoples R China.	zhi-1.chen@novartis.com			Novartis Education Office	Novartis Education Office	Dr Jiang has been funded by a fellowship from the Novartis Education Office. Other authors declare no conflict of interest.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; BERNSTEIN ID, 1980, SCIENCE, V207, P68, DOI 10.1126/science.6965328; Beuzeboc P, 1999, B CANCER, V86, P544; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Bowles MJ, 2001, BRIT MED J, V323, P1413, DOI 10.1136/bmj.323.7326.1413; Burstein HJ, 2001, J CLIN ONCOL, V19, P2722, DOI 10.1200/JCO.2001.19.10.2722; CHEN W, 2007, CANCER BIOL THER, V6, P763; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Fukuda K, 2009, INT J ONCOL, V34, P1201, DOI 10.3892/ijo_00000248; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; HAACKSORENSEN M, 2007, SCAND J CLIN LAB INV, V12, P1; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kauraniemi P, 2004, ONCOGENE, V23, P1010, DOI 10.1038/sj.onc.1207200; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marx AH, 2009, HUM PATHOL, V40, P769, DOI 10.1016/j.humpath.2008.11.014; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Nakamura Y, 2006, BRIT J DERMATOL, V154, P1062, DOI 10.1111/j.1365-2133.2006.07209.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oikonomou D, 2007, J CANCER RES CLIN, V133, P951, DOI 10.1007/s00432-007-0238-5; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Paik S, 2008, NEW ENGL J MED, V358, P1409, DOI 10.1056/NEJMc0801440; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Riley L, 2010, AACR 2010 M; Ruangpratheep Chetana, 2005, J Med Assoc Thai, V88 Suppl 3, pS281; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; SEEGER RC, 1982, J IMMUNOL, V128, P983; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wang KH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-288; Wang Q, 2009, ANTICANCER RES, V29, P1233; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yano T, 2006, ONCOL REP, V15, P65; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zou GM, 2008, J CELL PHYSIOL, V217, P598, DOI 10.1002/jcp.21541	72	89	96	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	6					671	682		10.1038/onc.2011.282	http://dx.doi.org/10.1038/onc.2011.282			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21743497				2022-12-25	WOS:000300222100001
J	Mendelson, A; Frank, E; Allred, C; Jones, E; Chen, M; Zhao, WL; Mao, JJ				Mendelson, Avital; Frank, Eric; Allred, Chad; Jones, Elena; Chen, Mo; Zhao, Wenli; Mao, Jeremy J.			Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro	FASEB JOURNAL			English	Article						tissue engineering; TGF-beta 3; SDF-1; chondrocytes	GROWTH-FACTOR; ARTICULAR-CARTILAGE; PROGENITOR CELLS; STROMAL CELLS; TISSUE; DIFFERENTIATION; REGENERATION; SCAFFOLDS; REPAIR; MICROSPHERES	Cell transplantation has been well explored for cartilage regeneration. We recently showed that the entire articular surface of a synovial joint can regenerate by endogenous cell homing and without cell transplantation. However, the sources of endogenous cells that regenerate articular cartilage remain elusive. Here, we studied whether cytokines not only chemotactically recruit adipose stem cells (ASCs), mesenchymal stem cells (MSCs), and synovium stem cells (SSCs) but also induce chondrogenesis of the recruited cells. Recombinant human transforming growth factor-beta 3 (TGF-beta 3; 100 ng) and/or recombinant human stromal derived factor-1 beta (SDF-1 beta; 100 ng) was control released into an acellular collagen sponge cube with underlying ASCs, MSCs, or SSCs in monolayer culture. Although all cell types randomly migrated into the acellular collagen sponge cube, TGF-beta 3 and/or SDF-1 beta recruited significantly more cells than the cytokine-free control group. In 6 wk, TGF-beta 3 alone recruited substantial numbers of ASCs (558 +/- 65) and MSCs (302 +/- 52), whereas codelivery of TGF-beta 3 and SDF-1 beta was particularly chemotactic to SSCs (400 +/- 120). Proliferation of the recruited cells accounted for some, but far from all, of the observed cellularity. TGF-beta 3 and SDF-1 beta codelivery induced significantly higher aggrecan gene expression than the cytokine-free group for ASCs, MSCs, and SSCs. Type II collagen gene expression was also significantly higher for ASCs and SSCs by SDF-1 and TGF-beta 3 codelivery. Remarkably, the expression of aggrecan and type II collagen was detected among all cell types. Thus, homing of multiple stem/progenitor cell populations may potentially serve as an alternative or adjunctive approach to cell transplantation for cartilage regeneration.-Mendelson, A., Frank, E., Allred, C., Jones, E., Chen, M., Zhao, W., Mao, J. J. Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro. FASEB J. 25, 3496-3504 (2011). www.fasebj.org	[Mendelson, Avital; Frank, Eric; Allred, Chad; Chen, Mo; Zhao, Wenli; Mao, Jeremy J.] Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, New York, NY 10032 USA; [Mendelson, Avital; Mao, Jeremy J.] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA; [Jones, Elena] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Columbia University; Columbia University; University of Leeds	Mao, JJ (corresponding author), Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, 630 W 168 St,PH7E-CDM, New York, NY 10032 USA.	jmao@columbia.edu	Jones, Elena/F-3136-2010	Mendelson, Avital/0000-0002-1120-9593; Jones, Elena/0000-0001-9365-2283	U.S. National Institutes of Health [RC2-D-E020767, R01-EB-0062621]	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Ryan V. Maneevese, Brian H. Sybo, Brandon R. Knapp, Stephanie Bohaczuk, and Andrew Chang for technical assistance. Adipose stem cells were a generous gift from Dr. Jeffrey M. Gimble (Pennington Biomedical Research Center, Louisiana State University, Baton Rogue, LA, USA). The present study is funded in part by U.S. National Institutes of Health grants RC2-D-E020767 and R01-EB-0062621.	Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bladergroen BA, 2009, TISSUE ENG PT A, V15, P1591, DOI 10.1089/ten.tea.2008.0348; Burger JA, 2001, J CLIN INVEST, V107, P305, DOI 10.1172/JCI11092; Chen T, 2007, STEM CELLS, V25, P392, DOI 10.1634/stemcells.2006-0145; Christopher MJ, 2009, BLOOD, V114, P1331, DOI 10.1182/blood-2008-10-184754; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; De Bari C, 2008, ARTHRITIS RHEUM, V58, P240, DOI 10.1002/art.23143; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647; Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102; Gao J, 2007, P I MECH ENG H, V221, P441, DOI 10.1243/09544119JEIM257; He XZ, 2010, INT J PHARMACEUT, V390, P107, DOI 10.1016/j.ijpharm.2009.12.063; Hildner F, 2010, J BIOMED MATER RES A, V94A, P978, DOI 10.1002/jbm.a.32761; Jones E, 2010, ANN RHEUM DIS, V69, P450, DOI 10.1136/ard.2008.106435; Jones EA, 2004, ARTHRITIS RHEUM-US, V50, P817, DOI 10.1002/art.20203; Karystinou A, 2009, RHEUMATOLOGY, V48, P1057, DOI 10.1093/rheumatology/kep192; Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI 10.1089/ten.TEA.2010.0181; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Kumar A, 2007, CR BIOL, V330, P485, DOI 10.1016/j.crvi.2007.01.006; Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI 10.1089/ten.TEA.2008.0653; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lepperdinger G, 2008, EXP GERONTOL, V43, P1018, DOI 10.1016/j.exger.2008.07.004; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Mao JJ, 2010, TISSUE ENG PART B-RE, V16, P257, DOI [10.1089/ten.teb.2009.0496, 10.1089/ten.TEB.2009.0496]; Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Mazzetti E, 2004, ARTHRITIS RHEUM-US, V50, P112, DOI 10.1002/art.11474; Moioli E. K., TISSUE ENG A, V16, P3299; Pelus LM, 2008, LEUKEMIA, V22, P466, DOI 10.1038/sj.leu.2405021; Raghunath J, 2005, CURR OPIN BIOTECH, V16, P503, DOI 10.1016/j.copbio.2005.08.004; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Schaefer D, 2002, ARTHRITIS RHEUM-US, V46, P2524, DOI 10.1002/art.10493; Schantz JT, 2007, TISSUE ENG, V13, P2615, DOI 10.1089/ten.2006.0438; Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Thangarajah H, 2009, STEM CELLS, V27, P266, DOI 10.1634/stemcells.2008-0276; Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6; Varshney RR, 2010, BIOMATERIALS, V31, P6876, DOI 10.1016/j.biomaterials.2010.05.038; Yun K, 2008, J BIOSCI BIOENG, V105, P122, DOI 10.1263/jbb.105.122; Zheng Z, 2011, J INVEST DERMATOL, V131, P769, DOI 10.1038/jid.2010.381	49	54	59	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3496	3504		10.1096/fj.10-176305	http://dx.doi.org/10.1096/fj.10-176305			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21746864	Green Published			2022-12-25	WOS:000295356400020
J	Sato, SM; Wissman, AM; McCollum, AF; Woolley, CS				Sato, Satoru M.; Wissman, Anne Marie; McCollum, Andrew F.; Woolley, Catherine S.			Quantitative Mapping of Cocaine-Induced Delta FosB Expression in the Striatum of Male and Female Rats	PLOS ONE			English	Article							EARLY GENE-EXPRESSION; SEX-DIFFERENCES; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; VENTRAL STRIATUM; DRUG-ABUSE; COMPARTMENTAL ORGANIZATION; DYNORPHIN EXPRESSION; ROTATIONAL BEHAVIOR; BASAL FOREBRAIN	Delta FosB plays a critical role in drug-induced long-term changes in the brain. In the current study, we evaluated locomotor activity in male and female rats treated with saline or cocaine for 2 weeks and quantitatively mapped Delta FosB expression in the dorsal striatum and nucleus accumbens of each animal by using an anti-FosB antibody that recognizes Delta FosB isoforms preferentially. Behavioral analysis showed that while there was little difference between males and females that sensitized to cocaine, nonsensitizing rats showed a large sex difference. Nonsensitizing males showed low behavioral activation in response to cocaine on the first day of treatment, and their activity remained low. In contrast, nonsensitizing females showed high activation on the first day of treatment and their activity remained high. Western blot and immunohistochemical analyses indicated that basal levels of Delta FosB were higher in the nucleus accumbens than the dorsal striatum, but that the effect of cocaine on Delta FosB was greater in the dorsal striatum. Immunostaining showed that the effect of cocaine in both the dorsal striatum and nucleus accumbens was primarily to increase the intensity of Delta FosB immunoreactivity in individual neurons, rather than to increase the number of cells that express Delta FosB. Detailed mapping of Delta FosB-labeled nuclei showed that basal Delta FosB levels were highest in the medial portion of the dorsal striatum and dorsomedial accumbens, particularly adjacent to the lateral ventricle, whereas the cocaine-induced increase in Delta FosB was most pronounced in the lateral dorsal striatum, where basal Delta FosB expression was lowest. Sex differences in Delta FosB expression were small and independent of cocaine treatment. We discuss implications of the sex difference in locomotor activation and regionally-specific Delta FosB induction by cocaine.	[Sato, Satoru M.; Wissman, Anne Marie; McCollum, Andrew F.; Woolley, Catherine S.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Sato, SM (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	cwoolley@northwestern.edu		Woolley, Catherine/0000-0002-8069-2646	National Institute of Health [R01 DA 020492]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020492] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institute of Health (www.nih.gov) R01 DA 020492 to CSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; BERENDSE HW, 1990, J COMP NEUROL, V299, P187, DOI 10.1002/cne.902990206; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; BRONSTEIN DM, 1994, MOL BRAIN RES, V23, P191, DOI 10.1016/0169-328X(94)90226-7; CAMP DM, 1988, BEHAV BRAIN RES, V30, P55, DOI 10.1016/0166-4328(88)90008-3; CASTNER SA, 1993, BRAIN RES, V610, P127, DOI 10.1016/0006-8993(93)91225-H; Castner SA, 1996, BRAIN RES, V712, P245, DOI 10.1016/0006-8993(95)01429-2; Colby CR, 2003, J NEUROSCI, V23, P2488; DELFS JM, 1990, J NEUROSCI, V10, P303; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Festa ED, 2004, NEUROPHARMACOLOGY, V46, P672, DOI 10.1016/j.neuropharm.2003.11.017; Forlano PM, 2010, J COMP NEUROL, V518, P1330, DOI 10.1002/cne.22279; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Harlan RE, 1998, MOL NEUROBIOL, V16, P221, DOI 10.1007/BF02741385; Hart SA, 2001, J COMP NEUROL, V440, P144, DOI 10.1002/cne.1376; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Hu M, 2006, SYNAPSE, V59, P122, DOI 10.1002/syn.20221; Hu M, 2003, J NEUROSCI, V23, P693, DOI 10.1523/JNEUROSCI.23-02-00693.2003; Jedynak JP, 2007, EUR J NEUROSCI, V25, P847, DOI 10.1111/j.1460-9568.2007.05316.x; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; Larson EB, 2010, J NEUROCHEM, V115, P112, DOI 10.1111/j.1471-4159.2010.06907.x; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; Lu XY, 1998, NEUROSCIENCE, V82, P767; Lynch WJ, 1999, PSYCHOPHARMACOLOGY, V144, P77, DOI 10.1007/s002130050979; Lynch WJ, 2002, PSYCHOPHARMACOLOGY, V164, P121, DOI 10.1007/s00213-002-1183-2; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Mello NK, 1997, PHARMACOL BIOCHEM BE, V57, P571, DOI 10.1016/S0091-3057(96)00433-9; Mermelstein PG, 1996, J NEUROSCI, V16, P595; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; Nelson A, 2006, J NEUROSCI, V26, P3805, DOI 10.1523/JNEUROSCI.4305-05.2006; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; Paxinos G, 2004, RAT BRAIN STEROTAXIC; PERIS J, 1991, BRAIN RES, V566, P255, DOI 10.1016/0006-8993(91)91706-7; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Radwanska K, 2006, NEUROSCIENCE, V137, P253, DOI 10.1016/j.neuroscience.2005.09.001; Robbins TW, 2008, ANN NY ACAD SCI, V1141, P1, DOI 10.1196/annals.1441.020; ROBERTS DCS, 1989, PSYCHOPHARMACOLOGY, V98, P408, DOI 10.1007/BF00451696; ROBINSON TE, 1984, PSYCHOPHARMACOLOGY, V84, P466, DOI 10.1007/BF00431451; ROBINSON TE, 1980, BRAIN RES BULL, V5, P539, DOI 10.1016/0361-9230(80)90260-9; Roth ME, 2004, NEUROSCI BIOBEHAV R, V28, P533, DOI 10.1016/j.neubiorev.2004.08.001; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Russo SJ, 2003, BRAIN RES, V970, P214, DOI 10.1016/S0006-8993(03)02346-1; STEINER H, 1993, J NEUROSCI, V13, P5066, DOI 10.1523/JNEUROSCI.13-12-05066.1993; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Valjent E, 2010, NEUROPSYCHOPHARMACOL, V35, P401, DOI 10.1038/npp.2009.143; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Walker QD, 2001, NEUROPSYCHOPHARMACOL, V25, P118, DOI 10.1016/S0893-133X(00)00248-7; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WISSMAN AM, 2011, NEUROPHARMA IN PRESS; Wright CI, 1996, J NEUROSCI, V16, P1877; Zaborszky L, 1999, ANN NY ACAD SCI, V877, P339, DOI 10.1111/j.1749-6632.1999.tb09276.x; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x; Zhang DS, 2002, J NEUROCHEM, V82, P1453, DOI 10.1046/j.1471-4159.2002.01089.x	73	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21783	10.1371/journal.pone.0021783	http://dx.doi.org/10.1371/journal.pone.0021783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747956	gold, Green Published, Green Submitted			2022-12-25	WOS:000292293400032
J	Ahidjo, BA; Kuhnert, D; McKenzie, JL; Machowski, EE; Gordhan, BG; Arcus, V; Abrahams, GL; Mizrahi, V				Ahidjo, Bintou Ahmadou; Kuhnert, Diane; McKenzie, Joanna L.; Machowski, Edith E.; Gordhan, Bhavna G.; Arcus, Vickery; Abrahams, Garth L.; Mizrahi, Valerie			VapC Toxins from Mycobacterium tuberculosis Are Ribonucleases that Differentially Inhibit Growth and Are Neutralized by Cognate VapB Antitoxins	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; PIN-DOMAIN; ANTIBIOTIC TOLERANCE; PERSISTER CELLS; CRYSTAL-STRUCTURE; HYPOXIC RESPONSE; OXIDATIVE STRESS; MUTANTS; PROTEIN	The chromosome of Mycobacterium tuberculosis (Mtb) encodes forty seven toxin-antitoxin modules belonging to the VapBC family. The role of these modules in the physiology of Mtb and the function(s) served by their expansion are unknown. We investigated ten vapBC modules from Mtb and the single vapBC from M. smegmatis. Of the Mtb vapCs assessed, only Rv0549c, Rv0595c, Rv2549c and Rv2829c were toxic when expressed from a tetracycline-regulated promoter in M. smegmatis. The same genes displayed toxicity when conditionally expressed in Mtb. Toxicity of Rv2549c in M. smegmatis correlated with the level of protein expressed, suggesting that the VapC level must exceed a threshold for toxicity to be observed. In addition, the level of Rv2456 protein induced in M. smegmatis was markedly lower than Rv2549c, which may account for the lack of toxicity of this and other VapCs scored as 'non-toxic'. The growth inhibitory effects of toxic VapCs were neutralized by expression of the cognate VapB as part of a vapBC operon or from a different chromosomal locus, while that of non-cognate antitoxins did not. These results demonstrated a specificity of interaction between VapCs and their cognate VapBs, a finding corroborated by yeast two-hybrid analyses. Deletion of selected vapC or vapBC genes did not affect mycobacterial growth in vitro, but rendered the organisms more susceptible to growth inhibition following toxic VapC expression. However, toxicity of 'non-toxic' VapCs was not unveiled in deletion mutant strains, even when the mutation eliminated the corresponding cognate VapB, presumably due to insufficient levels of VapC protein. Together with the ribonuclease (RNase) activity demonstrated for Rv0065 and Rv0617 - VapC proteins with similarity to Rv0549c and Rv3320c, respectively - these results suggest that the VapBC family potentially provides an abundant source of RNase activity in Mtb, which may profoundly impact the physiology of the organism.	[Ahidjo, Bintou Ahmadou; Kuhnert, Diane; Machowski, Edith E.; Gordhan, Bhavna G.; Abrahams, Garth L.; Mizrahi, Valerie] Univ Witwatersrand, MRC,Dept Sci & Technol,Natl Res Fdn, Natl Hlth Lab Serv,Ctr Excellence Biomed TB Res, Mol Mycobacteriol Res Unit,Fac Hlth Sci, Johannesburg, South Africa; [McKenzie, Joanna L.; Arcus, Vickery] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand	National Health Laboratory Service; National Research Foundation - South Africa; University of Witwatersrand; University of Waikato	Ahidjo, BA (corresponding author), Univ Witwatersrand, MRC,Dept Sci & Technol,Natl Res Fdn, Natl Hlth Lab Serv,Ctr Excellence Biomed TB Res, Mol Mycobacteriol Res Unit,Fac Hlth Sci, Johannesburg, South Africa.	valerie.mizrahi@uct.ac.za		Hicks, Joanna/0000-0002-0307-0923; Ahidjo, Bintou/0000-0002-3782-261X; Abrahams, Garth/0000-0001-7246-0901	Howard Hughes Medical Institute [55005522]; National Research Foundation; South African Medical Research Council	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Research Foundation; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an International Scholars grant from the Howard Hughes Medical Institute to V.M. (grant no. 55005522; www.hhmi.org), and by grants from the National Research Foundation (www.nrf.ac.za) and the South African Medical Research Council (www.mrc.ac.za). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barry CE, 2010, NAT REV MICROBIOL, V8, DOI 10.1038/nrmicro2236-c2; Bodogai M, 2006, MOL PLANT MICROBE IN, V19, P811, DOI 10.1094/MPMI-19-0811; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Brosch R, 1998, INFECT IMMUN, V66, P2221, DOI 10.1128/IAI.66.5.2221-2229.1998; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Bryk R, 2010, BIOCHEMISTRY-US, V49, P1616, DOI 10.1021/bi9016186; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Carroll P, 2007, FEMS MICROBIOL LETT, V274, P73, DOI 10.1111/j.1574-6968.2007.00842.x; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Downing KJ, 2004, TUBERCULOSIS, V84, P167, DOI 10.1016/j.tube.2003.12.004; Dubnau E, 2002, INFECT IMMUN, V70, P2787, DOI 10.1128/IAI.70.6.2787-2795.2002; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Firmani MA, 2002, J CLIN MICROBIOL, V40, P3162, DOI 10.1128/JCM.40.9.3162-3166.2002; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Goldstone RM, 2008, PROTEIN EXPRES PURIF, V57, P81, DOI 10.1016/j.pep.2007.08.015; Gupta A, 2009, FEMS MICROBIOL LETT, V290, P45, DOI 10.1111/j.1574-6968.2008.01400.x; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hopper S, 2000, INFECT IMMUN, V68, P896, DOI 10.1128/IAI.68.2.896-905.2000; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; KORCH SB, 2008, J BACTERIOL; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kumar P, 2008, J MOL BIOL, V383, P482, DOI 10.1016/j.jmb.2008.08.067; Kwan AHY, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng124; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Manganelli R, 2001, MOL MICROBIOL, V41, P423, DOI 10.1046/j.1365-2958.2001.02525.x; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Mowa MB, 2009, J BACTERIOL, V191, P985, DOI 10.1128/JB.01409-08; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 1997, MICROBIOL-UK, V143, P2267, DOI 10.1099/00221287-143-7-2267; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pham TT, 2007, MICROBIOL-SGM, V153, P2711, DOI 10.1099/mic.0.2007/008904-0; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Singh R, 2010, J BACTERIOL, V192, P1279, DOI 10.1128/JB.01285-09; Spoering AL, 2006, J BACTERIOL, V188, P5136, DOI 10.1128/JB.00369-06; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Vandal OH, 2009, J BACTERIOL, V191, P625, DOI 10.1128/JB.00932-08; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Wiuff C, 2005, ANTIMICROB AGENTS CH, V49, P1483, DOI 10.1128/AAC.49.4.1483-1494.2005; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zhao LX, 2008, FEBS LETT, V582, P710, DOI 10.1016/j.febslet.2008.01.045; ZHU L, 2010, J BIOL CHEM; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	73	63	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21738	10.1371/journal.pone.0021738	http://dx.doi.org/10.1371/journal.pone.0021738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738782	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100066
J	Mor, A; Aizman, E; George, J; Kloog, Y				Mor, Adi; Aizman, Elizabeta; George, Jacob; Kloog, Yoel			Ras Inhibition Induces Insulin Sensitivity and Glucose Uptake	PLOS ONE			English	Article							NF-KAPPA-B; SKELETAL-MUSCLE CELLS; PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; REGULATORY T-CELLS; NUCLEAR-FACTOR; FARNESYLTHIOSALICYLIC ACID; RECEPTOR SUBSTRATE-1; SIGNAL-TRANSDUCTION; DOWN-REGULATION	Background: Reduced glucose uptake due to insulin resistance is a pivotal mechanism in the pathogenesis of type 2 diabetes. It is also associated with increased inflammation. Ras inhibition downregulates inflammation in various experimental models. The aim of this study was to examine the effect of Ras inhibition on insulin sensitivity and glucose uptake, as well as its influence on type 2 diabetes development. Methods and Findings: The effect of Ras inhibition on glucose uptake was examined both in vitro and in vivo. Ras was inhibited in cells transfected with a dominant-negative form of Ras or by 5-fluoro-farnesylthiosalicylic acid (F-FTS), a small-molecule Ras inhibitor. The involvement of I kappa B and NF-kappa B in Ras-inhibited glucose uptake was investigated by immunoblotting. High fat (HF)-induced diabetic mice were treated with F-FTS to test the effect of Ras inhibition on induction of hyperglycemia. Each of the Ras-inhibitory modes resulted in increased glucose uptake, whether in insulin-resistant C2C12 myotubes in vitro or in HF-induced diabetic mice in vivo. Ras inhibition also caused increased IkB expression accompanied by decreased expression of NF-kappa B. In fat-induced diabetic mice treated daily with F-FTS, both the incidence of hyperglycemia and the levels of serum insulin were significantly decreased. Conclusions: Inhibition of Ras apparently induces a state of heightened insulin sensitization both in vitro and in vivo. Ras inhibition should therefore be considered as an approach worth testing for the treatment of type 2 diabetes.	[Mor, Adi; Aizman, Elizabeta; Kloog, Yoel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [George, Jacob] Kaplan Med Ctr, Dept Cardiol, Rehovot, Israel; [George, Jacob] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem	Mor, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel.	kloog@post.tau.ac.il			Israel Science Foundation [912/06]; Prajs-Drimmer Institute for The Development of Anti-Degenerative Drugs	Israel Science Foundation(Israel Science Foundation); Prajs-Drimmer Institute for The Development of Anti-Degenerative Drugs	This work was supported in part by The Israel Science Foundation 912/06 (Y. Kloog) and by the Prajs-Drimmer Institute for The Development of Anti-Degenerative Drugs (Y. Kloog and E. Aizman). Y. Kloog is the incumbent of the Jack H. Skirball Chair in Applied Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonson Z, 1998, BBA-MOL BASIS DIS, V1406, P40, DOI 10.1016/S0925-4439(97)00077-X; Aizman E, 2010, EUR J PHARMACOL, V643, P139, DOI 10.1016/j.ejphar.2010.06.029; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1989, CANCER RES, V49, P4682; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Louzao MC, 2008, GLYCOCONJUGATE J, V25, P503, DOI 10.1007/s10719-007-9075-7; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; Das UN, 2002, NUTRITION, V18, P430, DOI 10.1016/S0899-9007(01)00747-X; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Frost JA, 2000, J BIOL CHEM, V275, P19693, DOI 10.1074/jbc.M909860199; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; George J, 2002, CIRCULATION, V105, P2416, DOI 10.1161/01.CIR.0000016065.90068.96; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jove M, 2006, ENDOCRINOLOGY, V147, P552, DOI 10.1210/en.2005-0440; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Karin M, 2001, BIOFACTORS, V15, P87, DOI 10.1002/biof.5520150207; KARUSIS D, 2001, J NEUROIMMU IN PRESS; Karussis D, 2001, J NEUROIMMUNOL, V120, P1; Katzav A, 2003, IMMUNOBIOLOGY, V207, P47, DOI 10.1078/0171-2985-00208; Katzav A, 2001, CLIN EXP IMMUNOL, V126, P570, DOI 10.1046/j.1365-2249.2001.01674.x; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Mor A, 2008, EUR J IMMUNOL, V38, P1493, DOI 10.1002/eji.200838292; Mora A, 2009, EUR J PHARMACOL, V616, P301, DOI 10.1016/j.ejphar.2009.06.001; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Shalom-Feuerstein R, 2008, BBA-MOL CELL RES, V1783, P985, DOI 10.1016/j.bbamcr.2008.03.009; Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Wang LY, 2010, DIABETES, V59, P3117, DOI 10.2337/db09-1805; Weigert C, 2006, J BIOL CHEM, V281, P7060, DOI 10.1074/jbc.M509782200	45	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21712	10.1371/journal.pone.0021712	http://dx.doi.org/10.1371/journal.pone.0021712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738773	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100060
J	Santos, MCT; Goldfeder, MB; Zanchin, NIT; Oliveira, CC				Santos, Marcia C. T.; Goldfeder, Mauricio B.; Zanchin, Nilson I. T.; Oliveira, Carla C.			The Essential Nucleolar Yeast Protein Nop8p Controls the Exosome Function during 60S Ribosomal Subunit Maturation	PLOS ONE			English	Article							MESSENGER-RNA DEGRADATION; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; QUALITY-CONTROL; BIOGENESIS; INTERACTS; 5.8S; DYNAMICS; COMPLEX; RRP43P	The yeast nucleolar protein Nop8p has previously been shown to interact with Nip7p and to be required for 60S ribosomal subunit formation. Although depletion of Nop8p in yeast cells leads to premature degradation of rRNAs, the biochemical mechanism responsible for this phenotype is still not known. In this work, we show that the Nop8p amino-terminal region mediates interaction with the 5.8S rRNA, while its carboxyl-terminal portion interacts with Nip7p and can partially complement the growth defect of the conditional mutant strain Dnop8/GAL::NOP8. Interestingly, Nop8p mediates association of Nip7p to pre-ribosomal particles. Nop8p also interacts with the exosome subunit Rrp6p and inhibits the complex activity in vitro, suggesting that the decrease in 60S ribosomal subunit levels detected upon depletion of Nop8p may result from degradation of pre-rRNAs by the exosome. These results strongly indicate that Nop8p may control the exosome function during pre-rRNA processing.	[Santos, Marcia C. T.; Goldfeder, Mauricio B.; Oliveira, Carla C.] Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil; [Zanchin, Nilson I. T.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil; [Zanchin, Nilson I. T.] Univ Estadual Campinas, Fac Ciencias Aplicadas, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Santos, MCT (corresponding author), Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil.	ccoliv@iq.usp.br	Oliveira, Carla C/F-2323-2011; Zanchin, Nilson Ivo Tonin/AAB-4907-2019	Oliveira, Carla C/0000-0002-1098-9241; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [09/52826-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (09/52826-4 to C.C.O.). M. C. T. S. and M. B. G. were recipients of FAPESP fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Baker KE, 2006, RNA, V12, P1441, DOI 10.1261/rna.92706; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Coltri PP, 2007, BIOCHEMISTRY-US, V46, P14177, DOI 10.1021/bi7015876; de la Cruz J, 2004, GENETICS, V166, P1687, DOI 10.1534/genetics.166.4.1687; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Dechampesme AM, 1999, J CELL BIOL, V145, P1369, DOI 10.1083/jcb.145.7.1369; Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035; Dez C, 2004, MOL CELL BIOL, V24, P6324, DOI 10.1128/MCB.24.14.6324-6337.2004; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Granato DC, 2008, FEBS J, V275, P4164, DOI 10.1111/j.1742-4658.2008.06565.x; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; James P, 1996, GENETICS, V144, P1425; Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NUCLEIC ACIDS RES, V36, P4988, DOI 10.1093/nar/gkn469; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luz JS, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-22; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103; Milligan L, 2008, MOL CELL BIOL, V28, P5446, DOI 10.1128/MCB.00463-08; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Oliveira CC, 2002, NUCLEIC ACIDS RES, V30, P4186, DOI 10.1093/nar/gkf545; OLIVEIRA CC, 1995, J BIOL CHEM, V270, P8936, DOI 10.1074/jbc.270.15.8936; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Rodriguez-Mateos M, 2009, NUCLEIC ACIDS RES, V37, P7519, DOI 10.1093/nar/gkp806; Rosado IV, 2004, RNA, V10, P1073, DOI 10.1261/rna.7340404; Rosado IV, 2007, MOL CELL BIOL, V27, P1207, DOI 10.1128/MCB.01523-06; Sambrook J., 2002, MOL CLONING LAB MANU; Schilders G, 2005, NUCLEIC ACIDS RES, V33, P6795, DOI 10.1093/nar/gki982; Sekiguchi T, 2004, J BIOL CHEM, V279, P8343, DOI 10.1074/jbc.M305935200; Sekiguchi T, 2006, NUCLEIC ACIDS RES, V34, P4593, DOI 10.1093/nar/gkl603; Srivastava L, 2010, MOL CELL BIOL, V30, P2947, DOI 10.1128/MCB.00226-10; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001; Zanchin NIT, 1999, NUCLEIC ACIDS RES, V27, P1283, DOI 10.1093/nar/27.5.1283; Zanchin NIT, 1999, MOL CELL BIOL, V19, P1518	52	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21686	10.1371/journal.pone.0021686	http://dx.doi.org/10.1371/journal.pone.0021686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747919	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100056
J	Andrews-Hanna, JR; Seghete, KLM; Claus, ED; Burgess, GC; Ruzic, L; Banich, MT				Andrews-Hanna, Jessica R.; Seghete, Kristen L. Mackiewicz; Claus, Eric D.; Burgess, Gregory C.; Ruzic, Luka; Banich, Marie T.			Cognitive Control in Adolescence: Neural Underpinnings and Relation to Self-Report Behaviors	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; INFERIOR FRONTAL JUNCTION; MAPPING BRAIN MATURATION; HUMAN CEREBRAL-CORTEX; PREFRONTAL CORTEX; ATTENTIONAL CONTROL; WORKING-MEMORY; NEURODEVELOPMENTAL TRAJECTORIES; RESPONSE-INHIBITION; DEVELOPMENTAL FMRI	Background: Adolescence is commonly characterized by impulsivity, poor decision-making, and lack of foresight. However, the developmental neural underpinnings of these characteristics are not well established. Methodology/Principal Findings: To test the hypothesis that these adolescent behaviors are linked to under-developed proactive control mechanisms, the present study employed a hybrid block/event-related functional Magnetic Resonance Imaging (fMRI) Stroop paradigm combined with self-report questionnaires in a large sample of adolescents and adults, ranging in age from 14 to 25. Compared to adults, adolescents under-activated a set of brain regions implicated in proactive top-down control across task blocks comprised of difficult and easy trials. Moreover, the magnitude of lateral prefrontal activity in adolescents predicted self-report measures of impulse control, foresight, and resistance to peer pressure. Consistent with reactive compensatory mechanisms to reduced proactive control, older adolescents exhibited elevated transient activity in regions implicated in response-related interference resolution. Conclusions/Significance: Collectively, these results suggest that maturation of cognitive control may be partly mediated by earlier development of neural systems supporting reactive control and delayed development of systems supporting proactive control. Importantly, the development of these mechanisms is associated with cognitive control in real-life behaviors.	[Andrews-Hanna, Jessica R.; Seghete, Kristen L. Mackiewicz; Burgess, Gregory C.; Ruzic, Luka; Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Claus, Eric D.] Mind Res Network, Albuquerque, NM USA; [Banich, Marie T.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Banich, Marie T.] Univ Colorado, Dept Psychiat, Denver, CO 80202 USA	University of Colorado System; University of Colorado Boulder; Lovelace Respiratory Research Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Denver	Andrews-Hanna, JR (corresponding author), Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA.	Jessica.Andrews-Hanna@colorado.edu; Marie.Banich@colorado.edu	Seghete, Kristen/AAY-8365-2020; Claus, Eric/AAQ-5035-2021	Seghete, Kristen/0000-0001-9173-3979; BANICH, MARIE/0000-0001-9373-9194	John D. and Catherine T. MacArthur Foundation Research Network on Adolescent Development; Juvenile Justice; NIMH [P50 MH079485]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH079485] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation Research Network on Adolescent Development; Juvenile Justice; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Adolescent Development and Juvenile Justice and an NIMH-funded Interdisciplinary Behavioral Science Center grant (P50 MH079485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; ALBERT D, CHILD DEV IN PRESS; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Banich MT, 2009, NEUROPSYCHOLOGIA, V47, P3095, DOI 10.1016/j.neuropsychologia.2009.07.005; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; Bennett CM, 2006, HUM BRAIN MAPP, V27, P762, DOI 10.1002/hbm.20218; Brahmbhatt SB, 2010, BRAIN RES, V1354, P140, DOI 10.1016/j.brainres.2010.07.055; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Bunge SA, 2007, CURR OPIN NEUROBIOL, V17, P243, DOI 10.1016/j.conb.2007.02.005; Burgess GC, 2010, BIOL PSYCHIAT, V67, P632, DOI 10.1016/j.biopsych.2009.10.036; Burgund ED, 2006, NEUROIMAGE, V29, P812, DOI 10.1016/j.neuroimage.2005.08.056; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Chatham CH, 2009, P NATL ACAD SCI USA, V106, P5529, DOI 10.1073/pnas.0810002106; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Christakou A, 2011, NEUROIMAGE, V54, P1344, DOI 10.1016/j.neuroimage.2010.08.067; Christakou A, 2009, NEUROIMAGE, V48, P223, DOI 10.1016/j.neuroimage.2009.06.070; Cohen P, 2003, DEV PSYCHOL, V39, P657, DOI 10.1037/0012-1649.39.4.657; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Crone EA, 2006, J NEUROSCI, V26, P11239, DOI 10.1523/JNEUROSCI.2165-06.2006; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P825, DOI 10.1111/j.1467-7687.2009.00918.x; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Durston S, 2006, DEVELOPMENTAL SCI, V9, P1, DOI 10.1111/j.1467-7687.2005.00454.x; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grosbras MH, 2007, J NEUROSCI, V27, P8040, DOI 10.1523/JNEUROSCI.1360-07.2007; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; MACLEOD CM, 2001, PSYCHOL B, V109; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; Milham MP, 2001, COGNITIVE BRAIN RES, V12, P467, DOI 10.1016/S0926-6410(01)00076-3; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Monsell S, 2001, MEM COGNITION, V29, P137, DOI 10.3758/BF03195748; Neumann J, 2008, HUM BRAIN MAPP, V29, P177, DOI 10.1002/hbm.20380; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Rubia K, 2010, NEUROIMAGE, V51, P817, DOI 10.1016/j.neuroimage.2010.02.058; Scherf KS, 2006, J COGNITIVE NEUROSCI, V18, P1045, DOI 10.1162/jocn.2006.18.7.1045; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Ward B. D., 2000, SIMULTANEOUS INFEREN, DOI https://afni.nimh.nih.gov/pub/dist/doc/manuals/AlphaSim.pdf; WEINBERGER DA, 1990, J PERS, V58, P381, DOI 10.1111/j.1467-6494.1990.tb00235.x; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	84	92	95	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21598	10.1371/journal.pone.0021598	http://dx.doi.org/10.1371/journal.pone.0021598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	784FW	21738725	gold, Green Published, Green Submitted			2022-12-25	WOS:000292142800043
J	Wolny, M; Grzybek, M; Bok, E; Chorzalska, A; Lenoir, M; Czogalla, A; Adamczyk, K; Kolondra, A; Diakowski, W; Overduin, M; Sikorski, AF				Wolny, Marcin; Grzybek, Michal; Bok, Ewa; Chorzalska, Anna; Lenoir, Marc; Czogalla, Aleksander; Adamczyk, Klaudia; Kolondra, Adam; Diakowski, Witold; Overduin, Michael; Sikorski, Aleksander F.			Key Amino Acid Residues of Ankyrin-Sensitive Phosphatidylethanolamine/Phosphatidylcholine-Lipid Binding Site of beta I-Spectrin	PLOS ONE			English	Article							MEMBRANE PHOSPHOLIPIDS; ERYTHROCYTE SPECTRIN; CELL MEMBRANE; HIGH-AFFINITY; ROD DOMAIN; PROTEIN; MONOLAYER; BILAYER; IDENTIFICATION; DYSTROPHIN	It was shown previously that an ankyrin-sensitive, phosphatidylethanolamine/phosphatidylcholine (PE/PC) binding site maps to the N-terminal part of the ankyrin-binding domain of beta-spectrin (ankBDn). Here we have identified the amino acid residues within this domain which are responsible for recognizing monolayers and bilayers composed of PE/PC mixtures. In vitro binding studies revealed that a quadruple mutant with substituted hydrophobic residues W1771, L1775, M1778 and W1779 not only failed to effectively bind PE/PC, but its residual PE/PC-binding activity was insensitive to inhibition with ankyrin. Structure prediction and analysis, supported by in vitro experiments, suggests that "opening'' of the coiled-coil structure underlies the mechanism of this interaction. Experiments on red blood cells and HeLa cells supported the conclusions derived from the model and in vitro lipid-protein interaction results, and showed the potential physiological role of this binding. We postulate that direct interactions between spectrin ankBDn and PE-rich domains play an important role in stabilizing the structure of the spectrin-based membrane skeleton.	[Wolny, Marcin; Chorzalska, Anna; Czogalla, Aleksander; Adamczyk, Klaudia; Kolondra, Adam; Diakowski, Witold; Sikorski, Aleksander F.] Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-50138 Wroclaw, Poland; [Grzybek, Michal] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Bok, Ewa] Univ Zielona Gora, Dept Mol Biol, Zielona Gora, Poland; [Lenoir, Marc; Overduin, Michael] Univ Birmingham, Sch Canc Sci, Henry Wellcome Bldg Biomol NMR Spect, Birmingham, W Midlands, England	University of Wroclaw; Max Planck Society; University of Zielona Gora; University of Birmingham	Wolny, M (corresponding author), Univ Wroclaw, Biotechnol Fac, Lab Cytobiochem, PL-50138 Wroclaw, Poland.	afsbc@ibmb.uni.wroc.pl	Sikorski, Aleksander/HGD-5159-2022; Overduin, Michael/AAG-3632-2020; Sikorski, Aleksander F/C-3361-2009; Czogalla, Aleksander/M-8504-2019; Czogalla, Aleksander/A-9752-2014; Grzybek, Michal/D-3802-2017	Overduin, Michael/0000-0002-3114-6585; Czogalla, Aleksander/0000-0003-3035-059X; Kolondra, Adam/0000-0001-5849-7185; Wolny, Marcin/0000-0003-1030-7607; Lenoir, Marc/0000-0001-7410-2323; Grzybek, Michal/0000-0003-2083-0506; Sikorski, Aleksander F./0000-0003-3779-8266	Polish Ministry of Science and University Education [N N301 286037]; EU; University of Wroclaw; Office of the Marshal of the Lubuskie Voivodeship	Polish Ministry of Science and University Education; EU(European Commission); University of Wroclaw; Office of the Marshal of the Lubuskie Voivodeship	This study was supported by grant No. N N301 286037 from the Polish Ministry of Science and University Education, the EU PRISM project, the University of Wroclaw Research Fund, and by The European Social Fund grant from Office of the Marshal of the Lubuskie Voivodeship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2005, BIOCHEMISTRY-US, V44, P10681, DOI 10.1021/bi047331z; An XL, 2005, BIOCHEM BIOPH RES CO, V327, P794, DOI 10.1016/j.bbrc.2004.12.063; An XL, 2004, BLOOD CELL MOL DIS, V32, P430, DOI 10.1016/j.bcmd.2004.02.001; Bates PA, 2001, PROTEINS, P39; BENNETT V, 1979, NATURE, V280, P468, DOI 10.1038/280468a0; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; BIALKOWSKA K, 1994, BBA-BIOMEMBRANES, V1191, P21, DOI 10.1016/0005-2736(94)90228-3; Bok E, 2007, CELL BIOL INT, V31, P1482, DOI 10.1016/j.cellbi.2007.06.014; CHORZALSKA A, 2010, CELL MOL BIOL LETT; CZOGALLA A, CELL MOL LIFE SCI, V67, P2679; Czogalla A, 2007, MOL MEMBR BIOL, V24, P215, DOI 10.1080/09687860601102427; Czogalla A, 2008, BBA-BIOMEMBRANES, V1778, P2612, DOI 10.1016/j.bbamem.2008.07.020; Das A, 2006, J CELL BIOL, V175, P325, DOI 10.1083/jcb.200602095; Diakowski W, 1999, BIOCHEM J, V338, P83, DOI 10.1042/0264-6021:3380083; Diakowski Witold, 1994, Acta Biochimica Polonica, V41, P153; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Grzybek M, 2006, CHEM PHYS LIPIDS, V141, P133, DOI 10.1016/j.chemphyslip.2006.02.008; Hryniewicz-Jankowska A, 2004, BIOCHEM J, V382, P677, DOI 10.1042/BJ20040358; HU RJ, 1995, J CELL BIOL, V128, P1069, DOI 10.1083/jcb.128.6.1069; Ipsaro JJ, 2010, BLOOD, V115, P4093, DOI 10.1182/blood-2009-11-255604; Ipsaro JJ, 2009, BLOOD, V113, P5385, DOI 10.1182/blood-2008-10-184358; KENNEDY SP, 1991, J CELL BIOL, V115, P267, DOI 10.1083/jcb.115.1.267; Kolondra A, 2008, PROTEIN EXPRES PURIF, V60, P157, DOI 10.1016/j.pep.2008.04.002; Kolondra A, 2010, BBA-BIOMEMBRANES, V1798, P2084, DOI 10.1016/j.bbamem.2010.07.024; La-Borde PJ, 2010, BIOCHEM BIOPH RES CO, V392, P490, DOI 10.1016/j.bbrc.2010.01.046; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; MICHALAK K, 1993, GEN PHYSIOL BIOPHYS, V12, P163; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Ray S, 2004, MOL MEMBR BIOL, V21, P93, DOI 10.1080/09687680310001625800; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200; SIKORSKI A, 1996, CELL MOL BIOL LETT, V1, P97; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; THWAY T, J PHARM BIOMED ANAL, V51, P626; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153; Yi SJ, 1997, BIOCHEMISTRY-US, V36, P9596, DOI 10.1021/bi9704966; YU J, 1979, P NATL ACAD SCI USA, V76, P2340, DOI 10.1073/pnas.76.5.2340	45	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21538	10.1371/journal.pone.0021538	http://dx.doi.org/10.1371/journal.pone.0021538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738695	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800034
J	Chadwick, W; Boyle, JP; Zhou, Y; Wang, LY; Park, SS; Martin, B; Wang, R; Becker, KG; Wood, WH; Zhang, YQ; Peers, C; Maudsley, S				Chadwick, Wayne; Boyle, John P.; Zhou, Yu; Wang, Liyun; Park, Sung-Soo; Martin, Bronwen; Wang, Rui; Becker, Kevin G.; Wood, William H., III; Zhang, Yongqing; Peers, Chris; Maudsley, Stuart			Multiple Oxygen Tension Environments Reveal Diverse Patterns of Transcriptional Regulation in Primary Astrocytes	PLOS ONE			English	Article							DIETARY ENERGY-INTAKE; EXPRESSION PATTERNS; MOLECULAR-CLONING; OXIDATIVE STRESS; HYPOXIA; RECEPTOR; CELLS; GENE; ACTIVATION; GROWTH	The central nervous system normally functions at O-2 levels which would be regarded as hypoxic by most other tissues. However, most in vitro studies of neurons and astrocytes are conducted under hyperoxic conditions without consideration of O-2-dependent cellular adaptation. We analyzed the reactivity of astrocytes to 1, 4 and 9% O-2 tensions compared to the cell culture standard of 20% O-2, to investigate their ability to sense and translate this O-2 information to transcriptional activity. Variance of ambient O-2 tension for rat astrocytes resulted in profound changes in ribosomal activity, cytoskeletal and energy-regulatory mechanisms and cytokine-related signaling. Clustering of transcriptional regulation patterns revealed four distinct response pattern groups that directionally pivoted around the 4% O-2 tension, or demonstrated coherent ascending/decreasing gene expression patterns in response to diverse oxygen tensions. Immune response and cell cycle/cancer-related signaling pathway transcriptomic subsets were significantly activated with increasing hypoxia, whilst hemostatic and cardiovascular signaling mechanisms were attenuated with increasing hypoxia. Our data indicate that variant O-2 tensions induce specific and physiologically-focused transcript regulation patterns that may underpin important physiological mechanisms that connect higher neurological activity to astrocytic function and ambient oxygen environments. These strongly defined patterns demonstrate a strong bias for physiological transcript programs to pivot around the 4% O-2 tension, while uni-modal programs that do not, appear more related to pathological actions. The functional interaction of these transcriptional 'programs' may serve to regulate the dynamic vascular responsivity of the central nervous system during periods of stress or heightened activity.	[Chadwick, Wayne; Zhou, Yu; Wang, Liyun; Park, Sung-Soo; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Boyle, John P.; Peers, Chris] Univ Leeds, Inst Cardiovasc Res, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Martin, Bronwen; Wang, Rui] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Becker, Kevin G.; Wood, William H., III; Zhang, Yongqing] NIA, Gene Express & Genom Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Leeds; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chadwick, W (corresponding author), NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA.	c.s.peers@leeds.ac.uk; maudsleyst@mail.nih.gov	Boyle, John/N-4868-2016; Wang, Rui/I-5643-2019; Maudsley, Stuart/AAV-9929-2021; Zhou, Yu/M-7975-2014; Maudsley, Stuart/Q-4782-2019	Wang, Rui/0000-0001-7015-0272; Maudsley, Stuart/0000-0002-1868-184X; Becker, Kevin/0000-0002-6794-6656; Peers, Chris/0000-0002-8354-346X; Martin, Bronwen/0000-0002-9185-6925	National Institute on Aging/National Institutes of Health; Alzheimer's Research Trust (ART/PG) [2006/1]; The Alzheimer's Society; Medical Research Council; NATIONAL INSTITUTE ON AGING [ZIAAG000915, ZIAAG000319, ZICAG000616, ZIAAG000917, ZIAAG000916, ZIAAG000318, ZIAAG000325] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-PPG2011B-1] Funding Source: researchfish	National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Research Trust (ART/PG); The Alzheimer's Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was carried out by funding from the Intramural Research Program of the National Institute on Aging/National Institutes of Health, the Alzheimer's Research Trust (ART/PG 2006/1), The Alzheimer's Society and the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Alvarez S, 2010, J NEUROCHEM, V113, P772, DOI 10.1111/j.1471-4159.2010.06646.x; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Bedo G, 2005, INT J DEV BIOL, V49, P431, DOI 10.1387/ijdb.041901gb; Boggs DE, 2006, RESP PHYSIOL NEUROBI, V152, P92, DOI 10.1016/j.resp.2005.06.004; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Candore G, 2010, REJUV RES, V13, P301, DOI 10.1089/rej.2009.0993; Cao X, 2010, BRAIN RES, V1347, P142, DOI 10.1016/j.brainres.2010.05.072; Castaldi PJ, 2009, CHEST, V135, P737, DOI 10.1378/chest.08-1993; CHADWICK W, 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2010/604792; CHADWICK W, 2011, J SIGNAL TRANSUCT; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Clark MA, 2007, REGUL PEPTIDES, V144, P115, DOI 10.1016/j.regpep.2007.07.001; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dallas M, 2007, J NEUROSCI, V27, P3946, DOI 10.1523/JNEUROSCI.5030-06.2007; Do JH, 2008, MOL CELLS, V25, P279; Fujitani M, 2004, J NEUROCHEM, V91, P737, DOI 10.1111/j.1471-4159.2004.02738.x; Gerber SA, 2008, J IMMUNOL, V181, P1052, DOI 10.4049/jimmunol.181.2.1052; Grimpe B, 1999, GLIA, V28, P138, DOI 10.1002/(SICI)1098-1136(199911)28:2<138::AID-GLIA5>3.0.CO;2-8; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Han MD, 2006, DEV DYNAM, V235, P124, DOI 10.1002/dvdy.20531; Hongo S, 2006, J CELL BIOCHEM, V98, P185, DOI 10.1002/jcb.20763; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jessberger S, 2008, PSYCHOL AGING, V23, P684, DOI 10.1037/a0014188; Jiang W, 2008, BLOOD CELL MOL DIS, V41, P169, DOI 10.1016/j.bcmd.2008.04.006; Kane R, 2008, MOL VIS, V14, P1138; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Kim SM, 2010, FEBS LETT, V584, P213, DOI 10.1016/j.febslet.2009.11.063; Kim SH, 2010, CANCER RES, V70, P4054, DOI 10.1158/0008-5472.CAN-09-2110; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Lafont JE, 2008, J BIOL CHEM, V283, P4778, DOI 10.1074/jbc.M707729200; LaManna JC, 2007, ESSAYS BIOCHEM, V43, P139; Luo GH, 2008, TRANSPL P, V40, P2800, DOI 10.1016/j.transproceed.2008.08.004; Lynn EG, 2008, FEBS LETT, V582, P2857, DOI 10.1016/j.febslet.2008.07.016; Malthankar-Phatak GH, 2008, BRAIN RES, V1229, P147, DOI 10.1016/j.brainres.2008.06.074; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002398; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Maudsley S, 2006, NAT MED, V12, P392, DOI 10.1038/nm0406-392; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Morciano M, 2009, J NEUROCHEM, V108, P662, DOI 10.1111/j.1471-4159.2008.05824.x; Myers DA, 2008, AM J PHYSIOL-REG I, V294, pR1312, DOI 10.1152/ajpregu.00004.2008; Nakada N, 2002, DEV BRAIN RES, V135, P45, DOI 10.1016/S0165-3806(02)00303-6; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Nieminen AL, 2005, J CELL PHYSIOL, V204, P364, DOI 10.1002/jcp.20406; Oliveira CA, 2002, CLIN GENET, V61, P354, DOI 10.1034/j.1399-0004.2002.610506.x; Pallares I, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-75; PARPURA V, 1995, FEBS LETT, V360, P266, DOI 10.1016/0014-5793(95)00121-O; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Peers C, 2007, ESSAYS BIOCHEM, V43, P153, DOI 10.1042/bse0430153; Peuchen S, 1997, PROG NEUROBIOL, V52, P261, DOI 10.1016/S0301-0082(97)00010-5; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Sakuta H, 2001, SCIENCE, V293, P111, DOI 10.1126/science.1058379; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; SATO K, 1994, LEUKEMIA, V8, P1663; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Scragg JL, 2004, FASEB J, V18, P150, DOI 10.1096/fj.04-2659fje; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shirakura M, 2010, BIOCHEM BIOPH RES CO, V393, P800, DOI 10.1016/j.bbrc.2010.02.086; Shukunami C, 2001, BIOCHEM BIOPH RES CO, V280, P1323, DOI 10.1006/bbrc.2001.4271; SICK TJ, 1982, J APPL PHYSIOL, V53, P1354, DOI 10.1152/jappl.1982.53.6.1354; Takacova M, 2009, BIOCHEM J, V419, P419, DOI 10.1042/BJ20080952; Tanji K, 2003, BRAIN RES, V976, P125, DOI 10.1016/S0006-8993(03)02633-7; Taylor SC, 1999, J BIOL CHEM, V274, P31217, DOI 10.1074/jbc.274.44.31217; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vangeison G, 2009, NEUROSCIENTIST, V15, P579, DOI 10.1177/1073858409332405; Wakasugi K, 2004, BIOCHEM BIOPH RES CO, V318, P453, DOI 10.1016/j.bbrc.2004.04.045; Westberg JA, 2007, AM J PHYSIOL-HEART C, V293, pH1766, DOI 10.1152/ajpheart.00017.2007; Wiedmann MW, 2005, CURR CANCER DRUG TAR, V5, P171, DOI 10.2174/1568009053765771; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510; Zhao YH, 2006, MOL NEUROBIOL, V34, P181, DOI 10.1385/MN:34:3:181	74	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21638	10.1371/journal.pone.0021638	http://dx.doi.org/10.1371/journal.pone.0021638			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738745	Green Submitted, gold, Green Published			2022-12-25	WOS:000292092600067
J	Renzoni, A; Andrey, DO; Jousselin, A; Barras, C; Monod, A; Vaudaux, P; Lew, D; Kelley, WL				Renzoni, Adriana; Andrey, Diego O.; Jousselin, Ambre; Barras, Christine; Monod, Antoinette; Vaudaux, Pierre; Lew, Daniel; Kelley, William L.			Whole Genome Sequencing and Complete Genetic Analysis Reveals Novel Pathways to Glycopeptide Resistance in Staphylococcus aureus	PLOS ONE			English	Article							VANCOMYCIN-INTERMEDIATE RESISTANCE; CELL-WALL BIOSYNTHESIS; SERINE/THREONINE KINASE; BACILLUS-SUBTILIS; ANTIBIOTIC-RESISTANCE; MULTIDRUG-RESISTANCE; FUNCTIONAL-ANALYSIS; 2-COMPONENT SYSTEM; BIOFILM FORMATION; STRESS TOLERANCE	The precise mechanisms leading to the emergence of low-level glycopeptide resistance in Staphylococcus aureus are poorly understood. In this study, we used whole genome deep sequencing to detect differences between two isogenic strains: a parental strain and a stable derivative selected stepwise for survival on 4 mg/ml teicoplanin, but which grows at higher drug concentrations (MIC 8 mg/ml). We uncovered only three single nucleotide changes in the selected strain. Nonsense mutations occurred in stp1, encoding a serine/threonine phosphatase, and in yjbH, encoding a post-transcriptional negative regulator of the redox/thiol stress sensor and global transcriptional regulator, Spx. A missense mutation (G45R) occurred in the histidine kinase sensor of cell wall stress, VraS. Using genetic methods, all single, pairwise combinations, and a fully reconstructed triple mutant were evaluated for their contribution to low-level glycopeptide resistance. We found a synergistic cooperation between dual phospho-signalling systems and a subtle contribution from YjbH, suggesting the activation of oxidative stress defences via Spx. To our knowledge, this is the first genetic demonstration of multiple sensor and stress pathways contributing simultaneously to glycopeptide resistance development. The multifactorial nature of glycopeptide resistance in this strain suggests a complex reprogramming of cell physiology to survive in the face of drug challenge.	[Renzoni, Adriana; Andrey, Diego O.; Jousselin, Ambre; Barras, Christine; Monod, Antoinette; Vaudaux, Pierre; Lew, Daniel; Kelley, William L.] Univ Hosp Geneva, Infect Dis Serv, Geneva, Switzerland	University of Geneva	Renzoni, A (corresponding author), Univ Hosp Geneva, Infect Dis Serv, Geneva, Switzerland.	Adriana.Renzoni@hcuge.ch		jousselin, ambre/0000-0001-7003-5426; ANDREY, Diego/0000-0003-3247-9274; Renzoni, Adriana/0000-0002-4897-5208	Swiss National Science Foundation [3100A0-120428, 310030-125109]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation grant 3100A0-120428 (WLK) and 310030-125109 (DL) and an F. Hoffmann-La Roche MD-PhD training grant (DOA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey DO, 2010, J BACTERIOL, V192, P6077, DOI 10.1128/JB.00146-10; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Berger-Bachi B, 2006, INJURY, V37, P20, DOI 10.1016/j.injury.2006.04.005; Boyle-Vavra S, 2001, J ANTIMICROB CHEMOTH, V48, P617, DOI 10.1093/jac/48.5.617; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Cui L, 2009, ANTIMICROB AGENTS CH, V53, P1231, DOI 10.1128/AAC.01173-08; Cui LZ, 2005, ANTIMICROB AGENTS CH, V49, P3404, DOI 10.1128/AAC.49.8.3404-3413.2005; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; GALBUSERA E, 2010, ANTIMICROB AGENTS CH; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Garg SK, 2009, J BACTERIOL, V191, P1268, DOI 10.1128/JB.01289-08; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Howden BP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-39; Howden BP, 2006, ANTIMICROB AGENTS CH, V50, P3039, DOI 10.1128/AAC.00422-06; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Katayama Y, 2009, ANTIMICROB AGENTS CH, V53, P3190, DOI 10.1128/AAC.00834-08; Kato Y, 2010, J ANTIMICROB CHEMOTH, V65, P37, DOI 10.1093/jac/dkp394; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Kuroda M, 2000, BIOCHEM BIOPH RES CO, V269, P485, DOI 10.1006/bbrc.2000.2277; Liebeke M, 2010, CHEM BIOL, V17, P820, DOI 10.1016/j.chembiol.2010.06.012; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Maclayton DO, 2007, ANN PHARMACOTHER, V41, P235, DOI 10.1345/aph.1H414; Maki H, 2004, ANTIMICROB AGENTS CH, V48, P1953, DOI 10.1128/AAC.48.6.1953-1959.2004; McCallum N, 2006, BBA-GEN SUBJECTS, V1760, P1475, DOI 10.1016/j.bbagen.2006.06.008; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Paracuellos P, 2010, J MOL BIOL, V404, P847, DOI 10.1016/j.jmb.2010.10.012; Perichon B, 2009, ANTIMICROB AGENTS CH, V53, P4580, DOI 10.1128/AAC.00346-09; Pfeltz RF, 2000, ANTIMICROB AGENTS CH, V44, P294, DOI 10.1128/AAC.44.2.294-303.2000; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Renzoni A, 2006, ANTIMICROB AGENTS CH, V50, P3048, DOI 10.1128/AAC.00113-06; Renzoni A, 2009, ANTIMICROB AGENTS CH, V53, P903, DOI 10.1128/AAC.01287-08; Sieradzki K, 2003, J BACTERIOL, V185, P7103, DOI 10.1128/JB.185.24.7103-7110.2003; STAHL ML, 1983, J BACTERIOL, V154, P406, DOI 10.1128/JB.154.1.406-412.1983; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Tenover FC, 2009, INT J ANTIMICROB AG, V33, P564, DOI 10.1016/j.ijantimicag.2008.12.010; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Vaudaux P, 2010, ANTIMICROB AGENTS CH, V54, P3861, DOI 10.1128/AAC.00269-10; Yin SH, 2006, ANTIMICROB AGENTS CH, V50, P336, DOI 10.1128/AAC.50.1.336-343.2006; You CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-128; ZHU W, 2010, ANTIMICROB AGENTS CH	59	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21577	10.1371/journal.pone.0021577	http://dx.doi.org/10.1371/journal.pone.0021577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738716	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600054
J	Visweswaran, GRR; Dijkstra, BW; Kok, J				Visweswaran, Ganesh Ram R.; Dijkstra, Bauke W.; Kok, Jan			A Minimum of Three Motifs Is Essential for Optimal Binding of Pseudomurein Cell Wall-Binding Domain of Methanothermobacter thermautotrophicus	PLOS ONE			English	Article							METHANOBACTERIUM-THERMOAUTOTROPHICUM; ESCHERICHIA-COLI; LYTIC ENZYME; LYSM; BACTERIA	We have biochemically and functionally characterized the pseudomurein cell wall-binding (PMB) domain that is present at the C-terminus of the Surface (S)-layer protein MTH719 from Methanothermobacter thermautotrophicus. Chemical denaturation of the protein with guanidinium hydrochloride occurred at 3.8 M. A PMB-GFP fusion protein not only binds to intact pseudomurein of methanogenic archaea, but also to spheroplasts of lysozyme-treated bacterial cells. This binding is pH dependent. At least two of the three motifs that are present in the domain are necessary for binding. Limited proteolysis revealed a possible cleavage site in the spacing sequence between motifs 1 and 2 of the PMB domain, indicating that the motif region itself is protected from proteases.	[Visweswaran, Ganesh Ram R.; Kok, Jan] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Visweswaran, Ganesh Ram R.; Dijkstra, Bauke W.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, Groningen, Netherlands	University of Groningen; University of Groningen	Visweswaran, GRR (corresponding author), Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	jan.kok@rug.nl	Dijkstra, Bauke W./H-4308-2019; Kok, Jan/C-9972-2012; Visweswaran, Ganesh Ram R/H-7888-2013	Dijkstra, Bauke W./0000-0001-9731-6586; 	University of Groningen	University of Groningen	The study was funded by the University of Groningen, http://www.rug.nl/corporate/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; KIENER A, 1987, J BACTERIOL, V169, P1010, DOI 10.1128/jb.169.3.1010-1016.1987; KONIG H, 1979, ARCH MICROBIOL, V123, P295, DOI 10.1007/BF00406664; KONIG H, 1983, H-S Z PHYSIOL CHEM, V364, P627, DOI 10.1515/bchm2.1983.364.1.627; Luo YN, 2002, FEMS MICROBIOL LETT, V208, P47; Luo YN, 2001, J BACTERIOL, V183, P5788, DOI 10.1128/JB.183.19.5788-5792.2001; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Pfister P, 1998, MOL MICROBIOL, V30, P233, DOI 10.1046/j.1365-2958.1998.01073.x; STAX D, 1992, FEMS MICROBIOL LETT, V100, P433, DOI 10.1111/j.1574-6968.1992.tb05736.x; Steenbakkers PJM, 2006, MOL MICROBIOL, V62, P1618, DOI 10.1111/j.1365-2958.2006.05483.x; van Roosmalen ML, 2006, METHODS, V38, P144, DOI 10.1016/j.ymeth.2005.09.015; VANDIE IM, 1983, J GEN MICROBIOL, V129, P663; Visweswaran GRR, 2010, ARCHAEA, V2010, DOI 10.1155/2010/480492	16	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21582	10.1371/journal.pone.0021582	http://dx.doi.org/10.1371/journal.pone.0021582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738718	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600056
J	Zhang, CL; Li, AM; Gao, SL; Zhang, XC; Xiao, H				Zhang, Chengliang; Li, Aimin; Gao, Shenglan; Zhang, Xinchun; Xiao, Hua			The TIP30 Protein Complex, Arachidonic Acid and Coenzyme A Are Required for Vesicle Membrane Fusion	PLOS ONE			English	Article							TRANSPORT VESICLES; GOLGI CISTERNAE; PHOSPHOLIPASE-D; SNARE COMPLEX; LIPIDS; ENDOSOMES; RAB; MECHANISMS; EXOCYTOSIS; CURVATURE	Efficient membrane fusion has been successfully mimicked in vitro using artificial membranes and a number of cellular proteins that are currently known to participate in membrane fusion. However, these proteins are not sufficient to promote efficient fusion between biological membranes, indicating that critical fusogenic factors remain unidentified. We have recently identified a TIP30 protein complex containing TIP30, acyl-CoA synthetase long-chain family member 4 (ACSL4) and Endophilin B1 (Endo B1) that promotes the fusion of endocytic vesicles with Rab5a vesicles, which transport endosomal acidification enzymes vacuolar (H(+))-ATPases (V-ATPases) to the early endosomes in vivo. Here, we demonstrate that the TIP30 protein complex facilitates the fusion of endocytic vesicles with Rab5a vesicles in vitro. Fusion of the two vesicles also depends on arachidonic acid, coenzyme A and the synthesis of arachidonyl-CoA by ACSL4. Moreover, the TIP30 complex is able to transfer arachidonyl groups onto phosphatidic acid (PA), producing a new lipid species that is capable of inducing close contact between membranes. Together, our data suggest that the TIP30 complex facilitates biological membrane fusion through modification of PA on membranes.	[Zhang, Chengliang; Li, Aimin; Gao, Shenglan; Xiao, Hua] Michigan State Univ, Dept Biomed & Integrat Physiol, E Lansing, MI 48824 USA; [Zhang, Chengliang; Zhang, Xinchun] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Li, Aimin] So Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China	Michigan State University; Michigan State University; Southern Medical University - China	Zhang, CL (corresponding author), Michigan State Univ, Dept Biomed & Integrat Physiol, E Lansing, MI 48824 USA.	xiaoh@msu.edu	Zhang, Chengliang/E-6943-2016	Zhang, Chengliang/0000-0003-3798-4157; Zhang, Chengliang/0000-0001-6999-4670	NIDDK [RO1 DK066110-01]; Department of Defense [W81XWH-08-1-0377]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066110] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by RO1 DK066110-01 from the NIDDK, http://www2.niddk.nih.gov/, and W81XWH-08-1-0377 (to H.X.) from the Department of Defense, www.defense.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Cao Y, 1998, GENOMICS, V49, P327, DOI 10.1006/geno.1998.5268; Chattopadhyay S, 2003, J BIOL CHEM, V278, P39675, DOI 10.1074/jbc.M212594200; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; CREUTZ CE, 1981, J CELL BIOL, V91, P247, DOI 10.1083/jcb.91.1.247; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; FAHEY DA, 1986, BIOCHEMISTRY-US, V25, P4468, DOI 10.1021/bi00363a045; FUCHS R, 2002, CURR PROTOC CELL BIO, pCH3; GORVEL JP, 1995, J BIOL CHEM, V270, P2741, DOI 10.1074/jbc.270.6.2741; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jones D, 1999, BBA-MOL CELL BIOL L, V1439, P229, DOI 10.1016/S1388-1981(99)00097-9; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; KINNUNEN PKJ, 1992, CHEM PHYS LIPIDS, V63, P251, DOI 10.1016/0009-3084(92)90041-M; Kinnunen PKJ, 2000, BIOSCIENCE REP, V20, P465, DOI 10.1023/A:1010402819509; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Lee YC, 1996, BIOCHEMISTRY-US, V35, P3677, DOI 10.1021/bi9517502; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; MAYORGA LS, 1993, P NATL ACAD SCI USA, V90, P10255, DOI 10.1073/pnas.90.21.10255; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; PFANNER N, 1990, J CELL BIOL, V110, P955, DOI 10.1083/jcb.110.4.955; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xiao H, 2000, EMBO J, V19, P956, DOI 10.1093/emboj/19.5.956; Zhang CL, 2011, J BIOL CHEM, V286, P9373, DOI 10.1074/jbc.M110.207720	32	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21233	10.1371/journal.pone.0021233	http://dx.doi.org/10.1371/journal.pone.0021233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731680	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900016
J	Aly, HH; Oshiumi, H; Shime, H; Matsumoto, M; Wakita, T; Shimotohno, K; Seya, T				Aly, Hussein Hassan; Oshiumi, Hiroyuki; Shime, Hiroaki; Matsumoto, Misako; Wakita, Taka; Shimotohno, Kunitada; Seya, Tsukasa			Development of Mouse Hepatocyte Lines Permissive for Hepatitis C Virus (HCV)	PLOS ONE			English	Article							APOPTOSIS; ALPHA; LIVER; REPLICATION; SUPPRESSION; EXPRESSION; INFECTION; PROTEIN	The lack of a suitable small animal model for the analysis of hepatitis C virus (HCV) infection has hampered elucidation of the HCV life cycle and the development of both protective and therapeutic strategies against HCV infection. Human and mouse harbor a comparable system for antiviral type I interferon (IFN) induction and amplification, which regulates viral infection and replication. Using hepatocytes from knockout (ko) mice, we determined the critical step of the IFN-inducing/ amplification pathways regulating HCV replication in mouse. The results infer that interferon-beta promoter stimulator (IPS1) or interferon A receptor (IFNAR) were a crucial barrier to HCV replication in mouse hepatocytes. Although both IFNARko and IPS-1ko hepatocytes showed a reduced induction of type I interferons in response to viral infection, only IPS-1-/- cells circumvented cell death from HCV cytopathic effect and significantly improved J6JFH1 replication, suggesting IPS-1 to be a key player regulating HCV replication in mouse hepatocytes. We then established mouse hepatocyte lines lacking IPS-1 or IFNAR through immortalization with SV40T antigen. Expression of human (h)CD81 on these hepatocyte lines rendered both lines HCVcc-permissive. We also found that the chimeric J6JFH1 construct, having the structure region from J6 isolate enhanced HCV replication in mouse hepatocytes rather than the full length original JFH1 construct, a new finding that suggests the possible role of the HCV structural region in HCV replication. This is the first report on the entry and replication of HCV infectious particles in mouse hepatocytes. These mouse hepatocyte lines will facilitate establishing a mouse HCV infection model with multifarious applications.	[Aly, Hussein Hassan; Oshiumi, Hiroyuki; Shime, Hiroaki; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan; [Wakita, Taka] Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 1628640, Japan; [Shimotohno, Kunitada] Chiba Inst Technol, Res Inst, Chiba, Japan	Hokkaido University; National Institute of Infectious Diseases (NIID); Chiba Institute of Technology	Aly, HH (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	seya-tu@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Shime, Hiroaki/P-6454-2019; Seya, Tsukasa/A-4336-2012; Oshiumi, Hiroyuki/G-1645-2012; Shime, Hiroaki/D-8721-2012; Aly, Hussein Hassan/GWV-0669-2022	Shime, Hiroaki/0000-0003-0209-5034; Aly, Hussein H/0000-0002-2455-0694; Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Hokkaido University Leader Development System in the Basic Interdisciplinary Research Areas (L station); Mitsubishi Foundation; Mochida Foundation; NorthTec Foundation Waxman Foundation; Yakult Foundation; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23590558, 22114008, 22790371, 22790450] Funding Source: KAKEN	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Hokkaido University Leader Development System in the Basic Interdisciplinary Research Areas (L station); Mitsubishi Foundation; Mochida Foundation; NorthTec Foundation Waxman Foundation; Yakult Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research), the Ministry of Health, Labor, and Welfare of Japan, and the Hokkaido University Leader Development System in the Basic Interdisciplinary Research Areas (L station). Supports from Mitsubishi Foundation, Mochida Foundation, NorthTec Foundation Waxman Foundation and Yakult Foundation are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank Dr. Michinori Kohara (Tokyo Metropolitan Institute for Medical Science, Tokyo, Japan); Dr. Tadatsugu Taniguchi (University of Tokyo, Yokyo, Japan); Dr. Thomas Pietschmann (Division of Experimental Virology, TWINCORE, Hannover, Germany); and Dr. Makoto Hijikata (The Institute for Virus Research, Kyoto University, Japan) for their generous supply of research material. Dr. Hussein H. Aly was supported by a JSPS postdoctoral fellowship from the Japan Society for the Promotion of Science.	Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Aly HH, 2007, J HEPATOL, V46, P26, DOI 10.1016/j.jhep.2006.08.018; Aly HH, 2009, HEPATOLOGY, V50, P689, DOI 10.1002/hep.23034; Aly HH, 2009, BIOCHEM BIOPH RES CO, V379, P330, DOI 10.1016/j.bbrc.2008.12.054; Berg CP, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-213; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069; Ebihara T, 2008, HEPATOLOGY, V48, P48, DOI 10.1002/hep.22337; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Haid S, 2010, J VIROL, V84, P964, DOI 10.1128/JVI.01504-09; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishiyama T, 2003, CANCER SCI, V94, P757, DOI 10.1111/j.1349-7006.2003.tb01515.x; Ladu S, 2008, GASTROENTEROLOGY, V135, P1322, DOI 10.1053/j.gastro.2008.07.012; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Oshiumi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014258; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Ray RB, 1996, VIROLOGY, V226, P176, DOI 10.1006/viro.1996.0644; Schulze-Bergkamen H, 2004, SEMIN ONCOL, V31, P90, DOI 10.1053/j.seminoncol.2003.11.006; Seto W.K., 2010, J HEPATOL; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	33	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21284	10.1371/journal.pone.0021284	http://dx.doi.org/10.1371/journal.pone.0021284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731692	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700055
J	de Jong, MA; Wahlberg, N; van Eijk, M; Brakefield, PM; Zwaan, BJ				de Jong, Maaike A.; Wahlberg, Niklas; van Eijk, Marleen; Brakefield, Paul M.; Zwaan, Bas J.			Mitochondrial DNA Signature for Range-Wide Populations of Bicyclus anynana Suggests a Rapid Expansion from Recent Refugia	PLOS ONE			English	Article							PLASTICITY; LEPIDOPTERA; BUTTERFLIES; HAPLOTYPES; NEUTRALITY; EVOLUTION; BIOLOGY; MARKERS; TESTS; GENE	This study investigates the genetic diversity, population structure and demographic history of the afrotropical butterfly Bicyclus anynana using mitochondrial DNA (mtDNA). Samples from six wild populations covering most of the species range from Uganda to South Africa were compared for the cytochrome c oxidase subunit gene (COI). Molecular diversity indices show overall high mtDNA diversity for the populations, but low nucleotide divergence between haplotypes. Our results indicate relatively little geographic population structure among the southern populations, especially given the extensive distributional range and an expectation of limited gene flow between populations. We implemented neutrality tests to assess signatures of recent historical demographic events. Tajima's D test and Fu's FS test both suggested recent population growth for the populations. The results were only significant for the southernmost populations when applying Tajima's D, but Fu's FS indicated significant deviations from neutrality for all populations except the one closest to the equator. Based on our own findings and those from pollen and vegetation studies, we hypothesize that the species range of B. anynana was reduced to equatorial refugia during the last glacial period, and that the species expanded southwards during the past 10.000 years. These results provide crucial background information for studies of phenotypic and molecular adaptation in wild populations of B. anynana.	[de Jong, Maaike A.; van Eijk, Marleen; Brakefield, Paul M.; Zwaan, Bas J.] Leiden Univ, Inst Biol, Leiden, Netherlands; [de Jong, Maaike A.] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Wahlberg, Niklas] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Brakefield, Paul M.] Univ Cambridge, Dept Zool, Cambridge, England; [Zwaan, Bas J.] Wageningen Univ, Genet Lab, Wageningen, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Helsinki; University of Turku; University of Cambridge; Wageningen University & Research	de Jong, MA (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	maaike.dejong@helsinki.fi	Zwaan, Bas J/D-8721-2015; Wahlberg, Niklas/B-7765-2008; de Jong, Maaike/D-6978-2014	Zwaan, Bas J/0000-0002-8221-4998; Wahlberg, Niklas/0000-0002-1259-3363; de Jong, Maaike/0000-0003-4803-7411	Netherlands Organization for Scientific Research [814.01.012]; EU [FP6 036894]; Royal Netherlands Academy of Arts and Sciences (KNAW); Treub Foundation; Uyttenboogaart-Eliasen Foundation	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); Royal Netherlands Academy of Arts and Sciences (KNAW); Treub Foundation; Uyttenboogaart-Eliasen Foundation	Sources of funding: Earth and Life Sciences program of the Netherlands Organization for Scientific Research (Grant no. 814.01.012) www.nwo.nl; EU-funded Network of Excellence LifeSpan (FP6 036894) http://www.lifespannetwork.nl/; the Royal Netherlands Academy of Arts and Sciences (KNAW) www.knaw.nl; the Treub Foundation and the Uyttenboogaart-Eliasen Foundation, http://www.ue-stichting.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Brakefield PM, 2010, AM NAT, V176, pS77, DOI 10.1086/657059; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; BROWER AVZ, 1991, EVOLUTION, V45, P1281, DOI 10.1111/j.1558-5646.1991.tb04393.x; Caterino MS, 2000, ANNU REV ENTOMOL, V45, P1, DOI 10.1146/annurev.ento.45.1.1; Condamin M., 1973, Memoires Inst fond Afr noire, VNo. 88, P1; de Jong MA, 2010, CLIM RES, V43, P91, DOI 10.3354/cr00881; Douglass John F., 2003, Bulletin of the Allyn Museum, V143, P1; Elenga H, 2000, J BIOGEOGR, V27, P621, DOI 10.1046/j.1365-2699.2000.00430.x; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flenley JR, 1998, CLIMATIC CHANGE, V39, P177, DOI 10.1023/A:1005367822750; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; Fu YX, 1997, GENETICS, V147, P915; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HAMILTON A, 2001, AFRICAN RAIN FOREST, P183; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.es.18.110187.001413; Nei M., 1987, MOL EVOLUTIONARY GEN; Oostra V, 2011, P ROY SOC B-BIOL SCI, V278, P789, DOI 10.1098/rspb.2010.1560; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; TAJIMA F, 1989, GENETICS, V123, P585; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006	31	51	54	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21385	10.1371/journal.pone.0021385	http://dx.doi.org/10.1371/journal.pone.0021385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731725	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700072
J	Frauer, C; Hoffmann, T; Bultmann, S; Casa, V; Cardoso, MC; Antes, I; Leonhardt, H				Frauer, Carina; Hoffmann, Thomas; Bultmann, Sebastian; Casa, Valentina; Cardoso, M. Cristina; Antes, Iris; Leonhardt, Heinrich			Recognition of 5-Hydroxymethylcytosine by the Uhrf1 SRA Domain	PLOS ONE			English	Article							HEMI-METHYLATED DNA; MOLECULAR-DYNAMICS; METHYLTRANSFERASE; BINDING; 5-METHYLCYTOSINE; PROTEINS; CONVERSION; MUTATION; DNMT3A; DAMAGE	Recent discovery of 5-hydroxymethylcytosine (5hmC) in genomic DNA raises the question how this sixth base is recognized by cellular proteins. In contrast to the methyl-CpG binding domain (MBD) of MeCP2, we found that the SRA domain of Uhrf1, an essential factor in DNA maintenance methylation, binds 5hmC and 5-methylcytosine containing substrates with similar affinity. Based on the co-crystal structure, we performed molecular dynamics simulations of the SRA: DNA complex with the flipped cytosine base carrying either of these epigenetic modifications. Our data indicate that the SRA binding pocket can accommodate 5hmC and stabilizes the flipped base by hydrogen bond formation with the hydroxyl group.	[Frauer, Carina; Bultmann, Sebastian; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Hoffmann, Thomas; Antes, Iris] Tech Univ Munich, Dept Life Sci, D-8050 Freising Weihenstephan, Germany; [Casa, Valentina; Cardoso, M. Cristina] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Frauer, Carina; Hoffmann, Thomas; Bultmann, Sebastian; Antes, Iris; Leonhardt, Heinrich] Ctr Integrated Prot Sci Munich CIPSM, Munich, Germany	University of Munich; Technical University of Munich; Technical University of Darmstadt	Frauer, C (corresponding author), Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	antes@wzw.tum.de; h.leonhardt@lmu.de	Leonhardt, Heinrich/B-2791-2014; Cardoso, M. Cristina/F-5215-2011; Bultmann, Sebastian/AAC-7729-2020	Hoffmann, Thomas/0000-0002-2980-8324	Nanosystems Initiative Munich (NIM); Center for NanoSciences (CeNS) Munich; Deutsche Forschungsgemeinschaft (DFG) [SFB TR5]; Elite Network of Bavaria; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); Graduate School for Life Sciences Munich (LSM)	Nanosystems Initiative Munich (NIM); Center for NanoSciences (CeNS) Munich; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Elite Network of Bavaria; International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS); Graduate School for Life Sciences Munich (LSM)	This work was supported by grants from the Nanosystems Initiative Munich (NIM, http://www.nano-initiative-munich.de), the Center for NanoSciences (CeNS, http://www.cens.de) Munich, and by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB TR5, http://www.dfg.de) to HL. CF gratefully acknowledges support by the Elite Network of Bavaria (International Doctorate Program NanoBioTechnology, IDK-NBT, http://www.cens.de/doctorate-program) and the International Max Planck Research School for Molecular and Cellular Life Sciences (IMPRS-LS, http://www.imprs-ls.de). SB was supported by the Graduate School for Life Sciences Munich (LSM, http://www.lsm.bio.lmu.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Aqvist J, 2002, ACCOUNTS CHEM RES, V35, P358, DOI 10.1021/ar010014p; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frauer C, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1029; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Rottach A, 2009, J CELL BIOCHEM, V108, P43, DOI 10.1002/jcb.22253; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sasai N, 2009, INT J DEV BIOL, V53, P323, DOI 10.1387/ijdb.082652ns; SHARIF J, 2007, NATURE; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	42	138	146	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21306	10.1371/journal.pone.0021306	http://dx.doi.org/10.1371/journal.pone.0021306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731699	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700060
J	Windahl, SH; Andersson, N; Borjesson, AE; Swanson, C; Svensson, J; Moverare-Skrtic, S; Sjogren, K; Shao, RJ; Lagerquist, MK; Ohlsson, C				Windahl, Sara H.; Andersson, Niklas; Borjesson, Anna E.; Swanson, Charlotte; Svensson, Johan; Moverare-Skrtic, Sofia; Sjogren, Klara; Shao, Ruijin; Lagerquist, Marie K.; Ohlsson, Claes			Reduced Bone Mass and Muscle Strength in Male 5 alpha-Reductase Type 1 Inactivated Mice	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ANDROGEN RECEPTOR; STEROID 5-ALPHA-REDUCTASE; TESTOSTERONE-RECEPTOR; TRABECULAR BONE; CORTICAL BONE; GROWTH-PLATE; ALPHA; EXPRESSION; SRD5A3	Androgens are important regulators of bone mass but the relative importance of testosterone (T) versus dihydrotestosterone (DHT) for the activation of the androgen receptor (AR) in bone is unknown. 5 alpha-reductase is responsible for the irreversible conversion of T to the more potent AR activator DHT. There are two well established isoenzymes of 5 alpha-reductase (type 1 and type 2), encoded by separate genes (Srd5a1 and Srd5a2). 5 alpha-reductase type 2 is predominantly expressed in male reproductive tissues whereas 5 alpha-reductase type 1 is highly expressed in liver and moderately expressed in several other tissues including bone. The aim of the present study was to investigate the role of 5 alpha-areductase type 1 for bone mass using Srd5a1(-/-) mice. Four-month-old male Srd5a1(-/-) mice had reduced trabecular bone mineral density (-36%, p<0.05) and cortical bone mineral content (-15%, p<0.05) but unchanged serum androgen levels compared with wild type (WT) mice. The cortical bone dimensions were reduced in the male Srd5a1(-/-) mice as a result of a reduced cortical periosteal circumference compared with WT mice. T treatment increased the cortical periosteal circumference (p<0.05) in orchidectomized WT mice but not in orchidectomized Srd5a1(-/-) mice. Male Srd5a1(-/-) mice demonstrated a reduced forelimb muscle grip strength compared with WT mice (p<0.05). Female Srd5a1(-/-) mice had slightly increased cortical bone mass associated with elevated circulating levels of androgens. In conclusion, 5 alpha-reductase type 1 inactivated male mice have reduced bone mass and forelimb muscle grip strength and we propose that these effects are due to lack of 5 alpha-reductase type 1 expression in bone and muscle. In contrast, the increased cortical bone mass in female Srd5a1(-/-) mice, is an indirect effect mediated by elevated circulating androgen levels.	[Windahl, Sara H.; Andersson, Niklas; Borjesson, Anna E.; Swanson, Charlotte; Svensson, Johan; Moverare-Skrtic, Sofia; Sjogren, Klara; Lagerquist, Marie K.; Ohlsson, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden; [Shao, Ruijin] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Windahl, SH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden.	claes.ohlsson@medic.gu.se	Skrtic, Sofia/AAQ-1585-2020; Shao, Linus R/M-3059-2019; Lagerquist, Marie/A-9531-2010; Shao, Linus R/M-3134-2019; Ohlsson, Claes/AGP-3544-2022	Shao, Linus R/0000-0002-1339-9570; Lagerquist, Marie/0000-0002-9089-8605; Shao, Linus R/0000-0002-1339-9570; Ohlsson, Claes/0000-0002-9633-2805; Svensson, Johan/0000-0002-4487-6405; Tornqvist, Anna/0000-0003-2621-9038; Windahl, Sara/0000-0002-6611-6001; Andersson, Niklas/0000-0002-3493-7358; Sjogren, Klara/0000-0001-5776-7278	Swedish Research Council; Swedish Foundation for Strategic Research; COMBINE; Avtal om Lakarutbildning och Forskning /Lakarutbildningsavtalet research grant in Gothenburg; Lundberg Foundation; Torsten and Ragnar Soderberg's Foundation; Novo Nordisk Foundation; Reumatikerforbundet; Gustav V 80-ars fond; Ake Wiberg Foundation; Magnus Bergvall foundation; Tore Nilson Foundation; NIH (NIDDK) [DK071122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071122, R56DK071122] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); COMBINE; Avtal om Lakarutbildning och Forskning /Lakarutbildningsavtalet research grant in Gothenburg; Lundberg Foundation(European Commission); Torsten and Ragnar Soderberg's Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Reumatikerforbundet; Gustav V 80-ars fond; Ake Wiberg Foundation; Magnus Bergvall foundation; Tore Nilson Foundation; NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, COMBINE, the Avtal om Lakarutbildning och Forskning /Lakarutbildningsavtalet research grant in Gothenburg, the Lundberg Foundation, the Torsten and Ragnar Soderberg's Foundation, the Novo Nordisk Foundation, Reumatikerforbundet, Gustav V 80-ars fond, Ake Wiberg Foundation, The Magnus Bergvall foundation, The Tore Nilson Foundation and the NIH (NIDDK grant DK071122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts J, 1997, ENDOCRINOLOGY, V138, P5067, DOI 10.1210/en.138.11.5067; BHASIN S, J CLIN ENDOCRINOL ME, V95, P2536; Callewaert F, 2009, FASEB J, V23, P232, DOI 10.1096/fj.08-113456; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; DESLYPERE JP, 1992, MOL CELL ENDOCRINOL, V88, P15, DOI 10.1016/0303-7207(92)90004-P; Goodarzi MO, 2006, J CLIN ENDOCR METAB, V91, P4085, DOI 10.1210/jc.2006-0227; Issa S, 2002, J CLIN ENDOCR METAB, V87, P5401, DOI 10.1210/jc.2001-011902; Jablonka-Shariff A, 1999, BIOL REPROD, V61, P171, DOI 10.1095/biolreprod61.1.171; KAUFMAN M, 1983, J STEROID BIOCHEM, V18, P121, DOI 10.1016/0022-4731(83)90077-8; KAUFMAN M, 1993, J STEROID BIOCHEM, V45, P467, DOI 10.1016/0960-0760(93)90161-O; KOVACS WJ, 1984, J CLIN INVEST, V73, P1095, DOI 10.1172/JCI111295; Langlois VS, 2010, GEN COMP ENDOCR, V166, P489, DOI 10.1016/j.ygcen.2009.08.004; Mahendroo MS, 1999, MOL ENDOCRINOL, V13, P981, DOI 10.1210/me.13.6.981; Mahendroo MS, 1997, MOL ENDOCRINOL, V11, P917, DOI 10.1210/me.11.7.917; Mahendroo MS, 2001, ENDOCRINOLOGY, V142, P4652, DOI 10.1210/en.142.11.4652; Mahendroo MS, 1996, MOL ENDOCRINOL, V10, P380, DOI 10.1210/me.10.4.380; Mahendroo MS, 1999, REV REPROD, V4, P179, DOI 10.1530/ror.0.0040179; Mellstrom D, 2008, J BONE MINER RES, V23, P1552, DOI 10.1359/JBMR.080518; Moverare S, 2003, P NATL ACAD SCI USA, V100, P13573, DOI 10.1073/pnas.2233084100; Nilsson LO, 1999, J CLIN ENDOCR METAB, V84, P370, DOI 10.1210/jc.84.1.370; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Olsen NJ, 2001, ENDOCRINOLOGY, V142, P1278, DOI 10.1210/en.142.3.1278; Onoe Y, 1997, ENDOCRINOLOGY, V138, P4509, DOI 10.1210/en.138.10.4509; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SCHWEIKERT HU, 1980, ACTA ENDOCRINOL-COP, V95, P258, DOI 10.1530/acta.0.0950258; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; Stiles AR, 2010, CELL, V142, P196, DOI 10.1016/j.cell.2010.07.003; Storer TW, 2008, J AM GERIATR SOC, V56, DOI 10.1111/j.1532-5415.2008.01927.x; Tivesten A, 2004, J BONE MINER RES, V19, P1833, DOI 10.1359/JBMR.040819; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; van der Eerden BCJ, 2002, ENDOCRINOLOGY, V143, P4048, DOI 10.1210/en.2002-220093; Vandenput L, 2009, NAT REV ENDOCRINOL, V5, P437, DOI 10.1038/nrendo.2009.112; Vanderschueren D, 2004, ENDOCR REV, V25, P389, DOI 10.1210/er.2003-0003; Venken K, 2006, J BONE MINER RES, V21, P576, DOI 10.1359/JBMR.060103; Vidal O, 2000, P NATL ACAD SCI USA, V97, P5474, DOI 10.1073/pnas.97.10.5474; Vidal O, 1999, J BONE MINER RES, V14, P923, DOI 10.1359/jbmr.1999.14.6.923; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Windahl SH, 2000, BONE, V26, P117, DOI 10.1016/S8756-3282(99)00248-3; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730	40	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21402	10.1371/journal.pone.0021402	http://dx.doi.org/10.1371/journal.pone.0021402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731732	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700076
J	Law, EWL; Cheung, AKL; Kashuba, VI; Pavlova, TV; Zabarovsky, ER; Lung, HL; Cheng, Y; Chua, D; Kwong, DLW; Tsao, SW; Sasaki, T; Stanbridge, EJ; Lung, ML				Law, E. W. L.; Cheung, A. K. L.; Kashuba, V. I.; Pavlova, T. V.; Zabarovsky, E. R.; Lung, H. L.; Cheng, Y.; Chua, D.; Kwong, D. Lai-wan; Tsao, S. W.; Sasaki, T.; Stanbridge, E. J.; Lung, M. L.			Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma	ONCOGENE			English	Article						anti-angiogenic; fibulin-2; nasopharyngeal carcinoma; tumor suppressor; VEGF; methylation	EXTRACELLULAR-MATRIX PROTEIN; CHROMOSOME 3P21.3; COPY NUMBER; EXPRESSION; BREAST; CANCER; IDENTIFICATION; PROGRESSION; METASTASIS; ESOPHAGEAL	Fibulin-2 (FBLN2) has been identified as a candidate tumor-suppressor gene in nasopharyngeal carcinoma (NPC). Originally identified through a chromosome 3 NotI genomic microarray screen, it shows frequent deletion or methylation in NPC. FBLN2 is located on chromosome 3p25.1 and is associated with tumor development through its important interactions with the extracellular matrix (ECM) proteins. FBLN2 encodes two isoforms. The short isoform (FBLN2S) is expressed abundantly in normal tissues, but is dramatically downregulated in NPC, while the long isoform (FBLN2L) is either not detectable or is expressed only at low levels in both normal and tumor tissues. Reintroduction of this FBLN2S inhibited cell proliferation, migration, invasion and angiogenesis in vitro. Furthermore, in vivo studies in nude mice show its expression is associated with tumor and angiogenesis suppression. FBLN2-associated angiogenesis occurs via concomitant downregulation of vascular endothelial growth factor and matrix metalloproteinase 2. This study provides compelling evidence that FBLN2S has an important tumor-suppressive and anti-angiogenic role in NPC. Oncogene (2012) 31, 728-738; doi:10.1038/onc.2011.272; published online 11 July 2011	[Law, E. W. L.; Cheung, A. K. L.; Lung, H. L.; Cheng, Y.; Chua, D.; Kwong, D. Lai-wan; Lung, M. L.] Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China; [Law, E. W. L.; Cheung, A. K. L.; Lung, H. L.; Cheng, Y.; Chua, D.; Kwong, D. Lai-wan; Lung, M. L.] Univ Hong Kong, Ctr Canc Res, Pokfulam, Hong Kong, Peoples R China; [Kashuba, V. I.; Pavlova, T. V.; Zabarovsky, E. R.] Karolinska Inst, Dept Clin Sci & Educ, Dept Microbiol Tumor & Cell Biol, Sodersjukhuset, Stockholm, Sweden; [Zabarovsky, E. R.] Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Struct & Funct Genom, Moscow, Russia; [Chua, D.] Hong Kong Sanat & Hosp, Comprehens Oncol Ctr, Happy Valley, Hong Kong, Peoples R China; [Tsao, S. W.] Univ Hong Kong, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Sasaki, T.] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med 1, D-91054 Erlangen, Germany; [Stanbridge, E. J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of Hong Kong; University of Hong Kong; Karolinska Institutet; Sodersjukhuset Hospital; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; University of Hong Kong; University of Erlangen Nuremberg; University of California System; University of California Irvine	Lung, ML (corresponding author), Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China.	mlilung@hku.hk	Cheung, Arthur Kwok Leung/H-8940-2013; Zabarovsky, Eugene R/A-6645-2010; Kashuba, Vladimir I/N-3732-2017; Kashuba, Vladimir/AAO-7742-2020; Cheng, Yue/E-9853-2010; Lung, Maria Li/C-4495-2009	Kashuba, Vladimir I/0000-0001-9416-8282; Cheng, Yue/0000-0002-2472-1879; Cheung, Arthur Kwok Leung/0000-0001-5446-2209; Pavlova, Tatiana/0000-0002-2857-5696; Lung, Maria Li/0000-0003-2559-3626	University Grants Council [AoE/M-06/08]; Swedish Cancer Society; Swedish Research Council; Swedish Institute; Karolinska Institute	University Grants Council; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute; Karolinska Institute(Karolinska Institutet)	This work was supported by University Grants Council Area of Excellence grant AoE/M-06/08 to MLL and the Swedish Cancer Society, the Swedish Research Council, the Swedish Institute, and Karolinska Institute to ERZ.	Chattopadhyay I, 2010, MUTAT RES-GEN TOX EN, V696, P130, DOI 10.1016/j.mrgentox.2010.01.001; Cheng Y, 1998, P NATL ACAD SCI USA, V95, P3042, DOI 10.1073/pnas.95.6.3042; Cheung AKL, 2008, CANCER RES, V68, P8137, DOI 10.1158/0008-5472.CAN-08-0904; Cheung AKL, 2009, P NATL ACAD SCI USA, V106, P14478, DOI 10.1073/pnas.0900198106; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Dunwell TL, 2009, EPIGENETICS-US, V4, P185, DOI 10.4161/epi.4.3.8752; Fassler R, 1996, EXP CELL RES, V222, P111, DOI 10.1006/excr.1996.0014; Gallagher WM, 2005, TRENDS MOL MED, V11, P336, DOI 10.1016/j.molmed.2005.06.001; Grassel S, 1999, EUR J BIOCHEM, V263, P471, DOI 10.1046/j.1432-1327.1999.00523.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hill VK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-51; Li HM, 2006, INT J CANCER, V119, P1567, DOI 10.1002/ijc.22032; Li JF, 2002, P NATL ACAD SCI USA, V99, P10724, DOI 10.1073/pnas.132271699; Libra M, 2009, INT J ONCOL, V34, P897, DOI 10.3892/ijo_00000215; Lo PHY, 2010, CANCER RES, V70, P5567, DOI 10.1158/0008-5472.CAN-09-4510; Lung HL, 2006, CANCER RES, V66, P9385, DOI 10.1158/0008-5472.CAN-06-0590; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; MCDONNELL S, 1990, CANCER METAST REV, V9, P305; Mutirangura A, 1997, BRIT J CANCER, V76, P770, DOI 10.1038/bjc.1997.460; Nakao M, 2011, ONCOL REP, V25, P1603, DOI 10.3892/or.2011.1246; PAN TC, 1993, J CELL BIOL, V123, P1269, DOI 10.1083/jcb.123.5.1269; PFAFF M, 1995, EXP CELL RES, V219, P87, DOI 10.1006/excr.1995.1208; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Tsuda T, 2001, DEV DYNAM, V222, P89, DOI 10.1002/dvdy.1172; Wu Y, 2010, J THROMB HAEMOST, V8, P185, DOI 10.1111/j.1538-7836.2009.03662.x; Yau WL, 2006, INT J CANCER, V119, P2821, DOI 10.1002/ijc.22232; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478; Zhang H, 2004, CANCER GENET CYTOGEN, V150, P144, DOI 10.1016/j.cancergencyto.2003.09.007; ZHANG HY, 1995, DEV BIOL, V167, P18, DOI 10.1006/dbio.1995.1003	32	72	75	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	6					728	738		10.1038/onc.2011.272	http://dx.doi.org/10.1038/onc.2011.272			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MU	21743496				2022-12-25	WOS:000300222100006
J	Thomas, M; Lange-Grunweller, K; Weirauch, U; Gutsch, D; Aigner, A; Grunweller, A; Hartmann, RK				Thomas, M.; Lange-Gruenweller, K.; Weirauch, U.; Gutsch, D.; Aigner, A.; Gruenweller, A.; Hartmann, R. K.			The proto-oncogene Pim-1 is a target of miR-33a	ONCOGENE			English	Article						Pim-1; microRNA; miR-33a; proliferation; RNAi; siRNA	PROSTATE-CANCER CELLS; C-MYC; PROTEIN-KINASE; MICRORNAS; PHOSPHORYLATION; GENES; RNA; AKT; APOPTOSIS; GROWTH	The constitutively active serine/threonine kinase Pim-1 is upregulated in different cancer types, mainly based on the action of several interleukines and growth factors at the transcriptional level. So far, a regulation of oncogenic Pim-1 by microRNAs (miRNAs) has not been reported. Here, we newly establish miR-33a as a miRNA with potential tumor suppressor activity, acting through inhibition of Pim-1. A screen for miRNA expression in K562 lymphoma, LS174T colon carcinoma and several other cell lines revealed generally low endogenous miR33a levels relative to other miRNAs. Transfection of K562 and LS174T cells with a miR-33a mimic reduced Pim-1 levels substantially. In contrast, the cell-cycle regulator cyclin-dependent kinase 6 predicted to be a conserved miR-33a target, was not downregulated by the miR-33a mimic. Seed mutagenesis of the Pim-1 30-untranslated region in a luciferase reporter construct and in a Pim-1 cDNA expressed in Pim-1-deficient Skov-3 cells demonstrated specific and direct downregulation of Pim-1 by the miR-33a mimic. The persistence of this effect was comparable to that of a small interfering RNA-mediated knockdown of Pim-1, resulting in decelerated cell proliferation. In conclusion, we demonstrate the potential of miR-33a to act as a tumor suppressor miRNA, which suggests miR-33a replacement therapy through delivery of miR mimics as a novel therapeutic strategy. Oncogene (2012) 31, 918-928; doi: 10.1038/onc.2011.278; published online 11 July 2011	[Gruenweller, A.] Univ Marburg, Inst Pharmaceut Chem, Fac Pharm, AG Hartmann, D-35037 Marburg, Germany; [Weirauch, U.; Gutsch, D.; Aigner, A.] Univ Marburg, Inst Pharmacol, Fac Med, D-35037 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Grunweller, A (corresponding author), Univ Marburg, Inst Pharmaceut Chem, Fac Pharm, AG Hartmann, Marbacher Weg 6, D-35037 Marburg, Germany.	arnold.gruenweller@staff.uni-marburg.de; roland.hartmann@staff.uni-marburg.de	Aigner, Achim/R-4429-2017	Aigner, Achim/0000-0002-2778-6256	Fritz Thyssen Stiftung [10.06.1.186]; Deutsche Krebshilfe [109260, 106992]; DFG Forschergruppe Nanohale [AI 24/6-1]	Fritz Thyssen Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); DFG Forschergruppe Nanohale(German Research Foundation (DFG))	We thank Robert Prinz, Dorothee Hartmann, Dennis Streng, Meike Thomas and Heide Marika Genau for technical support. This study was supported by the Fritz Thyssen Stiftung (reference no. 10.06.1.186 to AG and RKH), the Deutsche Krebshilfe (reference no. 109260 to AG, RKH and AA, and reference no. 106992 to AA) and DFG Forschergruppe Nanohale (AI 24/6-1).	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Bachmann M, 2004, J BIOL CHEM, V279, P48319, DOI 10.1074/jbc.M404440200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grunweller A, 2003, NUCLEIC ACIDS RES, V31, P3185, DOI 10.1093/nar/gkg409; Herrera-Merchan A, 2010, CELL CYCLE, V9, P3277, DOI 10.4161/cc.9.16.12598; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Martelli AM, 2007, CURR MED CHEM, V14, P2009; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Xia ZP, 2009, J MED CHEM, V52, P74, DOI 10.1021/jm800937p; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Zhang T, 2010, J SURG ONCOL, V101, P513, DOI 10.1002/jso.21524; ZHANG W, 1993, CANCER RES, V53, P4772; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	58	99	102	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	7					918	928		10.1038/onc.2011.278	http://dx.doi.org/10.1038/onc.2011.278			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21743487				2022-12-25	WOS:000300615800010
J	Verhaegen, M; Checinska, A; Riblett, MB; Wang, S; Soengas, MS				Verhaegen, M.; Checinska, A.; Riblett, M. B.; Wang, S.; Soengas, M. S.			E2F1-dependent oncogenic addiction of melanoma cells to MDM2	ONCOGENE			English	Article						melanoma; senescence; oncogene dependency; MDM-2 inhibitors	TUMOR-SUPPRESSOR; P53 ACTIVATION; E3 LIGASE; APOPTOSIS; PROTEIN; DEGRADATION; INHIBITOR; EXPRESSION; UBIQUITINATION; INACTIVATION	One of the defining features of aggressive melanomas is their complexity. Hundreds of mutations and an ever increasing list of changes in the transcriptome and proteome distinguish normal from malignant melanocytic cells. Yet, despite this altered genetic background, a long-known attribute of melanomas is a relatively low rate of mutations in the p53 gene. However, it is unclear whether p53 is maintained in melanoma cells because it is required for their survival, or because it is functionally disabled. More pressing from a translational perspective, is to define whether there is a tumor cell-selective wiring of p53 that offers a window for therapeutic intervention. Here, we provide genetic and pharmacological evidence demonstrating that p53 represents a liability to melanoma cells, which they thwart by assuming an oncogenic dependency on the E3 ligase murine double minute-2 (MDM2). Specifically, we used a combination of RNA interference and two structurally independent small molecule inhibitors of the p53-MDM2 interaction to assess the relative requirement of both proteins for the viability of normal melanocytes and a broad panel of melanoma cell lines. We demonstrated in vitro and in vivo that MDM2 is selectively required to blunt latent pro-senescence signals in melanoma cells. Notably, the outcome of MDM2 inactivation depends not only on the mutational status of p53, but also on its ability to signal to the transcription factor E2F1. These data support MDM2 as a drug target in melanoma cells, and identify E2F1 as a biomarker to consider when stratifying putative candidates for clinical studies of p53-MDM2 inhibitors. Oncogene (2012) 31, 828-841; doi: 10.1038/onc.2011.277; published online 11 July 2011	[Checinska, A.; Soengas, M. S.] Spanish Natl Canc Res Ctr, Melanoma Lab, Mol Pathol Programme, CNIO, Madrid 28049, Spain; [Verhaegen, M.; Riblett, M. B.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI USA; [Verhaegen, M.; Riblett, M. B.; Wang, S.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Wang, S.] Univ Michigan, Dept Internal Med & Pharmacol, Ann Arbor, MI 48109 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Soengas, MS (corresponding author), Spanish Natl Canc Res Ctr, Melanoma Lab, Mol Pathol Programme, CNIO, Melchor Fernandez Almagro 3, Madrid 28049, Spain.	msoengas@cnio.es	Soengas, Maria S/H-6455-2015	Soengas, Maria S/0000-0003-0612-6299; Wang, Shaomeng/0000-0002-8782-6950	NIH [R01CA107237]; Spanish Ministry of Science and Innovation [SAF2008-01950]; Spanish Association Against Cancer (AECC); Dermatology Foundation;  [R01CA121279]; NATIONAL CANCER INSTITUTE [R01CA121279, R01CA107237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Association Against Cancer (AECC); Dermatology Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Joshua A Bauer, J Chadwick Brenner and Thomas E Carey for shRNA constructs against p53 and MDM2, Andrzej Dlugosz for support and Mikhail Nikiforov for helpful suggestions at early stages of this study. MSS was supported by R01CA107237 from the NIH, SAF2008-01950 from the Spanish Ministry of Science and Innovation, and a development grant from the Spanish Association Against Cancer (AECC). SW was funded by R01CA121279 and MV is the recipient of a Career Development Award from the Dermatology Foundation.	Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Avery-Kiejda KA, 2008, CLIN CANCER RES, V14, P1659, DOI 10.1158/1078-0432.CCR-07-1422; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; CASTRESANA JS, 1993, INT J CANCER, V55, P562, DOI 10.1002/ijc.2910550407; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Hoek KS, 2007, PIGM CELL RES, V20, P466, DOI 10.1111/j.1600-0749.2007.00412.x; Hofmann F, 1996, GENE DEV, V10, P2949, DOI 10.1101/gad.10.23.2949; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Huang BY, 2009, MOL CANCER RES, V7, P1497, DOI 10.1158/1541-7786.MCR-09-0144; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kass EM, 2009, CELL CYCLE, V8, P430, DOI 10.4161/cc.8.3.7624; Korotchkina LG, 2009, CELL CYCLE, V8, P3777, DOI 10.4161/cc.8.22.10121; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Long JT, 2010, BLOOD, V116, P71, DOI 10.1182/blood-2010-01-261628; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Moran DM, 2010, MOL CANCER THER, V9, P895, DOI 10.1158/1535-7163.MCT-09-1220; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Polsky D, 2003, ONCOGENE, V22, P3087, DOI 10.1038/sj.onc.1206449; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Satyamoorthy K, 2000, CELL GROWTH DIFFER, V11, P467; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Terzian T, 2010, PIGM CELL MELANOMA R, V23, P781, DOI 10.1111/j.1755-148X.2010.00773.x; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Verhaegen M, 2006, CANCER RES, V66, P11348, DOI 10.1158/0008-5472.CAN-06-1748; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	50	23	24	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	7					828	841		10.1038/onc.2011.277	http://dx.doi.org/10.1038/onc.2011.277			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21743494	Green Accepted, Green Submitted			2022-12-25	WOS:000300615800003
J	Barbieri, SS; Amadio, P; Gianellini, S; Zacchi, E; Weksler, BB; Tremoli, E				Barbieri, Silvia S.; Amadio, Patrizia; Gianellini, Sara; Zacchi, Elena; Weksler, Babette B.; Tremoli, Elena			Tobacco smoke regulates the expression and activity of microsomal prostaglandin E synthase-1: role of prostacyclin and NADPH-oxidase	FASEB JOURNAL			English	Article						prostanoids; reactive oxygen species; endothelial cells; signal transduction	SMOOTH-MUSCLE-CELLS; CIGARETTE-SMOKE; ENDOTHELIAL-CELLS; CYCLOOXYGENASE-2 EXPRESSION; SUPEROXIDE GENERATION; VASCULAR ENDOTHELIUM; INTERLEUKIN-1-BETA; ATHEROSCLEROSIS; ACTIVATION; DISEASE	Tobacco smoke (TS) interacts with interleukin-1 beta (IL-1 beta) to modulate generation of reactive oxygen species (ROS) and expression of cyclooxygenase-2. We explored molecular mechanisms by which TS/IL-1 beta alters expression and activity of microsomal-prostaglandin E synthase-1 (mPGES-1) and of prostacyclin synthase (PGIS) in mouse cardiac endothelial cells. TS (EC(50) similar to 5 puffs/L) interacting with IL-1 beta (2 mu g/L) up-regulates PGE(2) production and mPGES-1 expression, reaching a plateau at 4-6 h, but down-regulates prostacyclin (PGI(2)) release by increasing IL-1 beta-mediated PGIS tyrosine nitration. Inhibition of NADPH-oxidase, achieved pharmacologically and/or by silencing its catalytic subunit p47phox, or exogenous PGI(2) (carbaprostacyclin; IC(50) similar to 5 mu M) prevents production of both ROS and PGE(2), and negatively modulates mPGES-1 expression induced by TS/IL-1 beta. Moreover, inhibiting PGI(2), either using PGIS siRNA and/or CAY10441 (EC(50) similar to 20 nM), a PGI(2) receptor antagonist, increases NADPH-oxidase activation, mPGES-1 synthesis, and PGE(2) production. Finally, lower PGI(2) levels associated with higher PGIS tyrosine nitration, p47phox translocation to the membrane (an index of activation of NADPH-oxidase), and mPGES-1 expression and activity were detected in cardiovascular tissues of ApoE(-/-) mice exposed to cigarette smoke compared to control mice. In conclusion, cigarette smoke in association with cytokines alters the balance between PGI(2)/PGE(2), reducing PGI(2) production and increasing synthesis and activity of mPGES-1 via NADPH-oxidase activation, predisposing to development of pathological conditions.-Barbieri, S. S., Amadio, P., Gianellini, S., Zacchi, E., Weksler, B. B., Tremoli, E. Tobacco smoke regulates the expression and activity of microsomal prostaglandin E synthase-1: role of prostacyclin and NADPH-oxidase. FASEB J. 25, 3731-3740 (2011). www.fasebj.org	[Barbieri, Silvia S.; Tremoli, Elena] IRCCS, Ctr Cardiol Monzino, I-20138 Milan, Italy; [Amadio, Patrizia; Gianellini, Sara; Zacchi, Elena; Tremoli, Elena] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Weksler, Babette B.] Cornell Univ, Div Hematol Med Oncol, Weill Med Coll, New York, NY 10021 USA	IRCCS Centro Cardiologico Monzino; University of Milan; Cornell University	Barbieri, SS (corresponding author), IRCCS, Ctr Cardiol Monzino, Via Parea 4, I-20138 Milan, Italy.	silviabarbieri@yahoo.com	Barbieri, Silvia Stella/K-2130-2018; Amadio, Patrizia/K-3937-2018; TREMOLI, ELENA/I-8126-2018	Barbieri, Silvia Stella/0000-0002-7486-2637; Amadio, Patrizia/0000-0002-7439-2778; TREMOLI, ELENA/0000-0002-0929-6106	Reti [FIRB-2005-RBPR05NWWC]	Reti	The authors are grateful to Dr. A. Ieraci and Dr. D. Baldassarre for useful comments after reading this manuscript. This work was supported by Reti FIRB-2005-RBPR05NWWC.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Barbieri SS, 2008, ARTERIOSCL THROM VAS, V28, P732, DOI 10.1161/ATVBAHA.107.159434; Barbieri SS, 2007, FASEB J, V21, P1831, DOI 10.1096/fj.06-7557com; Barbieri SS, 2004, FREE RADICAL BIO MED, V37, P156, DOI 10.1016/j.freeradbiomed.2004.04.020; Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Castro P, 2004, EUR J PHARMACOL, V498, P279, DOI 10.1016/j.ejphar.2004.07.047; Chang TC, 2005, J BIOL CHEM, V280, P36567, DOI 10.1074/jbc.M504280200; Chattopadhyay M, 2010, J PHARMACOL EXP THER, V335, P443, DOI 10.1124/jpet.110.171017; Cheng SE, 2010, FREE RADICAL BIO MED, V48, P1410, DOI 10.1016/j.freeradbiomed.2010.02.026; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Chung KF, 2004, NEW ENGL J MED, V351, P1459; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1925, DOI 10.1161/01.ATV.0000177814.41505.41; Csiszar A, 2009, FRONT BIOSCI-LANDMRK, V14, P3128, DOI 10.2741/3440; Cyrus T, 2010, ATHEROSCLEROSIS, V208, P376, DOI 10.1016/j.atherosclerosis.2009.08.008; Dworakowski R, 2008, PHARMACOL REP, V60, P21; Ekberg-Jansson A, 2001, RESP MED, V95, P363, DOI 10.1053/rmed.2001.1050; Gross ND, 2005, CLIN CANCER RES, V11, P6087, DOI 10.1158/1078-0432.CCR-05-0733; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; Keith RL, 2004, CANCER RES, V64, P5897, DOI 10.1158/0008-5472.CAN-04-1070; Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977; Lau PP, 2006, ARTERIOSCL THROM VAS, V26, P143, DOI 10.1161/01.ATV.0000193510.19000.10; Lin CC, 2010, FREE RADICAL BIO MED, V48, P240, DOI 10.1016/j.freeradbiomed.2009.10.047; Mahfouz M, 2006, J ENVIRON PATHOL TOX, V25, P585, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i3.30; MONCADA S, 1981, CLIN RES PROC, V17, P687; Muzaffar S, 2004, CIRCULATION, V110, P1140, DOI 10.1161/01.CIR.0000139851.50067.E4; Nana-Sinkam SP, 2007, AM J RESP CRIT CARE, V175, P676, DOI 10.1164/rccm.200605-724OC; Niu XL, 2010, CIRCULATION, V121, P549, DOI 10.1161/CIRCULATIONAHA.109.908319; Oda K, 2007, HUM MOL GENET, V16, P592, DOI 10.1093/hmg/ddl483; Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, pH130, DOI 10.1152/ajpheart.00599.2006; Pauwels NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-134; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; REINDERS JH, 1986, ARTERIOSCLEROSIS, V6, P15, DOI 10.1161/01.ATV.6.1.15; Ryder MI, 2002, ORAL MICROBIOL IMMUN, V17, P331, DOI 10.1034/j.1399-302X.2002.170601.x; Schmidt P, 2003, J BIOL CHEM, V278, P12813, DOI 10.1074/jbc.M208080200; Shin VY, 2004, TOXICOL APPL PHARM, V195, P103, DOI 10.1016/j.taap.2003.10.009; UMEKI S, 1994, INT J BIOCHEM, V26, P1003, DOI 10.1016/0020-711X(94)90071-X; Vendrov AE, 2007, ARTERIOSCL THROM VAS, V27, P2714, DOI 10.1161/ATVBAHA.107.152629; Wang M, 2008, J INTERN MED, V263, P500, DOI 10.1111/j.1365-2796.2008.01938.x; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Wu KK, 1996, ANNU REV MED, V47, P315; Zou MH, 2000, ARCH BIOCHEM BIOPHYS, V376, P149, DOI 10.1006/abbi.2000.1699; Zou MH, 1997, BIOL CHEM, V378, P707, DOI 10.1515/bchm.1997.378.7.707	43	13	15	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3731	3740		10.1096/fj.11-181776	http://dx.doi.org/10.1096/fj.11-181776			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21737615				2022-12-25	WOS:000295356400041
J	Oberg, F; Sjohamn, J; Fischer, G; Moberg, A; Pedersen, A; Neutze, R; Hedfalk, K				Oberg, Fredrik; Sjohamn, Jennie; Fischer, Gerhard; Moberg, Andreas; Pedersen, Anders; Neutze, Richard; Hedfalk, Kristina			Glycosylation Increases the Thermostability of Human Aquaporin 10 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; METHYLOTROPHIC YEAST; SURFACE EXPRESSION; EPITHELIAL-CELLS; WATER; STABILITY; OLIGOSACCHARIDES; GLYCEROL; CHANNEL; BINDING	Human aquaporin10 (hAQP10) is a transmembrane facilitator of both water and glycerol transport in the small intestine. This aquaglyceroporin is located in the apical membrane of enterocytes and is believed to contribute to the passage of water and glycerol through these intestinal absorptive cells. Here we overproduced hAQP10 in the yeast Pichia pastoris and observed that the protein is glycosylated at Asn-133 in the extracellular loop C. This finding confirms one of three predicted glycosylation sites for hAQP10, and its glycosylation is unique for the human aquaporins overproduced in this host. Nonglycosylated protein was isolated using both glycan affinity chromatography and through mutating asparagine 133 to a glutamine. All three forms of hAQP10 where found to facilitate the transport of water, glycerol, erythritol, and xylitol, and glycosylation had little effect on functionality. In contrast, glycosylated hAQP10 showed increased thermostability of 3-6 degrees C compared with the nonglycosylated protein, suggesting a stabilizing effect of the N-linked glycan. Because only one third of hAQP10 was glycosylated yet the thermostability titration was mono-modal, we suggest that the presence of at least one glycosylated protein within each tetramer is sufficient to convey an enhanced structural stability to the remaining hAQP10 protomers of the tetramer.	[Oberg, Fredrik; Sjohamn, Jennie; Fischer, Gerhard; Moberg, Andreas; Neutze, Richard; Hedfalk, Kristina] Univ Gothenburg, Dept Chem Biochem, SE-40530 Gothenburg, Sweden; [Pedersen, Anders] Univ Gothenburg, Swedish NMR Ctr, SE-40530 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Hedfalk, K (corresponding author), Univ Gothenburg, Dept Chem Biochem, POB 462, SE-40530 Gothenburg, Sweden.	kristina.hedfalk@chem.gu.se	Öberg, Fredrik Kryh/B-1241-2011; Sjöhamn, Jennie/A-8266-2011; Hedfalk, Kristina/A-8244-2010; Neutze, Richard/A-7573-2010; Fischer, Gerhard/B-2900-2011; Pedersen, Anders/N-3888-2014	Öberg, Fredrik Kryh/0000-0002-7089-2118; Neutze, Richard/0000-0003-0986-6153; Fischer, Gerhard/0000-0001-9861-1528; Pedersen, Anders/0000-0001-8704-5129; Sjohamn, Jennie/0000-0001-9360-6279	Swedish Science Research Council; European Commission; Integrated Project EDICT	Swedish Science Research Council; European Commission(European CommissionEuropean Commission Joint Research Centre); Integrated Project EDICT	This work was supported by the Swedish Science Research Council, the European Commission Marie Curie Training Network Aquaglyceroporins, and the Integrated Project EDICT.	Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; ATKINSON PH, 1984, J CELL BIOL, V98, P2245, DOI 10.1083/jcb.98.6.2245; Beitz E, 2004, P NATL ACAD SCI USA, V101, P1153, DOI 10.1073/pnas.0307295101; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; Branden M, 2010, BIOPHYS J, V99, P124, DOI 10.1016/j.bpj.2010.03.059; Buck E, 2002, METHOD ENZYMOL, V344, P513; Buck TM, 2004, AM J PHYSIOL-CELL PH, V287, pC1292, DOI 10.1152/ajpcell.00561.2003; CREIGHTON TE, 1997, PROTEIN STRUCTURE PR, P268; ELBEIN AD, 1991, TRENDS BIOTECHNOL, V9, P346, DOI 10.1016/0167-7799(91)90117-Z; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; GRINNA LS, 1989, YEAST, V5, P107, DOI 10.1002/yea.320050206; Hamilton SR, 2003, SCIENCE, V301, P1244, DOI 10.1126/science.1088166; Hatakeyama S, 2001, BIOCHEM BIOPH RES CO, V287, P814, DOI 10.1006/bbrc.2001.5661; Heymann JB, 1998, J STRUCT BIOL, V121, P191, DOI 10.1006/jsbi.1997.3951; Horsefield R, 2008, P NATL ACAD SCI USA, V105, P13327, DOI 10.1073/pnas.0801466105; Invitrogen, 2002, PICH FERM PROC GUID; Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7; ISHIMURA K, 1984, CELL TISSUE RES, V238, P653; ITO S, 1974, PHILOS T ROY SOC B, V268, P55, DOI 10.1098/rstb.1974.0015; JAMIESON JD, 1968, J CELL BIOL, V39, P589, DOI 10.1083/jcb.39.3.589; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Keller P, 1997, J CELL SCI, V110, P3001; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khanna R, 2001, J BIOL CHEM, V276, P34028, DOI 10.1074/jbc.M105248200; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; Li HP, 2005, BIOL CELL, V97, P823, DOI 10.1042/BC20040091; LIS H, 1993, EUR J BIOCHEM, V218, P1, DOI 10.1111/j.1432-1033.1993.tb18347.x; LISANTI MP, 1990, J MEMBRANE BIOL, V113, P155, DOI 10.1007/BF01872889; Marshall R D, 1974, Biochem Soc Symp, P17; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P153, DOI 10.1016/B978-012491543-5/50013-9; Mobasheri A, 2004, HISTOCHEM CELL BIOL, V121, P463, DOI 10.1007/s00418-004-0657-1; MORRISET.JD, 1973, BIOCHEMISTRY-US, V12, P1290, DOI 10.1021/bi00731a008; Munro IC, 1998, FOOD CHEM TOXICOL, V36, P1139, DOI 10.1016/S0278-6915(98)00091-X; Nakagawa H, 2009, FEBS J, V276, P7237, DOI 10.1111/j.1742-4658.2009.07423.x; Newby Zachary E R, 2008, Nat Struct Mol Biol, V15, P619, DOI 10.1038/nsmb.1431; Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007; Oberg F, 2009, MOL MEMBR BIOL, V26, P215, DOI 10.1080/09687680902862085; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pfeil W, 2002, THERMOCHIM ACTA, V382, P169, DOI 10.1016/S0040-6031(01)00727-4; Sato Y, 2010, GERIATR GERONTOL INT, V10, pS32, DOI 10.1111/j.1447-0594.2010.00602.x; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tornroth-Horsefield S, 2010, FEBS LETT, V584, P2580, DOI 10.1016/j.febslet.2010.04.037; TRIMBLE RB, 1991, J BIOL CHEM, V266, P22807; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; VOET D, 2004, BIOCHEMISTRY-US, P369; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	57	44	49	0	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31915	31923		10.1074/jbc.M111.242677	http://dx.doi.org/10.1074/jbc.M111.242677			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21733844	hybrid, Green Published			2022-12-25	WOS:000294487500084
J	McDougall, WM; Okany, C; Smith, HC				McDougall, William M.; Okany, Chinelo; Smith, Harold C.			Deaminase Activity on Single-stranded DNA (ssDNA) Occurs in Vitro when APOBEC3G Cytidine Deaminase Forms Homotetramers and Higher-order Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FUNCTIONAL IMPLICATIONS; SOMATIC HYPERMUTATION; CATALYTIC DOMAIN; EDITING FACTORS; HIV-1 VIRIONS; RNA; RESTRICTION; MODEL; IDENTIFICATION	APOBEC3G (A3G) is a cytidine deaminase that catalyzes deamination of deoxycytidine (dC) on single-stranded DNA (ssDNA). The oligomeric state of A3G required to support deaminase activity remains unknown. We show under defined in vitro conditions that full-length and native A3G formed complexes with ssDNA in an A3G concentration-dependent but temperature-independent manner. Complexes assembled and maintained at 4 C did not have significant deaminase activity, but their enzymatic function could be restored by subsequent incubation at 37 C. This approach enabled complexes of a defined size range to be isolated and subsequently evaluated for their contribution to enzymatic activity. The composition of A3G bound to ssDNA was determined by protein-protein chemical cross-linking. A3G-ssDNA complexes of 16 S were necessary for deaminase activity and consisted of cross-linked A3G homotetramers and homodimers. At lower concentrations, A3G only formed 5.8 S homodimers on ssDNA with low deaminase activity. Monomeric A3G was not identified in 5.8 S or 16 S complexes. We propose that deaminase-dependent antiviral activity of A3G in vivo may require a critical concentration of A3G in viral particles that will promote oligomerization on ssDNA during reverse transcription.	[McDougall, William M.; Okany, Chinelo; Smith, Harold C.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [McDougall, William M.; Smith, Harold C.] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA; [Smith, Harold C.] Univ Rochester, Med Ctr, Ctr Canc, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Smith, HC (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	harold.smith@rochester.edu		Smith, Harold/0000-0001-6257-6791	Bill and Melinda Gates foundation; National Institutes of Health Developmental Center for AIDS (NIAID) [P30 078498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110119] Funding Source: NIH RePORTER	Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); National Institutes of Health Developmental Center for AIDS (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Bill and Melinda Gates foundation Grand Challenges in Exploration grant awarded (to H. C. S.) and by a National Institutes of Health Developmental Center for AIDS Research grant (NIAID Grant P30 078498) awarded to Steve Dewhurst.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; HARRIS SG, 1988, BIOCHEMISTRY-US, V27, P4595, DOI 10.1021/bi00413a002; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Khan MA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-48; MACELREVEY C, 2008, RNA DNA EDITING MOL, P369; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Salter JD, 2009, BIOCHEMISTRY-US, V48, P10685, DOI 10.1021/bi901642c; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Smith H., 2010, DNA RNA MODIFICATION, P181; Smith HC, 2007, METHOD ENZYMOL, V424, P389, DOI 10.1016/S0076-6879(07)24018-2; Smith HC, 2011, TRENDS BIOCHEM SCI, V36, P239, DOI 10.1016/j.tibs.2010.12.003; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Sowden MP, 2002, J CELL SCI, V115, P1027; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758	40	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30655	30661		10.1074/jbc.M111.269506	http://dx.doi.org/10.1074/jbc.M111.269506			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737457	Green Published, hybrid			2022-12-25	WOS:000294283600045
J	Molitoris, JK; McColl, KS; Swerdlow, S; Matsuyama, M; Lam, M; Finkel, TH; Matsuyama, S; Distelhorst, CW				Molitoris, Jason K.; McColl, Karen S.; Swerdlow, Sarah; Matsuyama, Mieko; Minh Lam; Finkel, Terri H.; Matsuyama, Shigemi; Distelhorst, Clark W.			Glucocorticoid Elevation of Dexamethasone-induced Gene 2 (Dig2/RTP801/REDD1) Protein Mediates Autophagy in Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; INDUCED APOPTOSIS; INOSITOL 1,4,5-TRISPHOSPHATE; OLIGONUCLEOTIDE ARRAYS; RAPAMYCIN PATHWAY; MAMMALIAN TARGET; LYMPHOMA-CELLS; INHIBITION; EXPRESSION; BCL-2	Glucocorticoid hormones, including dexamethasone, induce apoptosis in lymphocytes and consequently are used clinically as chemotherapeutic agents in many hematologic malignancies. Dexamethasone also induces autophagy in lymphocytes, although the mechanism is not fully elucidated. Through gene expression analysis, we found that dexamethasone induces the expression of a gene encoding a stress response protein variously referred to as Dig2, RTP801, or REDD1. This protein is reported to inhibit mammalian target of rapamycin (mTOR) signaling. Because autophagy is one outcome of mTOR inhibition, we investigated the hypothesis that Dig2/RTP801/REDD1 elevation contributes to autophagy induction in dexamethasone-treated lymphocytes. In support of this hypothesis, RNAi-mediated suppression of Dig2/RTP801/REDD1 reduces mTOR inhibition and autophagy in glucocorticoid-treated lymphocytes. We observed similar results in Dig2/Rtp801/Redd1 knock-out murine thymocytes treated with dexamethasone. Dig2/RTP801/REDD1 knockdown also leads to increased levels of dexamethasone-induced cell death, suggesting that Dig2/RTP801/REDD1-mediated autophagy promotes cell survival. Collectively, these findings demonstrate for the first time that elevation of Dig2/RTP801/REDD1 contributes to the induction of autophagy.	[Distelhorst, Clark W.] Case Western Reserve Univ, Div Hematol Oncol, Ctr Comprehens Canc, Dept Med, Cleveland, OH 44106 USA; [Molitoris, Jason K.; Swerdlow, Sarah] Case Western Reserve Univ, Ctr Comprehens Canc, Dept Pathol, Cleveland, OH 44106 USA; [Minh Lam] Case Western Reserve Univ, Ctr Comprehens Canc, Dept Dermatol, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Finkel, Terri H.] Univ Penn, Sch Med, Div Rheumatol, Dept Pediat, Philadelphia, PA 19104 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Pennsylvania	Distelhorst, CW (corresponding author), Case Western Reserve Univ, Div Hematol Oncol, Ctr Comprehens Canc, Dept Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	cwd@case.edu			National Institutes of Health [RO1 CA42755, CA85804, RO1 AG031903, T32HL007147, T32 GM007250]; Ohio Center for Innovative Immunosuppressive Therapeutics; NATIONAL CANCER INSTITUTE [R01CA042755, R01CA085804] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031903] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Center for Innovative Immunosuppressive Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA42755 and CA85804 (to C. W. D.), RO1 AG031903 (to S. M.), T32HL007147 (to S. J. S. and J. K. M.), and T32 GM007250 (to J. K. M.). This work was also supported in part by an Ohio Center for Innovative Immunosuppressive Therapeutics grant.	Abrams MT, 2004, J BIOL CHEM, V279, P55809, DOI 10.1074/jbc.M411767200; BAXTER JD, 1971, P NATL ACAD SCI USA, V68, P932, DOI 10.1073/pnas.68.5.932; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Bowen DA, 2007, LEUKEMIA LYMPHOMA, V48, P2412, DOI 10.1080/10428190701724801; Brafman A, 2004, INVEST OPHTH VIS SCI, V45, P3796, DOI 10.1167/iovs.04-0052; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chauhan D, 2002, ONCOGENE, V21, P1346, DOI 10.1038/sj.onc.1205205; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Davis MC, 2008, J BIOL CHEM, V283, P10357, DOI 10.1074/jbc.M800269200; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; Dougherty Thomas F., 1943, SCIENCE, V98, P367, DOI 10.1126/science.98.2547.367; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Gaynon PS, 1999, ADV EXP MED BIOL, V457, P593; Harr MW, 2010, AUTOPHAGY, V6, P912, DOI 10.4161/auto.6.7.13290; HENCH PS, 1949, P STAFF M MAYO CLIN, V24, P181; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Laane E, 2009, CELL DEATH DIFFER, V16, P1018, DOI 10.1038/cdd.2009.46; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Medh RD, 2003, GENOMICS, V81, P543, DOI 10.1016/S0888-7543(03)00045-4; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Molitoris JK, 2011, MOL ENDOCRINOL, V25, P409, DOI 10.1210/me.2010-0402; Obexer P, 2001, ONCOGENE, V20, P4324, DOI 10.1038/sj.onc.1204573; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; PEARSON OH, 1949, CANCER, V2, P943, DOI 10.1002/1097-0142(194911)2:6<943::AID-CNCR2820020602>3.0.CO;2-P; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reed J C, 1996, Cancer Treat Res, V84, P31; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schmidt S, 2006, BLOOD, V107, P2061, DOI 10.1182/blood-2005-07-2853; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; SIBLEY CH, 1974, CELL, V2, P213, DOI 10.1016/0092-8674(74)90013-0; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Swerdlow S, 2008, AUTOPHAGY, V4, P612, DOI 10.4161/auto.5920; Tissing WJE, 2007, BLOOD, V109, P3929, DOI 10.1182/blood-2006-11-056366; Tonko M, 2001, FASEB J, V15, P693, DOI 10.1096/fj.00-0327com; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Wang ZQ, 2003, J BIOL CHEM, V278, P23861, DOI 10.1074/jbc.M301843200; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAMAMOTO KR, 1974, P NATL ACAD SCI USA, V71, P3901, DOI 10.1073/pnas.71.10.3901; Yoshida NL, 2002, BIOCHEM BIOPH RES CO, V293, P1254; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	52	73	76	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30181	30189		10.1074/jbc.M111.245423	http://dx.doi.org/10.1074/jbc.M111.245423			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21733849	Green Published, hybrid			2022-12-25	WOS:000294046600075
J	Tu, CY; Chen, TJ; Chou, LF				Tu, Chun-Yi; Chen, Tzeng-Ji; Chou, Li-Fang			Application of Frequent Itemsets Mining to Analyze Patterns of One-Stop Visits in Taiwan	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; CHRONIC DISEASE; PRESCRIPTIONS; PREVALENCE; CARE	Background: The free choice of health care facilities without limitations on frequency of visits within the National Health Insurance in Taiwan gives rise to not only a high number of annual ambulatory visits per capita but also a unique "one-stop shopping'' phenomenon, which refers to a patient' visits to several specialties of the same healthcare facility in one day. The visits to multiple physicians would increase the potential risk of polypharmacy. The aim of this study was to analyze the frequency and patterns of one-stop visits in Taiwan. Methodology/Principal Findings: The claims datasets of 1 million nationally representative people within Taiwan's National Health Insurance in 2005 were used to calculate the number of patients with one-stop visits. The frequent itemsets mining was applied to compute the combination patterns of specialties in the one-stop visits. Among the total 13,682,469 ambulatory care visits in 2005, one-stop visits occurred 144,132 times and involved 296,822 visits (2.2% of all visits) by 66,294 (6.6%) persons. People tended to have this behavior with age and the percentage reached 27.5% (5,662 in 20,579) in the age group >= 80 years. In general, women were more likely to have one-stop visits than men (7.2% vs. 6.0%). Internal medicine plus ophthalmology was the most frequent combination with a visited frequency of 3,552 times (2.5%), followed by cardiology plus neurology with 3,183 times (2.2%). The most frequent three-specialty combination, cardiology plus neurology and gastroenterology, occurred only 111 times. Conclusions/Significance: Without the novel computational technique, it would be hardly possible to analyze the extremely diverse combination patterns of specialties in one-stop visits. The results of the study could provide useful information either for the hospital manager to set up integrated services or for the policymaker to rebuild the health care system.	[Tu, Chun-Yi; Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan; [Tu, Chun-Yi] Taoyuan Vet Hosp, Dept Family Med, Tao Yuan, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chou, Li-Fang] Natl Chengchi Univ, Dept Publ Finance, Taipei 11623, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Chengchi University	Tu, CY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Hosp & Hlth Care Adm, Taipei 112, Taiwan.	tjchen@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021		National Science Council [NSC 96-2416-H-004-007-MY2]; Taipei Veterans General Hospital [V98S2-006]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This study was supported by grants from the National Science Council (NSC 96-2416-H-004-007-MY2) and the Taipei Veterans General Hospital (V98S2-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, ACM SIGMOD RECORD, V22, P207, DOI DOI 10.1145/170035.170072; Berry M, 1997, DATA MINING TECHNIQU; Birns J, 2006, AGE AGEING, V35, P306, DOI 10.1093/ageing/afj057; Chen FP, 2008, J ETHNOPHARMACOL, V117, P84, DOI 10.1016/j.jep.2008.01.018; Chen TJ, 2003, CLIN THER, V25, P2453, DOI 10.1016/S0149-2918(03)80287-4; Chen TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-54; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Han J, 2006, DATA MINING CONCEPTS, DOI 10.1016/C2009-0-61819-5; Jackson Jane, 2009, Nurs Manag (Harrow), V15, P24; Kung YY, 2006, ALLERGY, V61, P1316, DOI 10.1111/j.1398-9995.2006.01152.x; Liu ZR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-394; Marengoni A, 2009, J AM GERIATR SOC, V57, P225, DOI 10.1111/j.1532-5415.2008.02109.x; Naughton C, 2006, AGE AGEING, V35, P633, DOI 10.1093/ageing/afl106; Nguyen Thach, 2005, J Interv Cardiol, V18, P107, DOI 10.1111/j.1540-8183.2005.4046a.x; Reid MJ, 2009, ANN ROY COLL SURG, V91, P301, DOI 10.1308/003588409X391910; ROMANO M, 2002, MODERN HEALTHCARE, V32, P32; Tamblyn RM, 1996, CAN MED ASSOC J, V154, P1177; 1996, ED MANAG, V8, P40	19	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e14824	10.1371/journal.pone.0014824	http://dx.doi.org/10.1371/journal.pone.0014824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786HC	21747926	gold, Green Submitted, Green Published			2022-12-25	WOS:000292293400001
J	Grant, AJ; Dickens, JC				Grant, Alan J.; Dickens, Joseph C.			Functional Characterization of the Octenol Receptor Neuron on the Maxillary Palps of the Yellow Fever Mosquito, Aedes aegypti	PLOS ONE			English	Article							ODORANT RECEPTOR; CARBON-DIOXIDE; CULEX-QUINQUEFASCIATUS; 1-OCTEN-3-OL; IDENTIFICATION; ATTRACTANT; PHEROMONE; RESPONSES; SENSILLA; DIPTERA	Background: 1-Octen-3-ol (octenol) is a common attractant released by vertebrates which in combination with carbon dioxide (CO2) attracts hematophagous arthropods including mosquitoes. A receptor neuron contained within basiconic sensilla on the maxillary palps of adult mosquitoes responds selectively to 1-octen-3-ol. Recently, an odorant receptor (AaegOR8) known to occur on the maxillary palps was expressed in a heterologous system and demonstrated to be selectively sensitive to (R)-(-)-1-octen-3-ol, one of two enantiomeric forms. Lesser responses were elicited by stimulation with the (S)-enantiomer and various structural analogs. Methodology/Principal Findings: Here we characterize the specificity of the octenol receptor neuron in the yellow fever mosquito, Aedes aegypti (L.), in vivo using single cell recordings. The octenol neuron is exquisitely sensitive to (R)-(-)-1-octen-3-ol; comparable responses to (S)-(+)-1-octen-3-ol were elicited only at stimulus doses over 100x that required for the (R)-enantiomer. An intermediate response closer to that elicited by the (R)-(-)-enantiomer was elicited by racemic 1-octen-3-ol. Small structural changes in (R)-(-)-1-octen-3-ol resulted in large decreases in responses. Increases in spike activity were also elicited in the octenol neuron by 2-undecanone, a known repellent; other repellents (DEET, IR3535 and picaridin) were inactive. Conclusions/Significance: The results of our electrophysiological studies of the octenol receptor neuron in vivo approximates results of a previous study of the octenol receptor (AaegOR8 with its obligate partner Aaeg\ORco) expressed heterologously in Xenopus oocytes. By comparison of our current results with those of the heterologous expression study, we conclude that specificity of the octenol receptor neuron can be explained largely by characteristics of the OR alone without other associated proteins present in vivo. Our findings show that repellents may have specific stimulatory effects on receptor neurons and support the notion of repellents as modulators of mosquito odorant receptor activity.	[Grant, Alan J.; Dickens, Joseph C.] ARS, Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci,USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Grant, AJ (corresponding author), ARS, Invas Insect Biocontrol & Behav Lab, Henry A Wallace Beltsville Agr Res Ctr, Inst Plant Sci,USDA, Beltsville, MD USA.	joseph.dickens@ars.usda.gov	Dickens, Dick/AGY-7295-2022		US Department of Defense through the Armed Forces Pest Management Board (AFPMB)	US Department of Defense through the Armed Forces Pest Management Board (AFPMB)(United States Department of Defense)	This work was supported in part by a grant to JCD from the Deployed War Fighter Protection (DWFP) Research Program, funded by the US Department of Defense through the Armed Forces Pest Management Board (AFPMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell A, 1996, PHYSIOL ENTOMOL, V21, P15, DOI 10.1111/j.1365-3032.1996.tb00830.x; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Bohbot JD, 2010, ECOL CONT VECTOR-BOR, V2, P17; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Bohbot JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007032; Debboun M, 2007, INSECT REPELLENTS PR; DICKENS JC, 1990, CHEM SENSES, V15, P311, DOI 10.1093/chemse/15.3.311; DICKENS JC, 1978, ENTOMOL EXP APPL, V24, P336, DOI 10.1007/BF02385082; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; FRENCH FE, 1989, J MED ENTOMOL, V26, P459, DOI 10.1093/jmedent/26.5.459; Grant AJ, 1996, CIBA F SYMP, V200, P233; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Grant AJ, 2010, ECOL CONT VECTOR-BOR, V2, P91; HALL DR, 1984, INSECT SCI APPL, V5, P335, DOI 10.1017/S1742758400008626; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kline DL, 2007, MED VET ENTOMOL, V21, P323, DOI 10.1111/j.1365-2915.2007.00697.x; KLINE DL, 1994, MED VET ENTOMOL, V8, P25, DOI 10.1111/j.1365-2915.1994.tb00379.x; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MCIVER SB, 1982, J MED ENTOMOL, V19, P489, DOI 10.1093/jmedent/19.5.489; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; TAKKEN W, 1989, J AM MOSQUITO CONTR, V5, P311; TUMLINSON JH, 1977, SCIENCE, V197, P789, DOI 10.1126/science.197.4305.789; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; Xia YF, 2006, INSECT BIOCHEM MOLEC, V36, P169, DOI 10.1016/j.ibmb.2005.12.003; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x	28	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21785	10.1371/journal.pone.0021785	http://dx.doi.org/10.1371/journal.pone.0021785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738794	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800045
J	Hsieh, M; Thao, K; Conti, M				Hsieh, Minnie; Kao Thao; Conti, Marco			Genetic Dissection of Epidermal Growth Factor Receptor Signaling during Luteinizing Hormone-Induced Oocyte Maturation	PLOS ONE			English	Article							GRANULOSA-CELLS; MEIOTIC ARREST; MOUSE OOCYTES; DEPENDENT ACTIVATION; FOLLICLE DEVELOPMENT; RODENT OOCYTES; CYCLIC-GMP; G-PROTEIN; CUMULUS; EXPRESSION	Recent evidence that luteinizing hormone (LH) stimulation of ovulatory follicles causes transactivation of the epidermal growth factor receptor (EGFR) has provided insights into the mechanisms of ovulation. However, the complete array of signals that promote oocyte reentry into the meiotic cell cycle in the follicle are still incompletely understood. To elucidate the signaling downstream of EGFR involved in oocyte maturation, we have investigated the LH responses in granulosa cells with targeted ablation of EGFR. Oocyte maturation and ovulation is disrupted when EGFR expression is progressively reduced. In granulosa cells from mice with either global or granulosa cell-specific disruption of EGFR signaling, LH-induced phosphorylation of MAPK3/1, p38MAPK, and connexin-43 is impaired. Although the LH-induced decrease in cGMP is EGFR-dependent in wild type follicles, LH still induces a decrease in cGMP in Egfr(delta/f) Cyp19-Cre follicles. Thus compensatory mechanisms appear activated in the mutant. Spatial propagation of the LH signal in the follicle also is dependent on the EGF network, and likely is important for the control of signaling to the oocyte. Thus, multiple signals and redundant pathways contribute to regulating oocyte reentry into the cell cycle.	[Hsieh, Minnie; Kao Thao; Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Hsieh, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	ContiM@obgyn.ucsf.edu			NIH [1RO1HD052909, RO1GM08527, R01HD052909]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052909] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work done in the authors' laboratory was supported by NIH 1RO1HD052909 and RO1GM08527. This work was also supported by NIH R01HD052909 to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM A, 1975, J CELL BIOL, V67, P894, DOI 10.1083/jcb.67.3.894; Andric N, 2008, ENDOCRINOLOGY, V149, P5549, DOI 10.1210/en.2008-0618; Andric N, 2010, MOL ENDOCRINOL, V24, P552, DOI 10.1210/me.2009-0450; Ashkenazi H, 2005, ENDOCRINOLOGY, V146, P77, DOI 10.1210/en.2004-0588; Conti M, 2002, BIOL REPROD, V67, P1653, DOI 10.1095/biolreprod.102.004952; DOWNS SM, 1988, J EXP ZOOL, V245, P86, DOI 10.1002/jez.1402450113; EDWARDS RG, 1965, NATURE, V208, P349, DOI 10.1038/208349a0; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Eppig John J., 1993, P185; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Hinckley M, 2005, DEV BIOL, V287, P249, DOI 10.1016/j.ydbio.2005.08.019; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Horner K, 2003, DEV BIOL, V258, P385, DOI 10.1016/S0012-1606(03)00134-9; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; HUBBARD CJ, 1982, BIOL REPROD, V26, P628, DOI 10.1095/biolreprod26.4.628; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; LEUNG PCK, 1992, ENDOCR REV, V13, P476, DOI 10.1210/er.13.3.476; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Norris RP, 2008, DEVELOPMENT, V135, P3229, DOI 10.1242/dev.025494; Norris RP, 2010, REPRODUCTION, V140, P655, DOI 10.1530/REP-10-0288; Norris RP, 2009, DEVELOPMENT, V136, P1869, DOI 10.1242/dev.035238; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; PENG XR, 1991, ENDOCRINOLOGY, V129, P3200, DOI 10.1210/endo-129-6-3200; Pincus G, 1935, J EXP MED, V62, P655; Prevot V, 2005, ENDOCRINOLOGY, V146, P1465, DOI 10.1210/en.2004-1146; Reizel Y, 2010, MOL ENDOCRINOL, V24, P402, DOI 10.1210/me.2009-0267; Richard FJ, 2001, BIOL REPROD, V65, P1444, DOI 10.1095/biolreprod65.5.1444; RICHARDS JS, 1994, ENDOCR REV, V15, P725, DOI 10.1210/er.15.6.725; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Sekiguchi T, 2004, J MOL ENDOCRINOL, V33, P281, DOI 10.1677/jme.0.0330281; Sela-Abramovich S, 2006, ENDOCRINOLOGY, V147, P2280, DOI 10.1210/en.2005-1011; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Su YQ, 2003, DEV BIOL, V263, P126, DOI 10.1016/S0012-1606(03)00437-8; TORNELL J, 1984, ACTA PHYSIOL SCAND, V122, P507, DOI 10.1111/j.1748-1716.1984.tb07539.x; TORNELL J, 1990, ACTA PHYSIOL SCAND, V139, P511, DOI 10.1111/j.1748-1716.1990.tb08953.x; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; Tsafriri A., 1994, MOL BIOL FEMALE REPR, P207; Vaccari S, 2009, BIOL REPROD, V81, P595, DOI 10.1095/biolreprod.109.077768; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	44	75	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21574	10.1371/journal.pone.0021574	http://dx.doi.org/10.1371/journal.pone.0021574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738714	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800023
J	Kim, C; Ahmed, JA; Eidex, RB; Nyoka, R; Waiboci, LW; Erdman, D; Tepo, A; Mahamud, AS; Kabura, W; Nguhi, M; Muthoka, P; Burton, W; Breiman, RF; Njenga, MK; Katz, MA				Kim, Curi; Ahmed, Jamal A.; Eidex, Rachel B.; Nyoka, Raymond; Waiboci, Lilian W.; Erdman, Dean; Tepo, Adan; Mahamud, Abdirahman S.; Kabura, Wamburu; Nguhi, Margaret; Muthoka, Philip; Burton, Wagacha; Breiman, Robert F.; Njenga, M. Kariuki; Katz, Mark A.			Comparison of Nasopharyngeal and Oropharyngeal Swabs for the Diagnosis of Eight Respiratory Viruses by Real-Time Reverse Transcription-PCR Assays	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CHILDREN; INFECTIONS; SPECIMENS; H5N1	Background: Many acute respiratory illness surveillance systems collect and test nasopharyngeal (NP) and/or oropharyngeal (OP) swab specimens, yet there are few studies assessing the relative measures of performance for NP versus OP specimens. Methods: We collected paired NP and OP swabs separately from pediatric and adult patients with influenza-like illness or severe acute respiratory illness at two respiratory surveillance sites in Kenya. The specimens were tested for eight respiratory viruses by real-time reverse transcription-polymerase chain reaction (qRT-PCR). Positivity for a specific virus was defined as detection of viral nucleic acid in either swab. Results: Of 2,331 paired NP/OP specimens, 1,402 (60.1%) were positive for at least one virus, and 393 (16.9%) were positive for more than one virus. Overall, OP swabs were significantly more sensitive than NP swabs for adenovirus (72.4% vs. 57.6%, p < 0.01) and 2009 pandemic influenza A (H1N1) virus (91.2% vs. 70.4%, p < 0.01). NP specimens were more sensitive for influenza B virus (83.3% vs. 61.5%, p = 0.02), parainfluenza virus 2 (85.7%, vs. 39.3%, p < 0.01), and parainfluenza virus 3 (83.9% vs. 67.4%, p < 0.01). The two methods did not differ significantly for human metapneumovirus, influenza A (H3N2) virus, parainfluenza virus 1, or respiratory syncytial virus. Conclusions: The sensitivities were variable among the eight viruses tested; neither specimen was consistently more effective than the other. For respiratory disease surveillance programs using qRT-PCR that aim to maximize sensitivity for a large number of viruses, collecting combined NP and OP specimens would be the most effective approach.	[Kim, Curi; Erdman, Dean] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Ahmed, Jamal A.; Eidex, Rachel B.; Nyoka, Raymond; Waiboci, Lilian W.; Tepo, Adan; Mahamud, Abdirahman S.; Breiman, Robert F.; Njenga, M. Kariuki; Katz, Mark A.] Ctr Dis Control & Prevent Kenya, Nairobi, Kenya; [Kabura, Wamburu] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Nguhi, Margaret] Int Rescue Comm, Nairobi, Kenya; [Muthoka, Philip] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Burton, Wagacha] United Nations High Commissioner Refugees, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Kim, C (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA USA.	mkatz@ke.cdc.gov						Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Covalciuc KA, 1999, J CLIN MICROBIOL, V37, P3971, DOI 10.1128/JCM.37.12.3971-3974.1999; Echavarria M., 2009, Principles and practice of clinical virology, P463, DOI 10.1002/9780470741405.ch19; Guarner J, 2009, ARCH MED RES, V40, P655, DOI 10.1016/j.arcmed.2009.10.001; Healing T., 2006, COLL PRES SHIPP SPEC; Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003; HERNES S, 2010, EUR J CLIN MICROBIOL; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lieberman D, 2009, J CLIN MICROBIOL, V47, P3439, DOI 10.1128/JCM.00886-09; Loens K, 2009, J CLIN MICROBIOL, V47, P21, DOI 10.1128/JCM.02037-08; Meerhoff TJ, 2010, EUR J CLIN MICROBIOL, V29, P365, DOI 10.1007/s10096-009-0865-7; de la Tabla VO, 2010, J CLIN MICROBIOL, V48, P3492, DOI 10.1128/JCM.01105-10; Robinson JL, 2008, CLIN INFECT DIS, V46, pE61, DOI 10.1086/529386; Sung RYT, 2008, J CLIN MICROBIOL, V46, P3073, DOI 10.1128/JCM.01209-08; *US CDCP, 2009, CDC PROT REALT RTPCR; WHO, 2005, HDB IMCI INT MAN CHI; WHO, 2009, WHO REG OFF EUR GUID; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; WOLD WSM, 2007, FIELD VIROLOGY, P02395; World Health Organization, 2008, PRACT GUID HARM VIR	25	105	108	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21610	10.1371/journal.pone.0021610	http://dx.doi.org/10.1371/journal.pone.0021610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738731	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800026
J	Lockridge, JL; Chen, XX; Zhou, Y; Rajesh, D; Roenneburg, DA; Hegde, S; Gerdts, S; Cheng, TY; Anderson, RJ; Painter, GF; Moody, DB; Burlingham, WJ; Gumperz, JE				Lockridge, Jennifer L.; Chen, Xiuxu; Zhou, Ying; Rajesh, Deepika; Roenneburg, Drew A.; Hegde, Subramanya; Gerdts, Sarah; Cheng, Tan-Yun; Anderson, Regan J.; Painter, Gavin F.; Moody, D. Branch; Burlingham, William J.; Gumperz, Jenny E.			Analysis of the CD1 Antigen Presenting System in Humanized SCID Mice	PLOS ONE			English	Article							T-CELL RECOGNITION; MYCOBACTERIUM-TUBERCULOSIS INFECTION; NKT CELLS; DISTINCT SUBSETS; LEPROSY LESIONS; DENDRITIC CELLS; ACTIVATION; SELF; EXPRESSION; MOLECULES	CD1 molecules are glycoproteins that present lipids and glycolipids for recognition by T cells. CD1-dependent immune activation has been implicated in a wide range of immune responses, however, our understanding of the role of this pathway in human disease remains limited because of species differences between humans and other mammals: whereas humans express five different CD1 gene products (CD1a, CD1b, CD1c, CD1d, and CD1e), muroid rodents express only one CD1 isoform (CD1d). Here we report that immune deficient mice engrafted with human fetal thymus, liver, and CD34(+) hematopoietic stem cells develop a functional human CD1 compartment. CD1a, b, c, and d isoforms were highly expressed by human thymocytes, and CD1a(+) cells with a dendritic morphology were present in the thymic medulla. CD1(+) cells were also detected in spleen, liver, and lungs. APCs from spleen and liver were capable of presenting bacterial glycolipids to human CD1-restricted T cells. ELISpot analyses of splenocytes demonstrated the presence of CD1-reactive IFN-gamma producing cells. CD1d tetramer staining directly identified human iNKT cells in spleen and liver samples from engrafted mice, and injection of the glycolipid antigen alpha-GalCer resulted in rapid elevation of human IFN-gamma and IL-4 levels in the blood indicating that the human iNKT cells are biologically active in vivo. Together, these results demonstrate that the human CD1 system is present and functionally competent in this humanized mouse model. Thus, this system provides a new opportunity to study the role of CD1-related immune activation in infections to human-specific pathogens.	[Lockridge, Jennifer L.; Chen, Xiuxu; Hegde, Subramanya; Gerdts, Sarah; Gumperz, Jenny E.] Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Zhou, Ying; Rajesh, Deepika; Roenneburg, Drew A.; Burlingham, William J.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI USA; [Cheng, Tan-Yun; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Anderson, Regan J.; Painter, Gavin F.] Ind Res Ltd, Carbohydrate Chem Team, Lower Hutt, New Zealand	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Brigham & Women's Hospital; Callaghan Innovation	Lockridge, JL (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jegumperz@wisc.edu		Rajesh, Deepika/0000-0002-8820-4328; Anderson, Regan/0000-0003-3467-9202	Pew Scholars Program in the Biomedical Sciences; NIH [R01AI060777, R21AI076707]; Medical Education and Research Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060777, R21AI076707] Funding Source: NIH RePORTER	Pew Scholars Program in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Education and Research Committee; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Major funding for this work was from an award to JEG from the Pew Scholars Program in the Biomedical Sciences and from NIH grants R01AI060777 and R21AI076707 to JEG, and by a grant from the Medical Education and Research Committee of the Wisconsin Partnership Program to WJB. GFP and RJA are employees of Industrial Research Ltd., which is a limited liability company fully owned by the government of New Zealand. The role these authors played in this study was to prepare the synthetic glycolipid a-GalCer and to formulate it for injection into mice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chen XX, 2007, J IMMUNOL, V178, P6181, DOI 10.4049/jimmunol.178.10.6181; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; Christiansen D, 2008, PLOS BIOL, V6, P1527, DOI 10.1371/journal.pbio.0060172; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Dascher CC, 2003, TRENDS IMMUNOL, V24, P412, DOI 10.1016/S1471-4906(03)00179-0; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; de Lalla C, 2011, EUR J IMMUNOL, V41, P602, DOI 10.1002/eji.201041211; Durante-Mangoni E, 2004, J IMMUNOL, V173, P2159, DOI 10.4049/jimmunol.173.3.2159; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Gilleron M, 2004, J EXP MED, V199, P649, DOI 10.1084/jem.20031097; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Gumperz JE, 2006, TRAFFIC, V7, P2, DOI 10.1111/j.1600-0854.2005.00364.x; Kenna T, 2007, CANCER IMMUNOL IMMUN, V56, P563, DOI 10.1007/s00262-006-0215-x; Kita H, 2002, GASTROENTEROLOGY, V123, P1031, DOI 10.1053/gast.2002.36020; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; MARTIN LH, 1986, P NATL ACAD SCI USA, V83, P9154, DOI 10.1073/pnas.83.23.9154; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; Miller MM, 2005, P NATL ACAD SCI USA, V102, P8674, DOI 10.1073/pnas.0500105102; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; Osman Y, 2000, EUR J IMMUNOL, V30, P1919, DOI 10.1002/1521-4141(200007)30:7<1919::AID-IMMU1919>3.0.CO;2-3; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Rajesh D, 2010, HUM IMMUNOL, V71, P551, DOI 10.1016/j.humimm.2010.02.019; Rosat JP, 1999, J IMMUNOL, V162, P366; Rymarchyk SL, 2008, IMMUNOLOGY, V125, P331, DOI 10.1111/j.1365-2567.2008.02846.x; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sieling PA, 2000, J IMMUNOL, V165, P5338, DOI 10.4049/jimmunol.165.9.5338; Sieling PA, 1999, J IMMUNOL, V162, P1851; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Spinozzi F, 2007, IMMUNOL ALLERGY CLIN, V27, P79, DOI 10.1016/j.iac.2006.11.004; Ulrichs T, 2003, INFECT IMMUN, V71, P3076, DOI 10.1128/IAI.71.6.3076-3087.2003; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Vincent MS, 2005, J IMMUNOL, V175, P6344, DOI 10.4049/jimmunol.175.10.6344; Wang XH, 2008, BLOOD, V112, P4128, DOI 10.1182/blood-2008-05-157529; Wei DG, 2005, J EXP MED, V202, P239, DOI 10.1084/jem.20050413; Yu KOA, 2005, IMMUNOL LETT, V100, P42, DOI 10.1016/j.imlet.2005.06.010; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	52	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21701	10.1371/journal.pone.0021701	http://dx.doi.org/10.1371/journal.pone.0021701			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738769	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800032
J	Nunn, CL; Thrall, PH; Leendertz, FH; Boesch, C				Nunn, Charles L.; Thrall, Peter H.; Leendertz, Fabian H.; Boesch, Christophe			The Spread of Fecally Transmitted Parasites in Socially-Structured Populations	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; IMPENETRABLE NATIONAL-PARK; GORILLA-GORILLA; TRANSMISSION; ECOLOGY; CRYPTOSPORIDIUM; CONSERVATION; PATHOGENS; DYNAMICS; PRIMATES	Mammals are infected by a wide array of gastrointestinal parasites, including parasites that also infect humans and domesticated animals. Many of these parasites are acquired through contact with infectious stages present in soil, feces or vegetation, suggesting that ranging behavior will have a major impact on their spread. We developed an individual-based spatial simulation model to investigate how range use intensity, home range overlap, and defecation rate impact the spread of fecally transmitted parasites in a population composed of social groups (i.e., a socially structured population). We also investigated the effects of epidemiological parameters involving host and parasite mortality rates, transmissibility, disease-related mortality, and group size. The model was spatially explicit and involved the spillover of a gastrointestinal parasite from a reservoir population along the edge of a simulated reserve, which was designed to mimic the introduction pathogens into protected areas. Animals ranged randomly within a "core" area, with biased movement toward the range center when outside the core. We systematically varied model parameters using a Latin hypercube sampling design. Analyses of simulation output revealed a strong positive association between range use intensity and the prevalence of infection. Moreover, the effects of range use intensity were similar in magnitude to effects of group size, mortality rates, and the per-contact probability of transmission. Defecation rate covaried positively with gastrointestinal parasite prevalence. Greater home range overlap had no positive effects on prevalence, with a smaller core resulting in less range overlap yet more intensive use of the home range and higher prevalence. Collectively, our results reveal that parasites with fecal-oral transmission spread effectively in socially structured populations. Future application should focus on parameterizing the model with empirically derived ranging behavior for different species or populations and data on transmission characteristics of different infectious organisms.	[Nunn, Charles L.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Thrall, Peter H.] CSIRO Plant Ind, Canberra, ACT, Australia; [Leendertz, Fabian H.] Robert Koch Inst, Res Grp Emerging Zoonoses, D-1000 Berlin, Germany; [Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Harvard University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Robert Koch Institute; Max Planck Society	Nunn, CL (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	cnunn@oeb.harvard.edu	Leendertz, Fabian Hubertus/H-8902-2019; Thrall, Peter/J-6672-2013		Max Planck Society; Harvard University	Max Planck Society(Max Planck SocietyFoundation CELLEX); Harvard University	This research was supported by the Max Planck Society and Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDOORY Y, 1969, MYCOPATH MYCOL APPL, V38, P7, DOI 10.1007/BF02051671; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; ANDERSON RM, 1982, POPULATION BIOL INFE; [Anonymous], 2009, LANG ENV STAT COMP; Appelbee AJ, 2005, TRENDS PARASITOL, V21, P370, DOI 10.1016/j.pt.2005.06.004; Ashford RW, 1996, J ZOOL, V239, P507, DOI 10.1111/j.1469-7998.1996.tb05939.x; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DUNBAR RIM, 1980, J ANIM ECOL, V49, P485, DOI 10.2307/4259; Ezenwa VO, 2004, BEHAV ECOL, V15, P446, DOI 10.1093/beheco/arh028; FREELAND W J, 1976, Biotropica, V8, P12, DOI 10.2307/2387816; FREELAND WJ, 1979, ECOLOGY, V60, P719, DOI 10.2307/1936609; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Gillespie TR, 2005, J APPL ECOL, V42, P699, DOI 10.1111/j.1365-2664.2005.01049.x; Goldberg TL, 2008, EMERG INFECT DIS, V14, P1375, DOI [10.3201/eid14.9.071196, 10.3201/eid1409.071196]; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; GULLAND FMD, 1993, P ROY SOC B-BIOL SCI, V254, P7, DOI 10.1098/rspb.1993.0119; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; HESS GR, 1994, CONSERV BIOL, V8, P256, DOI 10.1046/j.1523-1739.1994.08010256.x; Hugot JP, 1996, INT J PARASITOL, V26, P147, DOI 10.1016/0020-7519(95)00108-5; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; MITANI JC, 1979, BEHAV ECOL SOCIOBIOL, V5, P241, DOI 10.1007/BF00293673; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; Normand E, 2009, ANIM BEHAV, V77, P1195, DOI 10.1016/j.anbehav.2009.01.025; Nunn CL, 2008, EVOL ECOL, V22, P519, DOI 10.1007/s10682-007-9180-x; Nunn CL, 2006, BIOL LETTERS, V2, P351, DOI 10.1098/rsbl.2006.0485; Nunn CL, 2009, ANIM BEHAV, V77, P1515, DOI 10.1016/j.anbehav.2009.02.023; Nunn CL, 2000, AM NAT, V156, P519, DOI 10.1086/303405; Nunn CL, 2006, INFECT DIS PRIMATES; Rushton SP, 2000, J APPL ECOL, V37, P997, DOI 10.1046/j.1365-2664.2000.00553.x; Samuel W.M., 2001, PARASITIC DIS WILD M; SCOTT M E, 1988, Conservation Biology, V2, P40, DOI 10.1111/j.1523-1739.1988.tb00334.x; SEAHOLM SK, 1988, INT J BIOMED COMPUT, V23, P97, DOI 10.1016/0020-7101(88)90067-0; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Stoner KE, 1996, CONSERV BIOL, V10, P539, DOI 10.1046/j.1523-1739.1996.10020539.x; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; WASER PM, 1976, AM NAT, V110, P911, DOI 10.1086/283117; WEVERS D, VIROLOGY J IN PRESS; WILLIAMS ES, 2001, INFECT DIS WILD MAMM, P558	53	46	47	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21677	10.1371/journal.pone.0021677	http://dx.doi.org/10.1371/journal.pone.0021677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738763	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800030
J	Wang, R; Sperry, AO				Wang, Rong; Sperry, Ann O.			PP1 Forms an Active Complex with TLRR (lrrc67), a Putative PP1 Regulatory Subunit, during the Early Stages of Spermiogenesis in Mice	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 1C-GAMMA; EPIDIDYMAL SPERM MATURATION; MANCHETTE DEVELOPMENT; MOUSE TESTIS; MUTANT MICE; GERM-CELLS; PP1-GAMMA-2; SPERMATOGENESIS; IDENTIFICATION; MORPHOGENESIS	Mammalian spermatogenesis is a highly regulated developmental pathway that demands dramatic rearrangement of the cytoskeleton of the male germ cell. We have described previously a leucine rich repeat protein, TLRR (also known as lrrc67), which is associated with the spermatid cytoskeleton in mouse testis and is a binding partner of protein phosphatase-1 (PP1), an extremely well conserved signaling molecule. The activity of PP1 is modulated by numerous specific regulators of which TLRR is a candidate. In this study we measured the phosphatase activity of the TLRR-PP1 complex in the adult and the developing mouse testis, which contains varying populations of developing germ cell types, in order to determine whether TLRR acts as an activator or an inhibitor of PP1 and whether the phosphatase activity of this complex is developmentally regulated during spermatogenesis. Additionally, we assayed the ability of bacterially expressed TLRR to affect the enzymatic activity of PP1. Furthermore, we examined phosphorylation of TLRR, and elements of the spermatid cytoskeleton during the first wave of spermatogenesis in the developing testis. We demonstrate here that the TLRR complex is associated with a phosphatase activity in adult mouse testis. The relative phosphatase activity of this complex appears to reach a peak at about 21 days after birth, when pachytene spermatocytes and round spermatids are abundant in the seminiferous epithelium of the mouse testis. TLRR, in addition to tubulin and kinesin-1B, is phosphorylated during the first wave of spermatogenesis. These findings indicate that the TLRR-PP1 complex is active prior to translocation of TLRR toward the sperm flagella and that TLRR, and constituents of the spermatid cytoskeleton, may be subject to regulation by reversible phosphorylation during spermatogenesis in murine testis.	[Wang, Rong; Sperry, Ann O.] E Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Wang, R (corresponding author), E Carolina Univ, Dept Anat & Cell Biol, Brody Sch Med, Greenville, NC 27858 USA.	sperrya@ecu.edu			National Institutes of Health, National Institute of Health and Human Development [HD058027]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058027] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the National Institutes of Health, National Institute of Health and Human Development grant number HD058027 to AOS http://www.nichd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Chakrabarti R, 2007, ASIAN J ANDROL, V9, P445, DOI 10.1111/j.1745-7262.2007.00307.x; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; Cheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004861; CHERRY LM, 1984, CHROMOSOMA, V90, P265, DOI 10.1007/BF00287034; COLE A, 1988, BIOL REPROD, V38, P385, DOI 10.1095/biolreprod38.2.385; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; Henderson H., 2010, INT J ANDROL, P1; Hrabchak C, 2004, J BIOL CHEM, V279, P37079, DOI 10.1074/jbc.M403710200; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; Mishra S, 2003, BIOL REPROD, V69, P1572, DOI 10.1095/biolreprod.103.018739; Moreno RD, 2000, CELL MOTIL CYTOSKEL, V46, P235, DOI 10.1002/1097-0169(200008)46:4<235::AID-CM1>3.0.CO;2-G; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Oppedisano-Wells L, 2003, MOL REPROD DEV, V65, P157, DOI 10.1002/mrd.10284; SHIMA H, 1993, BIOCHEM BIOPH RES CO, V194, P930, DOI 10.1006/bbrc.1993.1910; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Wang R, 2010, BIOL CELL, V102, P173, DOI 10.1042/BC20090091; Wang R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-9; Wang WP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-62; WOLOSEWICK JJ, 1977, AM J ANAT, V150, P301, DOI 10.1002/aja.1001500206	26	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21767	10.1371/journal.pone.0021767	http://dx.doi.org/10.1371/journal.pone.0021767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738792	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800043
J	Gan, PP; McCarroll, JA; Byrne, FL; Garner, J; Kavallaris, M				Gan, Pei Pei; McCarroll, Joshua A.; Byrne, Frances L.; Garner, James; Kavallaris, Maria			Specific beta-Tubulin Isotypes Can Functionally Enhance or Diminish Epothilone B Sensitivity in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							MICROTUBULE-STABILIZING AGENTS; III-TUBULIN; MITOTIC ARREST; INHIBITS GROWTH; BINDING AGENTS; IN-VIVO; PACLITAXEL; PATUPILONE; RESISTANCE; MUTATIONS	Epothilones are a new class of microtubule stabilizing agents with promising preclinical and clinical activity. Their cellular target is beta-tubulin and factors influencing intrinsic sensitivity to epothilones are not well understood. In this study, the functional significance of specific beta-tubulin isotypes in intrinsic sensitivity to epothilone B was investigated using siRNA gene knockdown against beta II-, beta III- or beta IVb-tubulins in two independent non-small cell lung cancer (NSCLC) cell lines, NCI-H460 and Calu-6. Drug-treated clonogenic assays showed that sensitivity to epothilone B was not altered following knockdown of beta II-tubulin in both NSCLC cell lines. In contrast, knockdown of beta III-tubulin significantly increased sensitivity to epothilone B. Interestingly, beta IVb-tubulin knockdowns were significantly less sensitive to epothilone B, compared to mock- and control siRNA cells. Cell cycle analysis of beta III-tubulin knockdown cells showed a higher percentage of cell death with epothilone B concentrations as low as 0.5 nM. In contrast, beta IVb-tubulin knockdown cells displayed a decrease in epothilone B-induced G(2)-M cell cycle accumulation compared to control siRNA cells. Importantly, beta III-tubulin knockdowns displayed a significant dose-dependent increase in the percentage of apoptotic cells upon treatment with epothilone B, as detected using caspase 3/7 activity and Annexin-V staining. Higher concentrations of epothilone B were required to induce apoptosis in the beta IVb-tubulin knockdowns compared to control siRNA, highlighting a potential mechanism underlying decreased sensitivity to this agent. This study demonstrates that specific beta-tubulin isotypes can influence sensitivity to epothilone B and may influence differential sensitivity to this promising new agent.	[Gan, Pei Pei; McCarroll, Joshua A.; Byrne, Frances L.; Kavallaris, Maria] Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Randwick, NSW, Australia; [Garner, James] Univ New S Wales, Sch Chem, Sydney, NSW, Australia; [Kavallaris, Maria] Univ New S Wales, Australian Ctr Nanomed, Sydney, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Gan, PP (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Randwick, NSW, Australia.	m.kavallaris@ccia.unsw.edu.au	McCarroll, Joshua/E-8481-2010; Kavallaris, Maria/J-5240-2014; Byrne, Frances/AAW-7748-2020	McCarroll, Joshua/0000-0001-8807-3623; Byrne, Frances/0000-0002-8897-8438; Giannakakou, Paraskevi/0000-0001-7378-262X	Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales; Sydney Children's Hospital; New South Wales Cancer Council; Endeavour International Postgraduate Research Scholarship; University of New South Wales Faculty of Medicine; Balnaves Award; Anthony Rothe Postgraduate Award; NHMRC	Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales; Sydney Children's Hospital; New South Wales Cancer Council(Cancer Council New South Wales); Endeavour International Postgraduate Research Scholarship(Australian Government); University of New South Wales Faculty of Medicine; Balnaves Award; Anthony Rothe Postgraduate Award; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Children's Cancer Institute Australia for Medical Research, which is affiliated with the University of New South Wales and the Sydney Children's Hospital and grants from the New South Wales Cancer Council (MK). Endeavour International Postgraduate Research Scholarship (PPG), University of New South Wales Faculty of Medicine Fellowship (JAM), University of New South Wales Faculty of Medicine Early Career Research Award (JAM), Balnaves Award (JAM), Anthony Rothe Postgraduate Award (JLB), and by a NHMRC Senior Fellowship (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blade K, 1999, J CELL SCI, V112, P2213; BOLLAG DM, 1995, CANCER RES, V55, P2325; Dumontet C, 2009, MOL CANCER THER, V8, P17, DOI 10.1158/1535-7163.MCT-08-0986; Freedman H, 2009, J CHEM INF MODEL, V49, P424, DOI 10.1021/ci8003336; Gan PP, 2007, CANCER RES, V67, P9356, DOI 10.1158/0008-5472.CAN-07-0509; Gan PP, 2010, MOL CANCER THER, V9, P1339, DOI 10.1158/1535-7163.MCT-09-0679; Gan PP, 2008, CANCER RES, V68, P9817, DOI 10.1158/0008-5472.CAN-08-1501; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Joe PA, 2008, CELL MOTIL CYTOSKEL, V65, P476, DOI 10.1002/cm.20274; Kamath K, 2003, CANCER RES, V63, P6026; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Khawaja NR, 2008, MOL PHARMACOL, V74, P1072, DOI 10.1124/mol.108.048405; Kowalski RJ, 1997, J BIOL CHEM, V272, P2534; Lee JJ, 2008, CLIN CANCER RES, V14, P1618, DOI 10.1158/1078-0432.CCR-07-2201; Lee JJ, 2009, NAT CLIN PRACT ONCOL, V6, P85, DOI 10.1038/ncponc1281; Lin B, 2005, BLOOD, V105, P350, DOI 10.1182/blood-2004-06-2499; Magnani M, 2006, FEBS J, V273, P3301, DOI 10.1111/j.1742-4658.2006.05340.x; McCarroll JA, 2010, CANCER RES, V70, P4995, DOI 10.1158/0008-5472.CAN-09-4487; Milross CG, 1996, JNCI-J NATL CANCER I, V88, P1308, DOI 10.1093/jnci/88.18.1308; Mozzetti S, 2008, CANCER RES, V68, P10197, DOI 10.1158/0008-5472.CAN-08-2091; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; O'Reilly T, 2005, PROSTATE, V65, P231, DOI 10.1002/pros.20289; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Risinger AL, 2008, CANCER RES, V68, P8881, DOI 10.1158/0008-5472.CAN-08-2037; Rubin EH, 2005, J CLIN ONCOL, V23, P9120, DOI 10.1200/JCO.2005.03.0981; Seve P, 2008, LANCET ONCOL, V9, P168, DOI 10.1016/S1470-2045(08)70029-9; Vansteenkiste J, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.09.7097; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Yang CPH, 2005, MOL CANCER THER, V4, P987, DOI 10.1158/1535-7163.MCT-05-0024; Yang HL, 2007, J BIOL CHEM, V282, P27058, DOI 10.1074/jbc.M704101200	31	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21717	10.1371/journal.pone.0021717	http://dx.doi.org/10.1371/journal.pone.0021717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738778	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100063
J	Hodge, JM; Collier, FM; Pavlos, NJ; Kirkland, MA; Nicholson, GC				Hodge, Jason M.; Collier, Fiona M.; Pavlos, Nathan J.; Kirkland, Mark A.; Nicholson, Geoffrey C.			M-CSF Potently Augments RANKL-Induced Resorption Activation in Mature Human Osteoclasts	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; BLOOD MONONUCLEAR-CELLS; FACTOR-KAPPA-B; BONE-RESORPTION; RECEPTOR ACTIVATOR; C-SRC; DIFFERENTIATION; OSTEOPETROSIS; FACTOR-1; EXPRESSION	Macrophage-CSF (M-CSF) is critical for osteoclast (OC) differentiation and is reported to enhance mature OC survival and motility. However, its role in the regulation of bone resorption, the main function of OCs, has not been well characterised. To address this we analysed short-term cultures of fully differentiated OCs derived from human colony forming unit-granulocyte macrophages (CFU-GM). When cultured on dentine, OC survival was enhanced by M-CSF but more effectively by receptor activator of NFkB ligand (RANKL). Resorption was entirely dependent on the presence of RANKL. Co-treatment with M-CSF augmented RANKL-induced resorption in a concentration-dependent manner with a (200-300%) stimulation at 25 ng/mL, an effect observed within 4-6 h. M-CSF co-treatment also increased number of resorption pits and F-actin sealing zones, but not the number of OCs or pit size, indicating stimulation of the proportion of OCs activated. M-CSF facilitated RANKL-induced activation of c-fos and extracellular signal-regulated kinase (ERK) 1/2 phosphorylation, but not NFkB nor nuclear factor of activated T-cells, cytoplasmic-1 (NFATc1). The mitogen-activated protein kinase kinase (MEK) 1 inhibitor PD98059 partially blocked augmentation of resorption by M-CSF. Our results reveal a previously unidentified role of M-CSF as a potent stimulator of mature OC resorbing activity, possibly mediated via ERK upstream of c-fos.	[Hodge, Jason M.; Kirkland, Mark A.] Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic, Australia; [Hodge, Jason M.; Collier, Fiona M.; Kirkland, Mark A.] Barwon Hlth, Barwon Biomed Res, Geelong, Vic, Australia; [Pavlos, Nathan J.] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia; [Nicholson, Geoffrey C.] Univ Queensland, Sch Med, Rural Clin Sch, Toowoomba, Qld, Australia	University of Melbourne; University of Western Australia; University of Queensland	Hodge, JM (corresponding author), Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic, Australia.	jhodge@unimelb.edu.au	Nicholson, Geoffrey C/F-1901-2010	Nicholson, Geoffrey C/0000-0002-0152-1153; Pavlos, Nathan/0000-0001-7003-188X				Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bradley EW, 2008, J CELL BIOCHEM, V104, P1439, DOI 10.1002/jcb.21719; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Dai XM, 2004, BLOOD, V103, P1114, DOI 10.1182/blood-2003-08-2739; Desai MP, 2007, J CLIN LAB ANAL, V21, P55, DOI 10.1002/jcla.20166; Dey A, 2000, MOL BIOL CELL, V11, P3835, DOI 10.1091/mbc.11.11.3835; Edwards M, 1998, BONE, V22, P325, DOI 10.1016/S8756-3282(97)00284-6; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; FULLER K, 1993, J EXP MED, V178, P1733, DOI 10.1084/jem.178.5.1733; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; Grey A, 2000, ENDOCRINOLOGY, V141, P2129, DOI 10.1210/en.141.6.2129; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; HATTERSLEY G, 1991, BIOCHEM BIOPH RES CO, V177, P526, DOI 10.1016/0006-291X(91)92015-C; Hodge JM, 2007, J CELL BIOCHEM, V102, P759, DOI 10.1002/jcb.21331; Hodge JM, 2004, J BONE MINER RES, V19, P190, DOI 10.1359/JBMR.0301232; Holmes SG, 2004, BONE, V35, P471, DOI 10.1016/j.bone.2004.02.028; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; LAKKAKORPI PT, 1991, J BONE MINER RES, V6, P817; Lee SK, 2006, BONE, V38, P678, DOI 10.1016/j.bone.2005.10.011; Lee SK, 2006, CURR OPIN RHEUMATOL, V18, P411, DOI 10.1097/01.bor.0000231911.42666.78; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; LORENZO JA, 1987, ENDOCRINOLOGY, V121, P1164, DOI 10.1210/endo-121-3-1164; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Myers DE, 1999, FEBS LETT, V463, P295, DOI 10.1016/S0014-5793(99)01650-6; Nicholson GC, 2000, CLIN SCI, V99, P133, DOI 10.1042/CS19990355; Owens JM, 1999, J CELL PHYSIOL, V179, P170, DOI 10.1002/(SICI)1097-4652(199905)179:2<170::AID-JCP7>3.0.CO;2-K; Pavlos NJ, 2005, MOL CELL BIOL, V25, P5253, DOI 10.1128/MCB.25.12.5253-5269.2005; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Sarma U, 1996, BLOOD, V88, P2531, DOI 10.1182/blood.V88.7.2531.bloodjournal8872531; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Suehiro A, 1999, ARCH GERONTOL GERIAT, V29, P13, DOI 10.1016/S0167-4943(99)00015-1; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Wei S, 2005, IMMUNOBIOLOGY, V210, P109, DOI 10.1016/j.imbio.2005.05.005; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yao GQ, 2005, CALCIFIED TISSUE INT, V76, P371, DOI 10.1007/s00223-004-0099-8; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	42	54	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21462	10.1371/journal.pone.0021462	http://dx.doi.org/10.1371/journal.pone.0021462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738673	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100026
J	Knottnerus, ILH; Gielen, M; Lodder, J; Rouhl, RPW; Staals, J; Vlietinck, R; van Oostenbrugge, RJ				Knottnerus, Iris L. H.; Gielen, Marij; Lodder, Jan; Rouhl, Rob P. W.; Staals, Julie; Vlietinck, Robert; van Oostenbrugge, Robert J.			Estimating the Magnitude of Genetic Factors by Calculating the Genetic Relative Risk of Stroke in First-Ever Lacunar Stroke Patients	PLOS ONE			English	Article							MATTER HYPERINTENSITY VOLUME; FAMILY-HISTORY; ISCHEMIC-STROKE; PREVALENCE; POPULATION; SUBTYPES; COMMUNITY; SIBLINGS	Background: Positive family history of stroke is an independent risk factor for lacunar stroke. However, the magnitude of familial aggregation of a certain disease is better evaluated by the genetic relative risk. This is calculated by dividing the prevalence of specific disease in family members of patients by the prevalence of this disease in the general population. In a cohort of lacunar stroke patients, who were subtyped clinically and radiologically, we determined the genetic relative risk of stroke. Methods: By questionnaire and additional interview, we obtained a complete first-degree family history of stroke. The prevalence of stroke in first-degree relatives of these lacunar stroke patients was compared to the self-reported prevalence of stroke in a Dutch community based cohort of elderly volunteers. Secondly, the influence of proband characteristics and family composition on parental and sibling history of stroke were evaluated. Principal Findings: We collected data of 1066 first-degree relatives of 195 lacunar stroke patients. Strokes occurred in 13.5% of first-degree relatives. The genetic relative risk was 2.94 (95% CI 2.45-3.53) for overall first-degree relatives, 4.52 (95% CI 3.61-5.65) for patients' parents and 2.10 (95% CI 1.63-2.69) for patients' siblings. Age of proband and proband status for hypertension influenced the chance of having a parent with a history of stroke whereas the likelihood of having a concordant sibling increased with sibship size. Conclusions: We found an increased genetic relative risk of stroke in first-degree relatives of patients with lacunar stroke. Our data warrant further genomic research in this well-defined high risk population for stroke.	[Knottnerus, Iris L. H.; Lodder, Jan; Rouhl, Rob P. W.; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands; [Knottnerus, Iris L. H.; Lodder, Jan; Staals, Julie; van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Knottnerus, Iris L. H.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [Gielen, Marij] Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Genet & Cell Biol, Sect Complex Genet, Maastricht, Netherlands; [Gielen, Marij] Univ Birmingham, Unit Genet Epidemiol, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England; [Vlietinck, Robert] Catholic Univ Louvain, Dept Human Genet, Fac Med, B-3000 Leuven, Belgium	Maastricht University; Maastricht University; Medical Spectrum Twente; Maastricht University; University of Birmingham	Knottnerus, ILH (corresponding author), Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands.	iris.knottnerus@home.nl	gielen, marij/D-8010-2011		Netherlands Thrombosis Foundation [2007-3]	Netherlands Thrombosis Foundation	I.L.H. Knottnerus is supported by a research grant of the Netherlands Thrombosis Foundation (grant number 2007-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood LD, 2004, STROKE, V35, P1609, DOI 10.1161/01.STR.0000129643.77045.10; BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; Bots ML, 1996, STROKE, V27, P1499, DOI 10.1161/01.STR.27.9.1499; Burton PR, 2005, LANCET, V366, P941, DOI 10.1016/S0140-6736(05)67322-9; Carmelli D, 1998, STROKE, V29, P1177, DOI 10.1161/01.STR.29.6.1177; Flossmann E, 2005, CEREBROVASC DIS, V19, P1, DOI 10.1159/000081905; Geddes JML, 1996, J EPIDEMIOL COMMUN H, V50, P140, DOI 10.1136/jech.50.2.140; Hassan A, 2002, NEUROLOGY, V58, P1483, DOI 10.1212/WNL.58.10.1483; Jackson C, 2005, STROKE, V36, P891, DOI 10.1161/01.STR.0000157949.34986.30; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Jungehulsing GJ, 2008, NEUROEPIDEMIOLOGY, V30, P51, DOI 10.1159/000115750; Knottnerus ILH, 2010, STROKE, V41, P1617, DOI 10.1161/STROKEAHA.109.576223; Leistner S, 2008, EUR NEUROL, V59, P143, DOI 10.1159/000111877; Lindgren A, 2005, CEREBROVASC DIS, V20, P381, DOI 10.1159/000088668; Lisabeth LD, 2008, NEUROEPIDEMIOLOGY, V31, P33, DOI 10.1159/000136649; Markus HS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000225; Meschia JF, 2001, STROKE, V32, P2939, DOI 10.1161/hs1201.099795; Mullen SA, 2009, NEUROLOGY, V72, P558, DOI 10.1212/01.wnl.0000341942.29513.bd; Polychronopoulos P, 2002, J NEUROL SCI, V195, P117, DOI 10.1016/S0022-510X(01)00691-8; Rouhl RPW, 2008, J NEUROL, V255, P692, DOI 10.1007/s00415-008-0777-y; Staals J, 2009, STROKE, V40, P3264, DOI 10.1161/STROKEAHA.109.558049	22	3	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21439	10.1371/journal.pone.0021439	http://dx.doi.org/10.1371/journal.pone.0021439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747905	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100023
J	Kumar, PS; Brooker, MR; Dowd, SE; Camerlengo, T				Kumar, Purnima S.; Brooker, Michael R.; Dowd, Scot E.; Camerlengo, Terry			Target Region Selection Is a Critical Determinant of Community Fingerprints Generated by 16S Pyrosequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; BACTERIAL DIVERSITY; ORAL MICROFLORA; IDENTIFICATION; BIAS; PHYLOTYPES; FRAGMENTS	Pyrosequencing of 16S rRNA genes allows for in-depth characterization of complex microbial communities. Although it is known that primer selection can influence the profile of a community generated by sequencing, the extent and severity of this bias on deep-sequencing methodologies is not well elucidated. We tested the hypothesis that the hypervariable region targeted for sequencing and primer degeneracy play important roles in influencing the composition of 16S pyrotag communities. Subgingival plaque from deep sites of current smokers with chronic periodontitis was analyzed using Sanger sequencing and pyrosequencing using 4 primer pairs. Greater numbers of species were detected by pyrosequencing than by Sanger sequencing. Rare taxa constituted nearly 6% of each pyrotag community and less than 1% of the Sanger sequencing community. However, the different target regions selected for pyrosequencing did not demonstrate a significant difference in the number of rare and abundant taxa detected. The genera Prevotella, Fusobacterium, Streptococcus, Granulicatella, Bacteroides, Porphyromonas and Treponema were abundant when the V1-V3 region was targeted, while Streptococcus, Treponema, Prevotella, Eubacterium, Porphyromonas, Campylobacer and Enterococcus predominated in the community generated by V4-V6 primers, and the most numerous genera in the V7-V9 community were Veillonella, Streptococcus, Eubacterium, Enterococcus, Treponema, Catonella and Selenomonas. Targeting the V4-V6 region failed to detect the genus Fusobacterium, while the taxa Selenomonas, TM7 and Mycoplasma were not detected by the V7-V9 primer pairs. The communities generated by degenerate and non-degenerate primers did not demonstrate significant differences. Averaging the community fingerprints generated by V1-V3 and V7-V9 primers providesd results similar to Sanger sequencing, while allowing a significantly greater depth of coverage than is possible with Sanger sequencing. It is therefore important to use primers targeted to these two regions of the 16S rRNA gene in all deep-sequencing efforts to obtain representational characterization of complex microbial communities.	[Kumar, Purnima S.; Brooker, Michael R.] Ohio State Univ, Coll Dent, Div Periodontol, Columbus, OH 43210 USA; [Dowd, Scot E.] Res Testing Lab, Lubbock, TX USA; [Camerlengo, Terry] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kumar, PS (corresponding author), Ohio State Univ, Coll Dent, Div Periodontol, Columbus, OH 43210 USA.	kumar.83@osu.edu	Dowd, Scot E/M-5386-2017; Kumar, Purnima/S-6312-2019; Kumar, Purnima/F-6363-2013	Dowd, Scot E/0000-0002-6296-1427; Kumar, Purnima/0000-0001-5844-1341; Kumar, Purnima/0000-0001-5844-1341; , Michael/0000-0003-4988-7952	NIH [1R03DE018734-01A1]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE018734] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research was supported by NIH grant 1R03DE018734-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Anton AI, 2001, CLIN MICROBIOL INFEC, V7, P345, DOI 10.1046/j.1198-743x.2001.00260.x; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; CLAESSON MJ, NUCL ACIDS RES, V38, pE200; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; de Lillo A, 2006, ORAL MICROBIOL IMMUN, V21, P61, DOI 10.1111/j.1399-302X.2005.00255.x; Delima SL, 2010, J CLIN MICROBIOL, V48, P2344, DOI 10.1128/JCM.01821-09; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Gomes SC, 2006, J PERIODONTOL, V77, P1483, DOI 10.1902/jop.2006.060026; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hutter G, 2003, MICROBIOL-SGM, V149, P67, DOI 10.1099/mic.0.25791-0; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; KUNIN V, ENV MICROBIOL, V12, P118; LI L, J DENT RES; Martinez-Murcia AJ, 1999, INT J SYST BACTERIOL, V49, P601, DOI 10.1099/00207713-49-2-601; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Osborne Jason, 2002, PRACTICAL ASSESSMENT; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Riggio MP, 2008, ORAL DIS, V14, P251, DOI 10.1111/j.1601-0825.2007.01371.x; Shannon CE, 1997, M D COMPUT, V14, P306; Shchipkova AY, 2010, J DENT RES; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Trotha R, 2001, INFECTION, V29, P12, DOI 10.1007/s15010-001-0064-7; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	40	187	194	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20956	10.1371/journal.pone.0020956	http://dx.doi.org/10.1371/journal.pone.0020956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738596	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100010
J	Nowick, K; Fields, C; Gernat, T; Caetano-Anolles, D; Kholina, N; Stubbs, L				Nowick, Katja; Fields, Christopher; Gernat, Tim; Caetano-Anolles, Derek; Kholina, Nadezda; Stubbs, Lisa			Gain, Loss and Divergence in Primate Zinc-Finger Genes: A Rich Resource for Evolution of Gene Regulatory Differences between Species	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; RECOMBINATION HOTSPOTS; MEIOTIC RECOMBINATION; MOLECULAR EVOLUTION; KRAB; EXPRESSION; PRDM9; EXPANSION; PROTEINS; DOMAINS	The molecular changes underlying major phenotypic differences between humans and other primates are not well understood, but alterations in gene regulation are likely to play a major role. Here we performed a thorough evolutionary analysis of the largest family of primate transcription factors, the Kruppel-type zinc finger (KZNF) gene family. We identified and curated gene and pseudogene models for KZNFs in three primate species, chimpanzee, orangutan and rhesus macaque, to allow for a comparison with the curated set of human KZNFs. We show that the recent evolutionary history of primate KZNFs has been complex, including many lineage-specific duplications and deletions. We found 213 species-specific KZNFs, among them 7 human-specific and 23 chimpanzee-specific genes. Two human-specific genes were validated experimentally. Ten genes have been lost in humans and 13 in chimpanzees, either through deletion or pseudogenization. We also identified 30 KZNF orthologs with human-specific and 42 with chimpanzee-specific sequence changes that are predicted to affect DNA binding properties of the proteins. Eleven of these genes show signatures of accelerated evolution, suggesting positive selection between humans and chimpanzees. During primate evolution the most extensive re-shaping of the KZNF repertoire, including most gene additions, pseudogenizations, and structural changes occurred within the subfamily homininae. Using zinc finger (ZNF) binding predictions, we suggest potential impact these changes have had on human gene regulatory networks. The large species differences in this family of TFs stands in stark contrast to the overall high conservation of primate genomes and potentially represents a potent driver of primate evolution.	[Nowick, Katja; Fields, Christopher; Gernat, Tim; Caetano-Anolles, Derek; Kholina, Nadezda; Stubbs, Lisa] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Nowick, Katja; Caetano-Anolles, Derek; Kholina, Nadezda; Stubbs, Lisa] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nowick, K (corresponding author), Univ Leipzig, Bioinformat Grp, Paul Flechsig Inst Brain Res, Leipzig, Germany.	ljstubbs@illinois.edu	Caetano-Anoles, Derek/L-7251-2019; Nowick, Katja/J-8270-2014	Caetano-Anoles, Derek/0000-0001-7704-0578; Nowick, Katja/0000-0003-3993-4479; Gernat, Tim/0000-0002-5977-3900; Fields, Christopher/0000-0002-7749-5844; Stubbs, Lisa/0000-0002-9556-1972	U.S. National Institutes of Health, NIGMS [GM078368]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078368] Funding Source: NIH RePORTER	U.S. National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the U.S. National Institutes of Health, NIGMS under grant number GM078368 (awarded to L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; BELLEFROID EJ, 1993, EMBO J, V12, P1363, DOI 10.1002/j.1460-2075.1993.tb05781.x; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Hamilton AT, 2006, GENOME RES, V16, P584, DOI 10.1101/gr.4843906; Hamilton AT, 2003, COLD SPRING HARB SYM, V68, P131, DOI 10.1101/sqb.2003.68.131; Hecht J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000025; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Kaplan T, 2005, PLOS COMPUT BIOL, V1, P5, DOI 10.1371/journal.pcbi.0010001; Kim Mi Young, 2009, J Calif Dent Assoc, V37, P875; Lewis S.E., 2002, GENOME BIOL, V3, pRESEARCH0082, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; McKay Sheldon J, 2010, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0912s31; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nowick K, 2010, MOL BIOL EVOL, V27, P2606, DOI 10.1093/molbev/msq157; Nowick K, 2010, BRIEF FUNCT GENOMICS, V9, P65, DOI 10.1093/bfgp/elp056; Nowick K, 2009, P NATL ACAD SCI USA, V106, P22358, DOI 10.1073/pnas.0911376106; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Stubbs L, 2009, FOCUS ZINC FINGER PR, P13; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; Thomas JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-51; Uittenbogaard M., 2002, Gene Expression Patterns, V1, P115, DOI 10.1016/S1567-133X(01)00022-9; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Urs S, 2010, FASEB J, V24, P3264, DOI 10.1096/fj.10-155127; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3; Yang XH, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-48; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	43	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21553	10.1371/journal.pone.0021553	http://dx.doi.org/10.1371/journal.pone.0021553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738707	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100037
J	Ma, T; Liaset, B; Hao, Q; Petersen, RK; Fjaere, E; Ngo, HT; Lillefosse, HH; Ringholm, S; Sonne, SB; Treebak, JT; Pilegaard, H; Froyland, L; Kristiansen, K; Madsen, L				Ma, Tao; Liaset, Bjorn; Hao, Qin; Petersen, Rasmus Koefoed; Fjaere, Even; Ha Thi Ngo; Lillefosse, Haldis Haukas; Ringholm, Stine; Sonne, Si Brask; Treebak, Jonas Thue; Pilegaard, Henriette; Froyland, Livar; Kristiansen, Karsten; Madsen, Lise			Sucrose Counteracts the Anti-Inflammatory Effect of Fish Oil in Adipose Tissue and Increases Obesity Development in Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; EICOSAPENTAENOIC ACID; ADIPOCYTE DIFFERENTIATION; ENERGY-EXPENDITURE; BROWN ADIPOCYTES; DIABETIC MICE; HIGH-PROTEIN	Background: Polyunsaturated n-3 fatty acids (n-3 PUFAs) are reported to protect against high fat diet-induced obesity and inflammation in adipose tissue. Here we aimed to investigate if the amount of sucrose in the background diet influences the ability of n-3 PUFAs to protect against diet-induced obesity, adipose tissue inflammation and glucose intolerance. Methodology/Principal Findings: We fed C57BL/6J mice a protein-(casein) or sucrose-based high fat diet supplemented with fish oil or corn oil for 9 weeks. Irrespective of the fatty acid source, mice fed diets rich in sucrose became obese whereas mice fed high protein diets remained lean. Inclusion of sucrose in the diet also counteracted the well-known anti-inflammatory effect of fish oil in adipose tissue, but did not impair the ability of fish oil to prevent accumulation of fat in the liver. Calculation of HOMA-IR indicated that mice fed high levels of proteins remained insulin sensitive, whereas insulin sensitivity was reduced in the obese mice fed sucrose irrespectively of the fat source. We show that a high fat diet decreased glucose tolerance in the mice independently of both obesity and dietary levels of n-3 PUFAs and sucrose. Of note, increasing the protein: sucrose ratio in high fat diets decreased energy efficiency irrespective of fat source. This was accompanied by increased expression of Ppargc1a (peroxisome proliferator-activated receptor, gamma, coactivator 1 alpha) and increased gluconeogenesis in the fed state. Conclusions/Significance: The background diet influence the ability of n-3 PUFAs to protect against development of obesity, glucose intolerance and adipose tissue inflammation. High levels of dietary sucrose counteract the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in mice.	[Ma, Tao; Hao, Qin; Petersen, Rasmus Koefoed; Fjaere, Even; Lillefosse, Haldis Haukas; Ringholm, Stine; Sonne, Si Brask; Pilegaard, Henriette; Kristiansen, Karsten; Madsen, Lise] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Liaset, Bjorn; Fjaere, Even; Ha Thi Ngo; Lillefosse, Haldis Haukas; Froyland, Livar; Madsen, Lise] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Treebak, Jonas Thue] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Ma, T (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	kk@bio.ku.dk; lise.madsen@nifes.no	Sonne, Si Brask/A-4851-2012; Treebak, Jonas Thue/B-4521-2017; Pilegaard, Henriette/M-2315-2014; Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014	Sonne, Si Brask/0000-0003-3194-3805; Treebak, Jonas Thue/0000-0003-1488-7012; Pilegaard, Henriette/0000-0002-1071-0327; Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Liaset, Bjorn/0000-0002-8652-7801; Hao, Qin/0000-0002-6775-2181	Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; National Institute of Nutrition and Seafood Research, Norway; Danish Council for Strategic Research [NO 2101 06 0005]	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); National Institute of Nutrition and Seafood Research, Norway; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Natural Science Research Council, the Novo Nordisk Foundation, the Carlsberg Foundation, and the National Institute of Nutrition and Seafood Research, Norway. Part of the work was carried out as a part of the research program of the Danish Obesity Research Centre (DanORC). DanORC is supported by the Danish Council for Strategic Research (Grant NO 2101 06 0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2007, GENES NUTR, V2, P39, DOI 10.1007/s12263-007-0017-6; Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Arai T, 2009, J ATHEROSCLER THROMB, V16, P674, DOI 10.5551/jat.1313; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Arslan G, 2002, LIPIDS, V37, P935, DOI 10.1007/s11745-006-0983-2; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BELZUNG F, 1993, AM J PHYSIOL, V264, pR1111, DOI 10.1152/ajpregu.1993.264.6.R1111; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Erkkila A, 2008, PROG LIPID RES, V47, P172, DOI 10.1016/j.plipres.2008.01.004; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Froyland L, 1997, J LIPID RES, V38, P1851; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Harris William S, 2010, Curr Cardiol Rep, V12, P503, DOI 10.1007/s11886-010-0141-6; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huber J, 2007, INT J OBESITY, V31, P1004, DOI 10.1038/sj.ijo.0803511; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Madsen L, 1999, LIPIDS, V34, P951, DOI 10.1007/s11745-999-0445-x; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Madsen L, 2010, ANN NY ACAD SCI, V1190, P1, DOI 10.1111/j.1749-6632.2009.05262.x; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; Mikkelsen PB, 2000, AM J CLIN NUTR, V72, P1135; Murata Y, 2007, BIOCHEM BIOPH RES CO, V364, P301, DOI 10.1016/j.bbrc.2007.10.007; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pandey SK, 2002, ENDOCRINOLOGY, V143, P375, DOI 10.1210/en.143.2.375; Perez-Echarri N, 2008, EUR J NUTR, V47, P380, DOI 10.1007/s00394-008-0738-3; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; ROBINSON SM, 1990, AM J CLIN NUTR, V52, P72, DOI 10.1093/ajcn/52.1.72; Rokling-Andersen MH, 2009, BRIT J NUTR, V102, P995, DOI 10.1017/S0007114509353210; Ruzickova J, 2005, LIPIDS, V40, P115; Samane S, 2009, METABOLISM, V58, P909, DOI 10.1016/j.metabol.2009.02.013; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Wang HQ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1352, DOI 10.1152/ajpendo.00230.2001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	57	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21647	10.1371/journal.pone.0021647	http://dx.doi.org/10.1371/journal.pone.0021647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738749	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800052
J	Wich, SA; Vogel, ER; Larsen, MD; Fredriksson, G; Leighton, M; Yeager, CP; Brearley, FQ; van Schaik, CP; Marshall, AJ				Wich, Serge A.; Vogel, Erin R.; Larsen, Michael D.; Fredriksson, Gabriella; Leighton, Mark; Yeager, Carey P.; Brearley, Francis Q.; van Schaik, Carel P.; Marshall, Andrew J.			Forest Fruit Production Is Higher on Sumatra Than on Borneo	PLOS ONE			English	Article							RAIN-FOREST; REPRODUCTIVE PHENOLOGY; NEOTROPICAL FORESTS; TROPICAL FORESTS; SOIL NUTRIENTS; NATIONAL-PARK; TREE GROWTH; BODY-SIZE; EL-NINO; LITTERFALL	Background: Various studies have shown that the population densities of a number of forest vertebrates, such as orangutans, are higher on Sumatra than Borneo, and that several species exhibit smaller body sizes on Borneo than Sumatra and mainland Southeast Asia. It has been suggested that differences in forest fruit productivity between the islands can explain these patterns. Here we present a large-scale comparison of forest fruit production between the islands to test this hypothesis. Methodology/Principal Findings: Data on fruit production were collated from Sumatran and Bornean sites. At six sites we assessed fruit production in three forest types: riverine, peat swamp and dryland forests. We compared fruit production using time-series models during different periods of overall fruit production and in different tree size classes. We examined overall island differences and differences specifically for fruiting period and tree size class. The results of these analyses indicate that overall the Sumatran forests are more productive than those on Borneo. This difference remains when each of the three forest types (dryland, riverine, and peat) are examined separately. The difference also holds over most tree sizes and fruiting periods. Conclusions/Significance: Our results provide strong support for the hypothesis that forest fruit productivity is higher on Sumatra than Borneo. This difference is most likely the result of the overall younger and more volcanic soils on Sumatra than Borneo. These results contribute to our understanding of the determinants of faunal density and the evolution of body size on both islands.	[Wich, Serge A.; van Schaik, Carel P.] Univ Zurich, Inst Anthropol, Zurich, Switzerland; [Wich, Serge A.] Sumatran Orangutan Conservat Programme PanEco YEL, Medan, Sumatra, Indonesia; [Vogel, Erin R.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Washington, DC USA; [Larsen, Michael D.] George Washington Univ, Dept Stat, Washington, DC 20052 USA; [Fredriksson, Gabriella] Univ Amsterdam, Zool Museum, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Leighton, Mark] Great Ape World Heritage Species Project, Babson Pk, MA USA; [Yeager, Carey P.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA; [Brearley, Francis Q.] Manchester Metropolitan Univ, Sch Sci & Environm, Manchester M15 6BH, Lancs, England; [Marshall, Andrew J.] Univ Calif Davis, Dept Anthropol, Grad Grp Ecol, Davis, CA 95616 USA; [Marshall, Andrew J.] Univ Calif Davis, Dept Anthropol, Anim Behav Grad Grp, Davis, CA 95616 USA	University of Zurich; George Washington University; George Washington University; University of Amsterdam; State University System of Florida; University of Florida; Manchester Metropolitan University; University of California System; University of California Davis; University of California System; University of California Davis	Wich, SA (corresponding author), Univ Zurich, Inst Anthropol, Zurich, Switzerland.	sergealexander.wich@uzh.ch		Wich, Serge/0000-0003-3954-5174	Netherlands Foundation for the Advancement of Tropical Research (WOTRO); Netherlands Organisation for Scientific Research (NWO); Wildlife Conservation Society (WCS); Tropenbos Foundation; Borneo Orangutan Foundation; American Zoo and Aquarium Association; Conservation International and The Arnold Arboretum of Harvard University; European Commission; Government of Indonesia; National Geographic Society; Erb Foundation; Douroucoulli Foundation; Crystal Channel Foundation; Margot Marsh Biodiversity Foundation; Center For Field Research; International Scientific Support Trust; American Primatological Association; Page Yeager; Clare Booth Luce Professorship for Women in Science	Netherlands Foundation for the Advancement of Tropical Research (WOTRO); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Wildlife Conservation Society (WCS); Tropenbos Foundation; Borneo Orangutan Foundation; American Zoo and Aquarium Association; Conservation International and The Arnold Arboretum of Harvard University; European Commission(European CommissionEuropean Commission Joint Research Centre); Government of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); National Geographic Society(National Geographic Society); Erb Foundation; Douroucoulli Foundation; Crystal Channel Foundation; Margot Marsh Biodiversity Foundation; Center For Field Research; International Scientific Support Trust; American Primatological Association; Page Yeager; Clare Booth Luce Professorship for Women in Science	Financial support was provided by the Netherlands Foundation for the Advancement of Tropical Research (WOTRO), the Netherlands Organisation for Scientific Research (NWO), the Wildlife Conservation Society (WCS), the Tropenbos Foundation, the Borneo Orangutan Foundation, the Conservation Endowment Fund of the American Zoo and Aquarium Association, Conservation International and The Arnold Arboretum of Harvard University, the European Commission and the Government of Indonesia as the funding agencies for the Leuser Development Programme, The National Geographic Society, the Erb Foundation, the Douroucoulli Foundation, the Crystal Channel Foundation, the Margot Marsh Biodiversity Foundation, the Center For Field Research, the International Scientific Support Trust, the American Primatological Association, Page Yeager, and a Clare Booth Luce Professorship for Women in Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, LIFE LOGGING; APPANAH S, 1985, MALAY FOR, V4, P37; ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Baker TR, 2003, J TROP ECOL, V19, P109, DOI 10.1017/S0266467403003146; Brearley FQ, 2004, FOREST ECOL MANAG, V195, P385, DOI 10.1016/j.foreco.2004.02.048; Brearley FQ, 2007, J ECOL, V95, P828, DOI 10.1111/j.1365-2745.2007.01258.x; BROWN JH, 1981, AM ZOOL, V21, P877; Cannon CH, 2004, J VEG SCI, V15, P257, DOI 10.1111/j.1654-1103.2004.tb02260.x; Cannon CH, 2007, ECOL LETT, V10, P956, DOI 10.1111/j.1461-0248.2007.01089.x; Cannon CH, 2009, P NATL ACAD SCI USA, V106, P11188, DOI 10.1073/pnas.0809865106; Chave J, 2010, BIOGEOSCIENCES, V7, P43, DOI 10.5194/bg-7-43-2010; Clark DA, 2001, ECOL APPL, V11, P371, DOI 10.1890/1051-0761(2001)011[0371:NPPITF]2.0.CO;2; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Curran LM, 2000, ECOL MONOGR, V70, P101, DOI 10.1890/0012-9615(2000)070[0101:VRTSVI]2.0.CO;2; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Fredriksson GM, 2006, BIOL J LINN SOC, V89, P489, DOI 10.1111/j.1095-8312.2006.00688.x; Galdikas BMF, 1978, THESIS U CALIFORNIA; GENTRY AH, 1987, BIOTROPICA, V19, P216, DOI 10.2307/2388339; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Janson Charles H., 1999, P237, DOI 10.1017/CBO9780511542381.015; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Kay RF, 1997, P NATL ACAD SCI USA, V94, P13023, DOI 10.1073/pnas.94.24.13023; LaDeau SL, 2001, SCIENCE, V292, P95, DOI 10.1126/science.1057547; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; LONSDALE WM, 1988, ANN BOT-LONDON, V61, P319, DOI 10.1093/oxfordjournals.aob.a087560; MacKinnon K., 1996, ECOLOGY KALIMANTAN, V3; MARSHALL AJ, 2004, THESIS HARVARD U US; Marshall Andrew J., 2006, P313; Marshall Andrew J., 2009, P97; MEDWAY L, 1972, Biological Journal of the Linnean Society, V4, P117, DOI 10.1111/j.1095-8312.1972.tb00692.x; Meijaard E, 2004, RAFFLES B ZOOL, V52, P665; Meijaard E, 2004, J ZOOL, V263, P179, DOI 10.1017/S0952836904005011; Meijaard E, 2004, ZOOL J LINN SOC-LOND, V140, P63, DOI 10.1111/j.1096-3642.2004.00091.x; Meiri S, 2004, AM NAT, V163, P469, DOI 10.1086/382229; Meiri S, 2008, J BIOGEOGR, V35, P1087, DOI 10.1111/j.1365-2699.2008.01897.x; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Neter J., 1996, APPL LINEAR STAT MOD, V4th, P720; Numata S, 2003, AM J BOT, V90, P1025, DOI 10.3732/ajb.90.7.1025; OATES JF, 1990, ECOLOGY, V71, P328, DOI 10.2307/1940272; Paoli GD, 2007, ECOSYSTEMS, V10, P503, DOI 10.1007/s10021-007-9042-y; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; Peres CA, 1997, FOLIA PRIMATOL, V68, P199, DOI 10.1159/000157247; PROCTOR J, 1988, J ECOL, V76, P320, DOI 10.2307/2260596; PROCTOR J, 1983, J ECOL, V71, P261, DOI 10.2307/2259976; Proctor J., 1983, Malaysian Forester, V46, P60; R Development Core Team, 2009, R FDN STAT COMP; Reich PB, 1997, ECOLOGY, V78, P335, DOI 10.1890/0012-9658(1997)078[0335:NMAPIH]2.0.CO;2; Rice J., 1995, MATH STAT DATA ANAL; Rijksen H. D., 1978, FIELDSTUDY SUMATRAN; Sakai S, 1999, AM J BOT, V86, P1414, DOI 10.2307/2656924; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; SOKAL RR, 1994, BIOMETRY; Stevenson PR, 2001, BIOL J LINN SOC, V72, P161, DOI 10.1006/bijl.2000.0497; Terborgh J., 1987, P205; Van Schaik C, 2004, ORANGUTANS RED APES; Van Schaik C. P., 1986, J TROP ECOL, V2, P327, DOI DOI 10.1017/S0266467400000973; VANSCHAIK CP, 1985, BIOTROPICA, V17, P196, DOI 10.2307/2388217; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; WEBB CO, 1998, SEEDLING ECOLOGY TRE; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Whitmore T.C., 1984, pi; WHITMORE TC, 1998, INTRO TROPICAL RAIN; Wich S, 2004, PRIMATES, V45, P177, DOI 10.1007/s10329-004-0080-1; Wich SA, 2006, INT J PRIMATOL, V27, P1535, DOI 10.1007/s10764-006-9093-5; Wich SA, 2000, J TROP ECOL, V16, P563, DOI 10.1017/S0266467400001577; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006; WICH SA, 2009, ORANGUTANS GEOGRAHIC; Wich SA, 2006, FEEDING ECOLOGY APES, P335; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600; YEAGER CP, 1989, INT J PRIMATOL, V10, P497, DOI 10.1007/BF02739363; Zimmerman JK, 2007, J TROP ECOL, V23, P231, DOI 10.1017/S0266467406003890	75	43	43	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21278	10.1371/journal.pone.0021278	http://dx.doi.org/10.1371/journal.pone.0021278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738627	gold, Green Published, Green Accepted			2022-12-25	WOS:000292142800015
J	Ciufo, LF; Murray, PA; Thompson, A; Rigden, DJ; Rees, HH				Ciufo, Leonora F.; Murray, Patricia A.; Thompson, Anu; Rigden, Daniel J.; Rees, Huw H.			Characterisation of a Desmosterol Reductase Involved in Phytosterol Dealkylation in the Silkworm, Bombyx mori	PLOS ONE			English	Article							STEROL COMPOSITION; JUVENILE-HORMONE; DIETARY STEROLS; METABOLISM; NEMATODE; PLANT; CHOLESTEROL; DROSOPHILA; SEQUENCE; INSIGHTS	Most species of invertebrate animals cannot synthesise sterols de novo and many that feed on plants dealkylate phytosterols (mostly C-29 and C-28) yielding cholesterol (C-27). The final step of this dealkylation pathway involves desmosterol reductase (DHCR24)-catalysed reduction of desmosterol to cholesterol. We now report the molecular characterisation in the silkworm, Bombyx mori, of such a desmosterol reductase involved in production of cholesterol from phytosterol, rather than in de novo synthesis of cholesterol. Phylogenomic analysis of putative desmosterol reductases revealed the occurrence of various clades that allowed for the identification of a strong reductase candidate gene in Bombyx mori (BGIBMGA 005735). Following PCR-based cloning of the cDNA (1.6 kb) and its heterologous expression in Saccharomyces cerevisae, the recombinant protein catalysed reduction of desmosterol to cholesterol in an NADH- and FAD- dependent reaction. Conceptual translation of the cDNA, that encodes a 58.9 kDa protein, and database searching, revealed that the enzyme belongs to an FAD- dependent oxidoreductase family. Western blotting revealed reductase protein expression exclusively in the microsomal subcellular fraction and primarily in the gut. The protein is peripherally associated with microsomal membranes. 2D-native gel and PAGE analysis revealed that the reductase is part of a large complex with molecular weight approximately 250kDa. The protein occurs in midgut microsomes at a fairly constant level throughout development in the last two instars, but is drastically reduced during the wandering stage in preparation for metamorphosis. Putative Broad Complex transcription factor-binding sites detectable upstream of the DHCR24 gene may play a role in this down-regulation.	[Ciufo, Leonora F.; Murray, Patricia A.; Rigden, Daniel J.; Rees, Huw H.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Thompson, Anu] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Ciufo, LF (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	reeshh@liv.ac.uk		Murray, Patricia/0000-0003-1316-148X; Rigden, Daniel/0000-0002-7565-8937	Leverhulme Trust [F/00025/AB]	Leverhulme Trust(Leverhulme Trust)	This research was supported by the Leverhulme Trust, Grant Number: F/00025/AB (URL: http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AWATA N, 1975, BIOCHEM BIOPH RES CO, V64, P157, DOI 10.1016/0006-291X(75)90232-6; BROOKS CJW, 1968, LIPIDS, V3, P391, DOI 10.1007/BF02531277; Brown MR, 2009, ANNU REV ENTOMOL, V54, P105, DOI 10.1146/annurev.ento.53.103106.093334; Cappellozza L, 2005, APPL ENTOMOL ZOOL, V40, P405, DOI 10.1303/aez.2005.405; CHITWOOD DJ, 1987, J NEMATOL, V19, P352; CHITWOOD DJ, 1985, J NEMATOL, V17, P64; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; CHITWOOD DJ, 1984, LIPIDS, V19, P500, DOI 10.1007/BF02534482; CHITWOOD DJ, 1991, LIPIDS, V26, P619, DOI 10.1007/BF02536426; CLARKE GS, 1981, THESIS U LIVERPOOL; COLE RJ, 1968, LIFE SCI PT 1 PHYSI, V7, P713, DOI 10.1016/0024-3205(68)90315-9; COLE RJ, 1967, EXP PARASITOL, V21, P232, DOI 10.1016/0014-4894(67)90085-9; Desmond E, 2009, GENOME BIOL EVOL, V1, P364, DOI 10.1093/gbe/evp036; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUJIMOTO Y, 1980, BIOCHEMISTRY-US, V19, P1065, DOI 10.1021/bi00547a003; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Goad L.J., 1978, MARINE NATURAL PRODU, V2, P75; GOAD LJ, 1981, PURE APPL CHEM, V53, P837, DOI 10.1351/pac198153040837; Greeve I, 2000, J NEUROSCI, V20, P7345; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Hiruma K, 2010, J INSECT PHYSIOL, V56, P1390, DOI 10.1016/j.jinsphys.2010.03.029; Ijiro T, 2004, INSECT BIOCHEM MOLEC, V34, P963, DOI 10.1016/j.ibmb.2004.06.005; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; LOZANO R, 1987, LIPIDS, V22, P84, DOI 10.1007/BF02534858; LOZANO R, 1985, LIPIDS, V20, P102, DOI 10.1007/BF02534215; Madoui MA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-471; Madoui MA, 2009, NEW PHYTOL, V183, P291, DOI 10.1111/j.1469-8137.2009.02895.x; MALLORY FB, 1971, LIPIDS, V6, P149, DOI 10.1007/BF02533028; Martin-Creuzburg D, 2004, J CHEM ECOL, V30, P483, DOI 10.1023/B:JOEC.0000018624.94689.95; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nei M., 2000, MOL EVOLUTION PHYLOG; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; PENNOCK JF, 1977, INT REV BIOCHEM, V14, P153; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rees H.H., 1984, Nova Acta Leopoldina, V56, P267; REES HH, 1972, BIOSYNTHESIS, V1, P59; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SVOBODA JA, 1982, LIPIDS, V17, P220, DOI 10.1007/BF02535107; Svoboda JA, 1999, CRIT REV BIOCHEM MOL, V34, P49, DOI 10.1080/10409239991209183; SVOBODA JA, 1977, J NEMATOL, V9, P286; THOMPSON MJ, 1972, PROC R SOC SER B-BIO, V180, P203, DOI 10.1098/rspb.1972.0015; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Waterham HR, 2006, FEBS LETT, V580, P5442, DOI 10.1016/j.febslet.2006.07.027; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Zhou XF, 2002, DEVELOPMENT, V129, P2259; [No title captured]	61	20	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21316	10.1371/journal.pone.0021316	http://dx.doi.org/10.1371/journal.pone.0021316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738635	gold, Green Submitted, Green Published			2022-12-25	WOS:000292092600028
J	Curioni-Fontecedro, A; Nuber, N; Mihic-Probst, D; Seifert, B; Soldini, D; Dummer, R; Knuth, A; van den Broek, M; Moch, H				Curioni-Fontecedro, Alessandra; Nuber, Natko; Mihic-Probst, Daniela; Seifert, Burkhardt; Soldini, Davide; Dummer, Reinhard; Knuth, Alexander; van den Broek, Maries; Moch, Holger			Expression of MAGE-C1/CT7 and MAGE-C2/CT10 Predicts Lymph Node Metastasis in Melanoma Patients	PLOS ONE			English	Article							CANCER-TESTIS ANTIGENS; REPRESENTATIONAL-DIFFERENCE ANALYSIS; CANCER/TESTIS CT ANTIGENS; CYTOLYTIC T-LYMPHOCYTES; MULTIPLE-MYELOMA; HEPATOCELLULAR-CARCINOMA; CUTANEOUS MELANOMA; CELL PROLIFERATION; IMPROVED SURVIVAL; IMMUNE-RESPONSES	MAGE-C1/CT7 and MAGE-C2/CT10 are members of the large MAGE family of cancer-testis (CT) antigens. CT antigens are promising targets for immunotherapy in cancer because their expression is restricted to cancer and germ line cells and a proportion of cancer patients presents with immune responses against CT antigens, which clearly demonstrates their immunogenicity. This study investigates the expression of MAGE-C1/CT7 and MAGE-C2/CT10 in primary and metastatic melanoma. Immunohistochemical staining of tissue microarrays that consisted of 59 primary malignant melanomas of the skin, 163 lymph node and distant melanoma metastases and 68 melanoma cell lines was performed. We found MAGE-C1/CT7 expression in 15 out of 50 (24%) primary melanomas and 15 out of 50 (24%) cell lines, whereas MAGE-C2/CT10 was detected in 17 out of 51 (33%) primary melanomas and 14 out of 68 (17%) cell lines. MAGE-C1/CT7 and MAGE-C2/CT10 were both detected in 40% of melanoma metastases. Patients with MAGE-C1/CT7 or MAGE-C2/CT10 positive primary melanoma had significantly more lymph node metastases (p = 0.005 and p<0.001, resp.). Prediction of lymph node metastasis by MAGE-C1/CT7 and MAGE-C2/CT10 was independent of tumor cell proliferation rate (Ki67 labeling index) in a multivariate analysis (p = 0.01). Our results suggest that the expression of MAGE-C1/CT7 and MAGE-C2/CT10 in primary melanoma is a potent predictor of sentinel lymph node metastasis.	[Curioni-Fontecedro, Alessandra; Nuber, Natko; Knuth, Alexander; van den Broek, Maries] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland; [Curioni-Fontecedro, Alessandra; Nuber, Natko; Knuth, Alexander; van den Broek, Maries] Univ Zurich Hosp, Clin Oncol, CH-8091 Zurich, Switzerland; [Mihic-Probst, Daniela; Soldini, Davide; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Seifert, Burkhardt] Univ Zurich, Inst Social & Prevent Med, Biostat Unit, CH-8006 Zurich, Switzerland; [Dummer, Reinhard] Univ Zurich Hosp, Dermatol Clin, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital	Curioni-Fontecedro, A (corresponding author), Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland.	alessandra.curioni@usz.ch	knuth, alexander/H-2608-2014; van den Broek, Maries/L-6532-2019; Curioni-Fontecedro, Alessandra/R-4950-2018; Mihic-Probst, Daniela/AAB-6374-2021; van den Broek, Maries/G-4128-2016	knuth, alexander/0000-0002-9318-2784; Curioni-Fontecedro, Alessandra/0000-0002-5778-5270; Seifert, Burkhardt/0000-0002-5829-2478; van den Broek, Maries/0000-0002-9489-3692	Krebsliga Zurich; Cancer Research Institute/Ludwig Institute for Cancer Research/Cancer Vaccine Collaborative/Atlantic Philantropies; Terry Fox Foundation; Hanne Liebermann Foundation; Hartmann Muller Foundation; Ellinger Foundation	Krebsliga Zurich; Cancer Research Institute/Ludwig Institute for Cancer Research/Cancer Vaccine Collaborative/Atlantic Philantropies; Terry Fox Foundation; Hanne Liebermann Foundation; Hartmann Muller Foundation; Ellinger Foundation	The funding for materials and researchers involved in this study was kindly donated from the following charity organisations: Krebsliga Zurich (www.krebsliga-zh.ch), Cancer Research Institute/Ludwig Institute for Cancer Research/Cancer Vaccine Collaborative/Atlantic Philantropies (www.cancerresearch.org, www.licr.org), the Terry Fox Foundation (www.terryfox.org), the Hanne Liebermann Foundation, the Hartmann Muller Foundation (http://www.hms.uzh.ch/), and the Ellinger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Atanackovic D, 2007, BLOOD, V109, P1103, DOI 10.1182/blood-2006-04-014480; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Bajetta E, 2002, SEMIN ONCOL, V29, P427, DOI 10.1053/sonc.2002.35238; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; Curioni-Fontecedro A, 2008, LEUKEMIA, V22, P1646, DOI 10.1038/leu.2008.43; Dhodapkar Madhav V, 2003, Cancer Immun, V3, P9; Dummer R, 2010, ANN ONCOL, V21, pv194, DOI 10.1093/annonc/mdq188; Dummer R, 2001, DERMATOLOGY, V203, P75, DOI 10.1159/000051710; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gimotty PA, 2005, J CLIN ONCOL, V23, P8048, DOI 10.1200/JCO.2005.02.0735; Godelaine D, 2007, CANCER IMMUNOL IMMUN, V56, P753, DOI 10.1007/s00262-006-0244-5; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Hu SS, 2009, ARCH DERMATOL, V145, P1369, DOI 10.1001/archdermatol.2009.302; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; Kirkwood JM, 2006, CLIN CANCER RES, V12, p2331S, DOI 10.1158/1078-0432.CCR-05-2538; Kirkwood JM, 2008, J CLIN ONCOL, V26, P3445, DOI 10.1200/JCO.2007.14.6423; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee CC, 2008, J CLIN ONCOL, V26, P535, DOI 10.1200/JCO.2007.14.0285; Lee CC, 2009, J CLIN ONCOL, V27, P3489, DOI 10.1200/JCO.2008.18.9845; Lucas S, 1998, CANCER RES, V58, P743; Luftl M, 2004, BRIT J DERMATOL, V151, P1213, DOI 10.1111/j.1365-2133.2004.06260.x; Ma WB, 2004, INT J CANCER, V109, P698, DOI 10.1002/ijc.20038; Mihic-Probst D, 2006, INT J CANCER, V118, P2262, DOI 10.1002/ijc.21608; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; MORTON DL, 1991, ANN SURG, V214, P491, DOI 10.1097/00000658-199110000-00013; Moschos SJ, 2006, J CLIN ONCOL, V24, P3164, DOI 10.1200/JCO.2005.05.2498; Nuber N, 2010, P NATL ACAD SCI USA, V107, P15187, DOI 10.1073/pnas.1002155107; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Parmiani G, 2003, SEMIN CANCER BIOL, V13, P391, DOI 10.1016/j.semcancer.2003.09.001; Peng JR, 2005, CANCER LETT, V219, P223, DOI 10.1016/j.canlet.2004.07.028; Riener MO, 2009, INT J CANCER, V124, P352, DOI 10.1002/ijc.23966; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Sahin U, 1998, INT J CANCER, V78, P387, DOI 10.1002/(SICI)1097-0215(19981029)78:3<387::AID-IJC22>3.0.CO;2-2; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Serrone L, 2000, J EXP CLIN CANC RES, V19, P21; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Straume O, 2000, CLIN CANCER RES, V6, P1845; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; Wang Y, 2002, J IMMUNOL, V169, P1102, DOI 10.4049/jimmunol.169.2.1102; Zhuang Ran, 2006, Cancer Immun, V6, P7	44	35	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21418	10.1371/journal.pone.0021418	http://dx.doi.org/10.1371/journal.pone.0021418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738656	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000292092600038
J	Froelich, S; Tai, A; Kennedy, K; Zubair, A; Wang, P				Froelich, Steven; Tai, April; Kennedy, Katie; Zubair, Adnan; Wang, Pin			Virus-Receptor Mediated Transduction of Dendritic Cells by Lentiviruses Enveloped with Glycoproteins Derived from Semliki Forest Virus	PLOS ONE			English	Article							MOLECULE 3-GRABBING NONINTEGRIN; HUMAN-IMMUNODEFICIENCY-VIRUS; DC-SIGN; IN-VIVO; CANCER-IMMUNOTHERAPY; HIV-1 INFECTION; T-LYMPHOCYTES; VECTORS; TRANSMISSION; EXPRESSION	Lentiviruses have recently attracted considerable interest for their potential as a genetic modification tool for dendritic cells (DCs). In this study, we explore the ability of lentiviruses enveloped with alphaviral envelope glycoproteins derived from Semliki Forest virus (SFV) to mediate transduction of DCs. We found that SFV glycoprotein (SFV-G)-pseudotyped lentiviruses use C-type lectins (DC-SIGN and L-SIGN) as attachment factors for transduction of DCs. Importantly, SFV-G pseudotypes appear to have enhanced transduction towards C-type lectin-expressing cells when produced under conditions limiting glycosylation to simple high-mannose, N-linked glycans. These results, in addition to the natural DC tropism of SFV-G, offer evidence to support the use of SFV-G-bearing lentiviruses to genetically modify DCs for the study of DC biology and DC-based immunotherapy.	[Froelich, Steven; Tai, April; Kennedy, Katie; Zubair, Adnan; Wang, Pin] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Wang, Pin] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Froelich, S (corresponding author), Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.	pinwang@usc.edu			U.S. National Institute of Health [R01AI68978, P01CA132681]; California HIV/AIDS Research Program [ID09-USC-027]; NATIONAL CANCER INSTITUTE [P01CA132681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068978] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the U.S. National Institute of Health (R01AI68978 and P01CA132681) and California HIV/AIDS Research Program (ID09-USC-027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baribaud F, 2002, J VIROL, V76, P9135, DOI 10.1128/JVI.76.18.9135-9142.2002; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Breckpot K, 2003, J GENE MED, V5, P654, DOI 10.1002/jgm.400; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Dullaers M, 2006, J GENE MED, V8, P3, DOI 10.1002/jgm.846; Dyall J, 2001, BLOOD, V97, P114, DOI 10.1182/blood.V97.1.114; Esslinger C, 2003, J CLIN INVEST, V111, P1673, DOI 10.1172/JCI200317098; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Firat H, 2002, J GENE MED, V4, P38, DOI 10.1002/jgm.243; Froelich S, 2010, IMMUNOPHARM IMMUNOT, V32, P208, DOI 10.3109/08923970903420582; FUHRMANN U, 1984, NATURE, V307, P755, DOI 10.1038/307755a0; Gruber A, 2000, BLOOD, V96, P1327, DOI 10.1182/blood.V96.4.1327.h8001327_1327_1333; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Hu BL, 2011, IMMUNOL REV, V239, P45, DOI 10.1111/j.1600-065X.2010.00967.x; Joo KI, 2008, GENE THER, V15, P1384, DOI 10.1038/gt.2008.87; Kahl CA, 2004, J VIROL, V78, P1421, DOI 10.1128/JVI.78.3.1421-1430.2004; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lizee G, 2004, HUM GENE THER, V15, P393, DOI 10.1089/104303404322959542; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lozach Pierre-Yves, 2007, Methods Mol Biol, V379, P51; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; Marzi A, 2007, J INFECT DIS, V196, pS237, DOI 10.1086/520607; Metharom P, 2001, HUM GENE THER, V12, P2203, DOI 10.1089/10430340152710540; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Morizono K, 2010, J VIROL, V84, P6923, DOI 10.1128/JVI.00435-10; Obermaier Bianca, 2003, Biol Proced Online, V5, P197, DOI 10.1251/bpo62; Oki M, 2001, EXP HEMATOL, V29, P1210, DOI 10.1016/S0301-472X(01)00695-6; Palmowski MJ, 2004, J IMMUNOL, V172, P1582, DOI 10.4049/jimmunol.172.3.1582; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Ribas Antoni, 2002, Current Gene Therapy, V2, P57, DOI 10.2174/1566523023348129; SCHLEGEL R, 1983, CELL, V32, P639, DOI 10.1016/0092-8674(83)90483-X; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Song W, 1997, J EXP MED, V186, P1247, DOI 10.1084/jem.186.8.1247; Strang BL, 2005, J VIROL, V79, P1765, DOI 10.1128/JVI.79.3.1765-1771.2005; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sumimoto H, 2002, J IMMUNOL METHODS, V271, P153, DOI 10.1016/S0022-1759(02)00342-3; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Yang L, 2008, NAT BIOTECHNOL, V26, P326, DOI 10.1038/nbt1390; Zarei S, 2004, J VIROL, V78, P7843, DOI 10.1128/JVI.78.14.7843-7845.2004; Zarei S, 2002, J ALLERGY CLIN IMMUN, V109, P988, DOI 10.1067/mai.2002.124663	50	8	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21491	10.1371/journal.pone.0021491	http://dx.doi.org/10.1371/journal.pone.0021491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738680	Green Published, gold			2022-12-25	WOS:000292092600046
J	Lu, LY; Zhang, YC; Yeung, CH; Zhou, T				Lue, Linyuan; Zhang, Yi-Cheng; Yeung, Chi Ho; Zhou, Tao			Leaders in Social Networks, the Delicious Case	PLOS ONE			English	Article							COMPLEX NETWORKS; DYNAMICS	Finding pertinent information is not limited to search engines. Online communities can amplify the influence of a small number of power users for the benefit of all other users. Users' information foraging in depth and breadth can be greatly enhanced by choosing suitable leaders. For instance in delicious. com, users subscribe to leaders' collection which lead to a deeper and wider reach not achievable with search engines. To consolidate such collective search, it is essential to utilize the leadership topology and identify influential users. Google's PageRank, as a successful search algorithm in the World Wide Web, turns out to be less effective in networks of people. We thus devise an adaptive and parameter-free algorithm, the LeaderRank, to quantify user influence. We show that LeaderRank outperforms PageRank in terms of ranking effectiveness, as well as robustness against manipulations and noisy data. These results suggest that leaders who are aware of their clout may reinforce the development of social networks, and thus the power of collective search.	[Lue, Linyuan; Zhang, Yi-Cheng; Yeung, Chi Ho; Zhou, Tao] Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China; [Lue, Linyuan; Zhang, Yi-Cheng; Yeung, Chi Ho; Zhou, Tao] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Lue, Linyuan; Zhang, Yi-Cheng; Yeung, Chi Ho; Zhou, Tao] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland	University of Shanghai for Science & Technology; University of Electronic Science & Technology of China; University of Fribourg	Lu, LY (corresponding author), Univ Shanghai Sci & Technol, Res Ctr Complex Syst Sci, Shanghai, Peoples R China.	yi-cheng.zhang@unifr.ch	Zhou, Tao/D-5849-2012; zhou, tao/GQA-3572-2022; Yeung, Chi Ho/H-9673-2013	Yeung, Chi Ho/0000-0001-6207-7597; Zhou, Tao/0000-0003-0561-2316	Shanghai Leading Academic Discipline Project [S30501]; EU [213360, 231200]; National Natural Science Foundation of China [10635040, 90924011]; Swiss National Science Foundation [200020-132253]	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); EU(European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work is supported by the Shanghai Leading Academic Discipline Project (under grant S30501), QLectives projects (EU FET-Open Grants 213360 and 231200), National Natural Science Foundation of China under Grant Nos. 10635040 and 90924011 and the Swiss National Science Foundation (200020-132253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000494; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chen P, 2007, J INFORMETR, V1, P8, DOI 10.1016/j.joi.2006.06.001; Douceur JR, 2002, LECT NOTES COMPUT SC, V2429, P251, DOI 10.1007/3-540-45748-8_24; Easley D, 2010, NETWORKS CROWDS MARK; Galam S, 2002, EUR PHYS J B, V25, P403, DOI 10.1140/epjb/e20020045; GAYOAVELLO D, 2010, ARXIVORG10040816; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Lampe C., 2006, P 2006 20 ANN C COMP, P167, DOI [DOI 10.1145/1180875.1180901, 10.1145/1180875.1180901]; Legrain P, 2001, TRENDS GENET, V17, P346, DOI 10.1016/S0168-9525(01)02323-X; Levine Brian Neil, 2006, 2006052 U MASS AMH; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; Masum H, 2004, 1 MONDAY, V9, P7; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Page L., 1999, 199966 STANF INFOLAB; Park J, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10014; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; VIEIRA MV, 2007, P 16 ACM C INF KNOWL, P563; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021	25	463	512	11	165	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21202	10.1371/journal.pone.0021202	http://dx.doi.org/10.1371/journal.pone.0021202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738620	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600018
J	Minard, LV; Lin, LJ; Schultz, MC				Minard, Laura V.; Lin, Ling-ju; Schultz, Michael C.			SWI/SNF and Asf1 Independently Promote Derepression of the DNA Damage Response Genes under Conditions of Replication Stress	PLOS ONE			English	Article							HISTONE CHAPERONE ASF1; CHROMATIN REMODELING COMPLEX; TRANSCRIPTIONAL ACTIVATION; YEAST PHO5; EVICTION; DELETION; GENOME; RECRUITMENT; DISRUPTION; STRAINS	The histone chaperone Asf1 and the chromatin remodeler SWI/SNF have been separately implicated in derepression of the DNA damage response (DDR) genes in yeast cells treated with genotoxins that cause replication interference. Using genetic and biochemical approaches, we have tested if derepression of the DDR genes in budding yeast involves functional interplay between Asf1 and SWI/SNF. We find that Asf1 and SWI/SNF are both recruited to DDR genes under replication stress triggered by hydroxyurea, and have detected a soluble complex that contains Asf1 and the Snf2 subunit of SWI/SNF. SWI/SNF recruitment to DDR genes however does not require Asf1, and deletion of Snf2 does not affect Asf1 occupancy of DDR gene promoters. A checkpoint engagement defect is sufficient to explain the synthetic effect of deletion of ASF1 and SNF2 on derepression of the DDR genes in hydroxyurea-treated cells. Collectively, our results show that the DDR genes fall into a class in which Asf1 and SWI/SNF independently control transcriptional induction.	[Minard, Laura V.; Lin, Ling-ju; Schultz, Michael C.] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta	Minard, LV (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB, Canada.	michael.schultz@ualberta.ca			Canadian Institutes of Health Research (CIHR); Alberta Heritage Foundation for Medical Research (AHFMR); QEII; Government of Canada (CIHR); Government of Canada (Natural Science and Engineering Research Council of Canada)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); QEII; Government of Canada (CIHR)(Canadian Institutes of Health Research (CIHR)); Government of Canada (Natural Science and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Operating support for this work was provided by grants to M. C. S. from the Canadian Institutes of Health Research (CIHR) and the Alberta Heritage Foundation for Medical Research (AHFMR). Personnel support was provided by the Government of Alberta (AHFMR Research Scientist Award to M. C. S.; QEII Scholarships to L. V. M. and L. L.) and the Government of Canada (Master's Award from the CIHR and a scholarship from the Natural Science and Engineering Research Council of Canada to L. V. M.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Basrai MA, 1999, MOL CELL BIOL, V19, P7041; Brachmann CB, 1998, YEAST, V14, P115; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Flanagan JF, 1999, NUCLEIC ACIDS RES, V27, P2022, DOI 10.1093/nar/27.9.2022; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Gray M, 2001, NUCLEIC ACIDS RES, V29, P5156, DOI 10.1093/nar/29.24.5156; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; LAURENT BC, 1993, GENE DEV, V7, P583, DOI 10.1101/gad.7.4.583; Lee KK, 2004, BIOCHEM SOC T, V32, P899, DOI 10.1042/BST0320899; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Minard LV, 2011, J BIOL CHEM, V286, P7082, DOI 10.1074/jbc.M110.193813; Moshkin YM, 2002, GENE DEV, V16, P2621, DOI 10.1101/gad.231202; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; Park YJ, 2008, CURR OPIN STRUC BIOL, V18, P282, DOI 10.1016/j.sbi.2008.04.003; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Pondugula S, 2009, MOL CELL BIOL, V29, P4891, DOI 10.1128/MCB.00222-09; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Rocha W, 2008, FEBS LETT, V582, P1938, DOI 10.1016/j.febslet.2008.03.006; Schermer UJ, 2005, MOL CELL, V19, P279, DOI 10.1016/j.molcel.2005.05.028; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; SIKORSKI RS, 1989, GENETICS, V122, P19; Spry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4191, DOI 10.2741/2380; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Takahata S, 2009, MOL CELL, V34, P405, DOI 10.1016/j.molcel.2009.04.010; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; TRECO DA, 1993, CURRENT PROTOCOLS MO; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Vugt JJFA, 2007, BBA-GENE STRUCT EXPR, V1769, P153, DOI 10.1016/j.bbaexp.2007.01.013; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Williams SK, 2007, CURR OPIN GENET DEV, V17, P88, DOI 10.1016/j.gde.2007.02.001; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zhang Z, 2005, MOL CELL BIOL, V25, P7399, DOI 10.1128/MCB.25.17.7399-7411.2005	56	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21633	10.1371/journal.pone.0021633	http://dx.doi.org/10.1371/journal.pone.0021633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738741	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600066
J	Kenyon, EJ; McEwen, GK; Callaway, H; Elgar, G				Kenyon, Emma J.; McEwen, Gayle K.; Callaway, Heather; Elgar, Greg			Functional Analysis of Conserved Non-Coding Regions Around the Short Stature hox Gene (shox) in Whole Zebrafish Embryos	PLOS ONE			English	Article							HOMEOBOX GENE; POLARIZING ACTIVITY; EXPRESSION; LIMB; PATTERN; MECHANISMS; PHENOTYPES; DELETIONS; MUTATION; ELEMENTS	Background: Mutations in the SHOX gene are responsible for Leri-Weill Dyschondrosteosis, a disorder characterised by mesomelic limb shortening. Recent investigations into regulatory elements surrounding SHOX have shown that deletions of conserved non-coding elements (CNEs) downstream of the SHOX gene produce a phenotype indistinguishable from Leri-Weill Dyschondrosteosis. As this gene is not found in rodents, we used zebrafish as a model to characterise the expression pattern of the shox gene across the whole embryo and characterise the enhancer domains of different CNEs associated with this gene. Methodology/Principal Findings: Expression of the shox gene in zebrafish was identified using in situ hybridization, with embryos showing expression in the blood, putative heart, hatching gland, brain pharyngeal arch, olfactory epithelium, and fin bud apical ectodermal ridge. By identifying sequences showing 65% identity over at least 40 nucleotides between Fugu, human, dog and opossum we uncovered 35 CNEs around the shox gene. These CNEs were compared with CNEs previously discovered by Sabherwal et al., resulting in the identification of smaller more deeply conserved sub-sequence. Sabherwal et al.'s CNEs were assayed for regulatory function in whole zebrafish embryos resulting in the identification of additional tissues under the regulatory control of these CNEs. Conclusion/Significance: Our results using whole zebrafish embryos have provided a more comprehensive picture of the expression pattern of the shox gene, and a better understanding of its regulation via deeply conserved noncoding elements. In particular, we identify additional tissues under the regulatory control of previously identified SHOX CNEs. We also demonstrate the importance of these CNEs in evolution by identifying duplicated shox CNEs and more deeply conserved sub-sequences within already identified CNEs.	[Kenyon, Emma J.] Wellcome Trust Sanger Inst, Cambridge, Cambs, England; [McEwen, Gayle K.] Max Planck Inst Mol Genet, Berlin, Germany; [Callaway, Heather] UCL, London, Greater London, England; [Elgar, Greg] Natl Inst Med Res, MRC, London NW7 1AA, Greater London, England	Wellcome Trust Sanger Institute; Max Planck Society; University of London; University College London; MRC National Institute for Medical Research	Kenyon, EJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, Cambs, England.	ek1@sanger.ac.uk		Elgar, Greg/0000-0001-7323-1596; McEwen, Gayle/0000-0001-5134-1380	MRC National Institute for Medical Research [G0401138]; Medical Research Council [MC_U117597141, G0401138] Funding Source: researchfish; MRC [MC_U117597141, G0401138] Funding Source: UKRI	MRC National Institute for Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant from the MRC National Institute for Medical Research grant number G0401138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1995, DEV BIOL, V170, P243, DOI 10.1006/dbio.1995.1211; AVARON F, 2007, SHH GLI SIGNALLING D, DOI DOI 10.1007/978-0-387-39957-7; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blaschke RJ, 2007, CIRCULATION, V115, P1830, DOI 10.1161/CIRCULATIONAHA.106.637819; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; Durand C, 2010, EUR J HUM GENET, V18, P527, DOI 10.1038/ejhg.2009.216; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; Freitas R, 2006, NATURE, V442, P1033, DOI 10.1038/nature04984; Fried C, 2003, J EXP ZOOL PART B, V299B, P18, DOI 10.1002/jez.b.00037; Gillis JA, 2009, P NATL ACAD SCI USA, V106, P5720, DOI 10.1073/pnas.0810959106; Goode DK, 2011, DEVELOPMENT, V138, P879, DOI 10.1242/dev.055996; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Muller F, 1997, MOL REPROD DEV, V47, P404, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;404::AID-MRD6&gt;3.0.CO;2-O; Ogata T, 2001, J CLIN ENDOCR METAB, V86, P5498, DOI 10.1210/jc.86.11.5498; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Robertson SP, 2000, J MED GENET, V37, P959, DOI 10.1136/jmg.37.12.959; Ross JL, 2001, J CLIN ENDOCR METAB, V86, P5674, DOI 10.1210/jc.86.12.5674; Sabherwal N, 2007, HUM MOL GENET, V16, P210, DOI 10.1093/hmg/ddl470; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Spranger S, 1999, AM J MED GENET, V83, P367, DOI 10.1002/(SICI)1096-8628(19990423)83:5<367::AID-AJMG5>3.0.CO;2-K; Thisse B, 2004, ZFIN DIRECT DATA SUB; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; Vickerman L, 2011, DEV BIOL, V350, P323, DOI 10.1016/j.ydbio.2010.11.031; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Woolfe A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-100; Zinn AR, 2002, AM J MED GENET, V110, P158, DOI 10.1002/ajmg.10422	37	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21498	10.1371/journal.pone.0021498	http://dx.doi.org/10.1371/journal.pone.0021498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731768	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900045
J	Brandstaetter, AS; Rossler, W; Kleineidam, CJ				Brandstaetter, Andreas Simon; Roessler, Wolfgang; Kleineidam, Christoph Johannes			Friends and Foes from an Ant Brain's Point of View - Neuronal Correlates of Colony Odors in a Social Insect	PLOS ONE			English	Article							NESTMATE-RECOGNITION CUES; CUTICULAR HYDROCARBON COMPOSITION; DIRECT BEHAVIORAL EVIDENCE; ANTENNAL LOBE; KIN RECOGNITION; ENSEMBLE REPRESENTATIONS; OLFACTORY PATHWAY; HARVESTER ANTS; CAMPONOTUS; SYSTEM	Background: Successful cooperation depends on reliable identification of friends and foes. Social insects discriminate colony members (nestmates/friends) from foreign workers (non-nestmates/foes) by colony-specific, multi-component colony odors. Traditionally, complex processing in the brain has been regarded as crucial for colony recognition. Odor information is represented as spatial patterns of activity and processed in the primary olfactory neuropile, the antennal lobe (AL) of insects, which is analogous to the vertebrate olfactory bulb. Correlative evidence indicates that the spatial activity patterns reflect odor-quality, i.e., how an odor is perceived. For colony odors, alternatively, a sensory filter in the peripheral nervous system was suggested, causing specific anosmia to nestmate colony odors. Here, we investigate neuronal correlates of colony odors in the brain of a social insect to directly test whether they are anosmic to nestmate colony odors and whether spatial activity patterns in the AL can predict how odor qualities like "friend'' and "foe'' are attributed to colony odors. Methodology/Principal Findings: Using ant dummies that mimic natural conditions, we presented colony odors and investigated their neuronal representation in the ant Camponotus floridanus. Nestmate and non-nestmate colony odors elicited neuronal activity: In the periphery, we recorded sensory responses of olfactory receptor neurons (electroantennography), and in the brain, we measured colony odor specific spatial activity patterns in the AL (calcium imaging). Surprisingly, upon repeated stimulation with the same colony odor, spatial activity patterns were variable, and as variable as activity patterns elicited by different colony odors. Conclusions: Ants are not anosmic to nestmate colony odors. However, spatial activity patterns in the AL alone do not provide sufficient information for colony odor discrimination and this finding challenges the current notion of how odor quality is coded. Our result illustrates the enormous challenge for the nervous system to classify multi-component odors and indicates that other neuronal parameters, e. g., precise timing of neuronal activity, are likely necessary for attribution of odor quality to multi-component odors.	[Brandstaetter, Andreas Simon; Roessler, Wolfgang; Kleineidam, Christoph Johannes] Univ Wurzburg, Biozentrum, Dept Behav Physiol & Sociobiol Zool 2, Wurzburg, Germany; [Kleineidam, Christoph Johannes] Univ Konstanz, Dept Biol, Constance, Germany	University of Wurzburg; University of Konstanz	Brandstaetter, AS (corresponding author), CNRS, UPR 9034, LEGS, Bat 13,BP 1, Gif Sur Yvette, France.	Andreas.Brandstaetter@legs.cnrs-gif.fr	Rössler, Wolfgang/E-9526-2019; Kleineidam, Christoph J/A-6529-2009; Brandstaetter, Andreas/C-1605-2009	Rössler, Wolfgang/0000-0002-5195-8214; Kleineidam, Christoph J/0000-0003-0671-1455; 	German Research Foundation (DFG) [SFB 554/A6]; German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; University of Wurzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; University of Wurzburg	This research was supported by the German Research Foundation (DFG; SFB 554/A6). A.S.B. was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. This publication was funded by the German Research Foundation ( DFG) and the University of Wurzburg in the funding program: Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; BAGNERES AG, 1991, EXPERIENTIA, V47, P106, DOI 10.1007/BF02041269; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Brandstaetter AS, 2008, NATURWISSENSCHAFTEN, V95, P601, DOI 10.1007/s00114-008-0360-5; Brandstaetter AS, 2010, CHEM SENSES, V35, P323, DOI 10.1093/chemse/bjq022; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Buczkowski G, 2005, J CHEM ECOL, V31, P829, DOI 10.1007/s10886-005-3547-7; CARLIN NF, 1983, SCIENCE, V222, P1027, DOI 10.1126/science.222.4627.1027; CARLIN NF, 1986, BEHAV ECOL SOCIOBIOL, V19, P123, DOI 10.1007/BF00299947; CARLIN NF, 1987, BEHAV ECOL SOCIOBIOL, V20, P219, DOI 10.1007/BF00299736; CARLIN NF, 1987, BEHAV ECOL SOCIOBIOL, V20, P209, DOI 10.1007/BF00299735; D'Ettorre P, 2004, J EXP BIOL, V207, P1085, DOI 10.1242/jeb.00865; d'Ettorre P, 2010, ANT ECOLOGY, P194; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Deisig N, 2010, J NEUROPHYSIOL, V103, P2185, DOI 10.1152/jn.00342.2009; Dietemann V, 2003, P NATL ACAD SCI USA, V100, P10341, DOI 10.1073/pnas.1834281100; Dupuy F, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-28; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Endler A, 2004, P NATL ACAD SCI USA, V101, P2945, DOI 10.1073/pnas.0308447101; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Gadau J, 1996, MOL ECOL, V5, P785, DOI 10.1111/j.1365-294X.1996.tb00374.x; Galizia CG, 2008, ENTOMOL EXP APPL, V128, P81, DOI 10.1111/j.1570-7458.2007.00661.x; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 1999, NATURWISSENSCHAFTEN, V86, P533, DOI 10.1007/s001140050669; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Guerrieri FJ, 2008, J EXP BIOL, V211, P1109, DOI 10.1242/jeb.008508; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinze J, 2002, BEHAV ECOL SOCIOBIOL, V52, P59, DOI 10.1007/s00265-002-0491-1; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM, P522; Hourcade B, 2010, J NEUROSCI, V30, P6461, DOI 10.1523/JNEUROSCI.0841-10.2010; Hourcade B, 2009, LEARN MEMORY, V16, P607, DOI 10.1101/lm.1445609; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Kaib M, 2000, J COMP PHYSIOL A, V186, P939, DOI 10.1007/s003590000146; Katzerke A, 2006, BEHAV ECOL SOCIOBIOL, V61, P143, DOI 10.1007/s00265-006-0245-6; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Kleineidam Christoph J., 2009, P195; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Lahav S, 2001, J CHEM ECOL, V27, P927, DOI 10.1023/A:1010382919227; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; Lei H, 2008, J CHEM ECOL, V34, P915, DOI 10.1007/s10886-008-9487-2; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Martin JP, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00159; MICHENER CD, 1969, ANNU REV ENTOMOL, V14, P299, DOI 10.1146/annurev.en.14.010169.001503; MOREL L, 1988, BEHAV ECOL SOCIOBIOL, V22, P175, DOI 10.1007/BF00300567; Najar-Rodriguez AJ, 2010, J EXP BIOL, V213, P3388, DOI 10.1242/jeb.046284; Nakanishi A, 2010, J COMP NEUROL, V518, P2186, DOI 10.1002/cne.22326; Nielsen J, 1999, INSECT SOC, V46, P58, DOI 10.1007/s000400050113; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Perisse E, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-30; PROVOST E, 1993, INSECT BIOCHEM MOLEC, V23, P945, DOI 10.1016/0965-1748(93)90112-6; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Ruchty M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00174; Silbering AF, 2008, J NEUROSCI, V28, P13075, DOI 10.1523/JNEUROSCI.2973-08.2008; Singer TL, 1998, AM ZOOL, V38, P394; SOROKER V, 1994, NATURWISSENSCHAFTEN, V81, P510; Stroeymeyt N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012377; Thomas ML, 1999, NATURWISSENSCHAFTEN, V86, P87, DOI 10.1007/s001140050578; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; Vander Meer Robert K., 1998, P79; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2115, DOI 10.1007/BF01207442; Wagner D, 2000, J CHEM ECOL, V26, P2245, DOI 10.1023/A:1005529224856; Wagner D, 2001, J CHEM ECOL, V27, P1805, DOI 10.1023/A:1010408725464; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; WALLIS D. L., 1963, ANIMAL BEHAVIOUR, V11, P164, DOI 10.1016/0003-3472(63)90025-3; Zube C, 2008, J COMP NEUROL, V506, P425, DOI 10.1002/cne.21548	78	36	36	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21383	10.1371/journal.pone.0021383	http://dx.doi.org/10.1371/journal.pone.0021383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731724	gold, Green Published, Green Submitted			2022-12-25	WOS:000292035400032
J	Glotzbach, JP; Januszyk, M; Vial, IN; Wong, VW; Gelbard, A; Kalisky, T; Thangarajah, H; Longaker, MT; Quake, SR; Chu, G; Gurtner, GC				Glotzbach, Jason P.; Januszyk, Michael; Vial, Ivan N.; Wong, Victor W.; Gelbard, Alexander; Kalisky, Tomer; Thangarajah, Hariharan; Longaker, Michael T.; Quake, Stephen R.; Chu, Gilbert; Gurtner, Geoffrey C.			An Information Theoretic, Microfluidic-Based Single Cell Analysis Permits Identification of Subpopulations among Putatively Homogeneous Stem Cells	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; HEMATOPOIETIC STEM; CLUSTER-ANALYSIS; NOISE; HETEROGENEITY; ARCHITECTURE; EVOLUTION	An incomplete understanding of the nature of heterogeneity within stem cell populations remains a major impediment to the development of clinically effective cell-based therapies. Transcriptional events within a single cell are inherently stochastic and can produce tremendous variability, even among genetically identical cells. It remains unclear how mammalian cellular systems overcome this intrinsic noisiness of gene expression to produce consequential variations in function, and what impact this has on the biologic and clinical relevance of highly 'purified' cell subgroups. To address these questions, we have developed a novel method combining microfluidic-based single cell analysis and information theory to characterize and predict transcriptional programs across hundreds of individual cells. Using this technique, we demonstrate that multiple subpopulations exist within a well-studied and putatively homogeneous stem cell population, murine long-term hematopoietic stem cells (LT-HSCs). These subgroups are defined by nonrandom patterns that are distinguishable from noise and are consistent with known functional properties of these cells. We anticipate that this analytic framework can also be applied to other cell types to elucidate the relationship between transcriptional and phenotypic variation.	[Glotzbach, Jason P.; Januszyk, Michael; Vial, Ivan N.; Wong, Victor W.; Gelbard, Alexander; Thangarajah, Hariharan; Longaker, Michael T.; Gurtner, Geoffrey C.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Kalisky, Tomer; Quake, Stephen R.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Chu, Gilbert] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Chu, Gilbert] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Glotzbach, JP (corresponding author), Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA.	ggurtner@stanford.edu	Glotzbach, Jason P./O-4394-2019; Gelbard, Alexander/K-1976-2014	Glotzbach, Jason P./0000-0002-8002-9422; Gelbard, Alexander/0000-0003-0078-1305	National Institutes of Health, National Institute of Diabetes, Digestive Disease Kidney Disease [2 RO1 DK074095-07]; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health [NRSA F32DK088448-01]; American Heart Association [09POST2220348]; Hagey individual fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074095] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes, Digestive Disease Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Hagey individual fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was supported by National Institutes of Health, National Institute of Diabetes, Digestive Disease Kidney Disease Grant 2 RO1 DK074095-07 to GCG and the Oak Foundation and Hagey Laboratory for Pediatric Regenerative Medicine grants to GCG and MTL. JPG was supported by National Institutes of Health NRSA F32DK088448-01. MJ was supported by American Heart Association Individual Fellowship #09POST2220348 and INV was supported by a Hagey individual fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; BOZDOGAN H, 1984, ANN I STAT MATH, V36, P163, DOI 10.1007/BF02481962; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Glauche I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000447; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Ince RAA, 2010, NEURAL NETWORKS, V23, P713, DOI 10.1016/j.neunet.2010.05.008; Kerr G, 2008, COMPUT BIOL MED, V38, P283, DOI 10.1016/j.compbiomed.2007.11.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; LANDAUER R, 1961, IBM J RES DEV, V5, P183, DOI 10.1147/rd.53.0183; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Li XJ, 2011, LAB CHIP, V11, P1378, DOI 10.1039/c0lc00626b; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Metcalf D, 2007, IMMUNITY, V26, P669, DOI 10.1016/j.immuni.2007.05.012; Nakauchi H, 1999, ANN NY ACAD SCI, V872, P57, DOI 10.1111/j.1749-6632.1999.tb08453.x; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raaijmakers MHGP, 2008, CELL, V135, P1006, DOI 10.1016/j.cell.2008.11.034; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Ramos CA, 2006, PLOS GENET, V2, P1487, DOI 10.1371/journal.pgen.0020159; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld S, 2009, GENE REGUL SYST BIO, V3, P1; Scherrer K, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100123; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; VANVALEN L, 1974, J THEOR BIOL, V45, P235, DOI 10.1016/0022-5193(74)90053-8; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048	50	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21211	10.1371/journal.pone.0021211	http://dx.doi.org/10.1371/journal.pone.0021211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731674	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700046
J	Katiyar, SK; Mantena, SK; Meeran, SM				Katiyar, Santosh K.; Mantena, Sudheer K.; Meeran, Syed M.			Silymarin Protects Epidermal Keratinocytes from Ultraviolet Radiation-Induced Apoptosis and DNA Damage by Nucleotide Excision Repair Mechanism	PLOS ONE			English	Article							GREEN TEA POLYPHENOLS; INDUCED IMMUNOSUPPRESSION; SKIN-CANCER; ACTIVATION; PHOTOCARCINOGENESIS; INTERLEUKIN-12; ENHANCEMENT; CONTRIBUTE	Solar ultraviolet (UV) radiation is a well recognized epidemiologic risk factor for melanoma and non-melanoma skin cancers. This observation has been linked to the accumulation of UVB radiation-induced DNA lesions in cells, and that finally lead to the development of skin cancers. Earlier, we have shown that topical treatment of skin with silymarin, a plant flavanoid from milk thistle (Silybum marianum), inhibits photocarcinogenesis in mice; however it is less understood whether chemopreventive effect of silymarin is mediated through the repair of DNA lesions in skin cells and that protect the cells from apoptosis. Here, we show that treatment of normal human epidermal keratinocytes (NHEK) with silymarin blocks UVB-induced apoptosis of NHEK in vitro. Silymarin reduces the amount of UVB radiation-induced DNA damage as demonstrated by reduced amounts of cyclobutane pyrimidine dimers (CPDs) and as measured by comet assay, and that ultimately may lead to reduced apoptosis of NHEK. The reduction of UV radiation-induced DNA damage by silymarin appears to be related with induction of nucleotide excision repair (NER) genes, because UV radiation-induced apoptosis was not blocked by silymarin in NER-deficient human fibroblasts. Cytostaining and dot-blot analysis revealed that silymarin repaired UV-induced CPDs in NER-proficient fibroblasts from a healthy individual but did not repair UV-induced CPD-positive cells in NER-deficient fibroblasts from patients suffering from xeroderma pigmentosum complementation-A disease. Similarly, immunohistochemical analysis revealed that silymarin did not reduce the number of UVB-induced sunburn/apoptotic cells in the skin of NER-deficient mice, but reduced the number of sunburn cells in their wild-type counterparts. Together, these results suggest that silymarin exert the capacity to reduce UV radiation-induced DNA damage and, thus, prevent the harmful effects of UV radiation on the genomic stability of epidermal cells.	[Katiyar, Santosh K.; Mantena, Sudheer K.; Meeran, Syed M.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Katiyar, SK (corresponding author), Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA.	skatiyar@uab.edu	Meeran, Syed Musthapa/AAG-2157-2020	Meeran, Syed Musthapa/0000-0003-3859-146X	National Cancer Institute [RO1 CA140197]; Veterans Administration Merit Review Award; NATIONAL CANCER INSTITUTE [R01CA140197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration Merit Review Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	RO1 CA140197 by National Cancer Institute (http//www.cancer.gov) and the Veterans Administration Merit Review Award *SKK). The human keratinocytes were obtained from the UAB Skin Diseases Research Center (AR050948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Camenisch U, 2006, NAT STRUCT MOL BIOL, V13, P278, DOI 10.1038/nsmb1061; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dong L, 2010, CANCER RES, V70, P3547, DOI 10.1158/0008-5472.CAN-09-4596; Housman TS, 2003, J AM ACAD DERMATOL, V48, P425, DOI 10.1067/mjd.2003.186; Katiyar SK, 2010, CANCER PREV RES, V3, P179, DOI 10.1158/1940-6207.CAPR-09-0044; Katiyar SK, 2005, INT J ONCOL, V26, P169; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Katiyar SK, 1997, JNCI-J NATL CANCER I, V89, P556, DOI 10.1093/jnci/89.8.556; Katyar SK, 2008, PHOTOCHEM PHOTOBIOL, V84, P266, DOI 10.1111/j.1751-1097.2007.00241.x; Kolgen W, 2003, J INVEST DERMATOL, V121, P751, DOI 10.1046/j.1523-1747.2003.12476.x; Kulms D, 2002, ONCOGENE, V21, P5844, DOI 10.1038/sj.onc.1205743; Kulms D, 1999, P NATL ACAD SCI USA, V96, P7974, DOI 10.1073/pnas.96.14.7974; Mantena SK, 2006, MOL CANCER THER, V5, P296, DOI 10.1158/1535-7163.MCT-05-0448; Mantena SK, 2006, FREE RADICAL BIO MED, V40, P1603, DOI 10.1016/j.freeradbiomed.2005.12.032; Meeran SM, 2006, MOL CANCER THER, V5, P1660, DOI 10.1158/1535-7163.MCT-06-0095; Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354; Murphy G, 2001, EXP DERMATOL, V10, P155, DOI 10.1034/j.1600-0625.2001.010003155.x; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schwarz A, 2002, NAT CELL BIOL, V4, P26, DOI 10.1038/ncb717; Stege H, 2000, P NATL ACAD SCI USA, V97, P1790, DOI 10.1073/pnas.030528897; Vaid M, 2010, CANCER PREV RES, V3, P1621, DOI 10.1158/1940-6207.CAPR-10-0137	22	68	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21410	10.1371/journal.pone.0021410	http://dx.doi.org/10.1371/journal.pone.0021410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731736	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700079
J	Neal, CL; Xu, J; Li, P; Mori, S; Yang, J; Neal, NN; Zhou, X; Wyszomierski, SL; Yu, D				Neal, C. L.; Xu, J.; Li, P.; Mori, S.; Yang, J.; Neal, N. N.; Zhou, X.; Wyszomierski, S. L.; Yu, D.			Overexpression of 14-3-3 zeta in cancer cells activates PI3K via binding the p85 regulatory subunit	ONCOGENE			English	Article						14-3-3 zeta; breast cancer; PI3K; Akt	BREAST-CANCER; CAMP-PKA; 14-3-3-PROTEINS; INHIBITION; PROTEINS; SURVIVAL; GROWTH; PHOSPHORYLATION; ISOFORMS; RECEPTOR	The ubiquitously expressed 14-3-3 proteins regulate many pathways involved in transformation. Previously, we found that 14-3-3 zeta overexpression increased Akt phosphorylation in human mammary epithelial cells. Here, we investigated the clinical relevance and molecular mechanism of 14-3-3 zeta-overexpression-mediated Akt phosphorylation, and its potential impact on breast cancer progression. We found that 14-3-3 zeta overexpression was significantly (P = 0.005) associated with increased Akt phosphorylation in human breast tumors. Additionally, 14-3-3 zeta overexpression combined with strong Akt phosphorylation was significantly (P = 0.01) associated with increased cancer recurrence in patients. In contrast, knockdown of 14-3-3 zeta expression by small interfering RNA in cancer cell lines and tumor xenografts reduced Akt phosphorylation. Furthermore, 14-3-3 zeta enhanced Akt phosphorylation through activation of phosphoinositide 3-kinase (PI3K). Mechanistically, 14-3-3 zeta bound to the p85 regulatory subunit of PI3K and increased PI3K translocation to the cell membrane. A single 14-3-3-binding motif encompassing serine 83 on p85 is largely responsible for 14-3-3 zeta-mediated p85 binding and PI3K/Akt activation. Mutation of serine 83 to alanine on p85 inhibited 14-3-3 zeta binding to the p85 subunit of PI3K, reduced PI3K membrane localization and activation, impeded anchorage-independent growth and enhanced stress-induced apoptosis. These findings revealed a novel mechanism by which 14-3-3 zeta overexpression activates PI3K, a key node in the mitogenic signaling network known to promote malignancies in many cell types. Oncogene (2012) 31, 897-906; doi: 10.1038/onc.2011.284; published online 11 July 2011	[Neal, C. L.; Xu, J.; Li, P.; Mori, S.; Yang, J.; Neal, N. N.; Zhou, X.; Wyszomierski, S. L.; Yu, D.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xu, J.; Yang, J.; Yu, D.] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center	Yu, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Bolvard,Box 108, Houston, TX 77030 USA.	dyu@mdanderson.org		Xu, Jia/0000-0003-0254-6261; Yu, Dihua/0000-0001-6231-9381	NIH [P30-CA 16672, RO1-CA112567, PO1-CA099031]; Department of Defense (DOD) [BC050006, W81XWH-08-1-0712]; Susan G Komen Breast Cancer Foundation [KG091020]; NATIONAL CANCER INSTITUTE [R01CA112567, P01CA099031, P30CA016672] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from NIH P30-CA 16672 ( MDACC); RO1-CA112567, PO1-CA099031 project 4, Department of Defense (DOD) Center of Excellence (BC050006) subproject, DOD Synergistic Award W81XWH-08-1-0712 and Susan G Komen Breast Cancer Foundation Promise Grant KG091020 ( D Yu). Dr Dihua Yu is the Hubert L and Olive Stringer Distinguished Chair in Basic Science, MDACC. We thank Dr Lewis Cantley for providing p85 knockout MEFs. We also thank X Du, K Matias, T Chen, J Hannay, S Zhang and S Rehman for reagents, suggestions and manuscript reading.	AITKEN A, 1995, TRENDS BIOCHEM SCI, V20, P95, DOI 10.1016/S0968-0004(00)88971-9; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883; Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; BONNEFOYBERARD N, 1995, P NATL ACAD SCI USA, V92, P10142, DOI 10.1073/pnas.92.22.10142; Brachmann SA, 2005, MOL CELL BIOL, V25, P2593, DOI 10.1128/MCB.25.7.2593-2606.2005; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; Craparo A, 1997, J BIOL CHEM, V272, P11663; Danes CG, 2008, CANCER RES, V68, P1760, DOI 10.1158/0008-5472.CAN-07-3177; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kim SJ, 2005, FEBS LETT, V579, P534, DOI 10.1016/j.febslet.2004.12.024; Lonic A, 2008, MOL CELL BIOL, V28, P3372, DOI 10.1128/MCB.01837-07; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Munday AD, 2000, BLOOD, V96, P577; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Oksvold MP, 2004, FEBS LETT, V569, P207, DOI 10.1016/j.febslet.2004.05.068; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Tan M, 1997, CANCER RES, V57, P1199; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	32	67	68	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	7					897	906		10.1038/onc.2011.284	http://dx.doi.org/10.1038/onc.2011.284			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21743495	Green Accepted			2022-12-25	WOS:000300615800008
J	Behrendorff, N; Dolai, S; Hong, WJ; Gaisano, HY; Thorn, P				Behrendorff, Natasha; Dolai, Subhankar; Hong, Wanjin; Gaisano, Herbert Y.; Thorn, Peter			Vesicle-associated Membrane Protein 8 (VAMP8) Is a SNARE (Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor) Selectively Required for Sequential Granule-to-granule Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC ACINAR-CELLS; REGULATED EXOCYTOSIS; ZYMOGEN GRANULES; COMPOUND EXOCYTOSIS; MAST-CELLS; V-SNARE; RELEASE; SECRETION; DISTINCT; ENDOBREVIN/VAMP-8	Compound exocytosis is found in many cell types and is the major form of regulated secretion in acinar and mast cells. Its key characteristic is the homotypic fusion of secretory granules. These then secrete their combined output through a single fusion pore to the outside. The control of compound exocytosis remains poorly understood. Although soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) such as syntaxin 2, SNAP23 (synaptosome-associated protein of 23 kDa), and SNAP25 have been suggested to play a role, none has been proven. Vesicle-associated membrane protein 8 (VAMP8) is a SNARE first associated with endocytic processes but more recently has been suggested as an R-SNARE in regulated exocytosis. Secretion in acinar cells is reduced when VAMP8 function is inhibited and is less in VAMP8 knock-out mice. Based on electron microscopy experiments, it was suggested that VAMP8 may be involved in compound exocytosis. Here we have tested the hypothesis that VAMP8 controls homotypic granule-to-granule fusion during sequential compound exocytosis. We use a new assay to distinguish primary fusion events (fusion with the cell membrane) from secondary fusion events (granule-granule fusion). Our data show the pancreatic acinar cells from VAMP8 knock-out animals have a specific reduction in secondary granule fusion but that primary granule fusion is unaffected. Furthermore, immunoprecipitation experiments show syntaxin 2 association with VAMP2, whereas syntaxin 3 associates with VAMP8. Taken together our data indicate that granule-to-granule fusion is regulated by VAMP8 containing SNARE complexes distinct from those that regulate primary granule fusion.	[Behrendorff, Natasha; Thorn, Peter] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Dolai, Subhankar; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Hong, Wanjin] Inst Mol & Cellular Biol, Singapore 138673, Singapore	University of Queensland; University of Toronto; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Thorn, P (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	p.thorn@uq.edu.au	Behrendorff, Natasha/B-4908-2010; Thorn, Peter/F-7030-2010; HONG, Wanjin/E-9927-2010	Thorn, Peter/0000-0002-3228-770X; 	Australian Research Council [DP110100642]; National Health and Medical Research Council [APP1002520]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant DP110100642 (to P. T.) and National Health and Medical Research Council Grant APP1002520 (to P. T. and H. Y. G.).	Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; ALVAREZ DT, 1990, J GEN PHYSIOL, V95, P397, DOI DOI 10.1085/JGP.95.3.397; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Behrendorff N, 2010, GASTROENTEROLOGY, V139, P1711, DOI 10.1053/j.gastro.2010.07.051; BRAUN JEA, 1994, J BIOL CHEM, V269, P5328; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; FALKOWSKI MA, 2011, AM J PHYSL; Falkowski MA, 2010, J BIOL CHEM, V285, P35558, DOI 10.1074/jbc.M110.146597; Freedman SD, 1998, EUR J CELL BIOL, V75, P163, DOI 10.1016/S0171-9335(98)80058-7; Gaisano HY, 1996, GASTROENTEROLOGY, V111, P1661, DOI 10.1016/S0016-5085(96)70030-6; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hansen NJ, 1999, J BIOL CHEM, V274, P22871, DOI 10.1074/jbc.274.32.22871; ICHIKAWA A, 1965, J CELL BIOL, V24, P369, DOI 10.1083/jcb.24.3.369; Larina O, 2005, J CELL SCI, V118, P4131, DOI 10.1242/jcs.02533; Larina O, 2007, MOL BIOL CELL, V18, P3502, DOI 10.1091/mbc.E07-01-0024; Lippert U, 2007, FEBS LETT, V581, P3479, DOI 10.1016/j.febslet.2007.06.057; Loo LS, 2009, EUR J IMMUNOL, V39, P3520, DOI 10.1002/eji.200939378; Low JT, 2010, J CELL SCI, V123, P3201, DOI 10.1242/jcs.071225; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Pickett JA, 2005, J BIOL CHEM, V280, P1506, DOI 10.1074/jbc.M411967200; Polgar J, 2002, BLOOD, V100, P1081, DOI 10.1182/blood.V100.3.1081; Ren QS, 2007, MOL BIOL CELL, V18, P24, DOI 10.1091/mbc.E06-09-0785; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Steegmaier M, 2000, TRAFFIC, V1, P553, DOI 10.1034/j.1600-0854.2000.010705.x; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takahashi N, 2004, J CELL BIOL, V165, P255, DOI 10.1083/jcb.200312033; Thorn P, 1996, CELL CALCIUM, V20, P203, DOI 10.1016/S0143-4160(96)90107-4; Thorn P, 2004, P NATL ACAD SCI USA, V101, P6774, DOI 10.1073/pnas.0400336101; Turvey MR, 2004, PFLUG ARCH EUR J PHY, V448, P552, DOI 10.1007/s00424-004-1288-z; Valentijn JA, 2000, P NATL ACAD SCI USA, V97, P1091, DOI 10.1073/pnas.97.3.1091; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Wang CC, 2007, MOL BIOL CELL, V18, P1056, DOI 10.1091/mbc.E06-10-0974; Wang CC, 2010, MOL CELL BIOL, V30, P333, DOI 10.1128/MCB.00814-09; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; Wong SH, 1998, MOL BIOL CELL, V9, P1549, DOI 10.1091/mbc.9.6.1549	43	58	58	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29627	29634		10.1074/jbc.M111.265199	http://dx.doi.org/10.1074/jbc.M111.265199			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21733851	Green Published, hybrid			2022-12-25	WOS:000294046600021
J	Grasse, N; Mamedov, F; Becker, K; Styring, S; Rogner, M; Nowaczyk, MM				Grasse, Nicole; Mamedov, Fikret; Becker, Kristin; Styring, Stenbjorn; Roegner, Matthias; Nowaczyk, Marc M.			Role of Novel Dimeric Photosystem II (PSII)-Psb27 Protein Complex in PSII Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; D1 PROTEIN; PSB27 PROTEIN; THERMOSYNECHOCOCCUS-ELONGATUS; THERMOPHILIC CYANOBACTERIUM; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANE; MANGANESE CLUSTER; PHOTOINHIBITION; STRESS	The multisubunit membrane protein complex Photosystem II (PSII) catalyzes one of the key reactions in photosynthesis: the light-driven oxidation of water. Here, we focus on the role of the Psb27 assembly factor, which is involved in biogenesis and repair after light-induced damage of the complex. Weshow that Psb27 is essential for the survival of cyanobacterial cells grown under stress conditions. The combination of cold stress (30 degrees C) and high light stress (1000 mu mol of photons x m(-2) x s(-1)) led to complete inhibition of growth in a Delta psb27 mutant strain of the thermophilic cyanobacterium Thermosynechococcus elongatus, whereas wild-type cells continued to grow. Moreover, Psb27-containing PSII complexes became the predominant PSII species in preparations from wild-type cells grown under cold stress. Two different PSII-Psb27 complexes were isolated and characterized in this study. The first complex represents the known monomeric PSII-Psb27 species, which is involved in the assembly of PSII. Additionally, a novel dimeric PSII-Psb27 complex could be allocated in the repair cycle, i.e. in processes after inactivation of PSII, by N-15 pulse-label experiments followed by mass spectrometry analysis. Comparison with the corresponding PSII species from Delta psb27 mutant cells showed that Psb27 prevented the release of manganese from the previously inactivated complex. These results indicate a more complex role of the Psb27 protein within the life cycle of PSII, especially under stress conditions.	[Grasse, Nicole; Becker, Kristin; Roegner, Matthias; Nowaczyk, Marc M.] Ruhr Univ Bochum, Fac Biol & Biotechnol, D-44780 Bochum, Germany; [Mamedov, Fikret; Styring, Stenbjorn] Uppsala Univ, Angstrom Lab, Dept Chem, SE-75120 Uppsala, Sweden	Ruhr University Bochum; Uppsala University	Nowaczyk, MM (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, ND3-126,Univ Str 150, D-44780 Bochum, Germany.	marc.m.nowaczyk@rub.de	Nowaczyk, Marc/D-4214-2014; Mamedov, Fikret/A-1761-2016; Styring, Stenbjörn/L-8414-2016	Nowaczyk, Marc/0000-0002-9269-0672; Mamedov, Fikret/0000-0002-6218-3039; Styring, Stenbjörn/0000-0002-2803-9244	Deutsche Forschungsgemeinschaft [SFB 480, C1]; Protein Research Department of the Ruhr-Universitat Bochum; European Union; Swedish Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Protein Research Department of the Ruhr-Universitat Bochum; European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 480, Project C1; to N. G., M. M. N., and M. R.), the Protein Research Department of the Ruhr-Universitat Bochum (to M. M. N. and M. R.), and the European Union (SOLAR-H2) and by the Swedish Research Council (to F. M. and S. S.).	Albaum SP, 2009, BIOINFORMATICS, V25, P3128, DOI 10.1093/bioinformatics/btp568; Allakhverdiev SI, 2004, BBA-BIOENERGETICS, V1657, P23, DOI 10.1016/j.bbabio.2004.03.003; ANBUDURAI PR, 1994, P NATL ACAD SCI USA, V91, P8082, DOI 10.1073/pnas.91.17.8082; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; AWRAMIK SM, 1992, PHOTOSYNTH RES, V33, P75, DOI 10.1007/BF00039172; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; Cormann KU, 2009, BIOCHEMISTRY-US, V48, P8768, DOI 10.1021/bi9012726; Danielsson R, 2006, J BIOL CHEM, V281, P14241, DOI 10.1074/jbc.M600634200; Goussias C, 2002, PHILOS T R SOC B, V357, P1369, DOI 10.1098/rstb.2002.1134; GOUSSIAS C, 2002, PHILOS T R SOC LON B, V357, P1419; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103; Hongsthong A, 2008, FEMS MICROBIOL LETT, V288, P92, DOI 10.1111/j.1574-6968.2008.01330.x; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P171, DOI 10.1093/pcp/pch015; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Laczko-Dobos H, 2009, BIOCHEMISTRY-US, V48, P10120, DOI 10.1021/bi9011034; Liu HJ, 2011, J BIOL CHEM, V286, P24865, DOI 10.1074/jbc.M111.246231; Los Dmitry A., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P221; Mabbitt PD, 2009, BIOCHEMISTRY-US, V48, P8771, DOI 10.1021/bi901309c; Mamedov F, 2007, PHYSIOL PLANTARUM, V131, P41, DOI 10.1111/j.1399-3054.2007.00938.x; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; Muhlenhoff U, 1996, MOL GEN GENET, V252, P93, DOI 10.1007/s004389670011; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; Nowaczyk MM, 2010, EUR J CELL BIOL, V89, P974, DOI 10.1016/j.ejcb.2010.08.008; Ohnishi N, 2005, BIOCHEMISTRY-US, V44, P8494, DOI 10.1021/bi047518q; Rexroth S, 2004, BBA-BIOENERGETICS, V1658, P202, DOI 10.1016/j.bbabio.2004.05.014; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Rutherford AW, 2004, SCIENCE, V303, P1782, DOI 10.1126/science.1096767; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wei LL, 2010, J BIOL CHEM, V285, P21391, DOI 10.1074/jbc.M110.105064; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zhang LX, 1999, J BIOL CHEM, V274, P16062, DOI 10.1074/jbc.274.23.16062; Zhang LX, 2000, PLANT CELL, V12, P1769, DOI 10.1105/tpc.12.9.1769	45	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29548	29555		10.1074/jbc.M111.238394	http://dx.doi.org/10.1074/jbc.M111.238394			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737447	hybrid, Green Published			2022-12-25	WOS:000294046600012
J	Shen, W; Gorelick, RJ; Bambara, RA				Shen, Wen; Gorelick, Robert J.; Bambara, Robert A.			HIV-1 Nucleocapsid Protein Increases Strand Transfer Recombination by Promoting Dimeric G-quartet Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COPY-CHOICE RECOMBINATION; REVERSE TRANSCRIPTION; DNA-SYNTHESIS; GENOMIC RNA; RETROVIRAL RECOMBINATION; TRANSFER MECHANISM; G-QUADRUPLEXES; TELOMERIC DNA; BINDING-SITE	A preferred site for HIV-1 recombination was identified in vivo and in vitro surrounding the beginning of the HIV-1 gag gene. This G-rich gag hotspot for recombination contains three evenly spaced G-runs that stalled reverse transcriptase. Disruption of the G-runs suppressed both the associated pausing and strand transfer in vitro. Significantly, this same gag sequence was able to fold into a G-quartet monomer, dimer, and tetramer, depending on the cations employed. The pause band at the G-run (nucleotide (nt) 405-409), which was predicted to be involved in forming a G-quartet monomer, diminished with increased HIV-1 nucleocapsid (NC) protein. More NC induced stronger pauses at other G-runs (nt 363-367 and nt 382-384), a region that forms a G-quartet dimer, adhering the two RNA templates. We hypothesized that NC induces the unfolding of the monomeric G-quartet but stabilizes the dimeric interaction. We tested this by inserting a known G-quartet formation sequence, 5'-(UGGGGU)(4)-3', into a relatively structure-free template from the HIV-1 pol gene. Strand transfer assays were performed with cations that either encourage (K+) or discourage (Li+) G-quartet formation with or without NC. Strikingly, a G-quartet monomer was observed without NC, whereas a G-quartet dimer was observed with NC, both only in the presence of K+. Moreover, the transfer efficiency of the dimerized template (with K+ and NC) reached about 90%, approximately 2.5-fold of that of the non-dimerized template. Evidently, template dimerization induced by NC creates a proximity effect, leading to the unique high peak of transfer at the gag recombination hotspot.	[Shen, Wen; Bambara, Robert A.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Shen, Wen; Bambara, Robert A.] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA; [Gorelick, Robert J.] Inc NCI Frederick, SAIC Frederick, AIDS & Canc Virus Program, Frederick, MD 21702 USA	University of Rochester; University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Bambara, RA (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM049573]; NCI, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049573 (to R. A. B.) and by federal funds from the NCI, National Institutes of Health, under contract HHSN261200800001E.	ALLAIN B, 1994, EMBO J, V13, P973, DOI 10.1002/j.1460-2075.1994.tb06342.x; Auxilien S, 1999, J BIOL CHEM, V274, P4412, DOI 10.1074/jbc.274.7.4412; AWANG G, 1993, BIOCHEMISTRY-US, V32, P11453, DOI 10.1021/bi00093a024; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Berglund JA, 1997, NUCLEIC ACIDS RES, V25, P1042, DOI 10.1093/nar/25.5.1042; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; Chen JB, 2005, J VIROL, V79, P9337, DOI 10.1128/JVI.79.14.9337-9340.2005; CHEONG CJ, 1992, BIOCHEMISTRY-US, V31, P8406, DOI 10.1021/bi00151a003; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; DARLIX JL, 1993, CR ACAD SCI III-VIE, V316, P763; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P5380, DOI 10.1073/pnas.0500729102; DUESBERG PH, 1968, P NATL ACAD SCI USA, V60, P1511, DOI 10.1073/pnas.60.4.1511; Dykes C, 2004, VIROLOGY, V326, P262, DOI 10.1016/j.virol.2004.02.033; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; Fisher RJ, 1998, J VIROL, V72, P1902, DOI 10.1128/JVI.72.3.1902-1909.1998; Galetto R, 2004, J BIOL CHEM, V279, P36625, DOI 10.1074/jbc.M405476200; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; GREEN LM, 1990, P NATL ACAD SCI USA, V87, P6403, DOI 10.1073/pnas.87.16.6403; GUSCHLBAUER W, 1990, J BIOMOL STRUCT DYN, V8, P491, DOI 10.1080/07391102.1990.10507825; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; JI JP, 1994, NUCLEIC ACIDS RES, V22, P47, DOI 10.1093/nar/22.1.47; Kankia BI, 2005, NUCLEIC ACIDS RES, V33, P4395, DOI 10.1093/nar/gki741; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Lee R, 1998, BIOCHEMISTRY-US, V37, P900, DOI 10.1021/bi972197m; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; Levy DN, 2004, P NATL ACAD SCI USA, V101, P4204, DOI 10.1073/pnas.0306764101; Lyonnais S, 2003, NUCLEIC ACIDS RES, V31, P5754, DOI 10.1093/nar/gkg716; Mani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004399; MARQUET R, 1991, NUCLEIC ACIDS RES, V19, P2349, DOI 10.1093/nar/19.9.2349; MONCHAUD D, 2010, J NUCL ACIDS; Moumen A, 2001, NUCLEIC ACIDS RES, V29, P3814, DOI 10.1093/nar/29.18.3814; Moutouh L, 1996, P NATL ACAD SCI USA, V93, P6106, DOI 10.1073/pnas.93.12.6106; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; Roda RH, 2002, J BIOL CHEM, V277, P46900, DOI 10.1074/jbc.M208638200; Rong LW, 1998, J VIROL, V72, P9353, DOI 10.1128/JVI.72.11.9353-9358.1998; Salas TR, 2006, NUCLEIC ACIDS RES, V34, P4857, DOI 10.1093/nar/gkl564; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368; Simon-Loriere E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000418; SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wu WX, 1996, J VIROL, V70, P7132, DOI 10.1128/JVI.70.10.7132-7142.1996	52	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29838	29847		10.1074/jbc.M111.262352	http://dx.doi.org/10.1074/jbc.M111.262352			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737842	Green Published, hybrid			2022-12-25	WOS:000294046600043
J	Fang, D; Xu, GR; Hu, YL; Pan, C; Xie, LP; Zhang, RQ				Fang, Dong; Xu, Guangrui; Hu, Yilin; Pan, Cong; Xie, Liping; Zhang, Rongqing			Identification of Genes Directly Involved in Shell Formation and Their Functions in Pearl Oyster, Pinctada fucata	PLOS ONE			English	Article							MATRIX PROTEIN FAMILY; PRISMATIC LAYER FORMATION; CALMODULIN-LIKE PROTEIN; CARBONIC-ANHYDRASE; CALCIUM-BINDING; FRAMEWORK FORMATION; NACRE LAMELLAE; ORGANIC MATRIX; DUAL ROLE; MOLLUSK	Mollusk shell formation is a fascinating aspect of biomineralization research. Shell matrix proteins play crucial roles in the control of calcium carbonate crystallization during shell formation in the pearl oyster, Pinctada fucata. Characterization of biomineralization-related genes during larval development could enhance our understanding of shell formation. Genes involved in shell biomineralization were isolated by constructing three suppression subtractive hybridization (SSH) libraries that represented genes expressed at key points during larval shell formation. A total of 2,923 ESTs from these libraries were sequenced and gave 990 unigenes. Unigenes coding for secreted proteins and proteins with tandem-arranged repeat units were screened in the three SSH libraries. A set of sequences coding for genes involved in shell formation was obtained. RTPCR and in situ hybridization assays were carried out on five genes to investigate their spatial expression in several tissues, especially the mantle tissue. They all showed a different expression pattern from known biomineralization-related genes. Inhibition of the five genes by RNA interference resulted in different defects of the nacreous layer, indicating that they all were involved in aragonite crystallization. Intriguingly, one gene (UD_Cluster94.seq.Singlet1) was restricted to the 'aragonitic line'. The current data has yielded for the first time, to our knowledge, a suite of biomineralization-related genes active during the developmental stages of P. fucata, five of which were responsible for nacreous layer formation. This provides a useful starting point for isolating new genes involved in shell formation. The effects of genes on the formation of the 'aragonitic line', and other areas of the nacreous layer, suggests a different control mechanism for aragonite crystallization initiation from that of mature aragonite growth.	[Fang, Dong; Xu, Guangrui; Hu, Yilin; Pan, Cong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Fang, D (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30871911, 20876088, 40876068, U0831001]; National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30871911, 20876088, 40876068, U0831001 (Joint Fund with Guangdong) http://www.nsfc.gov.cn/Portal0/default124.htm; the National Basic Research Program of China 2010CB126405 http://www.973.gov.cn/English/Index. aspx and the National High Technology Research and Development Program of China 2010AA09Z405 http://www.most.gov.cn/eng/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272; ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162; Belcher A.M., 1996, CONTROL CRYSTAL PHAS; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; BENSON SC, 1986, J CELL BIOL, V102, P1878, DOI 10.1083/jcb.102.5.1878; CARIOLOU MA, 1988, J COMP PHYSIOL B, V157, P717, DOI 10.1007/BF00691002; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuif JP, 1996, AQUAT LIVING RESOUR, V9, P187, DOI 10.1051/alr:1996022; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang Z, 2008, PROG NAT SCI-MATER, V18, P405, DOI 10.1016/j.pnsc.2007.11.011; Fujimura Takuya, 1995, Venus the Japanese Journal of Malacology, V54, P25; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Gong NP, 2008, J STRUCT BIOL, V164, P33, DOI 10.1016/j.jsb.2008.05.009; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hofmann GE, 2008, MAR ECOL PROG SER, V373, P219, DOI 10.3354/meps07775; Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; JIAN L, 2009, FUNCTIONAL CHARACTER; KEITH J, 1993, COMP BIOCHEM PHYS B, V105, P487, DOI 10.1016/0305-0491(93)90078-J; Kim YK, 2010, BIOMATERIALS, V31, P6618, DOI 10.1016/j.biomaterials.2010.04.060; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Le TQ, 2006, EUR J ORAL SCI, V114, P320, DOI 10.1111/j.1600-0722.2006.00313.x; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Li S, 2004, COMP BIOCHEM PHYS B, V138, P235, DOI 10.1016/j.cbpc.2004.03.012; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Mann K, 2006, COMP BIOCHEM PHYS B, V143, P160, DOI 10.1016/j.cbpb.2005.11.003; Mann K, 2004, BBA-PROTEINS PROTEOM, V1696, P41, DOI 10.1016/j.bbapap.2003.09.006; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Matsushiro A, 2004, J BONE MINER METAB, V22, P163, DOI 10.1007/s00774-003-0484-9; Miranda LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010182; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyashita T, 2002, VELIGER, V45, P250; Miyashita T, 2008, BIOSCI BIOTECH BIOCH, V72, P37, DOI 10.1271/bbb.70302; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; MURAMOTO K, 1994, COMP BIOCHEM PHYS B, V107, P401, DOI 10.1016/0305-0491(94)90204-6; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; ROSE RA, 1994, AQUACULTURE, V126, P35, DOI 10.1016/0044-8486(94)90246-1; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Santambrogio P, 1996, BIOCHEM J, V314, P139, DOI 10.1042/bj3140139; Saruwatari K, 2009, BIOMATERIALS, V30, P3028, DOI 10.1016/j.biomaterials.2009.03.011; Schonitzer V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-71; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2007, BIOSCI BIOTECH BIOCH, V71, P1735, DOI 10.1271/bbb.70140; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; TAFT KL, 1994, INORG CHEM, V33, P1510, DOI 10.1021/ic00085a049; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Takahashi T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-240; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Uemura T, 1997, MAT SCI ENG C-BIO S, V4, P303, DOI 10.1016/S0928-4931(97)00015-5; Veis A., 1990, SCIENCE, V247, P1129; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Watanabe J, 2007, BIOMACROMOLECULES, V8, P2288, DOI 10.1021/bm0702915; WEINER S, 1979, CALCIFIED TISSUE INT, V29, P163, DOI 10.1007/BF02408072; WeiQuan Huang, 2001, Life Sciences, V68, P1727, DOI 10.1016/S0024-3205(01)00968-7; Weiss IM, 2006, FEBS LETT, V580, P1846, DOI 10.1016/j.febslet.2006.02.044; Weiss IM, 2006, J STRUCT BIOL, V153, P264, DOI 10.1016/j.jsb.2005.11.006; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Wilt FH, 2003, DIFFERENTIATION, V71, P237, DOI 10.1046/j.1432-0436.2003.7104501.x; Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114; Wynn A, 2005, COMP BIOCHEM PHYS B, V141, P294, DOI 10.1016/j.cbpc.2005.04.002; Yamashita I, 2001, THIN SOLID FILMS, V393, P12, DOI 10.1016/S0040-6090(01)01083-5; Yan ZG, 2007, BBA-GEN SUBJECTS, V1770, P1338, DOI 10.1016/j.bbagen.2007.06.018; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu ZY, 2006, COMP BIOCHEM PHYS B, V143, P190, DOI 10.1016/j.cbpb.2005.11.006; Zhang C, 2006, MAR BIOTECHNOL, V8, P624, DOI 10.1007/s10126-006-6037-1; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	89	99	101	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21860	10.1371/journal.pone.0021860	http://dx.doi.org/10.1371/journal.pone.0021860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747964	Green Published, gold, Green Submitted			2022-12-25	WOS:000292293400040
J	Kachi, Y; Nakao, M; Takeuchi, T; Yano, E				Kachi, Yuko; Nakao, Mutsuhiro; Takeuchi, Takeaki; Yano, Eiji			Association between Insomnia Symptoms and Hemoglobin A(1c) Level in Japanese Men	PLOS ONE			English	Article							DIABETES-MELLITUS; SLEEP DURATION; RISK; METAANALYSIS; DEPRESSION; PREVALENCE; COMMITTEE; QUALITY; SMOKING; HEALTH	Background: The evidence for an association between insomnia symptoms and blood hemoglobin A(1c) (HbA(1c)) level has been limited and inconclusive. The aim of this study was to assess whether each symptom of initial, middle, and terminal insomnia influences HbA(1c) level in Japanese men. Methods: This cross-sectional study examined 1,022 male workers aged 22-69 years with no history of diabetes at a Japanese company's annual health check-up in April 2010. High HbA(1c) was defined as a blood level of HbA(1c) >= 6.0%. Three types of insomnia symptoms (i.e., difficulty in initiating sleep, difficulty in maintaining sleep, and early morning awakening) from the previous month were assessed by 3 responses (i.e., lasting more than 2 weeks, sometimes, and seldom or never [reference group]). Results: The overall prevalence of high HbA(1c) was 5.2%. High HbA(1c) was positively and linearly associated with both difficulty in maintaining sleep (P for trend = .002) and early morning awakening (P for trend = .007). More specifically, after adjusting for potential confounding factors, high HbA(1c) was significantly associated with difficulty in maintaining sleep lasting more than 2 weeks (adjusted odds ratio, 6.79 [95% confidence interval, 1.86-24.85]) or sometimes (2.33 [1.19-4.55]). High HbA(1c) was also significantly associated with early morning awakening lasting more than 2 weeks (3.96 [1.24-12.59]). Conclusion: Insomnia symptoms, particularly difficulty in maintaining sleep and early morning awakening, were found to have a close association with high HbA(1c) in a dose-response relationship.	[Kachi, Yuko; Nakao, Mutsuhiro; Takeuchi, Takeaki; Yano, Eiji] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan	Teikyo University	Kachi, Y (corresponding author), Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan.	katti@orange.zero.jp			Ministry of Education, Culture, Sports, Science and Technology [22890195]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Grant-in-Aid for Research Activity Start-up (No. 22890195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstedt T, 2003, J INTERN MED, V254, P6, DOI 10.1046/j.1365-2796.2003.01195.x; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Benediktsdottir B, 2010, SLEEP MED, V11, P1043, DOI 10.1016/j.sleep.2010.08.006; Beneto A, 2009, SLEEP MED REV, V13, P287, DOI 10.1016/j.smrv.2008.09.006; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Fisher L, 2007, DIABETES CARE, V30, P542, DOI 10.2337/dc06-1614; Kayukawa Y., 1996, BIOMED THERAP, V30, P179; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2006, ARCH INTERN MED, V166, P1768, DOI 10.1001/archinte.166.16.1768; Lamond N, 2000, SLEEP, V23, P415; Ministry of Health Labour and Welfare in Japan, 2010, NAT HLTH NUTR SURV J; Nakajima H, 2008, SLEEP MED, V9, P745, DOI 10.1016/j.sleep.2007.07.017; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Nomura K, 2005, SLEEP, V28, P1328, DOI 10.1093/sleep/28.10.1328; Nomura K, 2009, SLEEP MED, V10, P626, DOI 10.1016/j.sleep.2008.06.010; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Seino Y., 2010, Journal of the Japan Diabetes Society, V53, P450, DOI 10.1111/j.2040-1124.2010.00074.x; SRIDHAR GR, 1994, DIABETES RES CLIN PR, V23, P183, DOI 10.1016/0168-8227(94)90103-1; Tachibana Naoko, 2003, Neurology, V60, pA38; Takeuchi T, 2004, J OCCUP HEALTH, V46, P489, DOI 10.1539/joh.46.489; Vgontzas AN, 2001, J CLIN ENDOCR METAB, V86, P3787, DOI 10.1210/jc.86.8.3787; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	25	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21420	10.1371/journal.pone.0021420	http://dx.doi.org/10.1371/journal.pone.0021420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747936	gold, Green Published, Green Submitted			2022-12-25	WOS:000292293400012
J	Leshem, O; Madar, S; Kogan-Sakin, I; Kamer, I; Goldstein, I; Brosh, R; Cohen, Y; Jacob-Hirsch, J; Ehrlich, M; Ben-Sasson, S; Goldfinger, N; Loewenthal, R; Gazit, E; Rotter, V; Berger, R				Leshem, Orit; Madar, Shalom; Kogan-Sakin, Ira; Kamer, Iris; Goldstein, Ido; Brosh, Ran; Cohen, Yehudit; Jacob-Hirsch, Jasmine; Ehrlich, Marcelo; Ben-Sasson, Shmuel; Goldfinger, Naomi; Loewenthal, Ron; Gazit, Ephraim; Rotter, Varda; Berger, Raanan			TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model	PLOS ONE			English	Article							TMPRSS2-ERG GENE FUSION; TANDEM REPEAT LOCI; CELL-LINE; EXPRESSION; ERG; RECEPTOR; ZEB1; OVEREXPRESSION; IDENTIFICATION; ACTIVATION	Prostate cancer is the most common non-dermatologic malignancy in men in the Western world. Recently, a frequent chromosomal aberration fusing androgen regulated TMPRSS2 promoter and the ERG gene (TMPRSS2/ERG) was discovered in prostate cancer. Several studies demonstrated cooperation between TMPRSS2/ERG and other defective pathways in cancer progression. However, the unveiling of more specific pathways in which TMPRSS2/ERG takes part, requires further investigation. Using immortalized prostate epithelial cells we were able to show that TMPRSS2/ERG over-expressing cells undergo an Epithelial to Mesenchymal Transition (EMT), manifested by acquisition of mesenchymal morphology and markers as well as migration and invasion capabilities. These findings were corroborated in vivo, where the control cells gave rise to discrete nodules while the TMPRSS2/ERG-expressing cells formed malignant tumors, which expressed EMT markers. To further investigate the general transcription scheme induced by TMPRSS2/ERG, cells were subjected to a microarray analysis that revealed a distinct EMT expression program, including up-regulation of the EMT facilitators, ZEB1 and ZEB2, and down-regulation of the epithelial marker CDH1(E-Cadherin). A chromatin immunoprecipitation assay revealed direct binding of TMPRSS2/ERG to the promoter of ZEB1 but not ZEB2. However, TMPRSS2/ERG was able to bind the promoters of the ZEB2 modulators, IL1R2 and SPINT1. This set of experiments further illuminates the mechanism by which the TMPRSS2/ERG fusion affects prostate cancer progression and might assist in targeting TMPRSS2/ERG and its downstream targets in future drug design efforts.	[Leshem, Orit; Cohen, Yehudit; Jacob-Hirsch, Jasmine; Berger, Raanan] Sheba Med Ctr, Sheba Canc Res Ctr, Ramat Gan, Israel; [Leshem, Orit; Ben-Sasson, Shmuel] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Madar, Shalom; Kogan-Sakin, Ira; Kamer, Iris; Goldstein, Ido; Brosh, Ran; Goldfinger, Naomi; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Ehrlich, Marcelo] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Loewenthal, Ron; Gazit, Ephraim] Sheba Med Ctr, Tissue Typing Unit, Ramat Gan, Israel	Chaim Sheba Medical Center; Hebrew University of Jerusalem; Weizmann Institute of Science; Tel Aviv University; Chaim Sheba Medical Center	Leshem, O (corresponding author), Sheba Med Ctr, Sheba Canc Res Ctr, Ramat Gan, Israel.	raanan.berger@sheba.health.gov.il	Goldstein, Ido/Y-6554-2019; Brosh, Ran/H-7309-2019; Jackson, Benjamin L/C-4297-2012; Brosh, Ran/HDL-9562-2022	Goldstein, Ido/0000-0003-0139-1499; Brosh, Ran/0000-0001-9714-8623; Ehrlich, Marcelo/0000-0002-2352-1808	Flight Attendant Medical Research Institute (FAMRI); EC [LSHC-CT-2004-503576]; Yad Abraham Center for Cancer Diagnosis and Therapy; Ridgefield Foundation	Flight Attendant Medical Research Institute (FAMRI); EC(European CommissionEuropean Commission Joint Research Centre); Yad Abraham Center for Cancer Diagnosis and Therapy; Ridgefield Foundation	This research was supported by a Center of Excellence grant from Flight Attendant Medical Research Institute (FAMRI), EC FP6 Grant LSHC-CT-2004-503576, the Yad Abraham Center for Cancer Diagnosis and Therapy and the Ridgefield Foundation, "Talpiot'' program for medical leadership at the Sheba Medical Center, and the Israeli Cancer Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bjorkman M, 2008, INT J CANCER, V123, P2774, DOI 10.1002/ijc.23885; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Carver BS, 2009, NATURE, V457, pE1, DOI 10.1038/nature07738; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; Chang SY, 2009, CYTOKINE, V45, P32, DOI 10.1016/j.cyto.2008.10.013; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Darnel AD, 2009, CANCER BIOL THER, V8, P125, DOI 10.4161/cbt.8.2.7134; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Drake JM, 2009, MOL BIOL CELL, V20, P2207, DOI 10.1091/mbc.E08-10-1076; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Evett IW, 1996, AM J HUM GENET, V58, P398; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; GUPTA S, 2010, CANC RES; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Iljin K, 2006, CANCER RES, V66, P10242, DOI 10.1158/0008-5472.CAN-06-1986; Ke XS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003368; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Ma Y, 2008, BLOOD, V111, P2339, DOI 10.1182/blood-2007-09-112128; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Mosquera JM, 2008, CLIN CANCER RES, V14, P3380, DOI 10.1158/1078-0432.CCR-07-5194; Pena C, 2006, INT J CANCER, V119, P2098, DOI 10.1002/ijc.22083; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sanders AJ, 2007, INT J MOL MED, V20, P613; Saramaki OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Teixeira MR, 2008, AM J SURG PATHOL, V32, P642, DOI 10.1097/PAS.0b013e31815b6056; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2009, EUR UROL, V56, P275, DOI 10.1016/j.eururo.2009.04.036; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Yoshimoto M, 2006, NEOPLASIA, V8, P465, DOI 10.1593/neo.06283; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhu M, 2009, FASEB J, V23; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	46	78	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21650	10.1371/journal.pone.0021650	http://dx.doi.org/10.1371/journal.pone.0021650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747944	Green Published, Green Submitted, gold			2022-12-25	WOS:000292293400020
J	Shi, JQ; Li, RY; Zou, J; Long, Y; Meng, JL				Shi, Jiaqin; Li, Ruiyuan; Zou, Jun; Long, Yan; Meng, Jinling			A Dynamic and Complex Network Regulates the Heterosis of Yield-Correlated Traits in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							OVERDOMINANT EPISTATIC LOCI; RECOMBINANT INBRED LINES; PRIMARY GENETIC-BASIS; GRAIN-YIELD; INBREEDING DEPRESSION; TESTCROSS PROGENIES; OILSEED RAPE; HEADING DATE; CROP YIELD; RICE	Although much research has been conducted, the genetic architecture of heterosis remains ambiguous. To unravel the genetic architecture of heterosis, a reconstructed F-2 population was produced by random intercross among 202 lines of a double haploid population in rapeseed (Brassica napus L.). Both populations were planted in three environments and 15 yield-correlated traits were measured, and only seed yield and eight yield-correlated traits showed significant mid-parent heterosis, with the mean ranging from 8.7% (branch number) to 31.4% (seed yield). Hundreds of QTL and epistatic interactions were identified for the 15 yield-correlated traits, involving numerous variable loci with moderate effect, genome-wide distribution and obvious hotspots. All kinds of mode-of-inheritance of QTL (additive, A; partial-dominant, PD; full-dominant, D; over-dominant, OD) and epistatic interactions (additive x additive, AA; additive x dominant/dominant x additive, AD/DA; dominant x dominant, DD) were observed and epistasis, especially AA epistasis, seemed to be the major genetic basis of heterosis in rapeseed. Consistent with the low correlation between marker heterozygosity and mid-parent heterosis/hybrid performance, a considerable proportion of dominant and DD epistatic effects were negative, indicating heterozygosity was not always advantageous for heterosis/hybrid performance. The implications of our results on evolution and crop breeding are discussed.	[Shi, Jiaqin; Li, Ruiyuan; Zou, Jun; Long, Yan; Meng, Jinling] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Shi, JQ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	jmeng@mail.hzau.edu.cn			National Basic Research and Development Program [2006CB101600]	National Basic Research and Development Program(National Basic Research Program of China)	Financial support for this work was provided by the National Basic Research and Development Program (2006CB101600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2005, EUPHYTICA, V146, P157, DOI 10.1007/s10681-005-3364-7; ALLARD R. W., 1956, HILGARDIA, V24, P235; ALLARD RW, 1988, J HERED, V79, P225, DOI 10.1093/oxfordjournals.jhered.a110503; Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Basunanda P, 2010, THEOR APPL GENET, V120, P271, DOI 10.1007/s00122-009-1133-z; Birchler JA, 2006, P NATL ACAD SCI USA, V103, P12957, DOI 10.1073/pnas.0605627103; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; CHEN W, 2008, MOL DISSECTION GENET; CHURCHILL GA, 1994, GENETICS, V138, P963; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; East EM, 1936, GENETICS, V21, P375; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Ford-Lloyd BV, 2001, HEREDITY, V87, P530, DOI 10.1046/j.1365-2540.2001.00937.x; Garcia AAF, 2008, GENETICS, V180, P1707, DOI 10.1534/genetics.107.082867; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Goffinet B, 2000, GENETICS, V155, P463; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; HUA J, 2003, GENETIC DISSECTION B; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Jiang WZ, 2008, THEOR APPL GENET, V116, P1117, DOI 10.1007/s00122-008-0740-4; KONG F, 2005, QUANTITAIVE GENETICS, P224; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Li ZK, 1997, GENETICS, V145, P453; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Li ZK, 2001, GENETICS, V158, P1737; Liao CY, 2001, THEOR APPL GENET, V103, P104, DOI 10.1007/s001220000528; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Lisec J, 2009, PLANT J, V59, P777, DOI 10.1111/j.1365-313X.2009.03910.x; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lu H, 2003, THEOR APPL GENET, V107, P494, DOI 10.1007/s00122-003-1271-7; Luo LJ, 2001, GENETICS, V158, P1755; Lysak MA, 2007, PLANT PHYSIOL, V145, P402, DOI 10.1104/pp.107.104380; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Matioli SR, 1999, HEREDITY, V83, P54, DOI 10.1038/sj.hdy.6885320; Mei HW, 2005, THEOR APPL GENET, V110, P649, DOI 10.1007/s00122-004-1890-7; Melchinger AE, 2007, GENETICS, V177, P1815, DOI 10.1534/genetics.107.077537; Melchinger AE, 2007, GENETICS, V177, P1827, DOI [10.1534/genetics.107.080564, 10.1534/genetics.107.084871]; Meyer RC, 2010, THEOR APPL GENET, V120, P227, DOI 10.1007/s00122-009-1074-6; Mika V, 2003, PLANT SOIL ENVIRON, V49, P141, DOI 10.17221/4104-PSE; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Qiu D, 2006, THEOR APPL GENET, V114, P67, DOI 10.1007/s00122-006-0411-2; Radoev M, 2008, GENETICS, V179, P1547, DOI 10.1534/genetics.108.089680; Reif JC, 2009, GENETICS, V181, P247, DOI 10.1534/genetics.108.093047; Rhode JM, 2005, AM NAT, V166, pE124, DOI 10.1086/491798; Roff DA, 2006, EVOLUTION, V60, P1981, DOI 10.1111/j.0014-3820.2006.tb01836.x; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Schauer N, 2008, PLANT CELL, V20, P509, DOI 10.1105/tpc.107.056523; SCHNELL FW, 1992, GENETICS, V131, P461; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Shull G.H., 1908, J HERED, V4, P296, DOI [10.1093/jhered/os-4.1.296, DOI 10.1093/JHERED/OS-4.1.296]; Singh H, 2004, HEREDITAS, V141, P106, DOI 10.1111/j.1601-5223.2004.01728.x; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; STUBER CW, 1992, GENETICS, V132, P823; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Terao T, 2010, THEOR APPL GENET, V120, P875, DOI 10.1007/s00122-009-1218-8; U. N., 1935, Japanese Journal of Botany, V7, P389; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; WILLIAMS W, 1959, NATURE, V184, P527, DOI 10.1038/184527a0; Xing YZ, 2008, THEOR APPL GENET, V116, P789, DOI 10.1007/s00122-008-0711-9; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; YAN J, 2003, STUDY GENETIC BASIS; Yan JB, 2006, EUPHYTICA, V149, P121, DOI 10.1007/s10681-005-9060-9; You AQ, 2006, GENETICS, V172, P1287, DOI 10.1534/genetics.105.047209; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; ZENG ZB, 1994, GENETICS, V136, P1457; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; ZHANG QF, 1994, THEOR APPL GENET, V89, P185, DOI 10.1007/BF00225139; Zhang YS, 2009, THEOR APPL GENET, V118, P1035, DOI 10.1007/s00122-008-0960-7	79	48	56	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21645	10.1371/journal.pone.0021645	http://dx.doi.org/10.1371/journal.pone.0021645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747942	Green Published, Green Submitted, gold			2022-12-25	WOS:000292293400018
J	Vestergaard-Poulsen, P; Wegener, G; Hansen, B; Bjarkam, CR; Blackband, SJ; Nielsen, NC; Jespersen, SN				Vestergaard-Poulsen, Peter; Wegener, Gregers; Hansen, Brian; Bjarkam, Carsten R.; Blackband, Stephen J.; Nielsen, Niels C.; Jespersen, Sune N.			Diffusion-Weighted MRI and Quantitative Biophysical Modeling of Hippocampal Neurite Loss in Chronic Stress	PLOS ONE			English	Article							CA3 PYRAMIDAL NEURONS; DENDRITIC ATROPHY; ADRENAL-STEROIDS; RESTRAINT STRESS; APICAL DENDRITES; SPATIAL MEMORY; DENTATE GYRUS; PSYCHOSOCIAL STRESS; SEX-DIFFERENCES; TENSOR MRI	Chronic stress has detrimental effects on physiology, learning and memory and is involved in the development of anxiety and depressive disorders. Besides changes in synaptic formation and neurogenesis, chronic stress also induces dendritic remodeling in the hippocampus, amygdala and the prefrontal cortex. Investigations of dendritic remodeling during development and treatment of stress are currently limited by the invasive nature of histological and stereological methods. Here we show that high field diffusion-weighted MRI combined with quantitative biophysical modeling of the hippocampal dendritic loss in 21 day restraint stressed rats highly correlates with former histological findings. Our study strongly indicates that diffusion-weighted MRI is sensitive to regional dendritic loss and thus a promising candidate for non-invasive studies of dendritic plasticity in chronic stress and stress-related disorders.	[Vestergaard-Poulsen, Peter; Hansen, Brian; Jespersen, Sune N.] Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark; [Wegener, Gregers] Aarhus Psychiat Univ Hosp, Ctr Basic Psychiat Res, Risskov, Denmark; [Nielsen, Niels C.] Aarhus Univ, Dept Chem, Ctr Insoluble Prot Struct, DK-8000 Aarhus, Denmark; [Nielsen, Niels C.] Aarhus Univ, Dept Chem, Interdisplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Blackband, Stephen J.] Univ Florida, McKnight Brain Inst, Dept Neurosci, Gainesville, FL USA; [Blackband, Stephen J.] Univ Florida, Natl High Magnet Field Lab, Gainesville, FL USA; [Bjarkam, Carsten R.] Aarhus Univ Hosp, Dept Neurosurg, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Aarhus University	Vestergaard-Poulsen, P (corresponding author), Aarhus Univ, Ctr Functionally Integrat Neurosci, Aarhus, Denmark.	peterv@pet.auh.dk	Wegener, Gregers/Z-3945-2019; Jespersen, Sune Nørhøj/B-1914-2008; Wegener, Gregers/A-1019-2011	Jespersen, Sune Nørhøj/0000-0003-3146-4329; Wegener, Gregers/0000-0002-0081-0068; Bjarkam, Carsten/0000-0002-0164-9595; Nielsen, Niels Chr./0000-0003-2978-4366	Danish National Research Foundation [95093538-2458, 100297]; Danish Biotechnological Instrument Centre	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Biotechnological Instrument Centre	This research was funded by the Danish National Research Foundation (95093538-2458, project 100297) and The Danish Biotechnological Instrument Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGER BE, 1984, J NEUROPHYSIOL, V52, P892, DOI 10.1152/jn.1984.52.5.892; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Coplan JD, 2010, NEUROSCI LETT, V480, P93, DOI 10.1016/j.neulet.2010.06.012; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; GOULD E, 1991, J COMP NEUROL, V313, P486, DOI 10.1002/cne.903130309; Gould E, 1997, J NEUROSCI, V17, P2492; Hardin RH, 1996, DISCRETE COMPUT GEOM, V15, P429, DOI 10.1007/BF02711518; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Katz M, 2009, DEV NEUROSCI-BASEL, V31, P293, DOI 10.1159/000216540; KERR DS, 1991, J NEUROSCI, V11, P1316; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kroenke CD, 2009, CEREB CORTEX, V19, P2916, DOI 10.1093/cercor/bhp061; Lambert KG, 1998, PHYSIOL BEHAV, V65, P43, DOI 10.1016/S0031-9384(98)00114-0; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lee T, 2009, NEUROREPORT, V20, P1554, DOI 10.1097/WNR.0b013e328332bb09; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Magarinos AM, 1996, J NEUROSCI, V16, P3534; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McEwen BS, 1995, VITAM HORM, V51, P371, DOI 10.1016/S0083-6729(08)61045-6; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McLaughlin KJ, 2007, BRAIN RES, V1161, P56, DOI 10.1016/j.brainres.2007.05.042; McLaughlin KJ, 2005, NEUROSCIENCE, V135, P1045, DOI 10.1016/j.neuroscience.2005.06.083; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; PASTERNAK JF, 1975, J COMP NEUROL, V160, P307, DOI 10.1002/cne.901600304; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Shepherd TM, 2009, MAGN RESON MED, V62, P26, DOI 10.1002/mrm.21977; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Sunanda Rao MS, 1995, BRAIN RES, V694, P312, DOI DOI 10.1016/0006-8993(95)00822-8.PUBMED:8974660; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Vestergaard-Poulsen P, 2007, J MAGN RESON IMAGING, V26, P529, DOI 10.1002/jmri.21030; WATANABE Y, 1992, EUR J PHARMACOL, V222, P157, DOI 10.1016/0014-2999(92)90830-W; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; Watson C., 2005, RAT BRAIN STEREOTACT; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0	48	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e20653	10.1371/journal.pone.0020653	http://dx.doi.org/10.1371/journal.pone.0020653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747929	Green Submitted, Green Published, gold			2022-12-25	WOS:000292293400004
J	Li, DJ; Shin, JH; Duan, DS				Li, Dejia; Shin, Jin-Hong; Duan, Dongsheng			iNOS Ablation Does Not Improve Specific Force of the Extensor Digitorum Longus Muscle in Dystrophin-Deficient mdx4cv Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; GLYCOPROTEIN COMPLEX; RYANODINE RECEPTOR; EXPRESSION; GENE; MOUSE; NNOS; MACROPHAGES	Nitrosative stress compromises force generation in Duchenne muscular dystrophy (DMD). Both inducible nitric oxide synthase (iNOS) and delocalized neuronal NOS (nNOS) have been implicated. We recently demonstrated that genetic elimination of nNOS significantly enhanced specific muscle forces of the extensor digitorum longus (EDL) muscle of dystrophin-null mdx4cv mice (Li D et al J. Path. 223:88-98, 2011). To determine the contribution of iNOS, we generated iNOS deficient mdx4cv mice. Genetic elimination of iNOS did not alter muscle histopathology. Further, the EDL muscle of iNOS/dystrophin DKO mice yielded specific twitch and tetanic forces similar to those of mdx4cv mice. Additional studies suggest iNOS ablation did not augment nNOS expression neither did it result in appreciable change of nitrosative stress markers in muscle. Our results suggest that iNOS may play a minor role in mediating nitrosative stress-associated force reduction in DMD.	[Li, Dejia; Shin, Jin-Hong; Duan, Dongsheng] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia	Li, DJ (corresponding author), Wuhan Univ, Dept Occupat & Environm Hlth, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China.	duand@missouri.edu	Shin, Jin-Hong/AAZ-8809-2020	Shin, Jin-Hong/0000-0002-5174-286X; Duan, Dongsheng/0000-0003-4109-1132	National Institutes of Health [AR-49419]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (AR-49419, DD) and the Muscular Dystrophy Association (DD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Amthor H, 2004, NEUROMUSCULAR DISORD, V14, P791, DOI 10.1016/j.nmd.2004.08.004; Batchelor CL, 2006, TRENDS CELL BIOL, V16, P198, DOI 10.1016/j.tcb.2006.02.001; Bellinger AM, 2008, J CLIN INVEST, V118, P445, DOI 10.1172/JCI34006; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018; Bostick B, 2009, MOL THER, V17, P253, DOI 10.1038/mt.2008.264; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Chao DS, 1996, J EXP MED, V184, P609, DOI 10.1084/jem.184.2.609; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Goldstein JA, 2010, J GEN PHYSIOL, V136, P29, DOI 10.1085/jgp.201010436; Hainsey TA, 2003, NEUROMUSCULAR DISORD, V13, P294, DOI 10.1016/S0960-8966(02)00286-9; Jackson MJ, 2007, J APPL PHYSIOL, V102, P1664, DOI 10.1152/japplphysiol.01102.2006; Kunkel LM, 2005, AM J HUM GENET, V76, P205, DOI 10.1086/428143; Lai Y, 2005, NAT BIOTECHNOL, V23, P1435, DOI 10.1038/nbt1153; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Li DJ, 2008, AM J PATHOL, V172, P1332, DOI 10.2353/ajpath.2008.071042; Li DJ, 2011, J PATHOL, V223, P88, DOI 10.1002/path.2799; Li DJ, 2010, J CELL SCI, V123, P2007, DOI 10.1242/jcs.064808; Li DJ, 2009, HUM MOL GENET, V18, P1209, DOI 10.1093/hmg/ddp015; Li S, 2006, HUM MOL GENET, V15, P1610, DOI 10.1093/hmg/ddl082; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Louboutin JP, 2001, MOL MED, V7, P355, DOI 10.1007/BF03402218; MACMICKING, 1995, CELL, V81, pU17; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Petrof BJ, 2002, AM J PHYS MED REHAB, V81, pS162, DOI 10.1097/00002060-200211001-00017; Romitti P., 2009, Morbidity and Mortality Weekly Report, V58, P1119; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; Shin JH, 2011, MUSCLE NERVE, V43, P283, DOI 10.1002/mus.21873; SHMIDT HHHW, 1992, CELL CALCIUM, V13, P427, DOI 10.1016/0143-4160(92)90055-W; Smith BF, 2011, LAB INVEST, V91, P216, DOI 10.1038/labinvest.2010.146; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Thompson M, 1996, J APPL PHYSIOL, V81, P2415, DOI 10.1152/jappl.1996.81.6.2415; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007; Yue YP, 2008, MOL THER, V16, P1944, DOI 10.1038/mt.2008.207	44	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21618	10.1371/journal.pone.0021618	http://dx.doi.org/10.1371/journal.pone.0021618			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738735	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800028
J	Zhang, Y; Lin, XP; Desrosiers, M; Zhang, W; Meng, N; Zhao, LP; Han, DM; Zhang, L				Zhang, Yuan; Lin, Xiaoping; Desrosiers, Martin; Zhang, Wei; Meng, Na; Zhao, Liping; Han, Demin; Zhang, Luo			Association Pattern of Interleukin-1 Receptor-Associated Kinase-4 Gene Polymorphisms with Allergic Rhinitis in a Han Chinese Population	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; MULTIFACTOR DIMENSIONALITY REDUCTION; T-CELLS; ASTHMA; EPISTASIS; INNATE; IRAK-4; EXPRESSION; LIPOPOLYSACCHARIDE; SUSCEPTIBILITY	Objective: Interleukin-1 receptor-associated kinase-4 (IRAK-4) encodes a kinase that is essential for NF-kB activation in Toll-like receptor and T-cell receptor signaling pathways, indicating a possible crosstalk between innate and acquired immunities. We attempted to determine whether the polymorphisms in the Interleukin-1 receptor-associated kinase-4 (IRAK-4) gene are associated with allergic rhinitis (AR) in the Han Chinese population. Methods: A population of 379 patients with AR and 333 healthy controls was studied. Blood was drawn for DNA extraction and total serum immunoglobulin E (IgE). A total of 11 single nucleotide polymorphisms (SNPs) in IRAK-4 were selected and individually genotyped. Results: Significant allelic differences between cases and controls were obtained for the SNP of rs3794262 in the IRAK-4 gene. In the stratified analysis for gender, two SNPs (rs4251431 and rs6582484) in males appeared as significant associations. Subgroup analysis for the presence of different allergen sensitivities displayed associations only in the house dust mite-allergic cohorts (rs3794262, rs4251481). None of the selected SNPs in IRAK-4 was associated with total IgE level. The haplotype analyisis indicated GCCTGCGA was significantly associated with AR. The SNP-SNP interaction information analysis indicated that the selected sets of polymorphisms had no synergistic effect. Conclusions: Our findings did not support the potential contribution of the IRAK-4 gene to serum IgE levels. However, the results demonstrated a gender-and allergen-dependant association pattern between polymorphisms in IRAK-4 and AR in Chinese population.	[Zhang, Yuan; Zhang, Wei; Meng, Na; Zhao, Liping; Han, Demin; Zhang, Luo] Beijing Inst Otorhinolaryngol, Key Lab Otolaryngol Head & Neck Surg, Minist Educ China, Beijing, Peoples R China; [Zhang, Yuan; Han, Demin; Zhang, Luo] Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing TongRen Hosp, Beijing, Peoples R China; [Lin, Xiaoping] Gen Hosp Shenyang Mil Command, Ctr Allergy & Immunotherapy, Shenyang, Liaoning, Peoples R China; [Desrosiers, Martin] Univ Montreal, Dept Otolaryngol, Hotel Dieu Hosp, Montreal, PQ, Canada; [Desrosiers, Martin] McGill Univ, Montreal Gen Hosp, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H3G 1A4, Canada	Ministry of Education, China; Capital Medical University; Laval University; Universite de Montreal; McGill University	Zhang, Y (corresponding author), Beijing Inst Otorhinolaryngol, Key Lab Otolaryngol Head & Neck Surg, Minist Educ China, Beijing, Peoples R China.	handm@trhos.com; dr.luozhang@gmail.com		Zhang, Luo/0000-0002-0910-9884	National Science Fund for Distinguished Young Scholars [81025007]; National Natural Science Foundation of China [30872846, 30973282]; Beijing Science and Technology Program [KZ200910025008]; Beijing Natural Science Foundation [7072017]; Special Fund of Sanitation Elite Reconstruction of Beijing [2009-2-007]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Special Fund of Sanitation Elite Reconstruction of Beijing	This work was supported by grants from the National Science Fund for Distinguished Young Scholars (81025007), National Natural Science Foundation of China (30872846 and 30973282), Beijing Science and Technology Program (KZ200910025008), Beijing Natural Science Foundation (7072017) and the Special Fund of Sanitation Elite Reconstruction of Beijing (2009-2-007) to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bacchetta R, 2007, J ALLERGY CLIN IMMUN, V120, P227, DOI 10.1016/j.jaci.2007.06.023; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer S, 2007, IMMUNOBIOLOGY, V212, P521, DOI 10.1016/j.imbio.2007.03.011; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Choudhry S, 2008, HUM GENET, V123, P455, DOI 10.1007/s00439-008-0495-7; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huebner M, 2008, J ALLERGY CLIN IMMUN, V121, P408, DOI 10.1016/j.jaci.2007.09.020; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Medvedev AE, 2003, J EXP MED, V198, P521, DOI 10.1084/jem.20030701; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Mullol J, 2008, J INVEST ALLERG CLIN, V18, P327; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Suzuki N, 2006, SCIENCE, V311, P1927, DOI 10.1126/science.1124256; Suzuki N, 2006, TRENDS IMMUNOL, V27, P566, DOI 10.1016/j.it.2006.10.003; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tewfik MA, 2009, ALLERGY, V64, P746, DOI 10.1111/j.1398-9995.2008.01889.x; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; von Mutius E, 2001, EUR RESPIR J, V18, P872, DOI 10.1183/09031936.01.00268401; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306	48	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21769	10.1371/journal.pone.0021769	http://dx.doi.org/10.1371/journal.pone.0021769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738793	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800044
J	Zhou, JM; Eksioglu, EA; Fortenbery, NR; Chen, XH; Wang, HQ; Epling-Burnette, PK; Djeu, JY; Wei, S				Zhou, Junmin; Eksioglu, Erika A.; Fortenbery, Nicole R.; Chen, Xianghong; Wang, Huaquan; Epling-Burnette, Pearlie K.; Djeu, Julie Y.; Wei, Sheng			Bone Marrow Mononuclear Cells Up-Regulate Toll-Like Receptor Expression and Produce Inflammatory Mediators in Response to Cigarette Smoke Extract	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; SIGNALING PATHWAYS; INNATE IMMUNITY; CANCER-CELLS; IN-VITRO; ACTIVATION; LIPOPOLYSACCHARIDE; KINASE	Several reports link cigarette smoking with leukemia. However, the effects of cigarette smoke extract (CSE) on bone marrow hematopoiesis remain unknown. The objective of this study was to elucidate the direct effects of cigarette smoke on human bone marrow hematopoiesis and characterize the inflammatory process known to result from cigarette smoking. Bone marrow mononuclear cells (BMCs) from healthy individuals when exposed to CSE had significantly diminished CFU-E, BFU-E and CFU-GM. We found increased nuclear translocation of the NF-kappa B p65 subunit and, independently, enhanced activation of AKT and ERK1/2. Exposure of BMCs to CSE induced IL-8 and TGF-beta 1 production, which was dependent on NF-kappa B and ERK1/2, but not on AKT. CSE treatment had no effect on the release of TNF-alpha, IL-10, or VEGF. Finally, CSE also had a significant induction of TLR2, TLR3 and TLR4, out of which, the up-regulation of TLR2 and TLR3 was found to be dependent on ERK1/2 and NF-kappa B activation, but not AKT. These results indicate that CSE profoundly inhibits the growth of erythroid and granulocyte-macrophage progenitors in the bone marrow. Further, CSE modulates NF-kappa B- and ERK1/2-dependent responses, suggesting that cigarette smoking may impair bone marrow hematopoiesis in vivo as well as induce inflammation, two processes that proceed malignant transformation.	[Zhou, Junmin; Eksioglu, Erika A.; Fortenbery, Nicole R.; Chen, Xianghong; Epling-Burnette, Pearlie K.; Djeu, Julie Y.; Wei, Sheng] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA; [Wang, Huaquan] Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; Tianjin Medical University	Zhou, JM (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA.	Sheng.wei@moffitt.org	Wang, Huaquan/AAN-6917-2021; Eksioglu, Erika/E-6315-2015	Eksioglu, Erika/0000-0003-4458-7192	National Institutes of Health [AI056213]; State of Florida/Department of Health [09KT-01]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Florida/Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant [AI056213] and a grant from the State of Florida/Department of Health fund [09KT-01]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Didierlaurent A, 2006, MOL CELL BIOL, V26, P735, DOI 10.1128/MCB.26.3.735-742.2006; Ehlers SL, 2011, BONE MARROW TRANSPL, V46, P285, DOI 10.1038/bmt.2010.113; Fong YC, 2008, J BONE MINER RES, V23, P961, DOI 10.1359/JBMR.080206; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Fromer L, 2008, INT J CLIN PRACT, V62, P1219, DOI 10.1111/j.1742-1241.2008.01807.x; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Garbin U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008225; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gribaldo L, 1999, EXP HEMATOL, V27, P1593, DOI 10.1016/S0301-472X(99)00107-1; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Haura EB, 2006, MED HYPOTHESES, V67, P951, DOI 10.1016/j.mehy.2005.12.050; Imler JL, 2001, TRENDS CELL BIOL, V11, P304, DOI 10.1016/S0962-8924(01)02004-9; Ishii M, 2008, EUR J IMMUNOL, V38, P2290, DOI 10.1002/eji.200838360; Khaldoyanidi S, 2001, BLOOD, V98, P303, DOI 10.1182/blood.V98.2.303; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Laan M, 2004, J IMMUNOL, V173, P4164, DOI 10.4049/jimmunol.173.6.4164; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Lichtman MA, 2007, LEUKEMIA, V21, P1137, DOI 10.1038/sj.leu.2404698; Liu XD, 2003, OSTEOPOROSIS INT, V14, P235, DOI 10.1007/s00198-002-1350-7; Liu XD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-66; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mortaz E, 2008, J LEUKOCYTE BIOL, V83, P575, DOI 10.1189/jlb.0907625; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Ozes ON, 1999, NATURE, V401, P82; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Parent-Massin D, 2010, TOXICOLOGY, V267, P112, DOI 10.1016/j.tox.2009.10.031; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Lu S, 2006, PROSTATE, V66, P996, DOI 10.1002/pros.20424; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Testa U, 2004, LEUKEMIA, V18, P1176, DOI 10.1038/sj.leu.2403383; van Eeden SF, 2000, EUR RESPIR J, V15, P915, DOI 10.1034/j.1399-3003.2000.15e18.x; Wang DH, 2009, J IMMUNOL, V182, P5757, DOI 10.4049/jimmunol.0803861; Wang JH, 2009, AM J RHINOL ALLERGY, V23, pE5, DOI 10.2500/ajra.2009.23.3407; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21173	10.1371/journal.pone.0021173	http://dx.doi.org/10.1371/journal.pone.0021173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738617	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100014
J	Jiang, YY; Sirinupong, N; Brunzelle, J; Yang, Z				Jiang, Yuanyuan; Sirinupong, Nualpun; Brunzelle, Joseph; Yang, Zhe			Crystal Structures of Histone and p53 Methyltransferase SmyD2 Reveal a Conformational Flexibility of the Autoinhibitory C-Terminal Domain	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; HSP90; CHROMATIN; PROTEIN; PROLIFERATION; METHYLATION; SPECIFICITY; DROSOPHILA; ENCODES; COMPLEX	SmyD2 belongs to a new class of chromatin regulators that control gene expression in heart development and tumorigenesis. Besides methylation of histone H3 K4, SmyD2 can methylate non-histone targets including p53 and the retinoblastoma tumor suppressor. The methyltransferase activity of SmyD proteins has been proposed to be regulated by autoinhibition via the intra-and interdomain bending of the conserved C-terminal domain (CTD). However, there has been no direct evidence of a conformational change in the CTD. Here, we report two crystal structures of SmyD2 bound either to the cofactor product S-adenosylhomocysteine or to the inhibitor sinefungin. SmyD2 has a two-lobed structure with the active site located at the bottom of a deep crevice formed between the CTD and the catalytic domain. By extensive engagement with the methyltransferase domain, the CTD stabilizes the autoinhibited conformation of SmyD2 and restricts access to the catalytic site. Unexpectedly, despite that the two SmyD2 structures are highly superimposable, significant differences are observed in the first two helices of the CTDs: the two helices bend outwards and move away from the catalytic domain to generate a less closed conformation in the sinefungin-bound structure. Although the overall fold of the individual domains is structurally conserved among SmyD proteins, SmyD2 appear to be a conformational "intermediate'' between a close form of SmyD3 and an open form of SmyD1. In addition, the structures reveal that the CTD is structurally similar to tetratricopeptide repeats (TPR), a motif through which many cochaperones bind to the heat shock protein Hsp90. Our results thus provide the first evidence for the intradomain flexibility of the TPR-like CTD, which may be important for the activation of SmyD proteins by Hsp90.	[Jiang, Yuanyuan; Sirinupong, Nualpun; Yang, Zhe] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Brunzelle, Joseph] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Wayne State University; United States Department of Energy (DOE); Argonne National Laboratory	Jiang, YY (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	zyang@med.wayne.edu	jiang, anyi/GPT-0379-2022; Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011	American Heart Association (AHA)	American Heart Association (AHA)(American Heart Association)	This work was supported, in part, by the American Heart Association (AHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Diehl F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009748; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kawamura S, 2008, CYTOTECHNOLOGY, V57, P161, DOI 10.1007/s10616-008-9128-1; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; SADDIC LA, 2010, J BIOL CHEM, V24, P24; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Soti C, 2002, J BIOL CHEM, V277, P7066, DOI 10.1074/jbc.M105568200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Thompson EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003008; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; XU S, 2011, NUCLEIC ACIDS RES, V25, P25; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	36	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21640	10.1371/journal.pone.0021640	http://dx.doi.org/10.1371/journal.pone.0021640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738746	Green Submitted, gold, Green Published			2022-12-25	WOS:000292142800049
J	Munoz-Abellan, C; Rabasa, C; Daviu, N; Nadal, R; Armario, A				Munoz-Abellan, Cristina; Rabasa, Cristina; Daviu, Nuria; Nadal, Roser; Armario, Antonio			Behavioral and Endocrine Consequences of Simultaneous Exposure to Two Different Stressors in Rats: Interaction or Independence?	PLOS ONE			English	Article							PITUITARY-ADRENAL RESPONSIVENESS; ANXIETY-RELATED BEHAVIOR; ELEVATED PLUS-MAZE; CAT ODOR; SINGLE EXPOSURE; MARKED DISSOCIATION; DEFENSIVE BEHAVIORS; ADRENOCORTICAL AXIS; PREDATOR EXPOSURE; LASTING INCREASES	Although behavioral and endocrine consequences of acute exposure to stressors have been extensively studied, little is known about how simultaneous exposure to two different stressors interacts to induce short-and long-term effects. In the present experiment we studied this interaction in adult male rats exposed to cat fur odor (impregnated cloth) or immobilization on boards either separately or simultaneously. We reasoned that exposure to the odor of a potential predator while immobilized, may potentiate its negative consequences as compared to exposure to only one of the stressors. Exposure to cat odor elicited the expected reduction of activity and avoidance of the area where the impregnated cloth was located. The endocrine response (plasma levels of ACTH and corticosterone, as a measure of the hypothalamic-pituitary-adrenal axis, HPA) was markedly greater after immobilization than after cat fur odor and no additive effects were found by simultaneous exposure to both stressors. Cat odor, but not immobilization, increased anxiety-like behavior as evaluated in the elevated plus-maze 7 days after the stressors, with no evidence of enhanced HPA activation. In addition, cat odor exposure resulted in long-lasting (8 days later) fear conditioning to the box containing a clean cloth, which was reflected by hypoactivity, avoidance of the cloth area and enhanced HPA activation. All these effects were similarly observed in rats exposed simultaneously to cat odor and immobilization. In rats only exposed to immobilization, only some weak behavioral signs of fear conditioning were found, but HPA activation in response to the context paired to immobilization was enhanced to the same extent as in cat odor-exposed animals, supporting a certain degree of endocrine conditioning. The present results did not reveal important behavioral interactions between the two stressors when animals experienced both simultaneously, whereas some interactions were found regarding HPA activation. Theoretical implications are discussed.	[Munoz-Abellan, Cristina; Rabasa, Cristina; Daviu, Nuria; Nadal, Roser; Armario, Antonio] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Munoz-Abellan, Cristina; Rabasa, Cristina; Daviu, Nuria; Armario, Antonio] Univ Autonoma Barcelona, Fac Biociencies, Unitat Fisiol Anim, E-08193 Barcelona, Spain; [Nadal, Roser] Univ Autonoma Barcelona, Fac Psicol, Unitat Psicobiol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Munoz-Abellan, C (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain.	Antonio.armario@uab.es	Armario, Antonio/C-9267-2011; Nadal, Roser/C-7977-2011; Daviu, Nuria/C-9528-2011	Armario, Antonio/0000-0001-9524-3635; Nadal, Roser/0000-0001-8972-2525; Daviu, Nuria/0000-0002-9843-2981	Ministerio de Ciencia e Innovacion [SAF2008-01175]; Instituto de Salud Carlos III (Redes Tematicas de Investigacion Cooperativa en Salud, Ministerio de Sanidad y Consumo) [RD06/0001/0015]; Plan Nacional sobre Drogas and Generalitat de Catalunya, Spain [SGR2009-16]; Ministerio de Educacion y Ciencia, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III (Redes Tematicas de Investigacion Cooperativa en Salud, Ministerio de Sanidad y Consumo)(Instituto de Salud Carlos III); Plan Nacional sobre Drogas and Generalitat de Catalunya, Spain; Ministerio de Educacion y Ciencia, Spain(Spanish Government)	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2008-01175), Instituto de Salud Carlos III (RD06/0001/0015, Redes Tematicas de Investigacion Cooperativa en Salud, Ministerio de Sanidad y Consumo), Plan Nacional sobre Drogas and Generalitat de Catalunya (SGR2009-16), Spain. CMA, ND and CR are recipients of fellowships from Ministerio de Educacion y Ciencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1991, PHYSIOL BEHAV, V50, P151, DOI 10.1016/0031-9384(91)90513-N; Adamec R, 1998, NEUROSCI BIOBEHAV R, V23, P301, DOI 10.1016/S0149-7634(98)00032-3; Adamec R, 2004, PHYSIOL BEHAV, V83, P401, DOI 10.1016/j.physbeh.2004.08.029; Adamec RE, 1999, PHYSIOL BEHAV, V65, P723; ADAMEC RE, 1993, PHYSIOL BEHAV, V54, P101, DOI 10.1016/0031-9384(93)90050-P; Adamec RE, 1997, BEHAV NEUROSCI, V111, P435; ANDERO R, 2010, HIPPOCAMPUS IN PRESS; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; [Anonymous], 2007, LEARNING BEHAV CONT; Armario Antonio, 2006, CNS & Neurological Disorders-Drug Targets, V5, P485, DOI 10.2174/187152706778559336; Belda X, 2004, BEHAV BRAIN RES, V154, P399, DOI 10.1016/j.bbr.2004.03.011; Belda X, 2008, HORM BEHAV, V54, P654, DOI 10.1016/j.yhbeh.2008.07.003; Blanchard RJ, 2001, NEUROSCI BIOBEHAV R, V25, P587, DOI 10.1016/S0149-7634(01)00043-4; BRUSH FR, 1991, BEHAV GENET, V21, P35, DOI 10.1007/BF01067665; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2003, BIOL PSYCHIAT, V53, P463, DOI 10.1016/S0006-3223(02)01909-1; Cohen H, 2000, EUR NEUROPSYCHOPHARM, V10, P429, DOI 10.1016/S0924-977X(00)00105-X; Cohen H, 1999, DEPRESS ANXIETY, V10, P8, DOI 10.1002/(SICI)1520-6394(1999)10:1<8::AID-DA2>3.0.CO;2-#; Daviu N, 2010, NEUROBIOL LEARN MEM, V94, P183, DOI 10.1016/j.nlm.2010.05.005; Dielenberg RA, 1999, PHARMACOL BIOCHEM BE, V62, P197, DOI 10.1016/S0091-3057(98)00064-1; Dielenberg RA, 1999, J COMP PSYCHOL, V113, P376, DOI 10.1037/0735-7036.113.4.376; Dielenberg RA, 2001, BRAIN RES, V897, P228, DOI 10.1016/S0006-8993(01)02227-2; ENGELAND WC, 1989, ENDOCRINOLOGY, V124, P2978, DOI 10.1210/endo-124-6-2978; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; FILE SE, 1993, PHYSIOL BEHAV, V54, P1109, DOI 10.1016/0031-9384(93)90333-B; FILE SE, 1994, PSYCHOPHARMACOLOGY, V113, P543, DOI 10.1007/BF02245237; Gagliano H, 2008, BEHAV BRAIN RES, V187, P239, DOI 10.1016/j.bbr.2007.09.006; Goswami S, 2010, LEARN MEMORY, V17, P494, DOI 10.1101/lm.1948910; Hardin J., 2003, GEN ESTIMATING EQUAT; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; Koks S, 2002, NEUROSCI LETT, V322, P116, DOI 10.1016/S0304-3940(02)00110-6; Landgraf R, 1999, J NEUROENDOCRINOL, V11, P405; LEMEVEL JC, 1979, ENDOCRINOLOGY, V105, P812; Li CI, 2004, BEHAV NEUROSCI, V118, P324, DOI 10.1037/0735-7044.118.2.324; Liebsch G, 1998, NEUROPSYCHOPHARMACOL, V19, P381, DOI 10.1016/S0893-133X(98)00042-6; Mackenzie L, 2010, NEUROSCIENCE, V169, P733, DOI 10.1016/j.neuroscience.2010.05.005; Marquez C, 2006, BEHAV BRAIN RES, V168, P13, DOI 10.1016/j.bbr.2005.10.004; Marquez C, 2002, BRAIN RES, V926, P181, DOI 10.1016/S0006-8993(01)03112-2; Mazur J.E., 2006, LEARN BEHAV; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McGregor IS, 1999, PSYCHOPHARMACOLOGY, V147, P174, DOI 10.1007/s002130051158; Mesches M H, 1999, J Neurosci, V19, pRC18; Munoz-Abellan C, 2010, PHYSIOL BEHAV, V99, P388, DOI 10.1016/j.physbeh.2009.12.008; Munoz-Abellan C, 2009, HORM BEHAV, V56, P465, DOI 10.1016/j.yhbeh.2009.08.002; Munoz-Abellan C, 2008, PSYCHONEUROENDOCRINO, V33, P1139, DOI 10.1016/j.psyneuen.2008.06.002; O'Connor KA, 2003, PSYCHONEUROENDOCRINO, V28, P481, DOI 10.1016/S0306-4530(02)00035-5; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Rotllant D, 2007, DEV NEUROBIOL, V67, P702, DOI 10.1002/dneu.20345; Siviy SM, 2006, BEHAV NEUROSCI, V120, P49, DOI 10.1037/0735-7044.120.1.49; Staples LG, 2010, NEUROBIOL LEARN MEM, V94, P435, DOI 10.1016/j.nlm.2010.09.009; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Valles A, 2000, AM J PHYSIOL-REG I, V279, pR1138, DOI 10.1152/ajpregu.2000.279.3.R1138; Zelena D, 2003, AM J PHYSIOL-ENDOC M, V285, pE1110, DOI 10.1152/ajpendo.00219.2003	56	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21426	10.1371/journal.pone.0021426	http://dx.doi.org/10.1371/journal.pone.0021426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731743	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900030
J	Borodina, I; Jensen, BM; Wagner, T; Hachem, MA; Sondergaard, I; Poulsen, LK				Borodina, Irina; Jensen, Bettina M.; Wagner, Tim; Hachem, Maher A.; Sondergaard, Ib; Poulsen, Lars K.			Expression of Enzymatically Inactive Wasp Venom Phospholipase A1 in Pichia pastoris	PLOS ONE			English	Article							REACTIVE CARBOHYDRATE DETERMINANTS; ALLERGEN-SPECIFIC IMMUNOTHERAPY; VES V 2; VESPULA-VULGARIS; N-GLYCANS; ANTIGEN 5; RECOMBINANT; PROTEINS; VACCINE; HYALURONIDASE	Wasp venom allergy is the most common insect venom allergy in Europe. It is manifested by large local reaction or anaphylactic shock occurring after a wasp sting. The allergy can be treated by specific immunotherapy with whole venom extracts. Wasp venom is difficult and costly to obtain and is a subject to composition variation, therefore it can be advantageous to substitute it with a cocktail of recombinant allergens. One of the major venom allergens is phospholipase A1, which so far has been expressed in Escherichia coli and in insect cells. Our aim was to produce the protein in secreted form in yeast Pichia pastoris, which can give high yields of correctly folded protein on defined minimal medium and secretes relatively few native proteins simplifying purification. Residual amounts of enzymatically active phospholipase A1 could be expressed, but the venom protein had a deleterious effect on growth of the yeast cells. To overcome the problem we introduced three different point mutations at the critical points of the active site, where serine137, aspartate165 or histidine229 were replaced by alanine (S137A, D165A and H229A). All the three mutated forms could be expressed in P. pastoris. The H229A mutant did not have any detectable phospholipase A1 activity and was secreted at the level of several mg/L in shake flask culture. The protein was purified by nickel-affinity chromatography and its identity was confirmed by MALDI-TOF mass spectrometry. The protein could bind IgE antibodies from wasp venom allergic patients and could inhibit the binding of wasp venom to IgE antibodies specific for phospholipase A1 as shown by Enzyme Allergo-Sorbent Test (EAST). Moreover, the recombinant protein was allergenic in a biological assay as demonstrated by its capability to induce histamine release of wasp venom-sensitive basophils. The recombinant phospholipase A1 presents a good candidate for wasp venom immunotherapy.	[Borodina, Irina; Wagner, Tim; Sondergaard, Ib] Tech Univ Denmark, Inst Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark; [Jensen, Bettina M.; Poulsen, Lars K.] Rigshosp, Dept 7551, CUH Gentofte, Allergy Clin,Dermato Allergol Dept K, Copenhagen O, Denmark; [Hachem, Maher A.] Tech Univ Denmark, Inst Syst Biol, Enzyme & Prot Ctr, DK-2800 Lyngby, Denmark	Technical University of Denmark; Rigshospitalet; Technical University of Denmark	Borodina, I (corresponding author), Tech Univ Denmark, Inst Syst Biol, Ctr Microbial Biotechnol, DK-2800 Lyngby, Denmark.	lkpallgy@mail.dk	Poulsen, Lars K/J-3065-2019; Borodina, Irina/G-5587-2013; Abou Hachem, Maher/M-4772-2019	Poulsen, Lars K/0000-0002-1730-847X; Abou Hachem, Maher/0000-0001-8250-1842; Borodina, Irina/0000-0002-8452-1393	Danish Research Council [274-07-0148]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was funded by Grant 274-07-0148 from the Danish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKHOLT V, 1989, ANAL BIOCHEM, V177, P318, DOI 10.1016/0003-2697(89)90059-6; Blank S, 2010, J IMMUNOL, V184, P5403, DOI 10.4049/jimmunol.0803709; Borodina I, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-74; CHARPIN D, 1992, J ALLERGY CLIN IMMUN, V90, P331, DOI 10.1016/S0091-6749(05)80011-9; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Crameri R, 2006, CURR OPIN IMMUNOL, V18, P761, DOI 10.1016/j.coi.2006.09.001; Golden DBK, 2005, J ALLERGY CLIN IMMUN, V115, P439, DOI 10.1016/j.jaci.2005.01.005; Jappe U, 2006, ALLERGY, V61, P1220, DOI 10.1111/j.1398-9995.2006.01232.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Karamloo F, 2005, EUR J IMMUNOL, V35, P3268, DOI 10.1002/eji.200425522; KING TP, 1983, MOL IMMUNOL, V20, P297, DOI 10.1016/0161-5890(83)90069-X; King TP, 1996, J ALLERGY CLIN IMMUN, V98, P588, DOI 10.1016/S0091-6749(96)70093-3; Kolarich D, 2005, FEBS J, V272, P5182, DOI 10.1111/j.1742-4658.2005.04841.x; Kolarich D, 2007, PROTEOMICS, V7, P1615, DOI 10.1002/pmic.200600800; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mayer A, 2006, CLIN CANCER RES, V12, P6509, DOI 10.1158/1078-0432.CCR-06-0769; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Monsalve RI, 1999, PROTEIN EXPRES PURIF, V16, P410, DOI 10.1006/prep.1999.1082; MOSBECH H, 2004, NOVART FDN SYMP, V257, P207; MOSBECH H, 2004, NOVART FDN SYMP, V257, P188; MOSBECH H, 2004, NOVART FDN SYMP, V257, P276; Mosbech Holger, 2004, Novartis Found Symp, V257, P177; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Seismann Henning, 2010, Clin Mol Allergy, V8, P7, DOI 10.1186/1476-7961-8-7; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; Seppala U, 2009, MOL IMMUNOL, V46, P2014, DOI 10.1016/j.molimm.2009.03.005; Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687; SKOV PS, 1984, AGENTS ACTIONS, V14, P414, DOI 10.1007/BF01973840; Suck R, 2000, INT ARCH ALLERGY IMM, V121, P284, DOI 10.1159/000024341; vanWandelen C, 1997, J CHROMATOGR A, V763, P11, DOI 10.1016/S0021-9673(96)00891-6; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Winkler B, 2003, IMMUNOLOGY, V110, P376, DOI 10.1046/j.1365-2567.2003.01751.x; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02	35	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21267	10.1371/journal.pone.0021267	http://dx.doi.org/10.1371/journal.pone.0021267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731687	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400017
J	Larios, OE; Coleman, BL; Drews, SJ; Mazzulli, T; Borgundvaag, B; Green, K; McGeer, AJ				Larios, Oscar E.; Coleman, Brenda L.; Drews, Steven J.; Mazzulli, Tony; Borgundvaag, Bjug; Green, Karen; McGeer, Allison J.		STOP-Flu Study	Self-Collected Mid-Turbinate Swabs for the Detection of Respiratory Viruses in Adults with Acute Respiratory Illnesses	PLOS ONE			English	Article							FLOCKED SWABS; VIRAL LOAD; INFLUENZA; CHILDREN	Background: The gold standard for respiratory virus testing is a nasopharyngeal (NP) swab, which is collected by a healthcare worker. Midturbinate (MT) swabs are an alternative due to their ease of collection and possible self-collection by patients. The objective of this study was to compare the respiratory virus isolation of flocked MT swabs compared to flocked NP swabs. Methods: Beginning in October 2008, healthy adults aged 18 to 69 years were recruited into a cohort and followed up for symptoms of influenza. They were asked to have NP and MT swabs taken as soon as possible after the onset of a fever or two or more respiratory symptoms with an acute onset. The swabs were tested for viral respiratory infections using Seeplex (R) RV12 multiplex PCR detection kit. Seventy six pairs of simultaneous NP and MT swabs were collected from 38 symptomatic subjects. Twenty nine (38%) of these pairs were positive by either NP or MT swabs or both. Sixty nine (91%) of the pair results were concordant. Two samples (3%) for hCV OC43/HKU1 and 1 sample (1%) for rhinovirus A/B were positive by NP but negative by MT. One sample each for hCV 229E/NL63, hCV OC43/HKU1, respiratory syncytial virus A, and influenza B were positive by MT but negative by NP. Conclusions: Flocked MT swabs are sensitive for the diagnosis of multiple respiratory viruses. Given the ease of MT collection and similar results between the two swabs, it is likely that MT swabs should be the preferred method of respiratory cell collection for outpatient studies. In light of this data, larger studies should be performed to ensure that this still holds true and data should also be collected on the patient preference of collection methods.	[Larios, Oscar E.] Royal Univ Hosp, Dept Med, Saskatoon, SK S7N 0W8, Canada; [Larios, Oscar E.] Royal Univ Hosp, Dept Lab Med, Saskatoon, SK S7N 0W8, Canada; [Larios, Oscar E.] Univ Saskatchewan, Fac Med, Saskatoon, SK, Canada; [Coleman, Brenda L.; Mazzulli, Tony; Green, Karen; McGeer, Allison J.] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada; [Coleman, Brenda L.; Mazzulli, Tony; Borgundvaag, Bjug; McGeer, Allison J.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Drews, Steven J.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Drews, Steven J.] Prov Lab Publ Hlth, Dept Microbiol, Calgary, AB, Canada; [Borgundvaag, Bjug] Mt Sinai Hosp, Dept Emergency Med, Toronto, ON M5G 1X5, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Calgary; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Larios, OE (corresponding author), Royal Univ Hosp, Dept Med, Saskatoon, SK S7N 0W8, Canada.	bcoleman@mtsinai.on.ca	Borgundvaag, Bjug/AAE-8228-2020; Borgundvaag, Bjug/AAH-4446-2020; Larios, Oscar E/D-1794-2010; McGeer, Allison/AAB-6885-2020; mcgeer, allison/H-7747-2014	McGeer, Allison/0000-0001-5647-6137; mcgeer, allison/0000-0001-5647-6137; McNeil, Shelly/0000-0001-5444-4166; Tripp, Ralph/0000-0002-2924-9956; Coleman, Brenda L./0000-0002-7144-4827	GlaxoSmithKline Inc; GSK	GlaxoSmithKline Inc(GlaxoSmithKline); GSK(GlaxoSmithKline)	This work was funded, in part, by an investigator-initiated research contract with GlaxoSmithKline Inc (http://www.gsk.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; OEL received travel support from Copan Diagnostics Inc. (http://www.copanusa.com) to present this research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. AJM has read the journal's policy and wishes to disclose the follow: receipt of funding from GSK for the pilot study from which this sub-study sprang. The results of the sub-study are not directly applicable to GSK and this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. No other authors have competing interests to declare.	Abu-Diab A, 2008, J CLIN MICROBIOL, V46, P2414, DOI 10.1128/JCM.00369-08; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Daley P, 2006, J CLIN MICROBIOL, V44, P2265, DOI 10.1128/JCM.02055-05; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Esposito S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-85; Forman MS, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1284; Ginocchio CC, 2007, J CLIN VIROL, V40, pS11, DOI 10.1016/S1386-6532(07)70004-5; GREENBERG SB, 1986, CUMITECH, V21; Heikkinen T, 2002, J CLIN MICROBIOL, V40, P4337, DOI 10.1128/JCM.40.11.4337-4339.2002; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Smieja M, 2010, J CLIN MICROBIOL, V48, P3340, DOI 10.1128/JCM.02235-09; Sung Rita Y T, 2009, Hong Kong Med J, V15, P24; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Yoo SJ, 2007, KOREAN J LAB MED, V27, P420, DOI 10.3343/kjlm.2007.27.6.420	17	54	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21335	10.1371/journal.pone.0021335	http://dx.doi.org/10.1371/journal.pone.0021335			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731708	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400025
J	Zhang, JC; Wu, J; Toyohara, J; Fujita, Y; Chen, HX; Hashimoto, K				Zhang, Jichun; Wu, Jin; Toyohara, Jun; Fujita, Yuko; Chen, Hongxian; Hashimoto, Kenji			Pharmacological Characterization of [H-3]CHIBA-3007 Binding to Glycine Transporter 1 in the Rat Brain	PLOS ONE			English	Article							D-SERINE; SCHIZOPHRENIA; INHIBITORS; GLYT1; LOCALIZATION; EXPRESSION; TYPE-1; GENE; CNS; NEUROTRANSMISSION	Glycine transporter-1 (GlyT-1) in glial cells regulates extracellular levels of glycine, which acts as an obligatory co-agonist at the N-methyl-D-aspartate (NMDA) receptors in the brain. In the present study, we developed a novel radioligand, [H-3]3-chloro-N-((S)-((R)-1-methylpiperidin-2-yl)(thiophen- 3-yl)methyl)-4- (trifluoromethyl) picolinamide ([H-3]CHIBA-3007), for studying GlyT-1 in the brain. The presence of a single saturable high-affinity binding component for [H-3]CHIBA-3007 binding to the rat brain membranes was detected. Scatchard analysis revealed an apparent equilibrium dissociation constant (K-d) of 1.61 +/- 0.16 nM and a maximal number of binding sites (B-max) of 692.8 +/- 22.8 fmol/mg protein (mean +/- SEM, n = 3). The specific binding of [H-3]CHIBA-3007 was inhibited by a number of GlyT-1 inhibitors, such as CHIBA-3007, desmethyl-CHIBA-3007, CHIBA-3008, SSR504734, NFPS/ALX5407, LY2365109 and Org24598, consistent with the pharmacological profiles of GlyT-1 inhibitors. Interestingly, the potency of eight GlyT-1 inhibitors (CHIBA-3007, desmethyl-CHIBA-3007, NFPS/ALX5407, LY2365109, Org24598, SSR504734, sarcosine, and glycine) for blocking in vitro specific binding of [H-3]CHIBA-3007 was significantly correlated with the potency of these inhibitors for inhibiting [C-14]glycine uptake in the rat brain membranes. In contrast, the GlyT-2 inhibitor ALX1393 exhibited very weak for [H-3]CHIBA-3007 binding. Furthermore, the regional distribution of [H-3]CHIBA-3007 binding in the rat brain was similar to the previously reported distribution of GlyT-1. The present findings suggest that [H-3]CHIBA-3007 would be a useful new radioligand for studying GlyT-1 in the brain.	[Zhang, Jichun; Wu, Jin; Toyohara, Jun; Fujita, Yuko; Chen, Hongxian; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Chiba University	Zhang, JC (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Toyohara, Jun/C-4461-2011; Hashimoto, Kenji/I-5800-2015	Toyohara, Jun/0000-0003-4721-405X; Hashimoto, Kenji/0000-0002-8892-0439	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan [06-46]	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation)	This work was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan (Grant ID 06-46, to Dr. Kenji Hashimoto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APRISON M. H., 1965, LIFE SCI, V4, P2075, DOI 10.1016/0024-3205(65)90325-5; Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; BOROWSKY B, 1993, NEURON, V10, P851, DOI 10.1016/0896-6273(93)90201-2; Burnet PWJ, 2008, SCHIZOPHR RES, V102, P283, DOI 10.1016/j.schres.2008.02.009; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Danysz W, 1998, PHARMACOL REV, V50, P597; Dargazanli G, 2005, [No title captured], Patent No. [WO2005037781A3, 2005037781]; Depoortere R, 2005, NEUROPSYCHOPHARMACOL, V30, P1963, DOI 10.1038/sj.npp.1300772; Eulenburg V, 2005, TRENDS BIOCHEM SCI, V30, P325, DOI 10.1016/j.tibs.2005.04.004; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hashimoto Kenji, 2007, Central Nervous System Agents in Medicinal Chemistry, V7, P177, DOI 10.2174/187152407781669161; Hashimoto K, 2008, EUR NEUROPSYCHOPHARM, V18, P414, DOI 10.1016/j.euroneuro.2007.07.009; Hashimoto Kenji, 2006, Recent Pat CNS Drug Discov, V1, P43, DOI 10.2174/157488906775245336; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; Hashimoto Kenji, 2004, Current Medicinal Chemistry - Central Nervous System Agents, V4, P147, DOI 10.2174/1568015043357011; Hashimoto K, 2011, CURR PHARM DESIGN, V17, P112, DOI 10.2174/138161211795049598; Hashimoto Kenji, 2010, Open Med Chem J, V4, P10, DOI 10.2174/1874104501004010010; Herdon HJ, 2010, NEUROPHARMACOLOGY, V59, P558, DOI 10.1016/j.neuropharm.2010.07.023; Javitt DC, 2008, BIOL PSYCHIAT, V63, P6, DOI 10.1016/j.biopsych.2007.09.017; Javitt DC, 2009, CURR OPIN DRUG DISC, V12, P468; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; KIM KM, 1994, MOL PHARMACOL, V45, P608; Kinney Gene G., 2005, Current Neuropharmacology, V3, P35, DOI 10.2174/1570159052773387; Lindsley CW, 2006, CURR TOP MED CHEM, V6, P1883, DOI 10.2174/156802606778249784; LIU QR, 1993, J BIOL CHEM, V268, P2106; Lowe JA, 2003, BIOORG MED CHEM LETT, V13, P1291, DOI 10.1016/S0960-894X(03)00126-4; Mallorga PJ, 2003, NEUROPHARMACOLOGY, V45, P585, DOI 10.1016/S0028-3908(03)00227-2; Mezler M, 2008, MOL PHARMACOL, V74, P1705, DOI 10.1124/mol.108.049312; Sekiguchi Y., 2008, PCT Int. Appl., Patent No. 2008018639; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; Sur C, 2004, EXPERT OPIN INV DRUG, V13, P515, DOI 10.1517/13543784.13.5.515; VANDENBERG RJ, 2001, EXPER OPIN THER TAR, V5, P507, DOI DOI 10.1517/14728222.5.4.507; ZAFRA F, 1995, EUR J NEUROSCI, V7, P1342, DOI 10.1111/j.1460-9568.1995.tb01125.x; Zafra F, 1997, MOL NEUROBIOL, V14, P117, DOI 10.1007/BF02740653; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zeng Z, 2008, NUCL MED BIOL, V35, P315, DOI 10.1016/j.nucmedbio.2007.12.002; 갠지하시모토, 2006, Clinical Psychopharmacology and Neuroscience, V4, P3	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21322	10.1371/journal.pone.0021322	http://dx.doi.org/10.1371/journal.pone.0021322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731704	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400021
J	Juhila, J; Sipila, T; Icay, K; Nicorici, D; Ellonen, P; Kallio, A; Korpelainen, E; Greco, D; Hovatta, I				Juhila, Juuso; Sipila, Tessa; Icay, Katherine; Nicorici, Daniel; Ellonen, Pekka; Kallio, Aleksi; Korpelainen, Eija; Greco, Dario; Hovatta, Iiris			MicroRNA Expression Profiling Reveals MiRNA Families Regulating Specific Biological Pathways in Mouse Frontal Cortex and Hippocampus	PLOS ONE			English	Article							DIGITAL GENE-EXPRESSION; CENTRAL-NERVOUS-SYSTEM; DIFFERENTIAL EXPRESSION; ALZHEIMERS-DISEASE; PROBE LEVEL; ADULT; BRAIN; RNA; PATTERNS; MIRBASE	MicroRNAs (miRNAs) are small regulatory molecules that cause post-transcriptional gene silencing. Although some miRNAs are known to have region-specific expression patterns in the adult brain, the functional consequences of the region-specificity to the gene regulatory networks of the brain nuclei are not clear. Therefore, we studied miRNA expression patterns by miRNA-Seq and microarrays in two brain regions, frontal cortex (FCx) and hippocampus (HP), which have separate biological functions. We identified 354 miRNAs from FCx and 408 from HP using miRNA-Seq, and 245 from FCx and 238 from HP with microarrays. Several miRNA families and clusters were differentially expressed between FCx and HP, including the miR-8 family, miR-182 vertical bar miR-96 vertical bar miR-183 cluster, and miR-212 vertical bar miR-312 cluster overexpressed in FCx and miR-34 family overexpressed in HP. To visualize the clusters, we developed support for viewing genomic alignments of miRNA-Seq reads in the Chipster genome browser. We carried out pathway analysis of the predicted target genes of differentially expressed miRNA families and clusters to assess their putative biological functions. Interestingly, several miRNAs from the same family/cluster were predicted to regulate specific biological pathways. We have developed a miRNA-Seq approach with a bioinformatic analysis workflow that is suitable for studying miRNA expression patterns from specific brain nuclei. FCx and HP were shown to have distinct miRNA expression patterns which were reflected in the predicted gene regulatory pathways. This methodology can be applied for the identification of brain region-specific and phenotype-specific miRNA-mRNA-regulatory networks from the adult and developing rodent brain.	[Juhila, Juuso; Nicorici, Daniel; Ellonen, Pekka; Hovatta, Iiris] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Juhila, Juuso; Sipila, Tessa; Icay, Katherine; Hovatta, Iiris] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland; [Juhila, Juuso; Sipila, Tessa; Icay, Katherine; Hovatta, Iiris] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Sipila, Tessa; Hovatta, Iiris] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Kallio, Aleksi; Korpelainen, Eija] IT Ctr Sci, CSC, Espoo, Finland; [Greco, Dario] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Karolinska Institutet	Juhila, J (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	iiris.hovatta@helsinki.fi	Greco, Dario/T-7113-2019; Hovatta, Iiris/D-6871-2012	Greco, Dario/0000-0001-9195-9003; Hovatta, Iiris/0000-0002-5990-7892; Korpelainen, Eija/0000-0002-4406-5602; Ellonen, Pekka/0000-0001-6072-0489; Nicorici, Daniel/0000-0002-0278-8263	Institute for Molecular Medicine (FIMM) of the University of Helsinki; Academy of Finland; Peter and Patricia Gruber Foundation; Helsinki Biomedical Graduate School; European Science Foundation	Institute for Molecular Medicine (FIMM) of the University of Helsinki; Academy of Finland(Academy of Finland); Peter and Patricia Gruber Foundation; Helsinki Biomedical Graduate School; European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by the Institute for Molecular Medicine (FIMM) of the University of Helsinki http://www.fimm.fi (IH), Academy of Finland http://www.aka.fi (IH), Rosalind Franklin Young Investigator Award from the Peter and Patricia Gruber Foundation http://www.gruberprizes.org/GruberPrizes/YoungScientists_RosalindFranklin.php (IH), the Helsinki Biomedical Graduate School http://www.hbgs.helsinki.fi (TS), and the European Science Foundation http://www.esf.org/ (TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Baracskay KL, 2006, SYNAPSE, V60, P271, DOI 10.1002/syn.20292; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Benjamini Y, 2001, ANN STAT, V29, P1165; Brugg B, 1996, J NEUROCHEM, V66, P733; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Clinton SM, 2005, AM J PSYCHIAT, V162, P1859, DOI 10.1176/appi.ajp.162.10.1859; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fiore R, 2007, EXPERT OPIN BIOL TH, V7, P1823, DOI 10.1517/14712598.7.12.1823; Fiore Roberto, 2007, ScientificWorldJournal, V7, P167; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; HOLM S, 1979, SCAND J STAT, V6, P65; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r25; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen KP, 2009, MOL PSYCHIATR, V14, P381, DOI 10.1038/mp.2008.15; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurin N, 2005, MOL PSYCHIATR, V10, P1117, DOI 10.1038/sj.mp.4001737; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Muinos-Gimeno M, 2011, BIOL PSYCHIAT, V69, P526, DOI 10.1016/j.biopsych.2010.10.010; Muinos-Gimeno M, 2009, HUM MUTAT, V30, P1062, DOI 10.1002/humu.21005; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Pradervand S, 2010, BIOTECHNIQUES, V48, P219, DOI 10.2144/000113367; Presutti C, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-S1-S5; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rinaldi A, 2010, BEHAV BRAIN RES, V208, P265, DOI 10.1016/j.bbr.2009.11.012; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Trantham-Davidson H, 2008, BEHAV BRAIN RES, V189, P244, DOI 10.1016/j.bbr.2007.12.031; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yang Xinan, 2006, Journal of Bioinformatics and Computational Biology, V4, P693, DOI 10.1142/S0219720006002120; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; ZHANG Y, 2010, J INTEGR BIOINFORM, V7, DOI DOI 10.2390/BIECOLL-JIB-2010-2127	64	60	61	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21495	10.1371/journal.pone.0021495	http://dx.doi.org/10.1371/journal.pone.0021495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731767	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700090
J	Asai, M; Yagishita, S; Iwata, N; Saido, TC; Ishiura, S; Maruyama, K				Asai, Masashi; Yagishita, Sosuke; Iwata, Nobuhisa; Saido, Takaomi C.; Ishiura, Shoichi; Maruyama, Kei			An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma model	FASEB JOURNAL			English	Article						Alzheimer's disease; CA-074Me; gamma-secretase; phosphorylation	GAMMA-SECRETASE INHIBITORS; ALZHEIMERS-DISEASE; INTRACELLULAR DOMAIN; BETA-SECRETASE; WILD-TYPE; APP; PHOSPHORYLATION; ENZYME; FAMILY; TRAFFICKING	gamma-Secretase catalyzes the cleavage of the intramembrane region of the Alzheimer amyloid precursor protein (APP), generating p3, amyloid-beta peptide (A beta), and the APP intracellular domain (AICD). Although a gamma-secretase inhibitor has been shown to cause an accumulation of the APP C-terminal fragments (CTFs) alpha and beta and to decrease levels of p3 or A beta and AICD, we found that treatment with a lysosomotropic weak base, such as chloroquine or ammonium chloride, caused simultaneous accumulation of both CTFs and AICD, suggesting that lysosomal proteases are also involved in processing of APP. This observation was reinforced by the results that cysteine protease inhibitor E-64d and cathepsin B specific inhibitor CA-074Me caused the accumulation of both CTFs and AICD with no change in known secretase activities. gamma-Secretase preferentially cleaved phosphorylated CTFs to produce A beta, but cathepsin B degraded CTFs regardless of phosphorylation. Our results suggest that cathepsin B plays novel roles in the metabolism of APP and that an inhibition of APP phosphorylation is an attractive therapeutic target for Alzheimer's disease.-Asai, M., Yagishita, S., Iwata, N., Saido, T. C., Ishiura, S., Maruyama, K. An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma model. FASEB J. 25, 3720-3730 (2011). www.fasebj.org	[Asai, Masashi; Maruyama, Kei] Saitama Med Univ, Dept Pharmacol, Fac Med, Moroyama, Saitama 3500495, Japan; [Asai, Masashi; Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Saitama, Japan; [Yagishita, Sosuke; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Saitama Medical University; RIKEN; University of Tokyo; Nagasaki University	Asai, M (corresponding author), Saitama Med Univ, Dept Pharmacol, Fac Med, 38 Moro Hongo, Moroyama, Saitama 3500495, Japan.	asai@saitama-med.ac.jp	Asai, Masashi/AAB-7672-2022; Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021	Asai, Masashi/0000-0001-6392-0910; Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903	Regional Innovation Cluster Program (City Area Type; Central Saitama Area); Shimabara Science Promotion Foundation; Japan Society for the Promotion of Science [20590260]	Regional Innovation Cluster Program (City Area Type; Central Saitama Area); Shimabara Science Promotion Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Dr. Raphael Kopan (Washington University, St. Louis, MO, USA) for providing a plasmid (Delta EMV: pCS2/Notch<SUP>Delta E</SUP>), Dr. Bart De Strooper (Katholieke Universiteit Leuven, Leuven, Belgium) for providing PS1 and PS2 double-knockout MEF PS1<SUP>-/-</SUP>PS2<SUP>-/-</SUP> cells, and Drs. Taisuke Tomita and Takeshi Iwatsubo (The University of Tokyo, Tokyo, Japan) for providing mNotch<SUP>Delta E</SUP>-N2a cells. The authors also thank Dr. Kazumi Ishidoh (Tokushima Bunri University, Tokushima, Japan) for his valuable advice. This work was supported by the Regional Innovation Cluster Program (City Area Type; Central Saitama Area), the Shimabara Science Promotion Foundation, and a Grant-in-Aid for Scientific Research (C; 20590260) from the Japan Society for the Promotion of Science.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Asai M, 2010, J NEUROSCI RES, V88, P3588, DOI 10.1002/jnr.22503; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; DICE JF, 1990, CRIT REV THER DRUG, V7, P211; Doerfler P, 2001, P NATL ACAD SCI USA, V98, P9312, DOI 10.1073/pnas.161102498; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; GEKLE M, 1995, AM J PHYSIOL-RENAL, V268, pF899, DOI 10.1152/ajprenal.1995.268.5.F899; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Guha S, 2008, INDIAN J BIOCHEM BIO, V45, P75; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Hook VYH, 2009, BIOCHEM BIOPH RES CO, V386, P284, DOI 10.1016/j.bbrc.2009.05.131; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim SH, 1996, J NEUROCHEM, V67, P1172; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Klein DM, 2009, J PHARMACOL EXP THER, V328, P813, DOI 10.1124/jpet.108.147082; Kouchi Z, 1999, BIOCHEM BIOPH RES CO, V254, P804, DOI 10.1006/bbrc.1998.9977; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Marks N, 2008, NEUROCHEM INT, V52, P184, DOI 10.1016/j.neuint.2007.06.020; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nakanishi H, 2003, AGEING RES REV, V2, P367, DOI 10.1016/S1568-1637(03)00027-8; Panza F, 2009, DRUG AGING, V26, P537, DOI 10.2165/11315770-000000000-00000; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; TAGAWA K, 1991, BIOCHEM BIOPH RES CO, V177, P377, DOI 10.1016/0006-291X(91)91994-N; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Van Acker GJD, 2002, AM J PHYSIOL-GASTR L, V283, pG794, DOI 10.1152/ajpgi.00363.2001; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vingtdeux V, 2005, NEUROBIOL DIS, V20, P625, DOI 10.1016/j.nbd.2005.05.004; Vingtdeux V, 2007, NEUROBIOL DIS, V25, P686, DOI 10.1016/j.nbd.2006.09.019; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	47	28	28	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3720	3730		10.1096/fj.11-182154	http://dx.doi.org/10.1096/fj.11-182154			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21746863				2022-12-25	WOS:000295356400040
J	Tomlinson, CG; Syson, K; Sengerova, B; Atack, JM; Sayers, JR; Swanson, L; Tainer, JA; Williams, NH; Grasby, JA				Tomlinson, Christopher G.; Syson, Karl; Sengerova, Blanka; Atack, John M.; Sayers, Jon R.; Swanson, Linda; Tainer, John A.; Williams, Nicholas H.; Grasby, Jane A.			Neutralizing Mutations of Carboxylates That Bind Metal 2 in T5 Flap Endonuclease Result in an Enzyme That Still Requires Two Metal Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 RNASE-H; DNA-BINDING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; WILD-TYPE; RESTRICTION-ENDONUCLEASE; SUBSTRATE-SPECIFICITY; CATALYTIC PARAMETERS; THERMUS-AQUATICUS; STRUCTURAL BASIS	Flap endonucleases (FENs) are divalent metal ion-dependent phosphodiesterases. Metallonucleases are often assigned a "two-metal ion mechanism" where both metals contact the scissile phosphate diester. The spacing of the two metal ions observed in T5FEN structures appears to preclude this mechanism. However, the overall reaction catalyzed by wild type (WT) T5FEN requires three Mg2+ ions, implying that a third ion is needed during catalysis, and so a two-metal ion mechanism remains possible. To investigate the positions of the ions required for chemistry, a mutant T5FEN was studied where metal 2 (M2) ligands are altered to eliminate this binding site. In contrast to WT T5FEN, the overall reaction catalyzed by D201I/D204S required two ions, but over the concentration range of Mg2+ tested, maximal rate data were fitted to a single binding isotherm. Calcium ions do not support FEN catalysis and inhibit the reactions supported by viable metal cofactors. To establish participation of ions in stabilization of enzyme-substrate complexes, dissociation constants of WT and D201I/D204S-substrate complexes were studied as a function of [Ca2+]. At pH 9.3 (maximal rate conditions), Ca2+ substantially stabilized both complexes. Inhibition of viable cofactor supported reactions of WT, and D201I/D204S T5FENs was biphasic with respect to Ca2+ and ultimately dependent on 1/[Ca2+](2). By varying the concentration of viable metal cofactor, Ca2+ ions were shown to inhibit competitively displacing two catalytic ions. Combined analyses imply that M2 is not involved in chemical catalysis but plays a role in substrate binding, and thus a two-metal ion mechanism is plausible.	[Tomlinson, Christopher G.; Syson, Karl; Sengerova, Blanka; Atack, John M.; Swanson, Linda; Williams, Nicholas H.; Grasby, Jane A.] Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England; [Sayers, Jon R.] Univ Sheffield, Sch Med & Biomed Sci, Henry Wellcome Labs Med Res, Sheffield S10 2RX, S Yorkshire, England; [Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Sheffield; University of Sheffield; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute	Grasby, JA (corresponding author), Univ Sheffield, Dept Chem, Ctr Chem Biol, Krebs Inst, Sheffield S3 7HF, S Yorkshire, England.	j.a.grasby@sheffield.ac.uk	Sayers, Jon R/AAP-6179-2020; Tainer, John/GWQ-4878-2022; Collis, Blanka/ABB-6858-2020; Atack, John/B-7961-2015; Sayers, Jon R/I-8974-2012	Sayers, Jon R/0000-0002-5082-1443; Tainer, John/0000-0003-1659-2429; Atack, John/0000-0002-7994-6995; Sayers, Jon R/0000-0002-5082-1443; Williams, Nicholas/0000-0002-4457-4220	Biotechnology and Biological Sciences Research Council [F0147321]; National Institutes of Health [CA081967]; BBSRC [BB/F014732/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA081967] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F014732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant F0147321. This work was also supported by National Institutes of Health Grant CA081967 (to J.A.T.).	Allen LM, 2009, BIOCHEM J, V418, P285, DOI 10.1042/BJ20081637; Bastock JA, 2007, J MOL BIOL, V368, P421, DOI 10.1016/j.jmb.2007.01.083; Bhagwat M, 1997, J BIOL CHEM, V272, P28531, DOI 10.1074/jbc.272.45.28531; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; Dervan JJ, 2002, P NATL ACAD SCI USA, V99, P8542, DOI 10.1073/pnas.082241699; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Dupureur CM, 2010, METALLOMICS, V2, P609, DOI 10.1039/c0mt00013b; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; Gangisetty O, 2005, J BIOL CHEM, V280, P12876, DOI 10.1074/jbc.M414025200; Hohl M, 2003, J BIOL CHEM, V278, P19500, DOI 10.1074/jbc.M213155200; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Lagunavicius A, 1997, BIOCHEMISTRY-US, V36, P11093, DOI 10.1021/bi963126a; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Orans J, 2011, CELL, V145, P212, DOI 10.1016/j.cell.2011.03.005; Patel D, 2002, J MOL BIOL, V320, P1025, DOI 10.1016/S0022-2836(02)00547-8; Pickering TJ, 1999, J BIOL CHEM, V274, P17711, DOI 10.1074/jbc.274.25.17711; Pickering TJ, 1999, NUCLEIC ACIDS RES, V27, P730, DOI 10.1093/nar/27.3.730; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Reid SL, 2001, BIOCHEMISTRY-US, V40, P2484, DOI 10.1021/bi001956p; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Sengerova B, 2010, BIOCHEMISTRY-US, V49, P8085, DOI 10.1021/bi100895j; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Syson K, 2008, J BIOL CHEM, V283, P28741, DOI 10.1074/jbc.M801264200; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; Tomlinson CG, 2010, BIOCHEM SOC T, V38, P433, DOI 10.1042/BST0380433; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Williams R, 2007, J MOL BIOL, V371, P34, DOI 10.1016/j.jmb.2007.04.063; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Xu Y, 1997, J MOL BIOL, V268, P284, DOI 10.1006/jmbi.1997.0967; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zheng L, 2002, BIOCHEMISTRY-US, V41, P10323, DOI 10.1021/bi025841s	41	12	12	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30878	30887		10.1074/jbc.M111.230391	http://dx.doi.org/10.1074/jbc.M111.230391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21734257	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000294283600067
J	Larkum, AWD; Salih, A; Kuhl, M				Larkum, Anthony W. D.; Salih, Anya; Kuehl, Michael			Rapid Mass Movement of Chloroplasts during Segment Formation of the Calcifying Siphonalean Green Alga, Halimeda macroloba	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-REEFS; PHOTOSYNTHESIS; CALCIFICATION; CHLOROPHYTA; BIOHERMS; PROVINCE; ECOLOGY	Background: The calcifying siphonalean green alga, Halimeda macroloba is abundant on coral reefs and is important in the production of calcium carbonate sediments. The process by which new green segments are formed over-night is revealed here for the first time. Methodology/Principal Findings: Growth of new segments was visualised by epifluorescence and confocal microscopy and by pulse amplitude modulation (PAM) fluorimetry. Apical colourless proto-segments were initiated on day 1, and formed a loose network of non-calcified, non-septate filaments, containing no chloroplasts. Rapid greening was initiated at dusk by i) the mass movement of chloroplasts into these filaments from the parent segment and ii) the growth of new filaments containing chloroplasts. Greening was usually complete in 3-5 h and certainly before dawn on day 2 when the first signs of calcification were apparent. Mass chloroplast movement took place at a rate of similar to 0.65 mu m/s. Photosynthetic yield and rate remained low for a period of 1 to several hours, indicating that the chloroplasts were made de novo. Use of the inhibitors colchicine and cytochalasin d indicated that the movement process is dependent on both microtubules and microfilaments. Significance: This unusual process involves the mass movement of chloroplasts at a high rate into new segments during the night and rapid calcification on the following day and may be an adaptation to minimise the impact of herbivorous activity.	[Larkum, Anthony W. D.] Univ Sydney, Sch Biol Sci, Camperdown, NSW, Australia; [Salih, Anya] Univ Western Sydney, Sch Nat Sci, Confocal Bioimaging Facil, Richmond, NSW, Australia; [Kuehl, Michael] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Larkum, Anthony W. D.; Kuehl, Michael] Univ Technol, Broadway, NSW, Australia	University of Sydney; Western Sydney University; University of Copenhagen; University of Technology Sydney	Larkum, AWD (corresponding author), Univ Sydney, Sch Biol Sci, Camperdown, NSW, Australia.	a.larkum@sydney.edu.au	Kühl, Michael/A-1977-2009	Kühl, Michael/0000-0002-1792-4790	Australian Research Council; Danish Natural Science Research Council; Carlsberg Foundation	Australian Research Council(Australian Research Council); Danish Natural Science Research Council(Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation)	The study was financed by the Australian Research Council (AWDL, AS), the Danish Natural Science Research Council (MK) and the Carlsberg Foundation (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ADV MAR BIOL; BOROWITZKA MA, 1976, J EXP BOT, V27, P879, DOI 10.1093/jxb/27.5.879; BOROWITZKA MA, 1974, PROTOPLASMA, V81, P131, DOI 10.1007/BF01275808; BOROWITZKA MA, 1977, J PHYCOL, V13, P6, DOI 10.1111/j.1529-8817.1977.tb02879.x; BOROWITZKA MA, 1976, J EXP BOT, V27, P894, DOI 10.1093/jxb/27.5.894; BOROWITZKA MA, 1974, 8 INT C EL MICR CANB, V2, P588; BOROWITZKA MA, 1986, BIOMINERALIZATION LO, P107; BOROWITZKA MA, 1982, BIOMINERALIZATION CH, P63; Braga JC, 1996, GEOLOGY, V24, P35, DOI 10.1130/0091-7613(1996)024<0035:ISOSRH>2.3.CO;2; De Beer D, 2001, PLANT CELL ENVIRON, V24, P1209, DOI 10.1046/j.1365-3040.2001.00772.x; Drew E.A., 1983, CORAL REEFS, V2, P101, DOI DOI 10.1007/BF02395280; DREW EA, 1988, CORAL REEFS, V6, P195, DOI 10.1007/BF00302016; DREW EA, 1990, BOT MAR, V33, P31, DOI 10.1515/botm.1990.33.1.31; DREW EA, 1992, J INTERDISCIPLINARY, V22, P128; FORNOS JJ, 1992, SEDIMENT GEOL, V75, P283, DOI 10.1016/0037-0738(92)90097-B; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; Larkum AWD, 2003, MAR BIOL, V142, P1073, DOI 10.1007/s00227-003-1022-y; Luning K, 2008, J PHYCOL, V44, P866, DOI 10.1111/j.1529-8817.2008.00535.x; Mantyka CS, 2007, CORAL REEFS, V26, P435, DOI 10.1007/s00338-007-0214-1; MARSHALL JF, 1988, CORAL REEFS, V6, P139, DOI 10.1007/BF00302010; ORME GR, 1988, CORAL REEFS, V6, P131, DOI 10.1007/BF00302009; PAUL VJ, 1988, CORAL REEFS, V6, P263, DOI 10.1007/BF00302022; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Ralph PJ, 2005, J PHYCOL, V41, P335, DOI 10.1111/j.1529-8817.2005.04034.x; Rees SA, 2007, CORAL REEFS, V26, P177, DOI 10.1007/s00338-006-0166-x; SABNIS DD, 1967, J CELL SCI, V2, P465; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; WILBUR K. M., 1969, PHYCOLOGIA, V8, P27, DOI 10.2216/I0031-8884-8-1-27.1; WILLIAMSON RE, 1993, ANNU REV PLANT PHYS, V44, P181, DOI 10.1146/annurev.pp.44.060193.001145; WOLANSKI E, 1988, ESTUAR COAST SHELF S, V26, P169, DOI 10.1016/0272-7714(88)90049-2; [No title captured]	31	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20841	10.1371/journal.pone.0020841	http://dx.doi.org/10.1371/journal.pone.0020841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750703	Green Published, gold			2022-12-25	WOS:000292512000009
J	Vangestel, C; Mergeay, J; Dawson, DA; Vandomme, V; Lens, L				Vangestel, Carl; Mergeay, Joachim; Dawson, Deborah A.; Vandomme, Viki; Lens, Luc			Developmental Stability Covaries with Genome-Wide and Single-Locus Heterozygosity in House Sparrows	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; MICROSATELLITE LOCI; LINKAGE DISEQUILIBRIUM; FITNESS CORRELATIONS; PAIRWISE RELATEDNESS; NULL ALLELES; PRIMER SETS; NUMBER; STRESS; COEFFICIENTS	Fluctuating asymmetry (FA), a measure of developmental instability, has been hypothesized to increase with genetic stress. Despite numerous studies providing empirical evidence for associations between FA and genome-wide properties such as multi-locus heterozygosity, support for single-locus effects remains scant. Here we test if, and to what extent, FA co-varies with single-and multilocus markers of genetic diversity in house sparrow (Passer domesticus) populations along an urban gradient. In line with theoretical expectations, FA was inversely correlated with genetic diversity estimated at genome level. However, this relationship was largely driven by variation at a single key locus. Contrary to our expectations, relationships between FA and genetic diversity were not stronger in individuals from urban populations that experience higher nutritional stress. We conclude that loss of genetic diversity adversely affects developmental stability in P. domesticus, and more generally, that the molecular basis of developmental stability may involve complex interactions between local and genome-wide effects. Further study on the relative effects of single-locus and genome-wide effects on the developmental stability of populations with different genetic properties is therefore needed.	[Vangestel, Carl; Vandomme, Viki; Lens, Luc] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium; [Mergeay, Joachim] Res Inst Nat & Forest, Res Grp Genet Div, Geraardsbergen, Belgium; [Dawson, Deborah A.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Ghent University; Research Institute for Nature & Forest; University of Sheffield	Vangestel, C (corresponding author), Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium.	Carl.Vangestel@UGent.be	Mergeay, Joachim/E-7670-2011	Mergeay, Joachim/0000-0002-6504-0551; Lens, Luc/0000-0002-0241-2215; vangestel, carl/0000-0003-1024-8213	Natural Environment Research Council, UK; Fund for Scientific Research - Flanders [G.0149.09]; Ghent University [01J01808]; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fund for Scientific Research - Flanders(FWO); Ghent University(Ghent University); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Genotyping was performed at the NERC Biomolecular Analysis Facility funded by the Natural Environment Research Council, UK. Fieldwork and genetic analyses were funded by research grants G.0149.09 of the Fund for Scientific Research - Flanders (to LL) and research grant 01J01808 of Ghent University (to LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO JS, 2010, MOL ECOL RESOUR; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Badyaev AV, 2000, P ROY SOC B-BIOL SCI, V267, P371, DOI 10.1098/rspb.2000.1011; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Borrell YJ, 2004, HEREDITY, V92, P585, DOI 10.1038/sj.hdy.6800477; Breuker CJ, 2006, TRENDS ECOL EVOL, V21, P488, DOI 10.1016/j.tree.2006.06.003; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; CHAKRABORTY R, 1981, GENETICS, V98, P461; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Clarke GM, 2000, P ROY SOC B-BIOL SCI, V267, P1815, DOI 10.1098/rspb.2000.1215; Clarke GM, 1997, TRENDS ECOL EVOL, V12, P89, DOI 10.1016/S0169-5347(97)01029-X; CLARKE GM, 1993, GENETICA, V89, P15, DOI 10.1007/BF02424502; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Coulson T, 1999, EVOLUTION, V53, P1951, DOI 10.1111/j.1558-5646.1999.tb04575.x; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; DAWSON DA, MOL ECOL RESOU UNPUB; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Gebhardt KJ, 2008, J FIELD ORNITHOL, V79, P286, DOI 10.1111/j.1557-9263.2008.00175.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Griffith SC, 2007, MOL ECOL NOTES, V7, P333, DOI 10.1111/j.1471-8286.2006.01598.x; Hansson B, 2004, EVOLUTION, V58, P870; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hansson B, 2010, MOL ECOL, V19, P1082, DOI 10.1111/j.1365-294X.2010.04556.x; Hartl GB, 1995, PHILOS T R SOC B, V350, P313, DOI 10.1098/rstb.1995.0167; Heath DD, 2002, CAN J FISH AQUAT SCI, V59, P77, DOI 10.1139/F01-192; Kark S, 2001, HEREDITY, V86, P119, DOI 10.1038/sj/hdy/6888560; Karvonen E, 2003, OIKOS, V100, P507, DOI 10.1034/j.1600-0706.2003.11851.x; Knierim U, 2007, PHYSIOL BEHAV, V92, P398, DOI 10.1016/j.physbeh.2007.02.014; Kretzmann M, 2006, J HERED, V97, P555, DOI 10.1093/jhered/esl043; Kruuk LEB, 2002, P ROY SOC B-BIOL SCI, V269, P1581, DOI 10.1098/rspb.2002.2049; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; LEARY RF, 1993, GENETICA, V89, P3, DOI 10.1007/BF02424501; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2000, J EVOLUTION BIOL, V13, P889, DOI 10.1046/j.1420-9101.2000.00232.x; Lerner IM, 1954, GENETIC HOMEOSTASIS; Liker A, 2008, J ANIM ECOL, V77, P789, DOI 10.1111/j.1365-2656.2008.01402.x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Ludwig W., 1932, RECHTS LINKS PROBLEM; MARKOW TA, 1995, ANNU REV ENTOMOL, V40, P105, DOI 10.1146/annurev.en.40.010195.000541; McRae AF, 2002, GENETICS, V160, P1113; MITTON JB, 1993, GENETICA, V89, P47, DOI 10.1007/BF02424505; MITTON JB, 1997, SELECTION NATURAL PO; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MULVEY M, 1994, EVOLUTION, V48, P1810, DOI [10.1111/j.1558-5646.1994.tb02216.x, 10.2307/2410510]; NEI M, 1978, GENETICS, V89, P583; Neumann K, 1996, MOL ECOL, V5, P307; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; Peach WJ, 2008, ANIM CONSERV, V11, P493, DOI 10.1111/j.1469-1795.2008.00209.x; Pemberton J.M., 1999, MICROSATELLITES EVOL, P151; Pertoldi C, 2006, HEREDITY, V96, P122, DOI 10.1038/sj.hdy.6800777; Polak M., 2003, CAUSES CONSEQUENCES; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Siikamaki P, 1998, EVOLUTION, V52, P1285, DOI 10.1111/j.1558-5646.1998.tb02010.x; Slate J, 2002, J EVOLUTION BIOL, V15, P20, DOI 10.1046/j.1420-9101.2002.00373.x; Sweigart A, 1999, HEREDITY, V83, P625, DOI 10.1038/sj.hdy.6886020; Takahashi KH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-284; Talloen W, 2010, BIOL J LINN SOC, V100, P103, DOI 10.1111/j.1095-8312.2010.01422.x; Tsitrone A, 2001, GENETICS, V159, P1845; Van Dongen S, 1998, ANN ZOOL FENN, V35, P79; van Dongen S, 1999, J EVOLUTION BIOL, V12, P94, DOI 10.1046/j.1420-9101.1999.00012.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vangestel C, 2011, ECOL INDIC, V11, P389, DOI 10.1016/j.ecolind.2010.06.009; Vangestel C, 2010, BIOL J LINN SOC, V101, P41, DOI 10.1111/j.1095-8312.2010.01493.x; Verbeke G, 2000, LINEAR MIXED MODELS; Vollestad LA, 1999, HEREDITY, V83, P206, DOI 10.1046/j.1365-2540.1999.00555.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Whitlock M, 1998, P ROY SOC B-BIOL SCI, V265, P1429, DOI 10.1098/rspb.1998.0453; Zachos FE, 2007, HEREDITY, V98, P392, DOI 10.1038/sj.hdy.6800954; ZOUROS E, 1993, GENETICA, V89, P35, DOI 10.1007/BF02424504	81	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21569	10.1371/journal.pone.0021569	http://dx.doi.org/10.1371/journal.pone.0021569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747940	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000292293400016
J	Kim, H; Zahir, T; Tator, CH; Shoichet, MS				Kim, Howard; Zahir, Tasneem; Tator, Charles H.; Shoichet, Molly S.			Effects of Dibutyryl Cyclic-AMP on Survival and Neuronal Differentiation of Neural Stem/Progenitor Cells Transplanted into Spinal Cord Injured Rats	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; IN-VITRO; AXONAL REGENERATION; CHITOSAN CHANNELS; PRECURSOR CELLS; PROTEIN-KINASE; GROWTH-FACTOR; CAMP; RECOVERY	Neural stem/progenitor cells (NSPCs) have great potential as a cell replacement therapy for spinal cord injury. However, poor control over transplant cell differentiation and survival remain major obstacles. In this study, we asked whether dibutyryl cyclic-AMP (dbcAMP), which was shown to induce up to 85% in vitro differentiation of NSPCs into neurons would enhance survival of transplanted NSPCs through prolonged exposure either in vitro or in vivo through the controlled release of dbcAMP encapsulated within poly(lactic-co-glycolic acid) (PLGA) microspheres and embedded within chitosan guidance channels. NSPCs, seeded in fibrin scaffolds within the channels, differentiated in vitro to betaIII-tubulin positive neurons by immunostaining and mRNA expression, in response to dbcAMP released from PLGA microspheres. After transplantation in spinal cord injured rats, the survival and differentiation of NSPCs was evaluated. Untreated NSPCs, NSPCs transplanted with dbcAMP-releasing microspheres, and NSPCs pre-differentiated with dbcAMP for 4 days in vitro were transplanted after rat spinal cord transection and assessed 2 and 6 weeks later. Interestingly, NSPC survival was highest in the dbcAMP pre-treated group, having approximately 80% survival at both time points, which is remarkable given that stem cell transplantation often results in less than 1% survival at similar times. Importantly, dbcAMP pre-treatment also resulted in the greatest number of in vivo NSPCs differentiated into neurons (37 +/- 4%), followed by dbcAMP-microsphere treated NSPCs (27 +/- 14%) and untreated NSPCs (15 +/- 7%). The reverse trend was observed for NSPC-derived oligodendrocytes and astrocytes, with these populations being highest in untreated NSPCs. This combination strategy of stem cell-loaded chitosan channels implanted in a fully transected spinal cord resulted in extensive axonal regeneration into the injury site, with improved functional recovery after 6 weeks in animals implanted with pre-differentiated stem cells in chitosan channels.	[Kim, Howard; Tator, Charles H.; Shoichet, Molly S.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Kim, Howard; Shoichet, Molly S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada; [Zahir, Tasneem; Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 1A1, Canada; [Tator, Charles H.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada; [Tator, Charles H.] Univ Hlth Network, Krembil Neurosci Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kim, H (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.	molly.shoichet@utoronto.ca			Canadian Institutes of Health Research (CIHR) [459627]; Krembil Foundation [481143]; Ontario Neurotrauma Foundation [2009-SCI-PHD-679]; Canadian Paraplegic Association, Ontario Branch	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Ontario Neurotrauma Foundation; Canadian Paraplegic Association, Ontario Branch	Funding was provided by the Canadian Institutes of Health Research (CIHR; fund no. 459627, operating grant; http://www.cihr-irsc.gc.ca), the Krembil Foundation(provided matching funds to CIHR, fund no. 481143, operating grant; http://www.krembilfoundation.ca), the Ontario Neurotrauma Foundation (grant no. 2009-SCI-PHD-679; student scholarship; http://www.onf.org), and the Canadian Paraplegic Association, Ontario Branch, titled Spinal Cord Regeneration. (This is a research grant that has no funding number associated with it; http://www.cpaont.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018; Aubert-Pouessel A, 2004, J CONTROL RELEASE, V95, P463, DOI 10.1016/j.jconrel.2003.12.012; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35; Bretzner F, 2010, J NEUROSCI RES, V88, P2833, DOI 10.1002/jnr.22440; Cai DM, 2002, NEURON, V35, P711, DOI 10.1016/S0896-6273(02)00826-7; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; COOKE MJ, J BIOMED MAT RES A, V93, P824; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; Davies Jeannette E, 2006, J Biol, V5, P7, DOI 10.1186/jbiol35; de Boer R, 2010, J BIOMED MATER RES A, V95A, P1067, DOI 10.1002/jbm.a.32900; Dworkin S, 2010, EXPERT OPIN THER TAR, V14, P869, DOI 10.1517/14728222.2010.501332; Dyke HJ, 2002, EXPERT OPIN INV DRUG, V11, P1; Fouad K, 2009, J NEUROTRAUM, V26, P733, DOI 10.1089/neu.2008.0730; Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040; Gao Y, 2003, J NEUROSCI, V23, P11770; Hakamata Y, 2001, BIOCHEM BIOPH RES CO, V286, P779, DOI 10.1006/bbrc.2001.5452; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; JOHNSON PJ, 2009, CELL TRANSPLANT; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Kim G, 2002, MOL BRAIN RES, V109, P134, DOI 10.1016/S0169-328X(02)00550-8; Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI 10.1021/bp070352a; Kim H, 2011, J BIOMED MATER RES A, V97A, P395, DOI 10.1002/jbm.a.33070; King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018; Kume T, 2008, NEUROSCI LETT, V443, P199, DOI 10.1016/j.neulet.2008.07.079; Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00155-9; Le Belle JE, 2004, J NEUROSCI RES, V76, P174, DOI 10.1002/jnr.20035; Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; MENA MA, 1995, J NEUROCHEM, V65, P2612; Mothe AJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1215, DOI 10.1369/jhc.5A6639.2005; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; Nakao N, 1998, NEUROSCIENCE, V82, P1009; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180; Nout YS, 2011, EXP NEUROL, V227, P159, DOI 10.1016/j.expneurol.2010.10.011; Olstorn H, 2011, NEUROSURGERY, V68, P213, DOI 10.1227/NEU.0b013e3181fd2c11; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Rossi SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011852; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Smith PM, 2000, EUR J NEUROSCI, V12, P2414, DOI 10.1046/j.1460-9568.2000.00137.x; Tang BL, 2007, CELL MOL NEUROBIOL, V27, P75, DOI 10.1007/s10571-006-9119-8; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005; Tojima T, 2003, J NEUROSCI RES, V74, P829, DOI 10.1002/jnr.10754; Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025; Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687; Whitaker CM, 2008, NEUROSCI LETT, V438, P200, DOI 10.1016/j.neulet.2008.03.087; Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036; Yang M, 2004, CELL TRANSPLANT, V13, P535, DOI 10.3727/000000004783983729; Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	57	56	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21744	10.1371/journal.pone.0021744	http://dx.doi.org/10.1371/journal.pone.0021744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738784	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800036
J	Fowler, DW; Woodward, HN; Freedman, EA; Larson, PL; Horner, JR				Fowler, Denver W.; Woodward, Holly N.; Freedman, Elizabeth A.; Larson, Peter L.; Horner, John R.			Reanalysis of "Raptorex kriegsteini": A Juvenile Tyrannosaurid Dinosaur from Mongolia	PLOS ONE			English	Article							LONG-BONE HISTOLOGY; THEROPOD DINOSAUR; PARK FORMATION; NORTH-AMERICA; MAIASAURA-PEEBLESORUM; CRANIOFACIAL ONTOGENY; TARBOSAURUS-BATAAR; GROWTH DYNAMICS; BUGIN-TSAV; ALBERTA	The carnivorous Tyrannosauridae are among the most iconic dinosaurs: typified by large body size, tiny forelimbs, and massive robust skulls with laterally thickened teeth. The recently described small-bodied tyrannosaurid Raptorex kreigsteini is exceptional as its discovery proposes that many of the distinctive anatomical traits of derived tyrannosaurids were acquired in the Early Cretaceous, before the evolution of large body size. This inference depends on two core interpretations: that the holotype (LH PV18) derives from the Lower Cretaceous of China, and that despite its small size, it is a subadult or young adult. Here we show that the published data is equivocal regarding stratigraphic position and that ontogenetic reanalysis shows there is no reason to conclude that LH PV18 has reached this level of maturity. The probable juvenile status of LH PV18 makes its use as a holotype unreliable, since diagnostic features of Raptorex may be symptomatic of its immature status, rather than its actual phylogenetic position. These findings are consistent with the original sale description of LH PV18 as a juvenile Tarbosaurus from the Upper Cretaceous of Mongolia. Consequently, we suggest that there is currently no evidence to support the conclusion that tyrannosaurid skeletal design first evolved in the Early Cretaceous at small body size.	[Fowler, Denver W.; Woodward, Holly N.; Freedman, Elizabeth A.; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Fowler, Denver W.; Woodward, Holly N.; Freedman, Elizabeth A.; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Larson, Peter L.] Black Hills Inst Geol Res Inc, Hill City, SD USA; [Larson, Peter L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; University of Manchester	Fowler, DW (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	df9465@yahoo.co.uk	Freedman, Elizabeth/J-1752-2012; Ballard, HollyNoelle/AED-7676-2022	Freedman, Elizabeth/0000-0002-5763-5272; Ballard, HollyNoelle/0000-0003-0413-0681; Fowler, Denver/0000-0001-9188-4371	Damaris Waggoner; David Sands	Damaris Waggoner; David Sands	Funding for the Museum of the Rockies graduate student fund was provided by Damaris Waggoner and David Sands. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH J, 2009, WASHINGTON POST 0918; BAGILS RZ, 2004, MESOZOIC FISHES, V3, P391; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Benson RBJ, 2010, SCIENCE, V327, P1613, DOI 10.1126/science.1187456; BOYLE A, 2009, MSNBC NEWS; Brinkman DB, 2002, J PALEONTOL, V76, P138, DOI 10.1666/0022-3360(2002)076<0138:TCFUJR>2.0.CO;2; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Carpenter K, 2005, LIFE O PAST, P23; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; CASE TJ, 1978, PALEOBIOLOGY, V4, P320, DOI 10.1017/S0094837300006023; Clark J, 2009, SCIENCE, V326, P373, DOI 10.1126/science.1181276; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; Currie PJ, 2005, LIFE O PAST, P537; Currie Philip J., 2008, P1; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Currie PJ, 2001, CAN J EARTH SCI, V38, P1729, DOI 10.1139/e01-042; CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Dilkes DW, 2001, CAN J EARTH SCI, V38, P1205, DOI 10.1139/e01-016; DODSON P, 1988, CAN J EARTH SCI, V25, P926, DOI 10.1139/e88-090; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DODSON P, 1976, J PALEONTOL, V50, P929; DONG ZM, 1977, VERTEBRAT PALASIATIC, V15, P307; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Evans DC, 2007, J VERTEBR PALEONTOL, V27, P642, DOI 10.1671/0272-4634(2007)27[642:AJPOHB]2.0.CO;2; Evans DC, 2005, LIFE O PAST, P349; Everhart Michael J., 2011, Transactions of the Kansas Academy of Science, V114, P59, DOI 10.1660/062.114.0105; Francillon-Vieillot H., 1990, P471; Herne MC, 2010, SCIENCE, V329, DOI 10.1126/science.1190100; Holmes RB, 2001, CAN J EARTH SCI, V38, P1423, DOI 10.1139/e01-036; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Holtz Thomas R. Jr, 2001, P64; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; Horner J.R., 1983, J VERTEBR PALEONTOL, V3, P29, DOI [DOI 10.1080/02724634.1983.10011954, 10.1080/02724634.1983.10011954]; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner John R., 1994, P312; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Knoll F, 2010, GONDWANA RES, V17, P171, DOI 10.1016/j.gr.2009.03.010; LI PX, 1994, ACTA GEOL SINICA, V7, P329; MA FZ, 1987, VERTEBRAT PALASIATIC, V25, P8; MADSEN JH, 1974, J PALEONTOL, V48, P27; MALEEV EA, 1955, DOKL AKAD NAUK SSSR+, V104, P634; Margottini L, 2011, SCIENCE, V332, P782, DOI 10.1126/science.332.6031.782; MARYANSKA T, 1979, LETHAIA, V12, P265, DOI 10.1111/j.1502-3931.1979.tb01006.x; MULLEN W, 2009, CHICAGO TRIBUNE 0918; Newbrey MG, 2010, CAN J EARTH SCI, V47, P1183, DOI 10.1139/E10-041; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Reisz RR, 2005, SCIENCE, V309, P761, DOI 10.1126/science.1114942; Rozhdestvensky AK, 1965, PALEONTOL ZH, V3, P95; RUSSELL DA, 1970, NATL MUS NAT HIST PU, V1, P1; Ryan MJ, 2005, LIFE O PAST, P312; Ryan MJ, 2005, CAN J EARTH SCI, V42, P1369, DOI 10.1139/E05-029; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Scannella J.B., 2009, CINCINNATI MUSEUM CT, V3, P148; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; Tanks DH, 2005, LIFE O PAST, P34; Trueman CN, 2006, GEOCHIM COSMOCHIM AC, V70, P4343, DOI 10.1016/j.gca.2006.06.1556; Trueman CN, 1997, GEOLOGY, V25, P263, DOI 10.1130/0091-7613(1997)025<0263:AGMTTT>2.3.CO;2; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Tucker AD, 1997, MAR FRESHWATER RES, V48, P343, DOI 10.1071/MF96113; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Weishampel DB, 2008, J VERTEBR PALEONTOL, V28, P1110, DOI 10.1671/0272-4634-28.4.1110; Whitlock JA, 2010, J VERTEBR PALEONTOL, V30, P442, DOI 10.1080/02724631003617647; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Zhang Jiang-Yong, 2002, Vertebrata Palasiatica, V40, P257	88	46	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21376	10.1371/journal.pone.0021376	http://dx.doi.org/10.1371/journal.pone.0021376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738646	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100021
J	Demirkan, G; Yu, KB; Boylan, JM; Salomon, AR; Gruppuso, PA				Demirkan, Gokhan; Yu, Kebing; Boylan, Joan M.; Salomon, Arthur R.; Gruppuso, Philip A.			Phosphoproteomic Profiling of In Vivo Signaling in Liver by the Mammalian Target of Rapamycin Complex 1 (mTORC1)	PLOS ONE			English	Article							HIGHLY SELECTIVE ENRICHMENT; ACID-SOLUBLE PROTEIN; PHOSPHORYLATED PEPTIDES; MASS-SPECTROMETRY; CELL-GROWTH; QUANTITATIVE-ANALYSIS; RAT-LIVER; KINASE; IDENTIFICATION; TRANSLATION	Background: Our understanding of signal transduction networks in the physiological context of an organism remains limited, partly due to the technical challenge of identifying serine/threonine phosphorylated peptides from complex tissue samples. In the present study, we focused on signaling through the mammalian target of rapamycin ( mTOR) complex 1 (mTORC1), which is at the center of a nutrient-and growth factor-responsive cell signaling network. Though studied extensively, the mechanisms involved in many mTORC1 biological functions remain poorly understood. Methodology/Principal Findings: We developed a phosphoproteomic strategy to purify, enrich and identify phosphopeptides from rat liver homogenates. Using the anticancer drug rapamycin, the only known target of which is mTORC1, we characterized signaling in liver from rats in which the complex was maximally activated by refeeding following 48 hr of starvation. Using protein and peptide fractionation methods, TiO2 affinity purification of phosphopeptides and mass spectrometry, we reproducibly identified and quantified over four thousand phosphopeptides. Along with 5 known rapamycin-sensitive phosphorylation events, we identified 62 new rapamycin-responsive candidate phosphorylation sites. Among these were PRAS40, gephyrin, and AMP kinase 2. We observed similar proportions of increased and reduced phosphorylation in response to rapamycin. Gene ontology analysis revealed over-representation of mTOR pathway components among rapamycin-sensitive phosphopeptide candidates. Conclusions/Significance: In addition to identifying potential new mTORC1-mediated phosphorylation events, and providing information relevant to the biology of this signaling network, our experimental and analytical approaches indicate the feasibility of large-scale phosphoproteomic profiling of tissue samples to study physiological signaling events in vivo.	[Demirkan, Gokhan; Boylan, Joan M.; Gruppuso, Philip A.] Brown Univ, Dept Pediat, Providence, RI 02912 USA; [Demirkan, Gokhan; Boylan, Joan M.; Gruppuso, Philip A.] Rhode Isl Hosp, Providence, RI USA; [Demirkan, Gokhan; Yu, Kebing; Salomon, Arthur R.; Gruppuso, Philip A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Yu, Kebing; Salomon, Arthur R.] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Demirkan, G (corresponding author), Brown Univ, Dept Pediat, Providence, RI 02912 USA.	Philip_Gruppuso@brown.edu	Yu, Kebing/D-4585-2014		USPHS [R01HD024455, 1R01AI083636, 2P20RR015578, R21AI083908]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083636, R21AI083908] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by USPHS grants R01HD024455 (to P.A.G.), and 1R01AI083636, 2P20RR015578 and R21AI083908 (to A.R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Alcolea MP, 2009, J PROTEOME RES, V8, P3808, DOI 10.1021/pr800955n; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Anand P, 2006, J NUTR, V136, P27, DOI 10.1093/jn/136.1.27; Anand P, 2005, J BIOL CHEM, V280, P16427, DOI 10.1074/jbc.M410576200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BRONSHTEIN IN, 2004, HDB MATH; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; Cao LL, 2006, ADV EXP MED BIOL, V584, P277; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; Gruppuso PA, 2008, AM J PHYSIOL-REG I, V295, pR558, DOI 10.1152/ajpregu.00091.2008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Han GH, 2008, PROTEOMICS, V8, P1346, DOI 10.1002/pmic.200700884; Han GH, 2010, ELECTROPHORESIS, V31, P1080, DOI 10.1002/elps.200900493; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hidalgo M, 2000, ONCOGENE, V19, P6680, DOI 10.1038/sj.onc.1204091; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Jin WH, 2004, RAPID COMMUN MASS SP, V18, P2169, DOI 10.1002/rcm.1604; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kweon HK, 2006, ANAL CHEM, V78, P1743, DOI 10.1021/ac0522355; Kyono Y, 2008, J PROTEOME RES, V7, P4585, DOI 10.1021/pr800305y; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lemeer S, 2009, CURR OPIN CHEM BIOL, V13, P414, DOI 10.1016/j.cbpa.2009.06.022; Liao LJ, 2008, J PROTEOME RES, V7, P4743, DOI 10.1021/pr8003198; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mayeur GL, 2003, EUR J BIOCHEM, V270, P4133, DOI 10.1046/j.1432-1033.2003.03807.x; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; Moser K, 2006, J PROTEOME RES, V5, P98, DOI 10.1021/pr0503073; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; OKA T, 1995, J BIOL CHEM, V270, P30060, DOI 10.1074/jbc.270.50.30060; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wolschin F, 2005, PROTEOMICS, V5, P4389, DOI 10.1002/pmic.200402049; WOOL IG, 1979, ANNU REV BIOCHEM, V48, P719, DOI 10.1146/annurev.bi.48.070179.003443; Wu JA, 2010, PROTEOMICS, V10, P2224, DOI 10.1002/pmic.200900788; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Yu KB, 2010, PROTEOMICS, V10, P2113, DOI 10.1002/pmic.200900159; Yu KB, 2009, PROTEOMICS, V9, P5350, DOI 10.1002/pmic.200900119; Yu KB, 2009, PROTEOMICS, V9, P3115, DOI 10.1002/pmic.200800899; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	75	50	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21729	10.1371/journal.pone.0021729	http://dx.doi.org/10.1371/journal.pone.0021729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738781	gold, Green Submitted, Green Published			2022-12-25	WOS:000292142800064
J	Castrillo, G; Turck, F; Leveugle, M; Lecharny, A; Carbonero, P; Coupland, G; Paz-Ares, J; Onate-Sanchez, L				Castrillo, Gabriel; Turck, Franziska; Leveugle, Magalie; Lecharny, Alain; Carbonero, Pilar; Coupland, George; Paz-Ares, Javier; Onate-Sanchez, Luis			Speeding Cis-Trans Regulation Discovery by Phylogenomic Analyses Coupled with Screenings of an Arrayed Library of Arabidopsis Transcription Factors	PLOS ONE			English	Article							WIDE COMPARATIVE-ANALYSIS; FUNCTIONAL GENOMICS; SEED-GERMINATION; GENE-EXPRESSION; PROTEIN; SEQUENCE; FAMILY; DNA; PROMOTER; ELEMENTS	Transcriptional regulation is an important mechanism underlying gene expression and has played a crucial role in evolution. The number, position and interactions between cis-elements and transcription factors (TFs) determine the expression pattern of a gene. To identify functionally relevant cis-elements in gene promoters, a phylogenetic shadowing approach with a lipase gene (LIP1) was used. As a proof of concept, in silico analyses of several Brassicaceae LIP1 promoters identified a highly conserved sequence (LIP1 element) that is sufficient to drive strong expression of a reporter gene in planta. A collection of ca. 1,200 Arabidopsis thaliana TF open reading frames (ORFs) was arrayed in a 96-well format (RR library) and a convenient mating based yeast one hybrid (Y1H) screening procedure was established. We constructed an episomal plasmid (pTUY1H) to clone the LIP1 element and used it as bait for Y1H screenings. A novel interaction with an HD-ZIP (AtML1) TF was identified and abolished by a 2 bp mutation in the LIP1 element. A role of this interaction in transcriptional regulation was confirmed in planta. In addition, we validated our strategy by reproducing the previously reported interaction between a MYB-CC (PHR1) TF, a central regulator of phosphate starvation responses, with a conserved promoter fragment (IPS1 element) containing its cognate binding sequence. Finally, we established that the LIP1 and IPS1 elements were differentially bound by HD-ZIP and MYB-CC family members in agreement with their genetic redundancy in planta. In conclusion, combining in silico analyses of orthologous gene promoters with Y1H screening of the RR library represents a powerful approach to decipher cis- and trans-regulatory codes.	[Castrillo, Gabriel; Paz-Ares, Javier] CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, Madrid, Spain; [Turck, Franziska; Coupland, George] Max Planck Inst Plant Breeding Res, Dept Plant Dev Biol, Cologne, Germany; [Leveugle, Magalie; Lecharny, Alain] INRA, Unite Rech Genom Vegetale, Evry, France; [Leveugle, Magalie; Lecharny, Alain] CNRS, Evry, France; [Carbonero, Pilar; Onate-Sanchez, Luis] Univ Politecn Madrid, Dept Biotechnol, Madrid, Spain; [Carbonero, Pilar; Onate-Sanchez, Luis] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Max Planck Society; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Castrillo, G (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, Madrid, Spain.	luis.onate@upm.es	Oñate-Sánchez, Luis J/C-6274-2017; Turck, Franziska/G-1240-2013; Coupland, George/AAP-8609-2020; Castrillo, Gabriel/Z-6321-2019	Oñate-Sánchez, Luis J/0000-0001-7047-5739; Turck, Franziska/0000-0002-4982-5949; Coupland, George/0000-0001-6988-4172; Castrillo, Gabriel/0000-0002-1557-6614; Paz-Ares, Javier/0000-0003-0553-9745	Knowledge Based Bio-Economy (KBBE); Spanish Ministry of Science and Innovation (MICINN) [CONSOLIDER CSD2007-00057, BIO2008-04715, BFU2009-11809, BIO2010-17334]; Marie Curie IRG [036524]	Knowledge Based Bio-Economy (KBBE); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie Curie IRG(European Commission)	This research was supported by two Knowledge Based Bio-Economy (KBBE) projects (REGULATORS and TRANSNET; French-German-Spanish trilateral program on plant Genomics), grants from the Spanish Ministry of Science and Innovation (MICINN; CONSOLIDER CSD2007-00057, BIO2008-04715, BFU2009-11809; BIO2010-17334) and a Marie Curie IRG grant to LO-S (036524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2001, PLANT J, V26, P487, DOI 10.1046/j.1365-313x.2001.01047.x; Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Brady SM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.114; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Bodt S, 2006, MOL BIOL EVOL, V23, P1293, DOI 10.1093/molbev/msk016; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dobi KC, 2007, MOL CELL BIOL, V27, P5575, DOI 10.1128/MCB.00459-07; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Franco-Zorrilla JM, 2004, J EXP BOT, V55, P285, DOI 10.1093/jxb/erh009; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Gong W, 2008, MOL PLANT, V1, P27, DOI 10.1093/mp/ssm009; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Haberer G, 2006, PLANT PHYSIOL, V142, P1589, DOI 10.1104/pp.106.085639; Hilson P, 2006, TRENDS PLANT SCI, V11, P133, DOI 10.1016/j.tplants.2006.01.006; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; Isabel-LaMoneda I, 2003, PLANT J, V33, P329, DOI 10.1046/j.1365-313X.2003.01628.x; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lee JY, 2005, DEVELOPMENT, V132, P5021, DOI 10.1242/dev.02067; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; LUDWIG MZ, 1995, MOL BIOL EVOL, V12, P1002; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; McGregor AP, 2001, EVOL DEV, V3, P397, DOI 10.1046/j.1525-142X.2001.01043.x; McGregor AP, 2001, DEV GENES EVOL, V211, P315, DOI 10.1007/s004270100148; MISTUDA N, 2010, PLANT CELL PHYSL, V51, P2145; Moreno-Risueno MA, 2007, MOL GENET GENOMICS, V277, P379, DOI 10.1007/s00438-006-0186-9; Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; OU B, 2011, MOL PLANT       0222; Paz-Ares J, 2002, COMP FUNCT GENOM, V3, P102, DOI 10.1002/cfg.146; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Samson F, 2004, NUCLEIC ACIDS RES, V32, pD347, DOI 10.1093/nar/gkh134; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Spensley M, 2009, PLANT CELL, V21, P2606, DOI 10.1105/tpc.109.069898; Thatcher LF, 2007, J BIOL CHEM, V282, P28915, DOI 10.1074/jbc.M702207200; Tominaga-Wada R, 2009, PLANT J, V60, P564, DOI 10.1111/j.1365-313X.2009.03976.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Weigel R., 2002, ARABIDOPSIS LAB MANU; Weiste C, 2007, PLANT J, V52, P382, DOI 10.1111/j.1365-313X.2007.03229.x; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6	62	64	71	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21524	10.1371/journal.pone.0021524	http://dx.doi.org/10.1371/journal.pone.0021524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738689	Green Published, gold			2022-12-25	WOS:000292092600049
J	Chang, CH; Toh, S; Lin, JW; Chen, ST; Kuo, CW; Chuang, LM; Lai, MS				Chang, Chia-Hsuin; Toh, Sengwee; Lin, Jou-Wei; Chen, Shu-Ting; Kuo, Chuei-Wen; Chuang, Lee-Ming; Lai, Mei-Shu			Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients - A Nationwide Cohort Study	PLOS ONE			English	Article							ANALOGS; MALIGNANCIES	Background: Preclinical and observational studies raise the concern about the safety of insulin glargine in terms of cancer initiation and promotion. This study is designed to examine cancer incidence associated with use of insulin glargine vs. intermediate/long-acting human insulin (HI). Methodology: A retrospective cohort study using the Taiwan National Health Insurance claims database was conducted to identify adult patients with type 2 diabetes mellitus and without a history of cancer who initiated insulin glargine (n = 10,190) or intermediate/long-acting HI (n = 49,253) during 2004-2007. Exclusive users were followed from the date of insulin initiation to the earliest of cancer diagnosis, death, disenrollment, or December 31 2007. We estimated adjusted hazard ratios and 95% confidence intervals (CIs) with Cox proportional hazards models adjusting for baseline propensity score. Findings: The incidence rate of all cancer per 1,000 person-years was 13.8 for insulin glargine initiators (179 cases) and 16.0 for intermediate/long-acting HI initiators (1,445 cases) during an average follow-up of 2 years. No significant difference in overall cancer risk between insulin glargine initiators and HI initiators was found. For men, however, the adjusted hazard ratio of insulin glargine use as compared with intermediate/long-acting HI was 2.15 (95% CI 1.01-4.59) for pancreatic cancer, and 2.42 (95% CI 1.50-8.40) for prostate cancer. The increased risk was not observed among women. Conclusions: Insulin glargine use did not increase the risk of overall cancer incidence as compared with HI. The positive associations with pancreatic and prostate cancer need further evaluation and validation.	[Chang, Chia-Hsuin; Chen, Shu-Ting; Chuang, Lee-Ming; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan; [Chang, Chia-Hsuin; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Toh, Sengwee] Harvard Univ, Sch Med, Dept Populat Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Lin, Jou-Wei] Natl Taiwan Univ Hosp, Yun Lin Branch, Ctr Cardiovasc, Dou Liou City, Yun Lin, Taiwan; [Kuo, Chuei-Wen] Natl Hlth Insurance Mediat Comm, Dept Hlth, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; National Taiwan University; National Taiwan University Hospital	Chang, CH (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Prevent Med, Taipei 10764, Taiwan.	leeming@ntu.edu.tw; mslai@ntu.edu.tw	Toh, Sengwee/D-7567-2017; Chuang, Lee-Ming/AAF-3324-2019	Toh, Sengwee/0000-0002-5160-0810; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Lai, Mei-shu/0000-0001-6130-3468; CHUANG, LEE-MING/0000-0003-0978-2662	Department of Health [DOH098-TD-D-113-098016]	Department of Health	This study was supported by Department of Health grant DOH098-TD-D-113-098016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colhoun HM, 2009, DIABETOLOGIA, V52, P1755, DOI 10.1007/s00125-009-1453-1; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Erbel S, 2008, DIABETES CARE, V31, P1105, DOI 10.2337/dc07-2015; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Grote VA, 2010, EXP CLIN ENDOCR DIAB, V118, P4, DOI 10.1055/s-0029-1243193; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Hernandez-Diaz S, 2010, DIABETOLOGIA, V53, P802, DOI 10.1007/s00125-010-1675-2; Home PD, 2009, DIABETOLOGIA, V52, P2499, DOI 10.1007/s00125-009-1530-5; Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Pollak M, 2010, INT J CLIN PRACT, V64, P628, DOI 10.1111/j.1742-1241.2010.02354.x; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rosenstock J, 2009, DIABETOLOGIA, V52, P1778, DOI 10.1007/s00125-009-1415-7; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; Who collaborating centre for drug statistics methodology, DEF DAIL DOS DEF GEN	19	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21368	10.1371/journal.pone.0021368	http://dx.doi.org/10.1371/journal.pone.0021368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738645	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600032
J	Khan, JA; Kudgus, RA; Szabolcs, A; Dutta, S; Wang, EF; Cao, S; Curran, GL; Shah, V; Curley, S; Mukhopadhyay, D; Robertson, JD; Bhattacharya, R; Mukherjee, P				Khan, Jameel Ahmad; Kudgus, Rachel A.; Szabolcs, Annamaria; Dutta, Shamit; Wang, Enfeng; Cao, Sheng; Curran, Geoffry L.; Shah, Vijay; Curley, Steven; Mukhopadhyay, Debabrata; Robertson, J. David; Bhattacharya, Resham; Mukherjee, Priyabrata			Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; FUNCTIONALIZED GOLD NANOPARTICLES; MONOCLONAL-ANTIBODY CETUXIMAB; PARTICLE-SIZE; MECHANISM; CHEMISTRY; DELIVERY; BIODISTRIBUTION; NANOTECHNOLOGY; TRAFFICKING	Background: Pancreatic cancer is the fourth leading cause of cancer related deaths in America. Monoclonal antibodies are a viable treatment option for inhibiting cancer growth. Tumor specific drug delivery could be achieved utilizing these monoclonal antibodies as targeting agents. This type of designer therapeutic is evolving and with the use of gold nanoparticles it is a promising approach to selectively deliver chemotherapeutics to malignant cells. Gold nanoparticles (GNPs) are showing extreme promise in current medicinal research. GNPs have been shown to non-invasively kill tumor cells by hyperthermia using radiofrequency. They have also been implemented as early detection agents due to their unique X-ray contrast properties; success was revealed with clear delineation of blood capillaries in a preclinical model by CT (computer tomography). The fundamental parameters for intelligent design of nanoconjugates are on the forefront. The goal of this study is to define the necessary design parameters to successfully target pancreatic cancer cells. Methodology/Principal Findings: The nanoconjugates described in this study were characterized with various physicochemical techniques. We demonstrate that the number of cetuximab molecules (targeting agent) on a GNP, the hydrodynamic size of the nanoconjugates, available reactive surface area and the ability of the nanoconjugates to sequester EGFR (epidermal growth factor receptor), all play critical roles in effectively targeting tumor cells in vitro and in vivo in an orthotopic model of pancreatic cancer. Conclusion: Our results suggest the specific targeting of tumor cells depends on a number of crucial components 1) targeting agent to nanoparticle ratio 2) availability of reactive surface area on the nanoparticle 3) ability of the nanoconjugate to bind the target and 4) hydrodynamic diameter of the nanoconjugate. We believe this study will help define the design parameters for formulating better strategies for specifically targeting tumors with nanoparticle conjugates.	[Khan, Jameel Ahmad; Kudgus, Rachel A.; Szabolcs, Annamaria; Dutta, Shamit; Wang, Enfeng; Mukhopadhyay, Debabrata; Bhattacharya, Resham; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Cao, Sheng; Shah, Vijay] Mayo Clin, Coll Med, Dept Med & Physiol, Rochester, MN USA; [Curley, Steven] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Mukhopadhyay, Debabrata; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN USA; [Robertson, J. David] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO USA; [Mukhopadhyay, Debabrata; Mukherjee, Priyabrata] Coll Med, Dept Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Khan, JA (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Mukherjee.priyabrata@mayo.edu		Robertson, John/0000-0002-6675-8469	National Institutes of Health [CA135011, CA136494, CA150190]; MD Anderson Cancer Center Developmental Grant (UTMD); NATIONAL CANCER INSTITUTE [R01CA136494, R01CA135011, R01CA150190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Cancer Center Developmental Grant (UTMD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health CA135011, CA136494, CA150190 and an MD Anderson Cancer Center Developmental Grant (UTMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013; Bhattacharya R, 2007, NANOMED-NANOTECHNOL, V3, P224, DOI 10.1016/j.nano.2007.07.001; Bhattacharya R, 2007, ADV MATER, V19, P711, DOI 10.1002/adma.200602098; Bhattacharyya S, 2010, P NATL ACAD SCI USA, V107, P14541, DOI 10.1073/pnas.1006507107; Biesso A, 2009, J AM CHEM SOC, V131, P2442, DOI 10.1021/ja8088873; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Chanda N, 2010, P NATL ACAD SCI USA, V107, P8760, DOI 10.1073/pnas.1002143107; Choi CHJ, 2010, P NATL ACAD SCI USA, V107, P1235, DOI 10.1073/pnas.0914140107; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Gannon Christopher J., 2008, Journal of Nanobiotechnology, V6, P2, DOI 10.1186/1477-3155-6-2; Hainfeld JF, 2006, BRIT J RADIOL, V79, P248, DOI 10.1259/bjr/13169882; Han G, 2007, NANOMEDICINE-UK, V2, P113, DOI 10.2217/17435889.2.1.113; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jans H, 2009, ANAL CHEM, V81, P9425, DOI 10.1021/ac901822w; Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698; Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liao HJ, 2009, CANCER RES, V69, P6179, DOI 10.1158/0008-5472.CAN-09-0049; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; Mangeney C, 2002, J AM CHEM SOC, V124, P5811, DOI 10.1021/ja010796h; Mirkin CA, 2000, NATURE, V405, P626, DOI 10.1038/35015190; Mukherjee P, 2005, CLIN CANCER RES, V11, P3530, DOI 10.1158/1078-0432.CCR-04-2482; Mukherjee Priyabrata, 2007, Journal of Nanobiotechnology, V5, P4, DOI 10.1186/1477-3155-5-4; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Park JW, 2002, CLIN CANCER RES, V8, P1172; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Patra CR, 2010, ADV DRUG DELIVER REV, V62, P346, DOI 10.1016/j.addr.2009.11.007; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Rocha-Lima Caio M, 2007, Cancer Control, V14, P295; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Slovin SF, 2009, CLIN GENITOURIN CANC, V7, pE77, DOI 10.3816/CGC.2009.n.028; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Stephan S, 2004, CLIN CANCER RES, V10, P6993, DOI 10.1158/1078-0432.CCR-04-0808; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Xie H, 2003, ANAL CHEM, V75, P5797, DOI 10.1021/ac034578d; Yen CW, 2009, J PHYS CHEM A, V113, P4340, DOI 10.1021/jp811014u	43	54	55	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20347	10.1371/journal.pone.0020347	http://dx.doi.org/10.1371/journal.pone.0020347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738572	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600001
J	Thomas, F; Cosse, A; Goulitquer, S; Raimund, S; Morin, P; Valero, M; Leblanc, C; Potin, P				Thomas, Francois; Cosse, Audrey; Goulitquer, Sophie; Raimund, Stefan; Morin, Pascal; Valero, Myriam; Leblanc, Catherine; Potin, Philippe			Waterborne Signaling Primes the Expression of Elicitor-Induced Genes and Buffers the Oxidative the Brown Alga Laminaria digitata	PLOS ONE			English	Article							INDUCED RESISTANCE; MOLECULAR-MECHANISMS; PLANT INTERACTIONS; TALKING TREES; GETTING READY; DEFENSE; COMMUNICATION; VOLATILES; COSTS; BURST	As marine sessile organisms, seaweeds must respond efficiently to biotic and abiotic challenges in their natural environment to reduce the fitness consequences of wounds and oxidative stress. This study explores the early steps of the defense responses of a large marine brown alga (the tangle kelp Laminaria digitata) and investigates its ability to transmit a warning message to neighboring conspecifics. We compared the early responses to elicitation with oligoguluronates in laboratory-grown and harvested wild individuals of L. digitata. We followed the release of H2O2 and the concomitant production of volatile organic compounds. We also monitored the kinetics of expression of defense-related genes following the oxidative burst. Laboratory-grown algae were transplanted in kelp habitats to further evaluate their responses to elicitation after a transient immersion in natural seawater. In addition, a novel conditioning procedure was established to mimic field conditions in the laboratory. Our experiments showed that L. digitata integrates waterborne cues present in the kelp bed and/or released from elicited neighboring plants. Indeed, the exposure to elicited conspecifics changes the patterns of oxidative burst and volatile emissions and potentiates this kelp for faster induction of genes specifically regulated in response to oligoguluronates. Thus, waterborne signals shape the elicitor-induced responses of kelps through a yet unknown mechanism reminiscent of priming in land plants.	[Thomas, Francois; Cosse, Audrey; Leblanc, Catherine; Potin, Philippe] Univ Paris 06, Marine Plants & Biomol Lab, Stn Biol Roscoff, Unite Mixte Rech 7139, Roscoff, France; [Thomas, Francois; Cosse, Audrey; Leblanc, Catherine; Potin, Philippe] CNRS, Stn Biol, Unite Mixte Rech 7139, Roscoff, France; [Goulitquer, Sophie] Univ Bretagne Occidentale, Fac Med, Inst Natl Sante & Rech Med,U613, Lab Biochim Epissage Canc Lipides & Apoptose, Brest, France; [Raimund, Stefan; Morin, Pascal; Valero, Myriam] Univ Paris 06, Stn Biol, Unite Mixte Rech 7144, Roscoff, France; [Raimund, Stefan; Morin, Pascal; Valero, Myriam] CNRS, Stn Biol, Unite Mixte Rech 7144, Roscoff, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Thomas, F (corresponding author), Univ Paris 06, Marine Plants & Biomol Lab, Stn Biol Roscoff, Unite Mixte Rech 7139, Roscoff, France.	potin@sb-roscoff.fr	Morin, Pascal/A-1112-2016; Valero, Myriam/C-7550-2011; Valero, Myriam/M-6052-2019	Morin, Pascal/0000-0003-2766-1821; Valero, Myriam/0000-0002-9000-1423; Valero, Myriam/0000-0002-9000-1423; Thomas, Francois/0000-0003-1896-0774; POTIN, Philippe/0000-0001-7358-6282	French National Research Agency (ANR) [ANR 06 BDIV 012]; Ministry of Higher Education and Research; Brittany Regional Council; ECOKELP; European Community (ESTeam) [MESTCT 2005-020737]	French National Research Agency (ANR)(French National Research Agency (ANR)); Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Brittany Regional Council(Region Bretagne); ECOKELP; European Community (ESTeam)(European Commission)	This work was partially funded by the ECOKELP program of the French National Research Agency (ANR) (ANR 06 BDIV 012). Ph.D. fellowships to F. T. and S. G were awarded by the Ministry of Higher Education and Research. A. C. was supported by a Ph.D. fellowship from the Brittany Regional Council and a postdoctoral fellowship from ECOKELP. S. R. received funding from the European Community Sixth Framework Programme (ESTeam MESTCT 2005-020737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	APT KE, 1995, MOL GEN GENET, V246, P455, DOI 10.1007/BF00290449; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Borell EM, 2004, OECOLOGIA, V140, P328, DOI 10.1007/s00442-004-1589-0; Broadgate WJ, 2004, MAR CHEM, V88, P61, DOI 10.1016/j.marchem.2004.03.002; Bruce TJA, 2007, PLANT SCI, V173, P603, DOI 10.1016/j.plantsci.2007.09.002; BRUIN J, 1995, TRENDS ECOL EVOL, V10, P167, DOI 10.1016/S0169-5347(00)89033-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Coleman RA, 2007, OECOLOGIA, V151, P454, DOI 10.1007/s00442-006-0601-2; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Cosse A., 2007, ADV BOT RES, V46, P221, DOI DOI 10.1016/S0065-2296(07)46006-2; Cosse A, 2009, NEW PHYTOL, V182, P239, DOI 10.1111/j.1469-8137.2008.02745.x; Dring MJ, 2006, ADV BOT RES, V43, P175, DOI 10.1016/S0065-2296(05)43004-9; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Galis I, 2009, PLANT CELL ENVIRON, V32, P617, DOI 10.1111/j.1365-3040.2008.01862.x; Goulitquer S, 2009, CHEMBIOCHEM, V10, P977, DOI 10.1002/cbic.200900004; Haavisto F, 2010, OECOLOGIA, V162, P685, DOI 10.1007/s00442-009-1494-7; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; HAYES MP, 1995, CYTOKINE, V7, P427, DOI 10.1006/cyto.1995.0058; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heyraud A, 1996, CARBOHYD RES, V289, P11, DOI 10.1016/0008-6215(96)00060-2; Jones CE, 2009, ATMOS CHEM PHYS, V9, P8757, DOI 10.5194/acp-9-8757-2009; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kupper FC, 2006, J EXP BOT, V57, P1991, DOI 10.1093/jxb/erj146; Kupper FC, 2009, PLANT CELL PHYSIOL, V50, P789, DOI 10.1093/pcp/pcp023; Kupper FC, 2002, J CHEM ECOL, V28, P2057, DOI 10.1023/A:1020706129624; Kupper FC, 2001, PLANT PHYSIOL, V125, P278, DOI 10.1104/pp.125.1.278; Lane A. L., 2008, P229, DOI 10.1007/978-3-540-74181-7_11; Palmer CJ, 2005, ENVIRON CHEM, V2, P282, DOI 10.1071/EN05078; Pelletreau K. N., 2008, P121, DOI 10.1007/978-3-540-74181-7_6; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Pohnert G, 2002, NAT PROD REP, V19, P108, DOI 10.1039/a806888g; POTIN P, 2008, ALGAL CHEM ECOLOGY, V18, P245; Pruvost J, 1999, ANALYST, V124, P1389, DOI 10.1039/a904597j; RHOADES DF, 1983, ACS SYM SER, V208, P55; Rohde S, 2004, J ECOL, V92, P1011, DOI 10.1111/j.0022-0477.2004.00936.x; SHONLE I, 1995, ECOLOGY, V76, P2660, DOI 10.2307/2265837; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Toth GB, 2000, P NATL ACAD SCI USA, V97, P14418, DOI 10.1073/pnas.250226997; Van Donk E, 2007, ECOL INFORM, V2, P112, DOI 10.1016/j.ecoinf.2007.03.002; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; VOS M, 2006, ANN BOT-LONDON, V97, P779; Walters D, 2007, PHYSIOL MOL PLANT P, V71, P3, DOI 10.1016/j.pmpp.2007.09.008; Yi HS, 2009, PLANT PHYSIOL, V151, P2152, DOI 10.1104/pp.109.144782; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	55	24	24	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21475	10.1371/journal.pone.0021475	http://dx.doi.org/10.1371/journal.pone.0021475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731761	Green Published, gold			2022-12-25	WOS:000292036900037
J	De Amicis, F; Giordano, F; Vivacqua, A; Pellegrino, M; Panno, ML; Tramontano, D; Fuqua, SAW; Ando, S				De Amicis, Francesca; Giordano, Francesca; Vivacqua, Adele; Pellegrino, Michele; Panno, Maria Luisa; Tramontano, Donatella; Fuqua, Suzanne A. W.; Ando, Sebastiano			Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38(MAPK)/CK2 signaling in human breast cancer cells	FASEB JOURNAL			English	Article						tamoxifen resistance; ER alpha; promoter	TRANSCRIPTIONAL REPRESSION; MUTANT P53; PROTEIN; APOPTOSIS; GROWTH; COREPRESSOR; SUPPRESSION; ACTIVATION; PATHWAY; AGONIST/ANTAGONIST	Agents to counteract acquired resistance to hormonal therapy for breast cancer would substantially enhance the long-term benefits of hormonal therapy. In the present study, we demonstrate how resveratrol (Res) inhibits human breast cancer cell proliferation, including MCF-7 tamoxifen-resistant cells (IC50 values for viability were in the 30-45 mu M range). We show that Res, through p38(MAPK) phosphorylation, causes induction of p53, which recruits at the estrogen receptor alpha (ER alpha) proximal promoter, leading to an inhibition of ER alpha expression in terms of mRNA and protein content. These events appear specifically p53 dependent, since they are drastically abrogated with p53-targeting siRNA. Coimmunoprecipitation assay showed specific interaction between p53, the Sin3A corepressor, and histone deacetylase 1 (HDAC1), which was phosphorylated. The enhancement of the tripartite complex p53/Sin3A/HDAC1, together with NF-Y on Res treatment, was confirmed by chromatin immunoprecipitation analyses, with a concomitant release of Sp1 and RNA polymerase II, thereby inhibiting the cell transcriptional machinery. The persistence of such effects in MCF-7 tamoxifen-resistant cells at a higher extent than parental MCF-7 cells addresses how Res may be considered a useful pharmacological tool to be exploited in the adjuvant settings for treatment of breast cancer developing hormonal resistance.-De Amicis, F., Giordano, F., Vivacqua, A., Pellegrino, M., Panno, M. L., Tramontano, D., Fuqua, S. A. W., Ando, S. Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38(MAPK)/CK2 signaling in human breast cancer cells. FASEB J. 25, 3695-3707 (2011). www.fasebj.org	[Ando, Sebastiano] Univ Calabria, Fac Pharm Nutr & Hlth Sci, Ctr Sanit, I-87030 Arcavacata Di Rende, CS, Italy; [De Amicis, Francesca; Vivacqua, Adele] Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy; [Giordano, Francesca; Pellegrino, Michele; Panno, Maria Luisa; Ando, Sebastiano] Univ Calabria, Dept Cellular Biol, I-87030 Arcavacata Di Rende, CS, Italy; [Tramontano, Donatella] Univ Naples Federico II, Dept Cellular & Mol Pathol L Califano, Naples, Italy; [Fuqua, Suzanne A. W.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA	University of Calabria; University of Calabria; University of Calabria; University of Naples Federico II; Baylor College of Medicine	Ando, S (corresponding author), Univ Calabria, Fac Pharm Nutr & Hlth Sci, Ctr Sanit, I-87030 Arcavacata Di Rende, CS, Italy.	sebastiano.ando@unical.it	vivacqua, adele/I-2771-2015; Tramontano, Donatella/AAS-1740-2020	vivacqua, adele/0000-0001-5333-8396; Pellegrino, Michele/0000-0002-4046-4243; GIORDANO, Francesca/0000-0002-7621-1969; De Amicis, Francesca/0000-0001-7079-1037; Tramontano, Donatella/0000-0002-9308-034X	Nazionale-Ministro dell'Istruzione, dell'Universita e della Ricerca; U.S. National Institutes of Health/National Cancer Institute [R01 CA72038]; NATIONAL CANCER INSTITUTE [R01CA072038] Funding Source: NIH RePORTER	Nazionale-Ministro dell'Istruzione, dell'Universita e della Ricerca; U.S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Programma di Ricerca di Rilevante Interesse Nazionale-Ministro dell'Istruzione, dell'Universita e della Ricerca, Ex 60%-2010, and U.S. National Institutes of Health/National Cancer Institute grant R01 CA72038 to S.A.W.F.	AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; Azios NG, 2007, NEOPLASIA, V9, P147, DOI 10.1593/neo.06778; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Bhat KPL, 2002, ANN NY ACAD SCI, V957, P210, DOI 10.1111/j.1749-6632.2002.tb02918.x; Bowers JL, 2000, ENDOCRINOLOGY, V141, P3657, DOI 10.1210/en.141.10.3657; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Ciolino HP, 1999, MOL PHARMACOL, V56, P760; Cui YK, 2006, CANCER RES, V66, P5950, DOI 10.1158/0008-5472.CAN-05-3243; De Amicis F, 2009, MOL ENDOCRINOL, V23, P454, DOI 10.1210/me.2008-0267; deGraffenried LA, 2002, J STEROID BIOCHEM, V82, P7, DOI 10.1016/S0960-0760(02)00151-6; Diel P, 2002, TOXICOL LETT, V127, P217, DOI 10.1016/S0378-4274(01)00503-3; Duval D, 2004, CELL DEATH DIFFER, V11, P331, DOI 10.1038/sj.cdd.4401337; ENCARNACION CA, 1993, BREAST CANCER RES TR, V26, P237, DOI 10.1007/BF00665801; Faniello MC, 1999, J BIOL CHEM, V274, P7623, DOI 10.1074/jbc.274.12.7623; Ferry-Dumazet H, 2002, CARCINOGENESIS, V23, P1327, DOI 10.1093/carcin/23.8.1327; Fontecave M, 1998, FEBS LETT, V421, P277, DOI 10.1016/S0014-5793(97)01572-X; Frech MS, 2005, CANCER RES, V65, P681; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Giordano C, 2010, BREAST CANCER RES TR, V119, P71, DOI 10.1007/s10549-009-0334-0; GRUNT TW, 1995, INT J CANCER, V63, P560, DOI 10.1002/ijc.2910630417; Guvakova MA, 1997, CANCER RES, V57, P2606; Hildesheim J, 2005, J BIOL CHEM, V280, P17221, DOI 10.1074/jbc.M410440200; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Hsieh TC, 1999, INT J ONCOL, V15, P245; HU XF, 1993, INT J CANCER, V55, P873, DOI 10.1002/ijc.2910550529; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Hutcheson IR, 2003, BREAST CANCER RES TR, V81, P81, DOI 10.1023/A:1025484908380; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LEVESQUE MA, 1994, BREAST CANCER RES TR, V30, P179, DOI 10.1007/BF00666062; Lin HY, 2006, FASEB J, V20, P1742, DOI 10.1096/fj.06-5743fje; Liu G, 1999, BIOCHEM BIOPH RES CO, V264, P359, DOI 10.1006/bbrc.1999.1525; Lu XB, 2003, MUTAT RES-FUND MOL M, V522, P69, DOI 10.1016/S0027-5107(02)00261-0; Moore L, 2007, MECH AGEING DEV, V128, P717, DOI 10.1016/j.mad.2007.10.011; Mukherjee S, 2010, DOSE-RESPONSE, V8, P478, DOI 10.2203/dose-response.09-015.Mukherjee; Panno ML, 2009, CURR CANCER DRUG TAR, V9, P469, DOI 10.2174/156800909788486786; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; Santen RJ, 2005, ENDOCR-RELAT CANCER, V12, pS61, DOI 10.1677/erc.1.01018; Scarlatti F, 2003, FASEB J, V17, P2339, DOI 10.1096/fj.03-0292fje; Shirley SH, 2009, CANCER RES, V69, P3405, DOI 10.1158/0008-5472.CAN-08-3628; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Stewart JR, 2000, BIOCHEM PHARMACOL, V60, P1355, DOI 10.1016/S0006-2952(00)00450-0; Sun JM, 2007, J BIOL CHEM, V282, P33227, DOI 10.1074/jbc.M703549200; Tsai SH, 1999, BRIT J PHARMACOL, V126, P673, DOI 10.1038/sj.bjp.0702357; Vivacqua A, 2009, MOL ENDOCRINOL, V23, P1815, DOI 10.1210/me.2009-0120; Yu CL, 1997, BIOCHEM BIOPH RES CO, V239, P617, DOI 10.1006/bbrc.1997.7522; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	55	60	61	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3695	3707		10.1096/fj.10-178871	http://dx.doi.org/10.1096/fj.10-178871			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21737614	Green Published			2022-12-25	WOS:000295356400038
J	Lehmann, L				Lehmann, Laurent			The Demographic Benefits of Belligerence and Bravery: Defeated Group Repopulation or Victorious Group Size Expansion?	PLOS ONE			English	Article							SUBDIVIDED POPULATIONS; KIN SELECTION; EVOLUTIONARY-THEORY; INCLUSIVE FITNESS; COMPETITION; DISPERSAL; ALTRUISM; DYNAMICS; WARFARE; WAR	Intraspecific coalitional aggression between groups of individuals is a widespread trait in the animal world. It occurs in invertebrates and vertebrates, and is prevalent in humans. What are the conditions under which coalitional aggression evolves in natural populations? In this article, I develop a mathematical model delineating conditions where natural selection can favor the coevolution of belligerence and bravery between small-scale societies. Belligerence increases an actor's group probability of trying to conquer another group and bravery increase the actors's group probability of defeating an attacked group. The model takes into account two different types of demographic scenarios that may lead to the coevolution of belligerence and bravery. Under the first, the fitness benefits driving the coevolution of belligerence and bravery come through the repopulation of defeated groups by fission of victorious ones. Under the second demographic scenario, the fitness benefits come through a temporary increase in the local carrying capacity of victorious groups, after transfer of resources from defeated groups to victorious ones. The analysis of the model suggests that the selective pressures on belligerence and bravery are stronger when defeated groups can be repopulated by victorious ones. The analysis also suggests that, depending on the shape of the contest success function, costly bravery can evolve in groups of any size.	Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	University of Lausanne	Lehmann, L (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	laurent.lehmann@unil.ch	lehmann, laurent/B-6875-2012		Swiss National Science Foundation (SNSF) [PP00P3-123344]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work has been supported by grant PP00P3-123344 from the Swiss National Science Foundation (SNSF, http://www.snf.ch/E/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajar E, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-22; ALEXANDER RD, 1990, ETHOL SOCIOBIOL, V11, P241, DOI 10.1016/0162-3095(90)90012-U; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Bowles S, 2009, SCIENCE, V324, P1293, DOI 10.1126/science.1168112; CHAGNON NA, 1988, SCIENCE, V239, P985, DOI 10.1126/science.239.4843.985; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Crofoot MC, 2010, MIND THE GAP: TRACING THE ORIGINS OF HUMAN UNIVERSALS, P171, DOI 10.1007/978-3-642-02725-3_8; DURHAM WH, 1976, Q REV BIOL, V51, P385, DOI 10.1086/409471; Eshel I, 1996, J MATH BIOL, V34, P485; Gandon S, 1999, J THEOR BIOL, V200, P345, DOI 10.1006/jtbi.1999.0994; Garfinkel M.R., 2007, HDB DEFENSE EC, V2, P649; Gat A, 2000, ANTHROPOL QUART, V73, P20; Gat A, 1999, J ANTHROPOL RES, V55, P563, DOI 10.1086/jar.55.4.3631615; Gat A, 2009, EUR J INT RELAT, V15, P571, DOI 10.1177/1354066109344661; Gat Azar, 2006, WAR HUMAN CIVILIZATI; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gillespie J. H., 2004, POPULATION GENETICS; Goodall J., 1986, CHIMPANZEES GOMBE PA; Grinstead C. M., 1997, INTRO PROBABILITY; Guillaume F, 2006, GENETICS, V173, P497, DOI 10.1534/genetics.105.046847; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; HAUSKEN K, 1995, J MATH ECON, V24, P655, DOI 10.1016/0304-4068(94)00709-J; Hausken K, 2004, ECON INQ, V42, P572, DOI 10.1093/ei/cbh082; HIRSHLEIFER J, 1991, AM ECON REV, V81, P130; HIRSHLEIFER J, 1989, PUBLIC CHOICE, V63, P101, DOI 10.1007/BF00153394; Hirshleifer J, 2001, DARK SIDE FORCE EC F; Holldobler B., 1990, pi; Horiuchi S, 2002, J THEOR BIOL, V218, P195, DOI 10.1006/jtbi.2002.3068; Johnstone RA, 2008, AM NAT, V172, P318, DOI 10.1086/589899; KARLIN S, 1968, J APPL PROBAB, V5, P487, DOI 10.2307/3211920; Keeley L. H., 1997, WAR CIVILIZATION MYT; Keller L, 1999, LEVELS SELECTION EVO; Kelly RC, 2005, P NATL ACAD SCI USA, V102, P15294, DOI 10.1073/pnas.0505955102; Lehmann L, 2008, P ROY SOC B-BIOL SCI, V275, P2877, DOI 10.1098/rspb.2008.0842; Lehmann L, 2009, EVOLUTION, V63, P2896, DOI 10.1111/j.1558-5646.2009.00778.x; Lehmann L, 2009, P R SOC B, V276, P4083, DOI 10.1098/rspb.2009.1465; Lehmann L, 2006, EVOLUTION, V60, P1137; Leturque H, 2002, THEOR POPUL BIOL, V62, P169, DOI 10.1006/tpbi.2002.1600; LEVIN BR, 1974, EVOLUTION, V28, P527, DOI 10.1111/j.1558-5646.1974.tb00787.x; Lion S, 2009, J EVOLUTION BIOL, V22, P1487, DOI 10.1111/j.1420-9101.2009.01769.x; Maynard Smith J., 1982, pi; Michod RE, 1999, DARWINIAN DYNAMICS; Pen I, 2000, EVOLUTION, V54, P293, DOI 10.1111/j.0014-3820.2000.tb00030.x; Rousset F, 2000, J EVOLUTION BIOL, V13, P814, DOI 10.1046/j.1420-9101.2000.00219.x; Rousset F, 2004, THEOR POPUL BIOL, V65, P127, DOI 10.1016/j.tpb.2003.09.003; Rousset F, 2002, HEREDITY, V88, P371, DOI 10.1038/sj.hdy.6800065; ROUSSET F, 2004, GENETIC STRUCTURE SE; Roze D, 2003, GENETICS, V165, P2153; Skaperdas S, 1996, ECON THEORY, V7, P283, DOI 10.1007/s001990050053; Smirnov O, 2007, J POLIT, V69, P927, DOI 10.1111/j.1468-2508.2007.00599.x; Szathmary E, 1995, MAJOR TRANSITIONS EV; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; TAYLOR PD, 1990, AM NAT, V135, P95, DOI 10.1086/285034; Tooby J., 1988, 881 I EV STUD; Turchin P., 2018, HIST DYNAMICS WHY ST, DOI [10.23943/princeton/9780691180779.001.0001, DOI 10.23943/PRINCETON/9780691180779.001.0001]; Vincent T. L., 2005, EVOLUTIONARY GAME TH; WADE MJ, 1985, AM NAT, V125, P61, DOI 10.1086/284328; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Whitlock MC, 2002, GENETICS, V160, P1191; Wright S, 1931, GENETICS, V16, P0097	62	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21437	10.1371/journal.pone.0021437	http://dx.doi.org/10.1371/journal.pone.0021437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	789JO	21750712	Green Submitted, Green Published, gold			2022-12-25	WOS:000292512000014
J	Cao, SH; Kumimoto, RW; Siriwardana, CL; Risinger, JR; Holt, BF				Cao, Shuanghe; Kumimoto, Roderick W.; Siriwardana, Chamindika L.; Risinger, Jan R.; Holt, Ben F., III			Identification and Characterization of NF-Y Transcription Factor Families in the Monocot Model Plant Brachypodium distachyon	PLOS ONE			English	Article							CCAAT-BINDING-FACTOR; AGROBACTERIUM-MEDIATED TRANSFORMATION; ARABIDOPSIS LEAFY COTYLEDON1; FACTOR CBF; B-SUBUNIT; FUNCTIONAL DOMAINS; FLOWERING-TIME; DNA-BINDING; COMPLEX; CONSTANS	Background: Nuclear Factor Y (NF-Y) is a heterotrimeric transcription factor composed of NF-YA, NF-YB and NF-YC proteins. Using the dicot plant model system Arabidopsis thaliana (Arabidopsis), NF-Y were previously shown to control a variety of agronomically important traits, including drought tolerance, flowering time, and seed development. The aim of the current research was to identify and characterize NF-Y families in the emerging monocot model plant Brachypodium distachyon (Brachypodium) with the long term goal of assisting in the translation of known dicot NF-Y functions to the grasses. Methodology/Principal Findings: We identified, annotated, and further characterized 7 NF-YA, 17 NF-YB, and 12 NF-YC proteins in Brachypodium (BdNF-Y). By examining phylogenetic relationships, orthology predictions, and tissue-specific expression patterns for all 36 BdNF-Y, we proposed numerous examples of likely functional conservation between dicots and monocots. To test one of these orthology predictions, we demonstrated that a BdNF-YB with predicted orthology to Arabidopsis floral-promoting NF-Y proteins can rescue a late flowering Arabidopsis mutant. Conclusions/Significance: The Brachypodium genome encodes a similar complement of NF-Y to other sequenced angiosperms. Information regarding NF-Y phylogenetic relationships, predicted orthologies, and expression patterns can facilitate their study in the grasses. The current data serves as an entry point for translating many NF-Y functions from dicots to the genetically tractable monocot model system Brachypodium. In turn, studies of NF-Y function in Brachypodium promise to be more readily translatable to the agriculturally important grasses.	[Cao, Shuanghe; Kumimoto, Roderick W.; Siriwardana, Chamindika L.; Risinger, Jan R.; Holt, Ben F., III] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Cao, SH (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	benholt@ou.edu	Holt, Ben F/D-1513-2011	CAO, SHUANGHE/0000-0002-2905-0728; Siriwardana, Chamindika/0000-0002-7746-9427	Oklahoma Center for the Advancement of Science and Technology (OCAST) [PSB10-013]; National Science Foundation (NSF) [IOS-0920258]	Oklahoma Center for the Advancement of Science and Technology (OCAST); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	Funding support for this project came from the Oklahoma Center for the Advancement of Science and Technology (OCAST, PSB10-013) and the National Science Foundation (NSF, IOS-0920258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; BALLIF J, 2011, PLANT PHYSL IN PRESS; Ballif J, 2011, PLANT PHYSIOL BIOCH, V49, P579, DOI 10.1016/j.plaphy.2011.01.013; Barker D, 2005, PLOS COMPUT BIOL, V1, P24, DOI 10.1371/journal.pcbi.0010003; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bevan MW, 2010, CURR OPIN BIOTECH, V21, P211, DOI 10.1016/j.copbio.2010.03.006; Bhattacharya A, 2003, CANCER RES, V63, P8167; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Zanetti ME, 2010, PLANT CELL, V22, P4142, DOI 10.1105/tpc.110.079137; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Frontini M, 2004, CELL CYCLE, V3, P217; Gabaldon T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-235; Gatta R, 2008, NUCLEIC ACIDS RES, V36, P6592, DOI 10.1093/nar/gkn699; Gray J, 2009, PLANT PHYSIOL, V149, P4, DOI 10.1104/pp.108.128504; Gusmaroli G, 2001, GENE, V264, P173, DOI 10.1016/S0378-1119(01)00323-7; Hall B. G., 2008, PHYLOGENETIC TREES M; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kagiya G, 2010, J BIOSCI BIOENG, V110, P118, DOI 10.1016/j.jbiosc.2009.12.013; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Klimaszewska K, 2010, PLANT CELL REP, V29, P723, DOI 10.1007/s00299-010-0859-z; KOZIEL M G, 1984, Journal of Molecular and Applied Genetics, V2, P549; Kumar Sachin, 2009, BMC Res Notes, V2, P93, DOI 10.1186/1756-0500-2-93; Kumimoto RW, 2008, PLANTA, V228, P709, DOI 10.1007/s00425-008-0773-6; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Kusnetsov V, 1999, J BIOL CHEM, V274, P36009, DOI 10.1074/jbc.274.50.36009; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; MAITY SN, 1992, J BIOL CHEM, V267, P8286; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Matuoka K, 2002, AGEING RES REV, V1, P639, DOI 10.1016/S1568-1637(02)00026-0; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; McNabb DS, 1997, MOL CELL BIOL, V17, P7008, DOI 10.1128/MCB.17.12.7008; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Ogawal R, 2007, BIOTECHNIQUES, V42, P628, DOI 10.2144/000112436; OLESEN JT, 1990, GENE DEV, V4, P1714, DOI 10.1101/gad.4.10.1714; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Sinha S, 1996, MOL CELL BIOL, V16, P328; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; STEPHENSON TJ, 2011, FUNCT INTEG IN PRESS; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Stephenson TJ, 2010, FUNCT INTEGR GENOMIC, V10, P265, DOI 10.1007/s10142-010-0158-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Thole V, 2010, PLANT BIOTECHNOL J, V8, P734, DOI 10.1111/j.1467-7652.2010.00518.x; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; XING YY, 1994, P NATL ACAD SCI USA, V91, P3009, DOI 10.1073/pnas.91.8.3009; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yang J, 2005, NEW PHYTOL, V165, P623, DOI 10.1111/j.1469-8137.2004.01260.x; Yoshioka Y, 2007, GENESIS, V45, P21, DOI 10.1002/dvg.20260; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x	91	67	77	6	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21805	10.1371/journal.pone.0021805	http://dx.doi.org/10.1371/journal.pone.0021805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738795	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800046
J	Muller-Sienerth, N; Dietz, L; Holtz, P; Kapp, M; Grigoleit, GU; Schmuck, C; Wajant, H; Siegmund, D				Mueller-Sienerth, Nicole; Dietz, Lena; Holtz, Philipp; Kapp, Markus; Grigoleit, Gotz Ulrich; Schmuck, Carsten; Wajant, Harald; Siegmund, Daniela			SMAC Mimetic BV6 Induces Cell Death in Monocytes and Maturation of Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							KAPPA-B ACTIVATION; ALPHA-DEPENDENT APOPTOSIS; CASPASE-8 ACTIVATION; CANCER; TRAF2; CIAP1; NECROSIS; COMPLEX; C-IAP1; RIP1	Background: Compounds mimicking the inhibitory effect of SMAC / DIABLO on X-linked inhibitor of apoptosis (XIAP) have been developed with the aim to achieve sensitization for apoptosis of tumor cells resistant due to deregulated XIAP expression. It turned out that SMAC mimetics also have complex effects on the NF kappa B system and TNF signaling. In view of the overwhelming importance of the NF kappa B transcription factors in the immune system, we analyzed here the effects of the SMAC mimetic BV6 on immune cells. Principal Findings: BV6 induced apoptotic and necrotic cell death in monocytes while T-cells, dendritic cells and macrophages were largely protected against BV6-induced cell death. In immature dendritic cells BV6 treatment resulted in moderate activation of the classical NF kappa B pathway, but it also diminished the stronger NF kappa B-inducing effect of TNF and CD40L. Despite its inhibitory effect on TNF- and CD40L signaling, BV6 was able to trigger maturation of immature DCs as indicated by upregulation of CD83, CD86 and IL12. Significance: The demonstrated effects of SMAC mimetics on immune cells may complicate the development of tumor therapeutic concepts based on these compounds but also arise the possibility to exploit them for the development of immune stimulatory therapies.	[Mueller-Sienerth, Nicole; Dietz, Lena; Kapp, Markus; Grigoleit, Gotz Ulrich; Wajant, Harald; Siegmund, Daniela] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Holtz, Philipp; Schmuck, Carsten] Univ Duisburg Essen, Dept Organ Chem 2, Essen, Germany	University of Wurzburg; University of Duisburg Essen	Muller-Sienerth, N (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany.	harald.wajant@mail.uni-wuerzburg.de	Wajant, Harald/A-3020-2017; Grigoleit, Goetz U/K-4555-2016	Wajant, Harald/0000-0002-2005-3949; Muller-Sienerth, Nicole/0000-0002-7527-5127	Deutsche Forschungsgemeinschaft [DFG Wa 1025/18-1, Wa 1025/21-1]; Wilhelm Sander-Stiftung [2009.052.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung	This work was supported by Deutsche Forschungsgemeinschaft (DFG Wa 1025/18-1 and Wa 1025/21-1) and Wilhelm Sander-Stiftung (project 2009.052.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Chen DJ, 2009, ANTI-CANCER DRUG, V20, P646, DOI 10.1097/CAD.0b013e32832ced78; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dougan M, 2010, J EXP MED, V207, P2195, DOI 10.1084/jem.20101123; Dupoux A, 2009, BLOOD, V113, P175, DOI 10.1182/blood-2008-02-137919; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Speirs K, 2004, J IMMUNOL, V172, P752, DOI 10.4049/jimmunol.172.2.752; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	30	44	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21556	10.1371/journal.pone.0021556	http://dx.doi.org/10.1371/journal.pone.0021556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738708	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800021
J	Huso, DL; Edie, S; Levine, MA; Schwindinger, W; Wang, YL; Juppner, H; Germain-Lee, EL				Huso, David L.; Edie, Sarah; Levine, Michael A.; Schwindinger, William; Wang, Yingli; Jueppner, Harald; Germain-Lee, Emily L.			Heterotopic Ossifications in a Mouse Model of Albright Hereditary Osteodystrophy	PLOS ONE			English	Article							STIMULATORY G-PROTEIN; GS-ALPHA GENE; PROGRESSIVE OSSEOUS HETEROPLASIA; TOTAL HIP-ARTHROPLASTY; ECTOPIC BONE-FORMATION; PSEUDOHYPOPARATHYROIDISM TYPE-1A; INACTIVATING MUTATIONS; TARGETED DISRUPTION; HORMONE RESISTANCE; SUBUNIT G(S)ALPHA	Albright hereditary osteodystrophy (AHO) is characterized by short stature, brachydactyly, and often heterotopic ossifications that are typically subcutaneous. Subcutaneous ossifications (SCO) cause considerable morbidity in AHO with no effective treatment. AHO is caused by heterozygous inactivating mutations in those GNAS exons encoding the alpha-subunit of the stimulatory G protein (G alpha(s)). When inherited maternally, these mutations are associated with obesity, cognitive impairment, and resistance to certain hormones that mediate their actions through G protein-coupled receptors, a condition termed pseudohypoparathyroidism type 1a (PHP1a). When inherited paternally, GNAS mutations cause only AHO but not hormonal resistance, termed pseudopseudohypoparathyroidism (PPHP). Mice with targeted disruption of exon 1 of Gnas (Gnas(E1-/+)) replicate human PHP1a or PPHP phenotypically and hormonally. However, SCO have not yet been reported in Gnas(E1+/-) mice, at least not those that had been analyzed by us up to 3 months of age. Here we now show that Gnas(E1-/+) animals develop SCO over time. The ossified lesions increase in number and size and are uniformly detected in adult mice by one year of age. They are located in both the dermis, often in perifollicular areas, and the subcutis. These lesions are particularly prominent in skin prone to injury or pressure. The SCO comprise mature bone with evidence of mineral deposition and bone marrow elements. Superficial localization was confirmed by radiographic and computerized tomographic imaging. In situ hybridization of SCO lesions were positive for both osteonectin and osteopontin. Notably, the ossifications were much more extensive in males than females. Because Gnas(E1-/+) mice develop SCO features that are similar to those observed in AHO patients, these animals provide a model system suitable for investigating pathogenic mechanisms involved in SCO formation and for developing novel therapeutics for heterotopic bone formation. Moreover, these mice provide a model with which to investigate the regulatory mechanisms of bone formation.	[Huso, David L.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA; [Edie, Sarah] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA; [Levine, Michael A.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Levine, Michael A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Schwindinger, William] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Wang, Yingli] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Jueppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA; [Jueppner, Harald] Harvard Univ, Sch Med, Boston, MA USA; [Germain-Lee, Emily L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Germain-Lee, Emily L.] Kennedy Krieger Inst, Albright Clin, Baltimore, MD USA; [Germain-Lee, Emily L.] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Kennedy Krieger Institute	Huso, DL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD 21218 USA.	germainlee@kennedykrieger.org		Edie, Sarah/0000-0003-2823-7571; Germain-Lee, Emily/0000-0002-5727-610X; Levine, Michael/0000-0003-0036-7809	Bosworth Family; Friedman Family	Bosworth Family; Friedman Family	This work was supported by generous donations to the research of E.L.G.-L. by the Bosworth Family, the Friedman Family, and the families/friends of patients with Albright hereditary osteodystrophy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbite NS, 2008, AM J MED GENET A, V146A, P1788, DOI 10.1002/ajmg.a.32346; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Bastepe M, 2010, ENDOCRINOLOGY, P1223; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Chen M, 2005, P NATL ACAD SCI USA, V102, P7386, DOI 10.1073/pnas.0408268102; Cortes W, 2006, J CRANIOFAC SURG, V17, P21, DOI 10.1097/01.scs.0000188906.42225.39; Davies AJ, 1993, J MED GENET, V30, P101; DEBEUR SMJ, 2001, PARATHYROIDS BASIC C, P807; DELEE J, 1976, CLIN ORTHOP RELAT R, P53; Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Germain-Lee EL, 2005, ENDOCRINOLOGY, V146, P4697, DOI 10.1210/en.2005-0681; Germain-Lee EL, 2003, J CLIN ENDOCR METAB, V88, P4059, DOI 10.1210/jc.2003-030028; Germain-Lee EL, 2002, BIOCHEM BIOPH RES CO, V296, P67, DOI 10.1016/S0006-291X(02)00833-1; Germain-Lee Emily L, 2006, Pediatr Endocrinol Rev, V3 Suppl 2, P318; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; HSU S, 2006, PEDIAT RES, V59; Hu H P, 1991, Acta Orthop Belg, V57, P169; HUSO D, 2007, END SOC 89 ANN M TOR; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; LAZANSKY MG, 1973, CLIN ORTHOP RELAT R, P96; Lebrun M, 2010, J CLIN ENDOCR METAB, V95, P3028, DOI 10.1210/jc.2009-1451; LEVINE MA, 1983, J CLIN INVEST, V72, P316, DOI 10.1172/JCI110971; Levine MA, 2000, ENDOCRINOLOGY, P1133; Lietman SA, 2005, CLIN ORTHOP RELAT R, P231, DOI 10.1097/01.blo.0000153279.90512.38; Liu J, 2003, J CLIN ENDOCR METAB, V88, P4336, DOI 10.1210/jc.2003-030393; Mantovani G, 2004, J CLIN ENDOCR METAB, V89, P6316, DOI 10.1210/jc.2004-0558; Mantovani G, 2003, J CLIN ENDOCR METAB, V88, P4070, DOI 10.1210/jc.2002-022028; Mantovani G, 2002, J CLIN ENDOCR METAB, V87, P4736, DOI 10.1210/jc.2002-020183; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; MORREY BF, 1984, CLIN ORTHOP RELAT R, P160; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; Safer JD, 2007, ENDOCRINOLOGY, V148, P1167, DOI 10.1210/en.2006-1442; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; Sakamoto A, 2005, J BONE MINER RES, V20, P663, DOI 10.1359/JBMR.041210; Sakamoto A, 2009, ENDOCR RES, V34, P1, DOI 10.1080/07435800902841280; Schwindinger WF, 1997, ENDOCRINOLOGY, V138, P4058, DOI 10.1210/en.138.10.4058; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262; SOBALLE K, 1988, CLIN ORTHOP RELAT R, P57; Thomson M, 2003, EXP DERMATOL, V12, P389, DOI 10.1034/j.1600-0625.2003.00068.x; Wang Y, 2002, J DERMATOL SCI, V30, P136, DOI 10.1016/S0923-1811(02)00074-9; Wang YL, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-22; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Yeh GL, 2000, J BONE MINER RES, V15, P2063, DOI 10.1359/jbmr.2000.15.11.2063; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	48	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21755	10.1371/journal.pone.0021755	http://dx.doi.org/10.1371/journal.pone.0021755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747923	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100067
J	Lim, PH; Pisat, NP; Gadhia, N; Pandey, A; Donovan, FX; Stein, L; Salt, DE; Eide, DJ; MacDiarmid, CW				Lim, Phaik Har; Pisat, Nilambari P.; Gadhia, Nidhi; Pandey, Abhinav; Donovan, Frank X.; Stein, Lauren; Salt, David E.; Eide, David J.; MacDiarmid, Colin W.			Regulation of Alr1 Mg Transporter Activity by Intracellular Magnesium	PLOS ONE			English	Article							YEAST PLASMA-MEMBRANE; ACTIN CYTOSKELETON; GENE ENCODES; METAL-IONS; PROTEIN; UBIQUITIN; ENDOCYTOSIS; CORA; VACUOLAR; FAMILY	Mg homeostasis is critical to eukaryotic cells, but the contribution of Mg transporter activity to homeostasis is not fully understood. In yeast, Mg uptake is primarily mediated by the Alr1 transporter, which also allows low affinity uptake of other divalent cations such as Ni2+, Mn2+, Zn2+ and Co2+. Using Ni2+ uptake to assay Alr1 activity, we observed approximately ninefold more activity under Mg-deficient conditions. The mnr2 mutation, which is thought to block release of vacuolar Mg stores, was associated with increased Alr1 activity, suggesting Alr1 was regulated by intracellular Mg supply. Consistent with a previous report of the regulation of Alr1 expression by Mg supply, Mg deficiency and the mnr2 mutation both increased the accumulation of a carboxy-terminal epitope-tagged version of the Alr1 protein (Alr1-HA). However, Mg supply had little effect on ALR1 promoter activity or mRNA levels. In addition, while Mg deficiency caused a seven-fold increase in Alr1-HA accumulation, the N-terminally tagged and untagged Alr1 proteins increased less than two-fold. These observations argue that the Mg-dependent accumulation of the C-terminal epitope-tagged protein was primarily an artifact of its modification. Plasma membrane localization of YFP-tagged Alr1 was also unaffected by Mg supply, indicating that a change in Alr1 location did not explain the increased activity we observed. We conclude that variation in Alr1 protein accumulation or location does not make a substantial contribution to its regulation by Mg supply, suggesting Alr1 activity is directly regulated via as yet unknown mechanisms.	[Lim, Phaik Har] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Pisat, Nilambari P.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Gadhia, Nidhi] Regeneron Pharmaceut Inc, Dept Pharmacol & Pharmacokinet, Tarrytown, NY 10591 USA; [Pandey, Abhinav] Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Donovan, Frank X.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Stein, Lauren] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Wauwatosa, WI USA; [Salt, David E.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Eide, David J.; MacDiarmid, Colin W.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	Baylor College of Medicine; Washington University (WUSTL); Regeneron; Utrecht University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Medical College of Wisconsin; University of Aberdeen; University of Wisconsin System; University of Wisconsin Madison	Lim, PH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	macdiarmid@nutrisci.wisc.edu	MacDiarmid, Colin/AAV-5920-2021	MacDiarmid, Colin/0000-0001-8578-5756; Donovan, Frank X./0000-0002-7712-2335	National Institutes of Health [GM056285]; University of Missouri Research Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri Research Board; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grant # GM056285 to DE) and the University of Missouri Research Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amighi J, 2004, STROKE, V35, P22, DOI 10.1161/01.STR.0000105928.95124.1F; Andreini C, 2008, J BIOL INORG CHEM, V13, P1205, DOI 10.1007/s00775-008-0404-5; Beeler T, 1997, BBA-BIOMEMBRANES, V1323, P310, DOI 10.1016/S0005-2736(96)00199-X; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; BENEDETTI H, 1994, MOL BIOL CELL, V5, P1023, DOI 10.1091/mbc.5.9.1023; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Burke D., 2000, METHODS YEAST GENETI; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; Chen J, 2009, CELL RES, V19, P887, DOI 10.1038/cr.2009.58; Chen XZ, 1999, J BIOL CHEM, V274, P35089, DOI 10.1074/jbc.274.49.35089; CHERNOW B, 1989, CHEST, V95, P391, DOI 10.1378/chest.95.2.391; Cohen A, 2000, J BIOL CHEM, V275, P33388, DOI 10.1074/jbc.M004611200; Cowan J. A., 1995, P1; Cromie MJ, 2010, J BACTERIOL, V192, P604, DOI 10.1128/JB.01239-09; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Drummond RSM, 2006, PLANT SCI, V170, P78, DOI 10.1016/j.plantsci.2005.08.018; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Eguez L, 2004, GENETICS, V167, P107, DOI 10.1534/genetics.167.1.107; Eide DJ, 1998, ANNU REV NUTR, V18, P441, DOI 10.1146/annurev.nutr.18.1.441; ELIN RJ, 1994, AM J CLIN PATHOL, V102, P616, DOI 10.1093/ajcp/102.5.616; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; FLATMAN PW, 1984, J MEMBRANE BIOL, V80, P1, DOI 10.1007/BF01868686; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hu J, 2009, J BIOL CHEM, V284, P15619, DOI 10.1074/jbc.M901581200; Jenness DD, 1997, MOL CELL BIOL, V17, P6236, DOI 10.1128/MCB.17.11.6236; Johansson MJO, 2010, GENE DEV, V24, P1491, DOI 10.1101/gad.1930710; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lee JM, 2006, CURR GENET, V49, P7, DOI 10.1007/s00294-005-0037-y; Li LG, 2001, PLANT CELL, V13, P2761, DOI 10.1105/tpc.13.12.2761; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; MacDiarmid CW, 1996, PLANT PHYSIOL, V112, P1101, DOI 10.1104/pp.112.3.1101; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Maguire ME, 2006, CURR OPIN STRUC BIOL, V16, P432, DOI 10.1016/j.sbi.2006.06.006; Mao DD, 2008, J INTEGR PLANT BIOL, V50, P1530, DOI 10.1111/j.1744-7909.2008.00770.x; MARUYAMA T, 1994, BBA-BIOMEMBRANES, V1194, P289, DOI 10.1016/0005-2736(94)90311-5; Moncrief MBC, 1999, J BIOL INORG CHEM, V4, P523, DOI 10.1007/s007750050374; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nikko E, 2007, TRAFFIC, V8, P566, DOI 10.1111/j.1600-0854.2007.00553.x; Papp-Wallace KM, 2008, J BACTERIOL, V190, P6509, DOI 10.1128/JB.00144-08; Papp-Wallace KM, 2007, MOL MEMBR BIOL, V24, P351, DOI 10.1080/09687680701441883; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Pisat NP, 2009, GENETICS, V183, P873, DOI 10.1534/genetics.109.106419; PISKACEK M, 2008, J CELL MOL MED; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; Sambrook J, 2001, MOL CLONING LAB MANU; Sarikaya AT, 2006, MOL BIOTECHNOL, V32, P139, DOI 10.1385/MB:32:2:139; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Springael JY, 2002, FEBS LETT, V517, P103, DOI 10.1016/S0014-5793(02)02586-3; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Supek F, 1996, P NATL ACAD SCI USA, V93, P5105, DOI 10.1073/pnas.93.10.5105; Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wachek M, 2006, FEBS J, V273, P4236, DOI 10.1111/j.1742-4658.2006.05424.x; Wendland B, 1996, J CELL BIOL, V135, P1485, DOI 10.1083/jcb.135.6.1485; WILLIAMS RJP, 1993, MAGNESIUM CELL, P15; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454; Zsurka G, 2001, GENOMICS, V72, P158, DOI 10.1006/geno.2000.6407; ZUBENKO GS, 1983, P NATL ACAD SCI-BIOL, V80, P510, DOI 10.1073/pnas.80.2.510	87	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20896	10.1371/journal.pone.0020896	http://dx.doi.org/10.1371/journal.pone.0020896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738593	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800006
J	Bai, M; McCullough, E; Song, KQ; Liu, WG; Yang, XK				Bai, Ming; McCullough, Erin; Song, Ke-Qing; Liu, Wan-Gang; Yang, Xing-Ke			Evolutionary Constraints in Hind Wing Shape in Chinese Dung Beetles (Coleoptera: Scarabaeinae)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; STATISTICAL SIGNIFICANCE; FLIGHT; ARTICULATION; MORPHOLOGY; DISTANCE; BEHAVIOR; BASE	This study examines the evolution hindwing shape in Chinese dung beetle species using morphometric and phylogenetic analyses. Previous studies have analyzed the evolution of wing shape within a single or very few species, or by comparing only a few wing traits. No study has analyzed wing shape evolution of a large number of species, or quantitatively compared morphological variation of wings with proposed phylogenetic relationships. This study examines the morphological variation of hindwings based on 19 landmarks, 119 morphological characters, and 81 beetle species. Only one most parsimonious tree (MPT) was found based on 119 wing and body characters. To better understand the possible role of the hindwing in the evolution of Scarabaeinae, additional phylogenetic analyses were proposed based on the only body features (106 characters, wing characters excluded). Two MPT were found based on 106 body characters, and five nodes were collapsed in a strict consensus. There was a strong correlation between the morphometric tree and all phylogenetic trees (r > 0.5). Reconstructions of the ancestral wing forms suggest that Scarabaeinae hindwing morphology has not changed substantially over time, but the morphological changes that do occur are focused at the base of the wing. These results suggest that flight has been important since the origin of Scarabaeinae, and that variation in hindwing morphology has been limited by functional constraints. Comparison of metric disparity values and relative evolutionary sequences among Scarabaeinae tribes suggest that the primitive dung beetles had relatively diverse hindwing morphologies, while advanced dung beetles have relatively similar wing morphologies. The strong correlation between the morphometric tree and phylogenetic trees suggest that hindwing features reflect the evolution of whole body morphology and that wing characters are suitable for the phylogenetic analyses. By integrating morphometric and cladistic approaches, this paper sheds new light on the evolution of dung beetle hind wings.	[Bai, Ming; Song, Ke-Qing; Liu, Wan-Gang; Yang, Xing-Ke] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [McCullough, Erin] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Montana System; University of Montana	Bai, M (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	yangxk@ioz.ac.cn			Chinese Academy of Sciences [KSCX3-IOZ-1004, KSCX2-EW-G-4, KSCX2-EW-Z-8]; National Natural Science Foundation of China [30900144, 31010103913]; National Basic Research Program of China (973 Program) [2011CB302102]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the Knowledge Innovation Program of Chinese Academy of Sciences (Nos. KSCX3-IOZ-1004, KSCX2-EW-G-4 and KSCX2-EW-Z-8), the National Natural Science Foundation of China (Nos. 30900144 and 31010103913), the National Basic Research Program of China (973 Program) (No. 2011CB302102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012850; Balthasar V., 1963, MONOGRAPHIE SCARABAE, V2; Beldade P, 2002, NATURE, V416, P844, DOI 10.1038/416844a; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bos FM, 2008, J FLUID MECH, V594, P341, DOI 10.1017/S0022112007009172; BREUKER CJ, 2007, J EXP ZOOLOG B, V308; BROWNE DJ, 1995, SYST ENTOMOL, V20, P145, DOI 10.1111/j.1365-3113.1995.tb00089.x; BROWNE DJ, 1994, SYST ENTOMOL, V19, P133, DOI 10.1111/j.1365-3113.1994.tb00583.x; BROWNE DJ, 1996, BONN ZOOL MONOGR, P1; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; Bullen RD, 2007, AUST J ZOOL, V55, P237, DOI 10.1071/ZO07010; Chapman R.E., 1990, P MICHIGAN MORPHOMET, P251; [程暮林 CHENG Mulin], 2006, [应用数学和力学, Applied Mathematics and Mechanics], V27, P533; Crowson R. A., 1961, Entomologist's Monthly Magazine, V96, P158; CROWSON RA, 1973, J NAT HIST, V7, P225, DOI 10.1080/00222937300770181; CROWSON RA, 1955, NATURAL CLASSIFICATI; DOLIN V G, 1975, Zoologicheskii Zhurnal, V54, P1618; DUJARDIN JP, 2006, COV SOFTWARE VERSION; Emlen DJ, 2006, COLEOPTS BULL, V60, P47, DOI 10.1649/0010-065X(2006)60[47:PEFAAB]2.0.CO;2; Evans MR, 2004, AM NAT, V163, P341, DOI 10.1086/381770; Forbes W. T. M., 1922, Annals of the Entomological Society of America, V15, P328; Forgie SA, 2006, MOL PHYLOGENET EVOL, V40, P662, DOI 10.1016/j.ympev.2006.04.018; GOLOBOFF P, 1995, NONA VERSION 2 0; Goodall C., 1987, Computer Science and Statistics: Proceedings of the 19th Symposium on the Interface, P86; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Halffter G., 1982, Publicaciones Instituto de Ecologia Mexico, P1; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; Hanski I., 1991, pi; HEDENSTROM A, 1992, P ROY SOC B-BIOL SCI, V247, P183, DOI 10.1098/rspb.1992.0026; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; IABLOKOFF-KHNZORIAN S M, 1977, Entomologische Abhandlungen (Dresden), V41, P135; Johansson F, 2009, BIOL J LINN SOC, V97, P362, DOI 10.1111/j.1095-8312.2009.01211.x; Kaboli M, 2007, IBIS, V149, P792, DOI 10.1111/j.1474-919X.2007.00714.x; KRELL FT, 2006, COLEOPTERISTS SOC MO, V5, P120; KUKALOVAPECK J, 1993, CAN ENTOMOL, V125, P181, DOI 10.4039/Ent125181-2; LAPOINTE FJ, 1992, SYST BIOL, V41, P378, DOI 10.2307/2992574; LOMMEN ST, 2009, EVOL DEV, V11; LUZZATTO M, 1994, THESIS U STUDI PAVIA; Maddison W, MESQUITE MODULAR SYS; MANTEL N, 1967, CANCER RES, V27, P209; MARCHETTI K, 1995, J AVIAN BIOL, V26, P177, DOI 10.2307/3677316; MARCUS LF, 1993, CONTRIHUTIONS TOMORP; Miller LA, 2001, AM ZOOL, V41, P1648; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V45, P674, DOI 10.1016/j.ympev.2007.06.009; Montreuil O, 1998, ANN SOC ENTOMOL FR, V34, P135; Nixon K. C., 1999, WINCLADA VERSION 1 0; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Philips TK, 2004, INVERTEBR SYST, V18, P53, DOI 10.1071/IS03030; Pretorius E, 2001, BIOL J LINN SOC, V74, P35, DOI 10.1111/j.1095-8312.2001.tb01375.x; Rohlf, 2007, NTSYS PC NUMERICAL T; Rohlf F.J., 1993, CONTRIBUTIONS MORPHO, P131; Rohlf F.J., 2003, TPS SMALL VERSION 1; Rohlf F. J., 2018, TPSUTIL VERSION 1 76; Rohlf F. J., 2006, TPS DIG DIGITIZE LAN; Rohlf FJ, 2006, TPS RELW RELATIVE WA; ROHLF FJ, 1990, ORDINATIONS STUDY MO; Rohlf FJ, 2004, TPS SPLIN THIN PLATE; *SCARABNET, 2009, SCARABNET GLOB TAX D; SCHOLTZ CH, 1990, J NAT HIST, V24, P1027, DOI 10.1080/00222939000770631; SOKAL RR, 1979, SYST ZOOL, V28, P227, DOI 10.2307/2412528; Stiles FG, 2005, AUK, V122, P872, DOI 10.1642/0004-8038(2005)122[0872:WMAFBO]2.0.CO;2; Toomey J, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2956372; Villalba S, 2002, J MOL EVOL, V55, P116, DOI 10.1007/s00239-002-2314-4; Voelker G, 2001, BIOL J LINN SOC, V73, P425, DOI 10.1111/j.1095-8312.2001.tb01371.x; Yang Xing-ke, 1994, P102; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zunino M., 1984, Bulletin de la Societe Entomologique de France, V88, P531; ZUNINO M, 1985, Folia Entomologica Mexicana, P101; ZUNINO M, 1984, B MUSEO REGIONALE SC, V2, P445	69	37	50	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21600	10.1371/journal.pone.0021600	http://dx.doi.org/10.1371/journal.pone.0021600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738727	Green Submitted, gold, Green Published			2022-12-25	WOS:000292092600060
J	Lightfoot, YL; Chen, J; Mathews, CE				Lightfoot, Yaima L.; Chen, Jing; Mathews, Clayton E.			Role of the Mitochondria in Immune-Mediated Apoptotic Death of the Human Pancreatic beta Cell Line beta Lox5	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; DEPENDENT DIABETES-MELLITUS; CYTOKINE-INDUCED INHIBITION; IFN-GAMMA; HUMAN ISLETS; INDEPENDENT PATHWAYS; INSULINOMA CELLS; CYTOCHROME-C; FACTOR AIF; TNF-ALPHA	Mitochondria are indispensable in the life and death of many types of eukaryotic cells. In pancreatic beta cells, mitochondria play an essential role in the secretion of insulin, a hormone that regulates blood glucose levels. Unregulated blood glucose is a hallmark symptom of diabetes. The onset of Type 1 diabetes is preceded by autoimmune-mediated destruction of beta cells. However, the exact role of mitochondria has not been assessed in beta cell death. In this study, we examine the role of mitochondria in both Fas- and proinflammatory cytokine-mediated destruction of the human beta cell line, beta Lox5. IFN gamma primed beta Lox5 cells for apoptosis by elevating cell surface Fas. Consequently, beta Lox5 cells were killed by caspase-dependent apoptosis by agonistic activation of Fas, but only after priming with IFN gamma. This beta cell line undergoes both apoptotic and necrotic cell death after incubation with the combination of the proinflammatory cytokines IFN gamma and TNF alpha. Additionally, both caspase-dependent and -independent mechanisms that require proper mitochondrial function are involved. Mitochondrial contributions to beta Lox5 cell death were analyzed using mitochondrial DNA (mtDNA) depleted beta Lox5 cells, or beta Lox5 rho(0) cells. beta Lox5 rho(0) cells are not sensitive to IFN gamma and TNF alpha killing, indicating a direct role for the mitochondria in cytokine-induced cell death of the parental cell line. However, beta Lox5 rho(0) cells are susceptible to Fas killing, implicating caspase-dependent extrinsic apoptotic death is the mechanism by which these human beta cells die after Fas ligation. These data support the hypothesis that immune mediators kill beta Lox5 cells by both mitochondrial-dependent intrinsic and caspase-dependent extrinsic pathways.	[Lightfoot, Yaima L.; Chen, Jing; Mathews, Clayton E.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Lightfoot, YL (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	clayton.mathews@pathology.ufl.edu			University of Florida; National Institutes of Health [DK074656]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK074656, R01DK074656] Funding Source: NIH RePORTER	University of Florida(University of Florida); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a University of Florida Experimental Pathology Innovative Grant Award (JC) and a grant from the National Institutes of Health [DK074656 (CEM)]. YL was funded by a supplement for diversity from the National Institutes of Health to DK074656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani A, 2000, J CLIN INVEST, V105, P459, DOI 10.1172/JCI8185; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Andersson AK, 2001, BIOCHEM BIOPH RES CO, V281, P396, DOI 10.1006/bbrc.2001.4361; Augstein P, 2004, J AUTOIMMUN, V23, P301, DOI 10.1016/j.jaut.2004.09.006; Augstein P, 2008, DIABETES VASC DIS RE, V5, P198, DOI 10.3132/dvdr.2008.032; Ball AJ, 2007, BIOCHEM BIOPH RES CO, V355, P331, DOI 10.1016/j.bbrc.2007.01.153; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Baroni MG, 1999, J ENDOCRINOL, V161, P59, DOI 10.1677/joe.0.1610059; BELLMANN K, 1995, J CLIN INVEST, V95, P2840, DOI 10.1172/JCI117989; Bellmann K, 1996, FEBS LETT, V391, P185, DOI 10.1016/0014-5793(96)00730-2; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Bottino R, 2002, DIABETES, V51, P2561, DOI 10.2337/diabetes.51.8.2561; Burkart V, 2000, J BIOL CHEM, V275, P19521, DOI 10.1074/jbc.M002265200; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Cavallo MG, 1996, J ENDOCRINOL, V150, P113, DOI 10.1677/joe.0.1500113; CETKOVICCVRLJE M, 1994, CYTOKINE, V6, P399, DOI 10.1016/1043-4666(94)90064-7; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chen J, 2006, DIABETES RES CLIN PR, V74, P148, DOI 10.1016/j.diabres.2006.03.024; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1993, BIOCHEMISTRY-US, V32, P13767, DOI 10.1021/bi00213a002; Cunha-Oliveira T, 2006, BRAIN RES, V1089, P44, DOI 10.1016/j.brainres.2006.03.061; Dai T, 2009, ENDOCRINOLOGY, V150, P3031, DOI 10.1210/en.2008-0732; Demeterco C, 2002, J CLIN ENDOCR METAB, V87, P3475, DOI 10.1210/jc.87.7.3475; Domingues AF, 2008, NEUROTOX RES, V13, P31, DOI 10.1007/BF03033365; Dorff G, 2002, BIOL CHEM, V383, P1357, DOI 10.1515/BC.2002.154; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Foulis AK, 2008, NOVART FDN SYMP, V292, P202; Foulis AK, 2008, NOVART FDN SYMP, V292, P13; Foulis AK, 2008, NOVART FDN SYMP, V292, P122; Foulis Alan K, 2008, Novartis Found Symp, V292, P2; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864; Hanafusa T, 2008, ANN NY ACAD SCI, V1150, P297, DOI 10.1196/annals.1447.052; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Imagawa A, 2001, DIABETES, V50, P1269, DOI 10.2337/diabetes.50.6.1269; Itkin-Ansari P, 2000, MOL ENDOCRINOL, V14, P814, DOI 10.1210/me.14.6.814; Itkin-Ansari P, 2003, ANN NY ACAD SCI, V1005, P138, DOI 10.1196/annals.1288.015; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Johannesen J, 2003, AUTOIMMUNITY, V36, P167, DOI 10.1080/0891693031000101288; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Li JH, 2005, J IMMUNOL, V175, P1858, DOI 10.4049/jimmunol.175.3.1858; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Macfarlane WM, 1997, FEBS LETT, V413, P304, DOI 10.1016/S0014-5793(97)00874-0; Mathews CE, 2005, J IMMUNOL, V175, P1248, DOI 10.4049/jimmunol.175.2.1248; Mathews CE, 2005, PEDIATR DIABETES, V6, P165, DOI 10.1111/j.1399-543X.2005.00123.x; Monetini L, 1999, AUTOIMMUNITY, V29, P171, DOI 10.3109/08916939908998532; Moriwaki M, 1999, DIABETOLOGIA, V42, P1332, DOI 10.1007/s001250051446; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; Ou D, 2005, HUM IMMUNOL, V66, P799, DOI 10.1016/j.humimm.2005.03.009; Ou D, 2002, DIABETOLOGIA, V45, P1678, DOI 10.1007/s00125-002-0926-2; Ou DW, 2006, CELL TRANSPLANT, V15, P399, DOI 10.3727/000000006783981837; Ou DW, 2005, HUM IMMUNOL, V66, P274, DOI 10.1016/j.humimm.2004.12.002; Ou DW, 2002, HUM IMMUNOL, V63, P256, DOI 10.1016/S0198-8859(02)00372-5; RABINOVITCH A, 1994, J CLIN ENDOCR METAB, V79, P1058, DOI 10.1210/jc.79.4.1058; Rabinovitch A, 1998, DIABETES METAB REV, V14, P129, DOI 10.1002/(SICI)1099-0895(199806)14:2<129::AID-DMR208>3.0.CO;2-V; RABINOVITCH A, 1990, J CLIN ENDOCR METAB, V71, P152, DOI 10.1210/jcem-71-1-152; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scarim AL, 1998, ENDOCRINOLOGY, V139, P5050, DOI 10.1210/en.139.12.5050; SOLDEVILA G, 1991, J AUTOIMMUN, V4, P291, DOI 10.1016/0896-8411(91)90025-8; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Stephens LA, 1997, J AUTOIMMUN, V10, P293, DOI 10.1006/jaut.1997.0133; Stephens LA, 1999, ENDOCRINOLOGY, V140, P3219, DOI 10.1210/en.140.7.3219; Su X, 2000, J IMMUNOL, V164, P2523, DOI 10.4049/jimmunol.164.5.2523; Suarez-Pinzon WL, 2000, DIABETOLOGIA, V43, P1149, DOI 10.1007/s001250051506; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Thomas HE, 2004, DIABETES, V53, P113, DOI 10.2337/diabetes.53.1.113; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Wang S, 1997, TRANSPLANT P, V29, P2219, DOI 10.1016/S0041-1345(97)00306-0; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904; Zumsteg U, 2000, DIABETES, V49, P39, DOI 10.2337/diabetes.49.1.39	77	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20617	10.1371/journal.pone.0020617	http://dx.doi.org/10.1371/journal.pone.0020617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738580	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600005
J	Guo, SC; Gonzalez-Perez, RR				Guo, Shanchun; Gonzalez-Perez, Ruben R.			Notch, IL-1 and Leptin Crosstalk Outcome (NILCO) Is Critical for Leptin-Induced Proliferation, Migration and VEGF/VEGFR-2 Expression in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR; ESTROGEN-RECEPTOR; SIGNALING PATHWAY; MAMMARY-TUMORS; ENDOTHELIAL-CELLS; FEMALE MICE; KAPPA-B; TRANSACTIVATION; ANGIOGENESIS; INVASIVENESS	High levels of pro-angiogenic factors, leptin, IL-1, Notch and VEGF (ligands and receptors), are found in breast cancer, which is commonly correlated with metastasis and lower survival of patients. We have previously reported that leptin induces the growth of breast cancer and the expression of VEGF/VEGFR-2 and IL-1 system. We hypothesized that Notch, IL-1 and leptin crosstalk outcome (NILCO) plays an essential role in the regulation of leptin-mediated induction of proliferation/migration and expression of pro-angiogenic molecules in breast cancer. To test this hypothesis, leptin's effects on the expression and activation of Notch signaling pathway and VEGF/VEGFR-2/IL-1 were determined in mouse (4T1, EMT6 and MMT) breast cancer cells. Remarkably, leptin up-regulated Notch1-4/JAG1/Dll-4, Notch target genes: Hey2 and survivin, together with IL1 and VEGF/VEGFR-2. RNA knockdown and pharmacological inhibitors of leptin signaling significantly abrogated activity of reporter gene-luciferase CSL (RBP-Jk) promoter, showing that it was linked to leptin-activated JAK2/STAT3, MAPK, PI-3K/mTOR, p38 and JNK signaling pathways. Interestingly, leptin upregulatory effects on cell proliferation/migration and c factors Notch, IL-1 and VEGF/VEGFR-2 were abrogated by a gamma-secretase inhibitor, DAPT, as well as siRNA against CSL. In addition, blockade of IL-1R tI inhibited leptin-induced Notch, Hey2 and survivin as well as VEGF/VEGFR-2 expression. These data suggest leptin is an inducer of Notch (expression/activation) and IL-1 signaling modulates leptin effects on Notch and VEGF/VEGFR-2. We show for the first time that a novel unveiled crosstalk between Notch, IL-1 and leptin (NILCO) occurs in breast cancer. Leptin induction of proliferation/migration and upregulation of VEGF/VEGFR-2 in breast cancer cells were related to an intact Notch signaling axis. NILCO could represent the integration of developmental, pro-inflammatory and proangiogenic signals critical for leptin-induced cell proliferation/migration and regulation of VEGF/VEGFR-2 in breast cancer. Targeting NILCO might help to design new pharmacological strategies aimed at controlling breast cancer growth and angiogenesis.	[Guo, Shanchun; Gonzalez-Perez, Ruben R.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Guo, SC (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	rgonzalez@msm.edu			National Institutes of Health/National Cancer Institute [1SC1CA138658-03]; Georgia Cancer Coalition Distinguished Cancer Scholar Award; Morehouse School of Medicine [NIH RR03034, 1C06 RR18386]; NATIONAL CANCER INSTITUTE [SC1CA138658] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018386] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Cancer Scholar Award; Morehouse School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This investigation was partially funded by grants from the National Institutes of Health/National Cancer Institute 1SC1CA138658-03; the Georgia Cancer Coalition Distinguished Cancer Scholar Award to RRG-P, and facilities and support services at Morehouse School of Medicine (NIH RR03034 and 1C06 RR18386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, ONCOGENE, V27, P6276, DOI 10.1038/onc.2008.303; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Artwohl M, 2002, INT J OBESITY, V26, P577, DOI 10.1038/sj.ijo.0801947; Bartella V, 2008, CANCER RES, V68, P4919, DOI 10.1158/0008-5472.CAN-08-0642; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Carino C, 2008, INT J CANCER, V123, P2782, DOI 10.1002/ijc.23887; Catalano S, 2004, J BIOL CHEM, V279, P19908, DOI 10.1074/jbc.M313191200; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Cleary MP, 2004, EXP BIOL MED, V229, P182, DOI 10.1177/153537020422900207; Cleary MP, 2003, BREAST CANCER RES TR, V77, P205, DOI 10.1023/A:1021891825399; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Eisenberg A, 2004, FEBS LETT, V565, P139, DOI 10.1016/j.febslet.2004.03.089; Garofalo C, 2004, CLIN CANCER RES, V10, P6466, DOI 10.1158/1078-0432.CCR-04-0203; Garonna E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018823; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Gonzalez RR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2321; Gonzalez-Perez RR, 2010, CELL SIGNAL, V22, P1350, DOI 10.1016/j.cellsig.2010.05.003; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Laud K, 2002, MOL CELL ENDOCRINOL, V188, P219, DOI 10.1016/S0303-7207(01)00678-5; MEHTA RS, 1993, CARCINOGENESIS, V14, P1693, DOI 10.1093/carcin/14.8.1693; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Miyoshi Y, 2006, INT J CANCER, V118, P1414, DOI 10.1002/ijc.21543; Nakopoulou L, 2002, HUM PATHOL, V33, P863, DOI 10.1053/hupa.2002.126879; O'Neill L A, 2000, Sci STKE, V2000, pre1; Okumura M, 2002, BBA-MOL CELL RES, V1592, P107, DOI 10.1016/S0167-4889(02)00276-8; Osipo C, 2008, LAB INVEST, V88, P11, DOI 10.1038/labinvest.3700700; Ray A, 2007, INT J ONCOL, V30, P1499; Ray A, 2010, EXPERT OPIN THER TAR, V14, P443, DOI 10.1517/14728221003716466; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Saxena NK, 2008, CANCER RES, V68, P9712, DOI 10.1158/0008-5472.CAN-08-1952; Soares R, 2004, MOL ENDOCRINOL, V18, P2333, DOI 10.1210/me.2003-0362; Soares R, 2003, ULTRASTRUCT PATHOL, V27, P33, DOI 10.1080/01913120309946; Soares Raquel, 2003, Angiogenesis, V6, P271, DOI 10.1023/B:AGEN.0000029413.32882.dd; Styer AK, 2008, ENDOCRINOLOGY, V149, P506, DOI 10.1210/en.2007-1225; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Whiteman MK, 2005, CANCER EPIDEM BIOMAR, V14, P2009, DOI 10.1158/1055-9965.EPI-05-0106; Zhou W, 2011, BRIT J CANCER, V104, P128, DOI 10.1038/sj.bjc.6606013	45	84	88	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21467	10.1371/journal.pone.0021467	http://dx.doi.org/10.1371/journal.pone.0021467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731759	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400041
J	Ogura, T				Ogura, Toshihiko			Three-Dimensional X-ray Observation of Atmospheric Biological Samples by Linear-Array Scanning-Electron Generation X-ray Microscope System	PLOS ONE			English	Article							CT IMAGE-RECONSTRUCTION; RHODOBACTER-CAPSULATUS; RESOLUTION; TOMOGRAPHY; PROJECTIONS; NANOSCALE; MOLECULES; CELLS	Recently, we developed a soft X-ray microscope called the scanning-electron generation X-ray microscope (SGXM), which consists of a simple X-ray detection system that detects X-rays emitted from the interaction between a scanning electron beam (EB) and the thin film of the sample mount. We present herein a three-dimensional (3D) X-ray detection system that is based on the SGXM technology and designed for studying atmospheric biological samples. This 3D X-ray detection system contains a linear X-ray photodiode (PD) array. The specimens are placed under a CuZn-coated Si(3)N(4) thin film, which is attached to an atmospheric sample holder. Multiple tilt X-ray images of the samples are detected simultaneously by the linear array of X-ray PDs, and the 3D structure is calculated by a new 3D reconstruction method that uses a simulated-annealing algorithm. The resulting 3D models clearly reveal the inner structure of the bacterium. In addition, the proposed method can easily be used for diverse samples in a broad range of scientific fields.	Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Ogura, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	t-ogura@aist.go.jp	Ogura, Toshihiko/M-4089-2018		Japan Society for the Promotion of Science [20300107]; Canon foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Canon foundation(Canon Foundation)	This study was supported by KAKENHI Grant-in-Aid for Scientific Research (B) (No. 20300107) of the Japan Society for the Promotion of Science, and the Canon foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FEF, 1999, FUZZY SET SYST, V103, P295, DOI 10.1016/S0165-0114(98)00229-2; Chao W, 2009, OPT EXPRESS, V17, P17669, DOI 10.1364/OE.17.017669; Chao WL, 2005, NATURE, V435, P1210, DOI 10.1038/nature03719; COSSLETT VE, 1953, J APPL PHYS, V24, P616, DOI 10.1063/1.1721338; de Smit E, 2008, NATURE, V456, P222, DOI 10.1038/nature07516; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; GORDON R, 1970, J THEOR BIOL, V29, P471, DOI 10.1016/0022-5193(70)90109-8; HANEISHI H, 1990, APPL OPTICS, V29, P259, DOI 10.1364/AO.29.000259; Jacobsen C, 1999, TRENDS CELL BIOL, V9, P44, DOI 10.1016/S0962-8924(98)01424-X; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139; Koshino M, 2007, SCIENCE, V316, P853, DOI 10.1126/science.1138690; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; LILBURN TG, 1992, BIOCHIM BIOPHYS ACTA, V1100, P160; Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Ogura T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/29/295501; Ogura T, 2010, BIOCHEM BIOPH RES CO, V391, P198, DOI 10.1016/j.bbrc.2009.11.031; Ogura T, 2009, BIOCHEM BIOPH RES CO, V385, P624, DOI 10.1016/j.bbrc.2009.05.107; Parkinson DY, 2008, J STRUCT BIOL, V162, P380, DOI 10.1016/j.jsb.2008.02.003; Sali A, 2003, NATURE, V422, P216, DOI 10.1038/nature01513; Shelswell KJ, 2005, J BACTERIOL, V187, P5040, DOI 10.1128/JB.187.14.5040-5043.2005; SMITH WE, 1983, OPT LETT, V8, P199, DOI 10.1364/OL.8.000199; Takahashi Y, 2010, NANO LETT, V10, P1922, DOI 10.1021/nl100891n; TOMIE T, 1991, SCIENCE, V252, P691, DOI 10.1126/science.2024121	29	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21516	10.1371/journal.pone.0021516	http://dx.doi.org/10.1371/journal.pone.0021516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731770	gold, Green Submitted, Green Published			2022-12-25	WOS:000292035400045
J	Xiao, F; Weng, JW; Fan, KN; Wang, WN				Xiao, Fei; Weng, Jingwei; Fan, Kangnian; Wang, Wenning			Detailed Regulatory Mechanism of the Interaction between ZO-1 PDZ2 and Connexin43 Revealed by MD Simulations	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; GAP-JUNCTION PROTEIN; TUMOR-SUPPRESSOR PROTEIN; ZONULA OCCLUDENS-1; MOLECULAR-DYNAMICS; DOMAIN PROTEINS; CHANNEL; BINDING; SITES; IDENTIFICATION	The gap junction protein connexin43 (Cx43) binds to the second PDZ domain of Zonula occludens-1 (ZO-1) through its C-terminal tail, mediating the regulation of gap junction plaque size and dynamics. Biochemical study demonstrated that the very C-terminal 12 residues of Cx43 are necessary and sufficient for ZO-1 PDZ2 binding and phosphorylation at residues Ser (-9) and Ser (-10) of the peptide can disrupt the association. However, only a crystal structure of ZO-1 PDZ2 in complex with a shorter 9 aa peptide of connexin43 was solved experimentally. Here, the interactions between ZO-1 PDZ2 and the short, long and phosphorylated Cx43 peptides were studied using molecular dynamics (MD) simulations and free energy calculation. The short peptide bound to PDZ2 exhibits large structural variations, while the extension of three upstream residues stabilizes the peptide conformation and enhanced the interaction. Phosphorylation at Ser(-9) significantly weakens the binding and results in conformational flexibility of the peptide. Glu210 of ZO-1 PDZ2 was found to be a key regulatory point in Cx43 binding and phosphorylation induced dissociation.	[Xiao, Fei; Fan, Kangnian; Wang, Wenning] Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China; [Weng, Jingwei; Wang, Wenning] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Xiao, F (corresponding author), Fudan Univ, Dept Chem, Shanghai Key Lab Mol Catalysis & Innovat Mat, Shanghai 200433, Peoples R China.	wnwang@fudan.edu.cn	Fan, K/GXH-3734-2022		National High Technology Research Program of China [2006AA02A320]; National Major Basic Research Program of China [2009CB918600, 2011CB808505]; National Science Foundation of China [20973040, 31070642]; Science & Technology Commission of Shanghai Municipality [08DZ2270500]; Shanghai Leading Academic Discipline Project [B108]	National High Technology Research Program of China(National High Technology Research and Development Program of China); National Major Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National High Technology Research Program of China (2006AA02A320), National Major Basic Research Program of China (2009CB918600, 2011CB808505), National Science Foundation of China (20973040, 31070642), Science & Technology Commission of Shanghai Municipality (08DZ2270500), and Shanghai Leading Academic Discipline Project (B108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoyev V, 2007, CELL SIGNAL, V19, P958, DOI 10.1016/j.cellsig.2006.11.007; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; FANNING AS, 1998, PROTEIN MODULES SIGN, P209; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Hansson T, 1997, J MOL BIOL, V265, P118, DOI 10.1006/jmbi.1996.0716; HEMMING NJ, 1995, J BIOL CHEM, V270, P5360, DOI 10.1074/jbc.270.10.5360; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; PEARLMAN DA, 1994, J PHYS CHEM-US, V98, P1487, DOI 10.1021/j100056a020; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Saras J, 1996, TRENDS BIOCHEM SCI, V21, P455, DOI 10.1016/S0968-0004(96)30044-3; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Staneva I, 2009, J MOL BIOL, V393, P1118, DOI 10.1016/j.jmb.2009.08.063; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; van Zeijl L, 2007, J CELL BIOL, V177, P881, DOI 10.1083/jcb.200610144; WILLOTT E, 1993, P NATL ACAD SCI USA, V90, P7834, DOI 10.1073/pnas.90.16.7834; WOODS DF, 1993, MECH DEVELOP, V44, P85, DOI 10.1016/0925-4773(93)90059-7; Yogo K, 2002, FEBS LETT, V531, P132, DOI 10.1016/S0014-5793(02)03441-5; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	48	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21527	10.1371/journal.pone.0021527	http://dx.doi.org/10.1371/journal.pone.0021527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731774	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400049
J	Huang, H; Shen, JK; Vinores, SA				Huang, Hu; Shen, Jikui; Vinores, Stanley A.			Blockade of VEGFR1 and 2 Suppresses Pathological Angiogenesis and Vascular Leakage in the Eye	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; CHOROIDAL NEOVASCULARIZATION; MACULAR DEGENERATION; PERMEABILITY FACTOR; TUMOR ANGIOGENESIS; MOUSE MODEL; EXPRESSION; HYPOXIA; INHIBITION	Objective: VEGFR1 and 2 signaling have both been increasingly shown to mediate complications of ischemic retinopathies, including retinopathy of prematurity (ROP), age-related macular degeneration (AMD), and diabetic retinopathy (DR). This study evaluates the effects of blocking VEGFR1 and 2 on pathological angiogenesis and vascular leakage in ischemic retinopathy in a model of ROP and in choroidal neovascularization (CNV) in a model of AMD. Materials and Methods: Neutralizing antibodies specific for mouse VEGFR1 (MF1) and VEGFR2 (DC101) were administrated systemically. CNV was induced by laser photocoagulation and assessed 14d after laser treatment. Retinal NV was generated in oxygen-induced ischemic retinopathy (OIR) and assessed at p17. NV quantification was determined by measuring NV tufts and vascular leakage was quantified by measuring [H-3]-mannitol leakage from blood vessels into the retina. Gene expression was measured by real-time quantitative (Q) PCR. Results: VEGFR1 and VEGFR2 expressions were up-regulated during CNV pathogenesis. Both MF1 and DC101 significantly suppressed CNV at 50 mg/kg: DC101 suppressed CNV by 73 +/- 5% (p<0.0001) and MF1 by 64 +/- 6% (p = 0.0002) in a dosage-dependent manner. The combination of MF1 and DC101 enhanced the inhibitory efficacy and resulted in an accumulation of retinal microglia at the CNV lesion. Similarly, both MF1 and DC101 significantly suppressed retinal NV in OIR at 50 mg/kg: DC101 suppressed retinal NV by 54 +/- 8% (p = 0.013) and MF1 by 50 +/- 7% (p<0.0002). MF1 was even more effective at inhibiting ischemia-induced BRB breakdown than DC101: the retina/lung leakage ratio for MF1 was reduced by 73 +/- 24%, p = 0.001 and for DC101 by 12 +/- 4%, p = 0.003. The retina/renal leakage ratio for MF1 was reduced by 52 +/- 28%, p = 0.009 and for DC101 by 13 +/- 4%, p = 0.001. Conclusion: Our study provides further evidence that both VEGFR1 and 2 mediate pathological angiogenesis and vascular leakage in these models of ocular disease and suggests that antagonist antibodies to these receptor tyrosine kinases (RTKs) are potential therapeutic agents.	[Huang, Hu; Shen, Jikui; Vinores, Stanley A.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Huang, H (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	svinores@jhmi.edu			National Eye Institute [EY017164]; Lilly/ImClone; Wilmer Eye Institute; NIH [P30EY1765]; NATIONAL EYE INSTITUTE [R01EY017164, P30EY001765] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Lilly/ImClone(Eli Lilly); Wilmer Eye Institute(Johns Hopkins University); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study was supported by NIH grant EY017164 from the National Eye Institute and a stipend from Lilly/ImClone (S. A. V.), The Louise L. Sloan Research Grant Award from Wilmer Eye Institute (H. H.), ARVO Travel Grant from the National Eye Institute (H. H.), and NIH core grant P30EY1765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest. A stipend was received from Lilly/ImClone as part of a Sponsored Research Agreement to partially support this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Brown JL, 2010, MOL CANCER THER, V9, P145, DOI 10.1158/1535-7163.MCT-09-0554; Caicedo A, 2005, EXP EYE RES, V81, P38, DOI 10.1016/j.exer.2005.01.013; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chappelow AV, 2008, DRUGS, V68, P1029, DOI 10.2165/00003495-200868080-00002; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Chen L, 2002, OCUL IMMUNOL INFLAMM, V10, P27, DOI 10.1076/ocii.10.1.27.10328; COLTON CA, 1992, J HISTOCHEM CYTOCHEM, V40, P505, DOI 10.1177/40.4.1372634; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Derevjanik NL, 2002, INVEST OPHTH VIS SCI, V43, P2462; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Dixon JA, 2009, EXPERT OPIN INV DRUG, V18, P1573, DOI 10.1517/13543780903201684; DOR Y, 2000, TRENDS CARDIOVAS MED, V7, P289; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Ferrara N, 2010, CYTOKINE GROWTH F R, V21, P21, DOI 10.1016/j.cytogfr.2009.11.003; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fu YL, 2007, INVEST OPHTH VIS SCI, V48, P5184, DOI 10.1167/iovs.07-0469; Guerin E, 2008, MICROVASC RES, V75, P302, DOI 10.1016/j.mvr.2007.12.001; Hackett SF, 2000, J CELL PHYSIOL, V184, P275, DOI 10.1002/1097-4652(200009)184:3<275::AID-JCP1>3.3.CO;2-Z; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Huang H, 2005, EXP EYE RES, V80, P727, DOI 10.1016/j.exer.2004.11.019; Huang H, 2008, DEV DYNAM, V237, P286, DOI 10.1002/dvdy.21408; Huang H, 2010, INVEST OPHTH VIS SCI, V51, P5825, DOI 10.1167/iovs.10-5576; Kumar A, 2010, J BIOL CHEM, V285, P15500, DOI 10.1074/jbc.M110.113787; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; MALECAZE F, 1994, ARCH OPHTHALMOL-CHIC, V112, P1476, DOI 10.1001/archopht.1994.01090230090028; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; MILLER JW, 1994, AM J PATHOL, V145, P574; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273; Okamoto N, 1997, AM J PATHOL, V151, P281; PEER J, 1995, LAB INVEST, V72, P638; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Prewett M, 1999, CANCER RES, V59, P5209; Rakic JM, 2003, INVEST OPHTH VIS SCI, V44, P3186, DOI 10.1167/iovs.02-1092; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; Rockwell Patricia, 1995, Molecular and Cellular Differentiation, V3, P315; ROQUE RS, 1993, CURR EYE RES, V12, P285, DOI 10.3109/02713689308999475; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Schlingemann RO, 2009, PROG BRAIN RES, V175, P253, DOI 10.1016/S0079-6123(09)17517-9; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Semenza GL, 1998, CHEST, V114, p40S, DOI 10.1378/chest.114.1_Supplement.40S; SEMKOVA I, 2010, INVEST OPHT IN PRESS; Sengupta N, 2010, INVEST OPHTH VIS SCI, V51, P2697, DOI 10.1167/iovs.09-4137; Shen JK, 2007, INVEST OPHTH VIS SCI, V48, P4335, DOI 10.1167/iovs.07-0113; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Tunon J, 2009, SURV OPHTHALMOL, V54, P339, DOI 10.1016/j.survophthal.2009.02.003; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Verbeke G., 2000, LINEAR MIXED MODELS, P568; Vinores SA, 2006, J CELL PHYSIOL, V206, P749, DOI 10.1002/jcp.20525; VINORES SA, 2007, ANGIOGENESIS BASIC S, P467; VINORES SA, 2002, GEN PHARMACOL, V35, P233; Wang ES, 2004, BLOOD, V104, P2893, DOI 10.1182/blood-2004-01-0226; Wang JJ, 2010, DIABETES, V59, P2297, DOI 10.2337/db09-1420; Witmer AN, 2002, INVEST OPHTH VIS SCI, V43, P849; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; Zhong XF, 2011, MOL VIS, V17, P492	67	76	85	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21411	10.1371/journal.pone.0021411	http://dx.doi.org/10.1371/journal.pone.0021411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731737	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700080
J	Sena, G; Frentz, Z; Birnbaum, KD; Leibler, S				Sena, Giovanni; Frentz, Zak; Birnbaum, Kenneth D.; Leibler, Stanislas			Quantitation of Cellular Dynamics in Growing Arabidopsis Roots with Light Sheet Microscopy	PLOS ONE			English	Article							RECONSTRUCTION; TRACKING	To understand dynamic developmental processes, living tissues have to be imaged frequently and for extended periods of time. Root development is extensively studied at cellular resolution to understand basic mechanisms underlying pattern formation and maintenance in plants. Unfortunately, ensuring continuous specimen access, while preserving physiological conditions and preventing photo-damage, poses major barriers to measurements of cellular dynamics in growing organs such as plant roots. We present a system that integrates optical sectioning through light sheet fluorescence microscopy with hydroponic culture that enables us to image, at cellular resolution, a vertically growing Arabidopsis root every few minutes and for several consecutive days. We describe novel automated routines to track the root tip as it grows, to track cellular nuclei and to identify cell divisions. We demonstrate the system's capabilities by collecting data on divisions and nuclear dynamics.	[Sena, Giovanni; Birnbaum, Kenneth D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Frentz, Zak; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	New York University; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	Sena, G (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	senag@nyu.edu	Sena, Giovanni/C-3297-2012	Sena, Giovanni/0000-0003-3626-5038	National Institutes of Health [R01 GM078279]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.D.B. is supported by a grant from the National Institutes of Health (R01 GM078279; http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin TI, 2000, PLANT MOL BIOL, V43, P545, DOI 10.1023/A:1006383921517; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Campilho A, 2006, PLANT J, V48, P619, DOI 10.1111/j.1365-313X.2006.02892.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chickarmane V, 2010, ANNU REV PLANT BIOL, V61, P65, DOI 10.1146/annurev-arplant-042809-112213; Dzyubachyk O, 2007, I S BIOMED IMAGING, P97, DOI 10.1109/ISBI.2007.356797; Fernandez R, 2010, NAT METHODS, V7, P547, DOI [10.1038/nmeth.1472, 10.1038/NMETH.1472]; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Fuchs E, 2002, OPT EXPRESS, V10, P145, DOI 10.1364/OE.10.000145; GOR V, 2005, IEEE COMP SOC C COMP; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; HOLMES TJ, 1988, J OPT SOC AM A, V5, P666, DOI 10.1364/JOSAA.5.000666; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Karp R. M, 1972, REDUCIBILITY COMBINA, P85; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller PJ, 2010, NAT METHODS, V7, P637, DOI [10.1038/NMETH.1476, 10.1038/nmeth.1476]; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Liu M, 2010, PLANT J, V62, P135, DOI 10.1111/j.1365-313X.2009.04117.x; Lucas Bruce D, 1981, P 7 INT JOINT C ART, DOI DOI 10.1042/CS0730285; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; PAWLEY JB, 2006, HDB BIOL CONFOCAL MI, P985; Pawley JB, 2006, HDB BIOL CONFOCAL MI, p[xxviii, 985]; Petricka JJ, 2008, CURR OPIN GENET DEV, V18, P354, DOI 10.1016/j.gde.2008.05.001; Sena G, 2009, NATURE, V457, P1150, DOI 10.1038/nature07597; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017	28	60	60	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21303	10.1371/journal.pone.0021303	http://dx.doi.org/10.1371/journal.pone.0021303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731697	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700059
J	Shoji, M; Sato, K; Yukitake, H; Kondo, Y; Narita, Y; Kadowaki, T; Naito, M; Nakayama, K				Shoji, Mikio; Sato, Keiko; Yukitake, Hideharu; Kondo, Yoshio; Narita, Yuka; Kadowaki, Tomoko; Naito, Mariko; Nakayama, Koji			Por Secretion System-Dependent Secretion and Glycosylation of Porphyromonas gingivalis Hemin-Binding Protein 35	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; GRAM-NEGATIVE BACTERIA; OUTER-MEMBRANE PROTEIN; C-TERMINAL-DOMAIN; ESCHERICHIA-COLI; STRUCTURAL-ANALYSIS; BIOFILM FORMATION; LIPOPOLYSACCHARIDE; GINGIPAINS; MUTANTS	The anaerobic Gram-negative bacterium Porphyromonas gingivalis is a major pathogen in severe forms of periodontal disease and refractory periapical perodontitis. We have recently found that P. gingivalis has a novel secretion system named the Por secretion system (PorSS), which is responsible for secretion of major extracellular proteinases, Arg-gingipains (Rgps) and Lys-gingipain. These proteinases contain conserved C-terminal domains (CTDs) in their C-termini. Hemin-binding protein 35 (HBP35), which is one of the outer membrane proteins of P. gingivalis and contributes to its haem utilization, also contains a CTD, suggesting that HBP35 is translocated to the cell surface via the PorSS. In this study, immunoblot analysis of P. gingivalis mutants deficient in the PorSS or in the biosynthesis of anionic polysaccharide-lipopolysaccharide (A-LPS) revealed that HBP35 is translocated to the cell surface via the PorSS and is glycosylated with A-LPS. From deletion analysis with a GFP-CTD[ HBP35] green fluorescent protein fusion, the C-terminal 22 amino acid residues of CTD[HBP35] were found to be required for cell surface translocation and glycosylation. The GFP-CTD fusion study also revealed that the CTDs of CPG70, peptidylarginine deiminase, P27 and RgpB play roles in PorSS-dependent translocation and glycosylation. However, CTD-region peptides were not found in samples of glycosylated HBP35 protein by peptide map fingerprinting analysis, and antibodies against CTD-regions peptides did not react with glycosylated HBP35 protein. These results suggest both that the CTD region functions as a recognition signal for the PorSS and that glycosylation of CTD proteins occurs after removal of the CTD region. Rabbits were used for making antisera against bacterial proteins in this study.	[Shoji, Mikio; Sato, Keiko; Yukitake, Hideharu; Narita, Yuka; Kadowaki, Tomoko; Naito, Mariko; Nakayama, Koji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 852, Japan; [Kondo, Yoshio] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pediat Dent, Nagasaki 852, Japan; [Nakayama, Koji] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Shoji, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Microbiol & Oral Infect, Nagasaki 852, Japan.	knak@nagasaki-u.ac.jp	Shoji, Mikio/J-8283-2018	Shoji, Mikio/0000-0002-7605-4721; NAITO, Mariko/0000-0003-0769-7747	Ministry of Education, Science, Sports, Culture, and Technology, Japan [20249073, 20791341]; Nagasaki University; Nagasaki University, Japan; Grants-in-Aid for Scientific Research [21592364] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagasaki University; Nagasaki University, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid (20249073 and 20791341 to KN and MS, respectively) for scientific research from the Ministry of Education, Science, Sports, Culture, and Technology, Japan; by the Global COE Program at Nagasaki University to KN; and in part by the president's discretionary fund of Nagasaki University, Japan to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIKO Y, 1990, ARCH ORAL BIOL, V35, P689, DOI 10.1016/0003-9969(90)90091-N; Aduse-Opoku J, 2006, INFECT IMMUN, V74, P449, DOI 10.1128/IAI.74.1.449-460.2006; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Chen YY, 2002, J BIOL CHEM, V277, P23433, DOI 10.1074/jbc.M200811200; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; Delgado-Partin VM, 1998, J BIOL CHEM, V273, P9927, DOI 10.1074/jbc.273.16.9927; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Genco CA, 1999, CLIN INFECT DIS, V28, P456, DOI 10.1086/515156; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x; Ito K, 2006, J MOL BIOL, V362, P228, DOI 10.1016/j.jmb.2006.06.083; Kondo Y, 2010, INFECT IMMUN, V78, P2846, DOI 10.1128/IAI.01448-09; Lepine G, 1996, INFECT IMMUN, V64, P1467; LEPINE G, 1995, ORAL MICROBIOL IMMUN, V10, P1, DOI 10.1111/j.1399-302X.1995.tb00110.x; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; MULVEY MR, 1988, GENE, V73, P337, DOI 10.1016/0378-1119(88)90498-2; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nakao R, 2008, BIOCHEM BIOPH RES CO, V365, P784, DOI 10.1016/j.bbrc.2007.11.035; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Paramonov NA, 2009, J BACTERIOL, V191, P5272, DOI 10.1128/JB.00019-09; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Saiki K, 2007, MICROBIOL IMMUNOL, V51, P483, DOI 10.1111/j.1348-0421.2007.tb03936.x; Saito S, 1997, GEN PHARMACOL, V28, P675, DOI 10.1016/S0306-3623(96)00366-7; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Sato K, 2009, MICROBIOL-SGM, V155, P1282, DOI 10.1099/mic.0.025163-0; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; Shoji M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-152; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Slaney JM, 2006, INFECT IMMUN, V74, P5352, DOI 10.1128/IAI.00304-06; Vanterpool E, 2005, INFECT IMMUN, V73, P3971, DOI 10.1128/IAI.73.7.3971-3982.2005; Vanterpool E, 2005, INFECT IMMUN, V73, P1357, DOI 10.1128/IAI.73.3.1357-1366.2005; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Yamaguchi M, 2010, INFECT IMMUN, V78, P3801, DOI 10.1128/IAI.00071-10; Zeituni AE, 2010, J BACTERIOL, V192, P4103, DOI 10.1128/JB.00275-10	45	108	110	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21372	10.1371/journal.pone.0021372	http://dx.doi.org/10.1371/journal.pone.0021372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731719	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700068
J	Fleisig, HB; Wong, JMY				Fleisig, H. B.; Wong, J. M. Y.			Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed human cells	ONCOGENE			English	Article						telomerase; cell cycle; growth kinetics	CANCER-CELLS; DNA-DAMAGE; IONIZING-RADIATION; CATALYTIC SUBUNIT; IN-VIVO; HUMAN-FIBROBLASTS; ENZYME-ACTIVITY; MAINTENANCE; EXPRESSION; RECOMBINATION	Constitutive telomerase activity maintains telomere length and confers immortal phenotypes to human cancers. The prevalence of telomerase, rather than a homologous recombination-based mechanism, in telomere length maintenance suggests that telomerase also has auxiliary roles in tumorigenesis. Here, we investigate growth advantages provided by the telomerase enzyme in oncogene-transformed human cells that do not require telomerase activity for telomere length control. Our data suggest that in oncogene-transformed cells, telomerase activity accelerates cell growth kinetics in a cell cycle phase-specific manner and promotes anchorage-independent growth. Coculture experiments demonstrated that this growth advantage conferred by telomerase activity is not due to increased cellular cross-talk. Growth advantages provided by telomerase required all functional aspects of the enzyme. Dissociation-of-activity-in-telomerase mutants and other functionally defective versions of telomerase were unable to promote oncogene-transformed cell growth, suggesting that canonical telomerase activities may be involved. We conclude that telomerase provides advantages to oncogene-transformed human cells, thereby supporting the development of telomerase-based anticancer chemotherapies targeting these growth-promoting effects. Oncogene (2012) 31, 954-965; doi:10.1038/onc.2011.292; published online 11 July 2011	[Fleisig, H. B.; Wong, J. M. Y.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Wong, JMY (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, 2146 East Mall, Vancouver, BC V6T 1Z3, Canada.	judy.wong@ubc.ca	Wong, Judy/AAG-1868-2021	Wong, Judy/0000-0001-5572-4143	Canadian Cancer Society Research Institute [019250]; Faculty of Pharmaceutical Sciences, UBC; Canada Research Chairs; Michael Smith Foundation for Health Research	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Faculty of Pharmaceutical Sciences, UBC; Canada Research Chairs(Canada Research ChairsCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	We thank Kathleen Collins and William Hahn for generously sharing reagents, Andy Johnson of the Biomedical Research Center at UBC for assistance with FACS analysis and Shirley Yeung, Raina Tamakawa, Naresh Thumati and Xi-Lei Zeng for technical help. Financial supported for this work was received from the Canadian Cancer Society Research Institute (operating grant no. 019250) and Research Reinvestment funds of the Faculty of Pharmaceutical Sciences, UBC. JMYW is supported by the Canada Research Chairs and the Michael Smith Foundation for Health Research Career Development programs.	Armbruster BN, 2004, MOL CELL BIOL, V24, P3552, DOI 10.1128/MCB.24.8.3552-3561.2004; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; Banik SSR, 2002, MOL CELL BIOL, V22, P6234, DOI 10.1128/MCB.22.17.6234-6246.2002; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2002, NAT REV CANCER, V2, P627, DOI 10.1038/nrc862; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cerone MA, 2001, HUM MOL GENET, V10, P1945, DOI 10.1093/hmg/10.18.1945; Chang S, 2002, P NATL ACAD SCI USA, V99, P12520, DOI 10.1073/pnas.212514699; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2003, HISTOL HISTOPATHOL, V18, P541, DOI 10.14670/HH-18.541; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Dong CK, 2005, CRIT REV ONCOL HEMAT, V54, P85, DOI 10.1016/j.critrevonc.2004.12.005; Etheridge KT, 2002, J BIOL CHEM, V277, P24764, DOI 10.1074/jbc.M201227200; Fakhoury J, 2010, J CELL SCI, V123, P1693, DOI 10.1242/jcs.063636; Fasching CL, 2005, CANCER RES, V65, P2722, DOI 10.1158/0008-5472.CAN-04-2881; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harley CB, 2002, ONCOGENE, V21, P494, DOI 10.1038/sj.onc.1205076; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Huard S, 2004, NUCLEIC ACIDS RES, V32, P2171, DOI 10.1093/nar/gkh546; HURLIN PJ, 1987, CANCER RES, V47, P5752; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; Jha KK, 1998, EXP CELL RES, V245, P1, DOI 10.1006/excr.1998.4272; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Lee SR, 2003, J BIOL CHEM, V278, P52531, DOI 10.1074/jbc.M311359200; Lindvall C, 2003, CANCER RES, V63, P1743; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Nagaprashantha LD, 2011, INT J CANCER, V128, P743, DOI 10.1002/ijc.25725; Nakamura M, 2005, HUM GENE THER, V16, P859, DOI 10.1089/hum.2005.16.859; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; OGATA T, 1993, MOL CELL BIOL, V13, P6036, DOI 10.1128/MCB.13.10.6036; Oulton R, 2004, MOL BIOL CELL, V15, P3244, DOI 10.1091/mbc.E04-03-0178; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Sharma GG, 2003, ONCOGENE, V22, P131, DOI 10.1038/sj.onc.1206063; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Tamakawa RA, 2010, CANCER RES, V70, P8684, DOI 10.1158/0008-5472.CAN-10-2227; Tokutake Y, 1998, BIOCHEM BIOPH RES CO, V247, P765, DOI 10.1006/bbrc.1998.8876; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232	52	12	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	8					954	965		10.1038/onc.2011.292	http://dx.doi.org/10.1038/onc.2011.292			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21743490				2022-12-25	WOS:000300709700002
J	Kuwae, A; Sjolinder, H; Eriksson, J; Eriksson, S; Chen, Y; Jonsson, AB				Kuwae, Asaomi; Sjolinder, Hong; Eriksson, Jens; Eriksson, Sara; Chen, Yao; Jonsson, Ann-Beth			NafA Negatively Controls Neisseria meningitidis Piliation	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; HUMAN EPITHELIAL-CELLS; IV PILI; MENINGOCOCCAL DISEASE; PATHOGENIC NEISSERIA; TWITCHING MOTILITY; OPA PROTEINS; SIALIC-ACID; GONORRHOEAE; ATTACHMENT	Bacterial auto-aggregation is a critical step during adhesion of N. meningitidis to host cells. The precise mechanisms and functions of bacterial auto-aggregation still remain to be fully elucidated. In this work, we characterize the role of a meningococcal hypothetical protein, NMB0995/NMC0982, and show that this protein, here denoted NafA, acts as an anti-aggregation factor. NafA was confirmed to be surface exposed and was found to be induced at a late stage of bacterial adherence to epithelial cells. A NafA deficient mutant was hyperpiliated and formed bundles of pili. Further, the mutant displayed increased adherence to epithelial cells when compared to the wild-type strain. In the absence of host cells, the NafA deficient mutant was more aggregative than the wild-type strain. The in vivo role of NafA in sepsis was studied in a murine model of meningococcal disease. Challenge with the NafA deficient mutant resulted in lower bacteremia levels and mortality when compared to the wild-type strain. The present study reveals that meningococcal NafA is an anti-aggregation factor with strong impact on the disease outcome. These data also suggest that appropriate bacterial auto-aggregation is controlled by both aggregation and anti-aggregation factors during Neisseria infection in vivo.	[Kuwae, Asaomi; Sjolinder, Hong; Eriksson, Jens; Eriksson, Sara; Chen, Yao; Jonsson, Ann-Beth] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Stockholm University	Kuwae, A (corresponding author), Kitasato Univ, Grad Sch Infect Control Sci, Lab Bacterial Infect, Minato Ku, Tokyo, Japan.	kuwae@lisci.kitasato-u.ac.jp		Eriksson, Jens/0000-0002-8945-2665	Swedish Research Council [Dnr 2006-4112, 2007-3369, 2008-2572, 2009-5679]; Swedish Cancer Society; JSPS (Japan Society for the Promotion of Science); Torsten and Ragnar Soderbergs Stiftelse; Stiftelsen Anna Brita och Bo Castegrens Minne; Tore Nilsons stiftelse for Medicinsk Forskning; Harald Jeanssons Stiftelser; Ake Wiberg stiftelse; Stiftelsen Lars Hiertas Minne; Magnus Bergvalls Stiftelse; Knut and Alice Wallenbergs Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Torsten and Ragnar Soderbergs Stiftelse; Stiftelsen Anna Brita och Bo Castegrens Minne; Tore Nilsons stiftelse for Medicinsk Forskning; Harald Jeanssons Stiftelser; Ake Wiberg stiftelse; Stiftelsen Lars Hiertas Minne; Magnus Bergvalls Stiftelse; Knut and Alice Wallenbergs Stiftelse	This work was supported by the Swedish Research Council (Dnr 2006-4112, 2007-3369, 2008-2572, 2009-5679, www.vr.se) the Swedish Cancer Society (www.cancerfonden.se), Torsten and Ragnar Soderbergs Stiftelse (www.soderbergsstiftelser.se), Stiftelsen Anna Brita och Bo Castegrens Minne, Tore Nilsons stiftelse for Medicinsk Forskning (http://www.torenilsonsstiftelse.nu), Harald Jeanssons Stiftelser (http://www.jeanssonsstiftelser.se/index.html), Ake Wiberg stiftelse (http://www.ake-wiberg.com), Stiftelsen Lars Hiertas Minne (http://www.larshiertasminne.se), Magnus Bergvalls Stiftelse (http://www.magnbergvallsstiftelse.nu) and Knut and Alice Wallenbergs Stiftelse (http://www.wallenberg.com/kaw). A. K. is the recipient of the JSPS (Japan Society for the Promotion of Science: http://www.jsps.go.jp/english/index.html) Postdoctoral Fellowships for Research Abroad 2007-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BRANDTZAEG P, 1992, J INFECT DIS, V166, P650, DOI 10.1093/infdis/166.3.650; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; Casey R, 2008, INFECT IMMUN, V76, P1298, DOI 10.1128/IAI.00741-07; Cattaneo R, 2004, J VIROL, V78, P4385, DOI 10.1128/JVI.78.9.4385-4388.2004; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; de Jonge MI, 2003, MOL MICROBIOL, V50, P1005, DOI 10.1046/j.1365-2958.2003.03749.x; de Vries FP, 1998, MOL MICROBIOL, V27, P1203, DOI 10.1046/j.1365-2958.1998.00763.x; Deghmane AE, 2002, MOL MICROBIOL, V43, P1555, DOI 10.1046/j.1365-2958.2002.02838.x; deVries FP, 1996, INFECT IMMUN, V64, P2998, DOI 10.1128/IAI.64.8.2998-3006.1996; Dietrich M, 2009, FEMS MICROBIOL LETT, V296, P248, DOI 10.1111/j.1574-6968.2009.01647.x; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; FRASCH CE, 1978, J BACTERIOL, V136, P1127, DOI 10.1128/JB.136.3.1127-1134.1978; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; JARVIS GA, 1987, INFECT IMMUN, V55, P174, DOI 10.1128/IAI.55.1.174-180.1987; Johansson L, 2005, J IMMUNOL, V175, P433, DOI 10.4049/jimmunol.175.1.433; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Jones A, 2009, J BACTERIOL, V191, P3861, DOI 10.1128/JB.01313-08; Uria MJ, 2008, J EXP MED, V205, P1423, DOI 10.1084/jem.20072577; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Kirchner M, 2005, MOL MICROBIOL, V56, P945, DOI 10.1111/j.1365-2958.2005.04600.x; Kirchner M, 2005, INFECT IMMUN, V73, P3072, DOI 10.1128/IAI.73.5.3072-3082.2005; MARCEAU M, 1995, MOL MICROBIOL, V17, P855, DOI 10.1111/j.1365-2958.1995.mmi_17050855.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Renauld-Mongenie G, 2004, INFECT IMMUN, V72, P3461, DOI 10.1128/IAI.72.6.3461-3470.2004; Schubert-Unkmeir A, 2007, INFECT IMMUN, V75, P899, DOI 10.1128/IAI.01508-06; Sjolinder H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000241; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Spinosa MR, 2007, INFECT IMMUN, V75, P3594, DOI 10.1128/IAI.01945-06; SWANSON J, 1973, J EXP MED, V137, P571, DOI 10.1084/jem.137.3.571; Tonjum T, 1998, MOL MICROBIOL, V29, P111, DOI 10.1046/j.1365-2958.1998.00910.x; Unkmeir A, 2002, MOL MICROBIOL, V46, P933, DOI 10.1046/j.1365-2958.2002.03222.x; VIRJI M, 1994, MOL MICROBIOL, V14, P173, DOI 10.1111/j.1365-2958.1994.tb01277.x; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x	47	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21749	10.1371/journal.pone.0021749	http://dx.doi.org/10.1371/journal.pone.0021749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747953	Green Submitted, gold, Green Published			2022-12-25	WOS:000292293400029
J	Ons, B; Verstraelen, L; Wagemans, J				Ons, Bart; Verstraelen, Leopold; Wagemans, Johan			A Computational Model of Visual Anisotropy	PLOS ONE			English	Article							ORIENTATION DISCRIMINATION; VERNIER ACUITY; OBLIQUE; PERCEPTION; STIMULI; SENSITIVITY; SELECTIVITY; SYMMETRY; CORTEX	Visual anisotropy has been demonstrated in multiple tasks where performance differs between vertical, horizontal, and oblique orientations of the stimuli. We explain some principles of visual anisotropy by anisotropic smoothing, which is based on a variation on Koenderink's approach in [1]. We tested the theory by presenting Gaussian elongated luminance profiles and measuring the perceived orientations by means of an adjustment task. Our framework is based on the smoothing of the image with elliptical Gaussian kernels and it correctly predicted an illusory orientation bias towards the vertical axis. We discuss the scope of the theory in the context of other anisotropies in perception.	[Ons, Bart; Wagemans, Johan] Univ Louvain, Expt Psychol Lab, Louvain, Belgium; [Verstraelen, Leopold] Univ Louvain, Dept Geometry, Louvain, Belgium		Ons, B (corresponding author), Univ Louvain, Expt Psychol Lab, Louvain, Belgium.	johan.wagemans@psy.kuleuven.be	Wagemans, Johan/M-3878-2019	Wagemans, Johan/0000-0002-7970-1541	Flemish Government [METH/08/02]	Flemish Government(European Commission)	This work was supported by the Methusalem grant by the Flemish Government awarded to JW (METH/08/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; CAMISA JM, 1977, PERCEPTION, V6, P165, DOI 10.1068/p060165; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V187, P437, DOI 10.1113/jphysiol.1966.sp008101; CORWIN TR, 1977, PERCEPT PSYCHOPHYS, V21, P445, DOI 10.3758/BF03199500; DAVIDOFF JB, 1974, PERCEPTION, V3, P47, DOI 10.1068/p030047; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; ESSOCK EA, 1990, VISION RES, V30, P1243, DOI 10.1016/0042-6989(90)90179-O; Essock EA, 2003, VISION RES, V43, P1329, DOI 10.1016/S0042-6989(03)00142-1; Essock EA, 1997, J EXP PSYCHOL HUMAN, V23, P515, DOI 10.1037/0096-1523.23.2.515; HEELEY DW, 1994, VISION RES, V34, P2059, DOI 10.1016/0042-6989(94)90317-4; HEELEY DW, 1988, VISION RES, V28, P337, DOI 10.1016/0042-6989(88)90162-9; KOENDERINK JJ, 1992, IMAGE VISION COMPUT, V10, P557, DOI 10.1016/0262-8856(92)90076-F; KOENDERINK JJ, 1984, BIOL CYBERN, V50, P363, DOI 10.1007/BF00336961; Koenderink JJ, 2002, LECT NOTES COMPUT SC, V2350, P158; Koenderink JJ, 1998, ADV IMAG ELECT PHYS, V103, P65, DOI 10.1016/S1076-5670(08)70015-6; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Machilsen B, 2009, J VISION, V9, DOI 10.1167/9.12.11; Ons B, 2010, KRAGUJEV J MATH, V34, P5; Verstraelen L, 2005, KRAGUJEV J MATH, V28, P7; WAGEMANS J, 1993, J EXP PSYCHOL HUMAN, V19, P364, DOI 10.1037/0096-1523.19.2.364; WAGEMANS J, 1995, SPATIAL VISION, V9, P9, DOI 10.1163/156856895X00098; WENDEROTH P, 1994, PERCEPTION, V23, P221, DOI 10.1068/p230221; Westheimer G, 1998, VISION RES, V38, P1097, DOI 10.1016/S0042-6989(97)00248-4; ZLASKOVA M, 1993, VISION RES, V33, P2073; [No title captured]	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21091	10.1371/journal.pone.0021091	http://dx.doi.org/10.1371/journal.pone.0021091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786GP	21738607	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800009
J	Song, SX; Chen, DK; Lu, JC; Liao, JW; Luo, YX; Yang, ZL; Fu, XH; Fan, XJ; Wei, YS; Yang, L; Wang, L; Wang, JP				Song, Shunxin; Chen, Dianke; Lu, Jiachun; Liao, Jiawei; Luo, Yanxin; Yang, Zuli; Fu, Xinhui; Fan, Xinjuan; Wei, Yisheng; Yang, Lei; Wang, Lei; Wang, Jianping			NF kappa B1 and NF kappa BIA Polymorphisms Are Associated with Increased Risk for Sporadic Colorectal Cancer in a Southern Chinese Population	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; B ACTIVATION; INSERTION/DELETION POLYMORPHISM; CHROMOSOMAL LOCALIZATION; PROMOTER POLYMORPHISM; UNTRANSLATED REGION; APOPTOSIS; NFKB1; GENE; PROGRESSION	Background: Nuclear factor kappa B (NF kappa B) plays a key role in the regulation of apoptosis. The function of NF kappa B is inhibited by binding to NF kappa B inhibitor (I kappa B), and disruption of the balance of NFkB and IkB is related to the development of many diseases, including tumors. Therefore, we hypothesized that the NF kappa B1 (-94del/insATTG) and NF kappa BIA (2758 A>G) polymorphisms were associated with colorectal cancer (CRC) susceptibility. Methods: In a hospital-based case-control study of 1001 CRC patients and 1005 cancer-free controls frequency matched by age and sex, we genotyped polymorphisms using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and performed luciferase assays and Western blotting analysis to identify whether genetic variants in NF kappa BIA alter its gene expressions and functions and thus cancer risk. Results: We found that both NF kappa B1-94 ins/delATTG and NF kappa BIA 2758 A>G polymorphisms were correlated with CRC risk (OR = 1.47; 95% CI = 1.14-1.86, and OR = 1.38; 95% CI = 1.14-1.66, respectively). Furthermore, when evaluated these two polymorphisms together, the combined genotypes with 2 variant (risk) alleles (2758GG and -94ins/ins+del/ins) were associated with an increased risk of CRC (OR = 1.71; 95% CI = 1.23-2.38) compared to 0 variant, and the significant trend for 2 variant (risk) alleles were more pronounced among subgroups of aged,60 years, women, never drinkers, never smokers, persons with a normal BMI and those with a family history of cancer(P-trend < 0.01). Moreover, luciferase assays showed that the G allele in the 3'UTR significantly decreased NF kappa BIA mRNA stability and the A allele regulation by miRNA449a in vitro and that the NF kappa BIA protein expression levels of the AA+AG variant carriers were significantly higher in peritumoral tissues than those of the 2758GG genotype. Conclusion: NF kappa B1 and NF kappa BIA polymorphisms appear to jointly contribute to risk of CRC. These two variants may be a genetic modifier for CRC susceptibility in this southern Chinese population.	[Song, Shunxin; Chen, Dianke; Liao, Jiawei; Luo, Yanxin; Yang, Zuli; Fu, Xinhui; Fan, Xinjuan; Wang, Lei; Wang, Jianping] Sun Yat Sen Univ, Gastrointestinal Inst, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Song, Shunxin; Luo, Yanxin; Yang, Zuli; Wang, Lei; Wang, Jianping] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Wei, Yisheng] Guangzhou Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Lu, Jiachun; Yang, Lei] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Song, SX (corresponding author), Sun Yat Sen Univ, Gastrointestinal Inst, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China.	leiwangyinghu@yahoo.com.cn; wangjply@yahoo.com.cn	Chen, Dianke/E-2248-2011		National Natural Scientific Foundation of China [81072042, 81072366, 81001108]; Guangdong Provincial Scientific Research Grants [8151008901000059, 10251008901000008]; Gongdong province government; Education Department of Chinese Government; Science and Technology Department of Chinese Government [00590101220610034]; Research Fund for the Doctoral Program of Higher Education of China [200805580074]; Yat-Sen Innovative Talents Cultivation Program for Excellent Tutors [88000-3126201]; Fundamental Research Funds for the Central Universities	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Scientific Research Grants; Gongdong province government; Education Department of Chinese Government; Science and Technology Department of Chinese Government; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Yat-Sen Innovative Talents Cultivation Program for Excellent Tutors; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Scientific Foundation of China grants [81072042 to Lei Wang, 81072366 to Jiachun Lu and 81001108 to Yisheng Wei], the Guangdong Provincial Scientific Research Grants [8151008901000059, 10251008901000008 to Lei Wang], the Gongdong province government, Education Department of Chinese Government, Science and Technology Department of Chinese Government [00590101220610034 to Jianping Wang], and the Research Fund for the Doctoral Program of Higher Education of China [200805580074 to Jianping Wang] and Yat-Sen Innovative Talents Cultivation Program for Excellent Tutors [88000-3126201 to Dianke Chen and Lei Wang] and supported by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri KI, 2005, CANCER METAST REV, V24, P301, DOI 10.1007/s10555-005-1579-7; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; BLANK V, 1992, TRENDS BIOCHEM SCI, V17, P135, DOI 10.1016/0968-0004(92)90321-Y; Borset M, 1999, EUR J HAEMATOL, V63, P345; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Campbell KJ, 2006, BIOCHEM SOC SYMP, V73, P165, DOI 10.1042/bss0730165; Cao Ka-Jia, 2008, Ai Zheng, V27, P225; Cheah PY, 2009, CRIT REV ONCOL HEMAT, V69, P45, DOI 10.1016/j.critrevonc.2008.08.001; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Curran JE, 2002, CANCER LETT, V188, P103, DOI 10.1016/S0304-3835(02)00460-3; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; GLAVAC D, 1994, HUM GENET, V93, P694, DOI 10.1007/BF00201573; Hayden Matthew S, 2006, Cell, V127, P1286; Heron E, 1995, GENOMICS, V30, P493, DOI 10.1006/geno.1995.1270; HOSHIYAMA Y, 1993, TOHOKU J EXP MED, V171, P153, DOI 10.1620/tjem.171.153; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim LH, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9130; Klein W, 2004, INT J COLORECTAL DIS, V19, P153, DOI 10.1007/s00384-003-0531-y; Kurylowicz A, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-10; LEBEAU MM, 1992, GENOMICS, V14, P529, DOI 10.1016/S0888-7543(05)80261-7; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Maldonado V, 1997, MUTAT RES-FUND MOL M, V381, P67, DOI 10.1016/S0027-5107(97)00150-4; MATHEW S, 1993, ONCOGENE, V8, P191; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Miller MR, 2010, OBESITY, V18, P555, DOI 10.1038/oby.2009.303; Ota N, 1999, J HUM GENET, V44, P129, DOI 10.1007/s100380050125; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Riemann K, 2007, INT J CLIN PHARM TH, V45, P423; Riemann K, 2006, PHARMACOGENET GENOM, V16, P783, DOI 10.1097/01.fpc.0000230414.74726.f6; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Sonenshein GE, 1997, SEMIN CANCER BIOL, V8, P113, DOI 10.1006/scbi.1997.0062; Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387; Tanaka H, 2009, MOL CANCER RES, V7, P557, DOI 10.1158/1541-7786.MCR-08-0197; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THOMPSON HJ, 1992, CANCER EPIDEM BIOMAR, V1, P597; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; von Roon AC, 2007, DIS COLON RECTUM, V50, P839, DOI 10.1007/s10350-006-0848-z; Wei YS, 2009, INT J CANCER, V125, P1876, DOI 10.1002/ijc.24575; Yu HG, 2003, ONCOLOGY-BASEL, V65, P37, DOI 10.1159/000071203; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhou B, 2009, CANCER LETT, V275, P72, DOI 10.1016/j.canlet.2008.10.002	54	59	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21726	10.1371/journal.pone.0021726	http://dx.doi.org/10.1371/journal.pone.0021726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738780	Green Submitted, Green Published, gold			2022-12-25	WOS:000292291800034
J	Fernandez, C; Schuhmann, K; Herzog, R; Fielding, B; Frayn, K; Shevchenko, A; James, P; Holm, C; Strom, K				Fernandez, Celine; Schuhmann, Kai; Herzog, Ronny; Fielding, Barbara; Frayn, Keith; Shevchenko, Andrej; James, Peter; Holm, Cecilia; Strom, Kristoffer			Altered Desaturation and Elongation of Fatty Acids in Hormone-Sensitive Lipase Null Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; ADIPOSE-TISSUE; PROTECTS MICE; OBESITY; DEFICIENCY; EXPRESSION; IDENTIFICATION; ADIPOGENESIS; METABOLISM; RESISTANCE	Background: Hormone-sensitive lipase (HSL) is expressed predominantly in adipose tissue, where it plays an important role in catecholamine-stimulated hydrolysis of stored lipids, thus mobilizing fatty acids. HSL exhibits broad substrate specificity and besides acylglycerides it hydrolyzes cholesteryl esters, retinyl esters and lipoidal esters. Despite its role in fatty acid mobilization, HSL null mice have been shown to be resistant to diet-induced obesity. The aim of this study was to define lipid profiles in plasma, white adipose tissue (WAT) and liver of HSL null mice, in order to better understand the role of this multifunctional enzyme. Methodology/ Principal Findings: This study used global and targeted lipidomics and expression profiling to reveal changed lipid profiles in WAT, liver and plasma as well as altered expression of desaturases and elongases in WAT and liver of HSL null mice on high fat diet. Decreased mRNA levels of stearoyl-CoA desaturase 1 and 2 in WAT were consistent with a lowered ratio of 16:1n7/16:0 and 18:1n9/18:0 in WAT and plasma. In WAT, increased ratio of 18:0/16:0 could be linked to elevated mRNA levels of the Elovl1 elongase. Conclusions: This study illustrates the importance of HSL for normal lipid metabolism in response to a high fat diet. HSL deficiency greatly influences the expression of elongases and desaturases, resulting in altered lipid profiles in WAT, liver and plasma. Finally, altered proportions of palmitoleate, a recently-suggested lipokine, in tissue and plasma of HSL null mice, could be an important factor mediating and contributing to the changed lipid profile, and possibly also to the decreased insulin sensitivity seen in HSL null mice.	[Fernandez, Celine; Holm, Cecilia; Strom, Kristoffer] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Schuhmann, Kai; Herzog, Ronny; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Fielding, Barbara; Frayn, Keith] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [James, Peter] Lund Univ, Dept Immunotechnol, Lund, Sweden	Lund University; Max Planck Society; University of Oxford; Lund University	Fernandez, C (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden.	kristoffer.strom@med.lu.se	Fernandez, Celine/ABH-9332-2020	Fernandez, Celine/0000-0003-1290-4982	Foundation of Tage Blucher for Medical Research; Novo Nordisk foundation; Royal Physiographic Society in Lund; Swedish Research Council [11284]; Swedish Diabetes Association; Bundesministerium f. Bildung u. Forschung (BMBF) [/0315757]; A. Pahlsson, Ahlen; Lars Hiertas Minne; Diabetesforeningen i Malmo med omnejd	Foundation of Tage Blucher for Medical Research; Novo Nordisk foundation(Novo Nordisk FoundationNovocure Limited); Royal Physiographic Society in Lund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association; Bundesministerium f. Bildung u. Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); A. Pahlsson, Ahlen; Lars Hiertas Minne; Diabetesforeningen i Malmo med omnejd	Financial support was provided by the Foundation of Tage Blucher for Medical Research (K.S.); the Novo Nordisk foundation and the Royal Physiographic Society in Lund (C.F.); the Swedish Research Council (project no 11284) and the Swedish Diabetes Association (C.H.); TRR 83 grant from Deutsche Forschungsgemeinschaft (DFG) and Virtual Liver (Code/0315757) grant from Bundesministerium f. Bildung u. Forschung (BMBF) (A.S.), and the following foundations: Novo Nordisk, A. Pahlsson, Ahlen, Lars Hiertas Minne, Diabetesforeningen i Malmo med omnejd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdge GC, 2000, BRIT J NUTR, V84, P781; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Evans K, 2002, DIABETES, V51, P2684, DOI 10.2337/diabetes.51.9.2684; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE820, DOI 10.1152/ajpendo.90206.2008; FOLCH J, 1957, J BIOL CHEM, V226, P497; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Grober J, 2003, J BIOL CHEM, V278, P6510, DOI 10.1074/jbc.M208513200; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Hansson O, 2005, J LIPID RES, V46, P2614, DOI 10.1194/jlr.M500028-JLR200; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kim YC, 2000, J LIPID RES, V41, P1310; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Raclot T, 2001, J LIPID RES, V42, P2049; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Shen WJ, 2011, BBA-MOL CELL BIOL L, V1811, P9, DOI 10.1016/j.bbalip.2010.10.001; Stewart WC, 2004, BIOCHEM BIOPH RES CO, V324, P355, DOI 10.1016/j.bbrc.2004.09.053; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2006, J LIPID RES, V47, P2028, DOI 10.1194/jlr.M600177-JLR200; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811	36	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21603	10.1371/journal.pone.0021603	http://dx.doi.org/10.1371/journal.pone.0021603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738729	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100044
J	Malcom, JW				Malcom, Jacob W.			Gene Networks and Metacommunities: Dispersal Differences Can Override Adaptive Advantage	PLOS ONE			English	Article							RAPID EVOLUTION; DYNAMICS; PRODUCTIVITY; ECOLOGY; FLOW; MONOPOLIZATION; BIODIVERSITY; POPULATION; DIVERSITY; SELECTION	Dispersal is an important mechanism contributing to both ecological and evolutionary dynamics. In metapopulation and metacommunity ecology, dispersal enables new patches to be colonized; in evolution, dispersal counter-acts local selection, leading to regional homogenization. Here, I consider a three-patch metacommunity in which two species, each with a limiting quantitative trait underlain by gene networks of 16 to 256 genes, compete with one another and disperse among patches. Incorporating dispersal among heterogeneous patches introduces a tradeoff not observed in single-patch simulations: if the difference between gene network size of the two species is greater than the difference in dispersal ability (e. g., if the ratio of network sizes is larger than the ratio of dispersal abilities), then genetic architecture drives community outcome. However, if the difference in dispersal abilities is greater than gene network differences, then any adaptive advantages afforded by genetic architecture are over-ridden by dispersal. Thus, in addition to the selective pressures imposed by competition that shape the genetic architecture of quantitative traits, dispersal among patches creates an escape that may further alter the effects of different genetic architectures. These results provide a theoretical expectation for what we may observe as the field of ecological genomics develops.	Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Malcom, JW (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	jmalcom@mail.utexas.edu	/AAD-1873-2020	/0000-0002-4904-8369	University of Texas at Austin	University of Texas at Austin	This work was supported in part by a start-up grant from the University of Texas at Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bohonak AJ, 2003, ECOL LETT, V6, P783, DOI 10.1046/j.1461-0248.2003.00486.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; CHEVERUD JM, 1995, GENETICS, V139, P1455; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DOBZHANSKY T, 1947, GENETICS, V32, P303; Etienne R, 2002, ECOL MODEL, V148, P153, DOI 10.1016/S0304-3800(01)00417-3; France KE, 2006, NATURE, V441, P1139, DOI 10.1038/nature04729; Frank SA, 1999, J THEOR BIOL, V197, P281, DOI 10.1006/jtbi.1998.0872; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Gravel D, 2010, AM NAT, V176, P289, DOI 10.1086/655426; Gravel D, 2010, ECOLOGY, V91, P2172, DOI 10.1890/09-0843.1; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hansen TF, 2006, AM NAT, V168, P168, DOI 10.1086/505768; Hanski I., 1999, METAPOPULATION ECOLO; HANSKI I, 1997, METAPOPULATION BIOL; Holt RD, 1997, AM NAT, V149, P563, DOI 10.1086/286005; Holyoak M, 2006, ECOLOGY, V87, P1370, DOI 10.1890/0012-9658(2006)87[1370:REEWNC]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Johnson KH, 1996, TRENDS ECOL EVOL, V11, P372, DOI 10.1016/0169-5347(96)10040-9; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; JOHNSTON JS, 1982, DISPERSAL CLINES OPU, P241; KIMBRELL T, 2009, EVOL ECOL; Kimbrell T, 2007, AM NAT, V169, P370, DOI 10.1086/511314; Leibold M.A, 2009, PRINCETON GUIDE ECOL, P312; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Loeuille N, 2008, AM NAT, V171, P788, DOI 10.1086/587745; Loreau M., 2010, POPULATIONS ECOSYSTE; Malcom J, PLOS ONE IN PRESS; Malcom JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014645; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Neter J, 1985, APPL LINEAR REGRESSI; Nichols J., 2001, DISPERSAL; Nuismer SL, 2004, EVOLUTION, V58, P1165, DOI 10.1111/j.0014-3820.2004.tb01697.x; Parris KM, 2004, ECOGRAPHY, V27, P392, DOI 10.1111/j.0906-7590.2004.03711.x; R Development Core Team, 2009, R FDN STAT COMP; Repsilber D, 2009, EURASIP J BIOINFO SY, V2009; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Urban MC, 2008, TRENDS ECOL EVOL, V23, P311, DOI 10.1016/j.tree.2008.02.007; Urban MC, 2006, ECOLOGY, V87, P1616, DOI 10.1890/0012-9658(2006)87[1616:EMTAEP]2.0.CO;2; URBAN MC, 2009, P BIOL SCI; Venail PA, 2008, NATURE, V452, P210, DOI 10.1038/nature06554; Wilenski U., 1999, NETLOGO; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767; Yoshida T, 2007, PLOS BIOL, V5, P1868, DOI 10.1371/journal.pbio.0050235	57	4	4	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21541	10.1371/journal.pone.0021541	http://dx.doi.org/10.1371/journal.pone.0021541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738698	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800036
J	Whiteman, IT; Minamide, LS; Goh, DL; Bamburg, JR; Goldsbury, C				Whiteman, Ineka T.; Minamide, Laurie S.; Goh, De Lian; Bamburg, James R.; Goldsbury, Claire			Rapid Changes in Phospho-MAP/Tau Epitopes during Neuronal Stress: Cofilin-Actin Rods Primarily Recruit Microtubule Binding Domain Epitopes	PLOS ONE			English	Article							TAU-PROTEIN; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NEUROPIL THREADS; NEUROFIBRILLARY PATHOLOGY; SENILE PLAQUES; PICKS-DISEASE; PHOSPHORYLATION; BRAIN; KINASE	Abnormal mitochondrial function is a widely reported contributor to neurodegenerative disease including Alzheimer's disease (AD), however, a mechanistic link between mitochondrial dysfunction and the initiation of neuropathology remains elusive. In AD, one of the earliest hallmark pathologies is neuropil threads comprising accumulated hyperphosphorylated microtubule-associated protein (MAP) tau in neurites. Rod-like aggregates of actin and its associated protein cofilin (AC rods) also occur in AD. Using a series of antibodies - AT270, AT8, AT100, S214, AT180, 12E8, S396, S404 and S422 - raised against different phosphoepitopes on tau, we characterize the pattern of expression and re-distribution in neurites of these phosphoepitope labels during mitochondrial inhibition. Employing chick primary neuron cultures, we demonstrate that epitopes recognized by the monoclonal antibody 12E8, are the only species rapidly recruited into AC rods. These results were recapitulated with the actin depolymerizing drug Latrunculin B, which induces AC rods and a concomitant increase in the 12E8 signal measured on Western blot. This suggests that AC rods may be one way in which MAP redistribution and phosphorylation is influenced in neurons during mitochondrial stress and potentially in the early pathogenesis of AD.	[Whiteman, Ineka T.; Goh, De Lian; Goldsbury, Claire] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Whiteman, Ineka T.; Goh, De Lian; Goldsbury, Claire] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia; [Minamide, Laurie S.; Bamburg, James R.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of Sydney; University of Sydney; Colorado State University	Whiteman, IT (corresponding author), Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia.	claire.goldsbury@sydney.edu.au		Whiteman, Ineka/0000-0002-3302-7416; Goldsbury, Claire/0000-0003-0647-1789	Sir Zelman Cowen University; Judith Jane Mason and Harold Stannett Williams Memorial Foundation; Rebecca Cooper Foundation; NHMRC; Sydney Medical School; National Institutes of Health [NS40371]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040371] Funding Source: NIH RePORTER	Sir Zelman Cowen University; Judith Jane Mason and Harold Stannett Williams Memorial Foundation; Rebecca Cooper Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Sir Zelman Cowen Universities Fund, The Judith Jane Mason and Harold Stannett Williams Memorial Foundation, The Rebecca Cooper Foundation, The NHMRC, Sydney Medical School and the National Institutes of Health grant NS40371 (JRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Baas PW, 2005, TRENDS CELL BIOL, V15, P183, DOI 10.1016/j.tcb.2005.02.001; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Blass JP, 2000, ANN NY ACAD SCI, V924, P170; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CORREAS I, 1990, BIOCHEM J, V269, P61, DOI 10.1042/bj2690061; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Davis RC, 2009, J ALZHEIMERS DIS, V18, DOI 10.3233/JAD-2009-1122; Dehmelt L, 2005, GENOME BIOL, V6; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; Delacourte A, 1998, ANN NEUROL, V43, P193, DOI 10.1002/ana.410430209; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gallo G, 2007, NAT CELL BIOL, V9, P133, DOI 10.1038/ncb0207-133; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Gauthier-Kemper A, 2011, J CELL BIOL, V192, P647, DOI 10.1083/jcb.201007161; Giannakopoulos P, 2007, NEUROPATH APPL NEURO, V33, P334, DOI 10.1111/j.1365-2990.2007.00827.x; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goldsbury C, 2008, AGING CELL, V7, P771, DOI 10.1111/j.1474-9726.2008.00423.x; Gordon-Krajcer W, 2007, NEUROCHEM RES, V32, P729, DOI 10.1007/s11064-006-9199-3; GRIFFITH LM, 1982, J BIOL CHEM, V257, P9143; GRIFFITH LM, 1978, J CELL BIOL, V78, P958, DOI 10.1083/jcb.78.3.958; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; He HJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-81; Hernandez F, 2004, NEUROSCI LETT, V357, P143, DOI 10.1016/j.neulet.2003.12.049; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Mandelkow EM, 2004, J CELL BIOL, V167, P99, DOI 10.1083/jcb.200401085; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Mitchell TW, 2000, J HISTOCHEM CYTOCHEM, V48, P1627, DOI 10.1177/002215540004801206; MORAGA DM, 1993, J NEUROCHEM, V61, P979, DOI 10.1111/j.1471-4159.1993.tb03611.x; Nelson PT, 2010, J ALZHEIMERS DIS, V21, P75, DOI 10.3233/JAD-2010-091603; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573; Praprotnik D, 1996, ACTA NEUROPATHOL, V91, P226, DOI 10.1007/s004010050420; Probst A, 1996, ACTA NEUROPATHOL, V92, P588, DOI 10.1007/s004010050565; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; SCHMIDT ML, 1993, MOL CHEM NEUROPATHOL, V18, P299, DOI 10.1007/BF03160121; SELDEN SC, 1983, J BIOL CHEM, V258, P7064; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shaw AE, 2004, ELECTROPHORESIS, V25, P2611, DOI 10.1002/elps.200406017; Smith MA, 2005, NEUROBIOL AGING, V26, P579, DOI 10.1016/j.neurobiolaging.2004.09.021; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Velasco ME, 1998, BRAIN RES, V813, P329, DOI 10.1016/S0006-8993(98)01034-8; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wen Y, 2004, BRAIN RES, V1022, P30, DOI 10.1016/j.brainres.2004.05.106; Whiteman IT, 2009, J NEUROSCI, V29, P12994, DOI 10.1523/JNEUROSCI.3531-09.2009; YAMAUCHI PS, 1993, BIOCHEM BIOPH RES CO, V190, P710, DOI 10.1006/bbrc.1993.1107; YAO J, 2011, PLOS ONE, V5; Yoshida H, 2002, BIOCHEMISTRY-US, V41, P15203, DOI 10.1021/bi026464m; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhou LX, 2006, BIOCHEM BIOPH RES CO, V348, P637, DOI 10.1016/j.bbrc.2006.07.099	68	22	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20878	10.1371/journal.pone.0020878	http://dx.doi.org/10.1371/journal.pone.0020878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738590	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800004
J	Mullins, JGL; Parker, JE; Cools, HJ; Togawa, RC; Lucas, JA; Fraaije, BA; Kelly, DE; Kelly, SL				Mullins, Jonathan G. L.; Parker, Josie E.; Cools, Hans J.; Togawa, Roberto C.; Lucas, John A.; Fraaije, Bart A.; Kelly, Diane E.; Kelly, Steven L.			Molecular Modelling of the Emergence of Azole Resistance in Mycosphaerella graminicola	PLOS ONE			English	Article							CANDIDA-ALBICANS; CYP51 GENE; 14-ALPHA-DEMETHYLASE CYP51; SENSITIVITY; FUNGICIDES; MUTATIONS; PROTEIN; SUBSTITUTION; INHIBITION; MECHANISMS	A structural rationale for recent emergence of azole (imidazole and triazole) resistance associated with CYP51 mutations in the wheat pathogen Mycosphaerella graminicola is presented, attained by homology modelling of the wild type protein and 13 variant proteins. The novel molecular models of M. graminicola CYP51 are based on multiple homologues, individually identified for each variant, rather than using a single structural scaffold, providing a robust structure-function rationale for the binding of azoles, including important fungal specific regions for which no structural information is available. The wild type binding pocket reveals specific residues in close proximity to the bound azole molecules that are subject to alteration in the variants. This implicates azole ligands as important agents exerting selection on specific regions bordering the pocket, that become the focus of genetic mutation events, leading to reduced sensitivity to that group of related compounds. Collectively, the models account for several observed functional effects of specific alterations, including loss of triadimenol sensitivity in the Y137F variant, lower sensitivity to tebuconazole of I381V variants and increased resistance to prochloraz of V136A variants. Deletion of Y459 and G460, which brings about removal of that entire section of beta turn from the vicinity of the binding pocket, confers resistance to tebuconazole and epoxiconazole, but sensitivity to prochloraz in variants carrying a combination of A379G I381V Delta Y459/G460. Measurements of binding pocket volume proved useful in assessment of scope for general resistance to azoles by virtue of their accommodation without bonding interaction, particularly when combined with analysis of change in positions of key amino acids. It is possible to predict the likely binding orientation of an azole molecule in any of the variant CYPs, providing potential for an in silico screening system and reliable predictive approach to assess the probability of particular variants exhibiting resistance to particular azole fungicides.	[Mullins, Jonathan G. L.; Parker, Josie E.; Kelly, Diane E.; Kelly, Steven L.] Swansea Univ, Inst Life Sci, Sch Med, Swansea, W Glam, Wales; [Cools, Hans J.; Lucas, John A.; Fraaije, Bart A.] Rothamsted Res, Dept Plant Pathol & Microbiol, Harpenden, Herts, England; [Togawa, Roberto C.] Embrapa Recursos Genet & Biotecnol, Lab Bioinformat, Brasilia, DF, Brazil	Swansea University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Mullins, JGL (corresponding author), Swansea Univ, Inst Life Sci, Sch Med, Swansea, W Glam, Wales.	j.g.l.mullins@swan.ac.uk	Fraaije, Bart/AAL-4604-2021; Lucas, John/D-9699-2013; Cools, Hans/B-5134-2008	Fraaije, Bart/0000-0001-8176-2258; Cools, Hans/0000-0003-2932-7130; Parker, Josie/0000-0002-3855-4194; Mullins, Jonathan/0000-0003-0144-2962; Togawa, Roberto/0000-0001-7179-3210	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/E02257X/1] Funding Source: researchfish; BBSRC [BB/E02257X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Part of this work was supported by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC). Rothamsted Research is an Institute of the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bean TP, 2009, FEMS MICROBIOL LETT, V296, P266, DOI 10.1111/j.1574-6968.2009.01645.x; BOSCOTT PE, 1994, J MOL GRAPH MODEL, V12, P185, DOI 10.1016/0263-7855(94)80086-3; Brunner PC, 2008, MOL PLANT PATHOL, V9, P305, DOI 10.1111/J.1364-3703.2007.00464.X; Canas-Gutierrez GP, 2009, PEST MANAG SCI, V65, P892, DOI 10.1002/ps.1770; Cools HJ, 2006, BIOCHEM SOC T, V34, P1219, DOI 10.1042/BST0341219; Cools HJ, 2010, APPL ENVIRON MICROB, V76, P2866, DOI 10.1128/AEM.02158-09; Cools HJ, 2008, PEST MANAG SCI, V64, P681, DOI 10.1002/ps.1568; Delye C, 1998, CURR GENET, V34, P399, DOI 10.1007/s002940050413; Delye C, 1997, GENE, V195, P29, DOI 10.1016/S0378-1119(97)00141-8; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Ferreira MED, 2005, MED MYCOL, V43, pS313, DOI 10.1080/13693780400029114; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; HARDWICK NV, 2001, FACTORS AFFECTING DI, P1989; Hendlich M, 1997, J MOL GRAPH MODEL, V15, P359, DOI 10.1016/S1093-3263(98)00002-3; JEFCOATE CR, 1978, BIOMEMBRANES C; Kelly SL, 1999, FEMS MICROBIOL LETT, V180, P171, DOI 10.1111/j.1574-6968.1999.tb08792.x; Lamb DC, 1997, FEMS MICROBIOL LETT, V149, P25, DOI 10.1111/j.1574-6968.1997.tb10303.x; LEROUX P, 2010, PEST MANAG SCI; Leroux P, 2007, PEST MANAG SCI, V63, P688, DOI 10.1002/ps.1390; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Sanglard D, 1998, ANTIMICROB AGENTS CH, V42, P241, DOI 10.1093/jac/42.2.241; Stammler G, 2008, CROP PROT, V27, P1448, DOI 10.1016/j.cropro.2008.07.007; Stergiopoulos I, 2003, PEST MANAG SCI, V59, P1333, DOI 10.1002/ps.766; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wyand RA, 2005, FUNGAL GENET BIOL, V42, P726, DOI 10.1016/j.fgb.2005.04.007	31	68	71	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20973	10.1371/journal.pone.0020973	http://dx.doi.org/10.1371/journal.pone.0020973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738598	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600009
J	Shih, YL; Huang, KF; Lai, HM; Liao, JH; Lee, CS; Chang, CM; Mak, HM; Hsieh, CW; Lin, CC				Shih, Yu-Ling; Huang, Kai-Fa; Lai, Hsin-Mei; Liao, Jiahn-Haur; Lee, Chai-Siah; Chang, Chiao-Min; Mak, Huey-Ming; Hsieh, Cheng-Wei; Lin, Chu-Chi			The N-Terminal Amphipathic Helix of the Topological Specificity Factor MinE Is Associated with Shaping Membrane Curvature	PLOS ONE			English	Article							DIVISION SITE SELECTION; CELL-DIVISION; ESCHERICHIA-COLI; STRUCTURAL BASIS; HYDROPHOBIC RESIDUES; CRYSTAL-STRUCTURE; PROPER PLACEMENT; DYNAMIN; PHOSPHOLIPIDS; LOCALIZATION	Pole-to-pole oscillations of the Min proteins in Escherichia coli are required for the proper placement of the division septum. Direct interaction of MinE with the cell membrane is critical for the dynamic behavior of the Min system. In vitro, this MinE-membrane interaction led to membrane deformation; however, the underlying mechanism remained unclear. Here we report that MinE-induced membrane deformation involves the formation of an amphipathic helix of MinE 2-9, which, together with the adjacent basic residues, function as membrane anchors. Biochemical evidence suggested that the membrane association induces formation of the helix, with the helical face, consisting of A2, L3, and F6, inserted into the membrane. Insertion of this helix into the cell membrane can influence local membrane curvature and lead to drastic changes in membrane topology. Accordingly, MinE showed characteristic features of protein-induced membrane tubulation and lipid clustering in in vitro reconstituted systems. In conclusion, MinE shares common protein signatures with a group of membrane trafficking proteins in eukaryotic cells. These MinE signatures appear to affect membrane curvature.	[Shih, Yu-Ling; Huang, Kai-Fa; Liao, Jiahn-Haur; Lee, Chai-Siah; Chang, Chiao-Min; Mak, Huey-Ming; Hsieh, Cheng-Wei; Lin, Chu-Chi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Shih, Yu-Ling; Lai, Hsin-Mei] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Shih, YL (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ylshih10@gate.sinica.edu.tw	Shih, Yu-Ling/F-8396-2011	Shih, Yu-Ling/0000-0002-8232-2569; Lee, Chai Siah/0000-0002-7688-4469	Academia Sinica [AS97-FP-M02-2, AS98-CDA-L07]; National Science Council, Taiwan [NSC97-2311-B-001-010-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work is supported by Academia Sinica (AS97-FP-M02-2, AS98-CDA-L07) and the National Science Council (NSC97-2311-B-001-010-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Campelo F, 2010, FEBS LETT, V584, P1830, DOI 10.1016/j.febslet.2009.10.023; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Cho W, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P369; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; Feig Michael, 2008, V443, P181, DOI 10.1007/978-1-59745-177-2_10; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani H, 2010, P NATL ACAD SCI USA, V107, P18416, DOI 10.1073/pnas.1007141107; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Howard M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278102; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Im W, 2005, P NATL ACAD SCI USA, V102, P6771, DOI 10.1073/pnas.0408135102; Kang GB, 2010, MOL MICROBIOL, V76, P1222, DOI 10.1111/j.1365-2958.2010.07160.x; King GF, 1999, MOL MICROBIOL, V31, P1161, DOI 10.1046/j.1365-2958.1999.01256.x; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Kozlov MM, 2010, NATURE, V463, P439, DOI 10.1038/463439a; Kraft CA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.299pl4; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; PICHOFF S, 1995, MOL MICROBIOL, V18, P321, DOI 10.1111/j.1365-2958.1995.mmi_18020321.x; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schwille P, 2009, CRIT REV BIOCHEM MOL, V44, P223, DOI 10.1080/10409230903074549; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003	55	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21425	10.1371/journal.pone.0021425	http://dx.doi.org/10.1371/journal.pone.0021425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738659	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600039
J	Libera, DD; Di Mitri, D; Bergami, A; Centonze, D; Gasperini, C; Grasso, MG; Galgani, S; Martinelli, V; Comi, G; Avolio, C; Martino, G; Borsellino, G; Sallusto, F; Battistini, L; Furlan, R				Libera, Dacia Dalla; Di Mitri, Diletta; Bergami, Alessandra; Centonze, Diego; Gasperini, Claudio; Grasso, Maria Grazia; Galgani, Simona; Martinelli, Vittorio; Comi, Giancarlo; Avolio, Carlo; Martino, Gianvito; Borsellino, Giovanna; Sallusto, Federica; Battistini, Luca; Furlan, Roberto			T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; IN-VITRO; FOXP3; EXPRESSION; CTLA4; INTERLEUKIN-2; AUTOIMMUNITY; INFLAMMATION; TOLERANCE; SECONDARY	FoxP3(+) Treg cells are believed to play a role in the occurrence of autoimmunity and in the determination of clinical recurrences. Contradictory reports are, however, available describing frequency and function of Treg cells during autoimmune diseases. We examined, by both polychromatic flow cytometry, and real-time RT-PCR, several Treg markers in peripheral blood mononuclear cells from patients with multiple sclerosis (MS), an autoimmune disease affecting the central nervous system. We found that Tregs, as defined by CD25, CD39, FoxP3, CTLA4, and GITR expression, were significantly decreased in stable MS patients as compared to healthy donors, but, surprisingly, restored to normal levels during an acute clinical attack. We conclude that Treg cells are not involved in causing clinical relapses, but rather react to inflammation in the attempt to restore homeostasis.	[Libera, Dacia Dalla; Bergami, Alessandra; Martinelli, Vittorio; Comi, Giancarlo; Martino, Gianvito; Furlan, Roberto] Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, I-20132 Milan, Italy; [Di Mitri, Diletta; Centonze, Diego; Grasso, Maria Grazia; Borsellino, Giovanna; Battistini, Luca] Fdn Santa Lucia, Rome, Italy; [Centonze, Diego] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy; [Gasperini, Claudio; Galgani, Simona] San Camillo Hosp, Lancisi Neurol Unit, Rome, Italy; [Avolio, Carlo] Univ Foggia, Dept Med & Occupat Sci, Foggia, Italy; [Sallusto, Federica] Inst Res Biomed, Bellinzona, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Foggia; Universita della Svizzera Italiana	Libera, DD (corresponding author), Ist Sci San Raffaele, Inst Expt Neurol, Div Neurosci, I-20132 Milan, Italy.	furlan.roberto@hsr.it	Martinelli, Vittorio/AAN-7240-2020; martino, gianvito/AAL-2682-2020; Centonze, Diego/J-7767-2016; Furlan, Roberto/N-5224-2019; Borsellino, Giovanna/K-3074-2016; Furlan, Roberto/J-9177-2016; Di Mitri, Diletta/AAA-4273-2019; Battistini, luca/ABE-1882-2021; Battistini, Luca/D-6920-2014; gasperini, claudio/K-5093-2016	martino, gianvito/0000-0003-1295-9131; Centonze, Diego/0000-0002-8390-8545; Furlan, Roberto/0000-0001-7376-9425; Borsellino, Giovanna/0000-0002-4227-6481; Furlan, Roberto/0000-0001-7376-9425; Battistini, Luca/0000-0002-6488-4891; grasso, maria grazia/0000-0003-1582-5534; Dalla Libera, Dacia/0000-0001-5028-4177; DI MITRI, DILETTA/0000-0002-9626-4259; gasperini, claudio/0000-0002-3959-4067	FISM; Italian Ministry of Health; Italian Ministry of Research	FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	This work has been supported by FISM (GB, LB, and RF), the Italian Ministry of Health (LB and RF), and the Italian Ministry of Research (RF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Curiel TJ, 2007, NAT MED, V13, P250, DOI 10.1038/nm0307-250; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gartner D, 2006, J NEUROIMMUNOL, V172, P73, DOI 10.1016/j.jneuroim.2005.11.003; Heggarty S, 2007, J NEUROIMMUNOL, V187, P187, DOI 10.1016/j.jneuroim.2007.04.017; Huan J, 2005, J NEUROSCI RES, V81, P45, DOI 10.1002/jnr.20522; Kasper LH, 2007, J NEUROL, V254, P10, DOI 10.1007/s00415-007-1003-z; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Liu GZ, 2008, CLIN EXP IMMUNOL, V154, P22, DOI 10.1111/j.1365-2249.2008.03730.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Malferrari G, 2005, EXP MOL PATHOL, V78, P55, DOI 10.1016/j.yexmp.2004.10.001; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Oaks MK, 2000, CELL IMMUNOL, V201, P144, DOI 10.1006/cimm.2000.1649; Palacios R, 2008, J NEUROIMMUNOL, V203, P108, DOI 10.1016/j.jneuroim.2008.06.021; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Putheti P, 2004, J CLIN IMMUNOL, V24, P155, DOI 10.1023/B:JOCI.0000019780.93817.82; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Venken K, 2006, J NEUROSCI RES, V83, P1432, DOI 10.1002/jnr.20852; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	44	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21386	10.1371/journal.pone.0021386	http://dx.doi.org/10.1371/journal.pone.0021386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731726	gold, Green Published, Green Submitted			2022-12-25	WOS:000292036900024
J	Yin, LH; Rao, P; Elson, P; Wang, JH; Ittmann, M; Heston, WDW				Yin, Lihong; Rao, Pravin; Elson, Paul; Wang, Jianghua; Ittmann, Michael; Heston, Warren D. W.			Role of TMPRSS2-ERG Gene Fusion in Negative Regulation of PSMA Expression	PLOS ONE			English	Article							MEMBRANE ANTIGEN PSMA; PROSTATE-CANCER PROGRESSION; ANDROGEN RECEPTOR; ERG; INTERNALIZATION; ANTIBODIES; PREDICTOR; CELLS; PTEN	Prostate specific membrane antigen (PSMA) is overexpressed in prostatic adenocarcinoma (CaP), and its expression is negatively regulated by androgen stimulation. However, it is still unclear which factors are involved in this downregulation. TMPRSS2-ERG fusion is the most common known gene rearrangement in prostate carcinoma. Androgen stimulation can increase expression of the TMPRSS2-ERG fusion in fusion positive prostate cancer cells. The purpose of this investigation is to determine whether PSMA expression can be regulated by the TMPRSS2-ERG gene fusion. We employed two PSMA positive cell lines: VCaP cells, which harbor TMPRSS2-ERG fusion, and LNCaP cells, which lack the fusion. After 24 hours of androgen treatment, TMPRSS2-ERG mRNA level was increased in VCaP cells. PSMA mRNA level was dramatically decreased in VCaP cells, while it only has moderate change in LNCaP cells. Treatment with the androgen antagonist flutamide partially restored PSMA expression in androgen-treated VCaP cells. Knocking down ERG by siRNA in VCaP cells enhances PSMA expression both in the presence and absence of synthetic androgen R1881. Overexpressing TMPRSS2-ERG fusions in LNCaP cells downregulated PSMA both in the presence or absence of R1881, while overexpressing wild type ERG did not. Using PSMA-based luciferase reporter assays, we found TMPRSS2-ERG fusion can inhibit PSMA activity at the transcriptional level. Our data indicated that downregulation of PSMA in androgen-treated VCaP cells appears partially mediated by TMPRSS2-ERG gene fusion.	[Yin, Lihong; Heston, Warren D. W.] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA; [Rao, Pravin; Heston, Warren D. W.] Cleveland Clin, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA; [Elson, Paul] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Wang, Jianghua; Ittmann, Michael] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Ittmann, Michael] Michael E DeBakey Vet Affairs Med Ctr VAMC, Houston, TX USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Baylor College of Medicine	Yin, LH (corresponding author), Cleveland Clin, Dept Canc Biol, Cleveland, OH 44106 USA.	hestonw@ccf.org			NIH [CA101069]; WDWH; Department of Defense [DAMD-W81XWH-09-1-0385]; NATIONAL CANCER INSTITUTE [R01CA101069] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WDWH; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from NIH CA101069, WDWH and from the Department of Defense Prostate Cancer Research program DAMD-W81XWH-09-1-0385, MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anilkumar G, 2003, CANCER RES, V63, P2645; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Bonaccorsi L, 2009, J ENDOCRINOL INVEST, V32, P590, DOI 10.1007/BF03346514; Cai CM, 2009, CANCER RES, V69, P6027, DOI 10.1158/0008-5472.CAN-09-0395; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chang SS, 1999, CANCER RES, V59, P3192; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Ghosh A, 2003, PROSTATE, V57, P140, DOI 10.1002/pros.10289; Haffner MC, 2009, HUM PATHOL, V40, P1754, DOI 10.1016/j.humpath.2009.06.003; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; ISRAELI RS, 1994, CANCER RES, V54, P1807; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Liu H, 1997, CANCER RES, V57, P3629; Liu H, 1998, CANCER RES, V58, P4055; Makkonen H, 2011, MOL CELL ENDOCRINOL, V331, P57, DOI 10.1016/j.mce.2010.08.008; Minner S, 2011, PROSTATE, V71, P281, DOI 10.1002/pros.21241; Mitsiades C, 2004, CLIN EXP METASTAS, V21, P495, DOI 10.1007/s10585-004-3217-0; O'Keefe DS, 2004, PROSTATE, V58, P200, DOI 10.1002/pros.10319; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tasch J, 2001, CRIT REV IMMUNOL, V21, P249; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang JH, 2008, CANCER RES, V68, P8516, DOI 10.1158/0008-5472.CAN-08-1147; Wright GL, 1996, UROLOGY, V48, P326, DOI 10.1016/S0090-4295(96)00184-7; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018	31	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21319	10.1371/journal.pone.0021319	http://dx.doi.org/10.1371/journal.pone.0021319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731703	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900021
J	L'Abbate, C; Cipriano, I; Perez-Hurtado, EC; Leao, SC; Carneiro, CRW; Machado, J				L'Abbate, Carolina; Cipriano, Ivone; Perez-Hurtado, Elizabeth Cristina; Leao, Sylvia Cardoso; Whitaker Carneiro, Celia Regina; Machado, Joel, Jr.			TGF-beta-Mediated Sustained ERK1/2 Activity Promotes the Inhibition of Intracellular Growth of Mycobacterium avium in Epithelioid Cells Surrogates	PLOS ONE			English	Article							ALPHA TNF-ALPHA; NITRIC-OXIDE; LEISHMANIA-MEXICANA; MURINE MACROPHAGES; KINASE-ACTIVITY; MAP KINASE; PROTEIN; COMPLEX; EXPRESSION; ACTIVATION	Transforming growth factor beta (TGF-beta) has been implicated in the pathogenesis of several diseases including infection with intracellular pathogens such as the Mycobacterium avium complex. Infection of macrophages with M. avium induces TGF-beta production and neutralization of this cytokine has been associated with decreased intracellular bacterial growth. We have previously demonstrated that epithelioid cell surrogates (ECs) derived from primary murine peritoneal macrophages through a process of differentiation induced by IL-4 overlap several features of epithelioid cells found in granulomas. In contrast to undifferentiated macrophages, ECs produce larger amounts of TGF-beta and inhibit the intracellular growth of M. avium. Here we asked whether the levels of TGF-beta produced by ECs are sufficient to induce a self-sustaining autocrine TGF-beta signaling controlling mycobacterial replication in infected-cells. We showed that while exogenous addition of increased concentration of TGF-beta to infected-macrophages counteracted M. avium replication, pharmacological blockage of TGF-beta receptor kinase activity with SB-431542 augmented bacterial load in infected-ECs. Moreover, the levels of TGF-beta produced by ECs correlated with high and sustained levels of ERK1/2 activity. Inhibition of ERK1/2 activity with U0126 increased M. avium replication in infected-cells, suggesting that modulation of intracellular bacterial growth is dependent on the activation of ERK1/2. Interestingly, blockage of TGF-beta receptor kinase activity with SB-431542 in infected-ECs inhibited ERK1/2 activity, enhanced intracellular M. avium burden and these effects were followed by a severe decrease in TGF-beta production. In summary, our findings indicate that the amplitude of TGF-beta signaling coordinates the strength and duration of ERK1/2 activity that is determinant for the control of intracellular mycobacterial growth.	[L'Abbate, Carolina; Perez-Hurtado, Elizabeth Cristina; Whitaker Carneiro, Celia Regina] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Disciplina Imunol, Sao Paulo, Brazil; [Cipriano, Ivone] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Biol Desenvolvimento, Sao Paulo, Brazil; [Leao, Sylvia Cardoso] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Disciplina Microbiol, Sao Paulo, Brazil; [Machado, Joel, Jr.] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	L'Abbate, C (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Disciplina Imunol, Sao Paulo, Brazil.	joel.jr@unifesp.br	Leao, Sylvia/O-9637-2016; Cipriano, Ivone/D-4953-2014; Leao, Sylvia/F-4431-2012; Pérez, Elizabeth C/E-8057-2012; Machado, Joel/C-5117-2012	Leao, Sylvia/0000-0003-2083-0119; Leao, Sylvia/0000-0003-2083-0119; Pérez, Elizabeth C/0000-0003-3038-9902; MACHADO JUNIOR, JOEL/0000-0001-7907-3314	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/01533-9, 02/6935-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant numbers 06/01533-9 and 02/6935-7. CL was awarded a fellowship by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; Alvarez-Rueda N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007581; Atfi A, 1997, J BIOL CHEM, V272, P1429, DOI 10.1074/jbc.272.3.1429; BARRALNETTO M, 1987, AM J PATHOL, V127, P271; BERMUDEZ LE, 1993, INFECT IMMUN, V61, P4126, DOI 10.1128/IAI.61.10.4126-4130.1993; BERMUDEZ LE, 1993, J IMMUNOL, V150, P1838; Blumenthal A, 2002, INFECT IMMUN, V70, P4961, DOI 10.1128/IAI.70.9.4961-4967.2002; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; Bouley DM, 2001, INFECT IMMUN, V69, P7820, DOI 10.1128/IAI.69.12.7820-7831.2001; Cameron P, 2004, J IMMUNOL, V173, P3297, DOI 10.4049/jimmunol.173.5.3297; Chinen LTD, 2006, MICROBES INFECT, V8, P965, DOI 10.1016/j.micinf.2005.09.017; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Cipriano IM, 2003, INFLAMMATION, V27, P201, DOI 10.1023/A:1025084413767; Dahl KE, 1996, INFECT IMMUN, V64, P399, DOI 10.1128/IAI.64.2.399-405.1996; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Dewas C, 2000, J IMMUNOL, V165, P5238, DOI 10.4049/jimmunol.165.9.5238; DING A, 1990, J IMMUNOL, V145, P940; DOI T, 1993, INFECT IMMUN, V61, P1980, DOI 10.1128/IAI.61.5.1980-1989.1993; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fujita J, 2002, MICROBIOL IMMUNOL, V46, P67, DOI 10.1111/j.1348-0421.2002.tb02660.x; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hanak V, 2006, RESP MED, V100, P610, DOI 10.1016/j.rmed.2005.08.005; Hartsough MT, 1996, J BIOL CHEM, V271, P22368, DOI 10.1074/jbc.271.37.22368; HORSBURGH CR, 1992, AIDS, V6, P512; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Khanolkar-Young S, 1998, CLIN EXP IMMUNOL, V113, P438; Klug K, 2011, INNATE IMMUN-LONDON, V17, P470, DOI 10.1177/1753425910377799; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Martiny A, 1999, MOL BIOCHEM PARASIT, V102, P1, DOI 10.1016/S0166-6851(99)00067-5; MULDER KM, 1992, J BIOL CHEM, V267, P5029; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Oliveira RS, 2000, J CLIN MICROBIOL, V38, P4643, DOI 10.1128/JCM.38.12.4643-4645.2000; Reed SG, 1999, MICROBES INFECT, V1, P1313, DOI 10.1016/S1286-4579(99)00252-X; Reilly AF, 2004, PEDIATR BLOOD CANCER, V43, P698, DOI 10.1002/pbc.20061; Rich JN, 2001, MICROSC RES TECHNIQ, V52, P363, DOI 10.1002/1097-0029(20010215)52:4<363::AID-JEMT1021>3.3.CO;2-6; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Sangari FJ, 2001, INFECT IMMUN, V69, P1515, DOI 10.1128/IAI.69.3.1515-1520.2001; Sano C, 1999, CLIN EXP IMMUNOL, V115, P435; Secott TE, 2002, INFECT IMMUN, V70, P2670, DOI 10.1128/IAI.70.5.2670-2675.2002; Seyler I, 1997, J LEUKOCYTE BIOL, V62, P374, DOI 10.1002/jlb.62.3.374; Shimizu T, 2002, INT J LEPROSY, V70, P250; Shiratsuchi H, 1996, J INFECT DIS, V173, P410, DOI 10.1093/infdis/173.2.410; Tomioka H, 1997, ANTIMICROB AGENTS CH, V41, P357, DOI 10.1128/AAC.41.2.357; Tomioka H, 2000, CLIN EXP IMMUNOL, V122, P335, DOI 10.1046/j.1365-2249.2000.01393.x; TOOSSI Z, 1995, J IMMUNOL, V154, P465; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; WARWICKDAVIES J, 1995, J IMMUNOL, V155, P3186; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wilson Mary E., 1996, Methods (Orlando), V9, P248, DOI 10.1006/meth.1996.0031; Xander P, 2007, MICROBES INFECT, V9, P1484, DOI 10.1016/j.micinf.2007.08.001; Xu Z, 2003, CELL RES, V13, P343, DOI 10.1038/sj.cr.7290179; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; YAJKO DM, 1995, J ACQ IMMUN DEF SYND, V9, P176; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	60	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21465	10.1371/journal.pone.0021465	http://dx.doi.org/10.1371/journal.pone.0021465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731758	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700088
J	Macotela, Y; Emanuelli, B; Bang, AM; Espinoza, DO; Boucher, J; Beebe, K; Gall, W; Kahn, CR				Macotela, Yazmin; Emanuelli, Brice; Bang, Anneli M.; Espinoza, Daniel O.; Boucher, Jeremie; Beebe, Kirk; Gall, Walter; Kahn, C. Ronald			Dietary Leucine - An Environmental Modifier of Insulin Resistance Acting on Multiple Levels of Metabolism	PLOS ONE			English	Article							AMINO-ACIDS; GLUCOSE-METABOLISM; SKELETAL-MUSCLE; INDUCED OBESITY; RECEPTOR SUBSTRATE-1; MAMMALIAN TARGET; PROTEIN INTAKE; BLOOD-GLUCOSE; WEIGHT-LOSS; PHOSPHORYLATION	Environmental factors, such as the macronutrient composition of the diet, can have a profound impact on risk of diabetes and metabolic syndrome. In the present study we demonstrate how a single, simple dietary factor-leucine-can modify insulin resistance by acting on multiple tissues and at multiple levels of metabolism. Mice were placed on a normal or high fat diet (HFD). Dietary leucine was doubled by addition to the drinking water. mRNA, protein and complete metabolomic profiles were assessed in the major insulin sensitive tissues and serum, and correlated with changes in glucose homeostasis and insulin signaling. After 8 weeks on HFD, mice developed obesity, fatty liver, inflammatory changes in adipose tissue and insulin resistance at the level of IRS-1 phosphorylation, as well as alterations in metabolomic profile of amino acid metabolites, TCA cycle intermediates, glucose and cholesterol metabolites, and fatty acids in liver, muscle, fat and serum. Doubling dietary leucine reversed many of the metabolite abnormalities and caused a marked improvement in glucose tolerance and insulin signaling without altering food intake or weight gain. Increased dietary leucine was also associated with a decrease in hepatic steatosis and a decrease in inflammation in adipose tissue. These changes occurred despite an increase in insulin-stimulated phosphorylation of p70S6 kinase indicating enhanced activation of mTOR, a phenomenon normally associated with insulin resistance. These data indicate that modest changes in a single environmental/nutrient factor can modify multiple metabolic and signaling pathways and modify HFD induced metabolic syndrome by acting at a systemic level on multiple tissues. These data also suggest that increasing dietary leucine may provide an adjunct in the management of obesity-related insulin resistance.	[Macotela, Yazmin; Emanuelli, Brice; Bang, Anneli M.; Espinoza, Daniel O.; Boucher, Jeremie; Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA 02215 USA; [Macotela, Yazmin; Emanuelli, Brice; Bang, Anneli M.; Espinoza, Daniel O.; Boucher, Jeremie; Kahn, C. Ronald] Harvard Univ, Sch Med, Boston, MA USA; [Beebe, Kirk; Gall, Walter] Metabolon Inc, Durham, NC USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Metabolon	Macotela, Y (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Emanuelli, Brice/M-2097-2016; Boucher, Jeremie/G-6602-2015; Kahn, Ronald/AAY-2435-2021	Emanuelli, Brice/0000-0001-5795-5666; Kahn, Ronald/0000-0002-7583-9228	Pew Latin American Fellows program; NIH [DK33201]; Loveman Foundation; Mary K. Iacocca Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082659, P30DK036836, R01DK033201, R37DK031036] Funding Source: NIH RePORTER	Pew Latin American Fellows program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loveman Foundation; Mary K. Iacocca Professorship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Pew Latin American Fellows program fellowship an ADA grant to YM, NIH grant DK33201 to CRK, the Loveman Foundation and the Mary K. Iacocca Professorship. Metabolon, Inc, acted as a funder only through employment of KB and WG. The role of Metabolon was performance of the metabolomic analysis reported in this study. Other than that, Metabolon had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi MG, 2009, MUTAT RES-FUND MOL M, V667, P35, DOI 10.1016/j.mrfmmm.2008.10.018; Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Bae EJ, 2008, MOL PHARMACOL, V73, P1502, DOI 10.1124/mol.107.044347; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; BRATUSCHMARRAIN PR, 1983, DIABETES, V32, P1028, DOI 10.2337/diabetes.32.11.1028; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calder PC, 2006, J NUTR, V136, p288S, DOI 10.1093/jn/136.1.288S; Carlson CJ, 2004, BIOCHEM BIOPH RES CO, V316, P533, DOI 10.1016/j.bbrc.2004.02.082; Draznin B, 2006, DIABETES, V55, P2392, DOI 10.2337/db06-0391; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; GALL WE, 2010, PLOS ONE IN PRESS; Gannon MC, 2003, AM J CLIN NUTR, V78, P734, DOI 10.1093/ajcn/78.4.734; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hinault C, 2006, DIABETOLOGIA, V49, P1017, DOI 10.1007/s00125-006-0201-z; Hinault C, 2004, FASEB J, V18, P1894, DOI 10.1096/fj.03-1409fje; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Kalogeropoulo D, 2008, METABOLISM, V57, P1747, DOI 10.1016/j.metabol.2008.09.001; Kawaguchi T, 2008, INT J MOL MED, V22, P105; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krieger JW, 2006, AM J CLIN NUTR, V83, P260; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Linn T, 2000, DIABETOLOGIA, V43, P1257, DOI 10.1007/s001250051521; Linn T, 1996, J CLIN ENDOCR METAB, V81, P3938, DOI 10.1210/jc.81.11.3938; Lynch CJ, 2000, J CELL BIOCHEM, V77, P234, DOI 10.1002/(SICI)1097-4644(20000501)77:2<234::AID-JCB7>3.0.CO;2-I; Nairizi A, 2009, J NUTR, V139, P715, DOI 10.3945/jn.108.100081; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Petzke KJ, 2007, J NUTR BIOCHEM, V18, P400, DOI 10.1016/j.jnutbio.2006.07.005; Romao I, 2008, J AM DIET ASSOC, V108, pS24, DOI 10.1016/j.jada.2008.01.022; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	44	203	233	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21187	10.1371/journal.pone.0021187	http://dx.doi.org/10.1371/journal.pone.0021187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731668	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700045
J	Schaer, DA; Li, YB; Merghoub, T; Rizzuto, GA; Shemesh, A; Cohen, AD; Li, YY; Avogadri, F; Toledo-Crow, R; Houghton, AN; Wolchok, JD				Schaer, David A.; Li, Yongbiao; Merghoub, Taha; Rizzuto, Gabrielle A.; Shemesh, Amos; Cohen, Adam D.; Li, Yanyun; Avogadri, Francesca; Toledo-Crow, Ricardo; Houghton, Alan N.; Wolchok, Jedd D.			Detection of Intra-Tumor Self Antigen Recognition during Melanoma Tumor Progression in Mice Using Advanced Multimode Confocal/Two Photon Microscope	PLOS ONE			English	Article							REGULATORY T-CELLS; CANCER IMMUNOSURVEILLANCE; SUPPRESSOR-CELLS; IMMUNE-RESPONSE; LYTIC FUNCTION; IMMUNOTHERAPY; LYMPHOCYTES; TOLERANCE; EFFECTOR; SYSTEM	Determining how tumor immunity is regulated requires understanding the extent to which the anti-tumor immune response "functions" in vivo without therapeutic intervention. To better understand this question, we developed advanced multimodal reflectance confocal/two photon fluorescence intra-vital imaging techniques to use in combination with traditional ex vivo analysis of tumor specific T cells. By transferring small numbers of melanoma-specific CD8+ T cells (Pmel-1), in an attempt to mimic physiologic conditions, we found that B16 tumor growth alone was sufficient to induce naive Pmel-1 T cell proliferation and acquisition of effector phenotype. Tumor-primed Pmel-1 T cells, are capable of killing target cells in the periphery and secrete IFN gamma, but are unable to mediate tumor regression. Within the tumor, Pmel-1 T cells have highly confined mobility, displaying long term interactions with tumor cells. In contrast, adoptively transferred non tumor-specific OT-I T cells show neither confined mobility, nor long term interaction with B16 tumor cells, suggesting that intra-tumor recognition of cognate self antigen by Pmel-1 T cells occurs during tumor growth. Together, these data indicate that lack of anti-tumor efficacy is not solely due to ignorance of self antigen in the tumor microenvironment but rather to active immunosuppressive influences preventing a protective immune response.	[Schaer, David A.; Merghoub, Taha; Rizzuto, Gabrielle A.; Shemesh, Amos; Li, Yanyun; Avogadri, Francesca; Houghton, Alan N.; Wolchok, Jedd D.] Sloan Kettering Inst Canc Res, Program Immunol, Swim Amer Lab, New York, NY USA; [Merghoub, Taha; Cohen, Adam D.; Houghton, Alan N.; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Li, Yongbiao; Toledo-Crow, Ricardo] Sloan Kettering Inst Canc Res, Res Engn Lab, New York, NY USA; [Rizzuto, Gabrielle A.; Houghton, Alan N.; Wolchok, Jedd D.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Schaer, DA (corresponding author), Sloan Kettering Inst Canc Res, Program Immunol, Swim Amer Lab, New York, NY USA.	wolchokj@mskcc.org	Rizzuto, Gabrielle/GWR-2224-2022; Cohen, Adam D/F-6729-2012; Merghoub, Taha/ABD-8362-2021	Cohen, Adam/0000-0003-0939-3843; Rizzuto, Gabrielle/0000-0003-3052-0253	NIH [R01CA56821, P01CA33049, P01CA59350, K12 CA120121-01]; NIH/NCI [T32 CA09149-30]; John D. Proctor Foundation; Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009149, P01CA033049, R01CA056821, P01CA059350, K12CA120121] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); John D. Proctor Foundation; Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support: This work was supported by NIH grants R01CA56821, P01CA33049, and P01CA59350 (to J.D.W. and A.N.H.), D.A.S. is supported by the NIH Clinical Training for Scholar Grant K12 CA120121-01, and received support from the NIH/NCI Immunology Training Grant T32 CA09149-30 and John D. Proctor Foundation: Margaret A. Cunningham Immune Mechanisms in Cancer Research Fellowship Award; Swim Across America (http://www.swimacrossamerica.org); the Mr. William H. Goodwin and Mrs. Alice Goodwin and the Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center (to J.D.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Cahalan MD, 2006, CURR OPIN IMMUNOL, V18, P476, DOI 10.1016/j.coi.2006.05.013; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Germain RN, 2008, IMMUNOL REV, V221, P163, DOI 10.1111/j.1600-065X.2008.00591.x; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Koneru M, 2006, J IMMUNOL, V176, P6103, DOI 10.4049/jimmunol.176.10.6103; Kowalczyk DW, 2001, J IMMUNOL METHODS, V253, P163, DOI 10.1016/S0022-1759(01)00356-8; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Monu N, 2007, CANCER RES, V67, P11447, DOI 10.1158/0008-5472.CAN-07-1441; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Speiser DE, 1997, J EXP MED, V186, P645, DOI 10.1084/jem.186.5.645; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	29	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21214	10.1371/journal.pone.0021214	http://dx.doi.org/10.1371/journal.pone.0021214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731676	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700047
J	Dupuis-Coronas, S; Lagarrigue, F; Ramel, D; Chicanne, G; Saland, E; Gaits-Iacovoni, F; Payrastre, B; Tronchere, H				Dupuis-Coronas, Sophie; Lagarrigue, Frederic; Ramel, Damien; Chicanne, Gaetan; Saland, Estelle; Gaits-Iacovoni, Frederique; Payrastre, Bernard; Tronchere, Helene			The Nucleophosmin-Anaplastic Lymphoma Kinase Oncogene Interacts, Activates, and Uses the Kinase PIKfyve to Increase Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-CELL LYMPHOMA; PHOSPHATIDYLINOSITOL 5-PHOSPHATE; NPM-ALK; EXTRACELLULAR-MATRIX; TYROSINE KINASE; PHOSPHOINOSITIDE; PATHWAY; INSULIN; PTDINS5P; METALLOPROTEINASES	NPM-ALK is a chimeric tyrosine kinase detected in most anaplastic large cell lymphomas that results from the reciprocal translocation t(2,5)(p23; q35) that fuses the N-terminal domain of nucleophosmin (NPM) to the catalytic domain of the anaplastic lymphoma kinase (ALK) receptor. The constitutive activity of the kinase is responsible for its oncogenicity through the stimulation of several downstream signaling pathways, leading to cell proliferation, migration, and survival. We demonstrated previously that the high level of phosphatidylinositol 5-phosphate measured in NPM-ALK-expressing cells is controlled by the phosphoinositide kinase PIKfyve, a lipid kinase known for its role in vesicular trafficking. Here, we show that PIKfyve associates with NPM-ALK and that the interaction involves the 181300 region of the oncogene. Moreover, we demonstrate that the tyrosine kinase activity of the oncogene controls PIKfyve lipid kinase activity but is dispensable for the formation of the complex. Silencing or inhibition of PIKfyve using siRNA or the PIKfyve inhibitor YM201636 have no effect on NPM-ALK-mediated proliferation and migration but strongly reduce invasive capacities of NPM-ALK-expressing cells and their capacity to degrade the extracellular matrix. Accordingly, immunofluorescence studies confirm a perturbation of matrix metalloproteinase 9 localization at the cell surface and defect in maturation. Altogether, these results suggest a role for PIKfyve in NPM-ALK-mediated invasion.	[Dupuis-Coronas, Sophie; Lagarrigue, Frederic; Ramel, Damien; Chicanne, Gaetan; Saland, Estelle; Gaits-Iacovoni, Frederique; Payrastre, Bernard; Tronchere, Helene] Univ Toulouse 3, Ctr Hosp Univ Toulouse, INSERM, U1048,I2MC, F-31432 Toulouse 4, France; [Payrastre, Bernard] CHU Toulouse, Hematol Lab, F-31432 Toulouse 4, France	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Tronchere, H (corresponding author), CHU Rangueil, INSERM, U1048, I2MC, F-31432 Toulouse 4, France.	helene.tronchere@inserm.fr	SALAND, Estelle/W-7996-2019; Chicanne, Gaëtan/M-5260-2014; TRONCHERE, Helene/M-5631-2014; Payrastre, Bernard/M-5295-2014	Chicanne, Gaetan/0000-0002-7081-2595; , Bernard/0000-0002-8693-0190; Lagarrigue, Frederic/0000-0002-4660-8666; Gaits-Iacovoni, Frederique/0000-0002-9853-0442; RAMEL, Damien/0000-0002-9089-1497	Ministere de l'Education Nationale de la Recherche et de la Technologie; Association pour la Recherche contre le Cancer; Agence Nationale de la Recherche (ANR) eRare; ANR Blanc; Pole de Competitivite Cancer-Bio Sante/Fonds Uniques Interministeriels des Poles de Competitivite	Ministere de l'Education Nationale de la Recherche et de la Technologie; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche (ANR) eRare(French National Research Agency (ANR)); ANR Blanc(French National Research Agency (ANR)); Pole de Competitivite Cancer-Bio Sante/Fonds Uniques Interministeriels des Poles de Competitivite	This work is supported by grants from Ministere de l'Education Nationale de la Recherche et de la Technologie, Association pour la Recherche contre le Cancer, Agence Nationale de la Recherche (ANR) eRare, ANR Blanc, and Pole de Competitivite Cancer-Bio Sante/Fonds Uniques Interministeriels des Poles de Competitivite.	Armstrong F, 2004, ONCOGENE, V23, P6071, DOI 10.1038/sj.onc.1207813; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Bonvini P, 2002, CANCER RES, V62, P1559; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Clarke JH, 2001, BIOCHEM J, V357, P905, DOI 10.1042/0264-6021:3570905; Coronas S, 2008, BIOCHEM BIOPH RES CO, V372, P351, DOI 10.1016/j.bbrc.2008.05.062; Coronas S, 2007, BIOCHEM SOC SYMP, V74, P117, DOI 10.1042/BSS2007c11; Cussac D, 2004, BLOOD, V103, P1464; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fiorani C, 2001, CLIN LYMPHOMA, V2, P29, DOI 10.3816/CLM.2001.n.009; Gehring EM, 2009, CELL PHYSIOL BIOCHEM, V24, P361, DOI 10.1159/000257428; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Horie R, 2004, CANCER CELL, V5, P353, DOI 10.1016/S1535-6108(04)00084-4; Hubinger G, 1999, EXP HEMATOL, V27, P1796, DOI 10.1016/S0301-472X(99)00116-2; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2003, J BIOL CHEM, V278, P50863, DOI 10.1074/jbc.M307260200; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2009, BIOCHEM BIOPH RES CO, V382, P566, DOI 10.1016/j.bbrc.2009.03.063; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Kim J, 2007, CANCER RES, V67, P9229, DOI 10.1158/0008-5472.CAN-07-1333; Klaus F, 2009, BIOCHEM BIOPH RES CO, V381, P407, DOI 10.1016/j.bbrc.2009.02.053; Lamant L, 2004, LEUKEMIA, V18, P1693, DOI 10.1038/sj.leu.2403464; Lecompte O, 2008, TRENDS BIOCHEM SCI, V33, P453, DOI 10.1016/j.tibs.2008.07.002; Meijer HJG, 2001, BIOCHEM J, V360, P491, DOI 10.1042/0264-6021:3600491; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Morris JB, 2000, FEBS LETT, V475, P57, DOI 10.1016/S0014-5793(00)01625-2; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Osborne SL, 2008, J BIOL CHEM, V283, P2804, DOI 10.1074/jbc.M704856200; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; Pendaries C, 2006, EMBO J, V25, P1024, DOI 10.1038/sj.emboj.7601001; Prakobwong S, 2011, INT J CANCER, V129, P88, DOI 10.1002/ijc.25656; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Sbrissa D, 2002, J BIOL CHEM, V277, P47276, DOI 10.1074/jbc.M207576200; Sbrissa D, 2001, MOL CELL ENDOCRINOL, V181, P35, DOI 10.1016/S0303-7207(01)00539-1; Schnaeker EM, 2004, CANCER RES, V64, P8924, DOI 10.1158/0008-5472.CAN-04-0324; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shojaiefard M, 2007, BIOCHEM BIOPH RES CO, V359, P843, DOI 10.1016/j.bbrc.2007.05.111; Sidera K, 2008, CELL CYCLE, V7, P1564, DOI 10.4161/cc.7.11.6054; Slupianek A, 2001, CANCER RES, V61, P2194; Sopjani M, 2010, J MEMBRANE BIOL, V233, P35, DOI 10.1007/s00232-009-9222-0; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Strutz-Seebohm N, 2007, CELL PHYSIOL BIOCHEM, V20, P729, DOI 10.1159/000110433; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Zou J, 2007, P NATL ACAD SCI USA, V104, P16834, DOI 10.1073/pnas.0708189104	57	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2011	286	37					32105	32114		10.1074/jbc.M111.227512	http://dx.doi.org/10.1074/jbc.M111.227512			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	818CK	21737449	hybrid, Green Published			2022-12-25	WOS:000294726800020
J	Tatum, D; Li, WT; Placer, M; Li, SS				Tatum, Danielle; Li, Wentao; Placer, Margaret; Li, Shisheng			Diverse Roles of RNA Polymerase II-associated Factor 1 Complex in Different Subpathways of Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-COUPLED REPAIR; DNA-DAMAGE CHECKPOINT; GLOBAL GENOMIC REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; HISTONE H2B UBIQUITYLATION; NUCLEOSOME CORE PARTICLE; SACCHAROMYCES-CEREVISIAE; PAF1 COMPLEX; NONTRANSCRIBED STRAND; ELONGATION-FACTORS	Transcription-coupled repair (TCR) and global genomic repair (GGR) are two pathways of nucleotide excision repair (NER). In Saccharomyces cerevisiae, Rad26 is important but not absolutely required for TCR. Rpb4, a nonessential RNA polymerase II (Pol II) subunit that forms a subcomplex with Rpb7, and the Spt4-Spt5 complex, a transcription elongation factor, have been shown to suppress Rad26-independent TCR. The Pol II-associated factor 1 complex (Paf1C) has been shown to function in transcription elongation, 3'-processing of mRNAs, and posttranslational modification of histones. Here we show that Paf1C plays a marginal role in facilitating Rad26-dependent TCR but significantly suppresses Rad26-independent TCR. The suppression of Rad26-independent TCR is achieved by cooperating with Spt4-Spt5. Wepropose a model that, in the absence of Rad26, a lesion is "locked" in the active center of a Pol II elongation complex, which is stabilized by the coordinated interactions of Rpb4-Rpb7, Spt4-Spt5, and Paf1C with each other and with the core Pol II. We also found that Paf1C facilitates GGR, especially in internucleosomal linker regions. The facilitation of GGR is achieved through enabling monoubiquitination of histone H2B lysine 123 by Bre1, which in turn permits di- and trimethylation of histone H3 lysine 79 by Dot1. To our best knowledge, among the NER-modulating factors documented so far, Paf1C appears to have the most diverse functions in different NER pathways or subpathways.	[Tatum, Danielle; Li, Wentao; Placer, Margaret; Li, Shisheng] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@vetmed.lsu.edu	Li, Wentao/AAU-1637-2020	Li, Wentao/0000-0003-2313-6384; Tatum, Danielle/0000-0002-3281-3853	National Science Foundation [MCB-0745229]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0745229.	Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Brueckner F, 2007, FEBS LETT, V581, P2757, DOI 10.1016/j.febslet.2007.05.014; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chen XF, 2007, MOL CELL BIOL, V27, P4617, DOI 10.1128/MCB.00404-07; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P227; Gaillard H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000364; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; Guzder SN, 1998, J BIOL CHEM, V273, P6292, DOI 10.1074/jbc.273.11.6292; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; LeJeune D, 2009, DNA REPAIR, V8, P40, DOI 10.1016/j.dnarep.2008.08.010; Levesque N, 2010, J BIOL CHEM, V285, P35113, DOI 10.1074/jbc.M110.116855; Li SS, 2007, DNA REPAIR, V6, P1596, DOI 10.1016/j.dnarep.2007.05.005; Li SS, 2006, MOL CELL BIOL, V26, P9430, DOI 10.1128/MCB.01656-06; Li SH, 2006, J BIOL CHEM, V281, P36643, DOI 10.1074/jbc.M604885200; Li SS, 1996, CARCINOGENESIS, V17, P1549, DOI 10.1093/carcin/17.8.1549; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 1997, J MOL BIOL, V271, P31, DOI 10.1006/jmbi.1997.1154; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Lloyd RS, 2005, MUTAT RES-FUND MOL M, V577, P77, DOI 10.1016/j.mrfmmm.2005.04.003; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; SWANSON MS, 1991, MOL CELL BIOL, V11, P3009, DOI 10.1128/MCB.11.6.3009; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Teng Y, 2008, EMBO REP, V9, P97, DOI 10.1038/sj.embor.7401112; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; VERHAGE R, 1994, MOL CELL BIOL, V14, P6135, DOI 10.1128/MCB.14.9.6135; Verhage RA, 1996, MOL CELL BIOL, V16, P496; Waters R, 2009, DNA REPAIR, V8, P146, DOI 10.1016/j.dnarep.2008.11.001; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102	67	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30304	30313		10.1074/jbc.M111.252981	http://dx.doi.org/10.1074/jbc.M111.252981			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737840	Green Published, hybrid			2022-12-25	WOS:000294283600008
J	Gaudin, F; Nasreddine, S; Donnadieu, AC; Emilie, D; Combadiere, C; Prevot, S; Machelon, V; Balabanian, K				Gaudin, Francoise; Nasreddine, Salam; Donnadieu, Anne-Claire; Emilie, Dominique; Combadiere, Christophe; Prevot, Sophie; Machelon, Veronique; Balabanian, Karl			Identification of the Chemokine CX(3)CL1 as a New Regulator of Malignant Cell Proliferation in Epithelial Ovarian Cancer	PLOS ONE			English	Article							INDUCED LEUCINE-ZIPPER; PROTECTS T-LYMPHOCYTES; ANTITUMOR RESPONSES; GENE-EXPRESSION; FALLOPIAN-TUBE; CLEAR-CELL; FRACTALKINE; RECEPTOR; ADHESION; MODEL	Background: Little is known about the molecules that contribute to the growth of epithelial ovarian carcinomas (EOC), which remain the most lethal gynecological cancer in women. The chemokine Fractalkine/CX(3)CL1 has been widely reported to play a biologically relevant role in tumor growth and spread. We report here the first investigation of the expression and role of CX(3)CL1 in EOC. Results: Epithelial cells from the surface of the ovary and the Fallopian tubes and from benign, borderline and malignant tumors all stained positive for CX(3)CL1. In tumor specimens from 54 women who underwent surgical treatment for EOC diagnosis, CX(3)CL1 immunoreactivity was unevenly distributed in epithelial tumor cells, and ranged from strong (33%) to absent (17%). This uneven distribution of CX(3)CL1 did not reflect the morphological heterogeneity of EOC. It was positively correlated with the proliferation index Ki-67 and with GILZ (glucocorticoid-induced leucine zipper), previously identified as an activator of the proliferation of malignant EOC cells. Hierarchical clustering analysis, including age at diagnosis, tumor grade, FIGO stage, Ki-67 index, CX(3)CL1, SDF-1/CXCL12 and GILZ immunostaining scores, distinguished two major clusters corresponding to low and high levels of proliferation and differing in terms of GILZ and CX(3)CL1 expression. GILZ overexpression in the carcinoma-derived BG1 cell line resulted in parallel changes in CX(3)CL1 products. Conversely, CX(3)CL1 promoted through its binding to CX(3)CR1 AKT activation and proliferation in BG1 cells. In a mouse subcutaneous xenograft model, the overexpression of GILZ was associated with higher expression of CX(3)CL1 and faster tumor growth. Conclusion: Our findings highlight the previously unappreciated constitutive expression of CX(3)CL1 preceding tumorigenesis in ovarian epithelial cells. Together with GILZ, this chemokine emerges as a regulator of cell proliferation, which may be of potential clinical relevance for the selection of the most appropriate treatment for EOC patients.	[Gaudin, Francoise; Nasreddine, Salam; Donnadieu, Anne-Claire; Emilie, Dominique; Machelon, Veronique; Balabanian, Karl] Univ Paris 11, INSERM, UMR S996, Clamart, France; [Emilie, Dominique] Hop Antoine Beclere, AP HP, Serv Microbiol Immunol Biol, Clamart, France; [Combadiere, Christophe] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, INSERM,UMR S945, Paris, France; [Prevot, Sophie] Hop Antoine Beclere, AP HP, Serv Anat & Cytol Pathol, Clamart, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Gaudin, F (corresponding author), Univ Paris 11, INSERM, UMR S996, Clamart, France.	veronique.machelon@u-psud.fr	Balabanian, Karl/I-2990-2016; Combadiere, Christophe/I-5639-2013; Balabanian, Karl/S-6250-2019	Balabanian, Karl/0000-0002-0534-3198; Combadiere, Christophe/0000-0002-1755-4531; Balabanian, Karl/0000-0002-0534-3198	Ligue contre le cancer (Comite Val d'Oise); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paris-Sud; European Union [LSHB-CT-2005-518167]	Ligue contre le cancer (Comite Val d'Oise); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Sud; European Union(European Commission)	This work was supported by the Ligue contre le cancer (Comite Val d'Oise), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite Paris-Sud, and the European Union FP6 (INNOCHEM, grant number LSHB-CT-2005-518167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Barbieri F, 2010, J ONCOL, V2010, DOI 10.1155/2010/426956; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Belot MP, 2007, J CELL BIOCHEM, V102, P1271, DOI 10.1002/jcb.21357; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Guo J, 2003, IMMUNOL LETT, V89, P1, DOI 10.1016/S0165-2478(03)00101-9; Guo J, 2003, INT J CANCER, V103, P212, DOI 10.1002/ijc.10816; Hannan NJ, 2004, J CLIN ENDOCR METAB, V89, P6119, DOI 10.1210/jc.2003-031379; Jamieson WL, 2008, CANCER RES, V68, P1715, DOI 10.1158/0008-5472.CAN-07-1315; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Khouja MH, 2007, INT J GYNECOL PATHOL, V26, P418, DOI 10.1097/pgp.0b013e31804216a0; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kryczek I, 2005, CANCER RES, V65, P465; Lavergne E, 2003, CANCER RES, V63, P7468; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Levanon K, 2010, ONCOGENE, V29, P1103, DOI 10.1038/onc.2009.402; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; Machelon V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-97; Marchesi F, 2008, CANCER RES, V68, P9060, DOI 10.1158/0008-5472.CAN-08-1810; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Ohta M, 2005, INT J ONCOL, V26, P41; Permuth-Wey Jennifer, 2009, V472, P413, DOI 10.1007/978-1-60327-492-0_20; Perros F, 2007, EUR RESPIR J, V29, P937, DOI 10.1183/09031936.00104706; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Redjimi N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-83; Runz S, 2007, GYNECOL ONCOL, V107, P563, DOI 10.1016/j.ygyno.2007.08.064; Schwartz DR, 2002, CANCER RES, V62, P4722; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Shimizu Y, 1998, CANCER-AM CANCER SOC, V82, P893, DOI 10.1002/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Vitale S, 2007, GUT, V56, P365, DOI 10.1136/gut.2005.088989; Yu YRA, 2007, INT J CANCER, V121, P316, DOI 10.1002/ijc.22660; Zhang Q, 2004, HUM REPROD, V19, P409, DOI 10.1093/humrep/deh085; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508; Zou WP, 2001, NAT MED, V7, P1339, DOI 10.1038/nm1201-1339	52	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21546	10.1371/journal.pone.0021546	http://dx.doi.org/10.1371/journal.pone.0021546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750716	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400007
J	Arikawa, M; Kakinuma, Y; Handa, T; Yamasaki, F; Sato, T				Arikawa, Mikihiko; Kakinuma, Yoshihiko; Handa, Takemi; Yamasaki, Fumiyasu; Sato, Takayuki			Donepezil, Anti-Alzheimer's Disease Drug, Prevents Cardiac Rupture during Acute Phase of Myocardial Infarction in Mice	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITION; VENTRICULAR FREE-WALL; TARGETED DELETION; HEART-FAILURE; INFLAMMATORY RESPONSE; VAGAL-STIMULATION; NEUROPROTECTION; ACETYLCHOLINE; MATRIX-METALLOPROTEINASE-9; ANGIOGENESIS	Background: We have previously demonstrated that the chronic intervention in the cholinergic system by donepezil, an acetylcholinesterase inhibitor, plays a beneficial role in suppressing long-term cardiac remodeling after myocardial infarction (MI). In comparison with such a chronic effect, however, the acute effect of donepezil during an acute phase of MI remains unclear. Noticing recent findings of a cholinergic mechanism for anti-inflammatory actions, we tested the hypothesis that donepezil attenuates an acute inflammatory tissue injury following MI. Methods and Results: In isolated and activated macrophages, donepezil significantly reduced intra-and extracellular matrix metalloproteinase-9 (MMP-9). In mice with MI, despite the comparable values of heart rate and blood pressure, the donepezil-treated group showed a significantly lower incidence of cardiac rupture than the untreated group during the acute phase of MI. Immunohistochemistry revealed that MMP-9 was localized at the infarct area where a large number of inflammatory cells including macrophages infiltrated, and the expression and the enzymatic activity of MMP-9 at the left ventricular infarct area was significantly reduced in the donepezil-treated group. Conclusion: The present study suggests that donepezil inhibits the MMP-9-related acute inflammatory tissue injury in the infarcted myocardium, thereby reduces the risk of left ventricular free wall rupture during the acute phase of MI.	[Arikawa, Mikihiko; Kakinuma, Yoshihiko; Handa, Takemi; Sato, Takayuki] Kochi Med Sch, Dept Cardiovasc Control, Nanko Ku, Kochi, Japan; [Yamasaki, Fumiyasu] Kochi Med Sch, Dept Clin Lab, Nanko Ku, Kochi, Japan	Kochi University; Kochi University	Arikawa, M (corresponding author), Kochi Med Sch, Dept Cardiovasc Control, Nanko Ku, Kochi, Japan.	marikawa@kochi-u.ac.jp		Kakinuma, Yoshihiko/0000-0001-5470-9128	Japan Society for the Promotion of Science [21790729]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (21790729) from Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Akasofu S, 2008, CHEM-BIOL INTERACT, V175, P222, DOI 10.1016/j.cbi.2008.04.045; Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Arikawa M, 2007, CIRCULATION, V116, P291; BATTS KP, 1990, HUM PATHOL, V21, P530, DOI 10.1016/0046-8177(90)90010-3; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Davis N, 2002, PERFUSION-UK, V17, P63, DOI 10.1191/0267659102pf521oa; De Ferrari GM, 2009, IEEE ENG MED BIO, P2037, DOI 10.1109/IEMBS.2009.5334414; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; DonnellyRoberts DL, 1996, BRAIN RES, V719, P36, DOI 10.1016/0006-8993(96)00063-7; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Fang L, 2008, CLIN SCI, V115, P99, DOI 10.1042/CS20070365; Figueras J, 1997, J AM COLL CARDIOL, V29, P512, DOI 10.1016/S0735-1097(96)00542-6; Gao XM, 2010, INT J CARDIOL, V143, P20, DOI 10.1016/j.ijcard.2009.01.019; Gao XM, 2005, CARDIOVASC RES, V65, P469, DOI 10.1016/j.cardiores.2004.10.014; Handa T, 2009, J CARD FAIL, V15, P805, DOI 10.1016/j.cardfail.2009.05.008; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Kakinuma Y, 2010, J MOL CELL CARDIOL, V48, P680, DOI 10.1016/j.yjmcc.2009.11.010; Katare RG, 2009, J THORAC CARDIOV SUR, V137, P223, DOI 10.1016/j.jtcvs.2008.08.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Leva Cristian, 2006, Interact Cardiovasc Thorac Surg, V5, P408, DOI 10.1510/icvts.2006.131037; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; LI MH, 2009, CIRCULATION S2, V120, pS1178; Lindsey ML, 2004, HEART FAIL REV, V9, P7, DOI 10.1023/B:HREV.0000011390.44039.b7; Lindsey ML, 2002, CIRCULATION, V105, P753, DOI 10.1161/hc0602.103674; Lu F, 2007, J MOL CELL CARDIOL, V43, P535, DOI 10.1016/j.yjmcc.2007.06.011; Matsumura S, 2005, J CLIN INVEST, V115, P599, DOI 10.1172/JCI200522304; McMullan MH, 2001, ANN THORAC SURG, V71, P1894, DOI 10.1016/S0003-4975(01)02625-X; Nagaoka I, 2000, INFLAMM RES, V49, P55, DOI 10.1007/s000110050559; Okazaki Y, 2010, J PHYSIOL SCI, V60, P67, DOI 10.1007/s12576-009-0071-5; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Peterson JT, 2001, CIRCULATION, V103, P2303; PFEFFER J, 1979, AM J CARDIOL, V44, P994, DOI 10.1016/0002-9149(79)90234-0; PFEFFER JM, 1985, CIRC RES, V57, P84, DOI 10.1161/01.RES.57.1.84; Purcaro A, 1997, AM J CARDIOL, V80, P397, DOI 10.1016/S0002-9149(97)00385-8; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Ryan RE, 2001, BRIT J PHARMACOL, V132, P1650, DOI 10.1038/sj.bjp.0703989; Sakaguchi G, 2008, ANN THORAC SURG, V85, P1344, DOI 10.1016/j.athoracsur.2007.12.073; Sato K, 2010, CLIN PHARMACOL THER, V88, P335, DOI 10.1038/clpt.2010.98; Schwartz PJ, 2008, EUR J HEART FAIL, V10, P884, DOI 10.1016/j.ejheart.2008.07.016; Schwartz PJ, 2009, HEART RHYTHM, V6, pS76, DOI 10.1016/j.hrthm.2009.08.012; Shepherd G, 1999, ANN PHARMACOTHER, V33, P812, DOI 10.1345/aph.18273; Spinale FG, 1999, CIRC RES, V85, P364, DOI 10.1161/01.RES.85.4.364; Takada Y, 2003, J PHARMACOL EXP THER, V306, P772, DOI 10.1124/jpet.103.050104; Takada-Takatori Y, 2008, J NEUROSCI RES, V86, P3575, DOI 10.1002/jnr.21798; WHITEHOUSE PJ, 1982, ANN NEUROL, V12, P494, DOI 10.1002/ana.410120517; Yang YN, 2008, AM J PHYSIOL-HEART C, V294, pH1815, DOI 10.1152/ajpheart.00831.2007; Zhang Y, 2006, J PHARMACOL SCI, V101, P214, DOI 10.1254/jphs.FP0051023	52	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20629	10.1371/journal.pone.0020629	http://dx.doi.org/10.1371/journal.pone.0020629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750701	gold, Green Submitted, Green Published			2022-12-25	WOS:000292512000007
J	Yu, J; Yaba, A; Kasiman, C; Thomson, T; Johnson, J				Yu, James; Yaba, Aylin; Kasiman, Corinna; Thomson, Travis; Johnson, Joshua			mTOR Controls Ovarian Follicle Growth by Regulating Granulosa Cell Proliferation	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; TRANSLATION INITIATION; RAPAMYCIN MTOR; FACTOR-I; PATHWAY; PROGRESSION; INHIBITION; TARGET; ACTIVATION; ANEUPLOIDY	We have shown that inhibition of mTOR in granulosa cells and ovarian follicles results in compromised granulosa proliferation and reduced follicle growth. Further analysis here using spontaneously immortalized rat granulosa cells has revealed that mTOR pathway activity is enhanced during M-phase of the cell cycle. mTOR specific phosphorylation of p70S6 kinase and 4E-BP, and expression of Raptor are all enhanced during M-phase. The predominant effect of mTOR inhibition by the specific inhibitor Rapamycin (RAP) was a dose-responsive arrest in the G1 cell cycle stage. The fraction of granulosa cells that continued to divide in the presence of RAP exhibited a dose-dependent increase in aberrant mitotic figures known as anaphase bridges. Strikingly, estradiol consistently decreased the incidence of aberrant mitotic figures. In mice treated with RAP, the mitotic index was reduced compared to controls, and a similar increase in aberrant mitotic events was noted. RAP injected during a superovulation regime resulted in a dose-dependent reduction in the numbers of eggs ovulated. Implications for the real-time regulation of follicle growth and dominance, including the consequences of increased numbers of aneuploid granulosa cells, are discussed.	[Yu, James; Johnson, Joshua] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Yaba, Aylin] Akdeniz Univ, Dept Histol & Embryol, TR-07058 Antalya, Turkey; [Kasiman, Corinna] Smith Coll, Northampton, MA 01063 USA; [Thomson, Travis] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Thomson, Travis] Univ Massachusetts, Sch Med, Program Cell & Dev Dynam, Worcester, MA USA	Yale University; Akdeniz University; Smith College; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Yu, J (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	josh.johnson@yale.edu	Yaba, Aylin/K-3414-2014; Johnson, Johnson/HDL-9124-2022	Johnson, Joshua/0000-0002-6016-8089	Yale Department of Obstetrics, Gynecology, and Reproductive Sciences; Donaghue Yale Women's Health Research Program	Yale Department of Obstetrics, Gynecology, and Reproductive Sciences; Donaghue Yale Women's Health Research Program	JJ is supported by Yale Department of Obstetrics, Gynecology, and Reproductive Sciences Research Funds and the Donaghue Yale Women's Health Research Program (http://medicine.yale.edu/whr/faculty/funding.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286; Akcakanat A, 2007, BIOCHEM BIOPH RES CO, V362, P330, DOI 10.1016/j.bbrc.2007.07.151; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Baerwald AR, 2003, BIOL REPROD, V69, P1023, DOI 10.1095/biolreprod.103.017772; Banu SK, 2008, TOXICOL APPL PHARM, V232, P180, DOI 10.1016/j.taap.2008.06.002; Barilli A, 2008, CARDIOVASC RES, V78, P563, DOI 10.1093/cvr/cvn024; Berga SL, 2006, ANN NY ACAD SCI, V1092, P114, DOI 10.1196/annals.1365.010; Berga SL, 2003, FERTIL STERIL, V80, P976, DOI 10.1016/S0015-0282(03)01124-5; Bonatti S, 1998, CHROMOSOMA, V107, P498, DOI 10.1007/s004120050335; Bonatti S, 2005, ENVIRON MOL MUTAGEN, V46, P164, DOI 10.1002/em.20145; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chavarro JE, 2008, FERTIL STERIL, V89, P668, DOI 10.1016/j.fertnstert.2007.03.089; Chavarro JE, 2007, OBSTET GYNECOL, V110, P1050, DOI 10.1097/01.AOG.0000287293.25465.e1; Chavarro JE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.057; Choe G, 2003, CANCER RES, V63, P2742; Dmitriev SE, 2003, MOL CELL BIOL, V23, P8925, DOI 10.1128/MCB.23.24.8925-8933.2003; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Gersak K, 2000, FERTIL STERIL, V74, P158, DOI 10.1016/S0015-0282(00)00578-1; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Ginther OJ, 2003, ANIM REPROD SCI, V78, P239, DOI 10.1016/S0378-4320(03)00093-9; Ginther OJ, 2002, BIOL REPROD, V67, P14, DOI 10.1095/biolreprod67.1.14; Ginther OJ, 2001, BIOL REPROD, V65, P638, DOI 10.1095/biolreprod65.3.638; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Gonzalez-Bulnes A, 2004, ANIM REPROD SCI, V84, P107, DOI 10.1016/j.anireprosci.2003.11.004; Grunwald K, 1998, HUM REPROD, V13, P2679, DOI 10.1093/humrep/13.10.2679; Gwinn DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009197; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kaleli S, 2005, FERTIL STERIL, V84, P802, DOI 10.1016/j.fertnstert.2005.02.040; Kim DH, 2003, CURR TOP MICROBIOL, V279, P259; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lujan ME, 2006, ENDOCRINOLOGY, V147, P483, DOI 10.1210/en.2005-0821; Matzuk MM, 2000, MOL CELL ENDOCRINOL, V163, P61, DOI 10.1016/S0303-7207(99)00241-5; Neale D, 2003, J Matern Fetal Neonatal Med, V13, P39, DOI 10.1080/713605755; Ponticelli C, 2004, J NEPHROL, V17, P762; QUIRK SM, 2004, J ANIM SCI E S, V82; Rousseau D, 1996, ONCOGENE, V13, P2415; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; STEIN LS, 1991, CANCER RES, V51, P696; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Straszewski-Chavez SL, 2004, MOL HUM REPROD, V10, P33, DOI 10.1093/molehr/gah001; Szoltys M, 2001, Reprod Biol, V1, P42; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Thomson TC, 2010, CELL DEATH DIFFER, V17, P1717, DOI 10.1038/cdd.2010.49; Thomson TC, 2010, MOL HUM REPROD, V16, P916, DOI 10.1093/molehr/gaq066; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Vazquez-Martin A, 2009, BIOCHEM BIOPH RES CO, V380, P638, DOI 10.1016/j.bbrc.2009.01.153; Wiederrecht G J, 1995, Prog Cell Cycle Res, V1, P53; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; WULLSCHLEGER S, 2005, J BIOL CHEM; Yaba A, 2008, REPROD SCI, V15, P128, DOI 10.1177/1933719107312037; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112; Zielak AE, 2008, MOL REPROD DEV, V75, P904, DOI 10.1002/mrd.20819	55	62	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21415	10.1371/journal.pone.0021415	http://dx.doi.org/10.1371/journal.pone.0021415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750711	Green Published, gold, Green Submitted			2022-12-25	WOS:000292512000013
J	Guerrero, R; Vernia, S; Sanz, R; Abreu-Rodriguez, I; Almaraz, C; Garcia-Hoyos, M; Michelucci, R; Tassinari, CA; Riguzzi, P; Nobile, C; Sanz, P; Serratosa, JM; Gomez-Garre, P				Guerrero, Rosa; Vernia, Santiago; Sanz, Raul; Abreu-Rodriguez, Irene; Almaraz, Carmen; Garcia-Hoyos, Maria; Michelucci, Roberto; Tassinari, Carlo Alberto; Riguzzi, Patrizia; Nobile, Carlo; Sanz, Pascual; Serratosa, Jose M.; Gomez-Garre, Pilar			A PTG Variant Contributes to a Milder Phenotype in Lafora Disease	PLOS ONE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; E3 UBIQUITIN LIGASE; GLYCOGEN-SYNTHESIS; PROTEIN; MUTATIONS; MALIN; ACCUMULATION; GENE; DEGRADATION; METABOLISM	Lafora disease is an autosomal recessive form of progressive myoclonus epilepsy with no effective therapy. Although the outcome is always unfavorable, onset of symptoms and progression of the disease may vary. We aimed to identify modifier genes that may contribute to the clinical course of Lafora disease patients with EPM2A or EPM2B mutations. We established a list of 43 genes coding for proteins related to laforin/malin function and/or glycogen metabolism and tested common polymorphisms for possible associations with phenotypic differences using a collection of Lafora disease families. Genotype and haplotype analysis showed that PPP1R3C may be associated with a slow progression of the disease. The PPP1R3C gene encodes protein targeting to glycogen (PTG). Glycogen targeting subunits play a major role in recruiting type 1 protein phosphatase (PP1) to glycogen-enriched cell compartments and in increasing the specific activity of PP1 toward specific glycogenic substrates (glycogen synthase and glycogen phosphorylase). Here, we report a new mutation (c.746A>G, N249S) in the PPP1R3C gene that results in a decreased capacity to induce glycogen synthesis and a reduced interaction with glycogen phosphorylase and laforin, supporting a key role of this mutation in the glycogenic activity of PTG. This variant was found in one of two affected siblings of a Lafora disease family characterized by a remarkable mild course. Our findings suggest that variations in PTG may condition the course of Lafora disease and establish PTG as a potential target for pharmacogenetic and therapeutic approaches.	[Guerrero, Rosa; Sanz, Raul; Almaraz, Carmen; Serratosa, Jose M.; Gomez-Garre, Pilar] Inst Invest Sanitaria Fdn Jimenez Diaz, Lab Neurol, Unidad Epilepsia, Serv Neurol, Madrid, Spain; [Guerrero, Rosa; Sanz, Raul; Almaraz, Carmen; Serratosa, Jose M.; Gomez-Garre, Pilar] CIBERER, Madrid, Spain; [Vernia, Santiago; Garcia-Hoyos, Maria; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia, Spain; [Vernia, Santiago; Garcia-Hoyos, Maria; Sanz, Pascual] CIBERER, Valencia, Spain; [Abreu-Rodriguez, Irene] Inst Biomed Sevilla IBiS, Lab Invest Biomed, Seville, Spain; [Michelucci, Roberto; Riguzzi, Patrizia] Bellaria Hosp, Dept Neurosci, Neurol Unit, Bologna, Italy; [Nobile, Carlo] CNR, Inst Neurosci, Sect Padua, Padua, Italy; [Gomez-Garre, Pilar] Inst Biomed Sevilla IBiS, Unidad Trastornos Movimiento, Serv Neurol & Neurofisiol Clin, Seville, Spain; [Tassinari, Carlo Alberto] Univ Bologna, Bologna, Italy	Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); AUSL di Bologna; Consiglio Nazionale delle Ricerche (CNR); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); University of Bologna	Guerrero, R (corresponding author), Inst Invest Sanitaria Fdn Jimenez Diaz, Lab Neurol, Unidad Epilepsia, Serv Neurol, Madrid, Spain.	serratosa@telefonica.net; pggarre@telefonica.net	Vernia, Santiago/Q-7038-2017; Michelucci, Roberto/AAB-9074-2020; Gómez-Garre, Pilar/AAG-8048-2020; Sanz, Pascual/K-2751-2014	Vernia, Santiago/0000-0001-6728-5555; Gómez-Garre, Pilar/0000-0002-0437-6182; Sanz, Pascual/0000-0002-2399-4103; Nobile, Carlo/0000-0002-0634-2218; Almaraz Pro, Maria del Carmen/0000-0002-6714-4450; Serratosa, Jose/0000-0003-2239-8948; Michelucci, Roberto/0000-0002-9655-7940; Tassinari, Carlo Alberto/0000-0002-4183-5165; Guerrero, Rosa/0000-0002-4138-4667	Fundacion Mutua Madrilena; Spanish Ministry of Education and Science [SAF2008-01907, SAF2007-61003]; Generalitat Valenciana [Prometeo 2009/051]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by grants from the Fundacion Mutua Madrilena to PGG and RG, the Spanish Ministry of Education and Science (SAF2008-01907, SAF2007-61003) to PS and JMS and from the Generalitat Valenciana (Prometeo 2009/051) to PS. There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Baykan B, 2005, EPILEPSIA, V46, P1695, DOI 10.1111/j.1528-1167.2005.00272.x; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; DePaoli-Roach AA, 2010, J BIOL CHEM, V285, P25372, DOI 10.1074/jbc.M110.148668; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Franceschetti S, 2006, EPILEPSIA, V47, P640, DOI 10.1111/j.1528-1167.2006.00479.x; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomez-Abad C, 2005, NEUROLOGY, V64, P982, DOI 10.1212/01.WNL.0000154519.10805.F7; Gomez-Abad C, 2007, EPILEPSIA, V48, P1011, DOI 10.1111/j.1528-1167.2007.01004.x; Gomez-Garre P, 2007, NEUROLOGY, V68, P1369, DOI 10.1212/01.wnl.0000260061.37559.67; Gomez-Garre P, 2000, EUR J HUM GENET, V8, P946, DOI 10.1038/sj.ejhg.5200571; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Singh S, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039479; TASSINARI CA, 1978, REV EEG NEUROPHYSIOL, V8, P107, DOI 10.1016/S0370-4475(78)80126-9; Van Heycop Ten Ham MW., 1974, HDB CLIN NEUROLOGY, V15, P382; Vernia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005907; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; WANG J, 2009, J BIOL CHEM, V277, P2377; Worby CA, 2008, J BIOL CHEM, V283, P4069, DOI 10.1074/jbc.M708712200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002	30	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21294	10.1371/journal.pone.0021294	http://dx.doi.org/10.1371/journal.pone.0021294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738631	Green Published, gold			2022-12-25	WOS:000292291800010
J	Prosdocimi, F; Bittencourt, D; da Silva, FR; Kirst, M; Motta, PC; Rech, EL				Prosdocimi, Francisco; Bittencourt, Daniela; da Silva, Felipe Rodrigues; Kirst, Matias; Motta, Paulo C.; Rech, Elibio L.			Spinning Gland Transcriptomics from Two Main Clades of Spiders (Order: Araneae) - Insights on Their Molecular, Anatomical and Behavioral Evolution	PLOS ONE			English	Article							GENOME SEQUENCE; TARANTULA SPIDER; SILK FIBROIN; BETA-SUBUNIT; MEPRIN; GENES; PROTEINS; DATABASE; IDENTIFICATION; GENERATION	Characterized by distinctive evolutionary adaptations, spiders provide a comprehensive system for evolutionary and developmental studies of anatomical organs, including silk and venom production. Here we performed cDNA sequencing using massively parallel sequencers (454 GS-FLX Titanium) to generate similar to 80,000 reads from the spinning gland of Actinopus spp. (infraorder: Mygalomorphae) and Gasteracantha cancriformis (infraorder: Araneomorphae, Orbiculariae clade). Actinopus spp. retains primitive characteristics on web usage and presents a single undifferentiated spinning gland while the orbiculariae spiders have seven differentiated spinning glands and complex patterns of web usage. MIRA, Celera Assembler and CAP3 software were used to cluster NGS reads for each spider. CAP3 unigenes passed through a pipeline for automatic annotation, classification by biological function, and comparative transcriptomics. Genes related to spider silks were manually curated and analyzed. Although a single spidroin gene family was found in Actinopus spp., a vast repertoire of specialized spider silk proteins was encountered in orbiculariae. Astacin-like metalloproteases (meprin subfamily) were shown to be some of the most sampled unigenes and duplicated gene families in G. cancriformis since its evolutionary split from mygalomorphs. Our results confirm that the evolution of the molecular repertoire of silk proteins was accompanied by the (i) anatomical differentiation of spinning glands and (ii) behavioral complexification in the web usage. Finally, a phylogenetic tree was constructed to cluster most of the known spidroins in gene clades. This is the first large-scale, multi-organism transcriptome for spider spinning glands and a first step into a broad understanding of spider web systems biology and evolution.	[Prosdocimi, Francisco] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil; [Bittencourt, Daniela] EMBRAPA Amazonia Ocidental, Manaus, Amazonas, Brazil; [Prosdocimi, Francisco] Univ Catolica Brasilia, Brasilia, DF, Brazil; [da Silva, Felipe Rodrigues] EMBRAPA Informat Agr, Sao Paulo, Brazil; [Kirst, Matias] Univ Florida, IFAS, Gainesville, FL 32611 USA; [Motta, Paulo C.] Dept Zool UnB, Brasilia, DF, Brazil; [Rech, Elibio L.] EMBRAPA CeNaRGen, Brasilia, DF, Brazil	Universidade Federal do Rio de Janeiro; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); State University System of Florida; University of Florida; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Prosdocimi, F (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio de Janeiro, Brazil.	prosdocimi@bioqmed.ufrj.br; rech@cenargen.embrapa.br	da Silva, Felipe Rodrigues/A-5627-2008; Prosdocimi, Francisco/F-6847-2012; Bittencourt, Daniela/D-9483-2013; Prosdocimi, Francisco/V-5252-2019	da Silva, Felipe Rodrigues/0000-0002-3527-6870; Prosdocimi, Francisco/0000-0002-6761-3069; Prosdocimi, Francisco/0000-0002-6761-3069; Matias de Carvalho Bittencourt, Daniela/0000-0002-3137-6567	CNPq; FAPDF	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by the Brazilian government funding agencies CNPq and FAPDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2001, GENOME RES, V11, P1425; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2009, J MOL BIOL, V385, P236, DOI 10.1016/j.jmb.2008.10.062; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043; Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013; Bittencourt D, 2010, COMP BIOCHEM PHYS B, V155, P419, DOI 10.1016/j.cbpb.2010.01.005; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BOND JS, 1986, CURR TOP CELL REGUL, V28, P263; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; *CEL, CEL WGS ASS MAN; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; CHEVREUX B, SEQUENCE ASSEMBLY MI; CODDINGTON JA, 1991, ANNU REV ECOL SYST, V22, P565, DOI 10.1146/annurev.es.22.110191.003025; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Da Silveira RB, 2007, BIOCHEM J, V406, P355, DOI 10.1042/BJ20070363; Feitosa L, 1998, TOXICON, V36, P1039, DOI 10.1016/S0041-0101(97)00083-4; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foelix RF, 1996, BIOL SPIDERS; Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Garb JE, 2007, MOL BIOL EVOL, V24, P2454, DOI 10.1093/molbev/msm179; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JIANG WP, 1992, FEBS LETT, V312, P110, DOI 10.1016/0014-5793(92)80916-5; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Lorenzini DM, 2006, DEV COMP IMMUNOL, V30, P545, DOI 10.1016/j.dci.2005.09.001; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARPLES B. J., 1967, J LINN SOC LONDON ZOOL, V46, P209; Mattick JS, 2009, ANN NY ACAD SCI, V1178, P29, DOI 10.1111/j.1749-6632.2009.04991.x; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Meisel RP, 2009, J MOL EVOL, V69, P81, DOI 10.1007/s00239-009-9254-1; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Mohrlen F, 2006, EVOL DEV, V8, P223, DOI 10.1111/j.1525-142X.2006.00092.x; MUMA M H, 1971, Florida Entomologist, V54, P345, DOI 10.2307/3493600; Nei M, 2000, MOL EVOLUTION PHYLOG; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; PALMER JM, 1985, J MORPHOL, V186, P195, DOI 10.1002/jmor.1051860205; PALMER JM, 1982, J MORPHOL, V174, P269, DOI 10.1002/jmor.1051740303; PEAKALL DB, 1964, J EXP ZOOL, V156, P345, DOI 10.1002/jez.1401560310; PEAKALL DB, 1965, NATURE, V207, P102, DOI 10.1038/207102a0; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Platnick N.I., 1976, American Museum Novitates, VNo. 2607, P1; Pontius J., 2003, NCBI HDB, P1; Prosdocimi F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000900014; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schutte A, 2007, BIOL CHEM, V388, P523, DOI 10.1515/BC.2007.060; Shakhnovich BE, 2006, GENOME RES, V16, P1529, DOI 10.1101/gr.5346206; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Soskine M, 2010, NAT REV GENET, V11, P572, DOI 10.1038/nrg2808; STRADLING DJ, 1994, BIOTROPICA, V26, P84, DOI 10.2307/2389113; Tai PL, 2004, INT J BIOL MACROMOL, V34, P295, DOI 10.1016/j.ijbiomac.2004.08.002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Telles GP, 2001, GENET MOL BIOL, V24, P17, DOI 10.1590/S1415-47572001000100004; Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250; Trevisan-Silva D, 2010, BIOCHIMIE, V92, P21, DOI 10.1016/j.biochi.2009.10.003; Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255; Vettore AL, 2003, GENOME RES, V13, P2725, DOI 10.1101/gr.1532103; VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Weiss B, 1999, CELL MOL LIFE SCI, V55, P334, DOI 10.1007/s000180050296; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324; WOLZ RL, 1991, BIOCHEMISTRY-US, V30, P8488, DOI 10.1021/bi00098a029; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yan L, 2000, DEVELOPMENT, V127, P129; Zhang XL, 2008, ADV EXP MED BIOL, V632, P105, DOI 10.1007/978-0-387-78952-1_9; Zhu JG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-117; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6; NUCL ACIDS RES, V38, pD142	89	31	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21634	10.1371/journal.pone.0021634	http://dx.doi.org/10.1371/journal.pone.0021634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738742	gold, Green Published			2022-12-25	WOS:000292290100049
J	Rachow, A; Zumla, A; Heinrich, N; Rojas-Ponce, G; Mtafya, B; Reither, K; Ntinginya, EN; O'Grady, J; Huggett, J; Dheda, K; Boehme, C; Perkins, M; Saathoff, E; Hoelscher, M				Rachow, Andrea; Zumla, Alimuddin; Heinrich, Norbert; Rojas-Ponce, Gabriel; Mtafya, Bariki; Reither, Klaus; Ntinginya, Elias N.; O'Grady, Justin; Huggett, Jim; Dheda, Keertan; Boehme, Catharina; Perkins, Mark; Saathoff, Elmar; Hoelscher, Michael			Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay-A Clinical Validation Study	PLOS ONE			English	Article							RIFAMPIN RESISTANCE; SMEAR MICROSCOPY; SUSCEPTIBILITY; PERFORMANCE; SPECIMENS; DIAGNOSIS; SETTINGS; SYSTEM; IMPACT	Background: A crucial impediment to global tuberculosis control is the lack of an accurate, rapid diagnostic test for detection of patients with active TB. A new, rapid diagnostic method, (Cepheid) Xpert MTB/RIF Assay, is an automated sample preparation and real-time PCR instrument, which was shown to have good potential as an alternative to current reference standard sputum microscopy and culture. Methods: We performed a clinical validation study on diagnostic accuracy of the Xpert MTB/RIF Assay in a TB and HIV endemic setting. Sputum samples from 292 consecutively enrolled adults from Mbeya, Tanzania, with suspected TB were subject to analysis by the Xpert MTB/RIF Assay. The diagnostic performance of Xpert MTB/RIF Assay was compared to standard sputum smear microscopy and culture. Confirmed Mycobacterium tuberculosis in a positive culture was used as a reference standard for TB diagnosis. Results: Xpert MTB/RIF Assay achieved 88.4% (95% CI = 78.4% to 94.9%) sensitivity among patients with a positive culture and 99% (95% CI = 94.7% to 100.0%) specificity in patients who had no TB. HIV status did not affect test performance in 172 HIV-infected patients (58.9% of all participants). Seven additional cases (9.1% of 77) were detected by Xpert MTB/RIF Assay among the group of patients with clinical TB who were culture negative. Within 45 sputum samples which grew non-tuberculous mycobacteria the assay's specificity was 97.8% (95% CI = 88.2% to 99.9%). Conclusions: The Xpert MTB/RIF Assay is a highly sensitive, specific and rapid method for diagnosing TB which has potential to complement the current reference standard of TB diagnostics and increase its overall sensitivity. Its usefulness in detecting sputum smear and culture negative patients needs further study. Further evaluation in high burden TB and HIV areas under programmatic health care settings to ascertain applicability, cost-effectiveness, robustness and local acceptance are required.	[Rachow, Andrea; Heinrich, Norbert; Reither, Klaus; Saathoff, Elmar; Hoelscher, Michael] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Rachow, Andrea; Rojas-Ponce, Gabriel; Mtafya, Bariki; Ntinginya, Elias N.] Natl Inst Med Res, Mbeya Med Res Programme, Mbeya, Tanzania; [Zumla, Alimuddin; O'Grady, Justin; Huggett, Jim; Dheda, Keertan] UCL, Sch Med, Windeyer Inst Med Sci, Dept Infect, London W1N 8AA, England; [Reither, Klaus] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Boehme, Catharina; Perkins, Mark] FIND, Geneva, Switzerland	University of Munich; University of London; University College London; UCL Medical School; University of Basel; Swiss Tropical & Public Health Institute; Foundation For Innovative New Diagnostics	Rachow, A (corresponding author), Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany.	arachow@mmrp.org	Hoelscher, Michael/D-3436-2012; N, Heinrich/B-3750-2014; O'Grady, Justin/I-2982-2012; ZUMLA, Alimuddin/ABA-8208-2020; Huggett, Jim/N-9316-2013	N, Heinrich/0000-0001-9252-7106; O'Grady, Justin/0000-0001-5412-7152; ZUMLA, Alimuddin/0000-0002-5111-5735; Reither, Klaus/0000-0001-6195-8237; Huggett, Jim/0000-0002-0945-1911	European Commission (E.C.); DG Research [LSHP-CT-2006-037785]; EC.AIDCO [ADAT SANTE/2006/129-931]; German Ministry for Education and Research (BmBF); EU; EDCTP; UK-MRC; NIHR; UCLH-CBRC	European Commission (E.C.)(European CommissionEuropean Commission Joint Research Centre); DG Research(European Commission); EC.AIDCO; German Ministry for Education and Research (BmBF)(Federal Ministry of Education & Research (BMBF)); EU(European Commission); EDCTP; UK-MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); UCLH-CBRC	This study was funded by the European Commission (E.C.), DG Research, (LSHP-CT-2006-037785), EC.AIDCO, (ADAT SANTE/2006/129-931), and by the German Ministry for Education and Research (BmBF). MH, AZ, JH, JO and KD receive support from the EU-FW7, EDCTP, UK-MRC, and the EU FW7. AZ receives support from the NIHR, UCLH-CBRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Buijtels PCAM, 2010, CLIN MICROBIOL INFEC, V16, P1142, DOI 10.1111/j.1469-0691.2009.03072.x; Chilima BZ, 2006, APPL ENVIRON MICROB, V72, P2343, DOI 10.1128/AEM.72.4.2343-2350.2006; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; HILLEMANN D, 2011, J CLIN MICROBIOL; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; MARLOWE EM, 2011, J CLIN MICROBIOL; MOURE R, 2010, J CLIN MICROBIOL; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Richter Elvira, 2009, Expert Rev Respir Med, V3, P497, DOI 10.1586/ers.09.45; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wang JY, 2004, J CLIN MICROBIOL, V42, P4599, DOI 10.1128/JCM.42.10.4599-4603.2004; WHO, 2010, M XDR TB SURV CONTR; World Health Organization (WHO), 2008, MOV RES FIND NEW WHO	21	123	128	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20458	10.1371/journal.pone.0020458	http://dx.doi.org/10.1371/journal.pone.0020458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738575	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000292290100002
J	Rokholm, B; Silventoinen, K; Angquist, L; Skytthe, A; Kyvik, KO; Sorensen, TIA				Rokholm, Benjamin; Silventoinen, Karri; Angquist, Lars; Skytthe, Axel; Kyvik, Kirsten Ohm; Sorensen, Thorkild I. A.			Increased Genetic Variance of BMI with a Higher Prevalence of Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY; WAIST CIRCUMFERENCE; SEX-DIFFERENCES; HERITABILITY; EPIDEMIOLOGY; OVERWEIGHT; TWIN	Background and objectives: There is no doubt that the dramatic worldwide increase in obesity prevalence is due to changes in environmental factors. However, twin studies suggest that genetic differences are responsible for the major part of the variation in body mass index (BMI) and other measures of body fatness within populations. Several recent studies suggest that the genetic effects on adiposity may be stronger when combined with presumed risk factors for obesity. We tested the hypothesis that a higher prevalence of obesity and overweight and a higher BMI mean is associated with a larger genetic variation in BMI. Methods: The data consisted of self-reported height and weight from two Danish twin surveys in 1994 and 2002. A total of 15,017 monozygotic and dizygotic twin pairs were divided into subgroups by year of birth (from 1931 through 1982) and sex. The genetic and environmental variance components of BMI were calculated for each subgroup using the classical twin design. Likewise, the prevalence of obesity, prevalence of overweight and the mean of the BMI distribution was calculated for each subgroup and tested as explanatory variables in a random effects meta-regression model with the square root of the additive genetic variance (equal to the standard deviation) as the dependent variable. Results: The size of additive genetic variation was positively and significantly associated with obesity prevalence (p = 0.001) and the mean of the BMI distribution (p = 0.015). The association with prevalence of overweight was positive but not statistically significant (p = 0.177). Conclusion: The results suggest that the genetic variation in BMI increases as the prevalence of obesity, prevalence of overweight and the BMI mean increases. The findings suggest that the genes related to body fatness are expressed more aggressively under the influence of an obesity-promoting environment.	[Rokholm, Benjamin; Angquist, Lars; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark; [Silventoinen, Karri] Univ Helsinki, Dept Social Res, Populat Res Unit, Helsinki, Finland; [Skytthe, Axel; Kyvik, Kirsten Ohm] Univ So Denmark, Danish Twin Registry, Inst Publ Hlth, Odense, Denmark	University of Copenhagen; University of Helsinki; University of Southern Denmark	Rokholm, B (corresponding author), Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark.	br@ipm.regionh.dk	Skytthe, Axel E/G-4820-2019; Kyvik, Kirsten O/K-5680-2016	Skytthe, Axel E/0000-0002-8629-4913; Kyvik, Kirsten O/0000-0003-2981-0245; Angquist, Lars/0000-0002-9516-4424; Silventoinen, Karri/0000-0003-1759-3079	Danish Research Council	Danish Research Council(Det Frie Forskningsrad (DFF))	The funder is The Danish Research Council (http://en.fi.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Andreasen CH, 2009, NUTRITION, V25, P998, DOI 10.1016/j.nut.2009.06.001; Bogardus C, 2009, OBESITY, V17, P209, DOI 10.1038/oby.2008.613; Christiansen L, 2003, TWIN RES, V6, P275, DOI 10.1375/136905203322296610; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Flegal KM, 2005, PHYSIOL BEHAV, V86, P599, DOI 10.1016/j.physbeh.2005.08.050; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Heitmann BL, 1997, AM J CLIN NUTR, V66, P672, DOI 10.1093/ajcn/66.3.672; Karnehed N, 2006, PUBLIC HEALTH NUTR, V9, P851, DOI 10.1017/PHN2005926; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; McCaffery JM, 2009, AM J CLIN NUTR, V89, P1011, DOI 10.3945/ajcn.2008.27170; Mustelin L, 2009, INT J OBESITY, V33, P29, DOI 10.1038/ijo.2008.258; Neale M. C, 2003, MX STAT MODELING, V6th; NEALE MC, 2006, METHODOLOGY GENETIC; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Olsen LW, 2006, EPIDEMIOLOGY, V17, P292, DOI 10.1097/01.ede.0000208349.16893.e0; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; SILVENTOINEN K, 2009, INT J OBES; Silventoinen K, 2009, AM J CLIN NUTR, V90, P1096, DOI 10.3945/ajcn.2009.27689; Skytthe A, 2006, TWIN RES HUM GENET, V9, P763; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Staub K, 2010, EUR J CLIN NUTR, V64, P335, DOI 10.1038/ejcn.2010.7; Sterne J, 2009, METAANALYSIS UPDATED; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Vimaleswaran KS, 2009, AM J CLIN NUTR, V90, P425, DOI 10.3945/ajcn.2009.27652; World Health Organization, 2000, WHO TECHN REP SER, V894	29	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20816	10.1371/journal.pone.0020816	http://dx.doi.org/10.1371/journal.pone.0020816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738588	gold, Green Submitted, Green Published			2022-12-25	WOS:000292290100008
J	Varthaman, A; Clement, M; Khallou-Laschet, J; Fornasa, G; Gaston, AT; Dussiot, M; Caligiuri, G; Cantor, H; Kaveri, S; Nicoletti, A				Varthaman, Aditi; Clement, Marc; Khallou-Laschet, Jamila; Fornasa, Giulia; Gaston, Anh-Thu; Dussiot, Michael; Caligiuri, Giuseppina; Cantor, Harvey; Kaveri, Srinivas; Nicoletti, Antonino			Physiological Induction of Regulatory Qa-1-Restricted CD8+T Cells Triggered by Endogenous CD4+T Cell Responses	PLOS ONE			English	Article							CD8-ALPHA-ALPHA+TCR-ALPHA-BETA(+) T-CELLS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; HLA-E; AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; VACCINATION; MOLECULE; RECEPTOR; MICE; SPECIFICITY	T cell-dependent autoimmune diseases are characterized by the expansion of T cell clones that recognize immunodominant epitopes on the target antigen. As a consequence, for a given autoimmune disorder, pathogenic T cell clones express T cell receptors with a limited number of variable regions that define antigenic specificity. Qa-1, a MHC class I-like molecule, presents peptides from the variable region of TCRs to Qa-1-restricted CD8+ T cells. The induction of V beta-specific CD8+ T cells has been harnessed in an immunotherapeutic strategy known as the "T cell vaccination'' (TCV) that comprises the injection of activated and attenuated CD4+ T cell clones so as to induce protective CD8+ T cells. We hypothesized that Qa-1-restricted CD8+ regulatory T cells could also constitute a physiologic regulatory arm of lymphocyte responses upon expansion of endogenous CD4+ T cells, in the absence of deliberate exogenous T cell vaccination. We immunized mice with two types of antigenic challenges in order to sequentially expand antigen-specific endogenous CD4+ T cells with distinct antigenic specificities but characterized by a common V beta chain in their TCR. The first immunization was performed with a non-self antigen while the second challenge was performed with a myelin-derived peptide known to drive experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. We show that regulatory V beta-specific Qa-1-restricted CD8+ T cells induced during the first endogenous CD4+ T cell responses are able to control the expansion of subsequently mobilized pathogenic autoreactive CD4+ T cells. In conclusion, apart from the immunotherapeutic TCV, Qa-1-restricted specialized CD8+ regulatory T cells can also be induced during endogenous CD4+ T cell responses. At variance with other regulatory T cell subsets, the action of these Qa-1-restricted T cells seems to be restricted to the immediate reactivation of CD4+ T cells.	[Varthaman, Aditi; Clement, Marc; Khallou-Laschet, Jamila; Fornasa, Giulia; Gaston, Anh-Thu; Dussiot, Michael; Caligiuri, Giuseppina; Nicoletti, Antonino] Univ Paris 07, INSERM, UMRS698, Paris, France; [Varthaman, Aditi; Clement, Marc; Khallou-Laschet, Jamila; Fornasa, Giulia; Gaston, Anh-Thu; Dussiot, Michael; Caligiuri, Giuseppina; Kaveri, Srinivas; Nicoletti, Antonino] Univ Paris 06, INSERM, UMRS872, Ctr Rech Cordeliers,Equipe 16, Paris, France; [Cantor, Harvey] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Cantor, Harvey] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Varthaman, A (corresponding author), Univ Paris 07, INSERM, UMRS698, Paris, France.	antonino.nicoletti@inserm.fr	Fornasa, Giulia/AAB-8912-2019; Caligiuri, Giuseppina/G-4810-2015; Nicoletti, Antonino/A-9460-2015; CLEMENT, Marc/GVS-8052-2022	Fornasa, Giulia/0000-0002-2250-7983; Caligiuri, Giuseppina/0000-0003-4973-2205; Nicoletti, Antonino/0000-0002-2623-0897; CLEMENT, Marc/0000-0002-6479-8360; Varthaman, Aditi/0000-0002-8703-5534; Laschet, Jamila/0000-0002-5090-4417; Kaveri, Srini/0000-0002-0837-4053	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was funded by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Chun T, 1998, IMMUNOLOGY, V94, P64; DeCloux A, 1997, J IMMUNOL, V158, P2183; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Itoh Y, 1997, P NATL ACAD SCI USA, V94, P12047, DOI 10.1073/pnas.94.22.12047; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; Kariyone A, 2003, INT IMMUNOL, V15, P1183, DOI 10.1093/intimm/dxg115; KIM HJ, NATURE, V467, P328; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Panoutsakopoulou V, 2004, J CLIN INVEST, V113, P1218, DOI 10.1172/JCI200420772; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Sullivan BA, 2002, IMMUNITY, V17, P95, DOI 10.1016/S1074-7613(02)00343-6; Tang X, 2006, J IMMUNOL, V177, P7645, DOI 10.4049/jimmunol.177.11.7645; VARTHAMAN A, J IMMUNOL, V184, P6585	22	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21628	10.1371/journal.pone.0021628	http://dx.doi.org/10.1371/journal.pone.0021628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738737	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600063
J	Schelleman, H; Brensinger, CM; Bilker, WB; Hennessy, S				Schelleman, Hedi; Brensinger, Colleen M.; Bilker, Warren B.; Hennessy, Sean			Antidepressant-Warfarin Interaction and Associated Gastrointestinal Bleeding Risk in a Case-Control Study	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; ATRIAL-FIBRILLATION; ELDERLY-PATIENTS; HEMORRHAGE; THERAPY; COHORT	Background: Bleeding is the most common and worrisome adverse effect of warfarin therapy. One of the factors that might increase bleeding risk is initiation of interacting drugs that potentiate warfarin. We sought to evaluate whether initiation of an antidepressant increases the risk of hospitalization for gastrointestinal bleeding in warfarin users. Methodology/Principal Findings: Medicaid claims data (1999-2005) were used to perform an observational case-control study nested within person-time exposed to warfarin in those >= 18 years. In total, 430,455 warfarin users contributed 407,370 person-years of warfarin use. The incidence rate of hospitalization for GI bleeding among warfarin users was 4.48 per 100 person-years (95% CI, 4.42-4.55). Each gastrointestinal bleeding cases was matched to 50 controls based on index date and state. Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR = 1.73 [95% CI, 1.25-2.38]), fluoxetine (OR = 1.63 [95% CI, 1.11-2.38]), paroxetine (OR = 1.64 [95% CI, 1.27-2.12]), amitriptyline (OR = 1.47 [95% CI, 1.02-2.11]). Also mirtazapine, which is not believed to interact with warfarin, increased the risk of GI bleeding (OR = 1.75 [95% CI, 1.30-2.35]). Conclusions/Significance: Warfarin users who initiated citalopram, fluoxetine, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding. However, the elevated risk with mirtazapine suggests that a drug-drug interaction may not have been responsible for all of the observed increased risk.	[Schelleman, Hedi; Brensinger, Colleen M.; Bilker, Warren B.; Hennessy, Sean] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Bilker, Warren B.; Hennessy, Sean] Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Schelleman, H (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.	hschelle@mail.med.upenn.edu	Bilker, Warren/AAS-3515-2021		National Institute on Aging [R01AG025152]; Clinical and Translational Science Award [5KL2RR024132]; Abbott; Amgen; Berlex; Merck; Novartis; Pfizer; Roche; Sanofi-aventis en Wyeth; Shire; Tekeda; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025152] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical and Translational Science Award; Abbott(Abbott Laboratories); Amgen(Amgen); Berlex; Merck(Merck & Company); Novartis(Novartis); Pfizer(Pfizer); Roche(Roche Holding); Sanofi-aventis en Wyeth; Shire; Tekeda; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by National Institute on Aging grant R01AG025152. Apart from suggestions from reviewers during the grant peer review process, this funder had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, or preparation, review, or approval of the manuscript. Part of the infrastructure for this study was funded by the Clinical and Translational Science Award 5KL2RR024132. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Schelleman has had travel to scientific conferences paid for by pharmacoepidemiology training funds contributed by pharmaceutical manufacturers (Abbott, Amgen, Berlex, Merck, Novartis, Pfizer, Roche, Sanofi-aventis en Wyeth). Ms. Brensinger has consulted for a law firm (Kaye Scholer LLP) representing Pfizer, unrelated to warfarin and antidepressants. Dr. Bilker has consulted for Johnson & Johnson and Astra Zeneca, unrelated to warfarin and antidepressants. Dr. Hennessy has received research funding from Shire and Tekeda, and consulted for Bayer, Teva, Wyeth, Astra-Zeneca, Endo and Amgen, all unrelated to warfarin and antidepressants. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Chen Y, 2009, PHARMACOEPIDEM DR S, V18, P196, DOI 10.1002/pds.1699; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; Dunn NR, 2000, BRIT MED J, V320, P1405; FLANDERS WD, 1986, AM J EPIDEMIOL, V124, P684, DOI 10.1093/oxfordjournals.aje.a114442; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Hansten PD, 2010, DRUG INTERACTIONS AN; Hennessy S, 2007, MED CARE, V45, P1216, DOI 10.1097/MLR.0b013e318148435a; Hennessy S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P281; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Kurdyak PA, 2005, J CLIN PSYCHOPHARM, V25, P561, DOI 10.1097/01.jcp.0000186869.67418.bc; Meijer WEE, 2004, ARCH INTERN MED, V164, P2367, DOI 10.1001/archinte.164.21.2367; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Opatrny L, 2008, BRIT J CLIN PHARMACO, V66, P76, DOI 10.1111/j.1365-2125.2008.03154.x; Schalekamp T, 2008, ARCH INTERN MED, V168, P180, DOI 10.1001/archinternmed.2007.32; Schelleman H, 2010, AM J MED, V123, P151, DOI 10.1016/j.amjmed.2009.07.020; Schmider J, 1997, BRIT J CLIN PHARMACO, V44, P495, DOI 10.1046/j.1365-2125.1997.00601.x; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Tournier M, 2008, J POPUL THER CLIN PH, V15, pE22; van Walraven C, 2001, BMJ-BRIT MED J, V323, P655, DOI 10.1136/bmj.323.7314.655; Wallerstedt SM, 2009, PHARMACOEPIDEM DR S, V18, P412, DOI 10.1002/pds.1737; 2010, MICROMEDEX 2 0; 2010, DRUG FACTS COMP ANSW	23	65	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21447	10.1371/journal.pone.0021447	http://dx.doi.org/10.1371/journal.pone.0021447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731754	Green Submitted, gold, Green Published			2022-12-25	WOS:000292036900032
J	Walia, G; Surolia, A				Walia, Guneet; Surolia, Avadhesha			Insights into the Regulatory Characteristics of the Mycobacterial Dephosphocoenzyme A Kinase: Implications for the Universal CoA Biosynthesis Pathway	PLOS ONE			English	Article							COENZYME-A BIOSYNTHESIS; ESCHERICHIA-COLI K-12; PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE; PANTOTHENATE KINASE; CRYSTAL-STRUCTURE; TUBERCULOSIS; THIOESTERS; AUXOTROPH	Being vastly different from the human counterpart, we suggest that the last enzyme of the Mycobacterium tuberculosis Coenzyme A biosynthetic pathway, dephosphocoenzyme A kinase (CoaE) could be a good anti-tubercular target. Here we describe detailed investigations into the regulatory features of the enzyme, affected via two mechanisms. Enzymatic activity is regulated by CTP which strongly binds the enzyme at a site overlapping that of the leading substrate, dephosphocoenzyme A (DCoA), thereby obscuring the binding site and limiting catalysis. The organism has evolved a second layer of regulation by employing a dynamic equilibrium between the trimeric and monomeric forms of CoaE as a means of regulating the effective concentration of active enzyme. We show that the monomer is the active form of the enzyme and the interplay between the regulator, CTP and the substrate, DCoA, affects enzymatic activity. Detailed kinetic data have been corroborated by size exclusion chromatography, dynamic light scattering, glutaraldehyde crosslinking, limited proteolysis and fluorescence investigations on the enzyme all of which corroborate the effects of the ligands on the enzyme oligomeric status and activity. Cysteine mutagenesis and the effects of reducing agents on mycobacterial CoaE oligomerization further validate that the latter is not cysteine-mediated or reduction-sensitive. These studies thus shed light on the novel regulatory features employed to regulate metabolite flow through the last step of a critical biosynthetic pathway by keeping the latter catalytically dormant till the need arises, the transition to the active form affected by a delicate crosstalk between an essential cellular metabolite (CTP) and the precursor to the pathway end-product (DCoA).	[Walia, Guneet; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Walia, G (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in			Department of Science and Technology (DST), Government of India; DST	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); DST(Department of Science & Technology (India))	This work was supported by a grant from the Department of Science and Technology (DST), Government of India. AS holds a JC Bose Fellowship of DST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley TP, 2001, VITAM HORM, V61, P157; Chohnan S, 1998, BIOSCI BIOTECH BIOCH, V62, P1122, DOI 10.1271/bbb.62.1122; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Geerlof A, 1999, J BIOL CHEM, V274, P27105, DOI 10.1074/jbc.274.38.27105; Genschel U, 2004, MOL BIOL EVOL, V21, P1242, DOI 10.1093/molbev/msh119; Ghaderi D, 2007, J MOL BIOL, V369, P746, DOI 10.1016/j.jmb.2007.03.037; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; GOTTSCHALK G, 1979, BACTERIAL METABOLISM, P35; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Mishra PK, 2001, J BACTERIOL, V183, P2774, DOI 10.1128/JB.183.9.2774-2778.2001; O'Toole N, 2003, PROTEIN SCI, V12, P327, DOI 10.1110/ps.0227803; Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428; Rubio S, 2008, PLANT PHYSIOL, V148, P546, DOI 10.1104/pp.108.124057; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; SERINA L, 1995, BIOCHEMISTRY-US, V34, P5066, DOI 10.1021/bi00015a018; Seto A, 2005, PROTEINS, V58, P235, DOI 10.1002/prot.20276; SONG WJ, 1994, J BIOL CHEM, V269, P27051; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; TAHILIANI AG, 1991, VITAM HORM, V46, P165; TRAUT TW, 1994, CRIT REV BIOCHEM MOL, V29, P125, DOI 10.3109/10409239409086799; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Walia G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015228; Walia G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007645; Yun M, 2000, J BIOL CHEM, V275, P28093; Zhao LH, 2003, EUR J MED CHEM, V38, P345, DOI 10.1016/S0223-5234(03)00047-3	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21390	10.1371/journal.pone.0021390	http://dx.doi.org/10.1371/journal.pone.0021390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731728	Green Submitted, Green Published, gold			2022-12-25	WOS:000292036900026
J	Zhao, JS; Li, WJ; Ge, D; Zhang, PJ; Li, JJ; Lu, CL; Ji, XD; Guan, DX; Gao, H; Xu, LY; Li, EM; Soukiasian, H; Koeffler, HP; Wang, XF; Xie, D				Zhao, Jiang-Sha; Li, Wen-Jie; Ge, Di; Zhang, Pei-Jing; Li, Jing-Jing; Lu, Chun-Lai; Ji, Xiao-Dan; Guan, Dong-Xian; Gao, Hong; Xu, Li-Yan; Li, Eng-Ming; Soukiasian, Harmik; Koeffler, H. Phillip; Wang, Xiao-Fan; Xie, Dong			Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44	PLOS ONE			English	Article							CANCER STEM-CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; PROSPECTIVE IDENTIFICATION; DIFFERENTIATION THERAPY; SUBPOPULATION; GROWTH	Background: Esophageal Squamous Cell Carcinoma (ESCC) is a major subtype of esophageal cancer causing significant morbility and mortality in Asia. Mechanism of initiation and progression of this disease is unclear. Tumor initiating cells (TICs) are the subpopulation of cells which have the ability to self-renew, as well as, to drive initiation and progression of cancer. Increasing evidence has shown that TICs exist in a variety of tumors. However, the identification and characterization of TICs in esophageal carcinoma has remained elusive. Methodology/Principal Findings: to identify TICs in ESCC, ESCC cell lines including two primary cells were used for screening suitable surface marker. Then colony formation assay, drug resistant assay and tumorigenicity assay in immune deficient mice were used to characterize TICs in ESCC. We found that just the CD44 expression correlated with tumorigenicity in ESCC cell lines. And then induced differentiation of ESCC cells by all-trans retinoic acid treatment led to decreased expression of CD44. The FACS isolated cell subpopulations with high CD44 expression showed increased colony formation and drug resistance in vitro, as well as significantly enhanced tumorigenicity in NOD/SICD mice, as compared to the low expressing CD44 ESCC cells. Conclusions/Significance: our study has discovered a novel TIC surface marker, CD44, which can be utilized to enrich efficiently the TICs in ESCC. These findings will be useful for further studies of these cells and exploring therapeutic approaches.	[Zhao, Jiang-Sha; Zhang, Pei-Jing; Li, Jing-Jing; Ji, Xiao-Dan; Guan, Dong-Xian; Gao, Hong; Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Mol Oncol Lab, Shanghai, Peoples R China; [Zhao, Jiang-Sha; Zhang, Pei-Jing; Li, Jing-Jing; Ji, Xiao-Dan; Guan, Dong-Xian; Gao, Hong; Xie, Dong] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Li, Wen-Jie] Zhengzhou Univ, Coll Publ Hlth, Zhengzhou, Peoples R China; [Ge, Di; Lu, Chun-Lai] Fudan Univ, Shanghai Med Coll, Dept Thorac Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Xu, Li-Yan; Li, Eng-Ming] Shantou Univ, Coll Med, Dept Biochem & Mol Biol, Shantou, Peoples R China; [Soukiasian, Harmik] Univ Calif Los Angeles, Sch Med, Dept Surg, Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Wang, Xiao-Fan] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Zhengzhou University; Fudan University; Shantou University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National University of Singapore; Duke University	Zhao, JS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Mol Oncol Lab, Shanghai, Peoples R China.	dxie@sibs.ac.cn	xu, li/GNH-3667-2022	Xie, Dong/0000-0003-2804-8578; Zhang, Peijing/0000-0003-1586-8710; Xie, Dong/0000-0002-1150-8657	Ministry of Science and Technology [2008ZX10002-017]; 863 Program [2007AA02Z4]; 973 Program [2007CB914704]; National Natural Science Funds for Distinguished Young Scholar [30725010]; National Natural Science Foundation of China [90813023, 30528003]; Chinese Academy of Sciences [KSCX2-YW-R-152, KSCX-YW-R-73]; Science and Technology Commission of Shanghai Municipality [08140902300]; NSFC [U0932001]; SIBS [2009KIP510]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 863 Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); NSFC(National Natural Science Foundation of China (NSFC)); SIBS	This work was supported by Ministry of Science and Technology Key program (2008ZX10002-017), 863 Program (2007AA02Z4), and 973 Program (2007CB914704), National Natural Science Funds for Distinguished Young Scholar (30725010), National Natural Science Foundation of China (90813023 and 30528003). Chinese Academy of Sciences Grant (KSCX2-YW-R-152 and KSCX-YW-R-73), and Science and Technology Commission of Shanghai Municipality (08140902300), NSFC-Guangdong Joint Fund (U0932001), and SIBS Fund (2009KIP510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Burkert J, 2008, J PATHOL, V214, P564, DOI 10.1002/path.2307; CASTAIGNE S, 1990, BLOOD, V76, P1704; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cooke G, 2008, DIGEST DIS SCI, V53, P2851, DOI 10.1007/s10620-008-0240-z; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Gotoda T, 2000, GUT, V46, P14, DOI 10.1136/gut.46.1.14; Huang DZ, 2009, STEM CELLS DEV, V18, P465, DOI 10.1089/scd.2008.0033; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Huang SD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Lichtenauer UD, 2008, ENDOCRINOLOGY, V149, P1314, DOI 10.1210/en.2007-1001; Liu WK, 2009, ONKOLOGIE, V32, P574, DOI 10.1159/000232346; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Muller A, 1997, CANCER LETT, V113, P95, DOI 10.1016/S0304-3835(97)04601-6; Nozoe T, 2004, J CANCER RES CLIN, V130, P334, DOI 10.1007/s00432-004-0542-2; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reim F, 2009, CANCER RES, V69, P8058, DOI 10.1158/0008-5472.CAN-09-0834; Roye GD, 1996, INT J CANCER, V69, P254, DOI 10.1002/(SICI)1097-0215(19960822)69:4<254::AID-IJC2>3.0.CO;2-W; Shimizu M, 2004, CLIN CANCER RES, V10, P1130, DOI 10.1158/1078-0432.CCR-0714-3; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; Wong FH, 2009, INT J ONCOL, V34, P117, DOI 10.3892/ijo_00000135; Xu XC, 1999, CANCER RES, V59, P2477; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhou ZQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-291	40	111	116	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21419	10.1371/journal.pone.0021419	http://dx.doi.org/10.1371/journal.pone.0021419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731740	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900029
J	Ngamphiw, C; Assawamakin, A; Xu, SH; Shaw, PJ; Yang, JO; Ghang, H; Bhak, J; Liu, E; Tongsima, S				Ngamphiw, Chumpol; Assawamakin, Anunchai; Xu, Shuhua; Shaw, Philip J.; Yang, Jin Ok; Ghang, Ho; Bhak, Jong; Liu, Edison; Tongsima, Sissades		HUGO Pan-Asian SNP Consortium	PanSNPdb: The Pan-Asian SNP Genotyping Database	PLOS ONE			English	Article							COPY-NUMBER; GENOME-WIDE; GENETIC DIVERSITY; HAPLOTYPE; POPULATION; BLOCK; MODEL; MAP	The HUGO Pan-Asian SNP consortium conducted the largest survey to date of human genetic diversity among Asians by sampling 1,719 unrelated individuals among 71 populations from China, India, Indonesia, Japan, Malaysia, the Philippines, Singapore, South Korea, Taiwan, and Thailand. We have constructed a database (PanSNPdb), which contains these data and various new analyses of them. PanSNPdb is a research resource in the analysis of the population structure of Asian peoples, including linkage disequilibrium patterns, haplotype distributions, and copy number variations. Furthermore, PanSNPdb provides an interactive comparison with other SNP and CNV databases, including HapMap3, JSNP, dbSNP and DGV and thus provides a comprehensive resource of human genetic diversity. The information is accessible via a widely accepted graphical interface used in many genetic variation databases. Unrestricted access to PanSNPdb and any associated files is available at: http://www4a.biotec.or.th/PASNP.	[Ngamphiw, Chumpol; Assawamakin, Anunchai; Shaw, Philip J.; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Pathumthani, Thailand; [Ngamphiw, Chumpol] Chulalongkorn Univ, Fac Grad Sch, Interdept Program BioMed Sci, Bangkok, Thailand; [Xu, Shuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Yang, Jin Ok] KRIBB, KOBIC, Taejon, South Korea; [Ghang, Ho; Bhak, Jong] Genome Res Fdn, Personal Genom Inst, Suwon, South Korea; [Bhak, Jong] TheragenEtex, Theragen BiO Inst, Suwon, South Korea; [Liu, Edison] Genome Inst Singapore, Singapore, Singapore	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Ngamphiw, C (corresponding author), Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Pathumthani, Thailand.	sissades@biotec.or.th	Hoh, Boon-Peng/H-8682-2016; Ngamphiw, Chumpol/ABB-6488-2021; XU, SHUHUA/D-5345-2009; Xu, Shuhua/AAH-7620-2020; Tongsima, Sissades/F-4891-2011; Ahmed, Ikhlak/Q-2494-2019	Hoh, Boon-Peng/0000-0001-9249-4965; Ngamphiw, Chumpol/0000-0002-8581-397X; XU, SHUHUA/0000-0002-1975-1002; Xu, Shuhua/0000-0002-1975-1002; Tongsima, Sissades/0000-0002-1491-1839; Ahmed, Ikhlak/0000-0002-5753-9627	National Center for Genetic Engineering and Biotechnology; National Science and Technology Development Agency (NSTDA) through the National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science Foundation of China [30971577]; Science and Technology Commission of Shanghai Municipality [09ZR1436400, 11QA1407600]; Bill and Melinda Gates Foundation under the Grand Challenges Explorations Initiative; KRIBB Research Initiative; Korean Ministry of Education, Science and Technology (MEST) [2010-0029345]; MOST; KRIBB internal fund of South Korea; Thailand Research Fund (TRF); Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University	National Center for Genetic Engineering and Biotechnology; National Science and Technology Development Agency (NSTDA) through the National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Bill and Melinda Gates Foundation under the Grand Challenges Explorations Initiative; KRIBB Research Initiative; Korean Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); MOST; KRIBB internal fund of South Korea; Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University(Chulalongkorn University)	The authors wish to thank the National Center for Genetic Engineering and Biotechnology for financial support. Anunchai Assawamakin was supported by the National Science and Technology Development Agency (NSTDA) Postdoctoral Fellowship offered through the National Center for Genetic Engineering and Biotechnology (BIOTEC). Shuhua Xu was supported by the National Science Foundation of China (30971577) and the Science and Technology Commission of Shanghai Municipality (09ZR1436400, 11QA1407600). Philip J. Shaw is supported by a grant from the Bill and Melinda Gates Foundation under the Grand Challenges Explorations Initiative. Jin Ok Yang was supported by KRIBB Research Initiative Program and the Korean Ministry of Education, Science and Technology (MEST) under grant number (2010-0029345). Ho Ghang and Jong Bhak were supported by MOST and KRIBB internal fund of South Korea. Sissades Tongsima was supported by the Thailand Research Fund (TRF), and also in part by the Center of Excellence in Molecular Genetics of Cancer and Human Diseases, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacobs S, 2007, CANCER RES, V67, P2544, DOI 10.1158/0008-5472.CAN-06-3597; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Pennisi E, 2010, SCIENCE, V330, P574, DOI 10.1126/science.330.6004.574; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	16	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21451	10.1371/journal.pone.0021451	http://dx.doi.org/10.1371/journal.pone.0021451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731755	gold, Green Submitted, Green Published			2022-12-25	WOS:000292035400040
J	Smith, B; Chen, ZG; Reimers, L; van Doorslaer, K; Schiffman, M; DeSalle, R; Herrero, R; Yu, K; Wacholder, S; Wang, T; Burk, RD				Smith, Benjamin; Chen, Zigui; Reimers, Laura; van Doorslaer, Koenraad; Schiffman, Mark; DeSalle, Rob; Herrero, Rolando; Yu, Kai; Wacholder, Sholom; Wang, Tao; Burk, Robert D.			Sequence Imputation of HPV16 Genomes for Genetic Association Studies	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL-CANCER; GENOTYPE IMPUTATION; HUMAN-POPULATIONS; NEOPLASIA; VARIANTS; PCR; CARCINOGENICITY; CLASSIFICATION; INFECTIONS	Background: Human Papillomavirus type 16 (HPV16) causes over half of all cervical cancer and some HPV16 variants are more oncogenic than others. The genetic basis for the extraordinary oncogenic properties of HPV16 compared to other HPVs is unknown. In addition, we neither know which nucleotides vary across and within HPV types and lineages, nor which of the single nucleotide polymorphisms (SNPs) determine oncogenicity. Methods: A reference set of 62 HPV16 complete genome sequences was established and used to examine patterns of evolutionary relatedness amongst variants using a pairwise identity heatmap and HPV16 phylogeny. A BLAST-based algorithm was developed to impute complete genome data from partial sequence information using the reference database. To interrogate the oncogenic risk of determined and imputed HPV16 SNPs, odds-ratios for each SNP were calculated in a case-control viral genome-wide association study (VWAS) using biopsy confirmed high-grade cervix neoplasia and self-limited HPV16 infections from Guanacaste, Costa Rica. Results: HPV16 variants display evolutionarily stable lineages that contain conserved diagnostic SNPs. The imputation algorithm indicated that an average of 97.5 +/- 1.03% of SNPs could be accurately imputed. The VWAS revealed specific HPV16 viral SNPs associated with variant lineages and elevated odds ratios; however, individual causal SNPs could not be distinguished with certainty due to the nature of HPV evolution. Conclusions: Conserved and lineage-specific SNPs can be imputed with a high degree of accuracy from limited viral polymorphic data due to the lack of recombination and the stochastic mechanism of variation accumulation in the HPV genome. However, to determine the role of novel variants or non-lineage-specific SNPs by VWAS will require direct sequence analysis. The investigation of patterns of genetic variation and the identification of diagnostic SNPs for lineages of HPV16 variants provides a valuable resource for future studies of HPV16 pathogenicity.	[Smith, Benjamin; Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Chen, Zigui; van Doorslaer, Koenraad; Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Reimers, Laura; Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Schiffman, Mark; Yu, Kai; Wacholder, Sholom] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Herrero, Rolando] Fdn INCIENSA, San Jose, Costa Rica; [Wang, Tao; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Museum of Natural History (AMNH); Yeshiva University; Albert Einstein College of Medicine	Smith, B (corresponding author), Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA.	robert.burk@einstein.yu.edu	Schiffman, Mark/B-9766-2015; Chen, Zigui/E-8490-2017; Iadeluca, Laura/V-2811-2017	Chen, Zigui/0000-0002-8577-1298; Iadeluca, Laura/0000-0002-2379-6094; Van Doorslaer, Koenraad/0000-0002-2985-0733	Public Health Service, National Cancer Institute [CA78527]; Center Grants to the Einstein Cancer Research Center; Center for AIDS Research (CFAR); American Museum of Natural History; National Cancer Institute, National Institutes of Health; Department of Health and Human Services; National Institutes of Health [N01-CP-21081, N01-CP-33061, N01-CP-40542, N01-CP-50535, N01-CP-81023]; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP081023, N01CP033061, N01CP040542, N01CP050535, N01CP021081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078527, U01CA078527] Funding Source: NIH RePORTER	Public Health Service, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); Center Grants to the Einstein Cancer Research Center; Center for AIDS Research (CFAR); American Museum of Natural History; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.D.B. is supported in part by Public Health Service award CA78527 from the National Cancer Institute and uses facilities supported by Center Grants to the Einstein Cancer Research Center and the Center for AIDS Research (CFAR). R.D. thanks the Louis and Dorothy Cullman Program in Molecular Systematics at the American Museum of Natural History for support. The Guanacaste cohort (design and conduct of the study, sample collection, management, analysis and interpretation of the data) for the enrollment and follow-up phases was supported by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. National Institutes of Health (N01-CP-21081, N01-CP-33061, N01-CP-40542, N01-CP-50535, N01-CP-81023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, some of the investigators are intramural NCI investigators, the agency funding the majority of this study.	Allen CT, 2010, LARYNGOSCOPE, V120, P1756, DOI 10.1002/lary.20936; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Burk RD, 2003, CANCER RES, V63, P7215; Burk RD, 2009, PUBLIC HEALTH GENOM, V12, P281, DOI 10.1159/000214919; Calleja-Macias IE, 2005, J VIROL, V79, P6565, DOI 10.1128/JVI.79.10.6565-6569.2005; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; GHEIT T, 2011, CANC EPIDEMIOL  0428; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kang HM, 2010, J COMPUT BIOL, V17, P547, DOI 10.1089/cmb.2009.0199; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li N, 2010, INT J CANC; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Molijn A, 2005, J CLIN VIROL, V32, pS43, DOI 10.1016/j.jcv.2004.12.004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Neale BM, 2010, COLD SPRING HARB PRO, V2010; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; REEVES WC, 1989, NEW ENGL J MED, V320, P1437, DOI 10.1056/NEJM198906013202201; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; Terai M, 2002, J INFECT DIS, V185, P1794, DOI 10.1086/340824; Terai M, 2001, J GEN VIROL, V82, P2035, DOI 10.1099/0022-1317-82-9-2035; Xi LF, 2007, J INFECT DIS, V195, P1340, DOI 10.1086/513441; Xi LF, 2010, J INFECT DIS, V202, P1667, DOI 10.1086/657083; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997	45	61	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21375	10.1371/journal.pone.0021375	http://dx.doi.org/10.1371/journal.pone.0021375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731721	Green Submitted, gold, Green Published			2022-12-25	WOS:000292035400031
J	Bohmann, K; Monadjem, A; Noer, CL; Rasmussen, M; Zeale, MRK; Clare, E; Jones, G; Willerslev, E; Gilbert, MTP				Bohmann, Kristine; Monadjem, Ara; Noer, Christina Lehmkuhl; Rasmussen, Morten; Zeale, Matt R. K.; Clare, Elizabeth; Jones, Gareth; Willerslev, Eske; Gilbert, M. Thomas P.			Molecular Diet Analysis of Two African Free-Tailed Bats (Molossidae) Using High Throughput Sequencing	PLOS ONE			English	Article							DNA; PREY; PCR; IDENTIFICATION; PREDATOR	Given the diversity of prey consumed by insectivorous bats, it is difficult to discern the composition of their diet using morphological or conventional PCR-based analyses of their faeces. We demonstrate the use of a powerful alternate tool, the use of the Roche FLX sequencing platform to deep-sequence uniquely 59 tagged insect-generic barcode cytochrome c oxidase I (COI) fragments, that were PCR amplified from faecal pellets of two free-tailed bat species Chaerephon pumilus and Mops condylurus (family: Molossidae). Although the analyses were challenged by the paucity of southern African insect COI sequences in the GenBank and BOLD databases, similarity to existing collections allowed the preliminary identification of 25 prey families from six orders of insects within the diet of C. pumilus, and 24 families from seven orders within the diet of M. condylurus. Insects identified to families within the orders Lepidoptera and Diptera were widely present among the faecal samples analysed. The two families that were observed most frequently were Noctuidae and Nymphalidae (Lepidoptera). Species-level analysis of the data was accomplished using novel bioinformatics techniques for the identification of molecular operational taxonomic units (MOTU). Based on these analyses, our data provide little evidence of resource partitioning between sympatric M. condylurus and C. pumilus in the Simunye region of Swaziland at the time of year when the samples were collected, although as more complete databases against which to compare the sequences are generated this may have to be re-evaluated.	[Bohmann, Kristine; Noer, Christina Lehmkuhl; Rasmussen, Morten; Willerslev, Eske; Gilbert, M. Thomas P.] Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Monadjem, Ara] Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Eswatini; [Zeale, Matt R. K.; Clare, Elizabeth; Jones, Gareth] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Bohmann, K (corresponding author), Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.	mtpgilbert@gmail.com	Willerslev, Eske/A-9619-2011; Monadjem, Ara/K-7279-2014; Willerslev, Eske/AAA-5686-2019; Gilbert, Marcus TP/A-8936-2013; Bohmann, Kristine/B-9617-2015	Willerslev, Eske/0000-0002-7081-6748; Monadjem, Ara/0000-0003-1906-4023; Gilbert, Marcus TP/0000-0002-5805-7195; Zeale, Matt/0000-0002-4997-9577; Lehmkuhl Noer, Christina/0000-0001-8303-5759; Jones, Gareth/0000-0002-1904-3735; Bohmann, Kristine/0000-0001-7907-064X	Bat Conservation International; Etatsraad Georg Bestle og Hustrus Mindelegat; Oticon Fonden; Danish Council for Independent Research Natural Sciences; Natural Sciences and Engineering Research Council of Canada; Royal Swaziland Sugar Corporation	Bat Conservation International; Etatsraad Georg Bestle og Hustrus Mindelegat; Oticon Fonden; Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Royal Swaziland Sugar Corporation	This study was supported by Bat Conservation International, Etatsraad Georg Bestle og Hustrus Mindelegat and the Oticon Fonden (KB and CN), the Danish Council for Independent Research Natural Sciences 'Skou' award (MTPG), and a Natural Sciences and Engineering Research Council of Canada postdoctoral fellowship (ELC). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by the Royal Swaziland Sugar Corporation, who provided field assistance and therefore had a role in data collection.	Aspetsberger F, 2003, AFR ZOOL, V38, P245; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bouchard Sylvie, 1998, Mammalian Species, V574, P1; CLARE EL, MOL ECOL IN PRESS; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; Faure PA, 2009, J MAMMAL, V90, P1148, DOI 10.1644/08-MAMM-A-332.1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FULLARD JH, 1981, J COMP PHYSIOL, V143, P363, DOI 10.1007/BF00611174; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Gonzalez JM, 2005, BIOINFORMATICS, V21, P333, DOI 10.1093/bioinformatics/bti008; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HAPPOLD DCD, 1989, J REPROD FERTIL, V85, P133; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jones G., 2004, ECHOLOCATION BATS DO, P345; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Monadjem A, 2008, ACTA CHIROPTEROL, V10, P339, DOI 10.3161/150811008X414917; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Poinar H, 2009, SCIENCE, V325, DOI [10.1126/science.1167531, 10.1126/science.1168182]; Roques KG, 2001, J APPL ECOL, V38, P268, DOI 10.1046/j.1365-2664.2001.00567.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schoeman MC, 2003, OECOLOGIA, V134, P154, DOI 10.1007/s00442-002-1107-1; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Svensson AM, 2003, OIKOS, V101, P239, DOI 10.1034/j.1600-0706.2003.12156.x; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Zeale MRK, 2011, MOL ECOL RESOUR, V11, P236, DOI 10.1111/j.1755-0998.2010.02920.x	37	154	162	0	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21441	10.1371/journal.pone.0021441	http://dx.doi.org/10.1371/journal.pone.0021441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731749	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700086
J	Adatto, I; Lawrence, C; Thompson, M; Zon, LI				Adatto, Isaac; Lawrence, Christian; Thompson, Michael; Zon, Leonard I.			A New System for the Rapid Collection of Large Numbers of Developmentally Staged Zebrafish Embryos	PLOS ONE			English	Article							DANIO-RERIO; VERTEBRATE; BEHAVIOR	The zebrafish is an excellent genetic and developmental model system used to study biology and disease. While the zebrafish model is associated with high fecundity, its reproductive potential has not been completely realized by scientists. One major issue is that embryo collection is inefficient. Here, we have developed an innovative breeding vessel designed to stimulate the natural reproductive behavior of the fish. This novel apparatus allows us to collect large numbers of developmentally synchronized embryos in brief and defined windows of time, and with minimal investments in labor and space. To demonstrate the efficacy of this approach, we placed three separate groups (n = 180) of fish in the vessel and allowed them to spawn for 10-minute intervals. During these trials, which were repeated three times, the fish produced 8600 +/- 917, 8400 +/- 794, and 6800 +/- 1997 embryos, respectively. This level of embryo production is nearly twice what we were able to achieve when using conventional crossing equipment with some of the same fish, and it required significantly less room and time to set up and break down. This system overcomes major space and labor restrictions inherent in spawning equipment currently used in the field, and will greatly accelerate efforts to improve the scale and throughput of experiments.	[Adatto, Isaac; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Adatto, Isaac; Zon, Leonard I.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Adatto, Isaac; Zon, Leonard I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Adatto, Isaac; Zon, Leonard I.] Harvard Stem Cell Inst, Boston, MA USA; [Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA USA; [Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Lawrence, Christian] Childrens Hosp, Aquat Resources Program, Boston, MA 02115 USA; [Thompson, Michael] Plast Concepts Inc, Billerica, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital	Adatto, I (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu			National Institutes of Health (NIH) [2P30DK049216-17]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	I.A. is supported by the National Institutes of Health (NIH) grant # 2P30DK049216-17. L.I.Z. is supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M. T. is the owner and president of Plastics Concepts, Inc. and supervised fabrication of the breeding vessel prototype.	Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Gerlach G, 2006, ANIM BEHAV, V72, P1119, DOI 10.1016/j.anbehav.2006.03.009; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Sessa AK, 2008, ZEBRAFISH, V5, P335, DOI 10.1089/zeb.2008.0535; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Spence R, 2007, BEHAVIOUR, V144, P953, DOI 10.1163/156853907781492726; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749	11	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21715	10.1371/journal.pone.0021715	http://dx.doi.org/10.1371/journal.pone.0021715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738776	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100062
J	Pierron, D; Chang, I; Arachiche, A; Heiske, M; Thomas, O; Borlin, M; Pennarun, E; Murail, P; Thoraval, D; Rocher, C; Letellier, T				Pierron, Denis; Chang, Ivan; Arachiche, Amal; Heiske, Margit; Thomas, Olivier; Borlin, Marine; Pennarun, Erwan; Murail, Pacal; Thoraval, Didier; Rocher, Christophe; Letellier, Thierry			Mutation Rate Switch inside Eurasian Mitochondrial Haplogroups: Impact of Selection and Consequences for Dating Settlement in Europe	PLOS ONE			English	Article							TIME DEPENDENCY; MTDNA VARIATION; AFRICAN POPULATIONS; SUBSTITUTION RATES; RELATIVE RATES; DNA; EVOLUTION; REVEALS; PERSPECTIVE; GENE	R-lineage mitochondrial DNA represents over 90% of the European population and is significantly present all around the planet (North Africa, Asia, Oceania, and America). This lineage played a major role in migration "out of Africa'' and colonization in Europe. In order to determine an accurate dating of the R lineage and its sublineages, we analyzed 1173 individuals and complete mtDNA sequences from Mitomap. This analysis revealed a new coalescence age for R at 54.500 years, as well as several limitations of standard dating methods, likely to lead to false interpretations. These findings highlight the association of a striking under-accumulation of synonymous mutations, an over-accumulation of non-synonymous mutations, and the phenotypic effect on haplogroup J. Consequently, haplogroup J is apparently not a Neolithic group but an older haplogroup (Paleolithic) that was subjected to an underestimated selective force. These findings also indicated an under-accumulation of synonymous and non-synonymous mutations localized on coding and non-coding (HVS1) sequences for haplogroup R0, which contains the major haplogroups H and V. These new dates are likely to impact the present colonization model for Europe and confirm the late glacial resettlement scenario.	[Pierron, Denis; Arachiche, Amal; Heiske, Margit; Thomas, Olivier; Borlin, Marine; Rocher, Christophe; Letellier, Thierry] Univ Bordeaux 2, INSERM, U688, Lab Physiopathol Mitochondriale, F-33076 Bordeaux, France; [Thoraval, Didier] Univ Bordeaux 2, CNRS, UMR 5095, Inst Biochim & Genet Cellulaires, F-33076 Bordeaux, France; [Murail, Pacal] Univ Bordeaux 1, CNRS, UMR 5199, Lab Anthropol Populat Passe PACEA, F-33405 Talence, France; [Chang, Ivan] Univ Calif Irvine, Inst Genom Biol, Irvine, CA USA; [Pennarun, Erwan] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Pennarun, Erwan] Estonian Bioctr, Tartu, Estonia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Irvine; University of Tartu; Estonian Biocentre	Pierron, D (corresponding author), Univ Bordeaux 2, INSERM, U688, Lab Physiopathol Mitochondriale, F-33076 Bordeaux, France.	thierry.letellier@u-bordeaux2.fr	Pennarun, Erwan/AAW-7041-2020	Pennarun, Erwan/0000-0002-8267-883X; Rocher, Christophe/0000-0003-1859-9704	Association Francaise contre les Myopathies; INSERM; Universite Victor Segalen Bordeaux-2; Aquitaine; Association contre les Maladies Mitochondriales; CNRS	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Victor Segalen Bordeaux-2; Aquitaine; Association contre les Maladies Mitochondriales; CNRS(Centre National de la Recherche Scientifique (CNRS))	The authors specially thank the Association Francaise contre les Myopathies, INSERM, Universite Victor Segalen Bordeaux-2, Aquitaine for financial support. D. Pierron was supported by a grant from the Association contre les Maladies Mitochondriales and a grant from the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Arenas M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-458; Bandelt HJ, 2008, HEREDITY, V100, P1, DOI 10.1038/sj.hdy.6801054; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; CHEN YS, 1995, AM J HUM GENET, V57, P133; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Forster P, 1996, AM J HUM GENET, V59, P935; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Howell N, 2008, HEREDITY, V101, P107, DOI 10.1038/hdy.2008.52; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2007, HUM MOL GENET, V16, P2281, DOI 10.1093/hmg/ddm180; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P2132, DOI 10.1093/molbev/msg230; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pierron D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-70; Pierron D, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-41; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Wilcox TP, 2004, MOL PHYLOGENET EVOL, V31, P1101, DOI 10.1016/j.ympev.2003.11.006	42	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21543	10.1371/journal.pone.0021543	http://dx.doi.org/10.1371/journal.pone.0021543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738700	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800037
J	Maher, P; Dargusch, R; Ehren, JL; Okada, S; Sharma, K; Schubert, D				Maher, Pamela; Dargusch, Richard; Ehren, Jennifer L.; Okada, Shinichi; Sharma, Kumar; Schubert, David			Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; FLAVONOID FISETIN; END-PRODUCTS; MICE; NEPHROPATHY; ACTIVATION; INFLAMMATION; OSTEOPONTIN	The elevated glycation of macromolecules by the reactive dicarbonyl and alpha-oxoaldehyde methylglyoxal (MG) has been associated with diabetes and its complications. We have identified a rare flavone, fisetin, which increases the level and activity of glyoxalase 1, the enzyme required for the removal of MG, as well as the synthesis of its essential co-factor, glutathione. It is shown that fisetin reduces two major complications of diabetes in Akita mice, a model of type 1 diabetes. Although fisetin had no effect on the elevation of blood sugar, it reduced kidney hypertrophy and albuminuria and maintained normal levels of locomotion in the open field test. This correlated with a reduction in proteins glycated by MG in the blood, kidney and brain of fisetin-treated animals along with an increase in glyoxalase 1 enzyme activity and an elevation in the expression of the rate-limiting enzyme for the synthesis of glutathione, a co-factor for glyoxalase 1. The expression of the receptor for advanced glycation end products (RAGE), serum amyloid A and serum C-reactive protein, markers of protein oxidation, glycation and inflammation, were also increased in diabetic Akita mice and reduced by fisetin. It is concluded that fisetin lowers the elevation of MG-protein glycation that is associated with diabetes and ameliorates multiple complications of the disease. Therefore, fisetin or a synthetic derivative may have potential therapeutic use for the treatment of diabetic complications.	[Maher, Pamela; Dargusch, Richard; Ehren, Jennifer L.; Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA; [Okada, Shinichi; Sharma, Kumar] Univ Calif San Diego, Dept Med, Ctr Renal Translat Med, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Maher, P (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pmaher@salk.edu			not-for-profit Fritz B. Burns Foundation; Juvenile Diabetes Research Foundation; Hewitt Foundation; National Institutes of Health [DK063491]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	not-for-profit Fritz B. Burns Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Hewitt Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the not-for-profit Fritz B. Burns Foundation (PM, DS), the Juvenile Diabetes Research Foundation (DS), the Hewitt Foundation (JLE) and National Institutes of Health grant DK063491 (PM, DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2000, J NUTR, V130, P2243; Asakawa A, 2007, INT J MOL MED, V19, P649; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Brouwers O, 2011, J BIOL CHEM, V286, P1374, DOI 10.1074/jbc.M110.144097; Brownlee M, 2000, METABOLISM, V49, P9, DOI 10.1016/S0026-0495(00)80078-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burdo JR, 2009, NEUROBIOL AGING, V30, P1910, DOI 10.1016/j.neurobiolaging.2008.02.010; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Choeiri C, 2005, BEHAV BRAIN RES, V157, P31, DOI 10.1016/j.bbr.2004.06.005; Closhen D, 2010, CYTOKINE, V50, P117, DOI 10.1016/j.cyto.2010.02.011; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Gamcsik MP, 2002, BIOCHEM PHARMACOL, V63, P843, DOI 10.1016/S0006-2952(01)00931-5; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Geraets L, 2009, BIOCHEM BIOPH RES CO, V382, P598, DOI 10.1016/j.bbrc.2009.03.071; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Jacobson AM, 2011, DIABETOLOGIA, V54, P245, DOI 10.1007/s00125-010-1883-9; Jolivalt CG, 2008, J NEUROSCI RES, V86, P3265, DOI 10.1002/jnr.21787; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; Maher P., 2010, MICRONUTRIENTS BRAIN, P189; Maher P, 2007, BRAIN RES, V1173, P117, DOI 10.1016/j.brainres.2007.07.061; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Maziere C, 2010, FREE RADICAL BIO MED, V48, P1382, DOI 10.1016/j.freeradbiomed.2010.02.022; Meerwaldt R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-29; Miyata T, 2010, NAT REV NEPHROL, V6, P83, DOI 10.1038/nrneph.2009.211; Nicholas SB, 2010, KIDNEY INT, V77, P588, DOI 10.1038/ki.2009.518; Ochrietor JD, 2000, CYTOKINE, V12, P888, DOI 10.1006/cyto.2000.0668; Prasain JK, 2007, MOL PHARMACEUT, V4, P846, DOI 10.1021/mp700116u; Queisser MA, 2010, DIABETES, V59, P670, DOI 10.2337/db08-1565; RamachandraRao SP, 2009, J AM SOC NEPHROL, V20, P1765, DOI 10.1681/ASN.2008090931; Reagan LP, 2008, EUR J PHARMACOL, V585, P64, DOI 10.1016/j.ejphar.2008.02.050; Sagara Y, 2004, J NEUROCHEM, V90, P1144, DOI 10.1111/j.1471-4159.2004.02563.x; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shia CS, 2009, J AGR FOOD CHEM, V57, P83, DOI 10.1021/jf802378q; Stirban A, 2008, MT SINAI J MED, V75, P328, DOI 10.1002/msj.20057; Susztak K, 2004, DIABETES, V53, P784, DOI 10.2337/diabetes.53.3.784; Takasawa R, 2008, BIOORGAN MED CHEM, V16, P3969, DOI 10.1016/j.bmc.2008.01.031; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wu L, 2002, ENDOTHELIUM-J ENDOTH, V9, P273, DOI 10.1080/10623320214734; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zheng LT, 2008, INT IMMUNOPHARMACOL, V8, P484, DOI 10.1016/j.intimp.2007.12.012; Zhu YQ, 2007, SEMIN NEPHROL, V27, P153, DOI 10.1016/j.semnephrol.2007.01.008	55	115	117	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21226	10.1371/journal.pone.0021226	http://dx.doi.org/10.1371/journal.pone.0021226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738623	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600020
J	Waldie, PA; Blomberg, SP; Cheney, KL; Goldizen, AW; Grutter, AS				Waldie, Peter A.; Blomberg, Simon P.; Cheney, Karen L.; Goldizen, Anne W.; Grutter, Alexandra S.			Long-Term Effects of the Cleaner Fish Labroides dimidiatus on Coral Reef Fish Communities	PLOS ONE			English	Article							ANILOCRA-APOGONAE; HOST FISH; DIVERSITY; REMOVAL; WRASSE; ECTOPARASITES; FACILITATION; DAMSELFISH; ABUNDANCE; BEHAVIOR	Cleaning behaviour is deemed a mutualism, however the benefit of cleaning interactions to client individuals is unknown. Furthermore, mechanisms that may shift fish community structure in the presence of cleaning organisms are unclear. Here we show that on patch reefs (61-285 m(2)) which had all cleaner wrasse Labroides dimidiatus (Labridae) experimentally removed (1-5 adults reef(-1)) and which were then maintained cleaner-fish free over 8.5 years, individuals of two site-attached (resident) client damselfishes (Pomacentridae) were smaller compared to those on control reefs. Furthermore, resident fishes were 37% less abundant and 23% less species rich per reef, compared to control reefs. Such changes in site-attached fish may reflect lower fish growth rates and/or survivorship. Additionally, juveniles of visitors (fish likely to move between reefs) were 65% less abundant on removal reefs suggesting cleaners may also affect recruitment. This may, in part, explain the 23% lower abundance and 33% lower species richness of visitor fishes, and 66% lower abundance of visitor herbivores (Acanthuridae) on removal reefs that we also observed. This is the first study to demonstrate a benefit of cleaning behaviour to client individuals, in the form of increased size, and to elucidate potential mechanisms leading to community-wide effects on the fish population. Many of the fish groups affected may also indirectly affect other reef organisms, thus further impacting the reef community. The large-scale effect of the presence of the relatively small and uncommon fish, Labroides dimidiadus, on other fishes is unparalleled on coral reefs.	[Waldie, Peter A.; Blomberg, Simon P.; Cheney, Karen L.; Goldizen, Anne W.; Grutter, Alexandra S.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland	Waldie, PA (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	a.grutter@uq.edu.au	Blomberg, Simone P/B-7613-2008; Cheney, Karen/L-3427-2018; Goldizen, Anne/G-7366-2012; Waldie, Peter/J-3896-2019; Cheney, Karen L/A-6827-2013; Grutter, Alexandra S/J-2737-2013	Blomberg, Simone P/0000-0003-1062-0839; Cheney, Karen/0000-0001-5622-9494; Goldizen, Anne/0000-0003-0101-4108; Waldie, Peter/0000-0002-9153-5638; Cheney, Karen L/0000-0001-5622-9494; Grutter, Alexandra S/0000-0003-1688-2821	Australian Research Council [RnumZL00/ARCFEL010600, A00105175, DP0557058]; University of Queensland [00/ARCCS251]	Australian Research Council(Australian Research Council); University of Queensland(University of Queensland)	This research was funded by the Australian Research Council (www.arc.gov.au) (grant numbers: RnumZL00/ARCFEL010600, A00105175, DP0557058) and The University of Queensland (www.uq.edu.au) (00/ARCCS251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J., 2003, STAT ANAL COMPOSITIO; Babak O, 2007, J APPL STAT, V34, P985, DOI 10.1080/02664760701590376; Bansemer C, 2002, ETHOLOGY, V108, P353, DOI 10.1046/j.1439-0310.2002.00777.x; Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; BELL JD, 1985, CORAL REEFS, V4, P41, DOI 10.1007/BF00302203; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bshary R, 2003, J ANIM ECOL, V72, P169, DOI 10.1046/j.1365-2656.2003.00683.x; Cheney KL, 2008, BEHAV ECOL, V19, P1063, DOI 10.1093/beheco/arn067; Cheney KL, 2001, ANIM BEHAV, V62, P927, DOI 10.1006/anbe.2001.1832; CLAGUE G, BIOL LETT IN PRESS; Cole AJ, 2009, CORAL REEFS, V28, P965, DOI 10.1007/s00338-009-0519-3; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Finley RJ, 2003, MAR ECOL PROG SER, V248, P305, DOI 10.3354/meps248305; Fogelman RM, 2009, INT J PARASITOL, V39, P577, DOI 10.1016/j.ijpara.2008.10.013; Forrester GE, 2006, ECOLOGY, V87, P1110, DOI 10.1890/0012-9658(2006)87[1110:PAASOR]2.0.CO;2; GORLICK DL, 1987, COPEIA, P41, DOI 10.2307/1446035; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Green A.L., 2009, MONITORING FUNCTIONA; Green BS, 2008, ADV MAR BIOL, V54, P1, DOI 10.1016/S0065-2881(08)00001-1; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; Grutter Alexandra S., 2007, P110; Grutter AS, 2011, FUNCT ECOL, V25, P586, DOI 10.1111/j.1365-2435.2010.01798.x; Grutter AS, 2002, PARASITOLOGY, V124, pS65, DOI 10.1017/S0031182002001488; GRUTTER AS, 1995, MAR ECOL PROG SER, V118, P51, DOI 10.3354/meps118051; Grutter AS, 2003, CURR BIOL, V13, P64, DOI 10.1016/S0960-9822(02)01393-3; Grutter AS, 2002, MAR ECOL PROG SER, V234, P247, DOI 10.3354/meps234247; GRUTTER AS, 1994, MAR ECOL PROG SER, V115, P21, DOI 10.3354/meps115021; Grutter AS, 1997, OECOLOGIA, V111, P137, DOI 10.1007/s004420050217; Grutter AS, 1999, NATURE, V398, P672, DOI 10.1038/19443; Grutter AS, 1996, J EXP MAR BIOL ECOL, V196, P285, DOI 10.1016/0022-0981(95)00135-2; Holbrook SJ, 2000, OECOLOGIA, V122, P109, DOI 10.1007/PL00008826; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jobling Malcolm, 2002, P97, DOI 10.1002/9780470693803.ch5; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Kulbicki M, 2005, AQUAT LIVING RESOUR, V18, P231, DOI 10.1051/alr:2005029; Lewis AR, 1997, CORAL REEFS, V16, P139, DOI 10.1007/s003380050068; LOSEY GS, 1972, COPEIA, P820, DOI 10.2307/1442741; LOSEY GS, 1995, ETHOLOGY, V100, P277; Marini L, 2010, BIOL CONSERV, V143, P2164, DOI 10.1016/j.biocon.2010.05.029; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; Ostlund-Nilsson S, 2005, MAR ECOL PROG SER, V287, P209, DOI 10.3354/meps287209; Quinn GP, 2002, EXPERIMENTAL DESIGN; R Development Core Team, 2010, LANG ENV STAT COMP; Raihani NJ, 2010, SCIENCE, V327, P171, DOI 10.1126/science.1183068; Randall J E, 1997, FISHES GREAT BARRIER, VSecond, P557; ROBERTS CM, 1995, CONSERV BIOL, V9, P988, DOI 10.1046/j.1523-1739.1995.9051332.x-i1; Rohde K, 2005, MARINE PARASITOLOGY, P1; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; Wabnitz Colette, 2003, P1; WICKSTEN MK, 1995, COPEIA, P477; Youngbluth M. J., 1968, Zeitschrift fuer Tierpsychologie, V25, P915	54	82	83	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21201	10.1371/journal.pone.0021201	http://dx.doi.org/10.1371/journal.pone.0021201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731670	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900014
J	Zahuczky, G; Kristof, E; Majai, G; Fesus, L				Zahuczky, Gabor; Kristof, Endre; Majai, Gyoengyike; Fesues, Laszlo			Differentiation and Glucocorticoid Regulated Apopto-Phagocytic Gene Expression Patterns in Human Macrophages. Role of Mertk in Enhanced Phagocytosis	PLOS ONE			English	Article							THP-1 CELLS; CLEARANCE; RECEPTORS; MONOCYTE; INFLAMMATION; NEUTROPHILS; COMPLEMENT; SYSTEM	The daily clearance of physiologically dying cells is performed safely mainly by cells in the mononuclear phagocyte system. They can recognize and engulf dying cells utilizing several cooperative mechanisms. In our study we show that the expression of a broad range of apopto-phagocytic genes is strongly up-regulated during differentiation of human monocytes to macrophages with different donor variability. The glucocorticoid dexamethasone has a profound effect on this process by selectively up-regulating six genes and down-regulating several others. The key role of the up-regulated mer tyrosine kinase (Mertk) in dexamethasone induced enhancement of phagocytosis could be demonstrated in human monocyte derived macrophages by gene silencing as well as blocking antibodies, and also in a monocyte-macrophage like cell line. However, the additional role of other glucocorticoid induced elements must be also considered since the presence of autologous serum during phagocytosis could almost completely compensate for the blocked function of Mertk.	[Zahuczky, Gabor; Kristof, Endre; Majai, Gyoengyike; Fesues, Laszlo] Univ Debrecen, Hungarian Acad Sci, Apoptosis & Genom Res Grp, Dept Biochem & Mol Biol, Debrecen, Hungary; [Majai, Gyoengyike] Univ Debrecen, Dept Internal Med 3, Debrecen, Hungary	Hungarian Academy of Sciences; University of Debrecen; University of Debrecen	Zahuczky, G (corresponding author), Univ Debrecen, Hungarian Acad Sci, Apoptosis & Genom Res Grp, Dept Biochem & Mol Biol, Debrecen, Hungary.	fesus@med.unideb.hu	Kristóf, Endre/AGB-5046-2022	Kristóf, Endre/0000-0002-2215-6984	Hungarian Scientific Research Fund [OTKA NI 67877]; Hungarian Ministry of Health; EU [MRTN-CT-2006-036032, MRTN-CT 2006-035624, LSHB-CT-2007-037730]; TAMOP [4.2.1./B-09/1/KONV-2010-0007]; European Social Fund	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Health; EU(European Commission); TAMOP; European Social Fund(European Social Fund (ESF))	The study has been funded by grants from the Hungarian Scientific Research Fund (OTKA NI 67877), the Hungarian Ministry of Health and EU (MRTN-CT-2006-036032, MRTN-CT 2006-035624, LSHB-CT-2007-037730) as well as the TAMOP 4.2.1./B-09/1/KONV-2010-0007 project implemented through the New Hungary Development Plan, co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; de Almeida CJG, 2005, CELL MOL LIFE SCI, V62, P1532, DOI 10.1007/s00018-005-4511-y; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Giles KM, 2001, J IMMUNOL, V167, P976, DOI 10.4049/jimmunol.167.2.976; Hart SP, 2004, CLIN EXP IMMUNOL, V135, P181, DOI 10.1111/j.1365-2249.2003.02330.x; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Liu YQ, 1999, J IMMUNOL, V162, P3639; Majai G, 2006, IMMUNOL LETT, V104, P94, DOI 10.1016/j.imlet.2005.11.016; Majai G, 2007, EUR J IMMUNOL, V37, P1343, DOI 10.1002/eji.200636398; McColl A, 2009, J IMMUNOL, V183, P2167, DOI 10.4049/jimmunol.0803503; MEAGHER LC, 1992, J LEUKOCYTE BIOL, V52, P269, DOI 10.1002/jlb.52.3.269; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Petrovski G, 2007, CELL DEATH DIFFER, V14, P1117, DOI 10.1038/sj.cdd.4402112; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; VANFURTH R, 1979, BLOOD, V54, P485; Yona S, 2007, IMMUNOL CELL BIOL, V85, P81, DOI 10.1038/sj.icb.7100034; ZIEGLERHEITBROCK HWL, 1994, J LEUKOCYTE BIOL, V55, P73, DOI 10.1002/jlb.55.1.73	35	40	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21349	10.1371/journal.pone.0021349	http://dx.doi.org/10.1371/journal.pone.0021349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731712	Green Submitted, gold, Green Published			2022-12-25	WOS:000292036900022
J	Liaw, H; Lee, D; Myung, K				Liaw, Hungjiun; Lee, Deokjae; Myung, Kyungjae			DNA-PK-Dependent RPA2 Hyperphosphorylation Facilitates DNA Repair and Suppresses Sister Chromatid Exchange	PLOS ONE			English	Article							REPLICATION PROTEIN-A; RADIATION-INDUCED PHOSPHORYLATION; S-PHASE CHECKPOINT; ATAXIA-TELANGIECTASIA; BINDING PROTEIN; P34 SUBUNIT; POLYMERASE-ETA; HUMAN-CELLS; HELA-CELLS; KINASE	Hyperphosphorylation of RPA2 at serine 4 and serine 8 (S4, S8) has been used as a marker for activation of the DNA damage response. What types of DNA lesions cause RPA2 hyperphosphorylation, which kinase(s) are responsible for them, and what is the biological outcome of these phosphorylations, however, have not been fully investigated. In this study we demonstrate that RPA2 hyperphosphorylation occurs primarily in response to genotoxic stresses that cause high levels of DNA double-strand breaks (DSBs) and that the DNA-dependent protein kinase complex (DNA-PK) is responsible for the modifications in vivo. Alteration of S4, S8 of RPA2 to alanines, which prevent phosphorylations at these sites, caused increased mitotic entry with concomitant increases in RAD51 foci and homologous recombination. Taken together, our results demonstrate that RPA2 hyperphosphorylation by DNA-PK in response to DSBs blocks unscheduled homologous recombination and delays mitotic entry. This pathway thus permits cells to repair DNA damage properly and increase cell viability.	[Liaw, Hungjiun; Lee, Deokjae; Myung, Kyungjae] NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Liaw, H (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	kmyung@mail.nih.gov	Liaw, Hungjiun/G-7034-2014	Liaw, Hungjiun/0000-0002-3481-709X	National Human Genome Research Institute, National Institutes of Health [HG012003-09]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003, Z01HG012003] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Human Genome Research Institute, National Institutes of Health (HG012003-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Anantha RW, 2008, P NATL ACAD SCI USA, V105, P12903, DOI 10.1073/pnas.0803001105; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; BOUBNOV NV, 1995, MOL CELL BIOL, V15, P5700; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; BRUSH GS, 1994, P NATL ACAD SCI USA, V91, P12520, DOI 10.1073/pnas.91.26.12520; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; Cheng XB, 1996, RADIOTHER ONCOL, V39, P43, DOI 10.1016/0167-8140(96)01712-4; Cruet-Hennequart S, 2008, DNA REPAIR, V7, P582, DOI 10.1016/j.dnarep.2007.12.012; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gately DP, 1998, MOL BIOL CELL, V9, P2361, DOI 10.1091/mbc.9.9.2361; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Lee DH, 2010, NAT STRUCT MOL BIOL, V17, P365, DOI 10.1038/nsmb.1769; Lee KY, 2008, MOL CELLS, V26, P5; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; Manthey KC, 2007, J CELL SCI, V120, P4221, DOI 10.1242/jcs.004580; Morgan SE, 1997, CANCER RES, V57, P3386; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; PAN ZQ, 1994, P NATL ACAD SCI USA, V91, P8343, DOI 10.1073/pnas.91.18.8343; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; SALAHUDDIN, 1990, GENE DEV, V4, P968, DOI 10.1101/gad.4.6.968; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Stephan H, 2009, NUCLEIC ACIDS RES, V37, P6028, DOI 10.1093/nar/gkp605; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Wang HY, 2001, CANCER RES, V61, P8554; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896	36	50	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21424	10.1371/journal.pone.0021424	http://dx.doi.org/10.1371/journal.pone.0021424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731742	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700082
J	Autry, JM; Rubin, JE; Pietrini, SD; Winters, DL; Robia, SL; Thomas, DD				Autry, Joseph M.; Rubin, John E.; Pietrini, Sean D.; Winters, Deborah L.; Robia, Seth L.; Thomas, David D.			Oligomeric Interactions of Sarcolipin and the Ca-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; MUSCLE SARCOPLASMIC-RETICULUM; FLUORESCENCE ENERGY-TRANSFER; SOLID-STATE NMR; CALCIUM-TRANSPORT; SKELETAL-MUSCLE; PHOSPHOLAMBAN OLIGOMERIZATION; ENDOPLASMIC-RETICULUM; ANTIMICROBIAL PEPTIDE; ATRIAL-FIBRILLATION	We have detected directly the interactions of sarcolipin (SLN) and the sarcoplasmic reticulum Ca-ATPase (SERCA) by measuring fluorescence resonance energy transfer (FRET) between fusion proteins labeled with cyan fluorescent protein (donor) and yellow fluorescent protein (acceptor). SLN is a membrane protein that helps control contractility by regulating SERCA activity in fast-twitch and atrial muscle. Here we used FRET microscopy and spectroscopy with baculovirus expression in insect cells to provide direct evidence for: 1) oligomerization of SLN and 2) regulatory complex formation between SLN and the fast-twitch muscle Ca-ATPase (SERCA1a isoform). FRET experiments demonstrated that SLN monomers self-associate into dimers and higher order oligomers in the absence of SERCA, and that SLN monomers also bind to SERCA monomers in a 1:1 binary complex when the two proteins are coexpressed. FRET experiments further demonstrated that the binding affinity of SLN for itself is similar to that for SERCA. Mutating SLN residue isoleucine-17 to alanine (I17A) decreased the binding affinity of SLN self-association and converted higher order oligomers into monomers and dimers. The I17A mutation also decreased SLN binding affinity for SERCA but maintained 1:1 stoichiometry in the regulatory complex. Thus, isoleucine-17 plays dual roles in determining the distribution of SLN homooligomers and stabilizing the formation of SERCA-SLN heterodimers. FRET results for SLN self-association were supported by the effects of SLN expression in bacterial cells. We propose that SLN exists as multiple molecular species in muscle, including SERCA-free (monomer, dimer, oligomer) and SERCA-bound (heterodimer), with transmembrane zipper residues of SLN serving to stabilize oligomeric interactions.	[Autry, Joseph M.; Rubin, John E.; Pietrini, Sean D.; Winters, Deborah L.; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Robia, Seth L.] Loyola Univ, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	University of Minnesota System; University of Minnesota Twin Cities; Loyola University Chicago	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall, Minneapolis, MN 55455 USA.	ddt@umn.edu	Thomas, David D/B-4257-2012; Autry, Joseph M./X-6839-2019	Autry, Joseph M./0000-0002-1144-725X; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [GM27906]; Lillehei Heart Institute; University of Minnesota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lillehei Heart Institute; University of Minnesota(University of Minnesota System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant GM27906 from the National Institutes of Health (to D. D. T.).; Supported by a grant from the Lillehei Heart Institute.; Supported by two grants from the Undergraduate Research Opportunities Program at the University of Minnesota.	Alkaabi KM, 2005, APPL BIOCHEM BIOTECH, V126, P149, DOI 10.1385/ABAB:126:2:149; Aly A, 2001, BIOPHYS J, V80, p26A; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 1997, J BIOL CHEM, V272, P15872, DOI 10.1074/jbc.272.25.15872; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Becucci L, 2007, BIOPHYS J, V93, P2678, DOI 10.1529/biophysj.107.109280; Becucci L, 2009, BIOPHYS J, V97, P2693, DOI 10.1016/j.bpj.2009.08.035; Becucci L, 2009, BIOPHYS J, V96, pL60, DOI 10.1016/j.bpj.2009.03.013; Bhupathy P, 2009, J MOL CELL CARDIOL, V47, P723, DOI 10.1016/j.yjmcc.2009.07.014; Buffy JJ, 2006, BIOCHEMISTRY-US, V45, P10939, DOI 10.1021/bi060728d; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Campanaro S, 2002, HUM MOL GENET, V11, P3283, DOI 10.1093/hmg/11.26.3283; Chen ZH, 2006, J BIOL CHEM, V281, P14163, DOI 10.1074/jbc.M601338200; COOK EA, 1989, BIOCHEM J, V264, P533, DOI 10.1042/bj2640533; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; Espagne A, 2011, BIOCHEMISTRY-US, V50, P437, DOI 10.1021/bi1015875; FUJII J, 1987, J CLIN INVEST, V79, P301, DOI 10.1172/JCI112799; Glaves JP, 2009, BIOPHYS J, V96, p211A, DOI 10.1016/j.bpj.2008.12.1866; Gramolini AO, 2006, P NATL ACAD SCI USA, V103, P2446, DOI 10.1073/pnas.0510883103; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Hughes E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M611668200; JONA I, 1989, ACTA PHYSIOL HUNG, V74, P215; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan D H, 1974, Methods Enzymol, V32, P291; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; Mascioni A, 2002, BIOCHEMISTRY-US, V41, P475, DOI 10.1021/bi011243m; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Nef HM, 2009, EUR HEART J, V30, P2155, DOI 10.1093/eurheartj/ehp240; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Pandey BK, 2011, BIOCHEM J, V436, P609, DOI 10.1042/BJ20110056; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Reddy LG, 1999, BIOCHEMISTRY-US, V38, P3954, DOI 10.1021/bi981795d; Remppis Andrew, 2002, Basic Research in Cardiology, V97; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; Shanmugam M, 2011, BIOCHEM BIOPH RES CO, V410, P97, DOI 10.1016/j.bbrc.2011.05.113; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; SKERJANC IS, 1993, J BIOL CHEM, V268, P15944; Smeazzetto S, 2010, BIOPHYS J, V98, p327A; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Thomas DD, 1998, ANN NY ACAD SCI, V853, P186, DOI 10.1111/j.1749-6632.1998.tb08266.x; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Uemura N, 2004, EUR J CLIN INVEST, V34, P723, DOI 10.1111/j.1365-2362.2004.01422.x; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Vittorini S, 2007, MOL MED, V13, P105, DOI 10.2119/2006-00054.Vittorini; Waggoner JR, 2004, PROTEIN EXPRES PURIF, V34, P56, DOI 10.1016/j.pep.2003.11.005; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	65	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31697	31706		10.1074/jbc.M111.246843	http://dx.doi.org/10.1074/jbc.M111.246843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21737843	hybrid, Green Published			2022-12-25	WOS:000294487500062
J	Sharma, NR; Mateu, G; Dreux, M; Grakoui, A; Cosset, FL; Melikyan, GB				Sharma, Nishi R.; Mateu, Guaniri; Dreux, Marlene; Grakoui, Arash; Cosset, Francois-Loic; Melikyan, Gregory B.			Hepatitis C Virus Is Primed by CD81 Protein for Low pH-dependent Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX-VIRUS; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; CELL ENTRY; STRUCTURAL-CHANGES; TRANSMEMBRANE DOMAINS; TARGET MEMBRANES; PORE FORMATION; GLYCOPROTEIN; RECEPTOR	Hepatitis C virus (HCV) entry into permissive cells is a complex process that involves interactions with at least four co-factors followed by endocytosis and low pH-dependent fusion with endosomes. The precise sequence of receptor engagement and their roles in promoting HCV E1E2 glycoprotein-mediated fusion are poorly characterized. Because cell-free HCV tolerates an acidic environment, we hypothesized that binding to one or more receptors on the cell surface renders E1E2 competent to undergo low pH-induced conformational changes and promote fusion with endosomes. To test this hypothesis, we examined the effects of low pH and of the second extracellular loop (ECL2) of CD81, one of the four entry factors, on HCV infectivity. Pretreatment with an acidic buffer or with ECL2 enhanced infection through changing the E1E2 conformation, as evidenced by the altered reactivity of these proteins with conformation-specific antibodies and stable association with liposomes. However, neither of the two treatments alone permitted direct fusion with the cell plasma membrane. Sequential HCV preincubation with ECL2 and acidic buffer in the absence of target cells resulted in a marked loss of infectivity, implying that the receptor-bound HCV is primed for low pH-dependent conformational changes. Indeed, soluble receptor-pretreated HCV fused with the cell plasma membrane at low pH under conditions blocking an endocytic entry pathway. These findings suggest that CD81 primes HCV for low pH-dependent fusion early in the entry process. The simple triggering paradigm and intermediate conformations of E1E2 identified in this study could help guide future vaccine and therapeutic efforts to block HCV infection.	[Sharma, Nishi R.; Melikyan, Gregory B.] Emory Univ, Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA 30322 USA; [Dreux, Marlene; Cosset, Francois-Loic] Univ Lyon, UCB Lyon 1, IFR128, F-69007 Lyon, France; [Mateu, Guaniri; Grakoui, Arash] Dept Med, Div Infect Dis, F-69007 Lyon, France; [Dreux, Marlene; Cosset, Francois-Loic] Ecole Normale Super Lyon, F-69364 Lyon, France; [Dreux, Marlene; Cosset, Francois-Loic] INSERM, U758, F-69364 Lyon, France; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Children's Healthcare of Atlanta (CHOA)	Melikyan, GB (corresponding author), Emory Univ, Childrens Ctr, Div Pediat Infect Dis, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Dreux, Marlene/M-7295-2014; Cosset, François-Loïc/M-5862-2019	Dreux, Marlene/0000-0002-6607-4796; Cosset, François-Loïc/0000-0001-8842-3726	National Institutes of Health [DK083356, AI070101]; USPHS; American Recovery and Reinvestment [R21 AI079714]; Agence Nationale pour la Recherche Contre le SIDA et les Hepatites Virales; European Research Council [ERC-2008-AdG-233130-HEPCENT]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070101, R21AI079714, R01AI070101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); American Recovery and Reinvestment; Agence Nationale pour la Recherche Contre le SIDA et les Hepatites Virales(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083356 and AI070101 from USPHS (to A. G.). This work was also supported by American Recovery and Reinvestment Act Grant R21 AI079714 (to G. M.), Agence Nationale pour la Recherche Contre le SIDA et les Hepatites Virales, and European Research Council Grant ERC-2008-AdG-233130-HEPCENT (to F.-L. C.).	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2006, VIROLOGY, V348, P1, DOI 10.1016/j.virol.2005.12.027; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Brazzoli M, 2008, J VIROL, V82, P8316, DOI 10.1128/JVI.00665-08; BRON R, 1993, EMBO J, V12, P693, DOI 10.1002/j.1460-2075.1993.tb05703.x; Campbell JN, 2004, BIOMACROMOLECULES, V5, P1728, DOI 10.1021/bm049878z; Carneiro FA, 2001, J BIOL CHEM, V276, P62, DOI 10.1074/jbc.M008753200; Catanese MT, 2010, J VIROL, V84, P34, DOI 10.1128/JVI.02199-08; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Codran A, 2006, J GEN VIROL, V87, P2583, DOI 10.1099/vir.0.81710-0; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Damico R, 2000, J VIROL, V74, P6469, DOI 10.1128/JVI.74.14.6469-6475.2000; Damico RL, 1998, P NATL ACAD SCI USA, V95, P2580, DOI 10.1073/pnas.95.5.2580; DOMS RW, 1985, J BIOL CHEM, V260, P2973; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Dreux M, 2006, J BIOL CHEM, V281, P18285, DOI 10.1074/jbc.M602706200; Drummer HE, 2007, J GEN VIROL, V88, P1144, DOI 10.1099/vir.0.82567-0; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Earp LJ, 2003, J VIROL, V77, P3058, DOI 10.1128/JVI.77.5.3058-3066.2003; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Hannah BP, 2009, J VIROL, V83, P6825, DOI 10.1128/JVI.00301-09; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Helle F, 2008, CELL MOL LIFE SCI, V65, P100, DOI 10.1007/s00018-007-7291-8; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Heo TH, 2006, VIRUS RES, V121, P58, DOI 10.1016/j.virusres.2006.04.002; Hernandez LD, 1997, J CELL BIOL, V139, P1455, DOI 10.1083/jcb.139.6.1455; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Keck ZY, 2004, J VIROL, V78, P7257, DOI 10.1128/JVI.78.13.7257-7263.2004; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; Lavillette D, 2006, J BIOL CHEM, V281, P3909, DOI 10.1074/jbc.M509747200; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Markosyan RM, 2007, J VIROL, V81, P11218, DOI 10.1128/JVI.01256-07; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; McKeating JA, 2004, J VIROL, V78, P8496, DOI 10.1128/JVI.78.16.8496-8505.2004; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Melikyan GB, 2004, J VIROL, V78, P3753, DOI 10.1128/JVI.78.7.3753-3762.2004; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Nakajima H, 2005, BIOCHEM BIOPH RES CO, V328, P1091, DOI 10.1016/j.bbrc.2005.01.056; Perrault M, 2009, BIOCHEM J, V423, P303, DOI 10.1042/BJ20091000; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; STEGMANN T, 1990, EMBO J, V9, P4231, DOI 10.1002/j.1460-2075.1990.tb07871.x; Tan YJ, 2003, VIROLOGY, V308, P250, DOI 10.1016/S0042-6822(02)00136-8; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; von Hahn T, 2006, HEPATOLOGY, V43, P932, DOI 10.1002/hep.21139; Whitbeck JC, 2006, J VIROL, V80, P3773, DOI 10.1128/JVI.80.8.3773-3780.2006; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Zeisel MB, 2007, HEPATOLOGY, V46, P1722, DOI 10.1002/hep.21994; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	81	72	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30361	30376		10.1074/jbc.M111.263350	http://dx.doi.org/10.1074/jbc.M111.263350			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737455	Green Published, hybrid			2022-12-25	WOS:000294283600014
J	Valapala, M; Vishwanatha, JK				Valapala, Mallika; Vishwanatha, Jamboor K.			Lipid Raft Endocytosis and Exosomal Transport Facilitate Extracellular Trafficking of Annexin A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT-RESISTANT MEMBRANES; CELL-SURFACE; ENDOSOME BIOGENESIS; APICAL MEMBRANE; ESCRT COMPLEXES; K562 CELLS; CALCIUM; DOMAINS; DYNAMICS; CAVEOLAE	Annexin A2 (AnxA2), a Ca2+-dependent phospholipid-binding protein, is known to associate with the plasma membrane and the endosomal system. Within the plasma membrane, AnxA2 associates in a Ca2+ dependent manner with cholesterol-rich lipid raft microdomains. Here, we show that the association of AnxA2 with the lipid rafts is influenced not only by intracellular levels of Ca2+ but also by N-terminal phosphorylation at tyrosine 23. Binding of AnxA2 to the lipid rafts is followed by the transport along the endocytic pathway to be associated with the intralumenal vesicles of the multivesicular endosomes. AnxA2-containing multivesicular endosomes fuse directly with the plasma membrane resulting in the release of the intralumenal vesicles into the extracellular environment, which facilitates the exogenous transfer of AnxA2 from one cell to another. Treatment with Ca2+ ionophore triggers the association of AnxA2 with the specialized microdomains in the exosomal membrane that possess raft-like characteristics. Phosphorylation at Tyr-23 is also important for the localization of AnxA2 to the exosomal membranes. These results suggest that AnxA2 is trafficked from the plasma membrane rafts and is selectively incorporated into the lumenal membranes of the endosomes to escape the endosomal degradation pathway. The Ca2+-dependent exosomal transport constitutes a novel pathway of extracellular transport of AnxA2.	[Valapala, Mallika; Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Dept Biomed Sci, Ft Worth, TX 76107 USA; [Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA; [Vishwanatha, Jamboor K.] Univ N Texas Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Vishwanatha, JK (corresponding author), 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	Jamboor.vishwanatha@unthsc.edu		Vishwanatha, Jamboor/0000-0002-0266-6020	National Center on Minority Health and Health Disparities [MD001633]; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001633] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by National Center on Minority Health and Health Disparities Grant MD001633.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697; Barwise JL, 1996, J CELL SCI, V109, P247; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Benlimame N, 1998, MOL BIOL CELL, V9, P1773, DOI 10.1091/mbc.9.7.1773; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brown Deborah A, 2002, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1110s51; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Creutz CE, 2005, BIOCHEMISTRY-US, V44, P13795, DOI 10.1021/bi051160w; Danielsen EM, 2003, BIOCHEMISTRY-US, V42, P14670, DOI 10.1021/bi0355239; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Foster Leonard J., 2007, V43, P35, DOI 10.1007/978-1-4020-5943-8_4; Fullekrug J, 2004, ANN NY ACAD SCI, V1014, P164, DOI 10.1196/annals.1294.017; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hayes MJ, 2009, BBA-MOL CELL RES, V1793, P1086, DOI 10.1016/j.bbamcr.2008.10.007; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Koga K, 2005, ANTICANCER RES, V25, P3703; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; MacDonald PE, 2005, J CELL SCI, V118, P5911, DOI 10.1242/jcs.02685; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Nelson WJ, 2004, NAT CELL BIOL, V6, P282, DOI 10.1038/ncb0404-282; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2004, DEV CELL, V7, P458, DOI 10.1016/j.devcel.2004.09.009; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pfeffer SR, 2001, NAT CELL BIOL, V3, pE108, DOI 10.1038/35074625; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Rubin D, 2003, AM J PHYSIOL-CELL PH, V285, pC377, DOI 10.1152/ajpcell.00060.2003; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Savina A, 2002, J CELL SCI, V115, P2505; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Turpin E, 1998, BBA-MOL CELL RES, V1402, P115, DOI 10.1016/S0167-4889(97)00151-1; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zeuschner D, 2001, EUR J CELL BIOL, V80, P499, DOI 10.1078/0171-9335-00184; Zhuang LY, 2002, CANCER RES, V62, P2227	64	128	131	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30911	30925		10.1074/jbc.M111.271155	http://dx.doi.org/10.1074/jbc.M111.271155			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737841	Green Published, hybrid			2022-12-25	WOS:000294283600070
J	Rodgers, GM; Ward, JR; Askwith, B; Morrell, LJ				Rodgers, Gwendolen M.; Ward, Jonathan R.; Askwith, Beth; Morrell, Lesley J.			Balancing the Dilution and Oddity Effects: Decisions Depend on Body Size	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; SHOALING BEHAVIOR; PREDATION RISK; SCHOOLING BEHAVIOR; KIN RECOGNITION; FISH; PREFERENCES; CHOICE; SEGREGATION; POPULATIONS	Background: Grouping behaviour, common across the animal kingdom, is known to reduce an individual's risk of predation; particularly through dilution of individual risk and predator confusion (predator inability to single out an individual for attack). Theory predicts greater risk of predation to individuals more conspicuous to predators by difference in appearance from the group (the 'oddity' effect). Thus, animals should choose group mates close in appearance to themselves (eg. similar size), whilst also choosing a large group. Methodology and Principal Findings: We used the Trinidadian guppy (Poecilia reticulata), a well known model species of group-living freshwater fish, in a series of binary choice trials investigating the outcome of conflict between preferences for large and phenotypically matched groups along a predation risk gradient. We found body-size dependent differences in the resultant social decisions. Large fish preferred shoaling with size-matched individuals, while small fish demonstrated no preference. There was a trend towards reduced preferences for the matched shoal under increased predation risk. Small fish were more active than large fish, moving between shoals more frequently. Activity levels increased as predation risk decreased. We found no effect of unmatched shoal size on preferences or activity. Conclusions and Significance: Our results suggest that predation risk and individual body size act together to influence shoaling decisions. Oddity was more important for large than small fish, reducing in importance at higher predation risks. Dilution was potentially of limited importance at these shoal sizes. Activity levels may relate to how much sampling of each shoal was needed by the test fish during decision making. Predation pressure may select for better decision makers to survive to larger size, or that older, larger fish have learned to make shoaling decisions more efficiently, and this, combined with their size relative to shoal-mates, and attractiveness as prey items influences shoaling decisions.	[Rodgers, Gwendolen M.; Ward, Jonathan R.; Askwith, Beth; Morrell, Lesley J.] Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Morrell, Lesley J.] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Leeds; University of Hull	Rodgers, GM (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	bsgmr@leeds.ac.uk	Morrell, Lesley J/A-4311-2008	Morrell, Lesley J/0000-0003-0256-7871	Biotechnology and Biological Sciences Research Council (BBSRC); Natural Environment Research Council (NERC) [NE/D008921/1]; Natural Environment Research Council [NE/D008921/1] Funding Source: researchfish; NERC [NE/D008921/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship to GMR and a Natural Environment Research Council (NERC) postdoctoral fellowship (NE/D008921/1) to LJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBER I, 1995, J FISH BIOL, V47, P524, DOI 10.1006/jfbi.1995.0156; Binoy VV, 2004, CURR SCI INDIA, V86, P207; Boland CRJ, 2003, ETHOLOGY, V109, P209, DOI 10.1046/j.1439-0310.2003.00860.x; BOTHAM MS, 2008, ECOLOGY IN PRESS; Bradner J, 2001, J FISH BIOL, V59, P960, DOI 10.1006/jfbi.2001.1712; Caro Tim, 2005, pXIII; Croft DP, 2006, AM NAT, V167, P867, DOI 10.1086/504853; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; FITZGERALD GJ, 1992, ETHOL ECOL EVOL, V4, P273, DOI 10.1080/08927014.1992.9523138; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Frommen JG, 2007, ZOOLOGY, V110, P369, DOI 10.1016/j.zool.2007.06.002; Gomez-Laplaza LM, 2005, BEHAVIOUR, V142, P827, DOI 10.1163/1568539054729141; Griffiths SW, 1999, BEHAV ECOL SOCIOBIOL, V45, P437, DOI 10.1007/s002650050582; Griffiths SW, 1998, ANIM BEHAV, V56, P689, DOI 10.1006/anbe.1998.0767; Griffiths SW, 1997, P ROY SOC B-BIOL SCI, V264, P547, DOI 10.1098/rspb.1997.0078; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; Hoare DJ, 2000, OIKOS, V89, P546, DOI 10.1034/j.1600-0706.2000.890314.x; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Houston AI, 2003, EVOL ECOL RES, V5, P195; Jones KA, 2010, ETHOLOGY, V116, P147, DOI 10.1111/j.1439-0310.2009.01727.x; Kelley JL, 2003, BEHAV ECOL SOCIOBIOL, V54, P225, DOI 10.1007/s00265-003-0621-4; KRAKAUER DC, 1995, BEHAV ECOL SOCIOBIOL, V36, P421, DOI 10.1007/BF00177338; KRAUSE J, 1994, ETHOLOGY, V98, P128; KRAUSE J, 1995, ANIM BEHAV, V50, P465, DOI 10.1006/anbe.1995.0260; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Ledesma JM, 2008, BEHAV PROCESS, V77, P384, DOI 10.1016/j.beproc.2007.10.006; MAGURRAN AE, 1995, ADV STUD BEHAV, V24, P155, DOI 10.1016/S0065-3454(08)60394-0; MAGURRAN AE, 1993, MAR BEHAV PHYSIOL, V23, P29, DOI 10.1080/10236249309378855; MAGURRAN AE, 1991, BEHAVIOUR, V118, P214, DOI 10.1163/156853991X00292; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; Mathis A, 2003, BEHAV ECOL, V14, P334, DOI 10.1093/beheco/14.3.334; McRobert SP, 1998, ANIM BEHAV, V56, P611, DOI 10.1006/anbe.1998.0846; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V259, P207, DOI 10.1098/rspb.1995.0030; Miller RC, 1922, ECOLOGY, V3, P122, DOI 10.2307/1929145; Morrell LJ, 2007, ANIM BEHAV, V74, P311, DOI 10.1016/j.anbehav.2006.10.021; Morrell LJ, 2004, BEHAV ECOL SOCIOBIOL, V56, P539, DOI 10.1007/s00265-004-0821-6; Peuhkuri N, 1999, BEHAV ECOL SOCIOBIOL, V46, P307, DOI 10.1007/s002650050624; Pitcher T. J, 1993, BEHAV TELEOST FISHES; Ranta Esa, 1994, Ecoscience, V1, P99; RODGERS GM, ANIMAL BEHAV, V79, P1025; Ruhl N, 2005, J FISH BIOL, V67, P1318, DOI 10.1111/j.0022-1112.2005.00826.x; SEGHERS BH, 1974, EVOLUTION, V28, P486, DOI 10.1111/j.1558-5646.1974.tb00774.x; Svensson PA, 2000, J FISH BIOL, V56, P1477, DOI 10.1111/j.1095-8649.2000.tb02158.x; Tegeder RW, 1995, PHILOS T R SOC B, V350, P381, DOI 10.1098/rstb.1995.0172; THEODORAKIS CW, 1989, ANIM BEHAV, V38, P496, DOI 10.1016/S0003-3472(89)80042-9; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Ward AJW, 2005, ENVIRON BIOL FISH, V72, P155, DOI 10.1007/s10641-004-9078-1; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Wong BBM, 2005, ETHOLOGY, V111, P179, DOI 10.1111/j.1439-0310.2004.01044.x; Wright D, 2006, NAT PROTOC, V1, P1828, DOI 10.1038/nprot.2006.287	52	27	27	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e14819	10.1371/journal.pone.0014819	http://dx.doi.org/10.1371/journal.pone.0014819			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750694	Green Published, gold, Green Submitted			2022-12-25	WOS:000292512000001
J	Lin, R; Rosahl, TW; Whiting, PJ; Fawcett, JW; Kwok, JCF				Lin, Rachel; Rosahl, Thomas W.; Whiting, Paul J.; Fawcett, James W.; Kwok, Jessica C. F.			6-Sulphated Chondroitins Have a Positive Influence on Axonal Regeneration	PLOS ONE			English	Article							SPINAL-CORD-INJURY; REACTIVE ASTROCYTES; NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; GLIAL SCAR; SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; CELL-MIGRATION; STAIRCASE TEST; RAT-BRAIN	Chondroitin sulphate proteoglycans (CSPGs) upregulated in the glial scar inhibit axon regeneration via their sulphated glycosaminoglycans (GAGs). Chondroitin 6-sulphotransferase-1 (C6ST-1) is upregulated after injury leading to an increase in 6-sulphated GAG. In this study, we ask if this increase in 6-sulphated GAG is responsible for the increased inhibition within the glial scar, or whether it represents a partial reversion to the permissive embryonic state dominated by 6-sulphated glycosaminoglycans (GAGs). Using C6ST-1 knockout mice (KO), we studied post-injury changes in chondroitin sulphotransferase (CSST) expression and the effect of chondroitin 6-sulphates on both central and peripheral axon regeneration. After CNS injury, wild-type animals (WT) showed an increase in mRNA for C6ST-1, C6ST-2 and C4ST-1, but KO did not upregulate any CSSTs. After PNS injury, while WT upregulated C6ST-1, KO showed an upregulation of C6ST-2. We examined regeneration of nigrostriatal axons, which demonstrate mild spontaneous axon regeneration in the WT. KO showed many fewer regenerating axons and more axonal retraction than WT. However, in the PNS, repair of the median and ulnar nerves led to similar and normal levels of axon regeneration in both WT and KO. Functional tests on plasticity after the repair also showed no evidence of enhanced plasticity in the KO. Our results suggest that the upregulation of 6-sulphated GAG after injury makes the extracellular matrix more permissive for axon regeneration, and that the balance of different CSs in the microenvironment around the lesion site is an important factor in determining the outcome of nervous system injury.	[Lin, Rachel; Fawcett, James W.; Kwok, Jessica C. F.] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Rosahl, Thomas W.; Whiting, Paul J.] Merck Sharp & Dohme Ltd, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England	University of Cambridge; Merck & Company	Lin, R (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.	jcfk2@cam.ac.uk	Kwok, Jessica/A-6740-2013	Whiting, Paul/0000-0002-4121-1379; Fawcett, James/0000-0002-7990-4568; Kwok, Jessica/0000-0002-9798-9083	Medical Research Council; Wellcome Trust; Christopher and Dana Reeve foundation; European Union; Framework 7 project Plasticise	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Christopher and Dana Reeve foundation; European Union(European Commission); Framework 7 project Plasticise	This research was funded by grants from the Medical Research Council, the Wellcome Trust, the Christopher and Dana Reeve foundation, the European Union Framework 6 network of excellence NeuroNE, the Framework 7 project Plasticise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher R A, 2001, Prog Brain Res, V132, P611; Baird AL, 2001, BRAIN RES BULL, V54, P243, DOI 10.1016/S0361-9230(00)00457-3; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Chung KY, 2000, DEVELOPMENT, V127, P2673; Clement AM, 1999, NEUROSCI LETT, V269, P125, DOI 10.1016/S0304-3940(99)00432-2; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Deepa SS, 2006, J BIOL CHEM, V281, P17789, DOI 10.1074/jbc.M600544200; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fawcett JW, 2006, ADV EXP MED BIOL, V557, P11; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Galtrey CM, 2007, BRAIN, V130, P926, DOI 10.1093/brain/awl372; Galtrey CM, 2007, J PERIPHER NERV SYST, V12, P11, DOI 10.1111/j.1529-8027.2007.00113.x; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; Golding JP, 1999, DEV BIOL, V216, P85, DOI 10.1006/dbio.1999.9497; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Kinoshita A, 2001, BIOCHEMISTRY-US, V40, P12654, DOI 10.1021/bi015577n; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Kubota Y, 1999, DEV DYNAM, V214, P55, DOI 10.1002/(SICI)1097-0177(199901)214:1<55::AID-DVDY6>3.0.CO;2-E; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; Kwok JCF, 2010, J NEUROCHEM, V114, P1447, DOI 10.1111/j.1471-4159.2010.06878.x; Liu J, 2006, J CELL SCI, V119, P933, DOI 10.1242/jcs.02796; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Mitsumoto Y, 1998, BIOCHEM BIOPH RES CO, V248, P660, DOI 10.1006/bbrc.1998.8986; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Moon LDF, 2003, J NEUROSCI RES, V71, P23, DOI 10.1002/jnr.10449; Perris R, 2000, MECH DEVELOP, V95, P3, DOI 10.1016/S0925-4773(00)00365-8; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Uchimura K, 2002, J BIOL CHEM, V277, P1443, DOI 10.1074/jbc.M104719200; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649	40	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21499	10.1371/journal.pone.0021499	http://dx.doi.org/10.1371/journal.pone.0021499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747937	Green Published, gold, Green Submitted			2022-12-25	WOS:000292293400013
J	Paul, J; Maiti, K; Read, M; Hure, A; Smith, J; Chan, EC; Smith, R				Paul, Jonathan; Maiti, Kaushik; Read, Mark; Hure, Alexis; Smith, Julia; Chan, Eng-Cheng; Smith, Roger			Phasic Phosphorylation of Caldesmon and ERK 1/2 during Contractions in Human Myometrium	PLOS ONE			English	Article							SMOOTH-MUSCLE; CHICKEN GIZZARD; TROPOMYOSIN; ACTIN; CALMODULIN; PROTEIN; BINDING	Human myometrium develops phasic contractions during labor. Phosphorylation of caldesmon (h-CaD) and extracellular signal-regulated kinase 1/2 (ERK 1/2) has been implicated in development of these contractions, however the phospho-regulation of these proteins is yet to be examined during periods of both contraction and relaxation. We hypothesized that protein phosphorylation events are implicated in the phasic nature of myometrial contractions, and aimed to examine h-CaD and ERK 1/2 phosphorylation in myometrium snap frozen at specific stages, including; (1) prior to onset of contractions, (2) at peak contraction and (3) during relaxation. We aimed to compare h-CaD and ERK 1/2 phosphorylation in vitro against results from in vivo studies that compared not-in-labor (NIL) and laboring (L) myometrium. Comparison of NIL (n = 8) and L (n = 8) myometrium revealed a 2-fold increase in h-CaD phosphorylation (ser-789; P = 0.012) during onset of labor in vivo, and was associated with significantly up-regulated ERK2 expression (P = 0.022), however no change in ERK2 phosphorylation was observed (P = 0.475). During in vitro studies (n = 5), transition from non-contracting tissue to tissue at peak contraction was associated with increased phosphorylation of both h-CaD and ERK 1/2. Furthermore, tissue preserved at relaxation phase exhibited diminished levels of h-CaD and ERK 1/2 phosphorylation compared to tissue preserved at peak contraction, thereby producing a phasic phosphorylation profile for h-CaD and ERK 1/2. h-CaD and ERK 1/2 are phosphorylated during myometrial contractions, however their phospho-regulation is dynamic, in that h-CaD and ERK 1/2 are phosphorylated and dephosphorylated in phase with contraction and relaxation respectively. Comparisons of NIL and L tissue are at risk of failing to detect these changes, as L samples are not necessarily preserved in the midst of an active contraction.	[Paul, Jonathan; Maiti, Kaushik; Read, Mark; Hure, Alexis; Smith, Julia; Chan, Eng-Cheng; Smith, Roger] Univ Newcastle, Fac Hlth, Mothers & Babies Res Ctr, Callaghan, NSW 2308, Australia; [Paul, Jonathan; Maiti, Kaushik; Read, Mark; Hure, Alexis; Smith, Julia; Chan, Eng-Cheng; Smith, Roger] John Hunter Hosp, Hunter Med Res Inst, New Lambton, Australia	University of Newcastle; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Paul, J (corresponding author), Univ Newcastle, Fac Hlth, Mothers & Babies Res Ctr, Callaghan, NSW 2308, Australia.	Jonathan.Paul@newcastle.edu.au	Hure, Alexis/D-6790-2011	Paul, Jonathan/0000-0003-3064-6358; Hure, Alexis/0000-0003-2225-0986; Smith, Roger/0000-0003-4720-0280	Australian Government National Health and Medical Research Council [455556]	Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the Australian Government National Health and Medical Research Council (grant number: 455556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Angelo G, 1999, J BIOL CHEM, V274, P30115, DOI 10.1074/jbc.274.42.30115; EWOANE C, 1990, BIOCH LIFE SCI ADV, V9, P71; FUJII T, 1988, J BIOCHEM-TOKYO, V104, P734, DOI 10.1093/oxfordjournals.jbchem.a122542; GRACEFFA P, 1987, FEBS LETT, V218, P139, DOI 10.1016/0014-5793(87)81034-7; HORIUCHI KY, 1988, BIOCHEMISTRY-US, V27, P8388, DOI 10.1021/bi00422a014; Huang RJ, 2003, BIOCHEMISTRY-US, V42, P2513, DOI 10.1021/bi0268605; Li YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007489; MARSTON SB, 1991, BIOCHEM J, V279, P1; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; SADOVSKY Y, 1992, NEW ENGL J MED, V326, P709; SOBUE K, 1991, J BIOL CHEM, V266, P12115; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; SZPACENKO A, 1986, FEBS LETT, V202, P182, DOI 10.1016/0014-5793(86)80683-4	13	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21542	10.1371/journal.pone.0021542	http://dx.doi.org/10.1371/journal.pone.0021542			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738699	Green Published, gold			2022-12-25	WOS:000292291800019
J	Elyazar, IRF; Gething, PW; Patil, AP; Rogayah, H; Kusriastuti, R; Wismarini, DM; Tarmizi, SN; Baird, JK; Hay, SI				Elyazar, Iqbal R. F.; Gething, Peter W.; Patil, Anand P.; Rogayah, Hanifah; Kusriastuti, Rita; Wismarini, Desak M.; Tarmizi, Siti N.; Baird, J. Kevin; Hay, Simon I.			Plasmodium falciparum Malaria Endemicity in Indonesia in 2010	PLOS ONE			English	Article							RISK; POPULATION; PREVALENCE; INFECTION; PROGRAM; MAPS; PREDICTION; SPACE; TOOLS; MODEL	Background: Malaria control programs require a detailed understanding of the contemporary spatial distribution of infection risk to efficiently allocate resources. We used model based geostatistics (MBG) techniques to generate a contemporary map of Plasmodium falciparum malaria risk in Indonesia in 2010. Methods: Plasmodium falciparum Annual Parasite Incidence (PfAPI) data (2006-2008) were used to map limits of P. falciparum transmission. A total of 2,581 community blood surveys of P. falciparum parasite rate (PfPR) were identified (1985-2009). After quality control, 2,516 were included into a national database of age-standardized 2-10 year old PfPR data (PfPR(2-10)) for endemicity mapping. A Bayesian MBG procedure was used to create a predicted surface of PfPR2-10 endemicity with uncertainty estimates. Population at risk estimates were derived with reference to a 2010 human population count surface. Results: We estimate 132.8 million people in Indonesia, lived at risk of P. falciparum transmission in 2010. Of these, 70.3% inhabited areas of unstable transmission and 29.7% in stable transmission. Among those exposed to stable risk, the vast majority were at low risk (93.39%) with the reminder at intermediate (6.6%) and high risk (0.01%). More people in western Indonesia lived in unstable rather than stable transmission zones. In contrast, fewer people in eastern Indonesia lived in unstable versus stable transmission areas. Conclusion: While further feasibility assessments will be required, the immediate prospects for sustained control are good across much of the archipelago and medium term plans to transition to the pre-elimination phase are not unrealistic for P. falciparum. Endemicity in areas of Papua will clearly present the greatest challenge. This P. falciparum endemicity map allows malaria control agencies and their partners to comprehensively assess the region-specific prospects for reaching pre-elimination, monitor and evaluate the effectiveness of future strategies against this 2010 baseline and ultimately improve their evidence-based malaria control strategies.	[Elyazar, Iqbal R. F.; Baird, J. Kevin] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Gething, Peter W.; Patil, Anand P.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Rogayah, Hanifah; Kusriastuti, Rita; Wismarini, Desak M.; Tarmizi, Siti N.] Indonesian Minist Hlth, Directorate Vector Borne Dis, Jakarta, Indonesia; [Baird, J. Kevin] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Eijkman Institute; University of Oxford; Ministry of Health - Indonesia; University of Oxford	Elyazar, IRF (corresponding author), Eijkman Oxford Clin Res Unit, Jakarta, Indonesia.	iqbal.elyazar@gmail.com; simon.hay@zoo.ox.ac.uk	Gething, Peter/GQR-1884-2022; Hay, Simon Iain/F-8967-2015; Gething, Peter/ABD-2110-2020	Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; 	University of Oxford-Li Ka Shing Foundation; Oxford Tropical Network; Wellcome Trust [079091, 091835, B9RJIXO]; Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Indonesian Ministry of Health; Wellcome Trust, U.K.; Eijkman Institute of Molecular Biology, Jakarta	University of Oxford-Li Ka Shing Foundation; Oxford Tropical Network; Wellcome Trust(Wellcome Trust); Science and Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Indonesian Ministry of Health; Wellcome Trust, U.K.(Wellcome Trust); Eijkman Institute of Molecular Biology, Jakarta	IE is funded by grants from the University of Oxford-Li Ka Shing Foundation Global Health Program and the Oxford Tropical Network. SIH is funded by a Senior Research Fellowship from the Wellcome Trust (#079091), which also supports PWG. SIH also acknowledges funding support from the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. APP is funded by a grant from the Wellcome Trust (#091835). HR, RK, DMW, SNT are funded by the Indonesian Ministry of Health. JKB is funded by a grant from the Wellcome Trust (#B9RJIXO). This work forms part of the output of the Malaria Atlas Project (MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The national assembly of parasite prevalence surveys was dependent on the generous contributions of data by a large number of people in the malaria research and control communities, and these individuals are listed on the MAP website (http://www.map.ac.uk/acknowledgements.html). We thank Catherine Moyes for comments and Jennie Charlton for proofreading this paper. The authors additionally acknowledge the support of the colleagues from the Sub-Directorate of Indonesian Malaria Control including Achmad Farchanny, Adhi Sambodo, Ali Romzan, Aris Munanto, Bangkit Hutajulu, Budi Pramono, Charles Tobing, Elvieda Samoedro, Niken W. Palupi, Nur Asni and Saktiyono. The authors also thank the support of the Eijkman Institute of Molecular Biology, Jakarta.	[Anonymous], 2009, MAL MICR QUAL ASS MA; Badan Pusat Statistik, 2010, HAS SENS PEND 2010 D; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Bicheron P., 2010, GLOBCOVER PRODUCTS D; Brooker S, 2002, TRENDS PARASITOL, V18, P70, DOI 10.1016/S1471-4922(01)02223-1; Brooker S, 2006, EMERG INFECT DIS, V12, P1600, DOI 10.3201/eid1210.060051; Clements ACA, 2006, TROP MED INT HEALTH, V11, P490, DOI 10.1111/j.1365-3156.2006.01594.x; *DEP KES, 2009, KEP MENT KES REP IND; Diggle PJ, 2007, ANN TROP MED PARASIT, V101, P499, DOI [10.1179/136485913X13789813917463, 10.1179/136485907X229121]; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Elyazar IRF, 2011, ADV PARASIT, V74, P41, DOI 10.1016/B978-0-12-385897-9.00002-1; Feachem RGA, 2009, SHRINKING MALARIA MA; Gething PW, 2006, PLOS MED, V3, P825, DOI 10.1371/journal.pmed.0030271; Global Malaria Programme, 2007, MAL EL FIELD MAN LOW; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, P8; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hay SI, 2010, PLOS MED, V7, P6; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Manh BH, 2011, INT J PARASITOL, V41, P109, DOI 10.1016/j.ijpara.2010.08.005; Noor AM, 2010, AM J TROP MED HYG, V83, P854, DOI 10.4269/ajtmh.2010.10-0331; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Noor AM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-159; Patil AP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-186; PULL JH, 1974, B WORLD HEALTH ORGAN, V51, P507; Reid H, 2010, AM J TROP MED HYG, V83, P861, DOI 10.4269/ajtmh.2010.10-0154; Reid H, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-150; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; SMITH DL, 2009, MEASURING MALARIA EL, P00108; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Stein ML, 2005, J AM STAT ASSOC, V100, P310, DOI 10.1198/016214504000000854; Stevens W, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-22; Takken W., 1990, ENV MEASURES MALARIA; Wallace A. R., 1863, J ROYAL GEOGRAPHICAL, V33, P217, DOI DOI 10.2307/1798448; Zanzibar Malaria Control Program, 2009, MAL EL ZANZ FEAS ASS; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	57	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21315	10.1371/journal.pone.0021315	http://dx.doi.org/10.1371/journal.pone.0021315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738634	Green Published, gold			2022-12-25	WOS:000292290100017
J	Lee, H; Park, MT; Choi, BH; Oh, ET; Song, MJ; Lee, J; Kim, C; Lim, BU; Park, HJ				Lee, Hyemi; Park, Moon-Taek; Choi, Bo-Hwa; Oh, Eun-Taex; Song, Min-Jeong; Lee, Jeonghun; Kim, Chulhee; Lim, Byung Uk; Park, Heon Joo			Endoplasmic Reticulum Stress-Induced JNK Activation Is a Critical Event Leading to Mitochondria-Mediated Cell Death Caused by beta-Lapachone Treatment	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; BREAST-CANCER CELLS; INDUCED APOPTOSIS; IONIZING-RADIATION; CYTOCHROME-C; MAP KINASES; CLEAVAGE; BAX; BCL-2; ERK	Background: beta-lapachone (beta-lap) is a bioreductive agent that is activated by the two-electron reductase NAD(P)H quinone oxidoreductase 1 (NQO1). Although beta-lap has been reported to induce apoptosis in various cancer types in an NQO1-dependent manner, the signaling pathways by which beta-lap causes apoptosis are poorly understood. Methodology/Principal Findings: beta-lap-induced apoptosis and related molecular signaling pathways in NQO1-negative and NQO1-overexpressing MDA-MB-231 cells were investigated. Pharmacological inhibitors or siRNAs against factors involved in beta-lap-induced apoptosis were used to clarify the roles played by such factors in beta-lap-activated apoptotic signaling pathways. beta-lap leads to clonogenic cell death and apoptosis in an NQO1-dependent manner. Treatment of NQO1-overexpressing MDA-MB-231 cells with beta-lap causes rapid disruption of mitochondrial membrane potential, nuclear translocation of AIF and Endo G from mitochondria, and subsequent caspase-independent apoptotic cell death. siRNAs targeting AIF and Endo G effectively attenuate beta-lap-induced clonogenic and apoptotic cell death. Moreover, beta-lap induces cleavage of Bax, which accumulates in mitochondria, coinciding with the observed changes in mitochondria membrane potential. Pretreatment with Salubrinal (Sal), an endoplasmic reticulum (ER) stress inhibitor, efficiently attenuates JNK activation caused by beta-lap, and subsequent mitochondria-mediated cell death. In addition, beta-lap-induced generation and mitochondrial translocation of cleaved Bax are efficiently blocked by JNK inhibition. Conclusions/Significance: Our results indicate that b-lap triggers induction of endoplasmic reticulum (ER) stress, thereby leading to JNK activation and mitochondria-mediated apoptosis. The signaling pathways that we revealed in this study may significantly contribute to an improvement of NQO1-directed tumor therapies.	[Lee, Hyemi; Park, Moon-Taek; Choi, Bo-Hwa; Oh, Eun-Taex; Song, Min-Jeong; Lim, Byung Uk; Park, Heon Joo] Inha Univ, Ctr Adv Med Educ Project BK21, Coll Med, Dept Microbiol, Inchon, South Korea; [Lee, Jeonghun; Kim, Chulhee] Inha Univ, Dept Polymer Sci & Engn, Inchon, South Korea	Inha University; Inha University	Lee, H (corresponding author), Inha Univ, Ctr Adv Med Educ Project BK21, Coll Med, Dept Microbiol, Inchon, South Korea.	park001@inha.ac.kr			Korea Health 21 RD Project [A062254]; KOSEF [2009-0093747]	Korea Health 21 RD Project; KOSEF(Korea Science and Engineering Foundation)	This work was supported by grants from the Korea Health 21 R&D Project (A062254), and the Nuclear R&D Program of KOSEF (2009-0093747). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarti I, 2010, APOPTOSIS, V15, P679, DOI 10.1007/s10495-010-0474-z; Ariyama H, 2006, J CELL BIOCHEM, V97, P724, DOI 10.1002/jcb.20678; Belgardt BF, 2010, AGING-US, V2, P621, DOI 10.18632/aging.100192; Bey EA, 2007, P NATL ACAD SCI USA, V104, P11832, DOI 10.1073/pnas.0702176104; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; BOOTHMAN DA, 1989, CANCER RES, V49, P605; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Choi HJ, 2009, EXP MOL MED, V41, P94, DOI 10.3858/emm.2009.41.2.012; Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; DEMARIA M, 2010, AGING ALBANY NY, V11, P823; DONG Y, 2011, CLIN CANCER RES, V15, P131; Dudekula S, 2010, AGING-US, V2, P1023, DOI 10.18632/aging.100263; GUIRAUD P, 1994, PLANTA MED, V60, P373, DOI 10.1055/s-2006-959504; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Katagiri C, 2005, J BIOL CHEM, V280, P14716, DOI 10.1074/jbc.M500200200; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Klekotka PA, 2001, J BIOL CHEM, V276, P32353, DOI 10.1074/jbc.M101921200; Lai CC, 1998, HISTOL HISTOPATHOL, V13, P89, DOI 10.14670/HH-13.89; Lee J. I., 2006, Experimental Oncology, V28, P30; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Masuda K, 2003, J BIOL CHEM, V278, P32448, DOI 10.1074/jbc.M213254200; Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854; Park HJ, 2005, INT J RADIAT ONCOL, V61, P212, DOI 10.1016/j.ijrobp.2004.09.018; Park MT, 2005, BLOOD, V105, P1724, DOI 10.1182/blood-2004-07-2938; Park MT, 2003, J BIOL CHEM, V278, P50624, DOI 10.1074/jbc.M309011200; Paumelle R, 2000, MOL BIOL CELL, V11, P3751, DOI 10.1091/mbc.11.11.3751; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Planchon SM, 1999, ONCOL REP, V6, P485; Preston TJ, 2001, ADV DRUG DELIVER REV, V49, P45, DOI 10.1016/S0169-409X(01)00127-2; Pu YS, 2004, PROSTATE, V60, P120, DOI 10.1002/pros.20057; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shiah SG, 1999, CANCER RES, V59, P391; Su LT, 2010, J MOL BIOL, V396, P858, DOI 10.1016/j.jmb.2010.01.014; Sun XG, 2006, CELL CYCLE, V5, P2029, DOI 10.4161/cc.5.17.3312; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Theruvath TP, 2008, TRANSPLANTATION, V85, P1500, DOI 10.1097/TP.0b013e31816fefb5; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wuerzberger SM, 1998, CANCER RES, V58, P1876; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yanase N, 2000, J INTERF CYTOK RES, V20, P1121, DOI 10.1089/107999000750053799; Yeo JK, 2002, CANCER LETT, V182, P83, DOI 10.1016/S0304-3835(02)00075-7	54	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21533	10.1371/journal.pone.0021533	http://dx.doi.org/10.1371/journal.pone.0021533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738692	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100032
J	Chuang, LY; Huang, HC; Lin, MC; Yang, CH				Chuang, Li-Yeh; Huang, Hsiu-Chen; Lin, Ming-Cheng; Yang, Cheng-Hong			Particle Swarm Optimization with Reinforcement Learning for the Prediction of CpG Islands in the Human Genome	PLOS ONE			English	Article							METHYLATION; CLUSTERS	Background: Regions with abundant GC nucleotides, a high CpG number, and a length greater than 200 bp in a genome are often referred to as CpG islands. These islands are usually located in the 59 end of genes. Recently, several algorithms for the prediction of CpG islands have been proposed. Methodology/Principal Findings: We propose here a new method called CPSORL to predict CpG islands, which consists of a complement particle swarm optimization algorithm combined with reinforcement learning to predict CpG islands more reliably. Several CpG island prediction tools equipped with the sliding window technique have been developed previously. However, the quality of the results seems to rely too much on the choices that are made for the window sizes, and thus these methods leave room for improvement. Conclusions/Significance: Experimental results indicate that CPSORL provides results of a higher sensitivity and a higher correlation coefficient in all selected experimental contigs than the other methods it was compared to (CpGIS, CpGcluster, CpGProd and CpGPlot). A higher number of CpG islands were identified in chromosomes 21 and 22 of the human genome than with the other methods from the literature. CPSORL also achieved the highest coverage rate (3.4%). CPSORL is an application for identifying promoter and TSS regions associated with CpG islands in entire human genomic. When compared to CpGcluster, the islands predicted by CPSORL covered a larger region in the TSS (12.2%) and promoter (26.1%) region. If Alu sequences are considered, the islands predicted by CPSORL (Alu) covered a larger TSS (40.5%) and promoter (67.8%) region than CpGIS. Furthermore, CPSORL was used to verify that the average methylation density was 5.33% for CpG islands in the entire human genome.	[Chuang, Li-Yeh] I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan; [Huang, Hsiu-Chen] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Huang, Hsiu-Chen] Chia Yi Christian Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Lin, Ming-Cheng; Yang, Cheng-Hong] Natl Kaohsiung Univ Appl Sci, Dept Elect Engn, Kaohsiung 807, Taiwan; [Yang, Cheng-Hong] Toko Univ, Dept Network Syst, Chiayi, Taiwan	I Shou University; National Cheng Kung University; National Kaohsiung University of Science & Technology	Chuang, LY (corresponding author), I Shou Univ, Inst Biotechnol & Chem Engn, Kaohsiung, Taiwan.	03281@cych.org.tw; chyang@cc.kuas.edu.tw	Yang, Cheng-Hong/M-7984-2013; Yang, Cheng-Hong/K-2438-2019; Chuang, Li-Yeh/E-5005-2011	Yang, Cheng-Hong/0000-0002-2741-0072; 	National Science Council in Taiwan [NSC96-2221-E-214-050-MY3, NSC98-2221-E-151-040-, NSC 98-2622-E-151-001-CC2, 98-2622-E-151-024-CC3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work is partly supported by the National Science Council in Taiwan under grants NSC96-2221-E-214-050-MY3, NSC98-2221-E-151-040-, NSC 98-2622-E-151-001-CC2 and 98-2622-E-151-024-CC3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barto A.G., 1997, ADV PSYCHOL, V121, P358; Chuang LY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq204; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Egan J.P., 1975, SIGNAL DETECTION THE; Fang F, 2006, BIOINFORMATICS, V22, P2204, DOI 10.1093/bioinformatics/btl377; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GUDISE VG, 2003, EVOLVING DIGITAL CIR, V461, P468; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hackenberg M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-327; Han L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-65; Hancock JM, 2001, MOL BIOL EVOL, V18, P1014, DOI 10.1093/oxfordjournals.molbev.a003873; Hanson R.K., 1997, DEV BRIEF ACTUARIAL; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jiang CZ, 2007, MOL BIOL EVOL, V24, P1991, DOI 10.1093/molbev/msm128; Kane MF, 1997, CANCER RES, V57, P808; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Lai HM, 2008, J MED BIOL ENG, V28, P23; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ponger L, 2002, BIOINFORMATICS, V18, P631, DOI 10.1093/bioinformatics/18.4.631; Ressom HW, 2005, BIOINFORMATICS, V21, P4039, DOI 10.1093/bioinformatics/bti670; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Takai Daiya, 2003, In Silico Biology, V3, P235; TYKOCINSKI ML, 1984, NUCLEIC ACIDS RES, V12, P4385, DOI 10.1093/nar/12.10.4385; Whitehead S. D., 1990, Proceedings. 5th IEEE International Symposium on Intelligent Control 1990 (Cat. No.90TH0333-5), P1289, DOI 10.1109/ISIC.1990.128621; Ye SJ, 2008, BIOINFORMATION, V2, P335, DOI 10.6026/97320630002335; Yegnasubramanian S, 2008, CANCER RES, V68, P8954, DOI 10.1158/0008-5472.CAN-07-6088	28	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21036	10.1371/journal.pone.0021036	http://dx.doi.org/10.1371/journal.pone.0021036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738602	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800010
J	Congreve, CR; Lieberman, BS				Congreve, Curtis R.; Lieberman, Bruce S.			Phylogenetic and Biogeographic Analysis of Sphaerexochine Trilobites	PLOS ONE			English	Article							EVOLUTION; PALEOBIOGEOGRAPHY; EXTINCTION; VICARIANCE; PATTERNS; FAUNAS	Background: Sphaerexochinae is a speciose and widely distributed group of cheirurid trilobites. Their temporal range extends from the earliest Ordovician through the Silurian, and they survived the end Ordovician mass extinction event (the second largest mass extinction in Earth history). Prior to this study, the individual evolutionary relationships within the group had yet to be determined utilizing rigorous phylogenetic methods. Understanding these evolutionary relationships is important for producing a stable classification of the group, and will be useful in elucidating the effects the end Ordovician mass extinction had on the evolutionary and biogeographic history of the group. Methodology/Principal Findings: Cladistic parsimony analysis of cheirurid trilobites assigned to the subfamily Sphaerexochinae was conducted to evaluate phylogenetic patterns and produce a hypothesis of relationship for the group. This study utilized the program TNT, and the analysis included thirty-one taxa and thirty-nine characters. The results of this analysis were then used in a Lieberman-modified Brooks Parsimony Analysis to analyze biogeographic patterns during the Ordovician-Silurian. Conclusions/Significance: The genus Sphaerexochus was found to be monophyletic, consisting of two smaller clades (one composed entirely of Ordovician species and another composed of Silurian and Ordovician species). By contrast, the genus Kawina was found to be paraphyletic. It is a basal grade that also contains taxa formerly assigned to Cydonocephalus. Phylogenetic patterns suggest Sphaerexochinae is a relatively distinctive trilobite clade because it appears to have been largely unaffected by the end Ordovician mass extinction. Finally, the biogeographic analysis yields two major conclusions about Sphaerexochus biogeography: Bohemia and Avalonia were close enough during the Silurian to exchange taxa; and during the Ordovician there was dispersal between Eastern Laurentia and the Yangtze block (South China) and between Eastern Laurentia and Avalonia.	[Congreve, Curtis R.] Univ Kansas, Dept Geol, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Congreve, CR (corresponding author), Univ Kansas, Dept Geol, Lawrence, KS 66045 USA.	oldjack327@yahoo.com		Congreve, Curtis/0000-0003-3476-1257	NSF [DEB-0716162]	NSF(National Science Foundation (NSF))	Support for this research was provided by NSF DEB-0716162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain JM, 1998, J PALEONTOL, V72, P698, DOI 10.1017/S0022336000040403; Adrain JM, 1998, SCIENCE, V280, P1922, DOI 10.1126/science.280.5371.1922; Adrain Jonathan M., 1997, Bulletin of the Natural History Museum Geology Series, V53, P79; Armstrong HA, 2001, J GEOL SOC LONDON, V158, P475, DOI 10.1144/jgs.158.3.475; BARTON DC, 1916, ST LOUIS WASHINGTON, V3, P101; BERRY WBN, 1973, GEOL SOC AM BULL, V84, P275, DOI 10.1130/0016-7606(1973)84<275:GCOLOS>2.0.CO;2; Beyrich E, 1845, UEBER EINIGE BOHMISC; BILLINGS E, 1861, PALAEZOIC FOSSILS CA; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; CHATTERTON BDE, 1989, PALEOBIOLOGY, V15, P118, DOI 10.1017/S0094837300009313; Cocks LRM, 2002, J GEOL SOC LONDON, V159, P631, DOI 10.1144/0016-764901-118; Congreve CR, 2010, J PALEONTOL, V84, P128, DOI 10.1666/09-026.1; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; FORTEY RA, 1992, TECTONOPHYSICS, V206, P147, DOI 10.1016/0040-1951(92)90373-E; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOULD SJ, 1980, PALEOBIOLOGY, V6, P119, DOI 10.1017/S0094837300012549; HARPER DAT, 1992, TERRA NOVA, V4, P204, DOI 10.1111/j.1365-3121.1992.tb00473.x; Hembree DI, 2006, PALAEOGEOGR PALAEOCL, V235, P340, DOI 10.1016/j.palaeo.2005.11.006; HILLIS DM, 1991, PHYLOGENETIC ANALYSIS OF DNA SEQUENCES, P278; HOLLOWAY D J, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V170, P1; Jell P. A., 2003, Memoirs of the Queensland Museum, V48, P331; KOBAYASHI T, 1976, P JPN ACAD, V52, P367, DOI 10.2183/pjab1945.52.367; Lane PD, 1971, BRIT CHEIRURIDAE TRI; Lee SB, 2008, PALAEOGEOGR PALAEOCL, V260, P315, DOI 10.1016/j.palaeo.2007.11.008; Lieberman, 2000, PALEOBIOGEOGRAPHY US; Lieberman BS, 2003, SPEC PAP PALAEONTOL, P59; Lieberman BS, 1996, PALEOBIOLOGY, V22, P66, DOI 10.1017/S009483730001602X; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Maguire KC, 2008, PALAEOGEOGR PALAEOCL, V267, P175, DOI 10.1016/j.palaeo.2008.06.014; Pribyl A., 1985, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V83, P107; Rambaut A., 2008, FIGTREE; RAMSKOLD L, 1983, PALAEONTOLOGY, V26, P175; RIEDL R, 1978, ORDER LIVING ORGANIS, P1; Rode AL, 2005, J PALEONTOL, V79, P267, DOI 10.1666/0022-3360(2005)079<0267:IEABAC>2.0.CO;2; ROSS RJ, 1951, PEABODY MUSEUM NATUR, V6, P1; SCOTESE CR, 2007, PALEOGIS; SCOTESE CR, 1991, 909 GEOL SURV CAN, P271; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; SHEEHAN PM, 1973, LETHAIA, V6, P147, DOI 10.1111/j.1502-3931.1973.tb01188.x; Speyer S.E., 1989, Historical Biology, V3, P27; SWOFFORD DL, 1998, PAUP; Thomas A.T., 1981, Palaeontographical Society Monographs (London), V134, P57; Torsvik TH, 1996, EARTH-SCI REV, V40, P229, DOI 10.1016/0012-8252(96)00008-6; TORSVIK TH, 1995, J GEOL SOC LONDON, V152, P279, DOI 10.1144/gsjgs.152.2.0279; WARBURG E, 1925, B GEOLOGICAL I U UPP, V17; WHITTINGTON H. B., 1963, BULL MUS COMP ZOOL HARVARD UNIV, V129, P1; WHITTINGTON H. B., 1965, BULL MUS COMP ZOOL HARVARD UNIV, V132, P275; Whittington H. B., 1997, TREATISE INVERTEBR O, V1; WILEY EO, 1979, SYST ZOOL, V28, P308; Zhou ZY., 2008, P LINNEAN SOC NEW S, V129, P183	50	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21304	10.1371/journal.pone.0021304	http://dx.doi.org/10.1371/journal.pone.0021304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738632	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600027
J	Hu, Y; Wang, JF; Li, XH; Ren, D; Zhu, J				Hu, Yi; Wang, Jinfeng; Li, Xiaohong; Ren, Dan; Zhu, Jun			Geographical Detector-Based Risk Assessment of the Under-Five Mortality in the 2008 Wenchuan Earthquake, China	PLOS ONE			English	Article							HETEROGENEITY; INJURIES; ERROR	On 12 May, 2008, a devastating earthquake registering 8.0 on the Richter scale occurred in Sichuan Province, China, taking tens of thousands of lives and destroying the homes of millions of people. Many of the deceased were children, particular children less than five years old who were more vulnerable to such a huge disaster than the adult. In order to obtain information specifically relevant to further researches and future preventive measures, potential risk factors associated with earthquake-related child mortality need to be identified. We used four geographical detectors (risk detector, factor detector, ecological detector, and interaction detector) based on spatial variation analysis of some potential factors to assess their effects on the under-five mortality. It was found that three factors are responsible for child mortality: earthquake intensity, collapsed house, and slope. The study, despite some limitations, has important implications for both researchers and policy makers.	[Hu, Yi] China Univ Geosci, Sch Earth & Mineral Resource, Beijing, Peoples R China; [Hu, Yi; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Li, Xiaohong; Ren, Dan; Zhu, Jun] Sichuan Univ, W China Hosp 2, Natl Off Maternal & Child Hlth Surveillance, Chengdu 610064, Sichuan, Peoples R China	China University of Geosciences; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Sichuan University	Hu, Y (corresponding author), China Univ Geosci, Sch Earth & Mineral Resource, Beijing, Peoples R China.	wangjf@lreis.ac.cn; zhujun028@163.com		Li, Xiaohong/0000-0003-0336-7302; Wang, Jinfeng/0000-0002-6687-9420	NSFC [41023010]; MOST, China [2009ZX10004-201, 2008BAI56B02, 2007DFC20180, 2007AA12Z233, 2006BAK01A13]; CAS, China [KZCX2-YW-308]	NSFC(National Natural Science Foundation of China (NSFC)); MOST, China(Ministry of Science and Technology, China); CAS, China(Chinese Academy of Sciences)	This study was supported by the NSFC (41023010), MOST, China (2009ZX10004-201, 2008BAI56B02, 2007DFC20180, 2007AA12Z233, 2006BAK01A13) and the CAS, China (KZCX2-YW-308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M.P., 1997, REGRESSION ANAL DUMM; [Anonymous], J GEOGR GEOL; [Anonymous], 1986, PRINCIPLES GEOGRAPHI; Armenian HK, 1997, INT J EPIDEMIOL, V26, P806, DOI 10.1093/ije/26.4.806; Brus DJ, 1997, GEODERMA, V80, P1, DOI 10.1016/S0016-7061(97)00072-4; Chen CT, 2009, GEOPH RES ABSTR, V11, P5615; Clark J. S, 2007, MODELS ECOLOGICAL DA; DEBRUYCKER M, 1985, INT J EPIDEMIOL, V14, P113, DOI 10.1093/ije/14.1.113; Ellidokuz H, 2005, CROAT MED J, V46, P613; FAN J, 2009, OVERVIEW EVALUATION, P19; Fisher N. I., 1987, STAT ANAL SPHERICAL; GRIFFITH DA, 1994, GEOGR ANAL, V26, P300; GRIMMETT RR, 1994, PROBABILITY RANDOM P; Gutierrez E, 2005, AM J EPIDEMIOL, V161, P1151, DOI 10.1093/aje/kwi149; Haining R.P., 1988, COMMUNICATIONS STAT, V17, P537; Hu YF, 2011, 2011 AASRI CONFERENCE ON APPLIED INFORMATION TECHNOLOGY (AASRI-AIT 2011), VOL 1, P1; Li LF, 2008, STOCH ENV RES RISK A, V22, P689, DOI 10.1007/s00477-007-0179-1; Liao YL, 2010, INT J GEOGR INF SCI, V24, P47, DOI 10.1080/13658810802186874; LIEPING Y, 2008, 14 WORLD C EARTHQ EN; Pai CH, 2007, NAT HAZARDS, V42, P19, DOI 10.1007/s11069-006-9043-8; Peek-Asa C, 2003, INJ PREV, V9, P62, DOI 10.1136/ip.9.1.62; Peek-Asa C, 2000, ANN EPIDEMIOL, V10, P5, DOI 10.1016/S1047-2797(99)00058-7; PEEKASA C, 1998, INT J EPIDEMIOL, P456; Press W. H., 1992, ART SCI COMPUTING; SPENCE RJS, 1990, REDUCING HUMAN CASUA, P1; TIEDEMANN H, 1989, P INT WORKSH EARTHQ, P420; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang JF, 2010, INT J GEOGR INF SCI, V24, P523, DOI 10.1080/13658810902873512; WATTS J, 2008, CHINESE QUAKE FORCED, P2008; Wood H. O., 1931, B SEISMOL SOC AM, V21, P277	30	79	103	7	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21427	10.1371/journal.pone.0021427	http://dx.doi.org/10.1371/journal.pone.0021427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738660	Green Published, gold			2022-12-25	WOS:000292092600040
J	Oikonomou, E; Koc, M; Sourkova, V; Andera, L; Pintzas, A				Oikonomou, Eftychia; Koc, Michal; Sourkova, Vladimira; Andera, Ladislav; Pintzas, Alexander			Selective BRAFV600E Inhibitor PLX4720, Requires TRAIL Assistance to Overcome Oncogenic PIK3CA Resistance	PLOS ONE			English	Article							COLON-CANCER CELLS; INDUCED APOPTOSIS; PATHWAY ACTIVATION; MAPK PATHWAY; RECEPTOR; RAF; TRANSFORMATION; MUTATION; KINASE; HSP90	Documented sensitivity of melanoma cells to PLX4720, a selective BRAFV600E inhibitor, is based on the presence of mutant BRAF(V600E) alone, while wt-BRAF or mutated KRAS result in cell proliferation. In colon cancer appearance of oncogenic alterations is complex, since BRAF, like KRAS mutations, tend to co-exist with those in PIK3CA and mutated PI3K has been shown to interfere with the successful application of MEK inhibitors. When PLX4720 was used to treat colon tumours, results were not encouraging and herein we attempt to understand the cause of this recorded resistance and discover rational therapeutic combinations to resensitize oncogene driven tumours to apoptosis. Treatment of two genetically different BRAF(V600E) mutant colon cancer cell lines with PLX4720 conferred complete resistance to cell death. Even though p-MAPK/ERK kinase (MEK) suppression was achieved, TRAIL, an apoptosis inducing agent, was used synergistically in order to achieve cell death by apoptosis in RKOBRAFV600E/PIK3CAH1047 cells. In contrast, for the same level of apoptosis in HT29(BRAFV600E/PIK3CAP449T) cells, TRAIL was combined with 17-AAG, an Hsp90 inhibitor. For cells where PLX4720 was completely ineffective, 17-AAG was alternatively used to target mutant BRAF(V600E). TRAIL dependence on the constitutive activation of BRAF(V600E) is emphasised through the overexpression of BRAF(V600E) in the permissive genetic background of colon adenocarcinoma Caco-2 cells. Pharmacological suppression of the PI3K pathway further enhances the synergistic effect between TRAIL and PLX4720 in RKO cells, indicating the presence of PIK3CA(MT) as the inhibitory factor. Another rational combination includes 17-AAG synergism with TRAIL in a BRAF(V600E) mutant dependent manner to commit cells to apoptosis, through DR5 and the amplification of the apoptotic pathway. We have successfully utilised combinations of two chemically unrelated BRAF(V600E) inhibitors in combination with TRAIL in a BRAF(V600E) mutated background and provided insight for new anti-cancer strategies where the activated PI3KCA mutation oncogene should be suppressed.	[Oikonomou, Eftychia; Pintzas, Alexander] Natl Hellen Res Fdn, Lab Signal Mediated Gene Express, Inst Biol Res & Biotechnol, Athens, Greece; [Koc, Michal; Sourkova, Vladimira; Andera, Ladislav] Czech Acad Sci, Lab Cell Signaling & Apoptosis, Inst Mol Genet, Prague, Czech Republic	National Hellenic Research Foundation; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Oikonomou, E (corresponding author), Natl Hellen Res Fdn, Lab Signal Mediated Gene Express, Inst Biol Res & Biotechnol, Athens, Greece.	apint@eie.gr	Andera, Ladislav/A-4536-2011; Andera, Ladislav/ABA-3403-2020; Koc, Michal/D-1234-2014	Koc, Michal/0000-0003-0928-4196; Horova, Vladimira/0000-0002-3969-2329	EU [LSHC-CT-2006-037278]	EU(European Commission)	This work was supported by EU grant LSHC-CT-2006-037278 "ONCODEATH'' to AP and LA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Hague A, 2005, BRIT J CANCER, V92, P736, DOI 10.1038/sj.bjc.6602387; Halilovic E, 2010, CANCER RES, V70, P6804, DOI 10.1158/0008-5472.CAN-10-0409; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Kopetz S, 2010, J CLIN ONCOL S, V28, p15s; Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; MacFarlane M, 2003, TOXICOL LETT, V139, P89, DOI 10.1016/S0378-4274(02)00422-8; Michl P, 2005, Z GASTROENTEROL, V43, P1133, DOI 10.1055/s-2005-858638; Oikonomou E, 2007, BRIT J CANCER, V97, P73, DOI 10.1038/sj.bjc.6603835; Oikonomou E, 2009, NEOPLASIA, V11, P1116, DOI 10.1593/neo.09514; Opel D, 2011, CLIN CANCER RES, V17, P3233, DOI 10.1158/1078-0432.CCR-10-2530; Park WS, 2001, GASTROENTEROLOGY, V121, P1219, DOI 10.1053/gast.2001.28663; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Roberts ML, 2006, INT J CANCER, V118, P616, DOI 10.1002/ijc.21386; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Rychahou PG, 2005, SURGERY, V138, P391, DOI 10.1016/j.surg.2005.05.012; Schwartsmann G, 2005, LANCET ONCOL, V6, P444, DOI 10.1016/S1470-2045(05)70226-6; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Siegelin MD, 2009, NEUROBIOL DIS, V33, P243, DOI 10.1016/j.nbd.2008.10.005; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Tominaga K, 2004, ALIMENT PHARM THER, V20, P143, DOI 10.1111/j.1365-2036.2004.01986.x; Tran SEF, 2001, J BIOL CHEM, V276, P16484, DOI 10.1074/jbc.M010384200; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vaculova A, 2006, FEBS LETT, V580, P6565, DOI 10.1016/j.febslet.2006.11.004; Vasilevskaya IA, 2005, BIOCHEM PHARMACOL, V70, P580, DOI 10.1016/j.bcp.2005.05.018; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	42	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21632	10.1371/journal.pone.0021632	http://dx.doi.org/10.1371/journal.pone.0021632			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738740	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600065
J	Xin, ZT; Carroll, KA; Kumar, N; Song, K; Ly, H				Xin, Zhong-Tao; Carroll, Kathryn A.; Kumar, Naveen; Song, Kui; Ly, Hinh			Transcriptional Activation of TINF2, a Gene Encoding the Telomere-Associated Protein TIN2, by Sp1 and NF-kappa B Factors	PLOS ONE			English	Article							BINDING; TRF1; EXPRESSION; GROWTH; LENGTH; TRANSACTIVATION; DYSFUNCTION; METASTASIS; INHIBITORS; SHELTERIN	The expression of the telomere-associated protein TIN2 has been shown to be essential for early embryonic development in mice and for development of a variety of human malignancies. Recently, germ-line mutations in TINF2, which encodes for the TIN2 protein, have been identified in a number of patients with bone-marrow failure syndromes. Yet, the molecular mechanisms that regulate TINF2 expression are largely unknown. To elucidate the mechanisms involved in human TINF2 regulation, we cloned a 2.7 kb genomic DNA fragment containing the putative promoter region and, through deletion analysis, identified a 406 bp region that functions as a minimal promoter. This promoter proximal region is predicted to contain several putative Sp1 and NF-kappa B binding sites based on bioinformatic analysis. Direct binding of the Sp1 and NF-kappa B transcription factors to the TIN2 promoter sequence was demonstrated by electrophoretic mobility shift assay (EMSA) and/or chromatin immunoprecipitation (ChIP) assays. Transfection of a plasmid carrying the Sp1 transcription factor into Sp-deficient SL2 cells strongly activated TIN2 promoter-driven luciferase reporter expression. Similarly, the NF-kappa B molecules p50 and p65 were found to strongly activate luciferase expression in NF-kappa B knockout MEFs. Mutating the predicted transcription factor binding sites effectively reduced TIN2 promoter activity. Various known chemical inhibitors of Sp1 and NF-kappa B could also strongly inhibit TIN2 transcriptional activity. Collectively, our results demonstrate the important roles that Sp1 and NF-kappa B play in regulating the expression of the human telomere-binding protein TIN2, which can shed important light on its possible role in causing various forms of human diseases and cancers.	[Xin, Zhong-Tao; Carroll, Kathryn A.; Kumar, Naveen; Song, Kui; Ly, Hinh] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University	Xin, ZT (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	hly@emory.edu			NIH [T32 GM008490]; American Cancer Society [RSG-06-162-01-GMC]; Emory Winship Cancer Institute [NCI-P30CA138292]; Atlanta Clinical and Translational Science Institute and Emory University Research Committee (ACTSI-URC) [UL1RR025008]; NATIONAL CANCER INSTITUTE [P30CA138292] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Emory Winship Cancer Institute; Atlanta Clinical and Translational Science Institute and Emory University Research Committee (ACTSI-URC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. A. C was supported in part by the NIH pre-doctoral training grant (T32 GM008490). This work was funded in part by a research scholar grant from the American Cancer Society (RSG-06-162-01-GMC) and seed grants from the Emory Winship Cancer Institute (NCI-P30CA138292) and the Atlanta Clinical and Translational Science Institute and Emory University Research Committee (ACTSI-URC) (UL1RR025008) to H. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bellon M, 2006, INT J CANCER, V119, P2090, DOI 10.1002/ijc.22026; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Carroll KA, 2009, INT J CLIN EXP PATHO, V2, P528; Chan SS, 2010, FEBS LETT, V584, P3773, DOI 10.1016/j.febslet.2010.06.016; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dittmer J, 1997, J BIOL CHEM, V272, P4953, DOI 10.1074/jbc.272.8.4953; DU HY, 2008, PEDIAT BLOOD CANC; EMILI A, 1994, MOL CELL BIOL, V14, P1582, DOI 10.1128/MCB.14.3.1582; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; HU H, 2010, J CANC RES CLIN ONCO; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Kaminker P, 2005, J CELL SCI, V118, P1321, DOI 10.1242/jcs.01709; Kaminker PG, 2009, CELL CYCLE, V8, P931, DOI 10.4161/cc.8.6.7941; Keith W Nicol, 2004, BMC Blood Disord, V4, P3, DOI 10.1186/1471-2326-4-3; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kumar AP, 1999, CANCER LETT, V137, P159, DOI 10.1016/S0304-3835(98)00351-6; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Sinha-Datta U, 2004, BLOOD, V104, P2523, DOI 10.1182/blood-2003-12-4251; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Teo HL, 2010, NAT CELL BIOL, V12, P758, DOI 10.1038/ncb2080; Trejo SR, 1997, J BIOL CHEM, V272, P27411, DOI 10.1074/jbc.272.43.27411; Tsangaris E, 2008, HUM GENET, V124, P507, DOI 10.1007/s00439-008-0576-7; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yamada K, 2002, ANTICANCER RES, V22, P1315; Yamada M, 2002, ANTICANCER RES, V22, P3303; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	48	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21333	10.1371/journal.pone.0021333	http://dx.doi.org/10.1371/journal.pone.0021333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731707	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400024
J	Esposito, D; Komarnytsky, S; Shapses, S; Raskin, I				Esposito, Debora; Komarnytsky, Slavko; Shapses, Sue; Raskin, Ilya			Anabolic effect of plant brassinosteroid	FASEB JOURNAL			English	Article						homobrassinolide; protein synthesis; muscle mass	GROWTH-FACTOR-I; ANDROGEN RECEPTOR; PROTEIN-SYNTHESIS; INSULIN; METABOLISM; EXPRESSION; VIRUS; VITRO; PHYTOECDYSTEROIDS; BRASSINOLIDE	Brassinosteroids are plant-derived polyhydroxylated derivatives of 5a-cholestane, structurally similar to cholesterol-derived animal steroid hormones and insect ecdysteroids, with no known function in mammals. 28-Homobrassinolide (HB), a steroidal lactone with potent plant growth-promoting property, stimulated protein synthesis and inhibited protein degradation in L6 rat skeletal muscle cells (EC50 4 mu M) mediated in part by PI3K/Akt signaling pathway. Oral administration of HB (20 or 60 mg/kg/d for 24 d) to healthy rats fed normal diet (protein content 23.9%) increased food intake, body weight gain, lean body mass, and gastrocnemius muscle mass as compared with vehicle-treated controls. The effect of HB administration increased slightly in animals fed a high-protein diet (protein content 39.4%). Both oral (up to 60 mg/kg) and subcutaneous (up to 4 mg/kg) administration of HB showed low androgenic activity when tested in the Hershberger assay. Moreover, HB showed no direct binding to the androgen receptor in vitro. HB treatment was also associated with an improved physical fitness of untrained healthy rats, as evident from a 6.7% increase in lower extremity strength, measured by grip test. In the gastrocnemius muscle of castrated animals, HB treatment significantly increased the number of type IIa and IIb fibers and the cross-sectional area of type I and type IIa fibers. These findings suggest that oral application of HB triggers selective anabolic response with minimal or no androgenic side-effects and begin to elucidate the putative cellular targets for plant brassinosteroids in mammals.-Esposito, D., Komarnytsky, S., Shapses, S., Raskin, I. Anabolic effect of plant brassinosteroid. FASEB J. 25, 3708-3719 (2011). www.fasebj.org	[Esposito, Debora; Komarnytsky, Slavko; Raskin, Ilya] Rutgers State Univ, Sch Environm & Biol Sci, Biotech Ctr, New Brunswick, NJ 08903 USA; [Shapses, Sue] Rutgers State Univ, Sch Environm & Biol Sci, Dept Nutr Sci, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Komarnytsky, S (corresponding author), N Carolina State Univ, Plants Human Hlth Inst, FBNS, 600 Laureate Way, Kannapolis, NC 28081 USA.	komarnytsky@ncsu.edu	Komarnytsky, Slavko/A-9575-2009	Komarnytsky, Slavko/0000-0003-4665-4993; Shapses, Sue/0000-0002-3128-2325	U.S. National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome [1-P50 AT002776-01]; Fogarty International Center of the National Institutes of Health [U01 TW006674]; FOGARTY INTERNATIONAL CENTER [U01TW006674] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER	U.S. National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. David Lagunoff (New Jersey Medical School-University of Medicine and Dentistry of New Jersey, Newark, NJ, USA) for muscle histology and microscopic imaging. This work was supported in part by the U.S. National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome, grant 1-P50 AT002776-01, and Fogarty International Center of the National Institutes of Health grant U01 TW006674 for the International Cooperative Biodiversity Groups and Rutgers University.	Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x; Bajguz A, 2000, PLANT PHYSIOL BIOCH, V38, P209, DOI 10.1016/S0981-9428(00)00733-6; Bajguz A, 2003, PHYTOCHEMISTRY, V62, P1027, DOI 10.1016/S0031-9422(02)00656-8; Bathori M, 2008, CURR MED CHEM, V15, P75, DOI 10.2174/092986708783330674; Castilla V, 2005, ANTIVIR RES, V68, P88, DOI 10.1016/j.antiviral.2005.07.007; CHANG CS, 1987, J STEROID BIOCHEM, V27, P123, DOI 10.1016/0022-4731(87)90303-7; Clouse SD, 2002, VITAM HORM, V65, P195, DOI 10.1016/S0083-6729(02)65065-4; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Dhaubhadel S, 2002, PLANT J, V29, P681, DOI 10.1046/j.1365-313X.2002.01257.x; DOUGLAS RG, 1991, J CLIN INVEST, V88, P614, DOI 10.1172/JCI115346; Fawcett J, 2001, ARCH BIOCHEM BIOPHYS, V385, P357, DOI 10.1006/abbi.2000.2160; Feldkoren BI, 2005, J STEROID BIOCHEM, V94, P481, DOI 10.1016/j.jsbmb.2004.12.036; Frost RA, 2007, J APPL PHYSIOL, V103, P378, DOI 10.1152/japplphysiol.00089.2007; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Gorelick-Feldman J, 2008, J AGR FOOD CHEM, V56, P3532, DOI 10.1021/jf073059z; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; HARPER JMM, 1987, J ENDOCRINOL, V112, P87, DOI 10.1677/joe.0.1120087; HERSHBERGER LG, 1953, P SOC EXP BIOL MED, V83, P175; IKEKAWA N, 1984, J CHROMATOGR, V290, P289, DOI 10.1016/S0021-9673(01)93583-6; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Kartal G, 2009, PLANT GROWTH REGUL, V58, P261, DOI 10.1007/s10725-009-9374-z; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kizelsztein P, 2009, AM J PHYSIOL-ENDOC M, V296, pE433, DOI 10.1152/ajpendo.90772.2008; Kuhn CM, 2002, RECENT PROG HORM RES, V57, P411, DOI 10.1210/rp.57.1.411; Kulaeva O. N., 2009, BRASSINOSTEROIDS, P141; Kuzmitskii BB, 1991, TECHNICAL REPORT, P1; Layman DK, 2003, J NUTR, V133, P411, DOI 10.1093/jn/133.2.411; Li BG, 2005, INT J BIOCHEM CELL B, V37, P2207, DOI 10.1016/j.biocel.2005.04.008; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Malikova J, 2008, PHYTOCHEMISTRY, V69, P418, DOI 10.1016/j.phytochem.2007.07.028; MANDEL JL, 1974, NATURE, V251, P618, DOI 10.1038/251618a0; Massey A. P., 2003, SYNTHESIS-STUTTGART, P0426; Michelini FM, 2008, J STEROID BIOCHEM, V108, P164, DOI 10.1016/j.jsbmb.2007.10.002; Michelini FM, 2004, STEROIDS, V69, P713, DOI 10.1016/j.steroids.2004.04.011; Mohler ML, 2009, J MED CHEM, V52, P3597, DOI 10.1021/jm900280m; Montgomery J. L., 2002, Methods in Cell Science, V24, P123, DOI 10.1023/A:1024498316958; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murkunde YV, 2010, INT J TOXICOL, V29, P517, DOI 10.1177/1091581810375620; Mussig C, 2005, PLANT BIOLOGY, V7, P110, DOI 10.1055/s-2005-837493; Naito AT, 2005, CIRC RES, V97, P144, DOI 10.1161/01.RES.0000175241.92285.f8; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nemhauser JL, 2004, J EXP BOT, V55, P265, DOI 10.1093/jxb/erh024; Oehme I, 2006, CELL DEATH DIFFER, V13, P189, DOI 10.1038/sj.cdd.4401730; Pushkala K, 2001, CYTOBIOS, V106, P201; Rahman F, 2007, TRENDS ENDOCRIN MET, V18, P371, DOI 10.1016/j.tem.2007.09.004; Romanutti C, 2007, INT J ANTIMICROB AG, V29, P311, DOI 10.1016/j.ijantimicag.2006.11.005; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rooyackers OE, 1997, ANNU REV NUTR, V17, P457, DOI 10.1146/annurev.nutr.17.1.457; Salas TR, 2004, J BIOL CHEM, V279, P19191, DOI 10.1074/jbc.M309560200; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; TAKATSUTO S, 1984, J CHEM SOC PERK T 1, P439, DOI 10.1039/p19840000439; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Wachsman MB, 2000, ANTIVIR CHEM CHEMOTH, V11, P71, DOI 10.1177/095632020001100107; Wachsman Monica B., 2002, Antiviral Chemistry & Chemotherapy, V13, P61; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Watanabe T, 2000, J CHEM RES, P18; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200	59	25	26	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3708	3719		10.1096/fj.11-181271	http://dx.doi.org/10.1096/fj.11-181271			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21746867	Green Published			2022-12-25	WOS:000295356400039
J	Auger, A; Beilhartz, GL; Zhu, SQ; Cauchon, E; Falgueyret, JP; Grobler, JA; Ehteshami, M; Gotte, M; Melnyk, RA				Auger, Anick; Beilhartz, Greg L.; Zhu, Siqi; Cauchon, Elizabeth; Falgueyret, Jean-Pierre; Grobler, Jay A.; Ehteshami, Maryam; Goette, Matthias; Melnyk, Roman A.			Impact of Primer-induced Conformational Dynamics of HIV-1 Reverse Transcriptase on Polymerase Translocation and Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NONNUCLEOSIDE INHIBITORS; RIBONUCLEASE-H; DNA-POLYMERASE; POLYPURINE TRACT; ACTIVE-SITE; IN-VITRO; INITIATION; MECHANISM; MUTATIONS	The rapid emergence and the prevalence of resistance mutations in HIV-1 reverse transcriptase (RT) underscore the need to identify RT inhibitors with novel binding modes and mechanisms of inhibition. Recently, two structurally distinct inhibitors, phosphonoformic acid (foscarnet) and INDOPY-1 were shown to disrupt the translocational equilibrium of RT during polymerization through trapping of the enzyme in the pre- and the post-translocation states, respectively. Here, we show that foscarnet and INDOPY-1 additionally display a shared novel inhibitory preference with respect to substrate primer identity. In RT-catalyzed reactions using RNA-primed substrates, translocation inhibitors were markedly less potent at blocking DNA polymerization than in equivalent DNA-primed assays; i.e. the inverse pattern observed with marketed non-nucleoside inhibitors that bind the allosteric pocket of RT. This potency profile was shown to correspond with reduced binding on RNA.DNA primer/template substrates versus DNA.DNA substrates. Furthermore, using site-specific footprinting with chimeric RNA.DNA primers, we demonstrate that the negative impact of the RNA primer on translocation inhibitor potency is overcome after 18 deoxyribonucleotide incorporations, where RT transitions primarily into polymerization-competent binding mode. In addition to providing a simple means to identify similarly acting translocation inhibitors, these findings suggest a broader role for the primer-influenced binding mode on RT translocation equilibrium and inhibitor sensitivity.	[Auger, Anick; Zhu, Siqi; Cauchon, Elizabeth; Falgueyret, Jean-Pierre; Melnyk, Roman A.] Merck Frosst Ctr Therapeut Res, Kirkland, PQ H9H 3L1, Canada; [Beilhartz, Greg L.; Ehteshami, Maryam; Goette, Matthias] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Grobler, Jay A.] Merck & Co Inc, West Point, PA 19486 USA	Merck & Company; McGill University; Merck & Company	Melnyk, RA (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	roman.melnyk@sickkids.ca	Melnyk, Roman/GQA-9908-2022		Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a grant from the Canadian Institutes of Health Research (to M. G.).	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; ARNOLD E, 1992, NATURE, V357, P85, DOI 10.1038/357085a0; DESTEFANO JJ, 1991, J BIOL CHEM, V266, P24295; Ehteshami M, 2008, J BIOL CHEM, V283, P29904, DOI 10.1074/jbc.M804882200; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; FU TB, 1992, J VIROL, V66, P4271, DOI 10.1128/JVI.66.7.4271-4278.1992; FURFINE ES, 1991, J BIOL CHEM, V266, P406; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Gotte M, 1998, J BIOL CHEM, V273, P10139, DOI 10.1074/jbc.273.17.10139; Gotte M, 1999, J BIOL CHEM, V274, P11159, DOI 10.1074/jbc.274.16.11159; Grobler JA, 2007, J BIOL CHEM, V282, P8005, DOI 10.1074/jbc.M608274200; Jochmans D, 2006, J VIROL, V80, P12283, DOI 10.1128/JVI.00889-06; Jones FD, 2007, VIROLOGY, V360, P341, DOI 10.1016/j.virol.2006.10.008; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, J BIOL CHEM, V282, P3337, DOI 10.1074/jbc.M607710200; Meyer PR, 2007, J MOL BIOL, V369, P41, DOI 10.1016/j.jmb.2007.03.006; OMER CA, 1984, J VIROL, V50, P465, DOI 10.1128/JVI.50.2.465-470.1984; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Scarth B, 2011, J MOL BIOL, V405, P349, DOI 10.1016/j.jmb.2010.10.009; Shaw-Reid CA, 2005, BIOCHEMISTRY-US, V44, P1595, DOI 10.1021/bi0486740; Shaw-Reid CA, 2003, J BIOL CHEM, V278, P2777, DOI 10.1074/jbc.C200621200; SMITH JK, 1984, J VIROL, V52, P314, DOI 10.1128/JVI.52.2.314-319.1984; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; WOHRL BM, 1990, BIOCHEMISTRY-US, V29, P10141, DOI 10.1021/bi00496a001; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zahn KE, 2011, J BIOL CHEM, V286, P25246, DOI 10.1074/jbc.M111.248864; Zhang ZJ, 2006, ANTIMICROB AGENTS CH, V50, P2772, DOI 10.1128/AAC.00127-06	32	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29575	29583		10.1074/jbc.M111.268235	http://dx.doi.org/10.1074/jbc.M111.268235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737446	Green Published, hybrid			2022-12-25	WOS:000294046600015
J	Balgi, AD; Diering, GH; Donohue, E; Lam, KKY; Fonseca, BD; Zimmerman, C; Numata, M; Roberge, M				Balgi, Aruna D.; Diering, Graham H.; Donohue, Elizabeth; Lam, Karen K. Y.; Fonseca, Bruno D.; Zimmerman, Carla; Numata, Masayuki; Roberge, Michel			Regulation of mTORC1 Signaling by pH	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-GROWTH; PHOSPHATIDIC-ACID; INTRACELLULAR PH; TUBEROUS SCLEROSIS; EXTRACELLULAR PH; CYTOPLASMIC PH; CARDIAC-ARREST; HUMAN CANCER; TUMOR PH	Background: Acidification of the cytoplasm and the extracellular environment is associated with many physiological and pathological conditions, such as intense exercise, hypoxia and tumourigenesis. Acidification affects important cellular functions including protein synthesis, growth, and proliferation. Many of these vital functions are controlled by mTORC1, a master regulator protein kinase that is activated by various growth-stimulating signals and inactivated by starvation conditions. Whether mTORC1 can also respond to changes in extracellular or cytoplasmic pH and play a role in limiting anabolic processes in acidic conditions is not known. Methodology/Findings: We examined the effects of acidifying the extracellular medium from pH 7.4 to 6.4 on human breast carcinoma MCF-7 cells and immortalized mouse embryo fibroblasts. Decreasing the extracellular pH caused intracellular acidification and rapid, graded and reversible inhibition of mTORC1, assessed by measuring the phosphorylation of the mTORC1 substrate S6K. Fibroblasts deleted of the tuberous sclerosis complex TSC2 gene, a major negative regulator of mTORC1, were unable to inhibit mTORC1 in acidic extracellular conditions, showing that the TSC1-TSC2 complex is required for this response. Examination of the major upstream pathways converging on the TSC1-TSC2 complex showed that Akt signaling was unaffected by pH but that the Raf/MEK/ERK pathway was inhibited. Inhibition of MEK with drugs caused only modest mTORC1 inhibition, implying that other unidentified pathways also play major roles. Conclusions: This study reveals a novel role for the TSC1/TSC2 complex and mTORC1 in sensing variations in ambient pH. As a common feature of low tissue perfusion, low glucose availability and high energy expenditure, acidic pH may serve as a signal for mTORC1 to downregulate energy-consuming anabolic processes such as protein synthesis as an adaptive response to metabolically stressful conditions.	[Balgi, Aruna D.; Diering, Graham H.; Donohue, Elizabeth; Lam, Karen K. Y.; Fonseca, Bruno D.; Zimmerman, Carla; Numata, Masayuki; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Roberge, Michel] Ctr Drug Res & Dev, Vancouver, BC, Canada	University of British Columbia	Balgi, AD (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada.	michelr@mail.ubc.ca		Lam, Karen/0000-0002-7881-3883; Zimmerman, Carla/0000-0002-5132-2101	Canadian Breast Cancer Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	Financial support for this study was obtained from the Canadian Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Baxter KA, 1996, J PHYSIOL-LONDON, V493, P457, DOI 10.1113/jphysiol.1996.sp021396; Becelli R, 2007, J CRANIOFAC SURG, V18, P1051, DOI 10.1097/scs.0b013e3180de63eb; BRAVO R, 1986, FEBS LETT, V195, P309, DOI 10.1016/0014-5793(86)80183-1; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; CHAILLET JR, 1985, J GEN PHYSIOL, V86, P765, DOI 10.1085/jgp.86.6.765; CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; DIERING GH, 2011, MOL BIOL CELL; ENGLAND BK, 1991, AM J PHYSIOL, V260, pC277, DOI 10.1152/ajpcell.1991.260.2.C277; Fischer B, 2000, J IMMUNOTHER, V23, P196, DOI 10.1097/00002371-200003000-00004; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Fukumura D, 2001, CANCER RES, V61, P6020; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gau CL, 2005, MOL CANCER THER, V4, P918, DOI 10.1158/1535-7163.MCT-04-0347; Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; JOHNSON BA, 1995, J APPL PHYSIOL, V78, P1579, DOI 10.1152/jappl.1995.78.4.1579; KARURI AR, 1993, BRIT J CANCER, V68, P1080, DOI 10.1038/bjc.1993.485; Kerkhoff E, 2001, ADV ENZYME REGUL, V41, P261, DOI 10.1016/S0065-2571(00)00023-6; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kraft CA, 2008, J BIOL CHEM, V283, P36636, DOI 10.1074/jbc.M804633200; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; LAMANNA JC, 1995, BRAIN RES, V687, P175, DOI 10.1016/0006-8993(95)00516-S; Levraut Jacques, 2003, Curr Opin Crit Care, V9, P260, DOI 10.1097/00075198-200308000-00002; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma L, 2007, CANCER RES, V67, P7106, DOI 10.1158/0008-5472.CAN-06-4798; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; MUSGROVE E, 1987, EXP CELL RES, V172, P65, DOI 10.1016/0014-4827(87)90093-0; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Robert F, 2006, RNA, V12, P717, DOI 10.1261/rna.2346806; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; van Sluis R, 1999, MAGN RESON MED, V41, P743, DOI 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z; VAUPEL P, 1989, CANCER RES, V49, P6449; Wakabayashi I, 2006, PLATELETS, V17, P454, DOI 10.1080/09537100600757489; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yao H, 2004, CELL CALCIUM, V36, P247, DOI 10.1016/j.ceca.2004.02.013; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	59	85	86	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21549	10.1371/journal.pone.0021549	http://dx.doi.org/10.1371/journal.pone.0021549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738705	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100036
J	Borkar, AN; Rout, MK; Hosur, RV				Borkar, Aditi Narendra; Rout, Manoj Kumar; Hosur, Ramakrishna V.			Visualization of Early Events in Acetic Acid Denaturation of HIV-1 Protease: A Molecular Dynamics Study	PLOS ONE			English	Article							DRUG-RESISTANCE; SH3 DOMAIN; SIMULATIONS; PROTEINS; MONOMER; INHIBITORS; STABILITY; COMPLEXES; HIERARCHY; SUBSTRATE	Protein denaturation plays a crucial role in cellular processes. In this study, denaturation of HIV-1 Protease (PR) was investigated by all-atom MD simulations in explicit solvent. The PR dimer and monomer were simulated separately in 9 M acetic acid (9 M AcOH) solution and water to study the denaturation process of PR in acetic acid environment. Direct visualization of the denaturation dynamics that is readily available from such simulations has been presented. Our simulations in 9 M AcOH reveal that the PR denaturation begins by separation of dimer into intact monomers and it is only after this separation that the monomer units start denaturing. The denaturation of the monomers is flagged off by the loss of crucial interactions between the alpha-helix at C-terminal and surrounding beta-strands. This causes the structure to transit from the equilibrium dynamics to random non-equilibrating dynamics. Residence time calculations indicate that denaturation occurs via direct interaction of the acetic acid molecules with certain regions of the protein in 9 M AcOH. All these observations have helped to decipher a picture of the early events in acetic acid denaturation of PR and have illustrated that the alpha-helix and the beta-sheet at the C-terminus of a native and functional PR dimer should maintain both the stability and the function of the enzyme and thus present newer targets for blocking PR function.	[Borkar, Aditi Narendra] Univ Pune, Inst Bioinformat & Biotechnol, Pune, Maharashtra, India; [Borkar, Aditi Narendra; Rout, Manoj Kumar; Hosur, Ramakrishna V.] Tata Inst Fundamental Res, Dept Chem Sci, Mumbai 400005, Maharashtra, India; [Hosur, Ramakrishna V.] Mumbai Univ Campus, UM DAE Ctr Excellence Basic Sci, Kalina, Santa Cruz Mumb, India	Savitribai Phule Pune University; Tata Institute of Fundamental Research (TIFR); UM-DAE Centre for Excellence in Basic Sciences	Borkar, AN (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	hosur@tifr.res.in		Borkar, Aditi Narendra/0000-0003-4361-6561; Borkar, Aditi/0000-0001-9278-1438	Department of Atomic Energy (DAE); Department of Science and Technology (DST), Government of India	Department of Atomic Energy (DAE)(Department of Atomic Energy (DAE)); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India))	Department of Atomic Energy (DAE) and Department of Science and Technology (DST), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bhavesh NS, 2003, J BIOL CHEM, V278, P19980, DOI 10.1074/jbc.M301615200; Bhavesh NS, 2001, FEBS LETT, V509, P218, DOI 10.1016/S0014-5793(01)03066-6; Broglia RA, 2005, PROTEIN SCI, V14, P2668, DOI 10.1110/ps.051670905; Broglia RA, 2001, J CHEM PHYS, V114, P7267, DOI 10.1063/1.1361076; Broglia RA, 2001, PROTEINS, V45, P421, DOI 10.1002/prot.1158; Chatterjee A, 2005, J BIOL CHEM, V280, P11369, DOI 10.1074/jbc.M412603200; Chen XF, 2004, J MOL MODEL, V10, P373, DOI 10.1007/s00894-004-0205-x; COLLINS JR, 1995, NAT STRUCT BIOL, V2, P334, DOI 10.1038/nsb0495-334; HARRISON RW, 1994, PROTEIN ENG, V7, P1353, DOI 10.1093/protein/7.11.1353; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Levy Y, 2004, J MOL BIOL, V340, P67, DOI 10.1016/j.jmb.2004.04.028; Levy Y, 2003, J PHYS CHEM B, V107, P3068, DOI 10.1021/jp0219956; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; Navon A, 2001, BIOCHEMISTRY-US, V40, P105, DOI 10.1021/bi001946o; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Perryman AL, 2004, PROTEIN SCI, V13, P1108, DOI 10.1110/ps.03468904; Pillai B, 2001, PROTEINS, V43, P57, DOI 10.1002/1097-0134(20010401)43:1<57::AID-PROT1017>3.0.CO;2-D; Rout MK, 2009, ARCH BIOCHEM BIOPHYS, V482, P33, DOI 10.1016/j.abb.2008.11.022; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tiana G, 2002, PROTEINS, V49, P82, DOI 10.1002/prot.10196; Trylska J, 2007, BIOPHYS J, V92, P4179, DOI 10.1529/biophysj.106.100560; Wallqvist A, 1998, PROTEIN ENG, V11, P999, DOI 10.1093/protein/11.11.999; Wartha F, 2005, J CHEM THEORY COMPUT, V1, P315, DOI 10.1021/ct049869o; Yan MC, 2008, PROTEINS, V70, P731, DOI 10.1002/prot.21539; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816; ZHANG O, 1995, BIOCHEMISTRY-US, V34, P6784, DOI 10.1021/bi00020a025; Zhu ZW, 2003, BIOCHEMISTRY-US, V42, P1326, DOI 10.1021/bi020496s	34	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e19830	10.1371/journal.pone.0019830	http://dx.doi.org/10.1371/journal.pone.0019830			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738569	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100001
J	Jagadeesan, B; Littlejohn, AEF; Amalaradjou, MAR; Singh, AK; Mishra, KK; La, D; Kihara, D; Bhunia, AK				Jagadeesan, Balamurugan; Littlejohn, Amy E. Fleishman; Amalaradjou, Mary Anne Roshni; Singh, Atul K.; Mishra, Krishna K.; La, David; Kihara, Daisuke; Bhunia, Arun K.			N-Terminal Gly(224)-Gly(411) Domain in Listeria Adhesion Protein Interacts with Host Receptor Hsp60	PLOS ONE			English	Article							MONOCYTOGENES VIRULENCE FACTOR; ACID-RICH PROTEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; SURFACE PROTEIN; ENTAMOEBA-HISTOLYTICA; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL ADHESION; ESCHERICHIA-COLI; INVASION PROTEIN; ALPHA-ENOLASE	Background: Listeria adhesion protein (LAP) is a housekeeping bifunctional enzyme consisting of N-terminal acetaldehyde dehydrogenase (ALDH) and C-terminal alcohol dehydrogenase (ADH). It aids Listeria monocytogenes in crossing the epithelial barrier through a paracellular route by interacting with its host receptor, heat shock protein 60 (Hsp60). To gain insight into the binding interaction between LAP and Hsp60, LAP subdomain(s) participating in the Hsp60 interaction were investigated. Methods: Using a ModBase structural model, LAP was divided into 4 putative subdomains: the ALDH region contains N1 (Met(1)-Pro(223)) and N2 (Gly(224)-Gly(411)), and the ADH region contains C1 (Gly(412)-Val(648)) and C2 (Pro(649)-Val(866)). Each subdomain was cloned and overexpressed in Escherichia coli and purified. Purified subdomains were used in ligand overlay, immunofluorescence, and bead-based epithelial cell adhesion assays to analyze each domain's affinity toward Hsp60 protein or human ileocecal epithelial HCT-8 cells. Results: The N2 subdomain exhibited the greatest affinity for Hsp60 with a K-D of 9.50 +/- 2.6 nM. The K-D of full-length LAP (7.2 +/- 0.5 nM) to Hsp60 was comparable to the N2 value. Microspheres (1 mu m diameter) coated with N2 subdomain showed significantly (P<0.05) higher binding to HCT-8 cells than beads coated with other subdomains and this binding was inhibited when HCT-8 cells were pretreated with anti-Hsp60 antibody to specifically block epithelial Hsp60. Furthermore, HCT-8 cells pretreated with purified N2 subdomain also reduced L. monocytogenes adhesion by about 4 log confirming its involvement in interaction with epithelial cells. Conclusion: These data indicate that the N2 subdomain in the LAP ALDH domain is critical in initiating interaction with mammalian cell receptor Hsp60 providing insight into the molecular mechanism of pathogenesis for the development of potential anti-listerial control strategies.	[Jagadeesan, Balamurugan; Littlejohn, Amy E. Fleishman; Amalaradjou, Mary Anne Roshni; Singh, Atul K.; Mishra, Krishna K.; Bhunia, Arun K.] Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, W Lafayette, IN 47907 USA; [Littlejohn, Amy E. Fleishman; Kihara, Daisuke; Bhunia, Arun K.] Purdue Univ, Purdue Univ Interdisciplinary Life Sci Program, W Lafayette, IN 47907 USA; [La, David; Kihara, Daisuke] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kihara, Daisuke] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Bhunia, Arun K.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Jagadeesan, B (corresponding author), Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, Smith Hall, W Lafayette, IN 47907 USA.	bhunia@purdue.edu	amalaradjou, mary anne roshni/D-2004-2012; Singh, Atul Kumar/H-6629-2019; Bhunia, Arun K./K-7639-2012	Singh, Atul Kumar/0000-0001-7343-3577; Bhunia, Arun K./0000-0003-3640-1554; Amalaradjou, Mary Anne Roshni/0000-0001-7411-2206; Jagadeesan, Balamurugan/0000-0002-2471-8290	U.S. Department of Agriculture [1935-42000-035, 2009-35603-05059]; Purdue Faculty; National Institute of General Medical Sciences of the National Institutes of Health [R01 GM075004]; National Science Foundation [DMS800568, IIS0915801, EF0850009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075004] Funding Source: NIH RePORTER	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Purdue Faculty; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AKB, AFL, MARA, AKS, KKM are supported by U.S. Department of Agriculture Grant # 1935-42000-035, and 2009-35603-05059, and Purdue Faculty Scholar Funding. DL and DK were supported by National Institute of General Medical Sciences of the National Institutes of Health (R01 GM075004) and National Science Foundation DMS800568, IIS0915801, and EF0850009. The funders had no role in study design, data collection, and data analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Ainscough SL, 2009, EXP EYE RES, V89, P629, DOI 10.1016/j.exer.2009.06.005; Alvarez-Dominguez C, 2008, TRAFFIC, V9, P325, DOI 10.1111/j.1600-0854.2007.00683.x; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Burkholder KM, 2009, MICROBES INFECT, V11, P859, DOI 10.1016/j.micinf.2009.05.006; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Dramsi S, 2004, MOL MICROBIOL, V53, P639, DOI 10.1111/j.1365-2958.2004.04138.x; Dziewanowska K, 2000, INFECT IMMUN, V68, P6321, DOI 10.1128/IAI.68.11.6321-6328.2000; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Gilot P, 1999, INFECT IMMUN, V67, P6698; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Ireton K, 2007, CELL MICROBIOL, V9, P1365, DOI 10.1111/j.1462-5822.2007.00933.x; Jagadeesan B, 2010, MICROBIOL-SGM, V156, P2782, DOI 10.1099/mic.0.036509-0; Jaradat ZW, 2003, MED MICROBIOL IMMUN, V192, P85, DOI 10.1007/S00430-002-0150-1; Kim KP, 2006, FEMS MICROBIOL LETT, V256, P324, DOI 10.1111/j.1574-6968.2006.00140.x; Kinhikar AG, 2006, MOL MICROBIOL, V60, P999, DOI 10.1111/j.1365-2958.2006.05151.x; Koba H, 2009, ORAL MICROBIOL IMMUN, V24, P162, DOI 10.1111/j.1399-302X.2008.00490.x; KOHLER S, 1990, INFECT IMMUN, V58, P1943; KUMARAN D, 2011, CRYSTAL STRUCTURE LA; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Lebrun M, 1996, MOL MICROBIOL, V21, P579, DOI 10.1111/j.1365-2958.1996.tb02566.x; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Milohanic E, 2004, INFECT IMMUN, V72, P4401, DOI 10.1128/IAI.72.8.4401-4409.2004; Nelson D, 2001, J DENT RES, V80, P371, DOI 10.1177/00220345010800011301; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Pandiripally VK, 1999, J MED MICROBIOL, V48, P117, DOI 10.1099/00222615-48-2-117; Pentecost M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000900; Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pizarro-Cerda J, 2006, J PATHOL, V208, P215, DOI 10.1002/path.1888; Pohl E, 2002, J BIOL CHEM, V277, P19938, DOI 10.1074/jbc.M112244200; Ranford J C, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400002015; Reis O, 2010, J INFECT DIS, V202, P551, DOI 10.1086/654880; Romero-Steiner S, 2006, VACCINE, V24, P3224, DOI 10.1016/j.vaccine.2006.01.042; Sabet C, 2008, INFECT IMMUN, V76, P1368, DOI 10.1128/IAI.01519-07; Santi-Rocca J, 2008, CELL MICROBIOL, V10, P202, DOI 10.1111/j.1462-5822.2007.01030.x; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Seigneur M, 2005, CELL MICROBIOL, V7, P569, DOI 10.1111/j.1462-5822.2005.00487.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wampler JL, 2004, INFECT IMMUN, V72, P931, DOI 10.1128/IAI.72.2.931-936.2004; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; YANG WG, 1994, MOL BIOCHEM PARASIT, V64, P253, DOI 10.1016/0166-6851(93)00020-A; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	56	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20694	10.1371/journal.pone.0020694	http://dx.doi.org/10.1371/journal.pone.0020694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738582	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100005
J	Lee, KM; Yu, J; Son, M; Lee, YW; Kim, KH				Lee, Kyung-Mi; Yu, Jisuk; Son, Moonil; Lee, Yin-Won; Kim, Kook-Hyung			Transmission of Fusarium boothii Mycovirus via Protoplast Fusion Causes Hypovirulence in Other Phytopathogenic Fungi	PLOS ONE			English	Article							NIVALENOL-PRODUCING CHEMOTYPES; GIBBERELLA-ZEAE; CRYPHONECTRIA-PARASITICA; CHESTNUT BLIGHT; GENETIC-RECOMBINATION; ENDOTHIA-PARASITICA; ROSELLINIA-NECATRIX; DSRNA MYCOVIRUS; GRAMINEARUM; PATHOGEN	There is increasing concern regarding the use of fungicides to control plant diseases, whereby interest has increased in the biological control of phytopathogenic fungi by the application of hypovirulent mycoviruses as a possible alternative to fungicides. Transmission of hypovirulence-associated double-stranded RNA (dsRNA) viruses between mycelia, however, is prevented by the vegetative incompatibility barrier that often exists between different species or strains of filamentous fungi. We determined whether protoplast fusion could be used to transmit FgV1-DK21 virus, which is associated with hypovirulence on F. boothii (formerly F. graminearum strain DK21), to F. graminearum, F. asiaticum, F. oxysporum f. sp. lycopersici, and Cryphonectria parasitica. Relative to virus-free strains, the FgV1-DK21 recipient strains had reduced growth rates, altered pigmentation, and reduced virulence. These results indicate that protoplast fusion can be used to introduce FgV1-DK21 dsRNA into other Fusarium species and into C. parasitica and that FgV1-DK21 can be used as a hypovirulence factor and thus as a biological control agent.	[Lee, Kyung-Mi] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, KM (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	kookkim@snu.ac.kr		Son, Moonil/0000-0002-1325-2085	Ministry of Education, Science, and Technology (MEST) [20110000959]	Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant from the Center for Fungal Pathogenesis (No. 20110000959) funded by the Ministry of Education, Science, and Technology (MEST). K-ML, JY, and MS were supported by graduate research fellowships from the MEST through the Brain Korea 21 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS G, 1987, EXP MYCOL, V11, P339, DOI 10.1016/0147-5975(87)90022-3; Aoki N, 2009, VIRUS RES, V140, P179, DOI 10.1016/j.virusres.2008.12.003; Baltz RH, 1999, J IND MICROBIOL BIOT, V22, P460, DOI 10.1038/sj.jim.2900659; Chen BS, 1996, PHYTOPATHOLOGY, V86, P301, DOI 10.1094/Phyto-86-301; Chiba S, 2009, J VIROL, V83, P12801, DOI 10.1128/JVI.01830-09; Chu YM, 2004, VIRUS GENES, V28, P135, DOI 10.1023/B:VIRU.0000012270.67302.35; Chu YM, 2002, APPL ENVIRON MICROB, V68, P2529, DOI 10.1128/AEM.68.5.2529-2534.2002; CHURCHILL ACL, 1990, CURR GENET, V17, P25, DOI 10.1007/BF00313245; DAS A, 1989, ENZYME MICROB TECH, V11, P2, DOI 10.1016/0141-0229(89)90104-X; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; FULBRIGHT DW, 1984, PHYTOPATHOLOGY, V74, P722, DOI 10.1094/Phyto-74-722; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; GOKHALE DV, 1992, J SCI IND RES INDIA, V51, P497; HERRING AJ, 1974, J GEN VIROL, V22, P387, DOI 10.1099/0022-1317-22-3-387; Hong SY, 2010, PLANT PATHOLOGY J, V26, P409, DOI 10.5423/PPJ.2010.26.4.409; Kanematsu S, 2004, PHYTOPATHOLOGY, V94, P561, DOI 10.1094/PHYTO.2004.94.6.561; Kanematsu S, 2010, PHYTOPATHOLOGY, V100, P922, DOI 10.1094/PHYTO-100-9-0922; Kim C, 1997, ARCH PHARM RES, V20, P448, DOI 10.1007/BF02973938; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; Kwon SJ, 2007, MOL CELLS, V23, P304, DOI 10.1007/s10059-009-0112-1; Lee T, 2002, APPL ENVIRON MICROB, V68, P2148, DOI 10.1128/AEM.68.5.2148-2154.2002; Lee T, 2001, APPL ENVIRON MICROB, V67, P2966, DOI 10.1128/AEM.67.7.2966-2972.2001; LESLIE JF, 1993, ANNU REV PHYTOPATHOL, V31, P127, DOI 10.1146/annurev.py.31.090193.001015; MADHOSINGH C, 1994, J PHYTOPATHOL, V142, P301, DOI 10.1111/j.1439-0434.1994.tb04543.x; NUSS DL, 1992, MICROBIOL REV, V56, P561, DOI 10.1128/MMBR.56.4.561-576.1992; Nuss DL, 2005, NAT REV MICROBIOL, V3, P632, DOI 10.1038/nrmicro1206; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; Pearson MN, 2009, MOL PLANT PATHOL, V10, P115, DOI 10.1111/j.1364-3703.2008.00503.x; PEBERDY JF, 1980, ENZYME MICROB TECH, V2, P23, DOI 10.1016/0141-0229(80)90004-6; PUHALLA JE, 1971, PHYTOPATHOLOGY, V61, P169, DOI 10.1094/Phyto-61-169; Rubinder K, 2000, CAN J MICROBIOL, V46, P669, DOI 10.1139/cjm-46-7-669; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; SHAIN L, 1992, CAN J BOT, V70, P557, DOI 10.1139/b92-070; Sun QH, 2009, EUKARYOT CELL, V8, P262, DOI 10.1128/EC.00338-08; Suzuki N, 2002, J VIROL, V76, P7747, DOI 10.1128/JVI.76.15.7747-7759.2002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; van Diepeningen A. D., 2000, FUNGAL GENET NEWSLET, V47, P99, DOI DOI 10.4148/1941-4765.1216; van Diepeningen AD, 1998, FUNGAL GENET BIOL, V25, P171, DOI 10.1006/fgbi.1998.1096; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang C, 2009, CAN J MICROBIOL, V55, P1070, DOI [10.1139/W09-064, 10.1139/w09-064]	42	37	39	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21629	10.1371/journal.pone.0021629	http://dx.doi.org/10.1371/journal.pone.0021629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738738	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100048
J	Toomey, MB; McGraw, KJ				Toomey, Matthew B.; McGraw, Kevin J.			The Effects of Dietary Carotenoid Supplementation and Retinal Carotenoid Accumulation on Vision-Mediated Foraging in the House Finch	PLOS ONE			English	Article							AVIAN COLOR-VISION; OIL DROPLETS; CARPODACUS-MEXICANUS; VISUAL PIGMENTS; FOOD COLOR; BIRDS; AVAILABILITY; LIGHT; DISCRIMINATION; TETRACHROMACY	Background: For many bird species, vision is the primary sensory modality used to locate and assess food items. The health and spectral sensitivities of the avian visual system are influenced by diet-derived carotenoid pigments that accumulate in the retina. Among wild House Finches (Carpodacus mexicanus), we have found that retinal carotenoid accumulation varies significantly among individuals and is related to dietary carotenoid intake. If diet-induced changes in retinal carotenoid accumulation alter spectral sensitivity, then they have the potential to affect visually mediated foraging performance. Methodology/Principal Findings: In two experiments, we measured foraging performance of house finches with dietarily manipulated retinal carotenoid levels. We tested each bird's ability to extract visually contrasting food items from a matrix of inedible distracters under high-contrast (full) and dimmer low-contrast (red-filtered) lighting conditions. In experiment one, zeaxanthin-supplemented birds had significantly increased retinal carotenoid levels, but declined in foraging performance in the high-contrast condition relative to astaxanthin-supplemented birds that showed no change in retinal carotenoid accumulation. In experiments one and two combined, we found that retinal carotenoid concentrations predicted relative foraging performance in the low-vs. high-contrast light conditions in a curvilinear pattern. Performance was positively correlated with retinal carotenoid accumulation among birds with low to medium levels of accumulation (similar to 0.5-1.5 mu g/retina), but declined among birds with very high levels (>2.0 mu g/retina). Conclusion/Significance: Our results suggest that carotenoid-mediated spectral filtering enhances color discrimination, but that this improvement is traded off against a reduction in sensitivity that can compromise visual discrimination. Thus, retinal carotenoid levels may be optimized to meet the visual demands of specific behavioral tasks and light environments.	[Toomey, Matthew B.; McGraw, Kevin J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Toomey, MB (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	matthew.toomey@asu.edu	Toomey, Matthew/AAJ-9133-2020	Toomey, Matthew/0000-0001-9184-197X	National Science Foundation [IOS-0910357, 0923694]; American Ornithologists' Union; Animal Behavior Society	National Science Foundation(National Science Foundation (NSF)); American Ornithologists' Union; Animal Behavior Society	This work was funded by grants from the National Science Foundation (IOS-0910357 to KJM and 0923694 to MBT and KJM), the American Ornithologists' Union to MBT, and the Animal Behavior Society to MBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles JM, 2008, AM NAT, V171, P327, DOI 10.1086/527493; Bascunan AL, 2009, ETHOLOGY, V115, P1066, DOI 10.1111/j.1439-0310.2009.01697.x; Bennett ATD, 2007, AM NAT, V169, pS1, DOI 10.1086/510163; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; Cummings ME, 2004, VISION RES, V44, P1127, DOI 10.1016/j.visres.2003.12.013; Das D, 1999, VISION RES, V39, P2801, DOI 10.1016/S0042-6989(99)00023-1; Douglas R.H., 1999, P95; Eaton MD, 2005, P NATL ACAD SCI USA, V102, P10942, DOI 10.1073/pnas.0501891102; Endler J. A., 1992, AM NAT, V139, pS125; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Goldsmith TH, 2005, J COMP PHYSIOL A, V191, P933, DOI 10.1007/s00359-005-0024-2; GOLDSMITH TH, 1984, VISION RES, V24, P1661, DOI 10.1016/0042-6989(84)90324-9; Grether GF, 2005, P ROY SOC B-BIOL SCI, V272, P2181, DOI 10.1098/rspb.2005.3197; Hart NS, 2006, J EXP BIOL, V209, P4776, DOI 10.1242/jeb.02568; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hill G. E., 2002, RED BIRD BROWN BAG F; Knott B, 2010, P ROY SOC B-BIOL SCI, V277, P953, DOI 10.1098/rspb.2009.1805; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lind O, 2009, VISION RES, V49, P1939, DOI 10.1016/j.visres.2009.05.003; Lythgoe J.N., 1979, ECOLOGY VISION; LYTHGOE JN, 1991, VISION RES, V31, P361, DOI 10.1016/0042-6989(91)90089-N; Maddocks SA, 2001, J EXP BIOL, V204, P2509; McGraw KJ, 2006, PHYSIOL BEHAV, V87, P103, DOI 10.1016/j.physbeh.2005.09.001; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; Osorio D, 2005, P ROY SOC B-BIOL SCI, V272, P1745, DOI 10.1098/rspb.2005.3156; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Partridge J.C., 1999, P251; Perez C, 2008, BEHAV ECOL, V19, P967, DOI 10.1093/beheco/arn053; Pike TW, 2007, BIOL LETTERS, V3, P353, DOI 10.1098/rsbl.2007.0072; Rovamo JM, 2001, VISION RES, V41, P1659, DOI 10.1016/S0042-6989(01)00036-0; SALT GW, 1952, ECOL MONOGR, V22, P121, DOI 10.2307/1943514; Schaefer HM, 2008, FUNCT ECOL, V22, P303, DOI 10.1111/j.1365-2435.2007.01363.x; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Stockton-Shields C., 1997, THESIS AUBURN U AUBU; Toomey MB, 2010, ARCH BIOCHEM BIOPHYS, V504, P161, DOI 10.1016/j.abb.2010.06.033; Toomey MB, 2010, J EXP BIOL, V213, P1709, DOI 10.1242/jeb.041004; Toomey MB, 2009, FUNCT ECOL, V23, P321, DOI 10.1111/j.1365-2435.2008.01498.x; Vorobyev M, 2003, P ROY SOC B-BIOL SCI, V270, P1255, DOI 10.1098/rspb.2003.2381; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286	42	19	20	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21653	10.1371/journal.pone.0021653	http://dx.doi.org/10.1371/journal.pone.0021653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747917	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100052
J	Wang, N; Chang, C; Yao, Q; Li, GH; Qin, LG; Chen, L; Chen, KP				Wang, Nan; Chang, Cheng; Yao, Qin; Li, Guohui; Qin, Lvgao; Chen, Liang; Chen, Keping			Display of Bombyx mori Alcohol Dehydrogenases on the Bacillus subtilis Spore Surface to Enhance Enzymatic Activity under Adverse Conditions	PLOS ONE			English	Article							COAT; PURIFICATION; ANTIGENS; DELIVERY; PROTEINS; YEAST; COTC	Alcohol dehydrogenases (ADHs) are oxidoreductases catalyzing the reversible oxidation of alcohols to corresponding aldehydes or ketones accompanied by nicotinamide adenine dinucleotide (NAD) or nicotinamide adenine dinucleotide phosphate (NADP) as coenzyme. ADHs attract major scientific and industrial interest for the evolutionary perspectives, afforded by their wide occurrence in nature, and for their use in industrial synthesis. However, the low activity of ADHs under extremes of pH and temperature often limits their application. To obtain ADH with high activity, in this study, we used Bombyx mori alcohol dehydrogenases (BmADH) as foreign gene and constructed a recombinant integrative plasmid pJS700-BmADH. This pJS700-BmADH was transformed into Bacillus subtilis by double cross-over and produced an amylase inactivated mutant. The fusion protein containing BmADH was expressed on the spore surface and recognized by BmADH-specific antibody. We also assayed the alcohol dehydrogenase activity of the fusion protein together with the native BmADH at different pH and temperature levels, which indicated the recombinant enzyme exhibits activity over wider ranges of temperature and pH than its native form, perhaps due to the resistance properties of B. subtilis spores against adverse conditions.	[Wang, Nan; Chang, Cheng; Yao, Qin; Li, Guohui; Qin, Lvgao; Chen, Liang; Chen, Keping] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu Prov, Peoples R China	Jiangsu University	Wang, N (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu Prov, Peoples R China.	kpchen@ujs.edu.cn		Chen, Liang/0000-0001-7371-3130	Jiangsu Sci-Tech Support Project-Agriculture [BE2008379]; National Program of High-Tech Research and Development (863 High-Tech Program) [2008AA10Z145]; National Natural Science Foundation [30871826]	Jiangsu Sci-Tech Support Project-Agriculture; National Program of High-Tech Research and Development (863 High-Tech Program)(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Jiangsu Sci-Tech Support Project-Agriculture (No. BE2008379), the National Program of High-Tech Research and Development (863 High-Tech Program, No. 2008AA10Z145), and the National Natural Science Foundation (No. 30871826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak I, 2005, MOL MICROBIOL, V55, P330, DOI 10.1111/j.1365-2958.2004.04445.x; Branden C.-I., 1975, ENZYMES, V11, P103; Chen W, 2002, BIOTECHNOL BIOENG, V79, P496, DOI 10.1002/bit.10407; Cutting S., 1990, MOL BIOL METHODS BAC; Dolega A, 2010, COORDIN CHEM REV, V254, P916, DOI 10.1016/j.ccr.2009.12.039; DONOVAN W, 1987, J MOL BIOL, V196, P1, DOI 10.1016/0022-2836(87)90506-7; Henriques AO, 2000, METHODS, V20, P95, DOI 10.1006/meth.1999.0909; Hirakawa H, 2004, J BIOSCI BIOENG, V97, P202, DOI 10.1263/jbb.97.202; Huang JM, 2008, VACCINE, V26, P6043, DOI 10.1016/j.vaccine.2008.09.024; Huo J, 2010, PROTEIN EXPRES PURIF, V72, P95, DOI 10.1016/j.pep.2010.01.014; Isticato R, 2004, J BACTERIOL, V186, P1129, DOI 10.1128/JB.186.4.1129-1135.2004; Isticato R, 2001, J BACTERIOL, V183, P6294, DOI 10.1128/JB.183.21.6294-6301.2001; Jung HC, 1998, NAT BIOTECHNOL, V16, P576, DOI 10.1038/nbt0698-576; Kim JH, 2005, BIOCHEM BIOPH RES CO, V331, P210, DOI 10.1016/j.bbrc.2005.03.144; Kim JH, 2007, J MICROBIOL BIOTECHN, V17, P677; LI Q, 2010, CHINESE J BIOTECHNOL, V26, P264; Mauriello EMF, 2004, VACCINE, V22, P1177, DOI 10.1016/j.vaccine.2003.09.031; Mazza P, 1994, Boll Chim Farm, V133, P3; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Oggioni MR, 2003, VACCINE, V21, pS96, DOI 10.1016/S0264-410X(03)00207-X; OKUMA Y, 1991, J FERMENT BIOENG, V71, P309, DOI 10.1016/0922-338X(91)90341-D; OUDMAN L, 1991, HEREDITY, V67, P103, DOI 10.1038/hdy.1991.69; RACKER E, 1955, METHOD ENZYMOL, V1, P500, DOI 10.1016/0076-6879(55)01084-7; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; RELLA R, 1987, EUR J BIOCHEM, V167, P475, DOI 10.1111/j.1432-1033.1987.tb13361.x; Sambrook J, 2001, MOL CLONING LAB MANU; VONWARTBURG JP, 1964, BIOCHEMISTRY-US, V3, P1775, DOI 10.1021/bi00899a033; Wernerus H, 2004, BIOTECHNOL APPL BIOC, V40, P209; Zhang ZH, 2006, HYPERTENSION, V48, P127, DOI 10.1161/01.HYP.0000224296.96235.dd	29	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21454	10.1371/journal.pone.0021454	http://dx.doi.org/10.1371/journal.pone.0021454			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738670	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100025
J	Yang, TL; Guo, Y; Shen, H; Lei, SF; Liu, YJ; Li, J; Liu, YZ; Yu, N; Chen, J; Xu, T; Cheng, Y; Tian, Q; Yu, P; Papasian, CJ; Deng, HW				Yang, Tie-Lin; Guo, Yan; Shen, Hui; Lei, Shu-Feng; Liu, Yong-Jun; Li, Jian; Liu, Yao-Zhong; Yu, Na; Chen, Jia; Xu, Ting; Cheng, Yu; Tian, Qing; Yu, Ping; Papasian, Christopher J.; Deng, Hong-Wen			Genetic Association Study of Common Mitochondrial Variants on Body Fat Mass	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN OBESITY; ATP-SYNTHASE; DISEASE; POPULATION; OVERWEIGHT; MUTATION; MTDNA	Mitochondria play a central role in ATP production and energy metabolism. Previous studies suggest that common variants in mtDNA are associated with several common complex diseases, including obesity. To test the hypothesis that common mtDNA variants influence obesity-related phenotypes, including BMI and body fat mass, we genotyped a total of 445 mtSNPs across the whole mitochondrial genome in a large sample of 2,286 unrelated Caucasian subjects. 72 of these 445 mtSNPs passed quality control criteria, and were used for subsequent analyses. We also classified all subjects into nine common European haplogroups. Association analyses were conducted for both BMI and body fat mass with single mtSNPs and mtDNA haplogroups. Two mtSNPs, mt4823 and mt8873 were detected to be significantly associated with body fat mass, with adjusted P values of 4.94610(-3) and 4.58610(-2), respectively. The minor alleles mt4823 C and mt8873 A were associated with reduced fat mass values and the effect size (beta) was estimated to be 3.52 and 3.18, respectively. These two mtSNPs also achieved nominally significant levels for association with BMI. For haplogroup analyses, we found that haplogroup X was strongly associated with both BMI (adjusted P = 8.31610(-3)) and body fat mass (adjusted P = 5.67610(-4)) Subjects classified as haplogroup X had lower BMI and fat mass values, with the beta estimated to be 2.86 and 6.03, respectively. Our findings suggest that common variants in mitochondria might play a role in variations of body fat mass. Further molecular and functional studies will be needed to clarify the potential mechanism.	[Yang, Tie-Lin; Guo, Yan] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Shaanxi, Peoples R China; [Yang, Tie-Lin; Guo, Yan] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Xian 710049, Shaanxi, Peoples R China; [Shen, Hui; Lei, Shu-Feng; Liu, Yong-Jun; Li, Jian; Liu, Yao-Zhong; Yu, Na; Chen, Jia; Xu, Ting; Cheng, Yu; Tian, Qing; Yu, Ping; Papasian, Christopher J.; Deng, Hong-Wen] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Deng, Hong-Wen] Beijing Jiaotong Univ, Sch Sci, Inst Biosci & Biotechnol, Beijing, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Tulane University; Beijing Jiaotong University	Guo, Y (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Shaanxi, Peoples R China.	guoyan253@xjtu.edu.cn; hdeng2@tulane.edu	Liu, Yong/GWQ-6163-2022; Liu, Yaozhong/ABD-5544-2020; Li, Jian/G-4445-2015; Yang, Tie-Lin/G-8365-2014; Guo, Yan/G-8742-2014	Yang, Tie-Lin/0000-0001-7062-3025; Guo, Yan/0000-0002-7364-2392; Deng, Hong-Wen/0000-0002-0387-8818	National Institutes of Health [R01 AR050496, R21 AG027110, R01 AG026564, R01 AR057049-01A1, R21 AA015973]; Specialized Center of Research grant [P50 AR055081]; National Science Foundation of China [81000363, 31000554]; Fundamental Research Funds for the Central Universities; Shanghai Leading Academic Discipline Project [S30501]; Ministry of Education; University of Shanghai for Science and Technology; Xi'an Jiaotong University; Ministry of Education of China; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081, R01AR057049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Specialized Center of Research grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ministry of Education; University of Shanghai for Science and Technology; Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work were supported by grants from the National Institutes of Health (R01 AR050496, R21 AG027110, R01 AG026564, R01 AR057049-01A1 and R21 AA015973) and a Specialized Center of Research grant (P50 AR055081). The study was also supported by grants from the National Science Foundation of China (81000363, 31000554), the Fundamental Research Funds for the Central Universities, Shanghai Leading Academic Discipline Project (S30501), a grant from Ministry of Education to Shanghai University of Science and Technology, and startup funds from University of Shanghai for Science and Technology and Xi'an Jiaotong University, and the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K; Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOUSTEK J, 1995, BBA-MOL BASIS DIS, V1271, P349, DOI 10.1016/0925-4439(95)00063-A; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Morava E, 2003, J INHERIT METAB DIS, V26, P720, DOI 10.1023/B:BOLI.0000005647.71704.25; Ogilvie I, 1999, FEBS LETT, V453, P179, DOI 10.1016/S0014-5793(99)00605-5; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; TATUCH Y, 1992, AM J HUM GENET, V50, P852; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a	23	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21595	10.1371/journal.pone.0021595	http://dx.doi.org/10.1371/journal.pone.0021595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747914	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100043
J	Lesting, J; Narayanan, RT; Kluge, C; Sangha, S; Seidenbecher, T; Pape, HC				Lesting, Joerg; Narayanan, Rajeevan T.; Kluge, Christian; Sangha, Susan; Seidenbecher, Thomas; Pape, Hans-Christian			Patterns of Coupled Theta Activity in Amygdala-Hippocampal-Prefrontal Cortical Circuits during Fear Extinction	PLOS ONE			English	Article							LATERAL AMYGDALA; SYNAPTIC PLASTICITY; PHASE PRECESSION; CONSCIOUS CATS; MEMORY; NEURONS; OSCILLATIONS; MECHANISMS; RETRIEVAL; SEQUENCES	Signals related to fear memory and extinction are processed within brain pathways involving the lateral amygdala (LA) for formation of aversive stimulus associations, the CA1 area of the hippocampus for context-dependent modulation of these associations, and the infralimbic region of the medial prefrontal cortex (mPFC) for extinction processes. While many studies have addressed the contribution of each of these modules individually, little is known about their interactions and how they function as an integrated system. Here we show, by combining multiple site local field potential (LFP) and unit recordings in freely behaving mice in a fear conditioning paradigm, that theta oscillations may provide a means for temporally and functionally connecting these modules. Theta oscillations occurred with high specificity in the CA1-LA-mPFC network. Theta coupling increased between all areas during retrieval of conditioned fear, and declined during extinction learning. During extinction recall, theta coupling partly rebounded in LA-mPFC and CA1-mPFC, and remained at a low level in CA1-LA. Interfering with theta coupling through local electrical microstimulation in CA1-LA affected conditioned fear and extinction recall depending on theta phase. These results support the hypothesis that theta coupling provides a means for inter-areal coordination in conditioned behavioral responsiveness. More specifically, theta oscillations seem to contribute to a population code indicating conditioned stimuli during recall of fear memory before and after extinction.	[Lesting, Joerg; Narayanan, Rajeevan T.; Kluge, Christian; Sangha, Susan; Seidenbecher, Thomas; Pape, Hans-Christian] Univ Munster, Inst Physiol 1, Munster, Germany; [Kluge, Christian] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Kluge, Christian] UCL, Inst Cognit Neurosci, London, England; [Kluge, Christian] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Pape, Hans-Christian] Univ Munster, Inst Expt Epilepsy Res, Munster, Germany	University of Munster; Otto von Guericke University; University of London; University College London; University of London; University College London; University of Munster	Lesting, J (corresponding author), Univ Munster, Inst Physiol 1, Munster, Germany.	papechris@ukmuenster.de		Sangha, Susan/0000-0002-6461-4146	Deutsche Forschungsgemeinschaft [SFB-TRR58, A02]; Max-Planck Society; Humboldt Foundation; International Human Frontier Science Program Organization	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Society(Max Planck Society); Humboldt Foundation(Alexander von Humboldt Foundation); International Human Frontier Science Program Organization(Human Frontier Science Program)	This study was sponsored with funding from the Deutsche Forschungsgemeinschaft (SFB-TRR58, A02 to TS and HCP; http://sfbtrr58.uni-muenster.de/), the Max-Planck Society and Humboldt Foundation (Research Award 2007 to HCP; http://www.mpg.de/mpForschungspreis?page = 2), as well as the International Human Frontier Science Program Organization (SS; http://www.hfsp.org/funding/postdoctoral-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Farinelli M, 2006, LEARN MEMORY, V13, P329, DOI 10.1101/lm.204806; Fink AE, 2009, J NEUROSCI, V29, P11203, DOI 10.1523/JNEUROSCI.1450-09.2009; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hugues S, 2007, LEARN MEMORY, V14, P520, DOI 10.1101/lm.625407; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Ji JZ, 2007, HIPPOCAMPUS, V17, P749, DOI 10.1002/hipo.20331; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Narayanan RT, 2007, NEUROREPORT, V18, P1107, DOI 10.1097/WNR.0b013e3282004992; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K	39	164	166	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21714	10.1371/journal.pone.0021714	http://dx.doi.org/10.1371/journal.pone.0021714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738775	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800063
J	McFarland, JM; Hahn, TTG; Mehta, MR				McFarland, James M.; Hahn, Thomas T. G.; Mehta, Mayank R.			Explicit-Duration Hidden Markov Model Inference of UP-DOWN States from Continuous Signals	PLOS ONE			English	Article							FORWARD-BACKWARD ALGORITHM; NEOCORTICAL NEURONS; SLOW OSCILLATIONS; IN-VIVO; PROBABILISTIC FUNCTIONS; SENSORY RESPONSES; DEPENDENCE; BURSTS; PHASE	Neocortical neurons show UP-DOWN state (UDS) oscillations under a variety of conditions. These UDS have been extensively studied because of the insight they can yield into the functioning of cortical networks, and their proposed role in putative memory formation. A key element in these studies is determining the precise duration and timing of the UDS. These states are typically determined from the membrane potential of one or a small number of cells, which is often not sufficient to reliably estimate the state of an ensemble of neocortical neurons. The local field potential (LFP) provides an attractive method for determining the state of a patch of cortex with high spatio-temporal resolution; however current methods for inferring UDS from LFP signals lack the robustness and flexibility to be applicable when UDS properties may vary substantially within and across experiments. Here we present an explicit-duration hidden Markov model (EDHMM) framework that is sufficiently general to allow statistically principled inference of UDS from different types of signals (membrane potential, LFP, EEG), combinations of signals (e. g., multichannel LFP recordings) and signal features over long recordings where substantial non-stationarities are present. Using cortical LFPs recorded from urethane-anesthetized mice, we demonstrate that the proposed method allows robust inference of UDS. To illustrate the flexibility of the algorithm we show that it performs well on EEG recordings as well. We then validate these results using simultaneous recordings of the LFP and membrane potential (MP) of nearby cortical neurons, showing that our method offers significant improvements over standard methods. These results could be useful for determining functional connectivity of different brain regions, as well as understanding network dynamics.	[McFarland, James M.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA USA; [McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Hahn, Thomas T. G.] Cent Inst Mental Hlth, Dept Psychiat, D-6800 Mannheim, Germany; [Hahn, Thomas T. G.] Max Planck Inst Med Res, Heidelberg, Germany; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA	Brown University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Central Institute of Mental Health; Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	McFarland, JM (corresponding author), Brown Univ, Dept Phys, Providence, RI 02912 USA.	james_mcfarland@brown.edu; MayankMehta@ucla.edu		Mehta, Mayank/0000-0003-2005-2468	Whitehall Foundation [2009-0594]; NSF [IIS-0969034]; NIH-CRCNS-BMBF [1-R01-MH-092925-01]; W.M. Keck Foundation; Max-Planck Society; BMBF [01GQ1003B, 01GQ1007]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	Whitehall Foundation; NSF(National Science Foundation (NSF)); NIH-CRCNS-BMBF; W.M. Keck Foundation(W.M. Keck Foundation); Max-Planck Society(Max Planck SocietyFoundation CELLEX); BMBF(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Whitehall Foundation (www.whitehall.org) grant #2009-0594, an NSF career award (grant #IIS-0969034), an NIH-CRCNS-BMBF grant #1-R01-MH-092925-01, the W.M. Keck Foundation, the Max-Planck Society and BMBF grants 01GQ1003B and 01GQ1007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Bishop C.M., 2006, PATTERN RECOGNITION; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Chen Z, 2009, NEURAL COMPUT, V21, P1797, DOI 10.1162/neco.2009.06-08-799; CHOI SC, 1969, TECHNOMETRICS, V11, P683, DOI 10.2307/1266892; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; CONTRERAS D, 1995, J NEUROSCI, V15, P604; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Curto C, 2009, J NEUROSCI, V29, P10600, DOI 10.1523/JNEUROSCI.2053-09.2009; Datta R, 2008, INT C PATT RECOG, P2593; EPHRAIM Y, 1989, IEEE T ACOUST SPEECH, V37, P1846, DOI 10.1109/29.45532; Ferguson JD, 1980, P S APPL HIDD MARK M, P143; Gerkin RC, 2010, J CLIN NEUROPHYSIOL, V27, P425, DOI 10.1097/WNP.0b013e3181fdf8bd; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2007, J NEUROPHYSIOL, V97, P4186, DOI 10.1152/jn.01114.2006; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; KAILATH T, 1967, IEEE T COMMUN TECHN, VCO15, P52, DOI 10.1109/TCOM.1967.1089532; Kasanetz F, 2002, J PHYSIOL-LONDON, V543, P577, DOI 10.1113/jphysiol.2002.0024786; Levinson S. E., 1986, Computer Speech and Language, V1, P29, DOI 10.1016/S0885-2308(86)80009-2; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MITCHELL C, 1995, IEEE T SPEECH AUDI P, V3, P213, DOI 10.1109/89.388149; MITCHELL C, 1993, IEEE INT C AC SPEECH, P11331; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Molle M, 2002, J NEUROSCI, V22, P10941; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Saleem AB, 2010, J COMPUT NEUROSCI, V29, P49, DOI 10.1007/s10827-010-0228-5; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Seamari Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000888; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; TERRELL GR, 1990, J AM STAT ASSOC, V85, P470, DOI 10.2307/2289786; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tokdar S, 2010, J COMPUT NEUROSCI, V29, P203, DOI 10.1007/s10827-009-0182-2; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; Yu SZ, 2010, ARTIF INTELL, V174, P215, DOI 10.1016/j.artint.2009.11.011; Yu SZ, 2006, IEEE T SIGNAL PROCES, V54, P1947, DOI 10.1109/TSP.2006.872540; Yu SZ, 2003, IEEE SIGNAL PROC LET, V10, P11, DOI 10.1109/LSP.2002.806705	52	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21606	10.1371/journal.pone.0021606	http://dx.doi.org/10.1371/journal.pone.0021606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738730	Green Published, gold			2022-12-25	WOS:000292142800045
J	Li, RS; Xia, W; Zhang, ZH; Wu, K				Li, Ruisong; Xia, Wei; Zhang, Zhihong; Wu, Kun			S100B Protein, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in Human Milk	PLOS ONE			English	Article							FACTOR MESSENGER-RNA; NEURITE EXTENSION; NEURON SURVIVAL; NERVOUS-SYSTEM; NITRIC-OXIDE; RAT; GDNF; DIFFERENTIATION; PURIFICATION; INFLAMMATION	Background: Human milk contains a wide variety of nutrients that contribute to the fulfillment of its functions, which include the regulation of newborn development. However, few studies have investigated the concentrations of S100B protein, brain-derived neurotrophic factor (BDNF), and glial cell line-derived neurotrophic factor (GDNF) in human milk. The associations of the concentrations of S100B protein, BDNF, and GDNF with maternal factors are not well explored. Methodology/Principal Findings: To investigate the concentrations of S100B protein, BDNF, and GDNF in human milk and characterize the maternal factors associated with their levels in human milk, human milk samples were collected at days 3, 10, 30, and 90 after parturition. Levels of S100B protein, BDNF, and GDNF, and their mRNAs in the samples were detected. Then, these concentrations were compared with lactation and other maternal factors. S100B protein levels in human milk samples collected at 3, 10, 30, and 90 d after parturition were 1249.79 +/- 398.10, 1345.05 +/- 539.16, 1481.83 +/- 573.30, and 1414.39 +/- 621.31 ng/L, respectively. On the other hand, the BDNF concentrations in human milk samples were 10.99 +/- 4.55, 13.01 +/- 5.88, 13.35 +/- 6.43, and 2.83 +/- 5.47 mu g/L, while those of GDNF were 10.90 +/- 1.65, 11.38 +/- 1., 11.29 +/- 3.10, and 11.40 +/- 2.21 g/L for the same time periods. Maternal post-pregnancy body mass index was positively associated with S100B levels in human milk (r = 0.335, P = 0.030 < 0.05). In addition, there was a significant correlation between the levels of S100B protein and BDNF (z = 2.09, P = 0.037 < 0.05). Delivery modes were negatively associated with the concentration of GDNF in human milk. Conclusions: S100B protein, BDNF, and GDNF are present in all samples of human milk, and they may be responsible for the long term effects of breast feeding.	[Li, Ruisong; Zhang, Zhihong; Wu, Kun] Harbin Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China; [Xia, Wei] Harbin Med Coll, Sch Publ Hlth, Dept Children Hlth & Hyg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Li, RS (corresponding author), Harbin Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin, Peoples R China.	wukun_15000@163.com	zhang, zh/GWV-4677-2022					Alexanian AR, 1999, FASEB J, V13, P1611, DOI 10.1096/fasebj.13.12.1611; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; BHATTACHARYYA A, 1992, J NEUROBIOL, V23, P451, DOI 10.1002/neu.480230410; Boesmans W, 2008, GUT, V57, DOI 10.1136/gut.2007.131839; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Chirico G, 2008, J NUTR, V138, p1801S, DOI 10.1093/jn/138.9.1801S; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; de Amici D, 2001, EUR J EPIDEMIOL, V17, P357, DOI 10.1023/A:1012731713393; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; Enstrom Amanda, 2008, Am J Biochem Biotechnol, V4, P121; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; Gazzolo D, 2004, CLIN NUTR, V23, P23, DOI 10.1016/S0261-5614(03)00084-0; Gazzolo D, 2003, BBA-GEN SUBJECTS, V1619, P209, DOI 10.1016/S0304-4165(02)00499-3; Gerlai R, 2001, EUR J NEUROSCI, V14, P1153, DOI 10.1046/j.0953-816x.2001.01724.x; Gromov L A, 1992, Neurosci Behav Physiol, V22, P25, DOI 10.1007/BF01186664; Haglid KG, 1997, BRAIN RES, V753, P196, DOI 10.1016/S0006-8993(96)01463-1; HAIMOTO H, 1985, AM J PATHOL, V121, P185; Hamosh M, 2001, PEDIATR CLIN N AM, V48, P69, DOI 10.1016/S0031-3955(05)70286-8; Hashimoto M, 2005, BIOMED RES-TOKYO, V26, P223, DOI 10.2220/biomedres.26.223; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x; Horwood LJ, 2001, ARCH DIS CHILD-FETAL, V84, pF23, DOI 10.1136/fn.84.1.F23; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; LEWIS D, 1986, BRAIN RES, V383, P159, DOI 10.1016/0006-8993(86)90016-8; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LIN LFH, 1994, J NEUROCHEM, V63, P758; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; MacDorman MF, 2008, BIRTH-ISS PERINAT C, V35, P3, DOI 10.1111/j.1523-536X.2007.00205.x; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; MUSUMECI M, 2008, NUTR METAB, V22, P5; Netto CBO, 2006, ARCH MED RES, V37, P683, DOI 10.1016/j.arcmed.2005.11.005; Nishi M, 1996, SYNAPSE, V23, P1, DOI 10.1002/(SICI)1098-2396(199605)23:1<1::AID-SYN1>3.0.CO;2-E; ODowd BS, 1997, NEUROBIOL LEARN MEM, V67, P197, DOI 10.1006/nlme.1997.3766; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Portela LVC, 2002, CLIN CHEM, V48, P950; Riol H, 1997, J NEUROSCI RES, V48, P53; Schanler RJ, 1999, PEDIATRICS, V103, P1150, DOI 10.1542/peds.103.6.1150; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; UEDA S, 1995, MOL BRAIN RES, V29, P365, DOI 10.1016/0169-328X(94)00269-K; VANELDIK LJ, 1991, BRAIN RES, V542, P280, DOI 10.1016/0006-8993(91)91579-P; Wartiovaara K, 1998, J PEDIATR SURG, V33, P1501, DOI 10.1016/S0022-3468(98)90485-7; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Zanardo V, 2010, BIRTH-ISS PERINAT C, V37, P275, DOI 10.1111/j.1523-536X.2010.00421.x; Zhang DK, 2010, J PATHOL, V222, P213, DOI 10.1002/path.2749; Zhang XB, 2008, PROG NEURO-PSYCHOPH, V32, P886, DOI 10.1016/j.pnpbp.2008.01.004	52	19	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21663	10.1371/journal.pone.0021663	http://dx.doi.org/10.1371/journal.pone.0021663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738758	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600070
J	Mas-Munoz, J; Komen, H; Schneider, O; Visch, SW; Schrama, JW				Mas-Munoz, Julia; Komen, Hans; Schneider, Oliver; Visch, Sander W.; Schrama, Johan W.			Feeding Behaviour, Swimming Activity and Boldness Explain Variation in Feed Intake and Growth of Sole (Solea solea) Reared in Captivity	PLOS ONE			English	Article							PLAICE PLEURONECTES-PLATESSA; TROUT SALMO-TRUTTA; FOOD-CONSUMPTION; ARCTIC CHARR; BROWN TROUT; ATLANTIC SALMON; DOVER SOLE; MACROPODUS-OPERCULARIS; INDIVIDUAL-DIFFERENCES; ANTIPREDATOR BEHAVIOR	The major economic constraint for culturing sole (Solea solea) is its slow and variable growth. The objective was to study the relationship between feed intake/efficiency, growth, and (non-) feeding behaviour of sole. Sixteen juveniles with an average (SD) growth of 2.7 (1.9) g/kg(0.8)/d were selected on their growth during a 4-week period in which they were housed communally with 84 other fish. Selected fish were housed individually during a second 4-week period to measure individual feed intake, growth, and behaviour. Fish were hand-fed three times a day during the dark phase of the day until apparent satiation. During six different days, behaviour was recorded twice daily during 3 minutes by direct observations. Total swimming activity, frequency of burying and of escapes were recorded. At the beginning and end of the growth period, two sequential behavioural tests were performed: "Novel Environment" and "Light Avoidance". Fish housed individually still exhibited pronounced variation in feed intake (CV = 23%), growth (CV = 25%) and behavior (CV = 100%). Differences in feed intake account for 79% of the observed individual differences in growth of sole. Fish with higher variation in feed intake between days and between meals within days had significantly a lower total feed intake (r = -0.65 and r = -0.77) and growth. Active fish showed significantly higher feed intake (r = 0.66) and growth (r = 0.58). Boldness during both challenge tests was related to fast growth: (1) fish which reacted with a lower latency time to swim in a novel environment had significantly higher feed intake (r = -0.55) and growth (r = -0.66); (2) fish escaping during the light avoidance test tended to show higher feed intake (P<0.1) and had higher growth (P<0.05). In conclusion, feeding consistency, swimming activity in the tank, and boldness during behavioral tests are related to feed intake and growth of sole in captivity.	[Mas-Munoz, Julia; Visch, Sander W.; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Komen, Hans; Schneider, Oliver] Wageningen Univ, Anim Breeding & Genet Grp, Wageningen, Netherlands; [Mas-Munoz, Julia; Schneider, Oliver] Wageningen IMARES, Yerseke, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Mas-Munoz, J (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands.	julia.mas@wur.nl	Komen, Hans/D-8876-2012	Schrama, Johan/0000-0001-7156-8806	Wageningen University; IMARES institute in The Netherlands; Zeeuwse Tong Project; European Fisheries	Wageningen University(European Commission); IMARES institute in The Netherlands; Zeeuwse Tong Project; European Fisheries	This research project has been funded by Wageningen University and IMARES institute in The Netherlands, which together are integrated in a project theme on development and production in sea and coastal areas. Moreover this research is supported by the Zeeuwse Tong Project (Zeeland Sole Project), co-funded by the European Fisheries Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aragao C, 2008, AMINO ACIDS, V34, P143, DOI 10.1007/s00726-007-0495-2; Armstrong JD, 1997, J ANIM ECOL, V66, P203, DOI 10.2307/6022; Berghahn R, 1995, NETH J SEA RES, V34, P131, DOI 10.1016/0077-7579(95)90021-7; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Blonk RJW, 2010, AQUACULTURE, V300, P43, DOI 10.1016/j.aquaculture.2009.12.028; Bridcut EE, 1995, CAN J FISH AQUAT SCI, V52, P2543, DOI 10.1139/f95-845; BURROWS MT, 1995, ANIM BEHAV, V50, P41, DOI 10.1006/anbe.1995.0219; CARO TM, 1986, ANIM BEHAV, V34, P1483, DOI 10.1016/S0003-3472(86)80219-6; CARTER CG, 1991, J FISH BIOL, V39, P873, DOI 10.1111/j.1095-8649.1991.tb04416.x; Carter CG, 1992, AQUAT LIVING RESOUR, V5, P225, DOI 10.1051/alr:1992022; CUI Y, 1988, J FISH BIOL, V32, P749, DOI 10.1111/j.1095-8649.1988.tb05414.x; CUI YB, 1990, COMP BIOCHEM PHYS A, V97, P551, DOI 10.1016/0300-9629(90)90126-D; Cutts CJ, 1998, J FISH BIOL, V52, P1026, DOI 10.1111/j.1095-8649.1998.tb00601.x; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Dinis MT, 1999, AQUACULTURE, V176, P27, DOI 10.1016/S0044-8486(99)00047-2; Duarte S, 2009, AQUACULT ENG, V41, P22, DOI 10.1016/j.aquaeng.2009.06.001; Ellis T, 1997, J FISH BIOL, V51, P389; Exadactylos A, 1998, J SEA RES, V40, P117, DOI 10.1016/S1385-1101(98)00015-X; FONDS M, 1992, NETH J SEA RES, V29, P127, DOI 10.1016/0077-7579(92)90014-6; FONDS M, 1989, AQUACULTURE BIOTECHN; Fraser DF, 2001, AM NAT, V158, P124, DOI 10.1086/321307; GERLAI R, 1990, BEHAV GENET, V20, P487, DOI 10.1007/BF01067715; GERVAI J, 1985, BEHAV GENET, V15, P503, DOI 10.1007/BF01065447; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; GOTCEITAS V, 1990, OECOLOGIA, V83, P346, DOI 10.1007/BF00317558; Grima L, 2010, AQUACULTURE, V302, P169, DOI 10.1016/j.aquaculture.2010.02.016; Hepher B., 1988, NUTR POND FISHES; Howell B., 2009, AQUACULTURE EUROPE, V34, P24; Howell BR, 1997, AQUACULTURE, V155, P355, DOI 10.1016/S0044-8486(97)00103-8; Huntingford F, 2005, BEHAVIOUR, V142, P1207, DOI 10.1163/156853905774539382; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; Imsland AK, 2003, REV FISH BIOL FISHER, V13, P379, DOI 10.1007/s11160-004-1632-6; JOBLING M, 1989, AQUACULTURE, V81, P367, DOI 10.1016/0044-8486(89)90160-9; JOBLING M, 1985, AQUACULTURE, V44, P83, DOI 10.1016/0044-8486(85)90011-0; JOBLING M, 1983, J FISH BIOL, V22, P577, DOI 10.1111/j.1095-8649.1983.tb04217.x; JOBLING M, 1994, J FISH BIOL, V44, P1069, DOI 10.1111/j.1095-8649.1994.tb01277.x; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Kadri S, 1997, J FISH BIOL, V50, P273, DOI 10.1006/jfbi.1996.0290; KOEBELE BP, 1985, ENVIRON BIOL FISH, V12, P181, DOI 10.1007/BF00005149; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kristiansen TS, 2007, APPL ANIM BEHAV SCI, V104, P236, DOI 10.1016/j.applanim.2006.09.007; Kristiansen TS, 2004, AQUACULTURE, V230, P137, DOI 10.1016/S0044-8486(03)00436-8; LAGARDERE JP, 1987, J FISH BIOL, V30, P91, DOI 10.1111/j.1095-8649.1987.tb05735.x; Lahti K, 2001, ANIM BEHAV, V62, P935, DOI 10.1006/anbe.2001.1821; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LUITING P, 1991, LIVEST PROD SCI, V27, P321, DOI 10.1016/0301-6226(91)90127-C; Martins CIM, 2011, AQUACULTURE, V312, P192, DOI 10.1016/j.aquaculture.2010.12.035; Martins CIM, 2005, AQUAC RES, V36, P1509, DOI 10.1111/j.1365-2109.2005.01372.x; MCCARTHY ID, 1992, J FISH BIOL, V41, P257, DOI 10.1111/j.1095-8649.1992.tb02655.x; MCCARTHY ID, 1994, P ROY SOC B-BIOL SCI, V257, P141, DOI 10.1098/rspb.1994.0107; METCALFE NB, 1986, J FISH BIOL, V28, P525, DOI 10.1111/j.1095-8649.1986.tb05190.x; Overton JL, 2010, AQUAC RES, V42, P31, DOI 10.1111/j.1365-2109.2010.02502.x; QUIAN X, 2002, APPL ICHTHYOLOGY, V18, P695; Ragland GJ, 2004, HEREDITY, V92, P569, DOI 10.1038/sj.hdy.6800462; Ryer CH, 1996, J FISH BIOL, V48, P686, DOI 10.1111/j.1095-8649.1996.tb01464.x; Ryer CH, 2008, J EXP MAR BIOL ECOL, V359, P62, DOI 10.1016/j.jembe.2008.02.017; *SAS I INC, 2002, SASOONLINEDOC VERS 9; Schram E, 2006, AQUACULTURE, V252, P339, DOI 10.1016/j.aquaculture.2005.07.011; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; SMAGULA CM, 1982, T AM FISH SOC, V111, P543, DOI 10.1577/1548-8659(1982)111<543:DVIFCB>2.0.CO;2; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; Wang N, 1998, AQUACULTURE, V167, P43, DOI 10.1016/S0044-8486(98)00299-3; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250	67	35	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21393	10.1371/journal.pone.0021393	http://dx.doi.org/10.1371/journal.pone.0021393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738651	Green Submitted, gold, Green Published			2022-12-25	WOS:000292092600036
J	Landrieu, I; Smet-Nocca, C; Amniai, L; Louis, JV; Wieruszeski, JM; Goris, J; Janssens, V; Lippens, G				Landrieu, Isabelle; Smet-Nocca, Caroline; Amniai, Laziza; Louis, Justin Vijay; Wieruszeski, Jean-Michel; Goris, Jozef; Janssens, Veerle; Lippens, Guy			Molecular Implication of PP2A and Pin1 in the Alzheimer's Disease Specific Hyperphosphorylation of Tau	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; PAIRED HELICAL FILAMENTS; PROLYL ISOMERASE PIN1; DEVELOPMENTAL REGULATION; PHOSPHORYLATION SITES; DEPHOSPHORYLATION; BINDING; RECOGNIZES; HOLOENZYME; EXPRESSION	Background: Tau phosphorylation and dephosphorylation regulate in a poorly understood manner its physiological role of microtubule stabilization, and equally its integration in Alzheimer disease (AD) related fibrils. A specific phospho-pattern will result from the balance between kinases and phosphatases. The heterotrimeric Protein Phosphatase type 2A encompassing regulatory subunit PR55/Ba (PP2A(T55 alpha)) is a major Tau phosphatase in vivo, which contributes to its final phosphorylation state. We use NMR spectroscopy to determine the dephosphorylation rates of phospho-Tau by this major brain phosphatase, and present site-specific and kinetic data for the individual sites including the pS202/pT205 AT8 and pT231 AT180 phospho-epitopes. Methodology/Principal Findings: We demonstrate the importance of the PR55/B alpha regulatory subunit of PP2A within this enzymatic process, and show that, unexpectedly, phosphorylation at the pT231 AT180 site negatively interferes with the dephosphorylation of the pS202/pT205 AT8 site. This inhibitory effect can be released by the phosphorylation dependent prolyl cis/trans isomerase Pin1. Because the stimulatory effect is lost with the dimeric PP2A core enzyme (PP2A(D)) or with a phospho-Tau T231A mutant, we propose that Pin1 regulates the interaction between the PR55/B alpha subunit and the AT180 phospho-epitope on Tau. Conclusions/Significance: Our results show that phosphorylation of T231 (AT180) can negatively influence the dephosphorylation of the pS202/pT205 AT8 epitope, even without an altered PP2A pool. Thus, a priming dephosphorylation of pT231 AT180 is required for efficient PP2A(T55 alpha)-mediated dephosphorylation of pS202/pT205 AT8. The sophisticated interplay between priming mechanisms reported for certain Tau kinases and the one described here for Tau phosphatase PP2A(T55 alpha) may contribute to the hyperphosphorylation of Tau observed in AD neurons.	[Landrieu, Isabelle; Smet-Nocca, Caroline; Amniai, Laziza; Wieruszeski, Jean-Michel; Lippens, Guy] Univ Lille N France, IFR 147, CNRS, UMR 8576, Villeneuve Dascq, France; [Louis, Justin Vijay; Goris, Jozef; Janssens, Veerle] Univ Louvain, Fac Med, Dept Mol Cell Biol, Prot Phosphorylat & Prote Grp, Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Landrieu, I (corresponding author), Univ Lille N France, IFR 147, CNRS, UMR 8576, Villeneuve Dascq, France.	isabelle.landrieu@univ-lille1.fr	Janssens, Veerle/I-7059-2016; Smet-Nocca, Caroline/U-3427-2019; Smet-Nocca, Caroline/G-2868-2012; Landrieu, Isabelle/AAF-8495-2019	Janssens, Veerle/0000-0002-6772-8448; Smet-Nocca, Caroline/0000-0002-9793-0882; Smet-Nocca, Caroline/0000-0002-9793-0882; Landrieu, Isabelle/0000-0002-4883-2637; Lippens, Guy/0000-0002-8236-0901	Region Nord; CNRS; Pasteur Institute of Lille; European Community (FEDER); French Research Ministry; University of Sciences and Technologies of Lille I; TGE RMN THC [Fr3050]; CNRS/Region Nord-Pas de Calais (France); 'Geconcerteerde OnderzoeksActies' of the Flemish government; 'Interuniversitary Attraction Poles' of the Belgian Science Policy [P6/28]; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen';  [ANR-05-blanc-6320-01]	Region Nord(Region Hauts-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur Institute of Lille; European Community (FEDER)(European Commission); French Research Ministry(Ministry of Research, France); University of Sciences and Technologies of Lille I; TGE RMN THC; CNRS/Region Nord-Pas de Calais (France)(Centre National de la Recherche Scientifique (CNRS)Region Hauts-de-France); 'Geconcerteerde OnderzoeksActies' of the Flemish government; 'Interuniversitary Attraction Poles' of the Belgian Science Policy; 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'(FWO); 	This work was supported by ANR-05-blanc-6320-01 grant. The NMR facilities were funded by the Region Nord, CNRS, Pasteur Institute of Lille, European Community (FEDER), French Research Ministry and the University of Sciences and Technologies of Lille I. Financial support from the TGE RMN THC Fr3050 for conducting the research is gratefully acknowledged. L.A. was supported by a pre-doctoral fellowship of the CNRS/Region Nord-Pas de Calais (France). J.V.L., J.G. and V.J. are supported by grants of the 'Geconcerteerde OnderzoeksActies' of the Flemish government, the 'Interuniversitary Attraction Poles' of the Belgian Science Policy P6/28 and the 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amniai L, 2009, FASEB J, V23, P1146, DOI 10.1096/fj.08-121590; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bertrand J, 2010, NEUROSCIENCE, V168, P323, DOI 10.1016/j.neuroscience.2010.04.009; Bodart JF, 2008, J MAGN RESON, V192, P252, DOI 10.1016/j.jmr.2008.03.006; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Cheng Q, 1996, BIOCHEMISTRY-US, V35, P15593, DOI 10.1021/bi960709b; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; Gauthier A, 2010, BIOL CHEM, V391, P639, DOI 10.1515/BC.2010.060; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; GOEDERT M, 1995, J NEUROCHEM, V65, P2804; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GONG CX, 1994, NEUROSCIENCE, V61, P765, DOI 10.1016/0306-4522(94)90400-6; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kins S, 2001, J BIOL CHEM, V276, P38193; Landrieu I, 2006, J AM CHEM SOC, V128, P3575, DOI 10.1021/ja054656+; Landrieu I, 2010, BIOCHEM SOC T, V38, P1006, DOI 10.1042/BST0381006; Lin YT, 2007, J NEUROCHEM, V103, P802, DOI 10.1111/j.1471-4159.2007.04792.x; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lippens G, 2008, CHEM BIOL, V15, P311, DOI 10.1016/j.chembiol.2008.03.008; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Luna-Munoz J, 2005, J ALZHEIMERS DIS, V8, P29; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Martens E, 2004, J MOL BIOL, V336, P971, DOI 10.1016/j.jmb.2003.12.047; Mochida S, 2010, SCIENCE, V330, P1670, DOI 10.1126/science.1195689; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Peterson DW, 2010, P NATL ACAD SCI USA, V107, P2884, DOI 10.1073/pnas.0912718107; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Schmidt K, 2002, EUR J NEUROSCI, V16, P2039, DOI 10.1046/j.1460-9568.2002.02274.x; Sillen A, 2007, BIOCHEMISTRY-US, V46, P3055, DOI 10.1021/bi061920i; Smet C, 2004, BIOCHEMISTRY-US, V43, P2032, DOI 10.1021/bi035479x; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Sontag E, 1999, J BIOL CHEM, V274, P25490, DOI 10.1074/jbc.274.36.25490; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; WAELKENS E, 1987, J BIOL CHEM, V262, P1049; Welburn Julie, 2004, V296, P219; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; YAMAMOTO H, 1995, J BIOCHEM-TOKYO, V118, P1224, DOI 10.1093/oxfordjournals.jbchem.a125011; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	48	54	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21521	10.1371/journal.pone.0021521	http://dx.doi.org/10.1371/journal.pone.0021521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731772	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400047
J	Sparkman, AM; Waits, LP; Murray, DL				Sparkman, Amanda M.; Waits, Lisette P.; Murray, Dennis L.			Social and Demographic Effects of Anthropogenic Mortality: A Test of the Compensatory Mortality Hypothesis in the Red Wolf	PLOS ONE			English	Article							SURVIVAL; HARVEST; POPULATIONS; MANAGEMENT; WOLVES; RATES	Whether anthropogenic mortality is additive or compensatory to natural mortality in animal populations has long been a question of theoretical and practical importance. Theoretically, under density-dependent conditions populations compensate for anthropogenic mortality through decreases in natural mortality and/or increases in productivity, but recent studies of large carnivores suggest that anthropogenic mortality can be fully additive to natural mortality and thereby constrain annual survival and population growth rate. Nevertheless, mechanisms underlying either compensatory or additive effects continue to be poorly understood. Using long-term data on a reintroduced population of the red wolf, we tested for evidence of additive vs. compensatory effects of anthropogenic mortality on annual survival and population growth rates, and the preservation and reproductive success of breeding pairs. We found that anthropogenic mortality had a strong additive effect on annual survival and population growth rate at low population density, though there was evidence for compensation in population growth at high density. When involving the death of a breeder, anthropogenic mortality was also additive to natural rates of breeding pair dissolution, resulting in a net decrease in the annual preservation of existing breeding pairs. However, though the disbanding of a pack following death of a breeder resulted in fewer recruits per litter relative to stable packs, there was no relationship between natural rates of pair dissolution and population growth rate at either high or low density. Thus we propose that short-term additive effects of anthropogenic mortality on population growth in the red wolf population at low density were primarily a result of direct mortality of adults rather than indirect socially-mediated effects resulting in reduced recruitment. Finally, we also demonstrate that per capita recruitment and the proportion of adults that became reproductive declined steeply with increasing population density, suggesting that there is potential for density-dependent compensation of anthropogenically-mediated population regulation.	[Sparkman, Amanda M.; Murray, Dennis L.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID USA	Trent University; Idaho; University of Idaho	Sparkman, AM (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	asparkma@gmail.com		Waits, Lisette/0000-0002-1323-0812	U.S. Fish and Wildlife Service (USFWS); Canada Research Chairs program	U.S. Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); Canada Research Chairs program(Canada Research Chairs)	The fieldwork was funded by the U.S. Fish and Wildlife Service (USFWS) and grants to DLM from the Canada Research Chairs program and the Natural Sciences and Engineering Research Council (Canada) supported data analysis and write-up. With the exception of the long-term fieldwork conducted by the USFWS upon which this manuscript is based, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JR, 2006, MULTIFACETED MOL APP; Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; ANDERSON DR, 1976, US FISH WILDLIFE SER, V128, P1; BARTMANN RM, 1992, WILDLIFE MONOGR, P1; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; BURNHAM KP, 1984, J WILDLIFE MANAGE, V48, P350, DOI 10.2307/3801166; Cooley HS, 2009, ECOLOGY, V90, P2913, DOI 10.1890/08-1805.1; Cote SD, 2001, WILDLIFE SOC B, V29, P726; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; FULLER TK, 1989, WILDLIFE MONOGR, P1; Fuller Todd K., 2003, P161; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; HARRINGTON FH, 1983, BEHAV ECOL SOCIOBIOL, V13, P19, DOI 10.1007/BF00295072; HEISEY DM, 1985, J WILDLIFE MANAGE, V49, P668, DOI 10.2307/3801692; KNOWLTON FF, 1972, J WILDLIFE MANAGE, V36, P369, DOI 10.2307/3799066; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MCCARLEY H, 1979, RECENT CHANGES DISTR; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Murray DL, 2006, J WILDLIFE MANAGE, V70, P1530, DOI 10.2193/0022-541X(2006)70[1530:OITSE]2.0.CO;2; Murray DL, 2010, BIOL CONSERV, V143, P2514, DOI 10.1016/j.biocon.2010.06.018; Pedersen HC, 2004, P ROY SOC B-BIOL SCI, V271, P381, DOI 10.1098/rspb.2003.2599; PHILLIPS MK, 2003, WOLVES BEHAV ECOLOGY; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Sandercock BK, 2011, J ANIM ECOL, V80, P244, DOI 10.1111/j.1365-2656.2010.01769.x; Sedinger JS, 2010, J WILDLIFE MANAGE, V74, P326, DOI 10.2193/2009-071; Smith DW, 2010, J WILDLIFE MANAGE, V74, P620, DOI 10.2193/2008-584; Sparkman AM, 2011, P ROY SOC B-BIOL SCI, V278, P1381, DOI 10.1098/rspb.2010.1921; Sparkman AM, 2011, BEHAV ECOL, V22, P199, DOI 10.1093/beheco/arq194; *US FISH WILDL SER, 2007, 5 YEAR STAT REV SUMM; *US FISH WILDL SER, 1984, RED WOLF REC PLAN; Wallach AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006861; [No title captured]	34	25	26	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e20868	10.1371/journal.pone.0020868	http://dx.doi.org/10.1371/journal.pone.0020868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21738589	Green Published, gold			2022-12-25	WOS:000292035400005
J	Liu, YL; Chiang, YH; Liu, GY; Hung, HC				Liu, Yi-Liang; Chiang, Yu-Hsiu; Liu, Guang-Yaw; Hung, Hui-Chih			Functional Role of Dimerization of Human Peptidylarginine Deiminase 4 (PAD4)	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; HISTONE DEIMINATION; MULTIPLE-SCLEROSIS; MOLECULAR-CLONING; GENE ORGANIZATION; STRUCTURAL BASIS; PROTEIN; CITRULLINATION; SEQUENCE; TARGET	Peptidylarginine deiminase 4 (PAD4) is a homodimeric enzyme that catalyzes Ca2+-dependent protein citrullination, which results in the conversion of arginine to citrulline. This paper demonstrates the functional role of dimerization in the regulation of PAD4 activity. To address this question, we created a series of dimer interface mutants of PAD4. The residues Arg8, Tyr237, Asp273, Glu281, Tyr435, Arg544 and Asp547, which are located at the dimer interface, were mutated to disturb the dimer organization of PAD4. Sedimentation velocity experiments were performed to investigate the changes in the quaternary structures and the dissociation constants (K-d) between wild-type and mutant PAD4 monomers and dimers. The kinetic data indicated that disrupting the dimer interface of the enzyme decreases its enzymatic activity and calcium-binding cooperativity. The K-d values of some PAD4 mutants were much higher than that of the wild-type (WT) protein (0.45 mu M) and were concomitant with lower k(cat) values than that of WT (13.4 s(-1)). The K-d values of the monomeric PAD4 mutants ranged from 16.8 to 45.6 mu M, and the k(cat) values of the monomeric mutants ranged from 3.3 to 7.3 s(-1). The k(cat) values of these interface mutants decreased as the K-d values increased, which suggests that the dissociation of dimers to monomers considerably influences the activity of the enzyme. Although dissociation of the enzyme reduces the activity of the enzyme, monomeric PAD4 is still active but does not display cooperative calcium binding. The ionic interaction between Arg8 and Asp547 and the Tyr435-mediated hydrophobic interaction are determinants of PAD4 dimer formation.	[Liu, Yi-Liang; Chiang, Yu-Hsiu; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Liu, Yi-Liang; Chiang, Yu-Hsiu; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Yi-Liang; Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Rheumatol Allergy & Immunol, Taichung, Taiwan	National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liu, YL (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/L-8061-2019; Hung, Hui-Chih/G-4485-2013	Hung, Hui-Chih/0000-0003-0180-1822; Hung, Hui-Chih/0000-0003-0180-1822	National Science Council, Republic of China [NSC-99-2113-M-005-010, NSC-99-2314-B-040-002-MY3]; Ministry of Education, Taiwan, Republic of China	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This work was supported by the National Science Council, Republic of China (NSC-99-2113-M-005-010 and NSC-99-2314-B-040-002-MY3) and in part, by the Ministry of Education, Taiwan, Republic of China under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; Andrade F, 2010, ARTHRITIS RHEUM-US, V62, P1630, DOI 10.1002/art.27439; Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Asaga H, 1998, BIOCHEM BIOPH RES CO, V243, P641, DOI 10.1006/bbrc.1998.8148; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Guerrin M, 2003, BIOCHEM J, V370, P167, DOI 10.1042/BJ20020870; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hung HC, 2007, APOPTOSIS, V12, P475, DOI 10.1007/s10495-006-0005-0; Ishigami A, 2002, ARCH BIOCHEM BIOPHYS, V407, P25, DOI 10.1016/S0003-9861(02)00516-7; Ishigami A, 2010, GERIATR GERONTOL INT, V10, pS53, DOI 10.1111/j.1447-0594.2010.00593.x; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Knuckley B, 2010, BIOCHEMISTRY-US, V49, P4852, DOI 10.1021/bi100363t; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Li P, 2010, ONCOGENE, V29, P3153, DOI 10.1038/onc.2010.51; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Liao YF, 2005, ANAL BIOCHEM, V347, P176, DOI 10.1016/j.ab.2005.09.027; Liu GY, 2006, APOPTOSIS, V11, P183, DOI 10.1007/s10495-006-3715-4; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Mizoguchi M, 1998, J HISTOCHEM CYTOCHEM, V46, P1303, DOI 10.1177/002215549804601110; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Nakashima K, 1999, J BIOL CHEM, V274, P27786, DOI 10.1074/jbc.274.39.27786; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Reparon-Schuijt CC, 2001, ARTHRITIS RHEUM, V44, P41, DOI 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0; ROGERS GE, 1977, BIOCHIM BIOPHYS ACTA, V495, P159, DOI 10.1016/0005-2795(77)90250-1; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Senshu T, 1999, J DERMATOL SCI, V21, P113, DOI 10.1016/S0923-1811(99)00026-2; Slack JL, 2011, CELL MOL LIFE SCI, V68, P709, DOI 10.1007/s00018-010-0480-x; SLACK JL, 2011, BIOCHEMISTR IN PRESS; Suzuki A, 2005, BIOCHEM BIOPH RES CO, V333, P418, DOI 10.1016/j.bbrc.2005.05.137; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, P1, DOI 10.1186/ar1027; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Wright PW, 2003, DEV BIOL, V256, P73, DOI 10.1016/S0012-1606(02)00126-4	51	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21314	10.1371/journal.pone.0021314	http://dx.doi.org/10.1371/journal.pone.0021314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731701	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700062
J	Hamai, A; Duperrier-Amouriaux, K; Pignon, P; Raimbaud, I; Memeo, L; Colarossi, C; Canzonieri, V; Perin, T; Classe, JM; Campone, M; Jezequel, P; Campion, L; Ayyoub, M; Valmori, D				Hamai, Ahmed; Duperrier-Amouriaux, Karine; Pignon, Pascale; Raimbaud, Isabelle; Memeo, Lorenzo; Colarossi, Cristina; Canzonieri, Vincenzo; Perin, Tiziana; Classe, Jean-Marc; Campone, Mario; Jezequel, Pascal; Campion, Loic; Ayyoub, Maha; Valmori, Danila			Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy	PLOS ONE			English	Article							TESTIS ANTIGEN NY-ESO-1; IMMUNE-RESPONSES; EXPRESSION; MELANOMA; EPITOPES; CELLS	The highly immunogenic human tumor antigen NY-ESO-1 (ESO) is a target of choice for anti-cancer immune therapy. In this study, we assessed spontaneous antibody (Ab) responses to ESO in a large cohort of patients with primary breast cancer (BC) and addressed the correlation between the presence of anti-ESO Ab, the expression of ESO in the tumors and their characteristics. We found detectable Ab responses to ESO in 1% of the patients. Tumors from patients with circulating Ab to ESO exhibited common characteristics, being mainly hormone receptor (HR)(-) invasive ductal carcinomas of high grade, including both HER2(-) and HER2(+) tumors. In line with these results, we detected ESO expression in 20% of primary HR(-) BC, including both ESO Ab(+) and Ab(-) patients, but not in HR(+) BC. Interestingly, whereas expression levels in ESO(+) BC were not significantly different between ESO Ab(+) and Ab(-) patients, the former had, in average, significantly higher numbers of tumor-infiltrated lymph nodes, indicating that lymph node invasion may be required for the development of spontaneous anti-tumor immune responses. Thus, the presence of ESO Ab identifies a tumor subtype of HR(-) (HER2(-) or HER2(+)) primary BC with frequent ESO expression and, together with the assessment of antigen expression in the tumor, may be instrumental for the selection of patients for whom ESO-based immunotherapy may complement standard therapy.	[Hamai, Ahmed; Duperrier-Amouriaux, Karine; Pignon, Pascale; Raimbaud, Isabelle; Ayyoub, Maha; Valmori, Danila] CLCC Rene Gauducheau, INSERM, U892, St Herblain, France; [Memeo, Lorenzo; Colarossi, Cristina] Mediterranean Inst Oncol, Pathol Unit, Catania, Italy; [Canzonieri, Vincenzo; Perin, Tiziana] IRCCS, Ctr Riferimento Oncol, Aviano, Pordenone, Italy; [Classe, Jean-Marc] CLCC Rene Gauducheau, Dept Surg, St Herblain, France; [Campone, Mario] CLCC Rene Gauducheau, Dept Med Oncol, St Herblain, France; [Jezequel, Pascal] CLCC Rene Gauducheau, Dept Oncobiol, St Herblain, France; [Campion, Loic] CLCC Rene Gauducheau, Dept Biostat, St Herblain, France; [Campone, Mario] IRT UN, INSERM, U892, Nantes, France; [Valmori, Danila] Univ Nantes, Fac Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Mediterranean Institute of Oncology; IRCCS Aviano (CRO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Hamai, A (corresponding author), CLCC Rene Gauducheau, INSERM, U892, St Herblain, France.	Maha.Ayyoub@univ-nantes.fr; Danila.Valmori@univ-nantes.fr	Ayyoub, Maha/A-2074-2017; Valmori, Danila/AAL-9766-2021; Canzonieri, Vincenzo/Z-5933-2019; Ayyoub, Maha/G-2778-2013; Canzonieri, Vincenzo/AAA-7951-2019; Perin, Tiziana/AAC-2403-2020; Campion, Loic/K-4726-2015; Jézéquel, Pascal/K-8206-2015; Ansquer, Catherine/M-1519-2015; Valmori, Danila/K-2439-2015	Ayyoub, Maha/0000-0003-2022-0898; Canzonieri, Vincenzo/0000-0001-6010-0976; Perin, Tiziana/0000-0002-9823-0167; Campion, Loic/0000-0003-4903-0908; Colarossi, Cristina/0000-0001-5395-8608; Memeo, Lorenzo/0000-0003-4251-7203	Cancer Research Institute; Ludwig Institute for Cancer Research; Institut National du Cancer; Canceropole Grand Ouest	Cancer Research Institute; Ludwig Institute for Cancer Research; Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Grand Ouest	This study was supported by the Cancer Research Institute (http://www.cancerresearch.org) and the Ludwig Institute for Cancer Research (http://www.licr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sera and surgical tumor specimens from breast cancer patients were obtained from the tumor bank of the Institut Regional du Cancer Nantes-Atlantique, supported by the Institut National du Cancer and the Canceropole Grand Ouest. We are grateful to Drs. G. Ritter and L.J. Old for providing the recombinant proteins and for helpful advice, and to Dr. Maryam Mehrpour for providing the BC lines. We would like to thank Mrs. Nicole Andrieux for assistance with clinical data analysis, and Mr. Sandro Barbuscia for IHC staining.	Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Burstein HJ, 2005, NEW ENGL J MED, V353, P1652, DOI 10.1056/NEJMp058197; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Hortobagyi GN, 2005, NEW ENGL J MED, V353, P1734, DOI 10.1056/NEJMe058196; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Odunsi K, 2003, CANCER RES, V63, P6076; Pageau GJ, 2007, NAT REV CANCER, V7, P628, DOI 10.1038/nrc2172; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Valmori D, 2005, CLIN IMMUNOL, V117, P24, DOI 10.1016/j.clim.2005.05.003; Valmori D, 2000, CANCER RES, V60, P4499; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104	21	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21129	10.1371/journal.pone.0021129	http://dx.doi.org/10.1371/journal.pone.0021129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21747904	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600045
J	Morgan, HP; McNae, IW; Nowicki, MW; Zhong, WH; Michels, PAM; Auld, DS; Fothergill-Gilmore, LA; Walkinshaw, MD				Morgan, Hugh P.; McNae, Iain W.; Nowicki, Matthew W.; Zhong, Wenhe; Michels, Paul A. M.; Auld, Douglas S.; Fothergill-Gilmore, Linda A.; Walkinshaw, Malcolm D.			The Trypanocidal Drug Suramin and Other Trypan Blue Mimetics Are Inhibitors of Pyruvate Kinases and Bind to the Adenosine Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-GRAPHICS; BRUCEI; DISCOVERY; ENZYMES; ANALOGS; GLUCOSE; INVIVO; MODEL	Ehrlich's pioneering chemotherapeutic experiments published in 1904 (Ehrlich, P., and Shiga, K. (1904) Berlin Klin. Wochenschrift 20, 329-362) described the efficacy of a series of dye molecules including trypan blue and trypan red to eliminate trypanosome infections in mice. The molecular structures of the dyes provided a starting point for the synthesis of suramin, which was developed and used as a trypanocidal drug in 1916 and is still in clinical use. Despite the biological importance of these dye-like molecules, the mode of action on trypanosomes has remained elusive. Here we present crystal structures of suramin and three related dyes in complex with pyruvate kinases from Leishmania mexicana or from Trypanosoma cruzi. The phenyl sulfonate groups of all four molecules (suramin, Ponceau S, acid blue 80, and benzothiazole-2,5-disulfonic acid) bind in the position of ADP/ATP at the active sites of the pyruvate kinases (PYKs). The binding positions in the two different trypanosomatid PYKs are nearly identical. We show that suramin competitively inhibits PYKs from humans (muscle, tumor, and liver isoenzymes, K-i = 1.1-17 mu M), T. cruzi (K-i = 108 mu M), and L. mexicana (K-i = 116 mu M), all of which have similar active sites. Synergistic effects were observed when examining suramin inhibition in the presence of an allosteric effector molecule, whereby IC50 values decreased up to 2-fold for both trypanosomatid and human PYKs. These kinetic and structural analyses provide insight into the promiscuous inhibition observed for suramin and into the mode of action of the dye-like molecules used in Ehrlich's original experiments.	[Morgan, Hugh P.; McNae, Iain W.; Nowicki, Matthew W.; Zhong, Wenhe; Fothergill-Gilmore, Linda A.; Walkinshaw, Malcolm D.] Univ Edinburgh, Struct Biochem Grp, Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Michels, Paul A. M.] Catholic Univ Louvain, Trop Dis Res Unit, Duve Inst, B-1200 Brussels, Belgium; [Michels, Paul A. M.] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium; [Auld, Douglas S.] NHGRI, NIH, Chem Genom Ctr, Rockville, MD 20850 USA	University of Edinburgh; Universite Catholique Louvain; Universite Catholique Louvain; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI)	Walkinshaw, MD (corresponding author), Univ Edinburgh, Struct Biochem Grp, Inst Struct & Mol Biol, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	m.walkinshaw@ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019; Michels, Paul A/A-5637-2009	Michels, Paul A/0000-0003-3726-6104; walkinshaw, malcolm/0000-0001-5955-9325; McNae, Iain/0000-0002-6312-7936	Medical Research Council; European Commission; Wellcome Trust; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council [G0600014] Funding Source: researchfish; MRC [G0600014] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by the Medical Research Council and by the European Commission through its International Cooperation with Developing Countries program.; We thank Professor Hee-won Park, Structural Genomics Consortium, University of Toronto, Canada for the gift of human PYK isoenzymes and Dr. J. Dornan for excellent advice and practical help. We also thank the staff at the synchrotron facilities at the European Synchrotron Radiation Facility (ESRF) and Diamond synchrotron radiation facility and also at the National Institutes of Health, Rockville, MD. The Centre for Translational and Chemical Biology and the Edinburgh Protein Production Facility were funded by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council (BBSRC).	AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; ASHIZAWA K, 1991, J BIOL CHEM, V266, P16842; Avliyakulov NK, 2000, EUR J BIOCHEM, V267, P1723, DOI 10.1046/j.1432-1327.2000.01169.x; Baghdiguian S, 1997, CANCER J - FRANCE, V10, P31; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Braga-Silva LA, 2007, FEMS IMMUNOL MED MIC, V51, P399, DOI 10.1111/j.1574-695X.2007.00321.x; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; De Clercq E, 2009, MED RES REV, V29, P571, DOI 10.1002/med.20149; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; EHRLICH P, 1904, BERLIN KLIN WOCHE 41, V20, P329; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FAIRLAMB AH, 1980, MOL BIOCHEM PARASIT, V1, P315, DOI 10.1016/0166-6851(80)90050-X; Freissmuth M, 1996, MOL PHARMACOL, V49, P602; Hannaert V, 2002, FEBS LETT, V514, P255, DOI 10.1016/S0014-5793(02)02374-8; Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X; Hsin KY, 2011, NUCLEIC ACIDS RES, V39, pD1042, DOI 10.1093/nar/gkq878; Huang SS, 1997, FEBS LETT, V416, P297, DOI 10.1016/S0014-5793(97)01213-1; Jagielski AK, 2006, EUR J PHARMACOL, V537, P205, DOI 10.1016/j.ejphar.2006.03.029; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; KLEINE F. K., 1922, Deutsche Medizinische Wochenschrift, V48, P1693, DOI 10.1055/s-0028-1136308; Klinger M, 1999, MOL PHARMACOL, V55, P462; LAROCCA RV, 1992, ANN ONCOL, V3, P571, DOI 10.1093/oxfordjournals.annonc.a058264; LAROCCA RV, 1990, J STEROID BIOCHEM, V37, P893, DOI 10.1016/0960-0760(90)90439-R; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; MAHONEY CW, 1990, J BIOL CHEM, V265, P5424; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; MISSET O, 1987, EUR J BIOCHEM, V162, P493, DOI 10.1111/j.1432-1033.1987.tb10667.x; MITSUYA H, 1984, SCIENCE, V226, P172, DOI 10.1126/science.6091268; Morgan HP, 2010, J BIOL CHEM, V285, P12892, DOI 10.1074/jbc.M109.079905; Morgan HP, 2010, ACTA CRYSTALLOGR F, V66, P215, DOI 10.1107/S1744309109053494; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Pal A, 2002, MOL BIOCHEM PARASIT, V122, P217, DOI 10.1016/S0166-6851(02)00096-8; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; SUBRAMANIAN S, 1984, CRC CR REV BIOCH MOL, V16, P169, DOI 10.3109/10409238409102302; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; VANSCHAFTINGEN E, 1987, EUR J BIOCHEM, V166, P653; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VOOGD TE, 1993, PHARMACOL REV, V45, P177; WILLSON M, 1993, MOL BIOCHEM PARASIT, V59, P201, DOI 10.1016/0166-6851(93)90218-M	51	61	61	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31232	31240		10.1074/jbc.M110.212613	http://dx.doi.org/10.1074/jbc.M110.212613			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21733839	Green Published, hybrid			2022-12-25	WOS:000294487500018
J	Qi, ZT; He, J; Su, YH; He, Q; Liu, JX; Yu, L; Al-Attas, O; Hussain, T; Ding, SZ; Ji, L; Qian, M				Qi, Zhengtang; He, Jie; Su, Yuhui; He, Qiang; Liu, Jingxia; Yu, Lu; Al-Attas, Omar; Hussain, Tajamul; Ding, Shuzhe; Ji, Liu; Qian, Min			Physical Exercise Regulates p53 Activity Targeting SCO2 and Increases Mitochondrial COX Biogenesis in Cardiac Muscle with Age	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; C-OXIDASE ACTIVITY; SKELETAL-MUSCLE; GENE-EXPRESSION; OXIDATIVE STRESS; TRANSLOCATION; DYSFUNCTION; TRANSCRIPTION; DEFICIENCY; APOPTOSIS	The purpose of this study was to outline the timelines of mitochondrial function, oxidative stress and cytochrome c oxidase complex (COX) biogenesis in cardiac muscle with age, and to evaluate whether and how these age-related changes were attenuated by exercise. ICR/CD-1 mice were treated with pifithrin-m (PFT mu), sacrificed and studied at different ages; ICR/CD-1 mice at younger or older ages were randomized to endurance treadmill running and sedentary conditions. The results showed that mRNA expression of p53 and its protein levels in mitochondria increased with age in cardiac muscle, accompanied by increased mitochondrial oxidative stress, reduced expression of COX subunits and assembly proteins, and decreased expression of most markers in mitochondrial biogenesis. Most of these age-related changes including p53 activity targeting cytochrome oxidase deficient homolog 2 (SCO2), p53 translocation to mitochondria and COX biogenesis were attenuated by exercise in older mice. PFTm, an inhibitor blocking p53 translocation to mitochondria, increased COX biogenesis in older mice, but not in young mice. Our data suggest that physical exercise attenuates age-related changes in mitochondrial COX biogenesis and p53 activity targeting SCO2 and mitochondria, and thereby induces antisenescent and protective effects in cardiac muscle.	[Qi, Zhengtang; He, Jie; Su, Yuhui; He, Qiang; Liu, Jingxia; Yu, Lu; Ding, Shuzhe; Ji, Liu] Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai, Peoples R China; [Qi, Zhengtang; Ding, Shuzhe; Ji, Liu] E China Normal Univ, Coll Phys Educ & Hlth, Shanghai 200062, Peoples R China; [Qi, Zhengtang; Qian, Min] E China Normal Univ, Inst Biomed Sci, Shanghai 200062, Peoples R China; [Al-Attas, Omar; Hussain, Tajamul] King Saud Univ, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia	East China Normal University; East China Normal University; King Saud University	Qi, ZT (corresponding author), Minist Educ, Key Lab Adolescent Hlth Assessment & Exercise Int, Shanghai, Peoples R China.	szding@tyxx.ecnu.edu.cn	Hussain, Tajamul/E-8151-2014	Hussain, Tajamul/0000-0001-7601-1417	National Natural Science Foundation of China [30871212]; Program for New Century Excellent Talents in University [790013P8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 30871212) and the Program for New Century Excellent Talents in University (Grant No. 790013P8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Arima Y, 2005, J BIOL CHEM, V280, P19166, DOI 10.1074/jbc.M410691200; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Bertoni-Freddari C, 2004, ANN NY ACAD SCI, V1019, P33, DOI 10.1196/annals.1297.007; Boveris A, 2008, FREE RADICAL BIO MED, V44, P224, DOI 10.1016/j.freeradbiomed.2007.08.015; Charlot JF, 2004, APOPTOSIS, V9, P333, DOI 10.1023/B:APPT.0000025810.58981.4c; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Corcoran CA, 2006, CANCER BIOL THER, V5, P1610, DOI 10.4161/cbt.5.12.3617; Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Daosukho C, 2005, FREE RADICAL BIO MED, V39, pS150; Ding H, 2010, BBA-GEN SUBJECTS, V1800, P250, DOI 10.1016/j.bbagen.2009.08.007; Donahue RJ, 2001, FASEB J, V15, P635, DOI 10.1096/fj.00-0262com; Dyachenko V, 2006, EXP GERONTOL, V41, P489, DOI 10.1016/j.exger.2006.03.003; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fattoretti P, 2004, ANN NY ACAD SCI, V1030, P303, DOI 10.1196/annals.1329.038; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Freisinger P, 2004, J INHERIT METAB DIS, V27, P67, DOI 10.1023/B:BOLI.0000016614.47380.2f; Garcia-Roves PM, 2006, AM J PHYSIOL-ENDOC M, V290, pE1172, DOI 10.1152/ajpendo.00633.2005; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Hao JJ, 2009, J CELL MOL MED, V13, P701, DOI 10.1111/j.1582-4934.2008.00342.x; Holley AK, 2010, ANN NY ACAD SCI, V1201, P72, DOI 10.1111/j.1749-6632.2010.05612.x; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hood DA, 2010, BBA-BIOENERGETICS, V1797, P106, DOI 10.1016/j.bbabio.2010.04.321; Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Johnson WT, 2008, J NUTR, V138, P1269, DOI 10.1093/jn/138.7.1269; Johnson WT, 2007, J NUTR BIOCHEM, V18, P97, DOI 10.1016/j.jnutbio.2006.03.005; Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; Koopman R, 2006, AM J PHYSIOL-ENDOC M, V290, pE1245, DOI 10.1152/ajpendo.00530.2005; Kuo WW, 2005, J BIOMED SCI, V12, P601, DOI 10.1007/s11373-005-7373-2; Leary SC, 2007, CELL METAB, V5, P9, DOI 10.1016/j.cmet.2006.12.001; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Liu JF, 2008, FEBS LETT, V582, P1319, DOI 10.1016/j.febslet.2008.03.013; Liu JK, 2009, ADV DRUG DELIVER REV, V61, P1343, DOI 10.1016/j.addr.2009.06.007; Liu JK, 2005, NUTR NEUROSCI, V8, P67, DOI 10.1080/10284150500047161; Ljubicic V, 2010, MECH AGEING DEV, V131, P79, DOI 10.1016/j.mad.2009.12.004; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; MARINGARCIA J, 1994, J MOL CELL CARDIOL, V26, P1029, DOI 10.1006/jmcc.1994.1123; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nemajerova A, 2005, FEBS LETT, V579, P6079, DOI 10.1016/j.febslet.2005.09.074; Ojaimi J, 1999, ANN NEUROL, V46, P656, DOI 10.1002/1531-8249(199910)46:4<656::AID-ANA16>3.3.CO;2-H; Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310; Ren JC, 2010, BIOCHEM BIOPH RES CO, V401, P64, DOI 10.1016/j.bbrc.2010.09.009; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Smith JAH, 2007, AM J PHYSIOL-ENDOC M, V292, pE413, DOI 10.1152/ajpendo.00142.2006; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015; Vesela K, 2008, APMIS, V116, P41, DOI 10.1111/j.1600-0463.2008.00772.x; Vina J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006; Wadley GD, 2010, J APPL PHYSIOL, V108, P1719, DOI 10.1152/japplphysiol.00127.2010; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Zhang XD, 2010, ACTA PHARMACOL SIN, V31, P1208, DOI 10.1038/aps.2010.151; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zuo XA, 2010, CARDIOVASC TOXICOL, V10, P208, DOI 10.1007/s12012-010-9080-0	65	23	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21140	10.1371/journal.pone.0021140	http://dx.doi.org/10.1371/journal.pone.0021140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750704	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400002
J	Yao, J; Chen, SH; Mao, ZS; Cadenas, E; Brinton, RD				Yao, Jia; Chen, Shuhua; Mao, Zisu; Cadenas, Enrique; Brinton, Roberta Diaz			2-Deoxy-D-Glucose Treatment Induces Ketogenesis, Sustains Mitochondrial Function, and Reduces Pathology in Female Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							A-BETA-DEPOSITION; CALORIC RESTRICTION; DIETARY RESTRICTION; GLUCOSE-METABOLISM; AMYLOID-BETA; AEROBIC GLYCOLYSIS; ENERGY-METABOLISM; COGNITIVE DECLINE; BRAIN; 2-DEOXYGLUCOSE	Previously, we demonstrated that mitochondrial bioenergetic deficits preceded Alzheimer's disease (AD) pathology in the female triple-transgenic AD (3xTgAD) mouse model. In parallel, 3xTgAD mice exhibited elevated expression of ketogenic markers, indicating a compensatory mechanism for energy production in brain. This compensatory response to generate an alternative fuel source was temporary and diminished with disease progression. To determine whether this compensatory alternative fuel system could be sustained, we investigated the impact of 2-deoxy-D-glucose (2-DG), a compound known to induce ketogenesis, on bioenergetic function and AD pathology burden in brain. 6-month-old female 3xTgAD mice were fed either a regular diet (AIN-93G) or a diet containing 0.04% 2-DG for 7 weeks. 2-DG diet significantly increased serum ketone body level and brain expression of enzymes required for ketone body metabolism. The 2-DG-induced maintenance of mitochondrial bioenergetics was paralleled by simultaneous reduction in oxidative stress. Further, 2-DG treated mice exhibited a significant reduction of both amyloid precursor protein (APP) and amyloid beta (A beta) oligomers, which was paralleled by significantly increased alpha-secretase and decreased gamma-secretase expression, indicating that 2-DG induced a shift towards a non-amyloidogenic pathway. In addition, 2-DG increased expression of genes involved in A beta clearance pathways, degradation, sequestering, and transport. Concomitant with increased bioenergetic capacity and reduced beta-amyloid burden, 2-DG significantly increased expression of neurotrophic growth factors, BDNF and NGF. Results of these analyses demonstrate that dietary 2-DG treatment increased ketogenesis and ketone metabolism, enhanced mitochondrial bioenergetic capacity, reduced beta-amyloid generation and increased mechanisms of beta-amyloid clearance. Further, these data link bioenergetic capacity with beta-amyloid generation and demonstrate that beta-amyloid burden was dynamic and reversible, as 2-DG reduced activation of the amyloidogenic pathway and increased mechanisms of beta-amyloid clearance. Collectively, these data provide preclinical evidence for dietary 2-DG as a disease-modifying intervention to delay progression of bioenergetic deficits in brain and associated b-amyloid burden.	[Yao, Jia; Chen, Shuhua; Mao, Zisu; Cadenas, Enrique; Brinton, Roberta Diaz] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Brinton, Roberta Diaz] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Yao, J (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	rbrinton@usc.edu		Brinton, Roberta/0000-0001-8450-772X	National Institute on Aging [2R01AG032236, 5P01AG026572]; Eileen L. Norris Foundation; NATIONAL INSTITUTE ON AGING [R01AG032236, P01AG026572] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eileen L. Norris Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported herein was supported by National Institute on Aging Grant 2R01AG032236 (to RDB), National Institute on Aging Grant 5P01AG026572 (Project 1 to EC and RDB) and Eileen L. Norris Foundation (to RDB). The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	AUESTAD N, 1991, J NEUROCHEM, V56, P1376, DOI 10.1111/j.1471-4159.1991.tb11435.x; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blass JP, 2000, ANN NY ACAD SCI, V903, P204, DOI 10.1111/j.1749-6632.2000.tb06370.x; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Brinton RD, 2008, ADV DRUG DELIVER REV, V60, P1504, DOI 10.1016/j.addr.2008.06.003; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; CHEN K, 2011, NEUROIMAGE; Corona C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017971; Costantini LC, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S16; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Dwarakanath BS, 2009, J CANCER RES THER, V5, P21, DOI 10.4103/0973-1482.55136; Fischer PM, 2008, NAT CHEM BIOL, V4, P448, DOI 10.1038/nchembio0808-448; Frier B, 2005, EXP GERONTOL, V40, P615, DOI 10.1016/j.exger.2005.04.011; Gasior M, 2006, BEHAV PHARMACOL, V17, P431, DOI 10.1097/00008877-200609000-00009; Guzman M, 2004, PROSTAG LEUKOTR ESS, V70, P287, DOI 10.1016/j.plefa.2003.05.001; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; HOYER S, 1991, ANN NY ACAD SCI, V640, P53, DOI 10.1111/j.1749-6632.1991.tb00190.x; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Ishii K, 1997, J NUCL MED, V38, P925; KERN KA, 1987, SURGERY, V102, P380; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P212, DOI 10.1016/j.bbadis.2009.10.007; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Mosconi L, 2005, EUR J NUCL MED MOL I, V32, P486, DOI [10.1007/s00259-008-1039-z, 10.1007/s00259-005-1762-7]; Mosconi L, 2008, NEUROBIOL AGING, V29, P676, DOI 10.1016/j.neurobiolaging.2006.12.008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Santos RX, 2010, INT J CLIN EXP PATHO, V3, P570; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wan RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1186, DOI 10.1152/ajpheart.00932.2003; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yao J, 2010, BBA-GEN SUBJECTS, V1800, P1121, DOI 10.1016/j.bbagen.2010.06.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2	59	104	108	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21788	10.1371/journal.pone.0021788	http://dx.doi.org/10.1371/journal.pone.0021788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747957	Green Submitted, Green Published, gold			2022-12-25	WOS:000292293400033
J	Williams, JL; Ellers-Kirk, C; Orth, RG; Gassmann, AJ; Head, G; Tabashnik, BE; Carriere, Y				Williams, Jennifer L.; Ellers-Kirk, Christa; Orth, Robert G.; Gassmann, Aaron J.; Head, Graham; Tabashnik, Bruce E.; Carriere, Yves			Fitness Cost of Resistance to Bt Cotton Linked with Increased Gossypol Content in Pink Bollworm Larvae	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; INSECT RESISTANCE; HOST-PLANT; HELICOVERPA-ARMIGERA; HELIOTHIS-VIRESCENS; TOXIN CRY1AC; CADHERIN; LEPIDOPTERA; CROPS; GELECHIIDAE	Fitness costs of resistance to Bacillus thuringiensis (Bt) crops occur in the absence of Bt toxins, when individuals with resistance alleles are less fit than individuals without resistance alleles. As costs of Bt resistance are common, refuges of non-Bt host plants can delay resistance not only by providing susceptible individuals to mate with resistant individuals, but also by selecting against resistance. Because costs typically vary across host plants, refuges with host plants that magnify costs or make them less recessive could enhance resistance management. Limited understanding of the physiological mechanisms causing fitness costs, however, hampers attempts to increase costs. In several major cotton pests including pink bollworm (Pectinophora gossypiella), resistance to Cry1Ac cotton is associated with mutations altering cadherin proteins that bind this toxin in susceptible larvae. Here we report that the concentration of gossypol, a cotton defensive chemical, was higher in pink bollworm larvae with cadherin resistance alleles than in larvae lacking such alleles. Adding gossypol to the larval diet decreased larval weight and survival, and increased the fitness cost affecting larval growth, but not survival. Across cadherin genotypes, the cost affecting larval growth increased as the gossypol concentration of larvae increased. These results suggest that increased accumulation of plant defensive chemicals may contribute to fitness costs associated with resistance to Bt toxins.	[Williams, Jennifer L.; Ellers-Kirk, Christa; Gassmann, Aaron J.; Tabashnik, Bruce E.; Carriere, Yves] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Orth, Robert G.; Head, Graham] Monsanto LLC, St Louis, MO USA; [Gassmann, Aaron J.] Iowa State Univ, Dept Entomol, Ames, IA USA	University of Arizona; Monsanto; Iowa State University	Williams, JL (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	ycarrier@ag.arizona.edu		Head, Graham/0000-0003-0521-0616	USDA [2003-04371]; Cotton Foundation; Cotton Inc.; National Cotton Council; Monsanto; Dow AgroSciences	USDA(United States Department of Agriculture (USDA)); Cotton Foundation; Cotton Inc.; National Cotton Council; Monsanto; Dow AgroSciences	This research was partly funded by USDA Biotechnology Risk Assessment Research Grant 2003-04371 (http://www.csrees.usda.gov/fo/biotechnologyriskassessment.cfm). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BE Tabashnik received support for research that is not related to this publication from the following sources: Cotton Foundation, Cotton Inc., National Cotton Council, Monsanto, and Dow AgroSciences. Tabashnik is also co-author of a patent application on engineering modified Bt toxins to counter pest resistance, which is related to research described by Soberon et al. (2007, Science 318: 1640-1642). Robert G. Orth and Graham Head are employed by a commercial company, Monsanto LLC, which provides transgenic crops for the control of pests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ADKISSON PL, 1960, J ECON ENTOMOL, V53, P759, DOI 10.1093/jee/53.5.759; Bagla P, 2010, SCIENCE, V327, P1439, DOI 10.1126/science.327.5972.1439; Bird LJ, 2007, BIOL CONTROL, V40, P196, DOI 10.1016/j.biocontrol.2006.11.004; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Carriere Y, 2005, J ECON ENTOMOL, V98, P947, DOI 10.1603/0022-0493-98.3.947; Carriere Y, 2004, J ECON ENTOMOL, V97, P1710, DOI 10.1603/0022-0493-97.5.1710; Carriere Y, 2001, P ROY SOC B-BIOL SCI, V268, P1475, DOI 10.1098/rspb.2001.1689; Carriere Y, 2006, J ECON ENTOMOL, V99, P1925, DOI 10.1603/0022-0493-99.6.1925; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Carriere Y, 2009, J INSECT PHYSIOL, V55, P1058, DOI 10.1016/j.jinsphys.2009.07.013; Committee on the Impact of Biotechnology on Farm-Level Economics and Sustainability and The National Research Council T, 2010, IMP GEN ENG CROPS FA; Crowder DW, 2009, J THEOR BIOL, V261, P423, DOI 10.1016/j.jtbi.2009.08.017; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Falconer D. S., 1981, INTRO QUANTITATIVE G; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2006, J ECON ENTOMOL, V99, P920, DOI 10.1603/0022-0493-99.3.920; Gassmann AJ, 2009, ANNU REV ENTOMOL, V54, P147, DOI 10.1146/annurev.ento.54.110807.090518; Gould F, 2006, J ECON ENTOMOL, V99, P2091, DOI 10.1603/0022-0493-99.6.2091; GRAHAM HM, 1971, J ECON ENTOMOL, V64, P376, DOI 10.1093/jee/64.2.376; Higginson DM, 2005, EVOLUTION, V59, P915, DOI 10.1111/j.0014-3820.2005.tb01765.x; Hill E, 2001, J MOL BIOL, V305, P1011, DOI 10.1006/jmbi.2000.4361; Hron RJ, 1999, J AM OIL CHEM SOC, V76, P1351, DOI 10.1007/s11746-999-0149-5; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Janmaat AF, 2005, P ROY SOC B-BIOL SCI, V272, P1031, DOI 10.1098/rspb.2004.3040; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Midboe EG, 2003, COMP BIOCHEM PHYS B, V135, P125, DOI 10.1016/S1096-4959(03)00054-X; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Onstad D. W., 2008, INSECT RESISTANCE MA; Orth RG, 2007, J CHEM ECOL, V33, P1131, DOI 10.1007/s10886-007-9284-3; Ramsey F. L., 2002, STAT SLEUTH COURSE M; Raymond B, 2007, BIOL LETT-UK, V3, P82, DOI 10.1098/rsbl.2006.0560; SAS, 2008, JMP 8 0; Schlichting K, 2006, J CELL SCI, V119, P1184, DOI 10.1242/jcs.02831; SHAVER T N, 1970, Journal of Economic Entomology, V63, P1802; Stipanovic RD, 2008, ENVIRON ENTOMOL, V37, P1081, DOI 10.1603/0046-225X(2008)37[1081:EORAGO]2.0.CO;2; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Tabashnik BE, 2000, P NATL ACAD SCI USA, V97, P12980, DOI 10.1073/pnas.97.24.12980; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005	46	38	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21863	10.1371/journal.pone.0021863	http://dx.doi.org/10.1371/journal.pone.0021863			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738799	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800050
J	Zhang, R; Jongejans, E; Shea, K				Zhang, Rui; Jongejans, Eelke; Shea, Katriona			Warming Increases the Spread of an Invasive Thistle	PLOS ONE			English	Article							SPECIES SUCCESS; CLIMATE-CHANGE; ELEVATED CO2; DISPERSAL; DISTANCE; CONSEQUENCES; DEMOGRAPHY; VELOCITY; GROWTH	Background: Global warming and shifted precipitation regimes increasingly affect species abundances and distributions worldwide. Despite a large literature on species' physiological, phenological, growth, and reproductive responses to such climate change, dispersal is rarely examined. Our study aims to test whether the dispersal ability of a non-native, wind-dispersed plant species is affected by climate change, and to quantify the ramifications for future invasion spread rates. Methodology/Principal Findings: We experimentally increased temperature and precipitation in a two-cohort, factorial field study (n = 80). We found an overwhelming warming effect on plant life history: warming not only improved emergence, survival, and reproduction of the thistle Carduus nutans, but also elevated plant height, which increased seed dispersal distances. Using spatial population models, we demonstrate that these empirical warming effects on demographic vital rates, and dispersal parameters, greatly exacerbate spatial spread. Predicted levels of elevated winter precipitation decreased seed production per capitulum, but this only slightly offset the warming effect on spread. Using a spread rate decomposition technique (c*-LTRE), we also found that plant height-mediated changes in dispersal contribute most to increased spread rate under climate change. Conclusions/Significance: We found that both dispersal and spread of this wind-dispersed plant species were strongly impacted by climate change. Dispersal responses to climate change can improve, or diminish, a species' ability to track climate change spatially, and should not be overlooked. Methods that combine both demographic and dispersal responses thus will be an invaluable complement to projections of suitable habitat under climate change.	[Zhang, Rui; Shea, Katriona] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Jongejans, Eelke] Radboud Univ Nijmegen, Dept Expt Plant Ecol, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Radboud University Nijmegen	Zhang, R (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	ruz104@psu.edu	Jongejans, Eelke/B-4832-2008; Shea, Katriona/B-7954-2008	Jongejans, Eelke/0000-0003-1148-7419; Shea, Katriona/0000-0002-7607-8248	National Science Foundation [DEB-0815373]; Netherlands Organisation for Scientific Research [863.08.006]; Direct For Biological Sciences [0815373] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a National Science Foundation grant (DEB-0815373) to KS and a Netherlands Organisation for Scientific Research veni-grant (863.08.006) to EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Chen M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024535; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Dukes JS, 2002, PLANT ECOL, V160, P225, DOI 10.1023/A:1015813919850; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Frumhoff PC, 2007, CONFRONTING CLIMATE; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Jeltsch F, 2008, PERSPECT PLANT ECOL, V9, P171, DOI 10.1016/j.ppees.2007.11.004; Jongejans E, 2008, J ECOL, V96, P687, DOI 10.1111/j.1365-2745.2008.01367.x; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Kuparinen A, 2009, P ROY SOC B-BIOL SCI, V276, P3081, DOI 10.1098/rspb.2009.0693; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Marchetto KM, 2010, ECOL RES, V25, P83, DOI 10.1007/s11284-009-0634-1; Matlack GR, 2004, J ECOL, V92, P1025, DOI 10.1111/j.0022-0477.2004.00908.x; MCCARTY MK, 1985, WEED SCI, V33, P664, DOI 10.1017/S0043174500083053; Molgaard, 1996, INT TUNDRA EXPT MANU; Nagel JM, 2004, ECOLOGY, V85, P100, DOI 10.1890/02-3005; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Polley HW, 2003, PLANT ECOL, V164, P85, DOI 10.1023/A:1021271226866; R Development Core Team, 2009, R FDN STAT COMP; Shea K, 2010, ECOL APPL, V20, P1148, DOI 10.1890/09-0316.1; Skarpaas O, 2007, AM NAT, V170, P421, DOI 10.1086/519854; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; Soons MB, 2008, J ECOL, V96, P581, DOI 10.1111/j.1365-2745.2008.01370.x; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Ziska LH, 2003, J EXP BOT, V54, P395, DOI 10.1093/jxb/erg027	37	25	25	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21725	10.1371/journal.pone.0021725	http://dx.doi.org/10.1371/journal.pone.0021725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738779	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100065
J	Lladser, ME; Gouet, R; Reeder, J				Lladser, Manuel E.; Gouet, Raul; Reeder, Jens			Extrapolation of Urn Models via Poissonization: Accurate Measurements of the Microbial Unknown	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; PROBABILITY; NUMBER; POPULATION; DIVERSITY; COVERAGE	The availability of high-throughput parallel methods for sequencing microbial communities is increasing our knowledge of the microbial world at an unprecedented rate. Though most attention has focused on determining lower-bounds on the a-diversity i.e. the total number of different species present in the environment, tight bounds on this quantity may be highly uncertain because a small fraction of the environment could be composed of a vast number of different species. To better assess what remains unknown, we propose instead to predict the fraction of the environment that belongs to unsampled classes. Modeling samples as draws with replacement of colored balls from an urn with an unknown composition, and under the sole assumption that there are still undiscovered species, we show that conditionally unbiased predictors and exact prediction intervals (of constant length in logarithmic scale) are possible for the fraction of the environment that belongs to unsampled classes. Our predictions are based on a Poissonization argument, which we have implemented in what we call the Embedding algorithm. In fixed i.e. non-randomized sample sizes, the algorithm leads to very accurate predictions on a sub-sample of the original sample. We quantify the effect of fixed sample sizes on our prediction intervals and test our methods and others found in the literature against simulated environments, which we devise taking into account datasets from a human-gut and -hand microbiota. Our methodology applies to any dataset that can be conceptualized as a sample with replacement from an urn. In particular, it could be applied, for example, to quantify the proportion of all the unseen solutions to a binding site problem in a random RNA pool, or to reassess the surveillance of a certain terrorist group, predicting the conditional probability that it deploys a new tactic in a next attack.	[Lladser, Manuel E.] Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA; [Gouet, Raul] Univ Chile, Ctr Modelamiento Matemat CNRS UMI 2807, Santiago, Chile; [Reeder, Jens] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universidad de Chile; University of Colorado System; University of Colorado Boulder	Lladser, ME (corresponding author), Univ Colorado, Dept Appl Math, Boulder, CO 80309 USA.	manuel.lladser@colorado.edu	Gouet, Raul/I-6302-2016; Lladser, Manuel/O-7557-2019	Gouet, Raul/0000-0003-3125-6773; Lladser, Manuel/0000-0001-6843-6845	NASA [ROSES NNX08AP60G]; NIH [R01 HG004872]; FONDAP; BASAL-CMM; Fondecyt [1090216]; German Academic Exchange Service (DAAD); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FONDAP; BASAL-CMM(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	M. Lladser was partially supported by NASA ROSES NNX08AP60G and NIH R01 HG004872. R. Gouet was supported by FONDAP, BASAL-CMM and Fondecyt 1090216. J. Reeder was supported by a post-doctoral scholarship from the German Academic Exchange Service (DAAD). M. Lladser and R. Gouet are thankful to the project Nucleo Milenio Informacion y Aleatoriedad, which facilitated a research visit to collaborate in person. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M., 1964, HDB MATH FUNCTIONS F; Aldous D. J., 1988, PROBABILITY APPROXIM; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CLAYTON MK, 1987, J AM STAT ASSOC, V82, P305, DOI 10.2307/2289168; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; Durrett R., 1999, ESSENTIALS STOCHASTI; ESTY WW, 1983, ANN STAT, V11, P905, DOI 10.1214/aos/1176346256; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hinsley F.H, 1993, CODEBREAKERS INSIDE; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Hwang HK, 2008, ANN PROBAB, V36, P992, DOI 10.1214/07-AOP350; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MAHMOUD HM, 2000, WIL INT S D, pR11; Mao CX, 2007, ANN STAT, V35, P917, DOI 10.1214/009053606000001280; Mao CX, 2002, BIOMETRIKA, V89, P669, DOI 10.1093/biomet/89.3.669; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STARR N, 1979, ANN STAT, V7, P644, DOI 10.1214/aos/1176344684; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322	30	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21105	10.1371/journal.pone.0021105	http://dx.doi.org/10.1371/journal.pone.0021105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738613	Green Submitted, gold, Green Published			2022-12-25	WOS:000292142800013
J	Downs, LM; Wallin-Hakansson, B; Boursnell, M; Marklund, S; Hedhammar, A; Truve, K; Hubinette, L; Lindblad-Toh, K; Bergstrom, T; Mellersh, CS				Downs, Louise M.; Wallin-Hakansson, Berit; Boursnell, Mike; Marklund, Stefan; Hedhammar, Ake; Truve, Katarina; Hubinette, Louise; Lindblad-Toh, Kerstin; Bergstrom, Tomas; Mellersh, Cathryn S.			A Frameshift Mutation in Golden Retriever Dogs with Progressive Retinal Atrophy Endorses SLC4A3 as a Candidate Gene for Human Retinal Degenerations	PLOS ONE			English	Article							CONE-ROD DYSTROPHY; RETINITIS-PIGMENTOSA; CARBONIC-ANHYDRASE; CONGENITAL AMAUROSIS; BICARBONATE; TRANSPORT; DYSPLASIA; EXCHANGER; BLINDNESS; AE1	Progressive retinal atrophy (PRA) in dogs, the canine equivalent of retinitis pigmentosa (RP) in humans, is characterised by vision loss due to degeneration of the photoreceptor cells in the retina, eventually leading to complete blindness. It affects more than 100 dog breeds, and is caused by numerous mutations. RP affects 1 in 4000 people in the Western world and 70% of causal mutations remain unknown. Canine diseases are natural models for the study of human diseases and are becoming increasingly useful for the development of therapies in humans. One variant, prcd-PRA, only accounts for a small proportion of PRA cases in the Golden Retriever (GR) breed. Using genome-wide association with 27 cases and 19 controls we identified a novel PRA locus on CFA37 (p(raw) = 1.94x10(-10), p(genome) = 1.0x10(-5)), where a 644 kb region was homozygous within cases. A frameshift mutation was identified in a solute carrier anion exchanger gene (SLC4A3) located within this region. This variant was present in 56% of PRA cases and 87% of obligate carriers, and displayed a recessive mode of inheritance with full penetrance within those lineages in which it segregated. Allele frequencies are approximately 4% in the UK, 6% in Sweden and 2% in France, but the variant has not been found in GRs from the US. A large proportion of cases (approximately 44%) remain unexplained, indicating that PRA in this breed is genetically heterogeneous and caused by at least three mutations. SLC4A3 is important for retinal function and has not previously been associated with spontaneously occurring retinal degenerations in any other species, including humans.	[Downs, Louise M.; Boursnell, Mike; Mellersh, Cathryn S.] Anim Hlth Trust, Canine Genet, Newmarket, Suffolk, England; [Wallin-Hakansson, Berit] Swedish Kennel Club SKK, Stockholm, Sweden; [Hedhammar, Ake] Swedish Univ Agr Sci SLU, Dept Clin Sci, Uppsala, Sweden; [Marklund, Stefan; Truve, Katarina; Hubinette, Louise; Bergstrom, Tomas] Swedish Univ Agr Sci SLU, Dept Anim Breeding & Genet, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Lindblad-Toh, Kerstin] Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA USA	Animal Health Trust; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Downs, LM (corresponding author), Anim Hlth Trust, Canine Genet, Newmarket, Suffolk, England.	louise.downs@aht.org.uk	; Bergstrom, Tomas/B-4681-2017	Truve, Katarina/0000-0002-2449-8283; Hedhammar, Ake/0000-0001-7048-3851; Burmeister, Louise/0000-0002-6551-055X; Bergstrom, Tomas/0000-0002-7480-2669; Boursnell, Mike/0000-0002-2554-8190	Kennel Club Charitable Trust; European Commission [GA-201370]; Swedish Kennel Club; European Science Foundation; Guide Dogs for the Blind Association	Kennel Club Charitable Trust; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Kennel Club; European Science Foundation(European Science Foundation (ESF)European Commission); Guide Dogs for the Blind Association	Supported by funding from the Kennel Club Charitable Trust, the European Commission (FP7-LUPA, GA-201370), the Research Fund of the Swedish Kennel Club, the European Science Foundation, the Guide Dogs for the Blind Association and donations from dog owners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre G D, 1998, Mol Vis, V4, P23; Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; Alper SL, 2002, J NEPHROL, V15, pS41; Alvarez BV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000839; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Beggs AH, 2010, P NATL ACAD SCI USA, V107, P14697, DOI 10.1073/pnas.1003677107; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Dahl NK, 2003, J BIOL CHEM, V278, P44949, DOI 10.1074/jbc.M308660200; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Dekomien G, 2000, CYTOGENET CELL GENET, V90, P261, DOI 10.1159/000056785; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GRONDAHL J, 1987, CLIN GENET, V31, P255; HAIM M, 1992, ACTA OPHTHALMOL, V70, P178; KANNER BI, 1993, SOC GEN PHY, V48, P243; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; KOBAYASHI S, 1994, J NEUROSCI, V14, P6266; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; Kukekova AV, 2009, MAMM GENOME, V20, P109, DOI 10.1007/s00335-008-9163-4; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; NEWMAN EA, 1991, GLIA, V4, P424, DOI 10.1002/glia.440040411; *OPTIGEN, 2008, PRA GOLD RETR; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; PARRY HB, 1953, BRIT J OPHTHALMOL, V37, P487, DOI 10.1136/bjo.37.8.487; PATTERSON DF, 1993, AM J HUM GENET, V52, P388; Petersen-Jones S, 2005, J SMALL ANIM PRACT, V46, P371, DOI 10.1111/j.1748-5827.2005.tb00333.x; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rozen S, 2000, Methods Mol Biol, V132, P365; Seddon JM, 2006, ANIM GENET, V37, P407, DOI 10.1111/j.1365-2052.2006.01484.x; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sterling D, 2001, JOP, V2, P165; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vince JW, 2000, BIOCHEMISTRY-US, V39, P5527, DOI 10.1021/bi992564p; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; WINKLER BS, 1977, INVEST OPHTH VIS SCI, V16, P766; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993; Zhang Q, 1998, GENE, V215, P231, DOI 10.1016/S0378-1119(98)00310-2	43	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21452	10.1371/journal.pone.0021452	http://dx.doi.org/10.1371/journal.pone.0021452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738669	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600042
J	Lecomte, N; Ahlstrom, O; Ehrich, D; Fuglei, E; Ims, RA; Yoccoz, NG				Lecomte, Nicolas; Ahlstrom, Oystein; Ehrich, Dorothee; Fuglei, Eva; Ims, Rolf A.; Yoccoz, Nigel G.			Intrapopulation Variability Shaping Isotope Discrimination and Turnover: Experimental Evidence in Arctic Foxes	PLOS ONE			English	Article							STABLE-CARBON ISOTOPES; LABORATORY EXPERIMENTS; FACTORS DELTA-N-15; ANIMAL-TISSUES; MIXING MODELS; CONSUMER-DIET; AVIAN BLOOD; FRACTIONATION; DELTA-C-13; NITROGEN	Background: Tissue-specific stable isotope signatures can provide insights into the trophic ecology of consumers and their roles in food webs. Two parameters are central for making valid inferences based on stable isotopes, isotopic discrimination difference in isotopic ratio between consumer and its diet) and turnover time (renewal process of molecules in a given tissue usually measured when half of the tissue composition has changed). We investigated simultaneously the effects of age, sex, and diet types on the variation of discrimination and half-life in nitrogen and carbon stable isotopes (delta(15)N and delta(13)C, respectively) in five tissues (blood cells, plasma, muscle, liver, nail, and hair) of a top predator, the arctic fox Vulpes lagopus. Methodology/Principal Findings: We fed 40 farmed foxes (equal numbers of adults and yearlings of both sexes) with diet capturing the range of resources used by their wild counterparts. We found that, for a single species, six tissues, and three diet types, the range of discrimination values can be almost as large as what is known at the scale of the whole mammalian or avian class. Discrimination varied depending on sex, age, tissue, and diet types, ranging from 0.3 parts per thousand to 5.3 parts per thousand (mean = 2.6%) for delta(15)N and from 0.2 parts per thousand to 2.9 parts per thousand (mean = 0.9%) for delta(13)C. We also found an impact of population structure on delta(15)N half-life in blood cells. Varying across individuals, delta(15)N half-life in plasma (6 to 10 days) was also shorter than for delta(13)C (14 to 22 days), though delta(15)N and delta(13)C half-lives are usually considered as equal. Conclusion/Significane: Overall, our multi-factorial experiment revealed that at least six levels of isotopic variations could co-occur in the same population. Our experimental analysis provides a framework for quantifying multiple sources of variation in isotopic discrimination and half-life that needs to be taken into account when designing and analysing ecological field studies.	[Lecomte, Nicolas; Ehrich, Dorothee; Ims, Rolf A.; Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Ahlstrom, Oystein] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway; [Fuglei, Eva] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian University of Life Sciences; Norwegian Polar Institute	Lecomte, N (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	nicolas.lecomte@uit.no	Yoccoz, Nigel/C-8561-2014; Ehrich, Dorothee/F-6492-2015	Yoccoz, Nigel/0000-0003-2192-1039; Ehrich, Dorothee/0000-0002-3028-9488; Lecomte, Nicolas/0000-0002-8473-5375	Norwegian Polar Institute; Norwegian Research Council; Norwegian University of Life Science; University of Tromso	Norwegian Polar Institute; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian University of Life Science; University of Tromso	This work was supported by (alphabetical order): Norwegian Polar Institute, Norwegian Research Council through the International Polar Year project "Arctic Predators" (http://www.arctic-predators.uit.no), Norwegian University of Life Science, and University of Tromso. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLSTROM O, 1995, ACTA AGR SCAND A-AN, V45, P74, DOI 10.1080/09064709509410916; Auerswald K, 2010, J APPL ECOL, V47, P936, DOI 10.1111/j.1365-2664.2009.01764.x; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Bearhop S, 2000, AUK, V117, P504, DOI 10.1642/0004-8038(2000)117[0504:IOLAUA]2.0.CO;2; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Burnham K. P., 1998, MODEL SELECTION INFE; Carleton SA, 2008, RAPID COMMUN MASS SP, V22, P3008, DOI 10.1002/rcm.3691; Carleton SA, 2010, FUNCT ECOL, V24, P805, DOI 10.1111/j.1365-2435.2010.01700.x; Caut S, 2008, CAN J ZOOL, V86, P438, DOI 10.1139/Z08-012; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2010, J APPL ECOL, V47, P948, DOI 10.1111/j.1365-2664.2010.01832.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cherry SG, 2011, J APPL ECOL, V48, P373, DOI 10.1111/j.1365-2664.2010.01908.x; Dalerum F, 2005, OECOLOGIA, V144, P647, DOI 10.1007/s00442-005-0118-0; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Elsdon TS, 2010, MAR ECOL PROG SER, V408, P195, DOI 10.3354/meps08518; Felicetti LA, 2003, CAN J ZOOL, V81, P763, DOI [10.1139/z03-054, 10.1139/Z03-054]; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Haramis GM, 2001, AUK, V118, P1008, DOI 10.1642/0004-8038(2001)118[1008:SIAOCW]2.0.CO;2; Henden JA, 2008, J APPL ECOL, V45, P1086, DOI 10.1111/j.1365-2664.2008.01515.x; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2003, CAN J ZOOL, V81, P1630, DOI 10.1139/Z03-140; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Kery M., 2010, INTRO WINBUGS ECOLOG; Klaassen M, 2010, FUNCT ECOL, V24, P796, DOI 10.1111/j.1365-2435.2010.01689.x; Matthews B, 2008, FRESHWATER BIOL, V53, P1942, DOI 10.1111/j.1365-2427.2008.02018.x; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Newsome SD, 2010, ECOL APPL, V20, P1744, DOI 10.1890/09-1502.1; Overman NC, 2001, CAN J FISH AQUAT SCI, V58, P1253, DOI 10.1139/cjfas-58-6-1253; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINHEIRO JC, 2006, IME LINEAR NONLINEAR; Podlesak DW, 2006, PHYSIOL BIOCHEM ZOOL, V79, P534, DOI 10.1086/502813; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; R Development Core Team, 2010, LANG ENV STAT COMP V; Reichlin TS, 2010, DIVERS DISTRIB, V16, P643, DOI 10.1111/j.1472-4642.2010.00664.x; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Roth JD, 2002, OECOLOGIA, V133, P70, DOI 10.1007/s00442-002-1004-7; Sakano H, 2005, ENVIRON BIOL FISH, V72, P13, DOI 10.1007/s10641-004-4187-4; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; Spence KO, 2005, OECOLOGIA, V146, P89, DOI 10.1007/s00442-005-0170-9; SPRINSON DB, 1949, J BIOL CHEM, V180, P715; SUTOH M, 1987, RADIOISOTOPES; Tarroux A, 2010, METHODS ECOL EVOL, V1, P231, DOI 10.1111/j.2041-210X.2010.00033.x; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Trueman CN, 2005, RAPID COMMUN MASS SP, V19, P3239, DOI 10.1002/rcm.2199; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Yoccoz N.G., 1991, B ECOL SOC AM, V72, P106; Zilversmit DB, 1943, J GEN PHYSIOL, V26, P325, DOI 10.1085/jgp.26.3.325	61	50	50	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21357	10.1371/journal.pone.0021357	http://dx.doi.org/10.1371/journal.pone.0021357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731715	Green Submitted, Green Published, gold			2022-12-25	WOS:000292035400028
J	Vestergaard, P; Stoen, OG; Swenson, JE; Mosekilde, L; Heickendorff, L; Frobert, O				Vestergaard, Peter; Stoen, Ole-Gunnar; Swenson, Jon E.; Mosekilde, Leif; Heickendorff, Lene; Frobert, Ole			Vitamin D Status and Bone and Connective Tissue Turnover in Brown Bears (Ursus arctos) during Hibernation and the Active State	PLOS ONE			English	Article							SPINAL-CORD-INJURY; DISUSE OSTEOPOROSIS; MAMMALIAN HIBERNATION; PARATHYROID-HORMONE; METABOLISM; FRACTURES; OSTEOCALCIN; AMERICANUS; CALCIUM; SKIN	Background: Extended physical inactivity causes disuse osteoporosis in humans. In contrast, brown bears (Ursus arctos) are highly immobilised for half of the year during hibernation without signs of bone loss and therefore may serve as a model for prevention of osteoporosis. Aim: To study 25-hydroxy-vitamin D (25OHD) levels and bone turnover markers in brown bears during the hibernating state in winter and during the active state in summer. We measured vitamin D subtypes (D(2) and D(3)), calcitropic hormones (parathyroid hormone [PTH], 1,25-dihydroxy-vitamin D [1,25(OH)(2)D]) and bone turnover parameters (osteocalcin, ICTP, CTX-I), PTH, serum calcium and PIIINP. Material and Methods: We drew blood from seven immobilised wild brown bears during hibernation in February and in the same bears while active in June. Results: Serum 25-hydroxy-cholecalciferol (25OHD(3)) was significantly higher in the summer than in the winter (22.8 +/- 4.6 vs. 8.8 +/- 2.1 nmol/l, two tailed p - 2p = 0.02), whereas 25-hydroxy-ergocalciferol (25OHD(2)) was higher in winter (54.2 +/- 8.3 vs. 18.7 +/- 1.7 nmol/l, 2p < 0.01). Total serum calcium and PTH levels did not differ between winter and summer. Activated 1,25(OH)(2)D demonstrated a statistically insignificant trend towards higher summer levels. Osteocalcin levels were higher in summer than winter, whereas other markers of bone turnover (ICTP and CTX-I) were unchanged. Serum PIIINP, which is a marker of connective tissue and to some degree muscle turnover, was significantly higher during summer than during winter. Conclusions: Dramatic changes were documented in the vitamin D(3)/D(2) ratio and in markers of bone and connective tissue turnover in brown bears between hibernation and the active state. Because hibernating brown bears do not develop disuse osteoporosis, despite extensive physical inactivity we suggest that they may serve as a model for the prevention of this disease.	[Vestergaard, Peter] Aarhus Univ Hosp, Osteoporosis Clin, DK-8000 Aarhus, Denmark; [Stoen, Ole-Gunnar; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Mosekilde, Leif] Aarhus Univ Hosp THG, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Heickendorff, Lene] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden	Aarhus University; Norwegian University of Life Sciences; Norwegian Institute Nature Research; Aarhus University; Aarhus University; Orebro University	Vestergaard, P (corresponding author), Aarhus Univ Hosp, Osteoporosis Clin, DK-8000 Aarhus, Denmark.	p-vest@post4.tele.dk	Swenson, Jon/E-2883-2013; Swenson, Jon/AAE-2890-2019; Støen, Ole-Gunnar/AAY-6457-2020	Frobert, Ole/0000-0002-5846-345X	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management, WWF Sweden; Research Council of Norway; Norwegian Institute for Nature Research	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management, WWF Sweden; Research Council of Norway(Research Council of Norway); Norwegian Institute for Nature Research(Bioforsk)	The Scandinavian Brown Bear Research Project was funded by the Swedish Environmental Protection Agency, the Norwegian Directorate for Nature Management, the Swedish Association for Hunting and Wildlife Management, WWF Sweden, the Research Council of Norway and the Norwegian Institute for Nature Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON A S, 1961, Arch Phys Med Rehabil, V42, P147; [Anonymous], 2007, HDB WILDLIFE CHEM IM; Camacho PM, 2008, CLIN CHEM LAB MED, V46, P1345, DOI 10.1515/CCLM.2008.310; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Crissey S, 2001, COMP BIOCHEM PHYS A, V128, P155, DOI 10.1016/S1095-6433(00)00289-0; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; Donahue SW, 2006, J EXP BIOL, V209, P1630, DOI 10.1242/jeb.02185; Fan L, 2008, J FOOD SCI, V73, pM292, DOI 10.1111/j.1750-3841.2008.00838.x; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; FLOYD T, 1990, CLIN ORTHOP RELAT R, P301; Friebe A, 2001, URSUS-SERIES, V12, P37; Frobert O, 2010, THROMB J, V8, DOI 10.1186/1477-9560-8-11; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Harcourt-Brown F, 2002, TXB RABBIT MED; Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230; HERMINGHUYSEN D, 1995, PHYSIOL BEHAV, V57, P271, DOI 10.1016/0031-9384(94)00246-2; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Holick MF, 2003, J CELL BIOCHEM, V88, P296, DOI 10.1002/jcb.10338; HORST RL, 1984, ARCH BIOCHEM BIOPHYS, V231, P67, DOI 10.1016/0003-9861(84)90363-1; Hymoller L, 2010, J DAIRY SCI, V93, P2025, DOI 10.3168/jds.2009-2991; Imel EA, 2010, J CLIN ENDOCR METAB, V95, P1846, DOI 10.1210/jc.2009-1671; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Leventis P, 2009, SCAND J RHEUMATOL, V38, P149, DOI 10.1080/03009740802419081; Lin RC, 2005, VET SURG, V34, P358, DOI 10.1111/j.1532-950X.2005.00055.x; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; Mcgee ME, 2008, BONE, V42, P396, DOI 10.1016/j.bone.2007.10.010; McGee ME, 2007, J ANAT, V210, P160, DOI 10.1111/j.1469-7580.2006.00681.x; McGee-Lawrence ME, 2009, BONE, V45, P1186, DOI 10.1016/j.bone.2009.08.011; McGee-Lawrence ME, 2009, J BIOMECH, V42, P1378, DOI 10.1016/j.jbiomech.2008.11.039; McGee-Lawrence ME, 2008, AM J PHYSIOL-REG I, V295, pR1999, DOI 10.1152/ajpregu.90648.2008; MCGRAW RL, 1994, CALCIFIED TISSUE INT, V55, P87, DOI 10.1007/BF00297180; Mechanick JI, 1997, ARCH PHYS MED REHAB, V78, P692, DOI 10.1016/S0003-9993(97)90075-7; NEWLANDER JA, 1952, J ANIM SCI, V11, P419, DOI 10.2527/jas1952.112419x; NIELSEN HK, 1991, J BONE MINER RES, V6, P435; PATTERSON G, 1999, PHYSL BIOCH STEROLS, V1; Persson IL, 2001, WILDLIFE BIOL, V7, P27, DOI 10.2981/wlb.2001.006; SCHNEIDER VS, 1993, ACTA ASTRONAUT, V29, P139, DOI 10.1016/0094-5765(93)90031-Q; SCHWARZ P, 1994, EUR J CLIN INVEST, V24, P553, DOI 10.1111/j.1365-2362.1994.tb01106.x; Sondergaard K, 1997, BRIT J DERMATOL, V136, P47, DOI 10.1046/j.1365-2133.1997.d01-1141.x; SORENSEN FB, 1990, EUR J CLIN INVEST, V20, P330; Vestergaard P, 1998, SPINAL CORD, V36, P790, DOI 10.1038/sj.sc.3100648	42	28	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21483	10.1371/journal.pone.0021483	http://dx.doi.org/10.1371/journal.pone.0021483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731765	Green Published, gold			2022-12-25	WOS:000292035400043
J	Cavassani, KA; Tristao, FSM; Oliveira, LL; Rocha, FA; Vancim, JO; Moreira, AP; Campanelli, AP; Panagio, LA; Milanezi, CM; Martinez, R; Rossi, MA; Silva, JS				Cavassani, Karen A.; Tristao, Fabrine S. M.; Oliveira, Leandro L.; Rocha, Fernanda A.; Vancim, Jaqueline O.; Moreira, Ana Paula; Campanelli, Ana Paula; Panagio, Luciano A.; Milanezi, Cristiane M.; Martinez, Roberto; Rossi, Marcos A.; Silva, Joao S.			Cell-Free Antigens from Paracoccidioides brasiliensis Drive IL-4 Production and Increase the Severity of Paracoccidioidomycosis	PLOS ONE			English	Article							RADIOATTENUATED YEAST-CELLS; PULMONARY PARACOCCIDIOIDOMYCOSIS; BALB/C MICE; IMMUNE-RESPONSE; IFN-GAMMA; INFECTION; MACROPHAGES; GLYCOPROTEIN; IMMUNIZATION; CYTOKINES	The thermally dimorphic fungus Paracoccidioides brasiliensis (Pb) is the causative agent of paracoccidioidomycosis (PCM), one of the most frequent systemic mycosis that affects the rural population in Latin America. PCM is characterized by a chronic inflammatory granulomatous reaction, which is consequence of a Th1-mediated adaptive immune response. In the present study we investigated the mechanisms involved in the immunoregulation triggered after a prior contact with cell-free antigens (CFA) during a murine model of PCM. The results showed that the inoculation of CFA prior to the infection resulted in disorganized granulomatous lesions and increased fungal replication in the lungs, liver and spleen, that paralleled with the higher levels of IL-4 when compared with the control group. The role of IL-4 in facilitating the fungal growth was demonstrated in IL-4-deficient- and neutralizing anti-IL-4 mAb-treated mice. The injection of CFA did not affect the fungal growth in these mice, which, in fact, exhibited a significant diminished amount of fungus in the tissues and smaller granulomas. Considering that in vivo anti-IL-4-application started one week after the CFA-inoculum, it implicates that IL-4-CFA-induced is responsible by the mediation of the observed unresponsiveness. Further, the characterization of CFA indicated that a proteic fraction is required for triggering the immunosuppressive mechanisms, while glycosylation or glycosphingolipids moieties are not. Taken together, our data suggest that the prior contact with soluble Pb antigens leads to severe PCM in an IL-4 dependent manner.	[Cavassani, Karen A.; Tristao, Fabrine S. M.; Rocha, Fernanda A.; Vancim, Jaqueline O.; Moreira, Ana Paula; Panagio, Luciano A.; Milanezi, Cristiane M.; Martinez, Roberto; Rossi, Marcos A.; Silva, Joao S.] Univ Sao Paulo, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Oliveira, Leandro L.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Sao Paulo, Brazil; [Campanelli, Ana Paula] Univ Sao Paulo, Sch Dent Bauru, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Cavassani, KA (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Sao Paulo, Brazil.	jsdsilva@fmrp.usp.br	Tristao, Fabrine/K-6590-2013; Campanelli, Ana Paula/B-9144-2012; Panagio, Luciano Aparecido/V-3027-2019; de Oliveira, Leandro Licursi/D-3616-2009; Silva, Joao/A-4484-2008	Panagio, Luciano Aparecido/0000-0002-2484-3147; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Silva, Joao/0000-0002-3410-3927; Campanelli, Ana Paula/0000-0002-0536-5469	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); National Counsel of Technological and Scientific Development (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and National Counsel of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SR, 1998, MED MYCOL, V36, P405, DOI 10.1080/02681219880000641; Arruda C, 2004, INFECT IMMUN, V72, P3932, DOI 10.1128/IAI.72.7.3932-3940.2004; Soares RDA, 2008, INFECT IMMUN, V76, P4214, DOI 10.1128/IAI.00753-07; Benard G, 1997, J INFECT DIS, V175, P1263, DOI 10.1086/593694; Benard G, 2001, CYTOKINE, V13, P248, DOI 10.1006/cyto.2000.0824; Bertini S, 2007, CLIN VACCINE IMMUNOL, V14, P150, DOI 10.1128/CVI.00285-06; Borges-Walmsley MI, 2002, TRENDS MICROBIOL, V10, P80, DOI 10.1016/S0966-842X(01)02292-2; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Calich VLG, 1998, BRAZ J MED BIOL RES, V31, P615, DOI 10.1590/S0100-879X1998000500003; CALICH VLG, 1979, CLIN IMMUNOL IMMUNOP, V12, P20, DOI 10.1016/0090-1229(79)90108-9; CAMARGO ZP, 1991, J MED VET MYCOL, V29, P31; Campanelli AP, 2003, J INFECT DIS, V187, P1496, DOI 10.1086/374646; Cano LE, 1998, INFECT IMMUN, V66, P800, DOI 10.1128/IAI.66.2.800-806.1998; CASOTTO M, 1990, J CLIN MICROBIOL, V28, P1188, DOI 10.1128/JCM.28.6.1188-1193.1990; Cenci E, 1999, J INFECT DIS, V180, P1957, DOI 10.1086/315142; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; COSTA TA, 2005, 9 INT M PAR AG DE LI, P29; Coutinho Ziadir Francisco, 2002, Cad. Saúde Pública, V18, P1441, DOI 10.1590/S0102-311X2002000500037; Martins EMD, 2009, MYCOPATHOLOGIA, V168, P51, DOI 10.1007/s11046-009-9197-5; Ferreira KS, 2006, IMMUNOL LETT, V103, P121, DOI 10.1016/j.imlet.2005.10.014; Ferreira KS, 2003, SCAND J IMMUNOL, V58, P290, DOI 10.1046/j.1365-3083.2003.01291.x; FIGUEROA JI, 1994, J CLIN MICROBIOL, V32, P1566, DOI 10.1128/JCM.32.6.1566-1574.1994; Franco MF., 1989, BAILLIERE CLIN TROP, V4, P185, DOI DOI 10.1590/S0036-46651994000100017; JIMENEZFINKEL BE, 1988, INFECT IMMUN, V56, P734, DOI 10.1128/IAI.56.4.734-743.1988; Karhawi ASK, 2000, MED MYCOL, V38, P225, DOI 10.1080/714030939; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; Livonesi MC, 2008, MED MYCOL, V46, P637, DOI 10.1080/13693780801982762; Livonesi MC, 2009, MICROBES INFECT, V11, P123, DOI 10.1016/j.micinf.2008.10.015; Martins EMDN, 2007, VACCINE, V25, P7893, DOI 10.1016/j.vaccine.2007.09.011; MCEWEN JG, 1987, J MED VET MYCOL, V25, P165; Moreira AP, 2010, CELL IMMUNOL, V263, P196, DOI 10.1016/j.cellimm.2010.03.016; MOSCARDIBACCHI M, 1994, J MED MICROBIOL, V40, P159, DOI 10.1099/00222615-40-3-159; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Peracoli MTS, 2003, MICROBES INFECT, V5, P413, DOI 10.1016/S1286-4579(03)00040-6; Pina A, 2004, INFECT IMMUN, V72, P2369, DOI 10.1128/IAI.72.4.2369-2378.2004; Popi AF, 2002, CELL IMMUNOL, V218, P87, DOI 10.1016/S0008-8749(02)00576-2; PUCCIA R, 1986, INFECT IMMUN, V53, P199, DOI 10.1128/IAI.53.1.199-206.1986; Restrepo A, 2001, MED MYCOL, V39, P233, DOI 10.1080/714031028; RESTREPO A, 1985, SABOURAUDIA, V23, P323; Restrepo-Moreno Angela, 1993, P251; RODRIGUES EG, 1994, J MED VET MYCOL, V32, P77; Saraiva ECO, 1996, J MED VET MYCOL, V34, P155; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; Taborda CP, 1998, INFECT IMMUN, V66, P786, DOI 10.1128/IAI.66.2.786-793.1998; Wang WX, 2002, PLANT PHYSIOL, V130, P865, DOI 10.1104/pp.002436; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21423	10.1371/journal.pone.0021423	http://dx.doi.org/10.1371/journal.pone.0021423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731741	gold, Green Submitted, Green Published			2022-12-25	WOS:000292033700081
J	Hao, DC; Ge, GB; Xiao, PG; Zhang, YY; Yang, L				Hao, Da Cheng; Ge, GuangBo; Xiao, PeiGen; Zhang, YanYan; Yang, Ling			The First Insight into the Tissue Specific Taxus Transcriptome via Illumina Second Generation Sequencing	PLOS ONE			English	Article							TAXOL BIOSYNTHESIS; RNA-SEQ; DNA; IDENTIFICATION; VISUALIZATION; CHLOROPLAST; DISCOVERY; GENOMICS; NEEDLES; TOOL	Background: Illumina second generation sequencing is now an efficient route for generating enormous sequence collections that represent expressed genes and quantitate expression level. Taxus is a world-wide endangered gymnosperm genus and forms an important anti-cancer medicinal resource, but the large and complex genomes of Taxus have hindered the development of genomic resources. The research of its tissue-specific transcriptome is absent. There is also no study concerning the association between the plant transcriptome and metabolome with respect to the plant tissue type. Methodology/Principal Findings: We performed the de novo assembly of Taxus mairei transcriptome using Illumina paired-end sequencing technology. In a single run, we produced 13,737,528 sequencing reads corresponding to 2.03 Gb total nucleotides. These reads were assembled into 36,493 unique sequences. Based on similarity search with known proteins, 23,515 Unigenes were identified to have the Blast hit with a cut-off E-value above 10(-5). Furthermore, we investigated the transcriptome difference of three Taxus tissues using a tag-based digital gene expression system. We obtained a sequencing depth of over 3.15 million tags per sample and identified a large number of genes associated with tissue specific functions and taxane biosynthetic pathway. The expression of the taxane biosynthetic genes is significantly higher in the root than in the leaf and the stem, while high activity of taxane-producing pathway in the root was also revealed via metabolomic analyses. Moreover, many antisense transcripts and novel transcripts were found; clusters with similar differential expression patterns, enriched GO terms and enriched metabolic pathways with regard to the differentially expressed genes were revealed for the first time. Conclusions/Significance: Our data provides the most comprehensive sequence resource available for Taxus study and will help define mechanisms of tissue specific functions and secondary metabolism in non-model plant organisms.	[Hao, Da Cheng] Dalian Jiaotong Univ, Inst Biotechnol, Dalian, Peoples R China; [Ge, GuangBo; Zhang, YanYan; Yang, Ling] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China; [Xiao, PeiGen] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China	Dalian Jiaotong University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS	Hao, DC (corresponding author), Dalian Jiaotong Univ, Inst Biotechnol, Dalian, Peoples R China.	hao@djtu.edu.cn; yling@dicp.ac.cn	Yang, Ling/F-5472-2012	ling, yang/0000-0001-7093-5926	Ministry of Science and Technology of China [2009AA02Z205]; Chinese Academy of Sciences [KSCX2-YW-G-050]; National Natural Science Foundation of China [30973590]; National Key Technology R&D Program in the 11th Five Year Plan of China [2008ZX10208]; China Postdoctoral Science Foundation [20080440019, 200902069]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program in the 11th Five Year Plan of China(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by the 863 program (2009AA02Z205) of the Ministry of Science and Technology of China, the Key Direction Program (KSCX2-YW-G-050) of the Chinese Academy of Sciences, the National Natural Science Foundation of China (30973590), the National Key Technology R&D Program in the 11th Five Year Plan of China (2008ZX10208), and the China Postdoctoral Science Foundation (20080440019 and 200902069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croteau Rodney, 2006, Phytochemistry Reviews, V5, P75, DOI 10.1007/s11101-005-3748-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fu CH, 2011, PLANT CELL PHYSIOL, V52, P238, DOI 10.1093/pcp/pcq201; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ge GB, 2008, PLANTA MED, V74, P773, DOI 10.1055/s-2008-1074531; Ge GB, 2008, RAPID COMMUN MASS SP, V22, P2315, DOI 10.1002/rcm.3616; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hampel D, 2009, ARCH BIOCHEM BIOPHYS, V487, P91, DOI 10.1016/j.abb.2009.05.018; Hao DC, 2008, PLANT SYST EVOL, V276, P89, DOI 10.1007/s00606-008-0069-0; Hao DC, 2008, BIOL PHARM BULL, V31, P260, DOI 10.1248/bpb.31.260; Hao DC, 2011, MOL GENET GENOMICS, V285, P197, DOI 10.1007/s00438-010-0598-4; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2003, ARCH BIOCHEM BIOPHYS, V413, P262, DOI 10.1016/S0003-9861(03)00090-0; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kaspera Rudiger, 2006, Phytochemistry Reviews, V5, P433, DOI 10.1007/s11101-006-9006-4; Ketchum REB, 2003, PHYTOCHEMISTRY, V62, P901, DOI 10.1016/S0031-9422(02)00711-2; Kingston DGI, 2001, CHEM COMMUN, P867, DOI 10.1039/b100070p; Lee EK, 2010, NAT BIOTECHNOL, V28, P1213, DOI 10.1038/nbt.1693; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Long RM, 2005, BIOCHEM BIOPH RES CO, V338, P410, DOI 10.1016/j.bbrc.2005.08.119; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mizrachi E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-681; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Morrissy S., 2010, CURR PROTOC HUM GENE; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; van Rozendaal ELM, 2000, PHYTOCHEMISTRY, V53, P383, DOI 10.1016/S0031-9422(99)00094-1; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wu Q, 2011, PLANTA MED, V77, P394, DOI 10.1055/s-0030-1250331; Xu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-540; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	40	134	164	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21220	10.1371/journal.pone.0021220	http://dx.doi.org/10.1371/journal.pone.0021220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731678	gold, Green Submitted, Green Published			2022-12-25	WOS:000292033700049
J	Zimmermann, HW; Seidler, S; Gassler, N; Nattermann, J; Luedde, T; Trautwein, C; Tacke, F				Zimmermann, Henning W.; Seidler, Sebastian; Gassler, Nikolaus; Nattermann, Jacob; Luedde, Tom; Trautwein, Christian; Tacke, Frank			Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis	PLOS ONE			English	Article							ALCOHOLIC HEPATITIS; NEUTROPHILIC INFILTRATION; MONOCYTE SUBSETS; CXC CHEMOKINES; EXPRESSION; INJURY; RECEPTORS; CIRRHOSIS; CELLS; RECRUITMENT	Background: Interleukin-8 (IL-8, CXCL8) is a potent chemoattractant for neutrophils and contributes to acute liver inflammation. Much less is known about IL-8 in chronic liver diseases (CLD), but elevated levels were reported from alcoholic and hepatitis C-related CLD. We investigated the regulation of IL-8, its receptors CXCR1 and CXCR2 and possible IL-8 responding cells in CLD patients. Methodology: Serum IL-8 levels were measured in CLD patients (n = 200) and healthy controls (n = 141). Intrahepatic IL-8, CXCR1 and CXCR2 gene expression was quantified from liver samples (n = 41), alongside immunohistochemical neutrophil (MPO) and macrophage (CD68) stainings. CXCR1 and CXCR2 expression was analyzed on purified monocytes from patients (n = 111) and controls (n = 31). In vitro analyses explored IL-8 secretion by different leukocyte subsets. Principal Findings: IL-8 serum levels were significantly increased in CLD patients, especially in end-stage cirrhosis. Interestingly, patients with cholestatic diseases exhibited highest IL-8 serum concentrations. IL-8 correlated with liver function, inflammatory cytokines and non-invasive fibrosis markers. Intrahepatically, IL-8 and CXCR1 expression were strongly up-regulated. However, intrahepatic IL-8 could only be associated to neutrophil infiltration in patients with primary biliary cirrhosis (PBC). In non-cholestatic cirrhosis, increased IL-8 and CXCR1 levels were associated with hepatic macrophage accumulation. In line, CXCR1, but not CXCR2 or CXCR3, expression was increased on circulating monocytes from cirrhotic patients. Moreover, monocyte-derived macrophages from CLD patients, especially the non-classical CD16(+) subtype, displayed enhanced IL-8 secretion in vitro. Conclusions: IL-8 is strongly activated in CLD, thus likely contributing to hepatic inflammation. Our study suggests a novel role of IL-8 for recruitment and activation of hepatic macrophages via CXCR1 in human liver cirrhosis.	[Zimmermann, Henning W.; Seidler, Sebastian; Luedde, Tom; Trautwein, Christian; Tacke, Frank] Univ Hosp, Dept Med 3, Aachen, Germany; [Gassler, Nikolaus] Univ Hosp, Inst Pathol, Aachen, Germany; [Nattermann, Jacob] Univ Bonn, Dept Med 1, D-5300 Bonn, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Bonn	Zimmermann, HW (corresponding author), Univ Hosp, Dept Med 3, Aachen, Germany.	frank.tacke@gmx.net	Luedde, Tom/AAE-9135-2022; Tacke, Frank/ABF-2212-2020	Luedde, Tom/0000-0002-6288-8821; 	German Research Foundation [DFG Ta434/2-1, DFG SFB/TRR 57]; RWTH-Aachen University	German Research Foundation(German Research Foundation (DFG)); RWTH-Aachen University	This work was supported by the German Research Foundation (DFG Ta434/2-1, DFG SFB/TRR 57), and by the Start-Program for Young Investigators and Interdisciplinary Centre for Clinical Research (IZKF) at RWTH-Aachen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afford SC, 1998, J PATHOL, V186, P82, DOI 10.1002/(SICI)1096-9896(199809)186:1<82::AID-PATH151>3.0.CO;2-D; Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bautista AP, 2002, ALCOHOL, V27, P17, DOI 10.1016/S0741-8329(02)00206-9; Bonecchi R, 2000, J IMMUNOL, V164, P3862, DOI 10.4049/jimmunol.164.7.3862; CARRE PC, 1991, J CLIN INVEST, V88, P1802, DOI 10.1172/JCI115501; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Dominguez M, 2009, GASTROENTEROLOGY, V136, P1639, DOI 10.1053/j.gastro.2009.01.056; Emadi S, 2005, BLOOD, V105, P464, DOI 10.1182/blood-2003-12-4415; French SW, 2002, ALCOHOL, V27, P43, DOI 10.1016/S0741-8329(02)00205-7; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Hashimoto S, 1996, EXP HEMATOL, V24, P123; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; HILL DB, 1993, HEPATOLOGY, V18, P576, DOI 10.1016/0270-9139(93)90358-T; Huang YS, 1996, J HEPATOL, V24, P377, DOI 10.1016/S0168-8278(96)80156-5; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Isse K, 2007, LIVER INT, V27, P672, DOI 10.1111/j.1478-3231.2007.01465.x; Jaeschke H, 2002, ALCOHOL, V27, P23, DOI 10.1016/S0741-8329(02)00200-8; Jaeschke H, 2006, LIVER INT, V26, P912, DOI 10.1111/j.1478-3231.2006.01327.x; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; KAPLANSKI G, 1994, BLOOD, V84, P4242, DOI 10.1182/blood.V84.12.4242.bloodjournal84124242; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Kirsch R, 2000, J GASTROEN HEPATOL, V15, P1298, DOI 10.1046/j.1440-1746.2000.02232.x; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Marra F, 2009, SEMIN IMMUNOPATHOL, V31, P345, DOI 10.1007/s00281-009-0169-0; MATSUSHIMA K, 1989, CYTOKINE, V1, P1; MOROHASHI H, 1995, J LEUKOCYTE BIOL, V57, P180, DOI 10.1002/jlb.57.1.180; Motoo Yoshiharu, 2004, JOP, V5, P138; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Neugebauer H, 2008, LIVER INT, V28, P1149, DOI 10.1111/j.1478-3231.2008.01829.x; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Polyak SJ, 2001, J VIROL, V75, P6209, DOI 10.1128/JVI.75.13.6209-6211.2001; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Schauer IG, 2008, UROLOGY, V72, P205, DOI 10.1016/j.urology.2007.11.083; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Seidler S, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-30; Shawcross DI, 2008, HEPATOLOGY, V48, P1202, DOI 10.1002/hep.22474; TACKE F, 2011, LIVER INT IN PRESS; Tacke F, 2011, J GASTROEN HEPATOL, V26, P523, DOI 10.1111/j.1440-1746.2010.06436.x; TRITTO G, 2011, J HEPATOL IN PRESS; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	45	180	200	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21381	10.1371/journal.pone.0021381	http://dx.doi.org/10.1371/journal.pone.0021381			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731723	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700071
J	Goncalves, AMD; de Sanctis, D; McSweeney, SM				Goncalves, Ana Maria D.; de Sanctis, Daniele; McSweeney, Sean M.			Structural and Functional Insights into DR2231 Protein, the MazG-like Nucleoside Triphosphate Pyrophosphohydrolase from Deinococcus radiodurans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; NUCLEIC-ACIDS; RADIATION; DUTPASE; PYROPHOSPHATASE; PERSPECTIVE; MECHANISM; DEATH; ASSAY	Deinococcus radiodurans is among the very few bacterial species extremely resistant to ionizing radiation, UV light, oxidizing agents, and cycles of prolonged desiccation. The proteome of D. radiodurans reflects the evolutionary pressure exerted by chronic exposure to (nonradioactive) forms of DNA and protein damage. A clear example of this adaptation is the overrepresentation of protein families involved in the removal of non-canonical nucleoside triphosphates (NTPs) whose incorporation into nascent DNA would promote mutagenesis and DNA damage. The three-dimensional structure of the DR2231 protein has been solved at 1.80A resolution. This protein had been classified as an all-alpha-helical MazG-like protein. The present study confirms that it holds the basic structural module characteristic of the MazG superfamily; two helices form a rigid domain, and two helices form a mobile domain and connecting loops. Contrary to what is known of MazG proteins, DR2231 protein shows a functional affinity with dUTPases. Enzymatic and isothermal calorimetry assays have demonstrated high specificity toward dUTP but an inability to hydrolyze dTTP, a typical feature of dUTPases. Co-crystallization with the product of hydrolysis, dUMP, in the presence of magnesium or manganese cations, suggests similarities with the dUTP/dUDP hydrolysis mechanism reported for dimeric dUTPases. The genome of D. radiodurans encodes for all enzymes required for dTTP synthesis from dCMP, thus bypassing the need of a dUTPase. We postulate that DR2231 protein is not essential to D. radiodurans and rather performs "house-cleaning" functions within the framework of oxidative stress response. We further propose DR2231 protein as an evolutionary precursor of dimeric dUTPases.	[Goncalves, Ana Maria D.; de Sanctis, Daniele; McSweeney, Sean M.] European Synchrotron Radiat Facil, Macromol Crystallog Grp, F-38043 Grenoble, France	European Synchrotron Radiation Facility (ESRF)	de Sanctis, D (corresponding author), European Synchrotron Radiat Facil, Macromol Crystallog Grp, Rue Jules Horowitz 6, F-38043 Grenoble, France.	daniele.de_sanctis@esrf.fr; seanmcs@esrf.fr	Domingues Gonçalves, Ana Maria/D-4542-2012	Domingues Gonçalves, Ana Maria/0000-0002-8714-8934	"Fundacao para a Ciencia e Tecnologia," Portugal [SFRH/BEST/15939/2005]; ESRF Structural Biology group at the ESRF beamlines	"Fundacao para a Ciencia e Tecnologia," Portugal(Portuguese Foundation for Science and Technology); ESRF Structural Biology group at the ESRF beamlines	Supported by "Fundacao para a Ciencia e Tecnologia," Portugal, Research Grant SFRH/BEST/15939/2005.; We acknowledge the High Throughput Crystallization (HTX) Laboratory (EMBL Grenoble, France) for access to the Cartesian PixSys and the support provided by the ESRF Structural Biology group at the ESRF beamlines and in the laboratory housed in the Carl-Ivar Branden building.	ALBAKRI GH, 1985, GENE, V33, P305, DOI 10.1016/0378-1119(85)90238-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bernier-Villamor V, 2002, FEBS LETT, V526, P147, DOI 10.1016/S0014-5793(02)03158-7; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Delano W. L., 2003, PYMOL MOL GENETICS G; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya H, 2003, NUCLEIC ACIDS RES, V31, P517, DOI 10.1093/nar/gkg137; Kang LW, 2003, J BACTERIOL, V185, P4110, DOI 10.1128/JB.185.14.4110-4118.2003; Koonin EV, 2000, BACTERIAL STRESS RESPONSES, P417; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee S, 2008, J BIOL CHEM, V283, P15232, DOI 10.1074/jbc.M800479200; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Makarova KS, 2000, GENETICA, V108, P25, DOI 10.1023/A:1004035424657; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moroz OV, 2004, J MOL BIOL, V342, P1583, DOI 10.1016/j.jmb.2004.07.050; Moroz OV, 2005, J MOL BIOL, V347, P243, DOI 10.1016/j.jmb.2005.01.030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musso-Buendia JA, 2009, J ENZYM INHIB MED CH, V24, P111, DOI 10.1080/14756360801915476 ; Nyman PO, 2001, CURR PROTEIN PEPT SC, V2, P277, DOI 10.2174/1389203013381071; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Quesada-Soriano I, 2008, BBA-PROTEINS PROTEOM, V1784, P1347, DOI 10.1016/j.bbapap.2008.05.014; Ranatunga W, 2004, J MOL BIOL, V339, P103, DOI 10.1016/j.jmb.2004.01.065; Robinson A, 2007, MOL MICROBIOL, V66, P610, DOI 10.1111/j.1365-2958.2007.05932.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Tellez-Sanz R, 2007, BIOCHIMIE, V89, P972, DOI 10.1016/j.biochi.2007.03.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Whittingham JL, 2005, STRUCTURE, V13, P329, DOI 10.1016/j.str.2004.11.015; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875; Zhang JJ, 2003, J BIOL CHEM, V278, P21408, DOI 10.1074/jbc.M213294200	58	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30691	30705		10.1074/jbc.M111.247999	http://dx.doi.org/10.1074/jbc.M111.247999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21733847	Green Published, hybrid			2022-12-25	WOS:000294283600049
J	Le Bihan-Duval, E; Nadaf, J; Berri, C; Pitel, F; Graulet, B; Godet, E; Leroux, SY; Demeure, O; Lagarrigue, S; Duby, C; Cogburn, LA; Beaumont, CM; Duclos, MJ				Le Bihan-Duval, Elisabeth; Nadaf, Javad; Berri, Cecile; Pitel, Frederique; Graulet, Benoit; Godet, Estelle; Leroux, Sophie Y.; Demeure, Olivier; Lagarrigue, Sandrine; Duby, Cecile; Cogburn, Larry A.; Beaumont, Catherine M.; Duclos, Michel J.			Detection of a Cis eQTL Controlling BMCO1 Gene Expression Leads to the Identification of a QTG for Chicken Breast Meat Color	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BETA-CAROTENE; BODY-COMPOSITION; MUSCLE GLYCOGEN; GROWTH CURVE; VITAMIN-A; SELECTION; QUALITY; ASTAXANTHIN; CONVERSION	Classical quantitative trait loci (QTL) analysis and gene expression QTL (eQTL) were combined to identify the causal gene (or QTG) underlying a highly significant QTL controlling the variation of breast meat color in a F2 cross between divergent high-growth (HG) and low-growth (LG) chicken lines. Within this meat quality QTL, BCMO1 (Accession number GenBank: AJ271386), encoding the beta-carotene 15, 15'-monooxygenase, a key enzyme in the conversion of beta-carotene into colorless retinal, was a good functional candidate. Analysis of the abundance of BCMO1 mRNA in breast muscle of the HG x LG F2 population allowed for the identification of a strong cis eQTL. Moreover, reevaluation of the color QTL taking BCMO1 mRNA levels as a covariate indicated that BCMO1 mRNA levels entirely explained the variations in meat color. Two fully-linked single nucleotide polymorphisms (SNP) located within the proximal promoter of BCMO1 gene were identified. Haplotype substitution resulted in a marked difference in BCMO1 promoter activity in vitro. The association study in the F2 population revealed a three-fold difference in BCMO1 expression leading to a difference of 1 standard deviation in yellow color between the homozygous birds at this haplotype. This difference in meat yellow color was fully consistent with the difference in carotenoid content (i.e. lutein and zeaxanthin) evidenced between the two alternative haplotypes. A significant association between the haplotype, the level of BCMO1 expression and the yellow color of the meat was also recovered in an unrelated commercial broiler population. The mutation could be of economic importance for poultry production by making possible a gene-assisted selection for color, a determining aspect of meat quality. Moreover, this natural genetic diversity constitutes a new model for the study of beta-carotene metabolism which may act upon diverse biological processes as precursor of the vitamin A.	[Le Bihan-Duval, Elisabeth; Nadaf, Javad; Berri, Cecile; Godet, Estelle; Beaumont, Catherine M.; Duclos, Michel J.] INRA, UR83, F-37380 Nouzilly, France; [Pitel, Frederique; Leroux, Sophie Y.] INRA, ENVT, Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France; [Graulet, Benoit] INRA, Herbivores UR1213, Ctr Clermont Ferrand Theix, F-63122 St Genes Champanelle, France; [Demeure, Olivier; Lagarrigue, Sandrine; Duby, Cecile] INRA, UMR Genet Anim 598, F-35042 Rennes, France; [Demeure, Olivier; Lagarrigue, Sandrine; Duby, Cecile] Agrocampus Ouest, UMR Genet Anim 598, Rennes, France; [Cogburn, Larry A.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA	INRAE; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE; INRAE; Institut Agro; Agrocampus Ouest; University of Delaware	Le Bihan-Duval, E (corresponding author), INRA, UR83, F-37380 Nouzilly, France.	lebihan@tours.inra.fr	Berri, Cécile/H-6409-2016; DUCLOS, Michel/AAQ-3957-2021; Pitel, Frédérique/C-2847-2009; , AGROCAMPUS OUEST/O-6651-2016	Berri, Cécile/0000-0002-3613-1825; DUCLOS, Michel/0000-0002-9305-3982; Pitel, Frédérique/0000-0002-1477-7633; Cogburn, Larry/0000-0003-0977-7580; Lagarrigue, Sandrine/0000-0002-4887-7245; , AGROCAMPUS OUEST/0000-0002-1800-4558	United States Department of Agriculture - Initiative for Future Agriculture and Food Systems [00-52100-9614]; AGENAE (France); INRA Departments of Animal Genetics and Animal Physiology (France); ANR [0426]	United States Department of Agriculture - Initiative for Future Agriculture and Food Systems(United States Department of Agriculture (USDA)); AGENAE (France); INRA Departments of Animal Genetics and Animal Physiology (France); ANR(French National Research Agency (ANR))	The creation of the original F2 resource population from the HG x LG intercross and the subsequent quantitative trait loci (QTL) analysis were funded by grants from the United States Department of Agriculture - Initiative for Future Agriculture and Food Systems Animal Genome Program [Grant # 00-52100-9614 to LAC], AGENAE (France) and INRA Departments of Animal Genetics and Animal Physiology (France). The expression QTL study was funded by a grant from the ANR Genanimal Program 2004 [Grant # 0426 to MD and SL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado CZ, 2007, POULTRY SCI, V86, P156, DOI 10.1093/ps/86.1.156; Beccavin C, 2001, J ENDOCRINOL, V168, P297, DOI 10.1677/joe.0.1680297; Berri C, 2005, BRIT POULTRY SCI, V46, P572, DOI 10.1080/00071660500303099; Berri C, 2001, POULTRY SCI, V80, P833, DOI 10.1093/ps/80.7.833; Biesalski HK, 2007, VITAM HORM, V75, P117, DOI 10.1016/S0083-6729(06)75005-1; Chauveau-Duriot B, 2010, ANAL BIOANAL CHEM, V397, P777, DOI 10.1007/s00216-010-3594-y; CHURCHILL GA, 1994, GENETICS, V138, P963; Duclos MJ, 1996, GROWTH REGULAT, V6, P176; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Fletcher D., 1999, POULTRY MEAT SCI, P159; Georges M, 2007, ANNU REV GENOM HUM G, V8, P131, DOI 10.1146/annurev.genom.8.080706.092408; Groenen MAM, 2000, GENOME RES, V10, P137; Groeneveld E., 1990, PEST USERS MANUAL; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Leung WC, 2009, FASEB J, V23, P1041, DOI 10.1096/fj.08-121962; Lietz G, 2010, ARCH BIOCHEM BIOPHYS, V502, P8, DOI 10.1016/j.abb.2010.06.032; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Mangin B, 1997, HEREDITY, V78, P345, DOI 10.1038/hdy.1997.57; Mignon-Grasteau S, 2001, POULTRY SCI, V80, P849, DOI 10.1093/ps/80.7.849; Mignon-Grasteu S, 1999, BRIT POULTRY SCI, V40, P44, DOI 10.1080/00071669987827; Moren M, 2002, FISH PHYSIOL BIOCHEM, V27, P71, DOI 10.1023/B:FISH.0000021819.46235.12; Nadaf J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-155; Nadaf J, 2009, PHYSIOL GENOMICS, V38, P241, DOI 10.1152/physiolgenomics.90384.2008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REMIGNON H, 1995, J MUSCLE RES CELL M, V16, P95, DOI 10.1007/BF00122527; RICARD F H, 1975, Annales de Genetique et de Selection Animale, V7, P427, DOI 10.1186/1297-9686-7-4-427; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Sangeetha RK, 2010, CAN J PHYSIOL PHARM, V88, P977, DOI [10.1139/Y10-074, 10.1139/y10-074]; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Sibut V, 2008, J ANIM SCI, V86, P2888, DOI 10.2527/jas.2008-1062	30	33	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e14825	10.1371/journal.pone.0014825	http://dx.doi.org/10.1371/journal.pone.0014825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750696	Green Published, Green Submitted, gold			2022-12-25	WOS:000292512000003
J	Hollenbach, JP; Resch, AM; Palakodeti, D; Graveley, BR; Heinen, CD				Hollenbach, Jessica P.; Resch, Alissa M.; Palakodeti, Dasaradhi; Graveley, Brenton R.; Heinen, Christopher D.			Loss of DNA Mismatch Repair Imparts a Selective Advantage in Planarian Adult Stem Cells	PLOS ONE			English	Article							METHYLATING AGENTS; GENE-EXPRESSION; CANCER; CHECKPOINT; MUTATION; IDENTIFICATION; REGENERATION; APOPTOSIS; BIOLOGY; MODELS	Lynch syndrome (LS) leads to an increased risk of early-onset colorectal and other types of cancer and is caused by germline mutations in DNA mismatch repair (MMR) genes. Loss of MMR function results in a mutator phenotype that likely underlies its role in tumorigenesis. However, loss of MMR also results in the elimination of a DNA damage-induced checkpoint/apoptosis activation barrier that may allow damaged cells to grow unchecked. A fundamental question is whether loss of MMR provides pre-cancerous stem cells an immediate selective advantage in addition to establishing a mutator phenotype. To test this hypothesis in an in vivo system, we utilized the planarian Schmidtea mediterranea which contains a significant population of identifiable adult stem cells. We identified a planarian homolog of human MSH2, a MMR gene which is mutated in 38% of LS cases. The planarian Smed-msh2 is expressed in stem cells and some progeny. We depleted Smed-msh2 mRNA levels by RNA-interference and found a striking survival advantage in these animals treated with a cytotoxic DNA alkylating agent compared to control animals. We demonstrated that this tolerance to DNA damage is due to the survival of mitotically active, MMR-deficient stem cells. Our results suggest that loss of MMR provides an in vivo survival advantage to the stem cell population in the presence of DNA damage that may have implications for tumorigenesis.	[Hollenbach, Jessica P.; Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA; [Hollenbach, Jessica P.; Heinen, Christopher D.] Univ Connecticut, Ctr Hlth, Ctr Mol Med, Farmington, CT USA; [Resch, Alissa M.; Palakodeti, Dasaradhi; Graveley, Brenton R.] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT USA	University of Connecticut; University of Connecticut; University of Connecticut	Hollenbach, JP (corresponding author), Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Farmington, CT 06030 USA.	cheinen@uchc.edu	Graveley, Brenton R/C-3108-2013	Graveley, Brenton/0000-0001-5777-5892	State of Connecticut Department of Public Health [2010-0088]; Raymond and Beverly Sackler Fund for the Arts and Sciences	State of Connecticut Department of Public Health; Raymond and Beverly Sackler Fund for the Arts and Sciences	This work was supported by the State of Connecticut Department of Public Health #2010-0088 (to CDH) and the Raymond and Beverly Sackler Fund for the Arts and Sciences (to BRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; de Wind N, 1998, CANCER RES, V58, P248; Edelmann L, 2004, AM J MED GENET C, V129C, P91, DOI 10.1002/ajmg.c.30021; Eisenhoffer GT, 2008, CELL STEM CELL, V3, P327, DOI 10.1016/j.stem.2008.07.002; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FOSTER JA, 1963, CANCER RES, V23, P300; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; HANDBERGTHORSAG.EF, 2008, BIOSCIENCE, V13, P6374; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Heinen CD, 2002, CANCER BIOL THER, V1, P477, DOI 10.4161/cbt.1.5.160; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin DP, 2004, CANCER RES, V64, P517, DOI 10.1158/0008-5472.CAN-03-2957; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Lynch H. T., 2003, HERED CANCER CLIN PR, V1, P7, DOI DOI 10.1186/1897-4287-1-1-7; Mastrocola AS, 2010, HUM MUTAT, V31, pE1699, DOI 10.1002/humu.21333; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Newmark PA, 2002, NAT REV GENET, V3, P210, DOI 10.1038/nrg759; Orii H, 2005, DEV GENES EVOL, V215, P143, DOI 10.1007/s00427-004-0460-y; Oviedo N. J., 2008, COLD SPRING HARBOR P; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pearson BJ, 2009, DEV DYNAM, V238, P443, DOI 10.1002/dvdy.21849; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102; Zhang H, 1999, CANCER RES, V59, P3021	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21808	10.1371/journal.pone.0021808	http://dx.doi.org/10.1371/journal.pone.0021808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747960	Green Published, gold, Green Submitted			2022-12-25	WOS:000292293400036
J	Izzotti, A; Longobardi, M; Cartiglia, C; Rathschuler, F; Sacca, SC				Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina; Rathschuler, Federico; Sacca, Sergio Claudio			Trabecular Meshwork Gene Expression after Selective Laser Trabeculoplasty	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; RANDOMIZED CLINICAL-TRIAL; AQUEOUS-HUMOR OUTFLOW; LAMINA-CRIBROSA CELLS; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; OXIDATIVE STRESS; IN-VITRO; DAMAGE	Background: Trabecular meshwork and Schlemm's canal are the tissues appointed to modulate the aqueous humour outflow from the anterior chamber. The impairment of their functions drives to an intraocular pressure increase. The selective laser trabeculoplasty is a laser therapy of the trabecular meshwork able to decrease intraocular pressure. The exact response mechanism to this treatment has not been clearly delineated yet. The herein presented study is aimed at studying the gene expression changes induced in trabecular meshwork cells by selective laser trabeculoplasty (SLT) in order to better understand the mechanisms subtending its efficacy. Methodology/Principal Findings: Primary human trabecular meshwork cells cultured in fibroblast medium underwent selective laser trabeculoplasty treatment. RNA was extracted from a pool of cells 30 minutes after treatment while the remaining cells were further cultured and RNA was extracted respectively 2 and 6 hours after treatment. Control cells stored in incubator in absence of SLT treatment were used as reference samples. Gene expression was evaluated by hybridization on miRNA-microarray and laser scanner analysis. Scanning electron microscopic examination was performed on 2 Trabecular meshwork samples after SLT at 4(th) and 6(th) hour from treatment. On the whole, selective laser trabeculoplasty modulates in trabecular meshwork the expression of genes involved in cell motility, intercellular connections, extracellular matrix production, protein repair, DNA repair, membrane repair, reactive oxygen species production, glutamate toxicity, antioxidant activities, and inflammation. Conclusions/Significance: SLT did not induce any phenotypic alteration in TM samples. TM is a complex tissue possessing a great variety of function pivotal for the active regulation of aqueous humour outflow from the anterior chamber. SLT is able to modulate these functions at the postgenomic molecular level without inducing damage either at molecular or phenotypic levels.	[Izzotti, Alberto; Longobardi, Mariagrazia; Cartiglia, Cristina] Univ Genoa, Fac Med, Dept Hlth Sci, Genoa, Italy; [Rathschuler, Federico; Sacca, Sergio Claudio] St Martino Hosp, Dept Head Neck Pathol, Ophthalmol Unit, Genoa, Italy	University of Genoa	Izzotti, A (corresponding author), Univ Genoa, Fac Med, Dept Hlth Sci, Genoa, Italy.	sergio.sacca@hsanmartino.it	Sacca, Sergio/D-5118-2018; Saccà, Sergio/AAG-3335-2019	Sacca, Sergio/0000-0001-6973-5978; Saccà, Sergio/0000-0001-6973-5978; izzotti, alberto/0000-0002-8588-0347	Glaucoma Foundation (New York, United States of America)	Glaucoma Foundation (New York, United States of America)	This study was supported by The Glaucoma Foundation (New York, United States of America). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Alvarado J, 1984, RECENT ADV GLAUCOMA, P3; Alvarado JA, 2005, BRIT J OPHTHALMOL, V89, P1500, DOI 10.1136/bjo.2005.081307; Alvarado Jorge A, 2005, Trans Am Ophthalmol Soc, V103, P148; Alvarado JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P731, DOI 10.1001/archophthalmol.2010.85; Balaratnasingam C, 2007, INVEST OPHTH VIS SCI, V48, P3632, DOI 10.1167/iovs.06-1002; Balaratnasingam C, 2008, BRAIN RES, V1244, P142, DOI 10.1016/j.brainres.2008.09.044; Borras T, 2003, PROG RETIN EYE RES, V22, P435, DOI 10.1016/S1350-9462(03)00018-1; BYLSMA SS, 1988, ARCH OPHTHALMOL-CHIC, V106, P544; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; Cvekl A, 2004, BIOESSAYS, V26, P374, DOI 10.1002/bies.20009; Cvenkel B, 2004, OPHTHALMOLOGICA, V218, P20, DOI 10.1159/000074562; Damji KF, 2006, BRIT J OPHTHALMOL, V90, P1490, DOI 10.1136/bjo.2006.098855; DEKATER AW, 1990, INVEST OPHTH VIS SCI, V31, P347; DUEKER DK, 1990, INVEST OPHTH VIS SCI, V31, P115; Epstein DL, 1997, INVEST OPHTH VIS SCI, V38, P1526; GAASTERLAND D, 1978, INVEST OPHTH VIS SCI, V17, P838; Goyal S, 2010, BRIT J OPHTHALMOL, V94, P1443, DOI 10.1136/bjo.2009.176024; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Guzey M, 2001, EUR J OPHTHALMOL, V11, P47, DOI 10.1177/112067210101100109; He Y, 2008, INVEST OPHTH VIS SCI, V49, P4912, DOI 10.1167/iovs.08-2192; Hof PR, 1998, EXP NEUROL, V153, P234, DOI 10.1006/exnr.1998.6881; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Izzotti A, 2004, FASEB J, V18, P1559, DOI 10.1096/fj.04-1877fje; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2010, J PROTEOME RES, V9, P4831, DOI 10.1021/pr1005372; Izzotti A, 1999, MUTAT RES-GEN TOX EN, V446, P215, DOI 10.1016/S1383-5718(99)00189-8; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; Izzotti A, 2009, BRAIN PATHOL, V19, P650, DOI 10.1111/j.1750-3639.2008.00229.x; Kaufman PL, 2008, EXP EYE RES, V86, P3, DOI 10.1016/j.exer.2007.10.007; Keller KE, 2007, INVEST OPHTH VIS SCI, V48, P1164, DOI 10.1167/iovs.06-0875; Kirwan RP, 2005, MOL VIS, V11, P798; Kompass KS, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-93; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lanzetta P, 1999, BRIT J OPHTHALMOL, V83, P29, DOI 10.1136/bjo.83.1.29; Latina MA, 1998, OPHTHALMOLOGY, V105, P2082, DOI 10.1016/S0161-6420(98)91129-0; Li GR, 2007, MOL VIS, V13, P2282; Luna C, 2009, MOL VIS, V15, P2488; Luna C, 2009, MOL VIS, V15, P534; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; Okuno T, 2006, EXP EYE RES, V82, P465, DOI 10.1016/j.exer.2005.08.004; Osborne NN, 2010, EXP EYE RES, V90, P750, DOI 10.1016/j.exer.2010.03.008; PARSHLEY DE, 1995, CURR EYE RES, V14, P537, DOI 10.3109/02713689508998400; Parshley DE, 1996, INVEST OPHTH VIS SCI, V37, P795; Read AT, 2007, EXP EYE RES, V84, P213, DOI 10.1016/j.exer.2006.10.001; Roedl JB, 2007, J NEURAL TRANSM, V114, P445, DOI 10.1007/s00702-006-0556-9; SACCA S, 1991, ALTERNATIVE LASER TR; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; SACCA SC, 2009, MUTAT RES, V667, P698; SACCA SC, 1991, B OCUL S5, V70, P323; Shifera AS, 2010, EXP EYE RES, V91, P42, DOI 10.1016/j.exer.2010.04.001; Singh K, 2009, CURR OPIN OPHTHALMOL, V20, P84, DOI 10.1097/ICU.0b013e328324e6c4; SMITH PJ, 1986, AM J VET RES, V47, P2445; Steely HT, 2000, EXP EYE RES, V70, P17, DOI 10.1006/exer.1999.0764; Vittal V, 2005, INVEST OPHTH VIS SCI, V46, P2857, DOI 10.1167/iovs.05-0075; Wiederholt M, 1998, Curr Opin Ophthalmol, V9, P46, DOI 10.1097/00055735-199804000-00009; Wiederholt M, 2000, PROG RETIN EYE RES, V19, P271, DOI 10.1016/S1350-9462(99)00015-4; WISE JB, 1979, ARCH OPHTHALMOL-CHIC, V97, P319, DOI 10.1001/archopht.1979.01020010165017; Wood JPM, 2010, LASER SURG MED, V42, P326, DOI 10.1002/lsm.20907; Wordinger R, 2002, MOL VIS, V8, P241; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029; Zode GS, 2007, INVEST OPHTH VIS SCI, V48, P5058, DOI 10.1167/iovs.07-0127	65	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e20110	10.1371/journal.pone.0020110	http://dx.doi.org/10.1371/journal.pone.0020110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747927	Green Published, Green Submitted, gold			2022-12-25	WOS:000292293400002
J	Kyme, AZ; Zhou, VW; Meikle, SR; Baldock, C; Fulton, RR				Kyme, Andre Z.; Zhou, Victor W.; Meikle, Steven R.; Baldock, Clive; Fulton, Roger R.			Optimised Motion Tracking for Positron Emission Tomography Studies of Brain Function in Awake Rats	PLOS ONE			English	Article							PET; ANESTHESIA; ISOFLURANE; SCANNER; SCHEME	Positron emission tomography (PET) is a non-invasive molecular imaging technique using positron-emitting radioisotopes to study functional processes within the body. High resolution PET scanners designed for imaging rodents and non-human primates are now commonplace in preclinical research. Brain imaging in this context, with motion compensation, can potentially enhance the usefulness of PET by avoiding confounds due to anaesthetic drugs and enabling freely moving animals to be imaged during normal and evoked behaviours. Due to the frequent and rapid motion exhibited by alert, awake animals, optimal motion correction requires frequently sampled pose information and precise synchronisation of these data with events in the PET coincidence data stream. Motion measurements should also be as accurate as possible to avoid degrading the excellent spatial resolution provided by state-of-the-art scanners. Here we describe and validate methods for optimised motion tracking suited to the correction of motion in awake rats. A hardware based synchronisation approach is used to achieve temporal alignment of tracker and scanner data to within 10 ms. We explored the impact of motion tracker synchronisation error, pose sampling rate, rate of motion, and marker size on motion correction accuracy. With accurate synchronisation (<100 ms error), a sampling rate of >20 Hz, and a small head marker suitable for awake animal studies, excellent motion correction results were obtained in phantom studies with a variety of continuous motion patterns, including realistic rat motion (<5% bias in mean concentration). Feasibility of the approach was also demonstrated in an awake rat study. We conclude that motion tracking parameters needed for effective motion correction in preclinical brain imaging of awake rats are achievable in the laboratory setting. This could broaden the scope of animal experiments currently possible with PET.	[Kyme, Andre Z.; Baldock, Clive; Fulton, Roger R.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Kyme, Andre Z.; Zhou, Victor W.; Meikle, Steven R.; Fulton, Roger R.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Meikle, Steven R.; Fulton, Roger R.] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Fulton, Roger R.] Westmead Hosp, Dept Med Phys, Sydney, NSW, Australia; [Zhou, Victor W.] Cent Queensland Univ, Sch Engn & Built Environm, Mackay, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Central Queensland University	Kyme, AZ (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.	a.kyme@physics.usyd.edu.au	Baldock, Clive/B-2893-2008; Meikle, Steven/AAH-4973-2020; Meikle, Steven R/A-5470-2009	Baldock, Clive/0000-0001-7559-3769; Meikle, Steven/0000-0001-7397-0364; Meikle, Steven R/0000-0001-7397-0364; Kyme, Andre/0000-0003-3297-5390; Fulton, Roger/0000-0003-2536-2190	Australian Research Council [DP 0663519, DP0988166]	Australian Research Council(Australian Research Council)	The work was supported by the Australian Research Council Discovery Projects (DP 0663519 and DP0988166, www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCLAY RJ, 1988, 2 UFAW; Bloomfield PM, 2003, PHYS MED BIOL, V48, P959, DOI 10.1088/0031-9155/48/8/301; Buhler P, 2004, IEEE T MED IMAGING, V23, P1176, DOI 10.1109/TMI.2004.831214; Cherry S., 2012, PHYS NUCL MED; Cherry SR, 2011, NAT METHODS, V8, P301, DOI 10.1038/nmeth0411-301; DEFRISE M, 1995, INVERSE PROBL, V11, P983, DOI 10.1088/0266-5611/11/5/003; Dong HL, 2006, ANESTHESIOLOGY, V104, P122, DOI 10.1097/00000542-200601000-00018; Fitzpatrick JM, 1998, IEEE T MED IMAGING, V17, P694, DOI 10.1109/42.736021; Fulton R, 2004, IEEE NUCL SCI CONF R, P4226; Fulton R, 2004, IEEE NUCL SCI CONF R, P3286, DOI 10.1109/NSSMIC.2003.1352598; Hosoi R, 2005, BRAIN RES, V1039, P199, DOI 10.1016/j.brainres.2005.01.064; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Kilbourn MR, 2007, NUCL MED BIOL, V34, P479, DOI 10.1016/j.nucmedbio.2007.04.008; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Kreuter JD, 2004, NEUROSCIENCE, V127, P233, DOI 10.1016/j.neuroscience.2004.04.047; Kyme AZ, 2008, PHYS MED BIOL, V53, P2651, DOI 10.1088/0031-9155/53/10/014; Lancelot S, 2010, TRENDS PHARMACOL SCI, V31, P411, DOI 10.1016/j.tips.2010.06.002; Luo F, 2007, J MAGN RESON IMAGING, V26, P557, DOI 10.1002/jmri.21083; Maclaren J, 2011, MAGN RESON MED, V65, P1724, DOI 10.1002/mrm.22754; Martin C, 2002, J NEUROSCI METH, V120, P25, DOI 10.1016/S0165-0270(02)00185-1; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; OHATA M, 1981, J CEREBR BLOOD F MET, V1, P187, DOI 10.1038/jcbfm.1981.19; Oria M, 2008, J NEUROTRAUM, V25, P266, DOI 10.1089/neu.2007.0393; PARRY TJ, 1993, PHYSIOL BEHAV, V53, P1011, DOI 10.1016/0031-9384(93)90283-L; Santarelli R, 2003, ACTA OTO-LARYNGOL, V123, P176, DOI 10.1080/0036554021000028108; Schulz D, 2011, NAT METHODS, V8, P347, DOI [10.1038/nmeth.1582, 10.1038/NMETH.1582]; Shimoji K, 2004, J NUCL MED, V45, P665; Stavdahl O, 2005, ROBOTICA, V23, P283, DOI 10.1017/S0263574704001304; Tai YC, 2005, J NUCL MED, V46, P455; WEISENBERGER AG, 2008, P 2008 IEEE NUCL SCI; Zhou VW, 2008, MOL IMAGING BIOL, V10, P315, DOI 10.1007/s11307-008-0157-0; Zhou VW, 2009, PHYS MED BIOL, V54, P5321, DOI 10.1088/0031-9155/54/17/016	32	56	57	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21727	10.1371/journal.pone.0021727	http://dx.doi.org/10.1371/journal.pone.0021727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747951	Green Submitted, Green Published, gold			2022-12-25	WOS:000292293400027
J	Luzardo, R; Silva, PA; Einicker-Lamas, M; Ortiz-Costa, S; do Carmo, MDT; Vieira-Filho, LD; Paixao, ADO; Lara, LS; Vieyra, A				Luzardo, Ricardo; Silva, Paulo A.; Einicker-Lamas, Marcelo; Ortiz-Costa, Susana; Tavares do Carmo, Maria da Graca; Vieira-Filho, Leucio D.; Paixao, Ana D. O.; Lara, Lucienne S.; Vieyra, Adalberto			Metabolic Programming during Lactation Stimulates Renal Na+ Transport in the Adult Offspring Due to an Early Impact on Local Angiotensin II Pathways	PLOS ONE			English	Article							ATPASE ACTIVITY; PHOSPHORYLATED INTERMEDIATE; PROTEIN RESTRICTION; GLOMERULAR NUMBER; SODIUM-TRANSPORT; NEPHRON NUMBER; BLOOD-PRESSURE; KIDNEY CORTEX; FOOD-INTAKE; LEPTIN	Background: Several studies have correlated perinatal malnutrition with diseases in adulthood, giving support to the programming hypothesis. In this study, the effects of maternal undernutrition during lactation on renal Na+-transporters and on the local angiotensin II (Ang II) signaling cascade in rats were investigated. Methodology/Principal Findings: Female rats received a hypoproteic diet (8% protein) throughout lactation. Control and programmed offspring consumed a diet containing 20% protein after weaning. Programming caused a decrease in the number of nephrons (35%), in the area of the Bowman's capsule (30%) and the capillary tuft (30%), and increased collagen deposition in the cortex and medulla (by 175% and 700%, respectively). In programmed rats the expression of (Na++K+) ATPase in proximal tubules increased by 40%, but its activity was doubled owing to a threefold increase in affinity for K+. Programming doubled the ouabain-insensitive Na+-ATPase activity with loss of its physiological response to Ang II, increased the expression of AT(1) and decreased the expression of AT(2) receptors), and caused a pronounced inhibition (90%) of protein kinase C activity with decrease in the expression of the alpha (24%) and epsilon (13%) isoforms. Activity and expression of cyclic AMP-dependent protein kinase decreased in the same proportion as the AT2 receptors (30%). In vivo studies at 60 days revealed an increased glomerular filtration rate (GFR) (70%), increased Na+ excretion (80%) and intense proteinuria (increase of 400% in protein excretion). Programmed rats, which had normal arterial pressure at 60 days, became hypertensive by 150 days. Conclusions/Significance: Maternal protein restriction during lactation results in alterations in GFR, renal Na+ handling and in components of the Ang II-linked regulatory pathway of renal Na+ reabsorption. At the molecular level, they provide a framework for understanding how metabolic programming of renal mechanisms contributes to the onset of hypertension in adulthood.	[Luzardo, Ricardo; Silva, Paulo A.; Einicker-Lamas, Marcelo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Luzardo, Ricardo; Silva, Paulo A.; Einicker-Lamas, Marcelo; Vieira-Filho, Leucio D.; Paixao, Ana D. O.; Lara, Lucienne S.; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Natl Inst Struct Biol & Bioimaging, Rio De Janeiro, Brazil; [Ortiz-Costa, Susana; Tavares do Carmo, Maria da Graca] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil; [Vieira-Filho, Leucio D.; Paixao, Ana D. O.] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil; [Lara, Lucienne S.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Pernambuco; Universidade Federal do Rio de Janeiro	Luzardo, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	avieyra@biof.ufrj.br	Morcillo, Lucienne/F-5771-2017; Fisiologia, Ciencias Biologicas/C-2407-2012	Morcillo, Lucienne/0000-0002-2204-8799; Vieira, Leucio/0000-0002-6041-1720	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS/DECIT); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); National Institutes of Science and Technology (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS/DECIT); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); National Institutes of Science and Technology (Brazil)	This work has been funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Ministerio da Saude/Departamento de Ciencia e Tecnologia (MS/DECIT), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) and National Institutes of Science and Technology (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript,	Alwasel SH, 2009, CLIN SCI, V117, P75, DOI 10.1042/CS20080294; ANDERSON S, 1986, J HYPERTENS, V4, pS236; APERIA A, 1994, FASEB J, V8, P436, DOI 10.1096/fasebj.8.6.8168694; Axelband F, 2009, REGUL PEPTIDES, V155, P81, DOI 10.1016/j.regpep.2009.03.014; Barker D. J. P., 1993, Nutrition and Health (Bicester), V9, P99; Barker D. J. P., 1994, MOTHERS BABIES DIS L; Barker DJP, 1997, BRIT MED BULL, V53, P96; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Barreira AL, 2009, CELL PHYSIOL BIOCHEM, V24, P585, DOI 10.1159/000257514; Beltowski J, 2004, ACTA BIOCHIM POL, V51, P1003; Beltowski J, 2007, CLIN EXP HYPERTENS, V29, P189, DOI 10.1080/10641960701361585; Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; BIOLLAZ J, 1986, HYPERTENSION, V8, P117, DOI 10.1161/01.HYP.8.2.117; Bonomo IT, 2005, HORM METAB RES, V37, P220, DOI 10.1055/s-2005-861381; Brenner B.M., 1997, KIDNEY INT S, P124; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; BURNIER M, 1994, HYPERTENSION, V23, P496, DOI 10.1161/01.HYP.23.4.496; Cabral LMP, 2007, J BIOL CHEM, V282, P24599, DOI 10.1074/jbc.M701669200; Caruso-Neves C, 2000, BBA-BIOMEMBRANES, V1468, P107, DOI 10.1016/S0005-2736(00)00248-0; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; CHAKRAVARTHY BR, 1994, BIOCHEM J, V304, P809, DOI 10.1042/bj3040809; CORMAN B, 1992, PRESSE MED, V21, P1238; Dagan A, 2007, AM J PHYSIOL-REG I, V292, pR1230, DOI 10.1152/ajpregu.00669.2006; Dagan A, 2009, AM J PHYSIOL-REG I, V297, pR93, DOI 10.1152/ajpregu.91006.2008; De Souza AM, 2007, BIOCHIMIE, V89, P1425, DOI 10.1016/j.biochi.2007.05.010; De Souza AM, 2004, REGUL PEPTIDES, V120, P167, DOI 10.1016/j.regpep.2004.03.005; Du ZP, 2003, AM J PHYSIOL-RENAL, V284, pF688, DOI 10.1152/ajprenal.00261.2002; EISEN EJ, 1976, J ANIM SCI, V42, P1008; Fowden AL, 2009, EXP PHYSIOL, V94, P607, DOI 10.1113/expphysiol.2008.046359; Fowden AL, 2006, PHYSIOLOGY, V21, P29, DOI 10.1152/physiol.00050.2005; HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Lara LD, 2006, BIOCHEM J, V395, P183, DOI 10.1042/BJ20051455; LARSSON L, 1980, KIDNEY INT, V18, P29, DOI 10.1038/ki.1980.107; Louzada RAN, 2010, CARDIOVASC DRUG THER, V24, P121, DOI 10.1007/s10557-010-6215-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manning J, 2002, AM J PHYSIOL-RENAL, V283, pF202, DOI 10.1152/ajprenal.00358.2001; McDonough AA, 2010, AM J PHYSIOL-REG I, V298, pR851, DOI 10.1152/ajpregu.00002.2010; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Mesquita FF, 2010, NEPHROL DIAL TRANSPL, V25, P380, DOI 10.1093/ndt/gfp505; MITCHELL KD, 2007, PHARMACOL REV, V59, P251; Mukherjea R, 1999, LIFE SCI, V65, P1183, DOI 10.1016/S0024-3205(99)00352-5; NEJAD KZ, 2006, HYPERTENSION, V47, P502; NOEL MB, 1993, PHYSIOL BEHAV, V54, P151, DOI 10.1016/0031-9384(93)90057-M; Pickavance L, 1998, BIOCHEM BIOPH RES CO, V248, P196, DOI 10.1006/bbrc.1998.8934; POST RL, 1965, J BIOL CHEM, V240, P1437; PROVERBIO F, 1981, BIOCHIM BIOPHYS ACTA, V646, P99, DOI 10.1016/0005-2736(81)90276-5; PROVERBIO F, 1989, CURR TOP MEMBR TRANS, V34, P105; QUEIROZMADEIRA EP, 2009, BIOCHIM BIOPHYS ACTA, V1798, P360; Rangel LBA, 2005, REGUL PEPTIDES, V127, P177, DOI 10.1016/j.regpep.2004.12.007; Rangel LBA, 2002, BBA-BIOMEMBRANES, V1564, P310, DOI 10.1016/S0005-2736(02)00472-8; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rocafull MA, 2011, BBA-BIOMEMBRANES, V1808, P1684, DOI 10.1016/j.bbamem.2011.02.010; SOLOMON S, 1977, J PHYSIOL-LONDON, V272, P573, DOI 10.1113/jphysiol.1977.sp012061; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Teixeira CV, 2002, J NUTR BIOCHEM, V13, P493, DOI 10.1016/S0955-2863(02)00197-3; Vehaskari VM, 2004, AM J PHYSIOL-RENAL, V287, pF262, DOI 10.1152/ajprenal.00055.2004; Ventrella V, 2010, BIOCHIMIE, V92, P128, DOI 10.1016/j.biochi.2009.10.010; Vieira LD, 2011, ARCH BIOCHEM BIOPHYS, V505, P91, DOI 10.1016/j.abb.2010.09.025; Vieira LD, 2009, CLIN EXP PHARMACOL P, V36, P1157, DOI 10.1111/j.1440-1681.2009.05212.x; VIEYRA A, 1986, J BIOL CHEM, V261, P4247; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x; WHITTEMB.G, 1970, PFLUG ARCH EUR J PHY, V316, P1, DOI 10.1007/BF00587893; Woods LL, 1998, AM J PHYSIOL-REG I, V275, pR1593, DOI 10.1152/ajpregu.1998.275.5.R1593; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Zallocchi Marisa, 2003, Med Sci Monit, V9, pBR85	68	31	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21232	10.1371/journal.pone.0021232	http://dx.doi.org/10.1371/journal.pone.0021232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747933	Green Published, gold, Green Submitted			2022-12-25	WOS:000292293400008
J	Meng, T; Kolpe, AB; Kiener, TK; Chow, VTK; Kwang, J				Meng, Tao; Kolpe, Annasaheb B.; Kiener, Tanja K.; Chow, Vincent T. K.; Kwang, Jimmy			Display of VP1 on the Surface of Baculovirus and Its Immunogenicity against Heterologous Human Enterovirus 71 Strains in Mice	PLOS ONE			English	Article							MOUTH-DISEASE; LETHAL ENTEROVIRUS-71; INFLUENZA-VIRUS; NEUTRALIZING ANTIBODIES; MAMMALIAN-CELLS; PROTECTS MICE; NEWBORN MICE; IE1 PROMOTER; INFECTION; OUTBREAK	Background: Human Enterovirus 71 (EV71) is a common cause of hand, foot and mouth disease (HFMD) in young children. It is often associated with severe neurological diseases and has caused high mortalities in recent outbreaks across the Asia Pacific region. Currently, there is no effective vaccine and antiviral agents available against EV71 infections. VP1 is one of the major immunogenic capsid protein of EV71 and plays a crucial role in viral infection. Antibodies against VP1 are important for virus neutralization. Methodology/Principal Finding: In the present study, infectious EV71 viruses were generated from their synthetic complementary DNA using the human RNA polymerase I reverse genetics system. Secondly, the major immunogenic capsid protein (VP1) of EV71-Fuyang (subgenogroup C4) was displayed on the surface of recombinant baculovirus Bac-Pie1-gp64-VP1 as gp64 fusion protein under a novel White Spot Syndrome Virus (WSSV) immediate early ie1 promoter. Baculovirus expressed VP1 was able to maintain its structural and antigenic conformity as indicated by immunofluorescence assay and western blot analysis. Interestingly, our results with confocal microscopy revealed that VP1 was able to localize on the plasma membrane of insect cells infected with recombinant baculovirus. In addition, we demonstrated with transmission electron microscopy that baculovirus successfully acquired VP1 from the insect cell membrane via the budding process. After two immunizations in mice, Bac-Pie1-gp64-VP1 elicited neutralization antibody titer of 1: 64 against EV71 (subgenogroup C4) in an in vitro neutralization assay. Furthermore, the antisera showed high cross-neutralization activities against all 11 subgenogroup EV71 strains. Conclusion: Our results illustrated that Bac-Pie1-gp64-VP1 retained native epitopes of VP1 and acted as an effective EV71 vaccine candidate which would enable rapid production without any biosafety concerns.	[Meng, Tao; Kolpe, Annasaheb B.; Kiener, Tanja K.; Kwang, Jimmy] Temasek Life Sci Lab, Singapore, Singapore; [Chow, Vincent T. K.; Kwang, Jimmy] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore, Singapore	National University of Singapore	Meng, T (corresponding author), Temasek Life Sci Lab, Singapore, Singapore.	kwang@tll.org.sg		Kolpe, Annasaheb/0000-0002-1255-1593; Chow, Vincent/0000-0003-2634-6213	Temasek Life Sciences Laboratory	Temasek Life Sciences Laboratory(National University of Singapore)	The authors are grateful for the financial support received from Temasek Life Sciences Laboratory (http://www.tll.org.sg/), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; Chang YY, 2009, ACTA BIOCH BIOPH SIN, V41, P998, DOI 10.1093/abbs/gmp093; Chen CW, 2011, VACCINE, V29, P2772, DOI 10.1016/j.vaccine.2011.01.094; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Foo DGW, 2007, MICROBES INFECT, V9, P1299, DOI 10.1016/j.micinf.2007.06.002; Gao H, 2007, J BIOTECHNOL, V131, P138, DOI 10.1016/j.jbiotec.2007.06.002; Grabherr R, 2010, CURR GENE THER, V10, P195, DOI 10.2174/156652310791321297; He F, 2009, EXPERT REV VACCINES, V8, P455, DOI 10.1586/ERV.09.2; He F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-238; Heymann DL, 2004, B WORLD HEALTH ORGAN, V82, P1; Ho HT, 2009, CLIN VACCINE IMMUNOL, V16, P726, DOI 10.1128/CVI.00465-08; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Kitagawa Y, 2005, J VIROL, V79, P3639, DOI 10.1128/JVI.79.6.3639-3652.2005; Kung SH, 2007, CLIN MICROBIOL INFEC, V13, P782, DOI 10.1111/j.1469-0691.2007.01745.x; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Li XL, 2009, BIOCHEM BIOPH RES CO, V390, P1126, DOI 10.1016/j.bbrc.2009.09.103; Lin YH, 2008, VACCINE, V26, P6361, DOI 10.1016/j.vaccine.2008.09.008; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu JN, 2010, VACCINE, V28, P7444, DOI 10.1016/j.vaccine.2010.08.080; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Miller L K, 1988, Biotechnology, V10, P457; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Musthaq SS, 2009, VIROLOGY, V391, P315, DOI 10.1016/j.virol.2009.06.017; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Prabakaran M, 2008, VIROLOGY, V380, P412, DOI 10.1016/j.virol.2008.08.002; Prabakaran M, 2010, J VIROL, V84, P11822, DOI 10.1128/JVI.00891-10; Prabakaran M, 2010, J VIROL, V84, P3201, DOI 10.1128/JVI.02175-09; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Ranganathan Shoba, 2002, Appl Bioinformatics, V1, P43; Singh S, 2002, J CLIN MICROBIOL, V40, P2823, DOI 10.1128/JCM.40.8.2823-2827.2002; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; TAKEDA N, 1994, J VIROL, V68, P854, DOI 10.1128/JVI.68.2.854-862.1994; Tami C, 2004, VACCINE, V23, P840, DOI 10.1016/j.vaccine.2004.03.070; Tan CS, 2007, ARCH VIROL, V152, P1069, DOI 10.1007/s00705-007-0941-1; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; van der Sanden S, 2010, J GEN VIROL, V91, P1949, DOI 10.1099/vir.0.019695-0; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; WHITFORD M, 1989, J VIROL, V63, P1393, DOI 10.1128/JVI.63.3.1393-1399.1989; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu TC, 2007, J VIROL, V81, P10310, DOI 10.1128/JVI.00372-07; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09	54	45	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21757	10.1371/journal.pone.0021757	http://dx.doi.org/10.1371/journal.pone.0021757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747954	gold, Green Submitted, Green Published			2022-12-25	WOS:000292293400030
J	Henssge, U; Do, T; Gilbert, SC; Cox, S; Clark, D; Wickstrom, C; Ligtenberg, AJM; Radford, DR; Beighton, D				Henssge, Uta; Thuy Do; Gilbert, Steven C.; Cox, Steven; Clark, Douglas; Wickstroem, Claes; Ligtenberg, A. J. M.; Radford, David R.; Beighton, David			Application of MLST and Pilus Gene Sequence Comparisons to Investigate the Population Structures of Actinomyces naeslundii and Actinomyces oris	PLOS ONE			English	Article							BETA-D-GALACTOSAMINE; GENOSPECIES 1; SALIVARY PROTEINS; TYPE-1 FIMBRIAE; ROOT SURFACES; SP-NOV; VISCOSUS; IDENTIFICATION; BINDING; RECEPTORS	Actinomyces naeslundii and Actinomyces oris are members of the oral biofilm. Their identification using 16S rRNA sequencing is problematic and better achieved by comparison of metG partial sequences. A. oris is more abundant and more frequently isolated than A. naeslundii. We used a multi-locus sequence typing approach to investigate the genotypic diversity of these species and assigned A. naeslundii (n = 37) and A. oris (n = 68) isolates to 32 and 68 sequence types (ST), respectively. Neighbor-joining and ClonalFrame dendrograms derived from the concatenated partial sequences of 7 house-keeping genes identified at least 4 significant subclusters within A. oris and 3 within A. naeslundii. The strain collection we had investigated was an under-representation of the total population since at least 3 STs composed of single strains may represent discrete clusters of strains not well represented in the collection. The integrity of these sub-clusters was supported by the sequence analysis of fimP and fimA, genes coding for the type 1 and 2 fimbriae, respectively. An A. naeslundii subcluster was identified with both fimA and fimP genes and these strains were able to bind to MUC7 and statherin while all other A. naeslundii strains possessed only fimA and did not bind to statherin. An A. oris subcluster harboured a fimA gene similar to that of Actinomyces odontolyticus but no detectable fimP failed to bind significantly to either MUC7 or statherin. These data are evidence of extensive genotypic and phenotypic diversity within the species A. oris and A. naeslundii but the status of the subclusters identified here will require genome comparisons before their phylogenic position can be unequivocally established.	[Henssge, Uta; Thuy Do; Gilbert, Steven C.; Cox, Steven; Clark, Douglas; Radford, David R.; Beighton, David] Kings Coll London, Inst Dent, Dept Microbiol, Henry Wellcome Labs Microbiol & Salivary Res, London WC2R 2LS, England; [Wickstroem, Claes] Malmo Univ, Fac Odontol, Dept Oral Biol, Malmo, Sweden; [Ligtenberg, A. J. M.] ACTA, Dept Oral Biochem, Amsterdam, Netherlands	University of London; King's College London; Malmo University; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Henssge, U (corresponding author), Kings Coll London, Inst Dent, Dept Microbiol, Henry Wellcome Labs Microbiol & Salivary Res, London WC2R 2LS, England.	david.beighton@kcl.ac.uk	Wickstrom, Claes/B-6338-2008; Radford, David R/E-9935-2011	Wickstrom, Claes/0000-0002-8183-8846; Radford, David R/0000-0001-8668-0358	Dental Institute, King's College London; Department of Health via the National Institute for Health Research (NIHR)	Dental Institute, King's College London; Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	The authors acknowledge support from the Dental Institute, King's College London, and from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bosch JA, 2003, J MICROBIOL METH, V53, P51, DOI 10.1016/S0167-7012(02)00220-8; BOWDEN G, 1993, J DENT RES, V72, P1171, DOI 10.1177/00220345930720080201; Bowden GHW, 1999, J DENT RES, V78, P1800, DOI 10.1177/00220345990780120601; Brailsford SR, 1998, CARIES RES, V32, P100, DOI 10.1159/000016438; BRENNAN MJ, 1984, INFECT IMMUN, V46, P459, DOI 10.1128/IAI.46.2.459-464.1984; CISAR JO, 1984, INFECT IMMUN, V46, P453, DOI 10.1128/IAI.46.2.453-458.1984; CISAR JO, 1984, J DENT RES, V63, P393, DOI 10.1177/00220345840630030701; CLARK WB, 1989, INFECT IMMUN, V57, P3003, DOI 10.1128/IAI.57.10.3003-3008.1989; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Do T, 2008, FEMS MICROBIOL LETT, V288, P156, DOI 10.1111/j.1574-6968.2008.01336.x; Drobni Mirva, 2006, BMC Microbiol, V6, P43; ELLEN RP, 1976, INFECT IMMUN, V14, P1119, DOI 10.1128/IAI.14.5.1119-1124.1976; Flora B, 2001, PROTEIN EXPRES PURIF, V23, P198, DOI 10.1006/prep.2001.1493; GIBBONS RJ, 1988, INFECT IMMUN, V56, P2990, DOI 10.1128/IAI.56.11.2990-2993.1988; GIBBONS RJ, 1989, J DENT RES, V68, P750, DOI 10.1177/00220345890680050101; GIBBONS RJ, 1988, INFECT IMMUN, V56, P439, DOI 10.1128/IAI.56.2.439-445.1988; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hall V, 1999, J CLIN MICROBIOL, V37, P2255, DOI 10.1128/JCM.37.7.2255-2261.1999; Hall V, 2001, J CLIN MICROBIOL, V39, P3555, DOI 10.1128/JCM.39.10.3555-3562.2001; Hallberg K, 1998, ORAL MICROBIOL IMMUN, V13, P188, DOI 10.1111/j.1399-302X.1998.tb00731.x; Hallberg K, 1998, ORAL MICROBIOL IMMUN, V13, P327, DOI 10.1111/j.1399-302X.1998.tb00687.x; Henssge U, 2009, INT J SYST EVOL MICR, V59, P509, DOI 10.1099/ijs.0.000950-0; JELANI T, 2009, FEMS YEAST RES, V9, P1102; JENSEN JL, 1992, J DENT RES, V71, P1569, DOI 10.1177/00220345920710090501; JOHNSON JL, 1990, INT J SYST BACTERIOL, V40, P273, DOI 10.1099/00207713-40-3-273; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; LEVINE MJ, 1987, J DENT RES, V66, P436, DOI 10.1177/00220345870660020901; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Li T, 1999, INFECT IMMUN, V67, P2053, DOI 10.1128/IAI.67.5.2053-2059.1999; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Proctor GB, 2005, J DENT RES, V84, P73, DOI 10.1177/154405910508400113; PUTNINS EE, 1993, J DENT RES, V72, P1374, DOI 10.1177/00220345930720100601; QURESHI JV, 1981, INFECT IMMUN, V31, P261, DOI 10.1128/IAI.31.1.261-266.1981; STROMBERG N, 1990, J BIOL CHEM, V265, P11251; STROMBERG N, 1992, INFECT IMMUN, V60, P3278; STROMBERG N, 1992, INFECT IMMUN, V60, P3268; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wickstrom C, 2000, BIOCHEM J, V351, P421, DOI 10.1042/0264-6021:3510421; Wickstrom C, 2009, MICROBIOL-SGM, V155, P53, DOI 10.1099/mic.0.022111-0; Ximenez-Fyvie LA, 1999, ORAL MICROBIOL IMMUN, V14, P257, DOI 10.1034/j.1399-302X.1999.140410.x	42	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21430	10.1371/journal.pone.0021430	http://dx.doi.org/10.1371/journal.pone.0021430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738661	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800014
J	Spilde, M; Lanzirotti, A; Qualls, C; Phillips, G; Ali, AM; Agenbroad, L; Appenzeller, O				Spilde, Mike; Lanzirotti, Antonio; Qualls, Clifford; Phillips, Genevieve; Ali, Abdul-Mehdi; Agenbroad, Larry; Appenzeller, Otto			Biologic Rhythms Derived from Siberian Mammoths' Hairs	PLOS ONE			English	Article							LIFE	Hair is preserved for millennia in permafrost; it enshrines a record of biologic rhythms and offers a glimpse at chronobiology as it was in extinct animals. Here we compare biologic rhythms gleaned from mammoth's hairs with those of modern human hair. Four mammoths' hairs came from varying locations in Siberia 4600 km, four time zones, apart ranging in age between 18,000 and 20,000 years before present. We used two contemporaneous human hairs for comparison. Power spectra derived from hydrogen isotope ratios along the length of the hairs gave insight into biologic rhythms, which were different in the mammoths depending on location and differed from humans. Hair growth for mammoths was,31 cms/year and,16 cms/year for humans. Recurrent annual rhythms of slow and fast growth varying from 3.4 weeks/cycles to 8.7 weeks/cycles for slow periods and 1.2 weeks/cycles to 2.2 weeks/cycles for fast periods were identified in mammoth's hairs. The mineral content of mammoth's hairs was measured by electron microprobe analysis (k-ratios), which showed no differences in sulfur amongst the mammoth hairs but significantly more iron then in human hair. The fractal nature of the data derived from the hairs became evident in Mandelbrot sets derived from hydrogen isotope ratios, mineral content and geographic location. Confocal microscopy and scanning electron microscopy showed varied degrees of preservation of the cuticle largely independent of age but not location of the specimens. X-ray fluorescence microprobe and fluorescence computed micro-tomography analyses allowed evaluation of metal distribution and visualization of hollow tubes in the mammoth's hairs. Seasonal variations in iron and copper content combined with spectral analyses gave insights into variation in food intake of the animals. Biologic rhythms gleaned from power spectral plots obtained by modern methods revealed life style and behavior of extinct mega-fauna.	[Spilde, Mike] Univ New Mexico, Inst Meteorit, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Lanzirotti, Antonio] Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA; [Qualls, Clifford] Univ New Mexico, Dept Math, Albuquerque, NM 87131 USA; [Qualls, Clifford] Univ New Mexico, Dept Stat, Albuquerque, NM 87131 USA; [Phillips, Genevieve] Univ New Mexico, Canc Res & Treatment Ctr, Fluorescence Microscopy Facil, Albuquerque, NM 87131 USA; [Ali, Abdul-Mehdi] Univ New Mexico, Analyt Chem Lab, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Agenbroad, Larry] Mammoth Site, Hot Springs, SD USA; [Appenzeller, Otto] New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM USA	University of New Mexico; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory; University of New Mexico; University of New Mexico; University of New Mexico; University of New Mexico	Spilde, M (corresponding author), Univ New Mexico, Inst Meteorit, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA.	oarun@unm.edu		Lanzirotti, Antonio/0000-0002-7597-5924	New Mexico Health Enhancement and Marathon Clinics (NMHEMC) Research Foundation	New Mexico Health Enhancement and Marathon Clinics (NMHEMC) Research Foundation	This work was supported by the New Mexico Health Enhancement and Marathon Clinics (NMHEMC) Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; Allen M, 2010, NATURE, V466, P31, DOI 10.1038/466031a; Appenzeller O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000636; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Brown JH, 2002, PHILOS T R SOC B, V357, P619, DOI 10.1098/rstb.2001.0993; Campbell KL, 2010, NAT GENET, V42, P536, DOI 10.1038/ng.574; Gibbons A, 2010, SCIENCE, V330, P1616, DOI 10.1126/science.330.6011.1616; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; WEST BG, 1997, SCIENCE, V276, P122	13	5	5	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21705	10.1371/journal.pone.0021705	http://dx.doi.org/10.1371/journal.pone.0021705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747920	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100057
J	McMahon, DP; Hayward, A; Kathirithamby, J				McMahon, Dino P.; Hayward, Alexander; Kathirithamby, Jeyaraney			The First Molecular Phylogeny of Strepsiptera (Insecta) Reveals an Early Burst of Molecular Evolution Correlated with the Transition to Endoparasitism	PLOS ONE			English	Article							AMINO-ACID REPLACEMENT; SUBSTITUTION RATE VARIATION; SUBUNIT RIBOSOMAL-RNA; MITOCHONDRIAL GENOME; DIVERSIFICATION; RATES; MODELS; SEQUENCES; ALIGNMENT; PARASITE	A comprehensive model of evolution requires an understanding of the relationship between selection at the molecular and phenotypic level. We investigate this in Strepsiptera, an order of endoparasitic insects whose evolutionary biology is poorly studied. We present the first molecular phylogeny of Strepsiptera, and use this as a framework to investigate the association between parasitism and molecular evolution. We find evidence of a significant burst in the rate of molecular evolution in the early history of Strepsiptera. The evolution of morphological traits linked to parasitism is significantly correlated with the pattern in molecular rate. The correlated burst in genotypic-phenotypic evolution precedes the main phase of strepsipteran diversification, which is characterised by the return to a low and even molecular rate, and a period of relative morphological stability. These findings suggest that the transition to endoparasitism led to relaxation of selective constraint in the strepsipteran genome. Our results indicate that a parasitic lifestyle can affect the rate of molecular evolution, although other causal life-history traits correlated with parasitism may also play an important role.	[McMahon, Dino P.; Hayward, Alexander; Kathirithamby, Jeyaraney] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	McMahon, DP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	dino.mcmahon@googlemail.com; jeyaraney.kathirithamby@zoo.ox.ac.uk	McMahon, Dino P/F-7006-2012; McMahon, Dino/S-2620-2019	McMahon, Dino P/0000-0003-1119-5299; McMahon, Dino/0000-0003-1119-5299; Hayward, Alexander/0000-0001-7413-718X	Leverhulme Trust [F/08502/G]; Elizabeth Hannah Jenkinson Fund	Leverhulme Trust(Leverhulme Trust); Elizabeth Hannah Jenkinson Fund	This work was supported by The Leverhulme Trust (F/08502/G). DPM was supported by an Elizabeth Hannah Jenkinson Fund for laboratory funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2007, MOL BIOL EVOL, V24, P1; Adachi J, 1996, J MOL EVOL, V42, P459; Ahrens D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-234; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bravo F, 2009, CLADISTICS, V25, P614, DOI 10.1111/j.1096-0031.2009.00264.x; Bromham L, 2002, EVOLUTION, V56, P1921; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Castro LR, 2005, MOL PHYLOGENET EVOL, V34, P469, DOI 10.1016/j.ympev.2004.11.005; Castro LR, 2007, SYST ENTOMOL, V32, P60, DOI 10.1111/j.1365-3113.2006.00356.x; Chan KMA, 2005, BIOINFORMATICS, V21, P1709, DOI 10.1093/bioinformatics/bti175; CROWSON RA, 1960, ANNU REV ENTOMOL, V5, P111, DOI 10.1146/annurev.en.05.010160.000551; Dorus S, 2004, NAT GENET, V36, P1326, DOI 10.1038/ng1471; Dowton M, 1995, J MOL EVOL, V41, P958, DOI 10.1007/BF00173176; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duff RJ, 1997, J MOL EVOL, V45, P631, DOI 10.1007/PL00006267; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gillespie JJ, 2005, INSECT MOL BIOL, V14, P625, DOI 10.1111/j.1365-2583.2005.00591.x; Gillespie JJ, 2004, MOL PHYLOGENET EVOL, V33, P936, DOI 10.1016/j.ympev.2004.08.004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; Hayward A, 2011, MOL ECOL, V20, P1508, DOI 10.1111/j.1365-294X.2011.05010.x; Ho SYW, 2009, BIOL LETTERS, V5, P421, DOI 10.1098/rsbl.2008.0729; Huelsenbeck John P., 2001, Tijdschrift voor Entomologie, V144, P165; Huelsenbeck JP, 1998, SYST BIOL, V47, P519; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Ishiwata K, 2011, MOL PHYLOGENET EVOL, V58, P169, DOI 10.1016/j.ympev.2010.11.001; Kathirithamby J, 2003, P NATL ACAD SCI USA, V100, P7655, DOI 10.1073/pnas.1131999100; KATHIRITHAMBY J, 1989, SYST ENTOMOL, V14, P41, DOI 10.1111/j.1365-3113.1989.tb00265.x; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Kathirithamby J, 2010, SYST ENTOMOL, V35, P234, DOI 10.1111/j.1365-3113.2009.00507.x; Kim H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011608; Kinzelbach RK, 1978, TIERWELT DEUTSCHLAND, V65, P166; KJER KM, 1994, BBA-GENE STRUCT EXPR, V1217, P147, DOI 10.1016/0167-4781(94)90028-0; Lanfear R, 2010, TRENDS ECOL EVOL, V25, P495, DOI 10.1016/j.tree.2010.06.007; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Longhorn SJ, 2010, MOL PHYLOGENET EVOL, V55, P846, DOI 10.1016/j.ympev.2010.03.024; MADDISON WP, 2006, MESQUITE MODULAR SYS; McKenna DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011887; McMahon DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-603; Moore BR, 2007, AM NAT, V170, pS28, DOI 10.1086/519460; NADEAU NJ, 2007, P ROY SOC B-BIOL SCI, V255, P37; Nee Sean, 1996, P230; Nylander J, 2004, MR MODELTEST V2 PROG; O'Connor TD, 2009, BIOINFORMATICS, V25, pI94, DOI 10.1093/bioinformatics/btp231; Omland KE, 1997, EVOLUTION, V51, P1381, DOI [10.2307/2411190, 10.1111/j.1558-5646.1997.tb01461.x]; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pohl H, 2005, CLADISTICS, V21, P328, DOI 10.1111/j.1096-0031.2005.00074.x; Pohl H, 2004, ARTHROPOD STRUCT DEV, V33, P31, DOI 10.1016/j.asd.2003.10.001; Pohl H, 2001, INSECT SYST EVOL, V32, P143, DOI 10.1163/187631201X00092; Pohl H, 2008, ZOOLOGY, V111, P318, DOI 10.1016/j.zool.2007.06.008; Poulin R., 2004, PARASITE BIODIVERSIT; Poulin R, 2008, TRENDS PARASITOL, V24, P24, DOI 10.1016/j.pt.2007.10.002; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P303; RAMBAUT A, 2007, AJ TRACER V1 4; Rambaut A, 2007, FIGTREE V1 0; Ramm SA, 2008, MOL BIOL EVOL, V25, P207, DOI 10.1093/molbev/msm242; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmid-Hempel P, 2008, TRENDS ECOL EVOL, V23, P318, DOI 10.1016/j.tree.2008.02.011; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Silvestri F., 1943, B LAB ZOOLOGIA GEN A, V32, P197; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Welch JJ, 2005, TRENDS ECOL EVOL, V20, P320, DOI 10.1016/j.tree.2005.02.007; Welch JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-53; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	88	39	41	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21206	10.1371/journal.pone.0021206	http://dx.doi.org/10.1371/journal.pone.0021206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738621	Green Submitted, gold, Green Published			2022-12-25	WOS:000292142800014
J	Polgar, G; Malavasi, S; Cipolato, G; Georgalas, V; Clack, JA; Torricelli, P				Polgar, Gianluca; Malavasi, Stefano; Cipolato, Giacomo; Georgalas, Vyron; Clack, Jennifer A.; Torricelli, Patrizia			Acoustic Communication at the Water's Edge: Evolutionary Insights from a Mudskipper	PLOS ONE			English	Article							PERIOPHTALMUS-SOBRINUS EGGERT; SOUND PRODUCTION; AUDITORY-SENSITIVITY; MOLECULAR PHYLOGENY; AGONISTIC BEHAVIOR; QUANTITATIVE-ANALYSIS; ONTOGENIC DEVELOPMENT; COURTSHIP SOUNDS; GOBIIDS PISCES; FISH	Coupled behavioural observations and acoustical recordings of aggressive dyadic contests showed that the mudskipper Periophthalmodon septemradiatus communicates acoustically while out of water. An analysis of intraspecific variability showed that specific acoustic components may act as tags for individual recognition, further supporting the sounds' communicative value. A correlative analysis amongst acoustical properties and video-acoustical recordings in slow-motion supported first hypotheses on the emission mechanism. Acoustic transmission through the wet exposed substrate was also discussed. These observations were used to support an "exaptation hypothesis", i.e. the maintenance of key adaptations during the first stages of water-to-land vertebrate eco-evolutionary transitions (based on eco-evolutionary and palaeontological considerations), through a comparative bioacoustic analysis of aquatic and semiterrestrial gobiid taxa. In fact, a remarkable similarity was found between mudskipper vocalisations and those emitted by gobioids and other soniferous benthonic fishes.	[Polgar, Gianluca] Univ Malaya, Inst Ocean & Earth Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Malavasi, Stefano; Cipolato, Giacomo; Georgalas, Vyron; Torricelli, Patrizia] Univ Ca Foscari Venezia, Dept Environm Sci Informat & Stat, Venice, Italy; [Clack, Jennifer A.] Univ Museum Zool, Cambridge, England	Universiti Malaya; Universita Ca Foscari Venezia; University of Cambridge	Polgar, G (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	gianluca.polgar@gmail.com	Georgalas, Vyron/G-5845-2011; Polgar, Gianluca/D-1450-2010; Malavasi, Stefano/F-6419-2014	Polgar, Gianluca/0000-0002-4901-6287; 	MIUR (Italian Ministry of Public Instructions, University and Scientific Research)	MIUR (Italian Ministry of Public Instructions, University and Scientific Research)(Ministry of Education, Universities and Research (MIUR))	This research was funded by the MIUR (Italian Ministry of Public Instructions, University and Scientific Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS BA, 1956, Z ANAT ENTWICKLUNGS, V119, P470; Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Ahnelt Harald, 2004, Proceedings of the California Academy of Sciences, V55, P358; Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Akihito, 2000, GENE, V259, P5, DOI 10.1016/S0378-1119(00)00488-1; ALEKSEEV AA, 1994, P GEOLOGIST ASSOC, V105, P41, DOI 10.1016/S0016-7878(08)80137-X; Algeo T.J., 2001, PLANTS INVADE LAND, P213, DOI DOI 10.7312/GENS11160-013; Amorim MCP, 2007, J MAR BIOL ASSOC UK, V87, P1017, DOI 10.1017/S0025315407056822; Amorim Maria Clara P., 2006, P71; Amorim MCP, 2005, ETHOLOGY, V111, P255, DOI 10.1111/j.1439-0310.2004.01061.x; AMORIM MCP, 2008, BEHAV, V165, P1065; [Anonymous], TERRESTRIAL ENV ORIG; [Anonymous], 2004, ACTA U LATVIENSIS; [Anonymous], 1981, HEARING SOUND COMMUN; BRILLET C, 1981, BIOL BEHAV, V6, P35; BRILLET C, 1975, Zeitschrift fuer Tierpsychologie, V39, P283; BRILLET C, 1983, BIOL BEHAV, V8, P49; BRILLET C, 1980, TERRE VIE-REV ECOL A, V34, P427; BRILLET C, 1980, BIOL BEHAV, V5, P297; BRILLET C, 1984, C R HEBD SEANCES A D, V198, P347; Buckingham MJ, 2000, J ACOUST SOC AM, V108, P2796, DOI 10.1121/1.1322018; Clack JA, 2006, PALAEOGEOGR PALAEOCL, V232, P167, DOI 10.1016/j.palaeo.2005.07.019; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA., 2012, GAINING GROUND ORIGI; Clack JA, 2007, INTEGR COMP BIOL, V47, P510, DOI 10.1093/icb/icm055; CLAYTON DA, 1982, COPEIA, P232; CLAYTON DA, 1988, J U KUWAIT-SCI, V15, P115; CLAYTON DA, 1986, J ZOOL, V209, P501, DOI 10.1111/j.1469-7998.1986.tb03607.x; Crawford JD, 1997, MAR FRESHW BEHAV PHY, V29, P65, DOI 10.1080/10236249709379001; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; De Jong K, 2007, ANIM BEHAV, V74, P1285, DOI 10.1016/j.anbehav.2007.02.023; DIESSELHORST G, 1938, WEBERSCHEN APPARAT Z, V25, P748; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; GORDON MS, 1969, J EXP BIOL, V50, P141; Graham JB, 1997, AIR BREATHING FISHES, DOI DOI 10.1016/B978-012294860-2/50006-4; Hill PSM, 2001, AM ZOOL, V41, P1135, DOI 10.1668/0003-1569(2001)041[1135:VAACAR]2.0.CO;2; HOESE DF, 1984, SPEC PUBL AM SOC ICH, V1, P588; Ishimatsu A, 1998, NATURE, V391, P237, DOI 10.1038/34560; Kihslinger RL, 2002, J COMP PSYCHOL, V116, P210, DOI 10.1037//0735-7036.116.2.210; Kobayashi T., 1972, Bulletin Fac Fish Nagasaki Univ, VNo. 33, P49; LADICH F, 1990, ETHOLOGY, V84, P193; LADICH F, 1989, ZOOL JAHRB ALLG ZOOL, V93, P501; Ladich Friedrich, 2006, P3; Lechner W, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-10; Lema SC, 2002, J COMP PSYCHOL, V116, P145, DOI 10.1037//0735-7036.116.2.145; LINDEMANN MA, 2004, 27 ANN MIDW RES M AS; Lindstrom K, 2000, ENVIRON BIOL FISH, V58, P411, DOI 10.1023/A:1007695526177; Lugli A, 2004, ETHOL ECOL EVOL, V16, P55; Lugli M, 1999, J FISH BIOL, V54, P691, DOI 10.1006/jfbi.1998.0898; Lugli M, 1997, MAR FRESHW BEHAV PHY, V29, P109, DOI 10.1080/10236249709379003; Lugli M, 1996, J FISH BIOL, V49, P648; LUGLI M, 1995, ENVIRON BIOL FISH, V43, P219, DOI 10.1007/BF00005853; Lugli M, 2007, J ACOUST SOC AM, V122, P2881, DOI 10.1121/1.2783113; Malavasi S, 2003, ENVIRON BIOL FISH, V66, P231, DOI 10.1023/A:1023923403180; Malavasi S, 2009, J FISH BIOL, V75, P1883, DOI 10.1111/j.1095-8649.2009.02430.x; Malavasi S, 2008, BIOL J LINN SOC, V93, P763, DOI 10.1111/j.1095-8312.2008.00947.x; Murdy E. O., 1989, REC AUSTR MUS S, V11, P1, DOI [DOI 10.3853/J.0812-7387.11.1989.93, 10.3853/j.0812-7387.11.1989.93]; MYRBERG AA, 2006, COMMUNICATION FISHES, V1, P149; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; NURSALL JR, 1974, AM ZOOL, V14, P1099; NURSALL JR, 1981, B MAR SCI, V31, P730; Pace CM, 2009, J EXP BIOL, V212, P2279, DOI 10.1242/jeb.029041; Parmentier E, 2009, J EXP BIOL, V212, P2022, DOI 10.1242/jeb.030270; Polgar G, 2010, J FISH BIOL, V77, P1645, DOI 10.1111/j.1095-8649.2010.02807.x; Polgar G, 2010, MAR ECOL PROG SER, V409, P199, DOI 10.3354/meps08597; Retallack GJ, 1997, SCIENCE, V276, P583, DOI 10.1126/science.276.5312.583; Rice AN, 2009, J EXP BIOL, V212, P1377, DOI 10.1242/jeb.028506; Rollo A, 2007, BEHAVIOUR, V144, P1, DOI 10.1163/156853907779947391; SABATIER JM, 1986, J ACOUST SOC AM, V80, P646, DOI 10.1121/1.394058; Schultze Hans-Peter, 1999, P373, DOI 10.1016/B978-012356040-7/50018-4; Simpson HJ, 2000, J ACOUST SOC AM, V107, P2329, DOI 10.1121/1.428618; Stadler John H., 2002, Bioacoustics, V13, P145; STEBBINS RC, 1961, COPEIA, P18; TAKEMURA A, 1984, B JPN SOC SCI FISH, V50, P561; TAVOLGA WILLIAM N., 1956, ZOOLOGICA [NEW YORK], V41, P49; Thacker CE, 2005, MOL PHYLOGENET EVOL, V37, P858, DOI 10.1016/j.ympev.2005.05.004; Thacker CE, 2003, MOL PHYLOGENET EVOL, V26, P354, DOI 10.1016/S1055-7903(02)00361-5; Thacker CE, 2009, COPEIA, P93, DOI 10.1643/CI-08-004; Thorson RF, 2002, ENVIRON BIOL FISH, V63, P321, DOI 10.1023/A:1014334425821; TORRICELLI P, 1990, Bioacoustics, V2, P261; Townsend Kathy A., 2005, Proceedings of the Royal Society of Queensland, V112, P53; Vasconcelos RO, 2008, J EXP BIOL, V211, P502, DOI 10.1242/jeb.008474; Wang HY, 2001, MOL PHYLOGENET EVOL, V20, P390, DOI 10.1006/mpev.2001.0957; WHANG A, 1994, ENVIRON BIOL FISH, V40, P141, DOI 10.1007/BF00002540; Wysocki LE, 2001, J COMP PHYSIOL A, V187, P177, DOI 10.1007/s003590100186; Zhang G, 1989, B FAC FISH NAGASAKI, V66, P21	86	15	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21434	10.1371/journal.pone.0021434	http://dx.doi.org/10.1371/journal.pone.0021434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738663	gold, Green Published			2022-12-25	WOS:000292142800020
J	Widdershoven, JCC; Spruijt, NE; Spliet, WGM; Breugem, CC; Kon, M; van der Molen, ABM				Widdershoven, Josine C. C.; Spruijt, Nicole E.; Spliet, Wim G. M.; Breugem, Corstiaan C.; Kon, Moshe; van der Molen, Aebele B. Mink			Histology of the Pharyngeal Constrictor Muscle in 22q11.2 Deletion Syndrome and Non-Syndromic Children with Velopharyngeal Insufficiency	PLOS ONE			English	Article							CARDIO-FACIAL SYNDROME; LEVATOR VELI PALATINI; VELOCARDIOFACIAL-SYNDROME; DIGEORGE-SYNDROME; SPHINCTER PHARYNGOPLASTY; SPEECH CHARACTERISTICS; ISOLATED STIMULATION; PRESCHOOL-CHILDREN; CANDIDATE GENE; NEURAL CREST	Plastic surgeons aim to correct velopharyngeal insufficiency manifest by hypernasal speech with a velopharyngoplasty. The functional outcome has been reported to be worse in patients with 22q11.2 deletion syndrome than in patients without the syndrome. A possible explanation is the hypotonia that is often present as part of the syndrome. To confirm a myogenic component of the etiology of velopharyngeal insufficiency in children with 22q11.2 deletion syndrome, specimens of the pharyngeal constrictor muscle were taken from children with and without the syndrome. Histologic properties were compared between the groups. Specimens from the two groups did not differ regarding the presence of increased perimysial or endomysial space, fiber grouping by size or type, internalized nuclei, the percentage type I fibers, or the diameters of type I and type II fibers. In conclusion, a myogenic component of the etiology of velopharyngeal insufficiency in children with 22q11.2 deletion syndrome could not be confirmed.	[Widdershoven, Josine C. C.] Maastricht Univ Med Ctr, Dept Otolaryngol Head & Neck Surg, Maastricht, Netherlands; [Spruijt, Nicole E.; Breugem, Corstiaan C.; Kon, Moshe; van der Molen, Aebele B. Mink] Univ Med Ctr Utrecht, Dept Plast Surg, Maastricht, Netherlands; [Spliet, Wim G. M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Widdershoven, JCC (corresponding author), Maastricht Univ Med Ctr, Dept Otolaryngol Head & Neck Surg, Maastricht, Netherlands.	josine.widdershoven@mumc.nl						Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Adachi T, 1997, J DENT RES, V76, P1745, DOI 10.1177/00220345970760110501; Arneja JS, 2008, PLAST RECONSTR SURG, V122, P845, DOI 10.1097/PRS.0b013e3181811a83; Arnold JS, 2006, DEVELOPMENT, V133, P977, DOI 10.1242/dev.02264; Bolland E, 2000, Eur J Paediatr Neurol, V4, P73, DOI 10.1053/ejpn.2000.0266; BROOKE MH, 1969, NEUROLOGY, V19, P591, DOI 10.1212/WNL.19.6.591; D'Antonio LL, 2001, CLEFT PALATE-CRAN J, V38, P455, DOI 10.1597/1545-1569(2001)038<0455:AOSCIC>2.0.CO;2; Devriendt K, 1998, J MED GENET, V35, P789, DOI 10.1136/jmg.35.9.789-a; Dworkin JP, 2004, LANG SPEECH HEAR SER, V35, P333, DOI 10.1044/0161-1461(2004/033); Farzaneh F, 2008, SCAND J PLAST RECONS, V42, P7, DOI 10.1080/02844310701694522; Garg V, 2001, DEV BIOL, V235, P62, DOI 10.1006/dbio.2001.0283; Gerdes M, 1999, AM J MED GENET, V85, P127, DOI 10.1002/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.0.CO;2-F; Gerdes M, 2001, GENET MED, V3, P40, DOI 10.1097/00125817-200101000-00009; Grifone R, 2008, DEV DYNAM, V237, P3071, DOI 10.1002/dvdy.21718; Havkin N, 2000, INT J PEDIATR OTORHI, V54, P103, DOI 10.1016/S0165-5876(00)00350-5; Hultman CS, 2000, PLAST RECONSTR SURG, V106, P16, DOI 10.1097/00006534-200007000-00004; Inman DS, 2005, BRIT J PLAST SURG, V58, P1051, DOI 10.1016/j.bjps.2005.05.019; Kelly RG, 2004, HUM MOL GENET, V13, P2829, DOI 10.1093/hmg/ddh304; Kitsiou-Tzeli S, 2004, IN VIVO, V18, P603; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Kogo M, 1996, CLEFT PALATE-CRAN J, V33, P273, DOI 10.1597/1545-1569(1996)033<0273:OOVCPF>2.3.CO;2; LEESE G, 1986, ACTA ANAT, V127, P77; Losken A, 2006, PLAST RECONSTR SURG, V117, P1493, DOI 10.1097/01.prs.0000206377.14083.ce; Losken A, 2003, PLAST RECONSTR SURG, V112, P1755, DOI 10.1097/01.PRS.0000090720.33554.8B; Mongini T, 2001, NEUROPEDIATRICS, V32, P107, DOI 10.1055/s-2001-13877; Okiyama N, 2005, BRIT J DERMATOL, V152, P1370, DOI 10.1111/j.1365-2133.2005.06622.x; Oskarsdottir S, 2005, DEV MED CHILD NEUROL, V47, P177, DOI 10.1017/S0012162205000320; Phua YS, 2008, CLEFT PALATE-CRAN J, V45, P172, DOI 10.1597/06-205.1; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Roubertie A, 2001, BRAIN DEV-JPN, V23, P810, DOI 10.1016/S0387-7604(01)00258-3; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; Sell D, 2001, CLEFT PALATE-CRAN J, V38, P30, DOI 10.1597/1545-1569(2001)038<0030:CLAPCI>2.0.CO;2; Shprintzen RJ, 2008, DEV DISABIL RES REV, V14, P3, DOI 10.1002/ddrr.2; Sie KCY, 2001, PLAST RECONSTR SURG, V108, P17, DOI 10.1097/00006534-200107000-00004; Sie KCY, 1998, LARYNGOSCOPE, V108, P1211, DOI 10.1097/00005537-199808000-00021; SMIRNE S, 1991, LANCET, V337, P597; Stal PS, 2000, J ANAT, V197, P275, DOI 10.1017/S0021878299006627; Sundman E, 2004, ACTA ANAESTH SCAND, V48, P423, DOI 10.1111/j.1399-6576.2004.00364.x; Van Aken K, 2007, DEV MED CHILD NEUROL, V49, P210, DOI 10.1111/j.1469-8749.2007.00210.x; Van Lierde KM, 2004, INT J PEDIATR OTORHI, V68, P865, DOI 10.1016/j.ijporl.2004.01.020; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Walker MB, 2006, CLIN GENET, V69, P471, DOI 10.1111/j.0009-9163.2006.00615.x; Widdershoven JCC, 2008, J PLAST RECONSTR AES, V61, P1016, DOI 10.1016/j.bjps.2008.02.007; Widdershoven JCC, 2008, ARCH OTOLARYNGOL, V134, P1159, DOI 10.1001/archotol.134.11.1159; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Xu HS, 2005, DEVELOPMENT, V132, P4387, DOI 10.1242/dev.02018; Zim Shane, 2003, Arch Facial Plast Surg, V5, P503, DOI 10.1001/archfaci.5.6.503	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21672	10.1371/journal.pone.0021672	http://dx.doi.org/10.1371/journal.pone.0021672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738760	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800056
J	Zajac, M; Law, J; Cvetkovic, DD; Pampillo, M; McColl, L; Pape, C; Di Guglielmo, GM; Postovit, LM; Babwah, AV; Bhattacharya, M				Zajac, Mateusz; Law, Jeffrey; Cvetkovic, Dragana Donna; Pampillo, Macarena; McColl, Lindsay; Pape, Cynthia; Di Guglielmo, Gianni M.; Postovit, Lynne M.; Babwah, Andy V.; Bhattacharya, Moshmi			GPR54 (KISS1R) Transactivates EGFR to Promote Breast Cancer Cell Invasiveness	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; METASTASIS-SUPPRESSOR GENE; PROTEIN-COUPLED RECEPTOR; FOCAL ADHESION KINASE; BETA-ARRESTIN; BETA(2)-ADRENERGIC RECEPTOR; SIGNAL TRANSACTIVATION; CARCINOMA CELLS; MIGRATION; INVASION	Kisspeptins (Kp), peptide products of the Kisspeptin-1 (KISS1) gene are endogenous ligands for a G protein-coupled receptor 54 (GPR54). Previous findings have shown that KISS1 acts as a metastasis suppressor in numerous cancers in humans. However, recent studies have demonstrated that an increase in KISS1 and GPR54 expression in human breast tumors correlates with higher tumor grade and metastatic potential. At present, whether or not Kp signaling promotes breast cancer cell invasiveness, required for metastasis and the underlying mechanisms, is unknown. We have found that kisspeptin-10 (Kp-10), the most potent Kp, stimulates the invasion of human breast cancer MDA-MB-231 and Hs578T cells using Matrigel-coated Transwell chamber assays and induces the formation of invasive stellate structures in three-dimensional invasion assays. Furthermore, Kp-10 stimulated an increase in matrix metalloprotease (MMP)-9 activity. We also found that Kp-10 induced the transactivation of epidermal growth factor receptor (EGFR). Knockdown of the GPCR scaffolding protein, beta-arrestin 2, inhibited Kp-10-induced EGFR transactivation as well as Kp-10 induced invasion of breast cancer cells via modulation of MMP-9 secretion and activity. Finally, we found that the two receptors associate with each other under basal conditions, and FRET analysis revealed that GPR54 interacts directly with EGFR. The stability of the receptor complex formation was increased upon treatment of cells by Kp-10. Taken together, our findings suggest a novel mechanism by which Kp signaling via GPR54 stimulates breast cancer cell invasiveness.	[Zajac, Mateusz; Law, Jeffrey; Cvetkovic, Dragana Donna; McColl, Lindsay; Pape, Cynthia; Di Guglielmo, Gianni M.; Babwah, Andy V.; Bhattacharya, Moshmi] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Pampillo, Macarena; Babwah, Andy V.] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada; [Pampillo, Macarena; Babwah, Andy V.] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada; [Pampillo, Macarena; Babwah, Andy V.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Postovit, Lynne M.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Zajac, M (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	Moshmi.Bhattacharya@schulich.uwo.ca		Postovit, Lynne-Marie/0000-0002-8088-4197	Canadian Institutes of Health Research/Canadian Breast Cancer Research Alliance (CIHR) [MOP 107972]; NSERC; Translational Breast Cancer Research Unit (TBCRU)	Canadian Institutes of Health Research/Canadian Breast Cancer Research Alliance (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Translational Breast Cancer Research Unit (TBCRU)	This study was funded by grants awarded to M. Bhattacharya by the Canadian Institutes of Health Research/Canadian Breast Cancer Research Alliance (CIHR) MOP 107972. The following are recipients of a salary award and studentships: M. Bhattacharya, A. V. Babwah, and L. M Postovit, CIHR New Investigator Awards, M. Zajac, Ontario Graduate Studentship, Jeff Law, NSERC studentships, Donna Cvetkovic, Translational Breast Cancer Research Unit (TBCRU) Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LS, CANC RES, V70, P3594; Aziziyeh AI, 2009, CELL SIGNAL, V21, P1207, DOI 10.1016/j.cellsig.2009.03.011; Bhattacharya M, 2002, NAT CELL BIOL, V4, P547, DOI 10.1038/ncb821; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Caceres M, 2005, EXP CELL RES, V309, P229, DOI 10.1016/j.yexcr.2005.05.020; Campos SM, 2008, CANCER INVEST, V26, P757, DOI 10.1080/07357900801971040; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Clarke RB, 2004, TRENDS ENDOCRIN MET, V15, P316, DOI 10.1016/j.tem.2004.07.004; Cortes-Reynosa P, 2008, MATRIX BIOL, V27, P220, DOI 10.1016/j.matbio.2007.11.003; Crisp S J, 1994, Methods Mol Biol, V32, P233; Darmoul D, 2004, MOL CANCER RES, V2, P514; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Franceschini I, 2006, NEUROSCI LETT, V401, P225, DOI 10.1016/j.neulet.2006.03.039; Fuentes LQ, 2008, CELL SIGNAL, V20, P1642, DOI 10.1016/j.cellsig.2008.05.009; Graham CH, 1996, AM J OBSTET GYNECOL, V175, P555; Gschwind A, 2002, CANCER RES, V62, P6329; Guerrero J, 2004, EXP CELL RES, V292, P201, DOI 10.1016/j.yexcr.2003.08.011; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Hatakeyama M, 2007, MOL BIOSYST, V3, P111, DOI 10.1039/b612800a; Hori A, 2001, BIOCHEM BIOPH RES CO, V286, P958, DOI 10.1006/bbrc.2001.5470; Huang J, 2007, CANCER RES, V67, P5906, DOI 10.1158/0008-5472.CAN-07-0691; Kim J, 2003, BIOCHEMISTRY-US, V42, P2887, DOI 10.1021/bi026942t; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Makri A, 2008, CANCER TREAT REV, V34, P682, DOI 10.1016/j.ctrv.2008.05.007; Marot D, 2007, ENDOCR-RELAT CANCER, V14, P691, DOI 10.1677/ERC-07-0012; Martin TA, 2005, CLIN EXP METASTAS, V22, P503, DOI 10.1007/s10585-005-4180-0; Masui T, 2004, BIOCHEM BIOPH RES CO, V315, P85, DOI 10.1016/j.bbrc.2004.01.021; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Navenot JM, 2005, CANCER RES, V65, P10450, DOI 10.1158/0008-5472.CAN-05-1757; Nicholson KM, 2003, BREAST CANCER RES TR, V81, P117, DOI 10.1023/A:1025765215765; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Pampillo M, 2009, MOL ENDOCRINOL, V23, P2060, DOI 10.1210/me.2009-0013; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Price JT, 1999, CANCER RES, V59, P5475; Raghuwanshi SK, 2008, J IMMUNOL, V180, P5699, DOI 10.4049/jimmunol.180.8.5699; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shoji S, 2009, EUR UROL, V55, P441, DOI 10.1016/j.eururo.2008.02.048; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Watt HL, 2009, CELL SIGNAL, V21, P428, DOI 10.1016/j.cellsig.2008.11.012; WOUTERS FS, 2006, CURR PROTOC NEUROSCI, pCH5; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zou L, 2008, FASEB J, V22, P355, DOI 10.1096/fj.07-9046com; Zuo YF, 2006, BIOCHEM BIOPH RES CO, V351, P361, DOI 10.1016/j.bbrc.2006.10.043	55	76	79	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21599	10.1371/journal.pone.0021599	http://dx.doi.org/10.1371/journal.pone.0021599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738726	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800044
J	McLachlan, SM; Aliesky, HA; Chen, CR; Williams, RW; Rapoport, B				McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Williams, Robert W.; Rapoport, Basil			Exceptional Hyperthyroidism and a Role for both Major Histocompatibility Class I and Class II Genes in a Murine Model of Graves' Disease	PLOS ONE			English	Article							THYROTROPIN RECEPTOR ECTODOMAIN; MONOCLONAL-ANTIBODY; MICE; AUTOANTIBODIES; SUSCEPTIBILITY; EXPRESSION; IDIOTYPES; INSIGHT; PROTEIN; CELLS	Autoimmune hyperthyroidism, Graves' disease, can be induced by immunizing susceptible strains of mice with adenovirus encoding the human thyrotropin receptor (TSHR) or its A-subunit. Studies in two small families of recombinant inbred strains showed that susceptibility to developing TSHR antibodies (measured by TSH binding inhibition, TBI) was linked to the MHC region whereas genes on different chromosomes contributed to hyperthyroidism. We have now investigated TSHR antibody production and hyperthyroidism induced by TSHR A-subunit adenovirus immunization of a larger family of strains (26 of the AXB and BXA strains). Analysis of the combined AXB and BXA families provided unexpected insight into several aspects of Graves' disease. First, extreme thyroid hyperplasia and hyperthyroidism in one remarkable strain, BXA13, reflected an inability to generate non-functional TSHR antibodies measured by ELISA. Although neutral TSHR antibodies have been detected in Graves' sera, pathogenic, functional TSHR antibodies in Graves' patients are undetectable by ELISA. Therefore, this strain immunized with A-subunit-adenovirus that generates only functional TSHR antibodies may provide an improved model for studies of induced Graves' disease. Second, our combined analysis of linkage data from this and previous work strengthens the evidence that gene variants in the immunoglobulin heavy chain V region contribute to generating thyroid stimulating antibodies. Third, a broad region that encompasses the MHC region on mouse chomosome 17 is linked to the development of TSHR antibodies (measured by TBI). Most importantly, unlike other strains, TBI linkage in the AXB and BXA families to MHC class I and class II genes provides an explanation for the unresolved class I/class II difference in humans.	[McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Rapoport, Basil] Cedars Sinai Res Inst, Thyroid Autoimmun Unit, Los Angeles, CA USA; [McLachlan, Sandra M.; Aliesky, Holly A.; Chen, Chun-Rong; Rapoport, Basil] Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; [Williams, Robert W.] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tennessee System; University of Tennessee Health Science Center	McLachlan, SM (corresponding author), Cedars Sinai Res Inst, Thyroid Autoimmun Unit, Los Angeles, CA USA.	mclachlans@cshs.org	Williams, Robert W./H-8789-2016	Williams, Robert W./0000-0001-8924-4447	National Institutes of Health [DK54684, DK19289, U01AA13499, U24AA13513, P20-DA-21131, U01CA105417, U24RR021760]; NATIONAL CANCER INSTITUTE [U01CA105417] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289, R01DK082390, R01DK054684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA021131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health Grants DK54684 (SMM), DK19289 (BR), U01AA13499, U24AA13513, P20-DA-21131, U01CA105417 and U24RR021760 (RWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliesky HA, 2006, ENDOCRINOLOGY, V147, P2789, DOI 10.1210/en.2006-0160; Chazenbalk GD, 1997, J BIOL CHEM, V272, P18959, DOI 10.1074/jbc.272.30.18959; Chazenbalk GD, 1999, J CLIN ENDOCR METAB, V84, P702, DOI 10.1210/jc.84.2.702; Chen CR, 2006, THYROID, V16, P427, DOI 10.1089/thy.2006.16.427; Chen CR, 2004, ENDOCRINOLOGY, V145, P4927, DOI 10.1210/en.2004-0716; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; CHURCHILL GA, 1994, GENETICS, V138, P963; HEUFELDER AE, 1992, J CLIN ENDOCR METAB, V74, P724, DOI 10.1210/jc.74.4.724; Jacobson EM, 2007, THYROID, V17, P949, DOI 10.1089/thy.2007.0153; Jacobson EM, 2009, J BIOL CHEM, V284, P34231, DOI 10.1074/jbc.M109.041574; Joshi MB, 2001, INFECT IMMUN, V69, P4884, DOI 10.1128/IAI.69.8.4884-4890.2001; Lozier JN, 2005, BLOOD, V105, P1029, DOI 10.1182/blood-2004-03-1126; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; Mayfield JA, 2007, GENES IMMUN, V8, P468, DOI 10.1038/sj.gene.6364411; MCGREGOR AM, 1992, J CLIN ENDOCR METAB, V74, P720, DOI 10.1210/jc.74.4.720; McLachlan SM, 2008, ENDOCRINOLOGY, V149, P2001, DOI 10.1210/en.2007-1517; McLachlan SM, 2011, ENDOCRINOLOGY, V152, P1172, DOI 10.1210/en.2010-1138; McLachlan SM, 2005, ENDOCR REV, V26, P800, DOI 10.1210/er.2004-0023; Metcalfe R, 2002, J CLIN ENDOCR METAB, V87, P1754, DOI 10.1210/jc.87.4.1754; Misharin AV, 2009, ENDOCRINOLOGY, V150, P3944, DOI 10.1210/en.2009-0181; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Morshed SA, 2010, ENDOCRINOLOGY, V151, P5537, DOI 10.1210/en.2010-0424; Nagayama Y, 2003, THYROID, V13, P233, DOI 10.1089/105072503321582024; Nagayama Y, 2002, J IMMUNOL, V168, P2789, DOI 10.4049/jimmunol.168.6.2789; Nagayama Y, 2007, THYROID, V17, P981, DOI 10.1089/thy.2007.0161; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; PISETSKY DS, 1977, J EXP MED, V146, P1603, DOI 10.1084/jem.146.6.1603; Rapoport B, 2010, GENES IMMUN, V11, P254, DOI 10.1038/gene.2010.8; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; RATANACHAIYAVONG S, 1991, CLIN EXP IMMUNOL, V84, P48; RUDIKOFF S, 1976, J EXP MED, V144, P1294, DOI 10.1084/jem.144.5.1294; Sanders J, 2005, THYROID, V15, P672, DOI 10.1089/thy.2005.15.672; Schwarz-Lauer L, 2003, ENDOCRINOLOGY, V144, P1718, DOI 10.1210/en.2002-0069; SEMMA M, 1981, IMMUNOLOGY, V42, P45; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Spindler KR, 2010, J IMMUNOL, V184, P3055, DOI 10.4049/jimmunol.0903363; STENSZKY V, 1985, J CLIN ENDOCR METAB, V61, P735, DOI 10.1210/jcem-61-4-735; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; TRAYSTMAN MD, 1991, CLIN EXP IMMUNOL, V86, P291, DOI 10.1111/j.1365-2249.1991.tb05812.x; Williams RW, 2001, GENOME BIOL, V2; Williams RW, 1998, J NEUROSCI, V18, P138	42	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21378	10.1371/journal.pone.0021378	http://dx.doi.org/10.1371/journal.pone.0021378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738647	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600033
J	Mukhopadhya, I; Thomson, JM; Hansen, R; Berry, SH; El-Omar, EM; Hold, GL				Mukhopadhya, Indrani; Thomson, John M.; Hansen, Richard; Berry, Susan H.; El-Omar, Emad M.; Hold, Georgina L.			Detection of Campylobacter concisus and Other Campylobacter Species in Colonic Biopsies from Adults with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LENGTH POLYMORPHISM ANALYSIS; BACTEROIDES-UREOLYTICUS; RAPID IDENTIFICATION; HELICOBACTER; PREVALENCE; EPIDEMIOLOGY; ARCOBACTER; DIVERSITY; SAMPLES	Introduction: The critical role of bacteria in the pathogenesis of ulcerative colitis (UC) is well recognized, but an individual causative microorganism has not been singled out so far. Campylobacter concisus and other non-jejuni species of Campylobacter have been implicated as putative aetiological agents in inflammatory bowel disease in children, but such studies have not been addressed in adults. This study investigated the prevalence of Campylobacter species in colonic biopsy samples from adults with UC and healthy controls. Methods: Adult patients who were undergoing diagnostic colonoscopy were recruited for the study, which included 69 patients with histologically proven UC and 65 healthy controls. DNA was extracted from the biopsy samples and subjected to Campylobacter genus specific and Campylobacter concisus specific polymerase chain reaction and sequencing. Results: Detection of all Campylobacter DNA utilising genus specific primers was significantly higher in cases of UC, with a prevalence of 73.9% (51/69) compared to 23.1% (15/65) in controls (p = 0.0001). Nested PCR for C. concisus DNA was positive in 33.3% (23/69) of biopsy samples fromsubjects with UC, which was significantly higher than the prevalence rate of 10.8% (7/65) from controls (p = 0.0019). Sequencing of the remaining Campylobacter positive samples revealed that Campylobacter ureolyticus was positive in 21.7% (15/69) of samples from UC subjects as opposed to 3.1% (2/65) in controls (p = 0.0013). Mixed Campylobacter species were more common in UC patients, 20.3% (14/69) as compared to controls 4.6% (3/65) (p = 0.0084). Conclusion: The higher prevalence of Campylobacter genus and more specifically C. concisus and C. ureolyticus in biopsy samples from adults with UC suggests these genera of bacteria may be involved in the chronic inflammation that is characteristically seen in UC. To the best of our knowledge this is the first report of this association of C. concisus and C. ureolyticus with UC in adults.	[Mukhopadhya, Indrani; Thomson, John M.; Hansen, Richard; Berry, Susan H.; El-Omar, Emad M.; Hold, Georgina L.] Univ Aberdeen, Div Appl Med, Gastrointestinal Res Grp, Aberdeen, Scotland	University of Aberdeen	Mukhopadhya, I (corresponding author), Univ Aberdeen, Div Appl Med, Gastrointestinal Res Grp, Foresterhill, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Mukhopadhya, Indrani/K-1113-2019; Hansen, Richard/G-3871-2011; El-Omar, Emad/AAT-7780-2021; Hold, Georgina Louise/AAG-9923-2020	Mukhopadhya, Indrani/0000-0003-2577-518X; Hold, Georgina Louise/0000-0001-7573-3397; El-Omar, Emad/0000-0002-0011-3924; Hansen, Richard/0000-0002-3944-6646	Broad Medical Research Program [IBD-0178]; GI Research Unit, Aberdeen Royal Infirmary	Broad Medical Research Program; GI Research Unit, Aberdeen Royal Infirmary	This work was funded by the Broad Medical Research Program (Grant number IBD-0178). JMT was supported by grants from the GI Research Unit, Aberdeen Royal Infirmary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabenhus R, 2005, J CLIN MICROBIOL, V43, P5091, DOI 10.1128/JCM.43.10.5091-5096.2005; Aabenhus R, 2002, SCAND J INFECT DIS, V34, P248, DOI 10.1080/00365540110080566; Armitage E, 2001, EUR J GASTROEN HEPAT, V13, P1439, DOI 10.1097/00042737-200112000-00007; Baumgart DC, 2011, INFLAMM BOWEL DIS, V17, P639, DOI 10.1002/ibd.21409; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; Bohr URM, 2004, J CLIN MICROBIOL, V42, P2766, DOI 10.1128/JCM.42.6.2766-2768.2004; Bullman S, 2011, FEMS IMMUNOL MED MIC, V61, P228, DOI 10.1111/j.1574-695X.2010.00760.x; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; DUERDEN BI, 1989, J MED MICROBIOL, V29, P63, DOI 10.1099/00222615-29-1-63; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Engberg J, 2005, CLIN MICROBIOL INFEC, V11, P288, DOI 10.1111/j.1469-0691.2005.01111.x; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Gillespie IA, 2009, EMERG INFECT DIS, V15, P2046, DOI 10.3201/eid1512.090280; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Hansen R, 2010, J GASTROENTEROL, V45, P266, DOI 10.1007/s00535-009-0191-y; HENDERSON P, 2011, INFLAMM BOWEL DIS; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Istivan TS, 2008, FEMS IMMUNOL MED MIC, V54, P224, DOI 10.1111/j.1574-695X.2008.00467.x; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Kalischuk LD, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-53; Lastovica AJ, 2009, J CLIN MICROBIOL, V47, P2360, DOI 10.1128/JCM.00568-09; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Macuch PJ, 2000, J DENT RES, V79, P785, DOI 10.1177/00220345000790021301; Man SM, 2010, J INFECT DIS, V202, P1855, DOI 10.1086/657316; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Marshall SM, 1999, J CLIN MICROBIOL, V37, P4158, DOI 10.1128/JCM.37.12.4158-4160.1999; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Saitoh S, 2002, CLIN DIAGN LAB IMMUN, V9, P54, DOI 10.1128/CDLI.9.1.54-59.2002; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Sonnenberg A, 2010, EUR J GASTROEN HEPAT, V22, P95, DOI 10.1097/MEG.0b013e32832e9d54; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tannock GW, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/954051; Thomson JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017184; Vandamme P, 2010, INT J SYST EVOL MICR, V60, P2016, DOI 10.1099/ijs.0.017152-0; Woolley PD, 2000, INT J STD AIDS, V11, P347, DOI 10.1258/0956462001915976; Zhang L, 2010, J CLIN MICROBIOL, V48, P2965, DOI 10.1128/JCM.02391-09; Zhang L, 2009, J CLIN MICROBIOL, V47, P453, DOI 10.1128/JCM.01949-08	39	99	103	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21490	10.1371/journal.pone.0021490	http://dx.doi.org/10.1371/journal.pone.0021490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738679	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600045
J	Liu, B; Wang, GS; Yang, J; Pan, XD; Yang, ZC; Zang, LQ				Liu, Bing; Wang, Genshu; Yang, Jie; Pan, Xuediao; Yang, Zhicheng; Zang, Linquan			Berberine Inhibits Human Hepatoma Cell Invasion without Cytotoxicity in Healthy Hepatocytes	PLOS ONE			English	Article							NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; MATRIX METALLOPROTEINASES; CANCER CELLS; APOPTOSIS; EXPRESSION; MIGRATION; PATHWAY; ACTIVATION; ADHESION	Conventional chemotherapy fails to cure metastatic hepatoma mainly due to its high hepatotoxicity. Many plant-derived agents have been accepted to effectively inhibit hepatoma cell invasion. However, the investigation that whether effectual plant-derived agents against invasive hepatoma cells exert unexpected cytotoxicity in healthy hepatocytes has been ignored. This study demonstrated that berberine exhibited significant cytotoxicity in HepG2 cells mainly through upregulation of reactive oxygen species (ROS) production but was ineffective in normal Chang liver cells. Berberine exerted anti-invasive effect on HepG2 cells through suppression of matrix metalloproteinase-9 (MMP-9) expression. Moreover, berberine could significantly inhibit the activity of PI3K-AKT and ERK pathways. Combination treatment of ERK pathway inhibitor PD98059 or AKT pathway inhibitor LY294002 and berberine could result in a synergistic reduction on MMP-9 expression along with an inhibition of cell invasion. Enhancement of ROS production by berberine had no influence on its suppressive effects on the activity of PI3K-AKT and ERK pathways, as well as MMP-9 expression and HepG2 cell invasion. In conclusion, our results suggest that berberine may be a potential alternative against invasive hepatoma cells through PI3K-AKT and ERK pathways-dependent downregulation of MMP-9 expression. This study also provides a previously neglected insight into the investigation of plant-derived agents-based therapy against tumor invasion with the consideration of damage to healthy cells.	[Liu, Bing; Pan, Xuediao; Yang, Zhicheng; Zang, Linquan] Guangdong Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China; [Wang, Genshu] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Liver Surg, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Jie] Guangxi Med Univ, Sch Pharm, Dept Pharmacol, Nanning, Peoples R China	Guangdong Pharmaceutical University; Sun Yat Sen University; Guangxi Medical University	Liu, B (corresponding author), Guangdong Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China.	gdpuhepatology@163.com						Abiru S, 2002, HEPATOLOGY, V35, P1117, DOI 10.1053/jhep.2002.32676; Arii S, 1996, HEPATOLOGY, V24, P316; Bahassi EM, 2004, CLIN EXP METASTAS, V21, P293, DOI 10.1023/B:CLIN.0000046132.46946.dd; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Groth S, 2005, J BIOL CHEM, V280, P33190, DOI 10.1074/jbc.M504249200; Gui SY, 2008, PHARMAZIE, V63, P516, DOI 10.1691/ph.2008.8018; He B, 2009, CLIN CANCER RES, V15, P5803, DOI 10.1158/1078-0432.CCR-09-0811; Ho YT, 2009, CANCER LETT, V279, P155, DOI 10.1016/j.canlet.2009.01.033; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Jantova S, 2003, J PHARM PHARMACOL, V55, P1143, DOI 10.1211/002235703322277186; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kim JH, 2004, ONCOL REP, V12, P1233; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Kim Won Ho, 1993, Yonsei Medical Journal, V34, P45; KOHN EC, 1995, CANCER RES, V55, P1856; Kozuki Y, 2000, CANCER LETT, V151, P111, DOI 10.1016/S0304-3835(99)00418-8; Kozuki Y, 2001, CANCER LETT, V167, P151, DOI 10.1016/S0304-3835(01)00476-1; Lin TH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-58; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Monvoisin A, 1999, J HEPATOL, V30, P511, DOI 10.1016/S0168-8278(99)80113-5; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Pervaiz S, 2002, CURR PHARM DESIGN, V8, P1723, DOI 10.2174/1381612023394025; Sanceau J, 2003, J BIOL CHEM, V278, P36537, DOI 10.1074/jbc.M304300200; Scheving LA, 2007, AM J PHYSIOL-GASTR L, V293, pG552, DOI 10.1152/ajpgi.00140.2007; Sener SF, 2005, J SURG ONCOL, V92, P1, DOI 10.1002/jso.20335; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Takahra T, 2004, INT J BIOCHEM CELL B, V36, P353, DOI 10.1016/S1357-2725(03)00260-7; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; Thomas MB, 2008, ANN SURG ONCOL, V15, P1008, DOI 10.1245/s10434-007-9705-0; Tsai PL, 2004, DRUG METAB DISPOS, V32, P405, DOI 10.1124/dmd.32.4.405; Tsang CM, 2009, INT J MOL MED, V24, P131, DOI 10.3892/ijmm_00000216; van Waveren C, 2006, CARCINOGENESIS, V27, P409, DOI 10.1093/carcin/bgi242; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Xu G, 2004, INT J ONCOL, V24, P893; Yagasaki K, 2000, CYTOTECHNOLOGY, V33, P229, DOI 10.1023/A:1008141918852; Ye MZ, 2009, J PHARM PHARMACOL, V61, P831, DOI [10.1211/jpp.61.07.0001, 10.1211/jpp/61.07.0001]; Zhang GY, 2000, CANCER LETT, V159, P169, DOI 10.1016/S0304-3835(00)00545-0; 2004, INT J CANC, V111, P174	48	92	101	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21416	10.1371/journal.pone.0021416	http://dx.doi.org/10.1371/journal.pone.0021416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21738655	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900028
J	Magico, AC; Bell, JB				Magico, Adam C.; Bell, John B.			Identification of a Classical Bipartite Nuclear Localization Signal in the Drosophila TEA/ATTS Protein Scalloped	PLOS ONE			English	Article							DNA-BINDING DOMAIN; CELL-PROLIFERATION; EXPORT SIGNALS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; IMPORTIN ALPHA-1; TEAD/TEF FAMILY; WING FORMATION; VIRUS TYPE-1	Drosophila melanogaster wing development has been shown to rely on the activity of a complex of two proteins, Scalloped (Sd) and Vestigial (Vg). Within this complex, Sd is known to provide DNA binding though its TEA/ATTS domain, while Vg modulates this binding and provides transcriptional activation through N- and C-terminal activation domains. There is also evidence that Sd is required for the nuclear translocation of Vg. Indeed, a candidate sequence which shows consensus to the bipartite family of nuclear localization signals (NLSs) has been identified within Sd previously, though it is not known if it is functional, or if additional unpredicted signals that mediate nuclear transport exist within the protein. By expressing various enhanced green fluorescent protein (eGFP) tagged constructs within Drosophila S2 cells, we demonstrate that this NLS is indeed functional and necessary for the proper nuclear localization of Sd. Additionally, the region containing the NLS is critical for the wildtype function of ectopically expressed Sd, in the context of wing development. Using site-directed mutagenesis, we have identified a group of five amino acids within this NLS which is critical for its function, as well as another group of two which is of lesser importance. Together with data that suggests that this sequence mediates interactions with Importin-alpha 3, we conclude that the identified NLS is likely a classical bipartite signal. Further dissection of Sd has also revealed that a large portion of the C-terminal domain of the protein is required its proper nuclear localization. Finally, a Leptomycin B (LB) sensitive signal which appears to facilitate nuclear export is identified, raising the possibility that Sd also contains a nuclear export signal (NES).	[Magico, Adam C.; Bell, John B.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Magico, AC (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	jbell@ualberta.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant (http://www.nserc-crsng.gc.ca/index_eng.asp) to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; CAMPBELL S, 1992, GENE DEV, V6, P367, DOI 10.1101/gad.6.3.367; Chan WM, 2007, FLY, V1, P340, DOI 10.4161/fly.5320; Chen HH, 2004, J BIOL CHEM, V279, P30800, DOI 10.1074/jbc.M400154200; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chow L, 2004, GENOME, V47, P849, DOI 10.1139/G04-060; Cressman DE, 2001, J IMMUNOL, V167, P3626, DOI 10.4049/jimmunol.167.7.3626; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; Delanoue R, 2004, CELL DEATH DIFFER, V11, P110, DOI 10.1038/sj.cdd.4401321; Deng H, 2009, MOL BIOL CELL, V20, P256, DOI 10.1091/mbc.E08-03-0288; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Garg A, 2007, GENETICS, V175, P659, DOI 10.1534/genetics.106.063966; Gassman NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017907; Gorjanacz M, 2002, DEV BIOL, V251, P271, DOI 10.1006/dbio.2002.0827; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; Halder G, 2001, DEVELOPMENT, V128, P3295; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; HWANG JJ, 1993, EMBO J, V12, P2337, DOI 10.1002/j.1460-2075.1993.tb05888.x; Jacquemin P, 1996, J BIOL CHEM, V271, P21775, DOI 10.1074/jbc.271.36.21775; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Kosugi S, 2008, TRAFFIC, V9, P2053, DOI 10.1111/j.1600-0854.2008.00825.x; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LALOUX I, 1990, MOL CELL BIOL, V10, P3541, DOI 10.1128/MCB.10.7.3541; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; MacKay JO, 2003, GENETICS, V163, P1365; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P971, DOI 10.1023/B:BIRY.0000043539.07961.4c; Mason DA, 2002, GENETICS, V161, P157; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Meyer BE, 1996, J VIROL, V70, P2350, DOI 10.1128/JVI.70.4.2350-2359.1996; North AJ, 2006, J CELL BIOL, V172, P9, DOI 10.1083/jcb.200507103; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Ratan R, 2008, GENETICS, V178, P839, DOI 10.1534/genetics.107.081778; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Srivastava A, 2004, GENETICS, V166, P1833, DOI 10.1534/genetics.166.4.1833; Srivastava A, 2002, GENESIS, V33, P40, DOI 10.1002/gene.10086; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; YLIKOMI T, 1992, EMBO J, V11, P3681, DOI 10.1002/j.1460-2075.1992.tb05453.x; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zheng C, 2005, J VIROL, V79, P11864, DOI 10.1128/JVI.79.18.11864-11872.2005	62	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21431	10.1371/journal.pone.0021431	http://dx.doi.org/10.1371/journal.pone.0021431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731746	Green Submitted, Green Published, gold			2022-12-25	WOS:000292035400037
J	Belbin, O; Crump, M; Bisceglio, GD; Carrasquillo, MM; Morgan, K; Younkin, SG				Belbin, Olivia; Crump, Michael; Bisceglio, Gina D.; Carrasquillo, Minerva M.; Morgan, Kevin; Younkin, Steven G.			Multiple Insulin Degrading Enzyme Variants Alter In Vitro Reporter Gene Expression	PLOS ONE			English	Article							AMYLOID BETA-PROTEIN; BLOCK SPANNING IDE; ALZHEIMERS-DISEASE; A-BETA; PEPTIDE; BRAIN; DEGRADATION; DEPOSITION; NEURONS	The insulin degrading enzyme (IDE) variant, v311 (rs6583817), is associated with increased post-mortem cerebellar IDE mRNA, decreased plasma beta-amyloid (A beta), decreased risk for Alzheimer's disease (AD) and increased reporter gene expression, suggesting that it is a functional variant driving increased IDE expression. To identify other functional IDE variants, we have tested v685, rs11187061 (associated with decreased cerebellar IDE mRNA) and variants on H6, the haplotype tagged by v311 (v10; rs4646958, v315; rs7895832, v687; rs17107734 and v154; rs4646957), for altered in vitro reporter gene expression. The reporter gene expression levels associated with the second most common haplotype (H2) successfully replicated the post-mortem findings in hepatocytoma (0.89 fold-change, p = 0.04) but not neuroblastoma cells. Successful in vitro replication was achieved for H6 in neuroblastoma cells when the sequence was cloned 5' to the promoter (1.18 fold-change, p = 0.006) and 3' to the reporter gene (1.29 fold change, p = 0.003), an effect contributed to by four variants (v10, v315, v154 and v311). Since IDE mediates A beta degradation, variants that regulate IDE expression could represent good therapeutic targets for AD.	[Belbin, Olivia; Crump, Michael; Bisceglio, Gina D.; Carrasquillo, Minerva M.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Belbin, Olivia; Morgan, Kevin] Univ Nottingham, Queens Med Ctr, Inst Genet, Sch Mol Med Sci, Nottingham NG7 2RD, England	Mayo Clinic; University of Nottingham	Belbin, O (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	kevin.morgan@nottingham.ac.uk		Belbin, Olivia/0000-0002-9805-8408; Morgan, Kevin/0000-0002-8217-2396; Belbin, Olivia/0000-0002-6109-6371	Alzheimer's Research Trust; Big Lottery Fund; US National Institutes of Health; NIA [R01 AG18023]; Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; NATIONAL INSTITUTE ON AGING [R01AG018023] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-BIG2009-1, ART-PPG2008A-3, ART-SB2010A-1] Funding Source: researchfish	Alzheimer's Research Trust; Big Lottery Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	Support for this research was provided by grants from the Alzheimer's Research Trust (OB and KM) and the Big Lottery Fund (KM), US National Institutes of Health, NIA (R01 AG18023, SGY), Robert and Clarice Smith Postdoctoral Fellowship (MMC), Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program (SGY) and by the Palumbo Professorship in Alzheimer's Disease Research (SGY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstrom JR, 1996, J NEUROSCI, V16, P7910; Bernstein HG, 1999, NEUROSCI LETT, V263, P161, DOI 10.1016/S0304-3940(99)00135-4; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Carrasquillo MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008764; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; McDermott JR, 1997, NEUROCHEM RES, V22, P49, DOI 10.1023/A:1027325304203; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872	16	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21429	10.1371/journal.pone.0021429	http://dx.doi.org/10.1371/journal.pone.0021429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731745	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700083
J	Chiluiza, D; Bargo, S; Callahan, R; Rhoads, RE				Chiluiza, David; Bargo, Sharon; Callahan, Robert; Rhoads, Robert E.			Expression of Truncated Eukaryotic Initiation Factor 3e (eIF3e) Resulting from Integration of Mouse Mammary Tumor Virus (MMTV) Causes a Shift from Cap-dependent to Cap-independent Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; PROTEIN-SYNTHESIS; MESSENGER-RNAS; MALIGNANT-TRANSFORMATION; CELL-DEATH; GENE; REVEALS; PATHWAYS; OVEREXPRESSION; INHIBITOR	Integration of mouse mammary tumor virus (MMTV) at the common integration site Int6 occurs in the gene encoding eIF3e, the p48 subunit of translation initiation factor eIF3. Integration is at any of several introns of the Eif3e gene and causes the expression of truncated Eif3e mRNAs. Ectopic expression of the truncated eIF3e protein resulting from integration at intron 5 (3e5) induces malignant transformation, but by an unknown mechanism. Because eIF3e makes up at least part of the binding site for eIF4G, we examined the effects of 3e5 expression on protein synthesis. We developed an NIH3T3 cell line that contains a single copy of the 3e5 sequence at a predetermined genomic site. Co-immunoprecipitation indicated diminished binding of eIF3 to eIF4G, signifying a reduction in recruitment of the mRNA-unwinding machinery to the 43 S preinitiation complex. Cell growth and overall protein synthesis were decreased. Translation driven by the eIF4G-independent hepatitis C virus internal ribosome entry sequence (HCV IRES) in a bicistronic mRNA was increased relative to cap-dependent translation. Endogenous mRNAs encoding XIAP, c-Myc, CYR61, and Pim-1, which are translated in a cap-independent manner, were shifted to heavier polysomes whereas mRNAs encoding GAPDH, actin, L32, and L34, which are translated in a cap-dependent manner, were shifted to lighter polysomes. We propose that expression of 3e5 diminishes eIF4G interaction with eIF3 and causes abnormal gene expression at the translational level. The correlation between up-regulation of cap-independent translation and MMTV-induced tumorigenesis contrasts with the well established model for malignant transformation involving up-regulation of highly cap-dependent translation.	[Chiluiza, David; Rhoads, Robert E.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71106 USA; [Bargo, Sharon; Callahan, Robert] NCI, Mammary Biol & Tumorigenesis Lab, NIH, Bethesda, MD 20892 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rhoads, RE (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA.	rrhoad@lsuhsc.edu			NIGMS, National Institutes of Health [R01GM20818]; NATIONAL CANCER INSTITUTE [ZIABC005148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020818] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant R01GM20818 from the NIGMS, National Institutes of Health.	Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Baranick BT, 2008, P NATL ACAD SCI USA, V105, P4733, DOI 10.1073/pnas.0710650105; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley CA, 2002, J BIOL CHEM, V277, P12559, DOI 10.1074/jbc.M111134200; Buttitta F, 2005, CLIN CANCER RES, V11, P3198, DOI 10.1158/1078-0432.CCR-04-2308; Byrd MP, 2002, MOL CELL BIOL, V22, P4499, DOI 10.1128/MCB.22.13.4499-4511.2002; CALLAHAN R, 1976, P NATL ACAD SCI USA, V73, P3579, DOI 10.1073/pnas.73.10.3579; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P309, DOI 10.1007/s10911-008-9092-6; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P269, DOI 10.1007/s10911-008-9094-4; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Diella F, 1997, DNA CELL BIOL, V16, P839, DOI 10.1089/dna.1997.16.839; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Fraser CS, 2009, NAT STRUCT MOL BIOL, V16, P397, DOI 10.1038/nsmb.1572; Grudzien E, 2006, J BIOL CHEM, V281, P1857, DOI 10.1074/jbc.M509121200; Grzmil M, 2010, ONCOGENE, V29, P4080, DOI 10.1038/onc.2010.152; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; HOAREAU AK, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Jin Y, 2004, CELL MOL NEUROBIOL, V24, P853, DOI 10.1007/s10571-004-6924-9; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Jopling CL, 2004, RNA, V10, P287, DOI 10.1261/rna.5138804; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; Kapasi P, 2007, MOL CELL, V25, P113, DOI 10.1016/j.molcel.2006.11.028; Kindich R, 2005, CLIN CHEM, V51, P649, DOI 10.1373/clinchem.2004.045013; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Korneeva NL, 2000, J BIOL CHEM, V275, P41369, DOI 10.1074/jbc.M007525200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; Mack DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1742; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Maquat LE, 2009, BIOCHEM SOC T, V37, P1287, DOI 10.1042/BST0371287; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Marchetti A, 2001, INT J ONCOL, V18, P175; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; Menendez JA, 2003, ENDOCR-RELAT CANCER, V10, P141, DOI 10.1677/erc.0.0100141; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Raafat A, 2009, ONCOGENE, V28, P219, DOI 10.1038/onc.2008.379; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Sizova DV, 1998, J VIROL, V72, P4775, DOI 10.1128/JVI.72.6.4775-4782.1998; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Tekmal R.R., 1997, FRONT BIOSCI, V2, P519; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; YAN RQ, 1992, J BIOL CHEM, V267, P23226; Zhang LL, 2007, J BIOL CHEM, V282, P5790, DOI 10.1074/jbc.M606284200	57	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31288	31296		10.1074/jbc.M111.267294	http://dx.doi.org/10.1074/jbc.M111.267294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21737453	Green Published, hybrid			2022-12-25	WOS:000294487500024
J	McMillin, DW; Delmore, J; Negri, J; Ooi, M; Klippel, S; Miduturu, CV; Gray, NS; Richardson, PG; Anderson, KC; Kung, AL; Mitsiades, CS				McMillin, Douglas W.; Delmore, Jake; Negri, Joseph; Ooi, Melissa; Klippel, Steffen; Miduturu, Chandrasekhar V.; Gray, Nathanael S.; Richardson, Paul G.; Anderson, Kenneth C.; Kung, Andrew L.; Mitsiades, Constantine S.			Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; GENE-EXPRESSION; BI 2536; MOLECULAR CLASSIFICATION; CHROMOSOMAL INSTABILITY; DRUG-RESISTANCE; CANCER-CELLS; PHASE-I; SURVIVAL; APOPTOSIS	Polo-like kinases (PLKs) play an important role in cell cycle progression, checkpoint control and mitosis. The high mitotic index and chromosomal instability of advanced cancers suggest that PLK inhibitors may be an attractive therapeutic option for presently incurable advanced neoplasias with systemic involvement, such as multiple myeloma (MM). We studied the PLK 1, 2, 3 inhibitor BI 2536 and observed potent (IC50,40 nM) and rapid (commitment to cell death,24 hrs) in vitro activity against MM cells in isolation, as well as in vivo activity against a traditional subcutaneous xenograft mousemodel. Tumor cells in MM patients, however, don't exist in isolation, but reside in and interact with the bone microenvironment. Therefore conventional in vitro and in vivo preclinical assays don't take into account how interactions between MM cells and the bone microenvironment can potentially confer drug resistance. To probe this question, we performed tumor cell compartment-specific bioluminescence imaging assays to compare the preclinical anti-MM activity of BI 2536 in vitro in the presence vs. absence of stromal cells or osteoclasts. We observed that the presence of these bone marrow non-malignant cells led to decreased anti-MM activity of BI 2536. We further validated these results in an orthotopic in vivo mouse model of diffuse MM bone lesions where tumor cells interact with non-malignant cells of the bone microenvironment. We again observed that BI 2536 had decreased activity in this in vivo model of tumor-bone microenvironment interactions highlighting that, despite BI 2536's promising activity in conventional assays, its lack of activity in microenvironmental models raises concerns for its clinical development for MM. More broadly, preclinical drug testing in the absence of relevant tumor microenvironment interactions may overestimate potential clinical activity, thus explaining at least in part the gap between preclinical vs. clinical efficacy in MM and other cancers.	[McMillin, Douglas W.; Delmore, Jake; Negri, Joseph; Ooi, Melissa; Klippel, Steffen; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Boston, MA 02115 USA; [McMillin, Douglas W.; Delmore, Jake; Negri, Joseph; Ooi, Melissa; Klippel, Steffen; Richardson, Paul G.; Anderson, Kenneth C.; Mitsiades, Constantine S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Miduturu, Chandrasekhar V.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Dept Canc Biol, Boston, MA 02115 USA; [Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kung, Andrew L.] Childrens Hosp Boston, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	McMillin, DW (corresponding author), Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Med Oncol, Boston, MA 02115 USA.	Constantine_Mitsiades@dfci.harvard.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; Ooi, Melissa/0000-0002-7392-0655	Dana-Farber Cancer Institute; Chambers Medical Foundation; Stepanian Fund for Myeloma Research; Cobb Family Fellowship; NIH [R01CA050947]; Millennium; Celgene; Amgen Pharmaceuticals; AVEO Pharma; EMD Serono; Sunesis; Gloucester Pharmaceuticals; Johnson Johnson; NATIONAL CANCER INSTITUTE [R01CA050947] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute; Chambers Medical Foundation; Stepanian Fund for Myeloma Research; Cobb Family Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium(Takeda Pharmaceutical Company Ltd); Celgene(Bristol-Myers SquibbCelgene Corporation); Amgen Pharmaceuticals(Amgen); AVEO Pharma(Dexcel Pharma); EMD Serono; Sunesis; Gloucester Pharmaceuticals; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by the "Dunkin Donuts Rising Stars" Program at the Dana-Farber Cancer Institute (C. S. M.), the Chambers Medical Foundation (P. G. R. and C. S. M.), the Stepanian Fund for Myeloma Research (P. G. R. and C. S. M.), the Cobb Family Fellowship (D. W. M.), and NIH grant R01CA050947 (C. S. M. and K. C. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; D. W. M. is an equity holder in Axios Biosciences. J.D., J.N., M.O., S. K., C. V. M., N.S.G., and A. L. K. have nothing to disclose. P. G. R. has received honoraria from Millennium and Celgene. K. C. A. has received research grants and honoraria from Millennium and Celgene. C. S. M. has received in the past Consultant honoraria from Millennium Pharmaceuticals, Novartis Pharmaceuticals, Bristol-Myers Squibb, Merck & Co., Kosan Pharmaceuticals, Celgene and Pharmion, licensing royalties from PharmaMar, and research funding from Amgen Pharmaceuticals, AVEO Pharma, EMD Serono, Sunesis, Gloucester Pharmaceuticals, and Johnson & Johnson.	Barlogie B, 2001, BLOOD, V98, P492, DOI 10.1182/blood.V98.2.492; BREITKREUTZ I, 2008, LEUKEMIA; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Burington B, 2008, CLIN CANCER RES, V14, P4821, DOI 10.1158/1078-0432.CCR-07-4568; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Food and Drug Administration, 2004, INN STAGN CHALL OPP; HOFFMANN MG, 2004, DIHYDROPTERIDINONES; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; HOLTRICH U, 1994, P NATL ACAD SCI USA, V91, P1736, DOI 10.1073/pnas.91.5.1736; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Mattioli M, 2005, ONCOGENE, V24, P2461, DOI 10.1038/sj.onc.1208447; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; McMillin DW, 2009, CANCER RES, V69, P5835, DOI 10.1158/0008-5472.CAN-08-4285; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Ng SS, 2006, CURR GENET, V50, P73, DOI 10.1007/s00294-006-0077-y; Olmos D, 2011, CLIN CANC RES; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Sebastian M, 2010, J THORAC ONCOL, V5, P1060, DOI 10.1097/JTO.0b013e3181d95dd4; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; STEWART HJ, 2010, EXP HEMATOL; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	26	29	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e20226	10.1371/journal.pone.0020226	http://dx.doi.org/10.1371/journal.pone.0020226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750699	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400001
J	Sarrion-Perdigones, A; Falconi, EE; Zandalinas, SI; Juarez, P; Fernandez-del-Carmen, A; Granell, A; Orzaez, D				Sarrion-Perdigones, Alejandro; Elvira Falconi, Erica; Zandalinas, Sara I.; Juarez, Paloma; Fernandez-del-Carmen, Asun; Granell, Antonio; Orzaez, Diego			GoldenBraid: An Iterative Cloning System for Standardized Assembly of Reusable Genetic Modules	PLOS ONE			English	Article							PLANT TRANSFORMATION; EXPRESSION; VECTORS	Synthetic Biology requires efficient and versatile DNA assembly systems to facilitate the building of new genetic modules/pathways from basic DNA parts in a standardized way. Here we present GoldenBraid (GB), a standardized assembly system based on type IIS restriction enzymes that allows the indefinite growth of reusable gene modules made of standardized DNA pieces. The GB system consists of a set of four destination plasmids (pDGBs) designed to incorporate multipartite assemblies made of standard DNA parts and to combine them binarily to build increasingly complex multigene constructs. The relative position of type IIS restriction sites inside pDGB vectors introduces a double loop ("braid'') topology in the cloning strategy that allows the indefinite growth of composite parts through the succession of iterative assembling steps, while the overall simplicity of the system is maintained. We propose the use of GoldenBraid as an assembly standard for Plant Synthetic Biology. For this purpose we have GB-adapted a set of binary plasmids for A. tumefaciens-mediated plant transformation. Fast GB-engineering of several multigene T-DNAs, including two alternative modules made of five reusable devices each, and comprising a total of 19 basic parts are also described.	[Sarrion-Perdigones, Alejandro; Elvira Falconi, Erica; Zandalinas, Sara I.; Juarez, Paloma; Fernandez-del-Carmen, Asun; Granell, Antonio; Orzaez, Diego] Univ Politecn Valencia, IBMCP, CSIC, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Sarrion-Perdigones, A (corresponding author), Univ Politecn Valencia, IBMCP, CSIC, Valencia, Spain.	dorzaez@ibmcp.upv.es	Sarrion-Perdigones, Alejandro/H-6750-2019; Granell, Antonio/G-3664-2010; ORZAEZ, DIEGO/X-2915-2019; Zandalinas, Sara I/AAH-1075-2019; Orzaez, Diego/H-3457-2012	Sarrion-Perdigones, Alejandro/0000-0002-4584-4827; ORZAEZ, DIEGO/0000-0003-1662-5403; Zandalinas, Sara I/0000-0002-1256-9371; Orzaez, Diego/0000-0003-1662-5403; Fernandez-del-Carmen, Maria Asuncion/0000-0002-9202-4960	Spanish Ministry of Science and Innovation [BIO2008-03434, BIO2010-15384]; Spanish Ministry of Education	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation grants BIO2008-03434 and BIO2010-15384. A. Sarrion-Perdigones is a recipient of a FPI fellowship of the Spanish Ministry of Science and Innovation and P. Juarez is a recipient of a FPU fellowship from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Carter GW, 2010, CHAOS, V20, DOI 10.1063/1.3455183; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Check E, 2005, NATURE, V438, P417, DOI 10.1038/438417a; Chen QJ, 2006, PLANT MOL BIOL, V62, P927, DOI 10.1007/s11103-006-9065-3; Chen QJ, 2010, PLANT PHYSIOL, V153, P41, DOI 10.1104/pp.109.152249; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Fujisawa M, 2009, J EXP BOT, V60, P1319, DOI 10.1093/jxb/erp006; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goderis IJWM, 2002, PLANT MOL BIOL, V50, P17, DOI 10.1023/A:1016052416053; Hamilton CM, 1997, GENE, V200, P107, DOI 10.1016/S0378-1119(97)00388-0; Haseloff J, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0176.focus; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Estornell LH, 2009, PLANT BIOTECHNOL J, V7, P298, DOI 10.1111/j.1467-7652.2009.00402.x; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Knight T., 2003, IDEMPOTENT VECTOR DE; Kobayashi K, 2006, PLANT CELL REP, V25, P1347, DOI 10.1007/s00299-006-0206-6; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Lin L, 2003, P NATL ACAD SCI USA, V100, P5962, DOI 10.1073/pnas.0931425100; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; MORBITZER R, 2011, NUCL ACIDS IN PRESS, DOI DOI 10.1093/NAR/GKR15; NAQVI S, 2009, TRENDS PLANT SCI; WEBER E, PLOS ONE, V6; Wieland WH, 2006, J BIOTECHNOL, V122, P382, DOI 10.1016/j.jbiotec.2005.12.020; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	33	188	204	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21622	10.1371/journal.pone.0021622	http://dx.doi.org/10.1371/journal.pone.0021622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750718	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400008
J	Lamb, JR; Zhang, CS; Xie, T; Wang, K; Zhang, B; Hao, K; Chudin, E; Fraser, HB; Millstein, J; Ferguson, M; Suver, C; Ivanovska, I; Scott, M; Philippar, U; Bansal, D; Zhang, Z; Burchard, J; Smith, R; Greenawalt, D; Cleary, M; Derry, J; Loboda, A; Watters, J; Poon, RTP; Fan, ST; Yeung, C; Lee, NPY; Guinney, J; Molony, C; Emilsson, V; Buser-Doepner, C; Zhu, J; Friend, S; Mao, M; Shaw, PM; Dai, HY; Luk, JM; Schadt, EE				Lamb, John R.; Zhang, Chunsheng; Xie, Tao; Wang, Kai; Zhang, Bin; Hao, Ke; Chudin, Eugene; Fraser, Hunter B.; Millstein, Joshua; Ferguson, Mark; Suver, Christine; Ivanovska, Irena; Scott, Martin; Philippar, Ulrike; Bansal, Dimple; Zhang, Zhan; Burchard, Julja; Smith, Ryan; Greenawalt, Danielle; Cleary, Michele; Derry, Jonathan; Loboda, Andrey; Watters, James; Poon, Ronnie T. P.; Fan, Sheung T.; Yeung, Chun; Lee, Nikki P. Y.; Guinney, Justin; Molony, Cliona; Emilsson, Valur; Buser-Doepner, Carolyn; Zhu, Jun; Friend, Stephen; Mao, Mao; Shaw, Peter M.; Dai, Hongyue; Luk, John M.; Schadt, Eric E.			Predictive Genes in Adjacent Normal Tissue Are Preferentially Altered by sCNV during Tumorigenesis in Liver Cancer and May Rate Limiting	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; HEPATOCELLULAR-CARCINOMA; SEGREGATION ERRORS; GENOMIC ANALYSIS; EXPRESSION; MICE; TUMORS; CLASSIFICATION; EVOLUTION; DISEASE	Background: In hepatocellular carcinoma (HCC) genes predictive of survival have been found in both adjacent normal (AN) and tumor (TU) tissues. The relationships between these two sets of predictive genes and the general process of tumorigenesis and disease progression remains unclear. Methodology/Principal Findings: Here we have investigated HCC tumorigenesis by comparing gene expression, DNA copy number variation and survival using similar to 250 AN and TU samples representing, respectively, the pre-cancer state, and the result of tumorigenesis. Genes that participate in tumorigenesis were defined using a gene-gene correlation meta-analysis procedure that compared AN versus TU tissues. Genes predictive of survival in AN (AN-survival genes) were found to be enriched in the differential gene-gene correlation gene set indicating that they directly participate in the process of tumorigenesis. Additionally the AN-survival genes were mostly not predictive after tumorigenesis in TU tissue and this transition was associated with and could largely be explained by the effect of somatic DNA copy number variation (sCNV) in cis and in trans. The data was consistent with the variance of AN-survival genes being rate-limiting steps in tumorigenesis and this was confirmed using a treatment that promotes HCC tumorigenesis that selectively altered AN-survival genes and genes differentially correlated between AN and TU. Conclusions/Significance: This suggests that the process of tumor evolution involves rate-limiting steps related to the background from which the tumor evolved where these were frequently predictive of clinical outcome. Additionally treatments that alter the likelihood of tumorigenesis occurring may act by altering AN-survival genes, suggesting that the process can be manipulated. Further sCNV explains a substantial fraction of tumor specific expression and may therefore be a causal driver of tumor evolution in HCC and perhaps many solid tumor types.	[Lamb, John R.; Zhang, Chunsheng; Xie, Tao; Wang, Kai; Zhang, Bin; Hao, Ke; Chudin, Eugene; Fraser, Hunter B.; Millstein, Joshua; Ferguson, Mark; Suver, Christine; Ivanovska, Irena; Zhang, Zhan; Burchard, Julja; Smith, Ryan; Greenawalt, Danielle; Derry, Jonathan; Molony, Cliona; Emilsson, Valur; Zhu, Jun; Mao, Mao; Dai, Hongyue; Schadt, Eric E.] Rosetta Inpharmat LLC, Seattle, WA USA; [Cleary, Michele; Loboda, Andrey; Watters, James; Buser-Doepner, Carolyn; Friend, Stephen; Shaw, Peter M.] Merck & Co Inc, Upper Gwynedd, PA USA; [Scott, Martin; Philippar, Ulrike; Bansal, Dimple] Merck & Co Inc, Boston, MA USA; [Poon, Ronnie T. P.; Fan, Sheung T.; Yeung, Chun; Lee, Nikki P. Y.; Luk, John M.] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Guinney, Justin] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Merck & Company; Merck & Company; Merck & Company; University of Hong Kong; Fred Hutchinson Cancer Center	Lamb, JR (corresponding author), Rosetta Inpharmat LLC, Seattle, WA USA.	john.lamb@pfizer.com; jmluk@nus.edu.sg; eschadt@pacificbiosciences.com	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940; Suver, Christine/0000-0002-2986-385X; Wang, Kai/0000-0003-0567-3004; Emilsson, Valur/0000-0001-9982-0524	Merck Co	Merck Co(Merck & Company)	This work was entirely funded by Merck & Co and its wholly owned subsidiary Rosetta Inpharmatics, Inc. Many of the authors were or are Merck employees. The manuscript was reviewed by Merck and approved for release into the public domain without alteration. Other than this Rosetta Inpharmatics and Merck had no role in study design, data collection and analysis, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; ATKIN NB, 1989, CANCER GENET CYTOGEN, V40, P3, DOI 10.1016/0165-4608(89)90140-4; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Costa JL, 2008, SEMIN RADIAT ONCOL, V18, P98, DOI 10.1016/j.semradonc.2007.10.005; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gisselsson D, 2008, CHROMOSOMA, V117, P511, DOI 10.1007/s00412-008-0169-1; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; HANSEMANN D, 1891, ARCH PATHOL ANAT PHY, V119, P299; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LEQUESNE JP, 2009, J PATHOL; Loeb LA, 2001, CANCER RES, V61, P3230; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nilsson B, 2009, BIOINFORMATICS, V25, P1078, DOI 10.1093/bioinformatics/btp091; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park CC, 2008, NAT GENET, V40, P421, DOI 10.1038/ng.113; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; SOBIN LH, 1988, CANCER, V61, P2310, DOI 10.1002/1097-0142(19880601)61:11<2310::AID-CNCR2820611127>3.0.CO;2-X; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wang YK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni177; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; XIE T, OMICS, V14, P91; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	40	56	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e20090	10.1371/journal.pone.0020090	http://dx.doi.org/10.1371/journal.pone.0020090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750698	Green Submitted, Green Published, gold			2022-12-25	WOS:000292512000005
J	Follo, C; Ozzano, M; Mugoni, V; Castino, R; Santoro, M; Isidoro, C				Follo, Carlo; Ozzano, Matteo; Mugoni, Vera; Castino, Roberta; Santoro, Massimo; Isidoro, Ciro			Knock-Down of Cathepsin D Affects the Retinal Pigment Epithelium, Impairs Swim-Bladder Ontogenesis and Causes Premature Death in Zebrafish	PLOS ONE			English	Article							D-DEFICIENT MICE; GENE-EXPRESSION; CELL-DEATH; EMBRYONIC-DEVELOPMENT; PROTEOMIC ANALYSIS; LYSOSOMAL STORAGE; OVARIAN-FOLLICLE; YOLK FORMATION; PROCATHEPSIN-D; TNF-ALPHA	The lysosomal aspartic protease Cathepsin D (CD) is ubiquitously expressed in eukaryotic organisms. CD activity is essential to accomplish the acid-dependent extensive or partial proteolysis of protein substrates within endosomal and lysosomal compartments therein delivered via endocytosis, phagocytosis or autophagocytosis. CD may also act at physiological pH on small-size substrates in the cytosol and in the extracellular milieu. Mouse and fruit fly CD knock-out models have highlighted the multi-pathophysiological roles of CD in tissue homeostasis and organ development. Here we report the first phenotypic description of the lack of CD expression during zebrafish (Danio rerio) development obtained by morpholino-mediated knock-down of CD mRNA. Since the un-fertilized eggs were shown to be supplied with maternal CD mRNA, only a morpholino targeting a sequence containing the starting ATG codon was effective. The main phenotypic alterations produced by CD knock-down in zebrafish were: 1. abnormal development of the eye and of retinal pigment epithelium; 2. absence of the swim-bladder; 3. skin hyper-pigmentation; 4. reduced growth and premature death. Rescue experiments confirmed the involvement of CD in the developmental processes leading to these phenotypic alterations. Our findings add to the list of CD functions in organ development and patho-physiology in vertebrates.	[Follo, Carlo; Ozzano, Matteo; Castino, Roberta; Isidoro, Ciro] Univ Piemonte Orientale, Dipartimento Sci Med, Lab Patol Mol, Novara, Italy; [Follo, Carlo; Ozzano, Matteo; Castino, Roberta; Isidoro, Ciro] Univ Piemonte Orientale, Ctr Biotecnol Ric Med Applicata, Novara, Italy; [Mugoni, Vera; Santoro, Massimo] Univ Turin, Ctr Mol Biotechnol, Turin, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; University of Turin	Follo, C (corresponding author), Univ Piemonte Orientale, Dipartimento Sci Med, Lab Patol Mol, Novara, Italy.	isidoro@med.unipmn.it	Isidoro, Ciro/J-6063-2016	Isidoro, Ciro/0000-0002-5494-3034; SANTORO, Massimo Mattia/0000-0003-4605-5085; Follo, Carlo/0000-0001-9711-2655				Abbott DE, 2010, CANCER BIOL THER, V9, P23, DOI 10.4161/cbt.9.1.10378; ADLER AJ, 1989, EXP EYE RES, V49, P1067, DOI 10.1016/S0014-4835(89)80027-2; Awano T, 2006, MOL GENET METAB, V87, P341, DOI 10.1016/j.ymgme.2005.11.005; BALDWIN ET, 1993, P NATL ACAD SCI USA, V90, P6796, DOI 10.1073/pnas.90.14.6796; Barrett A.J., 2008, CIBA F SYMP, V15, P37, DOI [10.1002/9780470720585.ch3, DOI 10.1002/9780470720585.CH3]; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Capasso C, 1999, BBA-PROTEIN STRUCT M, V1431, P64, DOI 10.1016/S0167-4838(99)00039-4; Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007; Carnevali O, 1999, BIOL REPROD, V60, P140, DOI 10.1095/biolreprod60.1.140; Castino R, 2008, ENDOCRINOLOGY, V149, P4095, DOI 10.1210/en.2008-0249; Castino R, 2007, FREE RADICAL BIO MED, V42, P1305, DOI 10.1016/j.freeradbiomed.2006.12.030; Chen H, 2009, INVEST OPHTH VIS SCI, V50, P1895, DOI 10.1167/iovs.08-2850; Cheng AL, 2008, J PROTEOME RES, V7, P2415, DOI 10.1021/pr7008548; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Demoz M, 2006, PROTEIN EXPRES PURIF, V45, P157, DOI 10.1016/j.pep.2005.07.024; Demoz M, 2002, BIOL CHEM, V383, P1237, DOI 10.1515/BC.2002.137; Erdmann S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1365, DOI 10.1152/ajpendo.00280.2007; Follo C, 2008, BIOTECHNOL APPL BIOC, V49, P175, DOI 10.1042/BA20070045; Follo C, 2007, INT J BIOCHEM CELL B, V39, P638, DOI 10.1016/j.biocel.2006.11.010; GEISLER R, 2008, DEVELOPMENT, V135, P387; GIESELMANN V, 1983, J CELL BIOL, V97, P1, DOI 10.1083/jcb.97.1.1; Handley CJ, 2001, MATRIX BIOL, V20, P543, DOI 10.1016/S0945-053X(01)00168-8; Hiramatsu N, 2002, J EXP ZOOL, V292, P11, DOI 10.1002/jez.1138; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Isidoro C, 1995, INT J CANCER, V63, P866, DOI 10.1002/ijc.2910630619; ISIDORO C, 1991, BIOCHEM J, V273, P363, DOI 10.1042/bj2730363; Jensen AM, 2004, CURR BIOL, V14, P711, DOI 10.1016/j.cub.2004.04.006; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knoll-Gellida A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-46; Kociok N, 2007, GRAEF ARCH CLIN EXP, V245, P101, DOI 10.1007/s00417-006-0266-x; Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; Krohne TU, 2010, EXP EYE RES, V90, P261, DOI 10.1016/j.exer.2009.10.014; Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701; Lee AY, 1998, NAT STRUCT BIOL, V5, P866, DOI 10.1038/2306; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396; Maldonado E, 2006, PIGM CELL RES, V19, P315, DOI 10.1111/j.1600-0749.2006.00320.x; Margaryan NV, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.5.12534; Minazaki CK, 2008, RES VET SCI, V84, P326, DOI 10.1016/j.rvsc.2007.06.013; MORRISON RL, 1991, J MORPHOL, V209, P229, DOI 10.1002/jmor.1052090209; Myllykangas L, 2005, NEUROBIOL DIS, V19, P194, DOI 10.1016/j.nbd.2004.12.019; Nakamura K, 1996, COMP BIOCHEM PHYS B, V113, P835, DOI 10.1016/0305-0491(95)02102-7; Nakanishi H, 2001, J NEUROSCI, V21, P7526, DOI 10.1523/JNEUROSCI.21-19-07526.2001; Nicotra G, 2010, CANCER BIOMARK, V7, P47, DOI 10.3233/CBM-2010-0143; Nielsen LB, 2001, COMP BIOCHEM PHYS B, V128, P351, DOI 10.1016/S1096-4959(00)00332-8; Nixon SJ, 2005, HUM MOL GENET, V14, P1727, DOI 10.1093/hmg/ddi179; Nuckels RJ, 2009, INVEST OPHTH VIS SCI, V50, P893, DOI 10.1167/iovs.08-2743; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; ROUGHLEY PJ, 1977, BIOCHEM J, V167, P639, DOI 10.1042/bj1670639; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Schonthaler HB, 2008, DEVELOPMENT, V135, P387, DOI 10.1242/dev.006098; SCOTT PG, 1981, EUR J BIOCHEM, V114, P59; Stalmans I, 2003, NAT MED, V9, P173, DOI 10.1038/nm819; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; TANG J, 1987, J CELL BIOCHEM, V33, P53, DOI 10.1002/jcb.240330106; Tyynela J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786; Tyynela J, 2001, Eur J Paediatr Neurol, V5 Suppl A, P43, DOI 10.1053/ejpn.2000.0433; Vashishta Aruna, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P385; Wallace R A, 1985, Dev Biol (N Y 1985), V1, P127; Workman P, 1998, BRIT J CANCER, V77, P1; Yoshizaki N, 2004, DEV GROWTH DIFFER, V46, P229, DOI 10.1111/j.1440-169X.2004.00740.x; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820; Zuzarte-Luis V, 2007, DEV DYNAM, V236, P880, DOI 10.1002/dvdy.21076	72	31	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21908	10.1371/journal.pone.0021908	http://dx.doi.org/10.1371/journal.pone.0021908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747967	Green Published, gold, Green Submitted			2022-12-25	WOS:000292293400043
J	Prunetti, L; Brugna, M; Lebrun, R; Giudici-Orticoni, MT; Guiral, M				Prunetti, Laurence; Brugna, Myriam; Lebrun, Regine; Giudici-Orticoni, Marie-Therese; Guiral, Marianne			The Elusive Third Subunit IIa of the Bacterial B-Type Oxidases: The Enzyme from the Hyperthermophile Aquifex aeolicus	PLOS ONE			English	Article							CYTOCHROME B(6)F COMPLEX; OPEN READING FRAME; THERMUS-THERMOPHILUS; C-OXIDASE; BACILLUS-STEAROTHERMOPHILUS; NATRONOBACTERIUM-PHARAONIS; RESPIRATORY-CHAIN; TERMINAL OXIDASES; OXYGEN REDUCTASE; BA(3) OXIDASE	The reduction of molecular oxygen to water is catalyzed by complicated membrane-bound metallo-enzymes containing variable numbers of subunits, called cytochrome c oxidases or quinol oxidases. We previously described the cytochrome c oxidase II from the hyperthermophilic bacterium Aquifex aeolicus as a ba(3)-type two-subunit (subunits I and II) enzyme and showed that it is included in a supercomplex involved in the sulfide-oxygen respiration pathway. It belongs to the B-family of the heme-copper oxidases, enzymes that are far less studied than the ones from family A. Here, we describe the presence in this enzyme of an additional transmembrane helix "subunit IIa", which is composed of 41 amino acid residues with a measured molecular mass of 5105 Da. Moreover, we show that subunit II, as expected, is in fact longer than the originally annotated protein (from the genome) and contains a transmembrane domain. Using Aquifex aeolicus genomic sequence analyses, N-terminal sequencing, peptide mass fingerprinting and mass spectrometry analysis on entire subunits, we conclude that the B-type enzyme from this bacterium is a three-subunit complex. It is composed of subunit I (encoded by coxA(2)) of 59000 Da, subunit II (encoded by coxB(2)) of 16700 Da and subunit IIa which contain 12, 1 and 1 transmembrane helices respectively. A structural model indicates that the structural organization of the complex strongly resembles that of the ba(3) cytochrome c oxidase from the bacterium Thermus thermophilus, the IIa helical subunit being structurally the lacking N-terminal transmembrane helix of subunit II present in the A-type oxidases. Analysis of the genomic context of genes encoding oxidases indicates that this third subunit is present in many of the bacterial oxidases from B-family, enzymes that have been described as two-subunit complexes.	[Prunetti, Laurence; Brugna, Myriam; Giudici-Orticoni, Marie-Therese; Guiral, Marianne] CNRS, Lab Bioenerget & Ingn Prot, UPR 9036, Inst Microbiol Mediterranee IFR88, Marseille, France; [Brugna, Myriam] Univ Aix Marseille 1, Marseille, France; [Lebrun, Regine] CNRS, Plate Forme Prot IFR88, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Prunetti, L (corresponding author), CNRS, Lab Bioenerget & Ingn Prot, UPR 9036, Inst Microbiol Mediterranee IFR88, Marseille, France.	guiral@ifr88.cnrs-mrs.fr		BRUGNA, Myriam/0000-0002-4017-3294	CNRS; Region-Provence-Alpes Cote d'Azur; French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region-Provence-Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche)(Ministry of Research, France)	This work was financially supported by the CNRS and the Region-Provence-Alpes Cote d'Azur. L. Prunetti had a fellowship of the French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BERTHOLD DA, 1995, J BIOL CHEM, V270, P29293, DOI 10.1074/jbc.270.49.29293; Brochier-Armanet C, 2009, MOL BIOL EVOL, V26, P285, DOI 10.1093/molbev/msn246; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Ducluzeau A. L., 2009, THESIS U PROVENCE MA; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; Falb M, 2005, GENOME RES, V15, P1336, DOI 10.1101/gr.3952905; GARCIAHORSMAN JA, 1994, J BACTERIOL, V176, P5587, DOI 10.1128/JB.176.18.5587-5600.1994; Giuffre A, 1999, BIOCHEMISTRY-US, V38, P1057, DOI 10.1021/bi9815389; Guiral M, 2009, J PROTEOME RES, V8, P1717, DOI 10.1021/pr8007946; Hager M, 1999, EMBO J, V18, P5834, DOI 10.1093/emboj/18.21.5834; Hemp James, 2008, V45, P1, DOI 10.1007/400_2007_046; Hunsicker-Wang LM, 2005, ACTA CRYSTALLOGR D, V61, P340, DOI 10.1107/S0907444904033906; Ishikawa R, 2002, ARCH MICROBIOL, V179, P42, DOI 10.1007/s00203-002-0496-1; Janzon J, 2007, IUBMB LIFE, V59, P563, DOI 10.1080/15216540701242482; KEIGHTLEY JA, 1995, J BIOL CHEM, V270, P20345, DOI 10.1074/jbc.270.35.20345; LUBBEN M, 1994, MOL MICROBIOL, V13, P327, DOI 10.1111/j.1365-2958.1994.tb00426.x; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; Mattar S, 1997, EUR J BIOCHEM, V250, P332, DOI 10.1111/j.1432-1033.1997.0332a.x; Nikaido K, 2000, BBA-BIOENERGETICS, V1456, P35, DOI 10.1016/S0005-2728(99)00102-4; Nikaido K, 1998, BBA-GENE STRUCT EXPR, V1397, P262, DOI 10.1016/S0167-4781(98)00043-8; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; Nunoura T, 2003, MICROBIOL-SGM, V149, P673, DOI 10.1099/mic.0.26000-0; Otten MF, 2001, EUR J BIOCHEM, V268, P2486, DOI 10.1046/j.1432-1327.2001.02131.x; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Prunetti L, 2010, J BIOL CHEM, V285, P41815, DOI 10.1074/jbc.M110.167841; Rodgers S, 2000, EUR J BIOCHEM, V267, P3753, DOI 10.1046/j.1432-1327.2000.01411.x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scharf B, 1997, BIOCHEMISTRY-US, V36, P4471, DOI 10.1021/bi962312d; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Soulimane T, 1997, BIOCHEM BIOPH RES CO, V237, P572, DOI 10.1006/bbrc.1997.7041; Soulimane T, 2000, PROTEIN SCI, V9, P2068, DOI 10.1110/ps.9.11.2068; Takahashi Y, 1996, EMBO J, V15, P3498, DOI 10.1002/j.1460-2075.1996.tb00718.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verissimo AF, 2007, FEMS MICROBIOL LETT, V269, P41, DOI 10.1111/j.1574-6968.2006.00598.x; Zickermann V, 2010, FEBS LETT, V584, P2516, DOI 10.1016/j.febslet.2010.04.021; ZIMMERMANN BH, 1988, P NATL ACAD SCI USA, V85, P5779, DOI 10.1073/pnas.85.16.5779	41	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21616	10.1371/journal.pone.0021616	http://dx.doi.org/10.1371/journal.pone.0021616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738733	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800027
J	Ginet, N; Pardoux, R; Adryanczyk, G; Garcia, D; Brutesco, C; Pignol, D				Ginet, Nicolas; Pardoux, Romain; Adryanczyk, Geraldine; Garcia, Daniel; Brutesco, Catherine; Pignol, David			Single-Step Production of a Recyclable Nanobiocatalyst for Organophosphate Pesticides Biodegradation Using Functionalized Bacterial Magnetosomes	PLOS ONE			English	Article							MAGNETOTACTIC BACTERIA; MAGNETIC PARTICLES; PROTEIN; GENE; NANOPARTICLES; SEPARATION	Enzymes are versatile catalysts in laboratories and on an industrial scale; improving their immobilization would be beneficial to broadening their applicability and ensuring their (re)use. Lipid-coated nano-magnets produced by magnetotactic bacteria are suitable for a universally applicable single-step method of enzyme immobilization. By genetically functionalizing the membrane surrounding these magnetite particles with a phosphohydrolase, we engineered an easy-to-purify, robust and recyclable biocatalyst to degrade ethyl-paraoxon, a commonly used pesticide. For this, we genetically fused the opd gene from Flavobacterium sp. ATCC 27551 encoding a paraoxonase to mamC, an abundant protein of the magnetosome membrane in Magnetospirillum magneticum AMB-1. The MamC protein acts as an anchor for the paraoxonase to the magnetosome surface, thus producing magnetic nanoparticles displaying phosphohydrolase activity. Magnetosomes functionalized with Opd were easily recovered from genetically modified AMB-1 cells: after cellular disruption with a French press, the magnetic nanoparticles are purified using a commercially available magnetic separation system. The catalytic properties of the immobilized Opd were measured on ethyl-paraoxon hydrolysis: they are comparable with the purified enzyme, with K(m) (and k(cat)) values of 58 mu M (and 178 s(-1)) and 43 mu M (and 314 s(-1)) for the immobilized and purified enzyme respectively. The Opd, a metalloenzyme requiring a zinc cofactor, is thus properly matured in AMB-1. The recycling of the functionalized magnetosomes was investigated and their catalytic activity proved to be stable over repeated use for pesticide degradation. In this study, we demonstrate the easy production of functionalized magnetic nanoparticles with suitably genetically modified magnetotactic bacteria that are efficient as a reusable nanobiocatalyst for pesticides bioremediation in contaminated effluents.	[Ginet, Nicolas; Adryanczyk, Geraldine; Garcia, Daniel; Brutesco, Catherine; Pignol, David] CEA, DSV, IBEB, Lab Bioenerget Cellulaire, St Paul Les Durance, France; [Pardoux, Romain] CEA, DSV, IBEB, Lab Interact Prot Met, St Paul Les Durance, France; [Ginet, Nicolas; Pardoux, Romain; Adryanczyk, Geraldine; Garcia, Daniel; Brutesco, Catherine; Pignol, David] CNRS, UMR Biol Vegetale & Microbiol Environm 6191, St Paul Les Durance, France; [Ginet, Nicolas; Pardoux, Romain; Adryanczyk, Geraldine; Garcia, Daniel; Brutesco, Catherine; Pignol, David] Aix Marseille Univ, St Paul Les Durance, France	CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Ginet, N (corresponding author), CEA, DSV, IBEB, Lab Bioenerget Cellulaire, St Paul Les Durance, France.	nicolas.ginet@cea.fr	Ginet, Nicolas/AEB-2370-2022	Ginet, Nicolas/0000-0002-5544-4376; PIGNOL, David/0000-0002-8070-0319	Centre National de la Recherche Scientifique (CNRS); Commissariat a l'Energie Atomique (CEA)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by Centre National de la Recherche Scientifique (CNRS) and Commissariat a l'Energie Atomique (CEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bellini S, 2009, CHIN J OCEANOL LIMN, V27, P3, DOI 10.1007/s00343-009-0003-5; Bellini S, 2009, CHIN J OCEANOL LIMN, V27, P6, DOI 10.1007/s00343-009-0006-2; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Elnashar M.M.M., 2010, J BIOMATER NANOBIOTE, V01, P61, DOI [10.4236/jbnb.2010.11008, DOI 10.4236/JBNB.2010.11008]; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Kim JB, 2008, TRENDS BIOTECHNOL, V26, P639, DOI 10.1016/j.tibtech.2008.07.009; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lang C, 2008, APPL ENVIRON MICROB, V74, P4944, DOI 10.1128/AEM.00231-08; Lang C, 2007, MACROMOL BIOSCI, V7, P144, DOI 10.1002/mabi.200600235; Lefevre CT, 2009, APPL ENVIRON MICROB, V75, P3835, DOI 10.1128/AEM.00165-09; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; MULBRY WW, 1989, J BACTERIOL, V171, P6740, DOI 10.1128/jb.171.12.6740-6746.1989; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Takahashi M, 2009, BIOTECHNOL PROGR, V25, P219, DOI 10.1002/btpr.101; Van Dyk JS, 2011, CHEMOSPHERE, V82, P291, DOI 10.1016/j.chemosphere.2010.10.033; Yoshino T, 2008, BIOTECHNOL BIOENG, V101, P470, DOI 10.1002/bit.21912; Yoshino T, 2009, BIOTECHNOL BIOENG, V103, P130, DOI 10.1002/bit.22240	19	50	54	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21442	10.1371/journal.pone.0021442	http://dx.doi.org/10.1371/journal.pone.0021442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738665	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800022
J	Han, WH; Takamatsu, Y; Yamamoto, H; Kasai, S; Endo, S; Shirao, T; Kojima, N; Ikeda, K				Han, Wenhua; Takamatsu, Yukio; Yamamoto, Hideko; Kasai, Shinya; Endo, Shogo; Shirao, Tomoaki; Kojima, Nobuhiko; Ikeda, Kazutaka			Inhibitory Role of Inducible cAMP Early Repressor (ICER) in Methamphetamine-Induced Locomotor Sensitization	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; ELEMENT-BINDING PROTEIN; CART MESSENGER-RNA; NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; GENE-EXPRESSION; COCAINE REWARD; CREB ACTIVITY; PEPTIDE; DOPAMINE	Background: The inducible cyclic adenosine monophosphate (cAMP) early repressor (ICER) is highly expressed in the central nervous system and functions as a repressor of cAMP response element-binding protein (CREB) transcription. The present study sought to clarify the role of ICER in the effects of methamphetamine (METH). Methods and Findings: We tested METH-induced locomotor sensitization in wildtype mice, ICER knockout mice, and ICER I-overexpressing mice. Both ICER wildtype mice and knockout mice displayed increased locomotor activity after continuous injections of METH. However, ICER knockout mice displayed a tendency toward higher locomotor activity compared with wildtype mice, although no significant difference was observed between the two genotypes. Moreover, compared with wildtype mice, ICER I-overexpressing mice displayed a significant decrease in METH-induced locomotor sensitization. Furthermore, Western blot analysis and quantitative real-time reverse transcription polymerase chain reaction demonstrated that ICER overexpression abolished the METH-induced increase in CREB expression and repressed cocaine- and amphetamine-regulated transcript (CART) and prodynorphin (Pdyn) expression in mice. The decreased CART and Pdyn mRNA expression levels in vivo may underlie the inhibitory role of ICER in METH-induced locomotor sensitization. Conclusions: Our data suggest that ICER plays an inhibitory role in METH-induced locomotor sensitization.	[Han, Wenhua; Takamatsu, Yukio; Yamamoto, Hideko; Kasai, Shinya; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Res Project Addict Subst, Tokyo 113, Japan; [Endo, Shogo; Kojima, Nobuhiko] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan; [Shirao, Tomoaki; Kojima, Nobuhiko] Gunma Univ, Dept Neurobiol & Behav, Grad Sch Med, Maebashi, Gunma 371, Japan; [Kojima, Nobuhiko] RIKEN, Brain Sci Inst, Lab Neurobiol Emot, Wako, Saitama, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Gerontology; Gunma University; RIKEN	Han, WH (corresponding author), Tokyo Metropolitan Inst Med Sci, Res Project Addict Subst, Bunkyo Ku, Tokyo 113, Japan.	nkojima@med.gunma-u.ac.jp	Ikeda, Kazutaka/I-4694-2013; Shirao, Tomoaki/I-9257-2016	Ikeda, Kazutaka/0000-0001-8342-0278; Shirao, Tomoaki/0000-0003-4323-028X	Ministry of Education, Science, Sports and Culture of Japan [17025054, 19659405, 20390162]; Ministry of Health, Labour and Welfare of Japan [H17-pharmaco-001, H19-iyaku-023, 19A-8]; Naito Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Naito Foundation(Naito Memorial Foundation)	This work was supported by research grants from the Ministry of Education, Science, Sports and Culture of Japan (17025054, 19659405, 20390162), the Ministry of Health, Labour and Welfare of Japan (H17-pharmaco-001, H19-iyaku-023, 19A-8 for Nervous and Mental Disorders), and the Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bilbao A, 2008, P NATL ACAD SCI USA, V105, P17549, DOI 10.1073/pnas.0803959105; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chefer VI, 2006, EUR J NEUROSCI, V23, P229, DOI 10.1111/j.1460-9568.2005.04525.x; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; Couceyro PR, 2005, J PHARMACOL EXP THER, V315, P1091, DOI 10.1124/jpet.105.091678; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; DiRocco DP, 2009, J NEUROSCI, V29, P2393, DOI 10.1523/JNEUROSCI.4356-08.2009; Dominguez G, 2004, MOL BRAIN RES, V126, P22, DOI 10.1016/j.molbrainres.2004.02.027; Dominguez G, 2002, J NEUROCHEM, V80, P885, DOI 10.1046/j.0022-3042.2002.00775.x; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Fagergren P, 1999, NEUROREPORT, V10, P3449, DOI 10.1097/00001756-199911080-00034; Fasano S, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.029.2009; Fukushima S, 2007, PSYCHOPHARMACOLOGY, V193, P55, DOI 10.1007/s00213-007-0749-4; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Hubert GW, 2006, NEUROPEPTIDES, V40, P409, DOI 10.1016/j.npep.2006.09.001; Hunter RG, 2005, BRAIN RES, V1048, P12, DOI 10.1016/j.brainres.2005.04.032; Jaworski J, 2003, J NEUROSCI, V23, P4519; Jaworski JN, 2008, BEHAV BRAIN RES, V191, P266, DOI 10.1016/j.bbr.2008.03.039; Kim S, 2007, REGUL PEPTIDES, V144, P6, DOI 10.1016/j.regpep.2007.07.003; Kojima N, 2008, J NEUROSCI, V28, P6459, DOI 10.1523/JNEUROSCI.0412-08.2008; Kreibich AS, 2004, J NEUROSCI, V24, P6686, DOI 10.1523/JNEUROSCI.1706-04.2004; Maiya R, 2009, P NATL ACAD SCI USA, V106, P1983, DOI 10.1073/pnas.0812491106; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Marie-Claire C, 2003, NEUROSCI LETT, V345, P77, DOI 10.1016/S0304-3940(03)00307-0; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Mioduszewska B, 2003, J NEUROCHEM, V87, P1313, DOI 10.1046/j.1471-4159.2003.02116.x; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Pierce RC, 1997, BRAIN RES REV, V25, P192, DOI 10.1016/S0165-0173(97)00021-0; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; Rogge GA, 2009, BRAIN RES, V1251, P42, DOI 10.1016/j.brainres.2008.11.011; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Shippenberg TS, 2007, PHARMACOL THERAPEUT, V116, P306, DOI 10.1016/j.pharmthera.2007.06.011; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; SPANGLER R, 1993, MOL BRAIN RES, V19, P323, DOI 10.1016/0169-328X(93)90133-A; SPIESS J, 1980, BIOCHEMISTRY-US, V19, P2861, DOI 10.1021/bi00554a007; STEWART J, 1993, BEHAV PHARMACOL, V4, P289; Tinti C, 1996, J BIOL CHEM, V271, P25375, DOI 10.1074/jbc.271.41.25375; Turgeon SM, 1997, BRAIN RES, V749, P120, DOI 10.1016/S0006-8993(96)01316-9; Valverde O, 2004, NEUROPSYCHOPHARMACOL, V29, P1122, DOI 10.1038/sj.npp.1300416; Vicentic A, 2007, J PHARMACOL EXP THER, V320, P499, DOI 10.1124/jpet.105.091512; Vrang N, 2002, NEUROREPORT, V13, P1215, DOI 10.1097/00001756-200207020-00029; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; WIDNELL KL, 1994, P NATL ACAD SCI USA, V91, P10947, DOI 10.1073/pnas.91.23.10947; Yoon HS, 2007, NEUROPHARMACOLOGY, V53, P344, DOI 10.1016/j.neuropharm.2007.05.014; Zhang Y, 2004, PSYCHOPHARMACOLOGY, V172, P422, DOI 10.1007/s00213-003-1688-3	48	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21637	10.1371/journal.pone.0021637	http://dx.doi.org/10.1371/journal.pone.0021637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738744	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800048
J	Liu, F; He, KM; Yang, XX; Xu, N; Liang, ZY; Xu, M; Zhao, XS; Han, QD; Zhang, YY				Liu, Fei; He, Kangmin; Yang, Xinxing; Xu, Ning; Liang, Zhangyi; Xu, Ming; Zhao, Xinsheng; Han, Qide; Zhang, Youyi			alpha(1A)-Adrenergic Receptor Induces Activation of Extracellular Signal-Regulated Kinase 1/2 through Endocytic Pathway	PLOS ONE			English	Article							PROTEIN-KINASE; MYOSIN-V; ALPHA(1)-ADRENOCEPTOR SUBTYPES; PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; CARDIAC-HYPERTROPHY; TRANSGENIC MICE; BETA-ARRESTINS; CELLS	G protein-coupled receptors (GPCRs) activate mitogen-activated protein kinases through a number of distinct pathways in cells. Increasing evidence has suggested that endosomal signaling has an important role in receptor signal transduction. Here we investigated the involvement of endocytosis in alpha(1A)-adrenergic receptor (alpha(1A)-AR)-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2). Agonist-mediated endocytic traffic of alpha(1A)-AR was assessed by real-time imaging of living, stably transfected human embryonic kidney 293A cells (HEK-293A). alpha(1A)-AR was internalized dynamically in cells with agonist stimulation, and actin filaments regulated the initial trafficking of alpha(1A)-AR. alpha(1A)-AR-induced activation of ERK1/2 but not p38 MAPK was sensitive to disruption of endocytosis, as demonstrated by 4 degrees C chilling, dynamin mutation and treatment with cytochalasin D (actin depolymerizing agent). Activation of protein kinase C (PKC) and C-Raf by alpha(1A)-AR was not affected by 4 degrees C chilling or cytochalasin D treatment. U73122 (a phospholipase C [PLC] inhibitor) and Ro 31-8220 (a PKC inhibitor) inhibited alpha(1B)-AR-but not alpha(1A)-AR-induced ERK1/2 activation. These data suggest that the endocytic pathway is involved in a1A-AR-induced ERK1/2 activation, which is independent of G(q)/PLC/PKC signaling.	[Liu, Fei; He, Kangmin; Xu, Ning; Xu, Ming; Han, Qide; Zhang, Youyi] Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100871, Peoples R China; [Liu, Fei; He, Kangmin; Xu, Ning; Xu, Ming; Han, Qide; Zhang, Youyi] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Yang, Xinxing; Liang, Zhangyi; Zhao, Xinsheng] Peking Univ, Beijing Natl Lab Mol Sci,Biodynam Opt Imaging Ctr, State Key Lab Struct Chem Unstable & Stable Speci, Dept Biol Chem,Coll Chem & Mol Engn, Beijing 100871, Peoples R China	Peking University; Chinese Academy of Sciences; Peking University	Liu, F (corresponding author), Peking Univ, Inst Vasc Med, Hosp 3, Beijing 100871, Peoples R China.	zhangyy@bjmu.edu.cn	He, Kangmin/F-8235-2012; Liang, Zhangyi/G-5372-2011		National Key Basic Research Program of People's Republic of China [2007CB935601, 2006CB910300]; Natural Science Foundation of China [81030001, 30821001, 20733001]	National Key Basic Research Program of People's Republic of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of People's Republic of China (2007CB935601, 2006CB910300) and the Natural Science Foundation of China (81030001, 30821001, 20733001) (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm and http://www.nsfc.gov.cn/Portal0/default106.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007306; Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Berts A, 1999, MOL PHARMACOL, V55, P296, DOI 10.1124/mol.55.2.296; Bliss SP, 2007, MOL ENDOCRINOL, V21, P538, DOI 10.1210/me.2006-0289; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Copik AJ, 2009, MOL PHARMACOL, V75, P713, DOI 10.1124/mol.108.050765; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; Flechtner-Mors M, 2004, OBES RES, V12, P612, DOI 10.1038/oby.2004.70; Flesch M, 2001, CIRCULATION, V104, P2273, DOI 10.1161/hc4401.099449; Gong KZ, 2008, J BIOL CHEM, V283, P29028, DOI 10.1074/jbc.M801313200; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Hu ZW, 1999, MOL ENDOCRINOL, V13, P3, DOI 10.1210/me.13.1.3; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Iaccarino G, 2001, J AM COLL CARDIOL, V38, P534, DOI 10.1016/S0735-1097(01)01396-1; Kohlhaas SL, 2007, J BIOL CHEM, V282, P12831, DOI 10.1074/jbc.M700438200; Koshimizu T, 2003, PHARMACOL THERAPEUT, V98, P235, DOI 10.1016/S0163-7258(03)00033-0; Liang ZY, 2007, BIOCHEM BIOPH RES CO, V353, P231, DOI 10.1016/j.bbrc.2006.11.116; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; O-Uchi J, 2008, CIRC RES, V102, P1378, DOI 10.1161/CIRCRESAHA.107.167734; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; TERZIC A, 1993, PHARMACOL REV, V45, P147; Toews ML, 2003, LIFE SCI, V74, P379, DOI 10.1016/j.lfs.2003.09.024; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WU DQ, 1992, J BIOL CHEM, V267, P25798; Xiao L, 2001, J MOL CELL CARDIOL, V33, P779, DOI 10.1006/jmcc.2001.1348; Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009; Xu N, 2007, ACTA PHARMACOL SIN, V28, P796, DOI 10.1111/j.1745-7254.2007.00545.x; Yamada H, 2009, J BIOL CHEM, V284, P34244, DOI 10.1074/jbc.M109.064204; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yue TL, 2000, CIRC RES, V86, P692, DOI 10.1161/01.RES.86.6.692; Zhang YY, 1999, J PHARMACOL EXP THER, V291, P829	49	12	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21520	10.1371/journal.pone.0021520	http://dx.doi.org/10.1371/journal.pone.0021520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738688	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800031
J	Miller, DL; Dou, CY; Sorenson, D; Liu, M				Miller, Douglas L.; Dou, Chunyan; Sorenson, Dorothy; Liu, Ming			Histological Observation of Islet Hemorrhage Induced by Diagnostic Ultrasound with Contrast Agent in Rat Pancreas	PLOS ONE			English	Article							IN-VIVO; BLOOD-FLOW; MODEL	Contrast enhanced diagnostic ultrasound CEDUS has been shown to induce capillary hemorrhage in heart and kidney. This study characterized the capillary hemorrhage induced in rat pancreas. The pancreata of anesthetized hairless rats were accessed by laparotomy. A 1.5 MHz diagnostic ultrasound probe with 2.3 MPa peak rarefactional pressure amplitude and 1 s intermittent trigger was used to scan the pancreas, located at the focus (3.8 cm), through saline coupling. The probe was swept to expose the entire organ in 5 min during infusion of Definity (R) contrast agent at 10 mu L/kg/min, and this was repeated in a reverse sweep. The entire pancreas was removed, spread flat for fixation and histological slides were prepared from the mid-plane. Slides were scored blind for islet hemorrhage over the entire area of the organ. Intra-islet microlesions were evident and hemorrhage surrounded many islets. The hemorrhage often impacted nearby acini, and expanded into inter-lobular septa. In CEDUS pancreata removed soon after scanning, 76.2+/-11.8% (n=6) of islets had evidence of hemorrhage and/or islet microlesions compared to 1.1+/-2.5% (n=5) for sham CEDUS (P<0.001). In pancreata removed after 4 hr, fibrin formation was detected by immunohistology in the hemorrhage and intra-islet microlesions. Diagnostic ultrasound with contrast agent induced substantial capillary hemorrhage in rat pancreas, concentrated particularly in the islets.	[Miller, Douglas L.; Dou, Chunyan; Sorenson, Dorothy; Liu, Ming] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Miller, DL (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA.	douglm@umich.edu			National Institutes of Health, DHHS, USA [EB00338]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000338] Funding Source: NIH RePORTER	National Institutes of Health, DHHS, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by PHS grant EB00338 awarded by the National Institutes of Health, DHHS, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea R, 2009, J GASTROINTEST LIVER, V18, P237; CANAS X, 1995, ENDOCRINOLOGY, V136, P3871, DOI 10.1210/en.136.9.3871; Chen S, 2010, GENE THER, V17, P1411, DOI 10.1038/gt.2010.85; D'Onofrio M, 2007, ABDOM IMAGING, V32, P171, DOI 10.1007/s00261-006-9010-6; Imaoka M, 2007, TOXICOL PATHOL, V35, P388, DOI 10.1080/01926230701230304; Iwase M, 2001, AM J PHYSIOL-REG I, V280, pR1601, DOI 10.1152/ajpregu.2001.280.6.R1601; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Martinez-Noguera A, 2001, EUR RADIOL, V11, P1594, DOI 10.1007/s003300101003; Masuyama T, 2004, BIOCHEM BIOPH RES CO, V314, P870, DOI 10.1016/j.bbrc.2003.12.180; MENGER MD, 1995, CLIN APPIED MICROCIR, pCH22; Miller DL, 2008, J ULTRAS MED, V27, P611, DOI 10.7863/jum.2008.27.4.611; Miller DL, 2007, ULTRASOUND MED BIOL, V33, P129, DOI 10.1016/j.ultrasmedbio.2006.07.033; Miller DL, 2010, IEEE T BIO-MED ENG, V57, P167, DOI 10.1109/TBME.2009.2030960; Miller DL, 2009, ULTRASOUND MED BIOL, V35, P869, DOI 10.1016/j.ultrasmedbio.2008.10.015; Muller Michael W, 2007, Pancreas, V35, pe30; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; Sakamoto H, 2008, ULTRASOUND MED BIOL, V34, P525, DOI 10.1016/j.ultrasmedbio.2007.09.018	17	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21617	10.1371/journal.pone.0021617	http://dx.doi.org/10.1371/journal.pone.0021617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738734	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800047
J	Emery, M; Schorderet, DF; Roduit, R				Emery, Martine; Schorderet, Daniel F.; Roduit, Raphael			Acute Hypoglycemia Induces Retinal Cell Death in Mouse	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; NEURONAL DEATH; GLUTATHIONE-PEROXIDASE; DIABETIC-RETINOPATHY; IN-VITRO; ACTIVATION; APOPTOSIS; INSULIN; DAMAGE; BRAIN	Background: Glucose is the most important metabolic substrate of the retina and maintenance of normoglycemia is an essential challenge for diabetic patients. Glycemic excursions could lead to cardiovascular disease, nephropathy, neuropathy and retinopathy. A vast body of literature exists on hyperglycemia namely in the field of diabetic retinopathy, but very little is known about the deleterious effect of hypoglycemia. Therefore, we decided to study the role of acute hypoglycemia in mouse retina. Methodology/Principal Findings: To test effects of hypoglycemia, we performed a 5-hour hyperinsulinemic/hypoglycemic clamp; to exclude an effect of insulin, we made a hyperinsulinemic/euglycemic clamp as control. We then isolated retinas from each group at different time-points after the clamp to analyze cells apoptosis and genes regulation. In parallel, we used 661W photoreceptor cells to confirm in vivo results. We showed herein that hypoglycemia induced retinal cell death in mouse via caspase 3 activation. We then tested the mRNA expression of glutathione transferase omega 1 (Gsto1) and glutathione peroxidase 3 (Gpx3), two genes involved in glutathione (GSH) homeostasis. The expression of both genes was up-regulated by low glucose, leading to a decrease of reduced glutathione (GSH). In vitro experiments confirmed the low-glucose induction of 661W cell death via superoxide production and activation of caspase 3, which was concomitant with a decrease of GSH content. Moreover, decrease of GSH content by inhibition with buthionine sulphoximine (BSO) at high glucose induced apoptosis, while complementation with extracellular glutathione ethyl ester (GSHee) at low glucose restored GSH level and reduced apoptosis. Conclusions/Significance: We showed, for the first time, that acute insulin-induced hypoglycemia leads to caspase 3-dependant retinal cell death with a predominant role of GSH content.	[Emery, Martine; Schorderet, Daniel F.; Roduit, Raphael] Inst Res Ophthalmol, Sion, Switzerland; [Emery, Martine; Schorderet, Daniel F.; Roduit, Raphael] Univ Lausanne, Dept Ophthalmol, Lausanne, Switzerland; [Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Emery, M (corresponding author), Inst Res Ophthalmol, Sion, Switzerland.	raphael.roduit@irovision.ch	Roduit, Raphael/AAC-3890-2021	Roduit, Raphael/0000-0001-7440-2799; Schorderet, Daniel/0000-0002-1331-504X				Ahuja-Jensen P, 2007, NEUROREPORT, V18, P797, DOI 10.1097/WNR.0b013e3280c1e344; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Choi IY, 2001, J CEREBR BLOOD F MET, V21, P653, DOI 10.1097/00004647-200106000-00003; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; DENEKE SM, 1989, AM J PHYSIOL, V257, pL163, DOI 10.1152/ajplung.1989.257.4.L163; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ganea E, 2006, CURR EYE RES, V31, P1, DOI 10.1080/02713680500477347; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Groeger G, 2009, J NEUROCHEM, V109, P1544, DOI 10.1111/j.1471-4159.2009.06081.x; Hamann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006616; Heidbreder M, 2007, BIOCHEM BIOPH RES CO, V352, P437, DOI 10.1016/j.bbrc.2006.11.027; Hernandez-Fonseca K, 2008, J NEUROSCI RES, V86, P1768, DOI 10.1002/jnr.21634; Hirata C, 1997, BIOCHEM BIOPH RES CO, V236, P712, DOI 10.1006/bbrc.1997.7036; KERN TS, 1994, INVEST OPHTH VIS SCI, V35, P2962; Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P2695; Mackey AM, 2008, CELL DEATH DIFFER, V15, P1291, DOI 10.1038/cdd.2008.43; McGowan JE, 2006, NEUROSCI LETT, V399, P111, DOI 10.1016/j.neulet.2006.01.034; Miranda M, 2007, FREE RADICAL BIO MED, V43, P1494, DOI 10.1016/j.freeradbiomed.2007.08.001; Nematollahi LR, 2009, METABOLISM, V58, P443, DOI 10.1016/j.metabol.2008.10.018; Nguyen TT, 2009, CURR DIABETES REP, V9, P277, DOI 10.1007/s11892-009-0043-4; Paramo B, 2010, NEUROSCIENCE, V167, P1057, DOI 10.1016/j.neuroscience.2010.02.074; Piaggi S, 2010, CARCINOGENESIS, V31, P804, DOI 10.1093/carcin/bgq031; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rahman I, 2001, BIOCHEM PHARMACOL, V62, P787, DOI 10.1016/S0006-2952(01)00702-X; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Ristoff E, 2007, J INHERIT METAB DIS, V30, P102, DOI 10.1007/s10545-006-0412-y; Ristoff E, 2001, J PEDIATR-US, V139, P79, DOI 10.1067/mpd.2001.114480; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P2392; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Zeevalk GD, 2000, J NEUROCHEM, V75, P1027, DOI 10.1046/j.1471-4159.2000.0751027.x	43	26	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21586	10.1371/journal.pone.0021586	http://dx.doi.org/10.1371/journal.pone.0021586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738719	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600057
J	Schernhammer, ES; Giovannucci, E; Baba, Y; Fuchs, CS; Ogino, S				Schernhammer, Eva S.; Giovannucci, Edward; Baba, Yoshifumi; Fuchs, Charles S.; Ogino, Shuji			B Vitamins, Methionine and Alcohol Intake and Risk of Colon Cancer in Relation to BRAF Mutation and CpG Island Methylator Phenotype (CIMP)	PLOS ONE			English	Article							ONE-CARBON METABOLISM; POPULATION-BASED SAMPLE; METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM; SPORADIC COLORECTAL-CANCER; MGMT PROMOTER METHYLATION; DNA METHYLATION; MICROSATELLITE INSTABILITY; MULTIVITAMIN USE; COMPETING RISKS; DIETARY-FOLATE	Background: One-carbon metabolism appears to play an important role in DNA methylation reaction. Evidence suggests that a low intake of B vitamins or high alcohol consumption increases colorectal cancer risk. How one-carbon nutrients affect the CpG island methylator phenotype (CIMP) or BRAF mutation status in colon cancer remains uncertain. Methods: Utilizing incident colon cancers in a large prospective cohort of women (the Nurses' Health Study), we determined BRAF status (N = 386) and CIMP status (N = 375) by 8 CIMP-specific markers [CACNA1G, CDKN2A (p16), CRABP1, IGF2, MLH1, NEUROG1, RUNX3, and SOCS1], and 8 other CpG islands (CHFR, HIC1, IGFBP3, MGMT, MINT-1, MINT-31, p14, and WRN). We examined the relationship between intake of one-carbon nutrients and alcohol and colon cancer risk, by BRAF mutation or CIMP status. Results: Higher folate intake was associated with a trend towards low risk of CIMP-low/0 tumors [ total folate intake >= 400 mg/day vs. <200 mu g/day; the multivariate relative risk = 0.73; 95% CI = 0.53-1.02], whereas total folate intake had no influence on CIMP-high tumor risks (P-heterogeneity = 0.73). Neither vitamin B-6, methionine or alcohol intake appeared to differentially influence risks for CIMP-high and CIMP-low/0 tumors. Using the 16-marker CIMP panel did not substantially alter our results. B vitamins, methionine or alcohol intake did not affect colon cancer risk differentially by BRAF status. Conclusions: This molecular pathological epidemiology study suggests that low level intake of folate may be associated with an increased risk of CIMP-low/0 colon tumors, but not that of CIMP-high tumors. However, the difference between CIMP-high and CIMP-low/0 cancer risks was not statistically significant, and additional studies are necessary to confirm these observations.	[Schernhammer, Eva S.; Fuchs, Charles S.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Schernhammer, Eva S.; Fuchs, Charles S.; Ogino, Shuji] Harvard Univ, Sch Med, Boston, MA USA; [Schernhammer, Eva S.] KFJ Spital, Ludwig Boltzmann Inst Appl Canc Res, Vienna, Austria; [Schernhammer, Eva S.] Appl Canc Res Inst Translat Res Vienna ACR ITR VI, Vienna, Austria; [Schernhammer, Eva S.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Baba, Yoshifumi; Fuchs, Charles S.; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ludwig Boltzmann Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Schernhammer, ES (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	eva.schernhammer@channing.harvard.edu	Schernhammer, Eva S/L-7898-2018	Schernhammer, Eva S/0000-0002-4337-9415; Ogino, Shuji/0000-0002-3909-2323	United States National Institutes of Health (NIH) [P01 CA87969, P01 CA55075, P50 CA127003, K07 CA122826, R01 CA151993]; Bennett Family Fund for Targeted Therapies Research; Entertainment Industry Foundation through National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA151993, P50CA127003, K07CA122826, P01CA055075] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bennett Family Fund for Targeted Therapies Research; Entertainment Industry Foundation through National Colorectal Cancer Research Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the United States National Institutes of Health (NIH) [P01 CA87969 (to S. Hankinson), P01 CA55075 (to W. Willett), P50 CA127003 (to C.S.F.), K07 CA122826 (to S.O.), R01 CA151993 (to S.O.)], the Bennett Family Fund for Targeted Therapies Research; and the Entertainment Industry Foundation through National Colorectal Cancer Research Alliance. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Candiloro ILM, 2009, CANCER PREV RES, V2, P862, DOI 10.1158/1940-6207.CAPR-09-0056; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Chen J, 1998, CARCINOGENESIS, V19, P2129, DOI 10.1093/carcin/19.12.2129; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; Curtin K, 2011, NUTR CANCER, V63, P357, DOI 10.1080/01635581.2011.535965; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; de Vogel S, 2011, CANCER CAUSE CONTROL, V22, P1, DOI 10.1007/s10552-010-9659-6; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fuchs CS, 2002, CANCER EPIDEM BIOMAR, V11, P227; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Giovannucci E, 2002, J NUTR, V132, p2350S, DOI 10.1093/jn/132.8.2350S; Glynn RJ, 2005, AM J EPIDEMIOL, V162, P975, DOI 10.1093/aje/kwi309; Gosden RG, 2007, NEW ENGL J MED, V356, P731, DOI 10.1056/NEJMe068284; Harnack L, 2002, NUTR CANCER, V43, P152, DOI 10.1207/S15327914NC432_5; Hawkins NJ, 2009, MODERN PATHOL, V22, P1588, DOI 10.1038/modpathol.2009.130; Hazra A, 2010, CANCER CAUSE CONTROL, V21, P331, DOI 10.1007/s10552-009-9464-2; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karpinski P, 2010, CANCER EPIDEMIOL, V34, P338, DOI 10.1016/j.canep.2010.03.002; Kawakami K, 2008, BRIT J CANCER, V98, P1555, DOI 10.1038/sj.bjc.6604346; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kim YI, 2004, ENVIRON MOL MUTAGEN, V44, P10, DOI 10.1002/em.20025; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; Ma J, 1997, CANCER RES, V57, P1098; Minoo P, 2007, J PATHOL, V212, P124, DOI 10.1002/path.2160; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Ogino S, 2007, CARCINOGENESIS, V28, P1985, DOI 10.1093/carcin/bgm160; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/jmoldx.2006.060082; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Oyama K, 2004, ANTICANCER RES, V24, P649; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Samowitz WS, 2008, GENE CHROMOSOME CANC, V47, P835, DOI 10.1002/gcc.20584; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Schemhammer ES, 2008, CANCER EPIDEM BIOMAR, V17, P2895, DOI 10.1158/1055-9965.EPI-08-0638; Schernhammer ES, 2008, GASTROENTEROLOGY, V135, P770, DOI 10.1053/j.gastro.2008.06.033; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Slattery ML, 2010, CANCER CAUSE CONTROL, V21, P1237, DOI 10.1007/s10552-010-9551-4; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Suzuki Hiromu, 2006, Asian Pac J Cancer Prev, V7, P177; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; van Engeland M, 2003, CANCER RES, V63, P3133; Van Guelpen B, 2010, CANCER CAUSE CONTROL, V21, P557, DOI 10.1007/s10552-009-9484-y; Wallace K, 2010, CANCER PREV RES, V3, P1552, DOI 10.1158/1940-6207.CAPR-10-0047; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; WILLETT WC, 1988, AM J EPIDEMIOL, V127, P188, DOI 10.1093/oxfordjournals.aje.a114780; WILLETT WC, 1987, NEW ENGL J MED, V316, P1174, DOI 10.1056/NEJM198705073161902; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; 1996, FED REG, P8797	64	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21102	10.1371/journal.pone.0021102	http://dx.doi.org/10.1371/journal.pone.0021102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738611	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600012
J	Talavera, D; Robertson, DL; Lovell, SC				Talavera, David; Robertson, David L.; Lovell, Simon C.			Characterization of Protein-Protein Interaction Interfaces from a Single Species	PLOS ONE			English	Article							INTERACTION SITES; RECOGNITION SITES; QUATERNARY STRUCTURE; HOT-SPOTS; PREDICTION; COMPLEXES; SEQUENCE; CONTACTS; INFORMATION; EVOLUTION	Most proteins attain their biological functions through specific interactions with other proteins. Thus, the study of protein-protein interactions and the interfaces that mediate these interactions is of prime importance for the understanding of biological function. In particular the precise determinants of binding specificity and their contributions to binding energy within protein interfaces are not well understood. In order to better understand these determinants an appropriate description of the interaction surface is needed. Available data from the yeast Saccharomyces cerevisiae allow us to focus on a single species and to use all the available structures, correcting for redundancy, instead of using structural representatives. This allows us to control for potentially confounding factors that may affect sequence propensities. We find a significant contribution of main-chain atoms to protein-protein interactions. These include interactions both with other main-chain and side-chain atoms on the interacting chain. We find that the type of interaction depends on both amino acid and secondary structure type involved in the contact. For example, residues in a-helices and large amino acids are the most likely to be involved in interactions through their side-chain atoms. We find an intriguing homogeneity when calculating the average solvation energy of different areas of the protein surface. Unexpectedly, homo-and hetero-complexes have quite similar results for all analyses. Our findings demonstrate that the manner in which protein-protein interactions are formed is determined by the residue type and the secondary structure found in the interface. However the homogeneity of the desolvation energy despite heterogeneity of interface properties suggests a complex relationship between interface composition and binding energy.	[Talavera, David; Robertson, David L.; Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, NH USA		Talavera, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, NH USA.	simon.lovell@manchester.ac.uk	Talavera, David/AAD-2088-2021	Talavera, David/0000-0002-8820-3931; Lovell, Simon/0000-0002-4092-8458	BBSRC [BB/F013337/1]; Biotechnology and Biological Sciences Research Council [BB/F013337/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by BBSRC grant number BB/F013337/1 (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Aloy P, 2002, P NATL ACAD SCI USA, V99, P5896, DOI 10.1073/pnas.092147999; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; de Vries SJ, 2008, CURR PROTEIN PEPT SC, V9, P394, DOI 10.2174/138920308785132712; de Vries SJ, 2006, BIOINFORMATICS, V22, P2094, DOI 10.1093/bioinformatics/btl275; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Hoskins J, 2006, PROTEIN SCI, V15, P1017, DOI 10.1110/ps.051589106; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kufareva I, 2007, PROTEINS, V67, P400, DOI 10.1002/prot.21233; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOVELL SC, MOL BIOL EVOL, V27, P2567; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Talavera D, 2006, PROTEIN SCI, V15, P2525, DOI 10.1110/ps.062406706; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Zhou HX, 2007, BIOINFORMATICS, V23, P2203, DOI 10.1093/bioinformatics/btm323; Zhou HX, 2001, PROTEINS, V44, P336, DOI 10.1002/prot.1099	46	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21053	10.1371/journal.pone.0021053	http://dx.doi.org/10.1371/journal.pone.0021053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738603	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000292092600010
J	Winters, M; Barta, JL; Monroe, C; Kemp, BM				Winters, Misa; Barta, Jodi Lynn; Monroe, Cara; Kemp, Brian M.			To Clone or Not To Clone: Method Analysis for Retrieving Consensus Sequences In Ancient DNA Samples	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MOLECULAR ANALYSIS; GENETIC-ANALYSIS; NEANDERTHAL DNA; ORIGIN; REVEAL; DIVERSITY; REMAINS; BONES; CONTAMINATION	The challenges associated with the retrieval and authentication of ancient DNA (aDNA) evidence are principally due to postmortem damage which makes ancient samples particularly prone to contamination from "modern" DNA sources. The necessity for authentication of results has led many aDNA researchers to adopt methods considered to be "gold standards" in the field, including cloning aDNA amplicons as opposed to directly sequencing them. However, no standardized protocol has emerged regarding the necessary number of clones to sequence, how a consensus sequence is most appropriately derived, or how results should be reported in the literature. In addition, there has been no systematic demonstration of the degree to which direct sequences are affected by damage or whether direct sequencing would provide disparate results from a consensus of clones. To address this issue, a comparative study was designed to examine both cloned and direct sequences amplified from similar to 3,500 year-old ancient northern fur seal DNA extracts. Majority rules and the Consensus Confidence Program were used to generate consensus sequences for each individual from the cloned sequences, which exhibited damage at 31 of 139 base pairs across all clones. In no instance did the consensus of clones differ from the direct sequence. This study demonstrates that, when appropriate, cloning need not be the default method, but instead, should be used as a measure of authentication on a case-by-case basis, especially when this practice adds time and cost to studies where it may be superfluous.	[Winters, Misa; Barta, Jodi Lynn; Monroe, Cara; Kemp, Brian M.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Barta, Jodi Lynn; Monroe, Cara; Kemp, Brian M.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Monroe, Cara] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Washington State University; Washington State University; University of California System; University of California Santa Barbara	Winters, M (corresponding author), Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA.	bmkemp@wsu.edu			National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2008-DN-BX-K008]; Interdisciplinary Training for Undergraduates in Biological and Mathematical Sciences (UBM) [EF-0531870]	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice; Interdisciplinary Training for Undergraduates in Biological and Mathematical Sciences (UBM)	This project was supported by Award No. 2008-DN-BX-K008 awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this publication/program/exhibition are those of the author(s) and do not necessarily reflect those of the Department of Justice. Support for Misa Winters was provided by the Interdisciplinary Training for Undergraduates in Biological and Mathematical Sciences (UBM) grant EF-0531870. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Bouwman AS, 2005, J ARCHAEOL SCI, V32, P703, DOI 10.1016/j.jas.2004.11.014; Bower MA, 2005, NUCLEIC ACIDS RES, V33, P2549, DOI 10.1093/nar/gki550; Capelli C, 2003, FORENSIC SCI INT, V131, P59, DOI 10.1016/S0379-0738(02)00396-1; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Collins MJ, 2009, P ROY SOC B-BIOL SCI, V276, P2971, DOI 10.1098/rspb.2009.0563; Cooper A, 2000, SCIENCE, V289, P1139; CROCKFORD SJ, 2004, UNL050 AL DEP TRANSP; Endicott P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000081; Fernandez E, 2009, J ARCHAEOL SCI, V36, P965, DOI 10.1016/j.jas.2008.11.009; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; Gilbert MTP, 2006, FORENSIC SCI INT, V156, P208, DOI 10.1016/j.forsciint.2005.02.021; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Handt O, 1996, AM J HUM GENET, V59, P368; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hebsgaard MB, 2009, ANTIQUITY, V83, P430, DOI 10.1017/S0003598X00098537; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; Hofreiter M, 2002, MOL BIOL EVOL, V19, P1244, DOI 10.1093/oxfordjournals.molbev.a004185; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Karanth KP, 2005, P NATL ACAD SCI USA, V102, P5090, DOI 10.1073/pnas.0408354102; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2010, HUM BIOL, V82, P227, DOI 10.3378/027.082.0207; Kim JH, 2005, MOL CELLS, V20, P325; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Kuch M, 2007, AM J PHYS ANTHROPOL, V132, P594, DOI 10.1002/ajpa.20536; Kuhn TS, 2010, MOL ECOL, V19, P1312, DOI 10.1111/j.1365-294X.2010.04565.x; Lambert DM, 2002, SCIENCE, V295, P2270, DOI 10.1126/science.1068105; Lari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010648; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Monsalve MV, 2002, AM J PHYS ANTHROPOL, V119, P288, DOI 10.1002/ajpa.10116; Moss M. L., 2006, J ISL COAST ARCHAEOL, V1, P165, DOI DOI 10.1080/15564890600934129; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; Poinar H, 2009, SCIENCE, V325, DOI [10.1126/science.1167531, 10.1126/science.1168182]; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 2001, P NATL ACAD SCI USA, V98, P4317, DOI 10.1073/pnas.061014798; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Speller CF, 2010, P NATL ACAD SCI USA, V107, P2807, DOI 10.1073/pnas.0909724107; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Zeder MA, 2006, TRENDS GENET, V22, P139, DOI 10.1016/j.tig.2006.01.007	63	41	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21247	10.1371/journal.pone.0021247	http://dx.doi.org/10.1371/journal.pone.0021247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	783OD	21738625	Green Published, gold			2022-12-25	WOS:000292092600022
J	Tong, SYC; Dakh, F; Hurt, AC; Deng, YM; Freeman, K; Fagan, PK; Barr, IG; Giffard, PM				Tong, Steven Y. C.; Dakh, Farshid; Hurt, Aeron C.; Deng, Yi-Mo; Freeman, Kevin; Fagan, Peter K.; Barr, Ian G.; Giffard, Philip M.			Rapid Detection of the H275Y Oseltamivir Resistance Mutation in Influenza A/H1N1 2009 by Single Base Pair RT-PCR and High-Resolution Melting	PLOS ONE			English	Article							VIRUS	Introduction: We aimed to design a real-time reverse-transcriptase-PCR (rRT-PCR), high-resolution melting (HRM) assay to detect the H275Y mutation that confers oseltamivir resistance in influenza A/H1N1 2009 viruses. Findings: A novel strategy of amplifying a single base pair, the relevant SNP at position 823 of the neuraminidase gene, was chosen to maintain specificity of the assay. Wildtype and mutant virus were differentiated when using known reference samples of cell-cultured virus. However, when dilutions of these reference samples were assayed, amplification of nonspecific primer-dimer was evident and affected the overall melting temperature (T-m) of the amplified products. Due to primer-dimer appearance at > 30 cycles we found that if the cycle threshold (C-T) for a dilution was > 30, the HRM assay did not consistently discriminate mutant from wildtype. Where the C-T was < 30 we noted an inverse relationship between C-T and T-m and fitted quadratic curves allowed the discrimination of wildtype, mutant and 30:70 mutant: wildtype virus mixtures. We compared the C-T values for a TaqMan H1N1 09 detection assay with those for the HRM assay using 59 clinical samples and demonstrated that samples with a TaqMan detection assay C-T > 32.98 would have an H275Y assay C-T > 30. Analysis of the TaqMan C-T values for 609 consecutive clinical samples predicted that 207 (34%) of the samples would result in an HRM assay C-T > 30 and therefore not be amenable to the HRM assay. Conclusions: The use of single base pair PCR and HRM can be useful for specifically interrogating SNPs. When applied to H1N1 09, the constraints this placed on primer design resulted in amplification of primer-dimer products. The impact primer-dimer had on HRM curves was adjusted for by plotting T-m against C-T. Although less sensitive than TaqMan assays, the HRM assay can rapidly, and at low cost, screen samples with moderate viral concentrations.	[Tong, Steven Y. C.; Dakh, Farshid; Giffard, Philip M.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Tong, Steven Y. C.] Royal Darwin Hosp, Dept Infect Dis, Darwin, NT, Australia; [Hurt, Aeron C.; Deng, Yi-Mo; Barr, Ian G.] World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic, Australia; [Freeman, Kevin; Fagan, Peter K.] Royal Darwin Hosp, No Terr Govt Pathol Serv Microbiol Lab, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; World Health Organization	Tong, SYC (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	Steven.tong@menzies.edu.au	Tong, Steven/N-2353-2013; Giffard, Philip/N-2293-2013	Tong, Steven/0000-0002-1368-8356; Dakh, Farshid/0000-0003-4010-1722; Deng, Yi-Mo/0000-0003-2177-8308; Barr, Ian/0000-0002-7351-418X; FREEMAN, KEVIN/0000-0002-6959-8712; Hurt, Aeron/0000-0003-1826-4314; Giffard, Phil/0000-0002-3030-9127	Australian National Health and Research Council [605829]	Australian National Health and Research Council(Australian Research Council)	ST is supported by an Australian National Health and Research Council Post-doctoral training fellowship (605829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P453; Baz M, 2009, NEW ENGL J MED, V361, P2296, DOI 10.1056/NEJMc0910060; Carr MJ, 2008, J VIROL METHODS, V153, P257, DOI 10.1016/j.jviromet.2008.07.011; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Chidlow GR, 2010, J VIROL METHODS, V169, P47, DOI 10.1016/j.jviromet.2010.06.014; Deyde VM, 2009, EXPERT REV MOL DIAGN, V9, P493, DOI 10.1586/ERM.09.21; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Guo LZ, 2009, ANTIVIR RES, V82, P29, DOI 10.1016/j.antiviral.2009.01.004; Hata M, 2010, J CLIN MICROBIOL, V48, P1983, DOI 10.1128/JCM.01862-09; Hindiyeh M, 2010, J CLIN MICROBIOL, V48, P1884, DOI 10.1128/JCM.02540-09; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Medina RA, 2011, J CLIN MICROBIOL, V49, P335, DOI 10.1128/JCM.01142-10; Mehta T, 2010, J CLIN MICROBIOL, V48, P4326, DOI 10.1128/JCM.01190-10; Renaud C, 2010, J CLIN VIROL, V49, P21, DOI 10.1016/j.jcv.2010.06.019; Speers DJ, 2010, MED J AUSTRALIA, V192, P166, DOI 10.5694/j.1326-5377.2010.tb03459.x; STEAIN MC, 2009, ANTIVIRAL RES, V84; Suzuki Y, 2011, J CLIN MICROBIOL, V49, P125, DOI 10.1128/JCM.01401-10; van der Vries E, 2010, J CLIN VIROL, V47, P34, DOI 10.1016/j.jcv.2009.09.030; Varillas D, 2011, J VIROL METHODS, V171, P284, DOI 10.1016/j.jviromet.2010.10.003; Whiley DM, 2009, J CLIN VIROL, V45, P203, DOI 10.1016/j.jcv.2009.05.032	22	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21446	10.1371/journal.pone.0021446	http://dx.doi.org/10.1371/journal.pone.0021446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731753	Green Published, gold			2022-12-25	WOS:000292036900031
J	Meng, E; Cai, TF; Li, WY; Zhang, H; Liu, YB; Peng, K; Liang, SP; Zhang, DY				Meng, Er; Cai, Tian-Fu; Li, Wen-Ying; Zhang, Hui; Liu, Yan-Bo; Peng, Kuan; Liang, Songping; Zhang, Dong-Yi			Functional Expression of Spider Neurotoxic Peptide Huwentoxin-I in E. coli	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; SELENOCOSMIA-HUWENA; ESCHERICHIA-COLI; SCANNING MUTAGENESIS; CHANNEL BLOCKER; VENOM; TRANSLOCATION; PURIFICATION; CYTOPLASM; SEQUENCE	The coding sequence of huwentoxin-I, a neurotoxic peptide isolated from the venom of the Chinese spider Ornithoctonus huwena, was amplified by PCR using the cDNA library constructed from the spider venom glands. The cloned fragment was inserted into the expression vector pET-40b and transformed into the E. coli strain BL21 (DE3). The expression of a soluble fusion protein, disulfide interchange protein (DsbC)-huwentoxin-I, was auto-induced in the periplasm of E. coli in the absence of IPTG. After partial purification using a Ni-NTA column, the expressed fusion protein was digested using enterokinase to release heteroexpressed huwentoxin-I and was further purified using RP-HPLC. The resulting peptide was subjected to gel electrophoresis and mass spectrometry analysis. The molecular weight of the heteroexpressed huwentoxin-I was 3750.69, which is identical to that of the natural form of the peptide isolated from spider venom. The physiological properties of the heteroexpressed huwentoxin-I were further analyzed using a whole-cell patch clamp assay. The heteroexpressed huwentoxin-I was able to block currents generated by human Na-v1.7 at an IC50 of 640 nmole/L, similar to that of the natural huwentoxin-I, which is 630 nmole/L.	[Meng, Er; Cai, Tian-Fu; Zhang, Hui; Liu, Yan-Bo; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Meng, Er; Li, Wen-Ying; Zhang, Dong-Yi] Natl Univ Def Technol, Coll Sci, Res Ctr Biol Informat, Changsha, Hunan, Peoples R China; [Peng, Kuan] Cent S Univ Forestry & Technol, Core Facil Biotechnol, Changsha, Hunan, Peoples R China	Hunan Normal University; National University of Defense Technology - China; Central South University of Forestry & Technology	Meng, E (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; dongyizhang@yahoo.cn			National Natural Science Foundation of China [30971432]; New Century Excellent Talents in University [NCET-05-0715]; Ministry of Science and Technology of China [2010CB529800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China, No. 30971432 to Dr. D.Y. Zhang; New Century Excellent Talents in University, No. NCET-05-0715 to Dr. D.Y. Zhang; the Ministry of Science and Technology of China "973" Project, No. 2010CB529800 to Dr. S. P. Liang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarraberes FA, 2001, BBA-BIOMEMBRANES, V1513, P1, DOI 10.1016/S0304-4157(01)00005-3; Anangi R, 2007, TOXIN REV, V26, P169, DOI 10.1080/15569540701209815; Chen J, 1999, J BIOL CHEM, V274, P19601, DOI 10.1074/jbc.274.28.19601; Chen JQ, 2005, TOXICON, V45, P15, DOI 10.1016/j.toxicon.2004.08.018; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; [刁建波 Diao Jianbo], 2003, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V19, P195; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; Ji WJ, 2005, PROTEIN EXPRES PURIF, V41, P454, DOI 10.1016/j.pep.2005.02.012; Jiang LP, 2009, PEPTIDES, V30, P669, DOI 10.1016/j.peptides.2008.12.012; KANG Y, 1994, J BIOTECHNOL, V36, P45, DOI 10.1016/0168-1656(94)90022-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li M, 2000, TOXICON, V38, P153, DOI 10.1016/S0041-0101(99)00123-3; LIANG SP, 1993, TOXICON, V31, P969, DOI 10.1016/0041-0101(93)90256-I; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; [刘君梁 Liu Junliang], 2005, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V21, P39; Maggio F, 2002, J BIOL CHEM, V277, P22806, DOI 10.1074/jbc.M202297200; Mergulhao FJM, 2005, BIOTECHNOL ADV, V23, P177, DOI 10.1016/j.biotechadv.2004.11.003; Miot M, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-4; Nie Dong-Song, 2002, Sheng Wu Gong Cheng Xue Bao, V18, P172; PARK CS, 1991, P NATL ACAD SCI USA, V88, P2046, DOI 10.1073/pnas.88.6.2046; Peng K, 2001, TOXICON, V39, P491, DOI 10.1016/S0041-0101(00)00150-1; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Qu YX, 1997, J PROTEIN CHEM, V16, P565, DOI 10.1023/A:1026314722607; Ren GP, 2007, J BACTERIOL, V189, P2777, DOI 10.1128/JB.01406-06; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; SMITH LA, 1993, BIOCHEMISTRY-US, V32, P5692, DOI 10.1021/bi00072a026; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tedford HW, 2004, J BIOL CHEM, V279, P44133, DOI 10.1074/jbc.M404006200; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; ZAPUN A, 1995, BIOCHEMISTRY-US, V34, P5075, DOI 10.1021/bi00015a019; ZHANG DG, 1993, J PROTEIN CHEM, V12, P735, DOI 10.1007/BF01024931; Zhou PA, 1997, TOXICON, V35, P39, DOI 10.1016/S0041-0101(96)00072-4	36	21	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21608	10.1371/journal.pone.0021608	http://dx.doi.org/10.1371/journal.pone.0021608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731778	gold, Green Published, Green Submitted			2022-12-25	WOS:000292035400051
J	Georgakopoulos, A; Xu, JD; Xu, CJ; Mauger, G; Barthet, G; Robakis, NK				Georgakopoulos, Anastasios; Xu, Jindong; Xu, Chijie; Mauger, Gweltas; Barthet, Gael; Robakis, Nikolaos K.			Presenilin1/gamma-secretase promotes the EphB2-induced phosphorylation of ephrinB2 by regulating phosphoprotein associated with glycosphingolipid-enriched microdomains/Csk binding protein	FASEB JOURNAL			English	Article						Alzheimer disease; PAG/Cbp; Src kinases	LONG-TERM POTENTIATION; T-CELL-ACTIVATION; TRANSMEMBRANE ADAPTER; SYNAPSE FORMATION; REVERSE SIGNALS; SRC KINASE; C-SRC; HIPPOCAMPAL; PLASTICITY; CSK	Reverse signaling through the ephrinB ligands is important for several morphogenetic events, such as axon guidance, neuronal plasticity, spine maturation, and synaptogenesis. Signaling is initiated by binding of EphB receptors to ephrinB ligands, stimulating their tyrosine phosphorylation via an unclear mechanism. Here we show that this mechanism involves presenilin1 (PS1)/gamma-secretase regulation of phosphoprotein associated with glycosphingolipid-enriched microdomains/Csk binding protein (PAG/Cbp), an adaptor protein that controls the activity of Src kinases. Using immunoprecipitation and Western blot of mouse primary neuronal and human embryonic kidney (HEK293) cell extracts overexpressing PAG/Cbp, we show that EphB2 induces tyrosine dephosphorylation of PAG/Cbp in a gamma-secretase-dependent manner. In these cells, PAG/Cbp dephosphorylation is promoted by the PS1/gamma-secretase-produced fragment of ephrinB2 cleavage (ephrinB2/CTF2), which forms complexes with PAG/Cbp when introduced exogenously. EphB2-induced tyrosine phosphorylation of ephrinB2 depends on PAG/Cbp because EphB2 cannot increase ephrinB2 phosphorylation in cells treated with anti-PAG siRNA or in PAG/Cbp-knockout (KO) cells. Furthermore, in contrast to WT PS1, familial Alzheimer disease (FAD) PS1 mutants expressed in PS1-KO mouse embryonic fibroblasts inhibited both the EphB2-induced dephosphorylation of PAG/Cbp and the phosphorylation of ephrinB2. PS1 FAD mutations may thus inhibit the function of ephrinB in the brain, promoting neurodegeneration in Alzheimer disease.-Georgakopoulos, A., Xu, J., Xu, C., Mauger, G., Barthet, G., Robakis, N. K. Presenilin1/gamma-secretase promotes the EphB2-induced phosphorylation of ephrinB2 by regulating phosphoprotein associated with glycosphingolipid-enriched microdomains/Csk binding protein. FASEB J. 25, 3594-3604 (2011). www.fasebj.org	[Georgakopoulos, Anastasios] NYU, Dept Psychiat, Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, New York, NY 10029 USA; NYU, Dept Neurosci, Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University	Georgakopoulos, A (corresponding author), NYU, Dept Psychiat, Mt Sinai Sch Med, Ctr Mol Biol & Genet Neurodegenerat, 1 Gustave L Levy Pl,Box 1229, New York, NY 10029 USA.	tassos.georgakopoulos@mssm.edu	Robakis, Nikolaos/AAA-1838-2021	Georgakopoulos, Anastasios/0000-0001-8241-6306; Barthet, Gael/0000-0003-4025-1616	U.S. National Institutes of Health [P50 AG005138, AG008200, AG017926]; Alzheimer's Association [IIRG-07-59620]; NATIONAL INSTITUTE ON AGING [R01AG017926, P50AG005138, R01AG008200, R37AG017926] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by U.S. National Institutes of Health grants P50 AG005138 to A.G. and AG008200 and AG017926 to N.K.R. and by Alzheimer's Association grant IIRG-07-59620 to A.G.	Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Aoto J, 2007, J NEUROSCI, V27, P7508, DOI 10.1523/JNEUROSCI.0705-07.2007; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Bouzioukh F, 2007, J NEUROSCI, V27, P11279, DOI 10.1523/JNEUROSCI.3393-07.2007; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Cary LA, 2000, NATURE, V404, P945, DOI 10.1038/35010257; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Horejsi V, 2004, IMMUNOL LETT, V92, P43, DOI 10.1016/j.imlet.2003.10.013; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; McCarthy JV, 2009, CELL MOL LIFE SCI, V66, P1534, DOI 10.1007/s00018-009-8435-9; OKADA M, 1989, J BIOL CHEM, V264, P20886; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Svec A, 2008, PATHOL RES PRACT, V204, P785, DOI 10.1016/j.prp.2008.06.006; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Xu JD, 2009, J BIOL CHEM, V284, P27220, DOI 10.1074/jbc.M109.048728; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4	35	22	23	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3594	3604		10.1096/fj.11-187856	http://dx.doi.org/10.1096/fj.11-187856			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21746865	Green Published			2022-12-25	WOS:000295356400029
J	Fujita-Sato, S; Ito, S; Isobe, T; Ohyama, T; Wakabayashi, K; Morishita, K; Ando, O; Isono, F				Fujita-Sato, Saori; Ito, Shuichiro; Isobe, Takashi; Ohyama, Takao; Wakabayashi, Kenji; Morishita, Kaoru; Ando, Osamu; Isono, Fujio			Structural Basis of Digoxin That Antagonizes ROR gamma t Receptor Activity and Suppresses Th17 Cell Differentiation and Interleukin (IL)-17 Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; GROWTH-FACTOR-BETA; NUCLEAR RECEPTOR; CRYSTAL-STRUCTURE; IL-17; LINEAGE; ALPHA; AUTOIMMUNITY; MODULATION; DISTINCT	The retinoic acid-related orphan nuclear receptor gamma t (ROR gamma t)/ROR gamma 2 is well known as a master regulator of interleukin 17 (IL-17)-producing helper T (Th17) cell development. To develop a therapeutic agent against Th17-mediated autoimmune diseases, we screened chemical compounds and successfully found that digoxin inhibited IL-17 production. Further studies revealed that digoxin bound to the ligand binding domain of ROR gamma t and suppressed Th17 differentiation without affecting Th1 differentiation. To better understand the structural basis for the inhibitory activity of digoxin, we determined the crystal structure of the ROR gamma t ligand-binding domain in complex with digoxin at 2.2 angstrom resolution. The structure reveals that digoxin binds to the ligand-binding pocket protruding between helices H3 and H11 from the pocket. In addition, digoxin disrupts the key interaction important for the agonistic activity, resulting in preventing the positioning of helix H12 in the active conformation, thus antagonizing coactivator interaction. Functional studies demonstrated that digoxin inhibited ROR gamma t activity and decreased IL-17 production but not ROR alpha activity. Digoxin inhibited IL-17 production in CD4(+) T cells from experimental autoimmune encephalomyelitis mice. Our data indicates that ROR gamma t is a promising therapeutic target for Th17-derived autoimmune diseases and our structural data will help to design novel ROR gamma t antagonists.	[Isobe, Takashi; Isono, Fujio] Daiichi Sankyo Co Ltd, R&D Div, Frontier Res Labs, Tokyo 1348630, Japan; [Fujita-Sato, Saori; Ando, Osamu] Daiichi Sankyo Co Ltd, R&D Div, Oncol Res Labs, Tokyo 1348630, Japan; [Ito, Shuichiro] Daiichi Sankyo Co Ltd, R&D Div, Lead Discovery & Optimizat Res Labs 2, Tokyo 1348630, Japan; [Ohyama, Takao; Morishita, Kaoru] Daiichi Sankyo Co Ltd, R&D Div, Biol Res Labs, Tokyo 1348630, Japan; [Wakabayashi, Kenji] Daiichi Sankyo RD Associe Co Ltd, Res Dept 3, Edogawa Ku, Tokyo 1348630, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Isono, F (corresponding author), Daiichi Sankyo Co Ltd, R&D Div, Frontier Res Labs, Tokyo 1348630, Japan.	isono.fujio.vd@daiichisankyo.co.jp						Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Crome SQ, 2009, EUR J IMMUNOL, V39, P1480, DOI 10.1002/eji.200838908; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Harrington LE, 2006, CURR OPIN IMMUNOL, V18, P349, DOI 10.1016/j.coi.2006.03.017; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; MAEDA H, 1994, JPN J CANCER RES, V85, P1137, DOI 10.1111/j.1349-7006.1994.tb02919.x; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medvedev A, 1996, GENE, V181, P199, DOI 10.1016/S0378-1119(96)00504-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Unutmaz D, 2009, EUR J IMMUNOL, V39, P1452, DOI 10.1002/eji.200939540; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Williams S, 2003, J BIOL CHEM, V278, P27138, DOI 10.1074/jbc.M302260200; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	48	99	111	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31409	31417		10.1074/jbc.M111.254003	http://dx.doi.org/10.1074/jbc.M111.254003			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21733845	hybrid, Green Published			2022-12-25	WOS:000294487500035
J	Rinehart, J; Vazquez, N; Kahle, KT; Hodson, CA; Ring, AM; Gulcicek, EE; Louvi, A; Bobadilla, NA; Gamba, G; Lifton, RP				Rinehart, Jesse; Vazquez, Norma; Kahle, Kristopher T.; Hodson, Caleb A.; Ring, Aaron M.; Gulcicek, Erol E.; Louvi, Angeliki; Bobadilla, Norma A.; Gamba, Gerardo; Lifton, Richard P.			WNK2 Kinase Is a Novel Regulator of Essential Neuronal Cation-Chloride Cotransporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; ALANINE-RICH KINASE; PROTEIN-KINASE; CELL-VOLUME; NA+-K+-2CL(-) COTRANSPORTER; INHERITED HYPERTENSION; NERVOUS-SYSTEM; BLOOD-PRESSURE; SPAK; EXPRESSION	NKCC1 and KCC2, related cation-chloride cotransporters (CCC), regulate cell volume and gamma-aminobutyric acid (GABA)-ergic neurotranmission by modulating the intracellular concentration of chloride [Cl-]. These CCCs are oppositely regulated by serine-threonine phosphorylation, which activates NKCC1 but inhibits KCC2. The kinase(s) that performs this function in the nervous system are not known with certainty. WNK1 and WNK4, members of the WNK(with no lysine [(K) under bar]) kinase family, either directly or via the downstream SPAK/OSR1 Ste 20-type kinases, regulate the furosemide-sensitive NKCC2 and the thiazide-sensitive NCC, kidney-specific CCCs. What role the novel WNK2 kinase plays in this regulatory cascade, if any, is unknown. Here, we show that WNK2, unlike other WNKs, is not expressed in kidney; rather, it is a neuron-enriched kinase primarily expressed in neocortical pyramidal cells, thalamic relay cells, and cerebellar granule and Purkinje cells in both the developing and adult brain. Bumetanide-sensitive and Cl--dependent Rb-86(+) uptake assays in Xenopus laevis oocytes revealed that WNK2 promotes Cl- accumulation by reciprocally activating NKCC1 and inhibiting KCC2 in a kinase-dependent manner, effectively bypassing normal tonicity requirements for cotransporter regulation. TiO2 enrichment and tandem mass spectrometry studies demonstrate WNK2 forms a protein complex in the mammalian brain with SPAK, a known phosphoregulator of NKCC1. In this complex, SPAK is phosphorylated at Ser-383, a consensus WNK recognition site. These findings suggest a role for WNK2 in the regulation of CCCs in the mammalian brain, with implications for both cell volume regulation and/or GABAergic signaling.	[Vazquez, Norma; Bobadilla, Norma A.; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mol Physiol Unit, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [Rinehart, Jesse; Hodson, Caleb A.; Ring, Aaron M.; Louvi, Angeliki; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Vazquez, Norma; Bobadilla, Norma A.; Gamba, Gerardo] Inst Nacl Cardiol Ignacio Chavez, Mexico City 14000, DF, Mexico; [Kahle, Kristopher T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Kahle, Kristopher T.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Gulcicek, Erol E.] Yale Univ, Keck Biotechnol Resource Lab, New Haven, CT 06510 USA	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Howard Hughes Medical Institute; Yale University; National Institute of Cardiology - Mexico; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yale University	Gamba, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mol Physiol Unit, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico.	gamba@biomedicas.unam.mx; richard.lifton@yale.edu	; Gamba, Gerardo/P-4873-2016	Ring, Aaron/0000-0003-3699-2446; Gamba, Gerardo/0000-0002-4378-9043	NIDA, National Institutes of Health [2P30DA018343]; Leducq Foundation Transatlantic Network on Hypertension; el Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico) [59992]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK089006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Leducq Foundation Transatlantic Network on Hypertension(Leducq Foundation); el Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by NIDA, National Institutes of Health Grant 2P30DA018343 (to J. R., E. E. G., and R. P. L.), the Leducq Foundation Transatlantic Network on Hypertension (to G. G. and R. P. L.), and el Consejo Nacional de Ciencia y Tecnologia (CONACYT-Mexico) Grant 59992 (to G. G.).	ARROYO JP, 2011, J AM SOC NE IN PRESS, V22; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; BREITWIESER GE, 1990, AM J PHYSIOL, V258, pC749, DOI 10.1152/ajpcell.1990.258.4.C749; Byun N, 2007, NEUROBIOL DIS, V28, P39, DOI 10.1016/j.nbd.2007.06.014; Cai H, 2006, KIDNEY INT, V69, P2162, DOI 10.1038/sj.ki.5000333; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; de los Heros P, 2006, P NATL ACAD SCI USA, V103, P1976, DOI 10.1073/pnas.0510947103; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 2005, AM J PHYSIOL-RENAL, V288, pF245, DOI 10.1152/ajprenal.00311.2004; Garzon-Muvdi T, 2007, AM J PHYSIOL-RENAL, V292, pF1197, DOI 10.1152/ajprenal.00335.2006; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; Golbang AP, 2006, AM J PHYSIOL-RENAL, V291, pF1369, DOI 10.1152/ajprenal.00468.2005; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Haas BR, 2010, CANCER RES, V70, P5597, DOI 10.1158/0008-5472.CAN-09-4666; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Jun P, 2009, NEURO-ONCOLOGY, V11, P414, DOI 10.1215/15228517-2008-096; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Kahle KT, 2005, P NATL ACAD SCI USA, V102, P16783, DOI 10.1073/pnas.0508307102; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Louvi A, 2000, DEVELOPMENT, V127, P4061; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 2002, AM J PHYSIOL-CELL PH, V283, pC1422, DOI 10.1152/ajpcell.00130.2002; Marty A, 2005, TRENDS NEUROSCI, V28, P284, DOI 10.1016/j.tins.2005.04.003; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; O'Reilly M, 2006, J AM SOC NEPHROL, V17, P2402, DOI 10.1681/ASN.2005111197; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617; Plotkin MD, 1997, AM J PHYSIOL-CELL PH, V272, pC173, DOI 10.1152/ajpcell.1997.272.1.C173; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rudnik-Schoneborn S, 2009, NEUROPEDIATRICS, V40, P129, DOI 10.1055/s-0029-1234084; Schomberg SL, 2003, J NEUROPHYSIOL, V89, P159, DOI 10.1152/jn.00229.2002; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song LY, 2002, MOL BRAIN RES, V103, P91, DOI 10.1016/S0169-328X(02)00190-0; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; TOLE S, 1995, J NEUROSCI, V15, P970; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093	64	65	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30171	30180		10.1074/jbc.M111.222893	http://dx.doi.org/10.1074/jbc.M111.222893			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21733846	Green Published, hybrid			2022-12-25	WOS:000294046600074
J	Yoon, MS; Sun, YT; Arauz, E; Jiang, Y; Chen, J				Yoon, Mee-Sup; Sun, Yuting; Arauz, Edwin; Jiang, Yu; Chen, Jie			Phosphatidic Acid Activates Mammalian Target of Rapamycin Complex 1 (mTORC1) Kinase by Displacing FK506 Binding Protein 38 (FKBP38) and Exerting an Allosteric Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; PHOSPHOLIPASE-D; CELL-GROWTH; PATHWAY; RHEB; TOR; INHIBITOR; NUTRIENT; PLD; PROGRESSION	Phosphatidic acid (PA) is a critical mediator of mitogenic activation of mammalian target of rapamycin complex 1 (mTORC1) signaling, a master regulator of mammalian cell growth and proliferation. The mechanism by which PA activates mTORC1 signaling has remained unknown. Here, we report that PA selectively stimulates mTORC1 but not mTORC2 kinase activity in cells and in vitro. Furthermore, we show that PA competes with the mTORC1 inhibitor, FK506 binding protein 38 (FKBP38), for mTOR binding at a site encompassing the rapamycin-FKBP12 binding domain. This leads to PA antagonizing FKBP38 inhibition of mTORC1 kinase activity in vitro and rescuing mTORC1 signaling from FKBP38 in cells. Phospholipase D 1, a PA-generating enzyme that is an established upstream regulator of mTORC1, is found to negatively affect mTOR-FKBP38 interaction, confirming the role of endogenous PA in this regulation. Interestingly, removal of FKBP38 alone is insufficient to activate mTORC1 kinase and signaling, which require PA even when the FKBP38 level is drastically reduced by RNAi. In conclusion, we propose a dual mechanism for PA activation of mTORC1: PA displaces FKBP38 from mTOR and allosterically stimulates the catalytic activity of mTORC1.	[Yoon, Mee-Sup; Sun, Yuting; Arauz, Edwin; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Jiang, Yu] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University of Illinois System; University of Illinois Urbana-Champaign; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, J (corresponding author), 601 S Goodwin Ave,B107, Urbana, IL 61801 USA.	jiechen@illinois.edu	Sun, Yuting/C-7906-2012; Diaz, Edwin Arauz/AAI-5457-2021	Chen, Jie/0000-0002-7887-3747	National Institutes of Health [AR048914, CA129821]; NATIONAL CANCER INSTITUTE [R01CA129821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068832, R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health grant AR048914 (to J. C.) CA129821 (to Y. J.).	Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Billon-Denis E, 2008, J LIPID RES, V49, P295, DOI 10.1194/jlr.M700171-JLR200; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Dunlop EA, 2009, CELL SIGNAL, V21, P1073, DOI 10.1016/j.cellsig.2009.02.024; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Ikenoue T, 2009, METHOD ENZYMOL, V452, P165, DOI 10.1016/S0076-6879(08)03611-2; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Peng L, 2010, J BIOL CHEM, V285, P20870, DOI 10.1074/jbc.M110.112045; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Sun Y, 2008, P NATL ACAD SCI USA, V105, P8286, DOI 10.1073/pnas.0712268105; Sun YT, 2008, CELL CYCLE, V7, P3118, DOI 10.4161/cc.7.20.6881; Uhlenbrock K, 2009, FEBS LETT, V583, P965, DOI 10.1016/j.febslet.2009.02.015; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566	35	93	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29568	29574		10.1074/jbc.M111.262816	http://dx.doi.org/10.1074/jbc.M111.262816			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737445	Green Published, hybrid			2022-12-25	WOS:000294046600014
J	Campbell, JL; Arora, J; Cowell, SF; Garg, A; Eu, P; Bhargava, SK; Bansal, V				Campbell, Jos L.; Arora, Jyoti; Cowell, Simon F.; Garg, Ashish; Eu, Peter; Bhargava, Suresh K.; Bansal, Vipul			Quasi-Cubic Magnetite/Silica Core-Shell Nanoparticles as Enhanced MRI Contrast Agents for Cancer Imaging	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MAGNETIC NANOPARTICLES; COLLOIDAL PARTICLES; SIZE; RELAXIVITY; GADOLINIUM; DIAGNOSIS; SILICA	Development of magnetic resonance imaging (MRI) contrast agents that can be readily applied for imaging of biological tissues under clinical settings is a challenging task. This is predominantly due to the expectation of an ideal MR agent being able to be synthesized in large quantities, possessing longer shelf life, reasonable biocompatibility, tolerance against its aggregation in biological fluids, and high relaxivity, resulting in better contrast during biological imaging. Although a repertoire of reports address various aforementioned issues, the previously reported results are far from optimal, which necessitates further efforts in this area. In this study, we demonstrate facile large-scale synthesis of sub-100 nm quasi-cubic magnetite and magnetite/ silica core-shell (Mag@SiO2) nanoparticles and their applicability as a biocompatible T2 contrast agent for MRI of biological tissues. Our study suggests that silica-coated magnetite nanoparticles reported in this study can potentially act as improved MR contrast agents by addressing a number of aforementioned issues, including longer shelf life and stability in biological fluids. Additionally, our in vitro and in vivo studies clearly demonstrate the importance of silica coating towards improved applicability of T2 contrast agents for cancer imaging.	[Campbell, Jos L.; Bhargava, Suresh K.; Bansal, Vipul] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Arora, Jyoti; Cowell, Simon F.] RMIT Univ, Sch Med Sci, Melbourne, Vic, Australia; [Arora, Jyoti] Cell Therapies & Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Garg, Ashish] Indian Inst Technol, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India; [Eu, Peter] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Peter Maccallum Cancer Center; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Peter Maccallum Cancer Center	Campbell, JL (corresponding author), RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia.	peter.eu@petermac.org; suresh.bhargava@rmit.edu.au; vipul.bansal@rmit.edu.au	Bhargava, Suresh K./AAQ-2675-2020; Bansal, Vipul/B-2485-2008; Garg, Ashish/F-9843-2010; Bhargava, Suresh K./C-5783-2011	Bhargava, Suresh K./0000-0002-3127-8166; Bansal, Vipul/0000-0002-3354-4317; Bhargava, Suresh K./0000-0002-3127-8166; Garg, Ashish/0000-0003-4163-5355				Alberola AP, 2009, BIOMATERIALS, V30, P3766, DOI 10.1016/j.biomaterials.2009.03.031; Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053; Bansal V, 2011, AUST J CHEM, V64, P279, DOI 10.1071/CH10343; Bardhan R, 2009, ADV FUNCT MATER, V19, P3901, DOI 10.1002/adfm.200901235; Bharde A, 2006, SMALL, V2, P135, DOI 10.1002/smll.200500180; Chen TJ, 2009, J BIOL INORG CHEM, V14, P253, DOI 10.1007/s00775-008-0445-9; CHIKAZUMI S, 1987, J MAGN MAGN MATER, V65, P245, DOI 10.1016/0304-8853(87)90043-6; Fang CL, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/12/125601; Goloverda G, 2009, J MAGN MAGN MATER, V321, P1372, DOI 10.1016/j.jmmm.2009.02.041; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; High WA, 2007, J AM ACAD DERMATOL, V56, P21, DOI 10.1016/j.jaad.2006.10.047; Hilger I, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/13/135103; Jun YW, 2005, J AM CHEM SOC, V127, P5732, DOI 10.1021/ja0422155; JUN YW, 2007, NANOBIOTECHNOLOGY, V2, P321; Kanal E, 2008, RADIOLOGY, V246, P11, DOI 10.1148/radiol.2461071267; Kobayashi H, 2005, ADV DRUG DELIVER REV, V57, P2271, DOI 10.1016/j.addr.2005.09.016; KOENIG SH, 1995, MAGNET RESON MED, V34, P227, DOI 10.1002/mrm.1910340214; Kuo PH, 2007, RADIOLOGY, V242, P647, DOI 10.1148/radiol.2423061640; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; Losic D, 2010, CHEM COMMUN, V46, P6323, DOI 10.1039/c0cc01305f; Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866; Lu J, 2009, BIOMATERIALS, V30, P2919, DOI 10.1016/j.biomaterials.2009.02.001; MANSOOR A, 2007, NANOTECHNOLOGY CANC, P201; Martina MS, 2005, J AM CHEM SOC, V127, P10676, DOI 10.1021/ja0516460; Morel AL, 2008, ACS NANO, V2, P847, DOI 10.1021/nn800091q; Mulder WJM, 2006, NMR BIOMED, V19, P142, DOI 10.1002/nbm.1011; Muller K, 2007, BIOMATERIALS, V28, P1629, DOI 10.1016/j.biomaterials.2006.12.002; Murakami Y, 2004, THIN SOLID FILMS, V461, P68, DOI 10.1016/j.tsf.2004.02.065; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; OHMORI M, 1992, J COLLOID INTERF SCI, V150, P594, DOI 10.1016/0021-9797(92)90229-F; OHMORI M, 1993, J COLLOID INTERF SCI, V160, P288, DOI 10.1006/jcis.1993.1398; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Paul KG, 2004, BIOCONJUGATE CHEM, V15, P394, DOI 10.1021/bc034194u; RAI K, 1990, J MAGN MAGN MATER, V85, P233; Saini A, 2004, CLIN RADIOL, V59, P1079, DOI 10.1016/j.crad.2004.04.014; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Sivakumar S, 2009, ADV MATER, V21, P1820, DOI 10.1002/adma.200802475; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; Suzuki K, 2004, LUNG CANCER, V46, P357, DOI 10.1016/j.lungcan.2004.05.011; Taboada E, 2009, ADV FUNCT MATER, V19, P2319, DOI 10.1002/adfm.200801681; Talelli M, 2009, LANGMUIR, V25, P2060, DOI 10.1021/la8036499; Tanaka K, 2010, LANGMUIR, V26, P11759, DOI 10.1021/la1015077; Tromsdorf UI, 2007, NANO LETT, V7, P2422, DOI 10.1021/nl071099b; Tsang SC, 2004, ANGEW CHEM INT EDIT, V43, P5645, DOI 10.1002/anie.200460552; van Straaten ECW, 2004, J NEUROL SCI, V226, P9, DOI 10.1016/j.jns.2004.09.003; Vogl TJ, 2003, EUR RADIOL, V13, P262, DOI 10.1007/s00330-002-1677-7; Wan JQ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235104; Wang YJ, 2008, NANO LETT, V8, P1741, DOI 10.1021/nl080877c; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167; Wuang SC, 2008, BIOMATERIALS, V29, P2270, DOI 10.1016/j.biomaterials.2008.01.028; Yoon TJ, 2006, SMALL, V2, P209, DOI [10.1002/smll.200500360, 10.1002/511111.200500360]; Yu X, 2000, MAGNET RESON MED, V44, P867, DOI 10.1002/1522-2594(200012)44:6<867::AID-MRM7>3.0.CO;2-P; YUAN F, 1995, CANCER RES, V55, P3752	54	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21857	10.1371/journal.pone.0021857	http://dx.doi.org/10.1371/journal.pone.0021857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747962	Green Published, Green Submitted, gold			2022-12-25	WOS:000292293400038
J	Greco, D; Kivi, N; Qian, K; Leivonen, SK; Auvinen, P; Auvinen, E				Greco, Dario; Kivi, Niina; Qian, Kui; Leivonen, Suvi-Katri; Auvinen, Petri; Auvinen, Eeva			Human Papillomavirus 16 E5 Modulates the Expression of Host MicroRNAs	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSIVE MICRORNAS; PROMOTES CELL-PROLIFERATION; MHC CLASS-I; DOWN-REGULATION; MATRIX METALLOPROTEINASE-12; TARGET PREDICTION; CERVICAL-CANCER; TYPE-16 E7; E-CADHERIN	Human papillomavirus (HPV) infection is a prerequisite of developing cervical cancer, approximately half of which are associated with HPV type 16. HPV 16 encodes three oncogenes, E5, E6, and E7, of which E5 is the least studied so far. Its roles in regulating replication and pathogenesis of HPV are not fully understood. Here we utilize high-throughput screening to coordinately investigate the effect of E5 on the expression of host protein-coding and microRNA genes. MicroRNAs form a class of 22nt long noncoding RNAs with regulatory activity. Among the altered cellular microRNAs we focus on the alteration in the expression of miR-146a, miR-203 and miR-324-5p and their target genes in a time interval of 96 hours of E5 induction. Our results indicate that HPV infection and subsequent transformation take place through complex regulatory patterns of gene expression in the host cells, part of which are regulated by the E5 protein.	[Greco, Dario; Qian, Kui; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Helsinki, Finland; [Greco, Dario] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Kivi, Niina; Auvinen, Eeva] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland; [Leivonen, Suvi-Katri] VTT Tech Res Ctr Finland, Turku, Finland; [Auvinen, Eeva] Univ Helsinki, Hosp Lab, Dept Virol & Immunol, Helsinki, Finland	University of Helsinki; Karolinska Institutet; University of Helsinki; VTT Technical Research Center Finland; University of Helsinki	Greco, D (corresponding author), Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Helsinki, Finland.	eeva.auvinen@helsinki.fi	Leivonen, Suvi-Katri/AAK-3096-2021; Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Qian, Kui/J-1942-2014; Greco, Dario/T-7113-2019	Auvinen, Petri/0000-0002-3947-4778; Qian, Kui/0000-0001-7170-533X; Greco, Dario/0000-0001-9195-9003; Leivonen, Suvi-Katri/0000-0003-3224-0757; Auvinen, Eeva/0000-0002-2094-985X	Finnish Cultural Foundation [12256]; Maud Kuistila Foundation; K. Albin Johansson Foundation; Sukupuolitautien Vastustamisyhdistys Foundation; Academy of Finland; Helsinki University	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Maud Kuistila Foundation; K. Albin Johansson Foundation; Sukupuolitautien Vastustamisyhdistys Foundation; Academy of Finland(Academy of Finland); Helsinki University	The work was supported by the Finnish Cultural Foundation (http://www.skr.fi/default.asp?docId=12256), Maud Kuistila Foundation (http://www.maudkuistilanmuistosaatio.fi/index.php?lang=en), K. Albin Johansson Foundation (http://www.foundationweb.net/johansson/), Sukupuolitautien Vastustamisyhdistys Foundation (http://sukupuolitaudit.info/yhdistys.htm), the Academy of Finland (http://www.aka.fi/fi/A/), and the Helsinki University Research Funds (http://www.helsinki.fi/rahastot/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi GH, 2006, VIRUS RES, V120, P208, DOI 10.1016/j.virusres.2006.02.005; Ashrafi GH, 2005, INT J CANCER, V113, P276, DOI 10.1002/ijc.20558; Auvinen E, 2004, ARCH VIROL, V149, P1745, DOI 10.1007/s00705-004-0325-8; Auvinen E, 2007, EXP CELL RES, V313, P824, DOI 10.1016/j.yexcr.2006.12.002; Balsitis S, 2006, CANCER RES, V66, P9393, DOI 10.1158/0008-5472.CAN-06-0984; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bohling T, 1996, AM J PATHOL, V148, P367; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Bottley G, 2008, ONCOGENE, V27, P1794, DOI 10.1038/sj.onc.1210798; Cai XZ, 2006, J VIROL, V80, P10890, DOI 10.1128/JVI.01175-06; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Campo MS, 2002, VIRUS RES, V89, P249, DOI 10.1016/S0168-1702(02)00193-4; CONRAD M, 1993, J VIROL, V67, P6170, DOI 10.1128/JVI.67.10.6170-6178.1993; Crusius K, 1998, EXP CELL RES, V241, P76, DOI 10.1006/excr.1998.4024; Crusius K, 1997, ONCOGENE, V15, P1437, DOI 10.1038/sj.onc.1201312; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fehrmann F, 2003, J VIROL, V77, P2819, DOI 10.1128/JVI.77.5.2819-2831.2003; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Genther SM, 2003, J VIROL, V77, P2832, DOI 10.1128/JVI.77.5.2832-2842.2003; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; HECK DV, 1992, P NATL ACAD SCI USA, V89, P4442, DOI 10.1073/pnas.89.10.4442; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hiscox S, 1999, J CELL SCI, V112, P3081; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; JOCHMUSKUDIELKA I, 1989, J NATL CANCER I, V81, P1698, DOI 10.1093/jnci/81.22.1698; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kivi N, 2008, ONCOGENE, V27, P2532, DOI 10.1038/sj.onc.1210916; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lambert PF, 2005, METH MOLEC MED, V119, P141; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; LEECHANACHAI P, 1992, ONCOGENE, V7, P19; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lewis C, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-30; Li W, 2010, INT J GYNECOL CANCER, V20, P227, DOI 10.1111/IGC.0b013e3181cceec5; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lozano E, 1998, MOL CARCINOGEN, V21, P273, DOI 10.1002/(SICI)1098-2744(199804)21:4<273::AID-MC6>3.0.CO;2-L; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Lyu J, 2005, J BIOL CHEM, V280, P21653, DOI 10.1074/jbc.m500374200; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Matsumoto S, 1998, AM J PATHOL, V153, P109, DOI 10.1016/S0002-9440(10)65551-4; Maufort JP, 2007, CANCER RES, V67, P6106, DOI 10.1158/0008-5472.CAN-07-0921; Maufort JP, 2010, CANCER RES, V70, P2924, DOI 10.1158/0008-5472.CAN-09-3436; Melar-New M, 2010, J VIROL, V84, P5212, DOI 10.1128/JVI.00078-10; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Nguyen M, 2002, J VIROL, V76, P13039, DOI 10.1128/JVI.76.24.13039-13048.2002; OELZE I, 1995, J VIROL, V69, P4489, DOI 10.1128/JVI.69.7.4489-4494.1995; Oetke C, 2000, ARCH VIROL, V145, P2183, DOI 10.1007/s007050070048; PIM D, 1992, ONCOGENE, V7, P27; Roberts APE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-201; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stoppler MC, 1996, VIROLOGY, V223, P251, DOI 10.1006/viro.1996.0475; STRAIGHT SW, 1993, J VIROL, V67, P4521, DOI 10.1128/JVI.67.8.4521-4532.1993; Suprynowicz FA, 2008, ONCOGENE, V27, P1071, DOI 10.1038/sj.onc.1210725; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tomakidi P, 2000, EUR J CELL BIOL, V79, P407, DOI 10.1078/0171-9335-00060; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Williams SMG, 2005, CANCER RES, V65, P6534, DOI 10.1158/0008-5472.CAN-05-0083; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yao Q, 2009, BIOCHEM BIOPH RES CO, V388, P539, DOI 10.1016/j.bbrc.2009.08.044; Zhang BY, 2003, VIROLOGY, V310, P100, DOI 10.1016/S0042-6822(03)00103-X; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	90	75	82	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21646	10.1371/journal.pone.0021646	http://dx.doi.org/10.1371/journal.pone.0021646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747943	gold, Green Submitted, Green Published			2022-12-25	WOS:000292293400019
J	Alen, MMF; De Burghgraeve, T; Kaptein, SJF; Balzarini, J; Neyts, J; Schols, D				Alen, Marijke M. F.; De Burghgraeve, Tine; Kaptein, Suzanne J. F.; Balzarini, Jan; Neyts, Johan; Schols, Dominique			Broad Antiviral Activity of Carbohydrate-Binding Agents against the Four Serotypes of Dengue Virus in Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULE 3-GRABBING NONINTEGRIN; HEPATITIS-C VIRUS; DC-SIGN; MANNOSE RECEPTOR; T-CELLS; DISEASE PATHOGENESIS; HEMORRHAGIC-FEVER; HIV-1 INFECTION; TRANS-INFECTION	Background: Dendritic cells (DC), present in the skin, are the first target cells of dengue virus (DENV). Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) is present on DC and recognizes N-glycosylation sites on the E-glycoprotein of DENV. Thus, the DC-SIGN/E-glycoprotein interaction can be considered as an important target for inhibitors of viral replication. We evaluated various carbohydrate-binding agents (CBAs) against all four described serotypes of DENV replication in Raji/DC-SIGN(+) cells and in monocyte-derived DC (MDDC). Methodology/Principal Findings: A dose-dependent anti-DENV activity of the CBAs Hippeastrum hybrid (HHA), Galanthus nivalis (GNA) and Urtica dioica (UDA), but not actinohivin (AH) was observed against all four DENV serotypes as analyzed by flow cytometry making use of anti-DENV antibodies. Remarkably, the potency of the CBAs against DENV in MDDC cultures was significantly higher (up to 100-fold) than in Raji/DC-SIGN(+) cells. Pradimicin-S (PRM-S), a small-size non-peptidic CBA, exerted antiviral activity in MDDC but not in Raji/DC-SIGN(+) cells. The CBAs act at an early step of DENV infection as they bind to the viral envelope of DENV and subsequently prevent virus attachment. Only weak antiviral activity of the CBAs was detected when administered after the virus attachment step. The CBAs were also able to completely prevent the cellular activation and differentiation process of MDDC induced upon DENV infection. Conclusions/Significance: The CBAs exerted broad spectrum antiviral activity against the four DENV serotypes, laboratory-adapted viruses and low passage clinical isolates, evaluated in Raji/DC-SIGN+ cells and in primary MDDC.	[Alen, Marijke M. F.; De Burghgraeve, Tine; Kaptein, Suzanne J. F.; Balzarini, Jan; Neyts, Johan; Schols, Dominique] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium	KU Leuven	Alen, MMF (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium.	Dominique.Schols@rega.kuleuven.be	Kaptein, Suzanne JF/O-8855-2018; Schols, Dominique/S-9057-2017; Kaptein, Suzanne JF/O-4714-2019; Neyts, Johan/U-8267-2017; Schols, Dominique/AAC-1309-2021	Kaptein, Suzanne JF/0000-0002-7935-0219; Schols, Dominique/0000-0003-3256-5850; Kaptein, Suzanne JF/0000-0002-7935-0219; Neyts, Johan/0000-0002-0033-7514; Schols, Dominique/0000-0003-3256-5850	European Commission EMPRO [503558, FP6-2003-INCO-DEV2 DENFRAME, 517711]; Fonds voor Wetenschappelijk Onderzoek (FWO) Krediet [G-485-08]; K. U. Leuven (Krediet) [EF/05/015, PF/10/018]; Dormeur Investment Service	European Commission EMPRO(European CommissionEuropean Commission Joint Research Centre); Fonds voor Wetenschappelijk Onderzoek (FWO) Krediet(FWO); K. U. Leuven (Krediet)(KU Leuven); Dormeur Investment Service	This work was supported by the European Commission EMPRO No. 503558 of the 6th Frame Work Programme, FP6-2003-INCO-DEV2 DENFRAME "Innovative Diagnostic Tools and Therapeutic Approaches for Dengue Disease" (Contract No.: 517711), the Fonds voor Wetenschappelijk Onderzoek (FWO) Krediet nr. G-485-08, the Centers of Excellence and Program Financing of the K. U. Leuven (Krediet nr. EF/05/015 and PF/10/018), and the Dormeur Investment Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alen MMF, 2009, VIROLOGY, V387, P67, DOI 10.1016/j.virol.2009.01.043; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; BALZARINI J, 1992, ANTIVIR RES, V18, P191, DOI 10.1016/0166-3542(92)90038-7; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Balzarini J, 2007, MOL PHARMACOL, V71, P3, DOI 10.1124/mol.106.030155; Balzarini J, 2010, ANTIMICROB AGENTS CH, V54, P1425, DOI 10.1128/AAC.01347-09; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bayry J, 2003, BLOOD, V101, P758, DOI 10.1182/blood-2002-05-1447; Bertaux C, 2007, VIROLOGY, V366, P40, DOI 10.1016/j.virol.2007.04.008; Chen YC, 1999, J VIROL, V73, P2650, DOI 10.1128/JVI.73.4.2650-2657.1999; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Chiba H, 2001, BIOCHEM BIOPH RES CO, V282, P595, DOI 10.1006/bbrc.2001.4495; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Francois KO, 2008, MOL PHARMACOL, V74, P330, DOI 10.1124/mol.108.047621; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013; Guy B, 2009, J CLIN VIROL, V46, pS16, DOI 10.1016/S1386-6532(09)70290-2; Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499; Hong PWP, 2007, J VIROL, V81, P8325, DOI 10.1128/JVI.01765-06; Hoorelbeke B, 2010, ANTIMICROB AGENTS CH, V54, P3287, DOI 10.1128/AAC.00254-10; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kwan WH, 2005, J VIROL, V79, P7291, DOI 10.1128/JVI.79.12.7291-7299.2005; Kyle JL, 2006, AM J TROP MED HYG, V75, P316; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Libraty DH, 2001, J VIROL, V75, P3501, DOI 10.1128/JVI.75.8.3501-3508.2001; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Luallen RJ, 2009, J VIROL, V83, P4861, DOI 10.1128/JVI.02537-08; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Mairuhu ATA, 2004, EUR J CLIN MICROBIOL, V23, P425, DOI 10.1007/s10096-004-1145-1; Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x; Marzi A, 2007, J INFECT DIS, V196, pS237, DOI 10.1086/520607; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005; Palucka AK, 2000, NAT MED, V6, P748, DOI 10.1038/77470; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Pollielta M, 2008, VIROLOGY, V370, P382, DOI 10.1016/j.virol.2007.08.033; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rogers KM, 2009, J INNATE IMMUN, V1, P405, DOI 10.1159/000226422; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; SAITOH K, 1993, J ANTIBIOT, V46, P406, DOI 10.7164/antibiotics.46.406; Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Sun PF, 2009, VIROLOGY, V383, P207, DOI 10.1016/j.virol.2008.10.022; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Takada A, 2003, REV MED VIROL, V13, P387, DOI 10.1002/rmv.405; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; VANDAMME EJM, 1991, EUR J BIOCHEM, V202, P23, DOI 10.1111/j.1432-1033.1991.tb16339.x; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553	67	51	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21658	10.1371/journal.pone.0021658	http://dx.doi.org/10.1371/journal.pone.0021658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738755	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800029
J	Ogata, Y; Horaguchi, T; Watanabe, N; Yamamoto, M				Ogata, Yousuke; Horaguchi, Takahiro; Watanabe, Noriya; Yamamoto, Miyuki			Comparison of the Choice Effect and the Distance Effect in a Number-Comparison Task by fMRI	PLOS ONE			English	Article							EVENT-RELATED FMRI; HUMAN INTRAPARIETAL CORTEX; ANTERIOR CINGULATE CORTEX; HUMAN PARIETAL CORTEX; ATTENTIONAL CONTROL; HUMAN BRAIN; CORTICAL MECHANISMS; RESPONSE-SELECTION; SUBANGULAR LESION; INFERIOR PARIETAL	Behavioral and neurophysiological studies of numerical comparisons have shown a "distance effect," whereby smaller numerical distances between two digits are associated with longer response times and higher activity in the parietal region. In this experiment, we introduced a two-choice condition (between either the smaller/lower or the larger/higher of two digits) and examined its effect on brain activity by fMRI. We observed longer response times and greater activity with the choice of smaller numbers ("choice effect") in several brain regions including the right temporo-parietal region, (pre)cuneus, superior temporal sulcus, precentral gyrus, superior frontal gyrus, bilateral insula, and anterior cingulate cortex. These regions correspond to areas that have been suggested to play a role in attentional shift and response conflict. However, brain activity associated with the distance effect disappeared even though the behavioral distance effect remained. Despite the absence of the distance effect on brain activity, several areas changed activity in relation to response time, including regions that were reported to change activity in both a distance effect and a reaction-time-related manner. The result suggested that the level of task load may change the activity of regions that are responsible for magnitude detection.	[Ogata, Yousuke; Yamamoto, Miyuki] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Horaguchi, Takahiro] Ibaraki Prefectural Univ Hlth Sci, Ctr Med Sci, Inashiki, Ibaraki, Japan; [Watanabe, Noriya] Tamagawa Univ, Grad Sch Engn, Tokyo, Japan	University of Tsukuba	Ogata, Y (corresponding author), Univ Tsukuba, Tsukuba, Ibaraki, Japan.	ogata-y@mike.md.tsukuba.ac.jp		Ogata, Yousuke/0000-0003-4613-7435; Watanabe, Noriya/0000-0002-7847-6338	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Grants-in-Aid for Scientific Research [23300082] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding was provided by the COE program from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government (http://www.jsps.go.jp/j-21coe/08_jigo/kekka_j.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres M, 2005, COGNITIVE BRAIN RES, V25, P283, DOI 10.1016/j.cogbrainres.2005.06.002; BALLAN M, 2010, SOC 40 ANN M SAN DIE; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Cantlon JF, 2005, P NATL ACAD SCI USA, V102, P16507, DOI 10.1073/pnas.0506463102; Chambers CD, 2004, NAT NEUROSCI, V7, P217, DOI 10.1038/nn1203; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DEHAENE S, 1989, PERCEPT PSYCHOPHYS, V45, P557, DOI 10.3758/BF03208063; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Delazer M, 1997, CORTEX, V33, P697, DOI 10.1016/S0010-9452(08)70727-5; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Downar J, 2001, NEUROIMAGE, V14, P1256, DOI 10.1006/nimg.2001.0946; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Garavan H, 2003, NEUROIMAGE, V20, P1132, DOI 10.1016/S1053-8119(03)00334-3; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Gobel SM, 2004, J COGNITIVE NEUROSCI, V16, P1536, DOI 10.1162/0898929042568442; GRAFMAN J, 1982, CORTEX, V18, P37, DOI 10.1016/S0010-9452(82)80017-8; Horaguchi T, 2008, NEUROSCI RES, V61, P294, DOI 10.1016/j.neures.2008.03.011; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; Kadosh RC, 2008, CEREB CORTEX, V18, P337, DOI 10.1093/cercor/bhm058; Kadosh RC, 2007, NEURON, V53, P307, DOI 10.1016/j.neuron.2006.12.025; Kaufmann L, 2005, NEUROIMAGE, V25, P888, DOI 10.1016/j.neuroimage.2004.12.041; Kowatari Y, 2009, HUM BRAIN MAPP, V30, P1678, DOI 10.1002/hbm.20633; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; Liu TS, 2003, CEREB CORTEX, V13, P1334, DOI 10.1093/cercor/bhg080; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Martory MD, 2003, NEUROCASE, V9, P319, DOI 10.1076/neur.9.4.319.15549; Mayer E, 1999, BRAIN, V122, P1107, DOI 10.1093/brain/122.6.1107; Merkley R, 2010, EXP BRAIN RES, V206, P455, DOI 10.1007/s00221-010-2419-8; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 1999, NEUROREPORT, V10, P1473, DOI 10.1097/00001756-199905140-00015; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Roberts KL, 2008, J COGNITIVE NEUROSCI, V20, P1063, DOI 10.1162/jocn.2008.20074; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Sawamura H, 2002, NATURE, V415, P918, DOI 10.1038/415918a; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Shapiro K, 2002, CURR BIOL, V12, P1320, DOI 10.1016/S0960-9822(02)01040-0; Shulman GL, 2002, CEREB CORTEX, V12, P1124, DOI 10.1093/cercor/12.11.1124; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	61	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21716	10.1371/journal.pone.0021716	http://dx.doi.org/10.1371/journal.pone.0021716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738777	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800033
J	Pirozzi, G; Tirino, V; Camerlingo, R; Franco, R; La Rocca, A; Liguori, E; Martucci, N; Paino, F; Normanno, N; Rocco, G				Pirozzi, Giuseppe; Tirino, Virginia; Camerlingo, Rosa; Franco, Renato; La Rocca, Aantonello; Liguori, Eleonora; Martucci, Nicola; Paino, Francesca; Normanno, Nicola; Rocco, Gaetano			Epithelial to Mesenchymal Transition by TGF beta-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line	PLOS ONE			English	Article							IN-VITRO; SELF-RENEWAL; BETA-CATENIN; E-CADHERIN; IDENTIFICATION; LEUKEMIA; CD133; MECHANISMS; EXPRESSION; BIOLOGY	Background: Cancer Stem Cells (CSCs) hypothesis asserts that only a small subset of cells within a tumour is capable of both tumour initiation and sustainment. The Epithelial-Mesenchymal Transition (EMT) is an embryonic developmental program that is often activated during cancer invasion and metastasis. The aim of this study is to shed light on the relationship between EMT and CSCs by using LC31 lung cancer primary cell line. Materials and Methods: A549 and LC31 cell lines were treated with 2 ng/ml TGF beta-1 for 30 days, and 80 days, respectively. To evaluate EMT, morphological changes were assessed by light microscopy, immunofluorescence and cytometry for following markers: cytokeratins, e-cadherin, CD326 (epithelial markers) and CD90, and vimentin (mesenchymal markers). Moreover, RT-PCR for Slug, Twist and beta-catenin genes were performed. On TGF beta-1 treated and untreated LC31 cell lines, we performed stemness tests such as pneumospheres growth and stem markers expression such as Oct4, Nanog, Sox2, c-kit and CD133. Western Blot for CD133 and tumorigenicity assays using NOD/SCID mice were performed. Results: TGF beta-1 treated LC31 cell line lost its epithelial morphology assuming a fibroblast-like appearance. The same results were obtained for the A549 cell line (as control). Immunofluorescence and cytometry showed up-regulation of vimentin and CD90 and down-regulation of cytocheratin, e-cadherin and CD326 in TGF beta-1 treated LC31 and A549 cell lines. Slug, Twist and beta-catenin m-RNA transcripts were up-regulated in TGF beta-1 treated LC31 cell line confirming EMT. This cell line showed also over-expression of Oct4, Nanog, Sox2 and CD133, all genes of stemness. In addition, in TGF beta-1 treated LC31 cell line, an increased pneumosphere-forming capacity and tumours-forming ability in NOD/SCID mice were detectable. Conclusions: The induction of EMT by TGF beta-1 exposure, in primary lung cancer cell line results in the acquisition of mesenchymal profile and in the expression of stem cell markers.	[Pirozzi, Giuseppe; Camerlingo, Rosa; Liguori, Eleonora; Normanno, Nicola] NCI, Dept Expt Oncol, Naples, Italy; [Tirino, Virginia; Paino, Francesca] Univ Naples 2, Dept Expt Med, Naples, Italy; [Franco, Renato] NCI, Dept Pathol, Naples, Italy; [La Rocca, Aantonello; Martucci, Nicola; Rocco, Gaetano] NCI, Dept Thorac Surg & Oncol, Naples, Italy	IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale	Pirozzi, G (corresponding author), NCI, Dept Expt Oncol, Naples, Italy.	pinopiro@tin.it	Camerlingo, Rosa/AAB-8349-2022; Rocco, Gaetano/K-4801-2016; paino, francesca/AAC-8150-2019; Normanno, Nicola/AAT-1107-2021	Rocco, Gaetano/0000-0003-4150-8604; paino, francesca/0000-0002-3186-1888; Franco, Renato/0000-0002-8340-3184; Normanno, Nicola/0000-0002-7158-2605; Camerlingo, Rosa/0000-0001-6488-9740; Tirino, Virginia/0000-0003-2731-5718				Angelo RCD, 2010, PROG MOL BIOL TRANSL, V95, P113, DOI 10.1016/B978-0-12-385071-3.00006-X; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ferrandina G, 2009, EXPERT OPIN THER TAR, V13, P823, DOI 10.1517/14728220903005616; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hayashida T, 2011, J ONCOL, V2011, DOI 10.1155/2011/591427; HIDA T, 1994, INT J CANCER, P108; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002; JU HK, 2007, J KOREAN MED SCI, V22, P898; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; LO JF, 2010, CANCER RES, V17, DOI DOI 10.1158/0008-5472; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Singh SK, 2003, CANCER RES, V63, P5821; Steinbach D, 2007, LEUKEMIA, V21, P1172, DOI 10.1038/sj.leu.2404692; Thiery JP, 2010, B CANCER, V97, P1285, DOI 10.1684/bdc.2010.1206; Thiery JP, 2001, B ACAD NAT MED PARIS, V185, P1279, DOI 10.1016/S0001-4079(19)34450-4; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tong M, 2006, CARCINOGENESIS, V27, P2170, DOI 10.1093/carcin/bgl053; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	46	140	145	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21548	10.1371/journal.pone.0021548	http://dx.doi.org/10.1371/journal.pone.0021548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738704	Green Submitted, Green Published, gold			2022-12-25	WOS:000292291800020
J	Rodriguez-Paris, J; Tamayo, ML; Gelvez, N; Schrijver, I				Rodriguez-Paris, Juan; Tamayo, Marta L.; Gelvez, Nancy; Schrijver, Iris			Allele-Specific Impairment of GJB2 Expression by GJB6 Deletion del(GJB6-D13S1854)	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; CONNEXIN 26 GENE; GAP-JUNCTIONS; MUTATION; MULTICENTER; PCR	Mutations in the GJB2 gene, which encodes connexin 26, are a frequent cause of congenital non-syndromic sensorineural hearing loss. Two large deletions, del(GJB6-D13S1830) and del(GJB6-D13S1854), which truncate GJB6 (connexin 30), cause hearing loss in individuals homozygous, or compound heterozygous for these deletions or one such deletion and a mutation in GJB2. Recently, we have demonstrated that the del(GJB6-D13S1830) deletion contributes to hearing loss due to an allele-specific lack of GJB2 mRNA expression and not as a result of digenic inheritance, as was postulated earlier. In the current study we investigated the smaller del(GJB6-D13S1854) deletion, which disrupts the expression of GJB2 at the transcriptional level in a manner similar to the more common del(GJB6-D13S1830) deletion. Interestingly, in the presence of this deletion, GJB2 expression remains minimally but reproducibly present. The relative allele-specific expression of GJB2 was assessed by reverse-transcriptase PCR and restriction digestions in three probands who were compound heterozygous for a GJB2 mutation and del(GJB6-D13S1854). Each individual carried a different sequence variant in GJB2. All three individuals expressed the mutated GJB2 allele in trans with del(GJB6-D13S1854), but expression of the GJB2 allele in cis with the deletion was almost absent. Our study clearly corroborates the hypothesis that the del(GJB6-D13S1854), similar to the larger and more common del(GJB6-D13S1830), removes (a) putative cis-regulatory element(s) upstream of GJB6 and narrows down the region of location.	[Rodriguez-Paris, Juan; Schrijver, Iris] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Tamayo, Marta L.; Gelvez, Nancy] Univ Javeriana, Inst Genet Humana, Bogota, Colombia; [Tamayo, Marta L.] Fdn Oftalmol Nacl, Bogota, Colombia; [Schrijver, Iris] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA	Stanford University; Pontificia Universidad Javeriana; Stanford University	Rodriguez-Paris, J (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	ischrijver@stanfordmed.org		Gelvez, Nancy/0000-0002-3925-1451; Tamayo, Martha Lucia/0000-0001-8297-3970	Arline and Pete Harman Faculty; Instituto de Genetica Humana-Universidad Javeriana [6207-12-16739]; Colciencias [120334319246]	Arline and Pete Harman Faculty; Instituto de Genetica Humana-Universidad Javeriana; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was generously supported by the Arline and Pete Harman Faculty Scholar Endowed Fund, by the Instituto de Genetica Humana-Universidad Javeriana-Grant # 6207-12-16739; and, by Colciencias-Grant # 120334319246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOCHEM BIOPH RES CO, V307, P362, DOI 10.1016/S0006-291X(03)01166-5; Common JEA, 2005, CLIN EXP DERMATOL, V30, P688, DOI 10.1111/j.1365-2230.2005.01878.x; del Castillo FJ, 2005, J MED GENET, V42, P588, DOI 10.1136/jmg.2004.028324; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Feldmann D, 2009, EUR J MED GENET, V52, P195, DOI 10.1016/j.ejmg.2008.11.006; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/00125817-200207000-00004; Lerer I, 2001, Hum Mutat, V18, P460, DOI 10.1002/humu.1222; Matos TD, 2007, J MED GENET, V44, P721, DOI 10.1136/jmg.2007.050682; Mueller RF, 1999, INT J PEDIATR OTORHI, V50, P3, DOI 10.1016/S0165-5876(99)00242-6; Ortolano S, 2008, P NATL ACAD SCI USA, V105, P18776, DOI 10.1073/pnas.0800831105; Pallares-Ruiz N, 2002, EUR J HUM GENET, V10, P72, DOI 10.1038/sj.ejhg.5200762; Putcha GV, 2007, GENET MED, V9, P413, DOI 10.1097/GIM.0b013e3180a03276; Raff T, 1997, BIOTECHNIQUES, V23, P456, DOI 10.2144/97233st02; Rodriguez-Paris J, 2009, BIOCHEM BIOPH RES CO, V389, P354, DOI 10.1016/j.bbrc.2009.08.152; Vinken M, 2009, BBA-REV CANCER, V1795, P53, DOI 10.1016/j.bbcan.2008.08.002; Wilch E, 2010, CLIN GENET, V78, P267, DOI 10.1111/j.1399-0004.2010.01387.x; Wilch E, 2006, AM J HUM GENET, V79, P174, DOI 10.1086/505333; Wilcox SA, 2000, MOL DIAGN, V5, P75, DOI 10.2165/00066982-200005010-00015; Zhao HB, 2006, J MEMBRANE BIOL, V209, P177, DOI 10.1007/s00232-005-0832-x	21	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21665	10.1371/journal.pone.0021665	http://dx.doi.org/10.1371/journal.pone.0021665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738759	gold, Green Submitted, Green Published			2022-12-25	WOS:000292290100054
J	Ali, S; van Mil, HGJ; Richardson, MK				Ali, Shaukat; van Mil, Harald G. J.; Richardson, Michael K.			Large-Scale Assessment of the Zebrafish Embryo as a Possible Predictive Model in Toxicity Testing	PLOS ONE			English	Article							FISH; VERTEBRATE; DECHORIONATION; NANOPARTICLES; MORPHOLOGY; ORGANISM; DISEASE; RERIO; LEAD	Background: In the drug discovery pipeline, safety pharmacology is a major issue. The zebrafish has been proposed as a model that can bridge the gap in this field between cell assays (which are cost-effective, but low in data content) and rodent assays (which are high in data content, but less cost-efficient). However, zebrafish assays are only likely to be useful if they can be shown to have high predictive power. We examined this issue by assaying 60 water-soluble compounds representing a range of chemical classes and toxicological mechanisms. Methodology/Principal Findings: Over 20,000 wild-type zebrafish embryos (including controls) were cultured individually in defined buffer in 96-well plates. Embryos were exposed for a 96 hour period starting at 24 hours post fertilization. A logarithmic concentration series was used for range-finding, followed by a narrower geometric series for LC50 determination. Zebrafish embryo LC50 (log mmol/L), and published data on rodent LD50 (log mmol/kg), were found to be strongly correlated (using Kendall's rank correlation tau and Pearson's product-moment correlation). The slope of the regression line for the full set of compounds was 0.73403. However, we found that the slope was strongly influenced by compound class. Thus, while most compounds had a similar toxicity level in both species, some compounds were markedly more toxic in zebrafish than in rodents, or vice versa. Conclusions: For the substances examined here, in aggregate, the zebrafish embryo model has good predictivity for toxicity in rodents. However, the correlation between zebrafish and rodent toxicity varies considerably between individual compounds and compound class. We discuss the strengths and limitations of the zebrafish model in light of these findings.	[Ali, Shaukat; van Mil, Harald G. J.; Richardson, Michael K.] Leiden Univ, Sylvius Lab, Inst Biol, Leiden, Netherlands; [van Mil, Harald G. J.] Leiden Univ, Math Inst, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Ali, S (corresponding author), Leiden Univ, Sylvius Lab, Inst Biol, Leiden, Netherlands.	m.k.richardson@biology.leidenuniv.nl	Richardson, Michael K/E-8269-2011; Ali, Shaukat/L-2987-2019	Richardson, Michael K/0000-0003-1222-8101; Ali, Shaukat/0000-0003-2481-1978	Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06010]; University of Azad Jammu and Kashmir, Pakistan [F-3/PD/Main, Mirpur/369/2007]	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science; University of Azad Jammu and Kashmir, Pakistan	This work was supported by the Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (M.K.R.) under grant number SSM06010, the University of Azad Jammu and Kashmir, Pakistan (S.A.) under project No. F-3/PD/Main & Mirpur/369/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Bai W, 2010, J NANOSCI NANOTECHNO, V10, P8670, DOI 10.1166/jnn.2010.2686; Braunbeck T, 2005, ALTEX-ALTERN TIEREXP, V22, P87; Brunelli E, 2008, ECOTOX ENVIRON SAFE, V71, P436, DOI 10.1016/j.ecoenv.2007.09.010; Bull J, 2000, SCIENCE, V287, P1409, DOI 10.1126/science.287.5457.1409; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Eyckmans M, 2010, COMP BIOCHEM PHYS C, V152, P270, DOI 10.1016/j.cbpc.2010.05.002; Fraysse B, 2006, ECOTOX ENVIRON SAFE, V63, P253, DOI 10.1016/j.ecoenv.2004.10.015; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; GORGE G, 1990, ECOTOX ENVIRON SAFE, V20, P246, DOI 10.1016/0147-6513(90)90004-O; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Halle W, 2003, ATLA-ALTERN LAB ANIM, V31, P89, DOI 10.1177/026119290303100204; Henn K, 2011, COMP BIOCHEM PHYS C, V153, P91, DOI 10.1016/j.cbpc.2010.09.003; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KUMAR K, 1986, ECOTOX ENVIRON SAFE, V12, P199, DOI 10.1016/0147-6513(86)90011-4; Labrot F, 1999, ARCH ENVIRON CON TOX, V36, P167, DOI 10.1007/s002449900457; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Lanzky PF, 1997, CHEMOSPHERE, V35, P2553, DOI 10.1016/S0045-6535(97)00324-X; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Martins J, 2007, ENVIRON INT, V33, P414, DOI 10.1016/j.envint.2006.12.006; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; MCKIM JM, 1978, B ENVIRON CONTAM TOX, V19, P608, DOI 10.1007/BF01685847; Mizell M, 1997, INT J DEV BIOL, V41, P411; *ORG EC COOP DEV, 1998, 212 OECD; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Redfern William S., 2008, Journal of Pharmacological and Toxicological Methods, V58, P110, DOI 10.1016/j.vascn.2008.05.006; ROCHE H, 1994, B ENVIRON CONTAM TOX, V52, P69, DOI 10.1007/BF00197359; Rogers JT, 2003, AQUAT TOXICOL, V64, P215, DOI 10.1016/S0166-445X(03)00053-5; Rubinstein AL, 2003, CURR OPIN DRUG DI DE, V6, P218; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Selderslaghs IWT, 2009, REPROD TOXICOL, V28, P308, DOI 10.1016/j.reprotox.2009.05.004; SHAZILI NAM, 1986, B ENVIRON CONTAM TOX, V36, P468, DOI 10.1007/BF01623536; Teraoka Hiroki, 2003, Congenital Anomalies, V43, P123, DOI 10.1111/j.1741-4520.2003.tb01036.x; Tropepe V, 2003, GENES BRAIN BEHAV, V2, P268, DOI 10.1034/j.1601-183X.2003.00038.x; Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16; United States Environmental Protection Agency, 1996, 8260B US EPA, P1; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Voelker D, 2007, AQUAT TOXICOL, V81, P355, DOI 10.1016/j.aquatox.2006.12.013; Wielhouwer EM, 2011, LAB CHIP, V11, P1815, DOI 10.1039/c0lc00443j; ZOK S, 1991, SCI TOTAL ENVIRON, V109, P411, DOI 10.1016/0048-9697(91)90196-L	48	130	138	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21076	10.1371/journal.pone.0021076	http://dx.doi.org/10.1371/journal.pone.0021076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738604	gold, Green Published, Green Submitted			2022-12-25	WOS:000292142800011
J	Broen, K; Levenga, H; Vos, J; van Bergen, K; Fredrix, H; Greupink-Draaisma, A; Kester, M; Falkenburg, JHF; de Mulder, P; de Witte, T; Griffioen, M; Dolstra, H				Broen, Kelly; Levenga, Henriette; Vos, Johanna; van Bergen, Kees; Fredrix, Hanny; Greupink-Draaisma, Annelies; Kester, Michel; Falkenburg, J. H. Frederik; de Mulder, Pieter; de Witte, Theo; Griffioen, Marieke; Dolstra, Harry			A Polymorphism in the Splice Donor Site of ZNF419 Results in the Novel Renal Cell Carcinoma-Associated Minor Histocompatibility Antigen ZAPHIR	PLOS ONE			English	Article							CYTOTOXIC T-CELLS; ABERRANT EXPRESSION; TRANSPLANTATION; LEUKEMIA; IMMUNOTHERAPY; FEASIBILITY; REGRESSION; CANCER; GENE	Nonmyeloablative allogeneic stem cell transplantation (SCT) can induce remission in patients with renal cell carcinoma (RCC), but this graft-versus-tumor (GVT) effect is often accompanied by graft-versus-host disease (GVHD). Here, we evaluated minor histocompatibility antigen (MiHA)-specific T cell responses in two patients with metastatic RCC who were treated with reduced-intensity conditioning SCT followed by donor lymphocyte infusion (DLI). One patient had stable disease and emergence of SMCY.A2-specific CD8+ T cells was observed after DLI with the potential of targeting SMCY-expressing RCC tumor cells. The second patient experienced partial regression of lung metastases from whom we isolated a MiHA-specific CTL clone with the capability of targeting RCC cell lines. Whole genome association scanning revealed that this CTL recognizes a novel HLA-B7-restricted MiHA, designated ZAPHIR, resulting from a polymorphism in the splice donor site of the ZNF419 gene. Tetramer analysis showed that emergence of ZAPHIR-specific CD8+ T cells in peripheral blood occurred in the absence of GVHD. Furthermore, the expression of ZAPHIR in solid tumor cell lines indicates the involvement of ZAPHIR-specific CD8+ T cell responses in selective GVT immunity. These findings illustrate that the ZNF419-encoded MiHA ZAPHIR is an attractive target for specific immunotherapy after allogeneic SCT.	[Broen, Kelly; Vos, Johanna; Fredrix, Hanny; Greupink-Draaisma, Annelies; Dolstra, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 ED Nijmegen, Netherlands; [Levenga, Henriette] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands; [van Bergen, Kees; Kester, Michel; Falkenburg, J. H. Frederik; Griffioen, Marieke] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands; [de Mulder, Pieter] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands; [de Witte, Theo] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen	Broen, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, NL-6525 ED Nijmegen, Netherlands.	h.dolstra@labgk.umcn.nl	Griffioen, Marieke/ABA-1561-2021; Van Bergen, Cornelis A.M./P-5782-2016	Griffioen, Marieke/0000-0002-3001-4441; Van Bergen, Cornelis A.M./0000-0001-6386-4517	NATIONAL CANCER INSTITUTE [R01CA118880] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA118880, R01CA118880] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akatsuka Y, 2003, J EXP MED, V197, P1489, DOI 10.1084/jem.20021925; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Burrows SR, 2000, J IMMUNOL, V165, P6229, DOI 10.4049/jimmunol.165.11.6229; Chao NJ, 2004, BIOL BLOOD MARROW TR, V10, P215, DOI 10.1016/j.bbmt.2003.10.003; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; Dolstra H, 1999, J EXP MED, V189, P301, DOI 10.1084/jem.189.2.301; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fujii S, 2001, LEUKEMIA LYMPHOMA, V42, P357, DOI 10.3109/10428190109064592; Goulmy E, 1997, IMMUNOL REV, V157, P125, DOI 10.1111/j.1600-065X.1997.tb00978.x; Hambach L, 2008, BLOOD, V112, P1844, DOI 10.1182/blood-2007-11-125492; Hobo W, 2010, BLOOD, V116, P4501, DOI 10.1182/blood-2010-04-278739; HOROWITZ MM, 1990, BLOOD, V75, P555; Jedema I, 2004, BLOOD, V103, P2677, DOI 10.1182/blood-2003-06-2070; Kawase T, 2007, BLOOD, V110, P1055, DOI 10.1182/blood-2007-02-075911; Kircher B, 2002, BRIT J HAEMATOL, V117, P935, DOI 10.1046/j.1365-2141.2002.03536.x; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Mutis T, 1999, BLOOD, V93, P2336, DOI 10.1182/blood.V93.7.2336.407k26_2336_2341; Overes IM, 2009, J IMMUNOTHER, V32, P539, DOI 10.1097/CJI.0b013e3181987c22; Overes IM, 2009, CANCER IMMUNOL IMMUN, V58, P429, DOI 10.1007/s00262-008-0569-3; Pedrazzoli P, 2002, CANCER, V94, P2409, DOI 10.1002/cncr.10491.abs; Rijke BC, 2005, J CLIN INVEST, V115, P3506, DOI 10.1172/JCI24832; Rini BI, 2002, J CLIN ONCOL, V20, P2017, DOI 10.1200/JCO.2002.08.068; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Torikai H, 2008, INT J HEMATOL, V87, P467, DOI 10.1007/s12185-008-0076-5; Tykodi SS, 2008, CLIN CANCER RES, V14, P5260, DOI 10.1158/1078-0432.CCR-08-0028; Tykodi SS, 2004, CLIN CANCER RES, V10, P7799, DOI 10.1158/1078-0432.CCR-04-0072; Ueno NT, 1998, J CLIN ONCOL, V16, P986, DOI 10.1200/JCO.1998.16.3.986; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; VANBERGEN CAM, 2010, CANC RES, V70; Yang JC, 2006, J CLIN ONCOL, V24, P5576, DOI 10.1200/JCO.2006.08.3774	31	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21699	10.1371/journal.pone.0021699	http://dx.doi.org/10.1371/journal.pone.0021699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738768	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800060
J	Duraffour, S; Matthys, P; van den Oord, JJ; De Schutter, T; Mitera, T; Snoeck, R; Andrei, G				Duraffour, Sophie; Matthys, Patrick; van den Oord, Joost J.; De Schutter, Tim; Mitera, Tania; Snoeck, Robert; Andrei, Graciela			Study of Camelpox Virus Pathogenesis in Athymic Nude Mice	PLOS ONE			English	Article							ACYCLIC NUCLEOSIDE PHOSPHONATES; VACCINIA VIRUS; COMPOUND ST-246; MONKEYPOX VIRUS; VARIOLA VIRUS; PET RATS; COWPOX; INFECTION; CIDOFOVIR; IDENTIFICATION	Camelpox virus (CMLV) is the closest known orthopoxvirus genetically related to variola virus. So far, CMLV was restricted to camelids but, recently, three human cases of camelpox have been described in India, highlighting the need to pursue research on its pathogenesis, which has been hampered by the lack of small animal models. Here, we confirm that NMRI immunocompetent mice are resistant to intranasal (i.n.) CMLV infection. However, we demonstrate that CMLV induced a severe disease following i.n. challenge of athymic nude mice, which was accompanied with a failure in gaining weight, leading to euthanasia of the animals. On the other hand, intracutaneous (i.c.) infection resulted in disease development without impacting the body weight evolution. CMLV replication in tissues and body fluids was confirmed in the two models. We further analyzed innate immune and B cell responses induced in the spleen and draining lymph nodes after exposure to CMLV. In both models, strong increases in CD11b(+)F4/80(+) macrophages were seen in the spleen, while neutrophils, NK and B cell responses varied between the routes of infection. In the lymph nodes, the magnitude of CD11c(+)CD8 alpha(+) lymphoid and CD11c(+)CD11b(+) myeloid dendritic cell responses increased in i.n. challenged animals. Analysis of cytokine profiles revealed significant increases of interleukin (IL)-6 and IL-18 in the sera of infected animals, while those of other cytokines were similar to uninfected controls. The efficacy of two antivirals (cidofovir or HPMPC, and its 2, 6-diaminopurine analog) was evaluated in both models. HPMPC was the most effective molecule affording 100% protection from morbidity. It appeared that both treatments did not affect immune cell responses or cytokine expression. In conclusion, we demonstrated that immunodeficient mice are permissive for CMLV propagation. These results provide a basis for studying the pathogenesis of CMLV, as well as for evaluating potential antiviral therapies in an immunodeficiency context.	[Duraffour, Sophie; De Schutter, Tim; Snoeck, Robert; Andrei, Graciela] Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Louvain, Belgium; [Matthys, Patrick; Mitera, Tania] Katholieke Univ Leuven, Rega Inst, Immunobiol Lab, Louvain, Belgium; [van den Oord, Joost J.] UZ Sint Raphael, Lab Morphol & Mol Pathol, Louvain, Belgium	KU Leuven; KU Leuven	Duraffour, S (corresponding author), Katholieke Univ Leuven, Rega Inst, Lab Virol & Chemotherapy, Louvain, Belgium.	sophie.duraffour@rega.kuleuven.be	Matthys, Patrick/B-4813-2018; Andrei, Graciela/V-7721-2017; Snoeck, Robert/V-3867-2017	Matthys, Patrick/0000-0002-9685-6836; Andrei, Graciela/0000-0003-2609-4896; Snoeck, Robert/0000-0002-7586-5434	FWO (Fund for Scientific Research-Flanders, Belgium) [G.0680.08, G.0555.08]; GOA (Geconcerteerd Onderzoek Actie) [10/014, 12/017]	FWO (Fund for Scientific Research-Flanders, Belgium)(FWO); GOA (Geconcerteerd Onderzoek Actie)	This research was supported by FWO (Fund for Scientific Research-Flanders, Belgium, Grants G.0680.08 and G.0555.08) and by GOA (Geconcerteerd Onderzoek Actie, Grants 10/014 and 12/017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008159; Abrahao JS, 2010, EMERG INFECT DIS, V16, P976, DOI 10.3201/eid1606.091187; Abu Elzein EME, 1999, REV SCI TECH OIE, V18, P749, DOI 10.20506/rst.18.3.1194; Afonso CL, 2002, VIROLOGY, V295, P1, DOI 10.1006/viro.2001.1343; Al-Zi'abi O, 2007, J VET MED SCI, V69, P541, DOI 10.1292/jvms.69.541; ALCAMI A, 1995, J VIROL, V69, P4633; ALFALLUJI MM, 1979, J HYG-CAMBRIDGE, V83, P267, DOI 10.1017/S002217240002605X; Americo JL, 2010, J VIROL, V84, P8172, DOI 10.1128/JVI.00621-10; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478; BAXBY D, 1972, LANCET, V2, P1063; Bayer-Garner IB, 2005, J CUTAN PATHOL, V32, P28, DOI 10.1111/j.0303-6987.2005.00254.x; BERA BC, 2011, VET MICROBI IN PRESS; Bhanuprakash V, 2010, ZOONOSES PUBLIC HLTH, V57, pE149, DOI 10.1111/j.1863-2378.2009.01314.x; Bhanuprakash V, 2010, TROP ANIM HEALTH PRO, V42, P1271, DOI 10.1007/s11250-010-9560-z; Bristol N, 2007, DISASTER MED PUBLIC, V1, P11, DOI 10.1097/DMP.0b013e3180690d58; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Campe H, 2009, EMERG INFECT DIS, V15, P777, DOI 10.3201/eid1505.090159; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P532; Chapman JL, 2010, VET PATHOL, V47, P852, DOI 10.1177/0300985810378649; Chaudhri G, 2004, P NATL ACAD SCI USA, V101, P9057, DOI 10.1073/pnas.0402949101; DAMON IK, 2007, FIELDS VIROLOGY, P2947; Dato V., 2009, Morbidity and Mortality Weekly Report, V58, P1204; DAVIES FG, 1975, J HYG-CAMBRIDGE, V75, P381, DOI 10.1017/S002217240002444X; Duraffour S, 2007, ANTIVIR THER, V12, P1205; Duraffour S, 2007, ANTIMICROB AGENTS CH, V51, P4410, DOI 10.1128/AAC.00838-07; Duraffour S, 2010, IDRUGS, V13, P181; Duroffour S, 2008, ANTIVIR THER, V13, P977; Gammon DB, 2008, J VIROL, V82, P12520, DOI 10.1128/JVI.01528-08; Glatz M, 2010, LANCET INFECT DIS, V10, P288, DOI 10.1016/S1473-3099(10)70054-2; Grosenbach DW, 2010, P NATL ACAD SCI USA, V107, P838, DOI 10.1073/pnas.0912134107; Gubser C, 2002, J GEN VIROL, V83, P855, DOI 10.1099/0022-1317-83-4-855; Gubser C, 2007, PLOS PATHOG, V3, P246, DOI 10.1371/journal.ppat.0030017; Gubser C, 2007, J GEN VIROL, V88, P1667, DOI 10.1099/vir.0.82748-0; HAFEZ SM, 1992, VACCINE, V10, P533, DOI 10.1016/0264-410X(92)90353-L; Hostetler KY, 2009, ANTIVIR RES, V82, pA84, DOI 10.1016/j.antiviral.2009.01.005; Jezek Z, 1983, J Hyg Epidemiol Microbiol Immunol, V27, P29; Kaiser J, 2007, SCIENCE, V316, P1418, DOI 10.1126/science.316.5830.1418; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Kinne J, 1998, J COMP PATHOL, V118, P257, DOI 10.1016/S0021-9975(07)80002-8; Knorr CW, 2006, ANTIVIR RES, V72, P125, DOI 10.1016/j.antiviral.2006.05.005; KRIZ B, 1982, J COMP PATHOL, V92, P1, DOI 10.1016/0021-9975(82)90037-8; Kurth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006883; Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4; Marris E, 2007, NAT MED, V13, P517, DOI 10.1038/nm0507-517; Medeiros-Silva DC, 2010, BRAZ J INFECT DIS, V14, P129, DOI 10.1590/S1413-86702010000200003; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Neyts J, 2004, ANTIMICROB AGENTS CH, V48, P2267, DOI 10.1128/AAC.48.6.2267-2273.2004; Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235; O'Gorman WE, 2010, CELL HOST MICROBE, V8, P174, DOI 10.1016/j.chom.2010.07.008; Osorio JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006592; Otterbein C K, 1996, Rev Elev Med Vet Pays Trop, V49, P114; Pfeffer M, 1996, VET MICROBIOL, V49, P135, DOI 10.1016/0378-1135(95)00181-6; Quenelle DC, 2004, ANTIVIR RES, V63, P33, DOI 10.1016/j.antiviral.2004.02.003; Ramshaw IA, 1997, IMMUNOL REV, V159, P119, DOI 10.1111/j.1600-065X.1997.tb01011.x; RAMYAR H, 1972, ZENTRALB VET RIEHE B, V19, P182; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Reading PC, 2003, J GEN VIROL, V84, P1973, DOI 10.1099/vir.0.19285-0; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Schoepp RJ, 2004, LAB INVEST, V84, P41, DOI 10.1038/labinvest.3700008; Sehgal C L, 1980, J Commun Dis, V12, P177; Smee DF, 2004, J INFECT DIS, V190, P1132, DOI 10.1086/422696; Smee DF, 2008, INT J ANTIMICROB AG, V31, P352, DOI 10.1016/j.ijantimicag.2007.11.013; Smee Donald F., 2008, Antiviral Chemistry & Chemotherapy, V19, P115; Stabenow J, 2010, J VIROL, V84, P3909, DOI 10.1128/JVI.02012-09; TANTAWI HH, 1978, ACTA VIROL, V22, P451; Thin G, 1882, J Anat Physiol, V16, P202; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977; von Bomhard W, 2011, VET DERMATOL, V22, P111, DOI 10.1111/j.1365-3164.2010.00923.x; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; Wernery U, 1999, J VET MED B, V46, P131, DOI 10.1111/j.0931-1793.1999.00250.x; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005	73	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21561	10.1371/journal.pone.0021561	http://dx.doi.org/10.1371/journal.pone.0021561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738709	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800040
J	Wang, CY; Li, H; Hao, XD; Liu, J; Wang, JX; Wang, WZ; Kong, QP; Zhang, YP				Wang, Cheng-Ye; Li, Hui; Hao, Xiao-Dan; Liu, Jia; Wang, Jia-Xin; Wang, Wen-Zhi; Kong, Qing-Peng; Zhang, Ya-Ping			Uncovering the Profile of Somatic mtDNA Mutations in Chinese Colorectal Cancer Patients	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATIONS; SPERMINE OXIDASE; POINT MUTATIONS; PROSTATE-CANCER; SEQUENCE; TUMORS; PHYLOGENY; GENOME; ERRORS; DAMAGE	In the past decade, a high incidence of somatic mitochondrial DNA (mtDNA) mutations has been observed, mostly based on a fraction of the molecule, in various cancerous tissues; nevertheless, some of them were queried due to problems in data quality. Obviously, without a comprehensive understanding of mtDNA mutational profile in the cancerous tissue of a specific patient, it is unlikely to disclose the genuine relationship between somatic mtDNA mutations and tumorigenesis. To achieve this objective, the most straightforward way is to directly compare the whole mtDNA genome variation among three tissues (namely, cancerous tissue, para-cancerous tissue, and distant normal tissue) from the same patient. Considering the fact that most of the previous studies on the role of mtDNA in colorectal tumor focused merely on the D-loop or partial segment of the molecule, in the current study we have collected three tissues (cancerous, para-cancerous and normal tissues) respectively recruited from 20 patients with colorectal tumor and completely sequenced the mitochondrial genome of each tissue. Our results reveal a relatively lower incidence of somatic mutations in these patients; intriguingly, all somatic mutations are in heteroplasmic status. Surprisingly, the observed somatic mutations are not restricted to cancer tissues, for the para-cancer tissues and distant normal tissues also harbor somatic mtDNA mutations with a lower frequency than cancerous tissues but higher than that observed in the general population. Our results suggest that somatic mtDNA mutations in cancerous tissues could not be simply explained as a consequence of tumorigenesis; meanwhile, the somatic mtDNA mutations in normal tissues might reflect an altered physiological environment in cancer patients.	[Wang, Cheng-Ye; Li, Hui; Hao, Xiao-Dan; Wang, Wen-Zhi; Kong, Qing-Peng; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Liu, Jia; Wang, Jia-Xin; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresource, Kunming 650091, Peoples R China; [Kong, Qing-Peng; Zhang, Ya-Ping] KIZ CUHK Joint Lab Bioresources & Mol Res Common, Kunming, Peoples R China; [Hao, Xiao-Dan; Wang, Wen-Zhi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, CY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	kongqp@yahoo.com.cn; zhangyp1@263.net.cn	hao, xiaodan/ABD-7161-2021	Hao, Xiao-dan/0000-0002-4611-8325	Science and Technology Committee of Yunnan Province [2007C103M]; National Natural Science Foundation of China	Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Science and Technology Committee of Yunnan Province (2007C103M), and the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akouchekian M, 2009, DIS COLON RECTUM, V52, P526, DOI 10.1007/DCR.0b013e31819acb99; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Cadet J, 2003, MUTAT RES-FUND MOL M, V531, P5, DOI 10.1016/j.mrfmmm.2003.09.001; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen JJZ, 2003, CARCINOGENESIS, V24, P1481, DOI 10.1093/carcin/bgg102; Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155; Goodwin AC, 2008, PROSTATE, V68, P766, DOI 10.1002/pros.20735; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Grzybowski T, 2000, ELECTROPHORESIS, V21, P548, DOI 10.1002/(SICI)1522-2683(20000201)21:3<548::AID-ELPS548>3.0.CO;2-U; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hibi K, 2001, INT J CANCER, V94, P429, DOI 10.1002/ijc.1480; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kong QP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003016; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Lievre A, 2005, J CLIN ONCOL, V23, P3517, DOI 10.1200/JCO.2005.07.044; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Mehrabi S, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-66; Ohta S, 2006, ONCOGENE, V25, P4768, DOI 10.1038/sj.onc.1209602; Osborne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005636; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Parr RL, 2006, J MOL DIAGN, V8, P312, DOI 10.2353/jmoldx.2006.050112; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Santos C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-167; Sobin, 2009, UICC TNM CLASSIFICAT; Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984; Suissa S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000474; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tan DJ, 2002, CANCER RES, V62, P972; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Vega A, 2004, ONCOGENE, V23, P1314, DOI 10.1038/sj.onc.1207214; von Kleist-Retzow JC, 2003, EXP PHYSIOL, V88, P155, DOI 10.1113/eph8802509; Wang CY, 2007, INT J CANCER, V121, P1253, DOI 10.1002/ijc.22822; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Yao YG, 2004, FORENSIC SCI INT, V141, P1, DOI 10.1016/j.forsciint.2003.12.004; Zhu WZ, 2005, CARCINOGENESIS, V26, P145, DOI 10.1093/carcin/bgh282	50	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21613	10.1371/journal.pone.0021613	http://dx.doi.org/10.1371/journal.pone.0021613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738732	gold, Green Published, Green Submitted			2022-12-25	WOS:000292142800046
J	Chen, WW; Hou, ZB; Li, CM; Xiong, S; Liu, HG				Chen, Weiwei; Hou, Zhibo; Li, Chunman; Xiong, Sheng; Liu, Henggui			Cloning and Characterization of Porcine 4Ig-B7-H3: A Potent Inhibitor of Porcine T-Cell Activation	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; PROGRAMMED DEATH 1; B7 FAMILY; COSTIMULATORY MOLECULE; EXPERIMENTAL-INFECTION; ENDOTHELIAL-CELLS; TUMOR VASCULATURE; TISSUE-EXPRESSION; IMMUNE-RESPONSE; DENDRITIC CELLS	Background: Members of the B7 superfamily costimulate the proliferation of lymphocytes during the initiation and maintenance of antigen-specific humoral and cell-mediated immune responses. B7-H3 (CD276) is a newly identified member of the B7 superfamily. It has been shown that B7-H3 plays a significant role in regulating T cell response in humans and mice, but it is not known whether a counterpart of human or murine B7-H3 exists in porcine species. Methodology/Principal Findings: We cloned the porcine 4ig-b7-h3 gene using a blast search at the NCBI database with human b7-h3, RT-PCR and 39-terminus RACE. Protein sequence analysis showed that the protein encoded by this gene contained 4Ig-like domains and was 90.88% identical with human 4Ig-B7-H3. Results of Dot-blot hybridization and RT-PCR showed that B7-H3 was broadly distributed in porcine tissues mainly as two isoforms, 2Ig-B7-H3 and 4Ig-B7-H3, of which 4Ig-B7-H3 was dominant. We further demonstrated that porcine 4Ig-B7-H3 was able to inhibit the proliferation and cytokine production of porcine T cells activated through the TCR pathway, similar to human B7-H3. Conclusion: We cloned the porcine 4ig-b7-h3 gene and demonstrated that the porcine 4Ig-B7-H3 serves as a negative regulator for the T-cell immune response.	[Liu, Henggui] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China; [Chen, Weiwei] Beijing 302 Hosp, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China; [Hou, Zhibo; Li, Chunman; Xiong, Sheng] Jinan Univ, Natl Engn Res Ctr Genet Med, Biomed R&D Ctr, Guangdong Prov Key Lab Bioengn Med, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Fifth Medical Center of Chinese PLA General Hospital; Jinan University	Liu, HG (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Harbin, Peoples R China.	Liuhenggui@gmail.com			Ministry of Science and Technology; Ministry of Health [2008ZX10004-008]; National Natural Science Foundation of China [30873082]; Ministry of Science and Technology of China [2008BAI63B05]; Program for New Century Excellent Talents in University [NCET-07-0376]; Jinan University; HOUBIO TECH CO. LTD.	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Jinan University(Jinan University); HOUBIO TECH CO. LTD.	This work was supported by the grants from the Ministry of Science and Technology and the Ministry of Health (2008ZX10004-008), the National Natural Science Foundation of China (30873082), the Ministry of Science and Technology of China (2008BAI63B05), the Program for New Century Excellent Talents in University (NCET-07-0376), the 211 Project of Jinan University to S. Xiong and grants from the donation of HOUBIO TECH CO. LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; Barach YS, 2010, TRENDS MOL MED; Batista L, 2004, CAN J VET RES, V68, P267; BOTNER A, 1994, VET MICROBIOL, V40, P351, DOI 10.1016/0378-1135(94)90122-8; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; Davis TA, 1996, INT IMMUNOL, V8, P1099, DOI 10.1093/intimm/8.7.1099; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Faas SJ, 2000, J IMMUNOL, V164, P6340, DOI 10.4049/jimmunol.164.12.6340; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Jeon DH, 2007, XENOTRANSPLANTATION, V14, P236, DOI 10.1111/j.1399-3089.2007.00403.x; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee H, 2010, J CANCER RES CLIN, V136, P1445, DOI 10.1007/s00432-010-0800-4; Leitner J, 2009, EUR J IMMUNOL; Li JCB, 2005, FEBS LETT, V579, P3055, DOI 10.1016/j.febslet.2005.04.060; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; LOOS M, 2008, CANC LETT; Loos M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-463; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Maher SE, 1996, J IMMUNOL, V157, P3838; Muthumani K, 2008, J VIROL, V82, P11536, DOI 10.1128/JVI.00485-08; Peng JM, 2010, VET IMMUNOL IMMUNOP, V136, P157, DOI 10.1016/j.vetimm.2010.03.001; Plege A, 2009, TRANSPLANTATION, V87, P975, DOI 10.1097/TP.0b013e31819c85e8; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Terzo EA, 2005, VET IMMUNOL IMMUNOP, V103, P9, DOI 10.1016/j.vetimm.2004.08.008; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Yi KH, 2009, IMMUNOL REV, V229, P145, DOI 10.1111/j.1600-065X.2009.00768.x; Yoo J, 2008, VET IMMUNOL IMMUNOP, V121, P359, DOI 10.1016/j.vetimm.2007.10.004; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030; Zang XX, 2010, MODERN PATHOL, V23, P1104, DOI 10.1038/modpathol.2010.95; Zhang GB, 2004, ACTA BIOCH BIOPH SIN, V36, P430, DOI 10.1093/abbs/36.6.430; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2005, CELL MOL IMMUNOL, V2, P307; Zhou YH, 2007, TISSUE ANTIGENS, V70, P96, DOI 10.1111/j.1399-0039.2007.00853.x	47	6	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21341	10.1371/journal.pone.0021341	http://dx.doi.org/10.1371/journal.pone.0021341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738638	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600031
J	Zhang, ZH; Pugh, BF				Zhang, Zhenhai; Pugh, B. Franklin			Genomic Organization of H2Av Containing Nucleosomes in Drosophila Heterochromatin	PLOS ONE			English	Article							POSITION-EFFECT VARIEGATION; HISTONE VARIANT; MOLECULAR ASPECTS; RNA-POLYMERASE; CHROMOSOMAL MATERIAL; DNA-SEQUENCES; CHROMATIN; MELANOGASTER; ACTIVATION; PROMOTERS	H2Av is a versatile histone variant that plays both positive and negative roles in transcription, DNA repair, and chromatin structure in Drosophila. H2Av, and its broader homolog H2A.Z, tend to be enriched toward 59 ends of genes, and exist in both euchromatin and heterochromatin. Its organization around euchromatin genes and other features have been described in many eukaryotic model organisms. However, less is known about H2Av nucleosome organization in heterochromatin. Here we report the properties and organization of individual H2Av nucleosomes around genes and transposable elements located in Drosophila heterochromatic regions. We compare the similarity and differences with that found in euchromatic regions. Our analyses suggest that nucleosomes are intrinsically positioned on inverted repeats of DNA transposable elements such as those related to the "1360" element, but are not intrinsically positioned on retrotransposon-related elements.	[Zhang, Zhenhai; Pugh, B. Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, ZH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Comparat Genom & Bioinformat, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	bfp2@psu.edu	Zhang, Zhenhai/GRX-5887-2022	Zhang, Zhenhai/0000-0002-4310-0525	NIH [HG004160]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004160, R56HG004160] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant from NIH (HG004160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALBERT I, 2008, BIOINFORMATICS; Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BELYAEVA ES, 1993, CHROMOSOMA, V102, P583, DOI 10.1007/BF00368351; BELYAEVA ES, 1991, CHROMOSOMA, V100, P453, DOI 10.1007/BF00364556; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brown SA, 1997, GENE DEV, V11, P3116, DOI 10.1101/gad.11.23.3116; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Eirin-Lopez JM, 2007, CURR GENOMICS, V8, P59, DOI 10.2174/138920207780076965; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Farris SD, 2005, J BIOL CHEM, V280, P25298, DOI 10.1074/jbc.M501784200; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Hardy S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000687; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; HOSKINS RA, 2002, GENOME BIOL, V0003; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Hughes JR, 2005, GENETICS, V171, P1183, DOI 10.1534/genetics.105.043976; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Kelly TK, 2010, MOL CELL, V39, P901, DOI 10.1016/j.molcel.2010.08.026; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; LOHE AR, 1993, GENETICS, V134, P1149; Lu BY, 2000, GENETICS, V155, P699; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Miele V, 2008, NUCLEIC ACIDS RES, V36, P3746, DOI 10.1093/nar/gkn262; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Romanish MT, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030010; Roy AM, 2000, J MOL BIOL, V302, P17, DOI 10.1006/jmbi.2000.4027; Santisteban MS, 2000, CELL, V103, P411, DOI 10.1016/S0092-8674(00)00133-1; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Stellwagen AE, 1998, TRENDS BIOCHEM SCI, V23, P486, DOI 10.1016/S0968-0004(98)01325-5; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; TRIFONOV EN, 1980, NUCLEIC ACIDS RES, V8, P4041, DOI 10.1093/nar/8.17.4041; UMBETOVA GH, 1991, CHROMOSOMA, V101, P55, DOI 10.1007/BF00360687; VALOUEV A, 2008, GENOME RES; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Wang JP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000175; Wang JPZ, 2005, NUCLEIC ACIDS RES, V33, P6743, DOI 10.1093/nar/gki977; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; ZHIMULEV IF, 1988, CHROMOSOMA, V96, P255, DOI 10.1007/BF00302365	68	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20511	10.1371/journal.pone.0020511	http://dx.doi.org/10.1371/journal.pone.0020511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738578	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600003
J	Gupta, K; Chakrabarti, A; Rana, S; Ramdeo, R; Roth, BL; Agarwal, ML; Tse, W; Agarwal, MK; Wald, DN				Gupta, Kalpana; Chakrabarti, Amitabha; Rana, Sonia; Ramdeo, Ritu; Roth, Bryan L.; Agarwal, Munna L.; Tse, William; Agarwal, Mukesh K.; Wald, David N.			Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; HL-60; APOPTOSIS; INDUCTION	As the defining feature of Acute Myeloid Leukemia (AML) is a maturation arrest, a highly desirable therapeutic strategy is to induce leukemic cell maturation. This therapeutic strategy has the potential of avoiding the significant side effects that occur with the traditional AML therapeutics. We identified a natural compound securinine, as a leukemia differentiation-inducing agent. Securinine is a plant-derived alkaloid that has previously been used clinically as a therapeutic for primarily neurological related diseases. Securinine induces monocytic differentiation of a wide range of myeloid leukemia cell lines as well as primary leukemic patient samples. Securinine's clinical potential for AML can be seen from its ability to induce significant growth arrest in cell lines and patient samples as well as its activity in significantly impairing the growth of AML tumors in nude mice. In addition, securinine can synergize with currently employed agents such as ATRA and decitabine to induce differentiation. This study has revealed securinine induces differentiation through the activation of DNA damage signaling. Securinine is a promising new monocytic differentiation inducing agent for AML that has seen previous clinical use for non-related disorders.	[Gupta, Kalpana; Ramdeo, Ritu; Wald, David N.] Case Western Reserve Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Chakrabarti, Amitabha; Rana, Sonia; Agarwal, Mukesh K.; Wald, David N.] Invenio Therapeut, Cleveland, OH USA; [Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Dept Pharmacol, Chapel Hill, NC USA; [Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Dept Med Chem, Chapel Hill, NC USA; [Agarwal, Munna L.] Case Western Reserve Sch Med, Dept Genet, Cleveland, OH USA; [Tse, William] W Virginia Univ, Dept Med, Morgantown, WV 26506 USA; [Wald, David N.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University; West Virginia University; Case Western Reserve University; University Hospitals of Cleveland	Gupta, K (corresponding author), Case Western Reserve Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	agarwamukesh@yahoo.com; dnw@case.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520	National Institutes of Health [R43 CA134089]; Children's Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [R43CA134089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was received from National Institutes of Health grant R43 CA134089 and Children's Leukemia Research Foundation (childrensleukemia.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; ALESHKINA Ia A, 1956, Farmakol Toksikol, V19, P11; *AM CANC SOC, 2006, DET GUID LEUK AC MYE; Asada M, 1998, LEUKEMIA, V12, P1944, DOI 10.1038/sj.leu.2401228; BEUTLER JA, 1985, BRAIN RES, V330, P135, DOI 10.1016/0006-8993(85)90014-9; BURAVTSEVA G R, 1958, Farmakol Toksikol, V21, P7; COLLINS SJ, 1980, INT J CANCER, V25, P213, DOI 10.1002/ijc.2910250208; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; Copperman R, 1973, Pa Med, V76, P36; COPPERMAN R, 1974, JAMA-J AM MED ASSOC, V228, P288, DOI 10.1001/jama.1974.03230280016013; Dong NZ, 1999, ACTA PHARMACOL SIN, V20, P267; Duke J. A., 1985, REFERENCE PUBLICATIO, pS219; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; GUGLIELMO P, 1980, Bollettino Societa Italiana Biologia Sperimentale, V56, P183; Hill L, 1976, P N G Med J, V18, P157; Kell Jonathan, 2004, Expert Opin Emerg Drugs, V9, P55, DOI 10.1517/14728214.9.1.55; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; NEWBURGER PE, 1984, J BIOL CHEM, V259, P3771; Pu H, 2001, Zhong Yao Cai, V24, P278; Rana SV, 2010, FASEB J, V24; Rana S, 2010, FASEB J, V24, P2126, DOI 10.1096/fj.09-148999; Tallmann M. S., 2004, Annals of Hematology, V83, pS81; Wald DN, 2008, CANCER RES, V68, P4369, DOI 10.1158/0008-5472.CAN-07-6559	25	40	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21203	10.1371/journal.pone.0021203	http://dx.doi.org/10.1371/journal.pone.0021203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731671	Green Submitted, Green Published, gold			2022-12-25	WOS:000292036900015
J	Alva-Medina, J; Maya-Mendoza, A; Dent, MAR; Aranda-Anzaldo, A				Alva-Medina, Janeth; Maya-Mendoza, Apolinar; Dent, Myrna A. R.; Aranda-Anzaldo, Armando			Continued Stabilization of the Nuclear Higher-Order Structure of Post-Mitotic Neurons In Vivo	PLOS ONE			English	Article							CELL-CYCLE; DROSOPHILA-MELANOGASTER; LIVER-REGENERATION; DNA-REPLICATION; TRANSGENIC MICE; CEREBRAL-CORTEX; VISUAL-CORTEX; LOOP DOMAINS; LIFE-SPAN; MATRIX	Background: Cellular terminal differentiation (TD) correlates with a permanent exit from the cell cycle and so TD cells become stably post-mitotic. However, TD cells express the molecular machinery necessary for cell proliferation that can be reactivated by experimental manipulation, yet it has not been reported the stable proliferation of any type of reactivated TD cells. Neurons become post-mitotic after leaving the ventricular zone. When neurons are forced to reenter the cell cycle they invariably undergo cell death. Wider evidence indicates that the post-mitotic state cannot solely depend on gene products acting in trans, otherwise mutations in the corresponding genes may lead to reentry and completion of the cell cycle in TD cells, but this has not been observed. In the interphase, nuclear DNA of metazoan cells is organized in supercoiled loops anchored to a nuclear nuclear matrix (NM). The DNA-NM interactions define a higher-order structure in the cell nucleus (NHOS). We have previously compared the NHOS of aged rat hepatocytes with that of early post-mitotic rat neurons and our results indicated that a very stable NHOS is a common feature of both senescent and post-mitotic cells in vivo. Principal Findings: In the present work we compared the NHOS in rat neurons from different post-natal ages. Our results show that the trend towards further stabilization of the NHOS in neurons continues throughout post-natal life. This phenomenon occurs in absence of overt changes in the post-mitotic state and transcriptional activity of neurons, suggesting that it is independent of functional constraints. Conclusions: Apparently the continued stabilization of the NHOS as a function of time is basically determined by thermodynamic and structural constraints. We discuss how the resulting highly stable NHOS of neurons may be the structural, non-genetic basis of their permanent and irreversible post-mitotic state.	[Alva-Medina, Janeth; Maya-Mendoza, Apolinar; Dent, Myrna A. R.; Aranda-Anzaldo, Armando] Univ Autonoma Estado Mexico, Fac Med, Lab Biol Mol & Neurociencias, Toluca, Mexico		Aranda-Anzaldo, A (corresponding author), Univ Autonoma Estado Mexico, Fac Med, Lab Biol Mol & Neurociencias, Toluca, Mexico.	aaa@uaemex.mx	Aranda-Anzaldo, Armando/A-6513-2014	Aranda-Anzaldo, Armando/0000-0002-5583-5465; Maya-Mendoza, Apolinar/0000-0001-7452-9896; Dent, Myrna/0000-0003-2304-499X	CONACYT-Mexico [48447-Q-25506]; UAEMex [2212/2006]	CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UAEMex	This work was funded by CONACYT-Mexico (www.conacyt.gob.mx), grant 48447-Q-25506 awarded to A. Aranda-Anzaldo, and UAEMex (www.uaemex.mx), grant 2212/2006 awarded to A. Aranda-Anzaldo and M.A.R. Dent. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; Alva-Medina J, 2010, BIOGERONTOLOGY, V11, P703, DOI 10.1007/s10522-010-9285-4; Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Anisimov V. N., 2009, OPEN LONGEVITY SCI, V3, P1; Aranda-Anzaldo A, 1999, BBA-GENE STRUCT EXPR, V1446, P181, DOI 10.1016/S0167-4781(99)00086-X; Aranda-Anzaldo A, 1997, RES VIROLOGY, V148, P397, DOI 10.1016/S0923-2516(97)83629-1; Aranda-Anzaldo A, 2009, AGING-US, V1, P598, DOI 10.18632/aging.100074; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Benham C, 1997, J MOL BIOL, V274, P181, DOI 10.1006/jmbi.1997.1385; BEREZNEY R, 1981, EXP CELL RES, V132, P1, DOI 10.1016/0014-4827(81)90076-8; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; Boulikas T, 1995, INT REV CYTOL, V162A, P279; BRODAL P, 1992, CENTRAL NERVOUS SYST, P45; BUONGIORNONARDELLI M, 1982, NATURE, V298, P100, DOI 10.1038/298100a0; Butany J, 2005, LANCET ONCOL, V6, P219, DOI 10.1016/S1470-2045(05)70093-0; CALLADINE CR, 2004, UNDERSTANDING DNA, P94; Rivera-Mulia JC, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-3; Rivera-Mulia JC, 2010, DNA RES, V17, P23, DOI 10.1093/dnares/dsp027; Cloutier TE, 2004, MOL CELL, V14, P355, DOI 10.1016/S1097-2765(04)00210-2; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; COOK PR, 1976, J CELL SCI, V22, P303; Dent MAR, 2010, FEBS LETT, V584, P2767, DOI 10.1016/j.febslet.2010.04.073; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; Forsyth NR, 2005, MECH AGEING DEV, V126, P685, DOI 10.1016/j.mad.2005.01.003; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Hartung EW, 1942, CANCER RES, V2, P837; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Iarovaia OV, 2009, J CELL BIOCHEM, V106, P170, DOI 10.1002/jcb.21987; Iarovaia OV, 2004, NUCLEIC ACIDS RES, V32, P2079, DOI 10.1093/nar/gkh532; Ivanovic-Matic S, 2000, IUBMB LIFE, V49, P511, DOI 10.1080/15216540050167052; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Lambert FL, 2002, J CHEM EDUC, V79, P187, DOI 10.1021/ed079p187; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; MARTIN GM, 1977, AM J PATHOL, V89, P484; Maya-Mendoza A, 2005, MECH AGEING DEV, V126, P767, DOI 10.1016/j.mad.2005.01.011; Maya-Mendoza A, 2004, J CELL BIOCHEM, V93, P1084, DOI 10.1002/jcb.20264; Maya-Mendoza A, 2003, NUCLEIC ACIDS RES, V31, P6168, DOI 10.1093/nar/gkg825; Maya-Mendoza A, 2003, ANAL BIOCHEM, V313, P196, DOI 10.1016/S0003-2697(02)00611-5; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Mika S, 2005, NUCLEIC ACIDS RES, V33, pD160; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nickerson JA, 2001, J CELL SCI, V114, P463; Ottaviani D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-201; Pajalunga D, 2007, CELL CYCLE, V6, P1415; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pajalunga D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011559; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2006, SCIENCE, V313, P928, DOI 10.1126/science.1131713; Ramana-Murty CV, 1988, BIOCHIM BIOPHYS ACTA, V949, P23; Razin SV, 1995, INT REV CYTOL, V162B, P405; Razin SV, 2001, CELL MOL BIOL LETT, V6, P59; ROTI JLR, 1993, ADV RADIAT BIOL, V17, P227; SCHARRER B, 1950, CANCER RES, V10, P403; SMALL D, 1985, NUCLEIC ACIDS RES, V13, P2413, DOI 10.1093/nar/13.7.2413; SMITH JR, 1974, J CELL BIOL, V62, P48, DOI 10.1083/jcb.62.1.48; SZOLLOSI D, 1988, J CELL SCI, V91, P603; Takahashi A, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-10; THOMPSON RJ, 1973, J NEUROCHEM, V21, P19, DOI 10.1111/j.1471-4159.1973.tb04222.x; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Trevilla-Garcia C, 2011, J CELL BIOCHEM, V112, P531, DOI 10.1002/jcb.22943; Tsutsui KM, 2005, ACTA MED OKAYAMA, V59, P113; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; WUNDERLICH F, 1977, J CELL BIOL, V73, P271, DOI 10.1083/jcb.73.2.271; Yamazaki Y, 2001, P NATL ACAD SCI USA, V98, P14022, DOI 10.1073/pnas.231489398; Zhang J, 2008, CELL CYCLE, V7, P3487, DOI 10.4161/cc.7.22.7045; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010; Zhang YL, 2004, P NATL ACAD SCI USA, V101, P8337, DOI 10.1073/pnas.0402319101	77	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21360	10.1371/journal.pone.0021360	http://dx.doi.org/10.1371/journal.pone.0021360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731716	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400029
J	Bazil, JN; Dash, RK				Bazil, Jason N.; Dash, Ranjan K.			A Minimal Model for the Mitochondrial Rapid Mode of Ca2+ Uptake Mechanism	PLOS ONE			English	Article							CALCIUM OSCILLATIONS; OXIDATIVE-PHOSPHORYLATION; SARCOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; HEART; TRANSPORT; KINETICS; LIVER; CELL; PULSES	Mitochondria possess a remarkable ability to rapidly accumulate and sequester Ca2+. One of the mechanisms responsible for this ability is believed to be the rapid mode (RaM) of Ca2+ uptake. Despite the existence of many models of mitochondrial Ca2+ dynamics, very few consider RaM as a potential mechanism that regulates mitochondrial Ca2+ dynamics. To fill this gap, a novel mathematical model of the RaM mechanism is developed herein. The model is able to simulate the available experimental data of rapid Ca2+ uptake in isolated mitochondria from both chicken heart and rat liver tissues with good fidelity. The mechanism is based on Ca2+ binding to an external trigger site(s) and initiating a brief transient of high Ca2+ conductivity. It then quickly switches to an inhibited, zero-conductive state until the external Ca2+ level is dropped below a critical value (similar to 100-150 nM). RaM's Ca2+- and time-dependent properties make it a unique Ca2+ transporter that may be an important means by which mitochondria take up Ca2+ in situ and help enable mitochondria to decode cytosolic Ca2+ signals. Integrating the developed RaM model into existing models of mitochondrial Ca2+ dynamics will help elucidate the physiological role that this unique mechanism plays in mitochondrial Ca2+-homeostasis and bioenergetics.	[Bazil, Jason N.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Bazil, JN (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	rdash@mcw.edu			National Institutes of Health [R01-HL095122, T32-HL094273]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095122, T32HL094273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants R01-HL095122 and T32-HL094273. www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; BROWN GC, 1992, BIOCHEM J, V284, P1; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; Chacon E, 1996, FEBS LETT, V382, P31, DOI 10.1016/0014-5793(96)00138-X; COLL KE, 1982, J BIOL CHEM, V257, P8696; Cortassa S, 2003, BIOPHYS J, V84, P2734, DOI 10.1016/S0006-3495(03)75079-6; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; DENTON RM, 1986, CELL CALCIUM, V7, P377, DOI 10.1016/0143-4160(86)90040-0; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; FLEISCHER S, 1967, J LIPID RES, V8, P170; GARLID KD, 1989, BIOCHIM BIOPHYS ACTA, V976, P109, DOI 10.1016/S0005-2728(89)80219-1; Ghebrehiwet B, 2002, IMMUNOBIOLOGY, V205, P421, DOI 10.1078/0171-2985-00143; GREENSTEIN JL, 2002, NATURE, V83, P2918; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Griffiths EJ, 2009, J MOL CELL CARDIOL, V46, P789, DOI 10.1016/j.yjmcc.2009.03.001; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Gunter TE, 2000, CELL CALCIUM, V28, P285, DOI 10.1054/ceca.2000.0168; Gunter TE, 1998, BBA-BIOENERGETICS, V1366, P5, DOI 10.1016/S0005-2728(98)00117-0; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gunter TE, 1998, BIOFACTORS, V8, P205, DOI 10.1002/biof.5520080306; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HAJNOCZKY G, 1999, MITOCHONDRIA, V274, P14157; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Haumann J, 2010, BIOPHYS J, V99, P997, DOI 10.1016/j.bpj.2010.04.069; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572; JOU MJ, 1996, NATURE, V497, P299; Kasparinsky FO, 1996, FEBS LETT, V389, P293, DOI 10.1016/0014-5793(96)00606-0; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lipniacki T, 2008, J THEOR BIOL, V254, P110, DOI 10.1016/j.jtbi.2008.05.001; LUKYANENKO V, 2009, NATURE, V41, P1957; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Marhl M, 1998, BIOPHYS CHEM, V71, P125, DOI 10.1016/S0301-4622(97)00139-7; Marhl M, 2000, BIOSYSTEMS, V57, P75, DOI 10.1016/S0303-2647(00)00090-3; Marhl M, 2010, BIOPHYS CHEM, V148, P42, DOI 10.1016/j.bpc.2010.02.006; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1981, NATURE, V196, P619; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Moreau B, 2008, CURR BIOL, V18, P855, DOI 10.1016/j.cub.2008.05.026; Nguyen MHT, 2007, AM J PHYSIOL-CELL PH, V292, pC2004, DOI 10.1152/ajpcell.00271.2006; Ohata H, 1998, J BIOENERG BIOMEMBR, V30, P207, DOI 10.1023/A:1020588618496; PALTY R, 2010, NATURE, V107, P436; Perc M, 2003, BIOPHYS CHEM, V104, P509, DOI 10.1016/S0301-4622(03)00038-3; Perc M, 2003, CHAOS SOLITON FRACT, V18, P759, DOI 10.1016/S0960-0779(03)00027-4; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2007, CHEM PHYS LETT, V437, P143, DOI 10.1016/j.cplett.2007.02.003; Perc M, 2009, CHAOS, V19, DOI 10.1063/1.3160017; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Peskoff A, 1998, BIOPHYS J, V74, P153, DOI 10.1016/S0006-3495(98)77776-8; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Pradhan RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013278; RAMESH V, 1998, NATURE, V853, P341; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; RUTTER GA, 1989, ANN NY ACAD SCI, V573, P206, DOI 10.1111/j.1749-6632.1989.tb14998.x; Sharma VK, 2000, J BIOENERG BIOMEMBR, V32, P97, DOI 10.1023/A:1005520714221; Shuai JW, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.068102; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; SPARAGNA GC, 1994, ANAL BIOCHEM, V219, P96, DOI 10.1006/abio.1994.1236; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; Wang SR, 1998, NAT STRUCT BIOL, V5, P476, DOI 10.1038/nsb0698-476; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; WINGROVE DE, 1986, J BIOL CHEM, V261, P5159; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961	75	16	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21324	10.1371/journal.pone.0021324	http://dx.doi.org/10.1371/journal.pone.0021324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731705	gold, Green Submitted, Green Published			2022-12-25	WOS:000292035400022
J	Peterburs, J; Pergola, G; Koch, B; Schwarz, M; Hoffmann, KP; Daum, I; Bellebaum, C				Peterburs, Jutta; Pergola, Giulio; Koch, Benno; Schwarz, Michael; Hoffmann, Klaus-Peter; Daum, Irene; Bellebaum, Christian			Altered Error Processing following Vascular Thalamic Damage: Evidence from an Antisaccade Task	PLOS ONE			English	Article							FRONTAL EYE FIELD; ANTERIOR CINGULATE CORTEX; BRAIN-STEM TELLS; COROLLARY DISCHARGE; CORTICAL CONTROL; PARIETAL CORTEX; ERP COMPONENTS; NEURAL SYSTEM; CEREBELLAR; MOVEMENTS	Event-related potentials (ERP) research has identified a negative deflection within about 100 to 150 ms after an erroneous response - the error-related negativity (ERN) - as a correlate of awareness-independent error processing. The short latency suggests an internal error monitoring system acting rapidly based on central information such as an efference copy signal. Studies on monkeys and humans have identified the thalamus as an important relay station for efference copy signals of ongoing saccades. The present study investigated error processing on an antisaccade task with ERPs in six patients with focal vascular damage to the thalamus and 28 control subjects. ERN amplitudes were significantly reduced in the patients, with the strongest ERN attenuation being observed in two patients with right mediodorsal and ventrolateral and bilateral ventrolateral damage, respectively. Although the number of errors was significantly higher in the thalamic lesion patients, the degree of ERN attenuation did not correlate with the error rate in the patients. The present data underline the role of the thalamus for the online monitoring of saccadic eye movements, albeit not providing unequivocal evidence in favour of an exclusive role of a particular thalamic site being involved in performance monitoring. By relaying saccade-related efference copy signals, the thalamus appears to enable fast error processing. Furthermore early error processing based on internal information may contribute to error awareness which was reduced in the patients.	[Peterburs, Jutta; Pergola, Giulio; Daum, Irene; Bellebaum, Christian] Ruhr Univ Bochum, Fac Psychol, Dept Neuropsychol, Inst Cognit Neurosci, Bochum, Germany; [Hoffmann, Klaus-Peter] Ruhr Univ Bochum, Dept Neurosci, Bochum, Germany; [Hoffmann, Klaus-Peter] Ruhr Univ Bochum, Fac Biol & Biotechnol, Bochum, Germany; [Koch, Benno; Schwarz, Michael] Klinikum Dortmund, Dept Neurol, Dortmund, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Klinikum Dortmund	Peterburs, J (corresponding author), Ruhr Univ Bochum, Fac Psychol, Dept Neuropsychol, Inst Cognit Neurosci, Bochum, Germany.	jutta.peterburs@ruhr-uni-bochum.de	Peterburs, Jutta/R-2352-2019; Pergola, Giulio/B-9754-2013	Peterburs, Jutta/0000-0003-3571-126X; Pergola, Giulio/0000-0002-9193-1841	German Research Society (Deutsche Forschungsgemeinschaft, DFG) [Be 4034/1-1]	German Research Society (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	This research was funded by the German Research Society (Deutsche Forschungsgemeinschaft, DFG) (Be 4034/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain S, 2004, CLIN NEUROPHYSIOL, V115, P2014, DOI 10.1016/j.clinph.2004.04.013; ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; Bellebaum C, 2006, BEHAV BRAIN RES, V169, P150, DOI 10.1016/j.bbr.2006.01.001; Bellebaum C, 2005, BRAIN, V128, P1139, DOI 10.1093/brain/awh474; Bellebaum C, 2006, EUR J NEUROSCI, V24, P2375, DOI 10.1111/j.1460-9568.2006.05114.x; Beste C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000086; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; Condy C, 2004, NEUROLOGY, V63, P1571, DOI 10.1212/01.WNL.0000142990.44979.5A; Crawford JR, 2005, NEUROPSYCHOLOGY, V19, P318, DOI 10.1037/0894-4105.19.3.318; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; DAHL G, 1986, REDUZIERTER WECHSLER; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Falkenstein M, 2001, NEUROREPORT, V12, P157, DOI 10.1097/00001756-200101220-00039; Falkenstein M, 2001, EXP BRAIN RES, V138, P258, DOI 10.1007/s002210100712; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fischer B, 1996, EXP BRAIN RES, V109, P507; GAYMARD B, 1994, EXP BRAIN RES, V102, P1; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Giannetti S, 2002, BRAIN RES BULL, V58, P481, DOI 10.1016/S0361-9230(02)00815-8; Golla H, 2008, EUR J NEUROSCI, V27, P132, DOI 10.1111/j.1460-9568.2007.05996.x; GROENEWEGEN HJ, 1988, NEUROSCIENCE, V24, P379, DOI 10.1016/0306-4522(88)90339-9; H?rting, 2000, WECHSLER GED CHTNIST; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Jenkinson N, 2010, CEREBELLUM, V9, P548, DOI 10.1007/s12311-010-0193-6; Jones E.G., 2012, THALAMUS; KALIL K, 1981, J COMP NEUROL, V195, P25, DOI 10.1002/cne.901950105; KAUFMAN EFS, 1985, BRAIN RES, V335, P257, DOI 10.1016/0006-8993(85)90478-0; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Kunimatsu J, 2010, J NEUROSCI, V30, P5108, DOI 10.1523/JNEUROSCI.0406-10.2010; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Mokler A, 1999, EXP BRAIN RES, V125, P511, DOI 10.1007/s002210050709; Morel A., 2007, STEREOTACTIC ATLAS H, DOI 10.3109/9781420016796; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ostendorf F, 2010, P NATL ACAD SCI USA, V107, P1229, DOI 10.1073/pnas.0910742107; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Pailing PE, 2002, PSYCHOPHYSIOLOGY, V39, P198, DOI 10.1017/S0048577201392107; Peterburs J, 2011, BEHAV BRAIN RES, V216, P496, DOI 10.1016/j.bbr.2010.08.025; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; Scudder CA, 2002, ANN NY ACAD SCI, V978, P63, DOI 10.1111/j.1749-6632.2002.tb07556.x; SEGRAVES MA, 1992, J NEUROPHYSIOL, V68, P1967, DOI 10.1152/jn.1992.68.6.1967; Seifert S, 2011, J NEUROSCI, V31, P3375, DOI 10.1523/JNEUROSCI.6242-10.2011; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; Stemmer B, 2004, NEUROPSYCHOLOGIA, V42, P118, DOI 10.1016/S0028-3932(03)00121-0; Suchan B, 2007, BEHAV BRAIN RES, V183, P206, DOI 10.1016/j.bbr.2007.06.013; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Turken U, 2008, NEUROSCI LETT, V441, P7, DOI 10.1016/j.neulet.2008.05.115; Ullsperger M, 2006, J COGNITIVE NEUROSCI, V18, P651, DOI 10.1162/jocn.2006.18.4.651; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; Versino M, 2000, J NEUROL NEUROSUR PS, V68, P234, DOI 10.1136/jnnp.68.2.234; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Zimmermann P., 2002, TESTBATTERIE AUFMERK	73	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21517	10.1371/journal.pone.0021517	http://dx.doi.org/10.1371/journal.pone.0021517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782TT	21731771	Green Published, gold			2022-12-25	WOS:000292035400046
J	Cheng, L; Booker, FL; Burkey, KO; Tu, C; Shew, HD; Rufty, TW; Fiscus, EL; Deforest, JL; Hu, SJ				Cheng, Lei; Booker, Fitzgerald L.; Burkey, Kent O.; Tu, Cong; Shew, H. David; Rufty, Thomas W.; Fiscus, Edwin L.; Deforest, Jared L.; Hu, Shuijin			Soil Microbial Responses to Elevated CO2 and O-3 in a Nitrogen-Aggrading Agroecosystem	PLOS ONE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; ORGANIC-MATTER; COMMUNITY COMPOSITION; TALLGRASS PRAIRIE; PINE FOREST; BIOMASS; ENRICHMENT; OZONE; METAANALYSIS; PLANT	Climate change factors such as elevated atmospheric carbon dioxide (CO2) and ozone (O-3) can exert significant impacts on soil microbes and the ecosystem level processes they mediate. However, the underlying mechanisms by which soil microbes respond to these environmental changes remain poorly understood. The prevailing hypothesis, which states that CO2- or O-3-induced changes in carbon (C) availability dominate microbial responses, is primarily based on results from nitrogen (N)-limiting forests and grasslands. It remains largely unexplored how soil microbes respond to elevated CO2 and O-3 in N-rich or N-aggrading systems, which severely hinders our ability to predict the long-term soil C dynamics in agroecosystems. Using a long-term field study conducted in a no-till wheat-soybean rotation system with open-top chambers, we showed that elevated CO2 but not O-3 had a potent influence on soil microbes. Elevated CO2 (1.5xambient) significantly increased, while O-3 (1.4xambient) reduced, aboveground (and presumably belowground) plant residue C and N inputs to soil. However, only elevated CO2 significantly affected soil microbial biomass, activities (namely heterotrophic respiration) and community composition. The enhancement of microbial biomass and activities by elevated CO2 largely occurred in the third and fourth years of the experiment and coincided with increased soil N availability, likely due to CO2-stimulation of symbiotic N-2 fixation in soybean. Fungal biomass and the fungi: bacteria ratio decreased under both ambient and elevated CO2 by the third year and also coincided with increased soil N availability; but they were significantly higher under elevated than ambient CO2. These results suggest that more attention should be directed towards assessing the impact of N availability on microbial activities and decomposition in projections of soil organic C balance in N-rich systems under future CO2 scenarios.	[Cheng, Lei; Tu, Cong; Shew, H. David; Hu, Shuijin] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Booker, Fitzgerald L.; Burkey, Kent O.; Fiscus, Edwin L.] ARS, Plant Sci Res Unit, USDA, Raleigh, NC USA; [Booker, Fitzgerald L.; Burkey, Kent O.; Rufty, Thomas W.; Fiscus, Edwin L.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Deforest, Jared L.] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; University System of Ohio; Ohio University	Cheng, L (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA.	shuijin_hu@ncsu.edu	DeForest, Jared/E-5777-2011; Cheng, Lei/G-8430-2011; Tu, Cong/H-9750-2013; Cheng, lei/E-6307-2013; chen, vivi/A-1085-2012	Cheng, Lei/0000-0002-5486-3632; Hu, Shuijin/0000-0002-3225-5126; DeForest, Jared/0000-0002-8390-9126	USDA-ARS Plant Science Research Unit (Raleigh, NC); USDA [2009-35101-05351]	USDA-ARS Plant Science Research Unit (Raleigh, NC); USDA(United States Department of Agriculture (USDA))	Lei Cheng was supported by a fellowship from the USDA-ARS Plant Science Research Unit (Raleigh, NC) and was in part by an USDA grant to SH (2009-35101-05351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2002, GLOBAL CHANGE BIOL, V8, P695, DOI 10.1046/j.1365-2486.2002.00498.x; Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; [Anonymous], 2006, SAS MIXED MODELS; Balser TC, 2005, SOIL BIOL BIOCHEM, V37, P601, DOI 10.1016/j.soilbio.2004.08.019; Barnard R, 2006, FUNCT ECOL, V20, P557, DOI 10.1111/j.1365-2435.2006.01146.x; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Blagodatskaya E, 2010, GLOBAL CHANGE BIOL, V16, P836, DOI 10.1111/j.1365-2486.2009.02006.x; Booker F, 2009, J INTEGR PLANT BIOL, V51, P337, DOI 10.1111/j.1744-7909.2008.00805.x; Booker FL, 2005, J EXP BOT, V56, P2139, DOI 10.1093/jxb/eri214; Booker FL, 2005, GLOBAL CHANGE BIOL, V11, P685, DOI 10.1111/j.1365-2486.2005.00939.x; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Cheng L, 2010, ECOL LETT, V13, P284, DOI 10.1111/j.1461-0248.2009.01421.x; COLEMAN DC, 1978, MICROBIAL ECOL, V4, P373, DOI 10.1007/BF02013280; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Dieleman WIJ, 2010, PLANT CELL ENVIRON, V33, P2001, DOI 10.1111/j.1365-3040.2010.02201.x; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; DUBOC P, 1995, J BIOTECHNOL, V43, P145, DOI 10.1016/0168-1656(95)00135-0; Feng XJ, 2010, GLOBAL CHANGE BIOL, V16, P2104, DOI 10.1111/j.1365-2486.2009.02080.x; Feng ZZ, 2008, GLOBAL CHANGE BIOL, V14, P2696, DOI 10.1111/j.1365-2486.2008.01673.x; Finzi AC, 2002, OECOLOGIA, V132, P567, DOI 10.1007/s00442-002-0996-3; Fiscus EL, 2005, PLANT CELL ENVIRON, V28, P997, DOI 10.1111/j.1365-3040.2005.01349.x; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Grantz DA, 2006, PLANT CELL ENVIRON, V29, P1193, DOI 10.1111/j.1365-3040.2006.01521.x; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hu SJ, 2006, PLANT SOIL, V289, P47, DOI 10.1007/s11104-006-9093-4; Hu SJ, 1999, TRENDS ECOL EVOL, V14, P433, DOI 10.1016/S0169-5347(99)01682-1; Hu SJ, 2005, GLOBAL CHANGE BIOL, V11, P213, DOI 10.1111/j.1365-2486.2005.00905.x; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Islam KR, 2000, GLOBAL CHANGE BIOL, V6, P255, DOI 10.1046/j.1365-2486.2000.00307.x; Jenkinson DS, 2004, SOIL BIOL BIOCHEM, V36, P5, DOI 10.1016/j.soilbio.2003.10.002; Jin VL, 2010, GLOBAL CHANGE BIOL, V16, P2334, DOI 10.1111/j.1365-2486.2010.02207.x; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kimball BA, 1995, GLOB CHANGE BIOL, V1, P429, DOI 10.1111/j.1365-2486.1995.tb00041.x; Kimball BA, 2002, ADV AGRON, V77, P293, DOI 10.1016/S0065-2113(02)77017-X; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Langley JA, 2009, SOIL BIOL BIOCHEM, V41, P54, DOI 10.1016/j.soilbio.2008.09.016; Liu LL, 2010, ECOL LETT, V13, P819, DOI 10.1111/j.1461-0248.2010.01482.x; McMaster GS, 1999, J AGRON CROP SCI, V183, P119, DOI 10.1046/j.1439-037x.1999.00325.x; Morgan PB, 2003, PLANT CELL ENVIRON, V26, P1317, DOI 10.1046/j.0016-8025.2003.01056.x; Nissen T, 2008, COMMUN SOIL SCI PLAN, V39, P1875, DOI 10.1080/00103620802073933; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Paustian K, 1997, SOIL USE MANAGE, V13, P230, DOI 10.1111/j.1475-2743.1997.tb00594.x; Pendall E, 2004, NEW PHYTOL, V162, P447, DOI 10.1111/j.1469-8137.2004.01054.x; Peralta AL, 2008, PLANT SOIL, V303, P69, DOI 10.1007/s11104-007-9474-3; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Phillips RL, 2002, OECOLOGIA, V131, P236, DOI 10.1007/s00442-002-0868-x; Pregitzer KS, 2008, NEW PHYTOL, V180, P153, DOI 10.1111/j.1469-8137.2008.02564.x; Prior SA, 2005, GLOBAL CHANGE BIOL, V11, P657, DOI 10.1111/j.1365-2486.2005.00935.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; RICE CW, 1994, PLANT SOIL, V165, P67, DOI 10.1007/BF00009963; Rillig MC, 1999, OECOLOGIA, V119, P572, DOI 10.1007/s004420050821; Rogers A, 2009, PLANT PHYSIOL, V151, P1009, DOI 10.1104/pp.109.144113; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Smith JL, 1990, SOIL BIOCH, V6, P357; Talhelm AF, 2009, ECOL LETT, V12, P1219, DOI 10.1111/j.1461-0248.2009.01380.x; Tu C, 2009, CROP SCI, V49, P1827, DOI 10.2135/cropsci2008.10.0603; USEPA, 2006, AIR QUAL CRIT OZ REL, P705; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Warembourg F. R., 1993, Nitrogen isotope techniques., P127; West JB, 2006, GLOBAL CHANGE BIOL, V12, P1400, DOI 10.1111/j.1365-2486.2006.01177.x; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Zak DR, 1996, ECOL APPL, V6, P257, DOI 10.2307/2269568; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x	73	28	29	13	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21377	10.1371/journal.pone.0021377	http://dx.doi.org/10.1371/journal.pone.0021377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731722	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700070
J	Mutig, K; Kahl, T; Saritas, T; Godes, M; Persson, P; Bates, J; Raffi, H; Rampoldi, L; Uchida, S; Hille, C; Dosche, C; Kumar, S; Castaneda-Bueno, M; Gamba, G; Bachmann, S				Mutig, Kerim; Kahl, Thomas; Saritas, Turgay; Godes, Michael; Persson, Pontus; Bates, James; Raffi, Hajamohideen; Rampoldi, Luca; Uchida, Shinichi; Hille, Carsten; Dosche, Carsten; Kumar, Satish; Castaneda-Bueno, Maria; Gamba, Gerardo; Bachmann, Sebastian			Activation of the Bumetanide-sensitive Na+, K+,2Cl(-) Cotransporter (NKCC2) Is Facilitated by Tamm-Horsfall Protein in a Chloride-sensitive Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; DISTAL CONVOLUTED TUBULE; SHORT-TERM STIMULATION; CL-COTRANSPORTER; ULTRASTRUCTURAL-LOCALIZATION; NA-K-2CL COTRANSPORTER; CAMP INCREASES; MACULA DENSA; MOUSE MODEL; UMOD GENE	Active transport of NaCl across thick ascending limb (TAL) epithelium is accomplished by Na+, K+,2Cl(-) cotransporter (NKCC2). The activity of NKCC2 is determined by vasopressin (AVP) or intracellular chloride concentration and includes its amino-terminal phosphorylation. Co-expressed Tamm-Horsfall protein (THP) has been proposed to interact with NKCC2. We hypothesized that THP modulates NKCC2 activity in TAL. THP-deficient mice (THP-/-) showed an increased abundance of intracellular NKCC2 located in subapical vesicles (+47% compared with wild type (WT) mice), whereas base-line phosphorylation of NKCC2 was significantly decreased (-49% compared with WT mice), suggesting reduced activity of the transporter in the absence of THP. Cultured TAL cells with low endogenous THP levels and low base-line phosphorylation of NKCC2 displayed sharp increases in NKCC2 phosphorylation (+38%) along with a significant change of intracellular chloride concentration upon transfection with THP. In NKCC2-expressing frog oocytes, co-injection with THP cRNA significantly enhanced the activation of NKCC2 under low chloride hypotonic stress (+112% versus +235%). Short term (30 min) stimulation of the vasopressin V2 receptor pathway by V2 receptor agonist (deamino-cis-D-Arg vasopressin) resulted in enhanced NKCC2 phosphorylation in WT mice and cultured TAL cells transfected with THP, whereas in the absence of THP, NKCC2 phosphorylation upon deamino-cis-D-Arg vasopressin was blunted in both systems. Attenuated effects of furosemide along with functional and structural adaptation of the distal convoluted tubule in THP-/- mice supported the notion that NaCl reabsorption was impaired in TAL lacking THP. In summary, these results are compatible with a permissive role for THP in the modulation of NKCC2-dependent TAL salt reabsorptive function.	[Mutig, Kerim; Kahl, Thomas; Saritas, Turgay; Bachmann, Sebastian] Charite, Dept Anat, D-10115 Berlin, Germany; [Godes, Michael; Persson, Pontus] Charite, Dept Physiol, D-10115 Berlin, Germany; [Bates, James; Raffi, Hajamohideen; Kumar, Satish] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Rampoldi, Luca] Ist Sci San Raffaele, Dulbecco Telethon Inst, Mol Genet Renal Disorders Unit Dibit, I-20132 Milan, Italy; [Uchida, Shinichi] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo 1138519, Japan; [Hille, Carsten; Dosche, Carsten] Univ Potsdam, Dept Phys Chem, D-14476 Potsdam, Germany; [Castaneda-Bueno, Maria; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Inst Invest Biomed, Mexico City 14000, DF, Mexico; [Castaneda-Bueno, Maria; Gamba, Gerardo] Inst Nacl Cardiol Ignacio Chavez, Mexico City 14000, DF, Mexico	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Oklahoma System; University of Oklahoma Health Sciences Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Tokyo Medical & Dental University (TMDU); University of Potsdam; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Gamba, G (corresponding author), IIB INNSZ INCICH, Vasco Quiroga 15,Colonia Secc 16, Mexico City 14000, DF, Mexico.	gamba@biomedicas.unam.mx; sbachm@charite.de	Uchida, Shinichi/D-1111-2013; Mutig, Kerim/L-9010-2017; Rampoldi, Luca/L-3639-2018; Rampoldi, Luca/AAN-6228-2020; Turgay, Saritas/AAH-5127-2020; CASTANEDA-BUENO, MARIA/GYR-1202-2022; Gamba, Gerardo/P-4873-2016	Mutig, Kerim/0000-0001-9006-5112; Rampoldi, Luca/0000-0002-0544-7042; Rampoldi, Luca/0000-0002-0544-7042; Turgay, Saritas/0000-0002-6691-9218; Hille, Carsten/0000-0003-3454-8077; Gamba, Gerardo/0000-0002-4378-9043; Castaneda-Bueno, Maria/0000-0002-5801-3504; Persson, Pontus/0000-0003-0926-2878	Deutsche Forschungsgemeinschaft [FOR 667]; Leducq Foundation; Consejo Nacional de Ciencia y Tecnologia [59992]; Fondazione Telethon Funding Source: Custom	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leducq Foundation(Leducq Foundation); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondazione Telethon(Fondazione Telethon)	This work was supported by the Deutsche Forschungsgemeinschaft (FOR 667) and Leducq Foundation and Consejo Nacional de Ciencia y Tecnologia Grant 59992 (to G.G.).	Abdallah JG, 2001, J AM SOC NEPHROL, V12, P1335, DOI 10.1681/ASN.V1271335; Amlal H, 1996, AM J PHYSIOL-CELL PH, V271, pC455, DOI 10.1152/ajpcell.1996.271.2.C455; Bachmann S, 1999, ANAT EMBRYOL, V200, P447, DOI 10.1007/s004290050294; Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; BACHMANN S, 1985, HISTOCHEMISTRY, V83, P531, DOI 10.1007/BF00492456; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; Dahan K, 2003, J AM SOC NEPHROL, V14, P2883, DOI 10.1097/01.ASN.0000092147.83480.B5; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; ELLISON DH, 1989, J CLIN INVEST, V83, P113, DOI 10.1172/JCI113847; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; HEBERT SC, 1981, AM J PHYSIOL, V241, pF412, DOI 10.1152/ajprenal.1981.241.4.F412; Hille C, 2009, PHOTOCH PHOTOBIO SCI, V8, P319, DOI 10.1039/b813797h; KAISSLING B, 1985, AM J PHYSIOL, V248, pF374, DOI 10.1152/ajprenal.1985.248.3.F374; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Malagolini N, 1997, KIDNEY INT, V52, P1340, DOI 10.1038/ki.1997.459; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Mutig K, 2007, AM J PHYSIOL-RENAL, V293, pF1166, DOI 10.1152/ajprenal.00196.2007; Mutig K, 2010, AM J PHYSIOL-RENAL, V298, pF502, DOI 10.1152/ajprenal.00476.2009; Na KY, 2003, AM J PHYSIOL-RENAL, V284, pF133, DOI 10.1152/ajprenal.00227.2002; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Reinalter SC, 2004, ACTA PHYSIOL SCAND, V181, P513, DOI 10.1111/j.1365-201X.2004.01325.x; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Rinehart J, 2005, P NATL ACAD SCI USA, V102, P16777, DOI 10.1073/pnas.0508303102; Sachs AN, 2008, AM J PHYSIOL-RENAL, V295, pF1799, DOI 10.1152/ajprenal.90510.2008; Saemann MD, 2005, J CLIN INVEST, V115, P468, DOI 10.1172/JCI200522720; Sandberg MB, 2007, AM J PHYSIOL-RENAL, V293, pF662, DOI 10.1152/ajprenal.00064.2007; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; SCHLATTER E, 1985, PFLUG ARCH EUR J PHY, V405, P367, DOI 10.1007/BF00595690; Schnermann J, 1998, AM J PHYSIOL-REG I, V274, pR263, DOI 10.1152/ajpregu.1998.274.2.R263; SCHROTER J, 1993, KIDNEY INT, V44, P401, DOI 10.1038/ki.1993.258; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574	45	118	126	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30200	30210		10.1074/jbc.M111.222968	http://dx.doi.org/10.1074/jbc.M111.222968			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737451	Green Published, hybrid			2022-12-25	WOS:000294046600077
J	Rosano, GL; Bruch, EM; Ceccarelli, EA				Rosano, German L.; Bruch, Eduardo M.; Ceccarelli, Eduardo A.			Insights into the CLP/HSP100 Chaperone System from Chloroplasts of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CLP PROTEASE; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; IN-VIVO; PROTEINS; IMPORT; ATP; STRESS; TRANSLOCATION; DEGRADATION	HSP100 proteins are molecular chaperones involved in protein quality control. They assist in protein (un)folding, prevent aggregation, and are thought to participate in precursor translocation across membranes. Caseinolytic proteins ClpC and ClpD from plant chloroplasts belong to the HSP100 family. Their role has hitherto been investigated by means of physiological studies and reverse genetics. In the present work, we employed an in vitro approach to delve into the structural and functional characteristics of ClpC2 and ClpD from Arabidopsis thaliana (AtClpC2 and AtClpD). They were expressed in Escherichia coli and purified to near-homogeneity. The proteins were detected mainly as dimers in solution, and, upon addition of ATP, the formation of hexamers was observed. Both proteins exhibited basal ATPase activity (K-m, 1.42 mM, V-max, 0.62 nmol/(min x mu g) for AtClpC2 and K-m similar to 19.80 mM, V-max similar to 0.19 nmol/(min x mu g) for AtClpD). They were able to reactivate the activity of heat-denatured luciferase (similar to 40% for AtClpC2 and similar to 20% for AtClpD). The Clp proteins tightly bound a fusion protein containing a model transit peptide. This interaction was detected by binding assays, where the chaperones were selectively trapped by the transit peptide-containing fusion, immobilized on glutathione-agarose beads. Association of HSP100 proteins to import complexes with a bound transit peptide-containing fusion was also observed in intact chloroplasts. The presented data are useful to understand protein quality control and protein import into chloroplasts in plants.	[Rosano, German L.; Bruch, Eduardo M.; Ceccarelli, Eduardo A.] Univ Nacl Rosario, CONICET, Div Mol Biol, Inst Biol Mol & Celular Rosario IBR,Fac Ciencias, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Ceccarelli, EA (corresponding author), Suipacha 531,S2002LRK, Rosario, Argentina.	ceccarelli@ibr.gov.ar	Ceccarelli, Eduardo A./M-8699-2014; Rosano, Germán/I-6429-2019; Ceccarelli, Eduardo A./V-2600-2019	Ceccarelli, Eduardo A./0000-0001-5776-3306; Rosano, Germán/0000-0002-8313-6813; Ceccarelli, Eduardo A./0000-0001-5776-3306	CONICET; Agencia de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT)	This study was supported by grants from CONICET and Agencia de Promocion Cientifica y Tecnologica (ANPCyT, Argentina).	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Andersson FI, 2006, J BIOL CHEM, V281, P5468, DOI 10.1074/jbc.M509661200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Chou ML, 2006, J CELL BIOL, V175, P893, DOI 10.1083/jcb.200609172; Constan D, 2004, PLANT PHYSIOL, V136, P3605, DOI 10.1104/pp.104.052928; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; GOTTESMAN S, 1990, J BIOL CHEM, V265, P7886; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; HARPER S, 2008, CURR PROTOC PROTEIN; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayes SA, 1996, J CELL BIOL, V132, P255, DOI 10.1083/jcb.132.3.255; HEINEKE D, 1991, PLANT PHYSIOL, V95, P1131, DOI 10.1104/pp.95.4.1131; Jackson-Constan D, 2001, BBA-MOL CELL RES, V1541, P102, DOI 10.1016/S0167-4889(01)00148-3; Kar NP, 2008, FEBS J, V275, P6149, DOI 10.1111/j.1742-4658.2008.06738.x; Kovacheva S, 2005, PLANT J, V41, P412, DOI 10.1111/j.1365-313X.2004.02307.x; Kovacheva S, 2007, PLANT J, V50, P364, DOI 10.1111/j.1365-313X.2007.03060.x; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Kubis Sybille E., 2008, V425, P171, DOI 10.1007/978-1-60327-210-0_16; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Maglica Z, 2008, J MOL BIOL, V384, P503, DOI 10.1016/j.jmb.2008.09.046; Martin J, 1997, CURR OPIN STRUC BIOL, V7, P41, DOI 10.1016/S0959-440X(97)80006-1; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; OLSEN LJ, 1989, J BIOL CHEM, V264, P6724; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PLAXTON WC, 1989, EUR J BIOCHEM, V181, P443, DOI 10.1111/j.1432-1033.1989.tb14745.x; Rial DV, 2000, EUR J BIOCHEM, V267, P6239, DOI 10.1046/j.1432-1327.2000.01707.x; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; Rial DV, 2003, J BIOL CHEM, V278, P46473, DOI 10.1074/jbc.M306684200; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schirmer EC, 1998, J BIOL CHEM, V273, P15546, DOI 10.1074/jbc.273.25.15546; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7; Shi LX, 2010, PLANT CELL, V22, P205, DOI 10.1105/tpc.109.071464; Sjogren LLE, 2004, PLANT PHYSIOL, V136, P4114, DOI 10.1104/pp.104.053835; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Turgay K, 1997, GENE DEV, V11, P119, DOI 10.1101/gad.11.1.119; Weaver LM, 1999, PLANT PHYSIOL, V119, P1209, DOI 10.1104/pp.119.4.1209; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; WOO KM, 1992, J BIOL CHEM, V267, P20429; Zheng B, 2002, PHYSIOL PLANTARUM, V114, P92, DOI 10.1034/j.1399-3054.2002.1140113.x	54	39	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29671	29680		10.1074/jbc.M110.211946	http://dx.doi.org/10.1074/jbc.M110.211946			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737456	Green Published, hybrid			2022-12-25	WOS:000294046600026
J	Kumar, VP; West, AH; Cook, PF				Kumar, Vidya Prasanna; West, Ann H.; Cook, Paul F.			Kinetic and Chemical Mechanisms of Homocitrate Synthase from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FEEDBACK INHIBITION; CRYSTAL-STRUCTURE; LYSINE; ENZYME; CELLS; IONS	The homocitrate synthase from Thermus thermophilus (TtHCS) is a metal-activated enzyme with either Mg2+ or Mn2+ capable of serving as the divalent cation. The enzyme exhibits a sequential kinetic mechanism. The mechanism is steady state ordered with alpha-ketoglutarate (alpha-Kg) binding prior to acetyl-CoA (AcCoA) with Mn2+, whereas it is steady state random with Mg2+, suggesting a difference in the competence of the E.Mn.alpha-Kg.AcCoA and E.Mg.alpha-Kg.AcCoA complexes. The mechanism is supported by product and dead-end inhibition studies. The primary isotope effect obtained with deuterioacetylCoA (AcCoA-d(3)) in the presence of Mg2+ is unity (value 1.0) at low concentrations of AcCoA, whereas it is 2 at high concentrations of AcCoA. Data suggest the presence of a slow conformational change induced by binding of AcCoA that accompanies deprotonation of the methyl group of AcCoA. The solvent kinetic deuterium isotope effect is also unity at low AcCoA, but is 1.7 at high AcCoA, consistent with the proposed slow conformational change. The maximum rate is pH independent with either Mg2+ or Mn2+ as the divalent metal ion, whereas V/K alpha-Kg (with Mn2+) decreases at low and high pH giving pK values of about 6.5 and 8.0. Lysine is a competitive inhibitor that binds to the active site of TtHCS, and shares some of the same binding determinants as alpha-Kg. Lysine binding exhibits negative cooperativity, indicating cross-talk between the two monomers of the TtHCS dimer. Data are discussed in terms of the overall mechanism of TtHCS.	[Kumar, Vidya Prasanna; West, Ann H.; Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Cook, PF (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	pcook@ou.edu	Kumar, Vidya/ABH-9877-2020		Grayce B. Kerr endowment	Grayce B. Kerr endowment	This work was supported by a grant from the Grayce B. Kerr endowment to the University of Oklahoma (to P. F. C.).	Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Andi B, 2004, BIOCHEMISTRY-US, V43, P11790, DOI 10.1021/bi048766p; Andi B, 2004, ARCH BIOCHEM BIOPHYS, V421, P243, DOI 10.1016/j.abb.2003.11.005; BAZELYANSKY M, 1986, BIOCHEMISTRY-US, V25, P125, DOI 10.1021/bi00349a019; Bulfer SL, 2010, J BIOL CHEM, V285, P10446, DOI 10.1074/jbc.M109.094383; Bulfer SL, 2009, J BIOL CHEM, V284, P35769, DOI 10.1074/jbc.M109.046821; Cleland W W, 1979, Methods Enzymol, V63, P103; Cook P. F., 2007, ENZYME KINETICS MECH, P121; Feller A, 1997, YEAST, V13, P1337, DOI 10.1002/(SICI)1097-0061(199711)13:14<1337::AID-YEA186>3.0.CO;2-O; Giuseppin MLF, 2000, METAB ENG, V2, P14, DOI 10.1006/mben.1999.0134; GRAY GS, 1976, CAN J MICROBIOL, V22, P1664, DOI 10.1139/m76-246; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hans MA, 2001, APPL MICROBIOL BIOT, V56, P776, DOI 10.1007/s002530100708; HURWITZ C, 1967, J BIOL CHEM, V242, P3719; Jiang YM, 2007, NEUROTOXICOLOGY, V28, P126, DOI 10.1016/j.neuro.2006.08.005; KARSTEN WE, 1995, J AM CHEM SOC, V117, P5914, DOI 10.1021/ja00127a002; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Lin Y, 2008, BIOCHEMISTRY-US, V47, P10809, DOI 10.1021/bi801370h; Okada T, 2010, J BIOL CHEM, V285, P4195, DOI 10.1074/jbc.M109.086330; QIAN J, 2008, THESIS U OKLAHOMA; Qian JH, 2008, BIOCHEMISTRY-US, V47, P6851, DOI 10.1021/bi800087k; Qian JH, 2006, BIOCHEMISTRY-US, V45, P12136, DOI 10.1021/bi060889h; QUINN DM, 1991, ENZYME MECH ISOTOPE, P73; Schobel F, 2010, EUKARYOT CELL, V9, P878, DOI 10.1128/EC.00020-10; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; TERSCHURE EG, 1995, J BACTERIOL, V177, P6672, DOI 10.1128/jb.177.22.6672-6675.1995; THOLEY G, 1988, NEUROCHEM RES, V13, P45, DOI 10.1007/BF00971853; TUCCI AF, 1972, ARCH BIOCHEM BIOPHYS, V153, P742, DOI 10.1016/0003-9861(72)90393-1; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6	29	5	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29428	29439		10.1074/jbc.M111.246355	http://dx.doi.org/10.1074/jbc.M111.246355			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21733842	Green Published, hybrid			2022-12-25	WOS:000293837000077
J	Ismail, F; Ikram, M; Purdie, K; Harwood, C; Leigh, I; Storey, A				Ismail, Ferina; Ikram, Mohamed; Purdie, Karin; Harwood, Catherine; Leigh, Irene; Storey, Alan			Cutaneous Squamous Cell Carcinoma (SCC) and the DNA Damage Response: pATM Expression Patterns in Pre-Malignant and Malignant Keratinocyte Skin Lesions	PLOS ONE			English	Article							GENE-PRODUCT; ATM; PROTEIN; LOCALIZATION; TUMOR	Recent evidence suggests that an initial barrier to the emergence of tumours is a DNA damage response that evokes a counter-response which arrests the growth of, or eliminates, damaged cells. Early precursor lesions express markers of an activated DNA damage response in several types of tumour, with a diminishing response in more advanced cancers. An important marker of DNA damage is ATM which becomes phosphorylated (pATM) upon activation. We have investigated pATM expression patterns in cultured keratinocytes, skin explants and a spectrum of pre-malignant to malignant keratinocyte skin lesions by immunohistochemistry. We found that pATM was mainly localised to the Golgi apparatus, which contrasts with its nuclear localisation in other tissues. Upon UV irradiation there is transient formation of pATM in nuclear foci, consistent with recruitment to the sites of DNA damage. By immunohistochemistry we show pATM expression in precancerous keratinocyte lesions is greater and predominantly nuclear when compared to the invasive lesions where pATM is weaker and predominantly cytoplasmic. Our results are consistent with the hypothesis that the DNA damage response acts as a barrier to cutaneous tumour formation, but also suggests that ATM expression in skin is different compared to other tissues. This may be a consequence of the constant exposure of skin to UVR, and has implications for skin carcinogenesis.	[Ismail, Ferina; Purdie, Karin; Harwood, Catherine] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Cutaneous Res, London, England; [Ikram, Mohamed] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Canc, London, England; [Leigh, Irene] Univ Dundee, Coll Med Dent & Nursing, Dundee, Scotland; [Storey, Alan] Univ Oxford, John Radcliffe Hosp, Dept Mol Oncol, Oxford OX3 9DU, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of Dundee; University of Oxford	Ismail, F (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Ctr Cutaneous Res, London, England.	f.ismail@qmul.ac.uk		Harwood, Catherine/0000-0002-1375-0965; Storey, Alan/0000-0003-2001-9772	Medical Research Council; MRC [G84/6471] Funding Source: UKRI; Cancer Research UK [13044] Funding Source: researchfish; Medical Research Council [G84/6471] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	FI was supported by funding from the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 2000, P NATL ACAD SCI USA, V97, P871, DOI 10.1073/pnas.97.2.871; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Brown KD, 1997, P NATL ACAD SCI USA, V94, P1840, DOI 10.1073/pnas.94.5.1840; CLEAVER JE, 1975, ANNU REV GENET, V9, P19, DOI 10.1146/annurev.ge.09.120175.000315; Dahle Jostein, 2005, J Carcinog, V4, P11, DOI 10.1186/1477-3163-4-11; Durham SE, 2003, BRIT J CANCER, V88, P90, DOI 10.1038/sj.bjc.6600773; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guzman E, 2003, APOPTOSIS, V8, P315, DOI 10.1023/A:1024112231953; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jans J, 2006, MOL CELL BIOL, V26, P8515, DOI 10.1128/MCB.00807-06; Lakin ND, 1996, ONCOGENE, V13, P2707; Lim DS, 1998, P NATL ACAD SCI USA, V95, P10146, DOI 10.1073/pnas.95.17.10146; MARKS R, 1986, BRIT J DERMATOL, V115, P649, DOI 10.1111/j.1365-2133.1986.tb06644.x; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Norbury CJ, 2001, ANNU REV PHARMACOL, V41, P367, DOI 10.1146/annurev.pharmtox.41.1.367; Oka A, 1998, NEUROSCI LETT, V252, P195, DOI 10.1016/S0304-3940(98)00576-X; Popp S, 2000, J INVEST DERMATOL, V115, P1095, DOI 10.1046/j.1523-1747.2000.00173.x; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P18, DOI 10.1111/j.1365-2133.2007.08267.x; Rowert-Huber J, 2007, BRIT J DERMATOL, V156, P8, DOI 10.1111/j.1365-2133.2007.07860.x; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; Sander CS, 2003, BRIT J DERMATOL, V148, P913, DOI 10.1046/j.1365-2133.2003.05303.x; Watters D, 1999, J BIOL CHEM, V274, P34277, DOI 10.1074/jbc.274.48.34277; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Yang DQ, 2000, NAT CELL BIOL, V2, P893, DOI 10.1038/35046542; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21271	10.1371/journal.pone.0021271	http://dx.doi.org/10.1371/journal.pone.0021271			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747934	Green Published, gold, Green Submitted			2022-12-25	WOS:000292293400009
J	Akachi, Y; Atun, R				Akachi, Yoko; Atun, Rifat			Effect of Investment in Malaria Control on Child Mortality in Sub-Saharan Africa in 2002-2008	PLOS ONE			English	Article							INTERVENTIONS; GOAL	Background: Around 8.8 million children under-five die each year, mostly due to infectious diseases, including malaria that accounts for 16% of deaths in Africa, but the impact of international financing of malaria control on under-five mortality in sub-Saharan Africa has not been examined. Methods and Findings: We combined multiple data sources and used panel data regression analysis to study the relationship among investment, service delivery/intervention coverage, and impact on child health by observing changes in 34 sub-Saharan African countries over 2002-2008. We used Lives Saved Tool to estimate the number of lives saved from coverage increase of insecticide-treated nets (ITNs)/indoor residual spraying (IRS). As an indicator of outcome, we also used under-five mortality rate. Global Fund investments comprised more than 70% of the Official Development Assistance (ODA) for malaria control in 34 countries. Each $1 million ODA for malaria enabled distribution of 50,478 ITNs [95%CI: 37,774-63,182] in the disbursement year. 1,000 additional ITNs distributed saved 0.625 lives [95%CI: 0.369-0.881]. Cumulatively Global Fund investments that increased ITN/IRS coverage in 2002-2008 prevented an estimated 240,000 deaths. Countries with higher malaria burden received less ODA disbursement per person-at-risk compared to lower-burden countries ($3.90 vs. $7.05). Increased ITN/IRS coverage in high-burden countries led to 3,575 lives saved per 1 million children, as compared with 914 lives in lower-burden countries. Impact of ITN/IRS coverage on under-five mortality was significant among major child health interventions such as immunisation showing that 10% increase in households with ITN/IRS would reduce 1.5 [95%CI: 0.3-2.8] child deaths per 1000 live births. Conclusions: Along with other key child survival interventions, increased ITNs/IRS coverage has significantly contributed to child mortality reduction since 2002. ITN/IRS scale-up can be more efficiently prioritized to countries where malaria is a major cause of child deaths to save greater number of lives with available resources.	[Akachi, Yoko; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England	Imperial College London	Akachi, Y (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	r.atun@imperial.ac.uk	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				Baum C.F., 2006, INTRO MODERN ECONOME; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Drukker DM, 2003, STATA J, V3, P168, DOI 10.1177/1536867X0300300206; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Friberg IK, 2010, INT J EPIDEMIOL, V39, P11, DOI 10.1093/ije/dyq017; *GLOB FUND, GLOB FUND 2010 INN I; Greene W., 2003, ECONOMETRIC ANAL; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; Hedeker D., 2006, LONGITUDINAL DATA AN; Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109; LENGELER C, 2010, COCHRANE DB SYST REV, V2; Mujkic Z., 2009, SPECTRUM, V3-4, P135; *OECD, OECD US GUID CRS AID; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; *ROLL BACK MAL, 2010, PROGR IMP SER, V1; Snow RW, 2010, LANCET, V376, P1409, DOI 10.1016/S0140-6736(10)61340-2; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; *WHO, WORLD MAL REP 2009; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; World Health Organization, 2004, GLOB BURD DIS 2004 U; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9; LIST MANUAL LIVES SA	30	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21309	10.1371/journal.pone.0021309	http://dx.doi.org/10.1371/journal.pone.0021309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738633	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800011
J	Aspinall, R; Prentice, AM; Ngom, PT				Aspinall, Richard; Prentice, Andrew M.; Ngom, Pa Tamba			Interleukin 7 from Maternal Milk Crosses the Intestinal Barrier and Modulates T-Cell Development in Offspring	PLOS ONE			English	Article							BREAST-FED INFANTS; THYMUS SIZE; PNEUMOCOCCAL VACCINE; IL-7; MORTALITY; WOMEN; BIRTH; IMMUNIZATION; LYMPHOCYTES; EXPRESSION	Background: Breastfeeding protects against illnesses and death in hazardous environments, an effect partly mediated by improved immune function. One hypothesis suggests that factors within milk supplement the inadequate immune response of the offspring, but this has not been able to account for a series of observations showing that factors within maternally derived milk may supplement the development of the immune system through a direct effect on the primary lymphoid organs. In a previous human study we reported evidence suggesting a link between IL-7 in breast milk and the thymic output of infants. Here we report evidence in mice of direct action of maternally-derived IL-7 on T cell development in the offspring. Methods and Findings: We have used recombinant IL-7 labelled with a fluorescent dye to trace the movement in live mice of IL-7 from the stomach across the gut and into the lymphoid tissues. To validate the functional ability of maternally derived IL-7 we cross fostered IL-7 knock-out mice onto normal wild type mothers. Subsets of thymocytes and populations of peripheral T cells were significantly higher than those found in knock-out mice receiving milk from IL-7 knock-out mothers. Conclusions/Significance: Our study provides direct evidence that interleukin 7, a factor which is critical in the development of T lymphocytes, when maternally derived can transfer across the intestine of the offspring, increase T cell production in the thymus and support the survival of T cells in the peripheral secondary lymphoid tissue.	[Aspinall, Richard; Ngom, Pa Tamba] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England; [Prentice, Andrew M.; Ngom, Pa Tamba] MRC Labs, Nutr Programme, Serrekunda, Gambia; [Prentice, Andrew M.] London Sch Hyg & Trop Med, Med Res Council Int Nutr Grp, London WC1, England; [Aspinall, Richard] Cranfield Univ, Cranfield MK43 0AL, Beds, England	Imperial College London; MRC Laboratory Molecular Biology; University of London; London School of Hygiene & Tropical Medicine; Cranfield University	Aspinall, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, London, England.	r.aspinall@cranfield.ac.uk	Aspinall, Richard/E-4924-2013; Prentice, Andrew/AAG-1961-2019	Aspinall, Richard/0000-0002-1648-1887	Medical Research Council International Nutrition Group; Islamic Development Bank; Westminster Medical School Research Trust	Medical Research Council International Nutrition Group; Islamic Development Bank(Islamic Development Bank); Westminster Medical School Research Trust	This work was supported by the Medical Research Council International Nutrition Group, the Islamic Development Bank and the Westminster Medical School Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2002, ACTA PAEDIATR, V91, P698, DOI 10.1080/080352502760069142; Andrew D, 2001, J IMMUNOL, V166, P1524, DOI 10.4049/jimmunol.166.3.1524; Aspinall R, 2001, CELL IMMUNOL, V212, P150, DOI 10.1006/cimm.2001.1848; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Bains I, 2009, BLOOD, V113, P5480, DOI 10.1182/blood-2008-10-184184; BEISEL WR, 1992, J NUTR, V122, P591, DOI 10.1093/jn/122.suppl_3.591; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brandtzaeg P, 2003, VACCINE, V21, P3382, DOI 10.1016/S0264-410X(03)00338-4; Collinson AC, 2003, ACTA PAEDIATR, V92, P1014, DOI 10.1080/08035250310004379; Danneman PJ, 1997, LAB ANIM SCI, V47, P386; DEREN JS, 1971, AM J CLIN NUTR, V24, P144; Deubzer HE, 2004, J INFECT DIS, V190, P1758, DOI 10.1086/424597; El Kassar N, 2004, BLOOD, V104, P1419, DOI 10.1182/blood-2004-01-0201; Finn A, 2002, J INFECT DIS, V186, P1422, DOI 10.1086/344356; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Garly ML, 2008, J PEDIATR-US, V153, P683, DOI 10.1016/j.jpeds.2008.04.069; Hasselbalch H, 1996, ACTA PAEDIATR, V85, P1029, DOI 10.1111/j.1651-2227.1996.tb14211.x; Hasselbalch H, 1999, EUR J PEDIATR, V158, P964, DOI 10.1007/s004310051258; JEFFRY UV, 1995, J EXP MED, V181, P1519; Jeppesen DL, 2004, PEDIATR ALLERGY IMMU, V15, P127, DOI 10.1111/j.1399-3038.2004.00032.x; Kim K, 1998, J IMMUNOL, V160, P5735; KOLDOVSKY O, 1989, J NUTR, V119, P1543, DOI 10.1093/jn/119.11.1543; Lawrence Robert M, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P7, DOI 10.1016/j.cppeds.2006.10.002; Lima K, 2010, CLIN EXP IMMUNOL, V161, P98, DOI 10.1111/j.1365-2249.2010.04152.x; LOSONSKY GA, 1982, J INFECT DIS, V145, P654, DOI 10.1093/infdis/145.2.654; MASCARTLEMONE F, 1988, SCAND J IMMUNOL, V28, P443, DOI 10.1111/j.1365-3083.1988.tb01474.x; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Moore SE, 1997, NATURE, V388, P434, DOI 10.1038/41245; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; MOSINGER B, 1959, NATURE, V184, P1245, DOI 10.1038/1841245a0; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; Ngom PT, 2004, AM J CLIN NUTR, V80, P722; Obaro SK, 2004, PEDIATR INFECT DIS J, V23, P1023, DOI 10.1097/01.inf.0000143651.54880.09; Prentice AM, 2000, ACTA PAEDIATR, V89, P8, DOI 10.1080/080352500750028979; SHAHID NS, 1995, LANCET, V346, P1252, DOI 10.1016/S0140-6736(95)91861-2; Takahata Y, 2001, PEDIATR RES, V50, P268, DOI 10.1203/00006450-200108000-00017; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; Walter J, 2007, JAIDS-J ACQ IMM DEF, V46, P200, DOI 10.1097/QAI.0b013e318141f942; Wilks AB, 2010, J IMMUNOL, V185, P7097, DOI 10.4049/jimmunol.1002751; World Health Organization (WHO), 2001, GLOB STRAT INF YOUNG; Wu L, 2006, CURR OPIN IMMUNOL, V18, P121, DOI 10.1016/j.coi.2006.01.006; WU L, 1991, NATURE, V349, P71, DOI 10.1038/349071a0; Yuan X, 1998, AM J PHYSIOL-GASTR L, V274, pG342, DOI 10.1152/ajpgi.1998.274.2.G342	44	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20812	10.1371/journal.pone.0020812	http://dx.doi.org/10.1371/journal.pone.0020812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738587	Green Published, gold, Green Accepted			2022-12-25	WOS:000292291800004
J	Hornblad, A; Eriksson, AU; Sock, E; Hill, RE; Ahlgren, U				Hornblad, Andreas; Eriksson, Anna U.; Sock, Elisabeth; Hill, Robert E.; Ahlgren, Ulf			Impaired Spleen Formation Perturbs Morphogenesis of the Gastric Lobe of the Pancreas	PLOS ONE			English	Article							GENE; ORGANOGENESIS; MOUSE; MICE; SPECIFICATION; MESENCHYME; DYNAMICS; NETWORK; SIGNALS; LIVER	Despite the extensive use of the mouse as a model for studies of pancreas development and disease, the development of the gastric pancreatic lobe has been largely overlooked. In this study we use optical projection tomography to provide a detailed three-dimensional and quantitative description of pancreatic growth dynamics in the mouse. Hereby, we describe the epithelial and mesenchymal events leading to the formation of the gastric lobe of the pancreas. We show that this structure forms by perpendicular growth from the dorsal pancreatic epithelium into a distinct lateral domain of the dorsal pancreatic mesenchyme. Our data support a role for spleen organogenesis in the establishment of this mesenchymal domain and in mice displaying perturbed spleen development, including Dh +/-, Bapx1-/- and Sox11-/-, gastric lobe development is disturbed. We further show that the expression profile of markers for multipotent progenitors is delayed in the gastric lobe as compared to the splenic and duodenal pancreatic lobes. Altogether, this study provides new information regarding the developmental dynamics underlying the formation of the gastric lobe of the pancreas and recognizes lobular heterogeneities regarding the time course of pancreatic cellular differentiation. Collectively, these data are likely to constitute important elements in future interpretations of the developing and/or diseased pancreas.	[Hornblad, Andreas; Eriksson, Anna U.; Ahlgren, Ulf] Umea Univ, Umea Ctr Mol Med, Umea, Sweden; [Sock, Elisabeth] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Zentrum, Erlangen, Germany; [Hill, Robert E.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Umea University; University of Erlangen Nuremberg; University of Edinburgh	Hornblad, A (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	Ulf.Ahlgren@ucmm.umu.se		Sock, Elisabeth/0000-0001-9925-3136; Hornblad, Andreas/0000-0003-1283-0784; Ahlgren, Ulf/0000-0001-5923-8572	Medical Research Council; Deutsche Forschungsgemeinschaft [So251/3-1]; Swedish Research Council; Kempe Foundations; Umea University; MRC [MC_U127584494, MC_PC_U127584494] Funding Source: UKRI; Medical Research Council [MC_U127584494, MC_PC_U127584494] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundations; Umea University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council core grant to REH, the Deutsche Forschungsgemeinschaft (So251/3-1) to ES, the Swedish Research Council, the Kempe Foundations and Umea University to UA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Asayesh A, 2006, GENE DEV, V20, P2208, DOI 10.1101/gad.381906; Bock P, 1997, MICROSC RES TECHNIQ, V37, P374; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Burn SF, 2008, DEV BIOL, V318, P303, DOI 10.1016/j.ydbio.2008.03.031; DEAR TN, 1995, DEVELOPMENT, V121, P2909; Deutsch G, 2001, DEVELOPMENT, V128, P871; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; GREEN MC, 1967, DEV BIOL, V15, P62, DOI 10.1016/0012-1606(67)90006-1; Hagai Hideo, 2003, J Hepatobiliary Pancreat Surg, V10, P48; Hecksher-Sorensen J, 2004, DEVELOPMENT, V131, P4665, DOI 10.1242/dev.01364; Herzer U, 1999, CURR BIOL, V9, P837, DOI 10.1016/S0960-9822(99)80369-8; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Kim BM, 2007, DEVELOPMENT, V134, P3603, DOI 10.1242/dev.009308; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Lu JR, 2000, P NATL ACAD SCI USA, V97, P9525, DOI 10.1073/pnas.97.17.9525; Pabst O, 1999, DEVELOPMENT, V126, P2215; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; ROBERTS CWM, 1994, NATURE, V368, P747, DOI 10.1038/368747a0; SAND FW, 2011, DEV BIOL; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Villasenor A, 2010, DEVELOPMENT, V137, P4295, DOI 10.1242/dev.052993; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; WESSELLS NK, 1967, DEV BIOL, V15, P237, DOI 10.1016/0012-1606(67)90042-5; Yoshitomi H, 2004, DEVELOPMENT, V131, P807, DOI 10.1242/dev.00960; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	35	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21753	10.1371/journal.pone.0021753	http://dx.doi.org/10.1371/journal.pone.0021753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738788	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800040
J	Kammerer, R; Buchner, A; Palluch, P; Pongratz, T; Oboukhovskij, K; Beyer, W; Johansson, A; Stepp, H; Baumgartner, R; Zimmermann, W				Kammerer, Robert; Buchner, Alexander; Palluch, Patrick; Pongratz, Thomas; Oboukhovskij, Konstantin; Beyer, Wolfgang; Johansson, Ann; Stepp, Herbert; Baumgartner, Reinhold; Zimmermann, Wolfgang			Induction of Immune Mediators in Glioma and Prostate Cancer Cells by Non-Lethal Photodynamic Therapy	PLOS ONE			English	Article							INDUCED PROTOPORPHYRIN-IX; NF-KAPPA-B; ANTITUMOR IMMUNITY; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMA; CARCINOMA-CELLS; STRESS-RESPONSE; EXPRESSION; ACTIVATION; DEATH	Background: Photodynamic therapy (PDT) uses the combination of photosensitizing drugs and harmless light to cause selective damage to tumor cells. PDT is therefore an option for focal therapy of localized disease or for otherwise unresectable tumors. In addition, there is increasing evidence that PDT can induce systemic anti-tumor immunity, supporting control of tumor cells, which were not eliminated by the primary treatment. However, the effect of non-lethal PDT on the behavior and malignant potential of tumor cells surviving PDT is molecularly not well defined. Methodology/Principal Findings: Here we have evaluated changes in the transcriptome of human glioblastoma (U87, U373) and human (PC-3, DU145) and murine prostate cancer cells (TRAMP-C1, TRAMP-C2) after non-lethal PDT in vitro and in vivo using oligonucleotide microarray analyses. We found that the overall response was similar between the different cell lines and photosensitizers both in vitro and in vivo. The most prominently upregulated genes encoded proteins that belong to pathways activated by cellular stress or are involved in cell cycle arrest. This response was similar to the rescue response of tumor cells following high-dose PDT. In contrast, tumor cells dealing with non-lethal PDT were found to significantly upregulate a number of immune genes, which included the chemokine genes CXCL2, CXCL3 and IL8/CXCL8 as well as the genes for IL6 and its receptor IL6R, which can stimulate proinflammatory reactions, while IL6 and IL6R can also enhance tumor growth. Conclusions: Our results indicate that PDT can support anti-tumor immune responses and is, therefore, a rational therapy even if tumor cells cannot be completely eliminated by primary phototoxic mechanisms alone. However, non-lethal PDT can also stimulate tumor growth-promoting autocrine loops, as seen by the upregulation of IL6 and its receptor. Thus the efficacy of PDT to treat tumors may be improved by controlling unwanted and potentially deleterious growth-stimulatory pathways.	[Kammerer, Robert] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany; [Buchner, Alexander] Univ Hosp Munich, Dept Urol, Munich, Germany; [Buchner, Alexander; Palluch, Patrick; Oboukhovskij, Konstantin; Zimmermann, Wolfgang] Univ Hosp Munich, Tumor Immunol Lab, LIFE Ctr, Munich, Germany; [Pongratz, Thomas; Beyer, Wolfgang; Johansson, Ann; Stepp, Herbert; Baumgartner, Reinhold] Univ Hosp Munich, Laser Res Lab, LIFE Ctr, Munich, Germany	Friedrich Loeffler Institute; University of Munich; University of Munich; University of Munich	Kammerer, R (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany.	wolfgang.zimmermann@med.uni-muenchen.de	Zimmermann, Wolfgang/L-9277-2013; Stepp, Herbert/E-1990-2013; Kammerer, Robert/AAQ-1338-2021	Kammerer, Robert/0000-0003-3038-8205; Buchner, Alexander/0000-0001-7895-7070	Deutsche Krebshilfe [107320]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by a grant from the Deutsche Krebshilfe (107320; http://www.krebshilfe.de/deutsche-krebshilfe.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HU, 2009, SURG ONCOL, V18, P219, DOI 10.1016/j.suronc.2009.02.002; Beck TJ, 2007, LASER SURG MED, V39, P386, DOI 10.1002/lsm.20507; Bento C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-89; Buytaert E, 2008, ONCOGENE, V27, P1916, DOI 10.1038/sj.onc.1210825; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Cecic I, 2006, INT IMMUNOPHARMACOL, V6, P1259, DOI 10.1016/j.intimp.2006.03.008; Cekaite L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-273; Chun JY, 2009, CLIN CANCER RES, V15, P4815, DOI 10.1158/1078-0432.CCR-09-0640; COHEN S, 1990, BIOCHEM J, V270, P325, DOI 10.1042/bj2700325; Decarvalho AC, 2007, GLIA, V55, P1053, DOI 10.1002/glia.20525; DESUZINGESMANDO.E, 2010, J BIOL CHEM; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Duan ZF, 2009, CANCER CHEMOTH PHARM, V63, P681, DOI 10.1007/s00280-008-0785-8; Eleouet S, 2000, NEUROL RES, V22, P361, DOI 10.1080/01616412.2000.11740685; Eljamel MS, 2008, LASER MED SCI, V23, P361, DOI 10.1007/s10103-007-0494-2; Eljamel S, 2010, PHOTODIAGN PHOTODYN, V7, P76, DOI 10.1016/j.pdpdt.2010.02.002; Foster BA, 1997, CANCER RES, V57, P3325; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Garg AD, 2010, APOPTOSIS, V15, P1050, DOI 10.1007/s10495-010-0479-7; Gingrich JR, 1996, CANCER RES, V56, P4096; Gollnick SO, 2010, IMMUNOL RES, V46, P216, DOI 10.1007/s12026-009-8119-4; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson A, 2010, PHOTOCHEM PHOTOBIOL, V86, P1373, DOI 10.1111/j.1751-1097.2010.00799.x; Joo JH, 2007, CANCER RES, V67, P7929, DOI 10.1158/0008-5472.CAN-07-0931; Kabingu E, 2009, CLIN CANCER RES, V15, P4460, DOI 10.1158/1078-0432.CCR-09-0400; KAMMERER R, 2009, MED LASER APPL, V24, P237; KICK G, 1995, CANCER RES, V55, P2373; Kousis PC, 2007, CANCER RES, V67, P10501, DOI 10.1158/0008-5472.CAN-07-1778; Lee SY, 2010, BRIT J CANCER, V103, P362, DOI 10.1038/sj.bjc.6605797; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lindner U, 2010, NAT REV UROL, V7, P562, DOI 10.1038/nrurol.2010.142; Liu B, 2009, CANCER SCI, V100, P2126, DOI 10.1111/j.1349-7006.2009.01290.x; Matroule JY, 2006, PHOTOCHEM PHOTOBIOL, V82, P1241, DOI 10.1562/2006-03-30-IR-862; Moore CM, 2009, NAT CLIN PRACT UROL, V6, P18, DOI 10.1038/ncpuro1274; Naderi A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-111; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Nowis D, 2005, ACTA BIOCHIM POL, V52, P339; Nozaki I, 2005, LAB INVEST, V85, P109, DOI 10.1038/labinvest.3700213; Prasmickaite L, 2006, FEBS LETT, V580, P5739, DOI 10.1016/j.febslet.2006.09.028; Sanovic R, 2009, INT J ONCOL, V35, P921, DOI 10.3892/ijo_00000407; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; Stummer W, 2008, J NEURO-ONCOL, V87, P103, DOI 10.1007/s11060-007-9497-x; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Susanto J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004023; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Verwanger T, 2002, INT J ONCOL, V21, P1353; Wild PJ, 2005, MOL CANCER THER, V4, P516, DOI 10.1158/1535-7163.MCT-04-0141; Yang H, 2010, CARCINOGENESIS, V31, P703, DOI 10.1093/carcin/bgq008; Zheng XG, 2008, CANCER LETT, V265, P177, DOI 10.1016/j.canlet.2008.02.023	55	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21834	10.1371/journal.pone.0021834	http://dx.doi.org/10.1371/journal.pone.0021834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738796	Green Published, gold			2022-12-25	WOS:000292291800047
J	Caswell, H				Caswell, Hal			Beyond R-0: Demographic Models for Variability of Lifetime Reproductive Output	PLOS ONE			English	Article							DYNAMIC HETEROGENEITY; POPULATION; HISTORY; VARIANCE; GROWTH; RATIO; FIRE; SIZE; SKEW	The net reproductive rate R-0 measures the expected lifetime reproductive output of an individual, and plays an important role in demography, ecology, evolution, and epidemiology. Well-established methods exist to calculate it from age- or stage-classified demographic data. As an expectation, R-0 provides no information on variability; empirical measurements of lifetime reproduction universally show high levels of variability, and often positive skewness among individuals. This is often interpreted as evidence of heterogeneity, and thus of an opportunity for natural selection. However, variability provides evidence of heterogeneity only if it exceeds the level of variability to be expected in a cohort of identical individuals all experiencing the same vital rates. Such comparisons require a way to calculate the statistics of lifetime reproduction from demographic data. Here, a new approach is presented, using the theory of Markov chains with rewards, obtaining all the moments of the distribution of lifetime reproduction. The approach applies to age- or stage-classified models, to constant, periodic, or stochastic environments, and to any kind of reproductive schedule. As examples, I analyze data from six empirical studies, of a variety of animal and plant taxa (nematodes, polychaetes, humans, and several species of perennial plants).	[Caswell, Hal] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Caswell, Hal] Max Planck Inst Demog Res, Rostock, Germany	Woods Hole Oceanographic Institution; Max Planck Society	Caswell, H (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	hcaswell@whoi.edu		Caswell, Hal/0000-0003-4394-6894	National Science Foundation [DEB-0816514]; Alexander von Humboldt Foundation; Division Of Environmental Biology [0816514] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by National Science Foundation Grant DEB-0816514 and by a Research Award from the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BARROWCLOUGH GF, 1993, AM NAT, V141, P281, DOI 10.1086/285473; Benito F., 1982, TRABAJOS ESTADISTICA, V33, P73, DOI DOI 10.1007/BF02888435; BRIDGES TS, 1994, J EXP MAR BIOL ECOL, V177, P99, DOI 10.1016/0022-0981(94)90146-5; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Caswell H., 2004, Animal Biodiversity and Conservation, V27, P471; Caswell H, 2001, ADV ECOL RES, V32, P1, DOI 10.1016/S0065-2504(01)32010-X; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell H., 2006, MAM2006, P319; Caswell H, 2009, OIKOS, V118, P1763, DOI 10.1111/j.1600-0706.2009.17620.x; Chen JJ, 2007, J GERONTOL A-BIOL, V62, P126, DOI 10.1093/gerona/62.2.126; Clutton-Brock T. H., 1988, REPROD SUCCESS; Clutton-Brock TH, 1998, TRENDS ECOL EVOL, V13, P288, DOI 10.1016/S0169-5347(98)01402-5; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; CROW JF, 1958, AM ANTHROPOL, V60, P1; CROXALL JP, 1990, J ANIM ECOL, V59, P775, DOI 10.2307/4895; Cushing JM, 2012, J BIOL DYNAM, V6, P166, DOI 10.1080/17513758.2010.544410; Cushing J.M., 1994, Natural Resource Modeling, V8, P297; De-Camino-Beck T, 2007, B MATH BIOL, V69, P1341, DOI 10.1007/s11538-006-9162-0; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Engen S, 2005, GENETICS, V170, P941, DOI 10.1534/genetics.104.028233; FEICHTINGER G, 1971, LECT NOTES OPERATION; Frigui I, 1999, TELECOMMUN SYST, V12, P51, DOI 10.1023/A:1019182325899; Fujiwara M, 2002, ECOLOGY, V83, P3257, DOI 10.2307/3072076; Gems David, 2002, P413; Grafen A., 1988, REPROD SUCCESS, P454, DOI DOI 10.1098/RSTB.2007.0011; Haydock J, 2002, P NATL ACAD SCI USA, V99, P7178, DOI 10.1073/pnas.102624199; Heesterbeek JAP, 2002, ACTA BIOTHEOR, V50, P189, DOI 10.1023/A:1016599411804; Henderson H. V., 1981, LINEAR MULTILINEAR A, V9, P271, DOI DOI 10.1080/03081088108817379; Horvitz CC, 2008, AM NAT, V172, P203, DOI 10.1086/589453; Howard R. A., 1960, DYNAMIC PROGRAMMING; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Hunter CM, 2005, ECOL MODEL, V188, P15, DOI 10.1016/j.ecolmodel.2005.05.002; Hunter CM, 2005, J ANIM ECOL, V74, P589, DOI 10.1111/j.1365-2656.2005.00929.x; IOSIFESCU M., 1980, FINITE MARKOV PROCES; Jenouvrier S, 2010, AM NAT, V175, P739, DOI 10.1086/652436; Kaye TN, 2003, ECOLOGY, V84, P1464, DOI 10.1890/0012-9658(2003)084[1464:TEOSTO]2.0.CO;2; Kaye TN, 2001, ECOL APPL, V11, P1366, DOI 10.1890/1051-0761(2001)011[1366:TEOFOT]2.0.CO;2; Kendall M. G., 1963, ADV THEORY STAT, VI; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Knight TM, 2009, FOREST ECOL MANAG, V257, P1095, DOI 10.1016/j.foreco.2008.11.018; Knight TM, 2004, ECOL APPL, V14, P915, DOI 10.1890/03-5048; Kozlowski J, 1999, OIKOS, V86, P185, DOI 10.2307/3546437; Lawler RR, 2009, OECOLOGIA, V161, P491, DOI 10.1007/s00442-009-1382-1; Levin L, 1996, ECOL APPL, V6, P1295, DOI 10.2307/2269608; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; *M PLANCK I DEM RE, 2010, HUM FERT DAT; Mangel M., 1988, DYNAMIC MODELING BEH; Metz J., 1986, LECT NOTES BIOMATHEM, DOI DOI 10.1007/978-3-662-13159-6; Newton I, 1989, LIFETIME REPROD BIRD; OCHRAN ME, 1992, ECOL MONOGR, V62, P345; PARAMONOV Y, 2010, P 10 INT C REL STAT, P104; Partridge L., 1989, P421; Pendergrass KL, 1999, ECOL APPL, V9, P1420, DOI 10.1890/1051-0761(1999)009[1420:TROPBI]2.0.CO;2; Pico FX, 2002, ECOLOGY, V83, P1991, DOI 10.2307/3071781; Puterman M. L., 1994, MARKOV DECISION PROC; Rhodes EC, 1940, J R STAT SOC, V103, P61, DOI 10.2307/2980551; ROCKWELL RF, 1995, CONSERV BIOL, V9, P1225, DOI 10.1046/j.1523-1739.1995.9051216.x-i1; Sladky K, 2005, OPERAT RES PROCEED, P319; Stearns S.C., 1992, pi; STEINER UK, 2011, NEUTRAL THEORY UNPUB; Steiner UK, 2010, J ANIM ECOL, V79, P436, DOI 10.1111/j.1365-2656.2009.01653.x; Tuljapurkar S, 2009, ECOL LETT, V12, P93, DOI 10.1111/j.1461-0248.2008.01262.x; *U CAL BERK US MAX, 2010, HUM MORT DAT; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Van Dijk NM, 2006, J APPL PROBAB, V43, P1044, DOI 10.1239/jap/1165505206; [No title captured]	69	51	51	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20809	10.1371/journal.pone.0020809	http://dx.doi.org/10.1371/journal.pone.0020809			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738586	gold, Green Published			2022-12-25	WOS:000292290100007
J	Fischer, A; Prufer, K; Good, JM; Halbwax, M; Wiebe, V; Andre, C; Atencia, R; Mugisha, L; Ptak, SE; Paabo, S				Fischer, Anne; Pruefer, Kay; Good, Jeffrey M.; Halbwax, Michel; Wiebe, Victor; Andre, Claudine; Atencia, Rebeca; Mugisha, Lawrence; Ptak, Susan E.; Paeaebo, Svante			Bonobos Fall within the Genomic Variation of Chimpanzees	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENETIC-STRUCTURE; NUCLEOTIDE DIVERSITY; DEMOGRAPHIC HISTORY; DNA POLYMORPHISM; SPECIES TREES; MIXED MODELS; POPULATIONS; PATTERNS; HUMANS	To gain insight into the patterns of genetic variation and evolutionary relationships within and between bonobos and chimpanzees, we sequenced 150,000 base pairs of nuclear DNA divided among 15 autosomal regions as well as the complete mitochondrial genomes from 20 bonobos and 58 chimpanzees. Except for western chimpanzees, we found poor genetic separation of chimpanzees based on sample locality. In contrast, bonobos consistently cluster together but fall as a group within the variation of chimpanzees for many of the regions. Thus, while chimpanzees retain genomic variation that predates bonobo-chimpanzee speciation, extensive lineage sorting has occurred within bonobos such that much of their genome traces its ancestry back to a single common ancestor that postdates their origin as a group separate from chimpanzees.	[Fischer, Anne; Pruefer, Kay; Good, Jeffrey M.; Halbwax, Michel; Wiebe, Victor; Ptak, Susan E.; Paeaebo, Svante] Max Plank Inst Evolutionary Anthropol, Leipzig, Germany; [Andre, Claudine] Lola Ya Bonobo Bonobo Sanctuary, Kinshasa, DEM REP CONGO; [Atencia, Rebeca] Jane Goodall Inst, Pointe Noire, Rep Congo; [Mugisha, Lawrence] CSWCT, Entebbe, Uganda	Max Planck Society	Fischer, A (corresponding author), Int Ctr Insect Physiol & Ecol, POB 30772, Nairobi, Kenya.	afischer@icipe.org	Mugisha, Lawrence/N-4916-2017	Mugisha, Lawrence/0000-0003-4932-3356	Max-Planck Gesellschaft; ERC [233297, TWOPAN]; TWOPAN; NSF [OISE-0754461]	Max-Planck Gesellschaft(Max Planck Society); ERC(European Research Council (ERC)European Commission); TWOPAN; NSF(National Science Foundation (NSF))	This work was financially supported by the Max-Planck Gesellschaft and the ERC grant 233297, TWOPAN. JMG was supported by an NSF international postdoctoral fellowship (OISE-0754461) during a portion of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; BJORK A, 2010, MOL BIOL EVOL; BRAGA J, 1995, CR ACAD SCI II, V320, P1025; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Deinard AS, 2000, AM J PHYS ANTHROPOL, V111, P25, DOI 10.1002/(SICI)1096-8644(200001)111:1<25::AID-AJPA3>3.0.CO;2-R; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Geraldes A, 2008, MOL ECOL, V17, P5349, DOI 10.1111/j.1365-294X.2008.04005.x; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heckman KL, 2007, MOL PHYLOGENET EVOL, V43, P353, DOI 10.1016/j.ympev.2007.03.005; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; HUDSON RR, 1992, GENETICS, V131, P509; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jensen-Seaman MI, 2001, J HERED, V92, P475, DOI 10.1093/jhered/92.6.475; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kano T., 1992, LAST APE PYGMY CHIMP; Kimura M, 1983, NEUTRAL THEORY MOL E, P384; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McGuire JA, 2007, EVOLUTION, V61, P2879, DOI 10.1111/j.1558-5646.2007.00239.x; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Napier JR, 1967, HDB LIVING PRIMATES; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Patterson N., 2006, NATURE; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SHEA BT, 1993, MULTIVARIATE CRANIOM; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Uchida A, 1996, TRENDS ECOL EVOL, V11, P163, DOI 10.1016/0169-5347(96)10007-0; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WEGMANN D, 2010, BAYESIAN INFERENCE D; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017; Wrangham R. W., 2001, ALL APES GREAT SMALL, V1; WU CI, 1991, GENETICS, V127, P429; Xu XW, 2010, MOL PHYLOGENET EVOL, V55, P1008, DOI 10.1016/j.ympev.2009.11.018; Yu N, 2003, GENETICS, V164, P1511; Zihlman A., 1996, GREAT APE SOC	56	44	45	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21605	10.1371/journal.pone.0021605	http://dx.doi.org/10.1371/journal.pone.0021605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747915	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100045
J	Indriati, E; Swisher, CC; Lepre, C; Quinn, RL; Suriyanto, RA; Hascaryo, AT; Grun, R; Feibel, CS; Pobiner, BL; Aubert, M; Lees, W; Anton, SC				Indriati, Etty; Swisher, Carl C., III; Lepre, Christopher; Quinn, Rhonda L.; Suriyanto, Rusyad A.; Hascaryo, Agus T.; Gruen, Rainer; Feibel, Craig S.; Pobiner, Briana L.; Aubert, Maxime; Lees, Wendy; Anton, Susan C.			The Age of the 20 Meter Solo River Terrace, Java, Indonesia and the Survival of Homo erectus in Asia	PLOS ONE			English	Article							TOOTH ENAMEL; COSMIC-RAY; U-UPTAKE; NGANDONG; PLEISTOCENE; HOMININ; SAPIENS; FLORES	Homo erectus was the first human lineage to disperse widely throughout the Old World, the only hominin in Asia through much of the Pleistocene, and was likely ancestral to H. sapiens. The demise of this taxon remains obscure because of uncertainties regarding the geological age of its youngest populations. In 1996, some of us co-published electron spin resonance (ESR) and uranium series (U-series) results indicating an age as young as 35-50 ka for the late H. erectus sites of Ngandong and Sambungmacan and the faunal site of Jigar (Indonesia). If correct, these ages favor an African origin for recent humans who would overlap with H. erectus in time and space. Here, we report Ar-40/Ar-39 incremental heating analyses and new ESR/U-series age estimates from the "20 m terrace'' at Ngandong and Jigar. Both data sets are internally consistent and provide no evidence for reworking, yet they are inconsistent with one another. The Ar-40/Ar-39 analyses give an average age of 546 +/- 12 ka (sd +/- 5 se) for both sites, the first reliable radiometric indications of a middle Pleistocene component for the terrace. Given the technical accuracy and consistency of the analyses, the argon ages represent either the actual age or the maximum age for the terrace and are significantly older than previous estimates. Most of the ESR/U-series results are older as well, but the oldest that meets all modeling criteria is 143 ka+20/-17. Most samples indicated leaching of uranium and likely represent either the actual or the minimum age of the terrace. Given known sources of error, the U-series results could be consistent with a middle Pleistocene age. However, the ESR and Ar-40/Ar-39 ages preclude one another. Regardless, the age of the sites and hominins is at least bracketed between these estimates and is older than currently accepted.	[Indriati, Etty; Suriyanto, Rusyad A.; Hascaryo, Agus T.] Gadjah Mada Univ, Fac Med, Lab Bio & Paleoanthropol, Yogyakarta, Indonesia; [Swisher, Carl C., III; Lepre, Christopher; Quinn, Rhonda L.; Feibel, Craig S.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA; [Lepre, Christopher] Columbia Univ, Lamont Doherty Earth Observ Palisades, New York, NY USA; [Quinn, Rhonda L.] Loyola Univ Chicago, Dept Anthropol, Chicago, IL USA; [Gruen, Rainer; Aubert, Maxime; Lees, Wendy] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Pobiner, Briana L.] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; [Anton, Susan C.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA	Gadjah Mada University; Rutgers State University New Brunswick; Columbia University; Loyola University Chicago; Australian National University; Smithsonian Institution; Smithsonian National Museum of Natural History; New York University	Indriati, E (corresponding author), Gadjah Mada Univ, Fac Med, Lab Bio & Paleoanthropol, Yogyakarta, Indonesia.	cswish@rci.rutgers.edu; susan.anton@nyu.edu	Aubert, Maxime/AAT-6198-2020; Grun, Rainer/A-1437-2012	Aubert, Maxime/0000-0002-4189-531X; Grun, Rainer/0000-0003-1366-3674; Quinn, Rhonda/0000-0003-2580-864X; Lepre, Christopher/0000-0001-9930-9339	U.S. NSF [BCS 0317292]; AAAS WISC program; UGM	U.S. NSF(National Science Foundation (NSF)); AAAS WISC program; UGM	The project was funded by the U.S. NSF BCS 0317292 to SCA, an AAAS WISC program grant to EI and SCA, and a UGM sabbatical grant to EI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamiec G., 1998, ANCIENT TL, V16, P37, DOI DOI 10.1016/S0277-3791(03)00021-0; Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Anton SC, 1999, AM J PHYS ANTHROPOL, V108, P223; Anton SC, 2002, AM J PHYS ANTHROPOL, V118, P301, DOI 10.1002/ajpa.10091; BARSTRA GJ, 1987, PALEAEOHIST GRONINGE, V29, P1; BARTSTRA GJ, 1988, J HUM EVOL, V17, P325, DOI 10.1016/0047-2484(88)90074-7; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Carr MJ, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001396; CARTMILL M, 2009, HUMAN LINEAGE; Deino AL, 2002, J HUM EVOL, V42, P185, DOI 10.1006/jhev.2001.0517; Eggins S, 2003, QUATERNARY SCI REV, V22, P1373, DOI 10.1016/S0277-3791(03)00064-7; Eggins SM, 2005, QUATERNARY SCI REV, V24, P2523, DOI 10.1016/j.quascirev.2005.07.006; Gibbons A, 1996, SCIENCE, V274, P1841, DOI 10.1126/science.274.5294.1841; Gordon AD, 2008, P NATL ACAD SCI USA, V105, P4650, DOI 10.1073/pnas.0710041105; Grun R, 1997, SCIENCE, V276, P1575, DOI 10.1126/science.276.5318.1575; Grun R, 1997, J HUM EVOL, V32, P83; Grun R, 2002, RADIAT MEAS, V35, P87, DOI 10.1016/S1350-4487(01)00255-4; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Grun R., 1994, ANCIENT TL, V12, P35; Grun R, 2008, QUAT GEOCHRONOL, V3, P150, DOI 10.1016/j.quageo.2007.09.004; Grun R, 2009, RADIAT MEAS, V44, P472, DOI 10.1016/j.radmeas.2009.02.011; Grun R, 2009, QUAT GEOCHRONOL, V4, P231, DOI 10.1016/j.quageo.2008.12.005; HUFFMAN OF, 2010, PALEOANTHROPOLOGY, P1, DOI DOI 10.4207/PA.2010.ART34; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; JACOB T, 1975, CATALOGUE FOSSIL H 3, P103; JOANNESBOYAU R, QUATERNARY GEO UNPUB; KLEIN RG, 1989, HUMAN CAREER; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; LUCA AP, 1980, YALE U PUB ANTHR, V78, P1; MARSH R, 1999, THESIS MCMASTER U HA; MOELYADI I, 1980, PROY PEN PALEOANTHRO; Oppenoorth W. F.. F., 1932, Wetens Meded Mijnb Batavia, Vno. 20, P49; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; PRESCOTT JR, 1988, NUCL TRACKS RAD MEAS, V14, P223; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; RIGHTMIRE GP, 1993, EVOLUTION HOMO ERECT; Shen GJ, 2009, NATURE, V458, P198, DOI 10.1038/nature07741; Sondaar P, 1996, GEOL RES DEV CENT PA, V8, P1; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Swisher CC, 1996, SCIENCE, V274, P1870, DOI 10.1126/science.274.5294.1870; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Turrin BD, 2008, J VOLCANOL GEOTH RES, V177, P848, DOI 10.1016/j.jvolgeores.2008.01.049; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3; VANDERPLICHT J, 1989, APPL GEOCHEM, V4, P339; VONKOENIGSWALD GHR, 1934, DE ING NED INDIE, V11, P185; Westaway KE, 2007, J HUM EVOL, V53, P709, DOI 10.1016/j.jhevol.2007.06.002; WIDIASMORO, 1976, PROY PEN PENG PURB D; Wolpoff M. H., 1999, PALEOANTHROPOLOGY; Yokoyama Y, 2008, J HUM EVOL, V55, P274, DOI 10.1016/j.jhevol.2008.01.006	51	73	74	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21562	10.1371/journal.pone.0021562	http://dx.doi.org/10.1371/journal.pone.0021562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21738710	Green Published, gold			2022-12-25	WOS:000292290100039
J	Lappe, C; Trainor, LJ; Herholz, SC; Pantev, C				Lappe, Claudia; Trainor, Laurel J.; Herholz, Sibylle C.; Pantev, Christo			Cortical Plasticity Induced by Short-Term Multimodal Musical Rhythm Training	PLOS ONE			English	Article							AUDITORY-EVOKED POTENTIALS; MISMATCH NEGATIVITY; NON-MUSICIANS; PROFESSIONAL PIANISTS; CEREBRAL HEMODYNAMICS; BEAT PERCEPTION; BRAIN; NONMUSICIANS; CORTEX; MOVEMENT	Performing music is a multimodal experience involving the visual, auditory, and somatosensory modalities as well as the motor system. Therefore, musical training is an excellent model to study multimodal brain plasticity. Indeed, we have previously shown that short-term piano practice increase the magnetoencephalographic (MEG) response to melodic material in novice players. Here we investigate the impact of piano training using a rhythmic-focused exercise on responses to rhythmic musical material. Musical training with non musicians was conducted over a period of two weeks. One group (sensorimotor-auditory, SA) learned to play a piano sequence with a distinct musical rhythm, another group (auditory, A) listened to, and evaluated the rhythmic accuracy of the performances of the SA-group. Training-induced cortical plasticity was evaluated using MEG, comparing the mismatch negativity (MMN) in response to occasional rhythmic deviants in a repeating rhythm pattern before and after training. The SA-group showed a significantly greater enlargement of MMN and P2 to deviants after training compared to the A-group. The training-induced increase of the rhythm MMN was bilaterally expressed in contrast to our previous finding where the MMN for deviants in the pitch domain showed a larger right than left increase. The results indicate that when auditory experience is strictly controlled during training, involvement of the sensorimotor system and perhaps increased attentional recources that are needed in producing rhythms lead to more robust plastic changes in the auditory cortex compared to when rhythms are simply attended to in the auditory domain in the absence of motor production.	[Lappe, Claudia; Herholz, Sibylle C.; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Trainor, Laurel J.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Trainor, Laurel J.] McMaster Univ, McMaster Inst Music & Mind, Hamilton, ON, Canada; [Herholz, Sibylle C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	University of Munster; McMaster University; McMaster University; McGill University	Lappe, C (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	pantev@uni-muenster.de		Trainor, Laurel/0000-0003-3397-2079	DFG	DFG(German Research Foundation (DFG))	The study was funded by the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza M, 2002, LEARN MEMORY, V9, P138, DOI 10.1101/lm.46502; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2006, EUR J NEUROSCI, V24, P1832, DOI 10.1111/j.1460-9568.2006.05031.x; Baumann S, 2005, ANN NY ACAD SCI, V1060, P186, DOI 10.1196/annals.1360.038; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Bosnyak D.J., 2007, INT C SER, V1300, P25, DOI DOI 10.1016/J.ICS.2006.12.040; Brattico E, 2003, NEUROREPORT, V14, P2489, DOI 10.1097/00001756-200312190-00039; BROWN S, 2003, B PSYCHOL ARTS, V4, P15; Brown S, 2007, BRAIN COGNITION, V63, P59, DOI 10.1016/j.bandc.2006.08.006; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Cross I, 2003, COGNITIVE NEUROSCIEN, P42, DOI [10.1093/acprof:oso/9780198525202.003.0004, DOI 10.1093/ACPROF:OSO/9780198525202.003.0004]; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Evers S, 1999, BRAIN, V122, P75, DOI 10.1093/brain/122.1.75; Fritz JB, 2007, HEARING RES, V229, P186, DOI 10.1016/j.heares.2007.01.009; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Gaser C, 2003, J NEUROSCI, V23, P9240; Geiser E, 2010, EUR J NEUROSCI, V32, P1979, DOI 10.1111/j.1460-9568.2010.07462.x; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hirata Y, 1999, NEUROREPORT, V10, P999, DOI 10.1097/00001756-199904060-00019; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Jongsma MLA, 2005, PSYCHOPHYSIOLOGY, V42, P191, DOI 10.1111/j.1469-8986.2005.00269.x; Jongsma MLA, 2004, BIOL PSYCHOL, V66, P129, DOI 10.1016/j.biopsycho.2003.10.002; KASIA M, 2008, NEUROBIOL LEARN MEM, V89, P153; Koesch S, 2002, CLIN NEUROPHYSIOL, V113, P862, DOI 10.1016/S1388-2457(02)00050-0; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Limb CJ, 2006, ANAT REC PART A, V288A, P382, DOI 10.1002/ar.a.20298; Marinoni M, 2000, J CLIN NEUROSCI, V7, P425, DOI 10.1054/jocn.1999.0683; Naatanen R, 1995, Int J Neurosci, V80, P317, DOI 10.3109/00207459508986107; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Petacchi A, 2005, HUM BRAIN MAPP, V25, P118, DOI 10.1002/hbm.20137; Pfordresher PQ, 2006, PERCEPT PSYCHOPHYS, V68, P362, DOI 10.3758/BF03193683; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; PROKSCH M, FURKLEINE KLAVIERK 2; PROKSCH M, FURKLEINE KLAVIERK 1; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Russeler J, 2001, NEUROSCI LETT, V308, P33, DOI 10.1016/S0304-3940(01)01977-2; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schonwiesner M, 2005, EUR J NEUROSCI, V22, P1521, DOI 10.1111/j.1460-9568.2005.04315.x; Schulz M, 2003, NEUROREPORT, V14, P157, DOI 10.1097/00001756-200301200-00029; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Trainor L.J., 2009, HDB MUSIC PSYCHOL, P171; Trainor LJ, 2009, CORTEX, V45, P35, DOI 10.1016/j.cortex.2007.10.014; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; ZATORRE RJ, 1991, BRAIN, V114, P2403, DOI 10.1093/brain/114.6.2403; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	66	64	65	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21493	10.1371/journal.pone.0021493	http://dx.doi.org/10.1371/journal.pone.0021493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21747907	Green Published, gold			2022-12-25	WOS:000292290100028
J	Laurson, J; Raj, K				Laurson, Joanna; Raj, Kenneth			Localisation of Human Papillomavirus 16 E7 Oncoprotein Changes with Cell Confluence	PLOS ONE			English	Article							HPV16 E7; E6 ONCOPROTEIN; GENE-PRODUCT; TYPE-16; PROTEIN; CARCINOMA; LINE; E7-ONCOPROTEIN; TRANSFORMATION; KERATINOCYTES	E7 is one of the best studied proteins of human papillomavirus type 16, largely because of its oncogenic potential linked to cervical cancer. Yet the sub-cellular location of E7 remains confounding, even though it has been shown to be able to shuttle between the nucleus and the cytoplasm. Here we show with immunocytochemistry that E7 proteins are located in the nucleus and cytoplasm in sub-confluent cells, but becomes cytoplasmic in confluent cells. The change in E7's location is independent of time in culture, cell division, cell cycle phase or cellular differentiation. Levels of E7 are also increased in confluent cells as determined by Western blotting. Our investigations have also uncovered how different analytical techniques influence the observation of where E7 is localised, highlighting the importance of technical choice in such analysis. Understanding the localisation of E7 will help us to better comprehend the function of E7 on its target proteins.	[Laurson, Joanna; Raj, Kenneth] Natl Inst Med Res, Div Virol, Med Res Council, London NW7 1AA, England	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Laurson, J (corresponding author), Natl Inst Med Res, Div Virol, Med Res Council, London NW7 1AA, England.	Joanna.Laurson@doube.net		Laurson-Doube, Joanna/0000-0001-9619-9170	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Hoffmann BL, 2000, J INVEST DERMATOL, V114, P444, DOI 10.1046/j.1523-1747.2000.00869.x; Angeline M, 2003, VIROLOGY, V317, P13, DOI 10.1016/j.virol.2003.08.024; Baldwin A, 2006, J VIROL, V80, P6669, DOI 10.1128/JVI.02497-05; Barrow-Laing L, 2010, VIROLOGY, V400, P233, DOI 10.1016/j.virol.2010.01.034; Dantur K, 2009, INT J CANCER, V125, P1902, DOI 10.1002/ijc.24579; Dreier K, 2011, VIROLOGY, V409, P54, DOI 10.1016/j.virol.2010.09.024; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; GISSMANN L, 1984, J INVEST DERMATOL, V83, pS26, DOI 10.1111/1523-1747.ep12281143; GREENFIELD I, 1991, P NATL ACAD SCI USA, V88, P11217, DOI 10.1073/pnas.88.24.11217; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Hoffmann R, 2006, J VIROL, V80, P4431, DOI 10.1128/JVI.80.9.4431-4439.2006; HUBBERT NL, 1992, J VIROL, V66, P6237, DOI 10.1128/JVI.66.10.6237-6241.1992; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Jeon JH, 2007, EXP MOL MED, V39, P621, DOI 10.1038/emm.2007.68; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Knapp AA, 2009, VIROLOGY, V383, P60, DOI 10.1016/j.virol.2008.09.037; Nguyen CL, 2007, J VIROL, V81, P13533, DOI 10.1128/JVI.01669-07; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Ressler S, 2007, CLIN CANCER RES, V13, P7067, DOI 10.1158/1078-0432.CCR-07-1222; SATO H, 1989, VIROLOGY, V170, P311, DOI 10.1016/0042-6822(89)90386-3; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Smith-McCune K, 1999, P NATL ACAD SCI USA, V96, P6999, DOI 10.1073/pnas.96.12.6999; SMOTKIN D, 1987, J VIROL, V61, P1686, DOI 10.1128/JVI.61.5.1686-1689.1987; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Veldman T, 2001, J VIROL, V75, P4467, DOI 10.1128/JVI.75.9.4467-4472.2001; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zatsepina O, 1997, ONCOGENE, V14, P1137, DOI 10.1038/sj.onc.1200946	30	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21501	10.1371/journal.pone.0021501	http://dx.doi.org/10.1371/journal.pone.0021501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738683	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100029
J	Gao, F; Zhang, RR				Gao, Feng; Zhang, Randy Ren			Enzymes Are Enriched in Bacterial Essential Genes	PLOS ONE			English	Article							TRANSPOSON MUTAGENESIS; STAPHYLOCOCCUS-AUREUS; BRUGIA-MALAYI; IDENTIFICATION; PREDICTION; PHENOTYPES; NETWORKS; DATABASE; MUTANTS; LIBRARY	Essential genes, those indispensable for the survival of an organism, play a key role in the emerging field, synthetic biology. Characterization of functions encoded by essential genes not only has important practical implications, such as in identifying antibiotic drug targets, but can also enhance our understanding of basic biology, such as functions needed to support cellular life. Enzymes are critical for almost all cellular activities. However, essential genes have not been systematically examined from the aspect of enzymes and the chemical reactions that they catalyze. Here, by comprehensively analyzing essential genes in 14 bacterial genomes in which large-scale gene essentiality screens have been performed, we found that enzymes are enriched in essential genes. Essential enzymes have overrepresented ligases ( especially those forming carbon-oxygen bonds and carbon-nitrogen bonds), nucleotidyltransferases and phosphotransferases, while have underrepresented oxidoreductases. Furthermore, essential enzymes tend to associate with more gene ontology domains. These results, from the aspect of chemical reactions, provide further insights into the understanding of functions needed to support natural cellular life, as well as synthetic cells, and provide additional parameters that can be integrated into gene essentiality prediction algorithms.	[Gao, Feng] Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China; [Zhang, Randy Ren] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA	Tianjin University; Wayne State University	Gao, F (corresponding author), Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China.	rzhang@med.wayne.edu	Gao, Feng/C-9913-2009	Gao, Feng/0000-0002-9563-3841	Wayne State University [176412]; National Natural Science Foundation of China [90408028, 30800642, 10747150]	Wayne State University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported in part by a fund (176412) from Wayne State University to RRZ, and by the National Natural Science Foundation of China (Grant Nos. 90408028, 30800642 and 10747150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cameron NMD, 2009, NAT BIOTECHNOL, V27, P1103, DOI 10.1038/nbt1209-1103; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen Y, 2005, BIOINFORMATICS, V21, P575, DOI 10.1093/bioinformatics/bti058; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; DENG J, 2010, NUCL ACIDS RES; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Gerdes S, 2006, CURR OPIN BIOTECH, V17, P448, DOI 10.1016/j.copbio.2006.08.006; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Henkel J, 2009, NAT BIOTECHNOL, V27, P1095, DOI 10.1038/nbt1209-1095; Holman AG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-243; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Knuth K, 2004, MOL MICROBIOL, V51, P1729, DOI 10.1046/j.1365-2958.2003.03944.x; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koonin EV, 2000, ANNU REV GENOM HUM G, V1, P99, DOI 10.1146/annurev.genom.1.1.99; Kumar S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001189; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; May M, 2009, NAT BIOTECHNOL, V27, P1112, DOI 10.1038/nbt1209-1112; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Pennisi E, 2010, SCIENCE, V328, P958, DOI 10.1126/science.328.5981.958; Rocha EPC, 2003, NAT GENET, V34, P377, DOI 10.1038/ng1209; Saha S, 2006, GENET MOL RES, V5, P224; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Soo K, 2006, J MICROBIOL BIOTECHN, V16, P623; Webb E. C., 1992, ENZYME NOMENCLATURE; Zhang R, 2004, NUCLEIC ACIDS RES, V32, pD271, DOI 10.1093/nar/gkh024; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	43	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21683	10.1371/journal.pone.0021683	http://dx.doi.org/10.1371/journal.pone.0021683			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738765	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800059
J	Kapoor, A; Hornig, M; Asokan, A; Williams, B; Henriquez, JA; Lipkin, WI				Kapoor, Amit; Hornig, Mady; Asokan, Aravind; Williams, Brent; Henriquez, Jose A.; Lipkin, W. Ian			Bocavirus Episome in Infected Human Tissue Contains Non-Identical Termini	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ACUTE GASTROENTERITIS; HOSPITALIZED CHILDREN; PARVOVIRUS; VIRUS; SAMPLES; SEQUENCES; THAILAND; PROFILE; CLONES	Human bocaviruses (HBoV) are highly prevalent human infections whose pathogenic potential remains unknown. Recent identification of the first non-human primate bocavirus [1] in captive gorillas raised the possibility of the persistent nature of bocavirus infection. To characterize bocavirus infection in humans, we tested intestinal biopsies from 22 children with gastrointestinal disease for the presence of HBoV DNA. Four HBoV-positive tissue samples were analyzed to determine whether viral DNA was present in the linear genomic, the episomal closed circular or the host genome-integrated form. Whereas one tissue sample positive for HBoV3 contained the episomal form (HBoV3-E1), none had the genome-integrated form. The complete genome sequence of HBoV3-E1 contains 5319 nucleotides of which 513 represent the non-coding terminal sequence. The secondary structure of HBoV3-E1 termini suggests several conserved and variable features among human and animal bocaviruses. Our observation that HBoV genome exists as head-to-tail monomer in infected tissue either reflects the likely evolution of alternative replication mechanism in primate bocaviruses or a mechanism of viral persistence in their host. Moreover, we identified the HBoV genomic terminal sequences that will be helpful in developing reverse genetic systems for these widely prevalent parvoviruses. Significance: HBoV have been found in healthy human controls as well as individuals with respiratory or gastrointestinal disease. Our findings suggest that HBoV DNA can exist as episomes in infected human tissues and therefore can likely establish persistent infection in the host. Previous efforts to grow HBoV in cell culture and to develop reverse genetic systems have been unsuccessful. Complete genomic sequence of the HBoV3 episome and its genomic termini will improve our understanding of HBoV replication mechanism and its pathogenesis.	[Kapoor, Amit; Hornig, Mady; Williams, Brent; Henriquez, Jose A.; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA; [Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA	Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Kapoor, A (corresponding author), Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA.	ak3117@columbia.edu	Lipkin, W. Ian/ABE-6216-2020; Hornig, Mady/AAE-8431-2020; Grieshaber-Bouyer, Ricardo/R-7512-2016	Lipkin, W. Ian/0000-0002-8768-9386; Hornig, Mady/0000-0001-7572-3092; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135	National Institutes of Health [AI090196, AI079231, AI57158, AI070411, EY017404]; NATIONAL EYE INSTITUTE [R24EY017404] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070411, U54AI057158, R21AI090196, R01AI079231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant awards AI090196, AI079231, AI57158, AI070411, and EY017404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque MCM, 2007, EMERG INFECT DIS, V13, P1756, DOI 10.3201/eid1311.070671; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2008, J CLIN VIROL, V41, P29, DOI 10.1016/j.jcv.2007.10.026; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Anderson LJ, 2007, CLIN INFECT DIS, V44, P911, DOI 10.1086/512438; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Bastien N, 2007, J CLIN MICROBIOL, V45, P610, DOI 10.1128/JCM.01044-06; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Brown KE, 2010, REV MED VIROL, V20, P231, DOI 10.1002/rmv.648; Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014; Catalano-Pons C, 2007, PEDIATR INFECT DIS J, V26, P959, DOI 10.1097/INF.0b013e3181256583; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; Chen CL, 2005, J VIROL, V79, P14781, DOI 10.1128/JVI.79.23.14781-14792.2005; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chieochansin T, 2008, J INFECTION, V56, P137, DOI 10.1016/j.jinf.2007.11.006; Chieochansin T, 2007, VIRUS RES, V129, P54, DOI 10.1016/j.virusres.2007.04.022; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; CLAUDE M, VIRUS TAXONOMY; DINA J, 2009, J PAEDIAT CHILD HLTH; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; GAGLIARDI TB, 2009, HUMAN BOCAVIRUS RESP, P1; Hornig M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003140; KAPOOR A, J INFECT DIS, V201, P1633; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J VIROL, V84, P12628, DOI 10.1128/JVI.01732-10; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lindner J, 2008, INTERVIROLOGY, V51, P116, DOI 10.1159/000137411; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Luft F, 2001, INT J CANCER, V92, P9, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1144>3.0.CO;2-L; Mackay IM, 2007, J INFECT DIS, V196, P968, DOI 10.1086/521311; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mears JA, 2002, J MOL BIOL, V321, P215, DOI 10.1016/S0022-2836(02)00568-5; Qiu J, 2007, J VIROL, V81, P12080, DOI 10.1128/JVI.00815-07; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Schnepp BC, 2009, J VIROL, V83, P1456, DOI 10.1128/JVI.01686-08; Sharp CP, 2010, J VIROL, V84, P10289, DOI 10.1128/JVI.01304-10; Simmonds P, 2008, CLIN INFECT DIS, V46, P547, DOI 10.1086/526533; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Tamura K., 2011, MOL BIOL EVOLU UNPUB; XU ZQ, 2011, J CLIN MICROBIOL; Yu JM, 2008, J CLIN VIROL, V42, P280, DOI 10.1016/j.jcv.2008.03.032; Ziegler S, 2008, J CLIN VIROL, V43, P349, DOI 10.1016/j.jcv.2008.07.006; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	71	78	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21362	10.1371/journal.pone.0021362	http://dx.doi.org/10.1371/journal.pone.0021362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738642	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800016
J	Agrawal, N; Leaman, DP; Rowcliffe, E; Kinkead, H; Nohria, R; Akagi, J; Bauer, K; Du, SX; Whalen, RG; Burton, DR; Zwick, MB				Agrawal, Nitish; Leaman, Daniel P.; Rowcliffe, Eric; Kinkead, Heather; Nohria, Raman; Akagi, Junya; Bauer, Katherine; Du, Sean X.; Whalen, Robert G.; Burton, Dennis R.; Zwick, Michael B.			Functional Stability of Unliganded Envelope Glycoprotein Spikes among Isolates of Human Immunodeficiency Virus Type 1 (HIV-1)	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; ENV-MEDIATED FUSION; NEUTRALIZING ANTIBODIES; ECTODOMAIN REGION; CD4-BINDING SITE; GP41 ECTODOMAIN; DISULFIDE BONDS; 2 MECHANISMS; GP120	The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in part to its genetic variability, structural heterogeneity and lability. However, the extent of lability in Env function, particularly for primary isolates across clades, has not been explored. Here, we probe stability of function for variant Envs of a range of isolates from chronic and acute infection, and from clades A, B and C, all on a constant virus backbone. Stability is elucidated in terms of the sensitivity of isolate infectivity to destabilizing conditions. A heat-gradient assay was used to determine T-90 values, the temperature at which HIV-1 infectivity is decreased by 90% in 1 h, which ranged between similar to 40 to 49 degrees C (n = 34). For select Envs (n = 10), the half-lives of infectivity decay at 37 degrees C were also determined and these correlated significantly with the T90 (p = 0.029), though two 'outliers' were identified. Specificity in functional Env stability was also evident. For example, Env variant HIV-1(ADA) was found to be labile to heat, 37 degrees C decay, and guanidinium hydrochloride but not to urea or extremes of pH, when compared to its thermostable counterpart, HIV-1(JR-CSF). Blue native PAGE analyses revealed that Env-dependent viral inactivation preceded complete dissociation of Env trimers. The viral membrane and membrane-proximal external region (MPER) of gp41 were also shown to be important for maintaining trimer stability at physiological temperature. Overall, our results indicate that primary HIV-1 Envs can have diverse sensitivities to functional inactivation in vitro, including at physiological temperature, and suggest that parameters of functional Env stability may be helpful in the study and optimization of native Env mimetics and vaccines.	[Agrawal, Nitish; Leaman, Daniel P.; Rowcliffe, Eric; Kinkead, Heather; Nohria, Raman; Akagi, Junya; Bauer, Katherine; Burton, Dennis R.; Zwick, Michael B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Du, Sean X.; Whalen, Robert G.] AltraVax Inc, Sunnyvale, CA USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Boston, MA USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Agrawal, N (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	zwick@scripps.edu	AGRAWAL, NITISH/E-3468-2013; AGRAWAL, NITISH/H-6186-2011	AGRAWAL, NITISH/0000-0003-0823-7355; Nohria, Raman/0000-0003-3313-4833	National Institutes of Health (NIH) [AI56375, AI77381, P01 AI056375, AI33292, T32 AI007606]; Summer Immunology and Virology Undergraduate Fellowship (SINAPSE); Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI NAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033292, R01AI033292, R21AI077381, P01AI056375, R33AI077381, T32AI007606] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Immunology and Virology Undergraduate Fellowship (SINAPSE); Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI NAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health (NIH) grants AI56375 (MBZ and DRB), AI77381 (MBZ), P01 AI056375 (RGW), AI33292 (DRB), T32 AI007606 (DPL), Summer Immunology and Virology Undergraduate Fellowship (SINAPSE) (RN), and the Neutralizing Antibody Consortium of the International AIDS Vaccine Initiative (IAVI NAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; Amin N, 2004, PROTEIN ENG DES SEL, V17, P787, DOI 10.1093/protein/gzh091; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Beddows S, 2005, VIROLOGY, V337, P136, DOI 10.1016/j.virol.2005.03.033; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burrer R, 2005, VIROLOGY, V333, P102, DOI 10.1016/j.virol.2004.12.034; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CAO J, 1993, J VIROL, V67, P2747, DOI 10.1128/JVI.67.5.2747-2755.1993; Casali M, 2008, VIROLOGY, V380, P91, DOI 10.1016/j.virol.2008.07.011; Cavacini L, 2003, AIDS, V17, P685, DOI 10.1097/00002030-200303280-00006; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cowan DA, 1997, COMP BIOCHEM PHYS A, V118, P429, DOI 10.1016/S0300-9629(97)00004-2; Crooks ET, 2008, VIROLOGY, V377, P364, DOI 10.1016/j.virol.2008.04.045; CROOKS ET, 2011, J VIROL IN PRESS; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Dey AK, 2008, VIROLOGY, V372, P187, DOI 10.1016/j.virol.2007.10.018; Epand RM, 2003, BIOCHEMISTRY-US, V42, P14677, DOI 10.1021/bi035587j; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Fouts TR, 1997, J VIROL, V71, P2779, DOI 10.1128/JVI.71.4.2779-2785.1997; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FU YK, 1993, J VIROL, V67, P3818, DOI 10.1128/JVI.67.7.3818-3825.1993; GACH JS, 2011, CURR TOP ME IN PRESS; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; HELSETH E, 1990, J VIROL, V64, P2416, DOI 10.1128/JVI.64.5.2416-2420.1990; HELSETH E, 1991, J VIROL, V65, P2119, DOI 10.1128/JVI.65.4.2119-2123.1991; Herrera C, 2005, VIROLOGY, V338, P154, DOI 10.1016/j.virol.2005.05.002; Herrera C, 2003, J VIROL, V77, P1084, DOI 10.1128/JVI.77.2.1084-1091.2003; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Jacobs A, 2005, J BIOL CHEM, V280, P27284, DOI 10.1074/jbc.M414411200; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Karlsson GB, 1996, J VIROL, V70, P6136, DOI 10.1128/JVI.70.9.6136-6142.1996; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kassa A, 2009, J VIROL, V83, P4476, DOI 10.1128/JVI.02110-08; Kirschner M, 2006, PROTEIN EXPRES PURIF, V48, P61, DOI 10.1016/j.pep.2006.02.017; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; LAYNE SP, 1991, J VIROL, V65, P3293, DOI 10.1128/JVI.65.6.3293-3300.1991; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Leaman DP, 2010, J VIROL, V84, P3382, DOI 10.1128/JVI.02363-09; Leavitt M, 2003, J VIROL, V77, P560, DOI 10.1128/JVI.77.1.560-570.2003; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liao ZH, 2003, AIDS RES HUM RETROV, V19, P675, DOI 10.1089/088922203322280900; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Lorizate M, 2006, BIOCHEMISTRY-US, V45, P14337, DOI 10.1021/bi0612521; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Mansy SS, 2008, P NATL ACAD SCI USA, V105, P13351, DOI 10.1073/pnas.0805086105; MCCUNE JM, 1988, CELL, V53, P55, DOI 10.1016/0092-8674(88)90487-4; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; MOORE JP, 1992, J VIROL, V66, P235, DOI 10.1128/JVI.66.1.235-243.1992; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Murakami T, 2008, MICROBIOL IMMUNOL, V52, P287, DOI 10.1111/j.1348-0421.2008.00008.x; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Or-Guil M, 2007, IMMUNOL REV, V216, P130; ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Peters PJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-5; Poignard P, 1996, J EXP MED, V183, P473, DOI 10.1084/jem.183.2.473; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Poss M, 1999, J VIROL, V73, P5255, DOI 10.1128/JVI.73.7.5255-5264.1999; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; Rainwater SMJ, 2007, CURR HIV RES, V5, P189, DOI 10.2174/157016207780076986; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Sharma S, 1996, P NATL ACAD SCI USA, V93, P11842, DOI 10.1073/pnas.93.21.11842; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WESTERVELT P, 1991, P NATL ACAD SCI USA, V88, P3097, DOI 10.1073/pnas.88.8.3097; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Wyatt R, 1997, J VIROL, V71, P9722, DOI 10.1128/JVI.71.12.9722-9731.1997; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang XZ, 2003, VIROLOGY, V313, P117, DOI 10.1016/S0042-6822(03)00273-3; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; York J, 2004, J VIROL, V78, P4921, DOI 10.1128/JVI.78.9.4921-4926.2004; Yuan W, 2005, VIROLOGY, V332, P369, DOI 10.1016/j.virol.2004.11.013; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2007, CURR HIV RES, V5, P608, DOI 10.2174/157016207782418443	112	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21339	10.1371/journal.pone.0021339	http://dx.doi.org/10.1371/journal.pone.0021339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738637	gold, Green Published, Green Submitted			2022-12-25	WOS:000292092600030
J	Domhan, S; Ma, LL; Tai, A; Anaya, Z; Beheshti, A; Zeier, M; Hlatky, L; Abdollahi, A				Domhan, Sophie; Ma, Lili; Tai, Albert; Anaya, Zachary; Beheshti, Afshin; Zeier, Martin; Hlatky, Lynn; Abdollahi, Amir			Intercellular Communication by Exchange of Cytoplasmic Material via Tunneling Nano-Tube Like Structures in Primary Human Renal Epithelial Cells	PLOS ONE			English	Article							FUNCTIONAL GAP-JUNCTIONS; CUTTING EDGE; NANOTUBES; MEMBRANE; EXPRESSION; MICROGLIA; MECHANISM; ALPHA; GAMMA	Transfer of cellular material via tunneling nanotubes (TNT) was recently discovered as a novel mechanism for intercellular communication. The role of intercellular exchange in communication of renal epithelium is not known. Here we report extensive spontaneous intercellular exchange of cargo vesicles and organelles between primary human proximal tubular epithelial cells (RPTEC). Cells were labeled with two different quantum dot nanocrystals (Qtracker 605 or 525) and intercellular exchange was quantified by high-throughput fluorescence imaging and FACS analysis. In co-culture, a substantial fraction of cells (67.5%) contained both dyes indicating high levels of spontaneous intercellular exchange in RPTEC. The double positive cells could be divided into three categories based on the preponderance of 605 Qtracker (46.30%), 525 Qtracker (48.3%) and approximately equal content of both Qtrackers (4.57%). The transfer of mitochondria between RPTECs was also detected using an organelle specific dye. Inhibition of TNT genesis by actin polymerization inhibitor (Latrunculin B) markedly reduced intercellular exchange (>60%) suggesting that intercellular exchange in RPTEC was in part mediated via TNT-like structures. In contrast, induction of cellular stress by Zeocin treatment increased tube-genesis in RPTEC. Our data indicates an unexpected dynamic of intercellular communication between RPTEC by exchange of cytosolic material, which may play an important role in renal physiology.	[Domhan, Sophie; Ma, Lili; Tai, Albert; Anaya, Zachary; Beheshti, Afshin; Hlatky, Lynn; Abdollahi, Amir] Tufts Univ, Dept Med, St Elizabeths Med Ctr, Ctr Canc Syst Biol, Boston, MA 02111 USA; [Domhan, Sophie; Abdollahi, Amir] Univ Heidelberg, Sch Med, Dept Radiat Oncol, Heidelberg Ion Therapy Ctr HIT, Heidelberg, Germany; [Domhan, Sophie; Abdollahi, Amir] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Domhan, Sophie; Zeier, Martin] Univ Heidelberg, Sch Med, Dept Nephrol, Heidelberg, Germany	St. Elizabeth's Medical Center; Tufts University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Domhan, S (corresponding author), Tufts Univ, Dept Med, St Elizabeths Med Ctr, Ctr Canc Syst Biol, Boston, MA 02111 USA.	Sophie.Domhan@tufts.edu	Beheshti, Afshin/AAH-7267-2019; Beheshti, Afshin/N-2241-2014	Beheshti, Afshin/0000-0003-4643-531X	NASA Specialized Center of Research [NNJ04HJ12G]; German Krebshilfe (Deutsche Krebshilfe) [Max-Eder 108876]; DFG [SPP1190]; German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung - BMBF) [03NUK004C]; University of Heidelberg	NASA Specialized Center of Research; German Krebshilfe (Deutsche Krebshilfe)(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung - BMBF)(Federal Ministry of Education & Research (BMBF)); University of Heidelberg	This work was supported in part by the NASA Specialized Center of Research NNJ04HJ12G, German Krebshilfe (Deutsche Krebshilfe, Max-Eder 108876), DFG National Priority Research Program: the Tumor-Vessel Interface "SPP1190", the German Federal Ministry of Research and Technology (Bundesministerium fur Bildung und Forschung - BMBF 03NUK004C) and the Olympia-Morata award of the University of Heidelberg to SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Eugenin EA, 2009, CELL IMMUNOL, V254, P142, DOI 10.1016/j.cellimm.2008.08.005; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gerdes HH, 2009, NAT CELL BIOL, V11, P235, DOI 10.1038/ncb0309-235; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Gurke S, 2008, EXP CELL RES, V314, P3669, DOI 10.1016/j.yexcr.2008.08.022; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Martinez AD, 2002, BRAIN RES, V943, P191, DOI 10.1016/S0006-8993(02)02621-5; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507; Zuba-Surma EK, 2007, FOLIA HISTOCHEM CYTO, V45, P279	18	79	83	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21283	10.1371/journal.pone.0021283	http://dx.doi.org/10.1371/journal.pone.0021283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738629	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600025
J	Salimpour, Y; Soltanian-Zadeh, H; Salehi, S; Emadi, N; Abouzari, M				Salimpour, Yousef; Soltanian-Zadeh, Hamid; Salehi, Sina; Emadi, Nazli; Abouzari, Mehdi			Neuronal Spike Train Analysis in Likelihood Space	PLOS ONE			English	Article							RECEPTIVE-FIELD PLASTICITY; WHISKER VIBRATION; DYNAMIC-ANALYSIS; CORTEX; INFORMATION; RESPONSES; MODEL; PREDICTION; FRAMEWORK; PATTERNS	Background: Conventional methods for spike train analysis are predominantly based on the rate function. Additionally, many experiments have utilized a temporal coding mechanism. Several techniques have been used for analyzing these two sources of information separately, but using both sources in a single framework remains a challenging problem. Here, an innovative technique is proposed for spike train analysis that considers both rate and temporal information. Methodology/Principal Findings: Point process modeling approach is used to estimate the stimulus conditional distribution, based on observation of repeated trials. The extended Kalman filter is applied for estimation of the parameters in a parametric model. The marked point process strategy is used in order to extend this model from a single neuron to an entire neuronal population. Each spike train is transformed into a binary vector and then projected from the observation space onto the likelihood space. This projection generates a newly structured space that integrates temporal and rate information, thus improving performance of distribution-based classifiers. In this space, the stimulus-specific information is used as a distance metric between two stimuli. To illustrate the advantages of the proposed technique, spiking activity of inferior temporal cortex neurons in the macaque monkey are analyzed in both the observation and likelihood spaces. Based on goodness-of-fit, performance of the estimation method is demonstrated and the results are subsequently compared with the firing rate-based framework. Conclusions/Significance: From both rate and temporal information integration and improvement in the neural discrimination of stimuli, it may be concluded that the likelihood space generates a more accurate representation of stimulus space. Further, an understanding of the neuronal mechanism devoted to visual object categorization may be addressed in this framework as well.	[Salimpour, Yousef; Soltanian-Zadeh, Hamid; Salehi, Sina; Emadi, Nazli; Abouzari, Mehdi] Inst Res Fundamental Sci IPM, Sch Cognit Sci SCS, Tehran, Iran; [Salimpour, Yousef] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD USA; [Soltanian-Zadeh, Hamid] Univ Tehran, Dept Elect & Comp Engn, Ctr Excellence Control & Intelligent Proc, Tehran, Iran; [Soltanian-Zadeh, Hamid] Henry Ford Hlth Syst, Dept Radiol, Image Anal Lab, Detroit, MI USA; [Salehi, Sina; Emadi, Nazli; Abouzari, Mehdi] Shahid Beheshti Univ Med Sci, Res Grp Brain & Cognit Sci, Tehran, Iran	Johns Hopkins University; Johns Hopkins Medicine; University of Tehran; Henry Ford Health System; Henry Ford Hospital; Shahid Beheshti University Medical Sciences	Salimpour, Y (corresponding author), Inst Res Fundamental Sci IPM, Sch Cognit Sci SCS, Tehran, Iran.	hamids@rad.hfh.edu	salehi, sina/F-2703-2013; Soltanian-Zadeh, Hamid/K-2903-2016; Soltanian-Zadeh, Hamid/AAD-7027-2022	salehi, sina/0000-0001-8027-6944; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Soltanian-Zadeh, Hamid/0000-0002-7302-6856; Abouzari, Mehdi/0000-0002-3585-698X	Iran National Science Foundation (INSF), Tehran, Iran	Iran National Science Foundation (INSF), Tehran, Iran(Iran National Science Foundation (INSF))	This work was supported in part by a grant from Iran National Science Foundation (INSF), Tehran, Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Barbieri R, 2004, NEURAL COMPUT, V16, P277, DOI 10.1162/089976604322742038; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Brown EN, 2004, MATH COMP BIOL SER, P253; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Brown EN, 2001, P NATL ACAD SCI USA, V98, P12261, DOI 10.1073/pnas.201409398; Butts DA, 2003, NETWORK-COMP NEURAL, V14, P177, DOI 10.1088/0954-898X/14/2/301; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Czanner G, 2008, J NEUROPHYSIOL, V99, P2672, DOI 10.1152/jn.00343.2007; Daley D., 2003, INTRO THEORY POINT P, V1; Dayan P., 2001, THEORETICAL NEUROSCI; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Ergun A, 2007, IEEE T BIO-MED ENG, V54, P419, DOI 10.1109/TBME.2006.888821; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Frank LM, 2002, J NEUROSCI, V22, P3817; Godsill SJ, 2004, J AM STAT ASSOC, V99, P156, DOI 10.1198/016214504000000151; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Ince RAA, 2010, NEURAL NETWORKS, V23, P713, DOI 10.1016/j.neunet.2010.05.008; Jacobsen M, 2005, POINT PROCESS THEORY; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Kiani R, 2005, J NEUROPHYSIOL, V94, P1587, DOI 10.1152/jn.00540.2004; Kiani R, 2007, J NEUROPHYSIOL, V97, P4296, DOI 10.1152/jn.00024.2007; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2004, NEURAL COMPUT, V16, P2533, DOI 10.1162/0899766042321797; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Rolls ET, 2002, COMPUTATIONAL NEUROS; Salimpour Y, 2009, I IEEE EMBS C NEUR E, P711; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shoham S, 2005, IEEE T BIO-MED ENG, V52, P1312, DOI 10.1109/TBME.2005.847542; Singh R, 2004, TECHNOMETRICS, V46, P318, DOI 10.1198/004017004000000347; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Smith AC, 2003, NEURAL COMPUT, V15, P965, DOI 10.1162/089976603765202622; Smith AC, 2007, J NEUROPHYSIOL, V97, P2516, DOI 10.1152/jn.00946.2006; Srinivasan L, 2007, IEEE T BIO-MED ENG, V54, P526, DOI 10.1109/TBME.2006.890508; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yu BM, 2007, J NEUROPHYSIOL, V97, P3763, DOI 10.1152/jn.00482.2006	49	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21256	10.1371/journal.pone.0021256	http://dx.doi.org/10.1371/journal.pone.0021256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738626	Green Submitted, gold, Green Published			2022-12-25	WOS:000292092600023
J	Broen, K; Greupink-Draaisma, A; Woestenenk, R; Schaap, N; Brickner, AG; Dolstra, H				Broen, Kelly; Greupink-Draaisma, Annelies; Woestenenk, Rob; Schaap, Nicolaas; Brickner, Anthony G.; Dolstra, Harry			Concurrent Detection of Circulating Minor Histocompatibility Antigen-Specific CD8(+) T Cells in SCT Recipients by Combinatorial Encoding MHC Multimers	PLOS ONE			English	Article							CLASS-I MOLECULES; MYELOID-LEUKEMIA; DIALLELIC GENE; H-Y; PEPTIDES; PRODUCTS; RESPONSES; PROTEIN; IDENTIFICATION; COMPLEXES	Allogeneic stem cell transplantation (SCT) is a potentially curative treatment for patients with hematologic malignancies. Its therapeutic effect is largely dependent on recognition of minor histocompatibility antigens (MiHA) by donor-derived CD8(+) T cells. Therefore, monitoring of multiple MiHA-specific CD8(+) T cell responses may prove to be valuable for evaluating the efficacy of allogeneic SCT. In this study, we investigated the use of the combinatorial encoding MHC multimer technique to simultaneously detect MiHA-specific CD8(+) T cells in peripheral blood of SCT recipients. Feasibility of this approach was demonstrated by applying dual-color encoding MHC multimers for a set of 10 known MiHA. Interestingly, single staining using a fluorochrome-and Qdot-based five-color combination showed comparable results to dual-color staining for most MiHA-specific CD8(+) T cell responses. In addition, we determined the potential value of combinatorial encoding MHC multimers in MiHA identification. Therefore, a set of 75 candidate MiHA peptides was predicted from polymorphic genes with a hematopoietic expression profile and further selected for high and intermediate binding affinity for HLA-A2. Screening of a large cohort of SCT recipients resulted in the detection of dual-color encoded CD8(+) T cells following MHC multimer-based T cell enrichment and short ex vivo expansion. Interestingly, candidate MiHA-specific CD8(+) T cell responses for LAG3 and TLR10 derived polymorphic peptides could be confirmed by genotyping of the respective SNPs. These findings demonstrate the potency of the combinatorial MHC multimer approach in the monitoring of CD8(+) T cell responses to known and potential MiHA in limited amounts of peripheral blood from allogeneic SCT recipients.	[Broen, Kelly; Greupink-Draaisma, Annelies; Woestenenk, Rob; Dolstra, Harry] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, Nijmegen, Netherlands; [Schaap, Nicolaas] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, Nijmegen, Netherlands; [Brickner, Anthony G.] Univ Pittsburgh, Dept Med, Inst Canc, Pittsburgh, PA USA; [Brickner, Anthony G.] Univ Pittsburgh, Dept Immunol, Inst Canc, Pittsburgh, PA USA	Radboud University Nijmegen; Radboud University Nijmegen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Broen, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Hematol Lab, Nijmegen, Netherlands.	h.dolstra@labgk.umcn.nl	Woestenenk, Rob/C-6119-2016; Brickner, Anthony/A-8088-2008; Schaap, Nicolaas/L-4625-2015; Dolstra, H./L-4276-2015	Schaap, Nicolaas/0000-0001-7696-4752; Dolstra, H./0000-0002-3998-687X	National Institutes of Health [R01CA118880]; Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA118880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01CA118880 and a grant from the Gabrielle's Angel Foundation for Cancer Research (to A.G.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka Y, 2003, J EXP MED, V197, P1489, DOI 10.1084/jem.20021925; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; Bleakley M, 2010, BLOOD, V115, P4923, DOI 10.1182/blood-2009-12-260539; Brickner AG, 2006, BLOOD, V107, P3779, DOI 10.1182/blood-2005-08-3501; Brickner AG, 2001, J EXP MED, V193, P195, DOI 10.1084/jem.193.2.195; den Haan JMM, 1998, SCIENCE, V279, P1054, DOI 10.1126/science.279.5353.1054; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; Engelhard VH, 2002, MOL IMMUNOL, V39, P127, DOI 10.1016/S0161-5890(02)00096-2; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Hadrup SR, 2010, CANCER IMMUNOL IMMUN, V59, P1425, DOI 10.1007/s00262-010-0824-2; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; Hambach L, 2008, BLOOD, V112, P1844, DOI 10.1182/blood-2007-11-125492; Hinrichs CS, 2011, BLOOD, V117, P808, DOI 10.1182/blood-2010-05-286286; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Keilholz U, 2009, BLOOD, V113, P6541, DOI 10.1182/blood-2009-02-202598; Kircher B, 2002, BRIT J HAEMATOL, V117, P935, DOI 10.1046/j.1365-2141.2002.03536.x; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; Meadows L, 1997, IMMUNITY, V6, P273, DOI 10.1016/S1074-7613(00)80330-1; Ofran Y, 2010, CLIN CANCER RES, V16, P1642, DOI 10.1158/1078-0432.CCR-09-2701; PARKER KC, 1994, J IMMUNOL, V152, P163; Pierce RA, 2001, J IMMUNOL, V167, P3223, DOI 10.4049/jimmunol.167.6.3223; Rijke BC, 2005, J CLIN INVEST, V115, P3506, DOI 10.1172/JCI24832; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Scheibenbogen C, 2002, BLOOD, V100, P2132, DOI 10.1182/blood-2002-01-0163; Schwab SR, 2003, SCIENCE, V301, P1367, DOI 10.1126/science.1085650; van Bergen CAM, 2007, BLOOD, V109, P4089, DOI 10.1182/blood-2006-08-043935; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Wang ZD, 2010, CHINESE MED J-PEKING, V123, P912, DOI 10.3760/cma.j.issn.0366-6999.2010.07.027; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Yewdell JW, 1996, J IMMUNOL, V157, P1823	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21266	10.1371/journal.pone.0021266	http://dx.doi.org/10.1371/journal.pone.0021266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731686	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000292036900018
J	McInnes, N; Sadlon, TJ; Brown, CY; Pederson, S; Beyer, M; Schultze, JL; McColl, S; Goodall, GJ; Barry, SC				McInnes, N.; Sadlon, T. J.; Brown, C. Y.; Pederson, S.; Beyer, M.; Schultze, J. L.; McColl, S.; Goodall, G. J.; Barry, S. C.			FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells	ONCOGENE			English	Article						SATB1; FOXP3; microRNA; gene regulation networks; breast cancer; tumour suppressor	MESSENGER-RNA EXPRESSION; REGULATORY T-CELLS; TARGET GENES; GASTRIC-CANCER; CUTTING EDGE; RECEPTOR; GROWTH; RESISTANCE; REPRESSOR; MIRNAS	The transcription factor FOXP3 has been identified as a tumour suppressor in the breast and prostate epithelia, but little is known about its specific mechanism of action. We have identified a feed-forward regulatory loop in which FOXP3 suppresses the expression of the oncogene SATB1. In particular, we demonstrate that SATB1 is not only a direct target of FOXP3 repression, but that FOXP3 also induces two miRs, miR-7 and miR-155, which specifically target the 30-UTR of SATB1 to further regulate its expression. We conclude that FOXP3-regulated miRs form part of the mechanism by which FOXP3 prevents the transformation of the healthy breast epithelium to a cancerous phenotype. Approaches aimed at restoring FOXP3 function and the miRs it regulates could help provide new approaches to target breast cancer. Oncogene (2012) 31, 1045-1054; doi:10.1038/onc.2011.293; published online 11 July 2011	[McInnes, N.; Sadlon, T. J.; Brown, C. Y.; Pederson, S.; Barry, S. C.] Womens & Childrens Hosp, Womens & Childrens Hlth Res Inst, Mol Immunol Lab, Adelaide, SA 5006, Australia; [McInnes, N.; Pederson, S.; Barry, S. C.] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Beyer, M.; Schultze, J. L.] Univ Bonn, Lab Genom & Immunoregulat, LIMES Inst, Bonn, Germany; [McColl, S.] Univ Adelaide, Dept Immunol, Adelaide, SA, Australia; [Goodall, G. J.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Goodall, G. J.] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia; [Barry, S. C.] Womens & Childrens Hosp, Dept Gastroenterol, Adelaide, SA 5006, Australia	University of Adelaide; University of Bonn; University of Adelaide; Centre for Cancer Biology; SA Pathology; University of Adelaide; Womens & Childrens Hospital Australia	Barry, SC (corresponding author), Womens & Childrens Hosp, Womens & Childrens Hlth Res Inst, Mol Immunol Lab, 72 King William Rd, Adelaide, SA 5006, Australia.	simon.barry@adelaide.edu.au	barry, simon/Y-4529-2019; Beyer, Marc/ABE-1408-2021; Schultze, Joachim L./ABA-8176-2020; Schultze, Joachim L/D-7794-2011	barry, simon/0000-0002-0597-7609; Beyer, Marc/0000-0001-9704-148X; Schultze, Joachim L./0000-0003-2812-9853; Schultze, Joachim L/0000-0003-2812-9853; Goodall, Gregory/0000-0003-1294-0692; Pederson, Stephen/0000-0001-8197-3303	NHMRC [565314]; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	We acknowledge the contributions to this research made by the following co-workers: Danika Hill, Silvia Nobbs, Elizabeth Melville, Suzanne Bresatz, Nicola Eastaff-Leung, Bridget Wilkinson and Marlena Sekutowski. This work was funded by NHMRC Grant 565314 (SCB).	Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Cheng C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r90; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Hanker LC, 2010, BREAST, DOI org/10.1016/j.breast.2010.10.002; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Iorns E, 2010, JNCI-J NATL CANCER I, V102, P1284, DOI 10.1093/jnci/djq243; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Jung DJ, 2010, J BIOL CHEM, V285, P7995, DOI 10.1074/jbc.M109.047985; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kohwi-Shigematsu T, 2010, J NATL CANCER I, V102, P1879, DOI 10.1093/jnci/djq440; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Ladoire S, 2011, BREAST CANCER RES TR, V125, P65, DOI 10.1007/s10549-010-0831-1; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Li QQ, 2010, CANCER SCI, V101, P80, DOI 10.1111/j.1349-7006.2009.01372.x; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Liu Y, 2010, TRENDS GENET, V26, P260, DOI 10.1016/j.tig.2010.03.004; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Martin F, 2010, ONCOGENE, V29, P4121, DOI 10.1038/onc.2010.174; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Patani N, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-18; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Richon VM, 2008, NAT BIOTECHNOL, V26, P655, DOI 10.1038/nbt0608-655; Sadlon TJ, 2010, J IMMUNOL, V185, P1071, DOI 10.4049/jimmunol.1000082; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Selcuklu SD, 2009, CANCER GENET CYTOGEN, V189, P15, DOI 10.1016/j.cancergencyto.2008.09.009; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	57	80	88	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	8					1045	1054		10.1038/onc.2011.293	http://dx.doi.org/10.1038/onc.2011.293			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	898BG	21743493	Green Published			2022-12-25	WOS:000300709700010
J	Cavanaugh, NA; Beard, WA; Batra, VK; Perera, L; Pedersen, LG; Wilson, SH				Cavanaugh, Nisha A.; Beard, William A.; Batra, Vinod K.; Perera, Lalith; Pedersen, Lee G.; Wilson, Samuel H.			Molecular Insights into DNA Polymerase Deterrents for Ribonucleotide Insertion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; RNA-POLYMERASE; TRIGGER LOOP; BETA; SUBSTRATE; SUGAR; DISCRIMINATION; PYRIMIDINES	DNA polymerases can misinsert ribonucleotides that lead to genomic instability. DNA polymerase beta discourages ribonucleotide insertion with the backbone carbonyl of Tyr-271; alanine substitution of Tyr-271, but not Phe-272, resulted in a > 10-fold loss in discrimination. The Y271A mutant also inserted ribonucleotides more efficiently than wild type on a variety of ribonucleoside (rNMP)-containing DNA substrates. Substituting Mn2+ for Mg2+ decreased sugar discrimination for both wild-type and mutant enzymes primarily by increasing the affinity for rCTP. This facilitated crystallization of ternary substrate complexes of both the wild-type and Y271A mutant enzymes. Crystallographic structures of Y271A- and wild type-substrate complexes indicated that rCTP is well accommodated in the active site but that O2' of rCTP and the carbonyl oxygen of Tyr-271 or Ala-271 are unusually close (similar to 2.5 and 2.6 angstrom, respectively). Structure-based modeling indicates that the local energetic cost of positioning these closely spaced oxygens is similar to 2.2 kcal/mol for the wild-type enzyme. Because the side chain of Tyr-271 also hydrogen bonds with the primer terminus, loss of this interaction affects its catalytic positioning. Our results support a model where DNA polymerase beta utilizes two strategies, steric and geometric, with a single protein residue to deter ribonucleotide insertion.	[Cavanaugh, Nisha A.; Beard, William A.; Batra, Vinod K.; Perera, Lalith; Pedersen, Lee G.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Pedersen, Lee G.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, NIH, 111 TW Alexander Dr,POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Perera, Lalith/ABB-9995-2021; perera, Lalith/B-6879-2012; Wilson, Samuel H/E-6644-2019; Pedersen, Lee G/E-3405-2013	perera, Lalith/0000-0003-0823-1631; Wilson, Samuel H/0000-0002-1702-5293; Pedersen, Lee G/0000-0003-1262-9861	National Institutes of Health [P41 RR-01081, Z01-ES0500158, Z01-ES050161]; NIEHS [1U19CA105010]; NATIONAL CANCER INSTITUTE [U19CA105010] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES043010, ZIAES050158, Z01ES050161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs. R. E. London and B. D. Freudenthal for critical reading of this manuscript and E. W. Hou for purification of the F272A mutant. Molecular graphics images were produced using the Chimera package (20) from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR-01081).; This work was supported, in whole or in part, by National Institutes of Health Research Project Grants Z01-ES0500158 and Z01-ES050161 (to S. H. W.) from the Intramural Research Program, NIEHS, in association with Grant 1U19CA105010.	ADAMS PD, 2010, ACTA CRYSTALLOGR D 2, V66, P213, DOI DOI 10.1107/S0907444909052925; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Beard WA, 2003, STRUCTURE, V11, P489, DOI 10.1016/S0969-2126(03)00051-0; Beard WA, 2002, J BIOL CHEM, V277, P8235, DOI 10.1074/jbc.M107286200; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; CASE DA, 2008, AMBER 10 U CAL SAN F; Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gardner AF, 2004, J BIOL CHEM, V279, P11834, DOI 10.1074/jbc.M308286200; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023; Kirouac KN, 2011, J MOL BIOL, V407, P382, DOI 10.1016/j.jmb.2011.01.037; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel PH, 2000, J BIOL CHEM, V275, P40266, DOI 10.1074/jbc.M005757200; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Schutz M, 1997, J CHEM PHYS, V107, P4597, DOI 10.1063/1.474820; Sherrer SM, 2010, BIOCHEMISTRY-US, V49, P10179, DOI 10.1021/bi101465n; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171	47	40	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31650	31660		10.1074/jbc.M111.253401	http://dx.doi.org/10.1074/jbc.M111.253401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21733843	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000294487500058
J	Lamsoul, I; Burande, CF; Razinia, Z; Houles, TC; Menoret, D; Baldassarre, M; Erard, M; Moog-Lutz, C; Calderwood, DA; Lutz, PG				Lamsoul, Isabelle; Burande, Clara F.; Razinia, Ziba; Houles, Thibault C.; Menoret, Delphine; Baldassarre, Massimiliano; Erard, Monique; Moog-Lutz, Christel; Calderwood, David A.; Lutz, Pierre G.			Functional and Structural Insights into ASB2 alpha, a Novel Regulator of Integrin-dependent Adhesion of Hematopoietic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; STEM-CELLS; BONE-MARROW; PROTEASOMAL DEGRADATION; TRANSGENIC MICE; FILAMIN BINDING; DIFFERENTIATION; FIBRONECTIN	By providing contacts between hematopoietic cells and the bone marrow microenvironment, integrins are implicated in cell adhesion and thereby in control of cell fate of normal and leukemia cells. The ASB2 gene, initially identified as a retinoic acid responsive gene and a target of the promyelocytic leukemia retinoic acid receptor alpha oncoprotein in acute promyelocytic leukemia cells, encodes two isoforms, a hematopoietic-type (ASB2 alpha) and a muscle-type (ASB2 alpha) that are involved in hematopoietic and myogenic differentiation, respectively. ASB2 alpha is the specificity subunit of an E3 ubiquitin ligase complex that targets filamins to proteasomal degradation. To examine the relationship of the ASB2 alpha structure to E3 ubiquitin ligase function, functional assays and molecular modeling were performed. We show that ASB2 alpha, through filamin A degradation, enhances adhesion of hematopoietic cells to fibronectin, the main ligand of beta 1 integrins. Furthermore, we demonstrate that a short N-terminal region specific to ASB2 alpha, together with ankyrin repeats 1 to 10, is necessary for association of ASB2 alpha with filamin A. Importantly, the ASB2 alpha N-terminal region comprises a 9-residue segment with predicted structural homology to the filamin-binding motifs of migfilin and beta integrins. Together, these data provide new insights into the molecular mechanisms of ASB2 alpha binding to filamin.	[Lutz, Pierre G.] CNRS, Inst Pharmacol & Biol Struct, UMR 5089, F-31077 Toulouse, France; [Lamsoul, Isabelle; Burande, Clara F.; Houles, Thibault C.; Menoret, Delphine; Erard, Monique; Moog-Lutz, Christel; Lutz, Pierre G.] Univ Toulouse 3, Univ Toulouse, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Razinia, Ziba; Baldassarre, Massimiliano; Calderwood, David A.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Razinia, Ziba; Baldassarre, Massimiliano; Calderwood, David A.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Transplanta, New Haven, CT 06520 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Yale University; Yale University	Lutz, PG (corresponding author), CNRS, Inst Pharmacol & Biol Struct, UMR 5089, 205 Route Narbonne, F-31077 Toulouse, France.	Pierre.Lutz@ipbs.fr	Calderwood, David A/AAC-6954-2019; Baldassarre, Massimiliano/AAI-6581-2021; Baldassarre, Massimiliano/E-6236-2011; Lutz, Pierre/B-8822-2009	Calderwood, David A/0000-0002-0791-4142; Baldassarre, Massimiliano/0000-0002-2498-4767; Baldassarre, Massimiliano/0000-0002-2498-4767; Lamsoul, Isabelle/0000-0002-7769-5627; Lutz, Pierre/0000-0003-0590-9101; /0000-0001-9299-744X	National Institutes of Health [GM068600]; Centre National de la Recherche Scientifique; Universite Paul Sabatier; Comite Leucemie de la Fondation de France; Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Comite Leucemie de la Fondation de France(Fondation de France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (Grant GM068600 to D. A. C.), and by grants from the Centre National de la Recherche Scientifique, the Universite Paul Sabatier, the Comite Leucemie de la Fondation de France and the Association pour la Recherche sur le Cancer (to P. G. L.).	Baldassarre M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007830; Becker PS, 2009, BLOOD, V113, P866, DOI 10.1182/blood-2007-12-124818; Bello NF, 2009, CELL DEATH DIFFER, V16, P921, DOI 10.1038/cdd.2009.27; Bendall LJ, 1998, LEUKEMIA, V12, P1375, DOI 10.1038/sj.leu.2401136; Brown D, 1997, P NATL ACAD SCI USA, V94, P2551, DOI 10.1073/pnas.94.6.2551; Burande CF, 2009, MOL CELL PROTEOMICS, V8, P1719, DOI 10.1074/mcp.M800410-MCP200; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Denis FM, 2005, J BIOL CHEM, V280, P9043, DOI 10.1074/jbc.M413564200; Fernandez-Vidal A, 2006, CANCER RES, V66, P7128, DOI 10.1158/0008-5472.CAN-05-2552; Grisolano JL, 1997, BLOOD, V89, P376, DOI 10.1182/blood.V89.2.376; Guibal FC, 2002, J BIOL CHEM, V277, P218, DOI 10.1074/jbc.M108476200; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; He LZ, 1997, P NATL ACAD SCI USA, V94, P5302, DOI 10.1073/pnas.94.10.5302; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Matsunaga T, 2008, LEUKEMIA, V22, P353, DOI 10.1038/sj.leu.2405017; Matsunaga T, 2003, NAT MED, V9, P1158, DOI 10.1038/nm909; Moog-Lutz C, 2003, BLOOD, V102, P3371, DOI 10.1182/blood-2002-11-3462; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nie L, 2011, CELL RES, V21, P754, DOI 10.1038/cr.2010.165; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Reavie L, 2010, NAT IMMUNOL, V11, P207, DOI 10.1038/ni.1839; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; TEIXIDO J, 1992, J CLIN INVEST, V90, P358, DOI 10.1172/JCI115870; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014	42	16	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30571	30581		10.1074/jbc.M111.220921	http://dx.doi.org/10.1074/jbc.M111.220921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737450	Green Published, hybrid			2022-12-25	WOS:000294283600036
J	Coluzza, I				Coluzza, Ivan			A Coarse-Grained Approach to Protein Design: Learning from Design to Understand Folding	PLOS ONE			English	Article							MONTE-CARLO; STATE	Computational studies have given a great contribution in building our current understanding of the complex behavior of protein molecules; nevertheless, a complete characterization of their free energy landscape still represents a major challenge. Here, we introduce a new coarse-grained approach that allows for an extensive sampling of the conformational space of a large number of sequences. We explicitly discuss its application in protein design, and by studying four representative proteins, we show that the method generates sequences with a relatively smooth free energy surface directed towards the target structures.	Univ Vienna, Dept Phys, Vienna, Austria	University of Vienna	Coluzza, I (corresponding author), Univ Vienna, Dept Phys, Vienna, Austria.	ivan.coluzza@univie.ac.at	Coluzza, Ivan/I-4170-2015	Coluzza, Ivan/0000-0001-7728-6033	Austrian Science Foundation (FWF) within the SFB ViCoM [F 41]; Intra-European mobility grant [24496]	Austrian Science Foundation (FWF) within the SFB ViCoM(Austrian Science Fund (FWF)); Intra-European mobility grant	The author acknowledges financial supported by the Austrian Science Foundation (FWF) within the SFB ViCoM (F 41), and Intra-European mobility grant FP6 Project No.: 24496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeln S, 2011, BIOPHYS J, V100, P693, DOI 10.1016/j.bpj.2010.11.088; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Banavar JR, 2009, P NATL ACAD SCI USA, V106, P6900, DOI 10.1073/pnas.0901429106; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betancourt MR, 1999, PROTEIN SCI, V8, P361; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Coluzza I, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051917; Coluzza I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046703; Coluzza I, 2005, CHEMPHYSCHEM, V6, P1779, DOI 10.1002/cphc.200400629; Coluzza I, 2007, BIOPHYS J, V92, P1150, DOI 10.1529/biophysj.106.084236; CREIGHTON, 1992, PROTEINS; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Deutsch JM, 1996, PHYS REV LETT, V76, P323, DOI 10.1103/PhysRevLett.76.323; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dolittle RF, 1989, PREDICTION PROTEIN S, P599; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Frenkel D, 2004, P NATL ACAD SCI USA, V101, P17571, DOI 10.1073/pnas.0407950101; Frenkel D., 2000, UNDERSTANDING MOL SI; GO N, 1978, P NATL ACAD SCI USA, V75, P559, DOI 10.1073/pnas.75.2.559; GUTIN AM, 1993, J CHEM PHYS, V98, P8174, DOI 10.1063/1.464522; Hoang TX, 2006, P NATL ACAD SCI USA, V103, P6883, DOI 10.1073/pnas.0601824103; Hoang TX, 2004, P NATL ACAD SCI USA, V101, P7960, DOI 10.1073/pnas.0402525101; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irback A, 2000, P NATL ACAD SCI USA, V97, P13614, DOI 10.1073/pnas.240245297; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Magee JE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207802; Maritan A, 2000, NATURE, V406, P287, DOI 10.1038/35018538; Mirny L, 2001, J MOL BIOL, V308, P123, DOI 10.1006/jmbi.2001.4602; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Seno F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078102; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Vendruscolo M, 1997, J CHEM PHYS, V106, P2970, DOI 10.1063/1.473356; Wilke CO, 2005, BIOPHYS J, V89, P3714, DOI 10.1529/biophysj.105.062125	37	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e20853	10.1371/journal.pone.0020853	http://dx.doi.org/10.1371/journal.pone.0020853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747930	Green Published, Green Submitted, gold			2022-12-25	WOS:000292293400005
J	O'Dwyer, L; Lamberton, F; Bokde, ALW; Ewers, M; Faluyi, YO; Tanner, C; Mazoyer, B; O'Neill, D; Bartley, M; Collins, DR; Coughlan, T; Prvulovic, D; Hampel, H				O'Dwyer, Laurence; Lamberton, Franck; Bokde, Arun L. W.; Ewers, Michael; Faluyi, Yetunde O.; Tanner, Colby; Mazoyer, Bernard; O'Neill, Des; Bartley, Mairead; Collins, D. Ronan; Coughlan, Tara; Prvulovic, David; Hampel, Harald			Multiple Indices of Diffusion Identifies White Matter Damage in Mild Cognitive Impairment and Alzheimer's Disease	PLOS ONE			English	Article							WALLERIAN DEGENERATION; VOXELWISE ANALYSIS; MYELIN BREAKDOWN; TRACT INTEGRITY; FIBER TRACTS; TENSOR; BRAIN; AGE; ABNORMALITIES; DEMENTIA	The study of multiple indices of diffusion, including axial (DA), radial (DR) and mean diffusion (MD), as well as fractional anisotropy (FA), enables WM damage in Alzheimer's disease (AD) to be assessed in detail. Here, tract-based spatial statistics (TBSS) were performed on scans of 40 healthy elders, 19 non-amnestic MCI (MCIna) subjects, 14 amnestic MCI (MCIa) subjects and 9 AD patients. Significantly higher DA was found in MCIna subjects compared to healthy elders in the right posterior cingulum/precuneus. Significantly higher DA was also found in MCIa subjects compared to healthy elders in the left prefrontal cortex, particularly in the forceps minor and uncinate fasciculus. In the MCIa versus MCIna comparison, significantly higher DA was found in large areas of the left prefrontal cortex. For AD patients, the overlap of FA and DR changes and the overlap of FA and MD changes were seen in temporal, parietal and frontal lobes, as well as the corpus callosum and fornix. Analysis of differences between the AD versus MCIna, and AD versus MCIa contrasts, highlighted regions that are increasingly compromised in more severe disease stages. Microstructural damage independent of gross tissue loss was widespread in later disease stages. Our findings suggest a scheme where WM damage begins in the core memory network of the temporal lobe, cingulum and prefrontal regions, and spreads beyond these regions in later stages. DA and MD indices were most sensitive at detecting early changes in MCIa.	[O'Dwyer, Laurence; Prvulovic, David; Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Lamberton, Franck; Mazoyer, Bernard] Univ Caen & Paris Descartes, Ctr Imaging Neurosci & Applicat Pathol, UMR 6232, CNRS,CEA, Paris, France; [Bokde, Arun L. W.] Trinity Coll Dublin, Cognit Syst Grp, Discipline Psychiat, Sch Med, Dublin, Ireland; [Bokde, Arun L. W.] Trinity Coll Dublin, Trinity Coll Inst Neurosci TCIN, Dublin, Ireland; [Ewers, Michael] Univ Calif San Francisco, Dept Radiol, VA Med Ctr, San Francisco, CA USA; [Faluyi, Yetunde O.] Addenbrookes Hosp, Liaison Psychiat Serv, Cambridge, England; [Faluyi, Yetunde O.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Tanner, Colby] Trinity Coll Dublin, Dept Zool, Dublin, Ireland; [Mazoyer, Bernard] Ctr Hosp Univ, Caen, France; [Mazoyer, Bernard] Inst Univ France, Paris, France; [O'Neill, Des; Bartley, Mairead; Collins, D. Ronan; Coughlan, Tara] Trinity Coll Dublin, Dept Med Gerontol, Dublin, Ireland	Goethe University Frankfurt; CEA; Centre National de la Recherche Scientifique (CNRS); Trinity College Dublin; Trinity College Dublin; University of California System; University of California San Francisco; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Trinity College Dublin; CHU de Caen NORMANDIE; Institut Universitaire de France; Trinity College Dublin	O'Dwyer, L (corresponding author), Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.	larodwyer@gmail.com	Mazoyer, Bernard M/B-6303-2012; mazoyer, bernard m/A-5369-2009; Tanner, Colby/H-4653-2012; Lamberton, Franck/GRO-7517-2022; O'Dwyer, Laurence/J-1699-2012; O'Neill, Desmond/D-1486-2013	Mazoyer, Bernard M/0000-0003-0970-2837; mazoyer, bernard m/0000-0003-0970-2837; Bokde, Arun/0000-0003-0114-4914; collins, Ronan/0000-0003-0404-8266; Hampel, Harald/0000-0003-0894-8982; Lamberton, Franck/0000-0002-4655-4397; O'Neill, Desmond/0000-0002-5542-9897	Science Foundation Ireland (SFI) [08/IN.1/B1846]; School of Medicine, Goethe University, Frankfurt, Germany; LOEWE; Irish Research Council for Science Engineering and Technology (IRCSET)	Science Foundation Ireland (SFI)(Science Foundation Ireland); School of Medicine, Goethe University, Frankfurt, Germany; LOEWE; Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Science Foundation Ireland (SFI) investigator neuroimaging program award 08/IN.1/B1846 to H.H. and institutional research funds of the School of Medicine, Goethe University, Frankfurt, Germany to H.H. This work was also supported by the Neurodegeneration & Alzheimer's disease research grant of the LOEWE program "Neuronal Coordination Research Focus Frankfurt" (NeFF) to H.H. and D.P. C.J.T. was supported by a fellowship from the Irish Research Council for Science Engineering and Technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; AGOSTA F, 2010, WHITE MATTER DAMAGE; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Bartzokis G, 2004, J ALZHEIMERS DIS, V6, pS53; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G., 2009, NEUROBIOL AGING; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bosch B, 2010, NEUROBIOL AGING; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BRUN A, 1986, ANN NEUROL, V19, P253, DOI 10.1002/ana.410190306; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Cabeza R, 2004, J COGNITIVE NEUROSCI, V16, P1583, DOI 10.1162/0898929042568578; Ciccarelli O, 2006, BRAIN, V129, P1859, DOI 10.1093/brain/awl100; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Douaud G, NEUROIMAGE IN PRESS; ENGLUND E, 1990, HISTOPATHOLOGY, V16, P433; Englund E, 1998, DEMENT GERIATR COGN, V9, P6, DOI 10.1159/000051183; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fellgiebel A, 2005, NEUROBIOL AGING, V26, P1193, DOI 10.1016/j.neurobiolaging.2004.11.006; Fellgiebel A, 2008, NEUROPSYCHOLOGIA, V46, P1698, DOI 10.1016/j.neuropsychologia.2007.12.010; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Gold BT, 2010, NEUROIMAGE, V52, P1487, DOI 10.1016/j.neuroimage.2010.05.036; Hampel H, 2010, NAT REV DRUG DISCOV, V9, P560, DOI 10.1038/nrd3115; Huang J, 2007, AM J NEURORADIOL, V28, P1943, DOI 10.3174/ajnr.A0700; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Kantarci K, 2005, NEUROLOGY, V64, P902, DOI 10.1212/01.WNL.0000153076.46126.E9; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Liu Y, 2009, NEUROBIOL AGING; Madden DJ, 2009, NEUROPSYCHOL REV, V19, P415, DOI 10.1007/s11065-009-9113-2; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Rovaris M, 2005, NEUROLOGY, V65, P1526, DOI 10.1212/01.wnl.0000184471.83948.e0; Salat DH, 2010, NEUROBIOL AGING, V31, P244, DOI 10.1016/j.neurobiolaging.2008.03.013; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Stenset V, 2011, NEUROBIOL AGING, V32, P581, DOI 10.1016/j.neurobiolaging.2009.04.014; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; Teipel SJ, 2007, NEUROIMAGE, V34, P985, DOI 10.1016/j.neuroimage.2006.07.047; Thomalla G, 2005, J NEUROL NEUROSUR PS, V76, P266, DOI 10.1136/jnnp.2004.046375; Thomas B, 2005, BRAIN, V128, P2562, DOI 10.1093/brain/awh600; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Yasmin H, 2008, NEURORADIOLOGY, V50, P293, DOI 10.1007/s00234-007-0353-7; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; ZHANG Y, 2008, NEUROBIOL AGING; Zhuang L, 2010, NEUROIMAGE, V53, P16, DOI 10.1016/j.neuroimage.2010.05.068; Zollinger LV, 2011, J MAGN RESON IMAGING, V33, P557, DOI 10.1002/jmri.22502	81	92	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21745	10.1371/journal.pone.0021745	http://dx.doi.org/10.1371/journal.pone.0021745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738785	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800037
J	Wu, DM; Qiu, YF; Gao, X; Yuan, XB; Zhai, QW				Wu, Dongmei; Qiu, Yifu; Gao, Xiang; Yuan, Xiao-Bing; Zhai, Qiwei			Overexpression of SIRT1 in Mouse Forebrain Impairs Lipid/Glucose Metabolism and Motor Function	PLOS ONE			English	Article							MITOCHONDRIAL-FUNCTION; INSULIN SENSITIVITY; ENERGY-METABOLISM; THYROID-HORMONE; MICE SHOW; DISEASE; PROTECTS; FAT; RESTRICTION; ACTIVATION	SIRT1 plays crucial roles in glucose and lipid metabolism, and has various functions in different tissues including brain. The brain-specific SIRT1 knockout mice display defects in somatotropic signaling, memory and synaptic plasticity. And the female mice without SIRT1 in POMC neuron are more sensitive to diet-induced obesity. Here we created transgenic mice overexpressing SIRT1 in striatum and hippocampus under the control of CaMKII alpha promoter. These mice, especially females, exhibited increased fat accumulation accompanied by significant upregulation of adipogenic genes in white adipose tissue. Glucose tolerance of the mice was also impaired with decreased Glut4 mRNA levels in muscle. Moreover, the SIRT1 overexpressing mice showed decreased energy expenditure, and concomitantly mitochondria-related genes were decreased in muscle. In addition, these mice showed unusual spontaneous physical activity pattern, decreased activity in open field and rotarod performance. Further studies demonstrated that SIRT1 deacetylated IRS-2, and upregulated phosphorylation level of IRS-2 and ERK1/2 in striatum. Meanwhile, the neurotransmitter signaling in striatum and the expression of endocrine hormones in hypothalamus and serum T3, T4 levels were altered. Taken together, our findings demonstrate that SIRT1 in forebrain regulates lipid/glucose metabolism and motor function.	[Wu, Dongmei; Qiu, Yifu; Zhai, Qiwei] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Peoples R China; [Yuan, Xiao-Bing] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Yuan, Xiao-Bing] Chinese Acad Sci, State Key Lab Neurobiol, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wu, DM (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	qwzhai@sibs.ac.cn		Yuan, Xiaobing/0000-0002-1632-8460; Zhai, Qiwei/0000-0002-9617-7403; Qiu, Yifu/0000-0001-5645-3189	National Natural Science Foundation of China [30825009, 30970619, 31030022, 81021002]; National Basic Research Program of China (973 Program) [2009CB918403, 2007CB914501, 2006CB503900]; Chinese Academy of Sciences [KSCX1-YW-02]; Director Foundation of Institute for Nutritional Sciences [20090101]; SA-SIBS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Director Foundation of Institute for Nutritional Sciences; SA-SIBS	This study was supported by grants from the National Natural Science Foundation of China (30825009, 30970619, 31030022 and 81021002), the National Basic Research Program of China (973 Program, 2009CB918403, 2007CB914501 and 2006CB503900), the Chinese Academy of Sciences (KSCX1-YW-02), the Director Foundation of Institute for Nutritional Sciences (20090101), and the SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baile CA, 2000, ANNU REV NUTR, V20, P105, DOI 10.1146/annurev.nutr.20.1.105; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BLOOM SR, 1987, BRIT MED J, V295, P288, DOI 10.1136/bmj.295.6593.288; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen G, 2007, GLIA, V55, P1509, DOI 10.1002/glia.20563; Choksi NY, 2003, BIRTH DEFECTS RES B, V68, P479, DOI 10.1002/bdrb.10045; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; da Costa VMC, 2001, J ENDOCRINOL, V171, P193, DOI 10.1677/joe.0.1710193; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Engel SR, 2009, MOL PSYCHIATR, V14, P448, DOI 10.1038/sj.mp.4002135; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Fujita S, 2010, BRAIN RES, V1322, P30, DOI 10.1016/j.brainres.2010.01.068; Gan L, 2008, NEURON, V58, P10, DOI 10.1016/j.neuron.2008.03.015; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gerfen CR, 2008, J NEUROSCI, V28, P7113, DOI 10.1523/JNEUROSCI.3952-07.2008; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Jin QH, 2010, CELL RES, V20, P470, DOI 10.1038/cr.2010.24; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kakefuda K, 2009, BIOCHEM BIOPH RES CO, V387, P784, DOI 10.1016/j.bbrc.2009.07.119; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; LAFFAN EW, 1989, BEHAV NEURAL BIOL, V52, P411, DOI 10.1016/S0163-1047(89)90532-3; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lanni A, 2003, FEBS LETT, V543, P5, DOI 10.1016/S0014-5793(03)00320-X; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; PRESS M, 1988, DIABETES METAB REV, V4, P391, DOI 10.1002/dmr.5610040406; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007	59	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21759	10.1371/journal.pone.0021759	http://dx.doi.org/10.1371/journal.pone.0021759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738790	Green Submitted, Green Published, gold			2022-12-25	WOS:000292291800041
J	Kim, SH; Kim, UK; Lee, WS; Bok, J; Song, JW; Seong, JK; Choi, JY				Kim, Sung Huhn; Kim, Un-Kyoung; Lee, Won-Sang; Bok, Jinwoong; Song, Jung-Whan; Seong, Je Kyung; Choi, Jae Young			Albumin-Like Protein is the Major Protein Constituent of Luminal Fluid in the Human Endolymphatic Sac	PLOS ONE			English	Article							VESTIBULAR AQUEDUCT SYNDROME; INNER-EAR; SERUM-ALBUMIN; HUMAN PLASMA; DUCT; SUBSTANCES; HYDROPS; COCHLEA	The endolymphatic sac (ES) is an inner ear organ that is connected to the cochleo-vestibular system through the endolymphatic duct. The luminal fluid of the ES contains a much higher concentration of proteins than any other compartment of the inner ear. This high protein concentration likely contributes to inner ear fluid volume regulation by creating an osmotic gradient between the ES lumen and the interstitial fluid. We characterized the protein profile of the ES luminal fluid of patients (n = 11) with enlarged vestibular aqueducts (EVA) by proteomics. In addition, we investigated differences in the protein profiles between patients with recent hearing deterioration and patients without hearing deterioration. The mean total protein concentration of the luminal fluid was 554.7 +/- 94.6 mg/dl. A total of 58 out of 517 spots detected by 2-DE were analyzed by MALDI-TOF MS. The protein profile of the luminal fluid was different from the profile of plasma. Proteins identified from 29 of the spots were also present in the MARC-filtered human plasma; however, the proteins identified from the other 25 spots were not detected in the MARC-filtered human plasma. The most abundant protein in the luminal fluid was albumin-like proteins, but most of them were not detected in MARC-filtered human plasma. The concentration of albumin-like proteins was higher in samples from patients without recent hearing deterioration than in patients with recent hearing deterioration. Consequently, the protein of ES luminal fluid is likely to be originated from both the plasma and the inner ear and considering that inner ear fluid volumes increase abnormally in patients with EVA following recent hearing deterioration, it is tempting to speculate that albumin-like proteins may be involved in the regulation of inner ear fluid volume through creation of an osmotic gradient during pathological conditions such as endolymphatic hydrops.	[Kim, Sung Huhn; Lee, Won-Sang; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Kim, Un-Kyoung] Kyungpook Natl Univ, Dept Biol, Taegu, South Korea; [Bok, Jinwoong] Yonsei Univ, Coll Med, Dept Anat, Seoul, South Korea; [Song, Jung-Whan] Ajou Univ, Coll Med, Dept Otorhinolaryngol, Suwon 441749, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Lab Dev Biol & Genom, Program Vet Sci BK21,Interdisciplinary Program Bi, Res Inst Vet Sci,Coll Vet Sci, Seoul, South Korea; [Seong, Je Kyung] Seoul Natl Univ, Program Canc Biol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Kyungpook National University; Yonsei University; Yonsei University Health System; Ajou University; Seoul National University (SNU); Seoul National University (SNU)	Kim, SH (corresponding author), Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.	jychoi@yuhs.ac	Bok, Jinwoong/M-2834-2019	Bok, Jinwoong/0000-0003-1958-1872; Seong, Je Kyung/0000-0003-1177-6958; choi, jae young/0000-0001-9493-3458; Kim, Sung Huhn/0000-0003-4408-3066	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A090200]; Ministry of Education, Science and Technology [2010-0011806]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (http://www.khidi.or.kr/index.do) (A090200) to JYC and a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (http://www.nrf.go.kr/html/kr/) (2010-0011806) to SHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho Sang Yun, 2008, V428, P57; Cho SY, 2005, PROTEOMICS, V5, P3386, DOI 10.1002/pmic.200401310; ERWALL C, 1988, HEARING RES, V35, P109, DOI 10.1016/0378-5955(88)90045-7; ERWALL C, 1988, ACTA OTO-LARYNGOL, V105, P209, DOI 10.3109/00016488809097000; ERWALL C, 1989, ACTA OTO-LARYNGOL, V107, P63, DOI 10.3109/00016488909127480; FRAYSSE BG, 1980, ANN OTO RHINOL LARYN, V89, P2, DOI 10.1177/00034894800896S201; FRIBERG U, 1986, ACTA OTO-LARYNGOL, V101, P172, DOI 10.3109/00016488609132825; FRIBERG U, 1988, ARCH OTOLARYNGOL, V114, P389; FRIBERG U, 1984, ARCH OTOLARYNGOL, V110, P421; FUKAZAWA K, 1991, ANAT REC, V230, P425, DOI 10.1002/ar.1092300315; GALEY FR, 1988, ACTA OTO-LARYNGOL, P1; GULCICEK EE, 2005, CURR PROTOC BIOINFOR, pCH13; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hirai S, 2006, LARYNGOSCOPE, V116, P2007, DOI 10.1097/01.mlg.0000237673.94781.0a; Koesling S, 2006, EUR J RADIOL, V57, P54, DOI 10.1016/j.ejrad.2005.09.005; Lang F, 2007, AM J PHYSIOL-CELL PH, V293, pC1187, DOI 10.1152/ajpcell.00024.2007; MAROVITZ WF, 1972, ANN OTO RHINOL LARYN, V81, P76, DOI 10.1177/000348947208100108; Okamoto K, 1998, NEURORADIOLOGY, V40, P167, DOI 10.1007/s002340050561; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Rask-Andersen H, 1999, HEARING RES, V138, P81, DOI 10.1016/S0378-5955(99)00153-7; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; Salt AN, 2001, ANN NY ACAD SCI, V942, P306; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spiegel JH, 2009, J LARYNGOL OTOL, V123, P919, DOI 10.1017/S0022215108004088; Sugiura M, 2006, J LARYNGOL OTOL, V120, P1084, DOI 10.1017/S0022215106003331; TEICHMANN I, 1964, ACTA BIOL ACAD SCI H, V14, P293; Thalmann I, 2006, ELECTROPHORESIS, V27, P1598, DOI 10.1002/elps.200500768	27	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21656	10.1371/journal.pone.0021656	http://dx.doi.org/10.1371/journal.pone.0021656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738753	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100053
J	Li, YQ; Wang, GY; Long, JY; Yu, ZL; Huang, BA; Li, XJ; Yu, TY; Liang, CH; Li, Z; Sun, P				Li, Yuanqing; Wang, Guangyi; Long, Jinyi; Yu, Zhuliang; Huang, Biao; Li, Xiaojian; Yu, Tianyou; Liang, Changhong; Li, Zheng; Sun, Pei			Reproducibility and Discriminability of Brain Patterns of Semantic Categories Enhanced by Congruent Audiovisual Stimuli	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; LANGUAGE; BINDING; IMAGES	One of the central questions in cognitive neuroscience is the precise neural representation, or brain pattern, associated with a semantic category. In this study, we explored the influence of audiovisual stimuli on the brain patterns of concepts or semantic categories through a functional magnetic resonance imaging (fMRI) experiment. We used a pattern search method to extract brain patterns corresponding to two semantic categories: "old people" and "young people." These brain patterns were elicited by semantically congruent audiovisual, semantically incongruent audiovisual, unimodal visual, and unimodal auditory stimuli belonging to the two semantic categories. We calculated the reproducibility index, which measures the similarity of the patterns within the same category. We also decoded the semantic categories from these brain patterns. The decoding accuracy reflects the discriminability of the brain patterns between two categories. The results showed that both the reproducibility index of brain patterns and the decoding accuracy were significantly higher for semantically congruent audiovisual stimuli than for unimodal visual and unimodal auditory stimuli, while the semantically incongruent stimuli did not elicit brain patterns with significantly higher reproducibility index or decoding accuracy. Thus, the semantically congruent audiovisual stimuli enhanced the within-class reproducibility of brain patterns and the between-class discriminability of brain patterns, and facilitate neural representations of semantic categories or concepts. Furthermore, we analyzed the brain activity in superior temporal sulcus and middle temporal gyrus (STS/MTG). The strength of the fMRI signal and the reproducibility index were enhanced by the semantically congruent audiovisual stimuli. Our results support the use of the reproducibility index as a potential tool to supplement the fMRI signal amplitude for evaluating multimodal integration.	[Li, Yuanqing; Long, Jinyi; Yu, Zhuliang; Yu, Tianyou] S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou, Guangdong, Peoples R China; [Wang, Guangyi] So Med Univ, Grad Sch, Guangzhou, Guangdong, Peoples R China; [Wang, Guangyi; Huang, Biao; Liang, Changhong] Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Li, Xiaojian] S China Normal Univ, Res Ctr Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Li, Zheng] Duke Univ, Dept Neurobiol, Durham, NC USA; [Sun, Pei] RIKEN Brain Sci Inst, Lab Cognit Brain Mapping, Saitama, Japan	South China University of Technology; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; South China Normal University; Duke University; RIKEN	Li, YQ (corresponding author), S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou, Guangdong, Peoples R China.	auyqli@scut.edu.cn; psun@brain.riken.jp	Sun, Pei/B-5191-2013; Liang, Chang Hong/L-1885-2016	Sun, Pei/0000-0003-4184-1079; 	National Natural Science Foundation of China [60825306, 60802068]; Natural Science Foundation of Guangdong Province, China [9251064101000012]; Science and Technology Programme Foundation of Guangdong Province, China [2009B080701053]; National 973 Program of China [2007CB311001]; SCUT [2009ZZ0055, 2009ZZ0059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Programme Foundation of Guangdong Province, China; National 973 Program of China(National Basic Research Program of China); SCUT	This work was supported by National Natural Science Foundation of China under grants 60825306 and 60802068, Natural Science Foundation of Guangdong Province, China under grant 9251064101000012, Science and Technology Programme Foundation of Guangdong Province, China under grant 2009B080701053, National 973 Program of China under grant 2007CB311001), and Fundamental Research Funds for the Central Universities, SCUT under grants 2009ZZ0055 and 2009ZZ0059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; BOGOUSSLAVSKY J, 1987, J NEUROL NEUROSUR PS, V50, P607, DOI 10.1136/jnnp.50.5.607; Bushara KO, 2003, NAT NEUROSCI, V6, P190, DOI 10.1038/nn993; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Fernandez G, 2003, NEUROLOGY, V60, P969, DOI 10.1212/01.WNL.0000049934.34209.2E; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fuster J. M., 2005, CORTEX MIND UNIFYING; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ishai A, 2003, J COGNITIVE NEUROSCI, V15, P946, DOI 10.1162/089892903770007335; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Li YQ, 2009, IEEE T BIO-MED ENG, V56, P2439, DOI 10.1109/TBME.2009.2025866; Liou M, 2003, J COGNITIVE NEUROSCI, V15, P935, DOI 10.1162/089892903770007326; Macaluso E, 2005, NEUROIMAGE, V26, P414, DOI 10.1016/j.neuroimage.2005.02.002; Macaluso E, 2004, NEUROIMAGE, V21, P725, DOI 10.1016/j.neuroimage.2003.09.049; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Smith AT, 2011, NEUROIMAGE, V56, P525, DOI 10.1016/j.neuroimage.2010.05.079; Taylor KI, 2006, P NATL ACAD SCI USA, V103, P8239, DOI 10.1073/pnas.0509704103; Thirion B, 2006, NEUROIMAGE, V33, P1104, DOI 10.1016/j.neuroimage.2006.06.062; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yoo SS, 2005, INT J NEUROSCI, V115, P55, DOI 10.1080/00207450490512650	36	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20801	10.1371/journal.pone.0020801	http://dx.doi.org/10.1371/journal.pone.0020801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21750692	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100006
J	Lovelock, CE; Ruess, RW; Feller, IC				Lovelock, Catherine E.; Ruess, Roger W.; Feller, Ilka C.			CO2 Efflux from Cleared Mangrove Peat	PLOS ONE			English	Article							LAND-USE; SEQUESTRATION; RESPIRATION; SEDIMENTS; COLLAPSE; FORESTS; FUTURE	Background: CO2 emissions from cleared mangrove areas may be substantial, increasing the costs of continued losses of these ecosystems, particularly in mangroves that have highly organic soils. Methodology/Principal Findings: We measured CO2 efflux from mangrove soils that had been cleared for up to 20 years on the islands of Twin Cays, Belize. We also disturbed these cleared peat soils to assess what disturbance of soils after clearing may have on CO2 efflux. CO2 efflux from soils declines from time of clearing from similar to 10 600 tonnes km 22 year 21 in the first year to 3000 tonnes km(2) year(-1) after 20 years since clearing. Disturbing peat leads to short term increases in CO2 efflux (27 umol m(-2)s(-1)), but this had returned to baseline levels within 2 days. Conclusions/Significance: Deforesting mangroves that grow on peat soils results in CO2 emissions that are comparable to rates estimated for peat collapse in other tropical ecosystems. Preventing deforestation presents an opportunity for countries to benefit from carbon payments for preservation of threatened carbon stocks.	[Lovelock, Catherine E.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Ruess, Roger W.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Feller, Ilka C.] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA	University of Queensland; University of Alaska System; University of Alaska Fairbanks; Smithsonian Institution; Smithsonian Environmental Research Center	Lovelock, CE (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	c.lovelock@uq.edu.au	Lovelock, Catherine E/G-7370-2012; Lovelock, Catherine E./AAF-7294-2020	Lovelock, Catherine E/0000-0002-2219-6855; Lovelock, Catherine E./0000-0002-2219-6855; Feller, Ilka/0000-0002-6391-1608	Smithsonian Marine Science Network; National Science Foundation [DEB-9981535]	Smithsonian Marine Science Network(Smithsonian InstitutionSmithsonian Tennenbaum Marine Observatories Network); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Smithsonian Marine Science Network and a National Science Foundation Biocomplexity award (DEB-9981535). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Alongi D.M., 2009, ENERGETICS MANGROVE, DOI [10.1007/978-1-4020-4271-3, DOI 10.1007/978-1-4020-4271-3]; Alongi DM, 2011, ENVIRON SCI POLICY, V14, P462, DOI 10.1016/j.envsci.2011.02.004; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Anglesen A, 2009, REALISING REDD NATL; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; BOYD CE, 1992, PROCEEDINGS OF THE SPECIAL SESSION ON SHRIMP FARMING, P166; Burford MA, 2003, MAR POLLUT BULL, V46, P1456, DOI 10.1016/S0025-326X(03)00282-0; Burford MA, 2001, MAR ECOL PROG SER, V224, P187, DOI 10.3354/meps224187; Cahoon DR, 2003, J ECOL, V91, P1093, DOI 10.1046/j.1365-2745.2003.00841.x; Chimner Rodney A., 2004, Wetlands Ecology and Management, V12, P419, DOI 10.1007/s11273-004-0255-y; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Couwenberg J, 2010, GLOBAL CHANGE BIOL, V16, P1715, DOI 10.1111/j.1365-2486.2009.02016.x; Crow SE, 2005, ECOLOGY, V86, P1825, DOI 10.1890/04-1575; DELAUNE RD, 1994, J COASTAL RES, V10, P1021; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Ellison AM, 1996, BIOTROPICA, V28, P549, DOI 10.2307/2389096; Emmett-Mattox S, 2010, NATL WETLANDS NEWSLE, V32, P6; Ewel KC, 2010, FRONT ECOL ENVIRON, V8, P20, DOI 10.1890/080090; Granek E, 2008, ESTUAR COAST SHELF S, V80, P555, DOI 10.1016/j.ecss.2008.09.012; HOUGHTON RA, 1995, GLOB CHANGE BIOL, V1, P275, DOI 10.1111/j.1365-2486.1995.tb00026.x; Kauffman JB, 2011, WETLANDS, V31, P343, DOI 10.1007/s13157-011-0148-9; Kauffman JB, 2009, ECOL APPL, V19, P1211, DOI 10.1890/08-1696.1; Lallier-Verges E, 2008, CHEM GEOL, V255, P388, DOI 10.1016/j.chemgeo.2008.07.009; Lee RY, 2008, BIOGEOCHEMISTRY, V87, P181, DOI 10.1007/s10533-008-9176-9; Lovelock CE, 2008, ECOSYSTEMS, V11, P342, DOI 10.1007/s10021-008-9125-4; McCleod E, 2011, FRONT ECOL IN PRESS; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; McKee KL, 2002, ECOLOGY, V83, P1065, DOI 10.2307/3071914; Muradian R, 2009, PAYMENT ECOSYSTEM SE, P1; Rutzler K, 1996, SCI AM, V274, P94; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; VALIELA I, 2001, BIOSCIENCE, V51, P807, DOI DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2	34	97	99	3	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21279	10.1371/journal.pone.0021279	http://dx.doi.org/10.1371/journal.pone.0021279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738628	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100016
J	Schott, RK; Evans, DC; Goodwin, MB; Horner, JR; Brown, CM; Longrich, NR				Schott, Ryan K.; Evans, David C.; Goodwin, Mark B.; Horner, John R.; Brown, Caleb Marshall; Longrich, Nicholas R.			Cranial Ontogeny in Stegoceras validum (Dinosauria: Pachycephalosauria): A Quantitative Model of Pachycephalosaur Dome Growth and Variation	PLOS ONE			English	Article							BONE-HISTOLOGY; ORNITHISCHIA PACHYCEPHALOSAURIA; RELATIVE GROWTH; LONG BONES; PATTERNS; ANATOMY; SUTURES; MICROSTRUCTURE; SYSTEMATICS; ALLOMETRY	Historically, studies of pachycephalosaurs have recognized plesiomorphically flat-headed taxa and apomorphically domed taxa. More recently, it has been suggested that the expression of the frontoparietal dome is ontogenetic and derived from a flat-headed juvenile morphology. However, strong evidence to support this hypothesis has been lacking. Here we test this hypothesis in a large, stratigraphically constrained sample of specimens assigned to Stegoceras validum, the best known pachycephalosaur, using multiple independent lines of evidence including conserved morphology of ornamentation, landmark-based allometric analyses of frontoparietal shape, and cranial bone histology. New specimens show that the diagnostic ornamentation of the parietosquamosal bar is conserved throughout the size range of the sample, which links flat-headed specimens to domed S. validum. High-resolution CT scans of three frontoparietals reveal that vascularity decreases with size and document a pattern that is consistent with previously proposed histological changes during growth. Furthermore, aspects of dome shape and size are strongly correlated and indicative of ontogenetic growth. These results are complementary and strongly support the hypothesis that the sample represents a growth series of a single taxon. Cranial dome growth is positively allometric, proceeds from a flat-headed to a domed state, and confirms the synonymy of Ornatotholus browni as a juvenile Stegoceras. This dataset serves as the first detailed model of growth and variation in a pachycephalosaur. Flat-headed juveniles possess three characters (externally open cranial sutures, tuberculate dorsal surface texture, and open supratemporal fenestrae) that are reduced or eliminated during ontogeny. These characters also occur in putative flat-headed taxa, suggesting that they may also represent juveniles of domed taxa. However, open cranial sutures and supratemporal fenestrae are plesiomorphic within Ornithischia, and thus should be expected in the adult stage of a primitive pachycephalosaur. Additional lines of evidence will be needed to resolve the taxonomic validity of flat-headed pachycephalosaur taxa.	[Schott, Ryan K.; Evans, David C.; Brown, Caleb Marshall] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Evans, David C.] Royal Ontario Museum, Toronto, ON M5S 2C6, Canada; [Goodwin, Mark B.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Longrich, Nicholas R.] Yale Univ, Dept Geol, New Haven, CT USA	University of Toronto; Royal Ontario Museum; University of California System; University of California Berkeley; Montana State University System; Montana State University Bozeman; Yale University	Schott, RK (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	ryan.schott@utoronto.ca		Longrich, Nicholas/0000-0002-9586-8907; Brown, Caleb/0000-0001-6463-8677; Schott, Ryan/0000-0002-4015-3955; Goodwin, Mark/0000-0001-7127-439X	NSERC; University of California Museum of Paleontology	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of California Museum of Paleontology	Funding was provided through a NSERC CGS M to RKS and an NSERC Discovery Grant to DCE. The University of California Museum of Paleontology provided funding to MBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BAKKER RT, 2006, NEW MEXICO MUSEUM NA, V35, P331; Botha J, 2005, PALAEONTOLOGY, V48, P385, DOI 10.1111/j.1475-4983.2005.00447.x; Botha J, 2004, ACTA PALAEONTOL POL, V49, P619; Botha J, 2000, J VERTEBR PALEONTOL, V20, P705, DOI 10.1671/0272-4634(2000)020[0705:GPDFTB]2.0.CO;2; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Butler RJ, 2009, ACTA PALAEONTOL POL, V54, P21, DOI 10.4202/app.2009.0104; CHAPMAN RE, 1981, J PALEONTOL, V55, P608; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; de Boef M, 2007, CAN J ZOOL, V85, P63, DOI 10.1139/Z06-195; DODSON P, 1975, J ZOOL, V175, P315; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DONG Z, 1978, VERTEBRAT PALASIATIC, V16, P222; EBERTH DA, 1993, CAN J EARTH SCI, V30, P174, DOI 10.1139/e93-016; Eberth DA, 2005, LIFE O PAST, P54; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Evans DC, 2011, J VERTEBR PALEONTOL, V31, P84, DOI 10.1080/02724634.2011.546287; Evans DC, 2010, ZOOL J LINN SOC-LOND, V159, P398, DOI 10.1111/j.1096-3642.2009.00611.x; Evans DC, 2005, LIFE O PAST, P349; Farke AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016196; GALTON P M, 1971, Journal of Paleontology, V45, P40; GALTON PM, 1983, CAN J EARTH SCI, V20, P462, DOI 10.1139/e83-043; Goodwin M.B., 1990, P189, DOI 10.1017/CBO9780511608377.017; Goodwin M, 2004, J VERTEBR PALEONTOL, V24, p65A; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Goodwin MB, 1998, J VERTEBR PALEONTOL, V18, P363, DOI 10.1080/02724634.1998.10011064; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; HAM AW, 1961, HISTOLOGY; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; Horner J, 2009, J VERTEBR PALEONTOL, V29, p117A; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; JASINSKI SE, 2011, NEW MEXICO IN PRESS; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Lambe LM., 1902, CONTRIBUTIONS CANADI, V3, P25; Legendre P., 1998, MODEL 2 REGRESSION U; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Longrich NR, 2011, CRETACEOUS RES, V32, P264, DOI 10.1016/j.cretres.2010.12.007; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; Markey MJ, 2007, J MORPHOL, V268, P89, DOI 10.1002/jmor.10504; Maryanska T., 1974, PALEONTOLOGICA POLON, V26, P133; Maryanska T, 2004, DINOSAURIA, 2ND EDITION, P464; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; PERLE A, 1982, Acta Palaeontologica Polonica, V27, P115; Pomfret JC, 2006, ANIM BEHAV, V71, P567, DOI 10.1016/j.anbehav.2005.05.023; Rasband W., 2006, IMAGEJ; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; Ryan MJ, 2005, LIFE O PAST, P312; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Schott RK, 2009, J VERTEBR PALEONTOL, V29, P771, DOI 10.1671/039.029.0329; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 2000, P480; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Smith RJ, 2009, AM J PHYS ANTHROPOL, V140, P476, DOI 10.1002/ajpa.21090; Sokal R. R., 2012, BIOMETRY; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; Sternberg C. M., 1945, JOUR PALEONTOL, V19, P534; SUES H-D, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V198, P1; Sullivan R.M., 2006, NEW MEXICO MUSEUM SC, V35, P329; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; SULLIVAN RM, 2006, NEW MEXICO MUSEUM NA, V35, P347; Sullivan R, 2007, J VERTEBR PALEONTOL, V27, p154A; Tumarkin-Deratzian AR, 2007, J HERPETOL, V41, P341, DOI 10.1670/0022-1511(2007)41[341:FBIWAA]2.0.CO;2; Tumarkin-Deratzian AR, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00283.x; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; WALL WP, 1979, CAN J EARTH SCI, V16, P1176, DOI 10.1139/e79-104; Wang Q, 2002, COMPUT VIS IMAGE UND, V85, P100, DOI 10.1006/cviu.2001.0955; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2; [No title captured]	76	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21092	10.1371/journal.pone.0021092	http://dx.doi.org/10.1371/journal.pone.0021092			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738608	gold, Green Published			2022-12-25	WOS:000292290100012
J	Haugen, M; Flannery, E; Tomchaney, M; Mori, A; Behura, SK; Severson, DW; Duman-Scheel, M				Haugen, Morgan; Flannery, Ellen; Tomchaney, Michael; Mori, Akio; Behura, Susanta K.; Severson, David W.; Duman-Scheel, Molly			Semaphorin-1a Is Required for Aedes aegypti Embryonic Nerve Cord Development	PLOS ONE			English	Article							GENE-EXPRESSION; AXON GUIDANCE; ANOPHELES-GAMBIAE; PROVIDES EVIDENCE; VECTOR MOSQUITOS; GENOME SEQUENCE; NANOS NOS; DROSOPHILA; NETRIN; CNS	Although mosquito genome projects have uncovered orthologues of many known developmental regulatory genes, extremely little is known about mosquito development. In this study, the role of semaphorin-1a (sema1a) was investigated during vector mosquito embryonic ventral nerve cord development. Expression of sema1a and the plexin A (plexA) receptor are detected in the embryonic ventral nerve cords of Aedes aegypti (dengue vector) and Anopheles gambiae (malaria vector), suggesting that Sema1a signaling may regulate mosquito nervous system development. Analysis of sema1a function was investigated through siRNA-mediated knockdown in A. aegypti embryos. Knockdown of sema1a during A. aegypti development results in a number of nerve cord phenotypes, including thinning, breakage, and occasional fusion of the longitudinal connectives, thin or absent commissures, and general distortion of the nerve cord. Although analysis of Drosophila melanogaster sema1a loss-of-function mutants uncovered many similar phenotypes, aspects of the longitudinal phenotypes differed between D. melanogaster and A. aegypti. The results of this investigation suggest that Sema1a is required for development of the insect ventral nerve cord, but that the developmental roles of this guidance molecule have diverged in dipteran insects.	[Haugen, Morgan; Tomchaney, Michael; Severson, David W.; Duman-Scheel, Molly] Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46634 USA; [Flannery, Ellen; Tomchaney, Michael; Mori, Akio; Behura, Susanta K.; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Flannery, Ellen; Tomchaney, Michael; Mori, Akio; Behura, Susanta K.; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame	Haugen, M (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, South Bend, IN 46634 USA.	mscheel@nd.edu	Flannery, Ellen/D-3941-2014	BEHURA, SUSANTA/0000-0002-0654-6288; behura, Susanta/0000-0003-1057-2435; Severson, David/0000-0002-5798-3365	University of Notre Dame College of Science; National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01AI081795-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081795] Funding Source: NIH RePORTER	University of Notre Dame College of Science; National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MT was supported by the University of Notre Dame College of Science Summer Undergraduate Research Fellowship program. This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases Award R01AI081795-01 to MD-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2007, P NATL ACAD SCI USA, V104, P9970, DOI 10.1073/pnas.0701515104; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Chen XG, 2008, ADV GENET, V64, P19, DOI 10.1016/S0065-2660(08)00802-X; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; CLEMONS A, 2010, COLD SPRING HARB PRO; Clemons A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016730; Duman-Scheel M, 1999, DEVELOPMENT, V126, P2327; Duman-Scheel M, 2007, EVOL DEV, V9, P131, DOI 10.1111/j.1525-142X.2007.00144.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flannery E, 2009, CURR DRUG TARGETS, V10, P611, DOI 10.2174/138945009788680383; Flannery E, 2010, DEV NEUROBIOL, V70, P473, DOI 10.1002/dneu.20788; Goltsev Y, 2004, DEV BIOL, V275, P435, DOI 10.1016/j.ydbio.2004.08.021; Goltsev Y, 2007, DEVELOPMENT, V134, P2415, DOI 10.1242/dev.02863; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HAUGEN M, 2010, COLD SPRING HARBOR P; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Juhn J, 2008, INSECT MOL BIOL, V17, P545, DOI 10.1111/j.1365-2583.2008.00823.x; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Kriventseva EV, 2008, NUCLEIC ACIDS RES, V36, pD271, DOI 10.1093/nar/gkm845; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Morlais I, 2003, MOL GENET GENOMICS, V269, P753, DOI 10.1007/s00438-003-0882-7; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; RAMINANI L N, 1975, International Journal of Insect Morphology and Embryology, V4, P517, DOI 10.1016/0020-7322(75)90028-8; RAMINANI LN, 1978, INT J INSECT MORPHOL, V7, P273, DOI 10.1016/0020-7322(78)90009-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Severson DW, 2004, J HERED, V95, P103, DOI 10.1093/jhered/esh023; Simanton W, 2009, EVOL DEV, V11, P260, DOI 10.1111/j.1525-142X.2009.00328.x; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yu HH, 2000, GENETICS, V156, P723; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	53	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21694	10.1371/journal.pone.0021694	http://dx.doi.org/10.1371/journal.pone.0021694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738767	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600072
J	Poustchi, H; George, J; Esmaili, S; Esna-Ashari, F; Ardalan, G; Sepanlou, SG; Alavian, SM				Poustchi, Hossein; George, Jacob; Esmaili, Saeed; Esna-Ashari, Farzaneh; Ardalan, Gelayol; Sepanlou, Sadaf Ghajarieh; Alavian, Seyed Moayed			Gender Differences in Healthy Ranges for Serum Alanine Aminotransferase Levels in Adolescence	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MECHANISMS LINKING OBESITY; METABOLIC SYNDROME; RISK; PREVALENCE; OVERWEIGHT; MORTALITY; CHILDREN; ASSOCIATION; PREDICTS	Background & Aims: There is a worldwide epidemic of obesity among adolescents who subsequently are at increased risk for the development of non alcoholic fatty liver disease (NAFLD). The serum alanine aminotransferase (ALT) is the most frequently used test for screening these individuals, but no age and gender-specific upper limits of normal (ULN) based on healthy population data in children are available. The objective of the present study was to define ULN for ALT in healthy children in order to use this as a tool for case finding. Methods: A total of 975 school children (aged 7-18 years) were included in the study cohort. Highly significant correlations (all p<0.001) were noted between ALT values and measures of BMI, systolic and diastolic blood pressure, insulin levels, HOMA-IR, total cholesterol and triglyceride concentrations. In order to define the population with no risk factors, we excluded subjects having abnormal values for factors that correlated with ALT. This population comprised 186 boys and 185 girls. Results: In boys, median serum ALT levels were 16 IU/L and 9, 11, 18, and 30 IU/L for the 5th, 25th, 75th, and 95th percentiles. In girls, median serum ALT was 13, and 7, 9, 16, and 21 IU/L for the 5th, 25th, 75th, and 95th percentiles, respectively. The ULNs for ALT were 30 IU/L and 21 IU/L for boys and girls respectively. We found a linear relationship between age and ALT in females (p<0.001) but not in males. By multiple logistic regression, independent predictors of an elevated ALT included the BMI, waist hip ratio and levels of serum total cholesterol. In females, age was an additional inverse predictor. Conclusions: In children and adolescents, these normal limits for ALT should be applied. Those with persistent elevations should be investigated further.	[Poustchi, Hossein; Esmaili, Saeed; Sepanlou, Sadaf Ghajarieh] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [George, Jacob] Univ Sydney, Storr Liver Unit, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [George, Jacob] Westmead Hosp, Sydney, NSW, Australia; [Esna-Ashari, Farzaneh] Shaheed Beheshti Univ Med Sci, Dept Community & Prevent Med, Tehran, Iran; [Ardalan, Gelayol] Minist Hlth & Med Educ, Youth & Sch Hlth Off, Tehran, Iran; [Alavian, Seyed Moayed] Baqiyatallah Univ Med Sci, Tehran Hepatitis Ctr, Baqiyatallah Res Ctr Gastroenterol & Liver Dis BR, Tehran, Iran	Tehran University of Medical Sciences; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Shahid Beheshti University Medical Sciences; Ministry of Health & Medical Education (MOHME); Baqiyatallah University of Medical Sciences (BMSU)	Poustchi, H (corresponding author), Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran.	editor@hepatmon.com	George, jacob/P-1496-2014; Sepanlou, Sadaf G/H-9343-2016; Esna-Ashari, Farzaneh/I-8724-2017	Sepanlou, Sadaf G/0000-0002-3669-5129; Esna-Ashari, Farzaneh/0000-0002-3151-4843; Esmaili, Saeed/0000-0002-2843-7277; Alavian., Seyed Moayed/0000-0002-4443-6602	Ministry of Health and Medical Education in Iran, the deputy of health	Ministry of Health and Medical Education in Iran, the deputy of health	The entire study was funded by The Ministry of Health and Medical Education in Iran, the deputy of health. There was no current external funding sources for this study. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Alavian SM, 2009, LIVER INT, V29, P159, DOI 10.1111/j.1478-3231.2008.01790.x; *AM AC PED, 2004, PEDIATRICS, V101, P141; [Anonymous], 2005, DIABETES CARE, V28, pS4; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniel S, 1999, AM J GASTROENTEROL, V94, P3010, DOI 10.1111/j.1572-0241.1999.01451.x; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Elinav E, 2005, AM J GASTROENTEROL, V100, P2201, DOI 10.1111/j.1572-0241.2005.41822.x; *EMRO, 2006, CLIN MAN DIAB MELL; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; George J, 2008, J PAEDIATR CHILD H, V44, P579, DOI 10.1111/j.1440-1754.2008.01386.x; Horowitz GL, DEFINING ESTABLISHIN; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ioannou GN, 2006, HEPATOLOGY, V43, P1145, DOI 10.1002/hep.21171; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jorgensen LGM, 2004, CLIN CHEM LAB MED, V42, P747, DOI 10.1515/CCLM.2004.126; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kariv R, 2006, LIVER INT, V26, P445, DOI 10.1111/j.1478-3231.2006.01197.x; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lee TH, 2008, HEPATOLOGY, V47, P880, DOI 10.1002/hep.22090; Loomba R, 2008, GASTROENTEROLOGY, V134, P953, DOI 10.1053/j.gastro.2008.01.037; Maggio ABR, 2008, J PEDIATR-US, V152, P489, DOI 10.1016/j.jpeds.2007.10.042; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rafeey Mandana, 2009, Ther Clin Risk Manag, V5, P371; Ritchie RF, 2004, CLIN CHEM LAB MED, V42, P702, DOI 10.1515/CCLM.2004.120; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842; SOLBERG HE, 1987, J CLIN CHEM CLIN BIO, V25, P337; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; Suzuki D, 2005, J GASTROEN HEPATOL, V20, P327, DOI 10.1111/j.1440-1746.2005.03724.x; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Van der Poorten D, 2007, HEPATOLOGY, V46, P1750, DOI 10.1002/hep.21918; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; World Health Organization, WHO GLOB STRAT DIET; 2008, CLIN GASTROENTEROL H, V6, P799	48	45	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21178	10.1371/journal.pone.0021178	http://dx.doi.org/10.1371/journal.pone.0021178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738618	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600017
J	Salt, JN; Yoshioka, K; Moeder, W; Goring, DR				Salt, Jennifer N.; Yoshioka, Keiko; Moeder, Wolfgang; Goring, Daphne R.			Altered Germination and Subcellular Localization Patterns for PUB44/SAUL1 in Response to Stress and Phytohormone Treatments	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; LESION MIMIC MUTANTS; REPEAT PROTEIN; CELL-DEATH; SELF-INCOMPATIBILITY; BIOCHEMICAL FUNCTION; RECEPTOR KINASES; ABSCISIC-ACID; ARABIDOPSIS; EXPRESSION	Background: In plants, the ubiquitin-proteasome system is emerging as a significant regulatory system throughout the plant lifecycle. The ubiquitination of a target protein requires the sequential actions of the E1, E2 and E3 enzymes, with the latter E3 enzyme conferring target selection in this process. There are a large number of predicted E3 enzymes in plant genomes, and very little is known about the functions of many of these predicted genes. Here we report here an analysis of two closely-related members of the Arabidopsis Plant U-box (PUB) family of E3 ubiquitin ligases, PUB43 and PUB44. Principal Findings: Homozygous pub44/pub44 mutant seedlings were found displayed a seedling lethal phenotype and this corresponded with widespread cell death lesions throughout the cotyledons and roots. Interestingly, heterozygous PUB44/pub44 seedlings were wild-type in appearance yet displayed intermediate levels of cell death lesions in comparison to pub44/pub44 seedlings. In contrast, homozygous pub43/pub43 mutants were viable and did not show any signs of cell death despite the PUB43 gene being more highly expressed than PUB44. The PUB44 mutants are not classical lesion mimic mutants as they did not have increased resistance to plant pathogens. We also observed increased germination rates in mutant seeds for both PUB44 and PUB43 under inhibitory concentrations of abscisic acid. Finally, the subcellular localization of PUB44 was investigated with transient expression assays in BY-2 cells. Under varying conditions, PUB44 was observed to be localized to the cytoplasm, plasma membrane, or nucleus. Conclusions: Based on mutant plant analyses, the Arabidopsis PUB43 and PUB44 genes are proposed to function during seed germination and early seedling growth. Given PUB44's ability to shuttle from the nucleus to the plasma membrane, PUB44 may be active in different subcellular compartments as part of these biological functions.	[Salt, Jennifer N.; Yoshioka, Keiko; Moeder, Wolfgang; Goring, Daphne R.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Yoshioka, Keiko; Goring, Daphne R.] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of Toronto	Salt, JN (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	d.goring@utoronto.ca		Goring, Daphne/0000-0001-5295-4744; Yoshioka, Keiko/0000-0002-3797-4277; Moeder, Wolfgang/0000-0003-3889-6183	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to DRG and KY and a Canada Research Chair to DRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amador V, 2001, CELL, V106, P343, DOI 10.1016/S0092-8674(01)00445-7; Andersen P, 2004, J BIOL CHEM, V279, P40053, DOI 10.1074/jbc.M405057200; Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Cho SK, 2006, PLANT PHYSIOL, V142, P1664, DOI 10.1104/pp.106.087965; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Downes BP, 2003, PLANT J, V35, P729, DOI 10.1046/j.1365-313X.2003.01844.x; Drechsel G, 2011, J EXP BOT, V62, P775, DOI 10.1093/jxb/erq313; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; FINKELSTEIN RR, 1994, PLANT PHYSIOL, V105, P1203, DOI 10.1104/pp.105.4.1203; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Gu TS, 1998, P NATL ACAD SCI USA, V95, P382, DOI 10.1073/pnas.95.1.382; Guiboileau A, 2010, CR BIOL, V333, P382, DOI 10.1016/j.crvi.2010.01.016; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoth S, 2002, J CELL SCI, V115, P4891, DOI 10.1242/jcs.00175; Kim M, 2003, BBA-PROTEINS PROTEOM, V1651, P50, DOI 10.1016/S1570-9639(03)00234-6; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu F, 2010, TRENDS BIOCHEM SCI, V35, P352, DOI 10.1016/j.tibs.2010.01.002; Liu P, 2007, CURR BIOL, V17, P734, DOI 10.1016/j.cub.2007.03.022; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Mudgil Y, 2004, PLANT PHYSIOL, V134, P59, DOI 10.1104/pp.103.029553; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Ni XM, 2010, PLANT SCI, V178, P158, DOI 10.1016/j.plantsci.2009.12.002; Park JJ, 2011, PLANT J, V65, P194, DOI 10.1111/j.1365-313X.2010.04416.x; Raab S, 2009, PLANT J, V59, P39, DOI 10.1111/j.1365-313X.2009.03846.x; SAMUEL MA, 2006, INT REV CYTOL, V253, P1, DOI DOI 10.1016/S0074-7696(06)53001-3; Samuel MA, 2008, PLANT PHYSIOL, V147, P2084, DOI 10.1104/pp.108.123380; Samuel MA, 2009, PLANT CELL, V21, P2655, DOI 10.1105/tpc.109.069740; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Stone SL, 2003, PLANT CELL, V15, P885, DOI 10.1105/tpc.009845; Toufighi K, 2005, PLANT J, V43, P153, DOI 10.1111/j.1365-313X.2005.02437.x; Trujillo M, 2008, CURR BIOL, V18, P1396, DOI 10.1016/j.cub.2008.07.085; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Vega-Sanchez ME, 2008, PLANT CELL, V20, P1456, DOI 10.1105/tpc.108.058610; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wiborg J, 2008, BIOCHEM J, V413, P447, DOI 10.1042/BJ20071568; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yin ZC, 2000, MOL PLANT MICROBE IN, V13, P869, DOI 10.1094/MPMI.2000.13.8.869; Yoshioka K, 2006, PLANT CELL, V18, P747, DOI 10.1105/tpc.105.038786; Zeng LR, 2008, MOL PLANT, V1, P800, DOI 10.1093/mp/ssn044; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	53	34	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21321	10.1371/journal.pone.0021321	http://dx.doi.org/10.1371/journal.pone.0021321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738636	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600029
J	Tang, FC; Barbacioru, C; Nordman, E; Bao, SQ; Lee, C; Wang, XH; Tuch, BB; Heard, E; Lao, KQ; Surani, MA				Tang, Fuchou; Barbacioru, Catalin; Nordman, Ellen; Bao, Siqin; Lee, Caroline; Wang, Xiaohui; Tuch, Brian B.; Heard, Edith; Lao, Kaiqin; Surani, M. Azim			Deterministic and Stochastic Allele Specific Gene Expression in Single Mouse Blastomeres	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; RNA-SEQ; MESSENGER-RNAS; GENOME-WIDE; ALTERNATIVE POLYADENYLATION; NONCODING RNAS; STEM-CELLS; TRANSCRIPTOME; REVEALS; WIDESPREAD	Stochastic and deterministic allele specific gene expression (ASE) might influence single cell phenotype, but the extent and nature of the phenomenon at the onset of early mouse development is unknown. Here we performed single cell RNA-Seq analysis of single blastomeres of mouse embryos, which revealed significant changes in the transcriptome. Importantly, over half of the transcripts with detectable genetic polymorphisms exhibit ASE, most notably, individual blastomeres from the same two-cell embryo show similar pattern of ASE. However, about 6% of them exhibit stochastic expression, indicated by altered expression ratio between the two alleles. Thus, we demonstrate that ASE is both deterministic and stochastic in early blastomeres. Furthermore, we also found that 1,718 genes express two isoforms with different lengths of 3'UTRs, with the shorter one on average 5-6 times more abundant in early blastomeres compared to the transcripts in epiblast cells, suggesting that microRNA mediated regulation of gene expression acquires increasing importance as development progresses.	[Tang, Fuchou; Bao, Siqin; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England; [Barbacioru, Catalin; Nordman, Ellen; Wang, Xiaohui; Tuch, Brian B.; Lao, Kaiqin] Life Technol, Appl Biosyst, Genet Syst, Foster City, CA USA; [Tang, Fuchou] Peking Univ, Sch Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Heard, Edith] Inst Curie, CNRS, INSERM, UMR3215,U934, F-75231 Paris, France	University of Cambridge; Thermo Fisher Scientific; Applied Biosystems; Peking University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tang, FC (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge, England.	kaiqinlao@gmail.com; a.surani@gurdon.cam.ac.uk	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; Surani, Azim/0000-0002-8640-4318	Wellcome Trust; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by a grant from the Wellcome Trust to M. A. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Bjornsson HT, 2008, GENOME RES, V18, P771, DOI 10.1101/gr.073254.107; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036; Cheung VG, 2008, AM J HUM GENET, V82, P1357, DOI 10.1016/j.ajhg.2008.05.003; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Gagneur J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.31; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Main BJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-422; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; NAGY A, 2003, MANIPULATING MOUSE E, P194; O'Neill MJ, 2005, HUM MOL GENET, V14, pR113, DOI 10.1093/hmg/ddi108; Palacios R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004150; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Sharov AA, 2003, PLOS BIOL, V1, P410, DOI 10.1371/journal.pbio.0000074; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	48	158	164	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21208	10.1371/journal.pone.0021208	http://dx.doi.org/10.1371/journal.pone.0021208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731673	gold, Green Submitted, Green Published			2022-12-25	WOS:000292035400014
J	Lu, D; Han, C; Wu, T				Lu, D.; Han, C.; Wu, T.			Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/beta-catenin signaling axis	ONCOGENE			English	Article						microsomal prostaglandin E synthase-1; beta-catenin; early growth response 1; hepatocellular carcinoma; liver	HUMAN HEPATOCELLULAR-CARCINOMA; BETA-CATENIN; CELL-GROWTH; CYCLIN D1; HEPATITIS-B; EXPRESSION; CYCLOOXYGENASE-2; TRANSCRIPTION; COX-2; INHIBITION	Microsomal prostaglandin E synthase-1 (mPGES-1) is a key enzyme that couples with cyclooxygenase-2 (COX-2) for the production of PGE2. Although COX-2 is known to mediate the growth and progression of several human cancers including hepatocellular carcinoma (HCC), the role of mPGES-1 in hepatocarcinogenesis is not well established. This study provides novel evidence for a key role of mPGES-1 in HCC growth and progression. Forced overexpression of mPGES-1 in two HCC cell lines (Hep3B and Huh7) increased tumor cell growth, clonogenic formation, migration and invasion, whereas knockdown of mPGES-1 inhibited these parameters, in vitro. In a mouse tumor xenograft model, mPGES-1 overexpressed cells formed palpable tumors at earlier time points and developed larger tumors when compared with the control (P<0.01); in contrast, mPGES-1 knockdown delayed tumor development and reduced tumor size (P<0.01). Mechanistically, mPGES-1-induced HCC cell proliferation, invasion and migration involve PGE2 production and activation of early growth response 1 (EGR1) and beta-catenin. Specifically, mPGES1-derived PGE2 induces the formation of EGR1-beta-catenin complex, which interacts with T-cell factor 4/lymphoid enhancer factor 1 transcription factors and activates the expression of b-catenin downstream genes. Our findings depict a novel crosstalk between mPGES-1/PGE2 and EGR1/beta-catenin signaling that is critical for hepatocarcinogenesis. Oncogene (2012) 31, 842-857; doi: 10.1038/onc.2011.287; published online 11 July 2011	[Lu, D.; Han, C.; Wu, T.] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA; [Lu, D.] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tulane University; Tongji University	Wu, T (corresponding author), Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave,SL-79, New Orleans, LA 70112 USA.	twu@tulane.edu			National Institutes of Health [CA106280, CA102325, CA134568, DK077776, CA137729]; NATIONAL CANCER INSTITUTE [R03CA137729, R01CA134568, R01CA106280, R01CA102325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK077776, R01DK077776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the National Institutes of Health grants CA106280, CA102325, CA134568 and DK077776 (to TW) and CA137729 (to CH).	Bae SH, 2001, CLIN CANCER RES, V7, P1410; Baron JA, 2006, GASTROENTEROLOGY, V131, P1674, DOI 10.1053/j.gastro.2006.08.079; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Branda M, 2006, HEPATOLOGY, V43, P891, DOI 10.1002/hep.21196; Caspi M, 2008, ONCOGENE, V27, P3546, DOI 10.1038/sj.onc.1211026; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cheng ASL, 2004, INT J ONCOL, V24, P853; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Couzin J, 2004, SCIENCE, V306, P1673, DOI 10.1126/science.306.5702.1673; DANESCH U, 1994, J BIOL CHEM, V269, P27258; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Han C, 2006, J CELL PHYSIOL, V207, P261, DOI 10.1002/jcp.20560; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kamei D, 2010, BIOCHEM J, V425, P361, DOI 10.1042/BJ20090045; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kapoor M, 2007, J BIOL CHEM, V282, P5356, DOI 10.1074/jbc.M610153200; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Kondo M, 1999, CLIN CANCER RES, V5, P4005; Lee KH, 2009, CLIN EXP METASTAS, V26, P685, DOI 10.1007/s10585-009-9266-7; Leng J, 2003, HEPATOLOGY, V38, P756, DOI 10.1053/jhep.2003.50380; Lim K, 2008, CANCER RES, V68, P553, DOI 10.1158/0008-5472.CAN-07-2295; Lim K, 2009, MOL CANCER THER, V8, P3046, DOI 10.1158/1535-7163.MCT-09-0551; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Monga SPS, 2006, HEPATOLOGY, V43, P401, DOI 10.1002/hep.21110; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moon Y, 2007, BIOCHEM PHARMACOL, V73, P125, DOI 10.1016/j.bcp.2006.08.017; Morisco C, 2001, J BIOL CHEM, V276, P28586, DOI 10.1074/jbc.M103166200; Murakami M, 2006, CURR PHARM DESIGN, V12, P943, DOI 10.2174/138161206776055912; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Ngiam N, 2010, AM J RESP CRIT CARE, V181, P947, DOI 10.1164/rccm.200908-1297OC; Parra E, 2009, ONCOL REP, V22, P1513, DOI 10.3892/or_00000595; Philipp-Staheli J, 2002, CANCER CELL, V1, P355, DOI 10.1016/S1535-6108(02)00054-5; Rahman MA, 2001, CLIN CANCER RES, V7, P1325; Saegusa M, 2004, AM J PATHOL, V164, P1739, DOI 10.1016/S0002-9440(10)63732-7; Saegusa M, 2008, J PATHOL, V216, P521, DOI 10.1002/path.2404; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Shiota G, 1999, HEPATO-GASTROENTEROL, V46, P407; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Subbaramaiah K, 2004, J BIOL CHEM, V279, P12647, DOI 10.1074/jbc.M312972200; Takii Y, 2007, LIVER INT, V27, P989, DOI 10.1111/j.1478-3231.2007.01530.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; Vanchieri C, 2004, J NATL CANCER I, V96, P1734, DOI 10.1093/jnci/96.23.1734; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wu T, 2006, CANCER TREAT REV, V32, P28, DOI 10.1016/j.ctrv.2005.10.004; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zucman-Rossi J, 2006, HEPATOLOGY, V43, P515, DOI 10.1002/hep.21068	67	33	33	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	2012	31	7					842	857		10.1038/onc.2011.287	http://dx.doi.org/10.1038/onc.2011.287			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21743491	Green Accepted			2022-12-25	WOS:000300615800004
J	Herrmann, A; Haake, A; Ammerpohl, O; Martin-Guerrero, I; Szafranski, K; Stemshorn, K; Nothnagel, M; Kotsopoulos, SK; Richter, J; Warner, J; Olson, J; Link, DR; Schreiber, S; Krawczak, M; Platzer, M; Nurnberg, P; Siebert, R; Hampe, J				Herrmann, Alexander; Haake, Andrea; Ammerpohl, Ole; Martin-Guerrero, Idoia; Szafranski, Karol; Stemshorn, Kathryn; Nothnagel, Michael; Kotsopoulos, Steve K.; Richter, Julia; Warner, Jason; Olson, Jeff; Link, Darren R.; Schreiber, Stefan; Krawczak, Michael; Platzer, Matthias; Nuernberg, Peter; Siebert, Reiner; Hampe, Jochen			Pipeline for Large-Scale Microdroplet Bisulfite PCR-Based Sequencing Allows the Tracking of Hepitype Evolution in Tumors	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; ELECTRONIC PCR; CANCER; GENE; GENOME; REVEALS; SIGNATURES; PROMOTERS; LYMPHOMA; DISEASE	Cytosine methylation provides an epigenetic level of cellular plasticity that is important for development, differentiation and cancerogenesis. We adopted microdroplet PCR to bisulfite treated target DNA in combination with second generation sequencing to simultaneously assess DNA sequence and methylation. We show measurement of methylation status in a wide range of target sequences (total 34 kb) with an average coverage of 95% (median 100%) and good correlation to the opposite strand (rho = 0.96) and to pyrosequencing (rho = 0.87). Data from lymphoma and colorectal cancer samples for SNRPN (imprinted gene), FGF6 (demethylated in the cancer samples) and HS3ST2 (methylated in the cancer samples) serve as a proof of principle showing the integration of SNP data and phased DNA-methylation information into "hepitypes" and thus the analysis of DNA methylation phylogeny in the somatic evolution of cancer.	[Herrmann, Alexander; Schreiber, Stefan; Hampe, Jochen] Univ Kiel, Inst Internal Med 1, Kiel, Germany; [Haake, Andrea; Ammerpohl, Ole; Martin-Guerrero, Idoia; Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Szafranski, Karol; Platzer, Matthias] Fritz Lipman Inst Ageing Res, Genome Anal Grp, Jena, Germany; [Stemshorn, Kathryn; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Nothnagel, Michael; Link, Darren R.; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Kotsopoulos, Steve K.; Warner, Jason; Olson, Jeff] RainDance Technol, Lexington, MA USA	University of Kiel; University of Kiel; University of Cologne; University of Kiel	Herrmann, A (corresponding author), Univ Kiel, Inst Internal Med 1, Kiel, Germany.	jhampe@1med.uni-kiel.de	Nothnagel, Michael/G-6545-2014; Krawczak, Michael/A-8964-2010; Nothnagel, Michael/H-6887-2012; Hampe, Jochen/A-2555-2010; Siebert, Reiner/A-8049-2010; Ammerpohl, Ole/G-2691-2010; Martin-Guerrero, Idoia/AAF-3446-2020; Nothnagel, Michael/L-7187-2019	Krawczak, Michael/0000-0003-2603-1502; Hampe, Jochen/0000-0002-2421-6127; Nothnagel, Michael/0000-0001-8305-7114; Martin-Guerrero, Idoia/0000-0002-0098-1908	German Ministry for Education and Research through German National Genome Research Network (NGFNplus); German Ministry for Education and Research through Systems Biology Networks; German Ministry for Education and Research; Government of the Basque Country	German Ministry for Education and Research through German National Genome Research Network (NGFNplus); German Ministry for Education and Research through Systems Biology Networks; German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Government of the Basque Country	This study was supported by the German Ministry for Education and Research through the German National Genome Research Network (NGFNplus) projects Colon Cancer Network "Oncogene", and "EMINet", through the Systems Biology Networks "HamatoSys" and "Virtual Liver" and through "Services@MediGrid". I. M-G. receives a stipend from the Government of the Basque Country. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Beck S, 2010, METHODS, V52, P201, DOI 10.1016/j.ymeth.2010.10.003; Bell CG, 2009, GENOME MED, V1, DOI 10.1186/gm56; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Costello J F, 2000, Brain Tumor Pathol, V17, P49, DOI 10.1007/BF02482735; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Faust C, 1998, DEVELOPMENT, V125, P4495; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; HOULSTON RS, 2008, NAT GENET; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rotmistrovsky K, 2004, NUCLEIC ACIDS RES, V32, pW108, DOI 10.1093/nar/gkh450; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Schwindt H, 2009, LEUKEMIA, V23, P1875, DOI 10.1038/leu.2009.120; Taylor KH, 2007, CANCER RES, V67, P8511, DOI 10.1158/0008-5472.CAN-07-1016; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; UKKONEN E, 1985, INFORM CONTROL, V64, P100, DOI 10.1016/S0019-9958(85)80046-2; Zeschnigk M, 2009, HUM MOL GENET, V18, P1439, DOI 10.1093/hmg/ddp054	41	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21332	10.1371/journal.pone.0021332	http://dx.doi.org/10.1371/journal.pone.0021332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750708	gold, Green Published, Green Submitted			2022-12-25	WOS:000292512000012
J	Nazmi, A; Dutta, K; Basu, A				Nazmi, Arshed; Dutta, Kallol; Basu, Anirban			RIG-I Mediates Innate Immune Response in Mouse Neurons Following Japanese Encephalitis Virus Infection	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; DEATH; CELLS; MINOCYCLINE; INTERFERON; EXPRESSION; INDUCTION; ALPHA; MDA5	Background: Neuroinflammation associated with Japanese encephalitis (JE) is mainly due to the activation of glial cells with subsequent release of proinflammatory mediators from them. The recognition of viral RNA, in part, by the pattern recognition receptor retinoic acid-inducible gene I (RIG-I) has been indicated to have a role in such processes. Even though neurons are also known to express this receptor, its role after JE virus (JEV) infections is yet to be elucidated. Methodology/Principal Findings: Upon infecting murine neuroblastoma cells and primary cortical neurons with JEV the expression profile of key proinflammatory cyto/chemokines were analyzed by qRT-PCR and bead array, both before and after ablation of RIG-I. Immunoblotting was performed to evaluate the levels of key molecules downstream to RIG-I leading to production of proinflammatory mediators. Changes in the intracellular viral antigen expression were confirmed by intracellular staining and immunoblotting. JEV infection induced neuronal expression of IL-6, IL-12p70, MCP-1, IP-10 and TNF-alpha in a time-dependent manner, which showed significant reduction upon RIG-I ablation. Molecules downstream to RIG-I showed significant changes upon JEV-infection, that were modulated following RIG-I ablation. Ablation of RIG-I in neurons also increased their susceptibility to JEV. Conclusions/Significance: In this study we propose that neurons are one of the potential sources of proinflammatory cyto/chemokines in JEV-infected brain that are produced via RIG-I dependent pathways. Ablation of RIG-I in neurons leads to increased viral load and reduced release of the cyto/chemokines.	[Nazmi, Arshed; Dutta, Kallol; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Nazmi, A (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	anirban@nbrc.ac.in	Dutta, Kallol/J-5827-2019; Nazmi, Arshed/I-2645-2015	Dutta, Kallol/0000-0001-6402-1300; Basu, Anirban/0000-0002-5200-2054; Nazmi, Arshed/0000-0002-5073-2061	Council of Scientific and Industrial Research (CSIR), Government of India [27(1638)/10]; CSIR; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The work is funded by a grant from the Council of Scientific and Industrial Research (CSIR), Government of India [27(1638)/10] to A.B. A.N. is a recipient of a Senior Research Fellowship from CSIR; K.D. is a recipient of a Research Associateship in Biotechnology and Life Sciences, from the Department of Biotechnology, Government of India; A.B. is a recipient of a National Bioscience Award for Career Development-2010 from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chakraborty S, 2010, NEUROCHEM INT, V56, P727, DOI 10.1016/j.neuint.2010.02.016; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0; Das S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008134; Dutta K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009984; Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kaushik DK, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-68; Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Mikkelsen SS, 2009, J BIOL CHEM, V284, P10774, DOI 10.1074/jbc.M807272200; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Mishra MK, 2009, NEUROCHEM INT, V54, P464, DOI 10.1016/j.neuint.2009.01.022; Nazmi A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000892; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	24	75	76	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21761	10.1371/journal.pone.0021761	http://dx.doi.org/10.1371/journal.pone.0021761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738791	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800042
J	Klais, R; Tamminen, T; Kremp, A; Spilling, K; Olli, K				Klais, Riina; Tamminen, Timo; Kremp, Anke; Spilling, Kristian; Olli, Kalle			Decadal-Scale Changes of Dinoflagellates and Diatoms in the Anomalous Baltic Sea Spring Bloom	PLOS ONE			English	Article							ALEXANDRIUM-FUNDYENSE; SCRIPPSIELLA-HANGOEI; GROWTH STRATEGIES; GULF; GERMINATION; PATTERNS; CYSTS; LIFE; SEDIMENTATION; EVOLUTIONARY	The algal spring bloom in the Baltic Sea represents an anomaly from the winter-spring bloom patterns worldwide in terms of frequent and recurring dominance of dinoflagellates over diatoms. Analysis of approximately 3500 spring bloom samples from the Baltic Sea monitoring programs revealed (i) that within the major basins the proportion of dinoflagellates varied from 0.1 (Kattegat) to.0.8 (central Baltic Proper), and (ii) substantial shifts (e. g. from 0.2 to 0.6 in the Gulf of Finland) in the dinoflagellate proportion over four decades. During a recent decade (1995-2004) the proportion of dinoflagellates increased relative to diatoms mostly in the northernmost basins (Gulf of Bothnia, from 0.1 to 0.4) and in the Gulf of Finland, (0.4 to 0.6) which are typically ice-covered areas. We hypothesize that in coastal areas a specific sequence of seasonal events, involving wintertime mixing and resuspension of benthic cysts, followed by proliferation in stratified thin layers under melting ice, favors successful seeding and accumulation of dense dinoflagellate populations over diatoms. This head-start of dinoflagellates by the onset of the spring bloom is decisive for successful competition with the faster growing diatoms. Massive cyst formation and spreading of cyst beds fuel the expanding and ever larger dinoflagellate blooms in the relatively shallow coastal waters. Shifts in the dominant spring bloom algal groups can have significant effects on major elemental fluxes and functioning of the Baltic Sea ecosystem, but also in the vast shelves and estuaries at high latitudes, where ice-associated cold-water dinoflagellates successfully compete with diatoms.	[Klais, Riina; Olli, Kalle] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Tamminen, Timo; Kremp, Anke; Spilling, Kristian] Ctr Marine Res, Finnish Environm Inst, Helsinki, Finland	University of Tartu; Tartu University Institute of Ecology & Earth Sciences; Finnish Environment Institute	Klais, R (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	riina.klais@ut.ee	Klais, Riina/G-6123-2010; Olli, Kalle/G-5389-2010; Spilling, Kristian/L-7932-2014; Kremp, Anke/I-8139-2013	Olli, Kalle/0000-0002-7943-5714; Spilling, Kristian/0000-0002-8390-8270; Klais-Peets, Riina/0000-0003-2895-1273	Estonian Science Foundation [7787]; Academy of Finland [128987]; 6th FP project THRESHOLDS [GOCE-003900]	Estonian Science Foundation; Academy of Finland(Academy of Finland); 6th FP project THRESHOLDS	This study was supported by the Estonian Science Foundation (grant 7787), the Academy of Finland (grant 128987), and the 6th FP project THRESHOLDS (GOCE-003900). The Estonian Science Foundation (http://www.etf.ee/index.php?page=3&) supported Riina Klais with a personal stipend supplement. The Academy of Finland (http://www.aka.fi/eng)supported financially Anke Kremp and Kristian Spilling. The large-scale phytoplankton dataset collection and harmonization was conducted within the EU 6th FP project THRESHOLDS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit J, 2005, ICES J MAR SCI, V62, P1205, DOI 10.1016/j.icesjms.2005.04.024; ANDERSON JT, 1981, CAN J BOT, V59, P1793, DOI 10.1139/b81-240; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; B.A.C.C. Author Team, 2008, ASS CLIM CHANG BALT; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Cloern JE, 2008, ECOL LETT, V11, P1294, DOI 10.1111/j.1461-0248.2008.01244.x; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Edler L., 1979, BALTIC MARINE BIOL P, V5, P38; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Fotheringham A. S., 2002, GEOGRAPHICALLY WEIGH; Gallegos CL, 2002, ESTUARIES, V25, P508, DOI 10.1007/BF02804886; GUILLARD RRL, 1977, ECOLOGY MARINE PLANK; HEISKANEN AS, 1993, MAR BIOL, V116, P161, DOI 10.1007/BF00350743; HEISKANEN AS, 1998, FACTORS GOVERNING SE; Humborg C, 2006, BIOGEOCHEMISTRY, V77, P265, DOI 10.1007/s10533-005-1533-3; Ishikawa A, 1997, J PLANKTON RES, V19, P1783, DOI 10.1093/plankt/19.11.1783; Jaanus A, 2006, HYDROBIOLOGIA, V554, P137, DOI 10.1007/s10750-005-1014-7; KONONEN K, 1984, OPHELIA, P101; Kremp A, 2000, J PLANKTON RES, V22, P2155, DOI 10.1093/plankt/22.11.2155; Kremp A, 2000, J PLANKTON RES, V22, P1311, DOI 10.1093/plankt/22.7.1311; Kremp A, 2001, MAR ECOL PROG SER, V216, P57, DOI 10.3354/meps216057; Kremp A, 2008, AQUAT MICROB ECOL, V50, P181, DOI 10.3354/ame01163; Li WKW, 2006, P ROY SOC B-BIOL SCI, V273, P1953, DOI 10.1098/rspb.2006.3529; LIGNELL R, 1993, MAR ECOL PROG SER, V94, P239, DOI 10.3354/meps094239; Logares R, 2008, ENVIRON MICROBIOL, V10, P1231, DOI 10.1111/j.1462-2920.2007.01538.x; Margalef R., 1979, P89; McGillicuddy DJ, 2005, DEEP-SEA RES PT II, V52, P2698, DOI 10.1016/j.dsr2.2005.06.021; McQuoid MR, 2004, LIMNOL OCEANOGR, V49, P1123, DOI 10.4319/lo.2004.49.4.1123; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Okolodkov YB, 1999, BOT MAR, V42, P333, DOI 10.1515/BOT.1999.038; Olli K, 2008, J MARINE SYST, V73, P284, DOI 10.1016/j.jmarsys.2007.04.009; Olli K, 2010, DEEP-SEA RES PT II, V57, P235, DOI 10.1016/j.dsr2.2009.09.009; Papush L, 2006, ESTUAR COAST SHELF S, V67, P53, DOI 10.1016/j.ecss.2005.09.017; PINCKNEY JL, 1997, CANADIAN J FISHERIES, V54; Pitkanen H, 2001, AMBIO, V30, P195, DOI 10.1639/0044-7447(2001)030[0195:INFCDI]2.0.CO;2; R Development Core Team, 2009, R FDN STAT COMP; Rahm L, 1996, MAR ECOL PROG SER, V130, P221, DOI 10.3354/meps130221; Rengefors K, 1998, J PHYCOL, V34, P568, DOI 10.1046/j.1529-8817.1998.340568.x; Reynolds C.S., 2006, PHYTOPLANKTON ECOLOG; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Smayda TJ, 2010, PROG OCEANOGR, V85, P92, DOI 10.1016/j.pocean.2010.02.006; Smayda T.J., 1980, SPECIES SUCCESSION; Smayda TJ, 2003, J SEA RES, V49, P95, DOI 10.1016/S1385-1101(02)00219-8; Smayda TJ, 2002, J OCEANOGR, V58, P281, DOI 10.1023/A:1015861725470; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Spilling K, 2008, J MARINE SYST, V73, P323, DOI 10.1016/j.jmarsys.2006.10.012; Spilling K, 2008, CONT SHELF RES, V28, P2488, DOI 10.1016/j.csr.2008.07.004; Spilling K, 2007, J PLANKTON RES, V29, P895, DOI 10.1093/plankt/fbm067; Spilling K, 2010, MAR BIOL, V157, P427, DOI 10.1007/s00227-009-1329-4; Stipa T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014532; Stock CA, 2007, CONT SHELF RES, V27, P2486, DOI 10.1016/j.csr.2007.06.008; Stoecker DK, 1997, J PHYCOL, V33, P585, DOI 10.1111/j.0022-3646.1997.00585.x; Sundstrom AM, 2009, J PHYCOL, V45, P938, DOI 10.1111/j.1529-8817.2009.00712.x; Tamminen T, 2007, MAR ECOL PROG SER, V340, P121, DOI 10.3354/meps340121; Trigueros JM, 2001, HYDROBIOLOGIA, V444, P119, DOI 10.1023/A:1017563031810; Tuomi P, 1999, J MARINE SYST, V23, P185, DOI 10.1016/S0924-7963(99)00057-3; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur Alain F., 2009, P1	61	110	112	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21567	10.1371/journal.pone.0021567	http://dx.doi.org/10.1371/journal.pone.0021567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747911	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100040
J	Moran, A; Thacker, SA; Arikan, AA; Mastrangelo, MAA; Wu, Y; Yu, B; Tweardy, DJ				Moran, Ana; Thacker, Stephen A.; Arikan, Ayse Akcan; Mastrangelo, Mary-Ann A.; Wu, Yong; Yu, Bi; Tweardy, David J.			IL-6-Mediated Activation of Stat3 alpha Prevents Trauma/Hemorrhagic Shock-Induced Liver Inflammation	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; ISCHEMIA-REPERFUSION INJURY; HEMORRHAGIC-SHOCK; NITRIC-OXIDE; SIGNAL TRANSDUCER; GENE-EXPRESSION; KAPPA-B; STAT3 ACTIVATION; TARGETING STAT3; PROTEIN AP2	Trauma complicated by hemorrhagic shock (T/HS) is the leading cause of morbidity and mortality in the United States for individuals under the age of 44 years. Initial survivors are susceptible to developing multiple organ failure (MOF), which is thought to be caused, at least in part, by excessive or maladaptive activation of inflammatory pathways. We previously demonstrated in rodents that T/HS results in liver injury that can be prevented by IL-6 administration at the start of resuscitation; however, the contribution of the severity of HS to the extent of liver injury, whether or not resuscitation is required, and the mechanism(s) for the IL-6 protective effect have not been reported. In the experiments described here, we demonstrated that the extent of liver inflammation induced by T/HS depends on the duration of hypotension and requires resuscitation. We established that IL-6 administration at the start of resuscitation is capable of completely reversing liver inflammation and is associated with increased Stat3 activation. Global assessment of the livers showed that the main effect of IL-6 was to normalize the T/HS-induced inflammation transcriptome. Pharmacological inhibition of Stat3 activity within the liver blocked the ability of IL-6 to prevent liver inflammation and to normalize the T/HS-induced liver inflammation transcriptome. Genetic deletion of a Stat3 beta, a naturally occurring, dominant-negative isoform of the Stat3, attenuated T/HS-induced liver inflammation, confirming a role for Stat3, especially Stat3 alpha, in preventing T/HS-mediated liver inflammation. Thus, T/HS-induced liver inflammation depends on the duration of hypotension and requires resuscitation; IL-6 administration at the start of resuscitation reverses T/HS-induced liver inflammation, through activation of Stat3 alpha, which normalized the T/HS-induced liver inflammation transcriptome.	[Moran, Ana; Mastrangelo, Mary-Ann A.; Wu, Yong; Yu, Bi; Tweardy, David J.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Arikan, Ayse Akcan] Baylor Coll Med, Dept Pediat, Crit Care Sect, Houston, TX 77030 USA; [Tweardy, David J.] Baylor Coll Med, Dept Mol, Houston, TX 77030 USA; [Thacker, Stephen A.] Baylor Coll Med, Dept Pediat, Pediat Infect Dis Sect, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Moran, A (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA.	dtweardy@bcm.tmc.edu	Tweardy, David/L-3929-2019	Akcan Arikan, Ayse/0000-0002-5123-6713	National Heart, Lung and Blood Institute of the National Institutes of Health [HL07619, T32-HL66991]; American Lung Association [H48839]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066991, F32HL007619] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported, in part, by grants HL07619 (DJT) and T32-HL66991 (AM), from the National Heart, Lung and Blood Institute of the National Institutes of Health, and H48839 (AM) from the American Lung Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; Alten JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001605; Ayuste EC, 2006, J TRAUMA, V60, P52, DOI 10.1097/01.ta.0000200156.05397.0b; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brundage SI, 2004, J TRAUMA, V57, P970, DOI 10.1097/01.TA.0000141970.68269.AC; Chen JP, 1997, BIOCHEM BIOPH RES CO, V239, P666, DOI 10.1006/bbrc.1997.7531; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Galun E, 2000, FASEB J, V14, P1979, DOI 10.1096/fj.99-0913com; Gao Q, 2004, MOL CELL PROTEOMICS, V3, P704, DOI 10.1074/mcp.M300131-MCP200; Harbrecht BG, 2001, AM SURGEON, V67, P122; Heckbert SR, 1998, J TRAUMA, V45, P545, DOI 10.1097/00005373-199809000-00022; Hierholzer C, 1998, TRANSPLANT P, V30, P2647, DOI 10.1016/S0041-1345(98)00771-4; Hierholzer C, 1998, AM J PHYSIOL-LUNG C, V275, pL611, DOI 10.1152/ajplung.1998.275.3.L611; Hierholzer C, 2003, ARCH ORTHOP TRAUM SU, V123, P55, DOI 10.1007/s00402-002-0438-z; Hierholzer C, 2002, SHOCK, V17, P98, DOI 10.1097/00024382-200202000-00003; Hierholzer C, 2001, ARCH ORTHOP TRAUM SU, V121, P219, DOI 10.1007/s004020000211; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; Hochepied T, 2000, EUR CYTOKINE NETW, V11, P597; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Horiguchi N, 2010, HEPATOLOGY, V51, P1724, DOI 10.1002/hep.23532; Jarrar D, 2000, J TRAUMA, V49, P879, DOI 10.1097/00005373-200011000-00015; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Jing N, 2003, DNA CELL BIOL, V22, P685, DOI 10.1089/104454903770946665; Jing NJ, 2005, CURR PHARM DESIGN, V11, P2841, DOI 10.2174/1381612054546761; Jing NJ, 2004, CANCER RES, V64, P6603, DOI 10.1158/0008-5472.CAN-03-4041; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kataoka K, 2003, BIOCHEM BIOPH RES CO, V300, P656, DOI 10.1016/S0006-291X(02)02905-4; Klein C, 2003, EUR J IMMUNOL, V33, P2251, DOI 10.1002/eji.200323651; Klune JR, 2010, SURG CLIN N AM, V90, P665, DOI 10.1016/j.suc.2010.04.003; KOBELT F, 1994, SHOCK, V2, P281, DOI 10.1097/00024382-199410000-00009; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Kupiec-Weglinski JW, 2005, TRANSPL P, V37, P1653, DOI 10.1016/j.transproceed.2005.03.134; Lafdil F, 2009, GASTROENTEROLOGY, V137, P2125, DOI 10.1053/j.gastro.2009.08.004; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li DY, 2003, J AM COLL CARDIOL, V41, P1048, DOI 10.1016/S0735-1097(02)02966-2; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Menezes J, 1999, AM J PHYSIOL-GASTR L, V277, pG144, DOI 10.1152/ajpgi.1999.277.1.G144; Meng ZH, 2000, SHOCK, V14, P41, DOI 10.1097/00024382-200014010-00008; Meng ZH, 2001, AM J PHYSIOL-CELL PH, V280, pC343, DOI 10.1152/ajpcell.2001.280.2.C343; Minino Arialdi M, 2006, Natl Vital Stat Rep, V54, P1; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Moran A, 2009, CTS-CLIN TRANSL SCI, V2, P41, DOI 10.1111/j.1752-8062.2008.00076.x; Moran A, 2008, INT J CLIN EXP MED, V1, P213; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Ono M, 2004, SHOCK, V21, P519, DOI 10.1097/01.shk.0000126905.75237.07; Partrick DA, 1999, AM J SURG, V178, P564, DOI 10.1016/S0002-9610(99)00240-8; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Rajnik M, 2002, SHOCK, V17, P322, DOI 10.1097/00024382-200204000-00015; Rolph MS, 2006, J IMMUNOL, V177, P7794, DOI 10.4049/jimmunol.177.11.7794; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; Sundar SV, 2005, BIOCHEM BIOPH RES CO, V332, P688, DOI 10.1016/j.bbrc.2005.05.008; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wu J, 2001, Chin J Traumatol, V4, P31; Xu Y, 2009, CELL PHYSIOL BIOCHEM, V23, P379, DOI 10.1159/000218184; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9	66	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21449	10.1371/journal.pone.0021449	http://dx.doi.org/10.1371/journal.pone.0021449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738667	gold, Green Submitted, Green Published			2022-12-25	WOS:000292290100024
J	Paron, I; Berchtold, S; Voros, J; Shamarla, M; Erkan, M; Hofler, H; Esposito, I				Paron, Igor; Berchtold, Sonja; Voeroes, Julia; Shamarla, Madhavi; Erkan, Mert; Hoefler, Heinz; Esposito, Irene			Tenascin-C Enhances Pancreatic Cancer Cell Growth and Motility and Affects Cell Adhesion through Activation of the Integrin Pathway	PLOS ONE			English	Article							STELLATE CELLS; EXPRESSION; PROLIFERATION; GLYCOPROTEINS; ASTROCYTOMA; INHIBITION; SURVIVAL; BINDING; TISSUES; TUMORS	Background: Pancreatic cancer (PDAC) is characterized by an abundant fibrous tissue rich in Tenascin-C (TNC), a large ECM glycoprotein mainly synthesized by pancreatic stellate cells (PSCs). In human pancreatic tissues, TNC expression increases in the progression from low-grade precursor lesions to invasive cancer. Aim of this study was the functional characterization of the effects of TNC on biologic relevant properties of pancreatic cancer cells. Methods: Proliferation, migration and adhesion assays were performed on pancreatic cancer cell lines treated with TNC or grown on a TNC-rich matrix. Stable transfectants expressing the large TNC splice variant were generated to test the effects of endogenous TNC. TNC-dependent integrin signaling was investigated by immunoblotting, immunofluorescence and pharmacological inhibition. Results: Endogenous TNC promoted pancreatic cancer cell growth and migration. A TNC-rich matrix also enhanced migration as well as the adhesion to the uncoated growth surface of poorly differentiated cell lines. In contrast, adhesion to fibronectin was significantly decreased in the presence of TNC. The effects of TNC on cell adhesion were paralleled by changes in the activation state of paxillin and Akt. Conclusion: TNC affects proliferation, migration and adhesion of poorly differentiated pancreatic cancer cell lines and might therefore play a role in PDAC spreading and metastasis in vivo.	[Paron, Igor; Berchtold, Sonja; Voeroes, Julia; Shamarla, Madhavi; Hoefler, Heinz; Esposito, Irene] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Paron, Igor; Berchtold, Sonja; Hoefler, Heinz; Esposito, Irene] Tech Univ Munich, Inst Pathol, Munich, Germany; [Erkan, Mert] Tech Univ Munich, Klinikum Rechts Isar, Dept Gen Surg, D-8000 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Paron, I (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany.	esposito@lrz.tum.de	P, I/D-8000-2011		Deutsche Krebshilfe [108038]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This study was supported by the Deutsche Krebshilfe (Grant number: 108038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Baxter NN, 2007, ANN SURG ONCOL, V14, P1320, DOI 10.1245/s10434-006-9249-8; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; CROSSIN KL, 1991, P NATL ACAD SCI USA, V88, P11403, DOI 10.1073/pnas.88.24.11403; DRUCKER BJ, 1988, IN VITRO CELL DEV B, V24, P1179, DOI 10.1007/BF02624187; END P, 1992, EUR J BIOCHEM, V209, P1041, DOI 10.1111/j.1432-1033.1992.tb17380.x; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Esposito I, 2007, NEOPLASIA, V9, P8, DOI 10.1593/neo.06646; Fischer D, 1997, MOL BIOL CELL, V8, P2055, DOI 10.1091/mbc.8.10.2055; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Giese A, 1996, J CELL SCI, V109, P2161; Hancox RA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2251; Huang WT, 2001, CANCER RES, V61, P8586; Ishiwata T, 2005, ANTICANCER RES, V25, P489; Jang JH, 2005, CANCER LETT, V229, P101, DOI 10.1016/j.canlet.2004.12.012; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones FS, 2000, DEV DYNAM, V218, P235, DOI 10.1002/(SICI)1097-0177(200006)218:2<235::AID-DVDY2>3.3.CO;2-7; Juuti A, 2004, J CLIN PATHOL, V57, P1151, DOI 10.1136/jcp.2003.015818; Kaarteenaho-Wiik R, 2003, HISTOPATHOLOGY, V42, P280, DOI 10.1046/j.1365-2559.2003.01568.x; KOUKOULIS GK, 1991, HUM PATHOL, V22, P636, DOI 10.1016/0046-8177(91)90285-W; Leins A, 2003, CANCER-AM CANCER SOC, V98, P2430, DOI 10.1002/cncr.11796; MIDWOOD KS, 2009, J CELL COMMUN SIGNAL; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Pas J, 2006, INT J BIOCHEM CELL B, V38, P1594, DOI 10.1016/j.biocel.2006.03.017; Rivera F, 2009, CANCER TREAT REV, V35, P335, DOI 10.1016/j.ctrv.2008.11.007; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; SRIRAMARAO P, 1993, J CELL SCI, V105, P1001; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Zamecnik J, 2004, NEOPLASMA, V51, P214	36	53	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21684	10.1371/journal.pone.0021684	http://dx.doi.org/10.1371/journal.pone.0021684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747918	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100055
J	Gandolfo, MA; Hermsen, EJ; Zamaloa, MC; Nixon, KC; Gonzalez, CC; Wilf, P; Cuneo, NR; Johnson, KR				Gandolfo, Maria A.; Hermsen, Elizabeth J.; Zamaloa, Maria C.; Nixon, Kevin C.; Gonzalez, Cynthia C.; Wilf, Peter; Ruben Cuneo, N.; Johnson, Kirk R.			Oldest Known Eucalyptus Macrofossils Are from South America	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; RIBOSOMAL DNA; CORYMBIA MYRTACEAE; PLANT DIVERSITY; EOCENE; PATAGONIA; ARGENTINA; AUSTRALIA; GENUS; CLASSIFICATION	The evolutionary history of Eucalyptus and the eucalypts, the larger clade of seven genera including Eucalyptus that today have a natural distribution almost exclusively in Australasia, is poorly documented from the fossil record. Little physical evidence exists bearing on the ancient geographical distributions or morphologies of plants within the clade. Herein, we introduce fossil material of Eucalyptus from the early Eocene (ca. 51.9 Ma) Laguna del Hunco paleoflora of Chubut Province, Argentina; specimens include multiple leaves, infructescences, and dispersed capsules, several flower buds, and a single flower. Morphological similarities that relate the fossils to extant eucalypts include leaf shape, venation, and epidermal oil glands; infructescence structure; valvate capsulate fruits; and operculate flower buds. The presence of a staminophore scar on the fruits links them to Eucalyptus, and the presence of a transverse scar on the flower buds indicates a relationship to Eucalyptus subgenus Symphyomyrtus. Phylogenetic analyses of morphological data alone and combined with aligned sequence data from a prior study including 16 extant eucalypts, one outgroup, and a terminal representing the fossils indicate that the fossils are nested within Eucalyptus. These are the only illustrated Eucalyptus fossils that are definitively Eocene in age, and the only conclusively identified extant or fossil eucalypts naturally occurring outside of Australasia and adjacent Mindanao. Thus, these fossils indicate that the evolution of the eucalypt group is not constrained to a single region. Moreover, they strengthen the taxonomic connections between the Laguna del Hunco paleoflora and extant subtropical and tropical Australasia, one of the three major ecologic-geographic elements of the Laguna del Hunco paleoflora. The age and affinities of the fossils also indicate that Eucalyptus subgenus Symphyomyrtus is older than previously supposed. Paleoecological data indicate that the Patagonian Eucalyptus dominated volcanically disturbed areas adjacent to standing rainforest surrounding an Eocene caldera lake.	[Gandolfo, Maria A.; Hermsen, Elizabeth J.; Nixon, Kevin C.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA; [Zamaloa, Maria C.] Univ Buenos Aires, Dept Ecol Genet & Evoluc, Buenos Aires, DF, Argentina; [Gonzalez, Cynthia C.; Ruben Cuneo, N.] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Johnson, Kirk R.] Denver Museum Nat & Sci, Denver, CO USA	Cornell University; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gandolfo, MA (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA.	mag4@cornell.edu		Hermsen, Elizabeth/0000-0003-2666-4385	National Science Foundation [DEB-0918932, DEB-0919071, DEB-0345750]; University of Pennsylvania Research Foundation; Andrew W. Mellon Foundation; Fulbright U.S. Scholar Program; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Pennsylvania Research Foundation; Andrew W. Mellon Foundation; Fulbright U.S. Scholar Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation grants DEB-0918932, DEB-0919071 and DEB-0345750 (www.nsf.org) and University of Pennsylvania Research Foundation, the Andrew W. Mellon Foundation (www.mellon.org) and the Fulbright U.S. Scholar Program (www.iie.org/fulbright). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE GJ, 1979, NATURE, V280, P387, DOI 10.1038/280387a0; ARAGON E., 1997, REV ASOC GEOL ARGENT, V52, P243; Basinger JF, 2007, CAN J BOT, V85, P204, DOI 10.1139/B07-001; Bayly MJ, 2008, CLADISTICS, V24, P131, DOI 10.1111/j.1096-0031.2007.00175.x; Bayly MJ, 2007, MOL PHYLOGENET EVOL, V44, P346, DOI 10.1016/j.ympev.2006.10.027; Berry E.W., 1938, GEOLOGICAL SOC AM SP, V12, P1, DOI DOI 10.1130/SPE12-P1; Berry E. W., 1925, J HOPKINS U STUDIES, V6, P182; Biffin E, 2010, ANN BOT-LONDON, V106, P79, DOI 10.1093/aob/mcq088; BLAKE S. T., 1977, AUSTROBAILEYA, V1, P43; Bohte A, 2005, PLANT SYST EVOL, V251, P53, DOI 10.1007/s00606-004-0161-z; Bohte A, 2005, PLANT SYST EVOL, V255, P17, DOI 10.1007/s00606-004-0291-3; Boland D.J., 2006, FOREST TREES AUSTR, P736; BRIGGS B. G., 1979, P LINNEAN SOC NEW S, V102, P158; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; BROOKER MIH, 1994, FIELD GUIDE EUCALYPT, V3, P383; Buechler W. K., 2004, ALTERNATIVE LEAF CLE; Carr DJ, 2002, BOT J LINN SOC, V139, P415, DOI 10.1046/j.1095-8339.2002.00062.x; CARR DJ, 1959, NATURE, V4698, P1549; Chippendale G.M., 1988, FLORA AUSTR, V19, P1; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Azpelicueta MD, 2011, J VERTEBR PALEONTOL, V31, P258, DOI 10.1080/02724634.2011.550351; Zamaloa MD, 2006, INT J PLANT SCI, V167, P1279, DOI 10.1086/507873; DRINNAN A N, 1991, Australian Systematic Botany, V4, P539, DOI 10.1071/SB9910539; DRINNAN A N, 1991, Australian Systematic Botany, V4, P553, DOI 10.1071/SB9910553; DRINNAN AN, 1988, PLANT SYST EVOL, V160, P219, DOI 10.1007/BF00936049; Frenguelli J., 1953, NOTAS MUSEO LA PLATA, V16, P209; GANDOLFO MA, 1988, B TORREY BOT CLUB, V115, P83, DOI 10.2307/2996138; GOLOBOFF P. A., 1999, NONA NO NAME 2 0 WIN; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOLOBOFF PA, 2007, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Greenwood D. R., 2000, Proceedings of the Royal Society of Victoria, V112, P65; Greenwood DR, 1996, AUST SYST BOT, V9, P95, DOI 10.1071/SB9960095; HEATHER W. A., 1955, EMPIRE FOREST REV, V34, P255; Hill K. D., 1995, Telopea, V6, P185; HILL RS, 1999, FLORA AUSTR, V1, P251; HOLMES W B K, 1982, Proceedings of the Linnean Society of New South Wales, V106, P299; Hyland, 1993, LEAF ATLAS AUSTR TRO; JOHNSON L A S, 1972, Proceedings of the Linnean Society of New South Wales, V97, P11; JOHNSON LAS, 1984, ANN MO BOT GARD, V71, P700, DOI 10.2307/2399159; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; Ladiges PY, 2003, J BIOGEOGR, V30, P989, DOI 10.1046/j.1365-2699.2003.00881.x; LADIGES PY, 1983, BOT J LINN SOC, V87, P105, DOI 10.1111/j.1095-8339.1983.tb00986.x; LADIGES PY, 1995, AUST SYST BOT, V8, P483, DOI 10.1071/SB9950483; Lange R. T., 1982, HIST AUSTRALASIAN VE, P44; LANGE RT, 1978, AUST J BOT, V26, P221, DOI 10.1071/BT9780221; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; NIXON KC, 1999, WINCLADA VER 1 9 SOF; PAIJMANS K, 1973, PAC SCI, V27, P260; Parra-O C, 2006, TAXON, V55, P653, DOI 10.2307/25065641; Parra-O C, 2009, AUST SYST BOT, V22, P384, DOI 10.1071/SB09028; Pascual Rosendo, 2007, Journal of Mammalian Evolution, V14, P75, DOI 10.1007/s10914-007-9039-5; Petrulevicius JF, 2009, J PALEONTOL, V83, P994, DOI 10.1666/08-073.1; Petrulevicus JF, 2005, J PALEONTOL, V79, P658, DOI 10.1666/0022-3360(2005)079[0658:AANFOD]2.0.CO;2; POLE M, 1993, J ROY SOC NEW ZEAL, V23, P313, DOI 10.1080/03036758.1993.10721229; Pryor LD, 1971, CLASSIFICATION EUCAL; Pryor LD, 1981, ECOLOGICAL BIOGEOGRA, P499; Rozefelds A. C., 1996, Tasforests, V8, P15; Slee A.V., 2020, EUCLID EUCALYPTS AUS; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Udovicic F., 2000, Kew Bulletin, V55, P633, DOI 10.2307/4118780; Whittock S, 2003, T ROY SOC SOUTH AUST, V127, P27; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilf P, 2009, AM J BOT, V96, P2031, DOI 10.3732/ajb.0900085; Wilson PG, 2001, AM J BOT, V88, P2013, DOI 10.2307/3558428	66	104	108	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21084	10.1371/journal.pone.0021084	http://dx.doi.org/10.1371/journal.pone.0021084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738605	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800012
J	Montero-Pau, J; Ramos-Rodriguez, E; Serra, M; Gomez, A				Montero-Pau, Javier; Ramos-Rodriguez, Eloisa; Serra, Manuel; Gomez, Africa			Long-Term Coexistence of Rotifer Cryptic Species	PLOS ONE			English	Article							DIAPAUSING EGG BANKS; BRACHIONUS-PLICATILIS; MORPHOLOGICAL STASIS; RESOURCE COMPETITION; PATTERNS; SPECIATION; COMPLEX; DNA; ZOOPLANKTON; PREDATION	Despite their high morphological similarity, cryptic species often coexist in aquatic habitats presenting a challenge in the framework of niche differentiation theory and coexistence mechanisms. Here we use a rotifer species complex inhabiting highly unpredictable and fluctuating salt lakes to gain insights into the mechanisms involved in stable coexistence in cryptic species. We combined molecular barcoding surveys of planktonic populations and paleogenetic analysis of diapausing eggs to reconstruct the current and historical coexistence dynamics of two highly morphologically similar rotifer species, B. plicatilis and B. manjavacas. In addition, we carried out laboratory experiments using clones isolated from eight lakes where both species coexist to explore their clonal growth responses to salinity, a challenging, highly variable and unpredictable condition in Mediterranean salt lakes. We show that both species have co-occurred in a stable way in one lake, with population fluctuations in which no species was permanently excluded. The seasonal occurrence patterns of the plankton in two lakes agree with laboratory experiments showing that both species differ in their optimal salinity. These results suggest that stable species coexistence is mediated by differential responses to salinity and its fluctuating regime. We discuss the role of fluctuating salinity and a persistent diapausing egg banks as a mechanism for species coexistence in accordance with the 'storage effect'.	[Montero-Pau, Javier; Ramos-Rodriguez, Eloisa; Serra, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Montero-Pau, Javier; Gomez, Africa] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Valencia; University of Hull	Montero-Pau, J (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	javier.montero@uv.es	Gomez, A/L-6505-2014; Montero-Pau, Javier/H-6711-2015; Ramos-Rodríguez, Eloísa/ABI-6376-2020; Ramos-Rodriguez, Eloisa/K-2819-2014; Serra, Manuel/H-7817-2015	Gomez, A/0000-0002-1297-4502; Montero-Pau, Javier/0000-0002-0864-8157; Ramos-Rodríguez, Eloísa/0000-0003-2440-0765; Ramos-Rodriguez, Eloisa/0000-0003-2440-0765; Serra, Manuel/0000-0003-1731-1529	Spanish Ministerio de Ciencia e Innovacion [CGL2009-07364]; National Environment Research Council (NERC) [NE/B501298/1]; Secretaria General de Universidades e Investigacion; Spanish Ministerio de Ciencia y Tecnologia [BES2004-5248]; Natural Environment Research Council [NE/B501298/1] Funding Source: researchfish	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); National Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Secretaria General de Universidades e Investigacion; Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2009-07364) to MS. AG was supported by a National Environment Research Council (NERC) Advanced Fellowship (NE/B501298/1). ER-R was supported by a fellowship by the Secretaria General de Universidades e Investigacion (Consejeria de Educacion y Ciencia, Junta de Andalucia), and JM-P by a fellowship by the Spanish Ministerio de Ciencia y Tecnologia (BES2004-5248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, P NATL ACAD SCI USA, V105, P12382, DOI 10.1073/pnas.0805039105; ALONSO M, 1990, HYDROBIOLOGIA, V197, P221, DOI 10.1007/BF00026952; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blair CP, 2005, EVOLUTION, V59, P304; Boronat L, 2001, HYDROBIOLOGIA, V442, P75, DOI 10.1023/A:1017522004975; Braune P, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-19; Brendonck L, 2003, HYDROBIOLOGIA, V491, P65, DOI 10.1023/A:1024454905119; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Caceres CE, 1997, P NATL ACAD SCI USA, V94, P9171, DOI 10.1073/pnas.94.17.9171; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Carmona MJ, 2009, J EVOLUTION BIOL, V22, P1975, DOI 10.1111/j.1420-9101.2009.01811.x; Carmona MJ, 1995, HYDROBIOLOGIA, V313, P365, DOI 10.1007/BF00025971; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chesson P, 2003, THEOR POPUL BIOL, V64, P354; Ciros-Perez J, 2004, LIMNOL OCEANOGR, V49, P40, DOI 10.4319/lo.2004.49.1.0040; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; Comin F.A., 1992, Limnetica, V8, P79; Cordova SE, 2001, FRESHWATER BIOL, V46, P1519, DOI 10.1046/j.1365-2427.2001.00768.x; Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Dominguez-Castro F, 2008, GLOBAL PLANET CHANGE, V63, P230, DOI 10.1016/j.gloplacha.2008.06.002; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Garcia-Ferrer I, 2003, HYDROBIOLOGIA, V506, P101, DOI 10.1023/B:HYDR.0000008593.32525.1d; Garcia-Roger EM, 2006, J EXP MAR BIOL ECOL, V336, P198, DOI 10.1016/j.jembe.2006.05.009; Garcia-Roger EM, 2005, J EXP MAR BIOL ECOL, V314, P149, DOI 10.1016/j.jembe.2004.08.023; Geller JB, 1999, CONSERV BIOL, V13, P661, DOI 10.1046/j.1523-1739.1999.97470.x; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 1996, J EVOLUTION BIOL, V9, P953, DOI 10.1046/j.1420-9101.1996.9060953.x; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Gomez A, 1997, OECOLOGIA, V111, P350, DOI 10.1007/s004420050245; GOMEZ A, 1995, J EVOLUTION BIOL, V8, P601, DOI 10.1046/j.1420-9101.1995.8050601.x; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hairston NG, 1996, LIMNOL OCEANOGR, V41, P1087, DOI 10.4319/lo.1996.41.5.1087; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jankowski T, 2003, LIMNOL OCEANOGR, V48, P1948, DOI 10.4319/lo.2003.48.5.1948; King CE, 1980, EVOLUTION ECOLOGY ZO, P315; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; KNOWLTON N, 1994, TRENDS ECOL EVOL, V9, P7, DOI 10.1016/0169-5347(94)90224-0; Lapesa S, 2004, FRESHWATER BIOL, V49, P1053, DOI 10.1111/j.1365-2427.2004.01249.x; Lapesa S., 2004, THESIS U VALENCIA; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Lowe CD, 2005, MAR BIOL, V146, P923, DOI 10.1007/s00227-004-1501-9; McCullagh P, 1989, GEN LINEAR MODELS; Mergeay J, 2005, LIMNOL OCEANOGR, V50, P1278, DOI 10.4319/lo.2005.50.4.1278; MIRACLE MR, 1989, HYDROBIOLOGIA, V186, P81, DOI 10.1007/BF00048900; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020314; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Nykanen M, 2009, J PALEOLIMNOL, V42, P551, DOI 10.1007/s10933-008-9304-5; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Ortells R, 2000, ARCH HYDROBIOL, V149, P529; Papakostas S, 2005, MAR BIOL, V147, P1129, DOI 10.1007/s00227-005-0012-7; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Rodo X, 1997, CLIM DYNAM, V13, P275, DOI 10.1007/s003820050165; Rodriguez-Puebla C, 1998, INT J CLIMATOL, V18, P299, DOI 10.1002/(SICI)1097-0088(19980315)18:3&lt;299::AID-JOC247&gt;3.0.CO;2-L; RODRIGUEZRODRIG.M, 2005, GEOGACETA, V37, P87; Sears ALW, 2007, ECOLOGY, V88, P2240, DOI 10.1890/06-0645.1; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x	65	47	51	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21530	10.1371/journal.pone.0021530	http://dx.doi.org/10.1371/journal.pone.0021530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738691	Green Published, gold			2022-12-25	WOS:000292142800032
J	Osborne, SE; Coombes, BK				Osborne, Suzanne E.; Coombes, Brian K.			Transcriptional Priming of Salmonella Pathogenicity Island-2 Precedes Cellular Invasion	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; III SECRETION SYSTEM; INFECTIOUS ENTEROCOLITIS; INTRACELLULAR SALMONELLA; NADPH OXIDASE; HOST-CELLS; IN-VIVO; H-NS; VIRULENCE; EXPRESSION	Invasive salmonellosis caused by Salmonella enterica involves an enteric stage of infection where the bacteria colonize mucosal epithelial cells, followed by systemic infection with intracellular replication in immune cells. The type III secretion system encoded in Salmonella Pathogenicity Island (SPI)-2 is essential for intracellular replication and the regulators governing high-level expression of SPI-2 genes within the macrophage phagosome and in inducing media thought to mimic this environment have been well characterized. However, low-level expression of SPI-2 genes is detectable in media thought to mimic the extracellular environment suggesting that additional regulatory pathways are involved in SPI-2 gene expression prior to cellular invasion. The regulators involved in this activity are not known and the extracellular transcriptional activity of the entire SPI-2 island in vivo has not been studied. We show that low-level, SsrB-independent promoter activity for the ssrA-ssrB two-component regulatory system and the ssaG structural operon encoded in SPI-2 is dependent on transcriptional input by OmpR and Fis under non-inducing conditions. Monitoring the activity of all SPI-2 promoters in real-time following oral infection of mice revealed invasion-independent transcriptional activity of the SPI2 T3SS in the lumen of the gut, which we suggest is a priming activity with functional relevance for the subsequent intracellular host-pathogen interaction.	[Osborne, Suzanne E.; Coombes, Brian K.] McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University	Osborne, SE (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	coombes@mcmaster.ca	Coombes, Brian K/A-1727-2009	Coombes, Brian/0000-0001-9883-1010	Canadian Institutes of Health Research (CIHR) [MOP-82704]; Canada Foundation for Innovation Leaders Opportunity Fund	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation)	This research was funded through an operating grant from the Canadian Institutes of Health Research (CIHR; MOP-82704) and an infrastructure grant from Canada Foundation for Innovation Leaders Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Bispham J, 2001, INFECT IMMUN, V69, P367, DOI 10.1128/IAI.69.1.367-377.2001; Brown NF, 2005, PLOS PATHOG, V1, P252, DOI 10.1371/journal.ppat.0010032; Bustamante VH, 2008, P NATL ACAD SCI USA, V105, P14591, DOI 10.1073/pnas.0801205105; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Coombes BK, 2005, P NATL ACAD SCI USA, V102, P17460, DOI 10.1073/pnas.0505401102; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Coombes BK, 2004, J BIOL CHEM, V279, P49804, DOI 10.1074/jbc.M404299200; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Duong N, 2007, J BIOL CHEM, V282, P34077, DOI 10.1074/jbc.M707352200; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; GALAN JE, 1991, INFECT IMMUN, V59, P2901; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lim S, 2006, MICROB PATHOGENESIS, V41, P33, DOI 10.1016/j.micpath.2006.03.005; Miao EA, 2002, J BACTERIOL, V184, P1493, DOI 10.1128/JB.184.5.1493-1497.2002; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Navarre WW, 2005, MOL MICROBIOL, V56, P492, DOI 10.1111/j.1365-2958.2005.04553.x; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Silphaduang U, 2007, J BACTERIOL, V189, P3669, DOI 10.1128/JB.00002-07; Stapleton MR, 2002, J BIOL CHEM, V277, P17630, DOI 10.1074/jbc.M110178200; Tlili A, 2011, FREE RADICAL BIO MED, V50, P438, DOI 10.1016/j.freeradbiomed.2010.11.024; Tomljenovic-Berube AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000875; VanderVen BC, 2009, TRAFFIC, V10, P372, DOI [10.1111/j.1600-0854.2008.00877.x, 10.1111/j.1600-0854.2009.00877.x]; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vivero A, 2008, J BACTERIOL, V190, P1152, DOI 10.1128/JB.01206-07; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Xu X, 2010, INFECT IMMUN, V78, P49, DOI 10.1128/IAI.00931-09; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306	41	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21648	10.1371/journal.pone.0021648	http://dx.doi.org/10.1371/journal.pone.0021648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738750	Green Submitted, gold, Green Published			2022-12-25	WOS:000292142800053
J	Rocha, J; Alberich, R				Rocha, Jairo; Alberich, Ricardo			The Significance of the ProtDeform Score for Structure Prediction and Alignment	PLOS ONE			English	Article							CLASSIFICATION; SELECTIVITY; SENSITIVITY; PROTEINS; SEQUENCE; CATH	Background: When a researcher uses a program to align two proteins and gets a score, one of her main concerns is how often the program gives a similar score to pairs that are or are not in the same fold. This issue was analysed in detail recently for the program TM-align with its associated TM-score. It was shown that because the TM-score is length independent, it allows a P-value and a hit probability to be defined depending only on the score. Also, it was found that the TM-scores of gapless alignments closely follow an Extreme Value Distribution (EVD). The program ProtDeform for structural protein alignment was developed recently and is characterised by the ability to propose different transformations of different protein regions. Our goal is to analyse its associated score to allow a researcher to have objective reasons to prefer one aligner over another, and carry out a better interpretation of the output. Results: The study on the ProtDeform score reveals that it is length independent in a wider score range than TM-scores and that PD-scores of gapless (random) alignments also approximately follow an EVD. On the CASP8 predictions, PD-scores and TM-scores, with respect to native structures, are highly correlated (0.95), and show that around a fifth of the predictions have a quality as low as 99.5% of the random scores. Using the Gold Standard benchmark, ProtDeform has lower probabilities of error than TM-align both at a similar speed. The analysis is extended to homology discrimination showing that, again, ProtDeform offers higher hit probabilities than TM-align. Finally, we suggest using three different P-values according to the three different contexts: Gapless alignments, optimised alignments for fold discrimination and that for superfamily discrimination. In conclusion, PD-scores are at the very least as valuable for prediction scoring as TM-scores, and on the protein classification problem, even more reliable.	[Rocha, Jairo] Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Spain; Univ Balearic Isl, IUNICS, Palma De Mallorca, Spain	Universitat de les Illes Balears; Universitat de les Illes Balears	Rocha, J (corresponding author), Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Spain.	jairo@uib.es	Rocha, Jairo/K-9850-2014; Alberich, Ricardo/L-8763-2014	Rocha, Jairo/0000-0002-8810-7376; Alberich, Ricardo/0000-0002-0707-8607	 [MTM 2009-07165]		This research has been supported in part by the grant MTM 2009-07165. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2007, NUCLEIC ACIDS RES, V35, pD253, DOI 10.1093/nar/gkl746; Csaba G, 2008, BIOINFORMATICS, V24, pI98, DOI 10.1093/bioinformatics/btn271; Csaba G, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-23; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kawabata T, 2000, PROTEINS, V41, P108, DOI 10.1002/1097-0134(20001001)41:1<108::AID-PROT130>3.3.CO;2-J; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Levitt M, 1998, P NATL ACAD SCI USA, V95, P5913, DOI 10.1073/pnas.95.11.5913; Menke M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040010; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pascual-Garcia A, 2010, PROTEINS, V78, P181, DOI 10.1002/prot.22616; Rocha J, 2009, BIOINFORMATICS, V25, P1625, DOI 10.1093/bioinformatics/btp296; Sierk ML, 2004, PROTEIN SCI, V13, P773, DOI 10.1110/ps.03328504; Standley DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-116; TAYLOR WR, 1989, J MOL BIOL, V208, P1, DOI 10.1016/0022-2836(89)90084-3; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; ZHANG Y, 2005, NUCLEIC ACIDS RES, V57, P702	20	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20889	10.1371/journal.pone.0020889	http://dx.doi.org/10.1371/journal.pone.0020889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738592	gold, Green Published, Green Submitted			2022-12-25	WOS:000292142800005
J	Wen, HX; Lu, YM; Yao, HH; Buch, S				Wen, Hongxiu; Lu, Yaman; Yao, Honghong; Buch, Shilpa			Morphine Induces Expression of Platelet-Derived Growth Factor in Human Brain Microvascular Endothelial Cells: Implication for Vascular Permeability	PLOS ONE			English	Article							RAPID DISEASE PROGRESSION; PROTEASE-ACTIVATED LIGAND; HIV-1 TAT; PDGF; RECEPTOR; METHYLNALTREXONE; TRANSACTIVATION; TRANSCRIPTION; ANGIOGENESIS; INVOLVEMENT	Despite the advent of antiretroviral therapy, complications of HIV-1 infection with concurrent drug abuse are an emerging problem. Morphine, often abused by HIV-infected patients, is known to accelerate neuroinflammation associated with HIV-1 infection. Detailed molecular mechanisms of morphine action however, remain poorly understood. Platelet-derived growth factor (PDGF) has been implicated in a number of pathological conditions, primarily due to its potent mitogenic and permeability effects. Whether morphine exposure results in enhanced vascular permeability in brain endothelial cells, likely via induction of PDGF, remains to be established. In the present study, we demonstrated morphine-mediated induction of PDGF-BB in human brain microvascular endothelial cells, an effect that was abrogated by the opioid receptor antagonistnaltrexone. Pharmacological blockade (cell signaling) and loss-of-function (Egr-1) approaches demonstrated the role of mitogen-activated protein kinases (MAPKs), PI3K/Akt and the downstream transcription factor Egr-1 respectively, in morphine-mediated induction of PDGF-BB. Functional significance of increased PDGF-BB manifested as increased breach of the endothelial barrier as evidenced by decreased expression of the tight junction protein ZO-1 in an in vitro model system. Understanding the regulation of PDGF expression may provide insights into the development of potential therapeutic targets for intervention of morphine-mediated neuroinflammation.	[Wen, Hongxiu; Lu, Yaman; Yao, Honghong; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Wen, HX (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	hyao@unmc.edu; sbuch@unmc.edu		Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212, DA020392, DA023397, DA024442, DA030285]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023397, R01DA024442, R01DA020392, R21DA030285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants MH-068212, DA020392, DA023397, DA024442 (SB) and DA030285 (HY) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2001, J MOL CELL CARDIOL, V33, P2179, DOI 10.1006/jmcc.2001.1480; Bell JE, 2006, J NEUROIMMUNE PHARM, V1, P182, DOI 10.1007/s11481-006-9018-2; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bokhari SM, 2009, J NEUROVIROL, V15, P219, DOI 10.1080/13550280902913628; Bruce-Keller AJ, 2008, GLIA, V56, P1414, DOI 10.1002/glia.20708; Cabral GA, 2006, J NEUROIMMUNE PHARM, V1, P280, DOI 10.1007/s11481-006-9023-5; Chen C, 2006, CURR NEUROVASC RES, V3, P171, DOI 10.2174/156720206778018767; Chen Y, 2008, J NEUROSCI, V28, P5836, DOI 10.1523/JNEUROSCI.4170-07.2008; Chen Y, 2009, MOL NEUROBIOL, V40, P101, DOI 10.1007/s12035-009-8074-z; DEUEL TF, 1987, ANNU REV CELL BIOL, V3, P443, DOI 10.1146/annurev.cb.03.110187.002303; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; Gupta K, 2002, CANCER RES, V62, P4491; HANNINK M, 1989, BIOCHIM BIOPHYS ACTA, V989, P1, DOI 10.1016/0304-419X(89)90031-0; HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x; James AB, 2005, J NEUROCHEM, V95, P796, DOI 10.1111/j.1471-4159.2005.03400.x; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Mahajan SD, 2008, J CLIN IMMUNOL, V28, P528, DOI 10.1007/s10875-008-9208-1; Perez-Casanova A, 2007, AIDS RES HUM RETROV, V23, P1004, DOI 10.1089/aid.2006.0286; Potula R, 2004, AM J PATHOL, V165, P815, DOI 10.1016/S0002-9440(10)63344-5; Rivera-Amill V, 2010, VIROLOGY, V398, P201, DOI 10.1016/j.virol.2009.11.046; Roy S, 2003, SURGERY, V134, P336, DOI 10.1067/msy.2003.247; Shin HJ, 2009, CLIN IMMUNOL, V131, P385, DOI 10.1016/j.clim.2009.02.009; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Singleton PA, 2006, MICROVASC RES, V72, P3, DOI 10.1016/j.mvr.2006.04.004; Singleton PA, 2007, AM J RESP CELL MOL, V37, P222, DOI 10.1165/rcmb.2006-0327OC; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Turchan-Cholewo J, 2009, J NEUROCHEM, V108, P202, DOI 10.1111/j.1471-4159.2008.05756.x; WINKLES JA, 1991, BIOCHEM BIOPH RES CO, V180, P519, DOI 10.1016/S0006-291X(05)81095-2; YAO H, 2010, BLOOD; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Yousif S, 2008, J NEUROCHEM, V107, P647, DOI 10.1111/j.1471-4159.2008.05647.x	34	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21707	10.1371/journal.pone.0021707	http://dx.doi.org/10.1371/journal.pone.0021707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738771	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800062
J	Patil, SB; Hurd, TW; Ghosh, AK; Murga-Zamalloa, CA; Khanna, H				Patil, Suresh B.; Hurd, Toby W.; Ghosh, Amiya K.; Murga-Zamalloa, Carlos A.; Khanna, Hemant			Functional Analysis of Retinitis Pigmentosa 2 (RP2) Protein Reveals Variable Pathogenic Potential of Disease-Associated Missense Variants	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA-2 PROTEIN; VERTEBRATE DEVELOPMENT; RETINAL DEGENERATION; CLINICAL FINDINGS; MUTATIONS; TRANSPORT; RHODOPSIN; RPGR; PHOTORECEPTORS; TRAFFICKING	Genetic mutations are frequently associated with diverse phenotypic consequences, which limits the interpretation of the consequence of a variation in patients. Mutations in the retinitis pigmentosa 2 (RP2) gene are associated with X-linked RP, which is a phenotypically heterogenic form of retinal degeneration. The purpose of this study was to assess the functional consequence of disease-associated mutations in the RP2 gene using an in vivo assay. Morpholino-mediated depletion of rp2 in zebrafish resulted in perturbations in photoreceptor development and microphthalmia (small eye). Ultrastructural and immunofluorescence analyses revealed defective photoreceptor outer segment development and lack of expression of photoreceptor-specific proteins. The retinopathy phenotype could be rescued by expressing the wild-type human RP2 protein. Notably, the tested RP2 mutants exhibited variable degrees of rescue of rod versus cone photoreceptor development as well as microphthalmia. Our results suggest that RP2 plays a key role in photoreceptor development and maintenance in zebrafish and that the clinical heterogeneity associated with RP2 mutations may, in part, result from its potentially distinct functional relevance in rod versus cone photoreceptors.	[Patil, Suresh B.; Khanna, Hemant] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01605 USA; [Patil, Suresh B.; Ghosh, Amiya K.; Murga-Zamalloa, Carlos A.; Khanna, Hemant] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Hurd, Toby W.; Ghosh, Amiya K.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Murga-Zamalloa, Carlos A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Patil, SB (corresponding author), Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01605 USA.	hemant.khanna@umassmed.edu	Murga-Zamalloa, Carlos/AAX-9387-2021	Murga-Zamalloa, Carlos/0000-0002-2238-5066	Foundation Fighting Blindness [EY007961]	Foundation Fighting Blindness(European Commission)	This study was supported by the Foundation Fighting Blindness (EY007961, http://www.blindness.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Berson EL, 1996, P NATL ACAD SCI USA, V93, P4526, DOI 10.1073/pnas.93.10.4526; Bird A C, 1987, Prog Clin Biol Res, V247, P3; BIRD AC, 1975, BRIT J OPHTHALMOL, V59, P177, DOI 10.1136/bjo.59.4.177; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chapple JP, 2000, HUM MOL GENET, V9, P1919, DOI 10.1093/hmg/9.13.1919; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; DERETIC D, 1995, J CELL SCI, V108, P215; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Deretic D, 1998, P NATL ACAD SCI USA, V95, P10620, DOI 10.1073/pnas.95.18.10620; DRYJA TP, 1995, INVEST OPHTH VIS SCI, V36, P1197; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Evans RJ, 2006, EXP EYE RES, V82, P543, DOI 10.1016/j.exer.2005.10.023; Evans RJ, 2005, METHOD ENZYMOL, V404, P468, DOI 10.1016/S0076-6879(05)04041-3; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Ghosh AK, 2010, HUM MOL GENET, V19, P90, DOI 10.1093/hmg/ddp469; Hardcastle AJ, 1999, AM J HUM GENET, V64, P1210, DOI 10.1086/302325; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Holopainen JM, 2010, BIOCHEMISTRY-US, V49, P7439, DOI 10.1021/bi1005249; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Ingham PW, 2009, HUM MOL GENET, V18, pR107, DOI 10.1093/hmg/ddp091; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107	37	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21379	10.1371/journal.pone.0021379	http://dx.doi.org/10.1371/journal.pone.0021379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738648	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600034
J	Chen, ZP; Resnik, E; McFarland, JM; Sakmann, B; Mehta, MR				Chen, Zhiping; Resnik, Evgeny; McFarland, James M.; Sakmann, Bert; Mehta, Mayank R.			Speed Controls the Amplitude and Timing of the Hippocampal Gamma Rhythm	PLOS ONE			English	Article							PHASE PRECESSION; UNIT-ACTIVITY; OSCILLATIONS; THETA; DYNAMICS; CA1; SYNCHRONIZATION; FREQUENCY; CORTEX; INTERNEURONS	Cortical and hippocampal gamma oscillations have been implicated in many behavioral tasks. The hippocampus is required for spatial navigation where animals run at varying speeds. Hence we tested the hypothesis that the gamma rhythm could encode the running speed of mice. We found that the amplitude of slow (20-45 Hz) and fast (45-120 Hz) gamma rhythms in the hippocampal local field potential (LFP) increased with running speed. The speed-dependence of gamma amplitude was restricted to a narrow range of theta phases where gamma amplitude was maximal, called the preferred theta phase of gamma. The preferred phase of slow gamma precessed to lower values with increasing running speed. While maximal fast and slow gamma occurred at coincident phases of theta at low speeds, they became progressively more theta-phase separated with increasing speed. These results demonstrate a novel influence of speed on the amplitude and timing of the hippocampal gamma rhythm which could contribute to learning of temporal sequences and navigation.	[Chen, Zhiping; McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Chen, Zhiping; McFarland, James M.; Mehta, Mayank R.] Univ Calif Los Angeles, Integrat Ctr Learning & Memory, Los Angeles, CA USA; [Resnik, Evgeny; Sakmann, Bert] Max Planck Inst Med Res, Dept Cell Physiol, Heidelberg, Germany; [McFarland, James M.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [Sakmann, Bert] Max Plank Florida Inst, Jupiter, FL USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Max Planck Society; Brown University; Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chen, ZP (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	MayankMehta@ucla.edu		Mehta, Mayank/0000-0003-2005-2468	NSF [0969034]; NIH/CRCNS [1-R01-MH-092925-01]; Whitehall foundation; W. M. Keck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH/CRCNS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall foundation; W. M. Keck foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants to M. R. M. from the NSF Career #0969034 (www.nsf.gov), NIH/CRCNS #1-R01-MH-092925-01 (www.nih.gov), Whitehall foundation (www.whitehall.org) and the W. M. Keck foundation (www.wmkeck.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hahn TTG, 2007, P NATL ACAD SCI USA, V104, P5169, DOI 10.1073/pnas.0700222104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hentschke H, 2007, EUR J NEUROSCI, V26, P1642, DOI 10.1111/j.1460-9568.2007.05779.x; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kay Leslie M, 2003, J Integr Neurosci, V2, P31, DOI 10.1142/S0219635203000196; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 2001, NEUROSCIENTIST, V7, P490, DOI 10.1177/107385840100700605; Mehta MR, 2000, NEUROCOMPUTING, V32, P905, DOI 10.1016/S0925-2312(00)00259-9; MONTGOMERY SM, 2007, P NATL ACAD SCI US; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sederberg PB, 2003, J NEUROSCI, V23, P10809; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Vinck M, 2010, J NEUROSCI, V30, P1250, DOI 10.1523/JNEUROSCI.1623-09.2010; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Wulff P, 2009, P NATL ACAD SCI USA, V106, P3561, DOI 10.1073/pnas.0813176106; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	45	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21408	10.1371/journal.pone.0021408	http://dx.doi.org/10.1371/journal.pone.0021408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731735	Green Published, gold			2022-12-25	WOS:000292036900027
J	Colombo, F; Baldan, F; Mazzucchelli, S; Martin-Padura, I; Marighetti, P; Cattaneo, A; Foglieni, B; Spreafico, M; Guerneri, S; Baccarin, M; Bertolini, F; Rossi, G; Mazzaferro, V; Cadamuro, M; Maggioni, M; Agnelli, L; Rebulla, P; Prati, D; Porretti, L				Colombo, Federico; Baldan, Francesca; Mazzucchelli, Silvia; Martin-Padura, Ines; Marighetti, Paola; Cattaneo, Alessandra; Foglieni, Barbara; Spreafico, Marta; Guerneri, Silvana; Baccarin, Marco; Bertolini, Francesco; Rossi, Giorgio; Mazzaferro, Vincenzo; Cadamuro, Massimiliano; Maggioni, Marco; Agnelli, Luca; Rebulla, Paolo; Prati, Daniele; Porretti, Laura			Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular Carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; MESENCHYMAL TRANSITION; GENE-EXPRESSION; IDENTIFICATION; PROGRESSION; LINES; ESTABLISHMENT; LEUKEMIA	Background and Aims: Increasing evidence that a number of malignancies are characterised by tumour cell heterogeneity has recently been published, but there is still a lack of data concerning liver cancers. The aim of this study was to investigate and characterise tumour-propagating cell (TPC) compartments within human hepatocellular carcinoma (HCC). Methods: After long-term culture, we identified three morphologically different tumour cell populations in a single HCC specimen, and extensively characterised them by means of flow cytometry, fluorescence microscopy, karyotyping and microarray analyses, single cell cloning, and xenotransplantation in NOD/SCID/IL2Rc gamma(-/-) mice. Results: The primary cell populations (hcc-1, -2 and -3) and two clones generated by means of limiting dilutions from hcc-1 (clone-1/7 and -1/8) differently expressed a number of tumour-associated stem cell markers, including EpCAM, CD49f, CD44, CD133, CD56, Thy-1, ALDH and CK19, and also showed different doubling times, drug resistance and tumorigenic potential. Moreover, we found that ALDH expression, in combination with CD44 or Thy-1 negativity or CD56 positivity identified subpopulations with a higher clonogenic potential within hcc-1, hcc-2 and hcc-3 primary cell populations, respectively. Karyotyping revealed the clonal evolution of the cell populations and clones within the primary tumour. Importantly, the primary tumour cell population with the greatest tumorigenic potential and drug resistance showed more chromosomal alterations than the others and contained clones with epithelial and mesenchymal features. Conclusions: Individual HCCs can harbor different self-renewing tumorigenic cell types expressing a variety of morphological and phenotypical markers, karyotypic evolution and different gene expression profiles. This suggests that the models of hepatic carcinogenesis should take into account TPC heterogeneity due to intratumour clonal evolution.	[Colombo, Federico; Baldan, Francesca; Mazzucchelli, Silvia; Cattaneo, Alessandra; Rebulla, Paolo; Prati, Daniele; Porretti, Laura] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Transfus Med Cellular Therapy & Cryobiol, Expt Hepatol Lab, Milan, Italy; [Martin-Padura, Ines; Marighetti, Paola; Bertolini, Francesco] European Inst Oncol, Lab Hematooncol, Milan, Italy; [Foglieni, Barbara; Spreafico, Marta; Prati, Daniele] Hosp A Manzoni, Dept Hematol, Lecce, Italy; [Guerneri, Silvana; Baccarin, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Med Genet Lab, Milan, Italy; [Rossi, Giorgio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Liver & Lung Transplant Unit, Milan, Italy; [Mazzaferro, Vincenzo] Natl Canc Inst, I-20133 Milan, Italy; [Cadamuro, Massimiliano] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy; [Cadamuro, Massimiliano] Osped Riuniti Bergamo, Liver Res Ctr, I-24100 Bergamo, Italy; [Maggioni, Marco] AO San Paolo Milan, Dept Med Surg & Dent, Div Pathol, Milan, Italy; [Maggioni, Marco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Med Surg & Dent, Div Pathol, Milan, Italy; [Agnelli, Luca] Univ Milan, Dept Med Sci, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS European Institute of Oncology (IEO); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Padua; Ospedali Riuniti di Bergamo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Colombo, F (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Ctr Transfus Med Cellular Therapy & Cryobiol, Expt Hepatol Lab, Milan, Italy.	labcitofl@policlinico.mi.it	Prati, Daniele/P-8215-2019; Porretti, Laura/J-6748-2015; Agnelli, Luca/H-8238-2012; bertolini, francesco/AAC-9780-2019; Colombo, Federico Simone/J-5586-2015; Maggioni, Marco/AAC-4617-2022; Rossi, Giorgio/M-3445-2015; Mazzaferro, Vincenzo/C-2726-2017; Mazzaferro, Vincenzo/AAL-4707-2020; Cadamuro, Massimiliano/AAC-6169-2022; Cattaneo, Alessandra/K-5049-2012; Rebulla, Paolo/I-7684-2015; Spreafico, Marta/C-5945-2014	Prati, Daniele/0000-0002-2281-7498; Porretti, Laura/0000-0001-8100-4262; bertolini, francesco/0000-0001-5660-3255; Colombo, Federico Simone/0000-0003-4480-3481; Maggioni, Marco/0000-0001-8603-8998; Rossi, Giorgio/0000-0002-5588-1306; Mazzaferro, Vincenzo/0000-0002-4013-8085; Cadamuro, Massimiliano/0000-0002-0899-7613; Cattaneo, Alessandra/0000-0002-4500-6540; Rebulla, Paolo/0000-0002-3875-5754; Spreafico, Marta/0000-0003-3378-5513; Agnelli, Luca/0000-0003-0582-6170	COPEV (Comitato per la Prevenzione dell'Epatite Virale); "Progetto di Ricerca a Concorso'' IRCCS Ospedale Policlinico, Milan; Associazione Italiana Studio Fegato (AISF); Associazione Italiana Ricerca sul Cancro (AIRC); CeLiveR	COPEV (Comitato per la Prevenzione dell'Epatite Virale); "Progetto di Ricerca a Concorso'' IRCCS Ospedale Policlinico, Milan; Associazione Italiana Studio Fegato (AISF); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); CeLiveR	This study was supported by grants from COPEV (Comitato per la Prevenzione dell'Epatite Virale); "Progetto di Ricerca a Concorso 2009/2010'' IRCCS Ospedale Policlinico, Milan; Associazione Italiana Studio Fegato (AISF); Associazione Italiana Ricerca sul Cancro (AIRC); and CeLiveR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Agnelli L, 2007, HAEMATOL-HEMATOL J, V92, P56, DOI 10.3324/haematol.10414; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BIGNER SH, 1987, CANCER GENET CYTOGEN, V24, P163, DOI 10.1016/0165-4608(87)90094-X; Bomken S, 2010, BRIT J CANCER, V103, P439, DOI 10.1038/sj.bjc.6605821; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Chifenti B, 2009, PANCREAS, V38, P184, DOI 10.1097/MPA.0b013e31818c746a; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Fabris L, 2008, HEPATOLOGY, V47, P719, DOI 10.1002/hep.22015; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lau SH, 2005, ACTA PHARMACOL SIN, V26, P659, DOI 10.1111/j.1745-7254.2005.00126.x; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Marquardt JU, 2010, J HEPATOL, V53, P568, DOI 10.1016/j.jhep.2010.05.003; Martin-Padura I, 2010, BLOOD, V116, P2616, DOI 10.1182/blood-2010-07-295584; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Merlo LMF, 2010, J CLIN INVEST, V120, P401, DOI 10.1172/JCI42088; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Porretti L, 2010, CYTOM PART A, V77A, P31, DOI 10.1002/cyto.a.20834; Rebuzzini P, 2008, CYTOGENET GENOME RES, V121, P18, DOI 10.1159/000124377; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shi GM, 2008, J CANCER RES CLIN, V134, P1155, DOI 10.1007/s00432-008-0407-1; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Steinemann D, 2006, CLIN GASTROENTEROL H, V4, P1283, DOI 10.1016/j.cgh.2006.07.010; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wong N, 2000, HEPATOLOGY, V32, P1060, DOI 10.1053/jhep.2000.19349	42	40	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21369	10.1371/journal.pone.0021369	http://dx.doi.org/10.1371/journal.pone.0021369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731718	Green Published, gold			2022-12-25	WOS:000292035400030
J	Frazer, C; Young, PG				Frazer, Corey; Young, Paul G.			Redundant Mechanisms Prevent Mitotic Entry Following Replication Arrest in the Absence of Cdc25 Hyper-Phosphorylation in Fission Yeast	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; S-PHASE ARREST; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; TYROSINE PHOSPHORYLATION; NUCLEAR EXCLUSION; KINASES CDS1; PROTEIN; PHOSPHATASE; GENE	Following replication arrest the Cdc25 phosphatase is phosphorylated and inhibited by Cds1. It has previously been reported that expressing Cdc25 where 9 putative amino-terminal Cds1 phosphorylation sites have been substituted to alanine results in bypass of the DNA replication checkpoint. However, these results were acquired by expression of the phosphorylation mutant using a multicopy expression vector in a genetic background where the DNA replication checkpoint is intact. In order to clarify these results we constructed a Cdc25(9A)-GFP native promoter integrant and examined its effect on the replication checkpoint at endogenous expression levels. In this strain the replication checkpoint operates normally, conditional on the presence of the Mik1 kinase. In response to replication arrest the Cdc25(9A)-GFP protein is degraded, suggesting the presence of a backup mechanism to eliminate the phosphatase when it cannot be inhibited through phosphorylation.	[Frazer, Corey; Young, Paul G.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Frazer, C (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	Paul.Young@queensu.ca			NSERC [9335-05]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by NSERC 9335-05 Cell Cycle Control. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; AVES SJ, 1985, EMBO J, V4, P457, DOI 10.1002/j.1460-2075.1985.tb03651.x; Baber-Furnari BA, 2000, MOL BIOL CELL, V11, P1; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Chen CT, 2008, CURR BIOL, V18, P1594, DOI 10.1016/j.cub.2008.08.067; Chen L, 1999, GENE DEV, V13, P675, DOI 10.1101/gad.13.6.675; Christensen PU, 2000, P NATL ACAD SCI USA, V97, P2579, DOI 10.1073/pnas.97.6.2579; Chu ZQ, 2009, MOL CELL BIOL, V29, P4959, DOI 10.1128/MCB.00562-09; Chua G, 2002, GENETICS, V162, P689; Collura A, 2005, MOL CELL BIOL, V25, P7889, DOI 10.1128/MCB.25.17.7889-7899.2005; Daga RR, 1999, J CELL SCI, V112, P3137; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; Diaz-Cuervo H, 2008, MOL BIOL CELL, V19, P2488, DOI 10.1091/mbc.E07-08-0737; DUCOMMUN B, 1990, BIOCHEM BIOPH RES CO, V167, P301, DOI 10.1016/0006-291X(90)91765-K; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; ENOCH T, 1990, CELL, V60, P665, DOI 10.1016/0092-8674(90)90669-6; Esteban V, 2004, J CELL SCI, V117, P2461, DOI 10.1242/jcs.01107; Esteban V, 2008, CELL CYCLE, V7, P1269, DOI 10.4161/cc.7.9.5947; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; FOX RM, 1985, PHARMACOL THERAPEUT, V30, P31, DOI 10.1016/0163-7258(85)90046-4; Froget B, 2008, MOL BIOL CELL, V19, P445, DOI 10.1091/mbc.E07-07-0728; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; GORDON CB, 1986, EMBO J, V5, P2981, DOI 10.1002/j.1460-2075.1986.tb04595.x; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Gutz H., 1974, HDB GENETICS, V1, P395; Kai M, 2003, MUTAT RES-FUND MOL M, V532, P59, DOI 10.1016/j.mrfmmm.2003.08.010; Karagiannis J, 2002, GENETICS, V162, P45; Knudsen KE, 1996, P NATL ACAD SCI USA, V93, P8278, DOI 10.1073/pnas.93.16.8278; Kovelman R, 1996, MOL CELL BIOL, V16, P86; KUMAGAI A, 1991, CELL, V64, P903, DOI 10.1016/0092-8674(91)90315-P; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; LEE MS, 1994, J BIOL CHEM, V269, P30530; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Lopez-Girona A, 2001, CURR BIOL, V11, P50, DOI 10.1016/S0960-9822(00)00026-9; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; MILLAR JBA, 1992, EMBO J, V11, P4933, DOI 10.1002/j.1460-2075.1992.tb05600.x; Mishra M, 2004, J CELL SCI, V117, P3897, DOI 10.1242/jcs.01244; MIYAMOTO M, 1994, EMBO J, V13, P1873, DOI 10.1002/j.1460-2075.1994.tb06456.x; MORENO S, 1990, NATURE, V344, P549, DOI 10.1038/344549a0; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; Moser BA, 2000, MOL CELL BIOL, V20, P4288, DOI 10.1128/MCB.20.12.4288-4294.2000; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; Ng SS, 2001, FEBS LETT, V503, P131, DOI 10.1016/S0014-5793(01)02720-X; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; PARKER LL, 1992, P NATL ACAD SCI USA, V89, P2917, DOI 10.1073/pnas.89.7.2917; PRENTICE HL, 1992, NUCLEIC ACIDS RES, V20, P621, DOI 10.1093/nar/20.3.621; Raleigh JM, 2000, J CELL SCI, V113, P1727; Rhind N, 2001, MOL CELL BIOL, V21, P1499, DOI 10.1128/MCB.21.5.1499-1508.2001; Rupes I, 2001, MOL BIOL CELL, V12, P3892, DOI 10.1091/mbc.12.12.3892; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; SEATON BL, 1992, GENE, V119, P83, DOI 10.1016/0378-1119(92)90069-2; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Soto T, 2007, MICROBIOL-SGM, V153, P1519, DOI 10.1099/mic.0.2006/004283-0; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Tanaka K, 2004, J BIOL CHEM, V279, P32079, DOI 10.1074/jbc.M404834200; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Willson J, 1997, NUCLEIC ACIDS RES, V25, P2138, DOI 10.1093/nar/25.11.2138; Wolfe BA, 2004, EMBO J, V23, P919, DOI 10.1038/sj.emboj.7600103; Wolfe BA, 2006, DEV CELL, V11, P423, DOI 10.1016/j.devcel.2006.07.016; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zeng Y, 1999, MOL CELL BIOL, V19, P7410; Zhao H, 2003, MOL CELL BIOL, V23, P8395, DOI 10.1128/MCB.23.22.8395-8403.2003; Zhu Y, 1997, EMBO J, V16, P1023, DOI 10.1093/emboj/16.5.1023	78	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21348	10.1371/journal.pone.0021348	http://dx.doi.org/10.1371/journal.pone.0021348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731711	gold, Green Submitted, Green Published			2022-12-25	WOS:000292035400026
J	Haidari, M; Zhang, W; Ganjehei, L; Ali, M; Chen, ZP				Haidari, Mehran; Zhang, Wei; Ganjehei, Leila; Ali, Muzammil; Chen, Zhenping			Inhibition of MLC Phosphorylation Restricts Replication of Influenza Virus-A Mechanism of Action for Anti-Influenza Agents	PLOS ONE			English	Article							PHOSPHOLIPASE-C-EPSILON; LIGHT CHAIN PHOSPHORYLATION; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE; NITRIC-OXIDE; CA2+ SENSITIZATION; MYOSIN PHOSPHATASE; HUMAN NEUTROPHIL; NUCLEAR EXPORT; CELL MOTILITY	Influenza A viruses are a severe threat worldwide, causing large epidemics that kill thousands every year. Prevention of influenza infection is complicated by continuous viral antigenic changes. Newer anti-influenza agents include MEK/ERK and protein kinase C inhibitors; however, the downstream effectors of these pathways have not been determined. In this study, we identified a common mechanism for the inhibitory effects of a significant group of anti-influenza agents. Our studies showed that influenza infection activates a series of signaling pathways that converge to induce myosin light chain (MLC) phosphorylation and remodeling of the actin cytoskeleton. Inhibiting MLC phosphorylation by blocking RhoA/Rho kinase, phospholipase C/protein kinase C, and HRas/Raf/MEK/ERK pathways with the use of genetic or chemical manipulation leads to the inhibition of influenza proliferation. In contrast, the induction of MLC phosphorylation enhances influenza proliferation, as does activation of the HRas/Raf/MEK/ERK signaling pathway. This effect is attenuated by inhibiting MLC phosphorylation. Additionally, in intracellular trafficking studies, we found that the nuclear export of influenza ribonucleoprotein depends on MLC phosphorylation. Our studies provide evidence that modulation of MLC phosphorylation is an underlying mechanism for the inhibitory effects of many anti-influenza compounds.	[Haidari, Mehran] Univ Texas Hlth Sci Ctr Houston, Div Cardiol, Dept Internal Med, Houston, TX 77225 USA; [Haidari, Mehran; Zhang, Wei; Ganjehei, Leila; Ali, Muzammil; Chen, Zhenping] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; Saint Lukes Episcopal Hospital; Texas Heart Institute	Haidari, M (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Cardiol, Dept Internal Med, Houston, TX 77225 USA.	Mehran.Haidari@uth.tmc.edu			American Heart Association South Central Affiliate [0865174F]; United States Army [W81XWH-04-2-0035]	American Heart Association South Central Affiliate(American Heart Association); United States Army(United States Department of DefenseUnited States Army)	The work was supported by the American Heart Association South Central Affiliate grant (0865174F) to M. Haidari and by United States Army grant W81XWH-04-2-0035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Arora DJS, 1998, ARCH VIROL, V143, P2029, DOI 10.1007/s007050050439; Bolz SS, 2003, CIRCULATION, V107, P3081, DOI 10.1161/01.CIR.0000074202.19612.8C; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Castano E, 2010, HISTOCHEM CELL BIOL, V133, P607, DOI 10.1007/s00418-010-0701-2; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ding Y, 2007, J IMMUNOL, V179, P647, DOI 10.4049/jimmunol.179.1.647; DRAZNIN MB, 1986, INT J BIOCHEM, V18, P917, DOI 10.1016/0020-711X(86)90073-X; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Feierbach B, 2006, PLOS PATHOG, V2, P763, DOI 10.1371/journal.ppat.0020085; Forest T, 2005, NAT CELL BIOL, V7, P429, DOI 10.1038/ncb1243; Gallagher ED, 2004, J BIOL CHEM, V279, P1872, DOI 10.1074/jbc.M309525200; Haidari M, 2010, ATHEROSCLEROSIS, V208, P90, DOI 10.1016/j.atherosclerosis.2009.07.028; Haidari M, 2009, PHYTOMEDICINE, V16, P1127, DOI 10.1016/j.phymed.2009.06.002; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; HARTSHORN KL, 1990, BLOOD, V75, P218; HARTSHORN KL, 1992, BLOOD, V79, P1049; Hirano K, 2007, J PHARMACOL SCI, V104, P109, DOI 10.1254/jphs.CP0070027; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Hofmann WA, 2009, INT REV CEL MOL BIO, V273, P219, DOI 10.1016/S1937-6448(08)01806-6; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; June CH, 2001, CURRENT PROTOCOLS CY; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 2004, FEBS LETT, V561, P37, DOI 10.1016/S0014-5793(04)00108-5; Ludwig S, 2007, FUTURE VIROL, V2, P91, DOI 10.2217/17460794.2.1.91; Madonna R, 2005, J BIOL CHEM, V280, P13503, DOI 10.1074/jbc.M411859200; Marjuki H, 2006, J BIOL CHEM, V281, P16707, DOI 10.1074/jbc.M510233200; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; NUGENT KM, 1984, ARCH VIROL, V81, P163, DOI 10.1007/BF01309305; OCHIAI H, 1991, ANTIVIR RES, V15, P149, DOI 10.1016/0166-3542(91)90032-M; OHKAWA T, J CELL BIOL, V190, P187; Olschlager V, 2004, ONCOGENE, V23, P6639, DOI 10.1038/sj.onc.1207883; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rimmelzwaan GF, 1999, J VIROL, V73, P8880, DOI 10.1128/JVI.73.10.8880-8883.1999; Root CN, 2000, J GEN VIROL, V81, P2697, DOI 10.1099/0022-1317-81-11-2697; SCHOLEY JM, 1980, NATURE, V287, P233, DOI 10.1038/287233a0; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sumikoshi M, 2008, J MED VIROL, V80, P1072, DOI 10.1002/jmv.21185; Sun XJ, 2007, CELL MICROBIOL, V9, P1672, DOI 10.1111/j.1462-5822.2007.00900.x; TRYBUS KM, 1984, J BIOL CHEM, V259, P8564; Vartiainen MK, 2008, FEBS LETT, V582, P2033, DOI 10.1016/j.febslet.2008.04.010; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Woods A, 2006, J BIOL CHEM, V281, P13134, DOI 10.1074/jbc.M509433200; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Xiao DL, 2005, AM J PHYSIOL-HEART C, V288, pH2828, DOI 10.1152/ajpheart.01189.2004; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790	59	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21444	10.1371/journal.pone.0021444	http://dx.doi.org/10.1371/journal.pone.0021444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731751	gold, Green Submitted, Green Published			2022-12-25	WOS:000292035400039
J	Lukasiewicz, KB; Greenwood, TM; Negron, VC; Bruzek, AK; Salisbury, JL; Lingle, WL				Lukasiewicz, Kara B.; Greenwood, Tammy M.; Negron, Vivian C.; Bruzek, Amy K.; Salisbury, Jeffrey L.; Lingle, Wilma L.			Control of Centrin Stability by Aurora A	PLOS ONE			English	Article							CENTROSOME DUPLICATION CYCLE; HUMAN BREAST-TUMORS; CELL-CYCLE; CHROMOSOMAL INSTABILITY; A OVEREXPRESSION; PROTEIN-KINASE; CANCER CELLS; AMPLIFICATION; PHOSPHORYLATION; IDENTIFICATION	Aurora A is an oncogenic serine/threonine kinase which can cause cell transformation and centrosome amplification when over-expressed. Human breast tumors show excess Aurora A and phospho-centrin in amplified centrosomes. Here, we show that Aurora A mediates the phosphorylation of and localizes with centrin at the centrosome, with both proteins reaching maximum abundance from prophase through metaphase, followed by their precipitous loss in late stages of mitosis. Overexpression of Aurora A results in excess phospho-centrin and centrosome amplification. In contrast, centrosome amplification is not seen in cells over-expressing Aurora A in the presence of a recombinant centrin mutant lacking the serine phosphorylation site at residue 170. Expression of a kinase dead Aurora A results in a decrease in mitotic index and abrogation of centrin phosphorylation. Finally, a recombinant centrin mutation that mimics centrin phosphorylation increases centrin's stability against APC/C-mediated proteasomal degradation. Taken together, these results suggest that the stability of centrin is regulated in part by Aurora A, and that excess phosphorylated centrin may promote centrosome amplification in cancer.	[Lukasiewicz, Kara B.; Greenwood, Tammy M.; Salisbury, Jeffrey L.; Lingle, Wilma L.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Negron, Vivian C.; Bruzek, Amy K.; Lingle, Wilma L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Lukasiewicz, KB (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cell Cycle Regulat, Program Cell Regulat & Metab, NIH, Bethesda, MD USA.	Salisbury@mayo.edu; lingle.wilma@mayo.edu		Salisbury, Jeffrey/0000-0001-9257-4578	Mayo Clinic Breast Cancer SPORE NIH [CA116201]; NIH [R01 CA072836]; The Breast Cancer Research Foundation [FNDTBCRF-16, 17]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R01CA072836, P50CA116201] Funding Source: NIH RePORTER	Mayo Clinic Breast Cancer SPORE NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Breast Cancer Research Foundation; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this research was through the following grants: Mayo Clinic Breast Cancer SPORE NIH CA116201 (W. L. Lingle, Core Leader and James Ingle, PI) (http://www.nih.gov/); NIH R01 CA072836 (J.L. Salisbury, PI) (http://www.nih.gov/); The Breast Cancer Research Foundation FNDTBCRF-16, 17 (W. L. Lingle, Project Leader and J.N. Ingle, PI), (http://www.bcrfcure.org/); and Predoctoral Fellowship from the Mayo Foundation (http://www.mayo.edu/), (K. B. Lukasiewicz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acu ID, 2010, CANCER RES, V70, P3320, DOI 10.1158/0008-5472.CAN-09-3800; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dar AA, 2009, ONCOGENE, V28, P866, DOI 10.1038/onc.2008.434; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUENSING A, 2007, ONCOGENE; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Goepfert TM, 2002, CANCER RES, V62, P4115; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HE S, 2010, CELL MOL LIFE SCI; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Kitajima S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000944; Klein UR, 2009, J CELL SCI, V122, P3312, DOI 10.1242/jcs.050245; Li JJ, 2004, P NATL ACAD SCI USA, V101, P18123, DOI 10.1073/pnas.0408273101; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lutz W, 2001, J BIOL CHEM, V276, P20774, DOI 10.1074/jbc.M101324200; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Miyoshi Y, 2001, INT J CANCER, V92, P370, DOI 10.1002/ijc.1200; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Paoletti A, 1996, J CELL SCI, V109, P3089; Qina L, 2009, CANCER LETT, V275, P77, DOI 10.1016/j.canlet.2008.10.011; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; UZAWA M, 1995, DEV BIOL, V171, P51, DOI 10.1006/dbio.1995.1259; VANDRE DD, 1989, J CELL SCI, V94, P245; Venoux M, 2008, HUM MOL GENET, V17, P215, DOI 10.1093/hmg/ddm298; Vidwans SJ, 1999, J CELL BIOL, V147, P1371, DOI 10.1083/jcb.147.7.1371; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Wigley WC, 1999, J CELL BIOL, V145, P481; Winey M, 1996, CURR BIOL, V6, P962, DOI 10.1016/S0960-9822(02)00639-5; Yang CH, 2010, MOL BIOL CELL, V21, P4361, DOI 10.1091/mbc.E10-04-0298; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	49	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21291	10.1371/journal.pone.0021291	http://dx.doi.org/10.1371/journal.pone.0021291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731694	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400019
J	Kinoshita, S; Wang, N; Inoue, H; Maeyama, K; Okamoto, K; Nagai, K; Kondo, H; Hirono, I; Asakawa, S; Watabe, S				Kinoshita, Shigeharu; Wang, Ning; Inoue, Haruka; Maeyama, Kaoru; Okamoto, Kikuhiko; Nagai, Kiyohito; Kondo, Hidehiro; Hirono, Ikuo; Asakawa, Shuichi; Watabe, Shugo			Deep Sequencing of ESTs from Nacreous and Prismatic Layer Producing Tissues and a Screen for Novel Shell Formation-Related Genes in the Pearl Oyster	PLOS ONE			English	Article							CALCIUM-CARBONATE CRYSTALS; MATRIX PROTEIN FAMILY; PINCTADA-FUCATA-MARTENSII; MUSSEL PINNA-NOBILIS; MOLECULAR-CLONING; BIOMINERALIZATION; EVOLUTION; PERLUCIN; BIVALVE; LECTIN	Background: Despite its economic importance, we have a limited understanding of the molecular mechanisms underlying shell formation in pearl oysters, wherein the calcium carbonate crystals, nacre and prism, are formed in a highly controlled manner. We constructed comprehensive expressed gene profiles in the shell-forming tissues of the pearl oyster Pinctada fucata and identified novel shell formation-related genes candidates. Principal Findings: We employed the GS FLX 454 system and constructed transcriptome data sets from pallial mantle and pearl sac, which form the nacreous layer, and from the mantle edge, which forms the prismatic layer in P. fucata. We sequenced 260477 reads and obtained 29682 unique sequences. We also screened novel nacreous and prismatic gene candidates by a combined analysis of sequence and expression data sets, and identified various genes encoding lectin, protease, protease inhibitors, lysine-rich matrix protein, and secreting calcium-binding proteins. We also examined the expression of known nacreous and prismatic genes in our EST library and identified novel isoforms with tissue-specific expressions. Conclusions: We constructed EST data sets from the nacre-and prism-producing tissues in P. fucata and found 29682 unique sequences containing novel gene candidates for nacreous and prismatic layer formation. This is the first report of deep sequencing of ESTs in the shell-forming tissues of P. fucata and our data provide a powerful tool for a comprehensive understanding of the molecular mechanisms of molluscan biomineralization.	[Kinoshita, Shigeharu; Wang, Ning; Inoue, Haruka; Asakawa, Shuichi; Watabe, Shugo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan; [Nagai, Kiyohito] Mikimoto Co Ltd, Pearl Res Inst, Shima, Mie, Japan; [Maeyama, Kaoru; Okamoto, Kikuhiko] Mikimoto Pharmaceut CO LTD, Ise, Mie, Japan; [Kondo, Hidehiro; Hirono, Ikuo] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Lab Genome Sci, Minato Ku, Tokyo, Japan	University of Tokyo; Tokyo University of Marine Science & Technology	Kinoshita, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan.	awatabe@mail.ecc.u-tokyo.ac.jp	Kondo, Hidehiro/O-1954-2014; Kinoshita, Shigeharu/AGY-8644-2022; Hirono, Ikuo/O-1940-2014	Kondo, Hidehiro/0000-0001-5102-6831; Hirono, Ikuo/0000-0002-2355-3121				Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Arnaud-Haond S, 2007, MAR BIOTECHNOL, V9, P113, DOI 10.1007/s10126-006-6033-5; Bedouet L, 2007, MAR BIOTECHNOL, V9, P437, DOI 10.1007/s10126-007-7120-y; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Fang Z, 2008, MAR BIOL, V153, P745, DOI 10.1007/s00227-007-0851-5; Force A, 1999, GENETICS, V151, P1531; GERHKE N, 2005, CHEM MATER, V17, P6514; Huang J, 2007, BBA-GEN SUBJECTS, V1770, P1037, DOI 10.1016/j.bbagen.2007.03.006; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Inoue N, 2011, ZOOL SCI, V28, P32, DOI 10.2108/zsj.28.32; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200; Kono M, 2000, BIOCHEM BIOPH RES CO, V269, P213, DOI 10.1006/bbrc.2000.2274; Liu HL, 2007, BIOCHEMISTRY-US, V46, P844, DOI 10.1021/bi061881a; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Mann S, 2001, BIOMINERALIZATION; Mao C., 2001, OCEANOL ACTA, V24, pS37; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sarashina Isao, 2006, Paleontological Research, V10, P311; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; SUZUKI T, 1990, DEV COMP IMMUNOL, V14, P161, DOI 10.1016/0145-305X(90)90088-V; SUZUKI T, 1989, COMP BIOCHEM PHYS B, V92, P455, DOI 10.1016/0305-0491(89)90116-8; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Takakura D, 2008, MAR BIOTECHNOL, V10, P290, DOI 10.1007/s10126-007-9063-8; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; TIM EC, 2010, CELL TISSUE RES, V339, P221; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Wang N, 2008, COMP BIOCHEM PHYS B, V149, P354, DOI 10.1016/j.cbpb.2007.10.007; Wang N, 2009, COMP BIOCHEM PHYS B, V154, P346, DOI 10.1016/j.cbpb.2009.07.012; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Yan ZG, 2007, BBA-GEN SUBJECTS, V1770, P1338, DOI 10.1016/j.bbagen.2007.06.018; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004; Zhang C, 2006, BIOCHEM BIOPH RES CO, V344, P735, DOI 10.1016/j.bbrc.2006.03.179	48	101	106	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21238	10.1371/journal.pone.0021238	http://dx.doi.org/10.1371/journal.pone.0021238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731681	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700051
J	Tourmente, M; Gomendio, M; Roldan, ERS				Tourmente, Maximiliano; Gomendio, Montserrat; Roldan, Eduardo R. S.			Mass-Specific Metabolic Rate and Sperm Competition Determine Sperm Size in Marsupial Mammals	PLOS ONE			English	Article							EJACULATE QUALITY; MALE-FERTILITY; TESTES SIZE; BODY-SIZE; EVOLUTION; VELOCITY; PHYLOGENY; MOTILITY; FERTILIZATION; TIMESCALE	Two complementary hypotheses have been proposed to explain variation in sperm size. The first proposes that post-copulatory sexual selection favors an increase in sperm size because it enhances sperm swimming speed, which is an important determinant of fertilization success in competitive contexts. The second hypothesis proposes that mass-specific metabolic rate acts as a constraint, because large animals with low mass-specific metabolic rates will not be able to process resources at the rates needed to produce large sperm. This constraint is expected to be particularly pronounced among mammals, given that this group contains some of the largest species on Earth. We tested these hypotheses among marsupials, a group in which mass-specific metabolic rates are roughly 30% lower than those of eutherian mammals of similar size, leading to the expectation that metabolic rate should be a major constraint. Our findings support both hypotheses because levels of sperm competition are associated with increases in sperm size, but low mass-specific metabolic rate constrains sperm size among large species. We also found that the relationship between sperm size and mass-specific metabolic rate is steeper among marsupials and shallower among eutherian mammals. This finding has two implications: marsupials respond to changes in mass-specific metabolic rate by modifying sperm length to a greater extent, suggesting that they are more constrained by metabolic rate. In addition, for any given mass-specific metabolic rate, marsupials produce longer sperm. We suggest that this is the consequence of marsupials diverting resources away from sperm numbers and into sperm size, due to their efficient sperm transport along the female tract and the existence of mechanisms to protect sperm.	[Tourmente, Maximiliano; Gomendio, Montserrat; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Tourmente, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Roldan, Eduardo R.S./M-7947-2014; Tourmente, Maximiliano/I-2852-2019	Roldan, Eduardo R.S./0000-0002-7545-4248; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Science and Innovation; Spanish Ministry of Education	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science and Innovation. M.T. is a postdoctoral researcher funded by the Programa Nacional de Movilidad de Recursos de investigacion of the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2005, J ZOOL, V267, P135, DOI 10.1017/S0952836905007284; Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Beck RMD, 2008, J MAMMAL, V89, P175, DOI 10.1644/06-MAMM-A-437.1; BEDFORD JM, 1984, PROC R SOC SER B-BIO, V221, P221, DOI 10.1098/rspb.1984.0031; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Eddy E M, 2007, Soc Reprod Fertil Suppl, V65, P45; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitzpatrick JL, 2010, BIOL LETTERS, V6, P797, DOI 10.1098/rsbl.2010.0231; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Froman DP, 1999, BIOL REPROD, V61, P400, DOI 10.1095/biolreprod61.2.400; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Gage MJG, 2003, P ROY SOC B-BIOL SCI, V270, P625, DOI 10.1098/rspb.2002.2258; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2011, P ROY SOC B-BIOL SCI, V278, P3135, DOI 10.1098/rspb.2011.0275; Gomenido Montserrat, 1998, P667, DOI 10.1016/B978-012100543-6/50041-6; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; KENAGY GJ, 1986, J MAMMAL, V67, P1, DOI 10.2307/1380997; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Meredith RW, 2009, MOL PHYLOGENET EVOL, V51, P554, DOI 10.1016/j.ympev.2009.02.009; Meredith RW, 2008, AUST J ZOOL, V56, P395, DOI 10.1071/ZO08044; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; MOLLER AP, 1989, FUNCT ECOL, V3, P91, DOI 10.2307/2389679; MOLLER AP, 1988, J HUM EVOL, V17, P479, DOI 10.1016/0047-2484(88)90037-1; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002; Olsson M, 1997, P ROY SOC B-BIOL SCI, V264, P455, DOI 10.1098/rspb.1997.0065; Paplinska JZ, 2010, MACROPODS: THE BIOLOGY OF KANGAROOS, WALLABIES AND RAT-KANGAROOS, P65; Parker GA, 2010, J THEOR BIOL, V264, P1003, DOI 10.1016/j.jtbi.2010.03.003; Parker G.A., 1984, P1; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; Phillips MJ, 2008, MOL PHYLOGENET EVOL, V46, P594, DOI 10.1016/j.ympev.2007.09.008; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P247, DOI 10.1016/B978-0-12-372568-4.00007-0; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Rose RW, 1997, J ZOOL, V243, P523, DOI 10.1111/j.1469-7998.1997.tb02798.x; Rosenthal Robert., 1991, META ANALYTIC PROCED; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Rosnow RL, 2003, CAN J EXP PSYCHOL, V57, P221, DOI 10.1037/h0087427; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Smithson M., 2003, CONFIDENCE INTERVALS; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Taggart D.A., 2003, P358; Taggart D.A., 1998, P623, DOI 10.1016/B978-012100543-6/50040-4; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Tourmente M, 2009, EVOLUTION, V63, P2513, DOI 10.1111/j.1558-5646.2009.00739.x; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Tyndale-Biscoe H, 2005, LIFE OF MARSUPIALS; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107; Westerman Michael, 2008, Australian Mammalogy, V29, P201	67	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21244	10.1371/journal.pone.0021244	http://dx.doi.org/10.1371/journal.pone.0021244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731682	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700052
J	Isakov, E; Stanhill, A				Isakov, Elada; Stanhill, Ariel			Stalled Proteasomes Are Directly Relieved by P97 Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; AAA-ATPASE CDC48/P97; 26 S PROTEASOME; ASSEMBLY PATHWAY; DEGRADATION; RECOGNITION; PARTICLE; COMPLEX; PROTEOTOXICITY; IDENTIFICATION	The 26 S proteasome is the eukaryotic protease responsible for the degradation of most cellular proteins. As such it accommodates the ability to function under diverse conditions that the cell may encounter. This function is supported by various adaptors that modulate various aspects in protein degradation, these include regulation of substrate delivery, deubiquitination, unfolding, and 20 S gate dilation. Here we show a new functional complex between the P97 and the proteasome that is assembled in response to proteasomal impairment. This entails P97 binding to the 26 S proteasome via the 19 S particle thereby forming an additional hexameric ATPase ring to relieve repression. P97-bound proteasomes showed selective binding toward the Npl4-ufd1 P97 co-factors, indicating a unique cellular role for P97 binding to proteasomes. P97-bound proteasomes display enhanced activity, showing a relief in proteolysis impairment. Our findings place P97 directly in non-ERAD proteasomal functions and establish a new checkpoint in UPS impairment. The ability to modulate proteasome activity and properly respond to protein misfolding, is of great importance in cellular regulation.	[Isakov, Elada; Stanhill, Ariel] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Stanhill, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel.	stanhill@tx.technion.ac.il		stanhill, ariel/0000-0002-0318-2212	Israeli Science Foundation [ISF 497/08]; ERC; Brain Power for Israel Foundation	Israeli Science Foundation(Israel Science Foundation); ERC(European Research Council (ERC)European Commission); Brain Power for Israel Foundation	This work was supported by the Israeli Science Foundation (ISF 497/08), ERC-FP7-IRG (to A. S.), and the Brain Power for Israel Foundation (to E. I.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Baumeister W, 1997, CURR OPIN STRUC BIOL, V7, P273, DOI 10.1016/S0959-440X(97)80036-X; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hartmann-Petersen R, 2004, CURR BIOL, V14, pR754, DOI 10.1016/j.cub.2004.09.012; HENDIL KB, 1988, BIOCHEM INT, V17, P471; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; MA CP, 1992, J BIOL CHEM, V267, P10515; Macario AJL, 2007, FRONT BIOSCI-LANDMRK, V12, P2588, DOI 10.2741/2257; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Meyer H, 2010, BIOCHEM CELL BIOL, V88, P23, DOI [10.1139/o09-119, 10.1139/O09-119]; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Thoms S, 2002, FEBS LETT, V520, P107, DOI 10.1016/S0014-5793(02)02777-1; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Vendruscolo M, 2003, PHILOS T R SOC A, V361, P1205, DOI 10.1098/rsta.2003.1194; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wilk S, 2000, ARCH BIOCHEM BIOPHYS, V383, P265, DOI 10.1006/abbi.2000.2086; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105	48	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30274	30283		10.1074/jbc.M111.240309	http://dx.doi.org/10.1074/jbc.M111.240309			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21733848	Green Published, hybrid			2022-12-25	WOS:000294283600005
J	Samak, G; Narayanan, D; Jaggar, JH; Rao, R				Samak, Geetha; Narayanan, Damodaran; Jaggar, Jonathan H.; Rao, RadhaKrishna			Ca(v)1.3 Channels and Intracellular Calcium Mediate Osmotic Stress-induced N-terminal c-Jun Kinase Activation and Disruption of Tight Junctions in Caco-2 Cell Monolayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY BOWEL-DISEASE; TYROSINE PHOSPHORYLATION; OXIDATIVE STRESS; PHOSPHOLIPASE-C; ACETALDEHYDE; MECHANISM; OCCLUDIN; PERMEABILITY; INTESTINE	We investigated the role of a Ca2+ channel and intracellular calcium concentration ([Ca2+](i)) in osmotic stress-induced JNK activation and tight junction disruption in Caco-2 cell monolayers. Osmotic stress-induced tight junction disruption was attenuated by 1,2-bis(2-aminophenoxyl) ethane-N, N,N',N'-tetraacetic acid (BAPTA)-mediated intracellular Ca2+ depletion. Depletion of extracellular Ca2+ at the apical surface, but not basolateral surface, also prevented tight junction disruption. Similarly, thapsigargin-mediated endoplasmic reticulum (ER) Ca2+ depletion attenuated tight junction disruption. Thapsigargin or extracellular Ca2+ depletion partially reduced osmotic stress-induced rise in [Ca2+](i), whereas thapsigargin and extracellular Ca2+ depletion together resulted in almost complete loss of rise in [Ca2+](i). L-type Ca2+ channel blockers (isradipine and diltiazem) or knockdown of the Ca(v)1.3 channel abrogated [Ca2+](i) rise and disruption of tight junction. Osmotic stress-induced JNK2 activation was abolished by BAPTA and isradipine, and partially reduced by extracellular Ca2+ depletion, thapsigargin, or Ca(v)1.3 knockdown. Osmotic stress rapidly induced c-Src activation, which was significantly attenuated by BAPTA, isradipine, or extracellular Ca2+ depletion. Tight junction disruption by osmotic stress was blocked by tyrosine kinase inhibitors (genistein and PP2) or siRNA-mediated knockdown of c-Src. Osmotic stress induced a robust increase in tyrosine phosphorylation of occludin, which was attenuated by BAPTA, SP600125 (JNK inhibitor), or PP2. These results demonstrate that Ca(v)1.3 and rise in [Ca2+](i) play a role in the mechanism of osmotic stress-induced tight junction disruption in an intestinal epithelial monolayer. [Ca2+](i) mediate osmotic stress-induced JNK activation and subsequent c-Src activation and tyrosine phosphorylation of tight junction proteins. Additionally, inositol 1,4,5-trisphosphate receptor-mediated release of ER Ca2+ also contributes to osmotic stress-induced tight junction disruption.	[Samak, Geetha; Narayanan, Damodaran; Jaggar, Jonathan H.; Rao, RadhaKrishna] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, R (corresponding author), 894 Union Ave, Memphis, TN 38163 USA.	rrao2@uthsc.edu			National Institutes of Health [R01-DK55532, R01-AA12307, HL067061, HL094378]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067061, R01HL094378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK55532 (to R.K.R.), R01-AA12307 (to R.K.R.), HL067061 (to J.H.J.), and HL094378 (to J.H.J.).	Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; BALDA MS, 1991, J MEMBRANE BIOL, V122, P193, DOI 10.1007/BF01871420; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; CHEROMCHA DP, 1988, DIGEST DIS SCI, V33, pS78, DOI 10.1007/BF01538135; Haorah J, 2007, J NEUROCHEM, V100, P324, DOI 10.1111/j.1471-4159.2006.04245.x; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Ma TY, 2000, MICROSC RES TECHNIQ, V51, P156, DOI 10.1002/1097-0029(20001015)51:2<156::AID-JEMT7>3.0.CO;2-J; Mace OJ, 2007, J PHYSIOL-LONDON, V580, P605, DOI 10.1113/jphysiol.2006.124784; MADARA JL, 1983, J CELL BIOL, V97, P125, DOI 10.1083/jcb.97.1.125; MANDEL LJ, 1993, NATURE, V361, P552, DOI 10.1038/361552a0; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Nakkrasae LI, 2010, J PHYSIOL SCI, V60, P9, DOI 10.1007/s12576-009-0068-0; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Reiter B, 2006, FASEB J, V20, P1802, DOI 10.1096/fj.06-5772com; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; SCHILLI R, 1982, GUT, V23, P326, DOI 10.1136/gut.23.4.326; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Stuart RO, 1996, J BIOL CHEM, V271, P13636, DOI 10.1074/jbc.271.23.13636; Suzuki T, 2008, J BIOL CHEM, V283, P3574, DOI 10.1074/jbc.M709141200; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; VERNIA P, 1988, DIGEST DIS SCI, V33, P1353, DOI 10.1007/BF01536987; Vikstrom E, 2010, EUR J CELL BIOL, V89, P584, DOI 10.1016/j.ejcb.2010.03.002; Ye JM, 1999, AM J PHYSIOL-RENAL, V277, pF524, DOI 10.1152/ajprenal.1999.277.4.F524	31	41	42	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30232	30243		10.1074/jbc.M111.240358	http://dx.doi.org/10.1074/jbc.M111.240358			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737448	Green Published, hybrid			2022-12-25	WOS:000294046600080
J	Grandclement, C; Pallandre, JR; Degano, SV; Viel, E; Bouard, A; Balland, J; Remy-Martin, JP; Simon, B; Rouleau, A; Boireau, W; Klagsbrun, M; Ferrand, C; Borg, C				Grandclement, Camille; Pallandre, Jean Rene; Degano, Severine Valmary; Viel, Erika; Bouard, Adeline; Balland, Jeremy; Remy-Martin, Jean-Paul; Simon, Benoit; Rouleau, Alain; Boireau, Wilfrid; Klagsbrun, Michael; Ferrand, Christophe; Borg, Christophe			Neuropilin-2 Expression Promotes TGF-beta 1-Mediated Epithelial to Mesenchymal Transition in Colorectal Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PROGNOSTIC-FACTOR; TUMOR-GROWTH; RECEPTOR; SEMAPHORIN; INHIBITOR; VEGF; IDENTIFICATION; COEXPRESSION; METASTASIS	Neuropilins, initially characterized as neuronal receptors, act as co-receptors for cancer related growth factors and were recently involved in several signaling pathways leading to cytoskeletal organization, angiogenesis and cancer progression. Then, we sought to investigate the ability of neuropilin-2 to orchestrate epithelial-mesenchymal transition in colorectal cancer cells. Using specific siRNA to target neuropilin-2 expression, or gene transfer, we first observed that neuropilin-2 expression endows HT29 and Colo320 for xenograft formation. Moreover, neuropilin-2 conferred a fibroblastic-like shape to cancer cells, suggesting an involvement of neuropilin-2 in epithelial-mesenchymal transition. Indeed, the presence of neuropilin-2 in colorectal carcinoma cell lines was correlated with loss of epithelial markers such as cytokeratin-20 and E-cadherin and with acquisition of mesenchymal molecules such as vimentin. Furthermore, we showed by surface plasmon resonance experiments that neuropilin-2 is a receptor for transforming-growth factor-beta 1. The expression of neuropilin-2 on colon cancer cell lines was indeed shown to promote transforming-growth factor-beta 1 signaling, leading to a constitutive phosphorylation of the Smad2/3 complex. Treatment with specific TGF beta-type1 receptor kinase inhibitors restored E-cadherin levels and inhibited in part neuropilin-2-induced vimentin expression, suggesting that neuropilin-2 cooperates with TGF beta-type1 receptor to promote epithelial-mesenchymal transition in colorectal cancer cells. Our results suggest a direct role of NRP2 in epithelial-mesenchymal transition and highlight a cross-talk between neuropilin-2 and TGF-beta 1 signaling to promote cancer progression. These results suggest that neuropilin-2 fulfills all the criteria of a therapeutic target to disrupt multiple oncogenic functions in solid tumors.	[Grandclement, Camille; Pallandre, Jean Rene; Bouard, Adeline; Balland, Jeremy; Remy-Martin, Jean-Paul; Ferrand, Christophe; Borg, Christophe] INSERM, UMR 645, Besancon, France; [Grandclement, Camille; Pallandre, Jean Rene; Bouard, Adeline; Balland, Jeremy; Remy-Martin, Jean-Paul; Ferrand, Christophe; Borg, Christophe] EFS Bourgogne Franche Comte, Besancon, France; [Degano, Severine Valmary] CHU Besancon, Dept Pathol, F-25030 Besancon, France; [Viel, Erika; Borg, Christophe] CHU Besancon, Dept Med Oncol, F-25030 Besancon, France; [Simon, Benoit; Rouleau, Alain; Boireau, Wilfrid] Univ Franche Comte, FEMTO ST Inst, F-25030 Besancon, France; [Klagsbrun, Michael] Childrens Hosp, Dept Surg & Pathol, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Technologie de Belfort-Montbeliard (UTBM); Harvard University; Boston Children's Hospital	Grandclement, C (corresponding author), INSERM, UMR 645, Besancon, France.	christophe.borg@efs.sante.fr	ROULEAU, Alain/AAC-4933-2019		University Hospital of Besancon [API-CHU]; French "agence nationale pour la recherche technologique"; regional council of Franche Comte; ligue contre le cancer du doubs	University Hospital of Besancon; French "agence nationale pour la recherche technologique"(French National Research Agency (ANR)); regional council of Franche Comte(Region Bourgogne-Franche-Comte); ligue contre le cancer du doubs	Grant API-CHU 2008 of the University Hospital of Besancon; CG received a fellowship from the French "agence nationale pour la recherche technologique"; JRP received a fellowship from the regional council of Franche Comte; a grant from the "ligue contre le cancer du doubs" supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiter K, 2005, ONCOGENE, V24, P8200, DOI 10.1038/sj.onc.1208960; Boireau W, 2009, BIOSENS BIOELECTRON, V24, P1121, DOI 10.1016/j.bios.2008.06.030; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Cai HB, 1999, J NEUROSCI, V19, P6519; CAI Y, 2010, PATHOL RES PRACT; Calicchio ML, 2009, AM J PATHOL, V174, P1638, DOI 10.2353/ajpath.2009.080517; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; CAO Y, 2010, J BIOL CHEM; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Cohen T, 2002, J PATHOL, V198, P77, DOI 10.1002/path.1179; Costa R, 2009, J CELL BIOCHEM, V108, P1410, DOI 10.1002/jcb.22378; Dallas NA, 2008, CLIN CANCER RES, V14, P8052, DOI 10.1158/1078-0432.CCR-08-1520; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Fakhari M, 2002, CANCER-AM CANCER SOC, V94, P258, DOI 10.1002/cncr.10177; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Fukahi K, 2004, CLIN CANCER RES, V10, P581, DOI 10.1158/1078-0432.CCR-0930-03; FUTAMURA MKH, 2007, CANCER RES, V15, P1451; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; GLINKA Y, 2010, CARCINOGENESIS; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gray MJ, 2008, J NATL CANCER I, V100, P109, DOI 10.1093/jnci/djm279; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Handa A, 2000, INT J ONCOL, V17, P291; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Lacal PM, 2000, J INVEST DERMATOL, V115, P1000, DOI 10.1046/j.1523-1747.2000.00199.x; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Osada R, 2006, HUM PATHOL, V37, P1414, DOI 10.1016/j.humpath.2006.04.031; Piek E, 1999, J CELL SCI, V112, P4557; Pino MS, 2009, GASTROENTEROLOGY; Portella G, 1998, CELL GROWTH DIFFER, V9, P393; Rieger J, 2003, GLIA, V42, P379, DOI 10.1002/glia.10210; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vales A, 2007, LEUKEMIA LYMPHOMA, V48, P1997, DOI 10.1080/10428190701534424; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yasuoka H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-220	49	67	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e20444	10.1371/journal.pone.0020444	http://dx.doi.org/10.1371/journal.pone.0020444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747928	Green Submitted, Green Published, gold			2022-12-25	WOS:000292293400003
J	Huttunen, R; Kuparinen, T; Jylhava, J; Aittoniemi, J; Vuento, R; Huhtala, H; Laine, J; Syrjanen, J; Hurme, M				Huttunen, Reetta; Kuparinen, Taru; Jylhava, Juulia; Aittoniemi, Janne; Vuento, Risto; Huhtala, Heini; Laine, Janne; Syrjanen, Jaana; Hurme, Mikko			Fatal Outcome in Bacteremia is Characterized by High Plasma Cell Free DNA Concentration and Apoptotic DNA Fragmentation: A Prospective Cohort Study	PLOS ONE			English	Article							ORGAN DYSFUNCTION; SEPSIS; DEATH; INFLAMMATION; PREDICTOR; MORTALITY; SHOCK	Introduction: Recent studies have shown that apoptosis plays a critical role in the pathogenesis of sepsis. High plasma cell free DNA (cf-DNA) concentrations have been shown to be associated with sepsis outcome. The origin of cf-DNA is unclear. Methods: Total plasma cf-DNA was quantified directly in plasma and the amplifiable cf-DNA assessed using quantitative PCR in 132 patients with bacteremia caused by Staphylococcus aureus, Streptococcus pneumoniae, beta-hemolytic streptococcae or Escherichia coli. The quality of cf-DNA was analyzed with a DNA Chip assay performed on 8 survivors and 8 nonsurvivors. Values were measured on days 1-4 after positive blood culture, on day 5-17 and on recovery. Results: The maximum cf-DNA values on days 1-4 (n = 132) were markedly higher in nonsurvivors compared to survivors (2.03 vs 1.26 ug/ml, p < 0.001) and the AUCROC in the prediction of case fatality was 0.81 (95% CI 0.69-0.94). cf-DNA at a cutoff level of 1.52 ug/ml showed 83% sensitivity and 79% specificity for fatal disease. High cf-DNA (> 1.52 ug/ml) remained an independent risk factor for case fatality in a logistic regression model. Qualitative analysis of cf-DNA showed that cf-DNA displayed a predominating low-molecular-weight cf-DNA band (150-200 bp) in nonsurvivors, corresponding to the size of the apoptotic nucleosomal DNA. cf-DNA concentration showed a significant positive correlation with visually graded apoptotic band intensity (R = 0.822, p < 0.001). Conclusions: Plasma cf-DNA concentration proved to be a specific independent prognostic biomarker in bacteremia. cf-DNA displayed a predominating low-molecular-weight cf-DNA band in nonsurvivors corresponding to the size of apoptotic nucleosomal DNA.	[Huttunen, Reetta; Laine, Janne; Syrjanen, Jaana] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Huttunen, Reetta; Syrjanen, Jaana] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kuparinen, Taru; Jylhava, Juulia; Hurme, Mikko] Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland; [Aittoniemi, Janne; Vuento, Risto; Hurme, Mikko] Pirkanmaa Hosp Dist, Ctr Lab Med, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University; Pirkanmaa Hospital District; Tampere University	Huttunen, R (corresponding author), Tampere Univ Hosp, Dept Internal Med, Tampere, Finland.	reetta.huttunen@uta.fi		Hurme, Mikko/0000-0002-8614-1044; Jylhava, Juulia/0000-0003-0250-4491; Syrjanen, Jaana/0000-0002-7335-573X	Tampere University Hospital; Finnish Medical Foundation; Orion-Farmos Research Foundation	Tampere University Hospital; Finnish Medical Foundation; Orion-Farmos Research Foundation	This study was financially supported by the Competitive Research Funding of Tampere University Hospital, the Finnish Medical Foundation, and the Orion-Farmos Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd JC, 1997, SCAND J CLIN LAB INV, V57, P46, DOI 10.1080/00365519709168308; Deligezer U, 2006, EXP MOL PATHOL, V80, P72, DOI 10.1016/j.yexmp.2005.05.001; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huttunen R, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-13; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Jahr S, 2001, CANCER RES, V61, P1659; Jylhava J, 2011, MECH AGEING DEV, V132, P20, DOI 10.1016/j.mad.2010.11.001; Legrand M, 2010, J MOL MED, V88, P127, DOI 10.1007/s00109-009-0585-6; MCCABE WR, 1962, ARCH INTERN MED, V110, P856, DOI 10.1001/archinte.1962.03620240038007; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Papathanassoglou EDE, 2000, CRIT CARE MED, V28, P537, DOI 10.1097/00003246-200002000-00042; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Saukkonen K, 2007, INTENS CARE MED, V33, P1624, DOI 10.1007/s00134-007-0686-z; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Turrel-Davin F, 2010, CRIT CARE, V14, DOI 10.1186/cc9181; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95; Zhong XY, 2007, CLIN CHEM, V53, P1609, DOI 10.1373/clinchem.2006.084509	23	59	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21700	10.1371/journal.pone.0021700	http://dx.doi.org/10.1371/journal.pone.0021700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747948	Green Published, Green Submitted, gold			2022-12-25	WOS:000292293400024
J	Drag, L; Hauck, D; Pokluda, P; Zimmermann, K; Cizek, L				Drag, Lukas; Hauck, David; Pokluda, Pavel; Zimmermann, Kamil; Cizek, Lukas			Demography and Dispersal Ability of a Threatened Saproxylic Beetle: A Mark-Recapture Study of the Rosalia Longicorn (Rosalia alpina)	PLOS ONE			English	Article							BOLITOPHAGUS-RETICULATUS; COLEOPTERA-CERAMBYCIDAE; OSMODERMA-EREMITA; IPS-TYPOGRAPHUS; LUCANUS-CERVUS; TREE HOLLOWS; CONSERVATION; HABITAT; SIZE; METAPOPULATION	The Rosalia longicorn or Alpine longhorn (Coleoptera: Cerambycidae) is an endangered and strictly protected icon of European saproxylic biodiversity. Despite its popularity, lack of information on its demography and mobility may compromise adoption of suitable conservation strategies. The beetle experienced marked retreat from NW part of its range; its single population survives N of the Alps and W of the Carpathians. The population inhabits several small patches of old beech forest on hill-tops of the Ralska Upland, Czech Republic. We performed mark-recapture study of the population and assessed its distribution pattern. Our results demonstrate the high mobility of the beetle, including dispersal between hills (up to 1.6 km). The system is thus interconnected; it contained similar to 2000 adult beetles in 2008. Estimated population densities were high, ranging between 42 and 84 adult beetles/hectare a year. The population survives at a former military-training ground despite long-term isolation and low cover of mature beech forest (similar to 1%). Its survival could be attributed to lack of forestry activities between the 1950s and 1990s, slow succession preventing canopy closure and undergrowth expansion, and probably also to the distribution of habitat patches on conspicuous hill-tops. In order to increase chances of the population for long term survival, we propose to stop clear-cuts of old beech forests, increase semi-open beech woodlands in areas currently covered by conifer plantations and active habitat management at inhabited sites and their wider environs.	[Drag, Lukas; Pokluda, Pavel; Zimmermann, Kamil; Cizek, Lukas] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Drag, Lukas; Hauck, David; Pokluda, Pavel; Zimmermann, Kamil; Cizek, Lukas] Biol Ctr ASCR, Inst Entomol, Ceske Budejovice, Czech Republic	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Drag, L (corresponding author), Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.	lukascizek@gmail.com	Hauck, David/AAD-8289-2022; Cizek, Lukas/K-7111-2015; Cizek, Lukas/G-7905-2014; Drag, Lukas/O-6749-2017	Hauck, David/0000-0003-0517-3667; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Drag, Lukas/0000-0002-6002-9214	Czech Ministry of Education [6007665801, LC06073]; Ministry of Environment [VaV/SP/2d3/153/08]; Czech Agency for Nature Conservation and Landscape Protection	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Czech Agency for Nature Conservation and Landscape Protection	This study was supported by the Czech Ministry of Education (6007665801, LC06073; http://www.msmt.cz/), Ministry of Environment (VaV/SP/2d3/153/08; http://www.mzp.cz/) and the Czech Agency for Nature Conservation and Landscape Protection (http://www.ochranaprirody.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguette M, 2003, ECOGRAPHY, V26, P153, DOI 10.1034/j.1600-0587.2003.03364.x; Baguette M, 2000, J APPL ECOL, V37, P100, DOI 10.1046/j.1365-2664.2000.00478.x; BENSE U, 2002, DGAAE NACHRICHTEN, V16, P57; BORUCKY J, 2007, OVERENI VYSKYTU EXTE; BOTTERWEG PF, 1982, Z ANGEW ENTOMOL, V94, P466; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; C?lix M., 2018, EUROPEAN RED LIST SA; *CENIA, 2010, HIST ORT MO CR PODKL; Ciach Michal, 2007, Polskie Pismo Entomologiczne, V76, P101; Cizek L, 2009, BEZDEZ, V18, P125; Cizek L, 2009, ENTOMOL FENNICA, V20, P200; COOK LM, 1967, J ANIM ECOL, V36, P57, DOI 10.2307/3014; CRAIG CC, 1953, BIOMETRIKA, V40, P170, DOI 10.2307/2333106; DOMINIK J, 1989, OCHRONA DREWNA OWADY; Dubois G., 2008, REV ECOLOGIE TERRE V, V63, P123; Dudley N., 2004, DEADWOOD LIVING FORE; Duelli P., 2005, MERKBLATT PRAXIS EID, V39, P1; EDWARDS JS, 1961, Q J MICROSC SCI, V102, P519; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Farka J., 2005, CERVENY SEZNAM OHROZ; FORSSE E, 1985, Z ANGEW ENTOMOL, V100, P47; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Franzen M, 2007, J ANIM ECOL, V76, P1224, DOI 10.1111/j.1365-2656.2007.01285.x; Fremlin M, 2009, PENSOFT SER FAUNIST, P161; Fric Z, 2007, BASIC APPL ECOL, V8, P377, DOI 10.1016/j.baae.2006.06.005; Geiser, 1998, SCHRIFTENREIHE LANDS, V55, P168; Gepp J, 2002, ENTOMOLOGICA AUSTRIA, V5, P3; Hedin J, 2008, BIODIVERS CONSERV, V17, P675, DOI 10.1007/s10531-007-9299-7; Heyrovsky L, 1955, FAUNA CSR, V5; Hill JK, 1996, J ANIM ECOL, V65, P725, DOI 10.2307/5671; HONCU M, 2002, BEZDEZ, V11, P219; HRDLICKA JIRI, 1964, ZIVA, V12, P145; Jendek Branislav, 2006, Folia Faunistica Slovaca, V11, P15; Jonsell M, 2003, ECOGRAPHY, V26, P421, DOI 10.1034/j.1600-0587.2003.03449.x; Jonsson M, 2003, ECOL ENTOMOL, V28, P159, DOI 10.1046/j.1365-2311.2003.00499.x; Jonsson M, 2003, J INSECT CONSERV, V7, P111, DOI 10.1023/A:1025552623766; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Komonen Atte, 2008, Endangered Species Research, V6, P149, DOI 10.3354/esr00074; KOVACS T, 1998, FOL HIST NAT MUS MAT, V22, P247; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lindhe A, 2005, BIODIVERS CONSERV, V14, P3033, DOI 10.1007/s10531-004-0314-y; Lopez-Pantoja G, 2008, CENT EUR J BIOL, V3, P431, DOI 10.2478/s11535-008-0044-3; MACKOVCIN P, 2002, CHRANENA UZEMI CR LI; Muller J, 2008, J INSECT CONSERV, V12, P107, DOI 10.1007/s10841-006-9065-2; Nalepa CA, 2005, ENVIRON ENTOMOL, V34, P425, DOI 10.1603/0046-225X-34.2.425; Nichols J., 2001, DISPERSAL; NILSSEN AC, 1984, ANN ENTOMOL FENN, V50, P37; Nilsson SG, 1997, ECOGRAPHY, V20, P491, DOI 10.1111/j.1600-0587.1997.tb00417.x; Okland B, 1996, BIODIVERS CONSERV, V5, P75, DOI 10.1007/BF00056293; OLEKSA A, 2011, CONSERVAT G IN PRESS; Ranius T, 2002, BIODIVERS CONSERV, V11, P931, DOI 10.1023/A:1015364020043; Ranius T, 2001, OECOLOGIA, V126, P363, DOI 10.1007/s004420000529; Ranius T, 2000, BIOL CONSERV, V95, P85, DOI 10.1016/S0006-3207(00)00007-0; Ray AM, 2009, J CHEM ECOL, V35, P96, DOI 10.1007/s10886-008-9576-2; Rink M, 2007, J ZOOL, V272, P235, DOI 10.1111/j.1469-7998.2006.00282.x; RUSSO D, 2011, J INSECT CO IN PRESS; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Sama G., 2002, ATLAS CERAMBYCIDAE E, V1; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Simandl Jiri, 2002, Acta Zoologica Bulgarica, V54, P59; Slama M.E.F., 1998, TESARIKOVITI CERAMBY; STARZYK J. R., 2004, POLSKA CZERWONA KSIE, P148; Thomaes A, 2008, BIOL CONSERV, V141, P1400, DOI 10.1016/j.biocon.2008.03.018; Thomas CD, 2000, P ROY SOC B-BIOL SCI, V267, P139, DOI 10.1098/rspb.2000.0978; Tikkamaki T, 2011, J INSECT CONSERV, V15, P401, DOI 10.1007/s10841-010-9313-3; Tsherepanov A. I., 1981, LONGICORN BEETLES N; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zar J. H., 1996, BIOSTATISTICAL ANAL	69	61	71	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21345	10.1371/journal.pone.0021345	http://dx.doi.org/10.1371/journal.pone.0021345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738640	Green Submitted, gold, Green Published			2022-12-25	WOS:000292291800012
J	Mei, F; Nagappan, G; Ke, Y; Sacktor, TC; Lu, B				Mei, Fan; Nagappan, Guhan; Ke, Yang; Sacktor, Todd C.; Lu, Bai			BDNF Facilitates L-LTP Maintenance in the Absence of Protein Synthesis through PKM zeta	PLOS ONE			English	Article							LONG-TERM POTENTIATION; KINASE-M-ZETA; SYNAPTIC PLASTICITY; MEMORY; HIPPOCAMPUS; TRAFFICKING; EXPRESSION; INCREASES	Late-phase long term potentiation (L-LTP) is thought to be the cellular basis for long-term memory (LTM). While LTM as well as L-LTP is known to depend on transcription and translation, it is unclear why brain-derived neurotrophic factor (BDNF) could sustain L-LTP when protein synthesis is inhibited. The persistently active protein kinase zeta (PKM zeta) is the only molecule implicated in perpetuating L-LTP maintenance. Here, in mouse acute brain slices, we show that inhibition of PKM zeta reversed BDNF-dependent form of L-LTP. While BDNF did not alter the steady-state level of PKM zeta, BDNF together with the L-LTP inducing theta-burst stimulation (TBS) increased PKM zeta level even without protein synthesis. Finally, in the absence of de novo protein synthesis, BDNF maintained TBS-induced PKM zeta at a sufficient level. These results suggest that BDNF sustains L-LTP through PKM zeta in a protein synthesis-independent manner, revealing an unexpected link between BDNF and PKM zeta.	[Mei, Fan; Ke, Yang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Mei, Fan; Nagappan, Guhan; Lu, Bai] NICHHD, Program Dev Neurobiol, Bethesda, MD 20892 USA; [Nagappan, Guhan; Lu, Bai] GlaxoSmithKline, R&D China, Shanghai, Peoples R China; [Sacktor, Todd C.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Sacktor, Todd C.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA	Peking University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); GlaxoSmithKline; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Mei, F (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100871, Peoples R China.	bai.b.lu@gsk.com	Mei, Fan/H-2665-2012; Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	National Institutes of Child Health and Human Development; National Institutes of Mental Health	National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Intramural Research Program of the National Institutes of Child Health and Human Development and the National Institutes of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DRAGUNOW M, 1993, NEUROSCI LETT, V160, P232, DOI 10.1016/0304-3940(93)90420-P; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Hernandez PJ, 2008, NEUROBIOL LEARN MEM, V89, P293, DOI 10.1016/j.nlm.2007.09.010; Huang YY, 2005, LEARN MEMORY, V12, P587, DOI 10.1101/lm.98905; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Jia JM, 2008, J BIOL CHEM, V283, P21242, DOI 10.1074/jbc.M800282200; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kelly MT, 2007, J NEUROSCI, V27, P3439, DOI 10.1523/JNEUROSCI.5612-06.2007; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Osten P, 1996, J NEUROSCI, V16, P2444; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sacktor TC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112pe9; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sajikumar S, 2011, P NATL ACAD SCI USA, V108, P2551, DOI 10.1073/pnas.1016849108; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; SHAO CY, 2008, PKMZETA MAINTAINS DE; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	32	53	55	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21568	10.1371/journal.pone.0021568	http://dx.doi.org/10.1371/journal.pone.0021568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747912	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100041
J	Gonzalez, CP; Maganda, MAN; Arias-Estrada, M; del Rio, G				Polanco Gonzalez, Carlos; Nuno Maganda, Marco Aurelio; Arias-Estrada, Miguel; del Rio, Gabriel			An FPGA Implementation to Detect Selective Cationic Antibacterial Peptides	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; PREDICTION; PROTEINS; DESIGN	Exhaustive prediction of physicochemical properties of peptide sequences is used in different areas of biological research. One example is the identification of selective cationic antibacterial peptides (SCAPs), which may be used in the treatment of different diseases. Due to the discrete nature of peptide sequences, the physicochemical properties calculation is considered a high-performance computing problem. A competitive solution for this class of problems is to embed algorithms into dedicated hardware. In the present work we present the adaptation, design and implementation of an algorithm for SCAPs prediction into a Field Programmable Gate Array (FPGA) platform. Four physicochemical properties codes useful in the identification of peptide sequences with potential selective antibacterial activity were implemented into an FPGA board. The speed-up gained in a single-copy implementation was up to 108 times compared with a single Intel processor cycle for cycle. The inherent scalability of our design allows for replication of this code into multiple FPGA cards and consequently improvements in speed are possible. Our results show the first embedded SCAPs prediction solution described and constitutes the grounds to efficiently perform the exhaustive analysis of the sequence-physicochemical properties relationship of peptides.	[Polanco Gonzalez, Carlos; del Rio, Gabriel] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biochem & Struct Biol, Mexico City 04510, DF, Mexico; [Nuno Maganda, Marco Aurelio] Univ Politecn Victoria, Cd Victoria, Tamaulipas, Mexico; [Arias-Estrada, Miguel] Inst Nacl Astrofis Opt & Electr, Dept Comp Sci, Puebla, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Astrofisica, Optica y Electronica	Gonzalez, CP (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca, Morelos, Mexico.	ariasmo@inaoep.mx; gdelrio@ifc.unam.mx	Nuno-Maganda, Marco Aurelio/AAR-7112-2020	Nuno-Maganda, Marco Aurelio/0000-0003-0102-8227; Polanco, Carlos/0000-0003-1673-2006	CONACYT [82308]; Macroproyecto Tecnologias para la Universidad de la Informacion y la computacion/UNAM	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Macroproyecto Tecnologias para la Universidad de la Informacion y la computacion/UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported in part by CONACYT project number 82308 and the Macroproyecto Tecnologias para la Universidad de la Informacion y la computacion/UNAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogdan IA, 2008, BIOINFORMATICS, V24, P1498, DOI 10.1093/bioinformatics/btn216; del Rio G, 2001, FEBS LETT, V494, P213, DOI 10.1016/S0014-5793(01)02348-1; Du QS, 2008, CURR PROTEIN PEPT SC, V9, P248, DOI 10.2174/138920308784534005; Ellerby HM, 2008, J MED CHEM, V51, P5887, DOI 10.1021/jm800495u; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Fjell CD, 2009, J MED CHEM, V52, P2006, DOI 10.1021/jm8015365; Hilpert Kai, 2008, V494, P127, DOI 10.1007/978-1-59745-419-3_8; Juretic D, 2009, J CHEM INF MODEL, V49, P2873, DOI 10.1021/ci900327a; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Lehnert U, 2004, Q REV BIOPHYS, V37, P121, DOI 10.1017/S003358350400397X; Polanco C, 2009, ACTA BIOCHIM POL, V56, P167; Raventos D, 2005, COMB CHEM HIGH T SCR, V8, P219, DOI 10.2174/1386207053764549; ROMERO P, 1997, NEURAL NETWORKS, V1, P90, DOI DOI 10.1109/ICNN.1997.611643; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Uversky Vladimir N., 2007, V408, P69; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	17	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21399	10.1371/journal.pone.0021399	http://dx.doi.org/10.1371/journal.pone.0021399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738652	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800018
J	Zhang, Y; Kang, YM; Tian, C; Zeng, Y; Jia, LX; Ma, X; Du, J; Li, HH				Zhang, Yuan; Kang, Yu-Ming; Tian, Cui; Zeng, Yong; Jia, Li-Xin; Ma, Xu; Du, Jie; Li, Hui-Hua			Overexpression of Nrdp1 in the Heart Exacerbates Doxorubicin-Induced Cardiac Dysfunction in Mice	PLOS ONE			English	Article							TRANSGENIC MICE; INDUCED CARDIOMYOPATHY; REPERFUSION INJURY; FAILURE; CARDIOTOXICITY; APOPTOSIS; DEGRADATION; EXPRESSION; PATHWAY; PARKIN	Background: Cardiac cell death and generation of oxidative stress contribute to doxorubicin (DOX)-induced cardiac dysfunction. E3 ligase Nrdp1 plays a critical role in the regulation of cell apoptosis, inflammation and production of reactive oxygen species (ROS), which may contribute to heart failure. However, the role of Nrdp1 in DOX-induced cardiac injury remains to be determined. Methods and Results: We examined the effect of Nrdp1 overexpression with DOX treatment in rat neonatal cardiomyocytes and mouse heart tissue. Cardiomyocytes were infected with adenovirus containing GFP (Ad-GFP), Nrdp1 wild-type (Ad-Nrdp1) or the dominant-negative form of Nrdp1 (Ad-Dn-Nrdp1), then treated with DOX for 24 hr. DOX treatment increased cell death and apoptosis, with Ad-Nrdp1 infection enhancing these actions but Ad-Dn-Nrdp1 infection attenuating these effects. Furthermore, 5 days after a single injection of DOX (20 mg/kg, intraperitoneally), Nrdp1 transgenic mice (TG) showed decreased cardiac function and increased apoptosis, autophagy and oxidative stress as compared with wild-type (WT) mice (P<0.01). Survival rate was significantly lower in Nrdp1 TG mice than in WT mice 10 days after DOX injection (P<0.01). Conclusions/Significance: These results were associated with decreased activation of Akt, extracellular signal-regulated kinase 1/2 (ERK1/2) and signal transducer and activator of transcription 3 (STAT3) signaling pathways. Nrdp1 may be a key mediator in the development of cardiac dysfunction after DOX treatment and associated with inhibition of Akt, ERK1/2 and STAT3. Nrdp1 may be a new therapeutic target in protecting against the cardiotoxic effects of DOX.	[Zhang, Yuan] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing 100730, Peoples R China; [Zhang, Yuan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Kang, Yu-Ming] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian 710049, Peoples R China; [Tian, Cui; Li, Hui-Hua] Capital Med Univ, Sch Basic Med Sci, Dept Pathol, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Zeng, Yong] Peking Union Med Hosp, Dept Cardiol, Beijing, Peoples R China; [Jia, Li-Xin; Du, Jie] Capital Med Univ, Key Lab Remodeling Related Cardiovasc Dis, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp,Lab Vasc Biol, Beijing, Peoples R China; [Ma, Xu] Natl Res Inst Family Planning, Dept Genet, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Xi'an Jiaotong University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Capital Medical University; National Research Institute for Family Planning - China	Zhang, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing 100730, Peoples R China.	jdu@bcm.edu; hhli1935@yahoo.cn			China Natural Science Foundation [81025001, 30971097, 30888004]; Beijing High-Level Talents Program [PHR20110507]; Chinese Academy of Science [KSCX2-YW-R-129]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing High-Level Talents Program; Chinese Academy of Science(Chinese Academy of Sciences)	This study was supported by grants from the China Natural Science Foundation (81025001, 30971097 and 30888004), the Beijing High-Level Talents Program (PHR20110507) and the Chinese Academy of Science (KSCX2-YW-R-129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Christiansen S, 2006, EUR J CARDIO-THORAC, V30, P611, DOI 10.1016/j.ejcts.2006.06.024; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Fan GC, 2006, CIRC RES, V99, P1233, DOI 10.1161/01.RES.0000251074.19348.af; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Kizaki K, 2006, PHARMACOL RES, V53, P341, DOI 10.1016/j.phrs.2006.01.001; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Riad A, 2008, EUR J HEART FAIL, V10, P233, DOI 10.1016/j.ejheart.2008.01.004; Riad A, 2009, CANCER RES, V69, P695, DOI 10.1158/0008-5472.CAN-08-3076; Sawyer DB, 1999, CIRC RES, V84, P257, DOI 10.1161/01.RES.84.3.257; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Su HF, 2006, ENDOCRINOLOGY, V147, P827, DOI 10.1210/en.2005-1098; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Teraoka K, 2000, EUR J HEART FAIL, V2, P373, DOI 10.1016/S1388-9842(00)00111-2; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Xiang P, 2009, CANCER CHEMOTH PHARM, V63, P343, DOI 10.1007/s00280-008-0744-4; Xie P, 2009, J BIOL CHEM, V284, P5488, DOI 10.1074/jbc.M806487200; Yang D, 2010, CELL PHYSIOL BIOCHEM, V25, P605, DOI 10.1159/000315079; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yu FR, 2008, NEUROSCI LETT, V440, P4, DOI 10.1016/j.neulet.2008.05.052; Zhang YA, 2011, BASIC RES CARDIOL, V106, P371, DOI 10.1007/s00395-011-0157-0; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200	31	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21104	10.1371/journal.pone.0021104	http://dx.doi.org/10.1371/journal.pone.0021104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738612	gold, Green Published			2022-12-25	WOS:000292092600013
J	Zhou, LH; Too, HP				Zhou, Lihan; Too, Heng-Phon			Mitochondrial Localized STAT3 Is Involved in NGF Induced Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PROTEIN-KINASE; SERINE PHOSPHORYLATION; SIGNALING PATHWAYS; PC12 CELLS; ACTIVATION; DIFFERENTIATION; RECEPTOR; TRK; NEURITOGENESIS	Background: Signal transducer and activator of transcription 3 (STAT3) plays critical roles in neural development and is increasingly recognized as a major mediator of injury response in the nervous system. Cytokines and growth factors are known to phosphorylate STAT3 at tyrosine(705) with or without the concomitant phosphorylation at serine(727), resulting in the nuclear localization of STAT3 and subsequent transcriptional activation of genes. Recent evidence suggests that STAT3 may control cell function via alternative mechanisms independent of its transcriptional activity. Currently, the involvement of STAT3 mono-phosphorylated at residue serine(727) (P-Ser-STAT3) in neurite outgrowth and the underlying mechanism is largely unknown. Principal Findings: In this study, we investigated the role of nerve growth factor (NGF) induced P-Ser-STAT3 in mediating neurite outgrowth. NGF induced the phosphorylation of residue serine(727) but not tyrosine(705) of STAT3 in PC12 and primary cortical neuronal cells. In PC12 cells, serine but not tyrosine dominant negative mutant of STAT3 was found to impair NGF induced neurite outgrowth. Unexpectedly, NGF induced P-Ser-STAT3 was localized to the mitochondria but not in the nucleus. Mitochondrial STAT3 was further found to be intimately involved in NGF induced neurite outgrowth and the production of reactive oxygen species (ROS). Conclusion: Taken together, the findings herein demonstrated a hitherto unrecognized novel transcription independent mechanism whereby the mitochondria localized P-Ser-STAT3 is involved in NGF induced neurite outgrowth.	[Zhou, Lihan; Too, Heng-Phon] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Zhou, Lihan; Too, Heng-Phon] Singapore Massachusetts Inst Technol Alliance, Singapore, Singapore	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Zhou, LH (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore.	heng-phon_too@nuhs.edu.sg			Singapore MIT-Alliance [C-382-651-001-091]; Singapore-Massachusetts Institute of Technology Alliance	Singapore MIT-Alliance; Singapore-Massachusetts Institute of Technology Alliance	This study is funded by the Singapore MIT-Alliance (grant number C-382-651-001-091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the following colleagues from the NUS Department of Biochemistry for their invaluable advice and generous technical support: Professor SIT Kim Ping and Lab, A/P TANG Bor Luen and Lab, A/P CLEMENT Marie-Veronique and Lab, and A/P CAO Xinmin and Lab. The authors would also like to acknowledge the Singapore-Massachusetts Institute of Technology Alliance for providing the necessary funding, and the Department of Biochemistry for the laboratory equipment.	Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; Brodie C, 1999, CELL GROWTH DIFFER, V10, P183; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Cattaneo E, 1999, TRENDS NEUROSCI, V22, P365, DOI 10.1016/S0166-2236(98)01378-2; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Fricker AD, 2005, MOL BRAIN RES, V138, P228, DOI 10.1016/j.molbrainres.2005.04.016; Galli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007541; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Jain N, 1999, J BIOL CHEM, V274, P24392, DOI 10.1074/jbc.274.34.24392; Johansson J, 2009, NEUROREPORT, V20, P828, DOI 10.1097/WNR.0b013e32832b7324; Kotake-Nara E, 2007, NEUROSCI LETT, V422, P223, DOI 10.1016/j.neulet.2007.06.026; Kuroki M, 1999, BIOCHEM J, V341, P691, DOI 10.1042/0264-6021:3410691; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Lufei CC, 2003, EMBO J, V22, P1325, DOI 10.1093/emboj/cdg135; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Miller MW, 2000, BRAIN RES, V852, P355, DOI 10.1016/S0006-8993(99)02176-9; Min JY, 2006, J NEURAL TRANSM, V113, P1821, DOI 10.1007/s00702-006-0500-z; Miranda C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009446; Munnamalai V, 2009, J NEUROCHEM, V108, P644, DOI 10.1111/j.1471-4159.2008.05787.x; Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Ruthel G, 2003, J NEUROSCI, V23, P8618; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Shi CS, 2004, J BIOL CHEM, V279, P17224, DOI 10.1074/jbc.M311875200; Suzukawa K, 2000, J BIOL CHEM, V275, P13175, DOI 10.1074/jbc.275.18.13175; Tso PH, 2009, NEUROCHEM RES, V34, P1101, DOI 10.1007/s11064-008-9880-9; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Verburg J, 2008, J NEUROSCI, V28, P8306, DOI 10.1523/JNEUROSCI.2614-08.2008; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wu HT, 2009, BBA-MOL CELL BIOL L, V1791, P8, DOI 10.1016/j.bbalip.2008.10.004; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Yokogami K, 2000, CURR BIOL, V10, P47, DOI 10.1016/S0960-9822(99)00268-7; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yung LY, 2008, CELL SIGNAL, V20, P1538, DOI 10.1016/j.cellsig.2008.04.007; Zorina Y, 2010, J BIOL CHEM, V285, P1358, DOI 10.1074/jbc.M109.049841	52	59	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21680	10.1371/journal.pone.0021680	http://dx.doi.org/10.1371/journal.pone.0021680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738764	gold, Green Published, Green Submitted			2022-12-25	WOS:000292092600071
J	Harris, DM; Hazan-Haley, I; Coombes, K; Bueso-Ramos, C; Liu, J; Liu, ZM; Li, P; Ravoori, M; Abruzzo, L; Han, L; Singh, S; Sun, M; Kundra, V; Kurzrock, R; Estrov, Z				Harris, David M.; Hazan-Haley, Inbal; Coombes, Kevin; Bueso-Ramos, Carlos; Liu, Jie; Liu, Zhiming; Li, Ping; Ravoori, Murali; Abruzzo, Lynne; Han, Lin; Singh, Sheela; Sun, Michael; Kundra, Vikas; Kurzrock, Razelle; Estrov, Zeev			Transformation of Human Mesenchymal Cells and Skin Fibroblasts into Hematopoietic Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN BONE-MARROW; COLONY-STIMULATING FACTOR; PROGENITOR CELLS; B-CELLS; GM-CSF; DIFFERENTIAL EXPRESSION; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; DNA METHYLATION	Patients with prolonged myelosuppression require frequent platelet and occasional granulocyte transfusions. Multi-donor transfusions induce alloimmunization, thereby increasing morbidity and mortality. Therefore, an autologous or HLA-matched allogeneic source of platelets and granulocytes is needed. To determine whether nonhematopoietic cells can be reprogrammed into hematopoietic cells, human mesenchymal stromal cells (MSCs) and skin fibroblasts were incubated with the demethylating agent 5-azacytidine (Aza) and the growth factors (GF) granulocyte-macrophage colony-stimulating factor and stem cell factor. This treatment transformed MSCs to round, non-adherent cells expressing T-, B-, myeloid-, or stem/progenitor-cell markers. The transformed cells engrafted as hematopoietic cells in bone marrow of immunodeficient mice. DNA methylation and mRNA array analysis suggested that Aza and GF treatment demethylated and activated HOXB genes. Indeed, transfection of MSCs or skin fibroblasts with HOXB4, HOXB5, and HOXB2 genes transformed them into hematopoietic cells. Further studies are needed to determine whether transformed MSCs or skin fibroblasts are suitable for therapy.	[Harris, David M.; Hazan-Haley, Inbal; Liu, Jie; Liu, Zhiming; Li, Ping; Estrov, Zeev] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Coombes, Kevin] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Bueso-Ramos, Carlos; Abruzzo, Lynne] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Ravoori, Murali; Han, Lin; Singh, Sheela; Kundra, Vikas] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Sun, Michael; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Harris, DM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	zestrov@mdanderson.org	Kurzrock, Razelle/AAU-9782-2020	Coombes, Kevin/0000-0002-7630-2123	M.D. Anderson Cancer Center	M.D. Anderson Cancer Center	This study was supported by a Multidisciplinary Research Program grant from M.D. Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarnas JC, 2004, ONCOLOGY-NY, V18, P867; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Ball LM, 2008, BONE MARROW TRANSPL, V42, pS60, DOI 10.1038/bmt.2008.286; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; BOYD AW, 1982, NATURE, V297, P691, DOI 10.1038/297691a0; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; BROXMEYER HE, 1991, J EXP MED, V174, P447, DOI 10.1084/jem.174.2.447; Burger JA, 1999, BLOOD, V94, P3658, DOI 10.1182/blood.V94.11.3658.423k11_3658_3667; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Choi SC, 2004, EXP MOL MED, V36, P515, DOI 10.1038/emm.2004.66; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; CONNELL D, 2009, BR J SPORTS MED; CONSTANTINIDES PG, 1977, NATURE, V267, P364, DOI 10.1038/267364a0; CONSTANTINIDES PG, 1978, DEV BIOL, V66, P57, DOI 10.1016/0012-1606(78)90273-7; DARMON M, 1984, EMBO J, V3, P961, DOI 10.1002/j.1460-2075.1984.tb01914.x; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Enjoji M, 1997, HEPATOLOGY, V26, P288, DOI 10.1002/hep.510260206; FAUSER AA, 1978, BLOOD, V52, P1243; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; Freireich EJ, 2000, BRIT J HAEMATOL, V111, P68, DOI 10.1046/j.1365-2141.2000.02144.x; Gluckman E, 2008, BONE MARROW TRANSPL, V41, P127, DOI 10.1038/sj.bmt.1705960; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Habib M, 1999, EXP CELL RES, V249, P46, DOI 10.1006/excr.1999.4434; Hai-Jiang W, 2008, AM J HEMATOL, V83, P922, DOI 10.1002/ajh.21262; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Haylock David N, 2007, Curr Stem Cell Res Ther, V2, P324, DOI 10.2174/157488807782793745; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Hirohata S, 2002, J LEUKOCYTE BIOL, V71, P987; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Ivins S, 2003, ONCOGENE, V22, P3685, DOI 10.1038/sj.onc.1206328; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jendiroba DB, 2000, BLOOD REV, V14, P219, DOI 10.1054/blre.2000.0134; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; JONES PA, 1985, CELL, V40, P485, DOI 10.1016/0092-8674(85)90192-8; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; KONIECZNY SF, 1984, CELL, V38, P791, DOI 10.1016/0092-8674(84)90274-5; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kundra V, 2002, J NUCL MED, V43, P406; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Lennartsson J, 2004, J BIOL CHEM, V279, P44544, DOI 10.1074/jbc.M404085200; Ma F, 2000, BRIT J HAEMATOL, V111, P1170, DOI 10.1046/j.1365-2141.2000.02432.x; MCNIECE IK, 1991, J IMMUNOL, V146, P3785; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; Milutinovic S, 2003, J BIOL CHEM, V278, P14985, DOI 10.1074/jbc.M213219200; Murphy PM, 2000, PHARMACOL REV, V52, P145; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Rebulla P, 2005, HAEMATOLOGICA, V90, P247; Sachan M, 2006, GENE, V380, P151, DOI 10.1016/j.gene.2006.05.029; Sachs UJH, 2007, TRANSFUS APHER SCI, V37, P273, DOI 10.1016/j.transci.2007.02.005; Sauter C, 2008, CURR OPIN HEMATOL, V15, P568, DOI 10.1097/MOH.0b013e3283136718; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Schmidt AH, 2007, BONE MARROW TRANSPL, V40, P823, DOI 10.1038/sj.bmt.1705832; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Sonderegger I, 2008, J EXP MED, V205, P2281, DOI 10.1084/jem.20071119; SORM F, 1964, EXPERIENTIA, V20, P202, DOI 10.1007/BF02135399; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Thirukkumaran CM, 2007, BONE MARROW TRANSPL, V40, P1, DOI 10.1038/sj.bmt.1705668; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tse W, 2008, CURR OPIN HEMATOL, V15, P279, DOI 10.1097/MOH.0b013e328304ae2c; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Winters JL, 2006, J CLIN APHERESIS, V21, P132, DOI 10.1002/jca.20039; Wood B, 2006, ARCH PATHOL LAB MED, V130, P680; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamada N, 2008, J ARTIF ORGANS, V11, P221, DOI 10.1007/s10047-008-0428-1; Yang D, 2005, RADIOLOGY, V235, P950, DOI 10.1148/radiol.2353040108; Yu BD, 2008, HUM MOL GENET, V17, pR54, DOI 10.1093/hmg/ddn086; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	98	25	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21250	10.1371/journal.pone.0021250	http://dx.doi.org/10.1371/journal.pone.0021250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731684	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700053
J	Murphy, DM; Buckley, PG; Das, S; Watters, KM; Bryan, K; Stallings, RL				Murphy, Derek M.; Buckley, Patrick G.; Das, Sudipto; Watters, Karen M.; Bryan, Kenneth; Stallings, Raymond L.			Co-Localization of the Oncogenic Transcription Factor MYCN and the DNA Methyl Binding Protein MeCP2 at Genomic Sites in Neuroblastoma	PLOS ONE			English	Article							FOCAL ADHESION KINASE; RETT-SYNDROME; HISTONE DEACETYLASE; TARGET GENES; MOUSE MODEL; EXPRESSION; PROMOTER; REPRESSION; REVEALS; PATHWAY	Background: MYCN is a transcription factor that is expressed during the development of the neural crest and its dysregulation plays a major role in the pathogenesis of pediatric cancers such as neuroblastoma, medulloblastoma and rhabdomyosarcoma. MeCP2 is a CpG methyl binding protein which has been associated with a number of cancers and developmental disorders, particularly Rett syndrome. Methods and Findings: Using an integrative global genomics approach involving chromatin immunoprecipitation applied to microarrays, we have determined that MYCN and MeCP2 co-localize to gene promoter regions, as well as inter/intragenic sites, within the neuroblastoma genome (MYCN amplified Kelly cells) at high frequency (70.2% of MYCN sites were also positive for MeCP2). Intriguingly, the frequency of co-localization was significantly less at promoter regions exhibiting substantial hypermethylation (8.7%), as determined by methylated DNA immunoprecipitation (MeDIP) applied to the same microarrays. Co-immunoprecipitation of MYCN using an anti-MeCP2 antibody indicated that a MYCN/MeCP2 interaction occurs at protein level. mRNA expression profiling revealed that the median expression of genes with promoters bound by MYCN was significantly higher than for genes bound by MeCP2, and that genes bound by both proteins had intermediate expression. Pathway analysis was carried out for genes bound by MYCN, MeCP2 or MYCN/MeCP2, revealing higher order functions. Conclusions: Our results indicate that MYCN and MeCP2 protein interact and co-localize to similar genomic sites at very high frequency, and that the patterns of binding of these proteins can be associated with significant differences in transcriptional activity. Although it is not yet known if this interaction contributes to neuroblastoma disease pathogenesis, it is intriguing that the interaction occurs at the promoter regions of several genes important for the development of neuroblastoma, including ALK, AURKA and BDNF.	[Murphy, Derek M.; Buckley, Patrick G.; Das, Sudipto; Watters, Karen M.; Bryan, Kenneth; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Murphy, Derek M.; Buckley, Patrick G.; Das, Sudipto; Watters, Karen M.; Bryan, Kenneth; Stallings, Raymond L.] Our Ladys Childrens Hosp, Childrens Res Ctr, Dublin, Ireland; [Buckley, Patrick G.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Royal College of Surgeons - Ireland	Murphy, DM (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	rstallings@rcsi.ie	Murphy, Derek/B-1285-2013; Stallings, Raymond/A-7213-2008	Bryan, Kenneth/0000-0002-9550-8354	Science Foundation Ireland [07/IN.1/B1776]; Children's Medical and Research Foundation; Cancer Research Ireland; U.S. National Institutes of Health [5R01CA127496]; NATIONAL CANCER INSTITUTE [R01CA127496] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; Cancer Research Ireland; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Science Foundation Ireland (07/IN.1/B1776), Children's Medical and Research Foundation, Cancer Research Ireland and the U.S. National Institutes of Health (5R01CA127496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AMIN C, 1993, MOL CELL BIOL, V13, P383, DOI 10.1128/MCB.13.1.383; Balmer D, 2002, HUM GENET, V110, P545, DOI 10.1007/s00439-002-0724-4; Beierle EA, 2008, CLIN CANCER RES, V14, P3299, DOI 10.1158/1078-0432.CCR-07-1511; Beierle EA, 2007, J BIOL CHEM, V282, P12503, DOI 10.1074/jbc.M701450200; Beierle EA, 2010, MOL CARCINOGEN, V49, P224, DOI 10.1002/mc.20592; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; BUCKLEY PG, 2010, INT J CANC; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Cotterman R, 2008, CANCER RES, V68, P9654, DOI 10.1158/0008-5472.CAN-08-1961; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Gonzales ML, 2010, CURR PSYCHIAT REP, V12, P127, DOI 10.1007/s11920-010-0097-7; Gupta A, 2006, CANCER RES, V66, P8100, DOI 10.1158/0008-5472.CAN-05-4519; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Konduri SD, 2003, ONCOGENE, V22, P4509, DOI 10.1038/sj.onc.1206695; Koppen A, 2007, EUR J CANCER, V43, P2413, DOI 10.1016/j.ejca.2007.07.024; Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540; LaSalle JM, 2009, EPIGENOMICS-UK, V1, P119, DOI [10.2217/epi.09.13, 10.2217/EPI.09.13]; Li QL, 2006, TRENDS GENET, V22, P197, DOI 10.1016/j.tig.2006.02.004; Lu HF, 2009, NEUROCHEM RES, V34, P1575, DOI 10.1007/s11064-009-9946-3; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; MESTDAGH P, 2010, ONCOGENE; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Murphy DM, 2011, MOL CARCINOGEN, V50, P403, DOI 10.1002/mc.20722; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Ramachandran K, 2009, CANCER RES, V69, P1527, DOI 10.1158/0008-5472.CAN-08-3609; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Shohet JM, 2002, CANCER RES, V62, P1123; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Van Roy N, 2009, GENOME MED, V1, DOI 10.1186/gm74; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; YANG TY, 2010, BMC CANC; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	53	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21436	10.1371/journal.pone.0021436	http://dx.doi.org/10.1371/journal.pone.0021436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731748	gold, Green Published, Green Submitted			2022-12-25	WOS:000292033700085
J	Nierth, A; Jaschke, A				Nierth, Alexander; Jaeschke, Andres			Radioactive Phosphorylation of Alcohols to Monitor Biocatalytic Diels-Alder Reactions	PLOS ONE			English	Article							PHOSPHORIC-ACID; ACTIVE-SITE; ENERGIEREICHEN PHOSPHATE; ZUR CHEMIE; RIBOZYME; CONDENSATION; ENZYME	Nature has efficiently adopted phosphorylation for numerous biological key processes, spanning from cell signaling to energy storage and transmission. For the bioorganic chemist the number of possible ways to attach a single phosphate for radioactive labeling is surprisingly small. Here we describe a very simple and fast one-pot synthesis to phosphorylate an alcohol with phosphoric acid using trichloroacetonitrile as activating agent. Using this procedure, we efficiently attached the radioactive phosphorus isotope P-32 to an anthracene diene, which is a substrate for the Diels-Alderase ribozyme-an RNA sequence that catalyzes the eponymous reaction. We used the P-32-substrate for the measurement of RNA-catalyzed reaction kinetics of several dye-labeled ribozyme variants for which precise optical activity determination (UV/vis, fluorescence) failed due to interference of the attached dyes. The reaction kinetics were analyzed by thin-layer chromatographic separation of the P-32-labeled reaction components and densitometric analysis of the substrate and product radioactivities, thereby allowing iterative optimization of the dye positions for future single-molecule studies. The phosphorylation strategy with trichloroacetonitrile may be applicable for labeling numerous other compounds that contain alcoholic hydroxyl groups.	[Nierth, Alexander; Jaeschke, Andres] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Nierth, A (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	jaeschke@uni-hd.de	Nierth, Alexander/K-9776-2015; Jäschke, Andres/F-1575-2010	Jäschke, Andres/0000-0002-4625-2655	Deutsche Forschungsgemeinschaft [Ja 794-3]; Volkswagen foundation [VW-I/82549]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagen foundation(Volkswagen); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (Ja 794-3), the Volkswagen foundation (VW-I/82549) and the Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezniak T, 2010, J AM CHEM SOC, V132, P12587, DOI 10.1021/ja101370e; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; Brun MA, 2009, J AM CHEM SOC, V131, P5873, DOI 10.1021/ja900149e; CRAMER F, 1962, CHEM BER-RECL, V95, P1657, DOI 10.1002/cber.19620950713; CRAMER F, 1962, LIEBIGS ANN CHEM, V654, P180; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; DOLINNAYA NG, 1991, NUCLEIC ACIDS RES, V19, P3067, DOI 10.1093/nar/19.11.3067; Dueymes C, 2008, TETRAHEDRON LETT, V49, P5300, DOI 10.1016/j.tetlet.2008.06.083; Fiammengo R, 2005, J AM CHEM SOC, V127, P9271, DOI 10.1021/ja051179m; FONTANEL ML, 1993, ANAL BIOCHEM, V214, P338, DOI 10.1006/abio.1993.1501; GLONEK T, 1976, BIOINORG CHEM, V5, P283, DOI 10.1016/S0006-3061(00)80290-2; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; HEITZ JR, 1968, ARCH BIOCHEM BIOPHYS, V127, P627, DOI 10.1016/0003-9861(68)90271-3; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HOKIN LE, 1963, BIOCHIM BIOPHYS ACTA, V67, P485; KANAYA E, 1986, BIOCHEMISTRY-US, V25, P7423, DOI 10.1021/bi00371a026; Kobitski AY, 2007, NUCLEIC ACIDS RES, V35, P2047, DOI 10.1093/nar/gkm072; Leuck M, 2004, TETRAHEDRON LETT, V45, P321, DOI 10.1016/j.tetlet.2003.10.167; Manoharan V, 2009, J AM CHEM SOC, V131, P6261, DOI 10.1021/ja900244x; Martin NI, 2007, BIOORG MED CHEM LETT, V17, P4938, DOI 10.1016/j.bmcl.2007.06.039; Melby ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018420; NEUFELD E, 1989, ANAL BIOCHEM, V177, P138, DOI 10.1016/0003-2697(89)90028-6; Nierth A, 2010, CHEM COMMUN, V46, P7975, DOI 10.1039/c0cc03162c; Nierth A, 2010, J AM CHEM SOC, V132, P2646, DOI 10.1021/ja9084397; PENEFSKY HS, 1967, METHOD ENZYMOL, V10, P702; SAFFHILL R, 1970, J ORG CHEM, V35, P2881, DOI 10.1021/jo00834a004; Sakakura A, 2008, HETEROCYCLES, V76, P657; Sakakura A, 2007, ANGEW CHEM INT EDIT, V46, P1423, DOI 10.1002/anie.200604333; Schmidt R. R., 2000, CARBOHYD CHEM-SPR, P5; Seelig B, 2000, ANGEW CHEM INT EDIT, V39, P4576, DOI 10.1002/1521-3773(20001215)39:24<4576::AID-ANIE4576>3.0.CO;2-J; Seelig B, 1999, CHEM BIOL, V6, P167, DOI 10.1016/S1074-5521(99)89008-5; Serganov A, 2005, NAT STRUCT MOL BIOL, V12, P218, DOI 10.1038/nsmb906; Stuhlmann F, 2002, J AM CHEM SOC, V124, P3238, DOI 10.1021/ja0167405; Tercel M, 2011, ANGEW CHEM INT EDIT, V50, P2606, DOI 10.1002/anie.201004456; Tinnefeld P, 2005, ANGEW CHEM INT EDIT, V44, P2642, DOI 10.1002/anie.200300647; van Herk T, 2005, ADV SYNTH CATAL, V347, P1155, DOI 10.1002/adsc.200505072; Vogel SR, 2005, CHEM COMMUN, P4922, DOI 10.1039/b510775j; Wiberg E., 2007, LEHRBUCH ANORGANISCH; Wombacher R, 2008, J AM CHEM SOC, V130, P8594, DOI 10.1021/ja802931q	39	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21391	10.1371/journal.pone.0021391	http://dx.doi.org/10.1371/journal.pone.0021391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731729	Green Submitted, Green Published, gold			2022-12-25	WOS:000292033700073
J	Ekland, EH; Schneider, J; Fidock, DA				Ekland, Eric H.; Schneider, Jessica; Fidock, David A.			Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches	FASEB JOURNAL			English	Article						Plasmodium falciparum; delayed death; drug discovery	PLASMODIUM-FALCIPARUM; TOXOPLASMA-GONDII; MALARIA PARASITE; DRUG-RESISTANCE; FLOW-CYTOMETRY; GROWTH; AUTOFLUORESCENCE; AZITHROMYCIN; CHLOROQUINE; INHIBITION	Malarial parasites have evolved resistance to all previously used therapies, and recent evidence suggests emerging resistance to the first-line artemisinins. To identify antimalarials with novel mechanisms of action, we have developed a high-throughput screen targeting the apicoplast organelle of Plasmodium falciparum. Antibiotics known to interfere with this organelle, such as azithromycin, exhibit an unusual phenotype whereby the progeny of drug-treated parasites die. Our screen exploits this phenomenon by assaying for "delayed death" compounds that exhibit a higher potency after two cycles of intraerythrocytic development compared to one. We report a primary assay employing parasites with an integrated copy of a firefly luciferase reporter gene and a secondary flow cytometry-based assay using a nucleic acid stain paired with a mitochondrial vital dye. Screening of the U. S. National Institutes of Health Clinical Collection identified known and novel antimalarials including kitasamycin. This inexpensive macrolide, used for agricultural applications, exhibited an in vitro IC50 in the 50 nM range, comparable to the 30 nM activity of our control drug, azithromycin. Imaging and pharmacologic studies confirmed kitasamycin action against the apicoplast, and in vivo activity was observed in a murine malaria model. These assays provide the foundation for high-throughput campaigns to identify novel chemotypes for combination therapies to treat multidrug-resistant malaria.-Ekland, E. H., Schneider, J., Fidock, D. A. Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches. FASEB J. 25, 3583-3593 (2011). www.fasebj.org	[Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, Hammer Hlth Sci Ctr, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ Coll Phys & Surg, Div Infect Dis, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University	Fidock, DA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, Hammer Hlth Sci Ctr, Rm 1502,701 W 168th St, New York, NY 10032 USA.	ee2196@columbia.edu; df2260@columbia.edu		Fidock, David/0000-0001-6753-8938	U.S. National Insitutes of Health [R21 NS059500]; American Recovery and Investment Act; Life Sciences Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059500] Funding Source: NIH RePORTER	U.S. National Insitutes of Health; American Recovery and Investment Act; Life Sciences Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Marcus Lee, Rich Eastman, Rebecca Muhle, Lindsie Goss, and Philipp Heinrich for experimental, technical, and computational assistance. The authors also thank Bamini Jayabalasingham and Andrea Ecker for constructive comments on the manuscript. The authors are grateful to Wesley C. Van Voorhis and Michael H. Gelb (University of Washington, Seattle, WA, USA) for providing BMS-388891. This work was funded in part by the U.S. National Insitutes of Health (R21 NS059500 to D.A.F.), including support as a competitive revision application funded by the American Recovery and Investment Act of 2009. E.H.E. gratefully acknowledges support from the Life Sciences Research Foundation as a Hoffmann-La Roche Fellow.	Alkadi HO, 2007, CHEMOTHERAPY, V53, P385, DOI 10.1159/000109767; Aregawi M., 2010, WORLD MALARIA REPORT, pxii; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Barthel D, 2008, ANTIMICROB AGENTS CH, V52, P774, DOI 10.1128/AAC.00892-07; Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhakdi SC, 2007, CYTOM PART A, V71A, P662, DOI 10.1002/cyto.a.20406; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Chico RM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-255; Dahl EL, 2008, TRENDS PARASITOL, V24, P279, DOI 10.1016/j.pt.2008.03.007; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; Dharia NV, 2010, GENOME RES, V20, P1534, DOI 10.1101/gr.105163.110; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Di L, 2006, DRUG DISCOV TODAY, V11, P446, DOI 10.1016/j.drudis.2006.03.004; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eastman R. T., 2011, AGENTS CHEMOTHER; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Ekland EH, 2008, INT J PARASITOL, V38, P743, DOI 10.1016/j.ijpara.2008.03.004; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Janbon M., 1963, GAZ MED FR S, V70, P9; Jimenez-Diaz MB, 2005, CYTOM PART A, V67A, P27, DOI 10.1002/cyto.a.20169; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kalanon M, 2010, BIOCHEM SOC T, V38, P775, DOI 10.1042/BST0380775; Kalilani L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001166; Kuo MR, 2003, J BIOL CHEM, V278, P20851, DOI 10.1074/jbc.M211968200; Luntamo M, 2010, AM J TROP MED HYG, V83, P1212, DOI 10.4269/ajtmh.2010.10-0264; McLeod R, 2001, INT J PARASITOL, V31, P109, DOI 10.1016/S0020-7519(01)00111-4; Muhle RA, 2009, INT J PARASITOL, V39, P1425, DOI 10.1016/j.ijpara.2009.05.001; Nallan L, 2005, J MED CHEM, V48, P3704, DOI 10.1021/jm0491039; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Noedl H, 2009, TRENDS PARASITOL, V25, P540, DOI 10.1016/j.pt.2009.09.001; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Okamoto N, 2009, EUKARYOT CELL, V8, P128, DOI 10.1128/EC.00267-08; PETERS W, 1965, EXP PARASITOL, V17, P80, DOI 10.1016/0014-4894(65)90012-3; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Plowe Christopher V, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS11, DOI 10.1016/j.trstmh.2008.11.002; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Schoepflin S, 2010, AM J TROP MED HYG, V82, P529, DOI 10.4269/ajtmh.2010.09-0334; Sidhu ABS, 2007, J BIOL CHEM, V282, P2494, DOI 10.1074/jbc.M608615200; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; Stanway RR, 2009, BIOL CELL, V101, P415, DOI 10.1042/BC20080202; Tan KR, 2011, AM J TROP MED HYG, V84, P517, DOI 10.4269/ajtmh.2011.10-0285; Tuma RS, 1999, ANAL BIOCHEM, V268, P278, DOI 10.1006/abio.1998.3067; VANDERHEYDE HC, 1995, CLIN DIAGN LAB IMMUN, V2, P417, DOI 10.1128/CDLI.2.4.417-425.1995; Vinetz J. M., 2011, GOODMAN GILMANS PHAR, P1383; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wells TN, 2010, DISCOV MED, V9, P389; WHO, 2010, WHO GUIDELINES TREAT, V2; Xie L, 2007, PARASITOLOGY, V134, P1151, DOI 10.1017/S0031182007002661; Zuther E, 1999, P NATL ACAD SCI USA, V96, P13387, DOI 10.1073/pnas.96.23.13387	59	69	69	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3583	3593		10.1096/fj.11-187401	http://dx.doi.org/10.1096/fj.11-187401			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21746861	Green Published			2022-12-25	WOS:000295356400028
J	Shan, D; Ge, Z; Ming, SA; Wang, L; Sante, M; He, WS; Zhou, JP; Liu, SL; Wang, L				Shan, Duo; Ge, Zeng; Ming, Shuai; Wang, Lan; Sante, Michael; He, Wensheng; Zhou, Jianping; Liu, Shanglong; Wang, Lu			Quality of Life and Related Factors among HIV-Positive Spouses from Serodiscordant Couples under Antiretroviral Therapy in Henan Province, China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; WHOQOL-BREF; PSYCHOMETRIC PROPERTIES; MEDICAL OUTCOMES; HIV/AIDS; INSTRUMENT; VALIDITY; TRANSMISSION; IMPACT; AIDS	Objective: To describe the quality of life and related factors in HIV-positive spouses undergoing ART from discordant couples. Methods: A cross-sectional study was conducted among 1,009 HIV-positive spouses from serodiscordant couples in Zhumadian, Henan Province, between October 1, 2008 and March 31, 2009. HIV-positive spouses were interviewed by local health professionals. Quality of life was evaluated by WHOQOL (Chinese Version). A multiple linear regression model was used to analyze the related factors. Results: The majority of subjects were female (56.39%), had received a high school education (44%), were of Han ethnicity (98.41%), and were farmers (90.09%); the median time period of receiving ART was 3.92 years. The physical, psychological, social, and environmental QOL scores of the subjects were 12.91 +/- 1.95, 12.35 +/- 1.80, 13.96 +/- 2.43, and 12.45 +/- 1.91 respectively. The multiple linear regression model identified the physical domain related factors to be CD4 count, educational level, and occupation; psychological domain related factors include age, educational level, and reported STD symptom; social domain related factors included education level; and environmental domain related factors included education level, reported STD symptoms, and occupation. Conclusion: Being younger, a farmer, having a lower level of education, a reported STD symptom, or lower CD4 count, could decrease one's quality of life, suggesting that the use of blanket ART programs alone may not necessarily improve quality of life. Subjects received lower scores in the psychological domain, suggesting that psychological intervention may also need to be strengthened.	[Shan, Duo; Ming, Shuai; Wang, Lan; Sante, Michael; Wang, Lu] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Ge, Zeng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Ge, Zeng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Ge, Zeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Wensheng; Zhou, Jianping] Zhumadian Ctr Dis Control & Prevent, Zhumadian City, Henan Province, Peoples R China; [Liu, Shanglong] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 430074, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Huazhong University of Science & Technology	Shan, D (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wanglu64@chinaaids.cn						Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Beard J, 2009, AIDS CARE, V21, P1343, DOI 10.1080/09540120902889926; Brooks JT, 2009, CLIN INFECT DIS, V48, P609, DOI 10.1086/596756; Burgoyne RW, 2008, J ANTIMICROB CHEMOTH, V61, P469, DOI 10.1093/jac/dkm499; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; DeBoer JB, 1996, QUAL LIFE RES, V5, P339, DOI 10.1007/BF00433918; Dube MP, 2010, J INFECT DIS, V201, P1783, DOI 10.1086/652751; Fang CT, 2002, QUAL LIFE RES, V11, P753, DOI 10.1023/A:1020870402019; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; Hsiung PC, 2005, QUAL LIFE RES, V14, P141, DOI 10.1007/s11136-004-6252-z; HYMES KB, 1981, LANCET, V2, P598; Kalichman SC, 2002, INT J STD AIDS, V13, P677, DOI 10.1258/095646202760326426; KAPLAN RM, 1995, PSYCHOSOM MED, V57, P138, DOI 10.1097/00006842-199503000-00006; Lee GM, 2006, PEDIATRICS, V117, P273, DOI 10.1542/peds.2005-0323; Leplege A, 1997, QUAL LIFE RES, V6, P585, DOI 10.1023/A:1018468301617; Liu ZY, 2009, CHINESE MED J-PEKING, V122, P2497, DOI 10.3760/cma.j.issn.0366-6999.2009.20.018; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Mrus JM, 2005, QUAL LIFE RES, V14, P479, DOI 10.1007/s11136-004-4693-z; *NASTAD, 2005, TURN POINT CONFR HIV; Nojomi Marzieh, 2008, Arch Iran Med, V11, P608; O'Carroll RE, 2000, QUAL LIFE RES, V9, P121, DOI 10.1023/A:1008901320492; O'Connell K, 2003, SOC SCI MED, V57, P1259, DOI 10.1016/S0277-9536(02)00506-3; Peterman AH, 1997, QUAL LIFE RES, V6, P572, DOI 10.1023/A:1018416317546; Rao D, 2009, AIDS CARE, V21, P64, DOI 10.1080/09540120802068795; Sakthong Phantipa, 2007, Journal of the Medical Association of Thailand, V90, P2449; Santos Elisabete Cristina Morandi dos, 2007, Rev. Saúde Pública, V41, P64; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Subramanian T, 2009, AIDS CARE, V21, P473, DOI 10.1080/09540120802283469; WACHTEL T, 1992, ANN INTERN MED, V116, P129, DOI 10.7326/0003-4819-116-2-129; *WHO, 2009, 2009 UPD HIV AIDS EP; *WHO, 2004, WHO QUAL LIFE WHOQOL; Wu AW, 2002, QUAL LIFE RES, V11, P273, DOI 10.1023/A:1015240103565; Wu AW, 1997, QUAL LIFE RES, V6, P481, DOI 10.1023/A:1018451930750; Yang Meei-Horng, 2003, J Nurs Res, V11, P217; Yen CF, 2004, PSYCHIAT CLIN NEUROS, V58, P501, DOI 10.1111/j.1440-1819.2004.01292.x; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang Heng, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P206	38	19	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21839	10.1371/journal.pone.0021839	http://dx.doi.org/10.1371/journal.pone.0021839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786GP	21738797	Green Submitted, Green Published, gold			2022-12-25	WOS:000292291800048
J	Silady, RA; Effgen, S; Koornneef, M; Reymond, M				Silady, Rebecca A.; Effgen, Sigi; Koornneef, Maarten; Reymond, Matthieu			Variation in Seed Dormancy Quantitative Trait Loci in Arabidopsis thaliana Originating from One Site	PLOS ONE			English	Article							INBRED LINE POPULATIONS; FLOWERING-TIME; NATURAL VARIATION	A Quantitative Trait Locus (QTL) analysis was performed using two novel Recombinant Inbred Line (RIL) populations, derived from the progeny between two Arabidopsis thaliana genotypes collected at the same site in Kyoto (Japan) crossed with the reference laboratory strain Landsberg erecta (Ler). We used these two RIL populations to determine the genetic basis of seed dormancy and flowering time, which are assumed to be the main traits controlling life history variation in Arabidopsis. The analysis revealed quantitative variation for seed dormancy that is associated with allelic variation at the seed dormancy QTL DOG1 (for Delay Of Germination 1) in one population and at DOG6 in both. These DOG QTL have been previously identified using mapping populations derived from accessions collected at different sites around the world. Genetic variation within a population may enhance its ability to respond accurately to variation within and between seasons. In contrast, variation for flowering time, which also segregated within each mapping population, is mainly governed by the same QTL.	[Silady, Rebecca A.; Effgen, Sigi; Koornneef, Maarten; Reymond, Matthieu] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Koornneef, Maarten] Wageningen Univ, Genet Lab, Wageningen, Netherlands	Max Planck Society; Wageningen University & Research	Silady, RA (corresponding author), So Connecticut State Univ, Dept Biol, New Haven, CT 06515 USA.	koornneef@mpipz.mpg.de		Koornneef, Maarten/0000-0002-7759-4869	Alexander von Humbolt fellowship; Max Planck Society	Alexander von Humbolt fellowship(Alexander von Humboldt Foundation); Max Planck Society(Max Planck Society)	Funding was provided by an Alexander von Humbolt fellowship to RS and by the Max Planck Society. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.	Alonso-Blanco C, 2003, GENETICS, V164, P711; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Bentsink L, 2010, P NATL ACAD SCI USA, V107, P4264, DOI 10.1073/pnas.1000410107; Caicedo AL, 2009, MOL BIOL EVOL, V26, P699, DOI 10.1093/molbev/msn300; Donohue K, 2005, EVOLUTION, V59, P740, DOI 10.1111/j.0014-3820.2005.tb01752.x; El-Lithy ME, 2006, GENETICS, V172, P1867, DOI 10.1534/genetics.105.050617; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; O'Neill CM, 2008, THEOR APPL GENET, V116, P623, DOI 10.1007/s00122-007-0696-9; Pico FX, 2008, GENETICS, V180, P1009, DOI 10.1534/genetics.108.089581; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Simon M, 2008, GENETICS, V178, P2253, DOI 10.1534/genetics.107.083899; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	16	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20886	10.1371/journal.pone.0020886	http://dx.doi.org/10.1371/journal.pone.0020886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738591	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800005
J	Tanasijevic, B; Rasmussen, TP				Tanasijevic, Borko; Rasmussen, Theodore P.			X Chromosome Inactivation and Differentiation Occur Readily in ES Cells Doubly-Deficient for MacroH2A1 and MacroH2A2	PLOS ONE			English	Article							HISTONE VARIANT MACROH2A; CORE HISTONE; TRANSCRIPTION; EXPRESSION; METHYLATION; INTERFERES; DELETION; SUBTYPES; SWI/SNF; GENOME	Macrohistones (mH2As) are unusual histone variants found exclusively in vertebrate chromatin. In mice, the H2afy gene encodes two splice variants, mH2A1.1 and mH2A1.2 and a second gene, H2afy2, encodes an additional mH2A2 protein. Both mH2A isoforms have been found enriched on the inactive X chromosome (Xi) in differentiated mammalian female cells, and are incorporated into the chromatin of developmentally-regulated genes. To investigate the functional significance of mH2A isoforms for X chromosome inactivation (XCI), we produced male and female embryonic stem cell (ESC) lines with stably-integrated shRNA constructs that simultaneously target both mH2A1 and mH2A2. Surprisingly, we find that female ESCs deficient for both mH2A1 and mH2A2 readily execute and maintain XCI upon differentiation. Furthermore, male and female mH2A-deficient ESCs proliferate normally under pluripotency culture conditions, and respond to several standard differentiation procedures efficiently. Our results show that XCI can readily proceed with substantially reduced total mH2A content.	[Tanasijevic, Borko; Rasmussen, Theodore P.] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; [Tanasijevic, Borko; Rasmussen, Theodore P.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Rasmussen, Theodore P.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut; University of Connecticut	Tanasijevic, B (corresponding author), Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA.	theodore.rasmussen@uconn.edu		Rasmussen, Theodore/0000-0001-9450-3394	National Institutes of Health [RO1AG23687]; NATIONAL INSTITUTE ON AGING [R01AG023687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the National Institutes of Health (RO1AG23687), http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; Angelov D, 2003, MOL CELL, V11, P1033, DOI 10.1016/S1097-2765(03)00100-X; Araya I, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-14; Barzily-Rokni M, 2011, NUCLEIC ACIDS RES, V39, P1326, DOI 10.1093/nar/gkq994; Boulard M, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-8; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chadwick BP, 2001, HUM MOL GENET, V10, P1101, DOI 10.1093/hmg/10.10.1101; Chang EY, 2008, BIOCHEMISTRY-US, V47, P13726, DOI 10.1021/bi8016944; Changolkar LN, 2007, MOL CELL BIOL, V27, P2758, DOI 10.1128/MCB.02334-06; Changolkar LN, 2006, MOL CELL BIOL, V26, P4410, DOI 10.1128/MCB.02258-05; Changolkar LN, 2010, MOL CELL BIOL; Choo JH, 2006, HUM MOL GENET, V15, P717, DOI 10.1093/hmg/ddi485; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costanzi C, 2001, J BIOL CHEM, V276, P21776, DOI 10.1074/jbc.M010919200; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Doyen CM, 2006, MOL CELL BIOL, V26, P1156, DOI 10.1128/MCB.26.3.1156-1164.2006; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hoyer-Fender S, 2000, EXP CELL RES, V258, P254, DOI 10.1006/excr.2000.4951; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kwiatkowski DL, 2009, J VIROL, V83, P8173, DOI 10.1128/JVI.00686-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YH, 2005, J CELL SCI, V118, P1607, DOI 10.1242/jcs.02291; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Mietton F, 2009, MOL CELL BIOL, V29, P150, DOI 10.1128/MCB.00997-08; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; PEHRSON JR, 1992, SCIENCE, V257, P1398; Pehrson JR, 1998, NUCLEIC ACIDS RES, V26, P2837, DOI 10.1093/nar/26.12.2837; Rasmussen TP, 1999, NUCLEIC ACIDS RES, V27, P3685, DOI 10.1093/nar/27.18.3685; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; Rasmussen TP, 2001, CHROMOSOMA, V110, P411, DOI 10.1007/s004120100158; Tanasijevic B, 2009, EPIGENETICS-US, V4, P330, DOI 10.4161/epi.4.5.9275; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	36	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21512	10.1371/journal.pone.0021512	http://dx.doi.org/10.1371/journal.pone.0021512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738686	Green Submitted, gold, Green Published			2022-12-25	WOS:000292291800018
J	Du, SX; Xu, L; Zhang, WG; Tang, S; Boenig, RI; Chen, H; Mariano, EB; Zwick, MB; Parren, PWHI; Burton, DR; Wrin, T; Petropoulos, CJ; Ballantyne, JA; Chambers, M; Whalen, RG				Du, Sean X.; Xu, Li; Zhang, Wenge; Tang, Susan; Boenig, Rebecca I.; Chen, Helen; Mariano, Ellaine B.; Zwick, Michael B.; Parren, Paul W. H. I.; Burton, Dennis R.; Wrin, Terri; Petropoulos, Christos J.; Ballantyne, John A.; Chambers, Michael; Whalen, Robert G.			A Directed Molecular Evolution Approach to Improved Immunogenicity of the HIV-1 Envelope Glycoprotein	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODY-RESPONSES; HUMAN MONOCLONAL-ANTIBODIES; CD4 BINDING-SITE; SUBTYPE-B; GP120; VACCINE; PROTEIN; COMPLEX; MACAQUES	A prophylactic vaccine is needed to slow the spread of HIV-1 infection. Optimization of the wild-type envelope glycoproteins to create immunogens that can elicit effective neutralizing antibodies is a high priority. Starting with ten genes encoding subtype B HIV-1 gp120 envelope glycoproteins and using in vitro homologous DNA recombination, we created chimeric gp120 variants that were screened for their ability to bind neutralizing monoclonal antibodies. Hundreds of variants were identified with novel antigenic phenotypes that exhibit considerable sequence diversity. Immunization of rabbits with these gp120 variants demonstrated that the majority can induce neutralizing antibodies to HIV-1. One novel variant, called ST-008, induced significantly improved neutralizing antibody responses when assayed against a large panel of primary HIV-1 isolates. Further study of various deletion constructs of ST-008 showed that the enhanced immunogenicity results from a combination of effective DNA priming, an enhanced V3-based response, and an improved response to the constant backbone sequences.	[Du, Sean X.; Xu, Li; Zhang, Wenge; Tang, Susan; Boenig, Rebecca I.; Chen, Helen; Mariano, Ellaine B.; Whalen, Robert G.] Maxygen Inc, Dept Infect Dis, Redwood City, CA USA; [Zwick, Michael B.; Parren, Paul W. H. I.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp, MIT, Boston, MA USA; [Burton, Dennis R.] Harvard, Boston, MA USA; [Wrin, Terri; Petropoulos, Christos J.] Monogram Biosci, San Francisco, CA USA; [Ballantyne, John A.; Chambers, Michael] Aldevron LLC, Fargo, ND USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Du, SX (corresponding author), Simcere Pharmaceut Grp, Nanjing, Peoples R China.	robert.whalen@altravax.com		Parren, Paul/0000-0002-4365-3859	NIH [P01 AI56375]; DOD [W9113M-05-C-0198]; Double Bottom Line Ventures; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056375, R01AI033292] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Double Bottom Line Ventures; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the NIH (P01 AI56375), DOD (contract W9113M-05-C-0198), and Double Bottom Line Ventures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Bacher JM, 2002, GENOME BIOL, V3; BARBAS CF, 1993, J MOL BIOL, V230, P812, DOI 10.1006/jmbi.1993.1203; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Beddows S, 2005, J VIROL, V79, P8812, DOI 10.1128/JVI.79.14.8812-8827.2005; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bojang K, 2009, HUM VACCINES, V5, P242, DOI 10.4161/hv.5.4.7050; Brideau-Andersen AD, 2007, P NATL ACAD SCI USA, V104, P8269, DOI 10.1073/pnas.0609001104; Carotenuto P, 1998, AIDS, V12, P1591, DOI 10.1097/00002030-199813000-00005; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; Du SX, 2008, PROTEIN EXPRES PURIF, V59, P223, DOI 10.1016/j.pep.2008.02.002; Du SX, 2009, VIROLOGY, V395, P33, DOI 10.1016/j.virol.2009.07.042; Dupuy LC, 2009, VACCINE, V27, P4152, DOI 10.1016/j.vaccine.2009.04.049; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Grundner C, 2004, VIROLOGY, V330, P233, DOI 10.1016/j.virol.2004.08.037; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Hammonds J, 2005, J VIROL, V79, P14804, DOI 10.1128/JVI.79.23.14804-14814.2005; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Kang Y, 2009, VACCINE, V27, P5120, DOI 10.1016/j.vaccine.2009.06.037; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Kurtzman AL, 2001, CURR OPIN BIOTECH, V12, P361, DOI 10.1016/S0958-1669(00)00228-7; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lazetic S, 2002, J BIOL CHEM, V277, P38660, DOI 10.1074/jbc.M205808200; Leong SR, 2003, P NATL ACAD SCI USA, V100, P1163, DOI 10.1073/pnas.0237327100; Li Y, 2008, J VIROL, V82, P638, DOI 10.1128/JVI.01691-07; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2003, CURR MOL MED, V3, P209, DOI 10.2174/1566524033479799; Minshull J, 2004, METHODS, V32, P416, DOI 10.1016/j.ymeth.2003.10.004; Morner A, 2009, J VIROL, V83, P540, DOI 10.1128/JVI.01102-08; Mooij P, 1998, AIDS, V12, pF15, DOI 10.1097/00002030-199805000-00002; Ness JE, 2002, NAT BIOTECHNOL, V20, P1251, DOI 10.1038/nbt754; Nishimura Y, 2002, J VIROL, V76, P2123, DOI 10.1128/jvi.76.5.2123-2130.2002; PANCERA M, 2010, J VIROL; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2003, J VIROL, V77, P5889, DOI 10.1128/JVI.77.10.5889-5901.2003; Pilgrim AK, 1997, J INFECT DIS, V176, P924, DOI 10.1086/516508; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Selvarajah S, 2008, AIDS RES HUM RETROV, V24, P301, DOI 10.1089/aid.2007.0158; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Srivastava IK, 2005, HUM VACCINES, V1, P45, DOI 10.4161/hv.1.2.1764; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang S, 2008, VACCINE, V26, P1098, DOI 10.1016/j.vaccine.2007.12.024; Wang SX, 2006, VIROLOGY, V350, P34, DOI 10.1016/j.virol.2006.02.032; Weaver EA, 2006, J VIROL, V80, P6745, DOI 10.1128/JVI.02484-05; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; Yang XZ, 2001, J VIROL, V75, P1165, DOI 10.1128/JVI.75.3.1165-1171.2001; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; 2003, EXPERT REV ANTI INFE, V1, P527	87	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20927	10.1371/journal.pone.0020927	http://dx.doi.org/10.1371/journal.pone.0020927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738594	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100009
J	Lai, CY; Yu, SL; Hsieh, MH; Chen, CH; Chen, HY; Wen, CC; Huang, YH; Hsiao, PC; Hsiao, CK; Liu, CM; Yang, PC; Hwu, HG; Chen, WJ				Lai, Chi-Yu; Yu, Sung-Liang; Hsieh, Ming H.; Chen, Chun-Houh; Chen, Hsuan-Yu; Wen, Chun-Chiang; Huang, Yung-Hsiang; Hsiao, Po-Chang; Hsiao, Chuhsing Kate; Liu, Chih-Min; Yang, Pan-Chyr; Hwu, Hai-Gwo; Chen, Wei J.			MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia	PLOS ONE			English	Article							CONTINUOUS PERFORMANCE-TEST; GENE-EXPRESSION; PREFRONTAL CORTEX; MONONUCLEAR-CELLS; BRAIN; IDENTIFICATION; INDIVIDUALS; DEFICITS; CLASSIFICATION; DYSREGULATION	Since brain tissue is not readily accessible, a new focus in search of biomarkers for schizophrenia is blood-based expression profiling of non-protein coding genes such as microRNAs (miRNAs), which regulate gene expression by inhibiting the translation of messenger RNAs. This study aimed to identify potential miRNA signature for schizophrenia by comparing genome-wide miRNA expression profiles in patients with schizophrenia vs. healthy controls. A genome-wide miRNA expression profiling was performed using a Taqman array of 365 human miRNAs in the mononuclear leukocytes of a learning set of 30 cases and 30 controls. The discriminating performance of potential biomarkers was validated in an independent testing set of 60 cases and 30 controls. The expression levels of the miRNA signature were then evaluated for their correlation with the patients' clinical symptoms, neurocognitive performances, and neurophysiological functions. A seven-miRNA signature (hsa-miR-34a, miR-449a, miR-564, miR-432, miR-548d, miR-572 and miR-652) was derived from a supervised classification with internal cross-validation, with an area under the curve (AUC) of receiver operating characteristics of 93%. The putative signature was then validated in the testing set, with an AUC of 85%. Among these miRNAs, miR-34a was differentially expressed between cases and controls in both the learning (P = 0.005) and the testing set (P = 0.002). These miRNAs were differentially correlated with patients' negative symptoms, neurocognitive performance scores, and event-related potentials. The results indicated that the mononuclear leukocyte-based miRNA profiling is a feasible way to identify biomarkers for schizophrenia, and the seven-miRNA signature warrants further investigation.	[Lai, Chi-Yu; Huang, Yung-Hsiang; Hsiao, Chuhsing Kate; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yu, Sung-Liang; Chen, Hsuan-Yu; Hsiao, Po-Chang; Hsiao, Chuhsing Kate; Yang, Pan-Chyr; Chen, Wei J.] Natl Taiwan Univ, Ctr Genom Med, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Hsieh, Ming H.; Wen, Chun-Chiang; Liu, Chih-Min; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei 10764, Taiwan; [Hsieh, Ming H.; Wen, Chun-Chiang; Liu, Chih-Min; Yang, Pan-Chyr; Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Chen, Chun-Houh; Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Hwu, Hai-Gwo; Chen, Wei J.] Natl Taiwan Univ, Neurobiol & Cognit Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Lai, CY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wjchen@ntu.edu.tw	Chen, Hsuan-Yu/AAE-8428-2019; Chen, Chun-houh/AAP-2640-2021; Hsieh, Ming H./B-2970-2010	Chen, Chun-houh/0000-0003-0899-7477; HWU, HAI-GWO/0000-0002-2582-2807; Hsiao, Po-Chang/0000-0002-5813-3389; Chen, Wei Jen/0000-0001-5899-5870; LIU, CHIH-MIN/0000-0001-7016-8990; YANG, PAN-CHYR/0000-0001-6330-6048; Hsieh, Ming H./0000-0002-3585-7843; YU, SUNG-LIANG/0000-0003-4535-9036; hsiao, chuhsing kate/0000-0003-4905-8484	National Taiwan University [97R0337, 97HP0023, 97HP0071]; National Science Council, Taiwan [NSC98-2314-B-002-125-MY3]; National Health Research Institutes, Taiwan [NHRI-EX99-9511PP]	National Taiwan University(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants from National Taiwan University (97R0337, 97HP0023 and 97HP0071), the National Science Council, Taiwan (NSC98-2314-B-002-125-MY3), and the National Health Research Institutes, Taiwan (NHRI-EX99-9511PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Chang CJ, 2002, SCHIZOPHRENIA BULL, V28, P379, DOI 10.1093/oxfordjournals.schbul.a006947; Chen WJ, 1998, SCHIZOPHRENIA BULL, V24, P163, DOI 10.1093/oxfordjournals.schbul.a033308; Chen WJ, 1998, AM J PSYCHIAT, V155, P1214, DOI 10.1176/ajp.155.9.1214; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng J. J., 1996, CHINESE PSYCHIAT, V10, P251; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Conde-Agudelo A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.064; Coyle JT, 2009, P NATL ACAD SCI USA, V106, P2975, DOI 10.1073/pnas.0813321106; Dwivedi Y, 2009, INT J NEUROPSYCHOPH, V12, P1337, DOI 10.1017/S1461145709990575; Freedman R, 1996, ARCH GEN PSYCHIAT, V53, P1114; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Glatt SJ, 2009, MOL PSYCHIATR, V14, P885, DOI 10.1038/mp.2008.30; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hassan SS, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.016; HEATON RK, WISCONSIN CARD SORTI; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Joyce EM, 2007, CURR OPIN PSYCHIATR, V20, P268; Kay S.R., 1991, POSITIVE NEGATIVE SY; Kerns D, 2010, SCHIZOPHR RES, V120, P150, DOI 10.1016/j.schres.2010.04.012; Keshavan MS, 2008, SCHIZOPHR RES, V106, P89, DOI 10.1016/j.schres.2008.07.020; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuzman MR, 2009, J PSYCHIATR RES, V43, P1073, DOI 10.1016/j.jpsychires.2009.03.005; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Lin CCH, 2000, J CLIN EXP NEUROPSYC, V22, P69, DOI 10.1076/1380-3395(200002)22:1;1-8;FT069; Liu L, 2010, PSYCHIAT RES, V176, P1, DOI 10.1016/j.psychres.2008.10.024; Liu SK, 1997, SCHIZOPHR RES, V25, P211, DOI 10.1016/S0920-9964(97)00026-1; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; *MAMI, MAMI MET PRED MICROR; Marazziti D, 2010, PSYCHIAT RES, V175, P54, DOI 10.1016/j.psychres.2009.03.009; Marques-Deak A, 2005, MOL PSYCHIATR, V10, P239, DOI 10.1038/sj.mp.4001643; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Miller BH, 2010, BRAIN RES, V1338, P89, DOI 10.1016/j.brainres.2010.03.035; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Ozdemir V, 2006, NAT BIOTECHNOL, V24, P942, DOI 10.1038/nbt0806-942; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Perkins DO, 2005, MOL PSYCHIATR, V10, P69, DOI 10.1038/sj.mp.4001577; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Schwarz E, 2008, BRIT J PHARMACOL, V153, pS133, DOI 10.1038/sj.bjp.0707658; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shibata H, 2009, PSYCHIAT RES, V167, P88, DOI 10.1016/j.psychres.2007.12.002; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tamminga CA, 2005, MOL PSYCHIATR, V10, P27, DOI 10.1038/sj.mp.4001563; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; van Heerden Johan H, 2009, BMC Res Notes, V2, P195, DOI 10.1186/1756-0500-2-195; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vawter MP, 2004, SCHIZOPHR RES, V67, P41, DOI 10.1016/S0920-9964(03)00151-8; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wu HM, 2010, COMPUT STAT DATA AN, V54, P767, DOI 10.1016/j.csda.2008.09.029; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yao YR, 2008, J PSYCHIATR RES, V42, P639, DOI 10.1016/j.jpsychires.2007.07.011; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131	74	174	190	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21635	10.1371/journal.pone.0021635	http://dx.doi.org/10.1371/journal.pone.0021635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738743	Green Submitted, gold, Green Published			2022-12-25	WOS:000292290100050
J	Yuan, Q; Isaacson, JS; Scanziani, M				Yuan, Qi; Isaacson, Jeffry S.; Scanziani, Massimo			Linking Neuronal Ensembles by Associative Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PLACE CELLS; HIPPOCAMPUS; MEMORY; CORTEX; SYSTEM; CODE; CA1	Synchronized activity in ensembles of neurons recruited by excitatory afferents is thought to contribute to the coding information in the brain. However, the mechanisms by which neuronal ensembles are generated and modified are not known. Here we show that in rat hippocampal slices associative synaptic plasticity enables ensembles of neurons to change by incorporating neurons belonging to different ensembles. Associative synaptic plasticity redistributes the composition of different ensembles recruited by distinct inputs such as to specifically increase the similarity between the ensembles. These results show that in the hippocampus, the ensemble of neurons recruited by a given afferent projection is fluid and can be rapidly and persistently modified to specifically include neurons from different ensembles. This linking of ensembles may contribute to the formation of associative memories.	[Yuan, Qi; Scanziani, Massimo] Univ Calif San Diego, Dept Neurobiol, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Yuan, Qi; Isaacson, Jeffry S.; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Yuan, Q (corresponding author), Univ Calif San Diego, Dept Neurobiol, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA.	massimo@ucsd.edu			NIDCD [R01 DC04682]; HHMI; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004682] Funding Source: NIH RePORTER	NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIDCD R01 DC04682 (JSI) and HHMI (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Hebb Donald O., 1949, ORG BEHAV; Heynen AJ, 1996, NATURE, V381, P163, DOI 10.1038/381163a0; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	16	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20486	10.1371/journal.pone.0020486	http://dx.doi.org/10.1371/journal.pone.0020486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738576	Green Published, gold			2022-12-25	WOS:000292290100003
J	Amaral, EP; Kipnis, TL; de Carvalho, ECQ; da Silva, WD; Leao, SC; Lasunskaia, EB				Amaral, Eduardo Pinheiro; Kipnis, Thereza Liberman; Queiroz de Carvalho, Eulogio Carlos; da Silva, Wilmar Dias; Leao, Sylvia Cardoso; Lasunskaia, Elena B.			Difference in Virulence of Mycobacterium avium Isolates Sharing Indistinguishable DNA Fingerprint Determined in Murine Model of Lung Infection	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; NUMBER TANDEM-REPEAT; SUBSP HOMINISSUIS; INDUCTION; COMPLEX; IS1245; IDENTIFICATION; MACROPHAGES; RESISTANCE; DIVERSITY	Background: Opportunistic Mycobacterium avium typically causes disease in immunocompromised patients and in some groups of apparently healthy individuals. The high virulence of some bacterial lineages increases the disease risk. High-resolution molecular genotyping studies of M. avium clinical isolates demonstrated that some genotype patterns were more prevalent than others, suggesting that close genetic relatedness of these successful isolates sharing a similar genotype could determine similar biological properties associated with high virulence. Methods and Findings: In this study, we aimed to compare the virulence and pathogenic properties of two epidemiologically unrelated M. avium isolates sharing an indistinguishable DNA fingerprint in a well-characterized model of pulmonary infection in mice, resistant or susceptible to mycobacteria. The mice, C57BL/6 wild-type or IFN-gamma gene disrupted (GKO), respectively, were intratracheally infected with two isolates, H27 (human blood isolate) and P104 (pig lymph node isolate), and the lungs were examined for bacterial loads, histopathology and cytokine gene expression. The obtained data demonstrated significant differences in the virulence properties of these strains. Although the H27 strain grew significantly faster than P104 in the early stage of infection, this bacterium induced protective immunity that started to reduce bacterial numbers in the wild-type mice, whereas the P104 strain established a chronic infection. In the GKO mice, both strains were capable of causing a chronic infection, associated with higher bacterial burdens and severe lung pathology, in a similar manner. Conclusions/Significance: The results demonstrated that the studied isolates differed in the pathogenic properties although were indistinguishable by actually widely used genotyping techniques demonstrating that the genotype similarity does not predict similarity in virulence of M. avium isolates.	[Amaral, Eduardo Pinheiro; Kipnis, Thereza Liberman; Lasunskaia, Elena B.] Univ Estadual Norte Fluminense, Lab Biol Recognit, Rio De Janeiro, Brazil; [Queiroz de Carvalho, Eulogio Carlos] Univ Estadual Norte Fluminense, Lab Anim Morphol & Pathol, Rio De Janeiro, Brazil; [da Silva, Wilmar Dias] Inst Butantan, Lab Immunochem, Sao Paulo, Brazil; [Leao, Sylvia Cardoso] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP)	Amaral, EP (corresponding author), Univ Estadual Norte Fluminense, Lab Biol Recognit, Rio De Janeiro, Brazil.	elena@uenf.br	Amaral, Eduardo EP/M-2456-2014; Lasunskaia, Elena/M-6259-2019; Leao, Sylvia/F-4431-2012; Dias da Silva, Wilmar/I-6549-2015; Lasunskaia, Elena B/J-6691-2014; Leao, Sylvia/O-9637-2016	Amaral, Eduardo EP/0000-0001-5465-8113; Lasunskaia, Elena/0000-0002-6726-273X; Leao, Sylvia/0000-0003-2083-0119; Lasunskaia, Elena B/0000-0002-6726-273X; Leao, Sylvia/0000-0003-2083-0119; Dias da Silva, Wilmar/0000-0001-5109-3081	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ [E-26/111.6111]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/MCT/DECIT [410555]; CNPq	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/MCT/DECIT(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by grants to EL from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ (E-26/111.6111, www.faperj.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq/MCT/DECIT (410555, www.mct.gov.br). EPA was supported by an award from CNPq. WDS was supported by an award from FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2007, J PATHOL, V212, P295, DOI 10.1002/path.2185; Bartos M, 2006, J MICROBIOL METH, V64, P333, DOI 10.1016/j.mimet.2005.05.009; BENSON C, 1994, AIDS RES HUM RETROV, V10, P913, DOI 10.1089/aid.1994.10.913; Blumenthal A, 2005, INFECT IMMUN, V73, P3330, DOI 10.1128/IAI.73.6.3330-3341.2005; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; Dhillon SS, 2000, CLIN INFECT DIS, V30, P572, DOI 10.1086/313726; Field SK, 2006, CHEST, V129, P1653, DOI 10.1378/chest.129.6.1653; Florido M, 2006, IMMUNOLOGY, V118, P122, DOI 10.1111/j.1365-2567.2006.02350.x; Florido M, 2004, IMMUNOLOGY, V111, P323, DOI 10.1111/j.1365-2567.2004.01812.x; Florido M, 1999, INFECT IMMUN, V67, P3610; Florido M, 2005, INFECT IMMUN, V73, P3577, DOI 10.1128/IAI.73.6.3577-3586.2005; Horan KL, 2006, J CLIN MICROBIOL, V44, P783, DOI 10.1128/JCM.44.3.783-789.2006; Hussain S, 1999, J IMMUNOL, V163, P2041; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Krzywinska E, 2004, MICROBIOL-SGM, V150, P1707, DOI 10.1099/mic.0.27088-0; Mijs W, 2002, INT J SYST EVOL MICR, V52, P1505, DOI 10.1099/00207713-52-5-1505; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Oliveira RS, 2003, J CLIN MICROBIOL, V41, P44, DOI 10.1128/JCM.41.1.44-49.2003; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Pearl JE, 2001, CELL IMMUNOL, V211, P43, DOI 10.1006/cimm.2001.1819; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porter JDH, 1996, J ANTIMICROB CHEMOTH, V37, P113, DOI 10.1093/jac/37.suppl_B.113; PRINCE DS, 1989, NEW ENGL J MED, V321, P863, DOI 10.1056/NEJM198909283211304; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Radomski N, 2010, J CLIN MICROBIOL, V48, P1026, DOI 10.1128/JCM.01869-09; Remus N, 2001, PEDIATR RES, V50, P8, DOI 10.1203/00006450-200107000-00005; Ritacco V, 1998, INT J TUBERC LUNG D, V2, P242; Sambrook J, 2001, MOL CLONING LAB MANU; Tateishi Y, 2009, MICROB PATHOGENESIS, V46, P6, DOI 10.1016/j.micpath.2008.10.007; Tirkkonen T, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-21; Turenne CY, 2008, J BACTERIOL, V190, P2479, DOI 10.1128/JB.01691-07; Turenne CY, 2007, CLIN MICROBIOL REV, V20, P205, DOI 10.1128/CMR.00036-06; Van Soolingen D, 1998, J CLIN MICROBIOL, V36, P3051, DOI 10.1128/JCM.36.10.3051-3054.1998; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21673	10.1371/journal.pone.0021673	http://dx.doi.org/10.1371/journal.pone.0021673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738761	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800057
J	Lichten, LA; Ryu, MS; Guo, L; Embury, J; Cousins, RJ				Lichten, Louis A.; Ryu, Moon-Suhn; Guo, Liang; Embury, Jennifer; Cousins, Robert J.			MTF-1-Mediated Repression of the Zinc Transporter Zip10 Is Alleviated by Zinc Restriction	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; TRACE-ELEMENTS; MAMMALIAN ZINC; MOUSE; GENE; EXPRESSION; BRAIN; PROMOTER; REGIONS; CANCER	The regulation of cellular zinc uptake is a key process in the overall mechanism governing mammalian zinc homeostasis and how zinc participates in cellular functions. We analyzed the zinc transporters of the Zip family in both the brain and liver of zinc-deficient animals and found a large, significant increase in Zip10 expression. Additionally, Zip10 expression decreased in response to zinc repletion. Moreover, isolated mouse hepatocytes, AML12 hepatocytes, and Neuro 2A cells also respond differentially to zinc availability in vitro. Measurement of Zip10 hnRNA and actinomycin D inhibition studies indicate that Zip10 was transcriptionally regulated by zinc deficiency. Through luciferase promoter constructs and ChIP analysis, binding of MTF-1 to a metal response element located 17 bp downstream of the transcription start site was shown to be necessary for zinc-induced repression of Zip10. Furthermore, zinc-activated MTF-1 causes down-regulation of Zip10 transcription by physically blocking Pol II movement through the gene. Lastly, ZIP10 is localized to the plasma membrane of hepatocytes and neuro 2A cells. Collectively, these results reveal a novel repressive role for MTF-1 in the regulation of the Zip10 zinc transporter expression by pausing Pol II transcription. ZIP10 may have roles in control of zinc homeostasis in specific sites particularly those of the brain and liver. Within that context ZIP10 may act as an important survival mechanism during periods of zinc inadequacy.	[Lichten, Louis A.; Ryu, Moon-Suhn; Guo, Liang; Cousins, Robert J.] Univ Florida, Dept Food Sci & Human Nutr, Coll Agr & Life Sci, Ctr Nutr Sci, Gainesville, FL 32611 USA; [Embury, Jennifer; Cousins, Robert J.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lichten, LA (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Coll Agr & Life Sci, Ctr Nutr Sci, Gainesville, FL 32611 USA.	cousins@ufl.edu		Ryu, Moon-Suhn/0000-0002-9533-9263; Guo, Liang/0000-0003-1633-1544	National Institute of Health [DK31127]; CALS Alumni Fellowships; University of Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031127, R01DK031127, R37DK031127, R56DK031127] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CALS Alumni Fellowships; University of Florida(University of Florida); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research described in this report was funded by National Institute of Health Grant DK31127 (RJC), CALS Alumni Fellowships (LAL and M-SR) and limited support from Boston Family Endowment Funds of the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen L, 2006, NEUROSCI LETT, V409, P163, DOI 10.1016/j.neulet.2006.09.033; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Ehsani S, 2011, PROG NEUROBIOL, V93, P405, DOI 10.1016/j.pneurobio.2010.12.001; EIDE, 2006, BIOCHIM BIOPHYS ACTA, P711; Embury JE, 2005, PEDIATR RES, V58, P283, DOI 10.1203/01.PDR.0000170000.78670.44; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; Guo L, 2010, P NATL ACAD SCI USA, V107, P2818, DOI 10.1073/pnas.0914941107; Hogstrand C, 2008, BIOCHEM SOC T, V36, P1252, DOI 10.1042/BST0361252; Kagara N, 2007, CANCER SCI, V98, P692, DOI 10.1111/j.1349-7006.2007.00446.x; KING JC, 2005, MODERN NUTR HLTH DIS, P271; Langmade SJ, 2000, J BIOL CHEM, V275, P34803, DOI 10.1074/jbc.M007339200; Lichten LA, 2007, FASEB J, V21, pA170; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lichten LA, 2009, AM J PHYSIOL-GASTR L, V296, pG860, DOI 10.1152/ajpgi.90676.2008; Lichtlen P, 2001, NUCLEIC ACIDS RES, V29, P1514, DOI 10.1093/nar/29.7.1514; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P9774, DOI 10.1073/pnas.86.24.9774; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Liuzzi JP, 2004, P NATL ACAD SCI USA, V101, P14355, DOI 10.1073/pnas.0406216101; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; MARGALIOTH EJ, 1983, CANCER, V52, P868, DOI 10.1002/1097-0142(19830901)52:5<868::AID-CNCR2820520521>3.0.CO;2-K; MCCABE MJ, 1993, LAB INVEST, V69, P101; McMahon RJ, 1998, P NATL ACAD SCI USA, V95, P4841, DOI 10.1073/pnas.95.9.4841; OLIN KL, 1995, AM J CLIN NUTR, V61, P1263, DOI 10.1093/ajcn/61.6.1263; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; PROHASKA JR, 1987, PHYSIOL REV, V67, P858, DOI 10.1152/physrev.1987.67.3.858; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; Ryu MS, 2008, J NUTR, V138, P2076, DOI 10.3945/jn.108.093575; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; SCHWARTZ AE, 1974, SURGERY, V76, P325; Searle P F, 1987, Experientia Suppl, V52, P407; Shagal D I, 1980, Med Tekh, P32; Stoytcheva ZR, 2010, BBA-GEN SUBJECTS, V1800, P416, DOI 10.1016/j.bbagen.2009.11.003; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Takeda A, 2000, BRAIN RES, V859, P352, DOI 10.1016/S0006-8993(00)02027-8; Tarohda T, 2004, ANAL BIOANAL CHEM, V380, P240, DOI 10.1007/s00216-004-2697-8; Taylor KM, 2004, TRENDS ENDOCRIN MET, V15, P461, DOI 10.1016/j.tem.2004.10.003; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; WALLWORK JC, 1983, J NUTR, V113, P1895, DOI 10.1093/jn/113.10.1895; Wang MH, 2010, MAMM GENOME, V21, P287, DOI 10.1007/s00335-010-9257-7; Watt NT, 2003, TRENDS BIOCHEM SCI, V28, P406, DOI 10.1016/S0968-0004(03)00166-X; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; XIAO H, 1989, MOL CELL BIOL, V9, P1746, DOI 10.1128/MCB.9.4.1746; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zheng DL, 2008, PHYSIOL GENOMICS, V34, P205, DOI 10.1152/physiolgenomics.90206.2008	53	83	85	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21526	10.1371/journal.pone.0021526	http://dx.doi.org/10.1371/journal.pone.0021526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738690	gold, Green Published, Green Submitted			2022-12-25	WOS:000292092600050
J	Proulx-Bonneau, S; Guezguez, A; Annabi, B				Proulx-Bonneau, Sebastien; Guezguez, Amel; Annabi, Borhane			A Concerted HIF-1 alpha/MT1-MMP Signalling Axis Regulates the Expression of the 3BP2 Adaptor Protein in Hypoxic Mesenchymal Stromal Cells	PLOS ONE			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; GLIOBLASTOMA CELLS; GLUCOSE-6-PHOSPHATE TRANSPORTER; INDUCIBLE FACTOR; GENE-EXPRESSION; UP-REGULATION; GLIOMA-CELLS; TUMOR-GROWTH	Increased plasticity, migratory and immunosuppressive abilities characterize mesenchymal stromal cells (MSC) which enable them to be active participants in the development of hypoxic solid tumours. Our understanding of the oncogenic adaptation of MSC to hypoxia however lacks the identification and characterization of specific biomarkers. In this study, we assessed the hypoxic regulation of 3BP2/SH3BP2 (Abl SH3-binding protein 2), an immune response adaptor/scaffold protein which regulates leukocyte differentiation and motility. Gene silencing of 3BP2 abrogated MSC migration in response to hypoxic cues and generation of MSC stably expressing the transcription factor hypoxia inducible factor 1alpha (HIF-1 alpha) resulted in increased endogenous 3BP2 expression as well as cell migration. Analysis of the 3BP2 promoter sequence revealed only one potential HIF-1 alpha binding site within the human but none in the murine sequence. An alternate early signalling cascade that regulated 3BP2 expression was found to involve membrane type-1 matrix metalloproteinase (MT1-MMP) transcriptional regulation which gene silencing abrogated 3BP2 expression in response to hypoxia. Collectively, we provide evidence for a concerted HIF-1 alpha/MT1-MMP signalling axis that explains the induction of adaptor protein 3BP2 and which may link protein binding partners together and stimulate oncogenic MSC migration. These mechanistic observations support the potential for malignant transformation of MSC within hypoxic tumour stroma and may contribute to evasion of the immune system by a tumour.	[Proulx-Bonneau, Sebastien; Guezguez, Amel; Annabi, Borhane] Univ Quebec, Dept Chim, Ctr Rech BIOMED, Oncol Mol Lab, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Proulx-Bonneau, S (corresponding author), Univ Quebec, Dept Chim, Ctr Rech BIOMED, Oncol Mol Lab, Montreal, PQ H3C 3P8, Canada.	annabi.borhane@uqam.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [288249-2010]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC; #288249-2010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annabi B, 2005, J NEUROCHEM, V94, P906, DOI 10.1111/j.1471-4159.2005.03256.x; Annabi B, 2004, J BIOL CHEM, V279, P21888, DOI 10.1074/jbc.M313694200; Annabi B, 2003, EXP HEMATOL, V31, P640, DOI 10.1016/S0301-472X(03)00090-0; Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; Annabi B, 2004, J CELL BIOCHEM, V91, P1146, DOI 10.1002/jcb.10763; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Batten P, 2007, PHILOS T R SOC B, V362, P1343, DOI 10.1098/rstb.2007.2120; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Belkaid A, 2007, NEOPLASIA, V9, P332, DOI 10.1593/neo.07142; Belkaid A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-7; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Currie JC, 2007, J BIOL CHEM, V282, P8142, DOI 10.1074/jbc.M610894200; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Deryugina EI, 2002, CANCER RES, V62, P580; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Fortier S, 2008, FEBS LETT, V582, P799, DOI 10.1016/j.febslet.2008.01.061; Fortier S, 2008, GLYCOBIOLOGY, V18, P195, DOI 10.1093/glycob/cwm133; Gingras D, 2008, FEBS LETT, V582, P399, DOI 10.1016/j.febslet.2007.12.029; GRIGORIADIS N, 2011, EXP NEUROL IN PRESS; GuezGuez A, 2010, J BIOL CHEM, V285, P20952, DOI 10.1074/jbc.M109.091124; Haas TL, 1999, J BIOL CHEM, V274, P22679, DOI 10.1074/jbc.274.32.22679; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Karow M, 2009, J CELL MOL MED, V13, P2506, DOI 10.1111/j.1582-4934.2008.00619.x; Kaufman DS, 2010, NAT CELL BIOL, V12, P926, DOI 10.1038/ncb1010-926; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Koh MY, 2010, RECENT RESULTS CANC, V180, P15, DOI 10.1007/978-3-540-78281-0_3; Koong AC, 2000, CANCER RES, V60, P883; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Langlois S, 2005, EXP CELL RES, V307, P452, DOI 10.1016/j.yexcr.2005.04.007; Le Bras S, 2007, FEBS LETT, V581, P967, DOI 10.1016/j.febslet.2007.01.084; Liu G, 2010, J IMMUNOL, V184, P3346, DOI 10.4049/jimmunol.0903789; Liu L, 2011, STEM CELLS IN PRESS; Lord-Dufour S, 2009, STEM CELLS, V27, P489, DOI 10.1634/stemcells.2008-0855; Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Oliver L, 2009, Curr Mol Pharmacol, V2, P263; Perasso L, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/534925; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279; Rattigan Y, 2010, EXP CELL RES, V316, P3417, DOI 10.1016/j.yexcr.2010.07.002; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Schichor C, 2006, EXP NEUROL, V199, P301, DOI 10.1016/j.expneurol.2005.11.027; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; Sina A, 2010, J CELL COMMUN SIGNAL, V4, P31, DOI 10.1007/s12079-009-0084-0; SNYDER EY, 2011, EXP NEUROL IN PRESS; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Sperandio S, 2009, MOL CARCINOGEN, V48, P38, DOI 10.1002/mc.20454; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Studeny M, 2002, CANCER RES, V62, P3603; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Yen BL, 2008, J CANC MOL, V4, P5; Zhang Y, 2011, MOL BIOL RE IN PRESS	69	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21511	10.1371/journal.pone.0021511	http://dx.doi.org/10.1371/journal.pone.0021511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738685	gold, Green Submitted, Green Published			2022-12-25	WOS:000292092600047
J	Sanchez-Partida, LG; Kelly, RDW; Sumer, H; Lo, CY; Aharon, R; Holland, MK; O'Bryan, MK; St John, JC				Sanchez-Partida, L. Gabriel; Kelly, Richard D. W.; Sumer, Huseyin; Lo, Camden Y.; Aharon, Rotem; Holland, Michael K.; O'Bryan, Moira K.; St John, Justin C.			The Generation of Live Offspring from Vitrified Oocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INTRACYTOPLASMIC SPERM INJECTION; MITOCHONDRIAL-DNA REPLICATION; MOUSE OOCYTES; LIQUID-NITROGEN; VIABLE BLASTOCYSTS; NUCLEAR TRANSFER; BOVINE OOCYTES; CRYOPRESERVATION; TREHALOSE	Oocyte cryopreservation is extremely beneficial for assisted reproductive technologies, the treatment of infertility and biotechnology and offers a viable alternative to embryo freezing and ovarian grafting approaches for the generation of embryonic stem cells and live offspring. It also offers the potential to store oocytes to rescue endangered species by somatic cell nuclear transfer and for the generation of embryonic stem cells to study development in these species. We vitrified mouse oocytes using a range of concentrations of trehalose (0 to 0.3 M) and demonstrated that 0.1 and 0.3 M trehalose had similar developmental rates, which were significantly different to the 0.2 M cohort (P < 0.05). As mitochondria are important for fertilisation outcome, we observed that the clustering and distribution of mitochondria of the 0.2 M cohort were more affected by vitifrication than the other groups. Nevertheless, all 3 cohorts were able to develop to blastocyst, following in vitro fertilisation, although developmental rates were better for the 0.1 and 0.3 M cohorts than the 0.2 M cohort (P < 0.05). Whilst blastocysts gave rise to embryonic stem-like cells, it was apparent from immunocytochemistry and RT-PCR that these cells did not demonstrate true pluripotency and exhibited abnormal karyotypes. However, they gave rise to teratomas following injection into SCID mice and differentiated into cells of each of the germinal layers following in vitro differentiation. The transfer of 2-cell embryos from the 0.1 and 0.3 M cohorts resulted in the birth of live offspring that had normal karyotypes (9/10). When 2-cell embryos from vitrified oocytes underwent vitrification, and were thawed and transferred, live offspring were obtained that exhibited normal karyotypes, with the exception of one offspring who was larger and died at 7 months. We conclude that these studies highlight the importance of the endometrial environment for the maintenance of genetic stability and thus the propagation of specific genetic traits.	[Sanchez-Partida, L. Gabriel; Kelly, Richard D. W.; Sumer, Huseyin; St John, Justin C.] Monash Univ, Ctr Reprod & Dev, Monash Inst Med Res, Clayton, Vic 3800, Australia; [Sanchez-Partida, L. Gabriel] Monash Univ, Australian Phen Network, Clayton, Vic 3800, Australia; [Kelly, Richard D. W.; St John, Justin C.] Univ Warwick, Mitochondrial & Reprod Genet Grp, Clin Sci Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Lo, Camden Y.] Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia; [Aharon, Rotem] Monash Inst Med Res, Monash Micro Imaging MHTP, Clayton, Vic, Australia; [Holland, Michael K.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	Monash University; Monash University; University of Warwick; Monash University; Monash University; University of Queensland; Monash University	Sanchez-Partida, LG (corresponding author), Monash Univ, Ctr Reprod & Dev, Monash Inst Med Res, Clayton, Vic 3800, Australia.	justin.stjohn@monash.edu	Holland, Michael/AAS-5529-2021; Holland, Michael K/D-6911-2013; O'Bryan, Moira K/F-8256-2012; St. John, Justin C/A-2942-2010	Holland, Michael/0000-0003-0360-0098; Holland, Michael K/0000-0003-0360-0098; O'Bryan, Moira K/0000-0001-7298-4940; St. John, Jus/0000-0002-3993-1449; Lo, Camden/0000-0002-6215-2363; Sumer, Huseyin/0000-0001-9413-5579	Medical Research Council (UK); Australian Phenomics Network (an initiative of the Australian Government National Collaborative Research Infrastructure Strategy); Department of Education, Science and Technology, Australia; National Health and Medical Research Council	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Phenomics Network (an initiative of the Australian Government National Collaborative Research Infrastructure Strategy)(Australian GovernmentDepartment of Industry, Innovation and Science); Department of Education, Science and Technology, Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was partially funded by the Medical Research Council (UK) and the Australian Phenomics Network (an initiative of the Australian Government National Collaborative Research Infrastructure Strategy). JCSJ received an Endeavour Award (Department of Education, Science and Technology, Australia) to undertake this work. MKOB is the recipient of a National Health and Medical Research Council Fellowship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2005, BIOL REPROD, V72, P1416, DOI 10.1095/biolreprod.104.037051; Ambrosini G, 2006, REPROD TOXICOL, V22, P250, DOI 10.1016/j.reprotox.2006.04.024; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; BARRITT JA, 2001, REPROD BIOMED ONLINE, V3, P47; Bielanski A, 2000, CRYOBIOLOGY, V40, P110, DOI 10.1006/cryo.1999.2227; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; BOLTON VN, 1984, J EMBRYOL EXP MORPH, V79, P139; BOUQUET M, 1993, BIOL REPROD, V49, P764, DOI 10.1095/biolreprod49.4.764; Bowles EJ, 2007, CURR TOP DEV BIOL, V77, P251, DOI 10.1016/S0070-2153(06)77010-7; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cobo A, 2010, FERTIL STERIL, V94, P1903, DOI 10.1016/j.fertnstert.2009.10.042; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Coticchio G, 2004, EUR J OBSTET GYN R B, V115, pS2, DOI 10.1016/j.ejogrb.2004.01.006; CROWE LM, 1984, BIOCHIM BIOPHYS ACTA, V769, P141, DOI 10.1016/0005-2736(84)90017-8; Dinnyes A., 1995, Theriogenology, V43, P197, DOI 10.1016/0093-691X(95)92351-9; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551; Eroglu A, 2009, BIOL REPROD, V80, P70, DOI 10.1095/biolreprod.108.070383; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972; FOOTE RH, 1993, J DAIRY SCI, V76, P1908, DOI 10.3168/jds.S0022-0302(93)77524-4; Fountain D, 1997, TRANSFUSION, V37, P585, DOI 10.1046/j.1537-2995.1997.37697335152.x; FRASER LR, 1984, J REPROD FERTIL, V72, P373, DOI 10.1530/jrf.0.0720373; Gardner DK, 1997, HUM REPROD UPDATE, V3, P367, DOI 10.1093/humupd/3.4.367; Gutierrez-Perez O, 2009, CRYOBIOLOGY, V58, P287, DOI 10.1016/j.cryobiol.2009.02.003; HONADEL TE, 1988, CRYOBIOLOGY, V25, P331, DOI 10.1016/0011-2240(88)90041-7; Jain JK, 2006, FERTIL STERIL, V86, P1037, DOI 10.1016/j.fertnstert.2006.07.1478; KASAI M, 1980, J REPROD FERTIL, V59, P51, DOI 10.1530/jrf.0.0590051; KAZEM R, 1995, HUM REPROD, V10, P2650, DOI 10.1093/oxfordjournals.humrep.a135761; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Lacham-Kaplan O, 2003, BIOL REPROD, V69, P1683, DOI 10.1095/biolreprod.103.018184; Lane M, 2001, MOL REPROD DEV, V58, P342, DOI 10.1002/1098-2795(200103)58:3&lt;342::AID-MRD13&gt;3.0.CO;2-X; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Mavrides A, 2005, EUR J OBSTET GYN R B, V118, P66, DOI 10.1016/j.ejogrb.2004.06.025; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; Mullen SF, 2004, HUM REPROD, V19, P1148, DOI 10.1093/humrep/deh201; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Parmegiani L, 2010, FERTIL STERIL, V94, P1525, DOI 10.1016/j.fertnstert.2009.05.089; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Sanchez-Partida LG, 1998, REPROD FERT DEVELOP, V10, P347, DOI 10.1071/R98053; Sanchez-Partida LG, 2008, FERTIL STERIL, V89, P742, DOI 10.1016/j.fertnstert.2007.02.066; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; SATHANANTHAN AH, 1988, GAMETE RES, V21, P385, DOI 10.1002/mrd.1120210407; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Stachecki JJ, 2002, CRYOBIOLOGY, V44, P5, DOI 10.1016/S0011-2240(02)00007-X; Tao T, 2008, J ASSIST REPROD GEN, V25, P287, DOI 10.1007/s10815-008-9236-z; Thouas GA, 2006, BIOL REPROD, V74, P969, DOI 10.1095/biolreprod.105.048611; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; VANDERELST J, 1992, CRYOBIOLOGY, V29, P549, DOI 10.1016/0011-2240(92)90060-F; VINCENT C, 1990, J REPROD FERTIL, V89, P253, DOI 10.1530/jrf.0.0890253; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhang XB, 2003, TRANSFUSION, V43, P265, DOI 10.1046/j.1537-2995.2003.00301.x	53	14	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21597	10.1371/journal.pone.0021597	http://dx.doi.org/10.1371/journal.pone.0021597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738724	gold, Green Published, Green Submitted			2022-12-25	WOS:000292092600059
J	Pradeep, CR; Kostler, WJ; Lauriola, M; Granit, RZ; Zhang, F; Jacob-Hirsch, J; Rechavi, G; Nair, HB; Hennessy, BT; Gonzalez-Angulo, AM; Tekmal, RR; Ben-Porath, I; Mills, GB; Domany, E; Yarden, Y				Pradeep, C-R; Koestler, W. J.; Lauriola, M.; Granit, R. Z.; Zhang, F.; Jacob-Hirsch, J.; Rechavi, G.; Nair, H. B.; Hennessy, B. T.; Gonzalez-Angulo, A. M.; Tekmal, R. R.; Ben-Porath, I.; Mills, G. B.; Domany, E.; Yarden, Y.			Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling	ONCOGENE			English	Article						breast cancer; DCIS; growth factor; spheroids; receptor tyrosine kinase; signal transduction	HUMAN-BREAST-CANCER; MAMMARY-GLAND DEVELOPMENT; STEM-CELL; 3-DIMENSIONAL CULTURES; MONOCLONAL-ANTIBODY; EPITHELIAL-CELLS; NEU ONCOGENE; NOTCH; ACTIVATION; OVEREXPRESSION	A large fraction of ductal carcinoma in situ ( DCIS), a non-invasive precursor lesion of invasive breast cancer, overexpresses the HER2/neu oncogene. The ducts of DCIS are abnormally filled with cells that evade apoptosis, but the underlying mechanisms remain incompletely understood. We overexpressed HER2 in mammary epithelial cells and observed growth factor-independent proliferation. When grown in extracellular matrix as three-dimensional spheroids, control cells developed a hollow lumen, but HER2-overexpressing cells populated the lumen by evading apoptosis. We demonstrate that HER2 overexpression in this cellular model of DCIS drives transcriptional upregulation of multiple components of the Notch survival pathway. Importantly, luminal filling required upregulation of a signaling pathway comprising Notch3, its cleaved intracellular domain and the transcriptional regulator HES1, resulting in elevated levels of c-MYC and cyclin D1. In line with HER2-Notch3 collaboration, drugs intercepting either arm reverted the DCIS-like phenotype. In addition, we report upregulation of Notch3 in hyperplastic lesions of HER2 transgenic animals, as well as an association between HER2 levels and expression levels of components of the Notch pathway in tumor specimens of breast cancer patients. Therefore, it is conceivable that the integration of the Notch and HER2 signaling pathways contributes to the pathophysiology of DCIS. Oncogene ( 2012) 31, 907-917; doi: 10.1038/onc.2011.279; published online 11 July 2011	[Pradeep, C-R; Koestler, W. J.; Lauriola, M.; Yarden, Y.] Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel; [Granit, R. Z.; Ben-Porath, I.] Hebrew Univ Jerusalem, Hadassah Sch Med, Dept Dev Biol & Canc Res, Inst Med Res Israel Canada, Jerusalem, Israel; [Zhang, F.; Hennessy, B. T.; Gonzalez-Angulo, A. M.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Jacob-Hirsch, J.; Rechavi, G.] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Jacob-Hirsch, J.; Rechavi, G.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Nair, H. B.] SW Natl Primate Res Ctr, San Antonio, TX USA; [Hennessy, B. T.] Beaumont Hosp, Dept Med Oncol, Dublin 9, Ireland; [Gonzalez-Angulo, A. M.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Tekmal, R. R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, San Antonio, TX 78229 USA; [Domany, E.] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; University of Texas System; UTMD Anderson Cancer Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Texas Biomedical Research Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health San Antonio; Weizmann Institute of Science	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, Candiotty Bldg,Room 302,1 Hertzl St, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	lauriola, mattia/N-6435-2014; DOMANY, EYTAN/K-1560-2012; YARDEN, YOSEF/K-1467-2012	lauriola, mattia/0000-0002-7966-0065; Bhaskaran Nair, Hareesh Babu/0000-0002-4309-9560; Granit, Roy Zvi/0000-0002-6487-2559; Hennessy, Bryan/0000-0002-7871-6477	National Cancer Institute [CA072981, CA121994-01, CA120248-01]; Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; Kekst Family Institute for Medical Genetics; Kirk Center for Childhood Cancer and Immunological Disorders; Bennett-Pritzker Endowment Fund; Marvelle Koffler Program for Breast Cancer Research; Leir Charitable Foundation; MD. Moross Institute for Cancer Research; Susan G Komen Foundation [FAS0703849]; Linda and Michael Jacobs Charitable Trust; NATIONAL CANCER INSTITUTE [K23CA121994, R37CA072981, R01CA072981, R21CA120248, P30CA016672] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Cancer Research Fund; Dr Miriam and Sheldon G Adelson Medical Research Foundation; Kekst Family Institute for Medical Genetics; Kirk Center for Childhood Cancer and Immunological Disorders; Bennett-Pritzker Endowment Fund; Marvelle Koffler Program for Breast Cancer Research; Leir Charitable Foundation; MD. Moross Institute for Cancer Research; Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); Linda and Michael Jacobs Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Amit Zeisel and Sara Lavi for help, Brenda Lilly for the Notch3 reporter, and Powel Brown, Corey Speers and the Kleberg Center for Molecular Markers at MD Anderson Cancer Center (CCSG grant NCI CA16672) for providing tumors for the RPPA analysis. We acknowledge research funding by the National Cancer Institute (CA072981, CA121994-01 and CA120248-01), the Israel Cancer Research Fund, Dr Miriam and Sheldon G Adelson Medical Research Foundation, Kekst Family Institute for Medical Genetics, Kirk Center for Childhood Cancer and Immunological Disorders, the Women's Health Research Center funded by Bennett-Pritzker Endowment Fund, Marvelle Koffler Program for Breast Cancer Research, Leir Charitable Foundation and the MD. Moross Institute for Cancer Research, the Susan G Komen Foundation (FAS0703849 to AMG, BTH and GBM), and a fellowship for PhD track for specialist medical doctors by the Linda and Michael Jacobs Charitable Trust (WJK). YY is the incumbent of the Harold and Zelda Goldenberg Professorial Chair and ED of the Henry J Leir Professorial Chair.	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Chen YY, 1997, J BIOL CHEM, V272, P14110, DOI 10.1074/jbc.272.22.14110; Clemenz AZ, 2009, CANCER RES, V69, p362s; Cohen B, 2010, BREAST CANCER RES TR, V123, P113, DOI 10.1007/s10549-009-0621-9; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Hennessy Bryan T, 2010, Clin Proteomics, V6, P129, DOI 10.1007/s12014-010-9055-y; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Ignatiadis M, 2009, CLIN CANCER RES, V15, P1848, DOI 10.1158/1078-0432.CCR-08-1844; Imatani A, 2000, ONCOGENE, V19, P223, DOI 10.1038/sj.onc.1203295; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jechlinger M, 2009, GENE DEV, V23, P1677, DOI 10.1101/gad.1801809; Katz M, 2007, NAT CELL BIOL, V9, P961, DOI 10.1038/ncb1622; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; LONARDO F, 1990, New Biologist, V2, P992; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Sriuranpong V, 2001, CANCER RES, V61, P3200; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Tekmal RR, 2007, J STEROID BIOCHEM, V106, P111, DOI 10.1016/j.jsbmb.2007.05.009; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; WALLASCH C, 1995, EMBO J, V14, P4267, DOI 10.1002/j.1460-2075.1995.tb00101.x; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whelan JT, 2007, CELL CYCLE, V6, P80, DOI 10.4161/cc.6.1.3648; Worthylake R, 1999, J BIOL CHEM, V274, P8865, DOI 10.1074/jbc.274.13.8865; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Zardawi SJ, 2010, HISTOPATHOLOGY, V56, P286, DOI 10.1111/j.1365-2559.2009.03475.x; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081	57	34	35	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	7					907	917		10.1038/onc.2011.279	http://dx.doi.org/10.1038/onc.2011.279			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	897BL	21743488	Green Accepted, Bronze			2022-12-25	WOS:000300615800009
J	Rahim, AA; Wong, AMS; Hoefer, K; Buckley, SMK; Mattar, CN; Cheng, SH; Chan, JKY; Cooper, JD; Waddington, SN				Rahim, Ahad A.; Wong, Andrew M. S.; Hoefer, Klemens; Buckley, Suzanne M. K.; Mattar, Citra N.; Cheng, Seng H.; Chan, Jerry K. Y.; Cooper, Jonathan D.; Waddington, Simon N.			Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system	FASEB JOURNAL			English	Article						targeted gene expression; perinatal gene therapy; neurodegenerative disease; peripheral nerves	NEURONAL CEROID-LIPOFUSCINOSIS; POSTTRANSCRIPTIONAL REGULATORY ELEMENT; GENE-THERAPY; ANATOMICAL CHARACTERIZATION; BRAIN DEVELOPMENT; IN-UTERO; MODEL; DELIVERY; STORAGE; ADULT	Several diseases of the nervous system are characterized by neurodegeneration and death in childhood. Conventional medicine is ineffective, but fetal or neonatal gene therapy may provide an alternative route to treatment. We evaluated the ability of single-stranded and self-complementary adeno-associated virus pseudotype 2/9 (AAV2/9) to transduce the nervous system and target gene expression to specific neural cell types following intravenous injection into fetal and neonatal mice, using control uninjected age-matched mice. Fetal and neonatal administration produced global delivery to the central (brain, spinal cord, and all layers of the retina) and peripheral (myenteric plexus and innervating nerves) nervous system but with different expression profiles within the brain; fetal and neonatal administration resulted in expression in neurons and protoplasmic astrocytes, respectively. Neither single-stranded nor self-complementary AAV2/9 triggered a microglia-mediated immune response following either administration. In summary, intravenous AAV2/9 targets gene expression to specific neural cell types dependent on developmental stage. This represents a powerful tool for studying nervous system development and disease. Furthermore, it may provide a therapeutic strategy for treatment of early lethal genetic diseases, such as Gaucher disease, and for disabling neuropathies, such as preterm brain injury.-Rahim, A. A., Wong, A. M. S., Hoefer, K., Buckley, S. M. K., Mattar, C. N., Cheng, S. H., Chan, J. K. Y., Cooper, J. D., Waddington, S. N. Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of central nervous system cell types and extensive transduction of the nervous system. FASEB J. 25, 3505-3518 (2011). www.fasebj.org	[Rahim, Ahad A.; Buckley, Suzanne M. K.; Waddington, Simon N.] UCL, Inst Womens Hlth, Gene Transfer Technol Grp, London WC1E 6HX, England; [Wong, Andrew M. S.; Hoefer, Klemens; Cooper, Jonathan D.] Kings Coll London, Inst Psychiat, Pediat Storage Disorders Lab, London WC2R 2LS, England; [Mattar, Citra N.; Chan, Jerry K. Y.] Natl Univ Singapore, Dept Obstet & Gynaecol, Expt Fetal Med Grp, Singapore 117548, Singapore; [Cheng, Seng H.] Genzyme Corp, Framingham, MA 01701 USA; [Chan, Jerry K. Y.] Kandang Kerbau Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore	University of London; University College London; University of London; King's College London; National University of Singapore; Sanofi-Aventis; Genzyme Corporation; KK Women's & Children's Hospital	Waddington, SN (corresponding author), UCL, Inst Womens Hlth, Gene Transfer Technol Grp, 86-96 Chenies Mews, London WC1E 6HX, England.	s.waddington@ucl.ac.uk	Cooper, Jonathan/V-9962-2019; rahim, abdul/AAC-6745-2021; Cheng, Seng H/AAC-6564-2022; Waddington, Simon/G-3778-2011; Cooper, Jonathan/C-8117-2009	Cooper, Jonathan/0000-0003-1339-4750; rahim, abdul/0000-0002-0269-9156; Waddington, Simon/0000-0003-4970-4730; Cooper, Jonathan/0000-0003-1339-4750; Buckley, Suzanne/0000-0003-1286-1003; Mattar, Citra Nurfarah/0000-0003-0068-6957	UK Medical Research Council [G1000709]; Wellcome Trust [WT089806MA, GR079491MA]; UK Gaucher Association; family of Ellie Carter; National Medical Research Council, Singapore [CSA/012/2009]; Batten Disease Family Association; Batten Disease Support and Research Association; Medical Research Council [G1000709] Funding Source: researchfish; MRC [G1000709] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Gaucher Association; family of Ellie Carter; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Batten Disease Family Association; Batten Disease Support and Research Association; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Gennadij Raivich (University College London) for advice and useful discussion. The authors thank Julie Johnson (University of Pennsylvania, Philadelphia, PA, USA) and the University of Pennsylvania Vector Core Facility (http://www.med.upenn.edu/gtp/vectorcore/) for provision of vectors. The authors also thank Takis Athanasopolous and Alberto Malerba (Royal Holloway, University of London, London, UK) for useful discussion and advice on vectorology. This work was funded by a UK Medical Research Council grant (G1000709) and a Wellcome Trust grant (WT089806MA). A.A.R. and S.N.W. have also received support from the UK Gaucher Association (funds donated by the family of Ellie Carter). J.K.Y.C. received support from the Clinician Scientist Award, National Medical Research Council, Singapore (CSA/012/2009). The Pediatric Storage Disorders Laboratory at King's College London is supported by The Wellcome Trust (GR079491MA), Batten Disease Family Association, and the Batten Disease Support and Research Association.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Coutelle C, 2005, GENE THER, V12, P1601, DOI 10.1038/sj.gt.3302632; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fritchie K, 2009, ACTA NEUROPATHOL, V117, P201, DOI 10.1007/s00401-008-0426-7; Galvin N, 2008, PEDIATR DEVEL PATHOL, V11, P185, DOI 10.2350/07-03-0242.1; Guggenbuhl P, 2008, JOINT BONE SPINE, V75, P116, DOI 10.1016/j.jbspin.2007.06.006; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Lei B, 2010, ADV EXP MED BIOL, V664, P671, DOI 10.1007/978-1-4419-1399-9_77; Loeb JE, 1999, HUM GENE THER, V10, P2295, DOI 10.1089/10430349950016942; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Rahim AA, 2009, GENE THER, V16, P509, DOI 10.1038/gt.2008.186; Roybal JL, 2010, SEMIN FETAL NEONAT M, V15, P46, DOI 10.1016/j.siny.2009.05.005; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Shen JS, 2004, J GENE MED, V6, P1206, DOI 10.1002/jgm.630; Shen JS, 2001, GENE THER, V8, P1081, DOI 10.1038/sj.gt.3301495; Shen S, 2011, J BIOL CHEM, V286, P13532, DOI 10.1074/jbc.M110.210922; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Sondhi D, 2008, EXP NEUROL, V213, P18, DOI 10.1016/j.expneurol.2008.04.022; Souweidane MM, 2010, J NEUROSURG-PEDIATR, V6, P115, DOI 10.3171/2010.4.PEDS09507; Tuchscherer M, 2002, VET IMMUNOL IMMUNOP, V86, P195, DOI 10.1016/S0165-2427(02)00035-1; Tyynela J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786; Visigalli I, 2010, BLOOD, V116, P5130, DOI 10.1182/blood-2010-04-278234; Waddington SN, 2007, CURR OPIN MOL THER, V9, P432; Waddington SN, 2004, BLOOD, V104, P2714, DOI 10.1182/blood-2004-02-0627; Waddington SN, 2004, GENE THER, V11, pS92, DOI 10.1038/sj.gt.3302375; Waddington SN, 2003, BLOOD, V101, P1359, DOI 10.1182/blood-2002-03-0779; Wen Shi Wu, 2004, Semin Fetal Neonatal Med, V9, P429, DOI 10.1016/j.siny.2004.04.002; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Yokoi K, 2007, INVEST OPHTH VIS SCI, V48, P3324, DOI 10.1167/iovs.06-1306; Zhang JY, 2005, NEUROIMAGE, V26, P1042, DOI 10.1016/j.neuroimage.2005.03.009; Zhang JY, 2003, NEUROIMAGE, V20, P1639, DOI 10.1016/S1053-8119(03)00410-5	45	70	73	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3505	3518		10.1096/fj.11-182311	http://dx.doi.org/10.1096/fj.11-182311			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21746868				2022-12-25	WOS:000295356400021
J	Heuts, DPHM; Gummadova, JO; Pang, JY; Rigby, SEJ; Scrutton, NS				Heuts, Dominic P. H. M.; Gummadova, Jennet O.; Pang, Jiayun; Rigby, Stephen E. J.; Scrutton, Nigel S.			Reaction of Vascular Adhesion Protein-1 (VAP-1) with Primary Amines MECHANISTIC INSIGHTS FROM ISOTOPE EFFECTS AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; OXIDASE SSAO; DEHYDROGENASE; BINDING; SURFACE; ENZYME; PLASMA; PHENYLHYDRAZINE; STEREOCHEMISTRY; INHIBITORS	Human vascular adhesion protein-1 (VAP-1) is an endothelial copper-dependent amine oxidase involved in the recruitment and extravasation of leukocytes at sites of inflammation. VAP-1 is an important therapeutic target for several pathological conditions. We expressed soluble VAP-1 in HEK293 EBNA1 cells at levels suitable for detailed mechanistic studies with model substrates. Using the model substrate benzylamine, we analyzed the steady-state kinetic parameters of VAP-1 as a function of solution pH. We found two macroscopic pK(a) values that defined a bell-shaped plot of turnover number k(cat,app) as a function of pH, representing ionizable groups in the enzyme-substrate complex. The dependence of (k(cat)/K-m)(app) onpHrevealed a single pK(a) value (similar to 9) that we assigned to ionization of the amine group in free benzylamine substrate. A kinetic isotope effect (KIE) of 6 to 7.6 on (k(cat)/K-m)(app) over the pH range of 6 to 10 was observed with d2-benzylamine. Over the same pH range, the KIE on k(cat) was found to be close to unity. The unusual KIE values on (k(cat)/K-m)(app) were rationalized using a mechanistic scheme that includes the possibility of multiple isotopically sensitive steps. We also report the analysis of quantitative structure-activity relationships (QSAR) using para-substituted protiated and deuterated phenylethylamines. With phenylethylamines we observed a large KIE on k(cat, app) (8.01 +/- 0.28 with phenylethylamine), indicating that C-H bond breakage is limiting for 2,4,5-trihydroxyphenylalanine quinone reduction. Poor correlations were observed between steady-state rate constants and QSAR parameters. We show the importance of combining KIE, QSAR, and structural studies to gain insight into the complexity of the VAP-1 steady-state mechanism.	[Heuts, Dominic P. H. M.; Gummadova, Jennet O.; Rigby, Stephen E. J.; Scrutton, Nigel S.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Pang, Jiayun] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M1 7DN, Lancs, England	University of Manchester; University of Manchester	Scrutton, NS (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk	Pang, Jiayun/B-4274-2012	Pang, Jiayun/0000-0003-0689-8440	Ramsay Memorial Foundation Trust; BBSRC [BB/D01963X/1, BB/E013007/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013007/1, BB/D01963X/1] Funding Source: researchfish	Ramsay Memorial Foundation Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by the Ramsay Memorial Foundation Trust.	Airenne TT, 2005, PROTEIN SCI, V14, P1964, DOI 10.1110/ps.051438105; ALTON G, 1995, ARCH BIOCHEM BIOPHYS, V316, P353, DOI 10.1006/abbi.1995.1047; BARY Y, 1979, J CHEM SOC PERK T 2, P938, DOI 10.1039/p29790000938; Basran J, 2001, J BIOL CHEM, V276, P42887, DOI 10.1074/jbc.M108296200; Bonaiuto E, 2010, BIOCHIMIE, V92, P858, DOI 10.1016/j.biochi.2010.03.006; Boomsma F, 2005, MED SCI MONITOR, V11, pRA122; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dalfo E, 2003, BBA-MOL BASIS DIS, V1638, P278, DOI 10.1016/S0925-4439(03)00094-2; DuBois JL, 2006, BIOCHEMISTRY-US, V45, P3178, DOI 10.1021/bi052025m; DuBois JL, 2004, METHOD ENZYMOL, V378, P17; Dupradeau FY, 2008, NUCLEIC ACIDS RES, V36, pD360, DOI 10.1093/nar/gkm887; Enrique-Tarancon G, 1998, J BIOL CHEM, V273, P8025, DOI 10.1074/jbc.273.14.8025; Ernberg K, 2010, ACTA CRYSTALLOGR F, V66, P1572, DOI 10.1107/S1744309110041515; FALK MC, 1983, BIOCHEMISTRY-US, V22, P3740, DOI 10.1021/bi00285a004; Federico R, 1997, BIOCHEM BIOPH RES CO, V240, P150, DOI 10.1006/bbrc.1997.7630; Gokturk C, 2007, AM J HYPERTENS, V20, P743, DOI 10.1016/j.amjhyper.2007.02.011; Hansch C, 1979, SUBSTITUENT CONSTANT, P1; Holt A, 2007, J NEURAL TRANSM, V114, P733, DOI 10.1007/s00702-007-0680-1; Hothi P, 2007, BIOCHEMISTRY-US, V46, P9250, DOI 10.1021/bi7007239; Hothi P, 2008, CHEMBIOCHEM, V9, P2839, DOI 10.1002/cbic.200800408; HYUN YL, 1995, BBA-PROTEIN STRUCT M, V1251, P198, DOI 10.1016/0167-4838(95)00117-D; HYUN YL, 1995, BIOCHEMISTRY-US, V34, P816, DOI 10.1021/bi00003a015; Jaakkola K, 1999, AM J PATHOL, V155, P1953, DOI 10.1016/S0002-9440(10)65514-9; Jakobsson E, 2005, ACTA CRYSTALLOGR D, V61, P1550, DOI 10.1107/S0907444905028805; Jalkanen S, 2008, ARTERIOSCL THROM VAS, V28, P18, DOI 10.1161/ATVBAHA.107.153130; Kemik O, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-83; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Kubinyi H, 1993, QSAR HANSCH ANAL REL; LINDSTROM A, 1976, EUR J BIOCHEM, V64, P321, DOI 10.1111/j.1432-1033.1976.tb10304.x; Macdonald PR, 2006, J BIOL CHEM, V281, P28408, DOI 10.1074/jbc.M605219200; MISRA HP, 1976, BIOCHEMISTRY-US, V15, P681, DOI 10.1021/bi00648a036; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; Ohman J, 2006, PROTEIN EXPRES PURIF, V46, P321, DOI 10.1016/j.pep.2005.10.027; Olivieri A, 2010, BBA-PROTEINS PROTEOM, V1804, P941, DOI 10.1016/j.bbapap.2010.01.003; Pang JY, 2010, CHEM COMMUN, V46, P3104, DOI 10.1039/c003107k; Perrin CL, 2005, J AM CHEM SOC, V127, P9641, DOI 10.1021/ja0511927; POSCHL E, 1994, EMBO J, V13, P3741, DOI 10.1002/j.1460-2075.1994.tb06683.x; PRECIOUS E, 1988, BIOCHEM PHARMACOL, V37, P707, DOI 10.1016/0006-2952(88)90145-1; Ruszczycky MW, 2006, J THEOR BIOL, V243, P328, DOI 10.1016/j.jtbi.2006.06.022; Salmi M, 2001, IMMUNITY, V14, P265, DOI 10.1016/S1074-7613(01)00108-X; Schramm VL, 2007, CURR OPIN CHEM BIOL, V11, P529, DOI 10.1016/j.cbpa.2007.07.013; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Stolen CM, 2004, FASEB J, V18, P702, DOI 10.1096/fj.03-0562fje; Swaroop A, 1988, GENOMICS, V2, P37, DOI 10.1016/0888-7543(88)90107-3; Wang EY, 2006, J MED CHEM, V49, P2166, DOI 10.1021/jm050538l; YANG CS, 1991, CHEM RES TOXICOL, V4, P408, DOI 10.1021/tx00022a002; Yraola F, 2009, CHEMMEDCHEM, V4, P495, DOI 10.1002/cmdc.200800393	49	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29584	29593		10.1074/jbc.M111.232850	http://dx.doi.org/10.1074/jbc.M111.232850			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737458	Green Published, hybrid			2022-12-25	WOS:000294046600016
J	Grover, VK; Valadez, JG; Bowman, AB; Cooper, MK				Grover, Vandana K.; Valadez, J. Gerardo; Bowman, Aaron B.; Cooper, Michael K.			Lipid Modifications of Sonic Hedgehog Ligand Dictate Cellular Reception and Signal Response	PLOS ONE			English	Article							CHOLESTEROL MODIFICATION; CRYSTAL-STRUCTURE; HUMAN HOMOLOG; FLOOR PLATE; SHH; PALMITOYLATION; REGION; DOMAIN; SITE; FORM	Background: Sonic hedgehog (Shh) signaling regulates cell growth during embryonic development, tissue homeostasis and tumorigenesis. Concentration-dependent cellular responses to secreted Shh protein are essential for tissue patterning. Shh ligand is covalently modified by two lipid moieties, cholesterol and palmitate, and their hydrophobic properties are known to govern the cellular release and formation of soluble multimeric Shh complexes. However, the influences of the lipid moieties on cellular reception and signal response are not well understood. Methodology/Principal Findings: We analyzed fully lipidated Shh and mutant forms to eliminate one or both adducts in NIH3T3 mouse embryonic fibroblasts. Quantitative measurements of recombinant Shh protein concentration, cellular localization, and signaling potency were integrated to determine the contributions of each lipid adduct on ligand cellular localization and signaling potency. We demonstrate that lipid modification is required for cell reception, that either adduct is sufficient to confer cellular association, that the cholesterol adduct anchors ligand to the plasma membrane and that the palmitate adduct augments ligand internalization. We further show that signaling potency correlates directly with cellular concentration of Shh ligand. Conclusions/Significance: The findings of this study demonstrate that lipid modification of Shh determines cell concentration and potency, revealing complementary functions of hydrophobic modification in morphogen signaling by attenuating cellular release and augmenting reception of Shh protein in target tissues.	[Grover, Vandana K.; Valadez, J. Gerardo; Bowman, Aaron B.; Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37235 USA; [Grover, Vandana K.; Bowman, Aaron B.; Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Vanderbilt Brain Inst, Nashville, TN USA; [Bowman, Aaron B.; Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Vanderbilt Kennedy Ctr, Nashville, TN USA; [Cooper, Michael K.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Cooper, Michael K.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Grover, VK (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37235 USA.	michael.cooper@vanderbilt.edu		Bowman, Aaron/0000-0001-8728-3346	NINDS [K02 NS053614]; March of Dimes Foundation; Vanderbilt Brain Institute; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS053614] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); March of Dimes Foundation(March of Dimes); Vanderbilt Brain Institute; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from NINDS (K02 NS053614), the March of Dimes Foundation, and the Vanderbilt Brain Institute Scholar's Program. Flow cytometry experiments were performed in the Vanderbilt Medical Center Flow Cytometry Shared Resource (supported by the Vanderbilt Ingram Cancer Center, P30 CA68485, and the Vanderbilt Digestive Disease Research Center, DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, FEBS J, V275, P318, DOI 10.1111/j.1742-4658.2007.06202.x; Bosanac I, 2009, NAT STRUCT MOL BIOL, V16, P691, DOI 10.1038/nsmb.1632; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Cohen MM, 2002, AM J MED GENET, V115, P245, DOI 10.1002/ajmg.10982; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Eaton S, 2008, NAT REV MOL CELL BIO, V9, P437, DOI 10.1038/nrm2414; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Feng J, 2004, DEVELOPMENT, V131, P4357, DOI 10.1242/dev.01301; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Huang X, 2007, DEVELOPMENT, V134, P2095, DOI 10.1242/dev.000729; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Lee JD, 2001, CURR BIOL, V11, P1147, DOI 10.1016/S0960-9822(01)00323-2; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 2000, J BIOL CHEM, V275, P10995, DOI 10.1074/jbc.275.15.10995; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Sambrook J, 2001, MOL CLONING LAB MANU; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Steinhauer J, 2009, CURR OPIN GENET DEV, V19, P308, DOI 10.1016/j.gde.2009.04.006; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Williams KP, 1999, J CELL SCI, V112, P4405; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310	57	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21353	10.1371/journal.pone.0021353	http://dx.doi.org/10.1371/journal.pone.0021353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747935	Green Published, Green Submitted, gold			2022-12-25	WOS:000292293400011
J	Zhang, YF; Wang, XF; Zhang, WX; Yu, F; Tian, JH; Li, DR; Guo, AG				Zhang, Yanfeng; Wang, Xuefang; Zhang, Wenxue; Yu, Fei; Tian, Jianhua; Li, Dianrong; Guo, Aiguang			Functional Analysis of the Two Brassica AP3 Genes Involved in Apetalous and Stamen Carpelloid Phenotypes	PLOS ONE			English	Article							FLORAL HOMEOTIC PROTEINS; MADS-BOX GENES; FLOWER DEVELOPMENT; CONTROLLING PETAL; EVOLUTION; DIVERSIFICATION; DUPLICATION; DIVERGENCE; PISTILLATA; GENOME	The Arabidopsis homeotic genes APETALA3 (AP3) and PISTILLATA (PI) are B genes which encode MADS-box transcription factors and specify petal and stamen identities. In the current study, the stamen carpelloid (SC) mutants, HGMS and AMS, of B. rapa and B. napus were investigated and two types of AP3 genes, B.AP3.a and B.AP3.b, were functional characterized. B.AP3.a and B.AP3.b share high similarity in amino acid sequences except for 8 residues difference located at the C-terminus. Loss of this 8 residues in B.AP3.b led to the change of PI-derived motifs. Meanwhile, B.AP3.a specified petal and stamen development, whereas B.AP3.b only specified stamen development. In B. rapa, the mutations of both genes generated the SC mutant HGMS. In B. napus that contained two B.AP3.a and two B.AP3.b, loss of the two B.AP3.a functions was the key reason for the apetalous mutation, however, the loss-of-function in all four AP3 was related to the SC mutant AMS. We inferred that the 8 residues or the PI-derived motif in AP3 gene probably relates to petal formation.	[Zhang, Yanfeng; Yu, Fei; Guo, Aiguang] NW A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, YF (corresponding author), NW A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	yczx98@126.com; guoaiguang@yahoo.com.cn			863 National High-tech Research and Development Program [2009AA101105]; Shaanxi Key Laboratory of Molecular Biology for Agriculture [200701]	863 National High-tech Research and Development Program(National High Technology Research and Development Program of China); Shaanxi Key Laboratory of Molecular Biology for Agriculture	This work was supported by a grant from 863 National High-tech Research and Development Program (2009AA101105) and the fund of Shaanxi Key Laboratory of Molecular Biology for Agriculture (200701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; de Martino G, 2006, PLANT CELL, V18, P1833, DOI 10.1105/tpc.106.042978; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Hernandez-Hernandez T, 2007, MOL BIOL EVOL, V24, P465, DOI 10.1093/molbev/msl182; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; Hileman LC, 2009, AM J BOT, V96, P83, DOI 10.3732/ajb.0800066; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Howell EC, 2008, GENETICS, V180, P1849, DOI 10.1534/genetics.108.095893; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Irish VF, 2009, J EXP BOT, V60, P2517, DOI 10.1093/jxb/erp159; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; Kim ST, 2004, AM J BOT, V91, P2102, DOI 10.3732/ajb.91.12.2102; Kramer EM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-30; Kramer EM, 1998, GENETICS, V149, P765; Kramer EM, 1999, NATURE, V399, P144, DOI 10.1038/20172; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Kramer EM, 2000, INT J PLANT SCI, V161, pS29, DOI 10.1086/317576; Lamb RS, 2003, P NATL ACAD SCI USA, V100, P6558, DOI 10.1073/pnas.0631708100; Litt A, 2003, GENETICS, V165, P821; Ostergaard L, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-10; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Piwarzyk E, 2007, PLANT PHYSIOL, V145, P1495, DOI 10.1104/pp.107.105346; Pylatuik JD, 2003, J EXP BOT, V54, P2385, DOI 10.1093/jxb/erg254; Rasmussen DA, 2009, AM J BOT, V96, P96, DOI 10.3732/ajb.0800038; Rijpkema A, 2006, ADV BOT RES, V44, P237, DOI 10.1016/S0065-2296(06)44006-4; Rijpkema AS, 2006, PLANT CELL, V18, P1819, DOI 10.1105/tpc.106.042937; Snowdon RJ, 2002, THEOR APPL GENET, V104, P533, DOI 10.1007/s00122-001-0787-y; Stellari GM, 2004, MOL BIOL EVOL, V21, P506, DOI 10.1093/molbev/msh044; Su KM, 2008, NEW PHYTOL, V178, P544, DOI 10.1111/j.1469-8137.2008.02382.x; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Vandenbussche M, 2004, PLANT CELL, V16, P741, DOI 10.1105/tpc.019166; Vandenbussche M, 2003, NUCLEIC ACIDS RES, V31, P4401, DOI 10.1093/nar/gkg642; WEIGEL D, 1994, CELL, V78, P203, DOI 10.1016/0092-8674(94)90291-7; Winter KU, 2002, MOL BIOL EVOL, V19, P587, DOI 10.1093/oxfordjournals.molbev.a004118; Zhang WenXue, 2005, Chinese Journal of Oil Crop Sciences, V27, P13; [张彦锋 Zhang Yanfeng], 2005, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V14, P164	38	13	14	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20930	10.1371/journal.pone.0020930	http://dx.doi.org/10.1371/journal.pone.0020930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738595	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800006
J	Ashe, KM; Bangari, D; Li, LY; Cabrera-Salazar, MA; Bercury, SD; Nietupski, JB; Cooper, CGF; Aerts, JMFG; Lee, ER; Copeland, DP; Cheng, SH; Scheule, RK; Marshall, J				Ashe, Karen M.; Bangari, Dinesh; Li, Lingyun; Cabrera-Salazar, Mario A.; Bercury, Scott D.; Nietupski, Jennifer B.; Cooper, Christopher G. F.; Aerts, Johannes M. F. G.; Lee, Edward R.; Copeland, Diane P.; Cheng, Seng H.; Scheule, Ronald K.; Marshall, John			Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease	PLOS ONE			English	Article							SUBSTRATE REDUCTION THERAPY; ENZYME REPLACEMENT THERAPY; SYNUCLEIN ACTIVATES MICROGLIA; GAUCHER-DISEASE; TAY-SACHS; ALPHA-SYNUCLEIN; DEPRIVATION THERAPY; CONTROLLED-TRIAL; MICE; GANGLIOSIDOSIS	The neuropathic glycosphingolipidoses are a subgroup of lysosomal storage disorders for which there are no effective therapies. A potential approach is substrate reduction therapy using inhibitors of glucosylceramide synthase (GCS) to decrease the synthesis of glucosylceramide and related glycosphingolipids that accumulate in the lysosomes. Genz-529468, a blood-brain barrier-permeant iminosugar-based GCS inhibitor, was used to evaluate this concept in a mouse model of Sandhoff disease, which accumulates the glycosphingolipid GM2 in the visceral organs and CNS. As expected, oral administration of the drug inhibited hepatic GM2 accumulation. Paradoxically, in the brain, treatment resulted in a slight increase in GM2 levels and a 20-fold increase in glucosylceramide levels. The increase in brain glucosylceramide levels might be due to concurrent inhibition of the non-lysosomal glucosylceramidase, Gba2. Similar results were observed with NB-DNJ, another iminosugar-based GCS inhibitor. Despite these unanticipated increases in glycosphingolipids in the CNS, treatment nevertheless delayed the loss of motor function and coordination and extended the lifespan of the Sandhoff mice. These results suggest that the CNS benefits observed in the Sandhoff mice might not necessarily be due to substrate reduction therapy but rather to off-target effects.	[Ashe, Karen M.; Bangari, Dinesh; Li, Lingyun; Cabrera-Salazar, Mario A.; Bercury, Scott D.; Nietupski, Jennifer B.; Cooper, Christopher G. F.; Lee, Edward R.; Copeland, Diane P.; Cheng, Seng H.; Scheule, Ronald K.; Marshall, John] Genzyme Corp, Framingham, MA 01701 USA; [Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Sanofi-Aventis; Genzyme Corporation; University of Amsterdam; Academic Medical Center Amsterdam	Ashe, KM (corresponding author), Genzyme Corp, Framingham, MA 01701 USA.	john.marshall@genzyme.com	Cheng, Seng H/AAC-6564-2022; Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Marshall, John/0000-0003-1361-2869	Genzyme Corporation	Genzyme Corporation(Sanofi-AventisGenzyme Corporation)	All support for these studies was provided by Genzyme Corporation, through the employment of Karen M. Ashe, Dinesh Bangari, Lingyun Li, Mario A. Cabrera-Salazar, Scott D. Bercury, Jennifer B. Nietupski, Christopher G. F. Cooper, Edward R. Lee, Diane P. Copeland, Seng H. Cheng, Ronald K. Scheule and John Marshall, who contributed to all aspects of the study. The described studies were part of the drug development program at Genzyme Corporation. The internal publication review committee approved the manuscript for publication.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Andersson U, 2004, NEUROBIOL DIS, V16, P506, DOI 10.1016/j.nbd.2004.04.012; Ashe KM, 2010, MOL GENET METAB, V100, P309, DOI 10.1016/j.ymgme.2010.05.001; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Bodennec J, 2002, FASEB J, V16, P1814, DOI 10.1096/fj.02-0149fje; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Davies EH, 2007, J INHERIT METAB DIS, V30, P935, DOI 10.1007/s10545-007-0577-z; GEISLER FH, 1991, NEW ENGL J MED, V324, P1829, DOI 10.1056/NEJM199106273242601; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Huang JQ, 1997, HUM MOL GENET, V6, P1879, DOI 10.1093/hmg/6.11.1879; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jeyakumar M, 2004, ANN NEUROL, V56, P642, DOI 10.1002/ana.20242; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Jeyakumar M, 1999, P NATL ACAD SCI USA, V96, P6388, DOI 10.1073/pnas.96.11.6388; Jeyakumar M, 2001, BLOOD, V97, P327, DOI 10.1182/blood.V97.1.327; Kasperzyk JL, 2005, J LIPID RES, V46, P744, DOI 10.1194/jlr.M400411-JLR200; Lachmann RH, 2001, EXPERT OPIN INV DRUG, V10, P455, DOI 10.1517/13543784.10.3.455; Lachmann Robin H, 2009, Expert Rev Endocrinol Metab, V4, P217, DOI 10.1586/eem.09.8; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Maegawa GHB, 2009, MOL GENET METAB, V98, P215, DOI 10.1016/j.ymgme.2009.06.005; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Masciullo M, 2010, J INHERIT METAB DIS, V33, pS355, DOI 10.1007/s10545-010-9186-3; McNally MA, 2007, J NEGAT RESULTS BIOM, V6, DOI 10.1186/1477-5751-6-8; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343; Norflus F, 1998, J CLIN INVEST, V101, P1881, DOI 10.1172/JCI2127; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074/jbc.M302964200; Platt FM, 2003, PHILOS T R SOC B, V358, P947, DOI 10.1098/rstb.2003.1279; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Schiffmann R, 2010, J INHERIT METAB DIS, V33, P373, DOI 10.1007/s10545-010-9047-0; Schiffmann R, 2008, ANN NEUROL, V64, P514, DOI 10.1002/ana.21491; Shapiro BE, 2009, GENET MED, V11, P425, DOI 10.1097/GIM.0b013e3181a1b5c5; Shen C, 2004, INT IMMUNOPHARMACOL, V4, P939, DOI 10.1016/j.intimp.2004.04.008; Suzuki K, 2003, NEUROREPORT, V14, P551, DOI 10.1097/00001756-200303240-00004; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wennekes T, 2010, J MED CHEM, V53, P689, DOI 10.1021/jm901281m; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Wraith JE, 2010, MOL GENET METAB, V99, P351, DOI 10.1016/j.ymgme.2009.12.006; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Wu YP, 2008, HUM MOL GENET, V17, P2257, DOI 10.1093/hmg/ddn126; Yamashita T, 2005, GENESIS, V43, P175, DOI 10.1002/gene.20167; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zimran A, 2007, J INHERIT METAB DIS, V30, P843, DOI 10.1007/s10545-007-0783-8	51	48	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21758	10.1371/journal.pone.0021758	http://dx.doi.org/10.1371/journal.pone.0021758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738789	Green Published, gold			2022-12-25	WOS:000292290100069
J	Bukhari, T; Takken, W; Githeko, AK; Koenraadt, CJM				Bukhari, Tullu; Takken, Willem; Githeko, Andrew K.; Koenraadt, Constantianus J. M.			Efficacy of Aquatain, a Monomolecular Film, for the Control of Malaria Vectors in Rice Paddies	PLOS ONE			English	Article							ORGANIC-SURFACE FILM; DAR-ES-SALAAM; AROSURF MSF; ANOPHELES-GAMBIAE; MOSQUITO-CONTROL; LECITHIN MONOLAYERS; CULEX-QUINQUEFASCIATUS; BACILLUS-SPHAERICUS; IRRIGATION SCHEME; FIELD EVALUATIONS	Background: Rice paddies harbour a large variety of organisms including larvae of malaria mosquitoes. These paddies are challenging for mosquito control because their large size, slurry and vegetation make it difficult to effectively apply a control agent. Aquatain, a monomolecular surface film, can be considered a suitable mosquito control agent for such breeding habitats due to its physical properties. The properties allow Aquatain to self-spread over a water surface and affect multiple stages of the mosquito life cycle. Methodology/Principal Findings: A trial based on a pre-test/post-test control group design evaluated the potential of Aquatain as a mosquito control agent at Ahero rice irrigation scheme in Kenya. After Aquatain application at a dose of 2 ml/m(2) on rice paddies, early stage anopheline larvae were reduced by 36%, and late stage anopheline larvae by 16%. However, even at a lower dose of 1 ml/m(2) there was a 93.2% reduction in emergence of anopheline adults and 69.5% reduction in emergence of culicine adults. No pupation was observed in treated buckets that were part of a field bio-assay carried out parallel to the trial. Aquatain application saved nearly 1.7 L of water in six days from a water surface of 0.2 m(2) under field conditions. Aquatain had no negative effect on rice plants as well as on a variety of non-target organisms, except backswimmers. Conclusions/Significance: We demonstrated that Aquatain is an effective agent for the control of anopheline and culicine mosquitoes in irrigated rice paddies. The agent reduced densities of aquatic larval stages and, more importantly, strongly impacted the emergence of adult mosquitoes. Aquatain also reduced water loss due to evaporation. No negative impacts were found on either abundance of non-target organisms, or growth and development of rice plants. Aquatain, therefore, appears a suitable mosquito control tool for use in rice agro-ecosystems.	[Bukhari, Tullu; Takken, Willem; Koenraadt, Constantianus J. M.] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Githeko, Andrew K.] Kenya Govt Med Res Ctr, Kisumu, Kenya	Wageningen University & Research; Kenya Medical Research Institute	Bukhari, T (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	tullu.bukhari@wur.nl		Koenraadt, Constantianus/0000-0001-7861-8781; Bukhari, Syeda/0000-0002-4291-9619	Higher Education Commission, Pakistan through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands	Higher Education Commission, Pakistan through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands(Netherlands Government)	Tullu Bukhari is funded by Higher Education Commission, Pakistan through Netherlands Organization for International Cooperation in Higher Education (NUFFIC), The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2000, J AM MOSQUITO CONTR, V16, P313; [Anonymous], 1992, BIOL MOSQUITOES DEV; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Bashir A. L., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P222; Batra CP, 2006, J AM MOSQUITO CONTR, V22, P426, DOI 10.2987/8756-971X(2006)22[426:EOAMMS]2.0.CO;2; Bukhari T, 2009, AM J TROP MED HYG, V80, P758, DOI 10.4269/ajtmh.2009.80.758; BURGESS JH, 1985, J AM MOSQUITO CONTR, V1, P245; Corbet SA, 2000, ENTOMOL EXP APPL, V94, P295, DOI 10.1023/A:1003920817649; Djouaka RF, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-56; Dolo G, 2004, ACTA TROP, V89, P147, DOI 10.1016/j.actatropica.2003.10.014; Fillinger U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-20; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; GARRETT WD, 1977, MOSQ NEWS, V37, P344; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Githeko A. K., 1996, Parassitologia (Rome), V38, P481; HERTLEIN B, 1985, J AM MOSQUITO CONTR, V1, P255; HESTER PG, 1989, J AM MOSQUITO CONTR, V5, P272; HESTER PG, 1991, J AM MOSQUITO CONTR, V7, P48; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; Jarju LBS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-170; Kamau L, 2006, J MED ENTOMOL, V43, P774, DOI 10.1603/0022-2585(2006)43[774:EOPROA]2.0.CO;2; KARANJA DMS, 1994, ACTA TROP, V56, P365, DOI 10.1016/0001-706X(94)90107-4; KARCH S, 1991, J AM MOSQUITO CONTR, V7, P176; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; KENNY EA, 1992, J AM MOSQUITO CONTR, V8, P325; KENNY EA, 1993, J AM MOSQUITO CONTR, V9, P361; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Klinkenberg E, 2003, ACTA TROP, V85, P71, DOI 10.1016/S0001-706X(02)00254-1; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; LANG HH, 1980, BEHAV ECOL SOCIOBIOL, V6, P233, DOI 10.1007/BF00569205; LEVY R, 1982, MOSQ NEWS, V42, P1; Levy R., 1984, Journal of the Florida Anti-Mosquito Association, V55, P31; LEVY R, 1984, MOSQ NEWS, V44, P592; LEVY R, 1981, MOSQ NEWS, V41, P291; LEVY R, 1980, MOSQ NEWS, V40, P27; LEVY R, 1986, J AM MOSQUITO CONTR, V2, P233; LEVY R, 1984, MOSQ NEWS, V44; LEVY R, 1982, MOSQ NEWS, V42; MORGAN JC, PLOS ONE, V5; Mulla MS, 2003, J AM MOSQUITO CONTR, V19, P39; Muturi EJ, 2006, J VECTOR ECOL, V31, P129, DOI 10.3376/1081-1710(2006)31[129:MSDAAI]2.0.CO;2; Mwangangi JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-228; Nayar JK, 2003, J VECTOR ECOL, V28, P190; Nelder M, 2010, AM J TROP MED HYG, V82, P831, DOI 10.4269/ajtmh.2010.09-0546; Ng'ang'a PN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-146; Paaijmans KP, 2008, INT J BIOMETEOROL, V52, P747, DOI 10.1007/s00484-008-0167-2; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Paaijmans KP, 2009, ACTA TROP, V109, P124, DOI 10.1016/j.actatropica.2008.07.010; RANSON H, TRENDS PARASITOL; REITER P, 1978, MOSQ NEWS, V38, P334; REITER P, 1978, ANN TROP MED PARASIT, V72, P163, DOI 10.1080/00034983.1978.11719299; REITER P, 1978, ANN TROP MED PARASIT, V72, P169, DOI 10.1080/00034983.1978.11719300; REITER P, 1980, ANN TROP MED PARASIT, V74, P541, DOI 10.1080/00034983.1980.11687382; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1989, PARASITOL TODAY, V5, P162, DOI 10.1016/0169-4758(89)90083-5; Stresman GH, 2010, ACTA TROP, V116, P167, DOI 10.1016/j.actatropica.2010.08.005; TAKAHASHI RM, 1984, MOSQ NEWS, V44, P363; Webb CE, 2009, J AM MOSQUITO CONTR, V25, P106, DOI 10.2987/08-5750.1; WEBB CE, 2010, FIELD ASSESSMENT AQU; WEBBER LA, 1984, MOSQ NEWS, V44, P68; WHITE SA, 1977, MOSQ NEWS, V37, P349; Yadouleton A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-118; YADOULETON AW, MALAR J, V9; 2008, ROLL BACK MALARIA GL	65	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21713	10.1371/journal.pone.0021713	http://dx.doi.org/10.1371/journal.pone.0021713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738774	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100061
J	Evans, O; Paulk, AC; van Swinderen, B				Evans, Oliver; Paulk, Angelique C.; van Swinderen, Bruno			An Automated Paradigm for Drosophila Visual Psychophysics	PLOS ONE			English	Article							OPTOKINETIC NYSTAGMUS; MOTION PERCEPTION; ATTENTION; MEMORY; MELANOGASTER; BRAIN; FLY; INTERNEURONS; SUPPRESSION; STIMULI	Background: Mutations that cause learning and memory defects in Drosophila melanogaster have been found to also compromise visual responsiveness and attention. A better understanding of attention-like defects in such Drosophila mutants therefore requires a more detailed characterization of visual responsiveness across a range of visual parameters. Methodology/Principal Findings: We designed an automated behavioral paradigm for efficiently dissecting visual responsiveness in Drosophila. Populations of flies walk through multiplexed serial choice mazes while being exposed to moving visuals displayed on computer monitors, and infra-red fly counters at the end of each maze automatically score the responsiveness of a strain. To test our new design, we performed a detailed comparison between wild-type flies and a learning and memory mutant, dunce(1). We first confirmed that the learning mutant dunce(1) displays increased responsiveness to a black/green moving grating compared to wild type in this new design. We then extended this result to explore responses to a wide range of psychophysical parameters for moving gratings (e.g., luminosity, contrast, spatial frequency, velocity) as well as to a different stimulus, moving dots. Finally, we combined these visuals (gratings versus dots) in competition to investigate how dunce(1) and wild-type flies respond to more complex and conflicting motion effects. Conclusions/Significance: We found that dunce(1) responds more strongly than wild type to high contrast and highly structured motion. This effect was found for simple gratings, dots, and combinations of both stimuli presented in competition.	[Evans, Oliver; Paulk, Angelique C.; van Swinderen, Bruno] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland	Evans, O (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	vanswinderen@uq.edu		van Swinderen, Bruno/0000-0001-6552-7418	Australian Research Council [FT100100725]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council Future Fellowship FT100100725 to BVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SK, 2010, P NATL ACAD SCI USA, V107, P13878, DOI 10.1073/pnas.1002436107; BAKER CL, 1991, J NEUROSCI, V11, P454; Bolzon DM, 2009, J NEUROSCI, V29, P14143, DOI 10.1523/JNEUROSCI.2857-09.2009; BORST A, 2010, ANN REV NEUROSCI; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; GOTZ KG, 1970, J EXP BIOL, V52, P419; GOTZ KG, 1973, J COMP PHYSIOL, V85, P235, DOI 10.1007/BF00694232; Haag J, 2010, P NATL ACAD SCI USA, V107, P20104, DOI 10.1073/pnas.1009381107; Heisenberg M., 1984, Vision in Drosophila.Genetics of microbehaviour.; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; KALMUS H, 1964, NATURE, V202, P1156, DOI 10.1038/2021156a0; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Masseck OA, 2009, ANN NY ACAD SCI, V1164, P430, DOI 10.1111/j.1749-6632.2009.03854.x; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nordstrom K, 2009, TRENDS NEUROSCI, V32, P383, DOI 10.1016/j.tins.2009.03.004; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; PFLUGFELDER GO, 1995, COMP BIOCHEM PHYS A, V110, P185, DOI 10.1016/0300-9629(94)00159-Q; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Rubinstein NJ, 2011, INVEST OPHTH VIS SCI, V52, P462, DOI 10.1167/iovs.10-6016; Sareen P, 2011, P NATL ACAD SCI USA, V108, P7230, DOI 10.1073/pnas.1102522108; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Srinivasan MV, 1999, VISION RES, V39, P2749, DOI 10.1016/S0042-6989(99)00002-4; Strauss R, 1997, J EXP BIOL, V200, P1281; STRAW AD, 2008, FRONT NEUROINFORM, DOI DOI 10.3389/NEURO.11.0044.2008; Tang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014455; van Swinderen B, 2007, DEV NEUROBIOL, V67, P129, DOI 10.1002/dneu.20334; van Swinderen B, 2007, SCIENCE, V315, P1590, DOI 10.1126/science.1137931; van Swinderen B, 2010, J NEUROSCI, V30, P1003, DOI 10.1523/JNEUROSCI.4516-09.2010; van Swinderen B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005989; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; Williams IM, 2006, J CLIN NEUROSCI, V13, P828, DOI 10.1016/j.jocn.2005.10.010; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Zhu Y, 2009, CURR BIOL, V19, P613, DOI 10.1016/j.cub.2009.02.053	34	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21619	10.1371/journal.pone.0021619	http://dx.doi.org/10.1371/journal.pone.0021619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738736	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100046
J	Gupta, V; Bassi, DE; Simons, JD; Devarajan, K; Al-Saleem, T; Uzzo, RG; Cukierman, E				Gupta, Vivekanand; Bassi, Daniel E.; Simons, Jeffrey D.; Devarajan, Karthik; Al-Saleem, Tahseen; Uzzo, Robert G.; Cukierman, Edna			Elevated Expression of Stromal Palladin Predicts Poor Clinical Outcome in Renal Cell Carcinoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED FIBROBLASTS; EXTRACELLULAR-MATRIX; MYOFIBROBLASTS; STROMAGENESIS; UTILITY; MARKER	The role that stromal renal cell carcinoma (RCC) plays in support of tumor progression is unclear. Here we sought to determine the predictive value on patient survival of several markers of stromal activation and the feasibility of a fibroblast-derived extracellular matrix (ECM) based three-dimensional (3D) culture stemming from clinical specimens to recapitulate stromal behavior in vitro. The clinical relevance of selected stromal markers was assessed using a well annotated tumor microarray where stromal-marker levels of expression were evaluated and compared to patient outcomes. Also, an in vitro 3D system derived from fibroblasts harvested from patient matched normal kidney, primary RCC and metastatic tumors was employed to evaluate levels and localizations of known stromal markers such as the actin binding proteins palladin, alpha-smooth muscle actin (alpha-SMA), fibronectin and its spliced form EDA. Results suggested that RCCs exhibiting high levels of stromal palladin correlate with a poor prognosis, as demonstrated by overall survival time. Conversely, cases of RCCs where stroma presents low levels of palladin expression indicate increased survival times and, hence, better outcomes. Fibroblast-derived 3D cultures, which facilitate the categorization of stromal RCCs into discrete progressive stromal stages, also show increased levels of expression and stress fiber localization of alpha-SMA and palladin, as well as topographical organization of fibronectin and its splice variant EDA. These observations are concordant with expression levels of these markers in vivo. The study proposes that palladin constitutes a useful marker of poor prognosis in non-metastatic RCCs, while in vitro 3D cultures accurately represent the specific patient's tumor-associated stromal compartment. Our observations support the belief that stromal palladin assessments have clinical relevance thus validating the use of these 3D cultures to study both progressive RCC-associated stroma and stroma-dependent mechanisms affecting tumorigenesis. The clinical value of assessing RCC stromal activation merits further study.	[Gupta, Vivekanand; Bassi, Daniel E.; Simons, Jeffrey D.; Cukierman, Edna] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Bassi, Daniel E.; Al-Saleem, Tahseen] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Uzzo, Robert G.] Fox Chase Canc Ctr, Dept Surg Oncol, Philadelphia, PA 19111 USA; [Devarajan, Karthik] Fox Chase Canc Ctr, Dept Biostat, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Gupta, V (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Edna.Cukierman@fccc.edu	Uzzo, Robert G./U-5238-2019; Cukierman, Edna/A-3951-2013; cukierman, edna/AAU-8932-2020; Gupta, Vivekanand/F-3530-2012	cukierman, edna/0000-0002-1452-9576; 	Fox Chase Cancer Center; American Urological Association Foundation; NCI/NIH [CA113451, CA06927]; NATIONAL CANCER INSTITUTE [R01CA113451, P30CA006927] Funding Source: NIH RePORTER	Fox Chase Cancer Center; American Urological Association Foundation; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Keystone Program in Personalized Kidney Cancer Therapy at Fox Chase Cancer Center (Institutional Funds) to EC, VG, TAS and RGU, an American Urological Association Foundation Research Scholar Program Award to VG (http://www.urologyhealth.org/research/grantprograms.cfm), as well as NCI/NIH CA113451 to EC and CA06927 to all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; BEACHAM DA, 2006, CURR PROTOCOLS CELL; Castello-Cros R, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-94; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; Chometon G, 2009, CLIN TRANSL ONCOL, V11, P75, DOI 10.1007/s12094-009-0317-y; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; GOETZ JG, 2011, CELL IN PRESS   0708; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Goicoechea SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010347; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; KOVACS G, 1989, AM J PATHOL, V134, P27; Kwon Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018872; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lohi J, 1998, HISTOL HISTOPATHOL, V13, P785, DOI 10.14670/HH-13.785; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Pan CC, 2004, HISTOPATHOLOGY, V45, P452, DOI 10.1111/j.1365-2559.2004.01962.x; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Quiros RM, 2008, GYNECOL ONCOL, V110, P99, DOI 10.1016/j.ygyno.2008.03.006; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Salaria SN, 2007, CANCER BIOL THER, V6, P324, DOI 10.4161/cbt.6.3.3904; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; *TEAM RDC, 2005, R PROJ STAT COMP; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Witkiewicz AK, 2008, CELL CYCLE, V7, P3021, DOI 10.4161/cc.7.19.6719	41	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21494	10.1371/journal.pone.0021494	http://dx.doi.org/10.1371/journal.pone.0021494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738681	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800029
J	Vidau, C; Diogon, M; Aufauvre, J; Fontbonne, R; Vigues, B; Brunet, JL; Texier, C; Biron, DG; Blot, N; El Alaoui, H; Belzunces, LP; Delbac, F				Vidau, Cyril; Diogon, Marie; Aufauvre, Julie; Fontbonne, Regis; Vigues, Bernard; Brunet, Jean-Luc; Texier, Catherine; Biron, David G.; Blot, Nicolas; El Alaoui, Hicham; Belzunces, Luc P.; Delbac, Frederic			Exposure to Sublethal Doses of Fipronil and Thiacloprid Highly Increases Mortality of Honeybees Previously Infected by Nosema ceranae	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE DEUTEROMYCOTINA; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; SYSTEMIC INSECTICIDES; BEAUVERIA-BASSIANA; BEE; PESTICIDES; RESISTANCE; TOXICITY; CHLORPYRIFOS	Background: The honeybee, Apis mellifera, is undergoing a worldwide decline whose origin is still in debate. Studies performed for twenty years suggest that this decline may involve both infectious diseases and exposure to pesticides. Joint action of pathogens and chemicals are known to threaten several organisms but the combined effects of these stressors were poorly investigated in honeybees. Our study was designed to explore the effect of Nosema ceranae infection on honeybee sensitivity to sublethal doses of the insecticides fipronil and thiacloprid. Methodology/Finding: Five days after their emergence, honeybees were divided in 6 experimental groups: (i) uninfected controls, (ii) infected with N. ceranae, (iii) uninfected and exposed to fipronil, (iv) uninfected and exposed to thiacloprid, (v) infected with N. ceranae and exposed 10 days post-infection (p. i.) to fipronil, and (vi) infected with N. ceranae and exposed 10 days p. i. to thiacloprid. Honeybee mortality and insecticide consumption were analyzed daily and the intestinal spore content was evaluated 20 days after infection. A significant increase in honeybee mortality was observed when N. ceranae-infected honeybees were exposed to sublethal doses of insecticides. Surprisingly, exposures to fipronil and thiacloprid had opposite effects on microsporidian spore production. Analysis of the honeybee detoxification system 10 days p. i. showed that N. ceranae infection induced an increase in glutathione-S-transferase activity in midgut and fat body but not in 7-ethoxycoumarin-O-deethylase activity. Conclusions/Significance: After exposure to sublethal doses of fipronil or thiacloprid a higher mortality was observed in N. ceranae-infected honeybees than in uninfected ones. The synergistic effect of N. ceranae and insecticide on honeybee mortality, however, did not appear strongly linked to a decrease of the insect detoxification system. These data support the hypothesis that the combination of the increasing prevalence of N. ceranae with high pesticide content in beehives may contribute to colony depopulation.	[Vidau, Cyril; Diogon, Marie; Aufauvre, Julie; Fontbonne, Regis; Vigues, Bernard; Biron, David G.; Blot, Nicolas; El Alaoui, Hicham; Delbac, Frederic] Clermont Univ, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Vidau, Cyril; Diogon, Marie; Aufauvre, Julie; Fontbonne, Regis; Vigues, Bernard; Texier, Catherine; Biron, David G.; Blot, Nicolas; El Alaoui, Hicham; Delbac, Frederic] CNRS, UMR 6023, LMGE, Aubiere, France; [Brunet, Jean-Luc; Belzunces, Luc P.] INRA, UMR Abeilles & Environm 406, Lab Toxicol Environm, Avignon, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); INRAE	Vidau, C (corresponding author), Clermont Univ, Univ Blaise Pascal, Lab Microorganismes Genome & Environm, BP 10448, Clermont Ferrand, France.	frederic.delbac@univ-bpclermont.fr	BRUNET, Jean-Luc/ABE-9178-2021; , Belzunces/P-7061-2019	BRUNET, Jean-Luc/0000-0002-3827-1135; , Belzunces/0000-0003-1798-9962; El Alaoui, Hicham/0000-0003-1926-0905; TOTTEY, Julie/0000-0001-6500-1117; Vidau, Cyril/0000-0002-1972-5648	Centre National de la Recherche Scientifique (CNRS); Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche''	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche''	This work was funded by a grant from the Centre National de la Recherche Scientifique (CNRS, MIE: Maladies Infectieuses et Environnement). C. V. acknowledges the support of a Fellowship from the CNRS. J.A. and R. F. were supported by grants from the "Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mazraawi Mohammad S, 2007, Commun Agric Appl Biol Sci, V72, P549; Alaux C, 2011, J INVERTEBR PATHOL, V106, P380, DOI 10.1016/j.jip.2010.12.005; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Alizadeh A, 2007, Commun Agric Appl Biol Sci, V72, P1011; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Bride JM, 1997, J ECON ENTOMOL, V90, P1514, DOI 10.1093/jee/90.6.1514; Cameron PJ, 2009, CROP PROT, V28, P421, DOI 10.1016/j.cropro.2009.01.002; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cruz AD, 2010, CELL BIOL TOXICOL, V26, P165, DOI 10.1007/s10565-009-9126-x; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; DESOUSA G, 1995, ANAL BIOCHEM, V229, P86, DOI 10.1006/abio.1995.1382; Dussaubat C, 2010, J CHEM ECOL, V36, P522, DOI 10.1007/s10886-010-9786-2; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Ericsson JD, 2007, J ECON ENTOMOL, V100, P31, DOI 10.1603/0022-0493(2007)100[31:SISWTI]2.0.CO;2; Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081; Farenhorst M, 2009, P NATL ACAD SCI USA, V106, P17443, DOI 10.1073/pnas.0908530106; Felix RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-312; Furlong MJ, 2001, J ECON ENTOMOL, V94, P344, DOI 10.1603/0022-0493-94.2.344; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gui ZZ, 2009, J ECON ENTOMOL, V102, P1591, DOI 10.1603/029.102.0425; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2010, APIDOLOGIE, V41, P375, DOI 10.1051/apido/2010019; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; KIEVITS JB, 2009, NEUROTOXIQUES SYSTEM, P10187; LADAS A, 1972, Apidologie, V3, P55, DOI 10.1051/apido:19720103; Lassiter TL, 2009, BRAIN RES BULL, V78, P313, DOI 10.1016/j.brainresbull.2008.09.020; Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009; LI DP, 1994, J INVERTEBR PATHOL, V63, P209, DOI 10.1006/jipa.1994.1038; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mariyono J, 2008, PEST MANAG SCI, V64, P1069, DOI 10.1002/ps.1602; Maxim L, 2007, SCI TOTAL ENVIRON, V376, P1, DOI 10.1016/j.scitotenv.2006.12.052; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; MOHAMED AKA, 1987, MYCOPATHOLOGIA, V99, P99, DOI 10.1007/BF00436913; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; OEPP/EPPO, 2003, B OEPP EPPO, V33, P141; Pachamuthu P, 2000, J ECON ENTOMOL, V93, P60, DOI 10.1603/0022-0493-93.1.60; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Purwar JP, 2006, MICROBIOL RES, V161, P38, DOI 10.1016/j.micres.2005.04.006; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Serebrov V V, 2006, Izv Akad Nauk Ser Biol, P712; Shiotsuki T, 1999, INSECT BIOCHEM MOLEC, V29, P731, DOI 10.1016/S0965-1748(99)00054-5; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; Vidau C, 2009, TOXICOL IN VITRO, V23, P589, DOI 10.1016/j.tiv.2009.01.017; Weddle PW, 2009, PEST MANAG SCI, V65, P1287, DOI 10.1002/ps.1865; YU SJ, 1984, PESTIC BIOCHEM PHYS, V22, P360, DOI 10.1016/0048-3575(84)90029-4; Zibaee A, 2009, BIOCONTROL SCI TECHN, V19, P485, DOI 10.1080/09583150902847127	57	279	287	6	196	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21550	10.1371/journal.pone.0021550	http://dx.doi.org/10.1371/journal.pone.0021550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738706	Green Published, gold			2022-12-25	WOS:000292142800039
J	Deus-de-Oliveira, N; Felix, SP; Carrielo-Gama, C; Fernandes, KV; DaMatta, RA; Machado, OLT				Deus-de-Oliveira, Natalia; Felix, Shayany P.; Carrielo-Gama, Camila; Fernandes, Keysson V.; DaMatta, Renato Augusto; Machado, Olga L. T.			Identification of Critical Amino Acids in the IgE Epitopes of Ric c 1 and Ric c 3 and the Application of Glutamic Acid as an IgE Blocker	PLOS ONE			English	Article							2S ALBUMIN PRECURSOR; RICINUS-COMMUNIS; CROSS-REACTIVITY; STORAGE PROTEIN; CASTOR-OIL; ALLERGENS; POLLEN; POLLINOSIS; SEQUENCE; UPDATE	Background: The allergenicity of Ricinus communis L. (castor bean, Euphorbiaceae) is associated with components of its seeds and pollen. Castor bean allergy has been described not only in laboratory workers, but also in personnel working in oil processing mills, fertilizer retail, the upholstery industry and other industrial fields. In the present study, we describe the critical amino acids in the IgE-binding epitopes in Ric c 1 and Ric c 3, two major allergens of R. communis. In addition, we also investigate the cross-reactivity between castor bean and some air and food allergen extracts commonly used in allergy diagnosis. Methodology/Principal Findings: The IgE reactivity of human sera from atopic patients was screened by immune-dot blot against castor bean allergens. Allergenic activity was evaluated in vitro using a rat mast cell activation assay and by ELISA. Cross-reactivity was observed between castor bean allergens and extracts from shrimp, fish, gluten, wheat, soybean, peanut, corn, house dust, tobacco and airborne fungal allergens. We observed that treatment of rat and human sera (from atopic patients) with glutamic acid reduced the IgE-epitope interaction. Conclusions/Significance: The identification of glutamic acid residues with critical roles in IgE-binding to Ric c 3 and Ric c 1 support the potential use of free amino acids in allergy treatment.	[Deus-de-Oliveira, Natalia; Felix, Shayany P.; Carrielo-Gama, Camila; Fernandes, Keysson V.; Machado, Olga L. T.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil; [DaMatta, Renato Augusto] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biol Celular & Tecidual, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Deus-de-Oliveira, N (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil.	olgauenf@yahoo.com.br	Machado, Olga LT/G-7461-2012; DaMatta, Renato/G-8367-2015; Machado, Olga/P-1944-2019	DaMatta, Renato/0000-0002-0108-9268; Machado, Olga/0000-0003-0647-1762	CNPq; CAPES; FAPERJ	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants CNPq, CAPES (graduate fellowships), and FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam MM, 2005, BIOMASS BIOENERG, V29, P293, DOI 10.1016/j.biombioe.2005.05.001; Bashir MEH, 1998, INT ARCH ALLERGY IMM, V115, P73, DOI 10.1159/000023833; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J., 2002, Allergy (Copenhagen), V57, P841, DOI 10.1034/j.1398-9995.2002.23625.x; Chan SL, 2008, J IMMUNOL, V181, P2586, DOI 10.4049/jimmunol.181.4.2586; Conceicao MM, 2005, ENERG FUEL, V19, P2185, DOI 10.1021/ef050016g; D'Amato G, 1998, ALLERGY, V53, P567, DOI 10.1111/j.1398-9995.1998.tb03932.x; daSilva JG, 1996, ARCH BIOCHEM BIOPHYS, V336, P10, DOI 10.1006/abbi.1996.0526; DUNN BM, 1974, J BIOL CHEM, V249, P3717; Egger M, 2006, ALLERGY, V61, P461, DOI 10.1111/j.1398-9995.2006.00994.x; Felix SP, 2008, PEPTIDES, V29, P497, DOI 10.1016/j.peptides.2007.12.013; Garcia-Gonzalez JJ, 1999, CLIN EXP ALLERGY, V29, P1265; IRWIN SD, 1990, MOL GEN GENET, V222, P400, DOI 10.1007/BF00633846; Klinglmayr E, 2009, ALLERGY, V64, P647, DOI 10.1111/j.1398-9995.2008.01844.x; MACHADO OLT, 1992, BRAZ J MED BIOL RES, V25, P567; MACHADO OLT, 2005, Patent No. 05066484; Ogunniyi DS, 2006, BIORESOURCE TECHNOL, V97, P1086, DOI 10.1016/j.biortech.2005.03.028; SHARIEF FS, 1982, J BIOL CHEM, V257, P4753; Singh A, 1997, J INVEST ALLERG CLIN, V7, P169; SINHA U, 1985, ANAL BIOCHEM, V151, P327, DOI 10.1016/0003-2697(85)90183-6; THORPE SC, 1988, J ALLERGY CLIN IMMUN, V82, P67, DOI 10.1016/0091-6749(88)90053-X; THORPE SC, 1988, J ALLERGY CLIN IMMUN, V82, P62, DOI 10.1016/0091-6749(88)90052-8; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; YOST DA, 1982, J BIOL CHEM, V257, P767	24	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21455	10.1371/journal.pone.0021455	http://dx.doi.org/10.1371/journal.pone.0021455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738671	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600043
J	Kitamura, E; Gribanova, YE; Farber, DB				Kitamura, Eiko; Gribanova, Yekaterina E.; Farber, Debora B.			Regulation of Retinoschisin Secretion in Weri-Rb1 Cells by the F-Actin and Microtubule Cytoskeleton	PLOS ONE			English	Article							X-LINKED RETINOSCHISIS; JUVENILE RETINOSCHISIS; MAST-CELLS; GRANULE EXOCYTOSIS; PROTEIN-KINASE; SMOOTH-MUSCLE; VESICLE TRANSPORT; GENE-THERAPY; MOUSE MODEL; CYCLIC-GMP	Retinoschisin is encoded by the gene responsible for X-linked retinoschisis (XLRS), an early onset macular degeneration that results in a splitting of the inner layers of the retina and severe loss in vision. Retinoschisin is predominantly expressed and secreted from photoreceptor cells as a homo-oligomer protein; it then associates with the surface of retinal cells and maintains the retina cellular architecture. Many missense mutations in the XLRS1 gene are known to cause intracellular retention of retinoschisin, indicating that the secretion process of the protein is a critical step for its normal function in the retina. However, the molecular mechanisms underlying retinoschisin's secretion remain to be fully elucidated. In this study, we investigated the role of the F-actin cytoskeleton in the secretion of retinoschisin by treating Weri-Rb1 cells, which are known to secrete retinoschisin, with cytochalasin D, jasplakinolide, Y-27632, and dibutyryl cGMP. Our results show that cytochalasin D and jasplakinolide inhibit retinoschisin secretion, whereas Y-27632 and dibutyryl cGMP enhance secretion causing F-actin alterations. We also demonstrate that high concentrations of taxol, which hyperpolymerizes microtubules, inhibit retinoschisin secretion. Our data suggest that retinoschisin secretion is regulated by the F-actin cytoskeleton, that cGMP or inhibition of ROCK alters F-actin structure enhancing the secretion, and that the microtubule cytoskeleton is also involved in this process.	[Kitamura, Eiko; Gribanova, Yekaterina E.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Kitamura, Eiko; Gribanova, Yekaterina E.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kitamura, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	farber@jsei.ucla.edu		Farber, Debora/0000-0002-3207-697X	National Eye Institute [EY 08285]; NATIONAL EYE INSTITUTE [P30EY000331, R01EY008285] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute grant EY 08285 (http://www.nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boran MS, 2007, J NEUROCHEM, V102, P216, DOI 10.1111/j.1471-4159.2007.04464.x; BOROVIKOV YS, 1995, J CELL SCI, V108, P657; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Carbajal ME, 1997, ENDOCRINOLOGY, V138, P5374, DOI 10.1210/en.138.12.5374; da Costa SR, 1998, J CELL SCI, V111, P1267; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Farber DB, 1997, CURR OPIN NEUROBIOL, V7, P666, DOI 10.1016/S0959-4388(97)80087-6; Feil Robert, 2008, V184, P529; Flaumenhaft R, 2005, BLOOD, V105, P3879, DOI 10.1182/blood-2004-04-1392; Gehrig AE, 1999, MAMM GENOME, V10, P303, DOI 10.1007/s003359900991; GEORGE NDL, 1995, BRIT J OPHTHALMOL, V79, P697, DOI 10.1136/bjo.79.7.697; Giau R, 2005, J NEUROSCI, V25, P8995, DOI 10.1523/JNEUROSCI.2430-05.2005; Grayson C, 2000, HUM MOL GENET, V9, P1873, DOI 10.1093/hmg/9.12.1873; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HAMMALVAREZ SF, 1993, J CELL SCI, V106, P955; Hammar E, 2009, ENDOCRINOLOGY, V150, P2072, DOI 10.1210/en.2008-1135; Jin J, 2008, INT J BIOCHEM CELL B, V40, P2240, DOI 10.1016/j.biocel.2008.03.004; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991; Kjellstrom S, 2007, INVEST OPHTH VIS SCI, V48, P3837, DOI 10.1167/iovs.07-0203; Ko ML, 2008, INVEST OPHTH VIS SCI, V49, P1615, DOI 10.1167/iovs.07-1189; KOFFER A, 1990, J CELL BIOL, V111, P919, DOI 10.1083/jcb.111.3.919; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; Lecuona E, 2003, MOL BIOL CELL, V14, P3888, DOI 10.1091/mbc.E02-12-0781; Lucas KA, 2000, PHARMACOL REV, V52, P375; Lyubchenko TA, 2003, J PHYSIOL-LONDON, V547, P835, DOI 10.1113/jphysiol.2002.033522; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; MCFALL RC, 1977, CANCER RES, V37, P1003; Min SH, 2005, MOL THER, V12, P644, DOI 10.1016/j.ymthe.2005.06.002; Molday LL, 2007, J BIOL CHEM, V282, P32792, DOI 10.1074/jbc.M706321200; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Pendleton A, 2001, CELL MOTIL CYTOSKEL, V48, P37; Persson PB, 2003, J PHYSIOL-LONDON, V552, P667, DOI 10.1113/jphysiol.2003.049890; Reid SNM, 1999, GENE, V227, P257, DOI 10.1016/S0378-1119(98)00578-2; Reid SNM, 2003, J NEUROSCI, V23, P6030, DOI 10.1523/JNEUROSCI.23-14-06030.2003; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sauer CG, 1997, NAT GENET, V17, P164, DOI 10.1038/ng1097-164; Sauzeau V, 2003, J BIOL CHEM, V278, P9472, DOI 10.1074/jbc.M212776200; Shi L, 2009, J BIOL CHEM, V284, P3966, DOI 10.1074/jbc.M806333200; Steiner-Champliaud MF, 2006, MOL VIS, V12, P892; Stephen R, 2008, PHOTOCHEM PHOTOBIOL, V84, P903, DOI 10.1111/j.1751-1097.2008.00323.x; Sullivan R, 1999, J BIOL CHEM, V274, P38140, DOI 10.1074/jbc.274.53.38140; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Takada Y, 2004, INVEST OPHTH VIS SCI, V45, P3302, DOI 10.1167/iovs.04-0156; TANNENBAUM J, 1983, MOL CELL BIOL, V3, P132, DOI 10.1128/MCB.3.1.132; Tashiro K, 2003, J CELL PHYSIOL, V197, P409, DOI 10.1002/jcp.10370; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Unno T, 1999, BRIT J PHARMACOL, V127, P1703, DOI 10.1038/sj.bjp.0702711; Vijayasarathy C, 2007, INVEST OPHTH VIS SCI, V48, P991, DOI 10.1167/iovs.06-0915; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wang T, 2002, HUM MOL GENET, V11, P3097, DOI 10.1093/hmg/11.24.3097; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weber BHF, 2002, P NATL ACAD SCI USA, V99, P6222, DOI 10.1073/pnas.092528599; Wu WWH, 2005, J BIOL CHEM, V280, P10721, DOI 10.1074/jbc.M413117200; Zeng Y, 2004, INVEST OPHTH VIS SCI, V45, P3279, DOI 10.1167/iovs.04-0576; Zulauf L, 2009, BIOCHEM BIOPH RES CO, V390, P1408, DOI 10.1016/j.bbrc.2009.10.166	62	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20707	10.1371/journal.pone.0020707	http://dx.doi.org/10.1371/journal.pone.0020707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738583	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600007
J	LaConti, JJ; Shivapurkar, N; Preet, A; Mays, AD; Peran, I; Kim, SE; Marshall, JL; Riegel, AT; Wellstein, A				LaConti, Joseph J.; Shivapurkar, Narayan; Preet, Anju; Mays, Anne Deslattes; Peran, Ivana; Kim, Sung Eun; Marshall, John L.; Riegel, Anna T.; Wellstein, Anton			Tissue and Serum microRNAs in the Kras(G12D) Transgenic Animal Model and in Patients with Pancreatic Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; DUCTAL ADENOCARCINOMAS; EXPRESSION PROFILES; BIOMARKERS; TUMORS; PLASMA; SIGNATURE; COOPERATE; MECHANISM; FEATURES	microRNAs (miRs) modulate the expression levels of mRNAs and proteins and can thus contribute to cancer initiation and progression. In addition to their intracelluar function, miRs are released from cells and shed into the circulation. We postulated that circulating miRs could provide insight into pathways altered during cancer progression and may indicate responses to treatment. Here we focus on pancreatic cancer malignant progression. We report that changes in miR expression patterns during progression of normal tissues to invasive pancreatic adenocarcinoma in the p48-Cre/LSL-Kras(G12D) mouse model mirrors the miR changes observed in human pancreatic cancer tissues. miR-148a/b and miR-375 expression were found decreased whereas miR-10, miR-21, miR-100 and miR-155 were increased when comparing normal tissues, premalignant lesions and invasive carcinoma in the mouse model. Predicted target mRNAs FGFR1 (miR-10) and MLH1 (miR-155) were found downregulated. Quantitation of nine microRNAs in plasma samples from patients distinguished pancreatic cancers from other cancers as well as non-cancerous pancreatic disease. Finally, gemcitabine treatment of control animals and p48-Cre/LSL-Kras(G12D) animals with pancreatic cancer caused distinct and up to 60-fold changes in circulating miRs that indicate differential drug effects on normal and cancer tissues. These findings support the significance of detecting miRs in the circulation and suggests that circulating miRs could serve as indicators of drug response.	[LaConti, Joseph J.; Shivapurkar, Narayan; Preet, Anju; Mays, Anne Deslattes; Peran, Ivana; Kim, Sung Eun; Marshall, John L.; Riegel, Anna T.; Wellstein, Anton] Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20007 USA	Georgetown University	LaConti, JJ (corresponding author), Georgetown Univ, Lombardi Canc Ctr, Washington, DC 20007 USA.	nms35@georgetown.edu; wellstea@georgetown.edu	Peran, Ivana/AAL-7480-2020	Peran, Ivana/0000-0001-7399-7452; Deslattes Mays, Anne/0000-0001-7951-3439; Wellstein, Anton/0000-0002-0570-4950	National Institutes of Health [CA108440]; US DOD CDMRP; Lombardi Cancer Center; Gordon Foundation; Lustgarten Foundation; Ruesch Center; NATIONAL CANCER INSTITUTE [R01CA108440, R01CA071508] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US DOD CDMRP(United States Department of Defense); Lombardi Cancer Center; Gordon Foundation; Lustgarten Foundation; Ruesch Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by National Institutes of Health grant CA108440 (AW), US DOD CDMRP (JJL), the Lombardi Cancer Center (NS), the Gordon Foundation (AW), the Lustgarten Foundation (ATR) and the Ruesch Center (JLM and AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buchholz M, 2005, CLIN CANCER RES, V11, P8048, DOI 10.1158/1078-0432.CCR-05-1274; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Gibby KA, 2009, P NATL ACAD SCI USA, V106, P8585, DOI 10.1073/pnas.0810952106; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Grutzmann R, 2003, VIRCHOWS ARCH, V443, P508, DOI 10.1007/s00428-003-0884-1; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Logsdon CD, 2003, CANCER RES, V63, P2649; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; MEDER B, 2010, BASIC RES C IN PRESS; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Seux M, 2009, PANCREATOLOGY, V9, P66, DOI 10.1159/000178876; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Singh M, 2007, PANCREATOLOGY, V7, P9, DOI 10.1159/000101873; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; UCAR A, 2010, NAT GENET; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VALERI N, 2010, P NATL ACAD SCI US; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Yamamoto H, 2001, CANCER RES, V61, P3139; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357	73	70	74	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e20687	10.1371/journal.pone.0020687	http://dx.doi.org/10.1371/journal.pone.0020687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738581	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600006
J	Plasilova, M; Chattopadhyay, C; Ghosh, A; Wenzel, F; Demougin, P; Noppen, C; Schaub, N; Szinnai, G; Terracciano, L; Heinimann, K				Plasilova, Martina; Chattopadhyay, Chandon; Ghosh, Apurba; Wenzel, Friedel; Demougin, Philippe; Noppen, Christoph; Schaub, Nathalie; Szinnai, Gabor; Terracciano, Luigi; Heinimann, Karl			Discordant Gene Expression Signatures and Related Phenotypic Differences in Lamin A- and A/C-Related Hutchinson-Gilford Progeria Syndrome (HGPS)	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN PC-1; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; IDIOPATHIC HYPERPHOSPHATASIA; INTERMEDIATE-FILAMENTS; DIABETES-MELLITUS; NUCLEAR LAMINS; BETA-CELL; A-TYPE; OSTEOPROTEGERIN	Hutchinson-Gilford progeria syndrome (HGPS) is a genetic disorder displaying features reminiscent of premature senescence caused by germline mutations in the LMNA gene encoding lamin A and C, essential components of the nuclear lamina. By studying a family with homozygous LMNA mutation (K542N), we showed that HGPS can also be caused by mutations affecting both isoforms, lamin A and C. Here, we aimed to elucidate the molecular mechanisms underlying the pathogenesis in both, lamin A- (sporadic) and lamin A and C-related (hereditary) HGPS. For this, we performed detailed molecular studies on primary fibroblasts of hetero- and homozygous LMNA K542N mutation carriers, accompanied with clinical examinations related to the molecular findings. By assessing global gene expression we found substantial overlap in altered transcription profiles (13.7%; 90/657) in sporadic and hereditary HGPS, with 83.3% (75/90) concordant and 16.7% (15/90) discordant transcriptional changes. Among the concordant ones we observed down-regulation of TWIST2, whose inactivation in mice and humans leads to loss of subcutaneous fat and dermal appendages, and loss of expression in dermal fibroblasts and periadnexial cells from a LMNA K542N/K542N patient further confirming its pivotal role in skin development. Among the discordant transcriptional profiles we identified two key mediators of vascular calcification and bone metabolism, ENPP1 and OPG, which offer a molecular explanation for the major phenotypic differences in vascular and bone disease in sporadic and hereditary HGPS. Finally, this study correlates reduced TWIST2 and OPG expression with increased osteocalcin levels, thereby linking altered bone remodeling to energy homeostasis in hereditary HGPS.	[Plasilova, Martina; Wenzel, Friedel; Schaub, Nathalie; Heinimann, Karl] Univ Basel, Dept Biomed, Res Grp Human Genet, Basel, Switzerland; [Plasilova, Martina; Wenzel, Friedel; Schaub, Nathalie; Heinimann, Karl] Univ Childrens Hosp, Div Med Genet, Basel, Switzerland; [Chattopadhyay, Chandon; Ghosh, Apurba] Inst Child Hlth, Kolkata, India; [Chattopadhyay, Chandon] SB Devi Char Home, Kolkata, India; [Demougin, Philippe] Univ Basel, Life Sci Training Facil, Basel, Switzerland; [Demougin, Philippe] Univ Basel, Biozentrum, Div Mol Psychol, Basel, Switzerland; [Demougin, Philippe] Univ Basel, Pharmazentrum, Basel, Switzerland; [Noppen, Christoph] Viollier AG, Basel, Switzerland; [Szinnai, Gabor] Univ Childrens Hosp Basel, Div Pediat Endocrinol Diabetol, Basel, Switzerland; [Terracciano, Luigi] Univ Basel, Inst Pathol, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Basel; University of Basel	Plasilova, M (corresponding author), Univ Basel, Dept Biomed, Res Grp Human Genet, Basel, Switzerland.	martina.plasilova@unibas.ch; karl.heinimann@unibas.ch	Terracciano, Luigi M./AAB-5335-2022	Terracciano, Luigi M./0000-0002-9393-9660; Szinnai, Gabor/0000-0003-0559-2597	Novartis Foundation [06B33]; University Children's Hospital of Basel	Novartis Foundation(Novartis); University Children's Hospital of Basel	This work was supported by the Novartis Foundation (Grant No. 06B33) to M.P. and K.H., and in part by the grant (Intramurale Forschungsfoerderung) from the University Children's Hospital of Basel to M.P. and K.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Chong B, 2003, J BONE MINER RES, V18, P2095, DOI 10.1359/jbmr.2003.18.12.2095; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; Cundy T, 2002, HUM MOL GENET, V11, P2119, DOI 10.1093/hmg/11.18.2119; Cundy T, 2005, NEW ENGL J MED, V353, P918, DOI 10.1056/NEJMoa050893; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FREIDENBERG GR, 1992, AM J DIS CHILD, V146, P93, DOI 10.1001/archpedi.1992.02160130095028; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Gastaldelli A, 2010, DIGEST LIVER DIS, V42, P310, DOI 10.1016/j.dld.2010.01.013; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Golledge J, 2004, STROKE, V35, P1636, DOI 10.1161/01.STR.0000129790.00318.a3; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; Lang C, 2003, EUR J CELL BIOL, V82, P143, DOI 10.1078/0171-9335-00305; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liang LL, 2009, ACTA PAEDIATR, V98, P1365, DOI 10.1111/j.1651-2227.2009.01324.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; Marji J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011132; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Minoo P, 2009, HUM PATHOL; Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030; Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; OLIVE M, 2010, ARTERIOSCLER THROMB; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Pereira S, 2008, MECH AGEING DEV, V129, P449, DOI 10.1016/j.mad.2008.04.003; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Piche ME, 2004, DIABETES CARE, V27, P2470, DOI 10.2337/diacare.27.10.2470; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Plasilova M, 2004, J MED GENET, V41, P609, DOI 10.1136/jmg.2004.019661; POLLOCK NK, 2010, J BONE MINER RES; Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490; ROBER RA, 1990, J CELL SCI, V95, P587; ROBER RA, 1989, DEVELOPMENT, V105, P365; Rosen CJ, 2010, CELL, V142, P198, DOI 10.1016/j.cell.2010.07.001; ROSENBLOOM AL, 1983, J PEDIATR-US, V102, P400, DOI 10.1016/S0022-3476(83)80660-X; Rusinol AE, 2006, J CELL SCI, V119, P3265, DOI 10.1242/jcs.03156; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Terracciano LM, 2000, AM J CLIN PATHOL, V114, P754, DOI 10.1309/NR6G-T872-F090-LBRW; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Verstraeten VLRM, 2006, HUM MOL GENET, V15, P2509, DOI 10.1093/hmg/ddl172; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wang J, 2006, J HUM GENET, V51, P934, DOI 10.1007/s10038-006-0042-0; Wang Y, 2008, HUM MOL GENET, V17, P2357, DOI 10.1093/hmg/ddn136; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	86	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21433	10.1371/journal.pone.0021433	http://dx.doi.org/10.1371/journal.pone.0021433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738662	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600041
J	Rane, AA; Chuang, JS; Shah, A; Hu, DP; Dalton, ND; Gu, YS; Peterson, KL; Omens, JH; Christman, KL				Rane, Aboli A.; Chuang, Joyce S.; Shah, Amul; Hu, Diane P.; Dalton, Nancy D.; Gu, Yusu; Peterson, Kirk L.; Omens, Jeffrey H.; Christman, Karen L.			Increased Infarct Wall Thickness by a Bio-Inert Material Is Insufficient to Prevent Negative Left Ventricular Remodeling after Myocardial Infarction	PLOS ONE			English	Article							PDGF-BB; INJECTION; ALGINATE; COLLAGEN; HEART; HYDROGELS; RAT; ANGIOGENESIS; DEGRADATION; EXPANSION	Background: Several injectable materials have been shown to preserve or improve cardiac function as well as prevent or slow left ventricular (LV) remodeling post-myocardial infarction (MI). However, it is unclear as to whether it is the structural support or the bioactivity of these polymers that lead to beneficial effects. Herein, we examine how passive structural enhancement of the LV wall by an increase in wall thickness affects cardiac function post-MI using a bio-inert, non-degradable synthetic polymer in an effort to better understand the mechanisms by which injectable materials affect LV remodeling. Methods and Results: Poly(ethylene glycol) (PEG) gels of storage modulus G' = 0.5 +/- 0.1 kPa were injected and polymerized in situ one week after total occlusion of the left coronary artery in female Sprague Dawley rats. The animals were imaged using magnetic resonance imaging (MRI) at 7 +/- 1 day(s) post-MI as a baseline and again post-injection 49 +/- 4 days after MI. Infarct wall thickness was statistically increased in PEG gel injected vs. control animals (p < 0.01). However, animals in the polymer and control groups showed decreases in cardiac function in terms of end diastolic volume, end systolic volume and ejection fraction compared to baseline (p < 0.01). The cellular response to injection was also similar in both groups. Conclusion: The results of this study demonstrate that passive structural reinforcement alone was insufficient to prevent post-MI remodeling, suggesting that bioactivity and/or cell infiltration due to degradation of injectable materials are likely playing a key role in the preservation of cardiac function, thus providing a deeper understanding of the influencing properties of biomaterials necessary to prevent post-MI negative remodeling.	[Rane, Aboli A.; Chuang, Joyce S.; Shah, Amul; Hu, Diane P.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dalton, Nancy D.; Gu, Yusu; Peterson, Kirk L.; Omens, Jeffrey H.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Rane, AA (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	christman@bioeng.ucsd.edu	Rane, Anders/L-2675-2013; gu, yu/GSD-4507-2022		NIH; NIH Roadmap for Medical Research [1-DP2-OD004309-01]; National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004309] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported in part by the NIH Director's New Innovator Award Program, part of the NIH Roadmap for Medical Research [1-DP2-OD004309-01]. http://commonfund.nih.gov/newinnovator/. A.A.R. would like to thank the National Science Foundation for a Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; Anumolu SS, 2010, BIOMATERIALS, V31, P964, DOI 10.1016/j.biomaterials.2009.10.010; Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Blom AS, 2005, CIRCULATION, V112, P1274, DOI 10.1161/CIRCULATIONAHA.104.499202; Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005; Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; Chuang JS, 2010, MAGN RESON MED, V64, P1281, DOI 10.1002/mrm.22547; CLEUTJENS JPM, 1995, J MOL CELL CARDIOL, V27, P1281, DOI 10.1016/S0022-2828(05)82390-9; Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003; Draget KI, 2003, BIOMACROMOLECULES, V4, P1661, DOI 10.1021/bm034105g; Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055; Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075; Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028; Harris J.M., 1992, POLY ETHYLENE GLYCOL; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860; Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107; Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716; Jackson BM, 2003, AM J PHYSIOL-HEART C, V284, pH475, DOI 10.1152/ajpheart.00360.2002; Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; KHADEMHOSSEINI JBA, 2008, MICRO NANOENGINEERIN; Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420; Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010; Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777; Lloyd-Jones, 2010, CIRCULATION, V121, pE260, DOI 10.1161/CIR.0b013e3181d7cf32; Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143; Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e; Mihardja SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010384; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039; Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056; PATHAK C, 2003, Patent No. 6566406; PFEFFER JM, 1991, AM J PHYSIOL, V260, pH1406, DOI 10.1152/ajpheart.1991.260.5.H1406; PFEFFER MA, 1995, ANNU REV MED, V46, P455, DOI 10.1146/annurev.med.46.1.455; Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c; Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058; Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008; Vick GW, 2009, CURR OPIN CARDIOL, V24, P567, DOI 10.1097/HCO.0b013e3283315553; Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270; Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009; WHITTAKER P, 1991, CIRCULATION, V84, P2123, DOI 10.1161/01.CIR.84.5.2123; Wu DQ, 2009, ACS APPL MATER INTER, V1, P319, DOI 10.1021/am8000456; Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059; Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x	57	83	84	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21571	10.1371/journal.pone.0021571	http://dx.doi.org/10.1371/journal.pone.0021571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731777	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400050
J	Higashi, DL; Biais, N; Weyand, NJ; Agellon, A; Sisko, JL; Brown, LM; So, M				Higashi, Dustin L.; Biais, Nicolas; Weyand, Nathan J.; Agellon, Al; Sisko, Jennifer L.; Brown, Lewis M.; So, Magdalene			N. elongata Produces Type IV Pili That Mediate Interspecies Gene Transfer with N. gonorrhoeae	PLOS ONE			English	Article							DNA UPTAKE SEQUENCE; NEISSERIA-GONORRHOEAE; ANTIGENIC VARIATION; SUBSP GLYCOLYTICA; BACTERIAL PILI; TRANSFORMATION; MENINGITIDIS; PREVALENCE; SPECIMENS; NOV	The genus Neisseria contains at least eight commensal and two pathogenic species. According to the Neisseria phylogenetic tree, commensals are basal to the pathogens. N. elongata, which is at the opposite end of the tree from N. gonorrhoeae, has been observed to be fimbriated, and these fimbriae are correlated with genetic competence in this organism. We tested the hypothesis that the fimbriae of N. elongata are Type IV pili (Tfp), and that Tfp functions in genetic competence. We provide evidence that the N. elongata fimbriae are indeed Tfp. Tfp, as well as the DNA Uptake Sequence (DUS), greatly enhance N. elongata DNA transformation. Tfp allows N. elongata to make intimate contact with N. gonorrhoeae and to mediate the transfer of antibiotic resistance markers between these two species. We conclude that Tfp functional for genetic competence is a trait of a commensal member of the Neisseria genus. Our findings provide a mechanism for the horizontal gene transfer that has been observed among Neisseria species.	[Higashi, Dustin L.; Weyand, Nathan J.; Sisko, Jennifer L.; So, Magdalene] Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA; [Higashi, Dustin L.; Weyand, Nathan J.; Sisko, Jennifer L.; So, Magdalene] Univ Arizona, Inst BIO5, Tucson, AZ USA; [Agellon, Al] Univ Arizona, Univ Spect & Imaging Facil, Tucson, AZ USA; [Biais, Nicolas; Brown, Lewis M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of Arizona; University of Arizona; University of Arizona; Columbia University	Higashi, DL (corresponding author), Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA.	somaggie@email.arizona.edu	So, Magdalene/ABB-8918-2020	So, Magdalene/0000-0001-8301-0674	NIH [AI068033]; BIO5 Institute; College of Medicine, University of Arizona; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIO5 Institute; College of Medicine, University of Arizona; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant AI068033 and funds from the BIO5 Institute and the College of Medicine, University of Arizona awarded to M. So. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho EL, 2005, FEMS MICROBIOL LETT, V249, P327, DOI 10.1016/j.femsle.2005.06.035; Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Ayala BP, 2001, CELL MICROBIOL, V3, P265, DOI 10.1046/j.1462-5822.2001.00112.x; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BOVRE K, 1970, J GEN MICROBIOL, V60, P67, DOI 10.1099/00221287-60-1-67; BOVRE K, 1977, ACTA PATH MICRO IM B, V85, P18; CATLIN BW, 1960, SCIENCE, V131, P608, DOI 10.1126/science.131.3400.608-a; CAUGANT DA, 1994, J CLIN MICROBIOL, V32, P323, DOI 10.1128/JCM.32.2.323-330.1994; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; CONTRERAS M, MICROBIOLOGY, V156, P3282; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Dillard J. P., 2006, CURR PROTOC MICROBIO, V2; Duffin PM, 2010, J BACTERIOL, V192, P4436, DOI 10.1128/JB.00442-10; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; FROHOLM LO, 1973, ACTA PATH MICRO IM B, VB 81, P525; Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; HENRIKSEN SD, 1976, INT J SYST BACTERIOL, V26, P478, DOI 10.1099/00207713-26-4-478; Higashi DL, 2009, MICROBIOL-SGM, V155, P4084, DOI 10.1099/mic.0.032656-0; JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; KNAPP J S, 1988, Clinical Microbiology Reviews, V1, P415; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LUJAN R, 1991, ANTIMICROB AGENTS CH, V35, P300, DOI 10.1128/AAC.35.2.300; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 1996, MOL MED, V2, P745, DOI 10.1007/BF03401658; MILLER K, 1985, J INFECTION, V10, P174, DOI 10.1016/S0163-4453(85)91690-1; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; OSBORNE NG, 1979, SEX TRANSM DIS, V6, P253, DOI 10.1097/00007435-197910000-00006; OTTOW JCG, 1975, ANNU REV MICROBIOL, V29, P79, DOI 10.1146/annurev.mi.29.100175.000455; PARGE HE, 1987, A VAN LEEUW J MICROB, V53, P447, DOI 10.1007/BF00415501; Qvarnstrom Y, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-11; SEGAL E, 1986, P NATL ACAD SCI USA, V83, P2177, DOI 10.1073/pnas.83.7.2177; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; SOX TE, 1979, J BACTERIOL, V138, P510, DOI 10.1128/JB.138.2.510-518.1979; SPARLING PF, 1966, J BACTERIOL, V92, P1364, DOI 10.1128/JB.92.5.1364-1371.1966; Takahashi Satoshi, 2008, Journal of Infection and Chemotherapy, V14, P442, DOI 10.1007/s10156-008-0649-5; Treangen TJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r60; Weyand NJ, 2010, J IMMUNOL, V184, P694, DOI 10.4049/jimmunol.0900522; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Wu HM, 2009, NEW ENGL J MED, V360, P886, DOI 10.1056/NEJMoa0806414; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; ZHANG QY, 1992, P NATL ACAD SCI USA, V89, P5366, DOI 10.1073/pnas.89.12.5366	47	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21373	10.1371/journal.pone.0021373	http://dx.doi.org/10.1371/journal.pone.0021373			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731720	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700069
J	Okamoto, M; Inoue, K; Iwamura, H; Terashima, K; Soya, H; Asashima, M; Kuwabara, T				Okamoto, Masahiro; Inoue, Koshiro; Iwamura, Hiroki; Terashima, Kazuyuki; Soya, Hideaki; Asashima, Makoto; Kuwabara, Tomoko			Reduction in paracrine Wnt3 factors during aging causes impaired adult neurogenesis	FASEB JOURNAL			English	Article						astrocytes; exercise; chromatin; retrotransposon	NEURAL STEM-CELLS; L1 RETROTRANSPOSITION; TREADMILL EXERCISE; DENTATE GYRUS; RAT; AGE; NEURONS; GENE; PROLIFERATION; HIPPOCAMPUS	The mammalian brain contains neural stem cells (NSCs) that enable continued neurogenesis throughout adulthood. However, NSC function and/or numbers decline with increasing age. Adult hippocampal neurogenesis is unique in that astrocytes secreting Wnt3 promote NSC differentiation in a paracrine manner. Here, we show that both the levels of Wnt3 protein and the number of Wnt3-secreting astrocytes influence the impairment of adult neurogenesis during aging. The age-associated reduction in Wnt3 levels affects the regulation of target genes, such as NeuroD1 and retrotransposon L1, as well as the expression of Dcx, which is located adjacent to the L1 loci. Interestingly, the decline in the extrinsic Wnt3 levels and in the intracellular expression of the target genes with aging was reversible. Exercise was found to significantly increase de novo expression of Wnt3 and thereby rescue impaired neurogenesis in aged animals. Furthermore, the chromatin state of NeuroD1, L1, and the L1 loci near Dcx changed relative to Wnt3 levels in an age-or stimulus-associated manner. These results suggest that the regulation of paracrine factors plays a critical role in hippocampal aging and neurogenesis.-Okamoto, M., Inoue, K., Iwamura, H., Terashima, K., Soya, H., Asashima, M., Kuwabara, T. Reduction in paracrine Wnt3 factors during aging causes impaired adult neurogenesis. FASEB J. 25, 3570 - 3582 (2011). www.fasebj.org	[Okamoto, Masahiro; Inoue, Koshiro; Iwamura, Hiroki; Terashima, Kazuyuki; Asashima, Makoto; Kuwabara, Tomoko] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Okamoto, Masahiro; Inoue, Koshiro; Iwamura, Hiroki; Soya, Hideaki] Univ Tsukuba, Lab Exercise Biochem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058574, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Kuwabara, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Cent 4,1-1-4 Higashi, Tsukuba, Ibaraki 3058562, Japan.	hsoya@taiiku.tsukuba.ac.jp; t.warashina@aist.go.jp	Kuwabara, Tomoko/M-1639-2018	Kuwabara, Tomoko/0000-0002-7668-0896	Japan National Institute of Advanced Industrial Science and Technology; Grants-in-Aid for Scientific Research [23240091] Funding Source: KAKEN	Japan National Institute of Advanced Industrial Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Hideto Takimoto and Takahiro Numabe for providing assistance for the care of animals. T.K. and M.A. were supported by various grants from the Japan National Institute of Advanced Industrial Science and Technology. T.K. was partly supported by a Grant-in-Aid for Young Scientists (B) and a Grant-in-Aid for Scientific Research (A).	Campuzano R, 2002, EUR J MED RES, V7, P93; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; des Portes V, 1998, CELL, V92, P51; Driscoll I, 2005, REV NEUROSCIENCE, V16, P87, DOI 10.1515/REVNEURO.2005.16.2.87; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galvan V, 2007, CLIN INTERV AGING, V2, P605; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Gogolla N, 2009, NEURON, V62, P510, DOI 10.1016/j.neuron.2009.04.022; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kim YP, 2004, NEUROSCI LETT, V355, P152, DOI 10.1016/j.neulet.2003.11.005; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lee SMK, 2000, DEVELOPMENT, V127, P457; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; McKinnon PJ, 1996, BRAIN RES, V709, P27, DOI 10.1016/0006-8993(95)01224-9; Miyaoka T, 1999, SCHIZOPHR RES, V38, P1, DOI 10.1016/S0920-9964(98)00179-0; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Okamoto H, 2010, BIOL PSYCHIAT, V68, P521, DOI 10.1016/j.biopsych.2010.04.023; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Piens M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-64; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Sheng JS, 2004, EUR J NEUROSCI, V20, P873, DOI 10.1111/j.1460-9568.2004.03567.x; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Wang CY, 2011, NEUROSCI LETT, V497, P122, DOI 10.1016/j.neulet.2011.04.044; Yu F, 2001, NUCLEIC ACIDS RES, V29, P4493, DOI 10.1093/nar/29.21.4493	45	106	110	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3570	3582		10.1096/fj.11-184697	http://dx.doi.org/10.1096/fj.11-184697			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21746862				2022-12-25	WOS:000295356400027
J	Liu, DW; Hsu, CH; Tsai, SM; Hsiao, CD; Wang, WP				Liu, Da-Wei; Hsu, Chia-Hao; Tsai, Su-Mei; Hsiao, Chung-Der; Wang, Wen-Pin			A Variant of Fibroblast Growth Factor Receptor 2 (Fgfr2) Regulates Left-Right Asymmetry in Zebrafish	PLOS ONE			English	Article							LEFT-RIGHT AXIS; KUPFFERS VESICLE; STRUCTURAL BASIS; VISCERAL ORGANS; NODAL FLOW; EMBRYOS; BRAIN; HEART; SPECIFICATION; ESTABLISHMENT	Many organs in vertebrates are left-right asymmetrical located. For example, liver is at the right side and stomach is at the left side in human. Fibroblast growth factor (Fgf) signaling is important for left-right asymmetry. To investigate the roles of Fgfr2 signaling in zebrafish left-right asymmetry, we used splicing blocking morpholinos to specifically block the splicing of fgfr2b and fgfr2c variants, respectively. We found that the relative position of the liver and the pancreas were disrupted in fgfr2c morphants. Furthermore, the left-right asymmetry of the heart became random. Expression pattern of the laterality controlling genes, spaw and pitx2c, also became random in the morphants. Furthermore, lefty1 was not expressed in the posterior notochord, indicating that the molecular midline barrier had been disrupted. It was also not expressed in the brain diencephalon. Kupffer's vesicle (KV) size became smaller in fgfr2c morphants. Furthermore, KV cilia were shorter in fgfr2c morphants. We conclude that the fgfr2c isoform plays an important role in the left-right asymmetry during zebrafish development.	[Liu, Da-Wei; Tsai, Su-Mei; Wang, Wen-Pin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Hsu, Chia-Hao; Wang, Wen-Pin] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan	Tzu Chi University; Tzu Chi University; Chung Yuan Christian University; Chung Yuan Christian University	Liu, DW (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	wpwang@mail.tcu.edu.tw	Hsiao, Chung-Der/W-4535-2019	Hsiao, Chung-Der/0000-0002-6398-8672; HSU, CHIA-HAO/0000-0001-6920-0316	National Science Council [NSC96-2311-B-320-002-MY2]; Tzu Chi University [TCMRC-P-99013-01]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu Chi University	This work was supported by grants from National Science Council (NSC96-2311-B-320-002-MY2) and Tzu Chi University (TCMRC-P-99013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Amack JD, 2007, DEV BIOL, V310, P196, DOI 10.1016/j.ydbio.2007.05.039; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Cheng PY, 2008, DEVELOPMENT, V135, P941, DOI 10.1242/dev.010595; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Fischer A, 2002, CURR BIOL, V12, P1807, DOI 10.1016/S0960-9822(02)01222-8; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Itoh N, 2007, ZEBRAFISH, V4, P179, DOI 10.1089/zeb.2007.0509; Kreiling JA, 2007, DEV DYNAM, V236, P1963, DOI 10.1002/dvdy.21191; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nakayama Y, 2008, DEV BIOL, V313, P752, DOI 10.1016/j.ydbio.2007.11.013; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Oteiza P, 2008, DEVELOPMENT, V135, P2807, DOI 10.1242/dev.022228; Oviedo NJ, 2007, CELL, V129, P645, DOI 10.1016/j.cell.2007.05.005; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Scholpp S, 2004, DEV GENES EVOL, V214, P285, DOI 10.1007/s00427-004-0409-1; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Supatto W, 2008, BIOPHYS J, V95, pL29, DOI 10.1529/biophysj.108.137786; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tian T, 2009, BIOCHEM BIOPH RES CO, V380, P537, DOI 10.1016/j.bbrc.2009.01.111; Tonou-Fujimori Noriko, 2002, Gene Expression Patterns, V2, P183, DOI 10.1016/S0925-4773(02)00422-7; Wang WD, 2006, BIOCHEM BIOPH RES CO, V347, P979, DOI 10.1016/j.bbrc.2006.06.174; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yamauchi H, 2009, DEV BIOL, V332, P177, DOI 10.1016/j.ydbio.2009.05.568; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263	40	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21793	10.1371/journal.pone.0021793	http://dx.doi.org/10.1371/journal.pone.0021793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747958	Green Submitted, gold, Green Published			2022-12-25	WOS:000292293400034
J	Schubert, G; Stoneking, CJ; Arandjelovic, M; Boesch, C; Eckhardt, N; Hohmann, G; Langergraber, K; Lukas, D; Vigilant, L				Schubert, Grit; Stoneking, Colin J.; Arandjelovic, Mimi; Boesch, Christophe; Eckhardt, Nadin; Hohmann, Gottfried; Langergraber, Kevin; Lukas, Dieter; Vigilant, Linda			Male-Mediated Gene Flow in Patrilocal Primates	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; CHIMPANZEES PAN-TROGLODYTES; EXTRA-GROUP PATERNITY; WILD CHIMPANZEES; SPIDER MONKEYS; PAIR PATERNITY; MOUSE LEMUR; POPULATION; DNA; BONOBOS	Background: Many group-living species display strong sex biases in dispersal tendencies. However, gene flow mediated by apparently philopatric sex may still occur and potentially alters population structure. In our closest living evolutionary relatives, dispersal of adult males seems to be precluded by high levels of territoriality between males of different groups in chimpanzees, and has only been observed once in bonobos. Still, male-mediated gene flow might occur through rare events such as extra-group matings leading to extra-group paternity (EGP) and female secondary dispersal with offspring, but the extent of this gene flow has not yet been assessed. Methodology/Principal Findings: Using autosomal microsatellite genotyping of samples from multiple groups of wild western chimpanzees (Pan troglodytes verus) and bonobos (Pan paniscus), we found low genetic differentiation among groups for both males and females. Characterization of Y-chromosome microsatellites revealed levels of genetic differentiation between groups in bonobos almost as high as those reported previously in eastern chimpanzees, but lower levels of differentiation in western chimpanzees. By using simulations to evaluate the patterns of Y-chromosomal variation expected under realistic assumptions of group size, mutation rate and reproductive skew, we demonstrate that the observed presence of multiple and highly divergent Y-haplotypes within western chimpanzee and bonobo groups is best explained by successful male-mediated gene flow. Conclusions/Significance: The similarity of inferred rates of male-mediated gene flow and published rates of EGP in western chimpanzees suggests this is the most likely mechanism of male-mediated gene flow in this subspecies. In bonobos more data are needed to refine the estimated rate of gene flow. Our findings suggest that dispersal patterns in these closely related species, and particularly for the chimpanzee subspecies, are more variable than previously appreciated. This is consistent with growing recognition of extensive behavioral variation in chimpanzees and bonobos.	[Schubert, Grit; Arandjelovic, Mimi; Boesch, Christophe; Eckhardt, Nadin; Hohmann, Gottfried; Langergraber, Kevin; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Schubert, Grit] Robert Koch Inst, Jr Res Grp Novel Zoonoses, D-1000 Berlin, Germany; [Stoneking, Colin J.] Univ Cambridge Emmanuel Coll, Cambridge CB2 3AP, England; [Langergraber, Kevin] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Lukas, Dieter] Univ Cambridge, Dept Zool, Large Anim Res Grp, Cambridge, England	Max Planck Society; Robert Koch Institute; University of Cambridge; Boston University; University of Cambridge	Schubert, G (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	vigilant@eva.mpg.de		Arandjelovic, Mimi/0000-0001-8920-9684; Lukas, Dieter/0000-0002-7141-3545	Max Planck Society; L.S.B. Leakey Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); L.S.B. Leakey Foundation	This study was financed by the Max Planck Society and supported by a grant from the L.S.B. Leakey Foundation to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann J, 1996, P NATL ACAD SCI USA, V93, P5797, DOI 10.1073/pnas.93.12.5797; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Arandjelovic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014761; Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2008, AM J PRIMATOL, V70, P519, DOI 10.1002/ajp.20524; Bradley BJ, 2001, CONSERV GENET, V2, P179, DOI 10.1023/A:1011847528045; Cant MA, 2001, J ZOOL, V254, P155, DOI 10.1017/S0952836901000668; Clutton-Brock TH, 2006, BIOL LETTERS, V2, P513, DOI 10.1098/rsbl.2006.0531; Clutton-Brock T. H., 1988, REPROD SUCCESS; Coulon A, 2006, P ROY SOC B-BIOL SCI, V273, P341, DOI 10.1098/rspb.2005.3329; DeYoung RW, 2005, J WILDLIFE MANAGE, V69, P1362, DOI 10.2193/0022-541X(2005)69[1362:TMTGTI]2.0.CO;2; Di Fiore A, 2003, YEARB PHYS ANTHROPOL, V46, P62, DOI 10.1002/ajpa.10382; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Eriksson J, 2004, MOL ECOL, V13, P3425, DOI 10.1111/j.1365-294X.2004.02332.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; FEDIGAN L M, 1984, Primates, V25, P279, DOI 10.1007/BF02382267; Fietz J, 2000, BEHAV ECOL SOCIOBIOL, V49, P8, DOI 10.1007/s002650000269; FOLEY RA, 1989, COMP SOCIOECOLOGY BE, P473; Gauffre B, 2009, P R SOC B, V276, P3487, DOI 10.1098/rspb.2009.0881; Gerloff U, 1999, P ROY SOC B-BIOL SCI, V266, P1189, DOI 10.1098/rspb.1999.0762; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Goodall J., 1979, GREAT APES, P13; Goossens B, 1998, BEHAV ECOL SOCIOBIOL, V43, P281, DOI 10.1007/s002650050492; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guschanski K, 2008, CURR BIOL, V18, P1809, DOI 10.1016/j.cub.2008.10.031; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammond RL, 2006, P ROY SOC B-BIOL SCI, V273, P479, DOI 10.1098/rspb.2005.3257; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Harris TR, 2009, MOL ECOL, V18, P1777, DOI 10.1111/j.1365-294X.2009.04139.x; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hohmann G, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P138, DOI 10.1017/CBO9780511606397.014; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Hohmann G, 2001, PRIMATES, V42, P91, DOI 10.1007/BF02640692; Hohmann G., 2003, PAN AFR NEWS, V10, P25, DOI DOI 10.5134/143430; HOLEKAMP KE, 1984, BEHAV ECOL SOCIOBIOL, V16, P21, DOI 10.1007/BF00293100; Idani G., 1990, African Study Monographs, V11, P153; Isvaran K, 2007, P ROY SOC B-BIOL SCI, V274, P219, DOI 10.1098/rspb.2006.3723; Jack KM, 2009, BEHAVIOUR, V146, P471, DOI 10.1163/156853909X404420; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KANO T, 1982, Primates, V23, P171, DOI 10.1007/BF02381159; Kano T., 1992, LAST APE PYGMY CHIMP; Kayser M, 2006, GENETICS, V173, P2179, DOI 10.1534/genetics.106.055632; LANGERGRABER KE, 2010, P ROYAL SOC B; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Marlowe FW, 2004, CURR ANTHROPOL, V45, P277, DOI 10.1086/382256; MCCRACKEN GF, 1981, BEHAV ECOL SOCIOBIOL, V8, P11, DOI 10.1007/BF00302840; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; MELNICK DJ, 1993, MOL BIOL EVOL, V10, P282; Moller LM, 2004, MOL ECOL, V13, P1607, DOI 10.1111/j.1365-294X.2004.02137.x; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; Munshi-South J, 2007, BEHAV ECOL SOCIOBIOL, V62, P201, DOI 10.1007/s00265-007-0454-7; Murdock G. P., 1981, ATLAS WORLD CULTURES; Nagy M, 2007, P ROY SOC B-BIOL SCI, V274, P3019, DOI 10.1098/rspb.2007.1008; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Newton-Fisher NE, 1999, FOLIA PRIMATOL, V70, P167, DOI 10.1159/000021690; Newton-Fisher NE, 2010, AM J PHYS ANTHROPOL, V142, P417, DOI 10.1002/ajpa.21241; Nichols J., 2001, DISPERSAL; NISHIDA T, 1985, Z TIERPSYCHOL, V67, P284; Nishida T., 1990, CHIMPANZEES MAHALE M; Nishimura A, 2003, INT J PRIMATOL, V24, P707, DOI 10.1023/A:1024681703616; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Pusey A, 1979, GREAT APES, P465; Radespiel U, 2008, AM J PRIMATOL, V70, P860, DOI 10.1002/ajp.20574; RODSETH L, 1991, CURR ANTHROPOL, V32, P221, DOI 10.1086/203952; Segurel L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000200; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; SOULSBURY CD, 2010, PLOS ONE, V5, P1; STRIER KB, 1990, INT J PRIMATOL, V11, P7, DOI 10.1007/BF02193693; Struhsaker T.T., 1975, RED COLOBUS MONKEY; Sweitzer RA, 1998, J ZOOL, V244, P159; SYMINGTON MM, 1987, BEHAV ECOL SOCIOBIOL, V20, P421, DOI 10.1007/BF00302985; Thompson ME, 2006, INT J PRIMATOL, V27, P1601, DOI 10.1007/s10764-006-9098-0; Townsend SW, 2007, CURR BIOL, V17, pR355, DOI 10.1016/j.cub.2007.03.020; Van Horn RC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1823, DOI 10.1007/s00265-007-0415-1; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Watts DP, 2001, BEHAVIOUR, V138, P299, DOI 10.1163/15685390152032488; Wegmann D, 2010, MOL BIOL EVOL, V27, P1425, DOI 10.1093/molbev/msq028; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Wilson ML, 2003, ANNU REV ANTHROPOL, V32, P363, DOI 10.1146/annurev.anthro.32.061002.120046; Wimmer B, 2002, BEHAV ECOL SOCIOBIOL, V52, P166, DOI 10.1007/s00265-002-0497-8; Wright S, 1943, GENETICS, V28, P114; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; Young AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1603, DOI 10.1098/rspb.2007.0316	99	34	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21514	10.1371/journal.pone.0021514	http://dx.doi.org/10.1371/journal.pone.0021514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747938	gold, Green Published, Green Submitted			2022-12-25	WOS:000292293400014
J	Kim, HJ; Joo, HJ; Kim, YH; Ahn, S; Chang, J; Hwang, KB; Lee, DH; Lee, KJ				Kim, Hee-Jung; Joo, Hye Joon; Kim, Yung Hee; Ahn, Soyeon; Chang, Jun; Hwang, Kyu-Baek; Lee, Dong-Hee; Lee, Kong-Joo			Systemic Analysis of Heat Shock Response Induced by Heat Shock and a Proteasome Inhibitor MG132	PLOS ONE			English	Article							UBIQUITIN-DEPENDENT DEGRADATION; INTESTINAL EPITHELIAL-CELLS; NEWLY SYNTHESIZED PROTEINS; STRESS-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; ABNORMAL PROTEINS; GENE-ONTOLOGY; C/EBP-BETA; THERMOTOLERANCE; ACTIVATION	The molecular basis of heat shock response (HSR), a cellular defense mechanism against various stresses, is not well understood. In this, the first comprehensive analysis of gene expression changes in response to heat shock and MG132 (a proteasome inhibitor), both of which are known to induce heat shock proteins (Hsps), we compared the responses of normal mouse fibrosarcoma cell line, RIF- 1, and its thermotolerant variant cell line, TR-RIF-1 (TR), to the two stresses. The cellular responses we examined included Hsp expressions, cell viability, total protein synthesis patterns, and accumulation of poly-ubiquitinated proteins. We also compared the mRNA expression profiles and kinetics, in the two cell lines exposed to the two stresses, using microarray analysis. In contrast to RIF-1 cells, TR cells resist heat shock caused changes in cell viability and whole-cell protein synthesis. The patterns of total cellular protein synthesis and accumulation of poly-ubiquitinated proteins in the two cell lines were distinct, depending on the stress and the cell line. Microarray analysis revealed that the gene expression pattern of TR cells was faster and more transient than that of RIF-1 cells, in response to heat shock, while both RIF-1 and TR cells showed similar kinetics of mRNA expression in response to MG132. We also found that 2,208 genes were up-regulated more than 2 fold and could sort them into three groups: 1) genes regulated by both heat shock and MG132, (e. g. chaperones); 2) those regulated only by heat shock (e. g. DNA binding proteins including histones); and 3) those regulated only by MG132 (e. g. innate immunity and defense related molecules). This study shows that heat shock and MG132 share some aspects of HSR signaling pathway, at the same time, inducing distinct stress response signaling pathways, triggered by distinct abnormal proteins.	[Kim, Hee-Jung; Kim, Yung Hee; Chang, Jun; Lee, Kong-Joo] Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea; [Joo, Hye Joon; Lee, Dong-Hee] Ewha Womans Univ, Div Life & Pharmaceut Sci, Dept Bioinspired Sci, Dept Life Sci, Seoul, South Korea; [Hwang, Kyu-Baek] Soongsil Univ, Sch Comp Sci & Engn, Seoul, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Dept Res & Educ, Songnam, South Korea	Ewha Womans University; Ewha Womans University; Soongsil University; Seoul National University (SNU)	Kim, HJ (corresponding author), Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea.	kjl@ewha.ac.kr		CHANG, JUN/0000-0002-8423-5987; Lee, Kong-Joo/0000-0001-7972-6020	Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR) at Ewha Womans University [R15-2006-020]; WCU [R31-2008-000-10010-0]; Brain Korea 21 (BK21) Project	Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR) at Ewha Womans University; WCU; Brain Korea 21 (BK21) Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported through the Center for Cell Signaling Research and Drug Discovery Research (CCS & DDR, R15-2006-020) at Ewha Womans University from the National Core Research Center (NCRC) program and by WCU project (R31-2008-000-10010-0). HJ Kim and HJ Joo were supported by Brain Korea 21 (BK21) Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibeau-Poirier A, 2008, CYTOKINE, V43, P359, DOI 10.1016/j.cyto.2008.07.012; Bush KT, 1997, J BIOL CHEM, V272, P9086; Caraglia M, 2004, AMINO ACIDS, V26, P409, DOI 10.1007/s00726-004-0085-5; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; Daino H, 2000, BLOOD, V95, P2577; GABAI VL, 1995, FEBS LETT, V375, P21, DOI 10.1016/0014-5793(95)01152-5; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; HAHN GM, 1988, CANCER RES, V48, P1803; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hungness ES, 2002, J AM COLL SURGEONS, V195, P619, DOI 10.1016/S1072-7515(02)01342-X; Hungness ES, 2002, BIOCHEM BIOPH RES CO, V290, P469, DOI 10.1006/bbrc.2001.6168; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kaspari M, 2008, FEBS LETT, V582, P666, DOI 10.1016/j.febslet.2008.01.040; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; Kim HJ, 2007, MOL CELLS, V23, P123; Kim HJ, 2002, MOL CELL BIOCHEM, V229, P139, DOI 10.1023/A:1017941131744; Kim HJ, 2002, J BIOL CHEM, V277, P23193, DOI 10.1074/jbc.M201007200; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEE KJ, 1988, J CELL PHYSIOL, V136, P411, DOI 10.1002/jcp.1041360304; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; Liebermann DA, 2003, BLOOD CELL MOL DIS, V31, P213, DOI 10.1016/S1079-9796(03)00160-8; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MOSSER DD, 1992, J CELL PHYSIOL, V151, P561, DOI 10.1002/jcp.1041510316; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Ott DE, 2003, J VIROL, V77, P3384, DOI 10.1128/JVI.77.6.3384-3393.2003; Park JE, 1998, ARCH PHARM RES, V21, P46, DOI 10.1007/BF03216752; Pinheiro J., 2010, NLME LINEAR NONLINEA, P1; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Robinson PN, 2004, BIOINFORMATICS, V20, P979, DOI 10.1093/bioinformatics/bth040; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SHERMAN MY, 2006, SCI STKE, pPE16; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tacchini L, 2003, INT J BIOCHEM CELL B, V35, P316, DOI 10.1016/S1357-2725(02)00164-4; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Woo Yong, 2004, J Biomol Tech, V15, P276	52	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20252	10.1371/journal.pone.0020252	http://dx.doi.org/10.1371/journal.pone.0020252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738571	Green Submitted, Green Published, gold			2022-12-25	WOS:000292291800003
J	Magnusson, K; Mendes, AM; Windbichler, N; Papathanos, PA; Nolan, T; Dottorini, T; Rizzi, E; Christophides, GK; Crisanti, A				Magnusson, Kalle; Mendes, Antonio M.; Windbichler, Nikolai; Papathanos, Philippos-Aris; Nolan, Tony; Dottorini, Tania; Rizzi, Ermanno; Christophides, George K.; Crisanti, Andrea			Transcription Regulation of Sex-Biased Genes during Ontogeny in the Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; MOLECULAR-CLONING; AEDES-AEGYPTI; EXPRESSION; DROSOPHILA; PROTEIN; MOSQUITOS; EVOLUTION; SPERM; IDENTIFICATION	In Anopheles gambiae, sex-regulated genes are responsible for controlling gender dimorphism and are therefore crucial in determining the ability of female mosquitoes to transmit human malaria. The identification and functional characterization of these genes will shed light on the sexual development and maturation of mosquitoes and provide useful targets for genetic control measures aimed at reducing mosquito fertility and/or distorting the sex ratio. We conducted a genome wide transcriptional analysis of sex-regulated genes from early developmental stages through adulthood combined with functional screening of novel gonadal genes. Our results demonstrate that the male-biased genes undergo a major transcription turnover starting from larval stages to adulthood. The male biased genes at the adult stage include a significant high number of unique sequences compared to the rest of the genome. This is in contrast to female-biased genes that are much more conserved and are mainly activated during late developmental stages. The high frequency of unique sequences would indicate that male-biased genes evolve more rapidly than the rest of the genome. This finding is particularly intriguing because A. gambiae is a strictly female monogamous species suggesting that driving forces in addition to sperm competition must account for the rapid evolution of male-biased genes. We have also identified and functionally characterized a number of previously unknown A. gambiae testis-and ovary-specific genes. Two of these genes, zero population growth and a suppressor of defective silencing 3 domain of the histone deacetylase co-repressor complex, were shown to play a key role in gonad development.	[Magnusson, Kalle; Mendes, Antonio M.; Windbichler, Nikolai; Papathanos, Philippos-Aris; Nolan, Tony; Christophides, George K.; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Dottorini, Tania] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Rizzi, Ermanno] CNR, Ist Tecnol Biomed, Milan, Italy	Imperial College London; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Magnusson, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	acrs@imperial.ac.uk	rizzi, ermanno/Q-3399-2016; Rizzi, Ermanno/J-7448-2012; Papathanos, Philippos/ABE-4869-2021; Nolan, Tony/I-4925-2012	rizzi, ermanno/0000-0002-9898-2326; Nolan, Tony/0000-0002-2982-8333; Papathanos, Philippos Aris/0000-0001-8508-4554; M. Mendes, Antonio/0000-0001-6562-5325; Christophides, George/0000-0002-3323-1687; Dottorini, Tania/0000-0001-7733-906X; Crisanti, Andrea/0000-0002-2406-4426; Windbichler, Nikolai/0000-0001-9896-1165	Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; BBSRC; Biotechnology and Biological Sciences Research Council [BB/E021794/1] Funding Source: researchfish; BBSRC [BB/E021794/1] Funding Source: UKRI	Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Grant of the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative (www.grandchallenges.org/) as well as by a Grant of the BBSRC (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Barillas-Mury C, 2005, CELL MICROBIOL, V7, P1539, DOI 10.1111/j.1462-5822.2005.00615.x; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Carlini DB, 2004, J EVOLUTION BIOL, V17, P779, DOI 10.1111/j.1420-9101.2004.00725.x; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Findlay GD, 2009, GENOME RES, V19, P886, DOI 10.1101/gr.089391.108; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Hahn MW, 2005, CURR BIOL, V15, pR192, DOI 10.1016/j.cub.2005.03.005; Hambuch TM, 2005, GENETICS, V170, P1691, DOI 10.1534/genetics.104.038109; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Iguchi N, 1999, FEBS LETT, V456, P315, DOI 10.1016/S0014-5793(99)00967-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Krzywinski J, 2004, GENETICS, V166, P1291, DOI 10.1534/genetics.166.3.1291; Lebo MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-80; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Sinden RE, 2004, INSECT BIOCHEM MOLEC, V34, P625, DOI 10.1016/j.ibmb.2004.03.015; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tai CT, 2001, CIRCULATION, V104, P1501, DOI 10.1161/hc3801.078813; Tazuke SI, 2002, DEVELOPMENT, V129, P2529; Thoemke K, 2005, DEV BIOL, V284, P500, DOI 10.1016/j.ydbio.2005.05.017; Tripet F, 2003, AM J TROP MED HYG, V68, P1; TRYSELIUS Y, 1992, EUR J BIOCHEM, V204, P395, DOI 10.1111/j.1432-1033.1992.tb16648.x; Tsuchida J, 1998, DEV BIOL, V197, P67, DOI 10.1006/dbio.1998.8885; Vilain E, 1998, MOL GENET METAB, V65, P74, DOI 10.1006/mgme.1998.2749; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Windbichler N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000291; Wolkowicz MJ, 2002, BIOL REPROD, V66, P241, DOI 10.1095/biolreprod66.1.241; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200	44	54	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21572	10.1371/journal.pone.0021572	http://dx.doi.org/10.1371/journal.pone.0021572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738713	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800022
J	Carroll, TD; Matzinger, SR; Fritts, L; McChesney, MB; Miller, CJ				Carroll, Timothy D.; Matzinger, Shannon R.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.			Memory B Cells and CD8+Lymphocytes Do Not Control Seasonal Influenza A Virus Replication after Homologous Re-Challenge of Rhesus Macaques	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; HUMORAL IMMUNE-RESPONSES; CD8(+) T-CELLS; VAGINAL CHALLENGE; SERUM ANTIBODY; PRIMATE MODEL; INFECTION; TRANSMISSION; LYMPHOCYTES; INTERFERON	This study sought to define the role of memory lymphocytes in the protection from homologous influenza A virus re-challenge in rhesus macaques. Depleting monoclonal antibodies (mAb) were administered to the animals prior to their second experimental inoculation with a human seasonal influenza A virus strain. Treatment with either anti-CD8 alpha or anti-CD20 mAbs prior to re-challenge had minimal effect on influenza A virus replication. Thus, in non-human primates with preexisting anti-influenza A antibodies, memory B cells and CD8 alpha(+) T cells do not contribute to the control of virus replication after re-challenge with a homologous strain of influenza A virus.	[Carroll, Timothy D.; Matzinger, Shannon R.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Carroll, Timothy D.; Matzinger, Shannon R.; Fritts, Linda; McChesney, Michael B.; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; [McChesney, Michael B.] Univ Calif Davis, Dept Pathol & Lab Med, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Carroll, TD (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu	Carroll, Timothy D/A-4605-2013	Carroll, Timothy D/0000-0002-3459-3364	National Center for Research Resources [P51RR00169]; National Institute of Allergy and Infectious Disease [U01AI57624, U01AI5726]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI057264] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant P51RR00169 from the National Center for Research Resources and grants U01AI57624 and U01AI5726 from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Baskin CR, 2007, J VIROL, V81, P11817, DOI 10.1128/JVI.00590-07; BERENDT RF, 1974, INFECT IMMUN, V9, P101, DOI 10.1128/IAI.9.1.101-105.1974; Carroll TD, 2010, VACCINE; Carroll TD, 2008, J IMMUNOL, V180, P2385, DOI 10.4049/jimmunol.180.4.2385; Couch R B, 2003, Dev Biol (Basel), V115, P25; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; DELEM A, 1978, J INFECT DIS, V137, P194, DOI 10.1093/infdis/137.2.194; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Gaufin T, 2009, BLOOD, V113, P4250, DOI 10.1182/blood-2008-09-177741; Genesca M, 2009, J INTERN MED, V265, P67, DOI 10.1111/j.1365-2796.2008.02051.x; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; GLEZEN WP, 1982, AM J EPIDEMIOL, V116, P589, DOI 10.1093/oxfordjournals.aje.a113441; GREENBERG SB, 1974, AM J EPIDEMIOL, V100, P209, DOI 10.1093/oxfordjournals.aje.a112029; Hartley CA, 1997, ARCH VIROL, V142, P75, DOI 10.1007/s007050050060; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Miller CJ, 2007, J VIROL, V81, P5024, DOI 10.1128/JVI.02444-06; Miller CJ, 1997, J VIROL, V71, P1911, DOI 10.1128/JVI.71.3.1911-1921.1997; MILLER DL, 1973, J HYG-CAMBRIDGE, V71, P535, DOI 10.1017/S0022172400046520; PYHALA R, 1975, INT J EPIDEMIOL, V4, P127, DOI 10.1093/ije/4.2.127; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimmelzwaan GF, 1997, J GEN VIROL, V78, P757, DOI 10.1099/0022-1317-78-4-757; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Salk JE, 1944, J IMMUNOL, V49, P87; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 2003, J VIROL, V77, P2165, DOI 10.1128/JVI.77.3.2165-2173.2003; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; TEDDER TE, 1994, IMMUNOL TODAY, V15, P450, DOI 10.1016/0167-5699(94)90276-3; TEDDER TE, 1994, IMMUNOL TODAY, V15, P437, DOI 10.1016/0167-5699(94)90274-7; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	40	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21756	10.1371/journal.pone.0021756	http://dx.doi.org/10.1371/journal.pone.0021756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747924	Green Published, Green Submitted, gold			2022-12-25	WOS:000292290100068
J	Pan, WQ; Issaq, S; Zhang, YP				Pan, Wenqi; Issaq, Sameer; Zhang, Yanping			The In Vivo Role of the RP-Mdm2-p53 Pathway in Signaling Oncogenic Stress Induced by pRb Inactivation and Ras Overexpression	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; RIBOSOMAL-PROTEIN L23; ARF TUMOR-SUPPRESSOR; C-MYC; PROSTATE-CANCER; STABILIZES P53; FEEDBACK LOOP; MDM2; INHIBITION; GROWTH	The Mdm2-p53 tumor suppression pathway plays a vital role in regulating cellular homeostasis by integrating a variety of stressors and eliciting effects on cell growth and proliferation. Recent studies have demonstrated an in vivo signaling pathway mediated by ribosomal protein (RP)-Mdm2 interaction that responds to ribosome biogenesis stress and evokes a protective p53 reaction. It has been shown that mice harboring a Cys-to-Phe mutation in the zinc finger of Mdm2 that specifically disrupts RP L11-Mdm2 binding are prone to accelerated lymphomagenesis in an oncogenic c-Myc driven mouse model of Burkitt's lymphoma. Because most oncogenes when upregulated simultaneously promote both cellular growth and proliferation, it therefore stands to reason that the RP-Mdm2-p53 pathway might also be essential in response to oncogenes other than c-Myc. Using genetically engineered mice, we now show that disruption of the RP-Mdm2-p53 pathway by an Mdm2(C305F) mutation does not accelerate prostatic tumorigenesis induced by inactivation of the pRb family proteins (pRb/p107/p130). In contrast, loss of p19Arf greatly accelerates the progression of prostate cancer induced by inhibition of pRb family proteins. Moreover, using ectopically expressed oncogenic H-Ras we demonstrate that p53 response remains intact in the Mdm2(C305F) mutant MEF cells. Thus, unlike the p19Arf-Mdm2-p53 pathway, which is considered a general oncogenic response pathway, the RP-Mdm2-p53 pathway appears to specifically suppress tumorigenesis induced by oncogenic c-Myc.	[Pan, Wenqi; Issaq, Sameer; Zhang, Yanping] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA; [Pan, Wenqi; Issaq, Sameer; Zhang, Yanping] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Pan, Wenqi] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Pan, WQ (corresponding author), Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA.	ypzhang@med.unc.edu			Leukemia and Lymphoma Society [1416-08]; American Cancer Society [MGO-114790]; National Institute of Health [CA100302, CA127770, CA87580]; NATIONAL CANCER INSTITUTE [R01CA100302, R01CA127770, K01CA087580] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants from the Leukemia and Lymphoma Society (No. 1416-08), American Cancer Society (No. MGO-114790), and National Institute of Health (No. CA100302, CA127770, CA87580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Ayrault O, 2006, EXP CELL RES, V312, P1185, DOI 10.1016/j.yexcr.2006.01.027; Bassi DE, 2010, NEOPLASIA, V12, P516, DOI 10.1593/neo.92030; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; CONTI CJ, 1988, CANCER RES, V48, P435; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; DYSON N, 1994, J CELL SCI, P81; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Guo QM, 2000, CANCER RES, V60, P5922; HEIDENBERG HB, 1995, J UROLOGY, V154, P414, DOI 10.1016/S0022-5347(01)67065-4; Hill R, 2005, CELL, V123, P1001, DOI 10.1016/j.cell.2005.09.030; Hill R, 2005, CANCER RES, V65, P10243, DOI 10.1158/0008-5472.CAN-05-1579; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298; Lindstrom MS, 2007, MOL CELL BIOL, V27, P1056, DOI 10.1128/MCB.01307-06; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Perry RP, 2007, GENE, V401, P1, DOI 10.1016/j.gene.2007.07.007; PICKSLEY SM, 1993, BIOESSAYS, V15, P689, DOI 10.1002/bies.950151008; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Roper E, 2001, EMBO REP, V2, P145, DOI 10.1093/embo-reports/kve020; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tolbert D, 2002, MOL CELL BIOL, V22, P370, DOI 10.1128/MCB.22.1.370-377.2002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; YUSPA SH, 1983, J INVEST DERMATOL, V81, pS162, DOI 10.1111/1523-1747.ep12540999; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21625	10.1371/journal.pone.0021625	http://dx.doi.org/10.1371/journal.pone.0021625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747916	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100047
J	Super, H; Romeo, A				Super, Hans; Romeo, August			Feedback Enhances Feedforward Figure-Ground Segmentation by Changing Firing Mode	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; NEURAL MODEL; THALAMIC NEURONS; DISTINCT MODES; MONKEY; V1; SEGREGATION; MECHANISMS; ATTENTION; DISCRIMINATION	In the visual cortex, feedback projections are conjectured to be crucial in figure-ground segregation. However, the precise function of feedback herein is unclear. Here we tested a hypothetical model of reentrant feedback. We used a previous developed 2-layered feedforwardspiking network that is able to segregate figure from ground and included feedback connections. Our computer model data show that without feedback, neurons respond with regular low-frequency (similar to 9 Hz) bursting to a figure-ground stimulus. After including feedback the firing pattern changed into a regular (tonic) spiking pattern. In this state, we found an extra enhancement of figure responses and a further suppression of background responses resulting in a stronger figure-ground signal. Such push-pull effect was confirmed by comparing the figure-ground responses withthe responses to a homogenous texture. We propose that feedback controlsfigure-ground segregation by influencing the neural firing patterns of feedforward projecting neurons.	[Super, Hans] Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Super, Hans; Romeo, August] Univ Barcelona, Fac Psychol, Dept Basic Psychol, Barcelona, Spain; [Super, Hans] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Inst Brain Cognit & Behav IR3C, Barcelona, Spain.	hans.super@icrea.es		Super, Hans/0000-0001-9328-0096	Spanish Ministry of Education and Science (MICINN) [PSI2010-18139, SAF2009-10367]; Catalan government (AGAUR) [2009-SGR-308]; ICREA Funding Source: Custom	Spanish Ministry of Education and Science (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan government (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ICREA(ICREA)	This work was supported by grants to HS (PSI2010-18139 & SAF2009-10367) from the Spanish Ministry of Education and Science (MICINN) and (2009-SGR-308) from Catalan government (AGAUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HA, 2009, J VISION, V9, DOI 10.1167/9.9.2; Andolina IM, 2007, P NATL ACAD SCI USA, V104, P1685, DOI 10.1073/pnas.0609318104; Angelucci A, 2002, J NEUROSCI, V22, P8633; Arnott SR, 2001, COGNITIVE BRAIN RES, V12, P383, DOI 10.1016/S0926-6410(01)00066-0; Baek K, 2005, IEEE T NEUR SYS REH, V13, P125, DOI 10.1109/TNSRE.2005.847388; Bastiaansen MCM, 2001, INT J PSYCHOPHYSIOL, V43, P91, DOI 10.1016/S0167-8760(01)00181-7; Bhatt R, 2007, VISION RES, V47, P3173, DOI 10.1016/j.visres.2007.07.013; Budd JML, 1998, P ROY SOC B-BIOL SCI, V265, P1037, DOI 10.1098/rspb.1998.0396; Corthout E, 1999, NEUROPSYCHOLOGIA, V37, P137; Craft E, 2007, J NEUROPHYSIOL, V97, P4310, DOI 10.1152/jn.00203.2007; De Weerd P, 1999, NAT NEUROSCI, V2, P753, DOI 10.1038/11234; Deco G, 2004, EUR J NEUROSCI, V20, P1089, DOI 10.1111/j.1460-9568.2004.03528.x; Destexhe A, 2002, PHILOS T ROY SOC B, V357, P1649, DOI 10.1098/rstb.2002.1154; Domijan D, 2008, J VISION, V8, DOI 10.1167/8.7.10; Grossberg S, 2001, CEREB CORTEX, V11, P37, DOI 10.1093/cercor/11.1.37; Grossberg S, 2007, PROG BRAIN RES, V165, P79, DOI 10.1016/S0079-6123(06)65006-1; Hayes RD, 2007, CEREB CORTEX, V17, P1117, DOI 10.1093/cercor/bhl021; Huang JY, 2007, BRAIN RES, V1138, P111, DOI 10.1016/j.brainres.2006.12.081; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jehee JFM, 2007, VISION RES, V47, P1153, DOI 10.1016/j.visres.2006.12.018; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Landman R, 2003, J COGNITIVE NEUROSCI, V15, P873, DOI 10.1162/089892903322370799; Le Masson G, 2002, NATURE, V417, P854, DOI 10.1038/nature00825; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Parkes LM, 2004, NEUROIMAGE, V21, P236, DOI 10.1016/j.neuroimage.2003.08.025; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Qiu FTT, 2007, NAT NEUROSCI, V10, P1492, DOI 10.1038/nn1989; Roelfsema PR, 2007, NEURON, V56, P785, DOI 10.1016/j.neuron.2007.10.006; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; Scholte HS, 2006, BRAIN RES, V1076, P106, DOI 10.1016/j.brainres.2005.10.051; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Sillito AM, 2006, TRENDS NEUROSCI, V29, P307, DOI 10.1016/j.tins.2006.05.001; Silvanto J, 2005, NAT NEUROSCI, V8, P143, DOI 10.1038/nn1379; Sincich LC, 2001, J NEUROSCI, V21, P4416, DOI 10.1523/JNEUROSCI.21-12-04416.2001; Smith FW, 2010, P NATL ACAD SCI USA, V107, P20099, DOI 10.1073/pnas.1000233107; SPORNS O, 1991, P NATL ACAD SCI USA, V88, P129, DOI 10.1073/pnas.88.1.129; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sun HJ, 1999, IEEE T NEURAL NETWOR, V10, P860, DOI 10.1109/72.774238; Super H, 2003, NEUROSCI LETT, V344, P75, DOI 10.1016/S0304-3940(03)00360-4; Super H, 2003, J NEUROSCI, V23, P3407; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Super H, 2007, NEUROPSYCHOLOGIA, V45, P3329, DOI 10.1016/j.neuropsychologia.2007.07.001; Super H, 2011, J COGNITIVE NEUROSCI, V23, P491, DOI 10.1162/jocn.2010.21512; Super H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010705; Thielscher A, 2003, NEUROSCIENCE, V122, P921, DOI 10.1016/j.neuroscience.2003.08.050; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; van der Velde F, 2001, J COGNITIVE NEUROSCI, V13, P479, DOI 10.1162/08989290152001907; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Wagatsuma N, 2008, J VISION, V8, DOI 10.1167/8.7.22; Wersing H, 2001, NEURAL COMPUT, V13, P357, DOI 10.1162/089976601300014574; WEYLAND TG, 2001, J NEUROPHYSIOL, V85, P1107; Zhang NR, 2010, J NEUROSCI, V30, P6482, DOI 10.1523/JNEUROSCI.5168-09.2010; Zhaoping L, 2005, NEURON, V47, P143, DOI 10.1016/j.neuron.2005.04.005; Zwickel T, 2007, BIOSYSTEMS, V89, P216, DOI 10.1016/j.biosystems.2006.04.019	63	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21641	10.1371/journal.pone.0021641	http://dx.doi.org/10.1371/journal.pone.0021641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738747	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800050
J	Boualia, SK; Gaitan, Y; Murawski, I; Nadon, R; Gupta, IR; Bouchard, M				Boualia, Sami K.; Gaitan, Yaned; Murawski, Inga; Nadon, Robert; Gupta, Indra R.; Bouchard, Maxime			Vesicoureteral Reflux and Other Urinary Tract Malformations in Mice Compound Heterozygous for Pax2 and Emx2	PLOS ONE			English	Article							NEPHRIC DUCT; EXPRESSION; MORPHOGENESIS; KIDNEY; LIM1; GENE; PROTOONCOGENE; ANOMALIES; DISTINCT; DEFECTS	Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chronic kidney disease in children. This disease group includes a spectrum of urinary tract defects including vesicoureteral reflux, duplex kidneys and other developmental defects that can be found alone or in combination. To identify new regulators of CAKUT, we tested the genetic cooperativity between several key regulators of urogenital system development in mice. We found a high incidence of urinary tract anomalies in Pax2;Emx2 compound heterozygous mice that are not found in single heterozygous mice. Pax2(+/-);Emx2(+/-) mice harbor duplex systems associated with urinary tract obstruction, bifid ureter and a high penetrance of vesicoureteral reflux. Remarkably, most compound heterozygous mice refluxed at low intravesical pressure. Early analysis of Pax2(+/-);Emx2(+/-) embryos point to ureter budding defects as the primary cause of urinary tract anomalies. We additionally establish Pax2 as a direct regulator of Emx2 expression in the Wolffian duct. Together, these results identify a haploinsufficient genetic combination resulting in CAKUT-like phenotype, including a high sensitivity to vesicoureteral reflux. As both genes are located on human chromosome 10q, which is lost in a proportion of VUR patients, these findings may help understand VUR and CAKUT in humans.	[Boualia, Sami K.; Gaitan, Yaned; Bouchard, Maxime] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Boualia, Sami K.; Gaitan, Yaned; Bouchard, Maxime] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada; [Murawski, Inga; Gupta, Indra R.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Murawski, Inga; Gupta, Indra R.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Nadon, Robert] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Boualia, SK (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	maxime.bouchard@mcgill.ca		Bouchard, Maxime/0000-0002-7619-9680	Canadian Institutes for Health Research [MOP-84470]; Canada Research Chair in Developmental Genetics of the Urogenital System; Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Developmental Genetics of the Urogenital System; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes for Health Research (MOP-84470) to MB. MB holds a Canada Research Chair in Developmental Genetics of the Urogenital System. IRG is supported by a grant from the Canadian Institutes for Health Research and is a Chercheur Boursier Clinicien Senior from the Fonds de la Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Bouchard M, 2000, DEV BIOL, V222, P135, DOI 10.1006/dbio.2000.9702; Cordell HJ, 2010, J AM SOC NEPHROL, V21, P113, DOI 10.1681/ASN.2009060624; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; Grote D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000316; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Jain S, 2009, ORGANOGENESIS, V5, P177, DOI 10.4161/org.5.4.10048; Kelly H, 2007, J MED GENET, V44, P710, DOI 10.1136/jmg.2007.051086; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mendelsohn C, 2009, ORGANOGENESIS, V5, P306; Minowada G, 1999, DEVELOPMENT, V126, P4465; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; MURAWSKI IJ, KIDNEY INT; Murawski IJ, 2008, PEDIATR NEPHROL, V23, P1021, DOI 10.1007/s00467-007-0704-y; Murawski IJ, 2007, AM J PHYSIOL-RENAL, V293, pF1736, DOI 10.1152/ajprenal.00221.2007; Nakanishi K, 2003, PEDIATR INT, V45, P610, DOI 10.1046/j.1442-200X.2003.01779.x; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pearse RV, 2007, DEV BIOL, V310, P388, DOI 10.1016/j.ydbio.2007.08.002; Pedersen A, 2005, DEV BIOL, V288, P571, DOI 10.1016/j.ydbio.2005.09.027; Sanyanusin P, 1996, NAT GENET, V13, P129, DOI 10.1038/ng0596-129c; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Srinivas S, 1999, DEVELOPMENT, V126, P1375; Torres M, 1995, DEVELOPMENT, V121, P4057; Uetani N, 2009, CLIN GENET, V75, P307, DOI 10.1111/j.1399-0004.2009.01175.x; Waggoner DJ, 1999, AM J MED GENET, V86, P1; Yoshida M, 1997, DEVELOPMENT, V124, P101; Yu OH, 2004, AM J PHYSIOL-RENAL, V287, pF1123, DOI 10.1152/ajprenal.00444.2003	35	18	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21529	10.1371/journal.pone.0021529	http://dx.doi.org/10.1371/journal.pone.0021529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731775	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900049
J	Choi, HW; Kim, JS; Choi, S; Jang, HJ; Kim, MJ; Choi, Y; Scholer, HR; Chung, HM; Do, JT				Choi, Hyun Woo; Kim, Jong Soo; Choi, Sol; Jang, Hyo Jin; Kim, Min Jung; Choi, Youngsok; Schoeler, Hans R.; Chung, Hyung Min; Do, Jeong Tae			Neural Stem Cells Achieve and Maintain Pluripotency without Feeder Cells	PLOS ONE			English	Article							CONDITIONED MEDIUM; DEFINED FACTORS; SOMATIC-CELLS; MOUSE EMBRYOS; FIBROBLASTS; GENERATION; CULTURE; GROWTH; OCT-4; ESTABLISHMENT	Background: Differentiated cells can be reprogrammed into pluripotency by transduction of four defined transcription factors. Induced pluripotent stem cells (iPS cells) are expected to be useful for regenerative medicine as well as basic research. Recently, the report showed that mouse embryonic fibroblasts (MEF) cells are not essential for reprogramming. However, in using fibroblasts as donor cells for reprogramming, individual fibroblasts that had failed to reprogram could function as feeder cells. Methodology/Principal Finding: Here, we show that adult mouse neural stem cells (NSCs), which are not functional feeder cells, can be reprogrammed into iPS cells using defined four factors (Oct4, Sox2, Klf4, and c-Myc) under feeder-free conditions. The iPS cells, generated from NSCs expressing the Oct4-GFP reporter gene, could proliferate for more than two months (passage 20). Generated and maintained without feeder cells, these iPS cells expressed pluripotency markers (Oct4 and Nanog), the promoter regions of Oct4 and Nanog were hypomethylated, could differentiated into to all three germ layers in vitro, and formed a germline chimera. These data indicate that NSCs can achieve and maintain pluripotency under feeder-free conditions. Conclusion/Significance: This study suggested that factors secreted by feeder cells are not essential in the initial/early stages of reprogramming and for pluripotency maintenance. This technology might be useful for a human system, as a feeder-free reprogramming system may help generate iPS cells of a clinical grade for tissue or organ regeneration.	[Choi, Hyun Woo; Kim, Jong Soo; Choi, Sol; Jang, Hyo Jin; Kim, Min Jung; Do, Jeong Tae] CHA Univ, Dept Biomed Sci Stem Cell & Dev Biol, Seoul, South Korea; [Kim, Min Jung; Chung, Hyung Min] CHA Bio & Diotech, Seoul, South Korea; [Choi, Youngsok] CHA Univ, Dept Biomed Sci, Seoul, South Korea; [Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany	Pochon Cha University; Pochon Cha University; Max Planck Society	Choi, HW (corresponding author), CHA Univ, Dept Biomed Sci Stem Cell & Dev Biol, Seoul, South Korea.	dojt@cha.ac.kr	, HS/AAB-4434-2019	, HS/0000-0003-2643-5136; Do, Jeong Tae/0000-0001-6721-1441; Choi, Youngsok/0000-0002-3862-4105	Ministry of Education, Science and Technology [20100028247]; Rural Development Administration [PJ008009]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant 20100028247) and the Next Generation Bio-Green 21 Program funded by the Rural Development Administration (Grant PJ008009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Baharvand H, 2010, METHODS MOL BIOL, V584, P425, DOI 10.1007/978-1-60761-369-5_23; Chen MF, 2009, CELL BIOL INT, V33, P1268, DOI 10.1016/j.cellbi.2009.06.004; Chin ACP, 2007, J BIOTECHNOL, V130, P320, DOI 10.1016/j.jbiotec.2007.04.013; Choo ABH, 2004, BIOTECHNOL BIOENG, V88, P321, DOI 10.1002/bit.20247; Do JT, 2009, STEM CELLS, V27, P2962, DOI 10.1002/stem.233; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lim JWE, 2002, PROTEOMICS, V2, P1187, DOI 10.1002/1615-9861(200209)2:9<1187::AID-PROT1187>3.0.CO;2-T; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prelle K, 2002, ANAT HISTOL EMBRYOL, V31, P169, DOI 10.1046/j.1439-0264.2002.00388.x; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008067; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie CQ, 2004, BIOCHEM BIOPH RES CO, V315, P581, DOI 10.1016/j.bbrc.2004.01.089; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou D, 2009, CELL BIOL INT, V33, P796, DOI 10.1016/j.cellbi.2009.04.008	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21367	10.1371/journal.pone.0021367	http://dx.doi.org/10.1371/journal.pone.0021367			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21738644	Green Published, gold, Green Submitted			2022-12-25	WOS:000292036900023
J	Krentsis, IM; Sela, I; Eiges, R; Blanchard, V; Berger, M; Cohen, MB; Mitrani-Rosenbaum, S				Krentsis, Irit Milman; Sela, Ilan; Eiges, Rachel; Blanchard, Veronique; Berger, Markus; Cohen, Michal Becker; Mitrani-Rosenbaum, Stella			GNE Is Involved in the Early Development of Skeletal and Cardiac Muscle	PLOS ONE			English	Article							ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; N-ACETYLNEURAMINIC ACID; BODY MYOPATHY MYOBLASTS; POLYSIALIC ACID; DISTAL MYOPATHY; KEY ENZYME; BIOSYNTHESIS; SIALYLATION; GENE; HYPOSIALYLATION	UDP-N-acetylglucosamine 2 epimerase/N-acetylmannosamime kinase (GNE) is a bifunctional enzyme which catalyzes the two key sequential steps in the biosynthetic pathway of sialic acid, the most abundant terminal monosaccharide on glycoconjugates of eukaryotic cells. GNE knock out (GNE KO) mice are embryonically lethal at day E8.5. Although the role of GNE in the sialic pathway has been well established as well as the importance of sialylation in many diverse biological pathways, less is known about the involvement of GNE in muscle development. To address this issue we have studied the role of GNE during in vitro embryogenesis by comparing the developmental profile in culture of embryonic stem cells (ES) from wild type and from GNE KO E3.5 mice embryos, during 45 days. Neuronal cells appeared rarely in GNE KO ES cultures and did not reach an advanced differentiated stage. Although primary cardiac cells appeared at the same time in both normal and GNE KO ES cultures, GNE KO cardiac cells degraded very soon and their beating capacity decayed rapidly. Furthermore very rare skeletal muscle committed cells were detected in the GNE KO ES cultures at any stage of differentiation, as assessed by analysis of the expression of either Pax7, MyoD and MyHC markers. Beyond the supporting evidence that GNE plays an important role in neuronal cell and brain development, these results show that GNE is strongly involved in cardiac tissue and skeletal muscle early survival and organization. These findings could open new avenues in the understanding of muscle function mechanisms in health and in disease.	[Krentsis, Irit Milman; Sela, Ilan; Cohen, Michal Becker; Mitrani-Rosenbaum, Stella] Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Med Ctr, Jerusalem, Israel; [Eiges, Rachel] Shaare Zedek Med Ctr, Stem Cell Res Lab, Inst Med Genet, Jerusalem, Israel; [Blanchard, Veronique; Berger, Markus] Charite, Inst Lab Med Clin Chem & Pathobiochem, Berlin, Germany	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Krentsis, IM (corresponding author), Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Med Ctr, Jerusalem, Israel.	stella@cc.huji.ac.il		eiges, rachel/0000-0001-8139-0933; Mitrani-Rosenbaum, Stella/0000-0001-5335-8709; Blanchard, Veronique/0000-0002-5980-6450	German-Israeli Science Foundation for Scientific Research and Development [I-9191-142.3/2006]; Israel Science Foundation [671/07]; Neuromuscular Disease Foundation; Bundesministerium fur Bildung und Forschung [03IP511]; Sonnenfeld foundation	German-Israeli Science Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Neuromuscular Disease Foundation; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Sonnenfeld foundation	These studies have been supported in part by the German-Israeli Science Foundation for Scientific Research and Development (www.gif.org.il) (I-9191-142.3/2006), the Israel Science Foundation (www.isf.org.il) (671/07) and the Neuromuscular Disease Foundation (www.neuromuscdisease.org). V.B. and M.B. were financially supported by the Bundesministerium fur Bildung und Forschung [InnoProfile 03IP511] and by the Sonnenfeld foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bieberich E, 2001, J BIOL CHEM, V276, P44396, DOI 10.1074/jbc.M107239200; Effertz K, 1999, J BIOL CHEM, V274, P28771, DOI 10.1074/jbc.274.40.28771; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2004, FEBS LETT, V566, P105, DOI 10.1016/j.febslet.2004.04.013; Hinderlich S, 2001, BIOL CHEM, V382, P291, DOI 10.1515/BC.2001.036; Kontou M, 2008, NEUROREPORT, V19, P1239, DOI 10.1097/WNR.0b013e32830b368a; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; Krause S, 2005, EXP CELL RES, V304, P365, DOI 10.1016/j.yexcr.2004.11.010; Krause S, 2007, NEUROLOGY, V69, P655, DOI 10.1212/01.wnl.0000267426.97138.fd; Li YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003131; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakamura K, 2010, PATHOBIOLOGY, V77, P191, DOI 10.1159/000292652; Noguchi S, 2004, J BIOL CHEM, V279, P11402, DOI 10.1074/jbc.M313171200; Nystedt J, 2010, STEM CELLS, V28, P258, DOI 10.1002/stem.250; Saito F, 2004, NEUROMUSCULAR DISORD, V14, P158, DOI 10.1016/j.nmd.2003.09.006; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sela I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016334; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; Weidemann W, 2006, FEBS LETT, V580, P6649, DOI 10.1016/j.febslet.2006.11.015; Weidemann W, 2010, GLYCOBIOLOGY, V20, P107, DOI 10.1093/glycob/cwp153; WOBUS AM, 1999, METHOD MOL BIOL, V184, P127	32	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21389	10.1371/journal.pone.0021389	http://dx.doi.org/10.1371/journal.pone.0021389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731727	Green Published			2022-12-25	WOS:000292036900025
J	Li, YZ; Yokohama-Tamaki, T; Tanaka, TS				Li, Yanzhen; Yokohama-Tamaki, Tamaki; Tanaka, Tetsuya S.			Short-Term Serum-Free Culture Reveals that Inhibition of Gsk3 beta Induces the Tumor-Like Growth of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTION FACTOR; POU-DOMAIN; PLURIPOTENCY; PROTEIN; ACTIVATION; GENE; DIFFERENTIATION; ESTABLISHMENT; DERIVATION	Here, we present evidence that the tumor-like growth of mouse embryonic stem cells (mESCs) is suppressed by short-term serum-free culture, which is reversed by pharmacological inhibition of Gsk3 beta. Mouse ESCs maintained under standard conditions using fetal bovine serum (FBS) were cultured in a uniquely formulated chemically-defined serum-free (CDSF) medium, namely ESF7, for three passages before being subcutaneously transplanted into immunocompromised mice. Surprisingly, the mESCs failed to produce teratomas for up to six months, whereas mESCs maintained under standard conditions generated well-developed teratomas in five weeks. Mouse ESCs cultured under CDSF conditions maintained the expression of Oct3/4, Nanog, Sox2 and SSEA1, and differentiated into germ cells in vivo. In addition, when mESCs were cultured under CDSF conditions supplemented with FBS, or when the cells were cultured under CDSF conditions followed by standard culture conditions, they consistently developed into teratomas. Thus, these results validate that the pluripotency of mESCs was not compromised by CDSF conditions. Mouse ESCs cultured under CDSF conditions proliferated significantly more slowly than mESCs cultured under standard conditions, and were reminiscent of Eras-null mESCs. In fact, their slower proliferation was accompanied by the downregulation of Eras and c-Myc, which regulate the tumor-like growth of mESCs. Remarkably, when mESCs were cultured under CDSF conditions supplemented with a pharmacological inhibitor of Gsk3 beta, they efficiently proliferated and developed into teratomas without upregulation of Eras and c-Myc, whereas mESCs cultured under standard conditions expressed Eras and c-Myc. Although the role of Gsk3 beta in the self-renewal of ESCs has been established, it is suggested with these data that Gsk3 beta governs the tumor-like growth of mESCs by means of a mechanism different from the one to support the pluripotency of ESCs.	[Li, Yanzhen; Yokohama-Tamaki, Tamaki; Tanaka, Tetsuya S.] Univ Illinois, Dept Anim Sci, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Li, YZ (corresponding author), Univ Illinois, Dept Anim Sci, Inst Genom Biol, 328 Mumford Hall, Urbana, IL 61801 USA.	ttanaka@illinois.edu			USDA [ILLU-538-323]; University of Illinois; Illinois Regenerative Medicine Institute	USDA(United States Department of Agriculture (USDA)); University of Illinois; Illinois Regenerative Medicine Institute	This work was supported by the USDA Hatch Project (ILLU-538-323), University of Illinois and the Illinois Regenerative Medicine Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; BERNSTINE EG, 1973, P NATL ACAD SCI USA, V70, P3899, DOI 10.1073/pnas.70.12.3899; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen L, 2008, STEM CELLS, V26, P1858, DOI 10.1634/stemcells.2008-0050; Chen LG, 2010, STEM CELLS, V28, P57, DOI 10.1002/stem.251; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Goldsborough M.D, 1998, FOCUS, V20, P8; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HEWLETT G, 1991, CYTOTECHNOLOGY, V5, P3, DOI 10.1007/BF00365530; Holliday MA, 1999, PEDIATR NEPHROL, V13, P989, DOI 10.1007/s004670050741; Itasaki N, 2010, DEV DYNAM, V239, P16, DOI 10.1002/dvdy.22009; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kameda T, 2005, STEM CELLS, V23, P1535, DOI 10.1634/stemcells.2005-0054; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SATO GH, 1975, BIOCHEM ACTION HORM, P391; Sato GH, 2010, IN VITRO CELL DEV-AN, V46, P590, DOI 10.1007/s11626-010-9315-1; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; SOPRANO DR, 1994, PLASMA RETINOL BINDI, P257; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka TS, 2008, GENESIS, V46, P347, DOI 10.1002/dvg.20404; Tanaka TS, 2006, DEV GROWTH DIFFER, V48, P381, DOI 10.1111/j.1440-169x.2006.00875.x; Tanaka TS, 2010, INT J DEV BIOL, V54, P1347, DOI 10.1387/ijdb.092862tt; Tanaka TS, 2009, REPROD FERT DEVELOP, V21, P67, DOI 10.1071/RD08219; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tanaka Y, 2009, CELL TRANSPLANT, V18, P381, DOI 10.3727/096368909788809794; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tompers DM, 2004, STEM CELLS, V22, P243, DOI 10.1634/stemcells.22-3-243; Umehara H, 2007, STEM CELLS, V25, P2705, DOI 10.1634/stemcells.2007-0086; Viswanathan S, 2003, BIOTECHNOL BIOENG, V84, P505, DOI 10.1002/bit.10799; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wang R, 2008, DIFFERENTIATION, V76, P931, DOI 10.1111/j.1432-0436.2008.00272.x; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001	85	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21355	10.1371/journal.pone.0021355	http://dx.doi.org/10.1371/journal.pone.0021355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731714	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400027
J	Hailu, M; Gebremariam, A; Alemseged, F; Deribe, K				Hailu, Mesay; Gebremariam, Abebe; Alemseged, Fissehaye; Deribe, Kebede			Birth Preparedness and Complication Readiness among Pregnant Women in Southern Ethiopia	PLOS ONE			English	Article							DISTRICT	Background: Birth preparedness and complication preparedness (BPACR) is a key component of globally accepted safe motherhood programs, which helps ensure women to reach professional delivery care when labor begins and to reduce delays that occur when mothers in labor experience obstetric complications. Objective: This study was conducted to assess practice and factors associated with BPACR among pregnant women in Aleta Wondo district in Sidama Zone, South Ethiopia. Methods: A community based cross sectional study was conducted in 2007, on a sample of 812 pregnant women. Data were collected using pre-tested and structured questionnaire. The collected data were analyzed by SPSS for windows version 12.0.1. The women were asked whether they followed the desired five steps while pregnant: identified a trained birth attendant, identified a health facility, arranged for transport, identified blood donor and saved money for emergency. Taking at least two steps was considered being well-prepared. Results: Among 743 pregnant women only a quarter (20.5%) of pregnant women identified skilled provider. Only 8.1% identified health facility for delivery and/or for obstetric emergencies. Preparedness for transportation was found to be very low (7.7%). Considerable (34.5%) number of families saved money for incurred costs of delivery and emergency if needed. Only few (2.3%) identified potential blood donor in case of emergency. Majority (87.9%) of the respondents reported that they intended to deliver at home, and only 60(8%) planned to deliver at health facilities. Overall only 17% of pregnant women were well prepared. The adjusted multivariate model showed that significant predictors for being well-prepared were maternal availing of antenatal services (OR = 1.91 95% CI; 1.21-3.01) and being pregnant for the first time (OR = 6.82, 95% CI; 1.27-36.55). Conclusion: BPACR practice in the study area was found to be low. Effort to increase BPACR should focus on availing antenatal care services.	[Hailu, Mesay] Sidam Zone Hlth Off, Hwassa, Ethiopia; [Hailu, Mesay; Gebremariam, Abebe] Coll Publ Hlth & Med Sci, Populat & Family Hlth Dept, Jimma, Ethiopia; [Alemseged, Fissehaye] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Epidemiol & Biostat, Jimma, Ethiopia	Jimma University	Hailu, M (corresponding author), Sidam Zone Hlth Off, Hwassa, Ethiopia.	kebededeka@yahoo.com	Dangisso, Mesay Hailu/AAU-7743-2020; Deribe, Kebede/I-5422-2019; Deribe, Kebede/K-7055-2019	Deribe, Kebede/0000-0002-8526-6996; 	Jimma University	Jimma University	This study was financially supported by Jimma University. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Baya B, 2004, MEASURING EFFECTS BE, P18; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; *FED DEM REP ETH, 2006, CENTR STAT AG STAT A; Fullerton Judith T, 2005, Health Care Women Int, V26, P561, DOI 10.1080/07399330591004881; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *J SNOW INC, 2000, ISS PROGR SAF MOTH C; JHPIEGO, 2001, MAT NEON HLTH PROGR; JHPIEGO, 2004, MON BIRTH PREP COMPL, P1; Johns Hopkins Bloomberg School of Public Health Family Care International Maternal and Neonatal Health Program., 2004, MON BIRTH PREP COMP; McPherson RA, 2006, J HEALTH POPUL NUTR, V24, P479; *MIN FIN EC DEV, 2008, ETH PROGR ACH MILL G; MOORE KM, 2000, COMMUNICATION INITIA; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; *SID ZON FIN EC DE, 2005, SID ADM ZON SOC DEM; *SID ZON HLTH DEP, 2006, ANN REP SID ZON HLTH; *SNNPR HLTH BUR, 2004, HLTH REL IND PLANN E; Stanton CK, 2004, EVALUATION REV, V28, P179, DOI 10.1177/0193841X03262577; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; *UN CHILDR FUND, 1996, PROGR NAT; *WHIT RIBB ALL SAF, 2002, SAV MOTH LIV WHAT WO; WHO, 1989, PREV MAT DEATHS; WHO, 1994, MOTH BAB PACK IMPL S; World Health Organization, 1998, WORLD HLTH DAY SAF M; World Health Organization, 2005, WORLD HLTH DAY MAK E	25	95	96	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21432	10.1371/journal.pone.0021432	http://dx.doi.org/10.1371/journal.pone.0021432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731747	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700084
J	Ross, AW; Helfer, G; Russell, L; Darras, VM; Morgan, PJ				Ross, Alexander W.; Helfer, Gisela; Russell, Laura; Darras, Veerle M.; Morgan, Peter J.			Thyroid Hormone Signalling Genes Are Regulated by Photoperiod in the Hypothalamus of F344 Rats	PLOS ONE			English	Article							GALANIN-LIKE PEPTIDE; TYPE-2 DEIODINASE GENE; THYROTROPIN-RELEASING-HORMONE; GROWTH-HORMONE; MEDIOBASAL HYPOTHALAMUS; SIBERIAN HAMSTER; ARCUATE NUCLEUS; NEUROPEPTIDE-Y; EXPRESSION; FISCHER-344	Seasonal animals adapt their physiology and behaviour in anticipation of climate change to optimise survival of their offspring. Intra-hypothalamic thyroid hormone signalling plays an important role in seasonal responses in mammals and birds. In the F344 rat, photoperiod stimulates profound changes in food intake, body weight and reproductive status. Previous investigations of the F344 rat have suggested a role for thyroid hormone metabolism, but have only considered Dio2 expression, which was elevated in long day photoperiods. Microarray analysis was used to identify time-dependent changes in photoperiod responsive genes, which may underlie the photoperiod-dependent phenotypes of the juvenile F344 rat. The most significant changes are those related to thyroid hormone metabolism and transport. Using photoperiod manipulations and melatonin injections into long day photoperiod (LD) rats to mimic short day (SD), we show photoinduction and photosuppression gene expression profiles and melatonin responsiveness of genes by in situ hybridization; TSH beta, CGA, Dio2 and Oatp1c1 genes were all elevated in LD whilst in SD, Dio3 and MCT-8 mRNA were increased. NPY was elevated in SD whilst GALP increased in LD. The photoinduction and photosuppression profiles for GALP were compared to that of GHRH with GALP expression following GHRH temporally. We also reveal gene sets involved in photoperiodic responses, including retinoic acid and Wnt/beta-catenin signalling. This study extends our knowledge of hypothalamic regulation by photoperiod, by revealing large temporal changes in expression of thyroid hormone signalling genes following photoperiod switch. Surprisingly, large changes in hypothalamic thyroid hormone levels or TRH expression were not detected. Expression of NPY and GALP, two genes known to regulate GHRH, were also changed by photoperiod. Whether these genes could provide links between thyroid hormone signalling and the regulation of the growth axis remains to be investigated.	[Ross, Alexander W.; Helfer, Gisela; Russell, Laura; Morgan, Peter J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Darras, Veerle M.] Katholieke Univ Leuven, Lab Comparat Endocrinol, Div Anim Physiol & Neurobiol, Louvain, Belgium	University of Aberdeen; KU Leuven	Ross, AW (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland.	p.morgan@abdn.ac.uk	Helfer, Gisela/S-9189-2019	Helfer, Gisela/0000-0003-0634-4683; Ross, Alexander/0000-0002-1799-1432; Morgan, Peter/0000-0002-5071-6512	Scottish Government, RSD; BBSRC [BB/G014272/1]; Biotechnology and Biological Sciences Research Council [BB/G014272/1] Funding Source: researchfish	Scottish Government, RSD; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge the Scottish Government, RSD (AWR, LR and PJM) and BBSRC grant number BB/G014272/1 (GH, AWR and PJM) for funding towards this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett P, 2007, ENDOCRINOLOGY, V148, P3608, DOI 10.1210/en.2007-0316; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Cunnningham MJ, 2004, J NEUROENDOCRINOL, V16, P10, DOI 10.1111/j.1365-2826.2004.01118.x; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; DARRAS VM, 1990, GEN COMP ENDOCR, V77, P212, DOI 10.1016/0016-6480(90)90305-6; Ebling FJP, 2008, J NEUROENDOCRINOL, V20, P576, DOI 10.1111/j.1365-2826.2008.01702.x; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Gahete MD, 2009, ANN NY ACAD SCI, V1163, P137, DOI 10.1111/j.1749-6632.2008.03660.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Heideman PD, 1997, BIOL REPROD, V57, P134, DOI 10.1095/biolreprod57.1.134; Heideman PD, 2001, J NEUROENDOCRINOL, V13, P223, DOI 10.1046/j.1365-2826.2001.00617.x; Herwig A, 2009, AM J PHYSIOL-REG I, V296, pR1307, DOI 10.1152/ajpregu.90755.2008; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kuramochi M, 2005, REGUL PEPTIDES, V126, P85, DOI 10.1016/j.regpep.2004.08.017; Larm JA, 2000, NEUROENDOCRINOLOGY, V72, P67, DOI 10.1159/000054573; Lawrence C, 2011, FRONT NEUROENDOCRIN, V32, P1, DOI 10.1016/j.yfrne.2010.06.001; MATZUK MM, 1988, MOL ENDOCRINOL, V2, P95, DOI 10.1210/mend-2-2-95; Nakao N, 2006, ENDOCRINOLOGY, V147, P1067, DOI 10.1210/en.2005-1090; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Ohtaki T, 1999, J BIOL CHEM, V274, P37041, DOI 10.1074/jbc.274.52.37041; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; Park S, 2005, NEUROENDOCRINOLOGY, V81, P360, DOI 10.1159/000089101; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Reyns GE, 2002, COMP BIOCHEM PHYS B, V132, P239, DOI 10.1016/S1096-4959(01)00528-0; Rich N, 2007, PHYSIOL BEHAV, V92, P814, DOI 10.1016/j.physbeh.2007.06.003; Ross AW, 2009, J NEUROENDOCRINOL, V21, P610, DOI 10.1111/j.1365-2826.2009.01878.x; Sanchez E, 2010, ENDOCRINOLOGY, V151, P3827, DOI 10.1210/en.2010-0279; SEGERSON TP, 1987, SCIENCE, V238, P78, DOI 10.1126/science.3116669; Shahab M, 2005, NEUROENDOCRINOLOGY, V81, P254, DOI 10.1159/000087649; Shearer KD, 2010, J NEUROCHEM, V112, P246, DOI 10.1111/j.1471-4159.2009.06455.x; Sugiyama D, 2003, J BIOL CHEM, V278, P43489, DOI 10.1074/jbc.M306933200; Takatsu Y, 2001, ENDOCRINOLOGY, V142, P1626, DOI 10.1210/en.142.4.1626; van der Deure WM, 2008, ENDOCRINOLOGY, V149, P5307, DOI 10.1210/en.2008-0430; Yasuo S, 2006, ENDOCRINOLOGY, V147, P432, DOI 10.1210/en.2005-0507; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2010, J NEUROENDOCRINOL, V22, P43, DOI 10.1111/j.1365-2826.2009.01936.x; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497; Yasuo S, 2007, AM J PHYSIOL-REG I, V292, pR1315, DOI 10.1152/ajpregu.00396.2006; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117	40	77	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21351	10.1371/journal.pone.0021351	http://dx.doi.org/10.1371/journal.pone.0021351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731713	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700066
J	Mutevedzi, PC; Lessells, RJ; Rodger, AJ; Newell, ML				Mutevedzi, Portia C.; Lessells, Richard J.; Rodger, Alison J.; Newell, Marie-Louise			Association of Age with Mortality and Virological and Immunological Response to Antiretroviral Therapy in Rural South African Adults	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTION; OLDER-ADULTS; HIGH-RATES; FOLLOW-UP; SCALE-UP; PROGRAM; INCOME; SEROCONVERSION; PREVALENCE	Objective: To assess whether treatment outcomes vary with age for adults receiving antiretroviral therapy (ART) in a large rural HIV treatment cohort. Design: Retrospective cohort analysis using data from a public HIV Treatment & Care Programme. Methods: Adults initiating ART 1(st) August 2004 - 31(st) October 2009 were stratified by age at initiation: young adults (16-24 years) mid-age adults (25-49 years) and older (>= 50 years) adults. Kaplan-Meier survival analysis was used to estimate mortality rates and age and person-time stratified Cox regression to determine factors associated with mortality. Changes in CD4 cell counts were quantified using a piecewise linear model based on follow-up CD4 cell counts measured at six-monthly time points. Results: 8846 adults were included, 808 (9.1%) young adults; 7119 (80.5%) mid-age adults and 919 (10.4%) older adults, with 997 deaths over 14,778 person-years of follow-up. Adjusting for baseline characteristics, older adults had 32% excess mortality (p = 0.004) compared to those aged 25-49 years. Overall mortality rates (MR) per 100 person-years were 6.18 (95% CI 4.90-7.78); 6.55 (95% CI 6.11-7.02) and 8.69 (95% CI 7.34-10.28) for young, mid-age and older adults respectively. In the first year on ART, for older compared to both young and mid-aged adults, MR per 100 person-years were significantly higher; 0-3 months (MR: 27.1 vs 17.17 and 21.36) and 3-12 months (MR: 9.5 vs 4.02 and 6.02) respectively. CD4 count reconstitution was lower, despite better virological response in the older adults. There were no significant differences in MR after 1year of ART. Baseline markers of advanced disease were independently associated with very early mortality (0-3 months) whilst immunological and virological responses were associated with mortality after 12months. Conclusions: Early ART initiation and improving clinical care of older adults are required to reduce high early mortality and enhance immunologic recovery, particularly in the initial phases of ART.	[Mutevedzi, Portia C.; Lessells, Richard J.; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Mutevedzi, Portia C.; Rodger, Alison J.] UCL, Dept Infect & Populat Hlth, London, England; [Lessells, Richard J.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Newell, Marie-Louise] UCL, Inst Child Hlth, London, England	University of Kwazulu Natal; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Mutevedzi, PC (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	pmutevedzi@africacentre.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Lessells, Richard/0000-0003-0926-710X	Wellcome Trust [082384/Z/07/Z]; United States Agency for International Development (USAID); President's Emergency Plan (PEPFAR) [674-A-00-08-00001-00]	Wellcome Trust(Wellcome Trust); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); President's Emergency Plan (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Africa Centre for Health and Population Studies is funded by a core grant from the Wellcome Trust (Grant number 082384/Z/07/Z) [www.wellcome.ac.uk]. The Hlabisa HIV Treatment and Care Programme receives support through the United States Agency for International Development (USAID) and the President's Emergency Plan (PEPFAR) under the terms of Award No. 674-A-00-08-00001-00. The opinions expressed herein are those of the authors and do not necessarily reflect the view of the USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker AG, 2001, J CLIN EPIDEMIOL, V54, pS16, DOI 10.1016/S0895-4356(01)00456-5; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, 2008, AIDS, V22, P1463, DOI 10.1097/QAD.0b013e3282f88d02; *DEP HLTH, 2004, NAT ANT TREATM GUID; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Franey C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-143; Gebo Kelly A, 2008, Aging health, V4, P615, DOI 10.2217/1745509X.4.6.615; Glynn JR, 2007, AIDS, V21, P625, DOI 10.1097/QAD.0b013e328017f857; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greenbaum AH, 2008, AIDS, V22, P2331, DOI 10.1097/QAD.0b013e32831883f9; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; HOULIHAN CF, 2010, INT J EPIDEMIOL 0212; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; LESSELLS RJ, 2010, J ACQUIR IM IN PRESS; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; May M, 2009, J INFECT DIS, V200, P1729, DOI 10.1086/648096; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Negin J, 2010, JAIDS-J ACQ IMM DEF, V55, P239, DOI 10.1097/QAI.0b013e3181e9b3f2; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Nogueras M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-159; Patterson K, 2007, HIV MED, V8, P406, DOI 10.1111/j.1468-1293.2007.00485.x; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tuboi SH, 2010, JAIDS-J ACQ IMM DEF, V53, P70, DOI 10.1097/QAI.0b013e3181c22d19; *UNAIDS, 2006, UND LAT EST 2006 REP; *UNAIDS, 2008, REP GLOB HIV AIDS EP; Van der Paal L, 2007, AIDS, V21, pS21, DOI 10.1097/01.aids.0000299407.52399.05; van Deventer HE, 2008, CLIN CHEM, V54, P1197, DOI 10.1373/clinchem.2007.099085; WALLRAUCH C, 2010, S AFR MED J IN PRESS; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	51	79	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21795	10.1371/journal.pone.0021795	http://dx.doi.org/10.1371/journal.pone.0021795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747959	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000292293400035
J	Eugster, MR; Loessner, MJ				Eugster, Marcel R.; Loessner, Martin J.			Rapid Analysis of Listeria monocytogenes Cell Wall Teichoic Acid Carbohydrates by ESI-MS/MS	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; LIPOTEICHOIC ACID; N-ACETYLGLUCOSAMINE; PEPTIDOGLYCAN; SURFACE; MUREIN; BIOSYNTHESIS; BIOCHEMISTRY; NUCLEOTIDES; PHYSIOLOGY	We report the application of electrospray ionization (ESI) mass spectrometry for compositional characterization of wall teichoic acids (WTA), a major component of Gram-positive bacterial cell walls. Tandem mass spectrometry (ESI-MS/MS) of purified and chemically hydrolyzed monomeric WTA components provided sufficient information to identify WTA monomers and their specific carbohydrate constituents. A lithium matrix was used for ionization of uncharged WTA monomers, and successfully applied to analyze the WTA molecules of four Listeria strains differing in carbohydrate substitution on a conserved polyribitol-phosphate backbone structure. Carbohydrate residues such as N-acetylglucosamine or rhamnose linked to the WTA could directly be identified by ESI-MS/MS, circumventing the need for quantitative analysis by gas chromatography. The presence of a terminal N-acetylglucosamine residue tethered to the ribitol was confirmed using fluorescently labeled wheat-germ agglutinin. In conclusion, the mass spectrometry method described here will greatly facilitate compositional analysis and characterization of teichoic acids and similar macromolecules from diverse bacterial species, and represents a significant advance in the identification of serovar-specific carbohydrates and sugar molecules on bacteria.	[Eugster, Marcel R.; Loessner, Martin J.] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Eugster, MR (corresponding author), ETH, Inst Food Nutr & Hlth, Zurich, Switzerland.	martin.loessner@ethz.ch	Loessner, Martin J/B-4316-2012	Loessner, Martin J/0000-0002-8162-2631	ETH Zurich	ETH Zurich(ETH Zurich)	This work was funded by ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; ARAKI Y, 1989, CRIT REV MICROBIOL, V17, P121, DOI 10.3109/10408418909105745; ARMSTRONG JJ, 1958, NATURE, V181, P1692, DOI 10.1038/1811692a0; Baddiley J, 1972, Essays Biochem, V8, P35; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cheng Y, 2008, APPL ENVIRON MICROB, V74, P1653, DOI 10.1128/AEM.01773-07; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; FIEDLER F, 1983, SYST APPL MICROBIOL, V4, P444, DOI 10.1016/S0723-2020(83)80002-2; FIEDLER F, 1988, INFECTION, V16, pS92, DOI 10.1007/BF01639729; FIEDLER F, 1984, SYST APPL MICROBIOL, V5, P360, DOI 10.1016/S0723-2020(84)80038-7; FIEDLER F, 1981, ARCH MICROBIOL, V129, P85, DOI 10.1007/BF00417186; FIEDLER F, 1987, B I PASTEUR, V85, P287; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Fischer W, 1994, BACTERIAL CELL WALL, P199; FUJII H, 1985, J BIOCHEM-TOKYO, V97, P883, DOI 10.1093/oxfordjournals.jbchem.a135130; GLASER L, 1964, J BIOL CHEM, V239, P3187; KAMISANGO K, 1983, J BIOCHEM-TOKYO, V93, P1401, DOI 10.1093/oxfordjournals.jbchem.a134275; KAYA S, 1985, EUR J BIOCHEM, V147, P41, DOI 10.1111/j.1432-1033.1985.tb08715.x; KOJIMA N, 1983, J BIOL CHEM, V258, P9043; LIPKIN D, 1969, J ORG CHEM, V34, P1539, DOI 10.1021/jo01258a003; LOESSNER MJ, 1990, APPL ENVIRON MICROB, V56, P1912, DOI 10.1128/AEM.56.6.1912-1918.1990; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Naumova IB, 2001, FEMS MICROBIOL REV, V25, P269, DOI 10.1016/S0168-6445(00)00064-4; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Seo HS, 2008, J BACTERIOL, V190, P2379, DOI 10.1128/JB.01795-07; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Tran HL, 1999, APPL ENVIRON MICROB, V65, P4793; UCHIKAWA KI, 1986, J BIOCHEM-TOKYO, V99, P315, DOI 10.1093/oxfordjournals.jbchem.a135486; ULLMANN WW, 1969, J BACTERIOL, V98, P486, DOI 10.1128/JB.98.2.486-493.1969; VALYASEVI R, 1990, APPL ENVIRON MICROB, V56, P1882, DOI 10.1128/AEM.56.6.1882-1889.1990; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Xia G, 2008, CHEM BIOL, V15, P95, DOI 10.1016/j.chembiol.2008.02.005	39	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21500	10.1371/journal.pone.0021500	http://dx.doi.org/10.1371/journal.pone.0021500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738682	Green Published, gold, Green Submitted			2022-12-25	WOS:000292291800017
J	Barron, EL; Sosnovtsev, SV; Bok, K; Prikhodko, V; Sandoval-Jaime, C; Rhodes, CR; Hasenkrug, K; Carmody, AB; Ward, JM; Perdue, K; Green, KY				Barron, Elyssa L.; Sosnovtsev, Stanislav V.; Bok, Karin; Prikhodko, Victor; Sandoval-Jaime, Carlos; Rhodes, Crystal R.; Hasenkrug, Kim; Carmody, Aaron B.; Ward, Jerrold M.; Perdue, Kathy; Green, Kim Y.			Diversity of Murine Norovirus Strains Isolated from Asymptomatic Mice of Different Genetic Backgrounds within a Single US Research Institute	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; MOUSE MODEL; CAPSID PROTEIN; INFECTION; SUFFICIENT; SEQUENCE; IMMUNITY; DOMAIN; VIRUS	Antibody prevalence studies in laboratory mice indicate that murine norovirus (MNV) infections are common, but the natural history of these viruses has not been fully established. This study examined the extent of genetic diversity of murine noroviruses isolated from healthy laboratory mice housed in multiple animal facilities within a single, large research institute-the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID-NIH) in Bethesda, Maryland, U. S. Ten distinct murine norovirus strains were isolated from various tissues and feces of asymptomatic wild type sentinel mice as well as asymptomatic immunodeficient (RAG 2(-/-)) mice. The NIH MNV isolates showed little cytopathic effect in permissive RAW264.7 cells in early passages, but all isolates examined could be adapted to efficient growth in cell culture by serial passage. The viruses, although closely related in genome sequence, were distinguishable from each other according to facility location, likely due to the introduction of new viruses into each facility from separate sources or vendors at different times. Our study indicates that the murine noroviruses are widespread in these animal facilities, despite rigorous guidelines for animal care and maintenance.	[Barron, Elyssa L.; Sosnovtsev, Stanislav V.; Bok, Karin; Prikhodko, Victor; Sandoval-Jaime, Carlos; Rhodes, Crystal R.; Green, Kim Y.] NIAID, Infect Dis Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hasenkrug, Kim; Carmody, Aaron B.] NIAID, Retrovirus Immunol Sect, NIH, Dept Hlth & Human Serv, Hamilton, MT USA; [Ward, Jerrold M.; Perdue, Kathy] NIAID, Comparat Med Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barron, EL (corresponding author), NIAID, Infect Dis Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	kgreen@niaid.nih.gov	Sandoval-Jaime, Carlos/AAR-7196-2020	Sandoval-Jaime, Carlos/0000-0001-6649-9180; Prikhodko, Victor/0000-0001-6006-9454	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001100, ZIAAI000753, ZIAAI000897] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard M, 2009, GASTROENTEROLOGY, V136, pA706; Ammann CG, 2009, J VIROL, V83, P13037, DOI 10.1128/JVI.01445-09; Bailey D, 2008, J VIROL, V82, P7725, DOI 10.1128/JVI.00237-08; Bok K, 2009, J VIROL, V83, P3647, DOI 10.1128/JVI.02028-08; Compton SR, 2010, J AM ASSOC LAB ANIM, V49, P11; Doom CM, 2009, VIROLOGY, V392, P153, DOI 10.1016/j.virol.2009.05.035; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Green K.Y, 2007, CALICIVIRIDAE NOROVI, P949; Hensley SE, 2009, J VIROL, V83, P7357, DOI 10.1128/JVI.00623-09; Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005; JIANG X, 1993, VIROLOGY, V195, P51, DOI 10.1006/viro.1993.1345; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kaufman SS, 2005, J PEDIATR GASTR NUTR, V40, P328, DOI 10.1097/01.MPG.0000155182.54001.48; LAMBDEN PR, SEQUENCE GENOME ORG; Lencioni KC, 2008, COMPARATIVE MED, V58, P522; Lochridge VP, 2007, J VIROL, V81, P12316, DOI 10.1128/JVI.01254-07; Muller B, 2007, ARCH VIROL, V152, P1709, DOI 10.1007/s00705-007-0989-y; Paik J, 2010, COMPARATIVE MED, V60, P189; Perdue KA, 2007, J AM ASSOC LAB ANIM, V46, P39; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan M, 2004, J VIROL, V78, P6233, DOI 10.1128/JVI.78.12.6233-6242.2004; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Ward JM, 2006, TOXICOL PATHOL, V34, P708, DOI 10.1080/01926230600918876; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	30	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21435	10.1371/journal.pone.0021435	http://dx.doi.org/10.1371/journal.pone.0021435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738664	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800021
J	Lee, PH; Kim, HS; Lee, JE; Choi, Y; Hong, JY; Nam, HS; Sohn, YH; Kim, HO				Lee, Phil Hyu; Kim, Han-Soo; Lee, Ji E.; Choi, Youjeong; Hong, Jin Yong; Nam, Hyo Suk; Sohn, Young H.; Kim, Hyun Ok			Comparison of Endothelial Progenitor Cells in Parkinson's Disease Patients Treated with Levodopa and Levodopa/COMT Inhibitor	PLOS ONE			English	Article							PLASMA HOMOCYSTEINE LEVELS; STROKE; NUMBER	Background: Levodopa treatment in Parkinson's disease (PD) increases in serum homocysteine levels due to its metabolism via catechol O-methyltransferase. Endothelial progenitor cells (EPCs) have the capacity to differentiate into mature endothelial cells and are markers for endothelial functions and cardiovascular risks. Along with traditional vascular risk factors, hyperhomocysteinemia is known to decrease the level of EPCs. In the present study, we hypothesized that that levodopa-induced hyperhomocysteinemia leads to a change in EPC levels. Methodology/Principal Findings: We prospectively enrolled PD patients who had been prescribed either levodopa/carbidopa (PD-L group, n=28) or levodopa/carbidopa/COMT inhibitor (PD-LC group, n=25) for more than 1 year. The number of circulating EPCs was measured by flow cytometry using dual staining of anti-CD34 and anti-KDR antibodies. The EPCs were divided into tertiles based on their distributions and a logistic regression analysis was used to estimate independent predictors of the highest tertile of EPCs. The number of endothelial progenitor cells was significantly decreased in PD-L patients (118+/-99/mL) compared with either PD-LC patients (269+/-258/mL, p=0.007) or controls (206+/-204/mL, p=0.012). The level of homocysteine was significantly increased in PD-L patients (14.9+/-5.3 mu mol/L) compared with either PD-LC patients (11.9+/-3.0 mmol/L, p=0.028) or controls (11.1+/-2.5 mmol/L, p=0.012). The level of homocysteine was negatively correlated with endothelial progenitor cell levels (r=-0.252, p=0.028) and was an independent predictor of the highest tertile of endothelial progenitor cell levels (OR; 0.749 [95% CI: 0.584-0.961]). Conclusions/Significance: These data indicate that a higher consumption of EPC for restoration of endothelial damage may be associated with chronic levodopa treatment in PD patients.	[Lee, Phil Hyu; Lee, Ji E.; Hong, Jin Yong; Nam, Hyo Suk; Sohn, Young H.] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Lee, Phil Hyu; Lee, Ji E.; Hong, Jin Yong; Nam, Hyo Suk; Sohn, Young H.] Yonsei Univ, Coll Med, Brain Res Inst, Seoul, South Korea; [Kim, Han-Soo; Choi, Youjeong; Kim, Hyun Ok] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Kim, Han-Soo; Choi, Youjeong; Kim, Hyun Ok] Yonsei Univ, Coll Med, Yonsei Cell Therapy Ctr, Seoul, South Korea; [Lee, Phil Hyu] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Lee, PH (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	phisland@chol.com; hyunok1019@yuhs.ac		Hong, Jin Yong/0000-0002-2476-3737; NAM, HYO SUK/0000-0002-4415-3995; Kim, Hyun Ok/0000-0002-4964-1963; Lee, Phil Hyu/0000-0001-9931-8462; Sohn, Young H./0000-0001-6533-2610	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A091159]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A091159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2009, J CEREBR BLOOD F MET, V29, P157, DOI 10.1038/jcbfm.2008.99; Chen JZ, 2004, J MOL CELL CARDIOL, V36, P233, DOI 10.1016/j.yjmcc.2003.10.005; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1422, DOI 10.1001/archneur.57.10.1422; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Jickling G, 2009, STROKE, V40, P3191, DOI 10.1161/STROKEAHA.109.554527; Lamberti P, 2005, MOVEMENT DISORD, V20, P69, DOI 10.1002/mds.20261; Lorenzen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011477; Muller T, 2004, ARCH NEUROL-CHICAGO, V61, P657, DOI 10.1001/archneur.61.5.657; Nakaso K, 2003, J NEUROL SCI, V207, P19, DOI 10.1016/S0022-510X(02)00353-2; Nanhoe-Mahabier W, 2009, NAT REV NEUROL, V5, P533, DOI 10.1038/nrneurol.2009.136; Postuma RB, 2004, NEUROLOGY, V63, P886, DOI 10.1212/01.WNL.0000137886.74175.5A; Rogers JD, 2003, ARCH NEUROL-CHICAGO, V60, P59, DOI 10.1001/archneur.60.1.59; Rouhl RPW, 2008, STROKE, V39, P2158, DOI 10.1161/STROKEAHA.107.507251; Shin JW, 2005, YONSEI MED J, V46, P260, DOI 10.3349/ymj.2005.46.2.260; Valkovic P, 2005, PARKINSONISM RELAT D, V11, P253, DOI 10.1016/j.parkreldis.2005.01.007; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yong SW, 2010, PARKINSONISM RELAT D, V16, P225, DOI 10.1016/j.parkreldis.2009.09.003; Zhu JH, 2006, ARCH MED RES, V37, P484, DOI 10.1016/j.arcmed.2005.09.017	23	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21536	10.1371/journal.pone.0021536	http://dx.doi.org/10.1371/journal.pone.0021536			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738693	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800033
J	Siegmund, KD; Marjoram, P; Tavare, S; Shibata, D				Siegmund, Kimberly D.; Marjoram, Paul; Tavare, Simon; Shibata, Darryl			High DNA Methylation Pattern Intratumoral Diversity Implies Weak Selection in Many Human Colorectal Cancers	PLOS ONE			English	Article							BREAST-CANCER; MICROSATELLITE INSTABILITY; PANCREATIC-CANCER; TUMOR EVOLUTION; CELL-LINES; METASTASIS; MUTATIONS; GENOME; PROGRESSION; DYNAMICS	Background: It is possible to infer the past of populations by comparing genomes between individuals. In general, older populations have more genomic diversity than younger populations. The force of selection can also be inferred from population diversity. If selection is strong and frequently eliminates less fit variants, diversity will be limited because new, initially homogeneous populations constantly emerge. Methodology and Results: Here we translate a population genetics approach to human somatic cancer cell populations by measuring genomic diversity within and between small colorectal cancer (CRC) glands. Control tissue culture and xenograft experiments demonstrate that the population diversity of certain passenger DNA methylation patterns is reduced after cloning but subsequently increases with time. When measured in CRC gland populations, passenger methylation diversity from different parts of nine CRCs was relatively high and uniform, consistent with older, stable lineages rather than mixtures of younger homogeneous populations arising from frequent cycles of selection. The diversity of six metastases was also high, suggesting dissemination early after transformation. Diversity was lower in DNA mismatch repair deficient CRC glands, possibly suggesting more selection and the elimination of less fit variants when mutation rates are elevated. Conclusion/Significance: The many hitchhiking passenger variants observed in primary and metastatic CRC cell populations are consistent with relatively old populations, suggesting that clonal evolution leading to selective sweeps may be rare after transformation. Selection in human cancers appears to be a weaker than presumed force after transformation, consistent with the observed rarity of driver mutations in cancer genomes. Phenotypic plasticity rather than the stepwise acquisition of new driver mutations may better account for the many different phenotypes within human tumors.	[Siegmund, Kimberly D.; Marjoram, Paul] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Tavare, Simon] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Tavare, Simon] Univ Cambridge, Dept Oncol, Cambridge, England; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Cambridge; University of Southern California	Siegmund, KD (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	dshibata@usc.edu			National Institutes of Health [R33 CA111940, R21 CA149990]; CRUK; NATIONAL CANCER INSTITUTE [R01CA097346, R21CA149990, R33CA111940] Funding Source: NIH RePORTER; Cancer Research UK [19556] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRUK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work was supported by grants from the National Institutes of Health (R33 CA111940 and R21 CA149990). ST is supported in part by a grant from CRUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Drescher KM, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/170432; DREWINKO B, 1976, CANCER RES, V36, P467; Dy GK, 2008, CANCER-AM CANCER SOC, V113, P1857, DOI 10.1002/cncr.23651; FELSENSTEIN J, 1974, GENETICS, V78, P737; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hong YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012002; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; KIMURA M, 1969, GENETICS, V61, P763; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; NORTON L, 1988, CANCER RES, V48, P7067; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Shibata D, 2006, CELL CYCLE, V5, P610, DOI 10.4161/cc.5.6.2570; Shibata D, 2011, CARCINOGENESIS, V32, P123, DOI 10.1093/carcin/bgq239; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Sinicrope FA, 2006, AM J GASTROENTEROL, V101, P2818, DOI 10.1111/j.1572-0241.2006.00845.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; UMAR A, 1994, J BIOL CHEM, V269, P14367; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	30	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21657	10.1371/journal.pone.0021657	http://dx.doi.org/10.1371/journal.pone.0021657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738754	Green Submitted, Green Published, gold			2022-12-25	WOS:000292142800054
J	Snively, E; Theodor, JM				Snively, Eric; Theodor, Jessica M.			Common Functional Correlates of Head-Strike Behavior in the Pachycephalosaur Stegoceras validum (Ornithischia, Dinosauria) and Combative Artiodactyls	PLOS ONE			English	Article							FRONTAL SINUSES; HELMET; MORPHOLOGY; GOATS; BONE	Background: Pachycephalosaurs were bipedal herbivorous dinosaurs with bony domes on their heads, suggestive of head-butting as seen in bighorn sheep and musk oxen. Previous biomechanical studies indicate potential for pachycephalosaur head-butting, but bone histology appears to contradict the behavior in young and old individuals. Comparing pachycephalosaurs with fighting artiodactyls tests for common correlates of head-butting in their cranial structure and mechanics. Methods/Principal Findings: Computed tomographic (CT) scans and physical sectioning revealed internal cranial structure of ten artiodactyls and pachycephalosaurs Stegoceras validum and Prenocephale prenes. Finite element analyses (FEA), incorporating bone and keratin tissue types, determined cranial stress and strain from simulated head impacts. Recursive partition analysis quantified strengths of correlation between functional morphology and actual or hypothesized behavior. Strong head-strike correlates include a dome-like cephalic morphology, neurovascular canals exiting onto the cranium surface, large neck muscle attachments, and dense cortical bone above a sparse cancellous layer in line with the force of impact. The head-butting duiker Cephalophus leucogaster is the closest morphological analog to Stegoceras, with a smaller yet similarly rounded dome. Crania of the duiker, pachycephalosaurs, and bighorn sheep Ovis canadensis share stratification of thick cortical and cancellous layers. Stegoceras, Cephalophus, and musk ox crania experience lower stress and higher safety factors for a given impact force than giraffe, pronghorn, or the non-combative llama. Conclusions/Significance: Anatomy, biomechanics, and statistical correlation suggest that some pachycephalosaurs were as competent at head-to-head impacts as extant analogs displaying such combat. Large-scale comparisons and recursive partitioning can greatly refine inference of behavioral capability for fossil animals.	[Snively, Eric] Ohio Univ, Dept Mech Engn, Athens, OH 45701 USA; [Theodor, Jessica M.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University System of Ohio; Ohio University; University of Calgary	Snively, E (corresponding author), Ohio Univ, Dept Mech Engn, Athens, OH 45701 USA.	es180210@ohio.edu		Theodor, Jessica/0000-0002-5159-7041	University of Calgary Alberta Ingenuity Russ College of Engineering Canada Foundation for Innovation National Science Foundation	University of Calgary Alberta Ingenuity Russ College of Engineering Canada Foundation for Innovation National Science Foundation	University of Calgary Alberta Ingenuity Russ College of Engineering Canada Foundation for Innovation National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2009, ANAT REC, V292, P1412, DOI 10.1002/ar.20987; BARGHUSEN H R, 1975, Paleobiology, V1, P295; BELL PR, 2009, ANAT REC, V292, P1339; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Bubenik A.B., 1990, P3; Carpenter Kenneth, 1997, Contributions to Geology University of Wyoming, V32, P19; Cowin S.C., 2001, BONE MECH HDB, V2nd; DAGG AI, GIRAFFE ITS BIOL BEH; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; ESTES RD, BEHAV GUIDE AFRICAN; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Farke AA, 2010, ZOOL J LINN SOC-LOND, V159, P988, DOI 10.1111/j.1096-3642.2009.00586.x; Geist V, 1976, MOUNTAIN SHEEP STUDY; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Hellmich C, 2008, ANN BIOMED ENG, V36, P108, DOI [10.1007/s10439-007-9393-8, 10.1016/S0021-9290(08)70202-1]; Hieronymus TL, 2009, ANAT REC, V292, P1370, DOI 10.1002/ar.20985; Ivins BJ, 2008, MIL MED, V173, P1168, DOI 10.7205/MILMED.173.12.1168; Jasinoski SC, 2009, ANAT REC, V292, P862, DOI 10.1002/ar.20906; JASLOW CR, 1995, J ZOOL, V235, P193; KATZ JL, 1984, CALCIFIED TISSUE INT, V36, pS31; Kitchen D., 1974, IUCN Publs (New Series), VNo. 24, P365; KITCHENER A, 1988, J ZOOL, V214, P1, DOI 10.1111/j.1469-7998.1988.tb04983.x; KITCHENER AC, 1992, BIOMECHANICS EVOLUTI, P229; Krieg H, 1944, NATURWISSENSCHAFTEN, V32, P148, DOI 10.1007/BF01467890; KUHN JL, 1989, J BIOMECH, V22, P95, DOI 10.1016/0021-9290(89)90032-8; Maity P, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003321; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mills NJ, 2006, P I MECH ENG L-J MAT, V220, P167, DOI 10.1243/14644207JMDA100; Mills NJ, 2010, INT J CRASHWORTHINES, V15, P331, DOI 10.1080/13588260903251000; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Snively E, 2008, PALAEONTOL ELECTRON, V11; Snively E, 2007, ZOOL J LINN SOC-LOND, V151, P759, DOI 10.1111/j.1096-3642.2007.00334.x; Sues H.-D., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1978, P459; Tsuihiji T, 2005, J MORPHOL, V263, P151, DOI 10.1002/jmor.10294; TURNER CH, 1990, J BIOMECH, V23, P549, DOI 10.1016/0021-9290(90)90048-8; VAHEY JW, 1987, J BIOMECH, V20, P29, DOI 10.1016/0021-9290(87)90264-8; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19	38	38	39	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21422	10.1371/journal.pone.0021422	http://dx.doi.org/10.1371/journal.pone.0021422			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738658	gold, Green Published, Green Submitted			2022-12-25	WOS:000292142800019
J	Vegliante, MC; Royo, C; Palomero, J; Salaverria, I; Balint, B; Martin-Guerrero, I; Agirre, X; Lujambio, A; Richter, J; Xargay-Torrent, S; Bea, S; Hernandez, L; Enjuanes, A; Calasanz, MJ; Rosenwald, A; Ott, G; Roman-Gomez, J; Prosper, F; Esteller, M; Jares, P; Siebert, R; Campo, E; Martin-Subero, JI; Amador, V				Carmela Vegliante, Maria; Royo, Cristina; Palomero, Jara; Salaverria, Itziar; Balint, Balazs; Martin-Guerrero, Idoia; Agirre, Xabier; Lujambio, Amaia; Richter, Julia; Xargay-Torrent, Silvia; Bea, Silvia; Hernandez, Luis; Enjuanes, Anna; Jose Calasanz, Maria; Rosenwald, Andreas; Ott, German; Roman-Gomez, Jose; Prosper, Felipe; Esteller, Manel; Jares, Pedro; Siebert, Reiner; Campo, Elias; Martin-Subero, Jose I.; Amador, Virginia			Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications	PLOS ONE			English	Article							MANTLE CELL LYMPHOMA; DEFINED BURKITTS-LYMPHOMA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; HIGH-RESOLUTION; DNA METHYLATION; NUCLEAR EXPRESSION; CANCER; MICROARRAY; SURVIVAL	Recent studies have shown aberrant expression of SOX11 in various types of aggressive B-cell neoplasms. To elucidate the molecular mechanisms leading to such deregulation, we performed a comprehensive SOX11 gene expression and epigenetic study in stem cells, normal hematopoietic cells and different lymphoid neoplasms. We observed that SOX11 expression is associated with unmethylated DNA and presence of activating histone marks (H3K9/14Ac and H3K4me3) in embryonic stem cells and some aggressive B-cell neoplasms. In contrast, adult stem cells, normal hematopoietic cells and other lymphoid neoplasms do not express SOX11. Such repression was associated with silencing histone marks H3K9me2 and H3K27me3. The SOX11 promoter of non-malignant cells was consistently unmethylated whereas lymphoid neoplasms with silenced SOX11 tended to acquire DNA hypermethylation. SOX11 silencing in cell lines was reversed by the histone deacetylase inhibitor SAHA but not by the DNA methyltransferase inhibitor AZA. These data indicate that, although DNA hypermethylation of SOX11 is frequent in lymphoid neoplasms, it seems to be functionally inert, as SOX11 is already silenced in the hematopoietic system. In contrast, the pathogenic role of SOX11 is associated with its de novo expression in some aggressive lymphoid malignancies, which is mediated by a shift from inactivating to activating histone modifications.	[Carmela Vegliante, Maria; Royo, Cristina; Palomero, Jara; Xargay-Torrent, Silvia; Bea, Silvia; Hernandez, Luis; Enjuanes, Anna; Jares, Pedro; Campo, Elias; Amador, Virginia] Univ Barcelona, Hematopathol Sect, Pathol Lab, Hosp Clin,Inst Invest Biomed August Pi & Sunyer I, Barcelona, Spain; [Salaverria, Itziar; Martin-Guerrero, Idoia; Richter, Julia; Siebert, Reiner] Univ Kiel, Inst Human Genet, Kiel, Germany; [Salaverria, Itziar; Martin-Guerrero, Idoia; Richter, Julia; Siebert, Reiner] Univ Hosp Schleswig Holstein, Kiel, Germany; [Balint, Balazs; Lujambio, Amaia; Esteller, Manel] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Clin Univ Navarra, Hematol Serv, E-31080 Pamplona, Spain; [Agirre, Xabier; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Clin Univ Navarra, Area Cell Therapy, E-31080 Pamplona, Spain; [Jose Calasanz, Maria] Univ Navarra, Dept Genet, E-31080 Pamplona, Spain; [Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany; [Roman-Gomez, Jose] Reina Sofia Hosp, Dept Hematol, Cordoba, Spain; [Campo, Elias; Martin-Subero, Jose I.] Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Navarra; University of Navarra; University of Navarra; University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Hospital Universitario Reina Sofia - Cordoba; University of Barcelona	Vegliante, MC (corresponding author), Univ Barcelona, Hematopathol Sect, Pathol Lab, Hosp Clin,Inst Invest Biomed August Pi & Sunyer I, Barcelona, Spain.	vamador@clinic.ub.es	Esteller, Manel/L-5956-2014; Campo, Elias/AAC-5593-2019; Agirre, Xabier/ABE-4110-2020; bea, silvia/K-7699-2014; Palomero, Jara/D-7204-2018; ENJUANES, Anna/H-3245-2015; Siebert, Reiner/A-8049-2010; Prosper, Felipe/H-6859-2017; Vegliante, Maria Carmela/K-1732-2018; Vegliante, Maria Carmela/AAC-5888-2022; SALAVERRIA, ITZIAR/L-2246-2015; SALAVERRIA, ITZIAR/AAW-9019-2021; Hernandez, Luis/D-4684-2018; Martin-Guerrero, Idoia/AAF-3446-2020; Calasanz, MJ/R-5813-2016; Royo, Cristina/H-3193-2015; Jares, Pedro/T-3778-2019	Esteller, Manel/0000-0003-4490-6093; Campo, Elias/0000-0001-9850-9793; bea, silvia/0000-0001-7192-2385; Palomero, Jara/0000-0002-2092-2526; ENJUANES, Anna/0000-0002-4679-6687; Prosper, Felipe/0000-0001-6115-8790; Vegliante, Maria Carmela/0000-0002-3165-1768; Vegliante, Maria Carmela/0000-0002-3165-1768; SALAVERRIA, ITZIAR/0000-0002-2427-9822; Hernandez, Luis/0000-0002-4854-3069; Calasanz, MJ/0000-0002-0374-3008; Royo, Cristina/0000-0002-1214-4656; Lujambio, Amaia/0000-0002-2798-1481; Balint, Balazs/0000-0002-5102-0787; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Martin-Guerrero, Idoia/0000-0002-0098-1908; Xargay-Torrent, Silvia/0000-0003-3410-6674; JARES, PEDRO/0000-0002-8401-579X	Comision Ministerio de Ciencia e Innovacion [BFU2009-09235, SAF2009-08663, SAF08/3630]; Instituto de Salud Carlos III Red Tematica de Investigacion Cooperativa de Cancer [2006RET2039]; Asociacion Espanola Contra el Cancer; Deutsche Krebshilfe [70-3173-Tr3]; Kinderkrebsinitative Buchholz/Holm-Seppensen; Alexander von Humboldt Foundation; Junta de Andalucia [2009/0206]	Comision Ministerio de Ciencia e Innovacion; Instituto de Salud Carlos III Red Tematica de Investigacion Cooperativa de Cancer(Instituto de Salud Carlos III); Asociacion Espanola Contra el Cancer; Deutsche Krebshilfe(Deutsche Krebshilfe); Kinderkrebsinitative Buchholz/Holm-Seppensen; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Junta de Andalucia(Junta de Andalucia)	This study was supported by the Comision Ministerio de Ciencia e Innovacion (BFU2009-09235 to VA, SAF2009-08663 to JIM-S, SAF08/3630 to EC), Instituto de Salud Carlos III Red Tematica de Investigacion Cooperativa de Cancer (2006RET2039 to EC), the Asociacion Espanola Contra el Cancer (to ME), the Deutsche Krebshilfe through the network project "Molecular Mechanisms in Malignant Lymphomas subproject M2 (70-3173-Tr3 to RS and JIM-S), the Kinderkrebsinitative Buchholz/Holm-Seppensen (to RS), the Alexander von Humboldt Foundation (to IS) and the Junta de Andalucia (2009/0206 to JR-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Chaganti RSK, 2000, SEMIN HEMATOL, V37, P396; Chen YH, 2010, MODERN PATHOL, V23, P105, DOI 10.1038/modpathol.2009.140; Dictor M, 2009, HAEMATOL-HEMATOL J, V94, P1563, DOI 10.3324/haematol.2009.008474; Ek S, 2008, BLOOD, V111, P800, DOI 10.1182/blood-2007-06-093401; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Gustavsson E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-187; Hartmann EM, 2010, BLOOD, V116, P953, DOI 10.1182/blood-2010-01-263806; Haslinger A, 2009, EUR J NEUROSCI, V29, P2103, DOI 10.1111/j.1460-9568.2009.06768.x; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; JAY P, 1995, GENOMICS, V29, P541, DOI 10.1006/geno.1995.9970; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kawamata N, 2008, BLOOD, V111, P776, DOI 10.1182/blood-2007-05-088310; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Lee CJ, 2002, J NEURO-ONCOL, V57, P201, DOI 10.1023/A:1015773818302; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Mozos A, 2009, HAEMATOL-HEMATOL J, V94, P1555, DOI 10.3324/haematol.2009.010264; Salaverria I, 2008, HAEMATOL-HEMATOL J, V93, P1327, DOI 10.3324/haematol.13071; Scholtysik R, 2010, HAEMATOL-HEMATOL J, V95, P2047, DOI 10.3324/haematol.2010.026831; Swerdlow S, 2008, WHO CLASSIFICATION T; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Wang X, 2008, BRIT J HAEMATOL, V143, P248, DOI 10.1111/j.1365-2141.2008.07329.x; Weigle B, 2005, ONCOL REP, V13, P139	37	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21382	10.1371/journal.pone.0021382	http://dx.doi.org/10.1371/journal.pone.0021382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738649	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600035
J	Bukh, AR; Melchjorsen, J; Offersen, R; Jensen, JMB; Toft, L; Stovring, H; Ostergaard, L; Tolstrup, M; Sogaard, OS				Bukh, Anne Roslev; Melchjorsen, Jesper; Offersen, Rasmus; Jensen, Jens Magnus Bernth; Toft, Lars; Stovring, Henrik; Ostergaard, Lars; Tolstrup, Martin; Sogaard, Ole Schmeltz			Endotoxemia Is Associated with Altered Innate and Adaptive Immune Responses in Untreated HIV-1 Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; MICROBIAL TRANSLOCATION; ANTI-GAL; BACTERIAL TRANSLOCATION; PLASMA-LEVELS; DISEASE; ALPHA; ACTIVATION; ANTIBODIES	Background: Microbial translocation may contribute to the immunopathogenesis in HIV infection. We investigated if microbial translocation and inflammation were associated with innate and adaptive immune responses in adults with HIV. Methodology/Principal Findings: This was an observational cohort study. Sera from HIV-infected and HIV-uninfected individuals were analyzed for microbial translocation (soluble CD14, lipopolysaccharides [LPS], endotoxin core antibody, and anti-a-galactosyl antibodies) and inflammatory markers (high sensitivity C-reactive protein, IL-6, IL-1 receptor antagonist, soluble tumor necrosis factor receptor II, and IL-10) with enzyme-linked immunosorbent assays. Peripheral blood mononuclear cells (PBMC) from HIV-infected persons and healthy controls (primed with single-stranded HIV-1-derived RNA) were stimulated with LPS, and cytokine production was measured. Finally, HIV-infected patients were immunized with Prevnar 7vPnC6CpG 7909 followed by Pneumo Novum PPV-23. Effects of microbial translocation and inflammation on immunization were analyzed in a predictive regression model. We included 96 HIV-infected individuals, 76 on highly active antiretroviral therapy (HAART), 20 HAART-naive, and 50 healthy controls. Microbial translocation and inflammatory markers were higher among HIV-infected persons than controls. Cytokine levels following LPS stimulation were increased in PBMCs from HAART-naive compared to HAART-treated HIV-infected persons. Further, RNA-priming of PBMCs from controls acted synergistically with LPS to augment cytokine responses. Finally, high serum LPS levels predicted poor vaccine responses among HAART-naive, but not among HAART-treated HIV-infected individuals. Conclusions/Significance: LPS acts synergistically with HIV RNA to stimulate innate immune responses in vitro and increasing serum LPS levels seem to predict poor antibody responses after vaccination among HAART-naive HIV-infected persons. Thus, our results suggest that microbial translocation may be associated with innate and adaptive immune dysfunction in untreated HIV infection.	[Bukh, Anne Roslev; Melchjorsen, Jesper; Offersen, Rasmus; Toft, Lars; Ostergaard, Lars; Tolstrup, Martin; Sogaard, Ole Schmeltz] Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark; [Jensen, Jens Magnus Bernth] Aarhus Univ Hosp Skejby, Dept Clin Immunol, Aarhus, Denmark; [Stovring, Henrik] Aarhus Univ, Dept Biostat, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Bukh, AR (corresponding author), Aarhus Univ Hosp Skejby, Dept Infect Dis, Aarhus, Denmark.	arbukh@gmail.com	Søgaard, Ole Schmeltz/AEP-7968-2022; Ostergaard, Lars/AAA-3020-2020; Støvring, Henrik/I-4683-2012; Offersen, Rasmus/R-4579-2017; Støvring, Henrik/H-5754-2019; Søgaard, Ole S/P-6058-2016; Bernth-Jensen, Jens Magnus/H-6694-2019	Søgaard, Ole Schmeltz/0000-0001-9107-2023; Ostergaard, Lars/0000-0003-2459-0511; Støvring, Henrik/0000-0002-5821-2351; Offersen, Rasmus/0000-0002-5038-4052; Støvring, Henrik/0000-0002-5821-2351; Ostergaard, Lars/0000-0002-7619-605X; Bernth Jensen, Jens Magnus/0000-0002-5004-7822; Tolstrup, Martin/0000-0001-7020-5173	Agnethe Lovgreen's Donation; Danish AIDS foundation [F08-15, F09-14]; foundation for Advancement of Medical Science (The AP Moller Foundation); Helga and Peter Kornings Foundation; Scandinavian Society of Antimicrobial Chemotherapy [2009-22208]; Aase and Einar Danielsens Foundation [106801]; Danish Medical Research Council; University of Aarhus	Agnethe Lovgreen's Donation; Danish AIDS foundation; foundation for Advancement of Medical Science (The AP Moller Foundation); Helga and Peter Kornings Foundation; Scandinavian Society of Antimicrobial Chemotherapy; Aase and Einar Danielsens Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Aarhus	Work was funded by Agnethe Lovgreen's Donation, the Danish AIDS foundation (F08-15 and F09-14), the foundation for Advancement of Medical Science (The AP Moller Foundation), the Helga and Peter Kornings Foundation, the Scandinavian Society of Antimicrobial Chemotherapy (2009-22208), and Aase and Einar Danielsens Foundation (106801). ARB and RO were recipients of scholarships from the Danish Medical Research Council. OSS and LT were recipients of fellowships from the University of Aarhus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Besselink MG, 2009, ANN SURG, V250, P712, DOI 10.1097/SLA.0b013e3181bce5bd; Bode C, 2003, BEST PRACT RES CL GA, V17, P575, DOI 10.1016/S1521-6918(03)00034-9; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Choudhry MA, 2004, ALCOHOL, V33, P199, DOI 10.1016/j.alcohol.2004.05.004; D'Alessandro M, 2002, CLIN IMMUNOL, V103, P63, DOI 10.1006/clim.2001.5180; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Epple HJ, 2009, GUT, V58, P220, DOI 10.1136/gut.2008.150425; Ferri E, 2010, J INFECT DIS, V202, P176, DOI 10.1086/653215; GALILI U, 1987, J EXP MED, V165, P693, DOI 10.1084/jem.165.3.693; GALILI U, 1988, INFECT IMMUN, V56, P1730, DOI 10.1128/IAI.56.7.1730-1737.1988; GALILI U, 1993, SPRINGER SEMIN IMMUN, V15, P155; Gonzalez R, 2010, HIV MED, V11, P535, DOI 10.1111/j.1468-1293.2010.00830.x; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Jagannathan M, 2009, J IMMUNOL, V183, P7461, DOI 10.4049/jimmunol.0901517; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI200113139; KONRADSEN HB, 1993, J IMMUNOL METHODS, V164, P13, DOI 10.1016/0022-1759(93)90270-H; Lee PI, 2009, J INFECT DIS, V199, P1664, DOI 10.1086/598953; Lester RT, 2008, AIDS, V22, P685, DOI 10.1097/QAD.0b013e3282f4de35; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mureith MW, 2010, AIDS, V24, P1841, DOI 10.1097/QAD.0b013e32833ad89a; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; Papasavvas E, 2009, AIDS, V23, P369, DOI 10.1097/QAD.0b013e32831e9c76; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Saethre M, 2002, XENOTRANSPLANTATION, V9, P350, DOI 10.1034/j.1399-3089.2002.01094.x; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Skovsted IC, 2007, VACCINE, V25, P6490, DOI 10.1016/j.vaccine.2007.06.034; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Sogaard OS, 2010, CLIN INFECT DIS, V51, P42, DOI 10.1086/653112; Sogaard OS, 2010, AIDS, V24, P1315, DOI 10.1097/QAD.0b013e328339fe0b; Subramaniam KS, 2003, J INFECT DIS, V187, P758, DOI 10.1086/368331; Wang M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000697; Yu P, 2000, CRIT CARE MED, V28, P2573, DOI 10.1097/00003246-200007000-00065	44	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21275	10.1371/journal.pone.0021275	http://dx.doi.org/10.1371/journal.pone.0021275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731690	gold, Green Submitted, Green Published			2022-12-25	WOS:000292036900020
J	Swenson, NG				Swenson, Nathan G.			Phylogenetic Beta Diversity Metrics, Trait Evolution and Inferring the Functional Beta Diversity of Communities	PLOS ONE			English	Article							FOREST IMPLICATIONS; PATTERNS; RELATEDNESS; SIMILARITY; SIGNAL; SCALE	The beta diversity of communities along gradients has fascinated ecologists for decades. Traditionally such studies have focused on the species composition of communities, but researchers are becoming increasingly interested in analyzing the phylogenetic composition in the hope of achieving mechanistic insights into community structure. To date many metrics of phylogenetic beta diversity have been published, but few empirical studies have been published. Further inferences made from such phylogenetic studies critically rely on the pattern of trait evolution. The present work provides a study of the phylogenetic dissimilarity of 96 tree communities in India. The work compares and contrasts eight metrics of phylogenetic dissimilarity, considers the role of phylogenetic signal in trait data and shows that environmental distance rather than spatial distance is the best correlate of phylogenetic dissimilarity in the study system.	Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University	Swenson, NG (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	swensonn@msu.edu	Swenson, Nathan/A-3514-2012	Swenson, Nathan/0000-0003-3819-9767	Michigan State University	Michigan State University	This work was supported by Michigan State University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; LOSOS JB, 1992, SYST BIOL, V41, P403, DOI 10.2307/2992583; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Ramesh B. R., 2010, ECOLOGY, V91, P3118, DOI DOI 10.1890/10-0133.1; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Schreeg LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013685; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2006, ECOLOGY, V87, P2418, DOI 10.1890/0012-9658(2006)87[2418:TPAPOS]2.0.CO;2; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	33	154	164	13	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21264	10.1371/journal.pone.0021264	http://dx.doi.org/10.1371/journal.pone.0021264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731685	gold, Green Submitted, Green Published			2022-12-25	WOS:000292036900017
J	Yang, W; Marr, LC				Yang, Wan; Marr, Linsey C.			Dynamics of Airborne Influenza A Viruses Indoors and Dependence on Humidity	PLOS ONE			English	Article							ABSOLUTE-HUMIDITY; SEASONAL FACTOR; SURVIVAL; PROTEIN; TRANSMISSION; INACTIVATION; DROPLETS; AEROSOL; SALIVA	There is mounting evidence that the aerosol transmission route plays a significant role in the spread of influenza in temperate regions and that the efficiency of this route depends on humidity. Nevertheless, the precise mechanisms by which humidity might influence transmissibility via the aerosol route have not been elucidated. We hypothesize that airborne concentrations of infectious influenza A viruses (IAVs) vary with humidity through its influence on virus inactivation rate and respiratory droplet size. To gain insight into the mechanisms by which humidity might influence aerosol transmission, we modeled the size distribution and dynamics of IAVs emitted from a cough in typical residential and public settings over a relative humidity (RH) range of 10-90%. The model incorporates the size transformation of virus-containing droplets due to evaporation and then removal by gravitational settling, ventilation, and virus inactivation. The predicted concentration of infectious IAVs in air is 2.4 times higher at 10% RH than at 90% RH after 10 min in a residential setting, and this ratio grows over time. Settling is important for removal of large droplets containing large amounts of IAVs, while ventilation and inactivation are relatively more important for removal of IAVs associated with droplets <5 mu m. The inactivation rate increases linearly with RH; at the highest RH, inactivation can remove up to 28% of IAVs in 10 min. Humidity is an important variable in aerosol transmission of IAVs because it both induces droplet size transformation and affects IAV inactivation rates. Our model advances a mechanistic understanding of the aerosol transmission route, and results complement recent studies on the relationship between humidity and influenza's seasonality. Maintaining a high indoor RH and ventilation rate may help reduce chances of IAV infection.			Yang, W (corresponding author), Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA 24061 USA.	lmarr@vt.edu	Lucas, Elizabeth A/E-2733-2010; Yang, Wan/K-7592-2013; Marr, Linsey/C-9698-2010	Yang, Wan/0000-0002-7555-9728; Marr, Linsey/0000-0003-3628-6891	National Science Foundation [CBET-0547107]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation under grant number CBET-0547107. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagger HL, 2006, EUR BIOPHYS J BIOPHY, V35, P367, DOI 10.1007/s00249-005-0035-5; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Douglas RG, 1975, INFLUENZA VIRUSES IN, P375; DUGUID JP, 1946, J HYG-CAMBRIDGE, V44, P471, DOI 10.1017/S0022172400019288; Effros RM, 2002, AM J RESP CRIT CARE, V165, P663, DOI 10.1164/ajrccm.165.5.2101018; Enberg N, 2001, ORAL SURG ORAL MED O, V92, P292, DOI 10.1067/moe.2001.116814; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; HEMMES JH, 1962, ANTON VAN LEE J M S, V28, P221, DOI 10.1007/BF02538737; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; HINDS WC, 1999, AEROSOL TECHNOLOGY P, P75; JENSEN MM, 1964, APPL MICROBIOL, V12, P418, DOI 10.1128/AEM.12.5.418-420.1964; Lai ACK, 2007, ATMOS ENVIRON, V41, P7473, DOI 10.1016/j.atmosenv.2007.05.045; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; LOUDON RG, 1967, AM REV RESPIR DIS, V95, P435; Lowen Anice, 2009, PLoS Curr, V1, pRRN1002; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; Michishige F, 2006, J MED INVESTIG, V53, P140, DOI 10.2152/jmi.53.140; Mikhailov E, 2004, ATMOS CHEM PHYS, V4, P323, DOI 10.5194/acp-4-323-2004; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; MURPHY BR, 1980, INFECT IMMUN, V29, P348; Myatt TA, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-55; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Parker ER, 1944, J LAB CLIN MED, V29, P37; Posada JA, 2010, J VIROL METHODS, V164, P88, DOI 10.1016/j.jviromet.2009.12.004; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Seinfeld J. H., 2006, Atmospheric chemistry and physics: from air pollution to climate change; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; SHECHMEISTER IL, 1950, J INFECT DIS, V87, P128, DOI 10.1093/infdis/87.2.128; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; TAMERIUS J, 2010, ENV HLTH PERSPECT; Tang IN, 1997, J GEOPHYS RES-ATMOS, V102, P23269, DOI 10.1029/97JD01806; Tang JWT, 2010, ARCH INTERN MED, V170, P861, DOI 10.1001/archinternmed.2010.108; Thomas Y, 2008, APPL ENVIRON MICROB, V74, P3002, DOI 10.1128/AEM.00076-08; Tompkins J. A., 2010, FACILITIES PLANNING, V4th; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; Yamamoto N, 2010, INDOOR AIR, V20, P85, DOI 10.1111/j.1600-0668.2009.00622.x; Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610; YANG W, 2011, J R SOC INT IN PRESS	50	171	175	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21481	10.1371/journal.pone.0021481	http://dx.doi.org/10.1371/journal.pone.0021481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731764	Green Submitted, gold, Green Published			2022-12-25	WOS:000292036900038
J	Guhr, T; Bloem, J; Derksen, NIL; Wuhrer, M; Koenderman, AHL; Aalberse, RC; Rispens, T				Guhr, Theresa; Bloem, Judith; Derksen, Ninotska I. L.; Wuhrer, Manfred; Koenderman, Anky H. L.; Aalberse, Rob C.; Rispens, Theo			Enrichment of Sialylated IgG by Lectin Fractionation Does Not Enhance the Efficacy of Immunoglobulin G in a Murine Model of Immune Thrombocytopenia	PLOS ONE			English	Article							INTRAVENOUS GAMMA-GLOBULIN; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE-DISEASES; IVIG; MECHANISMS; PURPURA; FC; GLYCOSYLATION; SUBCLASSES; RECEPTOR	Intravenous immunoglobulin G (IVIg) is widely used against a range of clinical symptoms. For its use in immune modulating therapies such as treatment of immune thrombocytopenic purpura high doses of IVIg are required. It has been suggested that only a fraction of IVIg causes this anti immune modulating effect. Recent studies indicated that this fraction is the Fc-sialylated IgG fraction. The aim of our study was to determine the efficacy of IVIg enriched for sialylated IgG (IVIg-SA (+)) in a murine model of passive immune thrombocytopenia (PIT). We enriched IVIg for sialylated IgG by Sambucus nigra agglutinin (SNA) lectin fractionation and determined the degree of sialylation. Analysis of IVIg-SA (+) using a lectin-based ELISA revealed that we enriched predominantly for Fab-sialylated IgG, whereas we did not find an increase in Fc-sialylated IgG. Mass spectrometric analysis confirmed that Fc sialylation did not change after SNA lectin fractionation. The efficacy of sialylated IgG was measured by administering IVIg or IVIg-SA (+) 24 hours prior to an injection of a rat anti-mouse platelet mAb. We found an 85% decrease in platelet count after injection of an anti-platelet mAb, which was reduced to a 70% decrease by injecting IVIg (p<0.01). In contrast, IVIg-SA (+) had no effect on the platelet count. Serum levels of IVIg and IVIg-SA (+) were similar, ruling out enhanced IgG clearance as a possible explanation. Our results indicate that SNA lectin fractionation is not a suitable method to enrich IVIg for Fc-sialylated IgG. The use of IVIg enriched for Fab-sialylated IgG abolishes the efficacy of IVIg in the murine PIT model.	[Guhr, Theresa; Derksen, Ninotska I. L.; Aalberse, Rob C.; Rispens, Theo] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Bloem, Judith; Koenderman, Anky H. L.] Sanquin, Prod Dev Dept, Amsterdam, Netherlands; [Wuhrer, Manfred] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Guhr, T (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	T.Rispens@sanquin.nl	Wuhrer, Manfred/ABE-9168-2020	Wuhrer, Manfred/0000-0002-0814-4995				Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Baerenwaldt A, 2010, EXPERT REV CLIN IMMU, V6, P425, DOI [10.1586/eci.10.9, 10.1586/ECI.10.9]; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; BERCHTOLD P, 1989, BLOOD, V73, P662; Crow AR, 2001, BRIT J HAEMATOL, V115, P679, DOI 10.1046/j.1365-2141.2001.03136.x; Dalziel M, 1999, GLYCOCONJUGATE J, V16, P801, DOI 10.1023/A:1007183915921; Fernandez-Cruz E, 2009, CLIN EXP IMMUNOL, V158, P60, DOI 10.1111/j.1365-2249.2009.04028.x; FINNEY JD, 1979, STAT METHOD BIOL ASS; Flynn GC, 2010, MOL IMMUNOL, V47, P2074, DOI 10.1016/j.molimm.2010.04.006; GELFAND EW, 1992, SEMIN HEMATOL, V29, P127; Huang HS, 2010, BLOOD, V116, P5002, DOI 10.1182/blood-2010-03-275123; IMBACH P, 1981, LANCET, V1, P1228; Imbach P, 2010, VOX SANG, V98, P385, DOI 10.1111/j.1423-0410.2009.01264.x; IMBACH P, 1991, CANCER-AM CANCER SOC, V68, P1422, DOI 10.1002/1097-0142(19910915)68:6+<1422::AID-CNCR2820681403>3.0.CO;2-5; Jin F, 2005, HUM IMMUNOL, V66, P403, DOI 10.1016/j.humimm.2005.01.029; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; KAVERI SV, 1991, CLIN EXP IMMUNOL, V86, P192; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Kumar A, 2006, INT ARCH ALLERGY IMM, V140, P185, DOI 10.1159/000093204; Lazarus AH, 2002, VOX SANG, V83, P53, DOI 10.1111/j.1423-0410.2002.tb05268.x; Looney RJ, 2006, BEST PRACT RES CL HA, V19, P3, DOI 10.1016/j.beha.2005.01.032; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Seite JF, 2010, BLOOD, V116, P1698, DOI 10.1182/blood-2009-12-261461; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Stadlmann J, 2010, J CLIN IMMUNOL, V30, pS15, DOI 10.1007/s10875-010-9409-2; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Teeling JL, 2001, BLOOD, V98, P1095, DOI 10.1182/blood.V98.4.1095; Tha-In T, 2008, TRENDS IMMUNOL, V29, P608, DOI 10.1016/j.it.2008.08.004; VLUG A, 1994, ANN BIOL CLIN-PARIS, V52, P561; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289	32	88	96	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21246	10.1371/journal.pone.0021246	http://dx.doi.org/10.1371/journal.pone.0021246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731683	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400016
J	Shimada, K; Crother, TR; Karlin, J; Chen, S; Chiba, N; Ramanujan, VK; Vergnes, L; Ojcius, DM; Arditi, M				Shimada, Kenichi; Crother, Timothy R.; Karlin, Justin; Chen, Shuang; Chiba, Norika; Ramanujan, V. Krishnan; Vergnes, Laurent; Ojcius, David M.; Arditi, Moshe			Caspase-1 Dependent IL-1 beta Secretion Is Critical for Host Defense in a Mouse Model of Chlamydia pneumoniae Lung Infection	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; IFN-GAMMA; NALP3 INFLAMMASOME; IMMUNE-RESPONSES; MICE DEFICIENT; APOPTOSIS; INNATE; INTERLEUKIN-1; ACTIVATION; INDUCTION	Chlamydia pneumoniae (CP) is an important human pathogen that causes atypical pneumonia and is associated with various chronic inflammatory disorders. Caspase-1 is a key component of the 'inflammasome', and is required to cleave pro-IL-1 beta to bioactive IL-1 beta. Here we demonstrate for the first time a critical requirement for IL-1 beta in response to CP infection. Caspase-1(-/-) mice exhibit delayed cytokine production, defective clearance of pulmonary bacteria and higher mortality in response to CP infection. Alveolar macrophages harbored increased bacterial numbers due to reduced iNOS levels in Caspase-1(-/-) mice. Pharmacological blockade of the IL-1 receptor in CP infected wild-type mice phenocopies Caspase-1-deficient mice, and administration of recombinant IL-1 beta rescues CP infected Caspase-1(-/-) mice from mortality, indicating that IL-1 beta secretion is crucial for host immune defense against CP lung infection. In vitro investigation reveals that CP-induced IL-1 beta secretion by macrophages requires TLR2/MyD88 and NLRP3/ASC/Caspase-1 signaling. Entry into the cell by CP and new protein synthesis by CP are required for inflammasome activation. Neither ROS nor cathepsin was required for CP infection induced inflammasome activation. Interestingly, Caspase-1 activation during CP infection occurs with mitochondrial dysfunction indicating a possible mechanism involving the mitochondria for CP-induced inflammasome activation.	[Shimada, Kenichi; Crother, Timothy R.; Karlin, Justin; Chen, Shuang; Chiba, Norika; Arditi, Moshe] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Shimada, Kenichi; Crother, Timothy R.; Karlin, Justin; Chen, Shuang; Chiba, Norika; Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ramanujan, V. Krishnan] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Vergnes, Laurent] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Merced; University of California System; University of California Merced	Shimada, K (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA.	arditi.moshe@cshs.org	Ojcius, David/ABE-6557-2020; Ramanujan, V Krishnan/O-2831-2014; Crother, Timothy R/E-2879-2010; Ramanujan, V Krishnan/A-6395-2011	Crother, Timothy R/0000-0001-8465-6127; Ojcius, David/0000-0003-1461-4495; vergnes, laurent/0000-0002-8804-589X	National Institutes of Health [HL-66436, AI-067995]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067995, R01AI067995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants HL-66436 and AI-067995 (to MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Blasi F, 2009, CLIN MICROBIOL INFEC, V15, P29, DOI 10.1111/j.1469-0691.2008.02130.x; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fox ES, 1998, J LEUKOCYTE BIOL, V63, P509, DOI 10.1002/jlb.63.4.509; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Frankenberg T, 2008, EUR J IMMUNOL, V38, P204, DOI 10.1002/eji.200737379; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Gerard HC, 2009, RHEUM DIS CLIN N AM, V35, P1, DOI 10.1016/j.rdc.2009.03.011; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gold ES, 2004, J EXP MED, V200, P581, DOI 10.1084/jem.20040546; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Joyee AG, 2008, CURR PHARM DESIGN, V14, P593, DOI 10.2174/138161208783885344; KaukorantaTolvanen SSE, 1996, MICROB PATHOGENESIS, V21, P215, DOI 10.1006/mpat.1996.0056; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LATZ E, 2010, CURR OPIN IMMUNOL; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MAYERBARBER KD, 2010, J IMMUNOLOGY BALTIMO, P1950; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Moayeri M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001222; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; NAKAHIRA K, 2010, NATURE IMMUNOLOGY; Netea MG, 2000, EUR J IMMUNOL, V30, P541, DOI 10.1002/1521-4141(200002)30:2<541::AID-IMMU541>3.0.CO;2-X; Netea MG, 2004, J IMMUNOL, V173, P1477, DOI 10.4049/jimmunol.173.2.1477; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Papaetis GS, 2009, EUR J INTERN MED, V20, P579, DOI 10.1016/j.ejim.2009.05.006; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Rottenberg ME, 2000, J IMMUNOL, V164, P4812, DOI 10.4049/jimmunol.164.9.4812; Rottenberg ME, 1999, J IMMUNOL, V162, P2829; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Rupp J, 2003, EUR RESPIR J, V22, P274, DOI 10.1183/09031936.03.00007303; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298; Zhou R, 2010, NATURE	50	89	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21477	10.1371/journal.pone.0021477	http://dx.doi.org/10.1371/journal.pone.0021477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731762	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400042
J	Van Bergen, NJ; Crowston, JG; Kearns, LS; Staffieri, SE; Hewitt, AW; Cohn, AC; Mackey, DA; Trounce, IA				Van Bergen, Nicole J.; Crowston, Jonathan G.; Kearns, Lisa S.; Staffieri, Sandra E.; Hewitt, Alex W.; Cohn, Amy C.; Mackey, David A.; Trounce, Ian A.			Mitochondrial Oxidative Phosphorylation Compensation May Preserve Vision in Patients with OPA1-Linked Autosomal Dominant Optic Atrophy	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN; OPA1 MUTATIONS; HETEROZYGOUS MUTATION; NERVE HEAD; COMPLEX-I; NEUROPATHY; GENE; DYSFUNCTION; MORPHOLOGY; DEFECTS	Autosomal Dominant Optic Atrophy (ADOA) is the most common inherited optic atrophy where vision impairment results from specific loss of retinal ganglion cells of the optic nerve. Around 60% of ADOA cases are linked to mutations in the OPA1 gene. OPA1 is a fission-fusion protein involved in mitochondrial inner membrane remodelling. ADOA presents with marked variation in clinical phenotype and varying degrees of vision loss, even among siblings carrying identical mutations in OPA1. To determine whether the degree of vision loss is associated with the level of mitochondrial impairment, we examined mitochondrial function in lymphoblast cell lines obtained from six large Australian OPA1-linked ADOA pedigrees. Comparing patients with severe vision loss (visual acuity [VA]<6/36) and patients with relatively preserved vision (VA>6/9) a clear defect in mitochondrial ATP synthesis and reduced respiration rates were observed in patients with poor vision. In addition, oxidative phosphorylation (OXPHOS) enzymology in ADOA patients with normal vision revealed increased complex II+III activity and levels of complex IV protein. These data suggest that OPA1 deficiency impairs OXPHOS efficiency, but compensation through increases in the distal complexes of the respiratory chain may preserve mitochondrial ATP production in patients who maintain normal vision. Identification of genetic variants that enable this response may provide novel therapeutic insights into OXPHOS compensation for preventing vision loss in optic neuropathies.	[Van Bergen, Nicole J.; Crowston, Jonathan G.; Kearns, Lisa S.; Staffieri, Sandra E.; Hewitt, Alex W.; Cohn, Amy C.; Trounce, Ian A.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Mackey, David A.] Univ Western Australia, Perth, WA 6009, Australia; [Mackey, David A.] Lions Eye Inst, Perth, WA, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Western Australia; Lions Eye Institute; University of Western Australia	Van Bergen, NJ (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.	i.trounce@unimelb.edu.au	Hewitt, Alex W/D-1936-2013; Mackey, David A/H-5340-2014; Staffieri, Sandra/R-1216-2019	Hewitt, Alex W/0000-0002-5123-5999; Mackey, David A/0000-0001-7914-4709; Staffieri, Sandra/0000-0003-3131-9359; Trounce, Ian/0000-0002-1070-8892; Kearns, Lisa/0000-0001-9432-4054	National Health and Medical Research Council [590200]; Ophthalmic Research Institute of Australia; Glaucoma Australia; Henry Greenfield Research Fund; Edols Trust	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; Glaucoma Australia; Henry Greenfield Research Fund; Edols Trust	The work was supported by the National Health and Medical Research Council [grant number 590200]; Ophthalmic Research Institute of Australia; Glaucoma Australia Fund; Henry Greenfield Research Fund and Edols Trust Fund. The Centre for Eye Research Australia receives operational infrastructure support from the Victorian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Bai RK, 2005, J MOL DIAGN, V7, P613, DOI 10.1016/S1525-1578(10)60595-8; Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171; Brown MD, 2001, AM J MED GENET, V104, P331, DOI 10.1002/1096-8628(2001)104:4<331::AID-AJMG10054>3.0.CO;2-8; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 2007, BIOSCIENCE REP, V27, P173, DOI 10.1007/s10540-007-9045-0; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; Chevrollier A, 2008, ANN NEUROL, V63, P794, DOI 10.1002/ana.21385; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cohn AC, 2008, BRIT J OPHTHALMOL, V92, P1333, DOI 10.1136/bjo.2007.134726; Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Ferre M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fuhrmann N, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-25; Garcia-Barcelo M, 2006, CLIN CHEM, V52, P46, DOI 10.1373/clinchem.2005.056192; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HEIDUSCHKA P, 2009, INVEST OPHTH VIS SCI, V51, P1424; Holladay JT, 2004, J CATARACT REFR SURG, V30, P287, DOI 10.1016/j.jcrs.2004.01.014; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Hutter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Johnston RL, 1999, OPHTHALMOLOGY, V106, P123, DOI 10.1016/S0161-6420(99)90013-1; Jun AS, 1996, MOL CELL BIOL, V16, P771; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; KJER P, 1959, Acta Ophthalmol Suppl, V164, P1; LEE S, 2010, EXP EYE RES     0804; Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278; Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3; Marchbank NJ, 2002, J MED GENET, V39, DOI 10.1136/jmg.39.8.e47; Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22; Meucci MA, 2005, PHARMACOGENOMICS, V6, P59, DOI 10.1517/14622416.6.1.59; Morgan JE, 2005, OPHTHALMOLOGY, V112, P855, DOI 10.1016/j.ophtha.2004.11.056; Morgan JE, 2005, BRIT J OPHTHALMOL, V89, P879, DOI 10.1136/bjo.2004.046169; O'Neill EC, 2010, NAT REV NEUROL, V6, P221, DOI 10.1038/nrneurol.2010.5; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Pierron D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-70; Pottier N, 2007, HUM MOL GENET, V16, P2261, DOI 10.1093/hmg/ddm178; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Shahrestani P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006867; Spinazzi M, 2008, HUM MOL GENET, V17, P3291, DOI 10.1093/hmg/ddn225; Stadlmann S, 2002, TRANSPLANTATION, V74, P1800, DOI 10.1097/01.TP.0000039262.25355.67; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793; Votruba M, 2004, EYE, V18, P1126, DOI 10.1038/sj.eye.6701570; Votruba M, 2003, BRIT J OPHTHALMOL, V87, P48, DOI 10.1136/bjo.87.1.48; White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038; Yu-Wai-Man P, 2009, INVEST OPHTH VIS SCI, V50, P4561, DOI 10.1167/iovs.09-3634; YUWAIMAN P, 2010, PROG RETIN EYE RES; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335	71	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21347	10.1371/journal.pone.0021347	http://dx.doi.org/10.1371/journal.pone.0021347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731710	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700065
J	Pietrosiuk, A; Lenherr, ED; Falk, S; Bonemann, G; Kopp, J; Zentgraf, H; Sinning, I; Mogk, A				Pietrosiuk, Aleksandra; Lenherr, Esther D.; Falk, Sebastian; Boenemann, Gabriele; Kopp, Juergen; Zentgraf, Hanswalter; Sinning, Irmgard; Mogk, Axel			Molecular Basis for the Unique Role of the AAA(+) Chaperone ClpV in Type VI Protein Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; N-DOMAIN; ADAPTER; DELIVERY; OLIGOMERIZATION; COMPLEXES; SYSTEM; SSPB	Ring-forming AAA(+) ATPases act in a plethora of cellular processes by remodeling macromolecules. The specificity of individual AAA(+) proteins is achieved by direct or adaptor-mediated association with substrates via distinct recognition domains. We investigated the molecular basis of substrate interaction for Vibrio cholerae ClpV, which disassembles tubular VipA/VipB complexes, an essential step of type VI protein secretion and bacterial virulence. We identified the ClpV recognition site within VipB, showed that productive ClpV-VipB interaction requires the oligomeric state of both proteins, solved the crystal structure of a ClpV N-domain-VipB peptide complex, and verified the interaction surface by mutant analysis. Our results show that the substrate is bound to a hydrophobic groove, which is formed by the addition of a single alpha-helix to the core N-domain. This helix is absent from homologous N-domains, explaining the unique substrate specificity of ClpV. A limited interaction surface between both proteins accounts for the dramatic increase in binding affinity upon ATP-driven ClpV hexamerization and VipA/VipB tubule assembly by coupling multiple weak interactions. This principle ensures ClpV selectivity toward the VipA/VipB macromolecular complex.	[Pietrosiuk, Aleksandra; Boenemann, Gabriele; Mogk, Axel] Heidelberg Univ, DKFZ ZMBH Alliance, ZMBH, D-69120 Heidelberg, Germany; [Lenherr, Esther D.; Falk, Sebastian; Kopp, Juergen; Sinning, Irmgard] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Kopp, Juergen] Excellenzcluster CellNetworks, D-69120 Heidelberg, Germany; [Zentgraf, Hanswalter] Deutsch Krebsforschungszentrum Angew Tumorvirol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Mogk, A (corresponding author), Heidelberg Univ, DKFZ ZMBH Alliance, ZMBH, INF282, D-69120 Heidelberg, Germany.	a.mogk@zmbh.uni-heidelberg.de	Falk, Sebastian/AAG-9706-2019; Falk, Sebastian/T-4796-2017	Falk, Sebastian/0000-0001-7848-4621; Falk, Sebastian/0000-0001-7848-4621; Kopp, Juergen/0000-0001-5633-7399	Deutsche Forschungsgemeinschaft [MO970/3-1, SFB 638]; Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, University of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, University of Heidelberg	This work was supported by Deutsche Forschungsgemeinschaft Grants MO970/3-1 (to A. M.) and SFB 638 (to I. S.).; Supported by the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology, University of Heidelberg.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; De Donatis GM, 2010, J BIOL CHEM, V285, P8771, DOI 10.1074/jbc.M109.053736; del Castillo U, 2010, FEBS LETT, V584, P929, DOI 10.1016/j.febslet.2010.01.029; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Effantin G, 2010, STRUCTURE, V18, P553, DOI 10.1016/j.str.2010.02.016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Kojetin DJ, 2009, J MOL BIOL, V387, P639, DOI 10.1016/j.jmb.2009.01.046; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Li JZ, 2003, STRUCTURE, V11, P323, DOI 10.1016/S0969-2126(03)00030-3; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schmidt R, 2009, RES MICROBIOL, V160, P629, DOI 10.1016/j.resmic.2009.08.018; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	44	79	83	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30010	30021		10.1074/jbc.M111.253377	http://dx.doi.org/10.1074/jbc.M111.253377			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21733841	hybrid, Green Published			2022-12-25	WOS:000294046600060
J	Ping, JH; Keleta, L; Forbes, NE; Dankar, S; Stecho, W; Tyler, S; Zhou, Y; Babiuk, L; Weingartl, H; Halpin, RA; Boyne, A; Bera, J; Hostetler, J; Fedorova, NB; Proudfoot, K; Katzel, DA; Stockwell, TB; Ghedin, E; Spiro, DJ; Brown, EG				Ping, Jihui; Keleta, Liya; Forbes, Nicole E.; Dankar, Samar; Stecho, William; Tyler, Shaun; Zhou, Yan; Babiuk, Lorne; Weingartl, Hana; Halpin, Rebecca A.; Boyne, Alex; Bera, Jayati; Hostetler, Jessicah; Fedorova, Nadia B.; Proudfoot, Katie; Katzel, Dan A.; Stockwell, Tim B.; Ghedin, Elodie; Spiro, David J.; Brown, Earl G.			Genomic and Protein Structural Maps of Adaptive Evolution of Human Influenza A Virus to Increased Virulence in the Mouse	PLOS ONE			English	Article							POLYMERASE SUBUNIT PB2; LOW-PH STABILITY; HOST-RANGE; MATRIX PROTEIN; SIALIDASE ACTIVITY; NS1 PROTEIN; PARALLEL EVOLUTION; MAMMALIAN-CELLS; MOLECULAR-BASIS; MUTATION-RATES	Adaptive evolution is characterized by positive and parallel, or repeated selection of mutations. Mouse adaptation of influenza A virus (IAV) produces virulent mutants that demonstrate positive and parallel evolution of mutations in the hemagglutinin (HA) receptor and non-structural protein 1 (NS1) interferon antagonist genes. We now present a genomic analysis of all 11 genes of 39 mouse adapted IAV variants from 10 replicate adaptation experiments. Mutations were mapped on the primary and structural maps of each protein and specific mutations were validated with respect to virulence, replication, and RNA polymerase activity. Mouse adapted (MA) variants obtained after 12 or 20-21 serial infections acquired on average 5.8 and 7.9 nonsynonymous mutations per genome of 11 genes, respectively. Among a total of 115 nonsynonymous mutations, 51 demonstrated properties of natural selection including 27 parallel mutations. The greatest degree of parallel evolution occurred in the HA receptor and ribonucleocapsid components, polymerase subunits (PB1, PB2, PA) and NP. Mutations occurred in host nuclear trafficking factor binding sites as well as sites of virus-virus protein subunit interaction for NP, NS1, HA and NA proteins. Adaptive regions included cap binding and endonuclease domains in the PB2 and PA polymerase subunits. Four mutations in NS1 resulted in loss of binding to the host cleavage and polyadenylation specificity factor (CPSF30) suggesting that a reduction in inhibition of host gene expression was being selected. The most prevalent mutations in PB2 and NP were shown to increase virulence but differed in their ability to enhance replication and demonstrated epistatic effects. Several positively selected RNA polymerase mutations demonstrated increased virulence associated with >300% enhanced polymerase activity. Adaptive mutations that control host range and virulence were identified by their repeated selection to comprise a defined model for studying IAV evolution to increased virulence in the mouse.	[Ping, Jihui; Keleta, Liya; Forbes, Nicole E.; Dankar, Samar; Stecho, William; Brown, Earl G.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Ping, Jihui; Keleta, Liya; Forbes, Nicole E.; Dankar, Samar; Stecho, William; Brown, Earl G.] Univ Ottawa, Emerging Pathogens Res Ctr, Ottawa, ON, Canada; [Tyler, Shaun] Publ Hlth Agcy Canada, Natl Microbiol Lab, Canadian Sci Ctr Human & Anim Hlth, Winnipeg, MB, Canada; [Zhou, Yan; Babiuk, Lorne] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Weingartl, Hana] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada; [Halpin, Rebecca A.; Boyne, Alex; Bera, Jayati; Hostetler, Jessicah; Fedorova, Nadia B.; Proudfoot, Katie; Katzel, Dan A.; Stockwell, Tim B.; Ghedin, Elodie; Spiro, David J.] J Craig Venter Inst, Viral Genom Grp, Rockville, MD USA; [Ping, Jihui; Keleta, Liya; Forbes, Nicole E.; Dankar, Samar; Zhou, Yan; Babiuk, Lorne; Weingartl, Hana; Brown, Earl G.] Univ Ottawa, Canadian Inst Hlth Res CIHR, Canadian Influenza Pathogenesis Team, Ottawa, ON, Canada; [Ghedin, Elodie] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Dept Computat & Syst Biol, Pittsburgh, PA USA	University of Ottawa; University of Ottawa; Canadian Science Centre for Human & Animal Health; Public Health Agency of Canada; University of Saskatchewan; Canadian Food Inspection Agency; J. Craig Venter Institute; University of Ottawa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ping, JH (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	Earl.Brown@uottawa.ca	Stecho, William/E-1656-2013; Ghedin, Elodie/Y-5654-2019	Stecho, William/0000-0002-2891-9348; Ghedin, Elodie/0000-0002-1515-725X; Forbes, Nicole/0000-0002-2645-695X; Katzel, Daniel/0000-0002-3191-0694; Stockwell, Timothy/0000-0002-3595-4539	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [N01-AI-30071, HHSN272200900007C]; CIHR Pandemic Preparedness Team [TPA-90188]; Canadian Institutes of Heath Research (CIHR, Institute of Infection and Immunity) [MOP-74526]; Influenza Genome	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CIHR Pandemic Preparedness Team(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Heath Research (CIHR, Institute of Infection and Immunity)(Canadian Institutes of Health Research (CIHR)); Influenza Genome	This project has been funded in part through the Influenza Genome Sequencing Project with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, http://www.niaid.nih.gov/, under contract numbers N01-AI-30071 and HHSN272200900007C; the CIHR Pandemic Preparedness Team grant to the CIHR Canadian Influenza Pathogenesis Team (EGB, LB, YZ, and HW) TPA-90188, and Canadian Institutes of Heath Research (CIHR, Institute of Infection and Immunity, http://www.cihr-irsc.gc.ca/, operating grant MOP-74526 (EGB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Arendt J, 2008, TRENDS ECOL EVOL, V23, P26, DOI 10.1016/j.tree.2007.09.011; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Basler CF, 2008, ANTIVIR RES, V79, P166, DOI 10.1016/j.antiviral.2008.04.006; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Brown E. G., 2008, Current Topics in Virology. Volume 7, P99; Brown EG, 2000, BIOMED PHARMACOTHER, V54, P196, DOI 10.1016/S0753-3322(00)89026-5; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Brown EG, 1999, VIRUS RES, V61, P63, DOI 10.1016/S0168-1702(99)00027-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Bull JJ, 1997, GENETICS, V147, P1497; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; CRECELIUS DM, 1984, VIROLOGY, V139, P164, DOI 10.1016/0042-6822(84)90337-4; DANIELS RS, 1987, EMBO J, V6, P1459, DOI 10.1002/j.1460-2075.1987.tb02387.x; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Engelhardt OG, 2006, REV MED VIROL, V16, P329, DOI 10.1002/rmv.512; Flick R, 1999, J GEN VIROL, V80, P2565, DOI 10.1099/0022-1317-80-10-2565; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayward JJ, 2010, J VIROL, V84, P12636, DOI 10.1128/JVI.01350-10; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Hu YW, 2005, VIROLOGY, V332, P538, DOI 10.1016/j.virol.2004.11.041; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; Kochs G., 2007, J VIROL; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; Li CJ, 2008, J VIROL, V82, P11880, DOI 10.1128/JVI.01445-08; Li JW, 2009, VIRUS RES, V144, P123, DOI 10.1016/j.virusres.2009.04.008; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lipatov AS, 2003, J VIROL, V77, P3816, DOI 10.1128/JVI.77.6.3816-3823.2003; Liu Qinfang, 2009, J Mol Genet Med, V3, P225; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Miller J, 2004, BEHAV RES METH INS C, V36, P11, DOI 10.3758/BF03195545; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Narasaraju T, 2009, MICROBES INFECT, V11, P2, DOI 10.1016/j.micinf.2008.09.013; NAYAK DP, 1989, ANNU REV MICROBIOL, V43, P465, DOI 10.1146/annurev.mi.43.100189.002341; Nelson M, 2009, PLOS CURR INFLUENZA; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2005, EVOLUTION, V59, P216; Palese P., 2007, FIELDS VIROLOGY, P1647; PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Pielak RM, 2009, P NATL ACAD SCI USA, V106, P7379, DOI 10.1073/pnas.0902548106; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Ralph P, 2010, GENETICS, V186, P647, DOI 10.1534/genetics.110.119594; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reid AH, 2004, NAT REV MICROBIOL, V2, P909, DOI 10.1038/nrmicro1027; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; Reid AH, 2003, AVIAN DIS, V47, P921, DOI 10.1637/0005-2086-47.s3.921; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Rigoni M, 2007, VIROLOGY, V364, P28, DOI 10.1016/j.virol.2007.02.031; Rolling T, 2009, J VIROL, V83, P6673, DOI 10.1128/JVI.00212-09; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smee Donald F., 2007, Antiviral Chemistry & Chemotherapy, V18, P317; SMEENK CA, 1994, J VIROL, V68, P530, DOI 10.1128/JVI.68.1.530-534.1994; Smeenk CA, 1996, VIRUS RES, V44, P79, DOI 10.1016/0168-1702(96)01329-9; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; STEINHAUER DA, 1991, P NATL ACAD SCI USA, V88, P11525, DOI 10.1073/pnas.88.24.11525; STEVENS J, 2004, SCIENCE; SUAREZ P, 1992, J VIROL, V66, P2491; Suzuki T, 2004, FEBS LETT, V557, P228, DOI 10.1016/S0014-5793(03)01503-5; Takahashi T, 2003, FEBS LETT, V543, P71, DOI 10.1016/S0014-5793(03)00403-4; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Takahashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015556; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Ward AC, 1997, VIRUS GENES, V14, P187, DOI 10.1023/A:1007979709403; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wichman HA, 2000, PHILOS T R SOC B, V355, P1677, DOI 10.1098/rstb.2000.0731; WIN C, 1859, ORIGIN SPECIES MEANS; Wood TE, 2005, GENETICA, V123, P157, DOI 10.1007/s10709-003-2738-9; Wu R, 2009, VET MICROBIOL, V138, P85, DOI 10.1016/j.vetmic.2009.03.010; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Ye ZP, 1999, J VIROL, V73, P7467, DOI 10.1128/JVI.73.9.7467-7473.1999; YE ZP, 1989, J VIROL, V63, P3586, DOI 10.1128/JVI.63.9.3586-3594.1989; YE ZP, 1987, J VIROL, V61, P239, DOI 10.1128/JVI.61.2.239-246.1987; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; Zhou B, 2011, J VIROL, V85, P357, DOI 10.1128/JVI.01694-10; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	123	66	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21740	10.1371/journal.pone.0021740	http://dx.doi.org/10.1371/journal.pone.0021740			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738783	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000292291800035
J	Eldawlatly, S; Oweiss, KG				Eldawlatly, Seif; Oweiss, Karim G.			Millisecond-Timescale Local Network Coding in the Rat Primary Somatosensory Cortex	PLOS ONE			English	Article							BARREL CORTEX; STIMULUS LOCATION; CELL ASSEMBLIES; INFORMATION; NEURONS; SPARSE; SYNCHRONIZATION; CONNECTIVITY; ORGANIZATION; OSCILLATIONS	Correlation among neocortical neurons is thought to play an indispensable role in mediating sensory processing of external stimuli. The role of temporal precision in this correlation has been hypothesized to enhance information flow along sensory pathways. Its role in mediating the integration of information at the output of these pathways, however, remains poorly understood. Here, we examined spike timing correlation between simultaneously recorded layer V neurons within and across columns of the primary somatosensory cortex of anesthetized rats during unilateral whisker stimulation. We used Bayesian statistics and information theory to quantify the causal influence between the recorded cells with millisecond precision. For each stimulated whisker, we inferred stable, whisker-specific, dynamic Bayesian networks over many repeated trials, with network similarity of 83.3 +/- 6% within whisker, compared to only 50.3 +/- 18% across whiskers. These networks further provided information about whisker identity that was approximately 6 times higher than what was provided by the latency to first spike and 13 times higher than what was provided by the spike count of individual neurons examined separately. Furthermore, prediction of individual neurons' precise firing conditioned on knowledge of putative pre-synaptic cell firing was 3 times higher than predictions conditioned on stimulus onset alone. Taken together, these results suggest the presence of a temporally precise network coding mechanism that integrates information across neighboring columns within layer V about vibrissa position and whisking kinetics to mediate whisker movement by motor areas innervated by layer V.	[Eldawlatly, Seif; Oweiss, Karim G.] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Oweiss, Karim G.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Eldawlatly, S (corresponding author), Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA.	koweiss@msu.edu	Eldawlatly, Seif/AAF-4857-2020	Eldawlatly, Seif/0000-0003-2873-0569	NINDS [NS054148]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R33NS054148, R21NS054148] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS grant number NS054148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., 1982, LOCAL CORTICAL CIRCU; Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Barth DS, 2003, J NEUROSCI, V23, P2502; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Devonshire IM, 2010, EUR J NEUROSCI, V32, P786, DOI 10.1111/j.1460-9568.2010.07322.x; Eldawlatly S, 2010, STATISTICAL SIGNAL PROCESSING FOR NEUROSCIENCE AND NEUROTECHNOLOGY, P129, DOI 10.1016/B978-0-12-375027-3.00005-3; Eldawlatly S, 2010, NEURAL COMPUT, V22, P158, DOI 10.1162/neco.2009.11-08-900; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Erchova IA, 2002, EUR J NEUROSCI, V15, P744, DOI 10.1046/j.0953-816x.2002.01898.x; Foffani G, 2004, J NEUROSCI, V24, P7266, DOI 10.1523/JNEUROSCI.2523-04.2004; Foffani G, 2009, J NEUROSCI, V29, P5964, DOI 10.1523/JNEUROSCI.4416-08.2009; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gerhard F, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI [10.3389/fncom.2011.00004, 10.3389/fncom.2011.00023]; Ghazanfar AA, 2001, CEREB CORTEX, V11, P183, DOI 10.1093/cercor/11.3.183; Ghazanfar AA, 1997, J NEUROPHYSIOL, V78, P506, DOI 10.1152/jn.1997.78.1.506; Ghazanfar AA, 1999, CEREB CORTEX, V9, P348, DOI 10.1093/cercor/9.4.348; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hebb Donald O., 1949, ORG BEHAV; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; IZRAELI R, 1995, EXP BRAIN RES, V104, P41; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jones MC, 1996, J AM STAT ASSOC, V91, P401, DOI 10.2307/2291420; Josic K, 2009, NEURAL COMPUT, V21, P2774, DOI 10.1162/neco.2009.10-08-879; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Kwon KY, 2009, I IEEE EMBS C NEUR E, P615; Lebedev MA, 2000, CEREB CORTEX, V10, P23, DOI 10.1093/cercor/10.1.23; Lindsey BG, 2000, RESP PHYSIOL, V122, P183, DOI 10.1016/S0034-5687(00)00158-4; Luo B, 2003, PATTERN RECOGN, V36, P2213, DOI 10.1016/S0031-3203(03)00084-0; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; MERCIER BE, 1990, P NATL ACAD SCI USA, V87, P4388, DOI 10.1073/pnas.87.11.4388; Mirabella G, 2001, CEREB CORTEX, V11, P164, DOI 10.1093/cercor/11.2.164; Murphy KP., 2002, THESIS UC BERKELEY; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; NICOLL A, 1993, NEURAL COMPUT, V5, P665, DOI 10.1162/neco.1993.5.5.665; Niessing J, 2010, NATURE, V465, P47, DOI 10.1038/nature08961; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Schiff ND, 1999, J NEUROPHYSIOL, V82, P2182, DOI 10.1152/jn.1999.82.5.2182; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shimegi S, 2000, J NEUROSCI, V20, P6241, DOI 10.1523/JNEUROSCI.20-16-06241.2000; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; Simons SB, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-43; Smith VA, 2006, PLOS COMPUT BIOL, V2, P1436, DOI 10.1371/journal.pcbi.0020161; Temereanca S, 2008, J NEUROSCI, V28, P11153, DOI 10.1523/JNEUROSCI.1586-08.2008; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vijayan S, 2010, J NEUROPHYSIOL, V103, P2074, DOI 10.1152/jn.00474.2009; Wiest MC, 2005, J NEUROPHYSIOL, V93, P2966, DOI 10.1152/jn.00556.2004; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Wright N, 2010, J NEUROPHYSIOL, V103, P709, DOI 10.1152/jn.00560.2009; Yu J, 2004, BIOINFORMATICS, V20, P3594, DOI 10.1093/bioinformatics/bth448; Zhang ML, 2004, J NEUROPHYSIOL, V92, P1464, DOI 10.1152/jn.01272.2003	71	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21649	10.1371/journal.pone.0021649	http://dx.doi.org/10.1371/journal.pone.0021649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738751	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100051
J	Kennelly, KP; Wallace, DM; Holmes, TM; Hankey, DJ; Grant, TS; O'Farrelly, C; Keegan, DJ				Kennelly, Kevin P.; Wallace, Deborah M.; Holmes, Toby M.; Hankey, Deborah J.; Grant, Timothy S.; O'Farrelly, Cliona; Keegan, David J.			Preparation of Pre-Confluent Retinal Cells Increases Graft Viability In Vitro and In Vivo: A Mouse Model	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; HEAT-SHOCK PROTEINS; APOPTOTIC CELLS; DENDRITIC CELLS; PIGMENT EPITHELIUM; VISUAL FUNCTION; PROINFLAMMATORY CYTOKINE; DYSTROPHIC RATS; SCHWANN-CELLS; RCS RAT	Purpose: Graft failure remains an obstacle to experimental subretinal cell transplantation. A key step is preparing a viable graft, as high levels of necrosis and apoptosis increase the risk of graft failure. Retinal grafts are commonly harvested from cell cultures. We termed the graft preparation procedure "transplant conditions" (TC). We hypothesized that culture conditions influenced graft viability, and investigated whether viability decreased following TC using a mouse retinal pigment epithelial (RPE) cell line, DH01. Methods: Cell viability was assessed by trypan blue exclusion. Levels of apoptosis and necrosis in vitro were determined by flow cytometry for annexin V and propidium iodide and Western blot analysis for the pro-and cleaved forms of caspases 3 and 7. Graft viability in vivo was established by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and cleaved caspase 3 immunolabeling of subretinal allografts. Results: Pre-confluent cultures had significantly less nonviable cells than post-confluent cultures (6.6%+/- 0.8% vs. 13.1%+/- 0.9%, p<0.01). Cell viability in either group was not altered significantly following TC. Caspases 3 and 7 were not altered by levels of confluence or following TC. Pre-confluent cultures had low levels of apoptosis/necrosis (5.6%+/- 1.1%) that did not increase following TC (4.8%+/- 0.5%). However, culturing beyond confluence led to progressively increasing levels of apoptosis and necrosis (up to 16.5%+/- 0.9%). Allografts prepared from post-confluent cultures had significantly more TUNEL-positive cells 3 hours post-operatively than grafts of pre-confluent cells (12.7%+/- 3.1% vs. 4.5%+/- 1.4%, p<0.001). Subretinal grafts of post-confluent cells also had significantly higher rates of cleaved caspase 3 than pre-confluent grafts (20.2%+/- 4.3% vs. 7.8%+/- 1.8%, p<0.001). Conclusion: Pre-confluent cells should be used to maximize graft cell viability.	[Kennelly, Kevin P.; Holmes, Toby M.] Univ Coll Dublin, Catherine McAuley Clin Res Ctr, Dublin 2, Ireland; [Kennelly, Kevin P.; Wallace, Deborah M.; Keegan, David J.] Mater Misericordiae Univ Hosp, Dept Ophthalmol, Dublin, Ireland; [Hankey, Deborah J.] UCL, Inst Ophthalmol, London, England; [O'Farrelly, Cliona] Trin Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [Grant, Timothy S.] Univ Coll Dublin, Sch Publ Hlth & Populat Sci, Dublin, Ireland	University College Dublin; Mater Misericordiae University Hospital; University College Dublin; University of London; University College London; Trinity College Dublin; University College Dublin	Kennelly, KP (corresponding author), Univ Coll Dublin, Catherine McAuley Clin Res Ctr, Dublin 2, Ireland.	kpkennelly@gmail.com		Wallace, Deborah/0000-0003-2363-106X	Health Research Board, Ireland [RP/2007/202]; Irish College of Ophthalmologists	Health Research Board, Ireland; Irish College of Ophthalmologists	This work was funded by the Health Research Board, Ireland (project grant RP/2007/202), and by an Irish College of Ophthalmologists Fellowship awarded to K. Kennelly in 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano D, 2006, J BIOL CHEM, V281, P17758, DOI 10.1074/jbc.M601812200; ALMAZAN G, 1992, BRAIN RES, V579, P234, DOI 10.1016/0006-8993(92)90056-F; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Catanuto P, 2009, EXP EYE RES, V88, P99, DOI 10.1016/j.exer.2008.10.013; CharriautMarlangue C, 1995, NEUROREPORT, V7, P61, DOI 10.1097/00001756-199512290-00014; Chen M, 2008, INVEST OPHTH VIS SCI, V49, P3699, DOI 10.1167/iovs.07-1522; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; Croxford JL, 2000, J IMMUNOL, V164, P2776, DOI 10.4049/jimmunol.164.5.2776; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; GOURAS P, 1985, CURR EYE RES, V4, P253, DOI 10.3109/02713688509000857; Hill CE, 2007, EUR J NEUROSCI, V26, P1433, DOI 10.1111/j.1460-9568.2007.05771.x; Kanuga N, 2002, INVEST OPHTH VIS SCI, V43, P546; Kato K, 1996, CELL STRUCT FUNCT, V21, P459, DOI 10.1247/csf.21.459; Keegan DJ, 2003, INVEST OPHTH VIS SCI, V44, P3526, DOI 10.1167/iovs.02-0097; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; MCLAREN MJ, 1993, EXP CELL RES, V204, P311, DOI 10.1006/excr.1993.1038; NABI IR, 1993, J CELL SCI, V104, P37; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; O'Connor KA, 2003, CYTOKINE, V24, P254, DOI 10.1016/j.cyto.2003.08.001; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Ronchetti A, 1999, J LEUKOCYTE BIOL, V66, P247, DOI 10.1002/jlb.66.2.247; Ronchetti A, 1999, J IMMUNOL, V163, P130; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Rovere P, 1998, J IMMUNOL, V161, P4467; Saito K, 2005, EXP CELL RES, V310, P229, DOI 10.1016/j.yexcr.2005.07.014; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SEATON AD, 1994, INVEST OPHTH VIS SCI, V35, P162; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Wallace DM, 2006, INVEST OPHTH VIS SCI, V47, P2765, DOI 10.1167/iovs.05-1383; Wang Y, 2005, J IMMUNOL, V174, P3306, DOI 10.4049/jimmunol.174.6.3306; Wyburn KR, 2005, TRANSPLANTATION, V80, P1641, DOI 10.1097/01.tp.0000173903.26886.20; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; YASUDA M, 1995, ARCH HISTOL CYTOL, V58, P185, DOI 10.1679/aohc.58.185; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869	53	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21365	10.1371/journal.pone.0021365	http://dx.doi.org/10.1371/journal.pone.0021365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738643	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100020
J	Sinkko, H; Lukkari, K; Jama, AS; Sihvonen, LM; Sivonen, K; Leivuori, M; Rantanen, M; Paulin, L; Lyra, C				Sinkko, Hanna; Lukkari, Kaarina; Jama, Abdullahi S.; Sihvonen, Leila M.; Sivonen, Kaarina; Leivuori, Mirja; Rantanen, Matias; Paulin, Lars; Lyra, Christina			Phosphorus Chemistry and Bacterial Community Composition Interact in Brackish Sediments Receiving Agricultural Discharges	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; RIBOSOMAL-RNA SEQUENCES; MARINE-SEDIMENTS; VERTICAL-DISTRIBUTION; MICROBIAL DIVERSITY; CHEMICAL CHARACTER; SULFATE REDUCTION; ORGANIC-MATTER; LAKE-SEDIMENTS; IRON	Background: External nutrient discharges have caused eutrophication in many estuaries and coastal seas such as the Baltic Sea. The sedimented nutrients can affect bacterial communities which, in turn, are widely believed to contribute to release of nutrients such as phosphorus from the sediment. Methods: We investigated relationships between bacterial communities and chemical forms of phosphorus as well as elements involved in its cycling in brackish sediments using up-to-date multivariate statistical methods. Bacterial community composition was determined by terminal restriction fragment length polymorphism and cloning of the 16S rRNA gene. Results and Conclusions: The bacterial community composition differed along gradients of nutrients, especially of different phosphorus forms, from the estuary receiving agricultural phosphorus loading to the open sea. This suggests that the chemical composition of sediment phosphorus, which has been affected by riverine phosphorus loading, influenced on bacterial communities. Chemical and spatial parameters explained 25% and 11% of the variation in bacterial communities. Deltaproteobacteria, presumptively sulphate and sulphur/iron reducing, were strongly associated to chemical parameters, also when spatial autocorrelation was taken into account. Sulphate reducers correlated positively with labile organic phosphorus and total nitrogen in the open sea sediments. Sulphur/iron reducers and sulphate reducers linked to iron reduction correlated positively with aluminium-and iron-bound phosphorus, and total iron in the estuary. The sulphate and sulphur/iron reducing bacteria can thus have an important role both in the mineralization and mobilization of nutrients from sediment. Significance: Novelty in our study is that relationships between bacterial community composition and different phosphorus forms, instead of total phosphorus, were investigated. Total phosphorus does not necessarily bring out interactions between bacteria and phosphorus chemistry since proportions of easily usable mobile (reactive) phosphorus and immobile phosphorus forms in different sediments can vary. Our study suggested possible feedbacks between different forms of phosphorus and bacterial community composition.	[Sinkko, Hanna; Jama, Abdullahi S.; Sihvonen, Leila M.; Sivonen, Kaarina; Lyra, Christina] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Lukkari, Kaarina] Ctr Marine Res, Finnish Environm Inst, Helsinki, Finland; [Sihvonen, Leila M.] Natl Inst Hlth & Welf, Helsinki, Finland; [Leivuori, Mirja] Finnish Environm Inst, Reference Lab, Helsinki, Finland; [Rantanen, Matias; Paulin, Lars] Univ Helsinki, Inst Biotechnol, Helsinki, Finland	University of Helsinki; Finnish Environment Institute; Finland National Institute for Health & Welfare; Finnish Environment Institute; University of Helsinki	Sinkko, H (corresponding author), Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland.	kaarina.sivonen@helsinki.fi		Sivonen, Kaarina/0000-0002-2904-0458; Sinkko, Hanna/0000-0002-4003-0429	Maj and Tor Nessling Foundation; Baltic Sea Research Program (BIREME) [202441]; Centre of Excellence [53305, 118637]; Academy of Finland [214457, 115400]	Maj and Tor Nessling Foundation; Baltic Sea Research Program (BIREME); Centre of Excellence; Academy of Finland(Academy of Finland)	This work was supported by Maj and Tor Nessling Foundation, Baltic Sea Research Program (BIREME, 202441), the Centre of Excellence (53305, 118637), and the grants of the Academy of Finland to K.S. (214457) and C.L. (115400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; AHLGREN J, 2006, ACTA U UPSALIENSIS, V160; Anderson M.J., 2003, DISTLM FORWARD FORTR; Anderson MJ, 1998, AUST J ECOL, V23, P158, DOI 10.1111/j.1442-9993.1998.tb00713.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2004, DISTLM V 5 FORTRAN C; Benitez-Nelson CR, 2004, LIMNOL OCEANOGR, V49, P1593, DOI 10.4319/lo.2004.49.5.1593; BERNER RA, 1970, AM J SCI, V268, P1, DOI 10.2475/ajs.268.1.1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BOYLE EA, 1977, GEOCHIM COSMOCHIM AC, V41, P1313, DOI 10.1016/0016-7037(77)90075-8; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Byrne ME, 2010, P NATL ACAD SCI USA, V107, P12263, DOI 10.1073/pnas.1001290107; CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Carman R, 1998, VIE MILIEU, V48, P229; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Conley DJ, 1999, HYDROBIOLOGIA, V410, P87, DOI 10.1023/A:1003784504005; DYBERN BI, 1981, BALTIC SEA, P351; Edlund A, 2006, ENVIRON MICROBIOL, V8, P223, DOI 10.1111/j.1462-2920.2005.00887.x; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Ekholm P, 2007, AGR FOOD SCI, V16, P282, DOI 10.2137/145960607784125401; Elmgren R, 2001, AMBIO, V30, P222, DOI 10.1639/0044-7447(2001)030[0222:UHIOTB]2.0.CO;2; Engebretson JJ, 2003, APPL ENVIRON MICROB, V69, P4823, DOI 10.1128/AEM.69.8.4823-4829.2003; GACHTER R, 1993, HYDROBIOLOGIA, V253, P103, DOI 10.1007/BF00050731; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; *HELCOM, 2010, HELCOM IN HOL ASS BA, V122; HELCOM, 1998, BALT SEA ENV P; HINGSTON FJ, 1972, J SOIL SCI, V23, P177, DOI 10.1111/j.1365-2389.1972.tb01652.x; Holmer M, 2001, FRESHWATER BIOL, V46, P431, DOI 10.1046/j.1365-2427.2001.00687.x; Howarth R, 2008, P NATL ACAD SCI USA, V105, pE103, DOI 10.1073/pnas.0807266106; Hupfer M, 2008, INT REV HYDROBIOL, V93, P415, DOI 10.1002/iroh.200711054; HUTCHENS E, 2006, GEOMICROBIOL J, V19, P343; Hyacinthe C, 2004, MAR CHEM, V91, P227, DOI 10.1016/j.marchem.2004.04.006; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; JENSEN HS, 1993, HYDROBIOLOGIA, V253, P47, DOI 10.1007/BF00050721; Jordan TE, 2008, LIMNOL OCEANOGR, V53, P172, DOI 10.4319/lo.2008.53.1.0172; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Kitts C L, 2001, Curr Issues Intest Microbiol, V2, P17; Kononova SV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P184, DOI 10.1023/A:1014409929875; KROM MD, 1981, GEOCHIM COSMOCHIM AC, V45, P207; KUEVER J, 2005, BERGEYS MANUAL SYS C, P1005; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Legendre P., 2012, NUMERICAL ECOLOGY; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lukkari K, 2008, BIOGEOCHEMISTRY, V90, P171, DOI 10.1007/s10533-008-9243-2; Lukkari K, 2009, BIOGEOCHEMISTRY, V96, P25, DOI 10.1007/s10533-009-9343-7; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P433, DOI 10.4319/lom.2007.5.433; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P445, DOI 10.4319/lom.2007.5.445; Lukkari K, 2009, BIOGEOCHEMISTRY, V94, P141, DOI 10.1007/s10533-009-9315-y; Mattila J, 2006, BOREAL ENVIRON RES, V11, P95; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; Mortimer CH, 1942, J ECOL, V30, P147, DOI 10.2307/2256691; Mortimer CH, 1941, J ECOL, V29, P280, DOI 10.2307/2256395; NAUTCH M, 2006, MAR ECOL-PROG SER, V321, P9; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Paoli A, 2008, FEMS MICROBIOL ECOL, V64, P219, DOI 10.1111/j.1574-6941.2008.00459.x; Park HS, 2008, ANTON LEEUW INT J G, V93, P79, DOI 10.1007/s10482-007-9181-3; R Development Core Team, 2007, R LANG ENV STAT COMP; Rivers AR, 2009, ENVIRON MICROBIOL, V11, P382, DOI 10.1111/j.1462-2920.2008.01778.x; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Sait L, 2003, APPL ENVIRON MICROB, V69, P2100, DOI 10.1128/AEM.69.4.2100-2109.2003; SHOLKOVITZ ER, 1976, GEOCHIM COSMOCHIM AC, V40, P831, DOI 10.1016/0016-7037(76)90035-1; SUZUMURA M, 1995, GEOCHIM COSMOCHIM AC, V59, P1021, DOI 10.1016/0016-7037(95)00006-2; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; Uusitalo R, 2003, J ENVIRON QUAL, V32, P2007, DOI 10.2134/jeq2003.2007; Uusitalo R, 2000, WATER RES, V34, P2477, DOI 10.1016/S0043-1354(99)00419-4; Valpasvuo-Jaatinen P, 1997, AMBIO, V26, P448; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Welch SA, 2002, GEOMICROBIOL J, V19, P343, DOI 10.1080/01490450290098414; YliHalla M, 1996, AGR FOOD SCI FINLAND, V5, P193, DOI 10.23986/afsci.72735	74	32	34	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21555	10.1371/journal.pone.0021555	http://dx.doi.org/10.1371/journal.pone.0021555			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747910	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100038
J	Brzuszkiewicz, E; Weiner, J; Wollherr, A; Thurmer, A; Hupeden, J; Lomholt, HB; Kilian, M; Gottschalk, G; Daniel, R; Mollenkopf, HJ; Meyer, TF; Bruggemann, H				Brzuszkiewicz, Elzbieta; Weiner, January; Wollherr, Antje; Thuermer, Andrea; Huepeden, Jennifer; Lomholt, Hans B.; Kilian, Mogens; Gottschalk, Gerhard; Daniel, Rolf; Mollenkopf, Hans-Joachim; Meyer, Thomas F.; Brueggemann, Holger			Comparative Genomics and Transcriptomics of Propionibacterium acnes	PLOS ONE			English	Article							ESCHERICHIA-COLI; HUMAN KERATINOCYTES; GENE-CLUSTER; P-ACNES; EXPRESSION; PROTEINS; SKIN; IDENTIFICATION; INFECTIONS; ACTIVATION	The anaerobic Gram-positive bacterium Propionibacterium acnes is a human skin commensal that is occasionally associated with inflammatory diseases. Recent work has indicated that evolutionary distinct lineages of P. acnes play etiologic roles in disease while others are associated with maintenance of skin homeostasis. To shed light on the molecular basis for differential strain properties, we carried out genomic and transcriptomic analysis of distinct P. acnes strains. We sequenced the genome of the P. acnes strain 266, a type I-1a strain. Comparative genome analysis of strain 266 and four other P. acnes strains revealed that overall genome plasticity is relatively low; however, a number of island-like genomic regions, encoding a variety of putative virulence-associated and fitness traits differ between phylotypes, as judged from PCR analysis of a collection of P. acnes strains. Comparative transcriptome analysis of strains KPA171202 (type I-2) and 266 during exponential growth revealed inter-strain differences in gene expression of transport systems and metabolic pathways. In addition, transcript levels of genes encoding possible virulence factors such as dermatan-sulphate adhesin, polyunsaturated fatty acid isomerase, iron acquisition protein HtaA and lipase GehA were upregulated in strain 266. We investigated differential gene expression during exponential and stationary growth phases. Genes encoding components of the energy-conserving respiratory chain as well as secreted and virulence-associated factors were transcribed during the exponential phase, while the stationary growth phase was characterized by upregulation of genes involved in stress responses and amino acid metabolism. Our data highlight the genomic basis for strain diversity and identify, for the first time, the actively transcribed part of the genome, underlining the important role growth status plays in the inflammation-inducing activity of P. acnes. We argue that the disease-causing potential of different P. acnes strains is not only determined by the phylotype-specific genome content but also by variable gene expression.	[Brzuszkiewicz, Elzbieta; Wollherr, Antje; Thuermer, Andrea; Huepeden, Jennifer; Gottschalk, Gerhard; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, Gottingen, Germany; [Weiner, January] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Lomholt, Hans B.; Kilian, Mogens] Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Core Facil Microarray, Berlin, Germany; [Meyer, Thomas F.; Brueggemann, Holger] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany	University of Gottingen; Max Planck Society; Aarhus University; Max Planck Society; Max Planck Society	Brzuszkiewicz, E (corresponding author), Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, Gottingen, Germany.	brueggemann@mpiib-berlin.mpg.de	Daniel, Rolf/AAQ-5933-2021; Mollenkopf, Hans-Joachim/AAH-2500-2019; Weiner, January/D-9470-2012; Meyer, Thomas F. F/J-2485-2013	Daniel, Rolf/0000-0002-8646-7925; Weiner, January/0000-0003-1438-7819; Meyer, Thomas F. F/0000-0002-6120-8679; Bruggemann, Holger/0000-0001-7433-0190; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Kilian, Mogens/0000-0002-5861-0472	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding was provided by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P7093, DOI 10.1128/AEM.01442-10; Falentin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011748; Farrar MD, 2007, J BACTERIOL, V189, P4161, DOI 10.1128/JB.00106-07; Farrar MD, 2000, FEMS MICROBIOL LETT, V191, P183, DOI 10.1016/S0378-1097(00)00387-6; Fehri LF, 2011, INT J MED MICROBIOL, V301, P69, DOI 10.1016/j.ijmm.2010.08.014; GAMPER M, 1991, J BACTERIOL, V173, P4742, DOI 10.1128/jb.173.15.4742-4750.1991; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; GRIBBON EM, 1993, J GEN MICROBIOL, V139, P1745, DOI 10.1099/00221287-139-8-1745; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Jakab E, 1996, YALE J BIOL MED, V69, P477; Jappe U, 2002, BRIT J DERMATOL, V146, P202, DOI 10.1046/j.1365-2133.2002.04602.x; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Liavonchanka A, 2006, P NATL ACAD SCI USA, V103, P2576, DOI 10.1073/pnas.0510144103; Lodes MJ, 2006, MICROBIOL-SGM, V152, P3667, DOI 10.1099/mic.0.29219-0; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Maghnouj A, 1998, J BACTERIOL, V180, P6468, DOI 10.1128/JB.180.24.6468-6475.1998; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; Miskin JE, 1997, MICROBIOL-UK, V143, P1745, DOI 10.1099/00221287-143-5-1745; Mujacic M, 2006, MOL MICROBIOL, V60, P1576, DOI 10.1111/j.1365-2958.2006.05207.x; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Soderquist B, 2010, ANAEROBE, V16, P304, DOI 10.1016/j.anaerobe.2009.10.009; Staden R, 2003, INTRO BIOINFORMATICS; Tanabe T, 2006, BBA-MOL BASIS DIS, V1762, P794, DOI 10.1016/j.bbadis.2006.07.006; Tech Maike, 2003, In Silico Biology, V3, P441; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; Wernersson R, 2007, NAT PROTOC, V2, P2677, DOI 10.1038/nprot.2007.370; Wilcox HE, 2007, BRIT J DERMATOL, V156, P460, DOI 10.1111/j.1365-2133.2006.07631.x; Wood H G, 1981, Curr Top Cell Regul, V18, P255; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x	50	90	94	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21581	10.1371/journal.pone.0021581	http://dx.doi.org/10.1371/journal.pone.0021581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738717	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600055
J	Clements, S; Chitwood, R; Schreck, CB				Clements, Shaun; Chitwood, Rob; Schreck, Carl B.			Effect of Commercially Available Egg Cures on the Survival of Juvenile Salmonids	PLOS ONE			English	Article							ACUTE TOXICITY; NADPH OXIDASE; SULFITE; TROUT; METABISULFITE; STEELHEAD; RADICALS; NITRITE; GROWTH	There is some concern that incidental consumption of eggs cured with commercially available cures for the purpose of sport fishing causes mortality in juvenile salmon. We evaluated this by feeding juvenile spring Chinook (Oncorhynchus tshawytscha) and steelhead (O. mykiss) with eggs cured with one of five commercially available cures. We observed significant levels of mortality in both pre-smolts and smolts. Depending on the experiment, 2, 3, or 4 of the cures were associated with mortality. Mortality tended to be higher in the smolts than in the parr, but there was no clear species effect. The majority of mortality occurred within the first 10 d of feeding. Removal of sodium sulfite from the cure significantly reduced the level of mortality. Soaking the eggs prior to feeding did not reduce mortality. We observed a clear relationship between the amount of cured egg consumed each day and the survival time. We conclude that consumption of eggs cured with sodium sulfite has the potential to cause mortality in juvenile steelhead and Chinook salmon in the wild.	[Clements, Shaun] Oregon Dept Fish & Wildlife, Corvallis, OR USA; [Chitwood, Rob] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Schreck, Carl B.] Oregon State Univ, US Geol Survey, Oregon Cooperat Fish & Wildlife Res Unit, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; United States Department of the Interior; United States Geological Survey	Clements, S (corresponding author), Oregon Dept Fish & Wildlife, Corvallis, OR USA.	Shaun.Clements@oregonstate.edu			Oregon Department of Fish and Wildlife Restoration and Enhancement Board [07-132]	Oregon Department of Fish and Wildlife Restoration and Enhancement Board	This study was partially funded by a grant (# 07-132) from the Oregon Department of Fish and Wildlife Restoration and Enhancement Board (http://www.dfw.state.or.us/fish/RE/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT JC, 1985, BEHAVIOUR, V92, P241; AKANJI MA, 1993, TOXICOLOGY, V81, P173, DOI 10.1016/0300-483X(93)90010-P; AKOGYERAM C, 1980, FED PROC, V39, P1836; BECKSPEIER I, 1993, FREE RADICAL BIO MED, V14, P661, DOI 10.1016/0891-5849(93)90148-N; Chamulitrat W, 1999, FREE RADICAL BIO MED, V27, P411, DOI 10.1016/S0891-5849(99)00088-X; Collaco CR, 2006, ANN ALLERG ASTHMA IM, V96, P550, DOI 10.1016/S1081-1206(10)63549-1; COLT J, 1981, AQUACULTURE, V24, P111, DOI 10.1016/0044-8486(81)90048-X; COOPERSTEIN SJ, 1963, J BIOL CHEM, V238, P3606; FENDERSO.OC, 1968, J FISH RES BOARD CAN, V25, P1, DOI 10.1139/f68-001; HARKNESS DR, 1969, BIOCHEM BIOPH RES CO, V34, P849, DOI 10.1016/0006-291X(69)90258-7; HAYATSU H, 1972, BIOCHEM BIOPH RES CO, V46, P120, DOI 10.1016/0006-291X(72)90638-9; HUGOT D, 1965, ANN BIOL ANIM BIOCH, V5, P53, DOI 10.1051/rnd:19650104; INOUYE B, 1980, TOXICOL APPL PHARM, V53, P101, DOI 10.1016/0041-008X(80)90386-5; McMichael GA, 1997, T AM FISH SOC, V126, P230, DOI 10.1577/1548-8659(1997)126&lt;0230:EORHRS&gt;2.3.CO;2; OZAWA T, 1987, BIOCHEM BIOPH RES CO, V142, P410, DOI 10.1016/0006-291X(87)90289-0; PFLEIDERER G, 1956, BIOCHEM Z, V328, P287; Rankin CH, 2006, CURR BIOL, V16, pR89, DOI 10.1016/j.cub.2006.01.025; Rencuzogullari E, 2001, MUTAT RES-GEN TOX EN, V490, P107, DOI 10.1016/S1383-5718(00)00142-X; ROY AB, 1976, AUST J EXP BIOL MED, V54, P111, DOI 10.1038/icb.1976.13; SANO H, 1976, WATER RES, V10, P139, DOI 10.1016/0043-1354(76)90113-5; SMITH CE, 1974, T AM FISH SOC, V103, P389, DOI 10.1577/1548-8659(1974)103&lt;389:ENTIRT&gt;2.0.CO;2; THURSTON RV, 1978, T AM FISH SOC, V107, P361, DOI 10.1577/1548-8659(1978)107&lt;361:ATOAAN&gt;2.0.CO;2; WALLEN IE, 1957, SEWAGE IND WASTES, V29, P695; YANG SF, 1973, ENVIRON RES, V6, P395, DOI 10.1016/0013-9351(73)90055-8	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21406	10.1371/journal.pone.0021406	http://dx.doi.org/10.1371/journal.pone.0021406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738653	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600037
J	Degauque, N; Boeffard, F; Foucher, Y; Ballet, C; Brouard, S; Soulillou, JP				Degauque, Nicolas; Boeffard, Francoise; Foucher, Yohann; Ballet, Caroline; Brouard, Sophie; Soulillou, Jean-Paul			The Blood of Healthy Individuals Exhibits CD8 T Cells with a Highly Altered TCR Vb Repertoire but with an Unmodified Phenotype	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NONMALIGNANT CLONAL EXPANSIONS; LENGTH DISTRIBUTION; ELDERLY HUMANS; INFECTION; RECEPTOR; AGE; SUBSETS; TRANSCRIPTOME; LYMPHOCYTES	CD8 T cell clonal expansions (TCE) have been observed in elderly, healthy individuals as well in old mice, and have been associated with the ageing process. Both chronic latent and non-persistent viral infections have been proposed to drive the development of distinct non-functional and functional TCE respectively. Biases in TCR V beta repertoire diversity are also recurrently observed in patients that have undergone strong immune challenge, and are preferentially observed in the CD8 compartment. Healthy adults can also exhibit CD8 T cells with strong alterations of their CDR3 length distribution. Surprisingly, no specific investigations have been conducted to analyze the CD8 T cell repertoire in normal adults, to determine if such alterations in TCR V beta repertoire share the features of TCE. In this study, we characterized the phenotype and function of the CD8 population in healthy individuals of 25-52 years of age. All but one of the EBV-positive HLA-B8 healthy volunteers that were studied were CMV-negative. Using a specific unsupervised statistical method, we identified Vb families with altered CDR3 length distribution and increased TCR V beta/HPRT transcript ratios in all individuals tested. The increase in TCR V beta/HPRT transcript ratio was more frequently associated with an increase in the percentage of the corresponding V beta(+) T cells than with an absence of modification of their percentage. However, in contrast with the previously described TCE, these CD8(+) T cells were not preferentially found in the memory CD8 subset, they exhibited normal effector functions (cytokine secretion and cytotoxic molecule expression) and they were not reactive to a pool of EBV/CMV/Flu virus peptides. Taken together, the combined analysis of transcripts and proteins of the TCR V beta repertoire led to the identification of different types of CD8(+) T cell clone expansion or contraction in healthy individuals, a situation that appears more complex than previously described in aged individuals.	[Degauque, Nicolas; Boeffard, Francoise; Foucher, Yohann; Ballet, Caroline; Brouard, Sophie; Soulillou, Jean-Paul] INSERM, UMR643, Nantes, France; [Degauque, Nicolas; Boeffard, Francoise; Foucher, Yohann; Ballet, Caroline; Brouard, Sophie; Soulillou, Jean-Paul] CHU Nantes, ITUN, F-44035 Nantes 01, France; [Degauque, Nicolas; Boeffard, Francoise; Foucher, Yohann; Ballet, Caroline; Brouard, Sophie; Soulillou, Jean-Paul] Univ Nantes, Fac Med, Nantes, France; [Foucher, Yohann] INSERM, EA 4275, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Degauque, N (corresponding author), INSERM, UMR643, Nantes, France.	jean-paul.soulillou@univ-nantes.fr	Foucher, Yohann/L-8995-2015; brouard, sophie c/Q-1285-2016; Foucher, Yohann/ABB-6362-2021; Foucher, Yohann/G-2714-2013; Degauque, Nicolas/R-4944-2017	Foucher, Yohann/0000-0003-0330-7457; Foucher, Yohann/0000-0003-0330-7457; Degauque, Nicolas/0000-0003-2990-3513	TTS	TTS	Recherche translationnelle Pays de la Loire - DiRC Grand Ouest. Nicolas Degauque is a recipient of a TTS post-fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Baron V, 2003, IMMUNITY, V18, P193, DOI 10.1016/S1074-7613(03)00020-7; Brouard S, 2005, AM J TRANSPLANT, V5, P330, DOI 10.1111/j.1600-6143.2004.00700.x; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; Chamberlain WD, 2000, CLIN IMMUNOL, V94, P160, DOI 10.1006/clim.1999.4832; Clambey ET, 2007, EXP GERONTOL, V42, P407, DOI 10.1016/j.exger.2006.11.008; Clambey ET, 2005, IMMUNOL REV, V205, P170, DOI 10.1111/j.0105-2896.2005.00265.x; Degauque N, 2004, INT J CANCER, V110, P721, DOI 10.1002/ijc.20149; Ely KH, 2007, J IMMUNOL, V179, P3535, DOI 10.4049/jimmunol.179.6.3535; FITZGERALD JE, 1995, J IMMUNOL, V154, P3538; Hislop AD, 2002, J EXP MED, V195, P893, DOI 10.1084/jem.20011692; Jager E, 2002, INT J CANCER, V98, P376, DOI 10.1002/ijc.10165; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Kohlmeier JE, 2010, J IMMUNOL, V185, P3456, DOI 10.4049/jimmunol.1001745; Laplaud DA, 2004, BRAIN, V127, P981, DOI 10.1093/brain/awh119; LeMaoult J, 2000, J IMMUNOL, V165, P2367, DOI 10.4049/jimmunol.165.5.2367; MORLEY JK, 1995, J IMMUNOL, V154, P6182; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; POSNETT DN, 1994, J EXP MED, V179, P609, DOI 10.1084/jem.179.2.609; Ricalton NS, 1998, J GERONTOL A-BIOL, V53, pB196, DOI 10.1093/gerona/53A.3.B196; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Sebille F, 2001, J IMMUNOL, V167, P3082, DOI 10.4049/jimmunol.167.6.3082; Tan LC, 1999, J IMMUNOL, V162, P1827; Team RDC, 2010, R LANG ENV STAT COMP	29	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21240	10.1371/journal.pone.0021240	http://dx.doi.org/10.1371/journal.pone.0021240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738624	Green Published, gold, Green Submitted			2022-12-25	WOS:000292092600021
J	Lu, SY; Kim, TJ; Chen, CE; Ouyang, M; Seong, J; Liao, XL; Wang, YX				Lu, Shaoying; Kim, Tae-jin; Chen, Chih-En; Ouyang, Mingxing; Seong, Jihye; Liao, Xiaoling; Wang, Yingxiao			Computational Analysis of the Spatiotemporal Coordination of Polarized PI3K and Rac1 Activities in Micro-Patterned Live Cells	PLOS ONE			English	Article							LOCALLY WEIGHTED REGRESSION; PHOSPHOINOSITIDE 3-KINASE; LIVING FIBROBLASTS; SPATIAL-ANALYSIS; ACTIN-FILAMENTS; MIGRATING CELLS; NEUTROPHIL CHEMOTAXIS; FOCAL ADHESIONS; GROWTH-FACTOR; ACTIVATION	Polarized molecular activities play important roles in guiding the cell toward persistent and directional migration. In this study, the polarized distributions of the activities of phosphatidylinositol 3-kinase (PI3K) and the Rac1 small GTPase were monitored using chimeric fluorescent proteins (FPs) in cells constrained on micro-patterned strips, with one end connecting to a neighboring cell (junction end) and the other end free of cell-cell contact (free end). The recorded spatiotemporal dynamics of the fluorescent intensity from different cells was scaled into a uniform coordinate system and applied to compute the molecular activity landscapes in space and time. The results revealed different polarization patterns of PI3K and Rac1 activity induced by the growth factor stimulation. The maximal intensity of different FPs, and the edge position and velocity at the free end were further quantified to analyze their correlation and decipher the underlying signaling sequence. The results suggest that the initiation of the edge extension occurred before the activation of PI3K, which led to a stable extension of the free end followed by the Rac1 activation. Therefore, the results support a concerted coordination of sequential signaling events and edge dynamics, underscoring the important roles played by PI3K activity at the free end in regulating the stable lamellipodia extension and cell migration. Meanwhile, the quantification methods and accompanying software developed can provide a convenient and powerful computational analysis platform for the study of spatiotemporal molecular distribution and hierarchy in live cells based on fluorescence images.	[Lu, Shaoying; Ouyang, Mingxing; Liao, Xiaoling; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Champaign, IL USA; [Kim, Tae-jin; Seong, Jihye; Wang, Yingxiao] Univ Illinois, Neurosci Program, Champaign, IL USA; [Chen, Chih-En; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Champaign, IL USA; [Wang, Yingxiao] Univ Illinois, Ctr Biophys & Computat Biol, Dept Mol & Integrat Physiol, Champaign, IL USA; [Liao, Xiaoling] Chongqing Univ Sci & Technol, Inst Biomat & Living Cell Imaging Technol, Chongqing, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chongqing University of Science & Technology	Lu, SY (corresponding author), Univ Illinois, Dept Bioengn, Champaign, IL USA.	yingxiao@illinois.edu	Seong, Jihye/N-2132-2017; Ouyang, Mingxing/J-4529-2013; Ouyang, Mingxing/C-9130-2011; Ouyang, Mingxing/F-8907-2019; Ouyang, Mingxing/AAF-5896-2019	Seong, Jihye/0000-0001-8450-3315; Ouyang, Mingxing/0000-0002-2910-0713	NIH [HL098472, CA139272, NS063405]; NSF [CBET0846429, CMMI0800870]; NATIONAL CANCER INSTITUTE [R21CA139272] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported in part by grants NIH HL098472, CA139272, NS063405, NSF CBET0846429, and CMMI0800870. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames W.F., 1977, NUMER METH PART D E; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Dawes AT, 2007, BIOPHYS J, V92, P744, DOI 10.1529/biophysj.106.090514; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fok S, 2008, BIOPHYS J, V95, P1523, DOI 10.1529/biophysj.107.115246; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Harris SJ, 2008, J BIOL CHEM, V283, P2465, DOI 10.1074/jbc.R700044200; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Haugh JM, 2004, BIOPHYS J, V86, P589, DOI 10.1016/S0006-3495(04)74137-5; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Kim TJ, 2009, SMALL, V5, P1453, DOI 10.1002/smll.200801846; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kurokawa K, 2005, BIOCHEM SOC T, V33, P631, DOI 10.1042/BST0330631; Lin XF, 2008, BIOPHYS J, V95, P3066, DOI 10.1529/biophysj.107.127761; Lu SY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000127; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Sabouri-Ghomi M, 2008, CURR OPIN CELL BIOL, V20, P541, DOI 10.1016/j.ceb.2008.05.004; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Schneider IC, 2005, BIOPHYS J, V89, P1420, DOI 10.1529/biophysj.105.061218; Schneider IC, 2004, BIOPHYS J, V86, P599, DOI 10.1016/S0006-3495(04)74138-7; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Watanabe N, 2004, EXP CELL RES, V301, P16, DOI 10.1016/j.yexcr.2004.08.020; Weiger MC, 2010, BIOPHYS J, V98, P67, DOI 10.1016/j.bpj.2009.09.051; Weiger MC, 2009, J CELL SCI, V122, P313, DOI 10.1242/jcs.037564; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yang JM, 2009, SMALL, V5, P1984, DOI 10.1002/smll.200801559	56	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21293	10.1371/journal.pone.0021293	http://dx.doi.org/10.1371/journal.pone.0021293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738630	Green Submitted, Green Published, gold			2022-12-25	WOS:000292092600026
J	Chen, ZS; Li, J; Xiao, YN; Zhang, JJ; Zhao, YY; Liu, YX; Ma, CC; Qiu, YM; Luo, J; Huang, GW; Korteweg, C; Gu, J				Chen, Zhengshan; Li, Jing; Xiao, Yanna; Zhang, Junjun; Zhao, Yingying; Liu, Yuxuan; Ma, Changchun; Qiu, Yamei; Luo, Jin; Huang, Guowei; Korteweg, Christine; Gu, Jiang			Immunoglobulin G Locus Events in Soft Tissue Sarcoma Cell Lines	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; HEAVY-CHAIN LOCUS; CLASS SWITCH RECOMBINATION; EPITHELIAL CANCER-CELLS; V(D)J RECOMBINATION; GENE REARRANGEMENTS; B-CELLS; EXPRESSION; ACTIVATION; ENHANCER	Recently immunoglobulins (Igs) have been found to be expressed by cells other than B lymphocytes, including various human carcinoma cells. Sarcomas are derived from mesenchyme, and the knowledge about the occurrence of Ig production in sarcoma cells is very limited. Here we investigated the phenomenon of immunoglobulin G (IgG) expression and its molecular basis in 3 sarcoma cell lines. The mRNA transcripts of IgG heavy chain and kappa light chain were detected by RTPCR. In addition, the expression of IgG proteins was confirmed by Western blot and immunofluorescence. Immuno-electron microscopy localized IgG to the cell membrane and rough endoplasmic reticulum. The essential enzymes required for gene rearrangement and class switch recombination, and IgG germ-line transcripts were also identified in these sarcoma cells. Chromatin immunoprecipitation results demonstrated histone H3 acetylation of both the recombination activating gene and Ig heavy chain regulatory elements. Collectively, these results confirmed IgG expression in sarcoma cells, the mechanism of which is very similar to that regulating IgG expression in B lymphocytes.	[Chen, Zhengshan; Li, Jing; Xiao, Yanna; Zhang, Junjun; Ma, Changchun; Qiu, Yamei; Luo, Jin; Huang, Guowei; Korteweg, Christine; Gu, Jiang] Shantou Univ Med Coll, Dept Pathol, Shantou, Peoples R China; [Zhao, Yingying; Liu, Yuxuan; Gu, Jiang] Peking Beijing Univ Hlth Sci Ctr, Dept Pathol, Beijing, Peoples R China	Peking University	Chen, ZS (corresponding author), Shantou Univ Med Coll, Dept Pathol, Shantou, Peoples R China.	jguemailbox@gmail.com	Chen, Zhengshan/J-7499-2014; Ma, Changchun/AAI-4282-2020; Liu, Yuxuan/F-4226-2018	Gu, Jiang/0000-0002-0706-8329; Liu, Yuxuan/0000-0003-4426-9290	National Natural Science Foundation of China [81001199, 81030033, 30971150, 30950110335]; Guangdong Colleges and Universities [LYM10079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Colleges and Universities	This work was supported by grants (81001199 to ZC, 81030033, 30971150 to JG, 30950110335 to KC) from the National Natural Science Foundation of China, and grant LYM10079 to ZC from the Innovative Talents Program of Guangdong Colleges and Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; CALAME KL, 1985, ANNU REV IMMUNOL, V3, P159, DOI 10.1146/annurev.iy.03.040185.001111; Chen W, 2009, AM J SURG PATHOL, V33, P863, DOI 10.1097/PAS.0b013e31819287b8; Chen ZS, 2010, CANCER-AM CANCER SOC, V116, P1953, DOI 10.1002/cncr.24892; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Huang J, 2008, INT J BIOCHEM CELL B, V40, P1604, DOI 10.1016/j.biocel.2007.12.004; Huang J, 2009, J HISTOCHEM CYTOCHEM, V57, P339, DOI 10.1369/jhc.2008.951434; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kuo TC, 2009, CURR OPIN IMMUNOL, V21, P173, DOI 10.1016/j.coi.2009.03.008; Lansford R, 1998, INT IMMUNOL, V10, P325, DOI 10.1093/intimm/10.3.325; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niu N, 2011, INT J BIOCHEM CELL B, V43, P556, DOI 10.1016/j.biocel.2010.12.012; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Qiu XY, 2003, CANCER RES, V63, P6488; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Sakai E, 1999, INT IMMUNOL, V11, P1709, DOI 10.1093/intimm/11.10.1709; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHLISSEL M, 1991, GENE DEV, V5, P1367, DOI 10.1101/gad.5.8.1367; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Zhang SA, 2010, CELL MOL LIFE SCI, V67, P985, DOI 10.1007/s00018-009-0231-z; Zhao YY, 2011, J HISTOCHEM CYTOCHEM, V59, P474, DOI 10.1369/0022155411400871; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010; Zheng J, 2009, J BIOL CHEM, V284, P13610, DOI 10.1074/jbc.M809524200	35	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21276	10.1371/journal.pone.0021276	http://dx.doi.org/10.1371/journal.pone.0021276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731691	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400018
J	Nunes, GLC; Simoes, A; Dyszy, FH; Shida, CS; Juliano, MA; Juliano, L; Gesteira, TF; Nader, HB; Murphy, G; Chaffotte, AF; Goldberg, ME; Tersariol, ILS; Almeida, PC				Nunes, Gabriel L. C.; Simoes, Alyne; Dyszy, Fabio H.; Shida, Claudio S.; Juliano, Maria A.; Juliano, Luiz; Gesteira, Tarsis F.; Nader, Helena B.; Murphy, Gillian; Chaffotte, Alain F.; Goldberg, Michel E.; Tersariol, Ivarne L. S.; Almeida, Paulo C.			Mechanism of Heparin Acceleration of Tissue Inhibitor of Metalloproteases-1 (TIMP-1) Degradation by the Human Neutrophil Elastase	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ELASTASE; SECRETORY LEUKOPROTEASE INHIBITOR; PORCINE PANCREATIC ELASTASE; CATHEPSIN-G; ALPHA(1)-PROTEINASE INHIBITOR; MATRIX METALLOPROTEINASES; SUBSTRATE-SPECIFICITY; SULFATE PROTEOGLYCANS; SERINE PROTEASES; TERMINAL DOMAIN	Heparin has been shown to regulate human neutrophil elastase (HNE) activity. We have assessed the regulatory effect of heparin on Tissue Inhibitor of Metalloproteases-1 [TIMP-1] hydrolysis by HNE employing the recombinant form of TIMP-1 and correlated FRET-peptides comprising the TIMP-1 cleavage site. Heparin accelerates 2.5-fold TIMP-1 hydrolysis by HNE. The kinetic parameters of this reaction were monitored with the aid of a FRET-peptide substrate that mimics the TIMP-1 cleavage site in pre-steady-state conditionsby using a stopped-flow fluorescence system. The hydrolysis of the FRET-peptide substrate by HNE exhibits a pre-steady-state burst phase followed by a linear, steady-state pseudo-first-order reaction. The HNE acylation step (k(2)=21 +/- 1 s(-1)) was much higher than the HNE deacylation step (k(3)=0.57 +/- 0.05 s(-1)). The presence of heparin induces a dramatic effect in the pre-steady-state behavior of HNE. Heparin induces transient lag phase kinetics in HNE cleavage of the FRET-peptide substrate. The pre-steady-state analysis revealed that heparin affects all steps of the reaction through enhancing the ES complex concentration, increasing k(1) 2.4-fold and reducing k(-1) 3.1-fold. Heparin also promotes a 7.8-fold decrease in the k(2) value, whereas the k(3) value in the presence of heparin was increased 58-fold. These results clearly show that heparin binding accelerates deacylation and slows down acylation. Heparin shifts the HNE pH activity profile to the right, allowing HNE to be active at alkaline pH. Molecular docking and kinetic analysis suggest that heparin induces conformational changes in HNE structure. Here, we are showing for the first time that heparin is able to accelerate the hydrolysis of TIMP-1 by HNE. The degradation of TIMP-1is associated to important physiopathological states involving excessive activation of MMPs.	[Nunes, Gabriel L. C.; Shida, Claudio S.; Tersariol, Ivarne L. S.; Almeida, Paulo C.] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Mogi Das Cruzes, Brazil; [Simoes, Alyne] Univ Sao Paulo, Dept Mat Dent, Sao Paulo, Brazil; [Dyszy, Fabio H.] Univ Sao Paulo, Grp Biofis Mol, Sao Paulo, Brazil; [Nunes, Gabriel L. C.; Juliano, Maria A.; Juliano, Luiz] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Gesteira, Tarsis F.; Nader, Helena B.; Tersariol, Ivarne L. S.; Almeida, Paulo C.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Murphy, Gillian] Univ Cambridge, Dept Oncol, Cambridge, England; [Chaffotte, Alain F.] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, Paris, France; [Goldberg, Michel E.] Inst Pasteur, Unite Repliement & Modelisat Prot, Paris, France	Universidade de Mogi das Cruzes; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of Cambridge; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nunes, GLC (corresponding author), Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, Mogi Das Cruzes, Brazil.	ivarne@umc.br; pcezaral@gmail.com	Nader, Helena Bonciani/D-9253-2012; Dyszy, Fábio/F-6782-2012; de Almeida, Paulo C/D-8285-2014; Shida, Claudio/H-3473-2013; Juliano, Luiz/D-7204-2012; Complexos, INCT Fluidos/H-9172-2013; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; Simoes, Alyne/G-2176-2012	de Almeida, Paulo C/0000-0002-5136-5152; Juliano, Luiz/0000-0002-5589-2822; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; Simoes, Alyne/0000-0002-4873-1393; NADER, HELENA/0000-0002-7569-2166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq]; Fundacao de Amparo a Pesquisa [FAEP]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq](Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa [FAEP]	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP], Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a Pesquisa [FAEP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Sabin J, 2004, STROKE, V35, P1316, DOI 10.1161/01.STR.0000126827.69286.90; BAICI A, 1980, BIOCHEM PHARMACOL, V29, P1723, DOI 10.1016/0006-2952(80)90131-8; Bekhouche M, 2010, J BIOL CHEM, V285, P15950, DOI 10.1074/jbc.M109.086447; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Bord S, 1997, J ANAT, V191, P39, DOI 10.1046/j.1469-7580.1997.19110039.x; Campbell EJ, 2007, J BIOL CHEM, V282, P14645, DOI 10.1074/jbc.M608346200; Chan SCH, 2009, AM J RESP CELL MOL, V41, P620, DOI 10.1165/rcmb.2008-0185OC; Coombs GS, 1999, J BIOL CHEM, V274, P24074, DOI 10.1074/jbc.274.34.24074; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; FROMMHERZ KJ, 1991, J BIOL CHEM, V266, P15356; Gandhi NS, 2008, BIOCHEMISTRY-US, V47, P4851, DOI 10.1021/bi702455e; Garcia-Verdugo I, 2010, BIOCHIMIE, V92, P1608, DOI 10.1016/j.biochi.2010.05.010; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Groth I, 2008, PLANTA MED, V74, P852, DOI 10.1055/s-2008-1074549; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HESS GP, 1970, PHILOS T ROY SOC B, V257, P89, DOI 10.1098/rstb.1970.0011; Hirata IY, 1995, LETT PEPT SCI, V1, P299, DOI DOI 10.1007/BF00119771; ITOH Y, 1995, J BIOL CHEM, V270, P16518, DOI 10.1074/jbc.270.28.16518; Jackson PL, 2010, MOL MED, V16, P159, DOI 10.2119/molmed.2009.00109; JORDAN RE, 1987, SCIENCE, V237, P777, DOI 10.1126/science.3649921; JORDAN RE, 1989, J BIOL CHEM, V264, P10493; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Koizumi M, 2008, J SYNCHROTRON RADIAT, V15, P308, DOI 10.1107/S0909049507060670; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 1997, BIOCHEM J, V325, P163, DOI 10.1042/bj3250163; Niemann CU, 2007, BLOOD, V109, P4478, DOI 10.1182/blood-2006-02-001719; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; PRATT CW, 1990, J BIOL CHEM, V265, P6092; Rajgopal R, 2008, THROMB RES, V122, P293, DOI 10.1016/j.thromres.2006.10.025; Rockwell NC, 2002, J BIOL CHEM, V277, P17531, DOI 10.1074/jbc.M111909200; Rockwell NC, 2001, BIOCHEMISTRY-US, V40, P3657, DOI 10.1021/bi0020877; Sandercock P, 1997, LANCET, V349, P1569; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schenker P, 2010, FEBS J, V277, P2486, DOI 10.1111/j.1742-4658.2010.07663.x; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Spencer JL, 2006, BIOCHEMISTRY-US, V45, P9104, DOI 10.1021/bi060338r; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P1305, DOI 10.1021/bi00379a016; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P2238, DOI 10.1021/bi00382a025; STEIN RL, 1983, J AM CHEM SOC, V105, P5111, DOI 10.1021/ja00353a042; STEIN RL, 1985, J AM CHEM SOC, V107, P5767, DOI 10.1021/ja00306a026; Tang J, 2010, NEUROL RES, V32, P541, DOI 10.1179/174313209X414560; Wiernicki I, 2010, ATHEROSCLEROSIS, V212, P161, DOI 10.1016/j.atherosclerosis.2010.04.033; YASUTAKE A, 1981, BIOCHEMISTRY-US, V20, P3675, DOI 10.1021/bi00516a002; Ying QL, 1996, AM J RESP CELL MOL, V15, P283, DOI 10.1165/ajrcmb.15.2.8703486; Ying QL, 2000, AM J RESP CELL MOL, V23, P506, DOI 10.1165/ajrcmb.23.4.3939; ZHANG D, 2008, BIOCHIM BIOPHYS ACTA, V1785, P827; Zidane M, 2000, ARCH INTERN MED, V160, P2369, DOI 10.1001/archinte.160.15.2369	58	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21525	10.1371/journal.pone.0021525	http://dx.doi.org/10.1371/journal.pone.0021525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731773	gold, Green Published, Green Submitted			2022-12-25	WOS:000292035400048
J	Pan, D; Kalfa, TA; Wang, D; Risinger, M; Crable, S; Ottlinger, A; Chandra, S; Mount, DB; Hubner, CA; Franco, RS; Joiner, CH				Pan, Dao; Kalfa, Theodosia A.; Wang, Daren; Risinger, Mary; Crable, Scott; Ottlinger, Anna; Chandra, Sharat; Mount, David B.; Huebner, Christian A.; Franco, Robert S.; Joiner, Clinton H.			K-Cl Cotransporter Gene Expression during Human and Murine Erythroid Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SICKLE RETICULOCYTES; BONE-MARROW; MOLECULAR CHARACTERIZATION; VOLUME; CELLS; CLONING; CATION; KCC4; MICE; TRANSPORT	The K-Cl cotransporter (KCC) regulates red blood cell (RBC) volume, especially in reticulocytes. Western blot analysis of RBC membranes revealed KCC1, KCC3, and KCC4 proteins in mouse and human cells, with higher levels in reticulocytes. KCC content was higher in sickle versus normal RBC, but the correlation with reticulocyte count was poor, with inter-individual variability in KCC isoform ratios. Messenger RNA for each isoform was measured by real time RT-quantitative PCR. In human reticulocytes, KCC3a mRNA levels were consistently the highest, 1-7-fold higher than KCC4, the second most abundant species. Message levels for KCC1 and KCC3b were low. The ratios of KCC RNA levels varied among individuals but were similar in sickle and normal RBC. During in vivo maturation of human erythroblasts, KCC3a RNA was expressed consistently, whereas KCC1 and KCC3b levels declined, and KCC4 message first increased and then decreased. In mouse erythroblasts, a similar pattern for KCC3 and KCC1 expression during in vivo differentiation was observed, with low KCC4 RNA throughout despite the presence of KCC4 protein in mature RBC. During differentiation of mouse erythroleukemia cells, protein levels of KCCs paralleled increasing mRNA levels. Functional properties of KCCs expressed in HEK293 cells were similar to each other and to those in human RBC. However, the anion dependence of KCC in RBC resembled most closely that of KCC3. The results suggest that KCC3 is the dominant isoform in erythrocytes, with variable expression of KCC1 and KCC4 among individuals that could result in modulation of KCC activity.	[Pan, Dao; Wang, Daren] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Mol & Cell Therapy Program, Cincinnati, OH 45229 USA; [Kalfa, Theodosia A.; Risinger, Mary; Crable, Scott; Ottlinger, Anna; Chandra, Sharat; Franco, Robert S.; Joiner, Clinton H.] Cincinnati Childrens Hosp, Med Ctr, Canc & Blood Dis Inst, Div Hematol, Cincinnati, OH 45229 USA; [Pan, Dao; Kalfa, Theodosia A.; Chandra, Sharat; Joiner, Clinton H.] Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH 45267 USA; [Franco, Robert S.] Univ Cincinnati, Sch Med, Dept Internal Med, Cincinnati, OH 45267 USA; [Mount, David B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst,Renal Div, Boston, MA 02115 USA; [Huebner, Christian A.] Univ Jena, Univ Hosp, Dept Clin Chem, D-07747 Jena, Germany	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Friedrich Schiller University of Jena	Pan, D (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Mol & Cell Therapy Program, Cincinnati, OH 45229 USA.	dao.pan@cchmc.org; clinton.joiner@cchmc.org	Hübner, Christian/A-2950-2017	Hübner, Christian/0000-0002-1030-4943; Kalfa, Theodosia/0000-0002-0426-9686	National Institutes of Health [HL070871, NS064330, DK57708]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL070871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070871 (to C. H. J.), NS064330 (to D. P.), and DK57708 (to D. B. M.).	Armsby CC, 1996, AM J PHYSIOL-CELL PH, V270, pC866, DOI 10.1152/ajpcell.1996.270.3.C866; BENNETT V, 1983, METHOD ENZYMOL, V96, P313; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Brugnara C, 2003, J PEDIAT HEMATOL ONC, V25, P927, DOI 10.1097/00043426-200312000-00004; BRUGNARA C, 1986, SCIENCE, V232, P388, DOI 10.1126/science.3961486; BRUGNARA C, 1989, BLOOD, V74, P487; CANESSA M, 1986, FEBS LETT, V200, P197, DOI 10.1016/0014-5793(86)80538-5; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Cohen RM, 2008, BLOOD, V112, P4284, DOI 10.1182/blood-2008-04-154112; Crable SC, 2005, EXP HEMATOL, V33, P624, DOI 10.1016/j.exphem.2005.02.006; De Franceschi L, 2007, HAEMATOLOGICA, V92, P1319, DOI 10.3324/haematol.11556; DUNHAM PB, 1980, P NATL ACAD SCI-BIOL, V77, P1711, DOI 10.1073/pnas.77.3.1711; FRANCO RS, 1995, J CLIN INVEST, V95, P2573, DOI 10.1172/JCI117958; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Hiki K, 1999, J BIOL CHEM, V274, P10661, DOI 10.1074/jbc.274.15.10661; Joiner CH, 2004, BLOOD, V104, P2954, DOI 10.1182/blood-2004-01-0112; Joiner CH, 2007, BLOOD, V109, P1728, DOI 10.1182/blood-2006-04-018630; KAJI D, 1986, J GEN PHYSIOL, V88, P719, DOI 10.1085/jgp.88.6.719; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Karadsheh MF, 2004, NEUROSCIENCE, V123, P381, DOI 10.1016/j.neuroscience.2003.10.004; Lauf PK, 2001, COMP BIOCHEM PHYS A, V130, P499, DOI 10.1016/S1095-6433(01)00421-4; LAUF PK, 1980, BIOCHEM BIOPH RES CO, V92, P1422, DOI 10.1016/0006-291X(80)90445-3; LOKEN MR, 1987, BLOOD, V69, P255; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Mercado A, 2005, AM J PHYSIOL-RENAL, V289, pF1246, DOI 10.1152/ajprenal.00464.2004; Mercado A, 2001, AM J PHYSIOL-CELL PH, V281, pC670, DOI 10.1152/ajpcell.2001.281.2.C670; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Nagel RL, 2003, BLOOD REV, V17, P167, DOI 10.1016/S0268-960X(03)00003-1; Pan D, 2002, MOL THER, V6, P19, DOI 10.1006/mthe.2002.0630; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Pearson MM, 2001, NEUROSCIENCE, V103, P481, DOI 10.1016/S0306-4522(00)00567-4; Pellegrino CM, 1998, BLOOD CELL MOL DIS, V24, P31, DOI 10.1006/bcmd.1998.0168; Rinehart J, 2010, CURR OPIN HEMATOL, V17, P191, DOI 10.1097/MOH.0b013e32833800d0; Rust MB, 2007, J CLIN INVEST, V117, P1708, DOI 10.1172/JCI30630; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Su WF, 1999, AM J PHYSIOL-CELL PH, V277, pC899, DOI 10.1152/ajpcell.1999.277.5.C899; Wang DR, 2009, P NATL ACAD SCI USA, V106, P19958, DOI 10.1073/pnas.0908528106	41	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30492	30503		10.1074/jbc.M110.206516	http://dx.doi.org/10.1074/jbc.M110.206516			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21733850	Green Published, hybrid			2022-12-25	WOS:000294283600028
J	Lin, WH; Martin, JL; Marsh, DJ; Jack, MM; Baxter, RC				Lin, Wen Hui; Martin, Janet L.; Marsh, Deborah J.; Jack, Michelle M.; Baxter, Robert C.			Involvement of Insulin-like Growth Factor-binding Protein-3 in the Effects of Histone Deacetylase Inhibitor MS-275 in Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; VIVO ANTITUMOR-ACTIVITY; BREAST-CANCER CELLS; IN-VIVO; SIGNALING PATHWAYS; PROSTATE-CANCER; GENE-EXPRESSION; LUNG-CANCER; IGFBP-3; INVASION	Insulin-like growth factor-binding protein-3 (IGFBP-3) expression is frequently suppressed in liver cancers and can be reactivated by histone deacetylase (HDAC) inhibition. This study examined the role of IGFBP-3 in mediating the effects of the HDAC inhibitor MS-275 in liver cancer cells and identified IGFBP-3-dependent proteins that regulate proliferation and migration. In HepG2 cells, MS-275 inhibited DNA synthesis, cell cycle activity, and cell viability concomitantly with increased binding of acetylated histone H3 to IGFBP-3 promoter sequences and induction of IGFBP-3 expression. IGFBP-3 down-regulation by siRNA significantly reversed the inhibition of cell viability and DNA synthesis by MS-275, indicating an intermediary role for IGFBP-3. Induction of the cyclin-dependent kinase inhibitor p21 by MS-275 was attenuated by IGFBP-3 down-regulation, providing an explanation for IGFBP-3-dependent effects of MS-275 on cell cycle activity. In contrast, MS-275 stimulated HepG2 cell migration, an effect also inhibited by IGFBP-3 down-regulation. Among genes whose induction by MS-275 was attenuated by IGFBP-3 down-regulation, LYVE1 and THBS2 (thrombospondin-2) were identified as mediators of IGFBP-3-dependent effects of MS-275. Silencing of either protein had no effect on the inhibition of HepG2 viability by MS-275 but reversed its stimulatory effect on cell migration. We conclude that among genes up-regulated by MS-275, IGFBP-3 is a key mediator of effects on hepatoma cell growth and migration, involving IGFBP-3-dependent proteins p21 (proliferation) and LYVE1 and THBS2 (migration). The enhanced cell motility that accompanies reactivation of IGFBP-3 expression in liver cancer by HDAC inhibition suggests the possibility of increased metastatic spread despite inhibited cell proliferation.	[Lin, Wen Hui; Martin, Janet L.; Marsh, Deborah J.; Baxter, Robert C.] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2065, Australia; [Jack, Michelle M.] Royal N Shore Hosp, Dept Endocrinol, Sydney, NSW 2065, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney	Baxter, RC (corresponding author), Royal N Shore Hosp, Kolling Inst Med Res, St Leonards, NSW 2065, Australia.	robert.baxter@sydney.edu.au	Marsh, Deborah J/I-1491-2014; Baxter, Robert C/F-3927-2012	Marsh, Deborah J/0000-0001-5899-4931; Baxter, Robert C/0000-0001-5061-2142				Aishima S, 2006, CANCER SCI, V97, P1182, DOI 10.1111/j.1349-7006.2006.00322.x; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Baradari V, 2007, WORLD J GASTROENTERO, V13, P4458; BAXTER RC, 1993, TRENDS ENDOCRIN MET, V4, P91, DOI 10.1016/1043-2760(93)90085-S; BAXTER RC, 1986, J CLIN INVEST, V78, P1504, DOI 10.1172/JCI112742; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; CHIN E, 1994, ENDOCRINOLOGY, V134, P2498, DOI 10.1210/en.134.6.2498; Choi HS, 2002, BIOCHEM BIOPH RES CO, V296, P1005, DOI 10.1016/S0006-291X(02)02001-6; Chuang ST, 2008, J UROLOGY, V179, P445, DOI 10.1016/j.juro.2007.09.106; Colombat M, 2003, J PATHOL, V201, P260, DOI 10.1002/path.1451; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Firth SM, 1999, PROTEIN EXPRES PURIF, V16, P202, DOI 10.1006/prep.1999.1075; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gahr S, 2008, ONCOL REP, V20, P1249, DOI 10.3892/or_00000137; Gong YW, 2000, MOL CELL BIOCHEM, V207, P101, DOI 10.1023/A:1007010818094; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Hanafusa T, 2002, CANCER LETT, V176, P149, DOI 10.1016/S0304-3835(01)00736-4; Hanafusa T, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-9; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Huang SS, 2003, J BIOL CHEM, V278, P43855, DOI 10.1074/jbc.M306411200; Jaboin J, 2002, CANCER RES, V62, P6108; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kettunen E, 2004, CANCER GENET CYTOGEN, V149, P98, DOI 10.1016/s0165-4608(03)00300-5; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Li MH, 2009, CANCER LETT, V276, P171, DOI 10.1016/j.canlet.2008.11.025; Luo SM, 2005, WORLD J GASTROENTERO, V11, P4272; Martin JL, 2009, J BIOL CHEM, V284, P25542, DOI 10.1074/jbc.M109.007120; Martin JL, 2003, J BIOL CHEM, V278, P2969, DOI 10.1074/jbc.M210739200; Massoner P, 2008, PROSTATE, V68, P1165, DOI 10.1002/pros.20785; Mattera D, 2003, CLIN ENDOCRINOL, V59, P699, DOI 10.1046/j.1365-2265.2003.01909.x; McElroy M, 2009, J SURG RES, V151, P68, DOI 10.1016/j.jss.2007.12.769; O'Han MK, 2009, GROWTH FACTORS, V27, P394, DOI 10.3109/08977190903185032; Oh SH, 2006, MOL CANCER THER, V5, P2685, DOI 10.1158/1535-7163.MCT-06-0142; Oh SH, 2006, CLIN CANCER RES, V12, P653, DOI 10.1158/1078-0432.CCR-05-1725; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; Park KS, 2007, BIOCHEM BIOPH RES CO, V356, P239, DOI 10.1016/j.bbrc.2007.02.112; Peng LH, 2008, INT J CANCER, V122, P558, DOI 10.1002/ijc.23100; Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181; Riester D, 2007, APPL MICROBIOL BIOT, V75, P499, DOI 10.1007/s00253-007-0912-1; Rocha RL, 1996, J NATL CANCER I, V88, P601, DOI 10.1093/jnci/88.9.601; Rosato RR, 2003, CANCER RES, V63, P3637; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; SCHARF JG, 1995, J HEPATOL, V23, P424, DOI 10.1016/0168-8278(95)80201-0; Torng PL, 2008, ONCOGENE, V27, P2137, DOI 10.1038/sj.onc.1210864; Xi YG, 2006, MOL CANCER THER, V5, P3078, DOI 10.1158/1535-7163.MCT-06-0424; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yuan RH, 2011, J GASTROINTEST SURG, V15, P321, DOI 10.1007/s11605-010-1373-x; Yumoto E, 2005, INT J ONCOL, V27, P1223; Zhang YJ, 2006, INT J CANCER, V119, P985, DOI 10.1002/ijc.21699	53	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29540	29547		10.1074/jbc.M111.263111	http://dx.doi.org/10.1074/jbc.M111.263111			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21737444	Green Published, hybrid			2022-12-25	WOS:000294046600011
J	Larrue, A; Rattner, A; Peter, ZA; Olivier, C; Laroche, N; Vico, L; Peyrin, F				Larrue, Aymeric; Rattner, Aline; Peter, Zsolt-Andrei; Olivier, Cecile; Laroche, Norbert; Vico, Laurence; Peyrin, Francoise			Synchrotron Radiation Micro-CT at the Micrometer Scale for the Analysis of the Three-Dimensional Morphology of Microcracks in Human Trabecular Bone	PLOS ONE			English	Article							HUMAN CORTICAL BONE; MICRODAMAGE ACCUMULATION; BIOMECHANICAL PROPERTIES; CANCELLOUS BONE; DAMAGE; FRACTURE; BISPHOSPHONATES; PROPAGATION; TURNOVER; STRENGTH	Bone quality is an important concept to explain bone fragility in addition to bone mass. Among bone quality factors, microdamage which appears in daily life is thought to have a marked impact on bone strength and plays a major role in the repair process. The starting point for all studies designed to further our understanding of how bone microdamage initiate or dissipate energy, or to investigate the impact of age, gender or disease, remains reliable observation and measurement of microdamage. In this study, 3D Synchrotron Radiation (SR) micro-CT at the micrometric scale was coupled to image analysis for the three-dimensional characterization of bone microdamage in human trabecular bone specimens taken from femoral heads. Specimens were imaged by 3D SR micro-CT with a voxel size of 1.4 mm. A new tailored 3D image analysis technique was developed to segment and quantify microcracks. Microcracks from human trabecular bone were observed in different tomographic sections as well as from 3D renderings. New 3D quantitative measurements on the microcrack density and morphology are reported on five specimens. The 3D microcrack density was found between 3.1 and 9.4/mm3 corresponding to a 2D density between 0.55 and 0.76 /mm2. The microcrack length and width measured in 3D on five selected microcrack ranged respectively from 164 mm to 209 mm and 100 mm to 120 mm. This is the first time that various microcracks in unloaded human trabecular bone - from the simplest linear crack to more complex cross-hatch cracks - have been examined and quantified by 3D imaging at this scale. The suspected complex morphology of microcracks is here considerably more evident than in the 2D observations. In conclusion, this technique opens new perspective for the 3D investigation of microcracks and the impact of age, disease or treatment.	[Larrue, Aymeric; Peter, Zsolt-Andrei; Olivier, Cecile; Peyrin, Francoise] Univ Lyon 1, CNRS 5220, INSERM, CREATIS,INSA Lyon,U1044, F-69622 Villeurbanne, France; [Larrue, Aymeric; Olivier, Cecile; Peyrin, Francoise] ESRF, Grenoble, France; [Rattner, Aline; Laroche, Norbert; Vico, Laurence] Univ Lyon, LBTO, INSERM, IFR143,IFRESIS,U890, St Etienne, France; [Peter, Zsolt-Andrei] Univ Paris 10, PST IUT Ville Avray, Dept GTE, Ville Davray, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; European Synchrotron Radiation Facility (ESRF); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Nanterre	Larrue, A (corresponding author), Univ Lyon 1, CNRS 5220, INSERM, CREATIS,INSA Lyon,U1044, F-69622 Villeurbanne, France.	peyrin@esrf.fr	Vico, Laurence/O-1927-2018; Peyrin, Francoise/G-2823-2013; Vico, Laurence/ABG-7239-2020	Vico, Laurence/0000-0002-2110-287X; Peyrin, Francoise/0000-0002-1988-3435; Vico, Laurence/0000-0002-2110-287X	Rhones-Alpes Region, France; CNRS/Inserm	Rhones-Alpes Region, France; CNRS/Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS))	This work was funded by the "Cluster de Recherche Handicap Vieillissement Neuroscience" of the Rhones-Alpes Region, France. It was also supported by the GDR STIC-Sante (Groupe de Recherche Science et Technologie de l'Information et de la Communication - Sante) CNRS/Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUET F, 2005, P 2005 INT C IM PROC, V2, P1158; Allen MR, 2006, BONE, V39, P872, DOI 10.1016/j.bone.2006.04.028; Arlot ME, 2008, J BONE MINER RES, V23, P1613, DOI 10.1359/JBMR.080517; Barth HD, 2010, BONE, V46, P1475, DOI 10.1016/j.bone.2010.02.025; Bonnassie A, 2003, IEEE T SYST MAN CY B, V33, P700, DOI 10.1109/TSMCB.2003.814298; BURR DB, 1990, CLIN ORTHOP RELAT R, P305, DOI 10.1097/00003086-199011000-00047; Chapurlat RD, 2007, J BONE MINER RES, V22, P1502, DOI 10.1359/JBMR.070609; Cloetens P, 1997, J APPL PHYS, V81, P5878, DOI 10.1063/1.364374; Davies CM, 2006, EUR CELLS MATER, V11, P57, DOI 10.22203/eCM.v011a07; Donahue Seth W., 2006, Critical Reviews in Biomedical Engineering, V34, P215, DOI 10.1615/CritRevBiomedEng.v34.i3.20; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; Fazzalari NL, 1998, BONE, V23, P373, DOI 10.1016/S8756-3282(98)00111-2; Fazzalari NL, 2002, BONE, V31, P697, DOI 10.1016/S8756-3282(02)00906-7; Fratzl P, 2008, NAT MATER, V7, P610, DOI 10.1038/nmat2240; Hazenberg JG, 2007, OSTEOPOROSIS INT, V18, P1, DOI 10.1007/s00198-006-0222-y; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221; Landrigan MD, 2011, BONE, V48, P443, DOI 10.1016/j.bone.2010.10.160; Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x; Leng HJ, 2008, J MECH BEHAV BIOMED, V1, P68, DOI 10.1016/j.jmbbm.2007.06.002; Lievers WB, 2010, MED ENG PHYS, V32, P921, DOI 10.1016/j.medengphy.2010.06.001; Martin RB, 2007, BONE, V40, P1159, DOI 10.1016/j.bone.2006.11.014; Martin-Badosa E, 2003, COMPUT MED IMAG GRAP, V27, P447, DOI 10.1016/S0895-6111(03)00031-4; Mashiba T, 2001, BONE, V28, P524, DOI 10.1016/S8756-3282(01)00414-8; Mohsin S, 2006, J ANAT, V209, P119, DOI 10.1111/j.1469-7580.2006.00554.x; Moore TLA, 2002, J BIOMECH ENG-T ASME, V124, P63, DOI 10.1115/1.1428745; Mori S, 1997, BONE, V21, P521, DOI 10.1016/S8756-3282(97)00200-7; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Norman TL, 1997, BONE, V20, P375, DOI 10.1016/S8756-3282(97)00004-5; Nuzzo S, 2002, MED PHYS, V29, P2672, DOI 10.1118/1.1513161; O'Brien FJ, 2000, J ANAT, V197, P413, DOI 10.1046/j.1469-7580.2000.19730413.x; Reilly GC, 2000, J BIOMECH, V33, P337, DOI 10.1016/S0021-9290(99)00167-0; Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Serra J., 1982, IMAGE ANAL MATH MORP; Taylor D, 1998, J BIOMECH, V31, P1177, DOI 10.1016/S0021-9290(98)00133-X; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Thurner PJ, 2006, BONE, V39, P289, DOI 10.1016/j.bone.2006.01.147; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Un K, 2006, J BIOMECH, V39, P1955, DOI 10.1016/j.jbiomech.2006.05.012; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Voide R, 2009, BONE, V45, P164, DOI 10.1016/j.bone.2009.04.248; Wang XA, 2006, J BIOMECH, V39, P781, DOI 10.1016/j.jbiomech.2005.02.007; Wang X, 2008, J BIOMECH, V41, P2654, DOI 10.1016/j.jbiomech.2008.06.011; Wang X, 2007, J BIOMECH, V40, P3397, DOI 10.1016/j.jbiomech.2007.05.009; Yeni YN, 2003, ANN BIOMED ENG, V31, P726, DOI 10.1114/1.1569264; Zarrinkalam K. H., 2005, European Journal of Morphology, V42, P81; ZIOUPOS P, 1994, J MATER SCI, V29, P978, DOI 10.1007/BF00351420	49	50	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21297	10.1371/journal.pone.0021297	http://dx.doi.org/10.1371/journal.pone.0021297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750707	Green Published, gold, Green Submitted			2022-12-25	WOS:000292655400003
J	Radoshitzky, SR; Longobardi, LE; Kuhn, JH; Retterer, C; Dong, L; Clester, JC; Kota, K; Carra, J; Bavari, S				Radoshitzky, Sheli R.; Longobardi, Lindsay E.; Kuhn, Jens H.; Retterer, Cary; Dong, Lian; Clester, Jeremiah C.; Kota, Krishna; Carra, John; Bavari, Sina			Machupo Virus Glycoprotein Determinants for Human Transferrin Receptor 1 Binding and Cell Entry	PLOS ONE			English	Article							HEMORRHAGIC-FEVER ARENAVIRUSES; GP-C; SUBTILASE SKI-1/S1P; SIGNAL PEPTIDE; IDENTIFICATION; CLEAVAGE; JUNIN	Machupo virus (MACV) is a highly pathogenic New World arenavirus that causes hemorrhagic fever in humans. MACV, as well as other pathogenic New World arenaviruses, enter cells after their GP1 attachment glycoprotein binds to their cellular receptor, transferrin receptor 1 (TfR1). TfR1 residues essential for this interaction have been described, and a co-crystal of MACV GP1 bound to TfR1 suggests GP1 residues important for this association. We created MACV GP1 variants and tested their effect on TfR1 binding and virus entry to evaluate the functional significance of some of these and additional residues in human and simian cells. We found residues R111, D123, Y122, and F226 to be essential, D155, and P160 important, and D114, S116, D140, and K169 expendable for the GP1-TfR1 interaction and MACV entry. Several MACV GP1 residues that are critical for the interaction with TfR1 are conserved among other New World arenaviruses, indicating a common basis of receptor interaction. Our findings also open avenues for the rational development of viral entry inhibitors.	[Radoshitzky, Sheli R.; Longobardi, Lindsay E.; Retterer, Cary; Dong, Lian; Clester, Jeremiah C.; Kota, Krishna; Carra, John; Bavari, Sina] USAMRIID, Div Toxicol, Frederick, MD USA; [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick IRF Frederick, DCR, NIH, Frederick, MD USA	United States Army Medical Research Institute of Infectious Diseases; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Radoshitzky, SR (corresponding author), USAMRIID, Div Toxicol, Frederick, MD USA.	sina.bavari@amedd.army.mil	Radoshitzky, Sheli S/F-2766-2019; Kota, Krishna/GPF-8474-2022; Bavari, Sina/L-3642-2019; Radoshitzky, Sheli/L-8410-2019; Kuhn, Jens H./B-7615-2011	Bavari, Sina/0000-0001-8424-5635; Radoshitzky, Sheli/0000-0001-8976-8056; Kuhn, Jens H./0000-0002-7800-6045	Joint Science and Technology Office Transformational Medical Technologies [TMTI0048_09_RD_T]; Defense Threat Reduction Agency [4.10022_08_RD_B]; NIAID [HHSN272200200016I]	Joint Science and Technology Office Transformational Medical Technologies; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was partially supported by the Joint Science and Technology Office Transformational Medical Technologies (proposal # TMTI0048_09_RD_T) and Defense Threat Reduction Agency (proposal #4.10022_08_RD_B) to SB. JHK performed this work as an employee of Tunnell Consulting, Inc., a subcontractor to Battelle Memorial Institute under its prime contract with NIAID, Contract No. HHSN272200200016I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Abraham J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000358; Agnihothram SS, 2007, J VIROL, V81, P4331, DOI 10.1128/JVI.02779-06; Aguilar PV, 2009, EMERG INFECT DIS, V15, P1526, DOI 10.3201/eid1509.090017; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Bowden TA, 2009, J VIROL, V83, P8259, DOI 10.1128/JVI.00761-09; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; BUCHMEIER MJ, 1987, J VIROL, V61, P982, DOI 10.1128/JVI.61.4.982-985.1987; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eschli B, 2006, J VIROL, V80, P5897, DOI 10.1128/JVI.00008-06; Flanagan ML, 2008, J VIROL, V82, P938, DOI 10.1128/JVI.01397-07; Kunz S, 2003, VIROLOGY, V314, P168, DOI 10.1016/S0042-6822(03)00421-5; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Martin VK, 2010, J VIROL, V84, P1176, DOI 10.1128/JVI.01625-09; *NIAID, 2010, NIAID CAT PRIOR PATH; Oldenburg J, 2007, VIROLOGY, V364, P132, DOI 10.1016/j.virol.2007.03.003; PETERS CJ, 1974, AM J EPIDEMIOL, V99, P425, DOI 10.1093/oxfordjournals.aje.a121631; Radoshitzky SR, 2008, P NATL ACAD SCI USA, V105, P2664, DOI 10.1073/pnas.0709254105; Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539; Reignier T, 2006, VIROLOGY, V353, P111, DOI 10.1016/j.virol.2006.05.018; Rojek JM, 2006, VIROLOGY, V349, P476, DOI 10.1016/j.virol.2006.02.033; Salvato MS, 2005, VIRUS TAXONOMY, P725; *US DHHS, 2007, HHS PUBL	26	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21398	10.1371/journal.pone.0021398	http://dx.doi.org/10.1371/journal.pone.0021398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750710	gold, Green Submitted, Green Published			2022-12-25	WOS:000292655400005
J	Brown, JD; Oligino, E; Rader, DJ; Saghatelian, A; Plutzky, J				Brown, Jonathan D.; Oligino, Eric; Rader, Daniel J.; Saghatelian, Alan; Plutzky, Jorge			VLDL Hydrolysis by Hepatic Lipase Regulates PPAR delta Transcriptional Responses	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; LIPOPROTEIN METABOLISM; ENDOTHELIAL LIPASE; FATTY-ACIDS; ALPHA; MICE; ATHEROSCLEROSIS; EXPRESSION; DEFICIENT; EICOSANOIDS	Background: PPARs (alpha,gamma,delta) are a family of ligand-activated transcription factors that regulate energy balance, including lipid metabolism. Despite these critical functions, the integration between specific pathways of lipid metabolism and distinct PPAR responses remains obscure. Previous work has revealed that lipolytic pathways can activate PPARs. Whether hepatic lipase (HL), an enzyme that regulates VLDL and HDL catabolism, participates in PPAR responses is unknown. Methods/Principal Findings: Using PPAR ligand binding domain transactivation assays, we found that HL interacted with triglyceride-rich VLDL (>HDL >> LDL, IDL) to activate PPAR delta preferentially over PPAR alpha or PPAR gamma, an effect dependent on HL catalytic activity. In cell free ligand displacement assays, VLDL hydrolysis by HL activated PPAR delta in a VLDL-concentration dependent manner. Extended further, VLDL stimulation of HL-expressing HUVECs and FAO hepatoma cells increased mRNA expression of canonical PPAR delta target genes, including adipocyte differentiation related protein (ADRP), angiopoietin like protein 4 and pyruvate dehydrogenase kinase-4. HL/VLDL regulated ADRP through a PPRE in the promoter region of this gene. In vivo, adenoviral-mediated hepatic HL expression in C57BL/6 mice increased hepatic ADRP mRNA levels by 30%. In ob/ob mice, a model with higher triglycerides than C57BL/6 mice, HL overexpression increased ADRP expression by 70%, demonstrating the importance of triglyceride substrate for HL-mediated PPAR delta activation. Global metabolite profiling identified HL/VLDL released fatty acids including oleic acid and palmitoleic acid that were capable of recapitulating PPARd activation and ADRP gene regulation in vitro. Conclusions: These data define a novel pathway involving HL hydrolysis of VLDL that activates PPARd through generation of specific monounsaturated fatty acids. These data also demonstrate how integrating cell biology with metabolomic approaches provides insight into specific lipid mediators and pathways of lipid metabolism that regulate transcription.	[Brown, Jonathan D.; Oligino, Eric; Plutzky, Jorge] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Brown, Jonathan D.] VA Boston Healthcare, W Roxbury, MA USA; [Oligino, Eric] Yale New Haven Med Ctr, Div Cardiol, New Haven, CT 06504 USA; [Rader, Daniel J.] Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Saghatelian, Alan] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Yale University; University of Pennsylvania; Pennsylvania Medicine; Harvard University	Brown, JD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA.	jplutzky@rics.bwh.harvard.edu	Plutzky, Jorge/V-3410-2019		National Institutes of Health [NHBLI HL048743, NHLBI HL071745, NHLBI K08HL105678-01]; Sarnoff Cardiovascular Research Foundation; Searle Scholars Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071745, P01HL048743, K08HL105678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sarnoff Cardiovascular Research Foundation; Searle Scholars Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This paper was supported by National Institutes of Health grants NHBLI HL048743 and NHLBI HL071745 (JP) and NHLBI K08HL105678-01 (JB), the Sarnoff Cardiovascular Research Foundation (JB, EO), and the Searle Scholars Award (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2006, CIRC RES, V98, P490, DOI 10.1161/01.RES.0000205846.46812.be; ApplebaumBowden D, 1996, J CLIN INVEST, V97, P799, DOI 10.1172/JCI118479; Braschi S, 1998, BBA-LIPID LIPID MET, V1392, P276, DOI 10.1016/S0005-2760(98)00046-0; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chawla A, 2003, P NATL ACAD SCI USA, V100, P1268, DOI 10.1073/pnas.0337331100; Chiu HK, 2010, ENDOCRINOLOGY, V151, P993, DOI 10.1210/en.2009-1100; Dugi KA, 2000, ARTERIOSCL THROM VAS, V20, P793, DOI 10.1161/01.ATV.20.3.793; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Duong M, 2003, BIOCHEMISTRY-US, V42, P13778, DOI 10.1021/bi034990n; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Freeman L, 2007, J LIPID RES, V48, P104, DOI 10.1194/jlr.M600321-JLR200; HEGELE RA, 1991, BIOCHEM BIOPH RES CO, V179, P78, DOI 10.1016/0006-291X(91)91336-B; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; Jansen H, 2002, J LIPID RES, V43, P1352, DOI 10.1194/jlr.R200008-JLR200; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Marx N, 2000, J IMMUNOL, V164, P6503, DOI 10.4049/jimmunol.164.12.6503; McCoy MG, 2002, J LIPID RES, V43, P921; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Nong ZX, 2003, J CLIN INVEST, V112, P367, DOI 10.1172/JCI200316484; Qian K, 2007, ATHEROSCLEROSIS, V195, P66, DOI 10.1016/j.atherosclerosis.2006.12.002; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Santamarina-Fojo S, 1998, CURR OPIN LIPIDOL, V9, P211, DOI 10.1097/00041433-199806000-00005; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tagore R, 2008, J AM CHEM SOC, V130, P14111, DOI 10.1021/ja806463c; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Teran-Garcia M, 2005, DIABETES, V54, P2251, DOI 10.2337/diabetes.54.7.2251; van Haperen R, 2009, BBA-MOL CELL BIOL L, V1791, P1031, DOI 10.1016/j.bbalip.2009.06.001; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	44	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21209	10.1371/journal.pone.0021209	http://dx.doi.org/10.1371/journal.pone.0021209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750705	Green Submitted, Green Published, gold			2022-12-25	WOS:000292512000010
J	Lebre, MC; Vergunst, CE; Choi, IYK; Aarrass, S; Oliveira, ASF; Wyant, T; Horuk, R; Reedquist, KA; Tak, PP				Lebre, Maria C.; Vergunst, Clarissa E.; Choi, Ivy Y. K.; Aarrass, Saida; Oliveira, Ana S. F.; Wyant, Tim; Horuk, Richard; Reedquist, Kris A.; Tak, Paul P.			Why CCR2 and CCR5 Blockade Failed and Why CCR1 Blockade Might Still Be Effective in the Treatment of Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CHEMOKINE RECEPTOR EXPRESSION; CONTROLLED CLINICAL-TRIAL; PROOF-OF-CONCEPT; SYNOVIAL TISSUE; DOUBLE-BLIND; INFLAMMATORY DISEASE; PERIPHERAL-BLOOD; MACROPHAGES; ANTAGONIST	Background: The aim of this study was to provide more insight into the question as to why blockade of CCR1, CCR2, and CCR5 may have failed in clinical trials in rheumatoid arthritis (RA) patients, using an in vitro monocyte migration system model. Methodology/Principal Findings: Monocytes from healthy donors (HD; n = 8) or from RA patients (for CCR2 and CCR5 antibody n = 8; for CCR1 blockade n = 13) were isolated from peripheral blood and pre-incubated with different concentrations of either anti-CCR1, anti-CCR2, or anti-CCR5 blocking antibodies (or medium or isotype controls). In addition, a small molecule CCR1 antagonist (BX471) was tested. Chemotaxis was induced by CCL2/MCP-1 (CCR2 ligand), CCL5/RANTES (CCR1 and CCR5 ligand), or by a mix of 5 RA synovial fluids (SFs), and cellular responses compared to chemotaxis in the presence of medium alone. Anti-CCR2 antibody treatment blocked CCL2/MCP-1-induced chemotaxis of both HD and RA monocytes compared to isotype control. Similarly, anti-CCR5 antibody treatment blocked CCL5/RANTES-induced chemotaxis of RA monocytes. While neither CCR2 nor CCR5 blocking antibodies were able to inhibit SF-induced monocyte chemotaxis, even when both receptors were blocked simultaneously, both anti-CCR1 antibodies and the CCR1 antagonist were able to inhibit SF-induced monocyte chemotaxis. Conclusions/Significance: The RA synovial compartment contains several ligands for CCR1, CCR2, and CCR5 as well as other chemokines and receptors involved in monocyte recruitment to the site of inflammation. The results suggest that CCR2 and CCR5 are not critical for the migration of monocytes towards the synovial compartment in RA. In contrast, blockade of CCR1 may be effective. Conceivably, CCR1 blockade failed in clinical trials, not because CCR1 is not a good target, but because very high levels of receptor occupancy at all times may be needed to inhibit monocyte migration in vivo.	[Lebre, Maria C.; Vergunst, Clarissa E.; Choi, Ivy Y. K.; Aarrass, Saida; Oliveira, Ana S. F.; Reedquist, Kris A.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Wyant, Tim] Millennium Pharmaceut Inc, Cambridge, MA USA; [Horuk, Richard] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Amsterdam; Academic Medical Center Amsterdam; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of California System; University of California Davis	Lebre, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.lebre@amc.uva.nl	Oliveira, Ana/L-1850-2014	Oliveira, Ana/0000-0002-2220-5862	Millennium Pharmaceuticals Inc.	Millennium Pharmaceuticals Inc.(Takeda Pharmaceutical Company Ltd)	The study was financed by Millennium Pharmaceuticals Inc. Dr. T. Wyant is an employee of Millennium Pharmaceuticals and contributed with reagents and with the writing of the manuscript. The funders therefore played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlMughales J, 1996, CLIN EXP IMMUNOL, V106, P230, DOI 10.1046/j.1365-2249.1996.d01-836.x; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Dairaghi DJ, 2011, CLIN PHARMACOL THER, V89, P726, DOI 10.1038/clpt.2011.33; GERLAG DM, 2010, ARTHRITIS RHEUM; Gladue RP, 2010, CURR TOP MED CHEM, V10, P1268; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Haringman JJ, 2004, ANN RHEUM DIS, V63, P1186, DOI 10.1136/ard.2004.020529; Haringman JJ, 2004, ARTHRITIS RES THER, V6, P93, DOI 10.1186/ar1172; Haringman JJ, 2003, ANN RHEUM DIS, V62, P715, DOI 10.1136/ard.62.8.715; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Jiao Z, 2007, SCAND J RHEUMATOL, V36, P428, DOI 10.1080/03009740701482800; Katschke KJ, 2001, ARTHRITIS RHEUM, V44, P1022, DOI 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.3.CO;2-E; Kinne RW, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2333; KOCH AE, 1994, J CLIN INVEST, V93, P921, DOI 10.1172/JCI117097; Koch AE, 2005, ARTHRITIS RHEUM, V52, P710, DOI 10.1002/art.20932; Patel DD, 2001, CLIN IMMUNOL, V98, P39, DOI 10.1006/clim.2000.4957; Pease JE, 2009, EXPERT OPIN THER PAT, V19, P199, DOI 10.1517/13543770802641353; Pease JE, 2009, EXPERT OPIN THER PAT, V19, P39, DOI 10.1517/13543770802641346; PlaterZyberk C, 1997, IMMUNOL LETT, V57, P117, DOI 10.1016/S0165-2478(97)00075-8; Proudfoot AEI, 2008, ARTHRITIS RHEUM, V58, P1889, DOI 10.1002/art.23590; Quinones MP, 2005, J MOL MED, V83, P672, DOI 10.1007/s00109-005-0637-5; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Thurlings RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007865; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P2013, DOI 10.1136/ard.2010.131235; Vergunst CE, 2008, ARTHRITIS RHEUM-US, V58, P1931, DOI 10.1002/art.23591; Vergunst CE, 2009, ARTHRITIS RHEUM-US, V60, P3572, DOI 10.1002/art.24978; Vierboom MPM, 2005, ARTHRITIS RHEUM-US, V52, P627, DOI 10.1002/art.20850; Volin MV, 1998, CLIN IMMUNOL IMMUNOP, V89, P44, DOI 10.1006/clin.1998.4590; Wijbrandts CA, 2007, ARTHRITIS RHEUM, V56, P3869, DOI 10.1002/art.22964	34	68	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21772	10.1371/journal.pone.0021772	http://dx.doi.org/10.1371/journal.pone.0021772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747955	Green Submitted, gold, Green Published			2022-12-25	WOS:000292293400031
J	Lever, M; George, PM; Atkinson, W; Molyneux, SL; Elmslie, JL; Slow, S; Richards, AM; Chambers, ST				Lever, Michael; George, Peter M.; Atkinson, Wendy; Molyneux, Sarah L.; Elmslie, Jane L.; Slow, Sandy; Richards, A. Mark; Chambers, Stephen T.			Plasma Lipids and Betaine Are Related in an Acute Coronary Syndrome Cohort	PLOS ONE			English	Article							GLYCINE BETAINE; GROWTH-PERFORMANCE; BLOOD-LIPIDS; COMMON FOODS; SUPPLEMENTATION; HOMOCYSTEINE; CHOLINE; HYPERHOMOCYSTEINEMIA; DERIVATIVES; METABOLISM	Background: Low plasma betaine has been associated with unfavorable plasma lipid profiles and cardiovascular risk. In some studies raised plasma betaine after supplementation is associated with elevations in plasma lipids. We aimed to measure the relationships between plasma and urine betaine and plasma lipids, and the effects of lipid-lowering drugs on these. Methodology: Fasting plasma samples were collected from 531 subjects (and urine samples from 415) 4 months after hospitalization for an acute coronary syndrome episode. In this cross-sectional study, plasma betaine and dimethylglycine concentrations and urine excretions were compared with plasma lipid concentrations. Subgroup comparisons were made for gender, with and without diabetes mellitus, and for drug treatment. Principal Findings: Plasma betaine negatively correlated with triglyceride (Spearman's r(s) = -20.22, p < 0.0001) and non-high-density lipoprotein cholesterol (r(s) = -20.27, p < 0.0001). Plasma betaine was a predictor of BMI (p < 0.05) and plasma non-high-density lipoprotein cholesterol and triglyceride (p < 0.001) independently of gender, age and the presence of diabetes. Using data grouped by plasma betaine decile, increasing plasma betaine was linearly related to decreases in BMI (p = 0.008) and plasma non-HDL cholesterol (p = 0.002). In a non-linear relationship betaine was negatively associated with elevated plasma triglycerides (p = 0.004) only for plasma betaine > 45 mu mol/L. Subjects taking statins had higher plasma betaine concentrations (p < 0.001). Subjects treated with a fibrate had lower plasma betaine (p = 0.003) possibly caused by elevated urine betaine loss (p < 0.001). The ratio of coenzyme Q to non-high-density lipoprotein cholesterol was higher in subjects with higher plasma betaine, and in subjects taking a statin. Conclusion: Low plasma betaine concentrations correlated with an unfavourable lipid profile. Betaine deficiency may be common in the study population. Controlled clinical trials of betaine supplementation should be conducted in appropriate populations to determine whether correction affects cardiovascular risk.	[Lever, Michael; George, Peter M.; Atkinson, Wendy; Molyneux, Sarah L.; Elmslie, Jane L.; Slow, Sandy] Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand; [Lever, Michael; George, Peter M.; Slow, Sandy; Chambers, Stephen T.] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand; [Richards, A. Mark] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch, New Zealand	Canterbury Health Laboratories; University of Otago; University of Otago	Lever, M (corresponding author), Canterbury Hlth Labs, Clin Biochem Unit, Christchurch, New Zealand.	michael.lever@otago.ac.nz	George, Peter M/A-1315-2013	George, Peter M/0000-0001-9100-3466; Chambers, Stephen/0000-0002-0698-3285; Molyneux, Sarah/0000-0001-6816-5619	National Heart Foundation of New Zealand [1090]; Paykel Trust; Neurological Foundation of New Zealand	National Heart Foundation of New Zealand; Paykel Trust; Neurological Foundation of New Zealand	This study was supported by a grant (1090) from the National Heart Foundation of New Zealand supplemented by grants from the Paykel Trust and the Neurological Foundation of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Danne O, 2010, EXPERT REV MOL DIAGN, V10, P159, DOI 10.1586/ERM.10.2; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; de Zwart FJ, 2003, FOOD CHEM, V83, P197, DOI 10.1016/S0308-8146(03)00063-3; Eklund M, 2005, NUTR RES REV, V18, P31, DOI 10.1079/NRR200493; Hayes KC, 2003, FOOD CHEM TOXICOL, V41, P1685, DOI 10.1016/S0278-6915(03)00196-0; Hwang YH, 2010, J MUSCLE FOODS, V21, P87, DOI 10.1111/j.1745-4573.2009.00169.x; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim SH, 2009, ANAL BIOANAL CHEM, V395, P1117, DOI 10.1007/s00216-009-3054-8; Konstantinova SV, 2008, J NUTR, V138, P914, DOI 10.1093/jn/138.5.914; Lever M, 2005, METABOLISM, V54, P1, DOI 10.1016/j.metabol.2004.07.007; Lever M, 2004, CLIN BIOCHEM, V37, P184, DOI 10.1016/j.clinbiochem.2003.11.004; Lever M, 2007, CLIN BIOCHEM, V40, P1225, DOI 10.1016/j.clinbiochem.2007.05.021; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Lever M, 2009, CARDIOVASC DRUG THER, V23, P395, DOI 10.1007/s10557-009-6188-1; Lever M, 2009, CLIN BIOCHEM, V42, P706, DOI 10.1016/j.clinbiochem.2009.02.001; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lv SW, 2009, EUR J NUTR, V48, P205, DOI 10.1007/s00394-009-0003-4; Martins JM, 2010, EUR J LIPID SCI TECH, V112, P295, DOI 10.1002/ejlt.200900066; Molyneux S, 2007, NUTR RES, V27, P307, DOI 10.1016/j.nutres.2007.04.011; Olthof MR, 2005, PLOS MED, V2, P446, DOI 10.1371/journal.pmed.0020135; Price RK, 2010, J NUTR, V140, P2153, DOI 10.3945/jn.110.126961; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; Schwab U, 2002, AM J CLIN NUTR, V76, P961, DOI 10.1093/ajcn/76.5.961; SCHWAB U, 2010, EUR J CLIN NUTR, P1; Schwahn BC, 2007, ATHEROSCLEROSIS, V195, pE100, DOI 10.1016/j.atherosclerosis.2007.06.030; Slow S, 2009, PHYSIOL RES, V58, P403, DOI 10.33549/physiolres.931569; Sparks JD, 2006, BIOCHEM J, V395, P363, DOI 10.1042/BJ20051966; Storer MK, 2006, J CHROMATOGR A, V1104, P263, DOI 10.1016/j.chroma.2005.11.123; Storer MK, 2006, ANAL CHIM ACTA, V558, P319, DOI 10.1016/j.aca.2005.10.060; Strakova J, 2010, NUTR RES, V30, P492, DOI 10.1016/j.nutres.2010.06.017; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Wang YZ, 2004, ANIM FEED SCI TECH, V116, P151, DOI 10.1016/j.anifeedsci.2004.05.003; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Zeisel SH, 2006, NUTR REV, V64, P77, DOI 10.1111/j.1753-4887.2006.tb00190.x; Zeisel SH, 2003, J NUTR, V133, P1302; Zhan XA, 2006, BRIT POULTRY SCI, V47, P576, DOI 10.1080/00071660600963438; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9	37	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21666	10.1371/journal.pone.0021666	http://dx.doi.org/10.1371/journal.pone.0021666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747945	gold, Green Published, Green Submitted			2022-12-25	WOS:000292293400021
J	Li, HD; Liu, WX; Michalak, M				Li, Hao-Dong; Liu, Wen-Xin; Michalak, Marek			Enhanced Clathrin-Dependent Endocytosis in the Absence of Calnexin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SYNAPTIC VESICLE ENDOCYTOSIS; MEDIATED ENDOCYTOSIS; CHAPERONE CALNEXIN; CALRETICULIN; MEMBRANE; BINDING; PROTEIN; ERP57; MECHANISMS	Background: Calnexin, together with calreticulin, constitute the calnexin/calreticulin cycle. Calnexin is a type I endoplasmic reticulum integral membrane protein and molecular chaperone responsible for the folding and quality control of newly-synthesized (glyco) proteins. The endoplasmic reticulum luminal domain of calnexin is responsible for lectin-like activity and interaction with nascent polypeptide chains. The role of the C-terminal, cytoplasmic portion of calnexin is not clear. Methodology/Principal Findings: Using yeast two hybrid screen and immunoprecipitation techniques, we showed that the Src homology 3-domain growth factor receptor-bound 2-like (Endophilin) interacting protein 1 (SGIP1), a neuronal specific regulator of endocytosis, forms complexes with the C-terminal cytoplasmic domain of calnexin. The calnexin cytoplasmic C-tail interacts with SGIP1 C-terminal domains containing the adaptor complexes medium subunit (Adap-Comp-Sub) region. Calnexin-deficient cells have enhanced clathrin-dependent endocytosis in neuronal cells and mouse neuronal system. This is reversed by expression of full length calnexin or calnexin C-tail. Conclusions/Significance: We show that the effects of SGIP1 and calnexin C-tail on clathrin-dependent endocytosis are due to modulation of the internalization of the receptor-ligand complexes. Enhanced clathrin-dependent endocytosis in the absence of calnexin may contribute to the neurological phenotype of calnexin-deficient mice.	[Li, Hao-Dong; Liu, Wen-Xin; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta	Li, HD (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	marek.michalak@ualberta.ca			Canadian Institutes of Health Research [MOP-15291]; Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Canada; AstraZeneca	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); AstraZeneca(AstraZeneca)	This work was supported by a grant from the Canadian Institutes of Health Research (MOP-15291). H-DL was supported by a postdoctoral fellowship from the Alberta Innovates-Health Solutions, Heart and Stroke Foundation of Canada and AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Coe H, 2008, CELL STRESS CHAPERON, V13, P497, DOI 10.1007/s12192-008-0049-x; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Denzel A, 2002, MOL CELL BIOL, V22, P7398, DOI 10.1128/MCB.22.21.7398-7404.2002; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gloor SM, 2001, BRAIN RES REV, V36, P258, DOI 10.1016/S0165-0173(01)00102-3; JACKSON AP, 1987, NATURE, V326, P154, DOI 10.1038/326154a0; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kraus A, 2010, J BIOL CHEM, V285, P18928, DOI 10.1074/jbc.M110.107201; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Lee W, 2005, BIOCHEM BIOPH RES CO, V338, P1018, DOI 10.1016/j.bbrc.2005.10.041; LENTER M, 1994, J BIOL CHEM, V269, P12263; Liu Jiang, 2003, Biol Res Nurs, V5, P117, DOI 10.1177/1099800403256860; Lozyk MD, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-54; MacDonald PE, 2005, J CELL SCI, V118, P5911, DOI 10.1242/jcs.02685; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; OU WJ, 1992, J BIOL CHEM, V267, P23789; Piddini E, 2003, CURR OPIN CELL BIOL, V15, P474, DOI 10.1016/S0955-0674(03)00072-3; Rappoport JZ, 2008, BIOCHEM J, V412, P415, DOI 10.1042/BJ20080474; Ritter B, 2004, BIOCHEM SOC T, V32, P769, DOI 10.1042/BST0320769; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Rosenbaum EE, 2006, NEURON, V49, P229, DOI 10.1016/j.neuron.2005.12.011; Royle SJ, 2010, TRAFFIC, V11, P1489, DOI 10.1111/j.1600-0854.2010.01104.x; Russell SJ, 2004, J BIOL CHEM, V279, P18861, DOI 10.1074/jbc.M400575200; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Silvennoinen L, 2004, J BIOL CHEM, V279, P13607, DOI 10.1074/jbc.M313054200; Smith SM, 2008, TRENDS NEUROSCI, V31, P559, DOI 10.1016/j.tins.2008.08.005; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takizawa T, 2004, J BIOCHEM, V136, P399, DOI 10.1093/jb/mvh133; TJOELKER LW, 1994, BIOCHEMISTRY-US, V33, P3229, DOI 10.1021/bi00177a013; Trevaskis J, 2005, ENDOCRINOLOGY, V146, P3757, DOI 10.1210/en.2005-0282; Uezu A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703815200; WADA I, 1991, J BIOL CHEM, V266, P19599; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zapun A, 1999, STRUCT FOLD DES, V7, pR173, DOI 10.1016/S0969-2126(99)80112-9; Zuppini A, 2002, BIOCHEMISTRY-US, V41, P2850, DOI 10.1021/bi015967+	46	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21678	10.1371/journal.pone.0021678	http://dx.doi.org/10.1371/journal.pone.0021678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747946	Green Published, gold, Green Submitted			2022-12-25	WOS:000292293400022
J	Scharf, ME; Karl, ZJ; Sethi, A; Boucias, DG				Scharf, Michael E.; Karl, Zachary J.; Sethi, Amit; Boucias, Drion G.			Multiple Levels of Synergistic Collaboration in Termite Lignocellulose Digestion	PLOS ONE			English	Article							RETICULITERMES-FLAVIPES; GENE-EXPRESSION; CELLULASE GENE; GUT; GLUCOSIDASE; HYDROLYSIS; PROTOZOA; GENOME; HOST	In addition to evolving eusocial lifestyles, two equally fascinating aspects of termite biology are their mutualistic relationships with gut symbionts and their use of lignocellulose as a primary nutrition source. Termites are also considered excellent model systems for studying the production of bioethanol and renewable bioenergy from 2nd generation (non-food) feedstocks. While the idea that gut symbionts are the sole contributors to termite lignocellulose digestion has remained popular and compelling, in recent years host contributions to the digestion process have become increasingly apparent. However, the degree to which host and symbiont, and host enzymes, collaborate in lignocellulose digestion remain poorly understood. Also, how digestive enzymes specifically collaborate (i.e., in additive or synergistic ways) is largely unknown. In the present study we undertook translational-genomic studies to gain unprecedented insights into digestion by the lower termite Reticulitermes flavipes and its symbiotic gut flora. We used a combination of native gut tissue preparations and recombinant enzymes derived from the host gut transcriptome to identify synergistic collaborations between host and symbiont, and also among enzymes produced exclusively by the host termite. Our findings provide important new evidence of synergistic collaboration among enzymes in the release of fermentable monosaccharides from wood lignocellulose. These monosaccharides (glucose and pentoses) are highly relevant to 2(nd)-generation bioethanol production. We also show that, although significant digestion capabilities occur in host termite tissues, catalytic tradeoffs exist that apparently favor mutualism with symbiotic lignocellulose-digesting microbes. These findings contribute important new insights towards the development of termite-derived biofuel processing biotechnologies and shed new light on selective forces that likely favored symbiosis and, subsequently, group living in primitive termites and their cockroach ancestors.	[Scharf, Michael E.; Karl, Zachary J.; Boucias, Drion G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA; [Scharf, Michael E.; Boucias, Drion G.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	State University System of Florida; University of Florida; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Scharf, ME (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	mscharf@purdue.edu			Consortium for Plant Biotechnology Research Inc.; Department of Energy (DOE) [DE-FG36-02GO12026]; United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative [2009-05245]; Phase I and II DOE-Small Business Innovation Research [DE-FG02-08ER85063, DE-85538 S08-II]	Consortium for Plant Biotechnology Research Inc.; Department of Energy (DOE)(United States Department of Energy (DOE)); United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); Phase I and II DOE-Small Business Innovation Research	Funding was provided by The Consortium for Plant Biotechnology Research Inc. (http://www.cpbr.org/) and the Department of Energy (DOE) (http://www.energy.gov/) prime agreement no. DE-FG36-02GO12026 to MES and DGB, the United States Department of Agriculture-National Institute of Food and Agriculture-Agriculture and Food Research Initiative (http://www.nifa.usda.gov/funding/rfas/afri.html) grant no. 2009-05245 to MES and DGB, and Phase I and II DOE-Small Business Innovation Research (http://www.energy.gov/) grant nos. DE-FG02-08ER85063 and DE-85538 S08-II to Chesapeake-PERL Inc. (Savage, MD) and MES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support of this research does not constitute an endorsement by the DOE or by The Consortium for Plant Biotechnology Research, Inc. of the views expressed in this publication. Chesapeake-PERL Inc. played a role in recombinant protein production, preparation, and purification but has voluntarily declined co-authorship.	BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Burnum KE, 2011, ISME J, V5, P161, DOI 10.1038/ismej.2010.97; Cleveland L. R., 1934, Mem Amer Acad Arts Sci Menasha, V17, P185; CLEVELAND L. R., 1928, BIOL BULL MARINE BIOL LAB, V54, P231, DOI 10.2307/1536855; Cleveland LR, 1923, P NATL ACAD SCI USA, V9, P424, DOI 10.1073/pnas.9.12.424; CLEVELAND LR, 1924, BIOL BULL, V46, P177; Coy MR, 2010, INSECT BIOCHEM MOLEC, V40, P723, DOI 10.1016/j.ibmb.2010.07.004; DESCHATELETS L, 1986, APPL MICROBIOL BIOT, V24, P379, DOI 10.1007/BF00294594; Dittmer NT, 2010, INSECT BIOCHEM MOLEC, V40, P179, DOI 10.1016/j.ibmb.2010.02.006; GUSAKOV AV, 1984, ENZYME MICROB TECH, V6, P275, DOI 10.1016/0141-0229(84)90130-3; Hongoh Y, 2008, SCIENCE, V322, P1108, DOI 10.1126/science.1165578; Hongoh Y, 2008, P NATL ACAD SCI USA, V105, P5555, DOI 10.1073/pnas.0801389105; Hungate RE, 1938, ECOLOGY, V19, P1, DOI 10.2307/1930363; Mathews C.K., 1990, BIOCHEMISTRY-US, V3d; Nalepa Christine A., 1994, P57; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; ROE JH, 1948, J BIOL CHEM, V173, P507; Scharf ME, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r62; Scharf ME, 2010, INSECT BIOCHEM MOLEC, V40, P611, DOI 10.1016/j.ibmb.2010.06.002; Scharf ME, 2008, BIOFUEL BIOPROD BIOR, V2, P540, DOI 10.1002/bbb.107; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Thorne BL, 2003, ANNU REV ENTOMOL, V48, P283, DOI 10.1146/annurev.ento.48.091801.112611; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527; Wilson E.O., 1971, INSECT SOC; Xiao ZZ, 2004, APPL BIOCHEM BIOTECH, V113, P1115, DOI 10.1385/ABAB:115:1-3:1115; Yapi DYA, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0401; Zhou XG, 2007, GENE, V395, P29, DOI 10.1016/j.gene.2007.01.004; Zhou XG, 2010, ARCH INSECT BIOCHEM, V74, P147, DOI 10.1002/arch.20368; [No title captured], DOI DOI 10.1021/BA-1984-0207.CH002	33	80	91	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21709	10.1371/journal.pone.0021709	http://dx.doi.org/10.1371/journal.pone.0021709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747950	Green Submitted, gold, Green Published			2022-12-25	WOS:000292293400026
J	Lehne, B; Lewis, CM; Schlitt, T				Lehne, Benjamin; Lewis, Cathryn M.; Schlitt, Thomas			From SNPs to Genes: Disease Association at the Gene Level	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-DYSTROGLYCAN; PATHWAY ANALYSIS; COMMON DISEASES; CROHNS-DISEASE; SUSCEPTIBILITY; IDENTIFICATION; VARIANTS; MUTATION; RECEPTOR	Interpreting Genome-Wide Association Studies (GWAS) at a gene level is an important step towards understanding the molecular processes that lead to disease. In order to incorporate prior biological knowledge such as pathways and protein interactions in the analysis of GWAS data it is necessary to derive one measure of association for each gene. We compare three different methods to obtain gene-wide test statistics from Single Nucleotide Polymorphism (SNP) based association data: choosing the test statistic from the most significant SNP; the mean test statistics of all SNPs; and the mean of the top quartile of all test statistics. We demonstrate that the gene-wide test statistics can be controlled for the number of SNPs within each gene and show that all three methods perform considerably better than expected by chance at identifying genes with confirmed associations. By applying each method to GWAS data for Crohn's Disease and Type 1 Diabetes we identified new potential disease genes.	[Lehne, Benjamin; Lewis, Cathryn M.; Schlitt, Thomas] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Lehne, B (corresponding author), Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England.	thomas.schlitt@kcl.ac.uk	Schlitt, Thomas/GWQ-8928-2022; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010; Schlitt, Thomas/F-2123-2010	Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Schlitt, Thomas/0000-0002-0508-3971	King's College London (KCL); Wellcome Trust [076113, 085475]; Medical Research Council [G9817803B] Funding Source: researchfish	King's College London (KCL); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by King's College London (KCL) and the KCL Systems Biomedicine Graduate Program (SBGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the Wellcome Trust Case-Control Consortium was provided by the Wellcome Trust under award 076113 and 085475.	[Anonymous], 1932, STAT METHODS RES WOR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballard David H, 2009, BMC Proc, V3 Suppl 7, pS91; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Brorsson C, 2009, DIABETES OBES METAB, V11, P60, DOI 10.1111/j.1463-1326.2008.01004.x; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Cui YH, 2008, GENETICS, V179, P637, DOI 10.1534/genetics.107.082370; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hong MG, 2009, HUM GENET, V126, P289, DOI 10.1007/s00439-009-0676-z; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lehne B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-92; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MOSKVINA V, 2008, MOL PSYCHIAT; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Perry JRB, 2009, DIABETES, V58, P1463, DOI 10.2337/db08-1378; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Warth A, 2008, MED HYPOTHESES, V70, P369, DOI 10.1016/j.mehy.2007.05.013; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	47	54	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e20133	10.1371/journal.pone.0020133	http://dx.doi.org/10.1371/journal.pone.0020133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738570	gold, Green Published, Green Submitted			2022-12-25	WOS:000292291800002
J	Pinho, AJ; Ferreira, PJSG; Neves, AJR; Bastos, CAC				Pinho, Armando J.; Ferreira, Paulo J. S. G.; Neves, Antonio J. R.; Bastos, Carlos A. C.			On the Representability of Complete Genomes by Multiple Competing Finite-Context (Markov) Models	PLOS ONE			English	Article							DNA-SEQUENCES; COMPRESSION; ALGORITHM; IDENTIFICATION; GENES; TOOL	A finite-context (Markov) model of order k yields the probability distribution of the next symbol in a sequence of symbols, given the recent past up to depth k. Markov modeling has long been applied to DNA sequences, for example to find gene-coding regions. With the first studies came the discovery that DNA sequences are non-stationary: distinct regions require distinct model orders. Since then, Markov and hidden Markov models have been extensively used to describe the gene structure of prokaryotes and eukaryotes. However, to our knowledge, a comprehensive study about the potential of Markov models to describe complete genomes is still lacking. We address this gap in this paper. Our approach relies on (i) multiple competing Markov models of different orders (ii) careful programming techniques that allow orders as large as sixteen (iii) adequate inverted repeat handling (iv) probability estimates suited to the wide range of context depths used. To measure how well a model fits the data at a particular position in the sequence we use the negative logarithm of the probability estimate at that position. The measure yields information profiles of the sequence, which are of independent interest. The average over the entire sequence, which amounts to the average number of bits per base needed to describe the sequence, is used as a global performance measure. Our main conclusion is that, from the probabilistic or information theoretic point of view and according to this performance measure, multiple competing Markov models explain entire genomes almost as well or even better than state-of-the-art DNA compression methods, such as XM, which rely on very different statistical models. This is surprising, because Markov models are local (short-range), contrasting with the statistical models underlying other methods, where the extensive data repetitions in DNA sequences is explored, and therefore have a non-local character.	[Pinho, Armando J.; Ferreira, Paulo J. S. G.; Neves, Antonio J. R.; Bastos, Carlos A. C.] Univ Aveiro, Signal Proc Lab, IEETA DETI, P-3800 Aveiro, Portugal	Universidade de Aveiro	Pinho, AJ (corresponding author), Univ Aveiro, Signal Proc Lab, IEETA DETI, P-3800 Aveiro, Portugal.	ap@ua.pt	Neves, Antonio J. R./AAF-9857-2019; Pinho, Armando J/A-2309-2012	Neves, Antonio J. R./0000-0001-5433-6667; Ferreira, Paulo/0000-0002-5147-0948; Bastos, Carlos/0000-0001-6869-4713; Pinho, Armando/0000-0002-9164-0016	Fundacao para a Ciencia e Tecnologia (FCT) [FCOMP-01-0124-FEDER-007252, PTDC/EIA/72569/2006, FCOMP-01-0124-FEDER-010099, PTDC/EIA-EIA/103099/2008]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported in part by the grants with the COMPETE reference FCOMP-01-0124-FEDER-007252 (FCT reference PTDC/EIA/72569/2006), and FCOMP-01-0124-FEDER-010099 (FCT reference PTDC/EIA-EIA/103099/2008), Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P8; ALLISON L, 1990, B MATH BIOL, V52, P431, DOI 10.1016/S0092-8240(05)80219-8; Bayes T., 1997, A M F R S PHILOS T R, V53, P370, DOI DOI 10.1098/RSTL.1763.0053; Behzadi B, 2005, LECT NOTES COMPUT SC, V3537, P190; BORODOVSKII MY, 1986, MOL BIOL+, V20, P833; BORODOVSKII MY, 1986, MOL BIOL+, V20, P826; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; Brown M, 1993, Proc Int Conf Intell Syst Mol Biol, V1, P47; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cao MD, 2007, IEEE DATA COMPR CONF, P43; Chen X, 2001, IEEE ENG MED BIOL, V20, P61, DOI 10.1109/51.940049; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dix TI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S10; Ferragina P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-252; Giancarlo R, 2009, BIOINFORMATICS, V25, P1575, DOI 10.1093/bioinformatics/btp117; Grumbach S, 1993, P IEEE DAT COMPR C D, P340; HARDY GF, 1889, COMMUNICATION, P457; Johnson W. E., 1932, MIND, V41, P409, DOI DOI 10.1093/MIND/XLI.164.409; Korodi G, 2005, ACM T INFORM SYST, V23, P3, DOI 10.1145/1055709.1055711; Korodi G, 2007, IEEE DATA COMPR CONF, P33; Laplace PS., 1774, MEMOIRES ACAD ROYALE, V6, P621; Liu ZQ, 2007, SPRINGER SER OPTIM A, V7, P47; Loewenstern D, 1997, IEEE DATA COMPR CONF, P151, DOI 10.1109/DCC.1997.581998; Manzini G, 2004, SOFTWARE PRACT EXPER, V34, P1397, DOI 10.1002/spe.619; MILOSAVLJEVIC A, 1993, COMPUT APPL BIOSCI, V9, P407; Minh DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-599; Pinho A. J., 2008, P 16 EUR SIGN PROC C; RHO M, 2010, NUCL ACIDS RES; Richard H, 2003, NUCLEIC ACIDS RES, V31, P3679, DOI 10.1093/nar/gkg613; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; RIVALS E, 1996, P DAT COMPR C DCC 96; Robelin D, 2003, NUCLEIC ACIDS RES, V31, P3669, DOI 10.1093/nar/gkg596; SALAMON P, 1992, COMPUT CHEM, V16, P117, DOI 10.1016/0097-8485(92)80038-2; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854; Sayood K., 2006, INTRO DATA COMPRESSI; Sjolander K, 1996, COMPUT APPL BIOSCI, V12, P327; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Tabus I, 2003, IEEE DATA COMPR CONF, P253; TAVARE S, 1989, B MATH BIOL, V51, P95; Venn J., 1876, LOGIC CHANCE, V2nd ed.; Venn J., 1866, LOGIC CHANCE; Venn J., 1888, LOGIC CHANCE; WHITTAKER ET, 1920, T FACULTY ACTUARIES, V8, P163; Zabell S.L., 1989, ERKENNTNIS, V31, P283, DOI DOI 10.1007/BF01236567; ZABELL SL, 1982, ANN STAT, V10, P1091; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275; ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714	49	40	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21588	10.1371/journal.pone.0021588	http://dx.doi.org/10.1371/journal.pone.0021588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738720	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800025
J	Aguirre, B; Costas, M; Cabrera, N; Mendoza-Hernandez, G; Helseth, DL; Fernandez, P; de Gomez-Puyou, MT; Perez-Montfort, R; Torres-Larios, A; Puyou, AG				Aguirre, Beatriz; Costas, Miguel; Cabrera, Nallely; Mendoza-Hernandez, Guillermo; Helseth, Donald L., Jr.; Fernandez, Paulette; Tuena de Gomez-Puyou, Marietta; Perez-Montfort, Ruy; Torres-Larios, Alfredo; Gomez Puyou, Armando			A Ribosomal Misincorporation of Lys for Arg in Human Triosephosphate Isomerase Expressed in Escherichia coli Gives Rise to Two Protein Populations	PLOS ONE			English	Article							GENETIC-CODE; SACCHAROMYCES-CEREVISIAE; MISSENSE ERRORS; GIARDIA-LAMBLIA; AGA CODONS; ARGININE; AMINO; MISTRANSLATION; LEVEL; TIM	We previously observed that human homodimeric triosephosphate isomerase (HsTIM) expressed in Escherichia coli and purified to apparent homogeneity exhibits two significantly different thermal transitions. A detailed exploration of the phenomenon showed that the preparations contain two proteins; one has the expected theoretical mass, while the mass of the other is 28 Da lower. The two proteins were separated by size exclusion chromatography in 3 M urea. Both proteins correspond to HsTIM as shown by Tandem Mass Spectrometry (LC/ESI-MS/MS). The two proteins were present in nearly equimolar amounts under certain growth conditions. They were catalytically active, but differed in molecular mass, thermostability, susceptibility to urea and proteinase K. An analysis of the nucleotides in the human TIM gene revealed the presence of six codons that are not commonly used in E. coli. We examined if they were related to the formation of the two proteins. We found that expression of the enzyme in a strain that contains extra copies of genes that encode for tRNAs that frequently limit translation of heterologous proteins (Arg, Ile, Leu), as well as silent mutations of two consecutive rare Arg codons (positions 98 and 99), led to the exclusive production of the more stable protein. Further analysis by LC/ESI-MS/MS showed that the 28 Da mass difference is due to the substitution of a Lys for an Arg residue at position 99. Overall, our work shows that two proteins with different biochemical and biophysical properties that coexist in the same cell environment are translated from the same nucleotide sequence frame.	[Aguirre, Beatriz; Cabrera, Nallely; Fernandez, Paulette; Tuena de Gomez-Puyou, Marietta; Perez-Montfort, Ruy; Torres-Larios, Alfredo; Gomez Puyou, Armando] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico; [Costas, Miguel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim Fis, Lab Biofis Quim, Mexico City 04510, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Helseth, Donald L., Jr.] Univ Illinois, CBC RRC Prote & Informat Serv, Chicago, IL USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Aguirre, B (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico.	torres@ifc.unam.mx; apuyou@ifc.unam.mx		Costas, Miguel/0000-0001-8604-6381; Torres-Larios, Alfredo/0000-0002-0702-350X; Cabrera Gonzalez, Elizabeth Nallely/0000-0001-8766-6996; Perez-Montfort, Ruy/0000-0003-0810-1159; FERNANDEZ-CARDENAS, Laura Paulette/0000-0002-4976-6467	Consejo Nacional de Ciencia y Tecnologia [60127-Q, 99844]; Universidad Nacional Autonoma de Mexico [IN202910, IN104210]; Instituto de Ciencia y Tecnologia del Distrito Federal [PIFUTP09-279, ICyTDF/304/2009]; Chicago Community Trust	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal; Chicago Community Trust	This work was supported by Consejo Nacional de Ciencia y Tecnologia grants 60127-Q to AT-L and 99844 to MC, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT) grants IN202910 to AT-L and IN104210 to MC, and Instituto de Ciencia y Tecnologia del Distrito Federal grants PIFUTP09-279 to AT-L and ICyTDF/304/2009 to RPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ESI services were provided by the CBC-UIC Research Resources Center Proteomics and Informatics Services Facility, which was established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium. The technical assistance of Selma Diaz Mazariegos is greatly appreciated. We gratefully acknowledge stimulating discussions with Dr. Jose Manuel Sanchez Ruiz at the early stages of this work.	Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; Calderone TL, 1996, J MOL BIOL, V262, P407, DOI 10.1006/jmbi.1996.0524; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; EDELMANN P, 1977, CELL, V10, P131, DOI 10.1016/0092-8674(77)90147-7; Forman MD, 1998, PROTEIN SCI, V7, P500; Freeland SJ, 1998, J MOL EVOL, V47, P238, DOI 10.1007/PL00006381; Gayathri P, 2007, ACTA CRYSTALLOGR D, V63, P206, DOI 10.1107/S0907444906046488; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Goldsmith M, 2009, P NATL ACAD SCI USA, V106, P6197, DOI 10.1073/pnas.0809506106; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Hernandez-Alcantara G, 2008, BBA-PROTEINS PROTEOM, V1784, P1493, DOI 10.1016/j.bbapap.2008.05.016; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kinter M., 2000, PROTEIN SEQUENCING I, DOI 10.1002/0471721980; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; LAUGHREA M, 1987, EUR J BIOCHEM, V169, P59, DOI 10.1111/j.1432-1033.1987.tb13580.x; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Lopez-Velazquez G, 2004, PROTEINS, V55, P824, DOI 10.1002/prot.20097; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Maes D, 1999, PROTEINS, V37, P441, DOI 10.1002/(SICI)1097-0134(19991115)37:3<441::AID-PROT11>3.3.CO;2-Z; Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174; *MATR SCI, SEQ DAT SET UT; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; MCPHERSON DT, 1988, NUCLEIC ACIDS RES, V16, P4111, DOI 10.1093/nar/16.9.4111; Meyerovich M, 2010, P NATL ACAD SCI USA, V107, P11543, DOI 10.1073/pnas.0912989107; Mottaz A, 2010, BIOINFORMATICS, V26, P851, DOI 10.1093/bioinformatics/btq028; Moura GR, 2009, CURR OPIN MICROBIOL, V12, P631, DOI 10.1016/j.mib.2009.09.004; Murakami H, 2009, NAT STRUCT MOL BIOL, V16, P353, DOI 10.1038/nsmb.1580; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PARKER J, 1989, MICROBIOL REV, V53, P273, DOI 10.1128/MMBR.53.3.273-298.1989; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Powers ET, 2008, CELL, V134, P204, DOI 10.1016/j.cell.2008.07.005; Rodriguez-Almazan C, 2008, J BIOL CHEM, V283, P23254, DOI 10.1074/jbc.M802145200; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; SEETHARAM R, 1988, BIOCHEM BIOPH RES CO, V155, P518, DOI 10.1016/S0006-291X(88)81117-3; STARK GR, 1965, BIOCHEMISTRY-US, V4, P1030, DOI 10.1021/bi00882a008; Szaflarski W, 2008, J MOL BIOL, V380, P193, DOI 10.1016/j.jmb.2008.04.060; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; Yu XC, 2009, ANAL CHEM, V81, P9282, DOI 10.1021/ac901541h; SWISSKNIFE PERL MODU; VARSPLIC UTILITY ALT	48	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21035	10.1371/journal.pone.0021035	http://dx.doi.org/10.1371/journal.pone.0021035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738601	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800009
J	Buonanno, M; de Toledo, SM; Azzam, EI				Buonanno, Manuela; de Toledo, Sonia M.; Azzam, Edouard I.			Increased Frequency of Spontaneous Neoplastic Transformation in Progeny of Bystander Cells from Cultures Exposed to Densely Ionizing Radiation	PLOS ONE			English	Article							CLUSTERED DNA DAMAGES; IN-VITRO; X-RAYS; POSTCONFLUENCE INHIBITION; ADAPTIVE RESPONSE; HUMAN FIBROBLASTS; ALPHA-PARTICLES; CANCER; EXPRESSION; DEPENDENCE	An increased risk of carcinogenesis caused by exposure to space radiation during prolonged space travel is a limiting factor for human space exploration. Typically, astronauts are exposed to low fluences of ionizing particles that target only a few cells in a tissue at any one time. The propagation of stressful effects from irradiated to neighboring bystander cells and their transmission to progeny cells would be of importance in estimates of the health risks of exposure to space radiation. With relevance to the risk of carcinogenesis, we investigated, in model C3H 10T1/2 mouse embryo fibroblasts (MEFs), modulation of the spontaneous frequency of neoplastic transformation in the progeny of bystander MEFs that had been in co-culture 10 population doublings earlier with MEFs exposed to moderate doses of densely ionizing iron ions (1 GeV/nucleon) or sparsely ionizing protons (1 GeV). An increase (P<0.05) in neoplastic transformation frequency, likely mediated by intercellular communication through gap junctions, was observed in the progeny of bystander cells that had been in co-culture with cells irradiated with iron ions, but not with protons.	[Buonanno, Manuela; de Toledo, Sonia M.; Azzam, Edouard I.] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Canc, Dept Radiol, Newark, NJ 07103 USA; [Buonanno, Manuela; Azzam, Edouard I.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Buonanno, M (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Canc, Dept Radiol, Newark, NJ 07103 USA.	azzamei@umdnj.edu	buonanno, manuela/AAM-1588-2020	buonanno, manuela/0000-0002-3455-3602	National Aeronautical Space Radiation Administration (NASA) [NNJ06HD91G]; National Institute of Health [CA049062]; NATIONAL CANCER INSTITUTE [P01CA049062] Funding Source: NIH RePORTER	National Aeronautical Space Radiation Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by Grant NNJ06HD91G from the National Aeronautical Space Radiation Administration (NASA) (www.nasa.gov) and by Grant CA049062 from the National Institute of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUTSAVAPROMPORN N, 2011, J RAD RES IN PRESS; Autsavapromporn N, 2011, RADIAT RES, V175, P347, DOI 10.1667/RR2372.1; Azzam EI, 1996, RADIAT RES, V146, P369, DOI 10.2307/3579298; AZZAM EI, 1994, RADIAT RES, V138, pS28, DOI 10.2307/3578755; Azzam EI, 2003, CANCER RES, V63, P7128; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; BALCERKUBICZEK EK, 1987, INT J RADIAT BIOL, V51, P219, DOI 10.1080/09553008714550721; BRENNER DJ, 1995, RADIAT RES, V142, P61, DOI 10.2307/3578967; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; Chappell LJ, 2010, RADIAT RES, V174, P691, DOI 10.1667/RR2204.1; CHARLTON DE, 1991, INT J RADIAT BIOL, V59, P447, DOI 10.1080/09553009114550401; Committee on the Evaluation of Radiation Shielding for Space Exploration N. R. C, 2008, MAN SPAC RAD RISK NE; Cucinotta FA, 2000, RADIAT RES, V153, P459, DOI 10.1667/0033-7587(2000)153[0459:MFRDOF]2.0.CO;2; Cucinotta FA, 2006, LANCET ONCOL, V7, P431, DOI 10.1016/S1470-2045(06)70695-7; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Durante M, 2010, NAT REV CLIN ONCOL, V7, P37, DOI 10.1038/nrclinonc.2009.183; Elmore E, 2006, RADIAT RES, V166, P832, DOI 10.1667/RR0682.1; Elmore E, 2009, RADIAT RES, V171, P764, DOI 10.1667/RR1673.1; Georgakilas AG, 2008, MOL BIOSYST, V4, P30, DOI 10.1039/b713178j; Gerashchenko BI, 2005, CYTOM PART A, V66A, P62, DOI 10.1002/cyto.a.20150; GOODHEAD DT, 1988, HEALTH PHYS, V55, P231, DOI 10.1097/00004032-198808000-00015; GRAY LH, 1953, BRIT J RADIOL, V26, P638, DOI 10.1259/0007-1285-26-312-638; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Little JB, 2003, ONCOGENE, V22, P6978, DOI 10.1038/sj.onc.1206988; Miller RC, 1999, P NATL ACAD SCI USA, V96, P19, DOI 10.1073/pnas.96.1.19; NCRP, 2006, 153 NCRP; Okada T, 2010, J RADIAT RES, V51, P355, DOI 10.1269/jrr.10016; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; RAAPHORST GP, 1986, INT J RADIAT BIOL, V49, P383; Redpath JL, 1998, RADIAT RES, V149, P517, DOI 10.2307/3579792; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; RHIM JS, 1993, CRIT REV ONCOGENESIS, V4, P313; RUECKERT RR, 1960, CANCER RES, V20, P944; Sawant SG, 2001, RADIAT RES, V155, P397, DOI 10.1667/0033-7587(2001)155[0397:TBEIRO]2.0.CO;2; SCHILLACI ME, 1989, RADIAT RES, V118, P83, DOI 10.2307/3577424; Shao CL, 2003, FASEB J, V17, P1422, DOI 10.1096/fj.02-1115com; Shore RE, 2009, HEALTH PHYS, V97, P481, DOI 10.1097/HP.0b013e3181ab98d9; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Sutherland BM, 2001, PHYS MEDICA, V17, P202; Sutherland BM, 2001, RADIAT PROT DOSIM, V97, P33, DOI 10.1093/oxfordjournals.rpd.a006635; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; Trosko JE, 2002, CURR DRUG TARGETS, V3, P465, DOI 10.2174/1389450023347371; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1	49	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21540	10.1371/journal.pone.0021540	http://dx.doi.org/10.1371/journal.pone.0021540			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738697	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800035
J	Franciosa, G; Scalfaro, C; Di Bonito, P; Vitale, M; Aureli, P				Franciosa, Giovanna; Scalfaro, Concetta; Di Bonito, Paola; Vitale, Marco; Aureli, Paolo			Identification of Novel Linear Megaplasmids Carrying a beta-Lactamase Gene in Neurotoxigenic Clostridium butyricum Type E Strains	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; INFANT BOTULISM; COMPLEX GENES; TOXIN; OUTBREAK; SIZE	Since the first isolation of type E botulinum toxin-producing Clostridium butyricum from two infant botulism cases in Italy in 1984, this peculiar microorganism has been implicated in different forms of botulism worldwide. By applying particular pulsed-field gel electrophoresis run conditions, we were able to show for the first time that ten neurotoxigenic C. butyricum type E strains originated from Italy and China have linear megaplasmids in their genomes. At least four different megaplasmid sizes were identified among the ten neurotoxigenic C. butyricum type E strains. Each isolate displayed a single sized megaplasmid that was shown to possess a linear structure by ATP-dependent exonuclease digestion. Some of the neurotoxigenic C. butyricum type E strains possessed additional smaller circular plasmids. In order to investigate the genetic content of the newly identified megaplasmids, selected gene probes were designed and used in Southern hybridization experiments. Our results revealed that the type E botulinum neurotoxin gene was chromosome-located in all neurotoxigenic C. butyricum type E strains. Similar results were obtained with the 16S rRNA, the tetracycline tet(P) and the lincomycin resistance protein lmrB gene probes. A specific mobA gene probe only hybridized to the smaller plasmids of the Italian C. butyricum type E strains. Of note, a beta-lactamase gene probe hybridized to the megaplasmids of eight neurotoxigenic C. butyricum type E strains, of which seven from clinical sources and the remaining one from a food implicated in foodborne botulism, whereas this beta-lactam antibiotic resistance gene was absent form the megaplasmids of the two soil strains examined. The widespread occurrence among C. butyricum type E strains associated to human disease of linear megaplasmids harboring an antibiotic resistance gene strongly suggests that the megaplasmids could have played an important role in the emergence of C. butyricum type E as a human pathogen.	[Franciosa, Giovanna; Scalfaro, Concetta; Vitale, Marco; Aureli, Paolo] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Di Bonito, Paola] Ist Super Sanita, Dept Infect Parasyt & Immunomediated Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Franciosa, G (corresponding author), Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.	giovanna.franciosa@iss.it	Di Bonito, Paola/AAI-3583-2021; Di Bonito, Paola/A-6675-2013; SCALFARO, CONCETTA/C-7041-2015; FRANCIOSA, GIOVANNA/C-7040-2015	Di Bonito, Paola/0000-0002-4737-374X; Di Bonito, Paola/0000-0002-4737-374X; SCALFARO, CONCETTA/0000-0001-8626-7563; FRANCIOSA, GIOVANNA/0000-0003-1520-4826	Istituto Superiore di Sanita, Rome, Italy	Istituto Superiore di Sanita, Rome, Italy	Funding was provided by the Istituto Superiore di Sanita, Rome, Italy (www.iss.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, PEDIATR NEUROL, V38, P55, DOI 10.1016/j.pediatrneurol.2007.08.013; Anniballi F, 2002, J FOOD PROTECT, V65, P1267, DOI 10.4315/0362-028X-65.8.1267; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; AURELI P, 1986, J INFECT DIS, V154, P207, DOI 10.1093/infdis/154.2.207; Bruggemann H, 2005, CURR OPIN MICROBIOL, V8, P601, DOI 10.1016/j.mib.2005.08.006; CASHORE WJ, 1981, J PEDIATR-US, V98, P308, DOI 10.1016/S0022-3476(81)80667-1; Chaudhry R, 1998, EMERG INFECT DIS, V4, P506, DOI 10.3201/eid0403.980347; DYKES JK, 2008, 45 INT RES COORD COM; Fenicia L, 2002, EUR J CLIN MICROBIOL, V21, P736, DOI 10.1007/s10096-002-0816-z; Fenicia L, 1999, CLIN INFECT DIS, V29, P1381, DOI 10.1086/313497; FENICIA L, 2008, CLOSTR BOT EP DIAGN; FRANCIOSA G, 1994, J CLIN MICROBIOL, V32, P1911, DOI 10.1128/JCM.32.8.1911-1917.1994; Franciosa G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004829; HAUSER D, 1992, FEMS MICROBIOL LETT, V99, P251, DOI 10.1111/j.1574-6968.1992.tb05576.x; Herschleb J, 2007, NAT PROTOC, V2, P677, DOI 10.1038/nprot.2007.94; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Hill KK, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-66; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; HUTSON RA, 1993, FEMS MICROBIOL LETT, V108, P103, DOI 10.1016/0378-1097(93)90495-N; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; KRAWIEC S, 1990, MICROBIOL REV, V54, P502, DOI 10.1128/MMBR.54.4.502-539.1990; LEVENE SD, 1987, P NATL ACAD SCI USA, V84, P4054, DOI 10.1073/pnas.84.12.4054; Li Y, 2007, J BACTERIOL, V189, P6128, DOI 10.1128/JB.00447-07; Marshall KM, 2007, BIOCHEM BIOPH RES CO, V361, P49, DOI 10.1016/j.bbrc.2007.06.166; Marshall KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011087; MCCROSKEY LM, 1986, J CLIN MICROBIOL, V23, P201, DOI 10.1128/JCM.23.1.201-202.1986; Meng X, 1999, J MED MICROBIOL, V48, P133, DOI 10.1099/00222615-48-2-133; Meng XQ, 1997, J CLIN MICROBIOL, V35, P2160, DOI 10.1128/JCM.35.8.2160-2162.1997; Meyer R, 2009, PLASMID, V62, P57, DOI 10.1016/j.plasmid.2009.05.001; Nakanishi S, 2010, ANAEROBE, V16, P253, DOI 10.1016/j.anaerobe.2009.10.002; Obladen M, 2009, NEONATOLOGY, V96, P203, DOI 10.1159/000215590; Pourshaban M, 2002, FEMS MICROBIOL LETT, V214, P119, DOI 10.1016/S0378-1097(02)00849-2; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Seki H, 2003, PEDIATR INT, V45, P86, DOI 10.1046/j.1442-200X.2003.01671.x; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; SUEN JC, 1988, J CLIN MICROBIOL, V26, P2191, DOI 10.1128/JCM.26.10.2191-2192.1988; Umeda K, 2009, J CLIN MICROBIOL, V47, P2720, DOI 10.1128/JCM.00077-09; Van Immerseel F, 2010, J MED MICROBIOL, V59, P141, DOI 10.1099/jmm.0.017541-0; Wang XM, 2000, APPL ENVIRON MICROB, V66, P4992, DOI 10.1128/AEM.66.11.4992-4997.2000; Zhang CH, 2009, CURR MICROBIOL, V59, P656, DOI 10.1007/s00284-009-9491-y; ZHOU Y, 1993, APPL ENVIRON MICROB, V59, P3825, DOI 10.1128/AEM.59.11.3825-3831.1993; ZHOU Y, 1995, INFECT IMMUN, V63, P2987	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21706	10.1371/journal.pone.0021706	http://dx.doi.org/10.1371/journal.pone.0021706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738770	Green Published, gold, Green Submitted			2022-12-25	WOS:000292142800061
J	Nelson, CD; Nonnecke, BJ; Reinhardt, TA; Waters, WR; Beitz, DC; Lippolis, JD				Nelson, Corwin D.; Nonnecke, Brian J.; Reinhardt, Timothy A.; Waters, W. Ray; Beitz, Donald C.; Lippolis, John D.			Regulation of Mycobacterium-Specific Mononuclear Cell Responses by 25-Hydroxyvitamin D-3	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; VITAMIN-D DEFICIENCY; CD4 T-CELLS; 1,25-DIHYDROXYVITAMIN D-3; MULTIPLE-SCLEROSIS; IN-VITRO; BOVINE TUBERCULOSIS; IMMUNE REGULATION; GENE-EXPRESSION; D-RECEPTOR	The active vitamin D metabolite, 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), has been shown to be an important regulator of innate and adaptive immune function. In addition, synthesis of 1,25(OH)(2)D-3 from 25-hydroxyvitamin D-3 (25(OH)D-3) by the enzyme 1 alpha-hydroxylase in monocytes upon activation by TLR signaling has been found to regulate innate immune responses of monocytes in an intracrine fashion. In this study we wanted to determine what cells expressed 1 alpha-hydroxylase in stimulated peripheral blood mononuclear cell (PBMC) cultures and if conversion of 25(OH)D-3 to 1,25(OH)(2)D-3 in PBMC cultures regulated antigen-specific immune responses. Initially, we found that stimulation of PBMCs from animals vaccinated with Mycobacterium bovis (M. bovis) BCG with purified protein derivative of M. bovis (M. bovis PPD) induced 1 alpha-hydroxylase gene expression and that treatment with a physiological concentration of 25(OH)D-3 down-regulated IFN-gamma and IL-17F gene expression. Next, we stimulated PBMCs from M. bovis BCG-vaccinated and non-vaccinated cattle with M. bovis PPD and sorted them by FACS according to surface markers for monocytes/macrophages (CD14), B cells (IgM), and T cells (CD3). Sorting the PBMCs revealed that 1 alpha-hydroxylase expression was induced in the monocytes and B cells, but not in the T cells. Furthermore, treatment of stimulated PBMCs with 25(OH) D-3 down-regulated antigen-specific IFN-gamma and IL-17F responses in the T cells, even though 1 alpha-hydroxylase expression was not induced in the T cells. Based on evidence of no T cell 1a-hydroxylase we hypothesize that activated monocytes and B cells synthesize 1,25(OH)(2)D-3 and that 1,25(OH)(2)D-3 down-regulates antigen-specific expression oIFN-gamma and IL-17F in T cells in a paracrine fashion.	[Nelson, Corwin D.; Nonnecke, Brian J.; Reinhardt, Timothy A.; Lippolis, John D.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Waters, W. Ray] ARS, Bacterial Dis Livestock Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Nelson, Corwin D.; Beitz, Donald C.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Beitz, Donald C.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Nelson, CD (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	john.lippolis@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509; Nelson, Corwin/0000-0003-0195-5610; Lippolis, John/0000-0003-2314-4384	United States Department of Agriculture, Agriculture Research Service [3625-32000-094-00]	United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture, Agriculture Research Service Internal Funding, Project Number: 3625-32000-094-00. The study design, data collection and analysis, decision to publish, or preparation of the manuscript is determined by the USDA. No current external funding sources for this study.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Adams JS, 2009, J IMMUNOL, V182, P4289, DOI 10.4049/jimmunol.0803736; Baeke F, 2010, J STEROID BIOCH MOL; Bogdan C, 2011, METHODS MOL BIOL, V677, P375, DOI 10.1007/978-1-60761-869-0_24; Burton JM, 2010, NEUROLOGY, V74, P1852, DOI 10.1212/WNL.0b013e3181e1cec2; Cantorna MT, 2010, P NUTR SOC, V69, P286, DOI 10.1017/S0029665110001722; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; Curtis MM, 2009, IMMUNOLOGY, V126, P177, DOI 10.1111/j.1365-2567.2008.03017.x; de Almeida DE, 2008, VET IMMUNOL IMMUNOP, V125, P234, DOI 10.1016/j.vetimm.2008.05.019; Dittel BN, 2008, BRAIN BEHAV IMMUN, V22, P421, DOI 10.1016/j.bbi.2007.11.010; Dong C, 2008, IMMUNOL REV, V226, P80, DOI 10.1111/j.1600-065X.2008.00709.x; Endsley JJ, 2009, VET IMMUNOL IMMUNOP, V128, P199, DOI 10.1016/j.vetimm.2008.10.312; Foote MR, 2007, J DAIRY SCI, V90, P5208, DOI 10.3168/jds.2007-0285; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Heaney RP, 2008, NUTR REV, V66, pS178, DOI 10.1111/j.1753-4887.2008.00102.x; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2008, ADV EXP MED BIOL, V624, P1, DOI 10.1007/978-0-387-77574-6_1; Hollis BW, 2009, NAT REV ENDOCRINOL, V5, P534, DOI 10.1038/nrendo.2009.178; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Horst RL, 2005, J MAMMARY GLAND BIOL, V10, P141, DOI 10.1007/s10911-005-5397-x; HORST RL, 1994, J DAIRY SCI, V77, P1936, DOI 10.3168/jds.S0022-0302(94)77140-X; Horst RL, 2003, ACTA VET SCAND, P35; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; KOIZUMI T, 1985, CELL IMMUNOL, V96, P455, DOI 10.1016/0008-8749(85)90377-6; Koszewski NJ, 1996, J STEROID BIOCHEM, V59, P377, DOI 10.1016/S0960-0760(96)00127-6; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; LEMIRE JM, 1995, J STEROID BIOCHEM, V53, P599, DOI 10.1016/0960-0760(95)00106-A; LEMIRE JM, 1985, J IMMUNOL, V134, P3032; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; MAYNE CG, 2011, EUROPEAN J IN PRESS; MULLER K, 1992, AUTOIMMUNITY, V14, P37; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nashold FE, 2001, J NEUROIMMUNOL, V119, P16, DOI 10.1016/S0165-5728(01)00360-5; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Nelson CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015469; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Nonnecke BJ, 2010, J DAIRY SCI, V93, P2684, DOI 10.3168/jds.2009-2892; NONNECKE BJ, 1993, VET IMMUNOL IMMUNOP, V38, P75, DOI 10.1016/0165-2427(93)90114-J; Palmer MT, 2011, J BIOL CHEM, V286, P997, DOI 10.1074/jbc.M110.163790; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Pedersen LB, 2007, J NEUROSCI RES, V85, P2480, DOI 10.1002/jnr.21382; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; REICHEL H, 1987, P NATL ACAD SCI USA, V84, P3385, DOI 10.1073/pnas.84.10.3385; REINHARDT TA, 1982, BIOCHEM BIOPH RES CO, V106, P1012, DOI 10.1016/0006-291X(82)91812-5; Rhodes SG, 2003, CLIN DIAGN LAB IMMUN, V10, P1129, DOI 10.1128/CDLI.10.6.1129-1135.2003; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Smolders J, 2010, J STEROID BIOCHEM, V121, P243, DOI 10.1016/j.jsbmb.2010.03.001; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Stoffels K, 2007, J STEROID BIOCHEM, V103, P567, DOI 10.1016/j.jsbmb.2006.12.091; Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Urashima M, 2010, AM J CLIN NUTR; Van Rhijn I, 2008, MICROBES INFECT, V10, P711, DOI 10.1016/j.micinf.2008.04.005; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI 10.1359/JBMR.07S221; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Waldron MR, 2003, J DAIRY SCI, V86, P3440, DOI 10.3168/jds.S0022-0302(03)73948-4; Wang TT, 2010, J BIOL CHEM, V285, P2237, DOI 10.1074/jbc.C109.071225; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Waters WR, 2001, CLIN DIAGN LAB IMMUN, V8, P1204, DOI 10.1128/CDLI.8.6.1204-1212.2001; Widdison S, 2008, MOL IMMUNOL, V45, P740, DOI 10.1016/j.molimm.2007.06.357; Williams B, 2008, PEDIATR INFECT DIS J, V27, P941, DOI 10.1097/INF.0b013e31817525df	78	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21674	10.1371/journal.pone.0021674	http://dx.doi.org/10.1371/journal.pone.0021674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738762	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800058
J	Wells, RC; Hill, RB				Wells, Robert C.; Hill, R. Blake			The Cytosolic Domain of Fis1 Binds and Reversibly Clusters Lipid Vesicles	PLOS ONE			English	Article							FISSION PROTEIN FIS1; TAIL-ANCHORED PROTEINS; DYNAMIN-RELATED GTPASE; MITOCHONDRIAL FISSION; MEMBRANE-FUSION; CYTOCHROME-C; PEROXISOMAL FISSION; DNM1P; BAX; BCL-X(L)	Every lipid membrane fission event involves the association of two apposing bilayers, mediated by proteins that can promote membrane curvature, fusion and fission. We tested the hypothesis that Fis1, a tail-anchored protein involved in mitochondrial and peroxisomal fission, promotes changes in membrane structure. We found that the cytosolic domain of Fis1 alone binds lipid vesicles, which is enhanced upon protonation and increasing concentrations of anionic phospholipids. Fluorescence and circular dichroism data indicate that the cytosolic domain undergoes a membrane-induced conformational change that buries two tryptophan side chains upon membrane binding. Light scattering and electron microscopy data show that membrane binding promotes lipid vesicle clustering. Remarkably, this vesicle clustering is reversible and vesicles largely retain their original shape and size. This raises the possibility that the Fis1 cytosolic domain might act in membrane fission by promoting a reversible membrane association, a necessary step in membrane fission.	[Wells, Robert C.; Hill, R. Blake] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Hill, R. Blake] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Wells, RC (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	hill@jhu.edu		Hill, Blake/0000-0001-6228-3905	National Institutes of Health (NIH) [R01GM067180, 2T32GM007231]; American Cancer Society [IRG-58-005-41]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R01GM067180] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant R01GM067180 (RBH) and American Cancer Society award IRG-58-005-41 (RBH). RCW was supported in part by a training grant from NIH (2T32GM007231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam G., 1968, STRUCTURAL CHEM MOL; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; BERGERS JJ, 1993, BIOCHEMISTRY-US, V32, P4641, DOI 10.1021/bi00068a023; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Branden M, 2006, P NATL ACAD SCI USA, V103, P19766, DOI 10.1073/pnas.0605909103; CALHOUN D B, 1986, Proteins Structure Function and Genetics, V1, P109, DOI 10.1002/prot.340010202; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Cevc G., 1987, PHOSPHOLIPID BILAYER; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5873, DOI 10.1021/bi00238a010; DECAMILLI P, 1995, CURR OPIN NEUROBIOL, V5, P559, DOI 10.1016/0959-4388(95)80059-X; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; Henderson MPA, 2007, METHODS, V41, P427, DOI 10.1016/j.ymeth.2006.07.004; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; KIM JH, 1989, ARCH BIOCHEM BIOPHYS, V274, P100, DOI 10.1016/0003-9861(89)90420-7; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; MERRILL AR, 1993, BIOCHEMISTRY-US, V32, P6974, DOI 10.1021/bi00078a023; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Motley AM, 2008, J CELL SCI, V121, P1633, DOI 10.1242/jcs.026344; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Murray D, 1997, STRUCTURE, V5, P985, DOI 10.1016/S0969-2126(97)00251-7; Nagotu S, 2008, TRAFFIC, V9, P1471, DOI 10.1111/j.1600-0854.2008.00772.x; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Picton LK, 2009, BIOCHEMISTRY-US, V48, P6598, DOI 10.1021/bi802221h; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schauss AC, 2006, J CELL SCI, V119, P3098, DOI 10.1242/jcs.03026; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Stachowiak O, 1996, BIOCHEMISTRY-US, V35, P15522, DOI 10.1021/bi961838v; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Tan FJ, 2011, PROTEIN SCI, V20, P62, DOI 10.1002/pro.536; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; Thuduppathy GR, 2006, J MOL BIOL, V359, P1045, DOI 10.1016/j.jmb.2006.03.052; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; TOCANNE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P111, DOI 10.1016/0304-4157(90)90005-W; VAZ WLC, 1978, EUR J BIOCHEM, V83, P299, DOI 10.1111/j.1432-1033.1978.tb12094.x; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Yamashita T, 2010, J PHYS CHEM B, V114, P592, DOI 10.1021/jp908768c; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104	78	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21384	10.1371/journal.pone.0021384	http://dx.doi.org/10.1371/journal.pone.0021384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738650	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800017
J	Tang, JLW; Nicolle, ADG; Pantelic, J; Jiang, MX; Sekhr, C; Cheong, DKW; Tham, KW				Tang, Julian W.; Nicolle, Andre D. G.; Pantelic, Jovan; Jiang, Mingxiu; Sekhr, Chandra; Cheong, David K. W.; Tham, Kwok Wai			Qualitative Real-Time Schlieren and Shadowgraph Imaging of Human Exhaled Airflows: An Aid to Aerosol Infection Control	PLOS ONE			English	Article							INFLUENZA-VIRUS; CLOSTRIDIUM-DIFFICILE; OXYGEN MASKS; TRANSMISSION; VENTILATION; DISPERSION; EFFICACY; REMOVAL	Using a newly constructed airflow imaging system, airflow patterns were visualized that were associated with common, everyday respiratory activities (e. g. breathing, talking, laughing, whistling). The effectiveness of various interventions (e. g. putting hands and tissues across the mouth and nose) to reduce the potential transmission of airborne infection, whilst coughing and sneezing, were also investigated. From the digital video footage recorded, it was seen that both coughing and sneezing are relatively poorly contained by commonly used configurations of single-handed shielding maneuvers. Only some but not all of the forward momentum of the cough and sneeze puffs are curtailed with various hand techniques, and the remaining momentum is disseminated in a large puff in the immediate vicinity of the cougher, which may still act as a nearby source of infection. The use of a tissue (in this case, 4-ply, opened and ready in the hand) proved to be surprisingly effective, though the effectiveness of this depends on the tissue remaining intact and not ripping apart. Interestingly, the use of a novel 'coughcatcher' device appears to be relatively effective in containing coughs and sneezes. One aspect that became evident during the experimental procedures was that the effectiveness of all of these barrier interventions is very much dependent on the speed with which the user can put them into position to cover the mouth and nose effectively. From these qualitative schlieren and shadowgraph imaging experiments, it is clear that making some effort to contain one's cough or sneeze puffs is worthwhile. Obviously, there will be a large amount of variation between individuals in the exact hand or tissue (the most common methods) configuration used for this and other practical factors may hinder such maneuvers in daily life, for example, when carrying shopping bags or managing young children.	[Tang, Julian W.; Nicolle, Andre D. G.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Pantelic, Jovan; Jiang, Mingxiu; Sekhr, Chandra; Cheong, David K. W.; Tham, Kwok Wai] Natl Univ Singapore, Dept Bldg, Sch Design & Environm, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Tang, JLW (corresponding author), Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.	jwtang49@hotmail.com	THAM, Kwok Wai/B-6541-2009; Sekhar, Chandra/F-3253-2017	THAM, Kwok Wai/0000-0002-2957-1152; Sekhar, Chandra/0000-0002-0814-8662; Cheong, David/0000-0001-7680-4281; Pantelic, Jovan/0000-0001-7541-8274; Tang, Julian/0000-0002-4963-1028	Singapore National Medical Research Council [NMRC/1208/2009]	Singapore National Medical Research Council(National Medical Research Council, Singapore)	This work was funded by a grant (on which ADGN was also supported as a post-doctoral research fellow) from the Singapore National Medical Research Council (NMRC/1208/2009) to JWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETTIN K, 1994, INFECT CONT HOSP EP, V15, P697; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Carro C, 2007, J HOSP INFECT, V67, P62, DOI 10.1016/j.jhin.2007.06.016; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Ferguson JK, 2009, MED J AUSTRALIA, V191, P454, DOI 10.5694/j.1326-5377.2009.tb02886.x; Hui DS, 2007, CHEST, V132, P540, DOI 10.1378/chest.07-0636; Hui DS, 2006, CHEST, V130, P822, DOI 10.1378/chest.130.3.822; Inouye S, 2003, LANCET, V362, P170, DOI 10.1016/S0140-6736(03)13874-3; Ip M, 2007, AM J INFECT CONTROL, V35, P684, DOI 10.1016/j.ajic.2007.05.007; Jabbar U, 2010, INFECT CONT HOSP EP, V31, P565, DOI 10.1086/652772; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Johnson DF, 2009, CLIN INFECT DIS, V49, P275, DOI 10.1086/600041; Lemieux C, 2007, EMERG INFECT DIS, V13, P173, DOI 10.3201/eid1301.061202; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Nielsen PV, 2009, J R SOC INTERFACE, V6, pS747, DOI 10.1098/rsif.2009.0228.focus; *OCC SAF HLTH ADM, 2007, OCC SAF HLTH ADM OSH; Oughton MT, 2009, INFECT CONT HOSP EP, V30, P939, DOI 10.1086/605322; Pantelic J, 2009, J R SOC INTERFACE, V6, pS715, DOI 10.1098/rsif.2009.0311.focus; Pifferi M, 2009, PEDIAT ALLERG IMM-UK, V20, P164, DOI 10.1111/j.1399-3038.2008.00742.x; Qian H, 2006, INDOOR AIR, V16, P111, DOI 10.1111/j.1600-0668.2005.00407.x; Stelzer-Braid S, 2009, J MED VIROL, V81, P1674, DOI 10.1002/jmv.21556; Stone RE, 2003, J VOICE, V17, P283, DOI 10.1067/S0892-1997(03)00074-2; Tang JW, 2008, NEW ENGL J MED, V359, pE19, DOI 10.1056/NEJMicm072576; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2011, J HOSP INFECT, V77, P213, DOI 10.1016/j.jhin.2010.09.037; Tang JW, 2007, LANCET INFECT DIS, V7, P758, DOI 10.1016/S1473-3099(07)70268-2; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Tang JWT, 2009, NEW ENGL J MED, V361, pE62, DOI 10.1056/NEJMicm0904279; Tang JW, 2005, J HOSP INFECT, V61, P283, DOI 10.1016/j.jhin.2005.05.017; Tellier R, 2007, LANCET INFECT DIS, V7, P759, DOI 10.1016/S1473-3099(07)70269-4; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; *US DEP HHS, 2009, HHS PUBL, P316; Weber DJ, 2003, JAMA-J AM MED ASSOC, V289, P1274, DOI 10.1001/jama.289.10.1274; *WHO, 2007, AV INFL INCL INFL A; Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus; YANG W, 2011, J R SOC INTERFACE	41	51	52	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21392	10.1371/journal.pone.0021392	http://dx.doi.org/10.1371/journal.pone.0021392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731730	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700074
J	Alves, FD; Boot, E; Schmitz, N; Nederveen, A; Vorstman, J; Lavini, C; Pouwels, P; de Haan, L; Linszen, D; van Amelsvoort, T				Alves, Fabiana da Silva; Boot, Erik; Schmitz, Nicole; Nederveen, Aart; Vorstman, Jacob; Lavini, Christina; Pouwels, Petra; de Haan, Lieuwe; Linszen, Don; van Amelsvoort, Therese			Proton Magnetic Resonance Spectroscopy in 22q11 Deletion Syndrome	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VELOCARDIOFACIAL SYNDROME; SCHIZOPHRENIC-PATIENTS; PREFRONTAL CORTEX; TEMPORAL-LOBE; GLUTAMATE; HYPERPROLINEMIA; METABOLITES; MYOINOSITOL; EXPRESSION	Objective: People with velo-cardio-facial syndrome or 22q11 deletion syndrome (22q11DS) have behavioral, cognitive and psychiatric problems. Approximately 30% of affected individuals develop schizophrenia-like psychosis. Glutamate dysfunction is thought to play a crucial role in schizophrenia. However, it is unknown if and how the glutamate system is altered in 22q11DS. People with 22q11DS are vulnerable for haploinsufficiency of PRODH, a gene that codes for an enzyme converting proline into glutamate. Therefore, it can be hypothesized that glutamatergic abnormalities may be present in 22q11DS. Method: We employed proton magnetic resonance spectroscopy (H-1-MRS) to quantify glutamate and other neurometabolites in the dorsolateral prefrontal cortex (DLPFC) and hippocampus of 22 adults with 22q11DS (22q11DS SCZ+) and without (22q11DS SCZ-) schizophrenia and 23 age-matched healthy controls. Also, plasma proline levels were determined in the 22q11DS group. Results: We found significantly increased concentrations of glutamate and myo-inositol in the hippocampal region of 22q11DS SCZ+ compared to 22q11DS SCZ-. There were no significant differences in levels of plasma proline between 22q11DS SCZ+ and 22q11DS SCZ-. There was no relationship between plasma proline and cerebral glutamate in 22q11DS. Conclusion: This is the first in vivo H-1-MRS study in 22q11DS. Our results suggest vulnerability of the hippocampus in the psychopathology of 22q11DS SCZ+. Altered hippocampal glutamate and myo-inositol metabolism may partially explain the psychotic symptoms and cognitive impairments seen in this group of patients.	[Alves, Fabiana da Silva; Boot, Erik; Schmitz, Nicole; de Haan, Lieuwe; Linszen, Don; van Amelsvoort, Therese] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Boot, Erik] Ctr People Intellectual Disabil, Zwammerdam, Netherlands; [Nederveen, Aart; Lavini, Christina] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Vorstman, Jacob] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Pouwels, Petra] VU Univ Med Ctr Amsterdam, Dept Phys & Med Technol, Amsterdam, Netherlands; [van Amelsvoort, Therese] Arkin Mental Hlth Care, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Alves, FD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	F.daSilvaAlves@amc.nl	Schmitz, Nicole/F-9471-2011; Boot, Erik/AAV-8592-2021	Schmitz, Nicole/0000-0003-4178-4756; Boot, Erik/0000-0002-0593-1539	Dutch Brain Foundation	Dutch Brain Foundation	The study was funded by the Dutch Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Bartha R, 1997, ARCH GEN PSYCHIAT, V54, P959; Beacher F, 2005, ARCH GEN PSYCHIAT, V62, P1360, DOI 10.1001/archpsyc.62.12.1360; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Beneyto M, 2007, NEUROPSYCHOPHARMACOL, V32, P1888, DOI 10.1038/sj.npp.1301312; Bertolino A, 2001, BIOL PSYCHIAT, V49, P39, DOI 10.1016/S0006-3223(00)00997-5; BLOEMEN OJ, 2011, BIOL PSYCHI IN PRESS; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Burbaeva GS, 2003, PROG NEURO-PSYCHOPH, V27, P675, DOI 10.1016/S0278-5846(03)00078-2; CANAVAN AGM, 1986, BRIT J CLIN PSYCHOL, V25, P81, DOI 10.1111/j.2044-8260.1986.tb00675.x; Catani M, 2001, NEUROREPORT, V12, P2315, DOI 10.1097/00001756-200108080-00007; Chang L, 2007, BIOL PSYCHIAT, V62, P1396, DOI 10.1016/j.biopsych.2007.05.025; Cohen SM, 1997, BRAIN RES, V769, P333, DOI 10.1016/S0006-8993(97)00721-X; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Delwing D, 2007, LIFE SCI, V81, P1645, DOI 10.1016/j.lfs.2007.09.031; Eliez S, 2001, AM J PSYCHIAT, V158, P447, DOI 10.1176/appi.ajp.158.3.447; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Goff DC, 1999, ARCH GEN PSYCHIAT, V56, P21, DOI 10.1001/archpsyc.56.1.21; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Goodman BK, 2000, J INHERIT METAB DIS, V23, P847, DOI 10.1023/A:1026773005303; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hoogendoorn MLC, 2008, SCHIZOPHR RES, V98, P84, DOI 10.1016/j.schres.2007.09.025; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Kane JA, 2003, J CLIN PSYCHIAT, V64, P5; Kates WR, 2006, J AM ACAD CHILD PSY, V45, P587, DOI 10.1097/01.chi.0000205704.33077.4a; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kegeles LS, 2000, PSYCHIAT RES-NEUROIM, V98, P163, DOI 10.1016/S0925-4927(00)00044-5; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lipska BK, 2004, J PSYCHIATR NEUROSCI, V29, P282; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; LUTKENHOFF ES, 2008, MOL PSYCHIA IN PRESS; Moghaddam B, 2004, PSYCHOPHARMACOLOGY, V174, P39, DOI 10.1007/s00213-004-1792-z; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Ohrmann P, 2007, J PSYCHIATR RES, V41, P625, DOI 10.1016/j.jpsychires.2006.07.002; Olbrich HM, 2008, WORLD J BIOL PSYCHIA, V9, P59, DOI 10.1080/15622970701227811; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phang JM, 2001, DISORDERS PROLINE HY, P1821; Pilowsky LS, 2006, MOL PSYCHIATR, V11, P118, DOI 10.1038/sj.mp.4001751; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Rusch N, 2008, SCHIZOPHR RES, V99, P155, DOI 10.1016/j.schres.2007.05.024; Schousboe A, 2003, NEUROCHEM RES, V28, P347, DOI 10.1023/A:1022397704922; Siger M, 2009, ALZ DIS ASSOC DIS, V23, P57, DOI 10.1097/WAD.0b013e3181875434; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Stone JM, 2010, BIOL PSYCHIAT, V68, P599, DOI 10.1016/j.biopsych.2010.05.034; Stone JM, 2009, BIOL PSYCHIAT, V66, P533, DOI 10.1016/j.biopsych.2009.05.006; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tayoshi S, 2009, SCHIZOPHR RES, V108, P69, DOI 10.1016/j.schres.2008.11.014; Theberge J, 2003, AM J PSYCHIAT, V160, P2231, DOI 10.1176/appi.ajp.160.12.2231; Theberge J, 2002, AM J PSYCHIAT, V159, P1944, DOI 10.1176/appi.ajp.159.11.1944; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041; Vorstman JAS, 2009, NEUROPSYCHOPHARMACOL, V34, P739, DOI 10.1038/npp.2008.132; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Willis A, 2008, AMINO ACIDS, V35, P673, DOI 10.1007/s00726-008-0111-0	62	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e21685	10.1371/journal.pone.0021685	http://dx.doi.org/10.1371/journal.pone.0021685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738766	Green Published, gold			2022-12-25	WOS:000292291800031
J	Ill-Raga, G; Palomer, E; Wozniak, MA; Ramos-Fernandez, E; Bosch-Morato, M; Tajes, M; Guix, FX; Galan, JJ; Clarimon, J; Antunez, C; Real, LM; Boada, M; Itzhaki, RF; Fandos, C; Munoz, FJ				Ill-Raga, Gerard; Palomer, Ernest; Wozniak, Matthew A.; Ramos-Fernandez, Eva; Bosch-Morato, Monica; Tajes, Marta; Guix, Francesc X.; Galan, Jose J.; Clarimon, Jordi; Antunez, Carmen; Real, Luis M.; Boada, Merce; Itzhaki, Ruth F.; Fandos, Cesar; Munoz, Francisco J.			Activation of PKR Causes Amyloid beta-Peptide Accumulation via De-Repression of BACE1 Expression	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1	BACE1 is a key enzyme involved in the production of amyloid beta-peptide (A beta) in Alzheimer's disease (AD) brains. Normally, its expression is constitutively inhibited due to the presence of the 5'untranslated region (5'UTR) in the BACE1 promoter. BACE1 expression is activated by phosphorylation of the eukaryotic initiation factor (eIF)2-alpha, which reverses the inhibitory effect exerted by BACE1 5'UTR. There are four kinases associated with different types of stress that could phosphorylate eIF2-alpha. Here we focus on the double-stranded (ds) RNA-activated protein kinase (PKR). PKR is activated during viral infection, including that of herpes simplex virus type 1 (HSV1), a virus suggested to be implicated in the development of AD, acting when present in brains of carriers of the type 4 allele of the apolipoprotein E gene. HSV1 is a dsDNA virus but it has genes on both strands of the genome, and from these genes complementary RNA molecules are transcribed. These could activate BACE1 expression by the PKR pathway. Here we demonstrate in HSV1-infected neuroblastoma cells, and in peripheral nervous tissue from HSV1-infected mice, that HSV1 activates PKR. Cloning BACE1 5'UTR upstream of a luciferase (luc) gene confirmed its inhibitory effect, which can be prevented by salubrinal, an inhibitor of the eIF2-alpha phosphatase PP1c. Treatment with the dsRNA analog poly (I:C) mimicked the stimulatory effect exerted by salubrinal over BACE1 translation in the 5'UTR-luc construct and increased A beta production in HEK-APPsw cells. Summarizing, our data suggest that PKR activated in brain by HSV1 could play an important role in the development of AD.	[Ill-Raga, Gerard; Palomer, Ernest; Ramos-Fernandez, Eva; Bosch-Morato, Monica; Tajes, Marta; Guix, Francesc X.; Fandos, Cesar; Munoz, Francisco J.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona, Spain; [Wozniak, Matthew A.; Itzhaki, Ruth F.] Univ Manchester, Manchester, Lancs, England; [Galan, Jose J.; Real, Luis M.] NeoCodex, Seville, Spain; [Clarimon, Jordi] Hosp Santa Creu & Sant Pau, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Neurol, Alzheimer Lab, Barcelona, Spain; [Antunez, Carmen] Hosp Virgen de la Arrixaca Murcia, Unidad Demencias, Fdn Alzheimur, Murcia, Spain; [Boada, Merce] Memory Clin ACE Fdn, Catalan Inst Appl Neurosci, Barcelona, Spain; [Boada, Merce] Hosp G Univ Vall dHebron, Dept Neurol, Barcelona, Spain	Pompeu Fabra University; University of Manchester; CIBERNED; Hospital of Santa Creu i Sant Pau; Hospital Clinico Universitario Virgen de la Arrixaca	Ill-Raga, G (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol & Channelopathies, Barcelona, Spain.	paco.munoz@upf.edu	Muñoz, F/E-6751-2014; Guix, Francesc/AAA-7462-2020; Tajes, Marta/ABG-2187-2020; Palomer, Ernest/CAI-0575-2022; Palomer, Ernest/CAF-4211-2022; ILL-Raga, Gerard/G-8864-2011; Real, Luis M/K-9646-2014	Muñoz, F/0000-0002-1343-3599; Tajes, Marta/0000-0002-9333-1794; Palomer, Ernest/0000-0001-8629-2443; Palomer, Ernest/0000-0001-8629-2443; ILL-Raga, Gerard/0000-0002-0898-5356; Clarimon, Jordi/0000-0002-6824-6942; Real, Luis M/0000-0003-4932-7429; Fandos, Cesar/0000-0001-7348-1376	Alzheimur Foundation; Spanish Ministerio de Ciencia y Tecnologia [FIS: PI07/0593, Red HERACLES RD06/0009/002]	Alzheimur Foundation; Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Neocodex is a private research organization (more than 70 articles in indexes of international research journals in the last 8 years). Neocodex's work on this project was design, implementation, analysis and interpretation of genetic studies of the PKR gene that is included in this manuscript. Neocodex also coordinates the construction of the DNA bank employed in this draft. The work was carried out with funds from this entity and a project funded by the Alzheimur Foundation. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by the Spanish Ministerio de Ciencia y Tecnologia (FIS: PI07/0593; Red HERACLES RD06/0009/002).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; BALL MJ, 1982, CAN J NEUROL SCI, V9, P303, DOI 10.1017/S0317167100044115; Barber GN, 2005, CELL DEATH DIFFER, V12, P563, DOI 10.1038/sj.cdd.4401643; Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023; Cassady KA, 2002, J VIROL, V76, P2029, DOI 10.1128/jvi.76.5.2029-2035.2002; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chang RCC, 2002, J NEUROCHEM, V83, P1215, DOI 10.1046/j.1471-4159.2002.01237.x; CHOU J, 1995, P NATL ACAD SCI USA, V92, P10516, DOI 10.1073/pnas.92.23.10516; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Coma M, 2008, NEUROBIOL AGING, V29, P969, DOI 10.1016/j.neurobiolaging.2007.01.009; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; DELTORO D, 2009, CURR MED CHEM CENTRA, P271; DEPIETRI TD, 2004, NUCLEIC ACIDS RES, V5, P1808; Der SD, 1997, P NATL ACAD SCI USA, V94, P3279, DOI 10.1073/pnas.94.7.3279; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gatta LB, 2002, NEUROREPORT, V13, P2031, DOI 10.1097/00001756-200211150-00008; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HINNEBUSCH AG, MECH REGULATION INIT, P184; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; JAMIESON GA, 1991, J MED VIROL, V33, P224, DOI 10.1002/jmv.1890330403; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; LEE SB, 1994, VIROLOGY, V199, P491, DOI 10.1006/viro.1994.1151; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Peel AL, 2004, J NEUROPATH EXP NEUR, V63, P97, DOI 10.1093/jnen/63.2.97; Peel AL, 2003, NEUROBIOL DIS, V14, P52, DOI 10.1016/S0969-9961(03)00086-X; Preece P, 2003, MOL BRAIN RES, V116, P155, DOI 10.1016/S0169-328X(03)00233-X; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; TAN SL, 1999, J INTERFERON CYTOKIN, V6, P543; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WEK RC, 2006, BIOCH SOC T 1, P7; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wozniak MA, 2009, J PATHOL, V217, P131, DOI 10.1002/path.2449; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2007, NEUROSCI LETT, V429, P95, DOI 10.1016/j.neulet.2007.09.077; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006	54	49	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21456	10.1371/journal.pone.0021456	http://dx.doi.org/10.1371/journal.pone.0021456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738672	Green Published, gold			2022-12-25	WOS:000292142800025
J	Magrach, A; Larrinaga, AR; Santamaria, L				Magrach, Ainhoa; Larrinaga, Asier R.; Santamaria, Luis			Changes in Patch Features May Exacerbate or Compensate for the Effect of Habitat Loss on Forest Bird Populations	PLOS ONE			English	Article							TEMPERATE RAIN-FORESTS; SEED DISPERSAL; CHILOE ARCHIPELAGO; SPECIES-DIVERSITY; CLIMATE-CHANGE; FRAGMENTATION; MODELS; ISLAND; HUMMINGBIRDS; CONSERVATION	One and a half centuries after Darwin visited Chiloe Island, what he described as "...an island covered by one great forest...'' has lost two-thirds of its forested areas. At this biodiversity hotspot, forest surface is becoming increasingly fragmented due to unregulated logging, clearing for pastures and replacement by exotic tree plantations. Decrease in patch size, increased isolation and "edge effects'' can influence the persistence of forest species in remnant fragments. We assessed how these variables affect local density for six forest birds, chosen to include the most important seed dispersers (four species) and bird pollinators (two species, one of which acts also as seed disperser), plus the most common insectivore (Aphrastura spinicauda). Based on cue-count point surveys (8 points per fragment), we estimated bird densities for each species in 22 forest fragments of varying size, shape, isolation and internal-habitat structure (e.g. tree size and epiphyte cover). Bird densities varied with fragment connectivity (three species) and shape (three species), but none of the species was significantly affected by patch size. Satellite image analyses revealed that, from 1985 to 2008, forested area decreased by 8.8% and the remaining forest fragments became 16% smaller, 58-73% more isolated and 11-50% more regular. During that period, bird density estimates for the northern part of Chiloe (covering an area of 1214.75 km(2)) decreased for one species (elaenia), increased for another two (chucao and hummingbird) and did not vary for three (rayadito, thrust and blackbird). For the first three species, changes in patch features respectively exacerbated, balanced and overcame the effects of forest loss on bird population size (landscape-level abundance). Hence, changes in patch features can modulate the effect of habitat fragmentation on forest birds, suggesting that spatial planning (guided by spatially-explicit models) can be an effective tool to facilitate their conservation.	[Magrach, Ainhoa; Larrinaga, Asier R.; Santamaria, Luis] CSIC UIB, Mediterranean Inst Adv Studies, IMEDEA, Mallorca, Balearic Isl, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Magrach, A (corresponding author), CSIC UIB, Mediterranean Inst Adv Studies, IMEDEA, Mallorca, Balearic Isl, Spain.	ainhoamagrach@hotmail.com	Santamaria, Luis/C-1438-2012; Magrach, Ainhoa/B-1038-2012; Larrinaga, Asier/B-3826-2013	Santamaria, Luis/0000-0002-5072-2912; Magrach, Ainhoa/0000-0003-2155-7556; Larrinaga, Asier/0000-0001-6813-8784	Banco Bilbao Vizcaya Argentaria (BBVA) Foundation; Basque Country Government; Spanish Research Council (CSIC)	Banco Bilbao Vizcaya Argentaria (BBVA) Foundation(BBVA Foundation); Basque Country Government(Basque Government); Spanish Research Council (CSIC)	Funding by the Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (project DOSEL) and the Basque Country Government (pre-doctoral fellowship for A. M.) are gratefully acknowledged. A. R. L. received funding from the JAEDOC program of the Spanish Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico Guillermo C, 2005, Ecol. austral, V15, P89; ARMESTO JJ, 1989, J BIOGEOGR, V16, P219, DOI 10.2307/2845258; ARMESTO JJ, 1987, J BIOGEOGR, V14, P367, DOI 10.2307/2844944; Armesto JJ, 2009, ECOL STUD-ANAL SYNTH, V207, P367, DOI 10.1007/978-3-540-92706-8_16; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Braschler B, 2009, ECOL ENTOMOL, V34, P321, DOI 10.1111/j.1365-2311.2008.01080.x; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Bunnell FL, 1999, WILDLIFE MANAGEMENT, pvii; Castellon TD, 2007, ECOL APPL, V17, P2152, DOI 10.1890/06-0945.1; Castellon TD, 2006, ECOL APPL, V16, P2223, DOI 10.1890/1051-0761(2006)016[2223:LHFAPO]2.0.CO;2; Collinge SK, 2002, LANDSCAPE ECOL, V17, P647, DOI 10.1023/A:1021536302195; Cornelius C, 2000, CONSERV BIOL, V14, P534, DOI 10.1046/j.1523-1739.2000.98409.x; CORNELIUS C, 2006, THESIS U MISSOURI ST; Davies KF, 1998, J ANIM ECOL, V67, P460, DOI 10.1046/j.1365-2656.1998.00210.x; Diaz IA, 2005, BIOL CONSERV, V123, P91, DOI 10.1016/j.biocon.2004.10.011; Echeverria C, 2008, ECOL MODEL, V212, P439, DOI 10.1016/j.ecolmodel.2007.10.045; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Exeler N, 2008, CONSERV GENET, V9, P1233, DOI 10.1007/s10592-007-9450-8; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Franklin AB, 2002, STUD AVIAN BIOL-SER, P20; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Hanski Ilkka, 2004, P3, DOI 10.1016/B978-012323448-3/50003-9; Jaramillo A., 2003, BIRDS CHILE; JOHNS AD, 1985, BIOL CONSERV, V31, P355, DOI 10.1016/0006-3207(85)90091-6; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Lang S, 2003, VLATE EXTENSION ARCG; LARA A, BOSQUES INFORM PAIS, P131; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lindenmayer DB, 2002, ECOL MONOGR, V72, P1, DOI 10.1890/0012-9615(2002)072[0001:EOFFOB]2.0.CO;2; LINHART YB, 1987, ECOLOGY, V68, P1696, DOI 10.2307/1939862; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Meyer CFJ, 2009, BIOTROPICA, V41, P95, DOI 10.1111/j.1744-7429.2008.00443.x; MITCHELL B, 2007, FRAGSTATSBATCH ARCGI; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Porter AH, 1999, CONSERV BIOL, V13, P850, DOI 10.1046/j.1523-1739.1999.98308.x; Restrepo C, 1999, ECOLOGY, V80, P668, DOI 10.1890/0012-9658(1999)080[0668:AETGAF]2.0.CO;2; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rozzi R, 1996, REV CHIL HIST NAT, V69, P125; Saunders D.A., 1995, BIRDS SW AUSTR ATLAS; Smith-Ramirez C, 2003, AUSTRAL ECOL, V28, P53, DOI 10.1046/j.1442-9993.2003.01248.x; SMITHRAMIREZ C, 1993, REV CHIL HIST NAT, V66, P65; STILES FG, 1975, ECOLOGY, V56, P285, DOI 10.2307/1934961; STOUFFER PC, 1995, CONSERV BIOL, V9, P1085, DOI 10.1046/j.1523-1739.1995.9051072.x-i1; THIOLLAY JM, 1992, CONSERV BIOL, V6, P47, DOI 10.1046/j.1523-1739.1992.610047.x; THOMAS L., 2006, DISTANCE 5 0 RELEASE; Wilcove D.S., 1986, P237; Willson MF, 2004, CONDOR, V106, P166, DOI 10.1650/7303; WILLSON MF, 1994, CONSERV BIOL, V8, P508, DOI 10.1046/j.1523-1739.1994.08020508.x; Willson MF, 1996, REV CHIL HIST NAT, V69, P343; Wilson TL, 2009, LANDSCAPE ECOL, V24, P351, DOI 10.1007/s10980-008-9309-5; Zanette L, 2001, J AVIAN BIOL, V32, P38, DOI 10.1034/j.1600-048X.2001.320106.x; [No title captured]	60	15	16	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21596	10.1371/journal.pone.0021596	http://dx.doi.org/10.1371/journal.pone.0021596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738723	gold, Green Submitted, Green Published			2022-12-25	WOS:000292142800042
J	Pacheco-Gomez, R; Roper, DI; Dafforn, TR; Rodger, A				Pacheco-Gomez, Raul; Roper, David I.; Dafforn, Timothy R.; Rodger, Alison			The pH Dependence of Polymerization and Bundling by the Essential Bacterial Cytoskeltal Protein FtsZ	PLOS ONE			English	Article							ESCHERICHIA-COLI; GTP; DICHROISM; ORIENTATION; DYNAMICS	There is a growing body of evidence that bacterial cell division is an intricate coordinated process of comparable complexity to that seen in eukaryotic cells. The dynamic assembly of Escherichia coli FtsZ in the presence of GTP is fundamental to its activity. FtsZ polymerization is a very attractive target for novel antibiotics given its fundamental and universal function. In this study our aim was to understand further the GTP-dependent FtsZ polymerization mechanism and our main focus is on the pH dependence of its behaviour. A key feature of this work is the use of linear dichroism (LD) to follow the polymerization of FtsZ monomers into polymeric structures. LD is the differential absorption of light polarized parallel and perpendicular to an orientation direction (in this case that provided by shear flow). It thus readily distinguishes between FtsZ polymers and monomers. It also distinguishes FtsZ polymers and less well-defined aggregates, which light scattering methodologies do not. The polymerization of FtsZ over a range of pHs was studied by right-angled light scattering to probe mass of FtsZ structures, LD to probe real-time formation of linear polymeric fibres, a specially developed phosphate release assay to relate guanosine triphosphate (GTP) hydrolysis to polymer formation, and electron microscopy (EM) imaging of reaction products as a function of time and pH. We have found that lowering the pH from neutral to 6.5 does not change the nature of the FtsZ polymers in solution-it simply facilitates the polymerization so the fibres present are longer and more abundant. Conversely, lowering the pH to 6.0 has much the same effect as introducing divalent cations or the FtsZ-associated protein YgfE (a putative ZapA orthologue in E. coli)-it stablizes associations of protofilaments.	[Pacheco-Gomez, Raul; Rodger, Alison] Univ Warwick, Mol Org, Coventry CV4 7AL, W Midlands, England; [Pacheco-Gomez, Raul; Rodger, Alison] Univ Warwick, Assembly Cells Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England; [Roper, David I.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Rodger, Alison] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Dafforn, Timothy R.] Univ Birmingham, Dept Biosci, Birmingham, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Birmingham	Pacheco-Gomez, R (corresponding author), Univ Warwick, Mol Org, Coventry CV4 7AL, W Midlands, England.	a.rodger@warwick.ac.uk	Rodger, Alison/A-1063-2009; Roper, David I/A-2323-2011; Dafforn, Tim/A-9072-2015	Rodger, Alison/0000-0002-7111-3024; Roper, David I/0000-0003-0009-621X; Dafforn, Tim/0000-0003-2257-6679	Engineering and Physical Sciences Research Council [GR/S47113/01, GR/T09224/01]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding from the Engineering and Physical Sciences Research Council (GR/S47113/01; GR/T09224/01) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; ERICKSON HP, 2009, P NAT ACAD SCI, P9238; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Marrington R, 2004, J BIOL CHEM, V279, P48821, DOI 10.1074/jbc.M404944200; MARRINGTON R, 2004, CALCIUM IND IN PRESS; MARRINGTON R, 2005, VALIDATION NEW MICRO, P1608; MARRINGTON R, 2004, POLARISED SPECTROSCO; Marrington R, 2006, CHIRALITY, V18, P680, DOI 10.1002/chir.20305; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; Mukherjee A, 1998, METHOD ENZYMOL, V298, P296, DOI 10.1016/S0076-6879(98)98026-0; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Norden B, 2010, LINEAR DICHROISM AND CIRCULAR DICHROISM: A TEXTBOOK ON POLARIZED LIGHT SPECTROSCOPY, P1; NORDH J, 1986, EUR BIOPHYS J BIOPHY, V14, P113, DOI 10.1007/BF00263068; Rodger A, 2002, PHYS CHEM CHEM PHYS, V4, P4051, DOI 10.1039/b205080n; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; SMALL E, 2003, MICROBIOLOGY, V149; Small E, 2007, J MOL BIOL, V369, P210, DOI 10.1016/j.jmb.2007.03.025; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07	30	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e19369	10.1371/journal.pone.0019369	http://dx.doi.org/10.1371/journal.pone.0019369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738567	Green Submitted, gold, Green Published			2022-12-25	WOS:000292142800001
J	Chadwick, W; Mitchell, N; Caroll, J; Zhou, Y; Park, SS; Wang, LY; Becker, KG; Zhang, YQ; Lehrmann, E; Wood, WH; Martin, B; Maudsley, S				Chadwick, Wayne; Mitchell, Nick; Caroll, Jenna; Zhou, Yu; Park, Sung-Soo; Wang, Liyun; Becker, Kevin G.; Zhang, Yongqing; Lehrmann, Elin; Wood, William H., III; Martin, Bronwen; Maudsley, Stuart			Amitriptyline-Mediated Cognitive Enhancement in Aged 3xTg Alzheimer's Disease Mice Is Associated with Neurogenesis and Neurotrophic Activity	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; COMMON MECHANISM; A-BETA; BRAIN; HIPPOCAMPAL; OLIGOMERS; MOUSE; TAU; ANGIOGENESIS; IMPAIRMENT	Approximately 35 million people worldwide suffer from Alzheimer's disease (AD). Existing therapeutics, while moderately effective, are currently unable to stem the widespread rise in AD prevalence. AD is associated with an increase in amyloid beta (A beta) oligomers and hyperphosphorylated tau, along with cognitive impairment and neurodegeneration. Several antidepressants have shown promise in improving cognition and alleviating oxidative stress in AD but have failed as long-term therapeutics. In this study, amitriptyline, an FDA-approved tricyclic antidepressant, was administered orally to aged and cognitively impaired transgenic AD mice (3xTgAD). After amitriptyline treatment, cognitive behavior testing demonstrated that there was a significant improvement in both long-and short-term memory retention. Amitriptyline treatment also caused a significant potentiation of non-toxic A beta monomer with a concomitant decrease in cytotoxic dimer A beta load, compared to vehicle-treated 3xTgAD controls. In addition, amitriptyline administration caused a significant increase in dentate gyrus neurogenesis as well as increases in expression of neurosynaptic marker proteins. Amitriptyline treatment resulted in increases in hippocampal brain-derived neurotrophic factor protein as well as increased tyrosine phosphorylation of its cognate receptor (TrkB). These results indicate that amitriptyline has significant beneficial actions in aged and damaged AD brains and that it shows promise as a tolerable novel therapeutic for the treatment of AD.	[Chadwick, Wayne; Zhou, Yu; Park, Sung-Soo; Wang, Liyun; Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Mitchell, Nick] NIA, Neurosci Lab, NIH, Baltimore, MD 21224 USA; [Caroll, Jenna] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Becker, Kevin G.; Zhang, Yongqing; Lehrmann, Elin; Wood, William H., III] NIA, Genom Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Chadwick, W (corresponding author), NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA.	maudsleyst@mail.nih.gov	Maudsley, Stuart/AAV-9929-2021; Zhou, Yu/M-7975-2014; Maudsley, Stuart/Q-4782-2019; Mitchell, Nicholas/A-7066-2018	Maudsley, Stuart/0000-0002-1868-184X; Mitchell, Nicholas/0000-0003-2088-5419; Martin, Bronwen/0000-0002-9185-6925; Lehrmann, Elin/0000-0002-9869-9475; Becker, Kevin/0000-0002-6794-6656	National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000318, ZIAAG000916, ZIAAG000917, ZIAAG000325, ZIAAG000915, ZIAAG000319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was carried out in-part by funding from the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Archer HA, 2007, ALZ DIS ASSOC DIS, V21, P101, DOI 10.1097/WAD.0b013e318065bfc2; Bradford D, 2010, J COMP NEUROL, V518, P3237, DOI 10.1002/cne.22397; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calissano P, 2010, DEV NEUROBIOL, V70, P372, DOI 10.1002/dneu.20759; Carrettiero DC, 2009, J NEUROSCI, V29, P2151, DOI 10.1523/JNEUROSCI.4660-08.2009; CHADWICK W, 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2010/604792; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; Chafekar SM, 2008, BBA-MOL BASIS DIS, V1782, P523, DOI 10.1016/j.bbadis.2008.06.003; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Chen WQ, 2007, ELECTROPHORESIS, V28, P4392, DOI 10.1002/elps.200700336; Chi ZH, 2006, NEUROREPORT, V17, P1807, DOI 10.1097/01.wnr.0000239968.06438.c5; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; FREIR DB, 2010, NEUROBIOL AGING 0122; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Golden E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010099; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hellweg R, 2008, PHARMACOPSYCHIATRY, V41, P66, DOI 10.1055/s-2007-1004594; Hongo S, 2006, J CELL BIOCHEM, V98, P185, DOI 10.1002/jcb.20763; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kee HJ, 2002, J CEREBR BLOOD F MET, V22, P1054, DOI 10.1097/00004647-200209000-00003; Lee JK, 2008, J NEUROSCI, V28, P8517, DOI 10.1523/JNEUROSCI.1806-08.2008; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Matheson SF, 2006, DEV NEUROSCI-BASEL, V28, P538, DOI 10.1159/000095116; Michael M, 2010, CURR BIOL, V20, P783, DOI 10.1016/j.cub.2010.03.048; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Nagy N, 2008, J MOL CELL CARDIOL, V44, P252, DOI 10.1016/j.yjmcc.2007.08.021; Nelson RL, 2007, EXP NEUROL, V205, P166, DOI 10.1016/j.expneurol.2007.01.037; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Rosario ER, 2006, J NEUROSCI, V26, P13384, DOI 10.1523/JNEUROSCI.2514-06.2006; Rozzini L, 2010, INT PSYCHOGERIATR, V22, P114, DOI 10.1017/S1041610209990184; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stranahan AM, 2009, CURR MED CHEM, V16, P4668, DOI 10.2174/092986709789878292; Tai YH, 2009, ANESTHESIOLOGY, V110, P1379, DOI 10.1097/ALN.0b013e31819fccd5; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XN, 2007, NAT NEUROSCI, V10, P177, DOI 10.1038/nn1841; Xu HY, 2003, NEUROPSYCHOPHARMACOL, V28, P53, DOI 10.1038/sj.npp.1300009; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zhang LH, 2008, BRAIN RES BULL, V77, P55, DOI 10.1016/j.brainresbull.2008.03.014; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	50	73	75	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21660	10.1371/journal.pone.0021660	http://dx.doi.org/10.1371/journal.pone.0021660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738757	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600069
J	Heni, M; Hennige, AM; Peter, A; Siegel-Axel, D; Ordelheide, AM; Krebs, N; Machicao, F; Fritsche, A; Haring, HU; Staiger, H				Heni, Martin; Hennige, Anita M.; Peter, Andreas; Siegel-Axel, Dorothea; Ordelheide, Anna-Maria; Krebs, Norbert; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald			Insulin Promotes Glycogen Storage and Cell Proliferation in Primary Human Astrocytes	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN ENERGY-METABOLISM; GLUCOSE-TRANSPORTER; STIMULATION; RAT; EXPRESSION; LACTATE; BARRIER; OBESITY	Introduction: In the human brain, there are at least as many astrocytes as neurons. Astrocytes are known to modulate neuronal function in several ways. Thus, they may also contribute to cerebral insulin actions. Therefore, we examined whether primary human astrocytes are insulin-responsive and whether their metabolic functions are affected by the hormone. Methods: Commercially available Normal Human Astrocytes were grown in the recommended medium. Major players in the insulin signaling pathway were detected by real-time RT-PCR and Western blotting. Phosphorylation events were detected by phospho-specific antibodies. Glucose uptake and glycogen synthesis were assessed using radio-labeled glucose. Glycogen content was assessed by histochemistry. Lactate levels were measured enzymatically. Cell proliferation was assessed by WST-1 assay. Results: We detected expression of key proteins for insulin signaling, such as insulin receptor beta-subunit, insulin receptor substrat-1, Akt/protein kinase B and glycogen synthase kinase 3, in human astrocytes. Akt was phosphorylated and PI-3 kinase activity increased following insulin stimulation in a dose-dependent manner. Neither increased glucose uptake nor lactate secretion after insulin stimulation could be evidenced in this cell type. However, we found increased insulin-dependent glucose incorporation into glycogen. Furthermore, cell numbers increased dose-dependently upon insulin treatment. Discussion: This study demonstrated that human astrocytes are insulin-responsive at the molecular level. We identified glycogen synthesis and cell proliferation as biological responses of insulin signaling in these brain cells. Hence, this cell type may contribute to the effects of insulin in the human brain.	[Heni, Martin; Hennige, Anita M.; Peter, Andreas; Siegel-Axel, Dorothea; Ordelheide, Anna-Maria; Krebs, Norbert; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen	Heni, M (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333	German Diabetes Association (DDG); University of Tubingen [1908-0-0]; German Federal Ministry of Education and Research (BMBF)	German Diabetes Association (DDG); University of Tubingen; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported in part by grants from the German Diabetes Association (DDG) and the University of Tubingen (fortune-program, grant 1908-0-0) to MH and a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The other part was funded by the institutional budget. Funding was obtained for direct costs (DDG, DZD, fortune) and for staff (fortune). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barres BA, 2003, GLIA, V43, P4, DOI 10.1002/glia.10252; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Cidad P, 2001, J NEUROCHEM, V79, P17, DOI 10.1046/j.1471-4159.2001.00523.x; Cloix JF, 2009, CURR MED CHEM, V16, P841, DOI 10.2174/092986709787549316; DRINGEN R, 1992, J NEUROCHEM, V58, P511, DOI 10.1111/j.1471-4159.1992.tb09750.x; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; Guthoff M, 2010, J CLIN ENDOCR METAB, V95, P748, DOI 10.1210/jc.2009-1677; Hallschmid M, 2009, DIABETOLOGIA, V52, P2264, DOI 10.1007/s00125-009-1501-x; Hamai M, 1999, J NEUROCHEM, V73, P400, DOI 10.1046/j.1471-4159.1999.0730400.x; HASELBACHER GK, 1985, P NATL ACAD SCI USA, V82, P2153, DOI 10.1073/pnas.82.7.2153; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Hilgetag CC, 2009, BRAIN STRUCT FUNCT, V213, P365, DOI 10.1007/s00429-009-0202-z; Kausch C, 2003, HORM METAB RES, V35, P570, DOI 10.1055/s-2003-43501; Kern W, 2006, DIABETOLOGIA, V49, P2790, DOI 10.1007/s00125-006-0409-y; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; KUM W, 1992, GLIA, V6, P264, DOI 10.1002/glia.440060404; Laron Zvi, 2009, Archives of Physiology and Biochemistry, V115, P112, DOI 10.1080/13813450902949012; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Mangia S, 2009, J NEUROCHEM, V109, P55, DOI 10.1111/j.1471-4159.2009.06003.x; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Mussig K, 2010, EXP CLIN ENDOCR DIAB, V118, P356, DOI 10.1055/s-0029-1243603; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; SWANSON RA, 1992, NEUROSCIENCE, V51, P451, DOI 10.1016/0306-4522(92)90329-Z; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wiesinger H, 1997, GLIA, V21, P22, DOI 10.1002/(SICI)1098-1136(199709)21:1<22::AID-GLIA3>3.0.CO;2-3; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	40	108	109	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21594	10.1371/journal.pone.0021594	http://dx.doi.org/10.1371/journal.pone.0021594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738722	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600058
J	Shin, J; Lee, HJ; Jung, DB; Jung, JH; Lee, HJ; Lee, EO; Lee, SG; Shim, BS; Choi, SH; Ko, SG; Ahn, KS; Jeong, SJ; Kim, SH				Shin, Jimin; Lee, Hyo-Jeong; Jung, Deok-Beom; Jung, Ji Hoon; Lee, Hyo-Jung; Lee, Eun-Ok; Lee, Seok Geun; Shim, Beom Sang; Choi, Seung Hoon; Ko, Seong Gyu; Ahn, Kwang Seok; Jeong, Soo-Jin; Kim, Sung-Hoon			Suppression of STAT3 and HIF-1 Alpha Mediates Anti-Angiogenic Activity of Betulinic Acid in Hypoxic PC-3 Prostate Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR 1-ALPHA; VEGF EXPRESSION; SIGNAL TRANSDUCER; HUMAN-MELANOMA; ACTIVATION; APOPTOSIS; INDUCTION; THERAPY; TRANSCRIPTION	Background: Signal transducer and activator of transcription 3 (STAT3) is a transcription factor that regulates various cellular processes such as cell survival, angiogenesis and proliferation. In the present study, we examined that betulinic acid (BA), a triterpene from the bark of white birch, had the inhibitory effects on hypoxia-mediated activation of STAT3 in androgen independent human prostate cancer PC-3 cells. Methodology/Principal Findings: BA inhibited the protein expression and the transcriptional activities of hypoxia-inducible factor-1 alpha (HIF-1 alpha) under hypoxic condition. Consistently, BA blocked hypoxia-induced phosphorylation, DNA binding activity and nuclear accumulation of STAT3. In addition, BA significantly reduced cellular and secreted levels of vascular endothelial growth factor (VEGF), a critical angiogenic factor and a target gene of STAT3 induced under hypoxia. Furthermore, BA prevented in vitro capillary tube formation in human umbilical vein endothelial cells (HUVECs) maintained in conditioned medium of hypoxic PC-3 cells, implying anti-angiogenic activity of BA under hypoxic condition. Of note, chromatin immunoprecipitation (ChiP) assay revealed that BA inhibited binding of HIF-1 alpha and STAT3 to VEGF promoter. Furthermore, silencing STAT3 using siRNA transfection effectively enhanced the reduced VEGF production induced by BA treatment under hypoxia. Conclusions/Significance: Taken together, our results suggest that BA has anti-angiogenic activity by disturbing the binding of HIF-1 alpha and STAT3 to the VEGF promoter in hypoxic PC-3 cells.	[Shin, Jimin; Lee, Hyo-Jeong; Jung, Deok-Beom; Jung, Ji Hoon; Lee, Hyo-Jung; Lee, Eun-Ok; Lee, Seok Geun; Shim, Beom Sang; Choi, Seung Hoon; Ko, Seong Gyu; Ahn, Kwang Seok; Jeong, Soo-Jin; Kim, Sung-Hoon] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea	Kyung Hee University	Shin, J (corresponding author), Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea.	sungkim7@khu.ac.kr	Shim, Bum-sang/AAH-9081-2020; Lee, Eun-Ok/AAH-9116-2020; Ahn, Kwang Seok/G-4249-2013; Lee, Seok-Geun/B-3408-2011	Lee, Seok-Geun/0000-0002-0060-5777; kim, sunghoon/0000-0002-1570-3230	Korean government (MEST) [2011-0063466]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the Korea Science and Engineering Foundation (KOSEF) Grant funded by the Korean government (MEST) (No. 2011-0063466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Chadalapaka G, 2010, MOL CANCER RES, V8, P739, DOI 10.1158/1541-7786.MCR-09-0493; Choo EJ, 2011, BIOL PHARM BULL, V34, P41, DOI 10.1248/bpb.34.41; DECLERCQ E, 1995, CLIN MICROBIOL REV, V8, P200, DOI 10.1128/CMR.8.2.200; Eichenmuller M, 2010, BRIT J CANCER, V103, P43, DOI 10.1038/sj.bjc.6605715; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fulda S, 1997, CANCER RES, V57, P4956; Fulda S, 2009, MOL NUTR FOOD RES, V53, P140, DOI 10.1002/mnfr.200700491; Gariboldi MB, 2010, BIOCHEM PHARMACOL, V80, P455, DOI 10.1016/j.bcp.2010.05.011; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Karna E, 2010, MOL CELL BIOCHEM, V340, P15, DOI 10.1007/s11010-010-0395-8; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Kim SH, 2011, EUR J PHARMACOL, V654, P10, DOI 10.1016/j.ejphar.2010.11.032; KINGSTON DGI, 1978, LLOYDIA, V41, P499; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Lee HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012358; Leeman-Neill RJ, 2009, CARCINOGENESIS, V30, P1848, DOI 10.1093/carcin/bgp211; MILES DH, 1974, J PHARM SCI, V63, P613, DOI 10.1002/jps.2600630427; Mukherjee PK, 1997, PLANTA MED, V63, P367, DOI 10.1055/s-2006-957705; Mullauer FB, 2010, ANTI-CANCER DRUG, V21, P215, DOI 10.1097/CAD.0b013e3283357c62; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Pandey MK, 2010, INT J CANCER, V127, P282, DOI 10.1002/ijc.25059; Park KY, 2010, BIOL PHARM BULL, V33, P1835, DOI 10.1248/bpb.33.1835; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rabi T, 2008, MOL CARCINOGEN, V47, P964, DOI 10.1002/mc.20447; Rieber M, 1998, DNA CELL BIOL, V17, P399, DOI 10.1089/dna.1998.17.399; Selzer E, 2000, J INVEST DERMATOL, V114, P935, DOI 10.1046/j.1523-1747.2000.00972.x; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; TRUMBULL ER, 1976, J PHARM SCI, V65, P1407, DOI 10.1002/jps.2600650938; Wei DY, 2003, ONCOGENE, V22, P319, DOI 10.1038/sj.onc.1206122; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Zhang JH, 2009, PHARM RES-DORDR, V26, P2066, DOI 10.1007/s11095-009-9932-0; Zhong H, 1999, CANCER RES, V59, P5830; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	40	61	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21492	10.1371/journal.pone.0021492	http://dx.doi.org/10.1371/journal.pone.0021492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731766	Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900042
J	Mumby, PJ; Harborne, AR; Brumbaugh, DR				Mumby, Peter J.; Harborne, Alastair R.; Brumbaugh, Daniel R.			Grouper as a Natural Biocontrol of Invasive Lionfish	PLOS ONE			English	Article							CORAL-REEF FISHES; INDO-PACIFIC LIONFISH; PTEROIS-VOLITANS; FLORIDA-KEYS; RECRUITMENT; PREDATION; MANGROVES; ENHANCE	Lionfish (Pterois volitans/miles) have invaded the majority of the Caribbean region within five years. As voracious predators of native fishes with a broad habitat distribution, lionfish are poised to cause an unprecedented disruption to coral reef diversity and function. Controls of lionfish densities within its native range are poorly understood, but they have been recorded in the stomachs of large-bodied Caribbean groupers. Whether grouper predation of lionfish is sufficient to act as a biocontrol of the invasive species is unknown, but pest biocontrol by predatory fishes has been reported in other ecosystems. Groupers were surveyed along a chain of Bahamian reefs, including one of the region's most successful marine reserves which supports the top one percentile of Caribbean grouper biomass. Lionfish biomass exhibited a 7-fold and non-linear reduction in relation to the biomass of grouper. While Caribbean grouper appear to be a biocontrol of invasive lionfish, the overexploitation of their populations by fishers, means that their median biomass on Caribbean reefs is an order of magnitude less than in our study. Thus, chronic overfishing will probably prevent natural biocontrol of lionfishes in the Caribbean.	[Mumby, Peter J.; Harborne, Alastair R.] Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia; [Mumby, Peter J.; Harborne, Alastair R.] Univ Exeter, Coll Life & Environm Sci, Hatherly Lab, Exeter, Devon, England; [Brumbaugh, Daniel R.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Brumbaugh, Daniel R.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of Queensland; University of Exeter; American Museum of Natural History (AMNH); University of California System; University of California Santa Cruz	Mumby, PJ (corresponding author), Univ Queensland, Sch Biol Sci, Marine Spatial Ecol Lab, St Lucia, Qld, Australia.	p.j.mumby@uq.edu.au	Mumby, Peter/F-9914-2010; Harborne, Alastair R/F-6155-2013	Mumby, Peter/0000-0002-6297-9053; Harborne, Alastair R/0000-0002-6818-8615	ARC; NERC [NE/F015704/1]; EU; Pew Fellowship; Natural Environment Research Council [NE/F015704/1, NE/G017344/1] Funding Source: researchfish; NERC [NE/G017344/1] Funding Source: UKRI	ARC(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); Pew Fellowship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by an ARC (http://www.arc.gov.au/) Laureate Fellowship, NERC (http://www.nerc.ac.uk/) grant, EU FORCE project, and Pew Fellowship (www.pewenvironment.org) to PJM and a NERC Fellowship (NE/F015704/1) to ARH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; [Anonymous], 1988, NMFSSEFC215 NOAA; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; BERNADSKY G, 1991, COPEIA, P230; Cerino C, 2010, THESIS E CAROLINA U; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Eggleston DB, 1998, B MAR SCI, V63, P111; Eilenberg J, 2001, BIOCONTROL, V46, P387, DOI 10.1023/A:1014193329979; Hein CL, 2006, CAN J FISH AQUAT SCI, V63, P383, DOI 10.1139/F05-229; Humann P., 2002, REEF FISH IDENTIFICA; JUD ZR, 2011, AQUATIC BIO IN PRESS; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Maljkovic A, 2008, CORAL REEFS, V27, P501, DOI 10.1007/s00338-008-0372-9; McClenachan L, 2009, CONSERV BIOL, V23, P636, DOI 10.1111/j.1523-1739.2008.01152.x; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; SADOVY Y, 1999, FAO FISHERIES SYNOPS, V157, P65; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Semmens BX, 2004, MAR ECOL PROG SER, V266, P239, DOI 10.3354/meps266239; Sluka R, 1998, B MAR SCI, V62, P219; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stallings CD, 2009, MAR ECOL PROG SER, V383, P251, DOI 10.3354/meps08004; Steneck RS, 2009, CORAL REEFS, V28, P367, DOI 10.1007/s00338-009-0470-3	30	112	121	5	196	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21510	10.1371/journal.pone.0021510	http://dx.doi.org/10.1371/journal.pone.0021510			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731769	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400044
J	Selamat, SA; Galler, JS; Joshi, AD; Fyfe, MN; Campan, M; Siegmund, KD; Kerr, KM; Laird-Offringa, IA				Selamat, Suhaida A.; Galler, Janice S.; Joshi, Amit D.; Fyfe, M. Nicky; Campan, Mihaela; Siegmund, Kimberly D.; Kerr, Keith M.; Laird-Offringa, Ite A.			DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma	PLOS ONE			English	Article							FRIZZLED-RELATED PROTEIN-1; CPG ISLAND METHYLATION; GROUND-GLASS OPACITY; PROMOTER HYPERMETHYLATION; ABERRANT METHYLATION; CANCER INCIDENCE; EPIGENETIC INACTIVATION; POTENTIAL BIOMARKER; SOMATIC MUTATIONS; RASSF1A PROMOTER	Background: Aberrant DNA methylation is common in lung adenocarcinoma, but its timing in the phases of tumor development is largely unknown. Delineating when abnormal DNA methylation arises may provide insight into the natural history of lung adenocarcinoma and the role that DNA methylation alterations play in tumor formation. Methodology/Principal Findings: We used MethyLight, a sensitive real-time PCR-based quantitative method, to analyze DNA methylation levels at 15 CpG islands that are frequently methylated in lung adenocarcinoma and that we had flagged as potential markers for non-invasive detection. We also used two repeat probes as indicators of global DNA hypomethylation. We examined DNA methylation in 249 tissue samples from 93 subjects, spanning the putative spectrum of peripheral lung adenocarcinoma development: histologically normal adjacent non-tumor lung, atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS, formerly known as bronchioloalveolar carcinoma), and invasive lung adenocarcinoma. Comparison of DNA methylation levels between the lesion types suggests that DNA hypermethylation of distinct loci occurs at different time points during the development of lung adenocarcinoma. DNA methylation at CDKN2A ex2 and PTPRN2 is already significantly elevated in AAH, while CpG islands at 2C35, EYA4, HOXA1, HOXA11, NEUROD1, NEUROD2 and TMEFF2 are significantly hypermethylated in AIS. In contrast, hypermethylation at CDH13, CDX2, OPCML, RASSF1, SFRP1 and TWIST1 and global DNA hypomethylation appear to be present predominantly in invasive cancer. Conclusions/Significance: The gradual increase in DNA methylation seen for numerous loci in progressively more transformed lesions supports the model in which AAH and AIS are sequential stages in the development of lung adenocarcinoma. The demarcation of DNA methylation changes characteristic for AAH, AIS and adenocarcinoma begins to lay out a possible roadmap for aberrant DNA methylation events in tumor development. In addition, it identifies which DNAmethylation changes might be used as molecular markers for the detection of preinvasive lesions.	[Selamat, Suhaida A.; Galler, Janice S.; Campan, Mihaela; Laird-Offringa, Ite A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; [Selamat, Suhaida A.; Galler, Janice S.; Campan, Mihaela; Laird-Offringa, Ite A.] Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Joshi, Amit D.; Siegmund, Kimberly D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Fyfe, M. Nicky; Kerr, Keith M.] Univ Aberdeen, Dept Pathol, Aberdeen Royal Infirm, Aberdeen, Scotland	University of Southern California; University of Southern California; University of Southern California; University of Aberdeen	Selamat, SA (corresponding author), Univ So Calif, Keck Sch Med, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA.	ilaird@usc.edu	Offringa, Ite/R-4101-2019	Selamat, Suhaida/0000-0002-7185-6995	Joan's Legacy (now called Uniting Against Lung Cancer); Thomas G. Labrecque Foundation; NIH/NCI [5R01CA120869]; National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [R01CA120869, P30CA014089, R01CA097346] Funding Source: NIH RePORTER	Joan's Legacy (now called Uniting Against Lung Cancer); Thomas G. Labrecque Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants to Ite Laird-Offringa from Joan's Legacy (now called Uniting Against Lung Cancer) and the Thomas G. Labrecque Foundation, and NIH/NCI grant 5R01CA120869. The project was also supported in part by award number P30CA014089 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Ahuja N, 1998, CANCER RES, V58, P5489; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-81; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Anisowicz Anthony, 2008, BMC Cancer, V8, P222, DOI 10.1186/1471-2407-8-222; Au JSK, 2004, LUNG CANCER, V45, P143, DOI 10.1016/j.lungcan.2004.01.012; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 2005, CARCINOGENESIS, V26, P1481, DOI 10.1093/carcin/bgi020; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Black WC, 2000, J NATL CANCER I, V92, P1280, DOI 10.1093/jnci/92.16.1280; Blanco D, 2007, NEOPLASIA, V9, P840, DOI 10.1593/neo.07517; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Chapman AD, 2000, BRIT J CANCER, V83, P632, DOI 10.1054/bjoc.2000.1317; Chen F, 2007, CANCER EPIDEM BIOMAR, V16, P2724, DOI 10.1158/1055-9965.EPI-07-0455; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Ferlay J, 2010, INT J CANC; Fiegl H, 2008, CLIN CANCER RES, V14, P3494, DOI 10.1158/1078-0432.CCR-07-4557; Fukui T, 2005, ONCOGENE, V24, P6323, DOI 10.1038/sj.onc.1208777; Funama Y, 2009, J COMPUT ASSIST TOMO, V33, P49, DOI 10.1097/RCT.0b013e31815e6291; Garcia M, 2007, GLOBAL CANC FACTS FI; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Hanabata T, 2004, ONCOL REP, V12, P177; Harkness EF, 2002, INT J CANCER, V102, P179, DOI 10.1002/ijc.10661; HAYASHI N, 1994, BIOCHEM BIOPH RES CO, V202, P1426, DOI 10.1006/bbrc.1994.2090; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Horner MJ, 2009, SEER CANC STAT REV 1; Ikeda K, 2007, CHEST, V132, P984, DOI 10.1378/chest.07-0793; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kawai H, 2005, ONCOL REP, V13, P547; Kawasaki E, 1996, DIABETES, V45, P1344, DOI 10.2337/diabetes.45.10.1344; Kerr KM, 2007, DIS MARKERS, V23, P5, DOI 10.1155/2007/985474; Kerr KM, 2001, J CLIN PATHOL, V54, P257, DOI 10.1136/jcp.54.4.257; Kim DH, 2003, CANCER RES, V63, P3743; Kim JS, 2005, CANCER, V104, P1825, DOI 10.1002/cncr.21409; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Koyi H, 2002, LUNG CANCER-J IASLC, V36, P9, DOI 10.1016/S0169-5002(01)00451-2; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Licchesi JDF, 2008, CARCINOGENESIS, V29, P895, DOI 10.1093/carcin/bgn017; Licchesi JDF, 2008, CLIN CANCER RES, V14, P2570, DOI 10.1158/1078-0432.CCR-07-2033; MANECKJEE R, 1990, P NATL ACAD SCI USA, V87, P3294, DOI 10.1073/pnas.87.9.3294; Maruyama R, 2004, CANCER-AM CANCER SOC, V100, P1472, DOI 10.1002/cncr.20144; Mehrotra J, 2004, CLIN CANCER RES, V10, P3104, DOI 10.1158/1078-0432.CCR-03-0118; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Morandi L, 2007, LUNG CANCER, V56, P35, DOI 10.1016/j.lungcan.2006.11.022; Muggerud AA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2466; *NAT LUNG SCREEN T, 2010, RAD; Navis AC, 2010, ACTA NEUROPATHOL, V119, P157, DOI 10.1007/s00401-009-0614-0; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Niklinska W, 2009, FOLIA HISTOCHEM CYTO, V47, P275, DOI 10.2478/v10042-009-0091-2; Niu RF, 2007, J EXP CLIN CANC RES, V26, P385; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; PARK SY, 2010, PROMOTER CPG ISLAND; Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097; Pike BL, 2008, LEUKEMIA, V22, P1035, DOI 10.1038/leu.2008.18; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Sakamoto H, 2007, J PATHOL, V212, P287, DOI 10.1002/path.2165; Sato M, 1998, HUM GENET, V103, P96, DOI 10.1007/s004390050790; Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shimada A, 2005, CANCER SCI, V96, P668, DOI 10.1111/j.1349-7006.2005.00100.x; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Suzuki M, 2006, CANCER-AM CANCER SOC, V106, P2200, DOI 10.1002/cncr.21853; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; Takamochi K, 2001, AM J PATHOL, V159, P1941, DOI 10.1016/S0002-9440(10)63041-6; Takeyama N, 2009, LIFE SCI, V84, P678, DOI 10.1016/j.lfs.2009.02.012; Tanaka K, 2007, BIOORG MED CHEM LETT, V17, P1912, DOI 10.1016/j.bmcl.2007.01.040; Tomizawa Y, 2002, CLIN CANCER RES, V8, P2362; Toyooka KO, 2001, CANCER RES, V61, P4556; Toyooka S, 2001, MOL CANCER THER, V1, P61; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; TRAVIS WD, 1999, WHO INT HISTOLOGICAL, P29; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tse LA, 2009, LUNG CANCER, V66, P22, DOI 10.1016/j.lungcan.2008.12.023; Tsou JA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-70; Ulivi P, 2006, J CELL PHYSIOL, V206, P611, DOI 10.1002/jcp.20503; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; Wang L, 2006, WORLD J GASTROENTERO, V12, P6949, DOI 10.3748/wjg.v12.i43.6949; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; WEISENBERGER DJ, 2008, NUCL ACIDS IN PRESS; Westra W H, 2000, Respir Res, V1, P163, DOI 10.1186/rr28; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406; Zhang YW, 2010, NEOPLASMA, V57, P228, DOI 10.4149/neo_2010_03_228; Zhong Y, 2001, CLIN CANCER RES, V7, P1683; Zou HZ, 2005, CANCER EPIDEM BIOMAR, V14, P830, DOI 10.1158/1055-9965.EPI-04-0506	104	73	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21443	10.1371/journal.pone.0021443	http://dx.doi.org/10.1371/journal.pone.0021443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731750	gold, Green Published, Green Submitted			2022-12-25	WOS:000292035400038
J	Enjalbert, B; Jourdan, F; Portais, JC				Enjalbert, Brice; Jourdan, Fabien; Portais, Jean-Charles			Intuitive Visualization and Analysis of Multi-Omics Data and Application to Escherichia coli Carbon Metabolism	PLOS ONE			English	Article							SOFTWARE	Combinations of 'omics' investigations (i.e, transcriptomic, proteomic, metabolomic and/or fluxomic) are increasingly applied to get comprehensive understanding of biological systems. Because the latter are organized as complex networks of molecular and functional interactions, the intuitive interpretation of multi-omics datasets is difficult. Here we describe a simple strategy to visualize and analyze multi-omics data. Graphical representations of complex biological networks can be generated using Cytoscape where all molecular and functional components could be explicitly represented using a set of dedicated symbols. This representation can be used i) to compile all biologically-relevant information regarding the network through web link association, and ii) to map the network components with multi-omics data. A Cytoscape plugin was developed to increase the possibilities of both multi-omic data representation and interpretation. This plugin allowed different adjustable colour scales to be applied to the various omics data and performed the automatic extraction and visualization of the most significant changes in the datasets. For illustration purpose, the approach was applied to the central carbon metabolism of Escherichia coli. The obtained network contained 774 components and 1232 interactions, highlighting the complexity of bacterial multi-level regulations. The structured representation of this network represents a valuable resource for systemic studies of E. coli, as illustrated from the application to multi-omics data. Some current issues in network representation are discussed on the basis of this work.	[Enjalbert, Brice; Portais, Jean-Charles] Univ Toulouse, INSA, UPS, INP, Toulouse, France; [Enjalbert, Brice; Portais, Jean-Charles] INRA, Ingn Syst Biol & Procedes UMR792, F-31931 Toulouse, France; [Enjalbert, Brice; Portais, Jean-Charles] CNRS, UMR5504, Toulouse, France; [Jourdan, Fabien] INRA, UMR Xenobiot 1089, F-31931 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE	Enjalbert, B (corresponding author), Univ Toulouse, INSA, UPS, INP, Toulouse, France.	jean-charles.portais@insa-toulouse.fr	Jourdan, Fabien/AAW-5075-2021	Jourdan, Fabien/0000-0001-9401-2894; Enjalbert, Brice/0000-0003-1291-1373; Portais, Jean-Charles/0000-0002-3480-0933	French "Agence Nationale de la Recherche" (ANR) [ANR-06-BYOS-0003-03]	French "Agence Nationale de la Recherche" (ANR)(French National Research Agency (ANR))	This work was supported by the French "Agence Nationale de la Recherche" (ANR, Project no ANR-06-BYOS-0003-03) from which BE received a post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourqui R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-29; Frankel F, 2008, NATURE, V455, P30, DOI 10.1038/455030a; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; HERMAN I, 2000, DENSITY FUNCTIONS VI, P49; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Le Fevre F, 2007, BIOINFORMATICS, V23, P1299, DOI 10.1093/bioinformatics/btm107; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Liebers A., 2001, Journal of Graph Algorithms and Applications, V5; MEDIGUE C, 1993, MICROBIOL REV, V57, P623; NEUWEGER H, 2010, BMC SYST BIOL, V23, P82; Noble, 2006, MUSIC LIFE BIOL GENO; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shannon PT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-176; Aoki Kiyoko F, 2005, Curr Protoc Bioinformatics, VChapter 1, DOI [10.1002/0471250953.bi0112s38, 10.1002/0471250953.bi0112s11]; Wegner K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-212	21	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21318	10.1371/journal.pone.0021318	http://dx.doi.org/10.1371/journal.pone.0021318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731702	Green Published, gold, Green Submitted			2022-12-25	WOS:000292033700063
J	Lee, JH; Voortman, J; Dingemans, AMC; Voeller, DM; Pham, T; Wang, YS; Giaccone, G				Lee, Jih-Hsiang; Voortman, Johannes; Dingemans, Anne-Marie C.; Voeller, Donna M.; Pham, Trung; Wang, Yisong; Giaccone, Giuseppe			MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer	PLOS ONE			English	Article							PREDICTS SURVIVAL; GENE-EXPRESSION; DOWN-REGULATION; MIR-34A; CARCINOMA; FAMILY; CHEMORESISTANCE; CHEMOTHERAPY; APOPTOSIS; INVASION	The role of microRNAs in small-cell lung carcinoma (SCLC) is largely unknown. miR-34a is known as a p53 regulated tumor suppressor microRNA in many cancer types. However, its therapeutic implication has never been studied in SCLC, a cancer type with frequent dysfunction of p53. We investigated the expression of a panel of 7 microRNAs (miR-21, miR-29b, miR-34a/b/c, miR-155, and let-7a) in 31 SCLC tumors, 14 SCLC cell lines, and 26 NSCLC cell lines. We observed significantly lower miR-21, miR-29b, and miR-34a expression in SCLC cell lines than in NSCLC cell lines. The expression of the 7 microRNAs was unrelated to SCLC patients' clinical characteristics and was neither prognostic in term of overall survival or progression-free survival nor predictive of treatment response. Overexpression or downregulation of miR-34a did not influence SCLC cell viability. The expression of these 7 microRNAs also did not predict in vitro sensitivity to cisplatin or etoposide in SCLC cell lines. Overexpression or downregulation of miR-34a did not influence sensitivity to cisplatin or etoposide in SCLC cell lines. In contrast to downregulation of the miR-34a target genes cMET and Axl by overexpression of miR-34a in NSCLC cell lines, the intrinsic expression of cMET and Axl was low in SCLC cell lines and was not influenced by overexpression of miR-34a. Our results suggest that the expression of the 7 selected microRNAs are not prognostic in SCLC patients, and miR-34a is unrelated to the malignant behavior of SCLC cells and is unlikely to be a therapeutic target.	[Lee, Jih-Hsiang; Voortman, Johannes; Voeller, Donna M.; Pham, Trung; Wang, Yisong; Giaccone, Giuseppe] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Dingemans, Anne-Marie C.] Maastricht Univ Med Ctr, GROW Sch Oncol & Dev Biol, Dept Resp Med, Maastricht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maastricht University; Maastricht University Medical Centre (MUMC)	Lee, JH (corresponding author), NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA.	giacconeg@mail.nih.gov	Voortman, J/AAO-1289-2020; Giaccone, Giuseppe/E-8297-2017	Giaccone, Giuseppe/0000-0002-5023-7562	National Institutes of Health, National Cancer Institute	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by the National Institutes of Health, National Cancer Institute intramural program. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Dingemans AMC, 1999, CLIN CANCER RES, V5, P2048; Du LQ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-75; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Guo LL, 2010, EUR J CANCER, V46, P1692, DOI 10.1016/j.ejca.2010.02.043; Harada T, 2011, ONCOGENE, V30, P1744, DOI 10.1038/onc.2010.545; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hurwitz JL, 2009, ONCOLOGIST, V14, P986, DOI 10.1634/theoncologist.2009-0026; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Ichimura A, 2010, MOL PHARMACOL, V77, P1016, DOI 10.1124/mol.109.063321; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Ranade AR, 2010, J THORAC ONCOL, V5, P1273, DOI 10.1097/JTO.0b013e3181dea6be; Voortman J, 2010, CANCER RES, V70, P8288, DOI 10.1158/0008-5472.CAN-10-1348; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	34	53	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21300	10.1371/journal.pone.0021300	http://dx.doi.org/10.1371/journal.pone.0021300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731696	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700058
J	Luk, JM; Burchard, J; Zhang, CS; Liu, AM; Wong, KF; Shek, FH; Lee, NP; Fan, ST; Poon, RT; Ivanovska, I; Philippar, U; Cleary, MA; Buser, CA; Shaw, PM; Lee, CN; Tenen, DG; Dai, HY; Mao, M				Luk, John M.; Burchard, Julja; Zhang, Chunsheng; Liu, Angela M.; Wong, Kwong F.; Shek, Felix H.; Lee, Nikki P.; Fan, Sheung Tat; Poon, Ronnie T.; Ivanovska, Irena; Philippar, Ulrike; Cleary, Michele A.; Buser, Carolyn A.; Shaw, Peter M.; Lee, Chuen-Neng; Tenen, Daniel G.; Dai, Hongyue; Mao, Mao			DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-CANCER; EXPRESSION; CELLS; PROGNOSIS; MOUSE-CHROMOSOME-12; IDENTIFICATION; PROGRESSION; ACTIVATION; BIOMARKERS; TARGETS	Hepatocellular carcinoma (HCC) is a heterogeneous and highly aggressive malignancy, for which there are no effective cures. Identification of a malignant stemlike subtype of HCC may offer patients with a dismal prognosis a potential targeted therapy using c-MET and Wnt pathway inhibitors. MicroRNAs (miRNAs) show promise as diagnostic and prognostic tools for cancer detection and stratification. Using a TRE-c-Met-driven transgenic HCC mouse model, we identified a cluster of 23 miRNAs that is encoded within the Dlk1Gtl2 imprinted region on chromosome 12qF1 overexpressed in all of the isolated liver tumors. Interestingly, this region is conserved among mammalian species and maps to the human DLK1-DIO3 region on chromosome 14q32.2. We thus examined the expression of the DLK1-DIO3 miRNA cluster in a cohort of 97 hepatitis B virus-associated HCC patients and identified a subgroup (n = 18) of patients showing strong coordinate overexpression of miRNAs in this cluster but not in other cancer types (breast, lung, kidney, stomach, and colon) that were tested. Expression levels of imprinted gene transcripts from neighboring loci in this 14q32.2 region and from a subset of other imprinted sites were concomitantly elevated in human HCC. Interestingly, overexpression of the DLK1-DIO3 miRNA cluster was positively correlated with HCC stem cell markers (CD133, CD90, EpCAM, Nestin) and associated with a high level of serum alpha-fetoprotein, a conventional biomarker for liver cancer, and poor survival rate in HCC patients. In conclusion, our findings suggest that coordinate up-regulation of the DLK1-DIO3 miRNA cluster at 14q32.2 may define a novel molecular (stem cell-like) subtype of HCC associated with poor prognosis.	[Luk, John M.; Liu, Angela M.] NUS, Dept Pharmacol, Singapore 117597, Singapore; [Luk, John M.; Wong, Kwong F.; Tenen, Daniel G.] NUS, Canc Sci Inst, Singapore 117597, Singapore; [Luk, John M.; Lee, Chuen-Neng] NUS, Dept Surg, Singapore 117597, Singapore; [Burchard, Julja; Zhang, Chunsheng; Ivanovska, Irena; Dai, Hongyue; Mao, Mao] Merck & Co Inc, Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Burchard, Julja; Cleary, Michele A.] Merck & Co Inc, Sirna Therapeut Inc, San Francisco, CA 94158 USA; [Zhang, Chunsheng; Ivanovska, Irena; Philippar, Ulrike; Dai, Hongyue] Merck Res Labs, Boston, MA 02115 USA; [Liu, Angela M.; Shek, Felix H.; Lee, Nikki P.; Fan, Sheung Tat; Poon, Ronnie T.] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Cleary, Michele A.; Buser, Carolyn A.] Merck & Co Inc, West Point, PA 19486 USA; [Shaw, Peter M.] Merck & Co Inc, Upper Gwynedd, PA 19454 USA; [Tenen, Daniel G.] Harvard Stem Cell Inst, Boston, MA 02115 USA	National University of Singapore; National University of Singapore; National University of Singapore; Merck & Company; Merck & Company; Merck & Company; University of Hong Kong; Merck & Company; Merck & Company; Harvard University	Luk, JM (corresponding author), NUS, Dept Pharmacol, Singapore 117597, Singapore.	jmluk@nus.edu.sg; Hongyue_dai@merck.com; mao.mao@pfizer.com	liang, yan/H-3894-2011; Lee, Chuen Neng/B-4516-2011; Luk, John/A-4085-2008	Lee, Chuen Neng/0000-0001-9748-4424; Luk, John/0000-0002-6323-7940; Tenen, Daniel/0000-0002-6423-3888; Zhang, Chengfei/0000-0002-6016-9436				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Eklund AC, 2006, NAT BIOTECHNOL, V24, P1071, DOI 10.1038/nbt0906-1071; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hao K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-389; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Ip WK, 2007, CANCER LETT, V250, P284, DOI 10.1016/j.canlet.2006.10.012; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Lee NP, 2009, J PROTEOME RES, V8, P1293, DOI 10.1021/pr800637z; Lee TKW, 2009, LIVER INT, V29, P955, DOI 10.1111/j.1478-3231.2009.02040.x; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu AM, 2011, OMICS, V15, P187, DOI 10.1089/omi.2010.0098; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Mok BW, 1999, FEBS LETT, V453, P243, DOI 10.1016/S0014-5793(99)00714-0; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Thorvaldsen JL, 2007, CELL, V130, DOI 10.1016/j.cell.2007.08.033; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Wu J, 2008, GENOMICS, V91, P443, DOI 10.1016/j.ygeno.2008.01.007; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang XR, 2010, GUT, V59, P953, DOI 10.1136/gut.2008.176271; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yao XM, 2003, J CLIN INVEST, V111, P265, DOI 10.1172/JCI200315109	39	121	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30706	30713		10.1074/jbc.M111.229831	http://dx.doi.org/10.1074/jbc.M111.229831			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21737452	Green Published, hybrid			2022-12-25	WOS:000294283600050
J	Nam, SW; Chen, X; Lim, J; Kim, SH; Kim, ST; Cho, YH; Yoon, J; Park, S				Nam, Seong-Won; Chen, Xiaoqiang; Lim, Jeesun; Kim, So Hyun; Kim, Sang-Tae; Cho, You-Hee; Yoon, Juyoung; Park, Sungsu			In Vivo Fluorescence Imaging of Bacteriogenic Cyanide in the Lungs of Live Mice Infected with Cystic Fibrosis Pathogens	PLOS ONE			English	Article							BURKHOLDERIA-CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; SELECTIVE CHEMOSENSOR; HYDROGEN-CYANIDE; RAT MODEL; GROWTH; EPIDEMIOLOGY; ACCUMULATION; DYSFUNCTION; INDUCTION	Background: Pseudomonas aeruginosa (PA) and Burkholderia cepacia complex (Bcc), commonly found in the lungs of cystic fibrosis (CF) patients, often produce cyanide (CN), which inhibits cellular respiration. CN in sputa is a potential biomarker for lung infection by CF pathogens. However, its actual concentration in the infected lungs is unknown. Methods and Findings: This work reports observation of CN in the lungs of mice infected with cyanogenic PA or Bcc strains using a CN fluorescent chemosensor (4',5'-fluorescein dicarboxaldehyde) with a whole animal imaging system. When the CN chemosensor was injected into the lungs of mice intratracheally infected with either PA or B. cepacia strains embedded in agar beads, CN was detected in the millimolar range (1.8 to 4 mM) in the infected lungs. CN concentration in PA-infected lungs rapidly increased within 24 hours but gradually decreased over the following days, while CN concentration in B. cepacia-infected lungs slowly increased, reaching a maximum at 5 days. CN concentrations correlated with the bacterial loads in the lungs. In vivo efficacy of antimicrobial treatments was tested in live mice by monitoring bacteriogenic CN in the lungs. Conclusions: The in vivo imaging method was also found suitable for minimally invasive testing the efficacy of antibiotic compounds as well as for aiding the understanding of bacterial cyanogenesis in CF lungs.	[Nam, Seong-Won; Chen, Xiaoqiang; Lim, Jeesun; Kim, So Hyun; Yoon, Juyoung; Park, Sungsu] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea; [Chen, Xiaoqiang; Yoon, Juyoung] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea; [Kim, Sang-Tae] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Cho, You-Hee] CHA Univ, Dept Pharm, Gyeonggi, South Korea; [Park, Sungsu] NUS, Mechanobiol Inst MBI, Singapore, Singapore	Ewha Womans University; Ewha Womans University; Ewha Womans University; Pochon Cha University; National University of Singapore	Nam, SW (corresponding author), Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea.	jyoon@ewha.ac.kr; nanopark@ewha.ac.kr	Park, Sungsu/L-1920-2013; Cho, You-Hee/AAF-8582-2020; Yoon, Juyoung/M-3248-2014; Park, Sungsu/AAF-4792-2020	Park, Sungsu/0000-0003-3062-1302; Cho, You-Hee/0000-0001-7942-5893	Korean Government (MEST) [20100001480, 2010-0018895, R31-2008-000-10010-0, R01-2008-000-20593-0]; Ewha Womans University	Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ewha Womans University	This work was equally supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MEST) (Science Research Center program 20100001480: National Research Lab program 2010-0018895: World Class University Program R31-2008-000-10010-0: Basic Science Research Program R01-2008-000-20593-0). The first author was supported by Research Program-Grant 2010 of Ewha Womans University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; CASTRIC P, 1994, CURR MICROBIOL, V29, P19, DOI 10.1007/BF01570186; Chen XQ, 2010, CHEM COMMUN, V46, P8953, DOI 10.1039/c0cc03398g; Chung SY, 2009, CHEM COMMUN, P2866, DOI 10.1039/b901140d; Cody WL, 2009, J BACTERIOL, V191, P2993, DOI 10.1128/JB.01156-08; Demidova TN, 2005, J PHOTOCH PHOTOBIO B, V81, P15, DOI 10.1016/j.jphotobiol.2005.05.007; Domaille DW, 2008, NAT CHEM BIOL, V4, P168, DOI 10.1038/nchembio.69; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Drevinek P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-121; Ekmekci Z, 2008, ORG LETT, V10, P461, DOI 10.1021/ol702823u; Enderby B, 2009, PEDIATR PULM, V44, P142, DOI 10.1002/ppul.20963; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Heo YJ, 2005, J MICROBIOL BIOTECHN, V15, P1368; HOWLAND MA, 2006, GOLDFRANKS TOXICOLOG, P1731; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; IWATA M, 1991, INFECT IMMUN, V59, P1514, DOI 10.1128/IAI.59.4.1514-1520.1991; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Lee KS, 2008, ORG LETT, V10, P49, DOI 10.1021/ol7025763; Leevy WM, 2006, J AM CHEM SOC, V128, P16476, DOI 10.1021/ja0665592; Leevy W Matthew, 2007, Drug Discov Today Dis Models, V4, P91, DOI 10.1016/j.ddmod.2007.07.001; Li L, 2005, TOXICOL SCI, V86, P116, DOI 10.1093/toxsci/kfi164; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lou XD, 2008, CHEM COMMUN, P5848, DOI 10.1039/b812746h; MCCARTHY WF, 2007, COBRA PREPRINT SERIE; Muller M, 2006, FREE RADICAL BIO MED, V41, P1670, DOI 10.1016/j.freeradbiomed.2006.09.004; NIELSON DW, 1981, P NATL ACAD SCI-BIOL, V78, P7119, DOI 10.1073/pnas.78.11.7119; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rajan S, 2000, AM J RESP CELL MOL, V23, P304, DOI 10.1165/ajrcmb.23.3.4098; Rasmussen TB, 2005, MICROBIOL-SGM, V151, P1325, DOI 10.1099/mic.0.27715-0; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Ren JQ, 2008, TALANTA, V75, P760, DOI 10.1016/j.talanta.2007.12.024; Richard JC, 2004, PEDIATR PULM, V37, P286, DOI 10.1002/ppul.20024; Ryall B, 2008, EUR RESPIR J, V32, P740, DOI 10.1183/09031936.00159607; Ryall B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-108; SCHUBERT J, 1968, J PHARMACOL EXP THER, V162, P352; SMITH ER, 1967, ANN NY ACAD SCI, V141, P386, DOI 10.1111/j.1749-6632.1967.tb34901.x; Soh N, 2006, ANAL BIOANAL CHEM, V386, P532, DOI 10.1007/s00216-006-0366-9; Speert DP, 2002, EMERG INFECT DIS, V8, P181; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Vock EH, 1998, MUTAT RES-GEN TOX EN, V413, P83, DOI 10.1016/S1383-5718(98)00019-9; Wang WH, 2005, J AM CHEM SOC, V127, P15949, DOI 10.1021/ja054962n; Xu Z, 2010, CHEM SOC REV, V39, P127, DOI 10.1039/b907368j; YAMAMOTO H, 1995, TOXICOL LETT, V80, P29, DOI 10.1016/0378-4274(95)03260-R	48	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2011	6	7							e21387	10.1371/journal.pone.0021387	http://dx.doi.org/10.1371/journal.pone.0021387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791HI	21750709	Green Published, Green Submitted, gold			2022-12-25	WOS:000292655400004
J	Caffrey, DR; Zhao, J; Song, ZL; Schaffer, ME; Haney, SA; Subramanian, RR; Seymour, AB; Hughes, JD				Caffrey, Daniel R.; Zhao, Juan; Song, Zhili; Schaffer, Michael E.; Haney, Steven A.; Subramanian, Romesh R.; Seymour, Albert B.; Hughes, Jason D.			siRNA Off-Target Effects Can Be Reduced at Concentrations That Match Their Individual Potency	PLOS ONE			English	Article							SMALL INTERFERING RNAS; EXPRESSION; DETERMINANTS; MATURATION; MICRORNAS; PROTEINS; BIOLOGY; DESIGN; DICER	Small interfering RNAs (siRNAs) are routinely used to reduce mRNA levels for a specific gene with the goal of studying its function. Several studies have demonstrated that siRNAs are not always specific and can have many off-target effects. The 39 UTRs of off-target mRNAs are often enriched in sequences that are complementary to the seed-region of the siRNA. We demonstrate that siRNA off-targets can be significantly reduced when cells are treated with a dose of siRNA that is relatively low (e. g. 1 nM), but sufficient to effectively silence the intended target. The reduction in off-targets was demonstrated for both modified and unmodified siRNAs that targeted either STAT3 or hexokinase II. Low concentrations reduced silencing of transcripts with complementarity to the seed region of the siRNA. Similarly, off-targets that were not complementary to the siRNA were reduced at lower doses, including up-regulated genes that are involved in immune response. Importantly, the unintended induction of caspase activity following treatment with a siRNA that targeted hexokinase II was also shown to be a concentration-dependent off-target effect. We conclude that off-targets and their related phenotypic effects can be reduced for certain siRNA that potently silence their intended target at low concentrations.	[Caffrey, Daniel R.; Zhao, Juan; Song, Zhili; Schaffer, Michael E.; Haney, Steven A.; Subramanian, Romesh R.; Seymour, Albert B.; Hughes, Jason D.] Pfizer Inc, Cambridge, MA USA; [Schaffer, Michael E.] Centocor R&D Inc, Radnor, PA USA; [Seymour, Albert B.] Shire HGT, Res & Dev, Lexington, MA USA; [Hughes, Jason D.] Merck Res Labs, Boston, MA USA	Pfizer; Johnson & Johnson; Johnson & Johnson USA; Shire Pharmaceuticals Limited; Merck & Company	Caffrey, DR (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Amherst, MA 01003 USA.	Daniel.Caffrey@umassmed.edu		Subramanian, Romesh/0000-0001-5586-9895	Pfizer Inc.	Pfizer Inc.(Pfizer)	This study was funded by Pfizer Inc. through the employment of all the authors, who contributed to all aspects of the study.	Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Anderson Emily, 2008, V442, P45, DOI 10.1007/978-1-59745-191-8_4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Birchler JA, 2008, SCIENCE, V320, P1023, DOI 10.1126/science.1159018; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; JACOBSEN A, SIGNATURES RNA BINDI, P1010; Judge AD, 2006, MOL THER, V13, P494, DOI 10.1016/j.ymthe.2005.11.002; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Mellor HR, 2007, CANCER METAST REV, V26, P553, DOI 10.1007/s10555-007-9080-0; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Ohi N, 1999, CELL DEATH DIFFER, V6, P314, DOI 10.1038/sj.cdd.4400493; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Robbins M, 2009, OLIGONUCLEOTIDES, V19, P89, DOI 10.1089/oli.2009.0180; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stabenau A, 2004, GENOME RES, V14, P929, DOI 10.1101/gr.1857204; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Ui-Tei K, 2008, NUCLEIC ACIDS RES, V36, P7100, DOI 10.1093/nar/gkn902; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	43	58	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21503	10.1371/journal.pone.0021503	http://dx.doi.org/10.1371/journal.pone.0021503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750714	Green Submitted, Green Published, gold			2022-12-25	WOS:000292512000015
J	Zhang, F; Baumer, N; Rode, M; Ji, P; Zhang, T; Berdel, WE; Muller-Tidow, C				Zhang, Feng; Baeumer, Nicole; Rode, Miriam; Ji, Ping; Zhang, Tao; Berdel, Wolfgang E.; Mueller-Tidow, Carsten			The Inhibitor of Growth Protein 5 (ING5) Depends on INCA1 as a Co-Factor for Its Antiproliferative Effects	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CYCLIN A1-CDK2 COMPLEX; HUMAN HEAD; EXPRESSION; FAMILY; GENE; A1; TRANSCRIPTION; REGULATORS; CANCER	The proteins of the Inhibitor of Growth (ING) family are involved in multiple cellular functions such as cell cycle regulation, apoptosis, and chromatin remodeling. For ING5, its actual role in growth suppression and the necessary partners are not known. In a yeast-two-hybrid approach with human bone marrow derived cDNA, we identified ING5 as well as several other proteins as interaction partners of Inhibitor of cyclin A1 (INCA1) that we previously characterized as a novel interaction partner of cyclin A1/CDK2. ING5 expression in leukemic AML blasts was severely reduced compared to normal bone marrow. In line, ING5 inhibited bone marrow colony formation upon retroviral transduction. However, Inca1(-/-) bone marrow colony formation was not suppressed by ING5. In murine embryonic fibroblast (MEF) cells from Inca1(+/+) and Inca1(-/-) mice, overexpression of ING5 suppressed cell proliferation only in the presence of INCA1, while ING5 had no effect in Inca1(-/-) MEFs. ING5 overexpression induced a delay in S-phase progression, which required INCA1. Finally, ING5 overexpression enhanced Fas-induced apoptosis in Inca1(+/+) MEFs, while Inca1(-/-) MEFs were protected from Fas antibody-induced apoptosis. Taken together, these results indicate that ING5 is a growth suppressor with suppressed expression in AML whose functions depend on its interaction with INCA1.	[Zhang, Feng; Baeumer, Nicole; Rode, Miriam; Ji, Ping; Berdel, Wolfgang E.; Mueller-Tidow, Carsten] Univ Munster, Dept Med Hematol Oncol, Munster, Germany; [Zhang, Feng] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Ji, Ping] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zhang, Tao] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China	University of Munster; Air Force Military Medical University; University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University	Zhang, F (corresponding author), Univ Munster, Dept Med Hematol Oncol, Munster, Germany.	muellerc@ukmuenster.de	Müller-Tidow, Carsten CMT/B-5257-2014; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232	Deutsche DFG [MU1328/6-1]	Deutsche DFG(German Research Foundation (DFG))	This work is supported by grants from the Deutsche DFG (MU1328/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMER N, 2011, J BIOL CHEM IN PRESS; Campos EI, 2004, CELL MOL LIFE SCI, V61, P2597, DOI 10.1007/s00018-004-4199-4; Cengiz B, 2010, INT J CANCER, V127, P2088, DOI 10.1002/ijc.25224; Diederichs S, 2005, INT J CANCER, V116, P207, DOI 10.1002/ijc.21034; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Garkavtsev I, 1996, NAT GENET, V14, P415, DOI 10.1038/ng1296-415; Garkavtsev I, 1998, NATURE, V391, P295, DOI 10.1038/34675; Grallert B, 2008, CELL CYCLE, V7, P2315, DOI 10.4161/cc.6389; Gunduz M, 2002, ONCOGENE, V21, P4462, DOI 10.1038/sj.onc.1205540; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Li XH, 2011, J ONCOL, V2011, DOI 10.1155/2011/963614; Li XH, 2010, J CANCER RES CLIN, V136, P1573, DOI 10.1007/s00432-010-0815-x; Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855; Muller C, 1999, J BIOL CHEM, V274, P11220, DOI 10.1074/jbc.274.16.11220; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Shi XB, 2005, J CELL BIOCHEM, V96, P1127, DOI 10.1002/jcb.20625; Shiseki M, 2003, CANCER RES, V63, P2373; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Xing YN, 2011, HUM PATHOL, V42, P25, DOI 10.1016/j.humpath.2010.05.024; Yang R, 1999, MOL CELL BIOL, V19, P2400; Yang R, 1997, CANCER RES, V57, P913; Yang R, 1999, BLOOD, V93, P2067; Zheng HC, 2011, HUM PATHOL, V42, P424, DOI 10.1016/j.humpath.2009.12.018	31	22	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2011	6	7							e21505	10.1371/journal.pone.0021505	http://dx.doi.org/10.1371/journal.pone.0021505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789JO	21750715	Green Published, Green Submitted, gold			2022-12-25	WOS:000292512000016
J	Chen, ZQ; Yi, HL; Li, M; Wang, CF; Zhang, JT; Yang, CW; Zhao, YC; Lu, YH				Chen, Ziqiang; Yi, Honglei; Li, Ming; Wang, Chuanfeng; Zhang, Jingtao; Yang, Changwei; Zhao, Yingchuan; Lu, Yanghu			Associations between Body Mass and the Outcome of Surgery for Scoliosis in Chinese Adults	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; ANTERIOR SPINAL OVERGROWTH; FOCUS GROUP DEBATE; GROWTH; OBESITY	Background: In this study we intended to prove that being overweight has an unfavorable impact on the surgical treatment outcome of adult idiopathic scoliosis (AdIS). Methods: This is a retrospective study on the surgical treatment of seventy-one more than 30 years old (58 females and 13 males; mean age 42.9 +/- 12.2) idiopathic scoliotic patients with a minimum follow up of at least 2 years. The patients were divided into an overweight group (BMI >= 23) and a non-overweight group (BMI < 23). Preoperative, postoperative first erect and final follow-up radiographic measures, perioperative data, the Oswestry disability index (ODI), and the visual analog scale (VAS) were reviewed and compared. Findings: In the overweight group, no significant differences in radiographic measures, perioperative data, preoperative comorbidities, or postoperative complications, except for the more frequent concomitance of preoperative thoracic kyphosis 37.9 +/- 7.7 vs. 26.5 +/- 11.8 (P = 0.000) and thoracolumbar kyphosis 14.9 +/- 10.1 overweighted group vs. 6.5 +/- 9.9 non-overweighted group respectively (P = 0.002) were found. A higher morbidity of hypertension 36.8% vs. 9.6% (P = 0.004) was also observed in the overweight group. Postoperative ODI and VAS improved significantly in both groups compared to preoperative values. The postoperative ODI of the overweight group (19.6 +/- 12.4) was significantly higher than that of the non-overweight group (12.4 +/- 7.9) (P = 0.022). Conclusions: Overweight adult idiopathic scoliotic patients had more frequent concomitance of preoperative thoracic kyphosis and thoracolumbar kyphosis and more serious postoperative pain. However, BMI did not affect the outcomes of surgical correction for coronal and sagittal scoliotic deformity and their postoperative complication rates were not significantly affected.	[Chen, Ziqiang; Yi, Honglei; Li, Ming; Wang, Chuanfeng; Zhang, Jingtao; Yang, Changwei; Zhao, Yingchuan; Lu, Yanghu] Second Mil Med Univ, Affiliated Changhai Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China; [Yi, Honglei] Chinese Peoples Liberat Army 89 Hosp, Weifang, Peoples R China	Naval Medical University	Chen, ZQ (corresponding author), Second Mil Med Univ, Affiliated Changhai Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.	limingch@21cn.com	Zhang, Jing/GWZ-7332-2022					ADJEI OB, 2008, 43 ANN M SCOL RES SO, P120; Aebi M, 2005, EUR SPINE J, V14, P925, DOI 10.1007/s00586-005-1053-9; Cheng JCY, 1999, SPINE, V24, P1218, DOI 10.1097/00007632-199906150-00008; DICKSON RA, 1988, LANCET, V1, P1151; Djurasovic M, 2008, SPINE, V33, P1789, DOI 10.1097/BRS.0b013e31817b8f6f; Fairbank J C, 1980, Physiotherapy, V66, P271; Fang A, 2005, SPINE, V30, P1460, DOI 10.1097/01.brs.0000166532.58227.4f; Guo X, 2005, EUR SPINE J, V14, P862, DOI 10.1007/s00586-005-1002-7; Guo X, 2003, J BONE JOINT SURG BR, V85B, P1026, DOI 10.1302/0301-620X.85B7.14046; Hangai M, 2008, SPINE J, V8, P732, DOI 10.1016/j.spinee.2007.07.392; JENSEN MP, 1994, J CONSULT CLIN PSYCH, V62, P172, DOI 10.1037/0022-006X.62.1.172; Mogul H R, 1999, Heart Dis, V1, P295; Patel JK, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12150-2; Patel N, 2007, J NEUROSURG-SPINE, V6, P291, DOI 10.3171/spi.2007.6.4.1; Stokes IAF, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-16; Upasani VV, 2008, SPINE, V33, P295, DOI 10.1097/BRS.0b013e3181624573; Vedantam R, 1998, SPINE, V23, P211, DOI 10.1097/00007632-199801150-00012; Wang W, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P129; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; WHO, 2004, LANCET, V363, P902; XIONG B, 1994, J ORTHOPAED RES, V12, P113, DOI 10.1002/jor.1100120114	21	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21601	10.1371/journal.pone.0021601	http://dx.doi.org/10.1371/journal.pone.0021601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747941	Green Submitted, Green Published, gold			2022-12-25	WOS:000292293400017
J	Cook, AL; Vitale, AM; Ravishankar, S; Matigian, N; Sutherland, GT; Shan, J; Sutharsan, R; Perry, C; Silburn, PA; Mellick, GD; Whitelaw, ML; Wells, CA; Mackay-Sim, A; Wood, SA				Cook, Anthony L.; Vitale, Alejandra M.; Ravishankar, Sugandha; Matigian, Nicholas; Sutherland, Greg T.; Shan, Jiangou; Sutharsan, Ratneswary; Perry, Chris; Silburn, Peter A.; Mellick, George D.; Whitelaw, Murray L.; Wells, Christine A.; Mackay-Sim, Alan; Wood, Stephen A.			NRF2 Activation Restores Disease Related Metabolic Deficiencies in Olfactory Neurosphere-Derived Cells from Patients with Sporadic Parkinson's Disease	PLOS ONE			English	Article							ANTIOXIDANT RESPONSE ELEMENT; MITOCHONDRIAL COMPLEX-I; TRANSCRIPTION FACTOR NRF2; SMALL MAF PROTEINS; OXIDATIVE STRESS; NF-E2-RELATED FACTOR-2; MEDIATED EXPRESSION; ENVIRONMENT INTERACTIONS; INTRAVENOUS GLUTATHIONE; ENDOTHELIAL-CELLS	Background: Without appropriate cellular models the etiology of idiopathic Parkinson's disease remains unknown. We recently reported a novel patient-derived cellular model generated from biopsies of the olfactory mucosa (termed olfactory neurosphere-derived (hONS) cells) which express functional and genetic differences in a disease-specific manner. Transcriptomic analysis of Patient and Control hONS cells identified the NRF2 transcription factor signalling pathway as the most differentially expressed in Parkinson's disease. Results: We tested the robustness of our initial findings by including additional cell lines and confirmed that hONS cells from Patients had 20% reductions in reduced glutathione levels and MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] metabolism compared to cultures from healthy Control donors. We also confirmed that Patient hONS cells are in a state of oxidative stress due to higher production of H2O2 than Control cultures. siRNA-mediated ablation of NRF2 in Control donor cells decreased both total glutathione content and MTS metabolism to levels detected in cells from Parkinson's Disease patients. Conversely, and more importantly, we showed that activation of the NRF2 pathway in Parkinson's disease hONS cultures restored glutathione levels and MTS metabolism to Control levels. Paradoxically, transcriptomic analysis after NRF2 pathway activation revealed an increased number of differentially expressed mRNAs within the NRF2 pathway in L-SUL treated Patient-derived hONS cells compared to L-SUL treated Controls, even though their metabolism was restored to normal. We also identified differential expression of the PI3K/AKT signalling pathway, but only post-treatment. Conclusions: Our results confirmed NRF2 as a potential therapeutic target for Parkinson's disease and provided the first demonstration that NRF2 function was inducible in Patient-derived cells from donors with uniquely varied genetic backgrounds. However, our results also demonstrated that the response of PD patient-derived cells was not co-ordinated in the same way as in Control cells. This may be an important factor when developing new therapeutics.	[Cook, Anthony L.; Vitale, Alejandra M.; Ravishankar, Sugandha; Matigian, Nicholas; Sutherland, Greg T.; Shan, Jiangou; Sutharsan, Ratneswary; Perry, Chris; Silburn, Peter A.; Mellick, George D.; Wells, Christine A.; Mackay-Sim, Alan; Wood, Stephen A.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Natl Ctr Adult Stem Cell Res, Brisbane, Qld 4111, Australia; [Perry, Chris] Princess Alexandra Hosp, Dept Otolaryngol Head & Neck Surg, Brisbane, Qld 4102, Australia; [Silburn, Peter A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Whitelaw, Murray L.] Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia	Griffith University; University of Queensland; University of Adelaide	Cook, AL (corresponding author), Univ Tasmania, Sch Human Life Sci, Hobart, Tas 7001, Australia.	s.wood@griffith.edu.au	Sutherland, Greg/Q-5582-2019; Sutherland, Greg T/C-8674-2015; Sutharsan, Ratneswary R/G-8761-2013; Cook, Anthony/K-9489-2018; Vitale, Alejandra M/F-2326-2011; Matigian, Nicholas/AAF-9390-2020; Mackay-Sim, Alan/C-3431-2008; Mellick, George D./A-7650-2010; Wells, Christine A/A-5071-2010; Sutharsan, Ratneswary/AAB-7410-2020; Matigian, Nicholas A/A-4935-2009; Wood, Stephen A/E-8357-2011	Sutherland, Greg/0000-0003-2493-9736; Sutherland, Greg T/0000-0003-2493-9736; Sutharsan, Ratneswary R/0000-0003-1287-4007; Cook, Anthony/0000-0003-1770-7910; Matigian, Nicholas/0000-0001-7735-9415; Mackay-Sim, Alan/0000-0003-4446-5371; Mellick, George D./0000-0002-7211-4651; Wells, Christine A/0000-0003-3133-3628; Sutharsan, Ratneswary/0000-0003-1287-4007; Matigian, Nicholas A/0000-0001-7735-9415; Wood, Stephen A/0000-0002-2576-7457	Australian Department of Health and Ageing	Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	This work was supported by an Australian Department of Health and Ageing grant to AM-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; Chu YP, 2010, ANN NY ACAD SCI, V1184, P55, DOI 10.1111/j.1749-6632.2009.05229.x; CLARK J, 2008, ANTIOXID REDOX SIGNA; Cook AL, 2009, J INVEST DERMATOL, V129, P392, DOI 10.1038/jid.2008.211; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cuadrado A, 2009, EXPERT OPIN THER TAR, V13, P319, DOI [10.1517/13543780802716501, 10.1517/13543780802716501 ]; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Dick FD, 2007, OCCUP ENVIRON MED, V64, P673, DOI 10.1136/oem.2006.032078; Duan WS, 2009, IN VITRO CELL DEV-AN, V45, P388, DOI 10.1007/s11626-009-9194-5; Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5; DUNIGAN DD, 1995, BIOTECHNIQUES, V19, P640; Elbaz A, 2008, CURR OPIN NEUROL, V21, P454, DOI 10.1097/WCO.0b013e3283050461; Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hauser RA, 2009, MOVEMENT DISORD, V24, P979, DOI 10.1002/mds.22401; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Hindle JV, 2010, AGE AGEING, V39, P156, DOI 10.1093/ageing/afp223; Hwang YP, 2008, FEBS LETT, V582, P2655, DOI 10.1016/j.febslet.2008.06.045; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Katsuoka F, 2005, J BIOL CHEM, V280, P4483, DOI 10.1074/jbc.M411451200; Katsuoka F, 2003, MOL CELL BIOL, V23, P1163, DOI 10.1128/MCB.23.4.1163-1174.2003; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Knight TR, 2008, TOXICOL SCI, V106, P329, DOI 10.1093/toxsci/kfn179; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Le Couteur David G, 2002, Rev Environ Health, V17, P51; Lee JM, 2003, J BIOL CHEM, V278, P37948, DOI 10.1074/jbc.M305204200; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Leonard MO, 2006, FASEB J, V20, P2624, DOI 10.1096/fj.06-5097fje; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; Martin HL, 2009, FASEB J, V23, P3263, DOI 10.1096/fj.08-125443; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; Mellick GD, 2006, J NEURAL TRANSM-SUPP, P159; Mellick GD, 2009, PARKINSONISM RELAT D, V15, P105, DOI 10.1016/j.parkreldis.2007.11.016; Menegon A, 1998, LANCET, V352, P1344, DOI 10.1016/S0140-6736(98)03453-9; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; Sakamoto K, 2009, MOL BIOL CELL, V20, P1606, DOI 10.1091/mbc.E08-07-0762; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Schapira AHV, 2010, EXP NEUROL, V224, P331, DOI 10.1016/j.expneurol.2010.03.028; Sechi G, 1996, PROG NEURO-PSYCHOPH, V20, P1159, DOI 10.1016/S0278-5846(96)00103-0; Segu VBG, 1998, METABOLISM, V47, P824, DOI 10.1016/S0026-0495(98)90120-2; Shavit JA, 1998, GENE DEV, V12, P2164, DOI 10.1101/gad.12.14.2164; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Venugopal R, 1996, P NATL ACAD SCI USA, V93, P14960, DOI 10.1073/pnas.93.25.14960; von Otter M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-36; Wang XT, 2007, HUM MOL GENET, V16, P1188, DOI 10.1093/hmg/ddm066; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Yang HP, 2010, HEPATOLOGY, V51, P1291, DOI 10.1002/hep.23471; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yates MS, 2006, CANCER RES, V66, P2488, DOI 10.1158/0008-5472.CAN-05-3823; YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619	76	68	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21907	10.1371/journal.pone.0021907	http://dx.doi.org/10.1371/journal.pone.0021907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747966	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000292293400042
J	Moll, G; Jitschin, R; von Bahr, L; Rasmusson-Duprez, I; Sundberg, B; Lonnies, L; Elgue, G; Nilsson-Ekdahl, K; Mougiakakos, D; Lambris, JD; Ringden, O; Le Blanc, K; Nilsson, B				Moll, Guido; Jitschin, Regina; von Bahr, Lena; Rasmusson-Duprez, Ida; Sundberg, Berit; Lonnies, Lena; Elgue, Graciela; Nilsson-Ekdahl, Kristina; Mougiakakos, Dimitrios; Lambris, John D.; Ringden, Olle; Le Blanc, Katarina; Nilsson, Bo			Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses	PLOS ONE			English	Article							STEM-CELLS; ISLET TRANSPLANTATION; STEM/PROGENITOR CELLS; APOPTOTIC CELLS; TISSUE-REPAIR; BLOOD; C5A; ACTIVATION; MSCS	Infusion of human third-party mesenchymal stromal cells (MSCs) appears to be a promising therapy for acute graft-versus-host disease (aGvHD). To date, little is known about how MSCs interact with the body's innate immune system after clinical infusion. This study shows, that exposure of MSCs to blood type ABO-matched human blood activates the complement system, which triggers complement-mediated lymphoid and myeloid effector cell activation in blood. We found deposition of complement component C3-derived fragments iC3b and C3dg on MSCs and fluid-phase generation of the chemotactic anaphylatoxins C3a and C5a. MSCs bound low amounts of immunoglobulins and lacked expression of complement regulatory proteins MCP (CD46) and DAF (CD55), but were protected from complement lysis via expression of protectin (CD59). Cell-surface-opsonization and anaphylatoxin-formation triggered complement receptor 3 (CD11b/CD18)-mediated effector cell activation in blood. The complement-activating properties of individual MSCs were furthermore correlated with their potency to inhibit PBMC-proliferation in vitro, and both effector cell activation and the immunosuppressive effect could be blocked either by using complement inhibitor Compstatin or by depletion of CD14/CD11b-high myeloid effector cells from mixed lymphocyte reactions. Our study demonstrates for the first time a major role of the complement system in governing the immunomodulatory activity of MSCs and elucidates how complement activation mediates the interaction with other immune cells.	[Moll, Guido; Jitschin, Regina; von Bahr, Lena; Sundberg, Berit; Lonnies, Lena; Mougiakakos, Dimitrios; Ringden, Olle; Le Blanc, Katarina] Karolinska Inst, Dept Lab Med Clin Immunol & Transfus Med, Stockholm, Sweden; [Moll, Guido; Jitschin, Regina; von Bahr, Lena; Sundberg, Berit; Lonnies, Lena; Mougiakakos, Dimitrios; Ringden, Olle; Le Blanc, Katarina] Karolinska Univ, Huddinge Hosp, Hematol Ctr, Stockholm, Sweden; [Rasmusson-Duprez, Ida; Elgue, Graciela; Nilsson-Ekdahl, Kristina; Nilsson, Bo] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mougiakakos, Dimitrios] Karolinska Inst, CCK, Dept Pathol & Oncol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Uppsala University; University of Pennsylvania; Karolinska Institutet	Moll, G (corresponding author), Karolinska Inst, Dept Lab Med Clin Immunol & Transfus Med, Stockholm, Sweden.	guido.moll@ki.se	Lambris, John/Q-5633-2018; Ekdahl, Kristina Nilsson/B-5301-2012; Le Blanc, Katarina/L-4631-2019; Moll, Guido/L-6321-2019; Moll, Guido/Q-1044-2018; Nilsson, Bo/B-3102-2012	Lambris, John/0000-0002-9370-5776; Moll, Guido/0000-0001-6173-5957; Nilsson, Bo/0000-0003-0057-2730	Swedish Cancer Society [08 0502, 07 0529]; Children's Cancer Foundation [08/071, 05/077]; Swedish Research Council [K2005-32P-15457-01A, K2008-64X-05971-28-3, K2007-65X-05647-28-3 950, 2009-4462, 2009-4675]; Tobias Foundation; Cancer Society in Stockholm; Swedish Society of Medicine; Stockholm County Council; Sven and Ebba-Christina Hagbergs Foundation; Karolinska Institutet; Swedish Research Council/Vinnova/Swedish Foundation Strategic Research [6076170]; National Institutes of Health (NIH) [GM-62134, AI-068730]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062134] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Tobias Foundation; Cancer Society in Stockholm; Swedish Society of Medicine; Stockholm County Council(Stockholm County Council); Sven and Ebba-Christina Hagbergs Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Research Council/Vinnova/Swedish Foundation Strategic Research(VinnovaSwedish Research Council); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Swedish Cancer Society (08 0502, 07 0529), the Children's Cancer Foundation (08/071, 05/077), the Swedish Research Council (K2005-32P-15457-01A, K2008-64X-05971-28-3), the Tobias Foundation, the Cancer Society in Stockholm, the Swedish Society of Medicine, the Stockholm County Council, the Sven and Ebba-Christina Hagbergs Foundation, and Karolinska Institutet (to K.L.B.); the Swedish Research Council (K2007-65X-05647-28-3 950, 2009-4462, 2009-4675) and Swedish Research Council/Vinnova/Swedish Foundation Strategic Research (6076170) (to B.N.) and partially supported by National Institutes of Health (NIH) grants (GM-62134 and AI-068730 (to J.D.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKRUM J, TRENDS MOL MED, V16, P203; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x; Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; IGNATIUS A, J CELL BIOCH; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Mason JC, 1999, BLOOD, V94, P1673, DOI 10.1182/blood.V94.5.1673.417a05_1673_1682; Mollnes TE, 2002, BLOOD, V100, P1869; Nauta AJ, 2003, TRENDS IMMUNOL, V24, P148, DOI 10.1016/S1471-4906(03)00030-9; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; NILSSON B, 1990, BIOCHEM J, V268, P55, DOI 10.1042/bj2680055; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Ostrand-Rosenberg S, 2008, NAT BIOTECHNOL, V26, P1348, DOI 10.1038/nbt1208-1348; Pittenger M, 2009, CELL STEM CELL, V5, P8, DOI 10.1016/j.stem.2009.06.013; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ringden O, 2007, LEUKEMIA, V21, P2271, DOI 10.1038/sj.leu.2404833; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Tjernberg J, 2008, TRANSPLANTATION, V85, P1193, DOI 10.1097/TP.0b013e31816b22f3; UCCELLI A, 2008, NAT REV IMMUNOL; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I	33	97	101	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2011	6	7							e21703	10.1371/journal.pone.0021703	http://dx.doi.org/10.1371/journal.pone.0021703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786HC	21747949	gold, Green Published, Green Submitted			2022-12-25	WOS:000292293400025
J	Thorsell, AG; Lee, WH; Persson, C; Siponen, MI; Nilsson, M; Busam, RD; Kotenyova, T; Schuler, H; Lehtio, L				Thorsell, Ann-Gerd; Lee, Wen Hwa; Persson, Camilla; Siponen, Marina I.; Nilsson, Martina; Busam, Robert D.; Kotenyova, Tetyana; Schuler, Herwig; Lehtio, Lari			Comparative Structural Analysis of Lipid Binding START Domains	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; CHOLESTEROL BINDING; GENE ENCODES; MECHANISM; MUTATIONS; ALIGNMENT; GEOMETRY; COMPLEX; TOOLS	Background: Steroidogenic acute regulatory (StAR) protein related lipid transfer (START) domains are small globular modules that form a cavity where lipids and lipid hormones bind. These domains can transport ligands to facilitate lipid exchange between biological membranes, and they have been postulated to modulate the activity of other domains of the protein in response to ligand binding. More than a dozen human genes encode START domains, and several of them are implicated in a disease. Principal Findings: We report crystal structures of the human STARD1, STARD5, STARD13 and STARD14 lipid transfer domains. These represent four of the six functional classes of START domains. Significance: Sequence alignments based on these and previously reported crystal structures define the structural determinants of human START domains, both those related to structural framework and those involved in ligand specificity.	[Thorsell, Ann-Gerd; Persson, Camilla; Siponen, Marina I.; Nilsson, Martina; Busam, Robert D.; Kotenyova, Tetyana; Schuler, Herwig; Lehtio, Lari] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden; [Lee, Wen Hwa] Univ Oxford, Struct Genom Consortium, Oxford, England; [Lehtio, Lari] Abo Akad Univ, Dept Biosci, Turku, Finland	Karolinska Institutet; University of Oxford; Abo Akademi University	Thorsell, AG (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se; lari.lehtio@abo.fi	Lee, Wen Hwa/G-1250-2013; Schuler, Herwig/E-5751-2011; Lee, Wen Hwa/GZA-8183-2022	Lee, Wen Hwa/0000-0002-4098-5225; Schuler, Herwig/0000-0003-4059-3501; Lee, Wen Hwa/0000-0002-4098-5225; Lehtio, Lari/0000-0001-7250-832X	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Academy of Finland [128322]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Finland(Academy of Finland)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. LL was also supported by the Academy of Finland Grant 128322. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Bens S, 2010, J CLIN ENDOCR METAB, V95, P1301, DOI 10.1210/jc.2009-1176; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bose HS, 2008, BIOCHEMISTRY-US, V47, P2277, DOI 10.1021/bi701966a; Bose HS, 2000, J CLIN ENDOCR METAB, V85, P3636, DOI 10.1210/jc.85.10.3636; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keegan RM, 2008, ACTA CRYSTALLOGR D, V64, P119, DOI 10.1107/S0907444907037195; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kudo N, 2010, J MOL BIOL, V396, P245, DOI 10.1016/j.jmb.2009.12.029; Lavigne P, 2010, SUBCELL BIOCHEM, V51, P425, DOI 10.1007/978-90-481-8622-8_15; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murcia M, 2006, J LIPID RES, V47, P2614, DOI 10.1194/jlr.M600232-JLR200; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Rodriguez-Agudo D, 2005, J LIPID RES, V46, P1615, DOI 10.1194/jlr.M400501-JLR200; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; Roostaee A, 2008, BIOCHEM J, V412, P553, DOI 10.1042/BJ20071264; Roostaee A, 2009, BIOSCIENCE REP, V29, P89, DOI 10.1042/BSR20080111; Shatsky M, 2004, NUCLEIC ACIDS RES, V32, pW503, DOI 10.1093/nar/gkh413; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Soccio RE, 2002, P NATL ACAD SCI USA, V99, P6943, DOI 10.1073/pnas.052143799; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Suematsu N, 2001, EUR J BIOCHEM, V268, P2700, DOI 10.1046/j.1432-1327.2001.02162.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73	43	92	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2011	6	6							e19521	10.1371/journal.pone.0019521	http://dx.doi.org/10.1371/journal.pone.0019521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786GP	21738568	Green Published, Green Submitted, gold			2022-12-25	WOS:000292291800001
J	Dredge, BK; Jensen, KB				Dredge, B. Kate; Jensen, Kirk B.			NeuN/Rbfox3 Nuclear and Cytoplasmic Isoforms Differentially Regulate Alternative Splicing and Nonsense-Mediated Decay of Rbfox2	PLOS ONE			English	Article							RNA-BINDING PROTEINS; NEURONAL MARKER NEUN; MESSENGER-RNA; EXPORT SIGNALS; CELF FAMILY; EXPRESSION; TRACT; BRAIN; NOVA; CRM1	Anti-NeuN (Neuronal Nuclei) is a monoclonal antibody used extensively to specifically detect post-mitotic neurons. Anti-NeuN reactivity is predominantly nuclear; by western it detects multiple bands ranging in molecular weight from 45 kDa to > 75 kDa. Expression screening putatively identified R3hdm2 as NeuN; however immunoprecipitation and mass spectrometry of the two major NeuN species at 45-50 kDa identified both as the RNA binding protein Rbfox3 (a member of the Fox family of alternative splicing factors), confirming and extending the identification of the 45 kDa band as Rbfox3 by Kim et al. Mapping of the anti-NeuN reactive epitopes in both R3hdm2 and Rbfox3 reveals a common proline-and glutamine-rich domain that lies at the N-terminus of the Rbfox3 protein. Our data suggests that alternative splicing of the Rbfox3 pre-mRNA itself leads to the production of four protein isoforms that migrate in the 45-50 kDa range, and that one of these splicing choices regulates Rbfox3/NeuN sub-cellular steady-state distribution, through the addition or removal of a short C-terminal extension containing the second half of a bipartite hydrophobic proline-tyrosine nuclear localization signal. Rbfox3 regulates alternative splicing of the Rbfox2 pre-mRNA, producing a message encoding a dominant negative form of the Rbfox2 protein. We show here that nuclear Rbfox3 isoforms can also enhance the inclusion of cryptic exons in the Rbfox2 mRNA, resulting in nonsense-mediated decay of the message, thereby contributing to the negative regulation of Rbfox2 by Rbfox3 through a novel mechanism.	[Dredge, B. Kate; Jensen, Kirk B.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Dredge, BK (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	kate.dredge@adelaide.edu.au	Jensen, Kirk/B-4756-2008; Jensen, Kirk/AAL-5883-2020	Jensen, Kirk/0000-0002-2084-1734; Jensen, Kirk/0000-0002-2084-1734; Dredge, Kate/0000-0002-6103-5165	ARC Special Research Centre for the Molecular Genetics of Development; ARC [DP0559550]; APD on ARC Discovery Project [DP0559550]	ARC Special Research Centre for the Molecular Genetics of Development(Australian Research Council); ARC(Australian Research Council); APD on ARC Discovery Project(Australian Research Council)	This project was funded by the ARC Special Research Centre for the Molecular Genetics of Development and ARC Discovery Project Grant DP0559550 arc.gov.au. BKD was funded in part as an APD on ARC Discovery Project Grant DP0559550. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; BUCKANOVICH RJ, 1993, NEURON, V11, P657, DOI 10.1016/0896-6273(93)90077-5; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Grishin NV, 1998, TRENDS BIOCHEM SCI, V23, P329, DOI 10.1016/S0968-0004(98)01258-4; Hall MP, 2004, MOL BIOL CELL, V15, P774, DOI 10.1091/mbc.E03-09-0692; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kiehl TR, 2001, MAMM GENOME, V12, P595, DOI 10.1007/s00335-001-2056-4; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Ladd AN, 2004, J BIOL CHEM, V279, P17756, DOI 10.1074/jbc.M310687200; Ladd AN, 2001, MOL CELL BIOL, V21, P1285, DOI 10.1128/MCB.21.4.1285-1296.2001; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Okano HJ, 1997, J NEUROSCI, V17, P3024; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Rahman L, 2002, GENOMICS, V80, P245, DOI 10.1006/geno.2002.6826; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Tang ZZ, 2009, MOL CELL BIOL, V29, P4757, DOI 10.1128/MCB.00608-09; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Van Nassauw L, 2005, HISTOCHEM CELL BIOL, V124, P369, DOI 10.1007/s00418-005-0019-7; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CJ, 2008, NAT PROD RES, V22, P1, DOI 10.1080/14786410701619076; Zhou HL, 2007, MOL CELL BIOL, V27, P830, DOI 10.1128/MCB.01015-06	45	66	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21585	10.1371/journal.pone.0021585	http://dx.doi.org/10.1371/journal.pone.0021585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21747913	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100042
J	Rothe, F; Ignatiadis, M; Chaboteaux, C; Haibe-Kains, B; Kheddoumi, N; Majjaj, S; Badran, B; Fayyad-Kazan, H; Desmedt, C; Harris, AL; Piccart, M; Sotiriou, C				Rothe, Francoise; Ignatiadis, Michail; Chaboteaux, Carole; Haibe-Kains, Benjamin; Kheddoumi, Naima; Majjaj, Samira; Badran, Bassam; Fayyad-Kazan, Hussein; Desmedt, Christine; Harris, Adrian L.; Piccart, Martine; Sotiriou, Christos			Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer	PLOS ONE			English	Article							SIGNATURE; PROGNOSIS; SURVIVAL; HYPOXIA; TARGETS; MIRNA	Purpose: Aberrant microRNA (miRNA) expression is associated with cancer and has potential diagnostic and prognostic value in various malignancies. In this study, we investigated miRNA profiling as a complementary tool to improve our understanding of breast cancer (BC) biology and to assess whether miRNA expression could predict clinical outcome of BC patients. Experimental Design: Global miRNA expression profiling using microarray technology was conducted in 56 systemically untreated BC patients who had corresponding mRNA expression profiles available. Results were further confirmed using qRT-PCR in an independent dataset of 89 ER-positive BC patients homogeneously treated with tamoxifen only. MiR-210 functional analyses were performed in MCF7 and MDA-MB-231 BC cell lines using lentiviral transduction. Results: Estrogen receptor (ER) status, tumor grade and our previously developed gene expression grade index (GGI) were associated with distinct miRNA profiles. Several miRNAs were found to be clinically relevant, including miR-210, its expression being associated with tumor proliferation and differentiation. Furthermore, miR-210 was associated with poor clinical outcome in ER-positive, tamoxifen-treated BC patients. Interestingly, the prognostic performance of miR-210 was similar to several reported multi-gene signatures, highlighting its important role in BC differentiation and tumor progression. Functional analyses in BC cell lines revealed that miR-210 is involved in cell proliferation, migration and invasion. Conclusions: This integrated analysis combining miRNA and mRNA expression demonstrates that miRNA expression provides additional biological information beyond mRNA expression. Expression of miR-210 is linked to tumor proliferation and appears to be a strong potential biomarker of clinical outcome in BC.	[Rothe, Francoise; Ignatiadis, Michail; Chaboteaux, Carole; Kheddoumi, Naima; Majjaj, Samira; Desmedt, Christine; Piccart, Martine; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Translat Res Unit, Brussels, Belgium; [Haibe-Kains, Benjamin] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Boston, MA 02115 USA; [Badran, Bassam; Fayyad-Kazan, Hussein] Univ Libre Bruxelles, Inst Jules Bordet, Lab Expt Hematol, Brussels, Belgium; [Harris, Adrian L.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Canc Res UK Mol Oncol Labs, Oxford OX3 9DU, England	Institut Jules Bordet; Universite Libre de Bruxelles; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Institut Jules Bordet; Universite Libre de Bruxelles; University of Oxford	Rothe, F (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Translat Res Unit, Brussels, Belgium.	christos.sotiriou@bordet.be	Desmedt, Christine/P-7438-2017; Harris, Adrian L/ABA-3343-2020; Haibe-Kains, Benjamin/D-3702-2011	Desmedt, Christine/0000-0002-5223-5579; Harris, Adrian L/0000-0003-1376-8409; Haibe-Kains, Benjamin/0000-0002-7684-0079; Fayyad-Kazan, Hussein/0000-0002-3465-4630	Belgian National Foundation for Cancer Research, FNRS; Breast Cancer Research Foundation; Brussels Region; MEDIC Foundation	Belgian National Foundation for Cancer Research, FNRS(Fonds de la Recherche Scientifique - FNRS); Breast Cancer Research Foundation; Brussels Region; MEDIC Foundation	This work was supported by the Belgian National Foundation for Cancer Research, FNRS (CS); by The Breast Cancer Research Foundation (FR, CS); the Brussels Region (CD) and by the MEDIC Foundation (FR, CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Burdette JE, 2007, ENDOCR-RELAT CANCER, V14, P679, DOI 10.1677/ERC-07-0054; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; COX DR, 1972, J R STAT SOC B, V34, P187; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kumar R, 2006, MOL CANCER RES, V4, P655, DOI 10.1158/1541-7786.MCR-05-0249; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	39	179	186	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20980	10.1371/journal.pone.0020980	http://dx.doi.org/10.1371/journal.pone.0020980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738599	Green Published, gold, Green Submitted			2022-12-25	WOS:000292290100011
J	Vasireddy, V; Chavali, VRM; Joseph, VT; Kadam, R; Lin, JH; Jamison, JA; Kompella, UB; Reddy, GB; Ayyagari, R				Vasireddy, Vidyullatha; Chavali, Venkata R. M.; Joseph, Victory T.; Kadam, Rajendra; Lin, Jonathan H.; Jamison, Jeffrey A.; Kompella, Uday B.; Reddy, Geereddy Bhanuprakash; Ayyagari, Radha			Rescue of Photoreceptor Degeneration by Curcumin in Transgenic Rats with P23H Rhodopsin Mutation	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; XENOPUS-LAEVIS MODEL; IN-VIVO; ENDOPLASMIC-RETICULUM; RETINAL DEGENERATION; MUTANT RHODOPSIN; GENE-THERAPY; CARDIOVASCULAR-DISEASE; TEMPORAL EXPRESSION; PROTEIN AGGREGATION	The P23H mutation in the rhodopsin gene causes rhodopsin misfolding, altered trafficking and formation of insoluble aggregates leading to photoreceptor degeneration and autosomal dominant retinitis pigmentosa (RP). There are no effective therapies to treat this condition. Compounds that enhance dissociation of protein aggregates may be of value in developing new treatments for such diseases. Anti-protein aggregating activity of curcumin has been reported earlier. In this study we present that treatment of COS-7 cells expressing mutant rhodopsin with curcumin results in dissociation of mutant protein aggregates and decreases endoplasmic reticulum stress. Furthermore we demonstrate that administration of curcumin to P23H-rhodopsin transgenic rats improves retinal morphology, physiology, gene expression and localization of rhodopsin. Our findings indicate that supplementation of curcumin improves retinal structure and function in P23H-rhodopsin transgenic rats. This data also suggest that curcumin may serve as a potential therapeutic agent in treating RP due to the P23H rhodopsin mutation and perhaps other degenerative diseases caused by protein trafficking defects.	[Vasireddy, Vidyullatha; Chavali, Venkata R. M.; Ayyagari, Radha] Univ Calif San Diego, Dept Ophthalmol, Jacobs Retina Ctr, La Jolla, CA 92093 USA; [Joseph, Victory T.; Lin, Jonathan H.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Kadam, Rajendra; Kompella, Uday B.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO USA; [Jamison, Jeffrey A.] Opthy DS Inc, Mattawan, MI USA; [Reddy, Geereddy Bhanuprakash] Natl Inst Nutr, Hyderabad 500007, Andhra Pradesh, India	University of California System; University of California San Diego; University of California System; University of California San Diego; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Vasireddy, V (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Jacobs Retina Ctr, La Jolla, CA 92093 USA.	rayyagari@ucsd.edu	Jamison, Jeffrey/Q-3152-2019; Reddy, G Bhanuprakash/AAJ-3494-2020	Reddy, G Bhanuprakash/0000-0003-4787-3944; Lin, Jonathan/0000-0002-7438-6941	NIH [NIH-EY018313, NIH-EY13198, NIH-EY017533, EY020361]; Research to Prevent Blindness Inc., USA; Indian Counsel of Medical Research, Department of Biotechnology and Department of Science and Technology, Government of India; NATIONAL EYE INSTITUTE [K08EY018313, R01EY017533, R01EY020846, RC1EY020361, R01EY013198] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Inc., USA(Research to Prevent Blindness (RPB)); Indian Counsel of Medical Research, Department of Biotechnology and Department of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaDepartment of Science & Technology (India)Indian Council of Medical Research (ICMR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants to JHL from NIH-EY018313; RA from NIH-EY13198; Research to Prevent Blindness Inc., USA (RA), NIH-EY017533 and EY020361 (UBK), and Indian Counsel of Medical Research, Department of Biotechnology and Department of Science and Technology, Government of India (BRG). Dr. Jamison is employed by the company Ophthy-DS Inc. In the current manuscript, Dr. Jamison performed the recording of physiological changes of the retina by electroretinography (ERG). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Adlerz L, 2003, MOL BRAIN RES, V119, P62, DOI 10.1016/j.molbrainres.2003.08.014; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Awasthi S, 1996, AM J CLIN NUTR, V64, P761, DOI 10.1093/ajcn/64.5.761; Bhattacharya U, 2009, CANCER SCI, V100, P1971, DOI 10.1111/j.1349-7006.2009.01251.x; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; Cheng AL, 2001, ANTICANCER RES, V21, P2895; COGAN D G, 1950, Trans Am Acad Ophthalmol Otolaryngol, V54, P629; Dejneka NS, 2001, BIOESSAYS, V23, P662, DOI 10.1002/bies.1092; Dohadwala MM, 2009, J NUTR, V139, p1788S, DOI 10.3945/jn.109.107474; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gorbatyuk M, 2007, VISION RES, V47, P1202, DOI 10.1016/j.visres.2006.11.026; Gorbatyuk M, 2007, EXP EYE RES, V84, P44, DOI 10.1016/j.exer.2006.08.014; GOTO Y, 1995, INVEST OPHTH VIS SCI, V36, P62; Hakimuddin F, 2008, NUTR RES, V28, P702, DOI 10.1016/j.nutres.2008.06.009; Harper CE, 2009, PROSTATE, V69, P1668, DOI 10.1002/pros.21017; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hauswirth WW, 2000, CLIN CHEM LAB MED, V38, P147, DOI 10.1515/CCLM.2000.022; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Jiang J, 2007, EUR J PHARMACOL, V561, P54, DOI 10.1016/j.ejphar.2006.12.028; Jurenka JS, 2009, ALTERN MED REV, V14, P141; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Khajavi M, 2005, AM J HUM GENET, V77, P841, DOI 10.1086/497541; Khajavi M, 2007, AM J HUM GENET, V81, P438, DOI 10.1086/519926; Koenekoop RK, 2008, OPHTHALMIC GENET, V29, P89, DOI 10.1080/13816810802216480; Lal B, 1999, PHYTOTHER RES, V13, P318, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;318::AID-PTR445&gt;3.0.CO;2-7; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; MacDonald IM, 2004, BRIT J OPHTHALMOL, V88, P305, DOI 10.1136/bjo.2003.024299; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5505, DOI 10.1167/iovs.06-0312; Mandal MNA, 2006, INVEST OPHTH VIS SCI, V47, P5514, DOI 10.1167/iovs.06-0449; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Mandal MNA, 2004, GENOMICS, V83, P626, DOI 10.1016/j.ygeno.2003.09.020; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Noorwez SM, 2009, J BIOL CHEM, V284, P33333, DOI 10.1074/jbc.M109.043364; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Pandya U, 2000, TOXICOL LETT, V115, P195, DOI 10.1016/S0378-4274(00)00191-0; Perez-Jimenez J, 2008, NUTR RES REV, V21, P158, DOI 10.1017/S0954422408125124; Pullakhandam R, 2009, ARCH BIOCHEM BIOPHYS, V485, P115, DOI 10.1016/j.abb.2009.02.013; Rajan RS, 2005, J BIOL CHEM, V280, P1284, DOI 10.1074/jbc.M406448200; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Reddy GB, 2009, INVEST OPHTH VIS SCI, V50, P3456, DOI 10.1167/iovs.08-2498; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Rochet Jean-Christophe, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000385; Romier B, 2009, NUTR REV, V67, P363, DOI 10.1111/j.1753-4887.2009.00210.x; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Rossi L, 2008, NEUROCHEM RES, V33, P2390, DOI 10.1007/s11064-008-9696-7; Roy P, 2009, CANCER BIOL THER, V8, P1281, DOI 10.4161/cbt.8.13.8728; Saliba RS, 2002, J CELL SCI, V115, P2907; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Suryanarayana P, 2005, INVEST OPHTH VIS SCI, V46, P2092, DOI 10.1167/iovs.04-1304; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Vasireddy V, 2006, INVEST OPHTH VIS SCI, V47, P4558, DOI 10.1167/iovs.06-0353; Vasireddy V, 2009, EXP EYE RES, V89, P905, DOI 10.1016/j.exer.2009.07.021; Verhoeff F H, 1930, Trans Am Ophthalmol Soc, V28, P176; WELEBER RG, 1991, WESTERN J MED, V155, P423; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhang R, 2008, EXP EYE RES, V86, P612, DOI 10.1016/j.exer.2008.01.005; ZHAO BL, 1989, CELL BIOPHYS, V14, P175, DOI 10.1007/BF02797132; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064; RETINA INT	73	66	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21193	10.1371/journal.pone.0021193	http://dx.doi.org/10.1371/journal.pone.0021193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738619	gold, Green Published, Green Submitted			2022-12-25	WOS:000292290100015
J	Wang, YY; Lai, SK; So, C; Schneider, C; Cone, R; Hanes, J				Wang, Ying-Ying; Lai, Samuel K.; So, Conan; Schneider, Craig; Cone, Richard; Hanes, Justin			Mucoadhesive Nanoparticles May Disrupt the Protective Human Mucus Barrier by Altering Its Microstructure	PLOS ONE			English	Article							HUMAN CERVICAL-MUCUS; PARTICLE TRACKING MEASUREMENTS; DIFFUSION; NETWORKS; MUCIN; HYDROGELS; SPUTUM; MUC5B; LAYER; RAT	Mucus secretions typically protect exposed surfaces of the eyes and respiratory, gastrointestinal and female reproductive tracts from foreign entities, including pathogens and environmental ultrafine particles. We hypothesized that excess exposure to some foreign particles, however, may cause disruption of the mucus barrier. Many synthetic nanoparticles are likely to be mucoadhesive due to hydrophobic, electrostatic or hydrogen bonding interactions. We therefore sought to determine whether mucoadhesive particles (MAP) could alter the mucus microstructure, thereby allowing other foreign particles to more easily penetrate mucus. We engineered muco-inert probe particles 1 mm in diameter, whose diffusion in mucus is limited only by steric obstruction from the mucus mesh, and used them to measure possible MAP-induced changes to the microstructure of fresh human cervicovaginal mucus. We found that a 0.24% w/v concentration of 200 nm MAP in mucus induced a similar to 10-fold increase in the average effective diffusivity of the probe particles, and a 2- to 3-fold increase in the fraction capable of penetrating physiologically thick mucus layers. The same concentration of muco-inert particles, and a low concentration (0.0006% w/v) of MAP, had no detectable effect on probe particle penetration rates. Using an obstruction-scaling model, we determined that the higher MAP dose increased the average mesh spacing ("pore'' size) of mucus from 380 nm to 470 nm. The bulk viscoelasticity of mucus was unaffected by MAP exposure, suggesting MAP may not directly impair mucus clearance or its function as a lubricant, both of which depend critically on the bulk rheological properties of mucus. Our findings suggest mucoadhesive nanoparticles can substantially alter the microstructure of mucus, highlighting the potential of mucoadhesive environmental or engineered nanoparticles to disrupt mucus barriers and cause greater exposure to foreign particles, including pathogens and other potentially toxic nanomaterials.	[Wang, Ying-Ying; So, Conan; Hanes, Justin] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Lai, Samuel K.; Schneider, Craig; Hanes, Justin] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Cone, Richard] Johns Hopkins Univ, Dept Biophys, Baltimore, MD USA; [Hanes, Justin] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Hanes, Justin] Johns Hopkins Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Hanes, Justin] Johns Hopkins Univ, Inst NanoBioTechnol, Ctr Canc Nanotechnol Excellence, Baltimore, MD USA; [Hanes, Justin] Johns Hopkins Univ, Sch Med, Ctr Nanomed, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Wang, YY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	hanes@jhu.edu	wang, yingying/GRS-3058-2022	Lai, Samuel/0000-0003-4721-528X	National Institutes of Health [5U01AI066726, P01HL51811, R21HL089816, R01HD062844]; National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062844] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089816, P01HL051811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (http://www.nih.gov/) grants 5U01AI066726 (R.C.), P01HL51811 (J.H.), R21HL089816 and R01HD062844 (J.H. and R.C.) and by a National Science Foundation (http://www.nsf.gov/) graduate research fellowship (Y.-Y.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institute of Biomedical Imaging and Bioengineering, the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2007, LARYNGOSCOPE, V117, P932, DOI 10.1097/MLG.0b013e3180383651; Amsden B, 1999, MACROMOLECULES, V32, P874, DOI 10.1021/ma980922a; Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f; Apgar J, 2000, BIOPHYS J, V79, P1095, DOI 10.1016/S0006-3495(00)76363-6; Boskey ER, 2003, SEX TRANSM DIS, V30, P107, DOI 10.1097/00007435-200302000-00002; Ceric F, 2005, J ELECTRON MICROSC, V54, P479, DOI 10.1093/jmicro/dfh106; Donaldson K, 2001, OCCUP ENVIRON MED, V58, P211, DOI 10.1136/oem.58.3.211; EPA, 1997, EXP FACT HDB; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gipson IK, 2001, J CLIN ENDOCR METAB, V86, P594, DOI 10.1210/jc.86.2.594; GREAVES JL, 1993, ADV DRUG DELIVER REV, V11, P349, DOI 10.1016/0169-409X(93)90016-W; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; ICRP, 1994, ANN ICRP, V24, P36; Jordan N, 1998, CLIN SCI, V95, P97, DOI 10.1042/CS19980081; Kim WD, 1997, EUR RESPIR J, V10, P1914, DOI 10.1183/09031936.97.10081914; King M, 2006, PAEDIATR RESPIR REV, V7, pS212, DOI 10.1016/j.prrv.2006.04.199; KING MV, 1991, CELL BIOPHYS, V18, P31, DOI 10.1007/BF02990514; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2010, P NATL ACAD SCI USA, V107, P598, DOI 10.1073/pnas.0911748107; Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012; Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; MERCER RR, 1994, AM J RESP CELL MOL, V10, P613, DOI 10.1165/ajrcmb.10.6.8003339; MOLLENHAUER HH, 1993, MICROSC RES TECHNIQ, V26, P496, DOI 10.1002/jemt.1070260604; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; ODEBLAD E, 1968, ACTA OBSTET GYN SCAN, VS 47, P57, DOI 10.3109/00016346809156845; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; *OSHA, OSHA OCC SAF HLTH GU; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; Puchelle Edith, 2002, Paediatr Respir Rev, V3, P115, DOI 10.1016/S1526-0550(02)00005-7; Shen H, 2006, BIOPHYS J, V91, P639, DOI 10.1529/biophysj.105.077404; SINGH EJ, 1975, AM J OBSTET GYNECOL, V123, P128, DOI 10.1016/0002-9378(75)90515-3; Suk JS, 2009, BIOMATERIALS, V30, P2591, DOI 10.1016/j.biomaterials.2008.12.076; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Vanhecke D, 2008, METHOD CELL BIOL, V88, P151, DOI 10.1016/S0091-679X(08)00409-3; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Yang M, 2011, ANGEW CHEM INT EDIT, V50, P2597, DOI 10.1002/anie.201006849	45	62	64	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e21547	10.1371/journal.pone.0021547	http://dx.doi.org/10.1371/journal.pone.0021547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	786FZ	21738703	Green Submitted, Green Published, gold			2022-12-25	WOS:000292290100035
J	Fimognari, C; Lenzi, M; Ferruzzi, L; Turrini, E; Scartezzini, P; Poli, F; Gotti, R; Guerrini, A; Carulli, G; Ottaviano, V; Cantelli-Forti, G; Hrelia, P				Fimognari, Carmela; Lenzi, Monia; Ferruzzi, Lorenzo; Turrini, Eleonora; Scartezzini, Paolo; Poli, Ferruccio; Gotti, Roberto; Guerrini, Alessandra; Carulli, Giovanni; Ottaviano, Virginia; Cantelli-Forti, Giorgio; Hrelia, Patrizia			Mitochondrial Pathway Mediates the Antileukemic Effects of Hemidesmus Indicus, a Promising Botanical Drug	PLOS ONE			English	Article							CELL-CYCLE; S-PHASE; PERMEABILITY TRANSITION; OVARIAN-CANCER; APOPTOSIS; CALCIUM; THERAPEUTICS; TARGETS; ARREST; DEATH	Background: Although cancers are characterized by the deregulation of multiple signalling pathways, most current anticancer therapies involve the modulation of a single target. Because of the enormous biological diversity of cancer, strategic combination of agents targeted against the most critical of those alterations is needed. Due to their complex nature, plant products interact with numerous targets and influence several biochemical and molecular cascades. The interest in further development of botanical drugs has been increasing steadily and the FDA recently approved the first new botanical prescription drug. The present study is designed to explore the potential antileukemic properties of Hemidesmus indicus with a view to contributing to further development of botanical drugs. Hemidesmus was submitted to an extensive in vitro preclinical evaluation. Methodology/Principal Findings: A variety of cellular assays and flow cytometry, as well as a phytochemical screening, were performed on different leukemic cell lines. We have demonstrated that Hemidesmus modulated many components of intracellular signaling pathways involved in cell viability and proliferation and altered the protein expression, eventually leading to tumor cell death, mediated by a loss of mitochondrial transmembrane potential and increased Bax/Bcl-2 ratio. ADP, adenine nucleotide translocator and mitochondrial permeability transition pore inhibitors did not reverse Hemidesmus-induced mitochondrial depolarization. Hemidesmus induced a significant [Ca(2+)](i) raise through the mobilization of intracellular Ca(2+) stores. Moreover, Hemidesmus significantly enhanced the antitumor activity of three commonly used chemotherapeutic drugs (methotrexate, 6-thioguanine, cytarabine). A clinically relevant observation is that its cytotoxic activity was also recorded in primary cells from acute myeloid leukemic patients. Conclusions/Significance: These results indicate the molecular basis of the antileukemic effects of Hemidesmus and identify the mitochondrial pathways and [Ca(2+)](i) as crucial actors in its anticancer activity. On these bases, we conclude that Hemidesmus can represent a valuable tool in the anticancer pharmacology, and should be considered for further investigations.	[Fimognari, Carmela; Lenzi, Monia; Ferruzzi, Lorenzo; Turrini, Eleonora; Cantelli-Forti, Giorgio; Hrelia, Patrizia] Univ Bologna, Dept Pharmacol, Bologna, Italy; [Scartezzini, Paolo; Poli, Ferruccio] Univ Bologna, Dept Evolutionary & Expt Biol, Bologna, Italy; [Gotti, Roberto] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Guerrini, Alessandra] Univ Ferrara, Dept Biol & Evolut, I-44100 Ferrara, Italy; [Carulli, Giovanni; Ottaviano, Virginia] Univ Pisa, Div Hematol, Dept Oncol Transplants & New Technol Med, Pisa, Italy	University of Bologna; University of Bologna; University of Bologna; University of Ferrara; University of Pisa	Fimognari, C (corresponding author), Univ Bologna, Dept Pharmacol, Bologna, Italy.	carmela.fimognari@unibo.it	Hrelia, Patrizia/AAC-2071-2020; Guerrini, Alessandra/N-1419-2015; Turrini, Eleonora/I-3629-2019; Fimognari, Carmela/J-7678-2019	Guerrini, Alessandra/0000-0002-6553-3938; Turrini, Eleonora/0000-0003-4743-1126; Fimognari, Carmela/0000-0002-2461-8214; gotti, roberto/0000-0003-0622-2248; HRELIA, Patrizia/0000-0002-8415-3711	Ministero dell'Istruzione dell'Universita e della Ricerca [2007SSZMPK]; FIRB Piattaforme/Reti [RBPR05NWWC_002]	Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); FIRB Piattaforme/Reti	This work was supported by Ministero dell'Istruzione dell'Universita e della Ricerca (http://sitouniversitario.cineca.it; grant number: 2007SSZMPK) and FIRB Piattaforme/Reti 2006 (http://sitofirb.cineca.it; grant number: RBPR05NWWC_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aggarwal BB, 2009, BIOCHEM PHARMACOL, V78, P1083, DOI 10.1016/j.bcp.2009.05.027; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006; Austin A., 2008, BR J BIOL SCI, V8, P1, DOI DOI 10.3923/jbs.2008.1.12; Borel F, 2002, J CELL SCI, V115, P2829; Bosanquet AG, 2008, INNOVATIVE LEUKEMIA, P23; BOSANQUET AG, 1994, FORUM TRENDS EXP CLI, V4, P179; Bosanquet Andrew G, 2004, J Exp Ther Oncol, V4, P145; Chen ST, 2008, NAT BIOTECHNOL, V26, P1077, DOI 10.1038/nbt1008-1077; Choi JH, 2008, FOOD CHEM TOXICOL, V46, P3486, DOI 10.1016/j.fct.2008.08.026; Cree IA, 2009, CURR OPIN OBSTET GYN, V21, P39, DOI 10.1097/GCO.0b013e32832210ff; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cuello M, 2001, GYNECOL ONCOL, V81, P380, DOI 10.1006/gyno.2001.6194; Das S, 2006, PHYTOTHER RES, V20, P784, DOI 10.1002/ptr.1963; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; Deepak D, 1997, PHYTOCHEMISTRY, V44, P145, DOI 10.1016/S0031-9422(96)00393-7; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; *GOV IND MIN HLTH, 1989, AYURV PHARM IND; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harper JL, 2003, BIOCHEM PHARMACOL, V65, P329, DOI 10.1016/S0006-2952(02)01488-0; Hsin YH, 2006, APOPTOSIS, V11, P2167, DOI 10.1007/s10495-006-0289-0; Ichikawa H, 2007, CURR PHARM DESIGN, V13, P3400, DOI 10.2174/138161207782360492; Jiang N, 2006, WORLD J GASTROENTERO, V12, P4694, DOI 10.3748/wjg.v12.i29.4694; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Khan N, 2007, CARCINOGENESIS, V28, P233, DOI 10.1093/carcin/bgl243; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Koh DW, 2005, PHARMACOL RES, V52, P5, DOI 10.1016/j.phrs.2005.02.011; Kotnis MS, 2004, NEPHROLOGY, V9, P142, DOI 10.1111/j.1440-1797.2004.00247.x; Lampronti I, 2005, MED CHEM, V1, P327, DOI 10.2174/1573406054368684; Levi F, 2007, ADV DRUG DELIVER REV, V59, P1015, DOI 10.1016/j.addr.2006.11.001; Macho A, 1999, CELL DEATH DIFFER, V6, P155, DOI 10.1038/sj.cdd.4400465; Macho A, 2004, BIOCHEM PHARMACOL, V68, P875, DOI 10.1016/j.bcp.2004.05.016; Meshinchi S, 2009, CLIN CANCER RES, V15, P4263, DOI 10.1158/1078-0432.CCR-08-1123; Moncada S, 2010, BRIT J PHARMACOL, V160, P217, DOI 10.1111/j.1476-5381.2010.00706.x; Nagourney Robert A, 2006, Curr Treat Options Oncol, V7, P103, DOI 10.1007/s11864-006-0045-2; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; NYGREN P, 2008, EXP OPIN MED DIAGN, V2, P1, DOI DOI 10.1517/17530059.2.1.1; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Pedeux R, 1998, J INVEST DERMATOL, V111, P472, DOI 10.1046/j.1523-1747.1998.00324.x; Prabakan M, 2000, FITOTERAPIA, V71, P55, DOI 10.1016/S0367-326X(99)00120-3; Previati M, 2007, J CHEM NEUROANAT, V34, P128, DOI 10.1016/j.jchemneu.2007.05.009; Qanungo S, 2005, CARCINOGENESIS, V26, P958, DOI 10.1093/carcin/bgi040; Qureshi S, 1997, Hindustan Antibiot Bull, V39, P56; Radhakrishnan SK, 2004, ONCOGENE, V23, P4173, DOI 10.1038/sj.onc.1207571; Roy SK, 2001, PHARMAZIE, V56, P244; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Sircar D, 2007, CHROMATOGRAPHIA, V65, P349, DOI 10.1365/s10337-006-0146-x; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toogood PL, 2002, CURR OPIN CHEM BIOL, V6, P472, DOI 10.1016/S1367-5931(02)00342-3; Tsang WY, 2007, J CELL BIOL, V178, P621, DOI 10.1083/jcb.200701166; *US DEP HHS, 2004, GUID IND; Williams SN, 2000, CHEM-BIOL INTERACT, V128, P211, DOI 10.1016/S0009-2797(00)00204-0; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhou JR, 2003, J NUTR, V133, P516, DOI 10.1093/jn/133.2.516; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	59	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21544	10.1371/journal.pone.0021544	http://dx.doi.org/10.1371/journal.pone.0021544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738701	gold, Green Published, Green Submitted			2022-12-25	WOS:000292142800038
J	Sarmady, M; Dampier, W; Tozeren, A				Sarmady, Mahdi; Dampier, William; Tozeren, Aydin			Sequence- and Interactome-Based Prediction of Viral Protein Hotspots Targeting Host Proteins: A Case Study for HIV Nef	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LINEAR MOTIFS; INTERACTION SITES; SH3 DOMAINS; EPITOPES; DYNAMICS; STRATEGIES; DISCOVERY; INFECTION; INSIGHTS	Virus proteins alter protein pathways of the host toward the synthesis of viral particles by breaking and making edges via binding to host proteins. In this study, we developed a computational approach to predict viral sequence hotspots for binding to host proteins based on sequences of viral and host proteins and literature-curated virus-host protein interactome data. We use a motif discovery algorithm repeatedly on collections of sequences of viral proteins and immediate binding partners of their host targets and choose only those motifs that are conserved on viral sequences and highly statistically enriched among binding partners of virus protein targeted host proteins. Our results match experimental data on binding sites of Nef to host proteins such as MAPK1, VAV1, LCK, HCK, HLA-A, CD4, FYN, and GNB2L1 with high statistical significance but is a poor predictor of Nef binding sites on highly flexible, hoop-like regions. Predicted hotspots recapture CD8 cell epitopes of HIV Nef highlighting their importance in modulating virus-host interactions. Host proteins potentially targeted or outcompeted by Nef appear crowding the T cell receptor, natural killer cell mediated cytotoxicity, and neurotrophin signaling pathways. Scanning of HIV Nef motifs on multiple alignments of hepatitis C protein NS5A produces results consistent with literature, indicating the potential value of the hotspot discovery in advancing our understanding of virus-host crosstalk.	[Sarmady, Mahdi; Dampier, William; Tozeren, Aydin] Drexel Univ, Ctr Integrated Bioinformat, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University	Sarmady, M (corresponding author), Drexel Univ, Ctr Integrated Bioinformat, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	aydin.tozeren@drexel.edu	Sarmady/M-9859-2019	Sarmady/0000-0001-6069-804X	GSK; Drexel University	GSK(GlaxoSmithKline); Drexel University	The study was partially supported by the GSK-Drexel University Bioinformatics Collaboration grant funded by GSK and the Drexel University Calhoun Endowment fellowships to Mahdi Sarmady and Will N. Dampier. Neither GSK nor Calhoun endowment had any role in the design and implementation of the study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Balakrishnan Sivaraman, 2009, BMC Genomics, V10 Suppl 3, pS30, DOI 10.1186/1471-2164-10-S3-S30; Betzi S, 2007, P NATL ACAD SCI USA, V104, P19256, DOI 10.1073/pnas.0707130104; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chatr-aryamontri A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S5; Choppin J, 2001, J IMMUNOL, V166, P6164, DOI 10.4049/jimmunol.166.10.6164; CLARK JWM, 2009, HIV DRUG RESISTANCE; Coleman S H, 2001, Expert Opin Ther Targets, V5, P1, DOI 10.1517/14728222.5.1.1; Currier JR, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-8; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; Davis FP, 2007, PROTEIN SCI, V16, P2585, DOI 10.1110/ps.073228407; DAWANY NB, 2010, INT J CANC; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Dickerson JE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-80; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Evans P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008942; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Geyer M, 2001, FEBS LETT, V496, P91, DOI 10.1016/S0014-5793(01)02394-8; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Greenway A, 1996, J VIROL, V70, P6701, DOI 10.1128/JVI.70.10.6701-6708.1996; Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Haffar O, 2005, J VIROL, V79, P13028, DOI 10.1128/JVI.79.20.13028-13036.2005; Henschel A, 2006, BIOINFORMATICS, V22, P550, DOI 10.1093/bioinformatics/bti782; Hiipakka M, 1999, J MOL BIOL, V293, P1097, DOI 10.1006/jmbi.1999.3225; HOPKINS BSJ, 1954, ANN BOT-LONDON, V18, P15; Kadaveru K, 2008, FRONT BIOSCI, V13, P6455, DOI 10.2741/3166; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Li HQ, 2006, BIOINFORMATICS, V22, P989, DOI 10.1093/bioinformatics/btl020; Li PL, 2005, VIROLOGY, V331, P367, DOI 10.1016/j.virol.2004.11.004; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; MASUZAKI R, 2010, PROS DIG LIVER DI S3, V42, pS281; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; McClune AC, 2010, CLIN LIVER DIS, V14, P461, DOI 10.1016/j.cld.2010.05.009; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Ofran Y, 2007, BIOINFORMATICS, V23, pE13, DOI 10.1093/bioinformatics/btl303; Park CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001009; Park IW, 2009, J LEUKOCYTE BIOL, V86, P1171, DOI 10.1189/jlb.0409261; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Racape J, 2006, P NATL ACAD SCI USA, V103, P18208, DOI 10.1073/pnas.0609029103; Richter SN, 2009, CURR MED CHEM, V16, P267, DOI 10.2174/092986709787002646; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; Schmid BV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-184; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Stein A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000789; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; TOZEREN A, 1987, BIOPHYS J, V52, P901, DOI 10.1016/S0006-3495(87)83284-8; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; van Dijk D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-96; Van Doorslaer K, 2010, ADV VIRUS RES, V77, P41, DOI 10.1016/S0065-3527(10)77002-0; Via A, 2000, CELL MOL LIFE SCI, V57, P1970, DOI 10.1007/PL00000677	64	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e20735	10.1371/journal.pone.0020735	http://dx.doi.org/10.1371/journal.pone.0020735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738584	Green Published, Green Submitted, gold			2022-12-25	WOS:000292142800003
J	Trotta, E				Trotta, Edoardo			The 3-Base Periodicity and Codon Usage of Coding Sequences Are Correlated with Gene Expression at the Level of Transcription Elongation	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PROTEIN EXPRESSION; RESPECTIVE CODONS; READING FRAME; TRANSFER-RNAS; YEAST; TRANSLATION; DNA	Background: Gene transcription is regulated by DNA transcriptional regulatory elements, promoters and enhancers that are located outside the coding regions. Here, we examine the characteristic 3-base periodicity of the coding sequences and analyse its correlation with the genome-wide transcriptional profile of yeast. Principal Findings: The analysis of coding sequences by a new class of indices proposed here identified two different sources of 3-base periodicity: the codon frequency and the codon sequence. In exponentially growing yeast cells, the codon-frequency component of periodicity accounts for 71.9% of the variability of the cellular mRNA by a strong association with the density of elongating mRNA polymerase II complexes. The mRNA abundance explains most of the correlation between the codon-frequency component of periodicity and protein levels. Furthermore, pyrimidine-ending codons of the four-fold degenerate small amino acids alanine, glycine and valine are associated with genes with double the transcription rate of those associated with purine-ending codons. Conclusions: We demonstrate that the 3-base periodicity of coding sequences is higher than expected by the codon usage frequency (CUF) and that its components, associated with codon bias and amino acid composition, are correlated with gene expression, principally at the level of transcription elongation. This indicates a role of codon sequences in maximising the transcription efficiency in exponentially growing yeast cells. Moreover, the results contrast with the common Darwinian explanation that attributes the codon bias to translational selection by an adjustment of synonymous codon frequencies to the most abundant isoaccepting tRNA. Here, we show that selection on codon bias likely acts at both the transcriptional and translational level and that codon usage and the relative abundance of tRNA could drive each other in order to synergistically optimize the efficiency of gene expression.	CNR, Inst Translat Pharmacol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Trotta, E (corresponding author), CNR, Inst Translat Pharmacol, Rome, Italy.	edoardo.trotta@ift.cnr.it	Trotta, Edoardo/AAW-4697-2020	Trotta, Edoardo/0000-0002-1417-9238				ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Boycheva S, 2003, BIOINFORMATICS, V19, P987, DOI 10.1093/bioinformatics/btg082; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Dekker J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r116; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; Eskesen ST, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-12; Frenkel FE, 2009, DNA RES, V16, P105, DOI 10.1093/dnares/dsp002; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; GUTIERREZ G, 1994, J THEOR BIOL, V167, P413, DOI 10.1006/jtbi.1994.1080; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Knuth D E, 1997, ART COMPUTER PROGRAM, V2; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kulaeva OI, 2010, P NATL ACAD SCI USA, V107, P11325, DOI 10.1073/pnas.1001148107; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Marin A, 2003, YEAST, V20, P703, DOI 10.1002/yea.992; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pelechano V, 2010, YEAST, V27, P413, DOI 10.1002/yea.1768; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Perez-Ortin Jose E., 2007, Briefings in Functional Genomics & Proteomics, V6, P282, DOI 10.1093/bfgp/elm029; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Ponty Y, 2006, BIOINFORMATICS, V22, P1534, DOI 10.1093/bioinformatics/btl113; Saeki H, 2009, MOL CELL, V35, P191, DOI 10.1016/j.molcel.2009.06.009; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHEPHERD JCW, 1981, P NATL ACAD SCI-BIOL, V78, P1596, DOI 10.1073/pnas.78.3.1596; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; TSONIS AA, 1991, J THEOR BIOL, V151, P323, DOI 10.1016/S0022-5193(05)80381-9; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05	50	18	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2011	6	6							e21590	10.1371/journal.pone.0021590	http://dx.doi.org/10.1371/journal.pone.0021590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	784FW	21738721	gold, Green Published, Green Submitted			2022-12-25	WOS:000292142800041
J	Thevenet, J; Gobert, RP; van Huijsduijnen, RH; Wiessner, C; Sagot, YJ				Thevenet, Jonathan; Gobert, Rosanna Pescini; van Huijsduijnen, Robertus Hooft; Wiessner, Christoph; Sagot, Yves Jean			Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; PARKINSONS-DISEASE; DENDRITIC CELLS; BLOOD; MOUSE; MICE; INFECTION; PROTEIN; ALPHA; ACCUMULATION	Genetic variants of Leucine-Rich Repeat Kinase 2 (LRRK2) are associated with a significantly enhanced risk for Parkinson disease, the second most common human neurodegenerative disorder. Despite major efforts, our understanding of LRRK2 biological function and regulation remains rudimentary. In the present study we analyze LRRK2 mRNA and protein expression in sub-populations of human peripheral blood mononuclear cells (PBMCs). LRRK2 mRNA and protein was found in circulating CD19(+) B cells and in CD14(+) monocytes, whereas CD4(+) and CD8(+) T cells were devoid of LRRK2 mRNA. Within CD14(+) cells the CD14(+) CD16(+) sub-population of monocytes exhibited high levels of LRRK2 protein, in contrast to CD14(+) CD16(-) cells. However both populations expressed LRRK2 mRNA. As CD14(+) CD16(+) cells represent a more mature subset of monocytes, we monitored LRRK2 expression after in vitro treatment with various stress factors known to induce monocyte activation. We found that IFN-gamma in particular robustly increased LRRK2 mRNA and protein levels in monocytes concomitant with a shift of CD14(+) CD16(-) cells towards CD14(+) CD16(+) cells. Interestingly, the recently described LRRK2 inhibitor IN-1 attenuated this shift towards CD14(+) CD16(+) after IFN-gamma stimulation. Based on these findings we speculate that LRRK2 might have a role in monocyte maturation. Our results provide further evidence for the emerging role of LRRK2 in immune cells and regulation at the transcriptional and translational level. Our data might also reflect an involvement of peripheral and brain immune cells in the disease course of PD, in line with increasing awareness of the role of the immune system in PD.	[Thevenet, Jonathan; Wiessner, Christoph; Sagot, Yves Jean] Merck Serono SA, TA NDD Res, Pharmacol Parkinsons Dis, Geneva, Switzerland; [Gobert, Rosanna Pescini; van Huijsduijnen, Robertus Hooft] Merck Serono SA, TA NDD Res, Multiple Sclerosis Drug Discovery, Geneva, Switzerland	Merck KGaA; EMD Serono Inc.; Merck KGaA; EMD Serono Inc.	Thevenet, J (corresponding author), Merck Serono SA, TA NDD Res, Pharmacol Parkinsons Dis, Geneva, Switzerland.	yves.sagot@merckserono.net	van Huijsduijnen, Rob A.M. Hooft/B-3653-2009	van Huijsduijnen, Rob A.M. Hooft/0000-0002-2261-9424; Pescini Gobert, Rosanna/0000-0002-2434-7530	Merck Serono SA	Merck Serono SA	This study was funded by Merck Serono SA. The company had a role in this study due to employment of one or more authors of this study.	ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490, DOI 10.1002/jlb.47.6.490; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Brodacki B, 2008, NEUROSCI LETT, V441, P158, DOI 10.1016/j.neulet.2008.06.040; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gerlini G, 2008, J IMMUNOL, V181, P2999, DOI 10.4049/jimmunol.181.5.2999; Gottfried-Blackmore A, 2009, P NATL ACAD SCI USA, V106, P20918, DOI 10.1073/pnas.0911509106; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Ingersoll MA, 2010, BLOOD, V115, pE10, DOI 10.1182/blood-2009-07-235028; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kruger R, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-33; Kubo M, 2010, J NEUROIMMUNOL, V229, P123, DOI 10.1016/j.jneuroim.2010.07.021; Larsen K, 2009, MOL BIOL REP, V36, P237, DOI 10.1007/s11033-007-9172-5; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Maekawa T, 2010, BIOCHEM BIOPH RES CO, V392, P431, DOI 10.1016/j.bbrc.2010.01.041; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; MOST J, 1992, J IMMUNOL, V148, P1635; MUTEZ E, 2010, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROBIOLAGING.2009.1010.1016; Nichols RJ, 2009, BIOCHEM J, V424, P47, DOI 10.1042/BJ20091035; Ohta E, 2010, BIOCHEM BIOPH RES CO, V391, P242, DOI 10.1016/j.bbrc.2009.11.043; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Randolph GJ, 2002, J EXP MED, V196, P517, DOI 10.1084/jem.20011608; Reale M, 2009, MINI-REV MED CHEM, V9, P1229, DOI 10.2174/138955709789055199; Rivas-Carvalho A, 2004, INT IMMUNOL, V16, P1251, DOI 10.1093/intimm/dxh127; Song IU, 2009, EUR NEUROL, V62, P99, DOI 10.1159/000222780; Stephanou A, 1999, J BIOL CHEM, V274, P1723, DOI 10.1074/jbc.274.3.1723; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Tan EK, 2008, MOL GENET METAB, V95, P113, DOI 10.1016/j.ymgme.2008.06.004; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	48	123	124	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2011	6	6							e21519	10.1371/journal.pone.0021519	http://dx.doi.org/10.1371/journal.pone.0021519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	783OD	21738687	Green Published, Green Submitted, gold			2022-12-25	WOS:000292092600048
J	Benziger, A; Philip, S; Raghavan, R; Ali, PHA; Sukumaran, M; Tharian, JC; Dahanukar, N; Baby, F; Peter, R; Devi, KR; Radhakrishnan, KV; Haniffa, MA; Britz, R; Antunes, A				Benziger, Allen; Philip, Siby; Raghavan, Rajeev; Ali, Palakkaparambil Hamsa Anvar; Sukumaran, Mithun; Tharian, Josin C.; Dahanukar, Neelesh; Baby, Fibin; Peter, Reynold; Devi, Karunakaran Rema; Radhakrishnan, Kizhakke Veetil; Haniffa, Mohamed AbdulKather; Britz, Ralf; Antunes, Agostinho			Unraveling a 146 Years Old Taxonomic Puzzle: Validation of Malabar Snakehead, Species-Status and Its Relevance for Channid Systematics and Evolution	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; SEQUENCE ALIGNMENT; FISHES; EOCENE; PERCIFORMES; PATTERN; MODEL; TREE	Background: The Malabar snakehead Channa diplogramma is one of the most enigmatic and least understood species within the family Channidae, which comprise one of the most important groups of freshwater food fish in tropical Asia. Since its description from peninsular India in 1865, it has remained a taxonomic puzzle with many researchers questioning its validity, based on its striking similarity with the South East Asian C. micropeltes. In this study, we assessed the identity of the Malabar snakehead, C. diplogramma, using morphological and molecular genetic analyses, and also evaluated its phylogenetic relationships and evolutionary biogeography. Methodology/Principal Findings: The morphometric and meristic analysis provided conclusive evidence to separate C. diplogramma and C. micropeltes as two distinct species. Number of caudal fin rays, lateral line scales, scales below lateral line; total vertebrae, pre-anal length and body depth were the most prominent characters that can be used to differentiate both the species. Channa diplogramma also shows several ontogenic color phases during its life history, which is shared with C. micropeltes. Finally, the genetic distance between both species for the partial mitochondrial 16S rRNA and COI sequences is also well above the intra-specific genetic distances of any other channid species compared in this study. Conclusions/Significance: The current distribution of C. diplogramma and C. micropeltes is best explained by vicariance. The significant variation in the key taxonomic characters and the results of the molecular marker analysis points towards an allopatric speciation event or vicariant divergence from a common ancestor, which molecular data suggests to have occurred as early as 21.76 million years ago. The resurrection of C. diplogramma from the synonymy of C. micropeltes has hence been confirmed 146 years after its initial description and 134 years after it was synonymised, establishing it is an endemic species of peninsular India and prioritizing its conservation value.	[Benziger, Allen] Fatima Mata Natl Coll, Dept Zool, Kollam, Kerala, India; [Benziger, Allen; Haniffa, Mohamed AbdulKather] St Xaviers Coll, Ctr Aquaculture Res & Extens, Palayankottai, Tamil Nadu, India; [Philip, Siby; Antunes, Agostinho] Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Oporto, Portugal; [Philip, Siby] Univ Porto, Dept Biol, Fac Ciencias, P-4100 Oporto, Portugal; [Philip, Siby; Raghavan, Rajeev; Ali, Palakkaparambil Hamsa Anvar; Tharian, Josin C.; Baby, Fibin] St Alberts Coll, Conservat Res Grp, Kochi, Kerala, India; [Raghavan, Rajeev] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Raghavan, Rajeev] Concert Ecol & Appl Technol, Kochi, Kerala, India; [Sukumaran, Mithun] Univ Malaysia Terengganu, Inst Trop Aquaculture, Kuala Terengganu, Malaysia; [Tharian, Josin C.] St Johns Coll, Dept Zool & Environm Sci, Anchal, Kerala, India; [Dahanukar, Neelesh] Indian Inst Sci Educ & Res, Pune, Maharashtra, India; [Peter, Reynold] Cent Marine Fisheries Res Inst, Marine Biotechnol Div, Kochi, Kerala, India; [Devi, Karunakaran Rema] So Reg Ctr, Zool Survey India, Chennai, Tamil Nadu, India; [Radhakrishnan, Kizhakke Veetil] S China Normal Univ, Sch Life Sci, Ichthyol Lab, Guangzhou, Guangdong, Peoples R China; [Britz, Ralf] Nat Hist Museum, Dept Zool, London SW7 5BD, England	Universidade do Porto; Universidade do Porto; St. Albert's College; University of Kent; Universiti Malaysia Terengganu; Indian Institute of Science Education & Research (IISER) Pune; Indian Council of Agricultural Research (ICAR); ICAR - Central Marine Fisheries Research Institute; Zoological survey of India; South China Normal University; Natural History Museum London	Benziger, A (corresponding author), Fatima Mata Natl Coll, Dept Zool, Kollam, Kerala, India.	aantunes@ciimar.up.pt	Raghavan, Rajeev/G-6430-2010; Raghavan, Rajeev P/D-4895-2011; Dahanukar, Neelesh/B-2816-2012; Raghavan, Rajeev/ABD-8719-2021	Dahanukar, Neelesh/0000-0001-7162-9023; Sukumaran, Mithun/0000-0003-1193-6931; Antunes, Agostinho/0000-0002-1328-1732	Portuguese Foundation for Science and Technology [SFRH/BD/47938/2008]; Critical Ecosystem Partnership Fund; Ashoka Trust for Research in Ecology and Environment; North of England Zoological Society-Chester Zoo (United Kingdom); Columbus Zoo-Ohio (United States of America); Endangered Species International (California, United States of America);  [PTDC/BIA-BDE/69144/2006];  [FCOMP-01-0124-FEDER-007065];  [PTDC/AAC-AMB/104983/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Critical Ecosystem Partnership Fund; Ashoka Trust for Research in Ecology and Environment; North of England Zoological Society-Chester Zoo (United Kingdom); Columbus Zoo-Ohio (United States of America); Endangered Species International (California, United States of America); ; ; 	The Portuguese Foundation for Science and Technology is acknowledged for the funding of Siby Philip's Ph.D. grant SFRH/BD/47938/2008 and the project PTDC/BIA-BDE/69144/2006 (FCOMP-01-0124-FEDER-007065) and PTDC/AAC-AMB/104983/2008. Field work in Western Ghats was supported by grants from Critical Ecosystem Partnership Fund and Ashoka Trust for Research in Ecology and Environment; North of England Zoological Society-Chester Zoo (United Kingdom); Columbus Zoo-Ohio (United States of America) and Endangered Species International (California, United States of America) to Rajeev Raghavan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2010, THESIS QUEENSLAND U; Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Berra TM, 2007, FRESHWATER FISH DIST; Braasch I, 2009, GENOME BIOL EVOL, V1, P479, DOI 10.1093/gbe/evp050; BRIGGS JC, 2003, BIOGEOGRAPHIC TECTON; CHAUDHRY S, 2009, IUCN 2010 IUCN RED; CHAUDHRY S, 2010, IUCN 2010 IUCN RED L; Courtenay WR, 2004, SNAKEHEADS PISCES CH; Cuvier G., 1831, HIST NATURELLE POISS, V7; Day F., 1878, P553; Day F., 1865, Proceedings of the Zoological Society, P2; DAY F, 1865, P ZOOL SOC LOND, P286; Day F, 1865, FISHES MALABAR; Ebanasar J., 2005, J INLAND FISHERIES S, V37, P60; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; Froese R., 2014, FISHBASE; Gam L.-H., 2006, MALAYS J BIOCH MOL B, V14, P25; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grady JM, 1999, CONSERV BIOL, V13, P1004, DOI 10.1046/j.1523-1739.1999.98572.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Haniffa M.A., 2010, FISHING CHIMES, V30, P34; Hora S. L., 1949, P NATL I SCI INDIA, V15, P309; Jayaram K.C., 1981, P1; Jhingran A.G., 1991, INLAND FISHES INDIA, V1; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; JOHNSINGH AJT, 2006, FIELD DAYS NATURALIS; Klaus S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-287; Kottelat Maurice, 1998, Ichthyological Exploration of Freshwaters, V9, P1; Kumazawa Y, 2000, MOL BIOL EVOL, V17, P1869, DOI 10.1093/oxfordjournals.molbev.a026288; Kumazawa Y, 1999, BIOL BIODIVERSITY, P35; Kurup B.M., 2004, P LARS2 2 LARGE RIVE, P163; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Li X, 2006, ICHTHYOL RES, V53, P148, DOI 10.1007/s10228-005-0321-3; McMillan WO, 1999, EVOLUTION, V53, P247, DOI 10.1111/j.1558-5646.1999.tb05350.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOLUR S, 2001, CONSERVATION ASSESSM; Murray AM, 2008, J VERTEBR PALEONTOL, V28, P41, DOI 10.1671/0272-4634(2008)28[41:EAFFPW]2.0.CO;2; Murray AM, 2006, J PALEONTOL, V80, P1172, DOI 10.1666/0022-3360(2006)80[1172:ANCTCF]2.0.CO;2; Musikasinthorn P, 2001, ICHTHYOL RES, V48, P319, DOI 10.1007/s10228-001-8153-2; *NBFGR, 2009, THREAT FRESHW FISH I; Palumbi S., 2002, SIMPLE FOOLS GUIDE P; Pethiyagoda Rohan, 1994, Journal of South Asian Natural History, V1, P97; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RAGHAVAN R, 2010, LEONARD SONNENSCHEIN, P169; Rainboth W.J., 1996, FAO SPECIES IDENTIFI; Randall JE, 1998, ZOOL STUD, V37, P227; Roberts T. R., 1989, MEMOIRS CALIFORNIA A, V14, P1; ROE L J, 1991, Contributions from the Museum of Paleontology University of Michigan, V28, P93; Ruber L, 2006, SYST BIOL, V55, P374, DOI 10.1080/10635150500541664; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; SINH LX, 2010, FARMING SNAKEHEAD FI; Smith E. P., 2002, BIPLOT 1 1 EXCEL ADD; Smith WL, 2006, J HERED, V97, P206, DOI 10.1093/jhered/esj034; Swartz ER, 2008, S AFR J SCI, V104, P293; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UNNITHAN VK, 2000, NBFGR NATP PUBLICATI, V1, P69; van der Laan W.N, CATALOG FISHES ELECT; VANSTEENIS CGGJ, 1979, BOT J LINN SOC, V79, P97, DOI 10.1111/j.1095-8339.1979.tb01511.x; Vishwanath W., 2009, Journal of Threatened Taxa, V1, P97; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WEBER M, 1922, FISHES INDOAUSTRLIAN, V4; Wee K.L., 1982, RECENT ADV AQUACULTU, P181; WEST RM, 1980, J PALEONTOL, V54, P508	68	34	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21272	10.1371/journal.pone.0021272	http://dx.doi.org/10.1371/journal.pone.0021272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731689	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000292036900019
J	Griener, TP; Strecker, JG; Humphries, RM; Mulvey, GL; Fuentealba, C; Hancock, REW; Armstrong, GD				Griener, Thomas P.; Strecker, Jonathan G.; Humphries, Romney M.; Mulvey, George L.; Fuentealba, Carmen; Hancock, Robert E. W.; Armstrong, Glen D.			Lipopolysaccharide Renders Transgenic Mice Expressing Human Serum Amyloid P Component Sensitive to Shiga Toxin 2	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; THROMBOTIC THROMBOCYTOPENIC PURPURA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; O157-H7 HEMORRHAGIC COLITIS; NECROSIS-FACTOR-ALPHA; ESCHERICHIA-COLI; MOUSE MODEL; BINDING-PROTEIN; IN-VIVO; CIRCULATING LEVELS	Transgenic C57BL/6 mice expressing human serum amyloid P component (HuSAP) are resistant to Shiga toxin 2 (Stx2) at dosages that are lethal in HuSAP-negative wild-type mice. However, it is well established that Stx2 initiates extra-intestinal complications such as the haemolytic-uremic syndrome despite the presence of HuSAP in human sera. We now demonstrate that co-administering purified Escherichia coli O55 lipopolysaccharide (LPS), at a dosage of 300 ng/g body weight, to HuSAP-transgenic mice increases their susceptibility to the lethal effects of Stx2. The enhanced susceptibility to Stx2 correlated with an increased expression of genes encoding the pro-inflammatory cytokine TNF alpha and chemokines of the CXC and CC families in the kidneys of LPS-treated mice, 48 hours after the Stx2/LPS challenge. Co-administering the glucocorticoid dexamethasone, but not the LPS neutralizing cationic peptide LL-37, protected LPS-sensitized HuSAP-transgenic mice from lethal doses of Stx2. Dexamethasone protection was specifically associated with decreased expression of the same inflammatory mediators (CXC and CC-type chemokines and TNF alpha) linked to enhanced susceptibility caused by LPS. The studies reveal further details about the complex cascade of host-related events that are initiated by Stx2 as well as establish a new animal model system in which to investigate strategies for diminishing serious Stx2-mediated complications in humans infected with enterohemorrhagic E. coli strains.	[Griener, Thomas P.; Strecker, Jonathan G.; Humphries, Romney M.; Mulvey, George L.; Armstrong, Glen D.] Univ Calgary, Fac Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Fuentealba, Carmen] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Humphries, Romney M.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA	University of Calgary; University of Calgary; University of British Columbia; University of California System; University of California Los Angeles	Griener, TP (corresponding author), Univ Calgary, Fac Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	glen.armstrong@ucalgary.ca	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503	Alberta Ingenuity Fund; NSERC Canada	Alberta Ingenuity Fund; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by a grant from the Alberta Ingenuity Fund (http://www.albertaingenuity.ca/). TPG and RMH were the recipients of NSERC Canada Graduate Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GD, 2006, J INFECT DIS, V193, P1120, DOI 10.1086/501472; ARMSTRONG GD, 2009, 7 INT S SHIG TOX VER; BARRETT TJ, 1989, INFECT IMMUN, V57, P3434, DOI 10.1128/IAI.57.11.3434-3437.1989; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; BITZAN M, 1993, INFECTION, V21, P140, DOI 10.1007/BF01710530; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; CHART H, 1989, J CLIN MICROBIOL, V27, P285, DOI 10.1128/JCM.27.2.285-290.1989; CHART H, 1989, J CLIN PATHOL, V42, P973, DOI 10.1136/jcp.42.9.973; de Haas CJC, 1999, INFECT IMMUN, V67, P2790, DOI 10.1128/IAI.67.6.2790-2796.1999; de Haas CJC, 1998, J IMMUNOL, V161, P3607; de Haas CJC, 1999, FEMS IMMUNOL MED MIC, V26, P197, DOI 10.1016/S0928-8244(99)00148-0; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; FITZPATRICK MM, 1992, KIDNEY INT, V42, P951, DOI 10.1038/ki.1992.372; Fukumoto K, 2005, PEDIATR SURG INT, V21, P20, DOI 10.1007/s00383-004-1256-x; Gomez SA, 2005, CLIN EXP IMMUNOL, V139, P65, DOI 10.1111/j.1365-2249.2005.02659.x; Gomez SA, 2003, CLIN EXP IMMUNOL, V131, P217, DOI 10.1046/j.1365-2249.2003.02057.x; Griener TP, 2007, J MED MICROBIOL, V56, P1423, DOI 10.1099/jmm.0.47282-0; HAREL Y, 1993, J CLIN INVEST, V92, P2110, DOI 10.1172/JCI116811; Ikeda M, 2004, PEDIATR NEPHROL, V19, P485, DOI 10.1007/s00467-003-1395-7; Inward CD, 1997, PEDIATR NEPHROL, V11, P556, DOI 10.1007/s004670050337; Inward CD, 1997, ARCH DIS CHILD, V77, P145, DOI 10.1136/adc.77.2.145; Kamitsuji H, 2000, CLIN NEPHROL, V53, P319; Karpman D, 1995, PEDIATR NEPHROL, V9, P694, DOI 10.1007/BF00868714; Keepers TR, 2007, INFECT IMMUN, V75, P1229, DOI 10.1128/IAI.01663-06; Keepers TR, 2006, J AM SOC NEPHROL, V17, P3404, DOI 10.1681/ASN.2006050419; Kimura T, 2001, J BIOL CHEM, V276, P41576, DOI 10.1074/jbc.M107819200; KOSTER F, 1978, NEW ENGL J MED, V298, P927, DOI 10.1056/NEJM197804272981702; Lentz EK, 2010, INFECT IMMUN, V78, P3689, DOI 10.1128/IAI.00616-10; Litalien C, 1999, PEDIATR NEPHROL, V13, P840, DOI 10.1007/s004670050712; Marcato P, 2003, INFECT IMMUN, V71, P6075, DOI 10.1128/IAI.71.10.6075-6078.2003; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nestoridi E, 2008, PEDIATR NEPHROL, V23, P221, DOI 10.1007/s00467-007-0636-6; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Palermo M, 2000, CLIN EXP IMMUNOL, V119, P77, DOI 10.1046/j.1365-2249.2000.01103.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Proulx F, 1999, CLIN DIAGN LAB IMMUN, V6, P773, DOI 10.1128/CDLI.6.5.773-773.1999; Proulx F, 1998, PEDIATR INFECT DIS J, V17, P899, DOI 10.1097/00006454-199810000-00010; Proulx F, 2002, PEDIATR RES, V52, P928, DOI 10.1203/01.PDR.0000034233.75228.0B; Psotka MA, 2009, INFECT IMMUN, V77, P959, DOI 10.1128/IAI.00679-08; Roche JK, 2007, AM J PATHOL, V170, P526, DOI 10.2353/ajpath.2007.060366; Rojnuckarin P, 2006, J THROMB HAEMOST, V4, P1148, DOI 10.1111/j.1538-7836.2006.01879.x; Rose Ellen, 2005, J Dtsch Dermatol Ges, V3, P200, DOI 10.1111/j.1610-0378.2005.04747.x; Sauter KAD, 2008, INFECT IMMUN, V76, P4469, DOI 10.1128/IAI.00592-08; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Stahl AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006990; Sugatani J, 2000, THROMB RES, V100, P61, DOI 10.1016/S0049-3848(00)00305-4; Suzuki K, 2000, J MED MICROBIOL, V49, P905, DOI 10.1099/0022-1317-49-10-905; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tsutsumi R, 2004, MICROBIOL IMMUNOL, V48, P27, DOI 10.1111/j.1348-0421.2004.tb03484.x; Valles PG, 2005, MEDICINA-BUENOS AIRE, V65, P395; Van Geet C, 1998, KIDNEY INT, V54, P1324, DOI 10.1046/j.1523-1755.1998.00103.x; Van Setten PA, 1998, PEDIATR RES, V43, P759, DOI 10.1203/00006450-199806000-00008; VANDEKAR NCAJ, 1994, PEDIATR RES, V36, P257, DOI 10.1203/00006450-199408000-00019; VANDEKAR NCAJ, 1995, BLOOD, V85, P734, DOI 10.1182/blood.V85.3.734.bloodjournal853734; vanSetten PA, 1997, KIDNEY INT, V51, P1245, DOI 10.1038/ki.1997.170; VANWIERINGEN PMV, 1976, PEDIATRICS, V58, P561; Wang XX, 2008, LIFE SCI, V83, P671, DOI 10.1016/j.lfs.2008.09.003; Weichhart T, 2010, IMMUNOL LETT, V129, P50, DOI 10.1016/j.imlet.2009.12.025; Westerholt S, 2003, CLIN DIAGN LAB IMMUN, V10, P1090, DOI 10.1128/CDLI.10.6.1090-1095.2003; ZHAO X, 1992, J BIOCHEM-TOKYO, V111, P736, DOI 10.1093/oxfordjournals.jbchem.a123828; Zhu XJ, 2009, J CLIN IMMUNOL, V29, P603, DOI 10.1007/s10875-009-9303-y	63	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21457	10.1371/journal.pone.0021457	http://dx.doi.org/10.1371/journal.pone.0021457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731756	Green Submitted, gold, Green Published			2022-12-25	WOS:000292036900033
J	Pennings, JLA; Schuurhof, A; Hodemaekers, HM; Buisman, A; de Rond, LCGH; Widjojoatmodjo, MN; Luytjes, W; Kimpen, JLL; Bont, L; Janssen, R				Pennings, Jeroen L. A.; Schuurhof, Annemieke; Hodemaekers, Hennie M.; Buisman, Annemarie; de Rond, Lia C. G. H.; Widjojoatmodjo, Myra N.; Luytjes, Willem; Kimpen, Jan L. L.; Bont, Louis; Janssen, Riny			Systemic Signature of the Lung Response to Respiratory Syncytial Virus Infection	PLOS ONE			English	Article							GENE-EXPRESSION; HOST-DEFENSE; RIBONUCLEASES; BRONCHIOLITIS; LEUKOCYTES; PROFILES; DISEASE; RISK; MICE	Respiratory Syncytial Virus is a frequent cause of severe bronchiolitis in children. To improve our understanding of systemic host responses to RSV, we compared BALB/c mouse gene expression responses at day 1, 2, and 5 during primary RSV infection in lung, bronchial lymph nodes, and blood. We identified a set of 53 interferon-associated and innate immunity genes that give correlated responses in all three murine tissues. Additionally, we identified blood gene signatures that are indicative of acute infection, secondary immune response, and vaccine-enhanced disease, respectively. Eosinophil-associated ribonucleases were characteristic for the vaccine-enhanced disease blood signature. These results indicate that it may be possible to distinguish protective and unfavorable patient lung responses via blood diagnostics.	[Pennings, Jeroen L. A.; Schuurhof, Annemieke; Hodemaekers, Hennie M.; Janssen, Riny] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Buisman, Annemarie; de Rond, Lia C. G. H.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands; [Schuurhof, Annemieke; Kimpen, Jan L. L.; Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Widjojoatmodjo, Myra N.; Luytjes, Willem] Netherlands Vaccine Inst, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Pennings, JLA (corresponding author), Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands.	Jeroen.Pennings@rivm.nl		Pennings, Jeroen L.A./0000-0002-9188-6358				Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloemers BLP, 2007, PEDIATRICS, V120, pE1076, DOI 10.1542/peds.2007-0788; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Fjaerli HO, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-175; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Janssen R, 2007, J VIROL, V81, P5958, DOI 10.1128/JVI.02220-06; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kumar S, 2000, MOL BIOL EVOL, V17, P738, DOI 10.1093/oxfordjournals.molbev.a026352; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; McNamara PS, 2002, BRIT MED BULL, V61, P13, DOI 10.1093/bmb/61.1.13; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Meissner HC, 2003, PEDIATR INFECT DIS J, V22, pS40, DOI 10.1097/00006454-200302001-00006; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pennings JLA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002596; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; Rosenberg HF, 2001, J LEUKOCYTE BIOL, V70, P691; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Schuurhof A, 2010, J VIROL, V84, P9584, DOI 10.1128/JVI.00302-10; Simoes EAF, 2003, PEDIATR INFECT DIS J, V22, pS13, DOI 10.1097/00006454-200302001-00003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Thach DC, 2005, GENES IMMUN, V6, P588, DOI 10.1038/sj.gene.6364244; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	30	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2011	6	6							e21461	10.1371/journal.pone.0021461	http://dx.doi.org/10.1371/journal.pone.0021461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782UF	21731757	gold, Green Published, Green Submitted			2022-12-25	WOS:000292036900034
J	Barrera-Vilarmau, S; Obregon, P; de Alba, E				Barrera-Vilarmau, Susana; Obregon, Patricia; de Alba, Eva			Intrinsic Order and Disorder in the Bcl-2 Member Harakiri: Insights into Its Proapoptotic Activity	PLOS ONE			English	Article							CELL-DEATH; AMINO-ACIDS; PROTEIN; PEPTIDES; BINDING; RECOGNITION; MECHANISM; APOPTOSIS; MICELLES; CHANNEL	Harakiri is a BH3-only member of the Bcl-2 family that localizes in membranes and induces cell death by binding to prosurvival Bcl-x(L) and Bcl-2. The cytosolic domain of Harakiri is largely disorder with residual alpha-helical conformation according to previous structural studies. As these helical structures could play an important role in Harakiri's function, we have used NMR and circular dichroism to fully characterize them at the residue-atomic level. In addition, we report structural studies on a peptide fragment spanning Harakiri's C-terminal hydrophobic sequence, which potentially operates as a transmembrane domain. We initially checked by enzyme immunoassays and NMR that peptides encompassing different lengths of the cytosolic domain are functional as they bind Bcl-x(L) and Bcl-2. The structural data in water indicate that the alpha-helical conformation is restricted to a 25-residue segment comprising the BH3 domain. However, structure calculation was precluded because of insufficient NMR restraints. To bypass this problem we used alcohol-water mixture to increase structure population and confirmed by NMR that the conformation in both milieus is equivalent. The resulting three-dimensional structure closely resembles that of peptides encompassing the BH3 domain of BH3-only members in complex with their prosurvival partners, suggesting that preformed structural elements in the disordered protein are central to binding. In contrast, the transmembrane domain forms in micelles a monomeric a-helix with a population close to 100%. Its three-dimensional structure here reported reveals features that explain its function as membrane anchor. Altogether these results are used to propose a tentative structural model of how Harakiri works.	[Barrera-Vilarmau, Susana; Obregon, Patricia; de Alba, Eva] CSIC, Ctr Invest Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Barrera-Vilarmau, S (corresponding author), CSIC, Ctr Invest Biol, Madrid, Spain.	dealbae@cib.csic.es	Barrera-Vilarmau, Susana/ABD-1039-2020	Barrera-Vilarmau, Susana/0000-0003-4868-6593	European Commission [IRG-046412]; Spanish Ministerio de Ciencia e Innovacion [BFU2008-03278, CSD2009-00088]; Comunidad de Madrid; Agencia CSIC IV PRICIT [CCG08-CSIC/SAL-3777]	European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); Agencia CSIC IV PRICIT	This work was supported by the European Commission Marie Curie International Reintegration Grant (IRG-046412 to E.d.A.), by the Spanish Ministerio de Ciencia e Innovacion through the Programa Ramon y Cajal to E.d.A., by Plan Nacional I+D+i (grant BFU2008-03278 to E.d.A.), by Comunidad de Madrid and Agencia CSIC IV PRICIT (grant CCG08-CSIC/SAL-3777 to E.d.A.), and by the Spanish Ministerio de Ciencia e Innovacioen through theConsolider-Ingenio 2010 program (grant CSD2009-00088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bernabeu A, 2007, BBA-BIOMEMBRANES, V1768, P1659, DOI 10.1016/j.bbamem.2007.02.023; Bocharov EV, 2007, J BIOL CHEM, V282, P16256, DOI 10.1074/jbc.M701745200; Bogner C, 2010, CURR OPIN CELL BIOL, V22, P845, DOI 10.1016/j.ceb.2010.08.002; Bruix M, 1997, EUR J BIOCHEM, V243, P384, DOI 10.1111/j.1432-1033.1997.0384a.x; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DAVID CS, 2000, CELL, V103, P839; de Alba E, 2009, J BIOL CHEM, V284, P32932, DOI 10.1074/jbc.M109.024273; deAlba E, 1996, FOLD DES, V1, P133, DOI 10.1016/S1359-0278(96)00022-3; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Goddard TD, KNELLER DG SPARKY, V3; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Horne WS, 2008, ANGEW CHEM INT EDIT, V47, P2853, DOI 10.1002/anie.200705315; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; MASOTTI L, 1980, CELL BIOPHYS, V2, P241, DOI 10.1007/BF02790452; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Myers JK, 1997, BIOCHEMISTRY-US, V36, P10923, DOI 10.1021/bi9707180; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; PERVUSHIN KV, 1994, EUR J BIOCHEM, V219, P571, DOI 10.1111/j.1432-1033.1994.tb19973.x; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Pinheiro AS, 2011, J AM CHEM SOC, V133, P73, DOI 10.1021/ja107810r; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Rath A, 2007, BIOPOLYMERS, V88, P217, DOI 10.1002/bip.20668; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sadqi M, 2009, P NATL ACAD SCI USA, V106, P4127, DOI 10.1073/pnas.0812108106; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sborgi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015575; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Uversky VN, 2010, STRUCTURE, V18, P1069, DOI 10.1016/j.str.2010.08.003; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	58	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21413	10.1371/journal.pone.0021413	http://dx.doi.org/10.1371/journal.pone.0021413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731739	Green Submitted, Green Published, gold			2022-12-25	WOS:000292035400035
J	Kelly, BL; Singh, G; Aiyar, A				Kelly, Ben L.; Singh, Gyanendra; Aiyar, Ashok			Molecular and Cellular Characterization of an AT-Hook Protein from Leishmania	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; EPSTEIN-BARR-VIRUS; POSITION-EFFECT VARIEGATION; ARGININE-RICH PEPTIDES; MAJOR LACK ANTIGEN; HISTONE H1; NUCLEAR ANTIGEN-1; HUMAN-CELLS; TRANSCRIPTION ACTIVATION; DEPENDENT RECRUITMENT	AT-rich DNA, and the proteins that bind it (AT-hook proteins), modulate chromosome structure and function in most eukaryotes. Unlike other trypanosomatids, the genome of Leishmania species is unusually GC-rich, and the regulation of Leishmania chromosome structure, replication, partitioning is not fully understood. Because AT-hook proteins modulate these functions in other eukaryotes, we examined whether AT-hook proteins are encoded in the Leishmania genome, to test their potential functions. Several Leishmania ORFs predicted to be AT-hook proteins were identified using in silico approaches based on sequences shared between eukaryotic AT-hook proteins. We have used biochemical, molecular and cellular techniques to characterize the L. amazonensis ortholog of the L. major protein LmjF06.0720, a potential AT-hook protein that is highly conserved in Leishmania species. Using a novel fusion between the AT-hook domain encoded by LmjF06.0720 and a herpesviral protein, we have demonstrated that LmjF06.0720 functions as an AT-hook protein in mammalian cells. Further, as observed for mammalian and viral AT-hook proteins, the AT-hook domains of LmjF06.0720 bind specific regions of condensed mammalian metaphase chromosomes, and support the licensed replication of DNA in mammalian cells. LmjF06.0720 is nuclear in Leishmania, and this localization is disrupted upon exposure to drugs that displace AT-hook proteins from AT-rich DNA. Coincidentally, these drugs dramatically alter the cellular physiology of Leishmania promastigotes. Finally, we have devised a novel peptido-mimetic agent derived from the sequence of LmjF06.0720 that blocks the proliferation of Leishmania promastigotes, and lowers amastigote parasitic burden in infected macrophages. Our results indicate that AT-hook proteins are critical for the normal biology of Leishmania. In addition, we have described a simple technique to examine the function of Leishmania chromatin-binding proteins in a eukaryotic context amenable to studying chromosome structure and function. Lastly, we demonstrate the therapeutic potential of compounds directed against AT-hook proteins in Leishmania.	[Kelly, Ben L.; Aiyar, Ashok] Lousiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Singh, Gyanendra; Aiyar, Ashok] Lousiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Kelly, BL (corresponding author), Lousiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.	bkell2@lsuhsc.edu; aaiyar@lsuhsc.edu			NIH [AI055172, CA112564]; NATIONAL CANCER INSTITUTE [R01CA112564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI055172] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the NIH (grant numbers AI055172 and CA112564). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JE, 2005, J BIOL CHEM, V280, P32184, DOI 10.1074/jbc.M505600200; Aiyar A, 1998, EMBO J, V17, P6394, DOI 10.1093/emboj/17.21.6394; Aiyar A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-29; AMBINDER RF, 1991, J VIROL, V65, P1466, DOI 10.1128/JVI.65.3.1466-1478.1991; Aras S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000469; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; Blattes R, 2006, EMBO J, V25, P2397, DOI 10.1038/sj.emboj.7601125; Bonnefoy E, 1999, MOL CELL BIOL, V19, P2803; Chuang RY, 1999, P NATL ACAD SCI USA, V96, P2656, DOI 10.1073/pnas.96.6.2656; Cui TJ, 2007, BIOCHEMISTRY-US, V46, P13059, DOI 10.1021/bi701269s; Dement GA, 2005, EXP CELL RES, V307, P388, DOI 10.1016/j.yexcr.2005.04.004; DICKINSON LA, 1995, MOL CELL BIOL, V15, P456, DOI 10.1128/MCB.15.1.456; DISNEY JE, 1989, J CELL BIOL, V109, P1975, DOI 10.1083/jcb.109.5.1975; Dragan AI, 2008, J MOL BIOL, V384, P335, DOI 10.1016/j.jmb.2008.09.015; Duncker BP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-214; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; GALLIE DR, 1991, MOL GEN GENET, V228, P258, DOI 10.1007/BF00282474; Girard F, 1998, EMBO J, V17, P2079, DOI 10.1093/emboj/17.7.2079; Giroux M, 2000, J IMMUNOL, V165, P3985, DOI 10.4049/jimmunol.165.7.3985; Hebner C, 2003, VIROLOGY, V311, P263, DOI 10.1016/S0042-6822(03)00122-3; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huth JR, 1997, NAT STRUCT BIOL, V4, P657, DOI 10.1038/nsb0897-657; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Janssen S, 2000, MOL CELL, V6, P1013, DOI 10.1016/S1097-2765(00)00100-3; Janssen S, 2000, MOL CELL, V6, P999, DOI 10.1016/S1097-2765(00)00099-X; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kar S, 2000, J BIOL CHEM, V275, P37789, DOI 10.1074/jbc.M002149200; Kelly BL, 2004, INFECT IMMUN, V72, P6924, DOI 10.1128/IAI.72.12.6924-6931.2004; Kelly BL, 2003, J EXP MED, V198, P1689, DOI 10.1084/jem.20031162; Kelly BL, 2001, MOL BIOCHEM PARASIT, V116, P101, DOI 10.1016/S0166-6851(01)00307-3; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; KIRCHMAIER AL, 1995, J VIROL, V69, P1280, DOI 10.1128/JVI.69.2.1280-1283.1995; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; Lee JK, 2001, P NATL ACAD SCI USA, V98, P13589, DOI 10.1073/pnas.251530398; LUPTON S, 1985, MOL CELL BIOL, V5, P2533, DOI 10.1128/MCB.5.10.2533; Manabe T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008004; MAREKOV LN, 1978, BIOCHIMIE, V60, P1347; MARKY LA, 1987, P NATL ACAD SCI USA, V84, P4359, DOI 10.1073/pnas.84.13.4359; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Masina S, 2007, EXP PARASITOL, V116, P83, DOI 10.1016/j.exppara.2006.11.002; MASUKATA H, 1993, MOL BIOL CELL, V4, P1121, DOI 10.1091/mbc.4.11.1121; MICKLEM G, 1993, NATURE, V366, P87, DOI 10.1038/366087a0; Monod C, 2002, EMBO REP, V3, P747, DOI 10.1093/embo-reports/kvf155; Nagpal S, 1999, J BIOL CHEM, V274, P22563, DOI 10.1074/jbc.274.32.22563; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; Noll TM, 1997, MOL BIOCHEM PARASIT, V84, P215, DOI 10.1016/S0166-6851(96)02801-0; Norseen J, 2008, EMBO J, V27, P3024, DOI 10.1038/emboj.2008.221; PEDEN KWC, 1980, SCIENCE, V209, P1392, DOI 10.1126/science.6251547; Puechberty J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-57; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; REEVES R, 1990, J BIOL CHEM, V265, P8573; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SAITOH Y, 1993, COLD SPRING HARB SYM, V58, P755, DOI 10.1101/SQB.1993.058.01.083; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Schulze JM, 2010, EPIGENETICS-US, V5, P573, DOI 10.4161/epi.5.7.12856; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sears J, 2003, J VIROL, V77, P11767, DOI 10.1128/JVI.77.21.11767-11780.2003; Singh G, 2009, J VIROL, V83, P4227, DOI 10.1128/JVI.02578-08; Smirlis D, 2006, MOL MICROBIOL, V60, P1457, DOI 10.1111/j.1365-2958.2006.05205.x; STINCHCOMB DT, 1979, NATURE, V282, P39, DOI 10.1038/282039a0; Strick R, 1995, CELL, V83, P1137, DOI 10.1016/0092-8674(95)90140-X; SUGDEN B, 1988, MOL BIOL MED, V5, P85; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Thomae AW, 2008, P NATL ACAD SCI USA, V105, P1692, DOI 10.1073/pnas.0707260105; Thomas S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-152; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tosato V, 2001, CURR GENET, V40, P186, DOI 10.1007/s002940100246; WARTELL RM, 1974, J BIOL CHEM, V249, P6719; WEGNER M, 1990, BIOCHEM BIOPH RES CO, V166, P1110, DOI 10.1016/0006-291X(90)90981-R; Zhang HY, 2004, MOL CELL BIOL, V24, P9424, DOI 10.1128/MCB.24.21.9424-9436.2004; Zhao J, 2000, J BIOL CHEM, V275, P27494; ZHAO K, 1993, EMBO J, V12, P3237, DOI 10.1002/j.1460-2075.1993.tb05993.x	79	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21412	10.1371/journal.pone.0021412	http://dx.doi.org/10.1371/journal.pone.0021412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21731738	Green Published, gold, Green Submitted			2022-12-25	WOS:000292035400034
J	Vaiman, D; Gascoin-Lachambre, G; Boubred, F; Mondon, F; Feuerstein, JM; Ligi, I; Grandvuillemin, I; Barbaux, S; Ghigo, E; Achard, V; Simeoni, U; Buffat, C				Vaiman, Daniel; Gascoin-Lachambre, Geraldine; Boubred, Farid; Mondon, Francoise; Feuerstein, Jean-Marc; Ligi, Isabelle; Grandvuillemin, Isabelle; Barbaux, Sandrine; Ghigo, Eric; Achard, Vincent; Simeoni, Umberto; Buffat, Christophe			The Intensity of IUGR-Induced Transcriptome Deregulations Is Inversely Correlated with the Onset of Organ Function in a Rat Model	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; IMPRINTING CONTROL REGION; LOW-PROTEIN-DIET; GENE-EXPRESSION; BIRTH-WEIGHT; FETAL-GROWTH; METHYLATION; RESTRICTION; HYPERTENSION; PREGNANCY	A low-protein diet applied during pregnancy in the rat results in intrauterine growth restricted (IUGR) fetuses. In humans, IUGR is associated with increased perinatal morbidity, higher incidence of neuro-developmental defects and increased risk of adult metabolic anomalies, such as diabetes and cardiovascular disease. Development and function of many organs are affected by environmental conditions such as those inducing fetal and early postnatal growth restriction. This phenomenon, termed "fetal programming" has been studied unconnectedly in some organs, but very few studies (if any) have investigated at the same time several organs, on a more comparative basis. However, it is quite probable that IUGR affects differentially most organ systems, with possible persistent changes in gene expression. In this study we address transcriptional alterations induced by IUGR in a multi-organ perspective, by systematic analysis of 20-days rat fetuses. We show that (1) expressional alterations are apparently stronger in organs functioning late in foetal or postnatal life than in organs that are functioning early (2) hierarchical classification of the deregulations put together kidney and placenta in one cluster, liver, lungs and heart in another; (3) the epigenetic machinery is set up especially in the placenta, while its alterations are rather mild in other organs; (4) the genes appear deregulated in chromosome clusters; (5) the altered expression cascades varies from organ to organ, with noticeably a very significant modification of the complement and coagulation cascades in the kidney; (6) we found a significant increase in TF binding site for HNF4 proteins specifically for liver genes that are down-regulated in IUGR, suggesting that this decrease is achieved through the action of HNF transcription factors, that are themselves transcriptionnally induced in the liver by IUGR (x 1.84 fold). Altogether, our study suggests that a combination of tissue-specific mechanisms contributes to bring about tissue-driven modifications of gene cascades. The question of these cascades being activated to adapt the organ to harsh environmental condition, or as an endpoint consequence is still raised.	[Vaiman, Daniel; Gascoin-Lachambre, Geraldine; Mondon, Francoise; Barbaux, Sandrine] Inst Cochin, INSERM, Paris, France; [Vaiman, Daniel; Gascoin-Lachambre, Geraldine; Mondon, Francoise; Barbaux, Sandrine] Univ Paris 05, Paris, France; [Gascoin-Lachambre, Geraldine; Mondon, Francoise; Barbaux, Sandrine] CNRS, UMRS8104, Paris, France; [Boubred, Farid; Feuerstein, Jean-Marc; Ligi, Isabelle; Grandvuillemin, Isabelle; Simeoni, Umberto] Hop Conception, Assistance Publ Hop Marseille, Div Neonatol, Marseille, France; [Feuerstein, Jean-Marc; Ligi, Isabelle; Grandvuillemin, Isabelle; Simeoni, Umberto] Univ Mediterranee, Fac Pharm, INSERM, UMR608, Marseille, France; [Ghigo, Eric; Buffat, Christophe] Univ Mediterranee, CNRS, URMITE, UMR 6236, Marseille, France; [Achard, Vincent] Hop Conception, Assistance Publ Hop Marseille, Reprod Biol Lab, Marseille, France; [Achard, Vincent] Aix Marseille Univ, Fac Med, INSERM, UMR 626, Marseille, France; [Buffat, Christophe] Hop Conception, Assistance Publ Hop Marseille, Mol Biol Lab, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vaiman, D (corresponding author), Inst Cochin, INSERM, Paris, France.	daniel.vaiman@inserm.fr	Simeoni, Umberto/GRO-6971-2022; SIMEONI, Umberto/AAQ-1870-2021; Barbaux, Sandrine C/B-2878-2019; Vaiman, Daniel/O-6030-2015; boubred, farid/D-9831-2014; Eric, Ghigo/N-9427-2016	Simeoni, Umberto/0000-0003-0730-9337; SIMEONI, Umberto/0000-0003-0730-9337; Barbaux, Sandrine C/0000-0002-8204-1855; Vaiman, Daniel/0000-0002-1915-0717; Boubred, Farid/0000-0003-3039-2036	INSERM; Hopitaux de Marseille; Chiesi Farmaceuti S.p.A.	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Hopitaux de Marseille; Chiesi Farmaceuti S.p.A.(Chiesi Pharmaceuticals Inc)	Funding was granted by INSERM and Hopitaux de Marseille, and Chiesi Farmaceuti S.p.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth A, 1998, EUR J CLIN NUTR, V52, pS34; Ashworth A, 1998, EUR J CLIN NUTR S1, V52, pS41; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bourque DK, 2010, PLACENTA, V31, P197, DOI 10.1016/j.placenta.2009.12.003; Buffat C, 2007, J PATHOL, V213, P337, DOI 10.1002/path.2233; Buffat C, 2007, ENDOCRINOLOGY, V148, P5549, DOI 10.1210/en.2007-0765; Ceccarelli V, 2011, MOL CELL BIOCHEM, V347, P29, DOI 10.1007/s11010-010-0609-0; Chelbi ST, 2008, MOL CELL ENDOCRINOL, V282, P120, DOI 10.1016/j.mce.2007.11.022; Chelbi ST, 2007, HYPERTENSION, V49, P76, DOI 10.1161/01.HYP.0000250831.52876.cb; CHELBI ST, 2011, EPIGENETICS IN PRESS; COMBS CA, 1993, OBSTET GYNECOL, V82, P365; Cox SM, 2001, INT J GYNECOL OBSTET, V72, P85; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; De Souza CT, 2010, J PHYSIOL-LONDON, V588, P2239, DOI 10.1113/jphysiol.2009.183996; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fauque P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-116; Fauque P, 2010, HUM MOL GENET, V19, P1779, DOI 10.1093/hmg/ddq059; Fernandez-Twinn DS, 2003, BRIT J NUTR, V90, P815, DOI 10.1079/BJN2003967; Franco MDP, 2002, CARDIOVASC RES, V56, P145, DOI 10.1016/S0008-6363(02)00508-4; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Galambos C, 2008, PATHOLOGY, V40, P124, DOI 10.1080/00313020701818981; Gardosi J, 2011, CLIN PERINATOL, V38, P21, DOI 10.1016/j.clp.2010.12.012; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Glaser RL, 2006, NUCLEIC ACIDS RES, V34, pD29, DOI 10.1093/nar/gkj101; Godlewski G, 1997, MICROSC RES TECHNIQ, V39, P314, DOI 10.1002/(SICI)1097-0029(19971115)39:4<314::AID-JEMT2>3.0.CO;2-H; Grantham-McGregor SM, 1998, EUR J CLIN NUTR, V52, pS59; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Koukoura O, 2011, PLACENTA, V32, P51, DOI 10.1016/j.placenta.2010.10.017; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Langley-Evans SC, 1999, BIOCHEM SOC T, V27, P88, DOI 10.1042/bst0270088; LangleyEvans SC, 1996, COMP BIOCHEM PHYS A, V114, P327, DOI 10.1016/0300-9629(96)00018-7; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nikolajev K, 2008, WORLD J PEDIATR, V4, P222, DOI 10.1007/s12519-008-0041-7; Oh-McGinnis R, 2011, DEV BIOL, V351, P277, DOI 10.1016/j.ydbio.2011.01.008; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; RESNICK O, 1979, NEUROSCI BIOBEHAV R, V3, P233, DOI 10.1016/0149-7634(79)90011-3; Richardus JH, 2003, BJOG-INT J OBSTET GY, V110, P97; Rutland CS, 2007, PLACENTA, V28, P734, DOI 10.1016/j.placenta.2006.07.001; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schwitzgebel VM, 2009, MOL CELL ENDOCRINOL, V304, P78, DOI 10.1016/j.mce.2009.02.019; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Struwe E, 2010, CLIN ENDOCRINOL, V72, P241, DOI 10.1111/j.1365-2265.2009.03659.x; THOMPSON RF, J BIOL CHEM; Torrens C, 2009, HYPERTENSION, V53, P661, DOI 10.1161/HYPERTENSIONAHA.108.122820; Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wolf G, 2003, NUTR REV, V61, P176, DOI 10.1301/nr.2003.may.176-179; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	61	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21222	10.1371/journal.pone.0021222	http://dx.doi.org/10.1371/journal.pone.0021222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21731679	gold, Green Published			2022-12-25	WOS:000292033700050
J	Verhulst, NO; Qiu, YT; Beijleveld, H; Maliepaard, C; Knights, D; Schulz, S; Berg-Lyons, D; Lauber, CL; Verduijn, W; Haasnoot, GW; Mumm, R; Bouwmeester, HJ; Claas, FHJ; Dicke, M; van Loon, JJA; Takken, W; Knight, R; Smallegange, RC				Verhulst, Niels O.; Qiu, Yu Tong; Beijleveld, Hans; Maliepaard, Chris; Knights, Dan; Schulz, Stefan; Berg-Lyons, Donna; Lauber, Christian L.; Verduijn, Willem; Haasnoot, Geert W.; Mumm, Roland; Bouwmeester, Harro J.; Claas, Frans H. J.; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem; Knight, Rob; Smallegange, Renate C.			Composition of Human Skin Microbiota Affects Attractiveness to Malaria Mosquitoes	PLOS ONE			English	Article							HUMAN AXILLARY ODOR; ANOPHELES-GAMBIAE; AEDES-AEGYPTI; PREFERENCES; SPECTROMETRY; MICROFLORA; RESPONSES; SELECTION; BEHAVIOR; ATTRACTS	The African malaria mosquito Anopheles gambiae sensu stricto continues to play an important role in malaria transmission, which is aggravated by its high degree of anthropophily, making it among the foremost vectors of this disease. In the current study we set out to unravel the strong association between this mosquito species and human beings, as it is determined by odorant cues derived from the human skin. Microbial communities on the skin play key roles in the production of human body odour. We demonstrate that the composition of the skin microbiota affects the degree of attractiveness of human beings to this mosquito species. Bacterial plate counts and 16S rRNA sequencing revealed that individuals that are highly attractive to An. gambiae s.s. have a significantly higher abundance, but lower diversity of bacteria on their skin than individuals that are poorly attractive. Bacterial genera that are correlated with the relative degree of attractiveness to mosquitoes were identified. The discovery of the connection between skin microbial populations and attractiveness to mosquitoes may lead to the development of new mosquito attractants and personalized methods for protection against vectors of malaria and other infectious diseases.	[Verhulst, Niels O.; Qiu, Yu Tong; Beijleveld, Hans; Dicke, Marcel; van Loon, Joop J. A.; Takken, Willem; Smallegange, Renate C.] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands; [Beijleveld, Hans] Univ Wageningen & Res Ctr, Subdept Environm Technol, Wageningen, Netherlands; [Maliepaard, Chris] Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands; [Knights, Dan; Knight, Rob] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Schulz, Stefan] Tech Univ Carolo Wilhelmina Braunschweig, Inst Organ Chem, Braunschweig, Germany; [Berg-Lyons, Donna; Lauber, Christian L.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Verduijn, Willem; Haasnoot, Geert W.; Claas, Frans H. J.] Leiden Univ, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Mumm, Roland] Univ Wageningen & Res Ctr, Business Unit Biosci, Wageningen, Netherlands; [Mumm, Roland] Ctr BioSyst Gen, Wageningen, Netherlands; [Bouwmeester, Harro J.] Univ Wageningen & Res Ctr, Lab Plant Physiol, Wageningen, Netherlands; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of Colorado System; University of Colorado Boulder; Braunschweig University of Technology; University of Colorado System; University of Colorado Boulder; Leiden University; Leiden University - Excl LUMC; Wageningen University & Research; Centre for BioSystems Genomics; Wageningen University & Research; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Verhulst, NO (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands.	Niels.Verhulst@wur.nl	Maliepaard, Chris/G-6041-2015; Pollet, Thomas V/H-3397-2012; Verhulst, Simon/B-1613-2009; Verhulst, Simon/S-3404-2019; Dicke, Marcel/B-2300-2010; Bouwmeester, Harro J/C-1414-2008; Smallegange, Renate C./L-1566-2019; Knight, Rob/D-1299-2010; Pollet, Thomas/M-6346-2019; Verhulst, Niels/AAH-4288-2019; Nettle, Daniel/B-2259-2008; van Loon, Joop J.A./B-3744-2009	Pollet, Thomas V/0000-0002-4210-935X; Verhulst, Simon/0000-0002-1143-6868; Verhulst, Simon/0000-0002-1143-6868; Dicke, Marcel/0000-0001-8565-8896; Smallegange, Renate C./0000-0002-6946-9777; Pollet, Thomas/0000-0002-4210-935X; Nettle, Daniel/0000-0001-9089-2599; Stulp, Gert/0000-0003-0173-5554; Bouwmeester, Harro/0000-0003-0907-2732; Schulz, Stefan/0000-0002-4810-324X; Mumm, Roland/0000-0002-0603-1508; van Loon, Joop J.A./0000-0002-4260-0501; Verhulst, Niels/0000-0002-1106-9711; Knight, Rob/0000-0002-0975-9019	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH) [121]; Earth and Life Science Foundation of the Netherlands Organization for Scientific Research	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Earth and Life Science Foundation of the Netherlands Organization for Scientific Research	This study was funded by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH# 121), and a grant from the Earth and Life Science Foundation of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; Ara K, 2006, CAN J MICROBIOL, V52, P357, DOI 10.1139/W05-130; Bernier UR, 1999, ANAL CHEM, V71, P1, DOI 10.1021/ac980990v; Braks MAH, 1999, PARASITOL TODAY, V15, P409, DOI 10.1016/S0169-4758(99)01514-8; Braks MAH, 1999, J CHEM ECOL, V25, P663, DOI 10.1023/A:1020970307748; Bruinsma M, 2010, OECOLOGIA, V162, P393, DOI 10.1007/s00442-009-1459-x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Costantini C, 1998, AM J TROP MED HYG, V58, P56, DOI 10.4269/ajtmh.1998.58.56; Costantini C, 1996, MED VET ENTOMOL, V10, P220, DOI 10.1111/j.1365-2915.1996.tb00734.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; KHAN AA, 1968, MOSQ NEWS, V28, P462; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Logan J. G., 2008, Outlooks on Pest Management, V19, P280, DOI 10.1564/19dec14; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Olanga EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-6; Penn D, 1998, ADV IMMUNOL, V69, P411, DOI 10.1016/S0065-2776(08)60612-4; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; RENNIE PJ, 1991, BRIT J DERMATOL, V124, P596, DOI 10.1111/j.1365-2133.1991.tb04958.x; Savelev SU, 2008, J CHEM ECOL, V34, P1253, DOI 10.1007/s10886-008-9524-1; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Taylor D., 2003, International Journal of Cosmetic Science, V25, P137, DOI 10.1046/j.1467-2494.2003.00181.x; Tims S, 2010, INT J LEGAL MED, V124, P477, DOI 10.1007/s00414-009-0352-9; Torr S, 2008, MED VET ENTOMOL, V22, P93, DOI 10.1111/j.1365-2915.2008.00723.x; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Verhulst NO, 2010, FEMS MICROBIOL ECOL, V74, P1, DOI 10.1111/j.1574-6941.2010.00908.x; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; WHITE GB, 1980, T ROY SOC TROP MED H, V74, P683; Wold S., 2006, MULTI MEGAVARIATE DA; Xu Y, 2007, METABOLOMICS, V3, P427, DOI 10.1007/s11306-007-0054-6; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324	45	199	201	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2011	6	12							e28991	10.1371/journal.pone.0028991	http://dx.doi.org/10.1371/journal.pone.0028991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SK	21738577	Green Published, gold			2022-12-25	WOS:000300676300020
J	Zhao, X; Mo, DL; Li, AN; Gong, W; Xiao, SQ; Zhang, Y; Qin, LM; Niu, YN; Guo, YX; Liu, XH; Cong, PQ; He, ZY; Wang, C; Li, JQ; Chen, YS				Zhao, Xiao; Mo, Delin; Li, Anning; Gong, Wen; Xiao, Shuqi; Zhang, Yue; Qin, Limei; Niu, Yuna; Guo, Yunxue; Liu, Xiaohong; Cong, Peiqing; He, Zuyong; Wang, Chong; Li, Jiaqi; Chen, Yaosheng			Comparative Analyses by Sequencing of Transcriptomes during Skeletal Muscle Development between Pig Breeds Differing in Muscle Growth Rate and Fatness	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; BINDING-PROTEIN GENE; FIBER TYPE; IN-VITRO; MOLECULAR REGULATION; EXPRESSION PROFILES; INTRAMUSCULAR FAT; WNT/BETA-CATENIN; MYOGENIC CELLS; LANDRACE PIGS	Understanding the dynamics of muscle transcriptome during development and between breeds differing in muscle growth is necessary to uncover the complex mechanism underlying muscle development. Herein, we present the first transcriptome-wide longissimus dorsi muscle development research concerning Lantang (LT, obese) and Landrace (LR, lean) pig breeds during 10 time-points from 35 days-post-coitus (dpc) to 180 days-post-natum (dpn) using Solexa/Illumina's Genome Analyzer. The data demonstrated that myogenesis was almost completed before 77 dpc, but the muscle phenotypes were still changed from 77 dpc to 28 dpn. Comparative analysis of the two breeds suggested that myogenesis started earlier but progressed more slowly in LT than in LR, the stages ranging from 49 dpc to 77 dpc are critical for formation of different muscle phenotypes. 595 differentially expressed myogenesis genes were identified, and their roles in myogenesis were discussed. Furthermore, GSK3B, IKBKB, ACVR1, ITGA and STMN1 might contribute to later myogenesis and more muscle fibers in LR than LT. Some myogenesis inhibitors (ID1, ID2, CABIN1, MSTN, SMAD4, CTNNA1, NOTCH2, GPC3 and HMOX1) were higher expressed in LT than in LR, which might contribute to more slow muscle differentiation in LT than in LR. We also identified several genes which might contribute to intramuscular adipose differentiation. Most important, we further proposed a novel model in which MyoD and MEF2A controls the balance between intramuscular adipogenesis and myogenesis by regulating CEBP family; Myf5 and MEF2C are essential during the whole myogenesis process while MEF2D affects muscle growth and maturation. The MRFs and MEF2 families are also critical for the phenotypic differences between the two pig breeds. Overall, this study contributes to elucidating the mechanism underlying muscle development, which could provide valuable information for pig meat quality improvement. The raw data have been submitted to Gene Expression Omnibus (GEO) under series GSE25406.	[Zhao, Xiao; Mo, Delin; Li, Anning; Gong, Wen; Xiao, Shuqi; Zhang, Yue; Qin, Limei; Niu, Yuna; Guo, Yunxue; Liu, Xiaohong; Cong, Peiqing; He, Zuyong; Chen, Yaosheng] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Chong; Li, Jiaqi] S China Agr Univ, Coll Anim Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; South China Agricultural University	Zhao, X (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	chyaosh@mail.sysu.edu.cn	He, Zuyong/AAU-9430-2021	Wang, Chong/0000-0002-1515-9669; Garrick, Dorian/0000-0001-8640-5372; Chen, Yaosheng/0000-0002-3871-7651; Mo, Delin/0000-0002-8738-4486; Dittmer, Keren/0000-0002-1813-2197; Li, Anning/0000-0001-7695-161X	National Natural Science Foundation of China [U0731003, 31072008]; National High Science and Technology Foundation of China [2006CB102101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Science and Technology Foundation of China	This research was supported by the Joint Funds of the National Natural Science Foundation of China (U0731003), the National High Science and Technology Foundation of China (2006CB102101) and National Natural Science Foundation of China (31072008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CURRENT GENOMICS; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; ASHMORE CR, 1973, J ANIM SCI, V36, P1088, DOI 10.2527/jas1973.3661088x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Aurino S, 2008, Acta Myol, V27, P90; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Balogh A, 1996, EXP CELL RES, V224, P8, DOI 10.1006/excr.1996.0106; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Cagnazzo M, 2006, J ANIM SCI, V84, P1; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Cerri PS, 2003, MICRON, V34, P365, DOI 10.1016/S0968-4328(03)00098-2; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Dayton W R, 2008, J Anim Sci, V86, pE217, DOI 10.2527/jas.2007-0456; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Gerbens F, 1998, MAMM GENOME, V9, P1022, DOI 10.1007/s003359900918; Gerbens F, 1999, J ANIM SCI, V77, P846; Gerbens F, 1997, MAMM GENOME, V8, P328, DOI 10.1007/s003359900433; Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67; Grifone R, 2007, DEV BIOL, V302, P602, DOI 10.1016/j.ydbio.2006.08.059; Guo J, 2011, J ANIM SCI, V89, P185, DOI 10.2527/jas.2010-2983; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kim JM, 2010, ANIM GENET, V41, P642, DOI 10.1111/j.1365-2052.2010.02042.x; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Kronnie GT, 2002, J MUSCLE RES CELL M, V23, P65; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; LEFAUCHEUR L, 1986, MEAT SCI, V16, P199, DOI 10.1016/0309-1740(86)90026-4; LI J, 2003, J GENET GENOMICS, V30, P835; Li YH, 2006, FEBS LETT, V580, P5423, DOI 10.1016/j.febslet.2006.09.011; Liu JQ, 2004, J BIOL CHEM, V279, P24493, DOI [10.1074/jbc.M402920200, 10.1074/jbc.M407050200]; Macqueen DJ, 2010, BIOCHEM BIOPH RES CO, V400, P599, DOI 10.1016/j.bbrc.2010.08.110; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; MASCARELLO F, 1992, J ANIM SCI, V70, P1806, DOI 10.2527/1992.7061806x; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Muir T, 2008, MOL REPROD DEV, V75, P1637, DOI 10.1002/mrd.20902; Murani E, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-109; Newcom DW, 2004, J ANIM SCI, V82, P2264; Ono Y, 2011, CELL DEATH DIFFER, V18, P222, DOI 10.1038/cdd.2010.95; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; PAS MFW, 2006, ARCH TIERZ DUMMERSTO, V49, P110; PAS MFW, 2005, ARCH ANIM BREED, V48, P141; Pas MFWT, 2005, J MUSCLE RES CELL M, V26, P157, DOI 10.1007/s10974-005-7004-6; PAS MT, 2004, MUSCLE DEV LIVESTOCK, P201; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Porrello A, 2000, J CELL BIOL, V151, P1295, DOI 10.1083/jcb.151.6.1295; Rajesh RV, 2010, COMP BIOCHEM PHYS D, V5, P234, DOI 10.1016/j.cbd.2010.06.004; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; SCHULER F, 1995, J CELL SCI, V108, P3795; Shan TZ, 2009, J CELL BIOCHEM, V107, P984, DOI 10.1002/jcb.22203; Shiseki M, 2003, CANCER RES, V63, P2373; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; SUZUKI A, 1991, MEAT SCI, V29, P31, DOI 10.1016/0309-1740(91)90021-H; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; te Pas MFW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-66; Tee JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005880; Waddell JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015055; WIGMORE PMC, 1983, J ANAT, V137, P235; Yang H, 2010, ANIM BIOTECHNOL, V21, P64, DOI 10.1080/10495390903385983; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Zhang Suzhen, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P753; Zhao SH, 2003, J ANIM SCI, V81, P2179; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	79	122	132	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2011	6	5							e19774	10.1371/journal.pone.0019774	http://dx.doi.org/10.1371/journal.pone.0019774			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XS	21637832	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052200014
J	Stulp, G; Verhulst, S; Pollet, TV; Nettle, D; Buunk, AP				Stulp, Gert; Verhulst, Simon; Pollet, Thomas V.; Nettle, Daniel; Buunk, Abraham P.			Parental Height Differences Predict the Need for an Emergency Caesarean Section	PLOS ONE			English	Article							MATERNAL HEIGHT; BIRTH-WEIGHT; SHOULDER DYSTOCIA; RISK; DELIVERY; SIZE; STATURE; WOMEN; PERFORMANCE; LABOR	More than 30% of all pregnancies in the UK require some form of assistance at delivery, with one of the more severe forms of assistance being an emergency Caesarean section (ECS). Previously it has been shown that the likelihood of a delivery via ECS is positively associated with the birth weight and size of the newborn and negatively with maternal height. Paternal height affects skeletal growth and mass of the fetus, and thus might also affect pregnancy outcomes. We hypothesized that the effect of newborn birth weight on the risk of ECS would decrease with increasing maternal height. Similarly, we predicted that there would be an increase in ECS risk as a function of paternal height, but that this effect would be relative to maternal height (i.e., parental height differences). We used data from the Millennium Cohort Study: a large-scale survey (N = 18,819 births) with data on babies born and their parents from the United Kingdom surveyed 9 to 12-months after birth. We found that in primiparous women, both maternal height and parental height differences interacted with birth weight and predicted the likelihood of an ECS. When carrying a heavy newborn, the risk of ECS was more than doubled for short women (46.3%) compared to tall women (21.7%), in agreement with earlier findings. For women of average height carrying a heavy newborn while having a relatively short compared to tall partner reduced the risk by 6.7%. In conclusion, the size of the baby, the height of the mother and parental height differences affect the likelihood of an ECS in primiparous women.	[Stulp, Gert; Pollet, Thomas V.; Nettle, Daniel; Buunk, Abraham P.] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Stulp, Gert; Verhulst, Simon] Univ Groningen, Dept Behav Biol, Groningen, Netherlands; [Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behaviour & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Buunk, Abraham P.] Royal Netherlands Acad Arts & Sci, Amsterdam, Netherlands	University of Groningen; University of Groningen; Newcastle University - UK	Stulp, G (corresponding author), Univ Groningen, Dept Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	g.stulp@rug.nl	Maliepaard, Chris/G-6041-2015; Pollet, Thomas V/H-3397-2012; Verhulst, Simon/B-1613-2009; Verhulst, Simon/S-3404-2019; Dicke, Marcel/B-2300-2010; Bouwmeester, Harro J/C-1414-2008; Smallegange, Renate C./L-1566-2019; Knight, Rob/D-1299-2010; Pollet, Thomas/M-6346-2019; Verhulst, Niels/AAH-4288-2019; Nettle, Daniel/B-2259-2008; van Loon, Joop J.A./B-3744-2009	Pollet, Thomas V/0000-0002-4210-935X; Verhulst, Simon/0000-0002-1143-6868; Verhulst, Simon/0000-0002-1143-6868; Dicke, Marcel/0000-0001-8565-8896; Smallegange, Renate C./0000-0002-6946-9777; Pollet, Thomas/0000-0002-4210-935X; Nettle, Daniel/0000-0001-9089-2599; Stulp, Gert/0000-0003-0173-5554; Bouwmeester, Harro/0000-0003-0907-2732; Schulz, Stefan/0000-0002-4810-324X; Mumm, Roland/0000-0002-0603-1508; van Loon, Joop J.A./0000-0002-4260-0501; Verhulst, Niels/0000-0002-1106-9711; Knight, Rob/0000-0002-0975-9019	Wellcome Trust; Royal Netherlands Academy of Arts and Sciences; NWO [451.10.032]	Wellcome Trust(Wellcome TrustEuropean Commission); Royal Netherlands Academy of Arts and Sciences; NWO(Netherlands Organization for Scientific Research (NWO))	The Millennium Cohort Study was commissioned by the Economic and Social Research Council (ESRC), whose funding has been supplemented by a consortium of government departments and the Wellcome Trust. This research was supported by grants to APB and DN from the Royal Netherlands Academy of Arts and Sciences and an NWO Veni grant to TVP (451.10.032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADADEVOH SWK, 1989, INT J GYNECOL OBSTET, V28, P243, DOI 10.1016/0020-7292(89)90725-X; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Awonuga Awoniyi O., 2007, Archives of Gynecology and Obstetrics, V276, P523, DOI 10.1007/s00404-007-0370-0; BAIRD D, 1949, LANCET, V256, P1079; BARKEMA HW, 1992, THERIOGENOLOGY, V37, P489, DOI 10.1016/0093-691X(92)90206-7; BELLOWS RA, 1982, J ANIM SCI, V55, P18, DOI 10.2527/jas1982.55118x; Brabin L, 2002, ACTA OBSTET GYN SCAN, V81, P502, DOI 10.1034/j.1600-0412.2002.810605.x; BRESLER JB, 1962, AM J PHYS ANTHROPOL, V20, P515, DOI 10.1002/ajpa.1330200412; CAMILLERI AP, 1981, EUR J OBSTET GYN R B, V12, P347, DOI 10.1016/0028-2243(81)90080-0; CATALANO PM, 1995, AM J OBSTET GYNECOL, V172, P1459, DOI 10.1016/0002-9378(95)90478-6; Chan BCP, 2009, J OBSTET GYNAECOL RE, V35, P307, DOI 10.1111/j.1447-0756.2008.00939.x; Colburn DJ, 1997, J ANIM SCI, V75, P1452; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; DEX S, 2004, MILLENNIUM COHORT ST, P1; Godfrey K, 2001, J BONE MINER RES, V16, P1694, DOI 10.1359/jbmr.2001.16.9.1694; Guegan JF, 2000, P ROY SOC B-BIOL SCI, V267, P2529, DOI 10.1098/rspb.2000.1316; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; JAMES DK, 1979, BRIT MED J, V1, P10, DOI 10.1136/bmj.1.6155.10; KAPPEL B, 1987, ACTA OBSTET GYN SCAN, V66, P153, DOI 10.3109/00016348709083038; Kirchengast S., 2007, ACTA MED LITU, V14, P1; Knight B, 2005, EARLY HUM DEV, V81, P823, DOI 10.1016/j.earlhumdev.2005.06.003; LANGER O, 1991, AM J OBSTET GYNECOL, V165, P831, DOI 10.1016/0002-9378(91)90424-P; McGuinness BJ, 1999, AUST NZ J OBSTET GYN, V39, P152, DOI 10.1111/j.1479-828X.1999.tb03360.x; Mee I, 2008, VET J, V176, P93, DOI 10.1016/j.tvjl.2007.12.032; Merchant KM, 2001, BRIT J OBSTET GYNAEC, V108, P689, DOI 10.1111/j.1471-0528.2001.00181.x; Mocanu EV, 2000, EUR J OBSTET GYN R B, V92, P229, DOI 10.1016/S0301-2115(99)00280-8; *NAT HLTH STAT MAT, 2005, MAT STAT; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nesbitt TS, 1998, AM J OBSTET GYNECOL, V179, P476, DOI 10.1016/S0002-9378(98)70382-5; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; Pawlowski B, 2003, P ROY SOC B-BIOL SCI, V270, P709, DOI 10.1098/rspb.2002.2294; READ AW, 1994, AM J PUBLIC HEALTH, V84, P37, DOI 10.2105/AJPH.84.1.37; SANDMIRE HF, 1988, INT J GYNECOL OBSTET, V26, P65, DOI 10.1016/0020-7292(88)90198-1; Shields Beverley M, 2006, BMC Pediatr, V6, P24, DOI 10.1186/1471-2431-6-24; Shy K, 2000, AM J OBSTET GYNECOL, V182, P1363, DOI 10.1067/mob.2000.106175; THOMSON AM, 1963, P NUTR SOC, V22, P55, DOI 10.1079/PNS19630013; Trevathan W, 2000, J HUM EVOL, V39, P583, DOI 10.1006/jhev.2000.0434; TURNER MJ, 1990, OBSTET GYNECOL, V76, P159; VANROOSMALEN J, 1992, INT J GYNECOL OBSTET, V37, P169, DOI 10.1016/0020-7292(92)90377-U; Veena SR, 2004, PAEDIATR PERINAT EP, V18, P361, DOI 10.1111/j.1365-3016.2004.00579.x; WHO, 2005, MAK EV MOTH CHILD CO; Wills AK, 2010, EARLY HUM DEV, V86, P535, DOI 10.1016/j.earlhumdev.2010.07.002; WITTER FR, 1995, OBSTET GYNECOL, V85, P947, DOI 10.1016/0029-7844(95)00082-3	43	199	201	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2011	6	6							e20497	10.1371/journal.pone.0020497	http://dx.doi.org/10.1371/journal.pone.0020497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	786FZ	21738577	Green Published, gold, Green Accepted			2022-12-25	WOS:000292290100004
J	Li, J; Chen, CS; Chen, CH; He, QH; Li, H; Li, J; Moyzis, RK; Xue, G; Dong, Q				Li, Jin; Chen, Chuansheng; Chen, Chunhui; He, Qinghua; Li, He; Li, Jun; Moyzis, Robert K.; Xue, Gui; Dong, Qi			Neurotensin Receptor 1 Gene (NTSR1) Polymorphism Is Associated with Working Memory	PLOS ONE			English	Article							PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; CORTICAL DOPAMINE; SCHIZOPHRENIA; LOCALIZATION; EXPRESSION; NEURONS; BRAIN; ENDOPHENOTYPE; STIMULATION	Background: Recent molecular genetics studies showed significant associations between dopamine-related genes (including genes for dopamine receptors, transporters, and degradation) and working memory, but little is known about the role of genes for dopamine modulation, such as those related to neurotensin (NT), in working memory. A recent animal study has suggested that NT antagonist administration impaired working memory in a learning task. The current study examined associations between NT genes and working memory among humans. Methods: Four hundred and sixty healthy undergraduate students were assessed with a 2-back working memory paradigm. 5 SNPs in the NTSR1 gene were genotyped. 5 ANOVA tests were conducted to examine whether and how working memory differed by NTSR1 genotype, with each SNP variant as the independent variable and the average accuracy on the working memory task as the dependent variable. Results: ANOVA results suggested that two SNPs in the NTSR1 gene (rs4334545 and rs6090453) were significantly associated with working memory. These results survived corrections for multiple comparisons. Conclusions: Our results demonstrated that NTSR1 SNP polymorphisms were significantly associated with variance in working memory performance among healthy adults. This result extended previous rodent studies showing that the NT deficiency impairs the working memory function. Future research should replicate our findings and extend to an examination of other dopamine modulators.	[Li, Jin; Chen, Chunhui; He, Qinghua; Li, He; Li, Jun; Xue, Gui; Dong, Qi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Jin; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [He, Qinghua; Xue, Gui] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Moyzis, Robert K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Beijing Normal University; University of California System; University of California Irvine; University of Southern California; University of California System; University of California Irvine	Li, J (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	cschen@uci.edu; dongqi@bnu.edu.cn	Xue, Gui/A-1762-2009; He, Qinghua/B-2573-2008	Xue, Gui/0000-0001-7891-8151; He, Qinghua/0000-0001-6396-6273; li, jin/0000-0002-4413-5746; Chen, Chuansheng/0000-0002-8224-1005	Ministry of Education of China [B07008]	Ministry of Education of China(Ministry of Education, China)	This research was supported by the 111 Project from the Ministry of Education of China (B07008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MJ, 1998, J COMP NEUROL, V402, P475; Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; Austin J, 2000, MOL PSYCHIATR, V5, P552, DOI 10.1038/sj.mp.4000761; Azmi N, 2006, BEHAV PHARMACOL, V17, P357, DOI 10.1097/01.fbp.0000224382.63744.20; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Binder EB, 2001, PHARMACOL REV, V53, P453; Binder EB, 2001, J NEUROSCI, V21, P601, DOI 10.1523/JNEUROSCI.21-02-00601.2001; Boudin H, 1996, J COMP NEUROL, V373, P76; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Fatigati MD, 2000, BRAIN RES, V876, P196, DOI 10.1016/S0006-8993(00)02654-8; Froehlich TE, 2007, BIOL PSYCHIAT, V62, P243, DOI 10.1016/j.biopsych.2006.09.039; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Hamid EH, 2002, BIOL PSYCHIAT, V51, P795, DOI 10.1016/S0006-3223(01)01325-7; HETIER E, 1988, N-S ARCH PHARMACOL, V337, P13; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huezo-Diaz P, 2004, SCHIZOPHR RES, V66, P193, DOI 10.1016/S0920-9964(03)00128-2; Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x; Kimberg DY, 2003, NEUROPSYCHOLOGIA, V41, P1020, DOI 10.1016/S0028-3932(02)00317-2; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Kremen WS, 2007, NEUROPSYCHOLOGY, V21, P569, DOI 10.1037/0894-4105.21.5.569; LAMBERT PD, 1995, ANN NY ACAD SCI, V757, P377, DOI 10.1111/j.1749-6632.1995.tb17496.x; LAURENT P, 1994, MAMM GENOME, V5, P303, DOI 10.1007/BF00389545; Le F, 1997, J BIOL CHEM, V272, P1315, DOI 10.1074/jbc.272.2.1315; Lee YS, 1999, SCHIZOPHR RES, V36, P92; Liang YQ, 2010, NEUROPHARMACOLOGY, V58, P1199, DOI 10.1016/j.neuropharm.2010.02.015; MAI JK, 1987, NEUROSCIENCE, V22, P499, DOI 10.1016/0306-4522(87)90349-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Ohinata K, 2007, PEPTIDES, V28, P1470, DOI 10.1016/j.peptides.2007.06.002; Petkova-Kirova P, 2008, NEUROCHEM INT, V53, P355, DOI 10.1016/j.neuint.2008.08.010; Prus AJ, 2007, BRAIN RES, V1184, P354, DOI 10.1016/j.brainres.2007.09.092; QUIRION R, 1983, PEPTIDES, V4, P609, DOI 10.1016/0196-9781(83)90005-0; QUIRION R, 1985, BRAIN RES, V327, P385, DOI 10.1016/0006-8993(85)91542-2; ROMPRE PP, 1992, EUR J PHARMACOL, V211, P295, DOI 10.1016/0014-2999(92)90384-G; Saperstein AM, 2006, SCHIZOPHRENIA BULL, V32, P498, DOI 10.1093/schbul/sbj072; SEROOGY KB, 1987, EXP BRAIN RES, V68, P277; SEUTIN V, 1989, NEUROPHARMACOLOGY, V28, P949, DOI 10.1016/0028-3908(89)90194-9; Sharma RP, 1997, AM J PSYCHIAT, V154, P1019; STUDLER JM, 1988, NEUROPEPTIDES, V11, P95, DOI 10.1016/0143-4179(88)90076-5; Tirado-Santiago G, 2006, BEHAV NEUROSCI, V120, P1093, DOI 10.1037/0735-7044.120.5.1093; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Xue G, 2004, NEUROIMAGE, V22, P1, DOI 10.1016/j.neuroimage.2004.01.013; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhu B, 2010, MEMORY, V18, P543, DOI 10.1080/09658211.2010.487051	54	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17365	10.1371/journal.pone.0017365	http://dx.doi.org/10.1371/journal.pone.0017365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21738684	Green Published, gold			2022-12-25	WOS:000288025500012
J	Liu, CC; Guo, MS; Lin, FHY; Hsiao, KN; Chang, KHW; Chou, AH; Wang, YC; Chen, YC; Yang, CS; Chong, PCS				Liu, Chia-Chyi; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Chang, Kate Hsuen-Wen; Chou, Ai-Hsiang; Wang, Yu-Chao; Chen, Yu-Ching; Yang, Chung-Shi; Chong, Pele Choi-Sing			Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System	PLOS ONE			English	Article							LETHAL ENTEROVIRUS-71; PUBLIC-HEALTH; DISEASE VIRUS; PROTECTS MICE; POLIOVIRUS; INFECTION; VACCINE; STRAIN; VP1; IDENTIFICATION	Background: Enterovirus 71 (EV71) infections manifest most commonly as a childhood exanthema known as hand-foot-and-mouth disease (HFMD) and can cause neurological disease during acute infection. Principal Finding: In this study, we describe the production, purification and characterization of EV71 virus produced from Vero cells grown in a five-liter serum-free bioreactor system containing 5 g/L Cytodex 1 microcarrier. The viral titer was >10(6) TCID(50)/mL by 6 days post infection when a MOI of 10(-5) was used at the initial infection. Two EV71 virus fractions were separated and detected when the harvested EV71 virus concentrate was purified by sucrose gradient zonal ultracentrifugation. The EV71 viral particles detected in the 24-28% sucrose fractions had an icosahedral structure 30-31 nm in diameter and had low viral infectivity and RNA content. Three major viral proteins (VP0, VP1 and VP3) were observed by SDS-PAGE. The EV71 viral particles detected in the fractions containing 35-38% sucrose were 33-35 nm in size, had high viral infectivity and RNA content, and were composed of four viral proteins (VP1, VP2, VP3 and VP4), as shown by SDS-PAGE analyses. The two virus fractions were formalin-inactivated and induced high virus neutralizing antibody responses in mouse immunogenicity studies. Both mouse antisera recognized the immunodominant linear neutralization epitope of VP1 (residues 211-225). Conclusion: These results provide important information for cell-based EV71 vaccine development, particularly for the preparation of working standards for viral antigen quantification.	[Liu, Chia-Chyi; Guo, Meng-Shin; Lin, Fion Hsiao-Yu; Hsiao, Kuang-Nan; Chang, Kate Hsuen-Wen; Chou, Ai-Hsiang; Chong, Pele Choi-Sing] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Miaoli County, Taiwan; [Wang, Yu-Chao; Chen, Yu-Ching; Yang, Chung-Shi] Natl Hlth Res Inst, Ctr Nanomed Res, Zhunan Town, Miaoli County, Taiwan; [Chong, Pele Choi-Sing] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Liu, CC (corresponding author), Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan Town, Miaoli County, Taiwan.	pelechong@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Chong, Pele/E-3855-2010; Yang, Chung-Shi/E-3999-2010; Loos, Ruth/Q-2862-2016	Liu, Chia-Chyi/0000-0002-6257-0389; Loos, Ruth/0000-0002-8532-5087	Department of Health, the Taiwan CDC; National Science Council; National Health Research Institutes, Taiwan	Department of Health, the Taiwan CDC; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Department of Health, the Taiwan CDC, the National Science Council and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chang GH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-106; Chiu CH, 2006, MICROBES INFECT, V8, P1671, DOI 10.1016/j.micinf.2006.01.021; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Curry S, 1997, J VIROL, V71, P9743, DOI 10.1128/JVI.71.12.9743-9752.1997; FERGUSON M, 1990, J GEN VIROL, V71, P1271, DOI 10.1099/0022-1317-71-6-1271; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Guang DM, 2007, MICROBES INFECT, V9, P1299; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; HUMMELER K, 1962, VIROLOGY, V16, P84, DOI 10.1016/0042-6822(62)90205-2; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; MAYER MM, 1957, J IMMUNOL, V78, P435; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; MINOR PD, 1980, J GEN VIROL, V51, P147, DOI 10.1099/0022-1317-51-1-147; MINOR PD, 1991, J GEN VIROL, V72, P2475, DOI 10.1099/0022-1317-72-10-2475; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; PANEZUTTI H, 1993, INFECT IMMUN, V61, P1867, DOI 10.1128/IAI.61.5.1867-1872.1993; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; VONSEEFRIED A, 1984, REV INFECT DIS, V6, pS345; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	35	139	164	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2011	6	5							e20005	10.1371/journal.pone.0020005	http://dx.doi.org/10.1371/journal.pone.0020005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763LP	21603631	Green Submitted, Green Published, gold			2022-12-25	WOS:000290558500041
J	Zhang, YJ; Ma, PF; Li, DZ				Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu			High-Throughput Sequencing of Six Bamboo Chloroplast Genomes: Phylogenetic Implications for Temperate Woody Bamboos (Poaceae: Bambusoideae)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GRASS FAMILY POACEAE; NATURAL HYBRIDIZATION; EVOLUTIONARY ANALYSIS; PLASTID GENOMES; GBSSI GENE; DNA; REGIONS; BAMBUSA; NUCLEAR	Background: Bambusoideae is the only subfamily that contains woody members in the grass family, Poaceae. In phylogenetic analyses, Bambusoideae, Pooideae and Ehrhartoideae formed the BEP clade, yet the internal relationships of this clade are controversial. The distinctive life history (infrequent flowering and predominance of asexual reproduction) of woody bamboos makes them an interesting but taxonomically difficult group. Phylogenetic analyses based on large DNA fragments could only provide a moderate resolution of woody bamboo relationships, although a robust phylogenetic tree is needed to elucidate their evolutionary history. Phylogenomics is an alternative choice for resolving difficult phylogenies. Methodology/Principal Findings: Here we present the complete nucleotide sequences of six woody bamboo chloroplast (cp) genomes using Illumina sequencing. These genomes are similar to those of other grasses and rather conservative in evolution. We constructed a phylogeny of Poaceae from 24 complete cp genomes including 21 grass species. Within the BEP clade, we found strong support for a sister relationship between Bambusoideae and Pooideae. In a substantial improvement over prior studies, all six nodes within Bambusoideae were supported with >= 0.95 posterior probability from Bayesian inference and 5/6 nodes resolved with 100% bootstrap support in maximum parsimony and maximum likelihood analyses. We found that repeats in the cp genome could provide phylogenetic information, while caution is needed when using indels in phylogenetic analyses based on few selected genes. We also identified relatively rapidly evolving cp genome regions that have the potential to be used for further phylogenetic study in Bambusoideae. Conclusions/Significance: The cp genome of Bambusoideae evolved slowly, and phylogenomics based on whole cp genome could be used to resolve major relationships within the subfamily. The difficulty in resolving the diversification among three clades of temperate woody bamboos, even with complete cp genome sequences, suggests that these lineages may have diverged very rapidly.	[Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Zhang, Yun-Jie; Ma, Peng-Fei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Chen, Wei/0000-0002-6383-7540; Chen, Guoxun/0000-0001-6226-4050	Chinese Academy of Sciences [KSCX-YW-N-029]; National Natural Science Foundation of China [30990244]; Innovation Teams of Yunnan Province, China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Teams of Yunnan Province, China	This project is supported by the Chinese Academy of Sciences through a project under the knowledge innovation program (KSCX-YW-N-029), National Natural Science Foundation of China (no. 30990244) and a program of Innovation Teams of Yunnan Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bystriakova N., 2003, BAMBOO BIODIVERSITY; Bystriakova N., 2004, BAMBOO BIODIVERSITY; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; CLARK LG, 1989, NATL GEOGR RES, V5, P459; CLARK LG, 1995, SYST BOT, V20, P436, DOI 10.2307/2419803; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; CUMMINGS MP, 1994, MOL BIOL EVOL, V11, P1; Davis JI, 2010, AM J BOT, V97, P874, DOI 10.3732/ajb.0900228; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Egan AN, 2008, MOL PHYLOGENET EVOL, V46, P532, DOI 10.1016/j.ympev.2007.10.006; Gaut BS, 1997, MOL BIOL EVOL, V14, P769, DOI 10.1093/oxfordjournals.molbev.a025817; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Gong X. S., 1994, J WUHAN BOT RES, V12, P277; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INBAR, 1999, SOC ISS CONSTR BAMB; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Judziewicz EJ, 1999, AM BAMBOOS; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Li D.-Z., 2006, FLORA CHINA, V22, P7; LI DZ, 1998, BAMBOO CONSERVATION; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Masood MS, 2004, GENE, V340, P133, DOI 10.1016/j.gene.2004.06.008; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Ohrnberger D, 1999, BAMBOOS WORLD ANNOTA; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RENVOIZE SA, 1992, GRASS EVOLUTION DOME; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun Y, 2005, BIOCHEM GENET, V43, P603, DOI 10.1007/s10528-005-9117-4; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Triplett JK, 2010, AM J BOT, V97, P471, DOI 10.3732/ajb.0900244; Triplett JK, 2010, SYST BOT, V35, P102, DOI 10.1600/036364410790862678; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang HQ, 2008, MOL PHYLOGENET EVOL, V48, P809, DOI 10.1016/j.ympev.2008.06.001; Yang JB, 2010, TAXON, V59, P1102, DOI 10.1002/tax.594010; Zeng CX, 2010, MOL PHYLOGENET EVOL, V56, P821, DOI 10.1016/j.ympev.2010.03.041; Zhang WP, 2000, MOL PHYLOGENET EVOL, V15, P135, DOI 10.1006/mpev.1999.0729; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	78	293	320	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20596	10.1371/journal.pone.0020596	http://dx.doi.org/10.1371/journal.pone.0020596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655229	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600106
J	Zhang, Y; Chen, W; Li, R; Li, Y; Ge, YB; Chen, GX				Zhang, Yan; Chen, Wei; Li, Rui; Li, Yang; Ge, Yuebin; Chen, Guoxun			Insulin-Regulated Srebp-1c and Pck1 mRNA Expression in Primary Hepatocytes from Zucker Fatty but Not Lean Rats Is Affected by Feeding Conditions	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; GENE-EXPRESSION; CALORIC RESTRICTION; SIGNALING PATHWAY; MISSENSE MUTATION; ACID SYNTHESIS; X-RECEPTOR; LIVER; OBESITY; RESISTANCE	Insulin regulates the transcription of genes for hepatic glucose and lipid metabolism. We hypothesized that this action may be impaired in hepatocytes from insulin resistant animals. Primary hepatocytes from insulin sensitive Zucker lean (ZL) and insulin resistant Zucker fatty (ZF) rats in ad libitum or after an overnight fasting were isolated, cultured and treated with insulin and other compounds for analysis of gene expression using real-time PCR. The mRNA levels of one insulin-induced (Srebp-1c) and one insulin-suppressed (Pck1) genes in response to insulin, glucagon, and compactin treatments in hepatocytes from ad libitum ZL and ZF rats were analyzed. Additionally, the effects of insulin and T1317 on their levels in hepatocytes from ad libitum or fasted ZL or ZF rats were compared. The mRNA levels of Srebp-1c, Fas, and Scd1, but not that of Insr, Gck and Pck1, were higher in freshly isolated hepatocytes from ad libitum ZF than that from ZL rats. These patterns of Srebp-1c and Pck1 mRNA levels remained in primary hepatocyte cultured in vitro. Insulin's ability to regulate Srebp-1c and Pck1 expression was diminished in hepatocytes from ad libitum ZF, but not ZL rats. Glucagon or compactin suppressed Srebp-1c mRNA expression in lean, but not fatty hepatocytes. However, glucagon induced Pck1 mRNA expression similarly in hepatocytes from ad libitum ZL and ZF rats. Insulin caused the same dose-dependent increase of Akt phosphorylation in hepatocytes from ad libitum ZL and ZF rats. It synergized with T1317 to induce Srebp-1c, and suppressed Pck1 mRNA levels in hepatocytes from fasted, but not that from ad libitum ZF rats. We demonstrated that insulin was unable to regulate its downstream genes' mRNA expression in hepatocytes from ad libitum ZF rats. This impairment can be partially restored in hepatocytes from ZF rats after an overnight fasting, a phenomenon that deserves further investigation.	[Zhang, Yan; Chen, Wei; Li, Rui; Li, Yang; Ge, Yuebin; Chen, Guoxun] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Ge, Yuebin] S Cent Univ Nationalities, Coll Pharm, Wuhan, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; South Central Minzu University	Zhang, Y (corresponding author), Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA.	gchen6@utk.edu	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Chen, Wei/0000-0002-6383-7540; Chen, Guoxun/0000-0001-6226-4050	American Heart Association [09SDG2140003]; University of Tennessee at Knoxville; Allen Foundation Inc.	American Heart Association(American Heart Association); University of Tennessee at Knoxville; Allen Foundation Inc.	This work was supported by the Scientist Development Grant from American Heart Association (09SDG2140003, to G.C.), a start-up fund from the University of Tennessee at Knoxville (to G.C.), and a research grant from Allen Foundation Inc. (to G.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1990, BIOCHEM J, V266, P91, DOI 10.1042/bj2660091; de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Chen GX, 2007, BIOCHEM BIOPH RES CO, V361, P805, DOI 10.1016/j.bbrc.2007.07.108; Chen GX, 2009, BIOCHEM J, V419, P645, DOI 10.1042/BJ20082368; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chirieac DV, 2004, AM J PHYSIOL-ENDOC M, V287, pE42, DOI 10.1152/ajpendo.00297.2003; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; CLARK JB, 1982, ENDOCRINOLOGY, V111, P964, DOI 10.1210/endo-111-3-964; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Garnett KE, 2005, J MOL ENDOCRINOL, V35, P13, DOI 10.1677/jme.1.01792; Griffen SC, 2001, DIABETES, V50, P63, DOI 10.2337/diabetes.50.1.63; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Horton JD, 2008, SCIENCE, V320, P1433, DOI 10.1126/science.1159651; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; OKAUCHI N, 1995, DIABETES RES CLIN PR, V27, P97, DOI 10.1016/0168-8227(95)01029-D; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784; STEVENS J, 1981, MOL CELL BIOCHEM, V37, P177, DOI 10.1007/BF02354886; Takaya K, 1996, BIOCHEM BIOPH RES CO, V225, P75, DOI 10.1006/bbrc.1996.1133; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Unger RH, 1997, TRENDS ENDOCRIN MET, V8, P276, DOI 10.1016/S1043-2760(97)00094-5; Zhou YP, 1999, METABOLISM, V48, P857, DOI 10.1016/S0026-0495(99)90219-6; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320; ZUCKER LM, 1972, J LIPID RES, V13, P234; ZUCKER LM, 1961, J HERED, V52, P275, DOI 10.1093/oxfordjournals.jhered.a107093	55	293	320	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21342	10.1371/journal.pone.0021342	http://dx.doi.org/10.1371/journal.pone.0021342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21655229	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700064
J	Chen, YJ; Huang, WC; Wei, YL; Hsu, SC; Yuan, P; Lin, HY; Wistuba, II; Lee, JJ; Yen, CJ; Su, WC; Chang, KY; Chang, WC; Chou, TC; Chou, CK; Tsai, CH; Hung, MC				Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Yuan, Ping; Lin, Heather Y.; Wistuba, Ignacio I.; Lee, J. Jack; Yen, Chia-Jui; Su, Wu-Chou; Chang, Kwang-Yu; Chang, Wen-Chang; Chou, Tse-Chuan; Chou, Chao-Kai; Tsai, Chang-Hai; Hung, Mien-Chie			Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR MUTATIONS; LUNG-CANCER PATIENTS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; ANTITUMOR-ACTIVITY; GENE-MUTATIONS; PHASE-II; ERLOTINIB; PROTEIN	Background: The sensitivity of non-small cell lung cancer (NSCLC) patients to EGFR tyrosine kinase inhibitors (TKIs) is strongly associated with activating EGFR mutations. Although not as sensitive as patients harboring these mutations, some patients with wild-type EGFR (wtEGFR) remain responsive to EGFR TKIs, suggesting that the existence of unexplored mechanisms renders most of wtEGFR-expressing cancer cells insensitive. Methodology/Principal Findings: Here, we show that acquired resistance of wtEGFR-expressing cancer cells to an EGFR TKI, gefitinib, is associated with elevated expression of breast cancer resistance protein (BCRP/ABCG2), which in turn leads to gefitinib efflux from cells. In addition, BCRP/ABCG2 expression correlates with poor response to gefitinib in both cancer cell lines and lung cancer patients with wtEGFR. Co-treatment with BCRP/ABCG2 inhibitors enhanced the anti-tumor activity of gefitinib. Conclusions/Significance: Thus, BCRP/ABCG2 expression may be a predictor for poor efficacy of gefitinib treatment, and targeting BCRP/ABCG2 may broaden the use of gefitinib in patients with wtEGFR.	[Chen, Yun-Ju; Huang, Wei-Chien; Wei, Ya-Ling; Hsu, Sheng-Chieh; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Huang, Wei-Chien] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Tsai, Chang-Hai] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chou, Chao-Kai; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yuan, Ping; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lin, Heather Y.; Lee, J. Jack] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Chang, Wen-Chang] Natl Cheng Kung Univ, Dept Pharmacol, Tainan 70101, Taiwan; [Yen, Chia-Jui; Su, Wu-Chou] Natl Cheng Kung Univ, Inst Clin Med, Tainan 70101, Taiwan; [Chou, Tse-Chuan] Natl Cheng Kung Univ, Dept Chem Engn, Tainan, Taiwan; [Huang, Wei-Chien] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Kwang-Yu] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Chou, Tse-Chuan] Tatung Univ, Dept Chem Engn, Taipei 104, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Asia University Taiwan; Asia University Taiwan; National Health Research Institutes - Taiwan; Tatung University	Chen, YJ (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan.	whuang@mail.cmu.edu.tw; mhung@mdanderson.org	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	National Science Council of Taiwan [NSC-96-2917-I-006-004, NSC-97-2320-B-039-033-MY3, NSC-98-3112-B-039-002]; National Health Research Institutes of Taiwan [NHRI-EX-98-9812BC, NSC-2632-B-001]; Cancer Center Research of Excellence [DOH-TD-C-111-005]; National Institutes of Health [NIH PO1 CA099031, NIH RO1 CA109311]; National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan); Cancer Center Research of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; Kadoorie Charitable Foundation; University of Texas MD Anderson Cancer Center; CMUH Sister Institution Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Science Council of Taiwan (NSC-96-2917-I-006-004 to Y.J. Chen; NSC-97-2320-B-039-033-MY3 and NSC-98-3112-B-039-002 to W.C. Huang), the National Health Research Institutes of Taiwan (NHRI-EX-98-9812BC to W.C. Huang), NSC-2632-B-001, and Cancer Center Research of Excellence (DOH-TD-C-111-005), National Institutes of Health (NIH PO1 CA099031 and NIH RO1 CA109311), National Breast Cancer Foundation, Inc., Kadoorie Charitable Foundation, and The University of Texas MD Anderson Cancer Center and CMUH Sister Institution Fund (to M.C. Hung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chang GC, 2006, J THORAC ONCOL, V1, P520, DOI 10.1097/01243894-200607000-00004; Coldren CD, 2006, MOL CANCER RES, V4, P521, DOI 10.1158/1541-7786.MCR-06-0095; Diestra JE, 2003, J UROLOGY, V170, P1383, DOI 10.1097/01.ju.0000074710.96154.c9; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Huang SF, 2004, CLIN CANCER RES, V10, P8195, DOI 10.1158/1078-0432.CCR-04-1245; HUANG WC, 2011, J BIOL CHEM; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kuo MT, 2007, ADV EXP MED BIOL, V608, P23; Lee DH, 2008, ANN ONCOL, V19, P2039, DOI 10.1093/annonc/mdn423; Lemos C, 2009, BRIT J CANCER, V100, P1120, DOI 10.1038/sj.bjc.6604980; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti S, 2008, MOL CANCER THER, V7, P2280, DOI 10.1158/1535-7163.MCT-07-2250; Nakamura Y, 2005, CANCER RES, V65, P1541, DOI 10.1158/0008-5472.CAN-03-2417; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez-Soler R, 2004, J CLIN ONCOL, V22, P3238, DOI 10.1200/JCO.2004.11.057; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, BIOCHEM PHARMACOL, V77, P781, DOI 10.1016/j.bcp.2008.11.007; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Sugimoto Y, 2005, CANCER SCI, V96, P457, DOI 10.1111/j.1349-7006.2005.00081.x; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takara K, 2006, CURR PHARM DESIGN, V12, P273, DOI 10.2174/138161206775201965; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Usuda J, 2007, LUNG CANCER, V58, P296, DOI 10.1016/j.lungcan.2007.05.019; Vasile E, 2008, J THORAC ONCOL, V3, P912, DOI 10.1097/JTO.0b013e318180275e; Wang XD, 2007, DRUG METAB DISPOS, V35, P268, DOI 10.1124/dmd.106.011684; Wu JY, 2008, AM J RESP CRIT CARE, V178, P847, DOI 10.1164/rccm.200803-389OC; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang CH, 2006, CANCER-AM CANCER SOC, V107, P1873, DOI 10.1002/cncr.22220; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zhang SZ, 2005, DRUG METAB DISPOS, V33, P341, DOI 10.1124/dmd.104.002501; Zhang SZ, 2004, MOL PHARMACOL, V65, P1208, DOI 10.1124/mol.65.5.1208	43	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2011	6	6							e21428	10.1371/journal.pone.0021428	http://dx.doi.org/10.1371/journal.pone.0021428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TT	21437249	Green Published, Green Submitted, gold			2022-12-25	WOS:000292035400036
J	Chen, YT; Ross, DS; Chiu, R; Zhou, XK; Chen, YY; Lee, PS; Hoda, SA; Simpson, AJ; Old, LJ; Caballero, O; Neville, AM				Chen, Yao-Tseng; Ross, Dara S.; Chiu, Rita; Zhou, Xi K.; Chen, Yunn-Yi; Lee, Peishan; Hoda, Syed A.; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro			Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers	PLOS ONE			English	Article							T-CELL RESPONSES; NY-ESO-1 EXPRESSION; PROTEIN EXPRESSION; ANTIBODY; IMMUNOGENICITY; IDENTIFICATION; CARCINOMA; FAMILY; GENES; CT45	Background: Cancer/testis (CT) antigens are protein antigens normally expressed only in germ cells of testis, and yet are expressed in a proportion of a wide variety of human cancers. CT antigens can elicit spontaneous immune responses in cancer patients with CT-positive cancers, and CT antigen-based therapeutic cancer vaccine trials are ongoing for "CT-rich" tumors. Although some previous studies found breast cancer to be "CT-poor", our recent analysis identified increased CT mRNA transcripts in the ER-negative subset of breast cancer. Methodology/Principal Findings: In this study, we performed a comprehensive immunohistochemical study to investigate the protein expression of eight CT genes in 454 invasive ductal carcinomas, including 225 ER/PR/HER2-negative (triple-negative) carcinomas. We found significantly more frequent expression of all eight CT antigens in ER-negative cancers, and five of them-MAGEA, CT7, NY-ESO-1, CT10 and CT45, were expressed in 12-24% of ER-negative cancers, versus 2-6% of ER-positive cancers (p < 0.001 to 0.003). In comparison, GAGE, SAGE1 and NXF2 were only expressed in 3-5% of ER-negative and 0-2% of ER-positive cancers. ER-negative cancers were also more likely to simultaneously co-express multiple CT antigens, with 27% (34/125) of ER-negative, CT-positive tumors expressing three or more CT antigens. HER2 status had no consistent effect on CT expression, and triple-negative carcinomas showed similar frequencies of MAGEA and NY-ESO-1 expression as ER-negative/HER2-positive carcinomas. More frequent CT expression was also found in tumors with higher nuclear grade (p < 0.001 to p = 0.01) and larger in size (> 2 cm). Conclusions/Significance: CT antigens are preferentially expressed in hormone receptor-negative and high-grade breast cancer. Considering the limited treatment options for ER/PR/HER2 triple-negative breast cancer, the potential of CT-based immunotherapy should be explored.	[Chen, Yao-Tseng; Ross, Dara S.; Hoda, Syed A.] Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Chiu, Rita; Lee, Peishan; Simpson, Andrew J.; Old, Lloyd J.; Caballero, Otavia; Neville, A. Munro] Ludwig Inst Canc Res, New York Branch, New York, NY USA; [Zhou, Xi K.] Cornell Univ, Weill Med Coll, Dept Publ Hlth, New York, NY 10021 USA; [Chen, Yunn-Yi] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Cornell University; Ludwig Institute for Cancer Research; Cornell University; University of California System; University of California San Francisco	Chen, YT (corresponding author), Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.	ytchen@med.cornell.edu	Center, Univ of Texas-M D Anderson Cancer/AAE-8182-2019; Hung, Mien-Chie/ABD-5911-2021; Huang, Wei-Chien/D-1740-2012; Chang, Kwang-Yu/G-9161-2011; Huang, Wei-Chien/H-3126-2019; Lee, Jack/P-7331-2019; Zhang, Jun/G-4598-2010	Center, Univ of Texas-M D Anderson Cancer/0000-0001-5469-9214; Hung, Mien-Chie/0000-0003-4317-4740; Huang, Wei-Chien/0000-0001-6467-8716; Huang, Wei-Chien/0000-0001-6467-8716; Lee, Jack/0000-0002-4584-929X; CHOU, CHAO-KAI/0000-0001-5231-5264; Zhang, Jun/0000-0002-6601-9180; SHENG, WANG-HUEI/0000-0002-5605-7853; Su, Wu-Chou/0000-0003-2953-4105; CHEN, YEE-CHUN/0000-0002-1816-9010; Xia, Ningshao/0000-0003-0179-5266; TSAI, KEH-SUNG/0000-0001-8528-1566; WANG, JANN-TAY/0000-0002-0924-3469; Mizuguchi, Kenji/0000-0003-3021-7078; CHANG, SHAN-CHWEN/0000-0001-6505-4139	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Ludwig Institute for Cancer Research < http://www.licr.org/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandic D, 2006, CROAT MED J, V47, P32; Boon T, 1997, IMMUNOL TODAY, V18, P267, DOI 10.1016/S0167-5699(97)80020-5; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen YT, 2010, P NATL ACAD SCI USA, V107, P3093, DOI 10.1073/pnas.0915050107; Chen YT, 2009, INT J CANCER, V124, P2893, DOI 10.1002/ijc.24296; Chen YT, 1998, P NATL ACAD SCI USA, V95, P6919, DOI 10.1073/pnas.95.12.6919; CHEN YT, 1994, P NATL ACAD SCI USA, V91, P1004, DOI 10.1073/pnas.91.3.1004; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gure AO, 2000, INT J CANCER, V85, P726, DOI 10.1002/(SICI)1097-0215(20000301)85:5<726::AID-IJC21>3.0.CO;2-F; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kurashige T, 2001, CANCER RES, V61, P4671; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Rimoldi D, 2000, INT J CANCER, V86, P749; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stockert E, 1998, J EXP MED, V187, P1349, DOI 10.1084/jem.187.8.1349; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Zhuang Ran, 2006, Cancer Immun, V6, P7	29	463	478	15	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2011	6	3							e17876	10.1371/journal.pone.0017876	http://dx.doi.org/10.1371/journal.pone.0017876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	737CD	21437249	Green Submitted, Green Published, gold			2022-12-25	WOS:000288545100041
